data_1bsh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bsh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 1.6 t -152.75 158.45 42.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.743 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.608 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 2.2 p90 -159.58 175.09 13.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 2.3 t-160 -99.41 124.79 44.85 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 108.742 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.673 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -114.7 159.91 19.98 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.709 178.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.464 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.26 90.17 1.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.993 -1.067 . . . . 0.0 110.204 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 16' ' ' PHE . 1.8 p -100.13 132.15 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.077 -1.014 . . . . 0.0 109.25 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 m -152.76 171.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -141.18 72.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.654 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 61.82 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 55.22 58.23 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.556 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -147.45 154.24 40.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.79 76.91 1.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.458 ' SD ' HG22 ' A' ' 62' ' ' ILE . 5.7 mmt -79.72 -63.65 1.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 109.888 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.673 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 18.6 t80 -135.24 121.86 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.445 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -152.84 103.17 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.316 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' O ' HG11 ' A' ' 20' ' ' VAL . . . 158.91 -164.21 33.59 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.5 ' C ' HG11 ' A' ' 20' ' ' VAL . 9.1 mt -56.6 155.88 6.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.057 -1.261 . . . . 0.0 108.709 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.665 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -168.44 116.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.021 -1.049 . . . . 0.0 109.99 -177.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 2.6 mt-10 -66.5 -47.53 72.71 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 108.761 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 17.6 tttt -172.95 144.44 1.28 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.124 -0.985 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 44.3 pt -98.26 -145.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.535 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.12 127.27 0.36 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 109.481 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 t -116.53 133.27 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.411 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 31.0 m -129.09 91.84 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.42 168.22 21.07 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.6 -50.98 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 109.488 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.28 99.51 7.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.386 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.99 140.95 4.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -152.13 26.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.77 150.97 41.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.067 -1.021 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -99.54 -114.92 3.63 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.608 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 17.9 mm -149.58 152.64 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.098 -1.237 . . . . 0.0 109.327 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.544 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -151.58 171.82 6.11 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.4 Cg_endo -73.23 78.24 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.028 1.819 . . . . 0.0 110.2 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.32 36.1 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.568 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 11.4 t-160 -87.11 28.99 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -1.224 . . . . 0.0 109.831 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 71' ' ' VAL . . . 58.99 158.32 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.065 -1.022 . . . . 0.0 109.554 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.8 78.7 3.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.777 2.318 . . . . 0.0 110.682 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.553 HD11 ' CE1' ' A' ' 38' ' ' HIS . 25.3 mt -100.35 173.43 6.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -171.16 57.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' HD22 ' A' ' 69' ' ' LEU . 71.4 p -114.62 -136.9 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.25 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.39 164.21 11.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.928 -1.107 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 46' ' ' LYS . 3.0 mt -109.1 9.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.791 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER 55.54 158.33 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.672 . . . . 0.0 110.176 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.69 -175.66 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.733 2.289 . . . . 0.0 110.287 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 116.06 -161.05 13.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.453 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 15.9 ptm -102.91 179.57 4.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 109.248 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -150.85 138.87 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.032 -1.043 . . . . 0.0 110.646 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 52' ' ' ILE . 66.3 ttt180 -119.67 161.32 20.89 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 36.1 mt -157.23 167.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.72 -1.238 . . . . 0.0 110.876 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.453 ' N ' HG23 ' A' ' 52' ' ' ILE . 24.5 t -142.64 107.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HB3' ' HA3' ' A' ' 57' ' ' GLY . 15.6 tttm -68.67 149.89 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 110.326 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -54.27 -52.58 60.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 8.69 33.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 54' ' ' LYS . . . -108.38 178.01 21.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.42 ' O ' ' HB3' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -84.82 -77.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.586 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 58' ' ' HIS . 17.0 pt-20 -179.59 139.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 109.84 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -138.21 156.8 47.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 6.1 p90 -128.65 125.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.493 ' C ' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -100.46 -146.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.228 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -175.51 132.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.034 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 63' ' ' TYR . 1.1 mt -139.07 -171.82 3.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -139.79 -64.78 0.48 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.79 136.54 8.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.34 165.62 33.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 79' ' ' LEU . 1.1 pp -101.65 -176.24 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -1.197 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.52 ' CB ' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -148.62 169.38 20.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 110.364 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.72 111.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 39' ' ' ALA . 6.2 p -99.53 144.6 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.441 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.534 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.48 178.34 1.04 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 36.3 Cg_endo -79.05 81.55 2.77 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.501 2.134 . . . . 0.0 110.922 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.15 -21.72 5.46 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 4.3 p30 -159.39 135.71 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.239 . . . . 0.0 109.864 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' N ' ' A' ' 77' ' ' THR . 9.6 p -99.18 168.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 109.271 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.508 ' N ' HG23 ' A' ' 76' ' ' VAL . 99.3 m -164.12 137.67 5.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.257 -0.902 . . . . 0.0 109.063 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.52 HG13 ' CB ' ' A' ' 69' ' ' LEU . 4.6 m -140.83 165.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.57 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.5 mt -131.6 149.49 52.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.866 . . . . 0.0 109.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.25 176.68 10.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 109.52 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.94 -56.58 2.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.5 m -105.08 123.13 47.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' CE ' ' A' ' 15' ' ' MET . . . -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.579 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 13.7 mt -101.61 150.7 5.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.213 -0.93 . . . . 0.0 109.461 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 87' ' ' GLN . 8.3 ttm180 -119.74 155.85 31.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.479 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 87' ' ' GLN . . . -44.45 93.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 2.4 mt-30 162.32 -72.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.083 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 90' ' ' ASP . 1.3 p30 40.71 50.63 2.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 89' ' ' LEU . 86.0 mt 43.17 -93.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 88' ' ' ASP . 8.0 p-10 -49.48 159.64 0.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 109.329 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.526 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 27.6 mt-10 -141.26 -56.68 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.65 -14.34 54.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -76.58 -10.56 59.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' HB1' ' A' ' 97' ' ' ALA . . . -89.01 -21.71 23.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.961 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -27.67 68.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.44 -0.787 . . . . 0.0 109.376 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.72 -15.2 61.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . . . -68.04 -45.66 73.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -61.2 -17.03 51.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -89.9 -40.17 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -75.73 -12.25 60.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.942 . . . . 0.0 109.292 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.434 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -86.89 -15.36 39.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.132 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -46.67 67.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.365 -0.834 . . . . 0.0 109.407 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -49.51 -23.26 1.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' TYR . 54.1 m80 -86.7 -36.89 18.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 114' ' ' TYR . 17.5 mt -79.04 -6.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 p -101.06 -16.54 17.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.523 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.36 130.73 37.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.711 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.09 131.47 51.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 21.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.779 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.98 -176.63 33.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.421 ' OD1' ' CG1' ' A' ' 112' ' ' VAL . 1.3 p30 -81.12 -29.37 34.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.144 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.3 m -119.37 22.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.81 -99.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -0.817 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.47 ' HB2' ' HA ' ' A' ' 105' ' ' ILE . 17.6 p90 -65.3 -18.9 65.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.021 -1.049 . . . . 0.0 108.214 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.08 80.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -77.15 -17.5 58.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.341 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.27 -17.85 53.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.2 t -62.01 -28.81 69.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -75.87 -27.89 57.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -85.52 -8.22 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.923 . . . . 0.0 109.494 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -90.41 -57.93 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -22.29 65.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -87.07 -19.53 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.85 -34.61 33.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.478 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 125' ' ' ILE . 2.8 mp -75.89 -6.09 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.378 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.46 76.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.572 ' HG2' ' CG ' ' A' ' 63' ' ' TYR . 5.1 tm0? -81.39 -14.29 57.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.524 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 34.6 tp -78.73 -25.02 44.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.0 109.69 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -45.71 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.939 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.58 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 35.7 m -70.41 -32.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 91' ' ' GLU . 2.2 tt -78.24 -25.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.094 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 128' ' ' LEU . 1.4 mm-40 -74.66 -22.13 59.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.104 -0.997 . . . . 0.0 110.243 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.571 HD13 ' CZ ' ' A' ' 61' ' ' PHE . 1.4 pp -90.54 0.45 57.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.995 -1.066 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.5 t -89.07 4.6 47.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.665 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -30.08 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.597 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 11.56 23.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.16 -47.27 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.452 -179.874 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.477 ' HE3' ' O ' ' A' ' 3' ' ' THR . 2.1 ttp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.326 0.584 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.477 ' O ' ' HE3' ' A' ' 2' ' ' MET . 65.9 p -50.94 164.74 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 109.604 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.588 ' CE2' HG21 ' A' ' 34' ' ' ILE . 1.3 p90 -142.22 -144.86 0.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.714 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 12.7 t-80 -129.62 126.71 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.79 -1.194 . . . . 0.0 111.221 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.62 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -99.75 130.9 46.01 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.542 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -139.49 75.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 109.746 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' HA ' HG11 ' A' ' 78' ' ' VAL . 2.4 p -104.01 111.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.57 -178.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.493 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -158.01 111.95 2.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.762 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.71 -89.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.735 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -134.71 62.23 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.66 142.64 12.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.478 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 14' ' ' GLN . 6.1 pt20 -106.55 107.68 18.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.452 ' HE3' ' HG2' ' A' ' 85' ' ' ARG . 6.6 mtt -79.66 -60.68 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.62 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -130.84 111.07 11.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.923 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.452 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.5 p -136.97 92.19 2.7 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.69 -161.27 32.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.2 mt -76.82 159.13 30.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.035 -1.274 . . . . 0.0 109.799 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -157.15 162.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.227 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -122.29 -37.52 2.8 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.448 ' O ' HG21 ' A' ' 52' ' ' ILE . 7.9 ttpp -160.77 110.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.98 . . . . 0.0 110.661 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.2 152.11 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 25' ' ' VAL . 1.9 tt0 -134.45 145.32 48.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.075 . . . . 0.0 109.964 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.492 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 3.1 t -131.95 125.46 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.434 -0.791 . . . . 0.0 108.96 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 88.8 m -116.06 97.86 6.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.353 -0.842 . . . . 0.0 109.395 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -103.24 -100.02 2.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 m -128.83 -81.0 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.53 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.78 166.29 3.7 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -156.54 32.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.242 -1.152 . . . . 0.0 109.597 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -102.7 150.08 23.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.529 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.45 -112.42 3.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.588 HG21 ' CE2' ' A' ' 4' ' ' TYR . 19.5 mm -154.32 147.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -1.141 . . . . 0.0 109.537 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -157.13 -172.77 0.34 Allowed Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 36.3 Cg_endo -81.11 31.15 0.51 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.0 1.8 . . . . 0.0 110.71 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.07 26.48 0.2 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.526 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 57.1 t60 -70.12 -4.85 23.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -1.084 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 38' ' ' HIS . . . 77.05 168.24 0.12 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 36.1 Cg_endo -78.1 74.19 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.626 2.218 . . . . 0.0 110.524 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.428 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.52 142.65 27.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.307 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HG ' ' C ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -139.84 32.54 2.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 68' ' ' ILE . 5.3 t -100.67 -156.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.178 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -108.01 -177.35 3.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.032 -1.042 . . . . 0.0 109.663 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 1.3 mp -126.48 177.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -108.08 167.13 9.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.394 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.479 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 35.4 Cg_endo -78.16 140.75 17.95 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.619 2.213 . . . . 0.0 110.516 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 168.43 -162.79 36.58 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.464 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.1 ptm -100.66 -170.65 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 109.211 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 50' ' ' ILE . 19.1 mt -158.09 140.63 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.987 . . . . 0.0 110.296 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' N ' HG21 ' A' ' 50' ' ' ILE . 2.1 ttp180 -130.49 119.19 22.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 23' ' ' ILE . 18.8 mt -123.46 170.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.116 . . . . 0.0 110.965 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.6 t -134.57 101.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -61.17 119.9 9.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 0.0 109.633 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' LYS . 31.1 mt-30 43.22 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -152.19 66.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 109.558 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.38 -128.01 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -69.28 -165.74 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 51.3 mp0 -129.95 -178.94 4.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 59.8 mm-40 -129.51 137.29 50.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -111.69 98.41 7.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 108.834 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 63' ' ' TYR . 4.0 mt -111.04 161.57 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 109.998 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.488 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 1.2 t80 -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -165.83 -171.09 1.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.829 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.451 ' N ' ' HB ' ' A' ' 82' ' ' THR . 3.1 t -160.48 139.76 10.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.782 . . . . 0.0 109.27 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' SER . . . 63.08 125.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.98 159.81 11.23 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 15.0 mt -106.65 123.7 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -101.61 127.88 48.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.554 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 4.0 pt-20 -131.08 146.11 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.502 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 12.1 p -102.27 163.92 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.052 -1.03 . . . . 0.0 109.928 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.441 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 2.4 mt-30 -141.32 172.58 5.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 0.0 109.338 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.5 79.91 3.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.577 2.185 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.68 -12.55 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.495 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 4.8 p30 -149.28 172.4 14.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -1.181 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG21 ' N ' ' A' ' 77' ' ' THR . 2.8 p -145.66 151.45 14.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.482 ' N ' HG21 ' A' ' 76' ' ' VAL . 68.3 p -136.58 172.92 12.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -178.97 127.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 109.151 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -104.91 134.66 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.885 . . . . 0.0 109.265 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.437 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -129.6 -179.91 5.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.0 109.625 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.55 -29.17 5.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.343 -0.848 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 51.9 m -103.12 119.97 39.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.72 98.73 3.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.488 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 96.3 mt -109.71 -27.87 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.56 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 84' ' ' ILE . 22.1 mtm180 61.32 126.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.475 ' CA ' ' CG2' ' A' ' 130' ' ' VAL . . . -44.3 -29.7 1.76 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 88' ' ' ASP . 67.3 mt-30 -71.25 -64.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -1.122 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASP . 14.0 t0 44.4 41.32 4.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.58 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 88' ' ' ASP . 2.1 t70 -115.75 99.87 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' CB ' HG23 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -96.39 0.06 50.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.51 -14.17 62.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.385 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -82.88 -2.79 55.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.39 -23.62 21.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 0.0 108.856 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -29.44 63.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.45 -0.781 . . . . 0.0 109.235 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.13 -57.87 9.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.45 69.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -55.16 -41.08 71.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.427 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -60.68 -51.83 67.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -76.58 -0.36 22.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.701 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -85.64 -30.7 23.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.127 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 4.7 tp10 -80.55 -26.03 38.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -82.15 -13.61 56.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.97 -31.51 20.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.495 HG22 HD11 ' A' ' 105' ' ' ILE . 37.3 mt -77.85 -1.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.317 -0.864 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.3 m -105.83 78.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.29 167.9 2.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.3 m 64.85 -152.22 0.28 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 108' ' ' SER . 12.0 t-80 174.34 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.257 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.94 169.61 40.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.85 -59.42 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.2 16.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.96 -96.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.502 ' C ' ' CD1' ' A' ' 114' ' ' TYR . 13.7 p90 -74.14 -15.77 61.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 108.53 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.11 -19.83 65.69 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.62 -14.71 62.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.491 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.0 -6.67 57.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.502 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.26 -16.61 42.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.95 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -5.03 55.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.629 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.25 -52.28 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.35 94.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.542 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -61.08 -32.46 72.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.887 . . . . 0.0 109.633 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.24 -8.58 50.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 109.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 tp -88.89 5.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 109.354 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.35 -13.27 55.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.445 ' O ' HG21 ' A' ' 130' ' ' VAL . 24.2 pt20 -89.69 -13.39 37.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -89.63 -29.5 18.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -73.13 -19.73 61.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.585 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 10.2 m -90.12 -27.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.727 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 128' ' ' LEU . 22.1 pt -75.57 -16.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.35 -47.74 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -45.17 95.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 130' ' ' VAL . 12.3 p -49.17 -26.54 2.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -57.81 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -110.07 50.42 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.23 -48.66 1.96 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.371 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.393 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -174.01 156.16 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.775 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.584 ' OH ' ' CG2' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -143.55 -142.28 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.205 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.531 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 17.5 t-80 -134.73 131.23 37.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.852 -1.155 . . . . 0.0 110.993 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.646 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -99.11 131.84 44.85 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.171 -0.956 . . . . 0.0 108.714 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.489 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -142.42 75.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.85 -1.156 . . . . 0.0 109.68 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 78' ' ' VAL . 1.4 p -105.11 117.14 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.34 164.24 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -128.8 -159.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.363 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.93 -74.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 109.388 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -136.95 53.69 1.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.77 109.92 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -65.2 154.64 37.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.302 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.516 ' CE ' ' HB3' ' A' ' 83' ' ' ALA . 3.8 mmt -118.84 -58.64 1.94 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.753 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.646 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.56 111.2 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.957 . . . . 0.0 109.677 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 95.0 p -131.93 78.02 1.79 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 20' ' ' VAL . . . -174.7 167.08 39.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.4 mt -50.73 166.67 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.205 -1.174 . . . . 0.0 109.278 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.608 ' CG2' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -167.09 169.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -144.94 -63.63 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 109.517 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.525 ' O ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -90.43 103.45 16.13 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 0.0 108.657 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.608 ' CG1' ' CG2' ' A' ' 20' ' ' VAL . 3.1 mp -115.48 156.46 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.0 109.142 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -151.76 131.38 13.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.117 . . . . 0.0 109.741 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 t -145.57 127.15 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.332 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -148.34 127.73 13.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -137.49 -92.46 0.29 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -138.3 -40.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.0 109.445 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.05 -91.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.87 -172.5 5.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -164.58 41.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.134 -1.215 . . . . 0.0 109.777 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.95 165.2 26.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.879 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.84 174.39 26.62 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 27.0 mm -99.21 160.96 3.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.636 -1.508 . . . . 0.0 109.515 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.619 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -162.59 171.21 6.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.4 Cg_endo -70.13 83.96 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.37 1.38 . . . . 0.0 109.618 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.34 14.36 0.83 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 43.1 t60 -53.88 157.85 2.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.84 -1.388 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -58.46 173.87 0.39 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.332 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.83 63.6 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.614 2.209 . . . . 0.0 110.602 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' ' NE2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -59.42 160.61 6.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.882 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.524 ' O ' ' CA ' ' A' ' 70' ' ' GLU . 85.5 mt -115.97 -92.08 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.983 . . . . 0.0 110.649 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 7.1 p -122.66 27.2 7.91 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 121.596 -0.69 . . . . 0.0 110.242 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LEU . . . -113.64 119.35 37.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.868 -1.145 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 5.2 tt -112.4 176.49 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.417 -0.802 . . . . 0.0 109.174 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -120.4 130.98 24.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.973 -1.08 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 36.4 Cg_endo -79.34 -164.51 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.547 2.165 . . . . 0.0 110.384 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 90.32 -133.77 11.98 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.489 ' N ' ' HB3' ' A' ' 126' ' ' ALA . 5.1 ppp? -114.57 174.8 5.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -1.085 . . . . 0.0 109.41 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -149.99 116.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.368 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -104.94 123.61 48.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.815 . . . . 0.0 108.959 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.562 HG22 ' CG2' ' A' ' 23' ' ' ILE . 2.6 mt -129.98 -176.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.001 -1.062 . . . . 0.0 109.916 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' LYS . 6.8 t -158.14 109.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -57.57 114.01 2.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.578 -0.701 . . . . 0.0 110.398 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.466 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 40.59 61.93 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.771 . . . . 0.0 110.151 179.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 43.08 44.8 4.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.779 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.57 -122.29 2.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -52.05 146.98 7.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.306 -1.114 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.61 123.04 47.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.099 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -128.04 121.16 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.339 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.586 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.0 p90 -113.28 147.83 36.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.222 -0.923 . . . . 0.0 109.908 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.481 ' CG2' ' SD ' ' A' ' 15' ' ' MET . 1.7 mt -120.07 -158.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.424 -0.797 . . . . 0.0 109.139 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 7.6 t80 -172.44 133.32 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.447 HD21 ' CB ' ' A' ' 80' ' ' ALA . 2.1 mp -140.43 -174.54 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -128.12 5.16 5.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.49 160.04 8.32 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 45' ' ' ILE . . . 162.16 -175.5 38.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' THR . 1.4 pt -103.16 137.8 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -1.12 . . . . 0.0 109.258 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.529 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' CA ' ' O ' ' A' ' 42' ' ' LEU . 15.2 pt-20 -126.59 139.41 53.21 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 39' ' ' ALA . 9.2 p -100.51 142.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.461 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.4 mm100 -124.74 158.75 61.27 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 109.097 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -76.95 86.47 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.603 2.202 . . . . 0.0 110.477 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.64 2.28 10.61 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.519 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 175.7 175.68 0.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -1.178 . . . . 0.0 109.213 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 5' ' ' HIS . 2.3 p -150.63 148.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.167 -0.958 . . . . 0.0 109.132 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.429 HG23 ' HB3' ' A' ' 7' ' ' ASP . 7.5 p -140.86 142.86 34.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 109.573 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.52 ' HB ' ' CD1' ' A' ' 45' ' ' ILE . 3.0 m -148.36 138.28 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.425 ' CD2' ' C ' ' A' ' 79' ' ' LEU . 1.2 tt -114.49 135.74 53.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.447 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -122.2 179.42 4.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -115.39 -11.28 11.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.494 HG21 ' N ' ' A' ' 83' ' ' ALA . 9.3 m -127.53 161.4 28.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.516 ' HB3' ' CE ' ' A' ' 15' ' ' MET . . . -167.57 122.32 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.586 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 48.3 mt -117.37 -45.22 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.288 -0.882 . . . . 0.0 109.267 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.485 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 3.0 ttt180 74.6 147.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.436 -0.79 . . . . 0.0 109.646 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.443 ' HA2' HG22 ' A' ' 130' ' ' VAL . . . -58.12 -21.87 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ASP . 57.8 mt-30 -81.45 -63.67 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.448 ' HB3' ' CG2' ' A' ' 84' ' ' ILE . 2.8 p30 40.35 30.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.62 -0.675 . . . . 0.0 109.867 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ASP . 1.2 mp 50.48 -179.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 91' ' ' GLU . 4.9 m-20 43.96 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.437 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 1.3 mt-10 172.97 -30.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.488 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 -17.4 48.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.85 . . . . 0.0 109.561 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 4.5 29.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.673 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' O ' ' CD1' ' A' ' 128' ' ' LEU . . . -90.84 -30.35 17.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.459 ' HA ' HD12 ' A' ' 128' ' ' LEU . 4.8 mtt -73.32 -5.06 37.22 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.361 -0.837 . . . . 0.0 109.596 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.06 1.61 56.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.636 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . . . -89.34 -42.51 11.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.653 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -19.55 63.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -89.89 -26.99 20.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 9.1 pttt -89.3 -11.3 43.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.621 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 105' ' ' ILE . . . -90.47 -58.49 2.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.613 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.53 63.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.715 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -52.83 -38.34 61.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 109.889 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -88.38 -26.33 22.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.603 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 107' ' ' SER . 12.0 mt -88.24 22.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 109.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.2 m -54.99 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER 67.37 118.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.0 t -137.74 118.98 14.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 109' ' ' HIS . 52.2 t-80 -113.28 56.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 111' ' ' ASP . . . -138.48 125.7 3.25 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 68.8 m-20 -44.88 -80.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -1.201 . . . . 0.0 109.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 113' ' ' ASP . 20.6 m -117.53 -10.0 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.414 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.5 OUTLIER -48.02 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.335 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -70.94 -14.88 62.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.043 -1.036 . . . . 0.0 108.26 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -66.26 -23.36 66.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.569 -0.707 . . . . 0.0 109.264 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.42 -54.17 13.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.327 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.9 -20.21 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.19 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -79.01 -44.24 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.16 68.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.381 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.54 -20.7 64.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 125' ' ' ILE . 7.6 mt -90.0 -24.0 21.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.416 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -59.75 -16.77 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.586 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.3 96.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -70.66 -5.97 33.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -85.79 -13.16 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.149 -0.97 . . . . 0.0 109.289 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HB3' ' N ' ' A' ' 49' ' ' MET . . . -87.36 -24.56 24.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.293 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -83.55 -15.48 49.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.414 -0.804 . . . . 0.0 109.489 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 95' ' ' MET . 0.7 OUTLIER -80.19 -22.74 41.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.601 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.449 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 1.9 ttp180 -85.24 -35.31 21.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.785 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.586 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 18.3 m -76.34 -28.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.459 ' O ' ' OG1' ' A' ' 134' ' ' THR . 7.1 tt -76.9 -38.45 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 109.267 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.96 -23.86 48.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.07 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.579 HD11 ' CE2' ' A' ' 61' ' ' PHE . 41.4 mt -76.4 -37.63 56.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.25 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 72.0 p -59.29 -16.75 23.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.775 . . . . 0.0 109.65 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -76.18 -44.08 39.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -14.12 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.36 -80.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.491 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -133.88 174.58 10.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.58 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 1.1 p90 -148.39 -136.03 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.4 OUTLIER -151.05 138.37 19.4 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.817 -1.177 . . . . 0.0 110.423 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.608 ' HB2' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -102.18 148.06 25.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.503 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 1.1 t0 -144.92 72.02 1.32 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.017 -1.052 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.52 ' HB ' ' CG1' ' A' ' 78' ' ' VAL . 2.9 p -106.81 138.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.352 -0.842 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.452 ' N ' HG21 ' A' ' 8' ' ' VAL . 32.8 m -145.88 173.26 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.687 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.9 t -170.25 113.76 0.47 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.056 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 65.96 26.48 10.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.075 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.1 mm-40 63.46 24.09 13.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.517 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.4 tt0 -78.07 -22.49 48.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.144 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 6.3 mt-30 63.46 100.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.522 ' HE3' ' CB ' ' A' ' 83' ' ' ALA . 16.7 mmm -101.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -135.67 111.66 9.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.623 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 17' ' ' SER . 27.6 p -135.32 77.69 1.69 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.47 179.98 48.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.0 mt -60.26 161.91 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -1.193 . . . . 0.0 109.492 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.582 HG13 ' CZ ' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -157.75 159.3 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.81 . . . . 0.0 108.829 -179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.468 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.1 -52.75 2.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -0.937 . . . . 0.0 110.138 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -141.02 108.12 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.769 -1.207 . . . . 0.0 111.28 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -103.13 155.91 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.483 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 2.0 tm0? -146.76 115.61 6.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.416 -1.427 . . . . 0.0 110.724 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.535 ' CG2' ' HG2' ' A' ' 46' ' ' LYS . 3.3 t -103.92 133.62 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.233 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.464 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 54.7 m -125.01 102.72 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.549 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -123.07 -110.06 1.98 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 t -132.37 -77.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -1.16 . . . . 0.0 109.63 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.81 -24.75 67.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.74 151.37 18.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -142.81 11.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -1.076 . . . . 0.0 109.315 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.4 mt -116.64 156.45 27.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -100.03 -114.59 3.65 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.58 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 15.9 mm -154.98 143.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -1.049 . . . . 0.0 109.245 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -154.35 -172.13 0.31 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -78.94 8.86 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.805 1.67 . . . . 0.0 110.423 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.91 11.42 3.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 84.6 t60 -53.26 156.22 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.629 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.48 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -70.08 173.22 4.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.668 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -77.75 76.05 4.48 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.758 2.305 . . . . 0.0 110.386 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.3 140.29 34.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.607 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -155.51 29.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 109.563 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.3 p -121.76 -139.54 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.219 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' A' ' 45' ' ' ILE . . . -99.79 119.97 38.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -160.74 -166.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.757 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.667 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 13.3 mttt 71.5 46.41 0.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.8 Cg_endo -80.32 152.67 20.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 94.01 -152.71 20.84 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.696 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.527 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 7.2 ptm -99.56 -171.67 2.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -1.024 . . . . 0.0 109.503 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 50' ' ' ILE . 40.9 mt -150.0 156.18 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.44 ' NH1' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 4.6 mt -121.26 162.8 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 110.476 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 74.9 t -133.38 118.95 33.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 154.71 -98.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 56' ' ' HIS . 1.9 tt0 37.75 47.44 0.84 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.6 t-160 81.8 -68.89 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.606 -0.684 . . . . 0.0 109.494 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -161.54 77.94 0.17 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.458 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 168.19 -160.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.149 . . . . 0.0 109.489 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.19 158.42 43.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.288 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -147.23 115.96 6.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.683 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.612 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 14.1 p90 -103.24 140.55 37.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.449 HG22 ' HB3' ' A' ' 15' ' ' MET . 0.7 OUTLIER -115.58 -156.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.945 . . . . 0.0 109.566 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 49' ' ' MET . 8.9 t80 -177.46 111.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.195 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 50' ' ' ILE . 1.6 mp -134.85 -179.91 5.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 109.336 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -71.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.82 62.83 0.63 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.37 -179.62 50.63 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 10.0 mm -101.45 118.37 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.515 ' HB2' ' CG1' ' A' ' 45' ' ' ILE . 4.1 mm? -99.47 157.69 16.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.36 133.01 11.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 108.993 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' O ' HG11 ' A' ' 71' ' ' VAL . 12.7 p -99.69 136.26 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.655 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.479 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -119.03 173.59 3.34 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.38 -0.825 . . . . 0.0 109.456 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.2 Cg_endo -78.23 73.3 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.621 2.214 . . . . 0.0 110.515 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.6 3.67 32.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.418 ' O ' HG21 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -151.67 -175.3 5.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' HD13 ' A' ' 6' ' ' LEU . 4.5 t -158.64 146.78 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.263 -0.898 . . . . 0.0 109.034 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.435 HG21 ' HB3' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -138.22 157.5 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -168.46 135.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.83 109.02 12.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.75 179.34 4.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.623 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -105.17 -42.76 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.43 HG22 HD13 ' A' ' 84' ' ' ILE . 14.8 m -109.42 100.4 9.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.522 ' CB ' ' HE3' ' A' ' 15' ' ' MET . . . -122.38 94.33 4.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.189 -0.945 . . . . 0.0 109.379 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' HA ' ' OD2' ' A' ' 88' ' ' ASP . 3.3 mp -100.1 84.54 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.518 ' N ' ' OD2' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -66.36 133.7 51.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.62 -121.58 11.0 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.406 ' CD ' ' OE1' ' A' ' 91' ' ' GLU . 11.6 pt20 -124.32 53.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -1.106 . . . . 0.0 109.565 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 85' ' ' ARG . 1.6 p30 -63.09 -13.37 35.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.4 mt -114.57 -90.89 0.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 m-20 -117.1 -179.9 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.422 ' CB ' HD13 ' A' ' 131' ' ' ILE . 4.9 pt-20 -145.77 -43.54 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.863 . . . . 0.0 109.215 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.27 -18.46 39.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -0.828 . . . . 0.0 109.462 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.3 3.62 51.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -13.43 34.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.196 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.34 -18.04 34.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.374 -0.829 . . . . 0.0 109.364 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.8 -14.95 57.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.51 -5.71 58.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 109.598 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HG2' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -89.85 -24.23 21.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -89.21 -21.44 23.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 109.401 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.32 -31.93 29.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . . . -90.36 -39.66 12.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.0 -11.64 59.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.331 -0.856 . . . . 0.0 109.535 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 99' ' ' ARG . 15.5 tt0 -90.28 -37.41 14.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.6 -30.63 46.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 107' ' ' SER . 31.3 mt -89.18 4.3 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.649 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 107' ' ' SER . 1.3 t -45.65 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER 77.25 121.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.429 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.1 141.29 18.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -111.28 -173.4 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.49 117.6 0.75 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -48.97 -69.91 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 19.9 m -121.03 12.17 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 18.4 t0 -66.22 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -0.868 . . . . 0.0 109.211 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 32.1 t80 -75.72 -5.5 45.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.54 -7.91 59.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -78.31 -29.43 47.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.603 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -78.24 -6.39 54.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.096 -1.002 . . . . 0.0 109.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.76 -8.8 59.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.577 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.73 -34.87 17.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 123' ' ' LYS . 8.7 pt-20 -75.3 -27.42 59.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -79.29 -41.86 27.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.433 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.74 -11.67 59.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.246 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.56 -32.7 65.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.95 -26.99 54.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 125' ' ' ILE . 3.0 mp -81.84 2.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.91 . . . . 0.0 109.479 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.58 -26.68 60.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.471 ' OE1' ' CE2' ' A' ' 63' ' ' TYR . 12.6 mt-30 -74.56 -5.11 40.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 128' ' ' LEU . 6.7 tt -79.78 -19.19 49.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -90.06 -49.5 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.612 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 5.0 m -66.85 -38.64 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 109.588 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.516 HD11 HG23 ' A' ' 131' ' ' ILE . 2.6 tt -54.97 -39.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.539 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -43.59 -38.3 2.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.468 HD23 ' CD2' ' A' ' 61' ' ' PHE . 9.0 mp -62.75 -51.55 66.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.148 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.9 p -50.84 -31.59 17.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.613 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 19.5 mttt -62.3 -42.9 99.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.54 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 20.6 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.455 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.18 -55.14 5.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.498 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER 53.94 117.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.75 0.786 . . . . 0.0 110.47 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 3.3 p90 -130.69 -153.41 0.56 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.186 -0.946 . . . . 0.0 108.641 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.476 ' ND1' ' N ' ' A' ' 6' ' ' LEU . 21.6 t-80 -129.53 144.56 51.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.943 -1.098 . . . . 0.0 109.852 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.601 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -138.21 164.19 29.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.225 -0.922 . . . . 0.0 108.958 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.57 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 8.3 t0 -160.02 94.69 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.98 -1.075 . . . . 0.0 109.964 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.493 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 5.0 m -104.34 147.3 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 108.958 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.493 ' CG2' ' C ' ' A' ' 8' ' ' VAL . 1.7 t -154.74 177.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.2 p -138.62 -160.89 1.11 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.27 -51.27 8.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.53 66.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.708 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -147.01 139.38 24.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.18 132.07 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.49 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.463 ' CE ' ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -127.45 -72.88 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.647 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 47.9 t80 -151.41 112.83 4.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.26 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.404 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 56.9 p -141.74 92.84 2.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.44 -153.1 21.26 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 21.4 mt -67.12 177.07 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.058 -1.26 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.647 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 177.17 159.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.13 -0.981 . . . . 0.0 108.658 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.512 ' HG3' ' CG2' ' A' ' 3' ' ' THR . 1.0 OUTLIER -129.75 -71.36 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.03 113.93 26.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.116 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.561 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -125.45 141.01 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.474 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 2.2 pt20 -145.54 129.66 17.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 109.885 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.9 128.4 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -111.73 116.56 30.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.51 -144.07 3.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLU . 89.3 p -77.39 122.65 25.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.121 . . . . 0.0 109.592 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 28' ' ' SER . 1.4 tp10 60.07 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.687 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.14 169.07 38.91 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -171.38 46.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -1.138 . . . . 0.0 109.319 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.402 HD12 ' OH ' ' A' ' 35' ' ' TYR . 8.8 mt -150.21 146.82 27.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.68 -99.49 2.24 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.611 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 20.5 mm -156.53 151.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.514 -0.992 . . . . 0.0 109.241 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -148.47 173.9 3.84 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.8 Cg_endo -73.26 81.77 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.908 1.739 . . . . 0.0 110.01 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.24 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -48.88 164.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.243 . . . . 0.0 109.413 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 71' ' ' VAL . . . -78.28 170.62 15.38 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.332 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.2 Cg_endo -77.19 73.93 5.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.581 2.188 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 41' ' ' LEU . 4.0 mm? -78.37 161.56 27.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 2.8 pp -169.08 36.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 108.972 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.1 -95.37 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.565 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.452 ' N ' ' OG1' ' A' ' 43' ' ' THR . . . -137.44 162.49 33.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.922 -1.111 . . . . 0.0 109.869 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.465 ' HB ' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -100.95 139.87 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -75.01 139.18 72.83 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.725 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.6 -162.04 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.716 2.277 . . . . 0.0 110.365 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.06 -141.12 15.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.407 ' HE2' HG11 ' A' ' 130' ' ' VAL . 12.8 ptm -108.78 174.41 5.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -1.144 . . . . 0.0 109.012 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -154.67 119.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.934 -1.104 . . . . 0.0 110.282 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.476 ' N ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.52 150.92 21.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.574 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 5.4 tt -143.84 167.9 12.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.617 -1.302 . . . . 0.0 111.384 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 53' ' ' VAL . 38.8 t -134.56 90.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -53.81 121.76 8.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.325 -0.859 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.532 ' HA ' ' CG2' ' A' ' 3' ' ' THR . 1.3 tt0 45.38 -158.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.171 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -77.67 103.78 7.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.944 . . . . 0.0 109.115 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 103.3 178.77 26.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 t-160 62.45 129.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -1.229 . . . . 0.0 109.448 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.2 mp0 -134.31 134.14 41.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.454 ' CB ' HG23 ' A' ' 52' ' ' ILE . 3.1 tt0 -104.85 170.48 7.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 0.0 109.596 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.619 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -133.07 122.86 24.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.169 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.5 mp -137.89 169.22 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.078 -1.013 . . . . 0.0 109.863 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -158.21 144.07 17.05 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.98 -164.26 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 110.035 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 33.6 p -105.1 -144.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.435 -0.791 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 80' ' ' ALA . . . -96.02 -135.19 8.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 128.44 -167.32 20.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 78' ' ' VAL . 19.6 tt -105.04 125.1 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 109.062 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.481 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 2.4 pp -113.51 167.91 10.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.244 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 0.8 OUTLIER -161.79 123.63 2.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 9.9 p -99.95 145.01 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.984 -1.072 . . . . 0.0 110.418 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.519 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.18 175.58 2.49 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -76.96 75.8 4.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.509 2.139 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.03 -35.6 2.35 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 2.3 p30 -143.66 149.81 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.254 . . . . 0.0 109.85 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 6' ' ' LEU . 6.3 p -127.09 145.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.879 . . . . 0.0 109.413 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.518 ' N ' HG21 ' A' ' 76' ' ' VAL . 19.3 p -132.85 155.06 49.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' HB ' ' A' ' 45' ' ' ILE . 2.1 p -162.74 153.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 108.952 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.458 ' N ' HG21 ' A' ' 78' ' ' VAL . 6.4 mt -129.74 160.98 31.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 109.808 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 66' ' ' GLY . . . -149.91 -148.51 0.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 80' ' ' ALA . 11.0 m-20 -128.22 -33.39 2.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.667 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 83' ' ' ALA . 48.3 m -112.5 164.22 13.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 82' ' ' THR . . . -172.08 86.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 109.63 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.2 mp -105.67 134.17 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -0.915 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.7 ttt85 -58.51 153.86 15.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -51.52 -33.82 33.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.43 44.23 1.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.679 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.9 -32.75 72.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.79 -159.99 0.71 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.44 ' CB ' ' HB2' ' A' ' 93' ' ' ARG . 29.8 m-20 -62.21 179.48 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.33 -60.82 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.4 -12.65 59.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.44 ' HB2' ' CB ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -85.57 0.39 52.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.676 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.62 -1.75 57.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -0.998 . . . . 0.0 109.469 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.01 -22.56 21.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.779 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -80.71 -9.5 59.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.568 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.05 -24.42 35.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HB3' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -88.11 -27.5 21.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 3.9 ttm180 -67.35 -42.39 83.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -33.86 35.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.9 -14.02 59.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 26.5 tp10 -78.8 -23.01 45.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 2.9 tm-20 -54.37 -30.4 51.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 -46.08 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 105' ' ' ILE . 34.4 mt -52.14 -40.67 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.701 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 107' ' ' SER . 0.3 OUTLIER -92.98 58.18 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 108' ' ' SER . 6.2 p 178.8 155.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.664 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER 76.6 173.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.72 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 -171.52 3.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.795 . . . . 0.0 109.252 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.64 162.71 15.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.3 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -1.117 . . . . 0.0 109.472 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 15.5 m 39.97 33.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.425 -0.797 . . . . 0.0 110.031 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.16 -96.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 109.118 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -73.51 -15.84 61.3 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.013 -1.054 . . . . 0.0 108.401 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.06 -35.17 79.81 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.44 -11.84 61.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -0.782 . . . . 0.0 109.219 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HB2' HG12 ' A' ' 105' ' ' ILE . . . -76.77 -12.13 59.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 109.647 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -19.94 41.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.651 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.1 48.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.02 -32.77 22.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.659 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.457 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.75 -66.26 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.686 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -44.34 -25.46 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.835 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.9 ttmt -63.43 -53.14 56.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.73 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.3 -27.86 66.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.697 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.2 mm -75.15 -5.5 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 109.747 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.98 -1.67 40.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.442 ' O ' HG21 ' A' ' 130' ' ' VAL . 16.0 tt0 -89.81 -28.73 19.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -69.33 -15.91 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -80.63 -27.26 37.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.619 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.7 m -89.58 -28.61 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.553 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.489 ' N ' HG21 ' A' ' 130' ' ' VAL . 25.9 pt -66.56 -20.43 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.805 . . . . 0.0 109.537 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -78.27 -26.06 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.453 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -87.39 -47.68 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.948 . . . . 0.0 109.543 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 133' ' ' LEU . 28.5 p -43.82 -27.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -48.34 -67.03 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.0 26.88 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 0.0 109.769 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 133' ' ' LEU . . . -100.4 -36.58 9.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mmm . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.56 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' THR . 3.3 tpp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.205 0.526 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.513 HG21 ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER 57.89 147.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.777 . . . . 0.0 109.845 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.581 ' CE2' HG21 ' A' ' 34' ' ' ILE . 1.9 p90 -152.2 -164.42 1.96 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.23 -0.919 . . . . 0.0 108.953 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.8 t60 -116.87 145.16 43.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.119 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.618 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -137.49 152.01 49.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.7 OUTLIER -149.2 91.71 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.092 . . . . 0.0 110.034 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.518 HG12 ' CD1' ' A' ' 6' ' ' LEU . 3.3 m -100.66 141.3 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.288 -0.883 . . . . 0.0 109.012 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.416 HG12 ' C ' ' A' ' 8' ' ' VAL . 6.4 m -152.89 176.8 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.444 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -120.45 -150.2 0.45 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.37 -32.06 18.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -147.18 55.29 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG3' ' OG ' ' A' ' 10' ' ' SER . 17.1 pt20 175.93 122.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 15' ' ' MET . 15.5 mt-30 -96.37 165.52 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.922 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.442 ' HE3' ' CB ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -141.91 -91.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 109.111 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 31.7 t80 -96.01 120.55 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.212 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.406 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 29.9 p -152.53 80.35 1.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.54 20.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.501 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 24.4 mt -62.94 175.0 0.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.011 -1.287 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.62 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 179.5 160.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 108.993 -177.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 2.8 tm-20 -122.25 -51.18 1.99 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 110.087 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 18.3 tttp -153.74 122.56 6.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.134 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.565 ' CG2' ' CG1' ' A' ' 52' ' ' ILE . 11.2 pt -106.64 -170.13 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' CG ' ' CB ' ' A' ' 51' ' ' ARG . 5.0 pt20 -179.95 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.619 -1.3 . . . . 0.0 110.274 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 49' ' ' MET . 1.5 p -101.19 133.65 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.36 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -120.7 135.32 55.16 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.281 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . 179.47 -76.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -158.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -1.121 . . . . 0.0 109.507 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -67.77 -82.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . -51.8 117.98 6.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.18 64.28 1.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -112.98 160.81 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.386 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -111.37 -111.46 3.24 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.581 HG21 ' CE2' ' A' ' 4' ' ' TYR . 23.5 mm -156.11 140.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.981 . . . . 0.0 108.806 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.608 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -146.6 -172.05 0.3 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 35.7 Cg_endo -80.96 42.76 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.23 1.953 . . . . 0.0 110.606 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.46 34.09 0.04 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -74.58 145.31 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -1.13 . . . . 0.0 109.606 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.55 165.89 1.1 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.788 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.494 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.2 Cg_endo -78.62 73.38 5.93 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.685 2.257 . . . . 0.0 110.466 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.91 147.86 25.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.287 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -156.87 44.22 0.38 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' HG21 ' A' ' 68' ' ' ILE . 32.0 p -123.69 -110.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -101.4 155.39 18.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.822 -1.174 . . . . 0.0 109.584 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.7 tt -104.56 177.08 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -86.43 113.38 52.22 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 109.636 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 45' ' ' ILE . 35.5 Cg_endo -78.61 122.15 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.483 2.122 . . . . 0.0 110.353 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.48 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 162.42 -127.72 1.76 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 1.7 ppp? -113.48 167.7 10.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.257 -1.143 . . . . 0.0 109.024 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 1.5 tt -150.39 149.31 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.931 -1.106 . . . . 0.0 110.393 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.542 ' CB ' ' CG ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -116.49 177.96 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.89 153.86 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.828 -1.17 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 18.1 t -137.97 149.51 24.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 10.1 tppt? 90.06 -112.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.581 ' HG3' ' CE1' ' A' ' 16' ' ' PHE . 18.8 tt0 53.62 58.32 5.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.547 -1.345 . . . . 0.0 109.155 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.1 m170 58.53 43.03 19.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.266 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 71.48 86.18 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.466 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 167.2 125.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.588 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.54 133.76 53.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.115 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.78 168.59 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CD2' HG13 ' A' ' 130' ' ' VAL . 0.8 OUTLIER -125.51 134.06 52.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.292 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 2.0 mt -101.73 -147.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.189 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 9.1 t80 -178.75 122.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 109.23 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.451 ' CD2' ' CB ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -120.21 161.57 20.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.81 -14.04 14.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.6 161.99 9.96 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 156.69 -167.46 33.63 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.469 HG21 ' O ' ' A' ' 43' ' ' THR . 7.2 mt -101.72 170.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -1.073 . . . . 0.0 109.158 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB2' ' CG1' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -155.0 163.87 39.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.697 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -157.44 134.64 10.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 109.202 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 14.5 p -100.39 152.73 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.783 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.452 ' N ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -131.6 170.51 11.1 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 109.245 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -77.54 103.62 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.485 2.123 . . . . 0.0 110.325 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . 83.84 1.53 89.86 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 74' ' ' GLY . 13.4 m-80 -152.63 170.09 21.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -1.214 . . . . 0.0 109.391 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 75' ' ' ASN . 6.1 t -150.79 144.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.246 -0.909 . . . . 0.0 109.266 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -151.6 138.46 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.071 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.471 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 3.2 m -139.71 158.28 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.05 149.97 40.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.19 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -147.96 -175.84 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.851 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -123.32 -31.42 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.636 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.496 ' CG2' HD13 ' A' ' 84' ' ' ILE . 14.7 m -112.5 162.86 15.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 82' ' ' THR . . . -161.83 81.93 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.679 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.581 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -99.9 70.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.937 . . . . 0.0 109.326 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -44.04 161.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 131' ' ' ILE . . . -48.62 -59.04 6.92 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -116.9 60.0 0.75 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -1.144 . . . . 0.0 109.497 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -50.63 -63.63 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -142.87 -88.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.66 179.15 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -149.61 -39.74 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.16 32.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -78.31 -8.28 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.25 28.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.3 mtt -71.43 -6.73 42.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.516 -0.74 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 4.6 mt-10 -81.44 -40.65 23.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.53 -65.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.16 -31.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -59.53 -56.81 17.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.124 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.39 3.99 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 110.028 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.77 -46.3 10.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 109.638 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -65.56 -33.59 76.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.829 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -15.19 58.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.104 -0.998 . . . . 0.0 109.769 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -80.31 -65.18 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.84 -15.03 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 107' ' ' SER . 28.0 t -78.25 78.97 4.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 109.463 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 106' ' ' SER . 2.2 p 176.9 129.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' SER . 16.5 m 54.52 104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.421 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.54 -154.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 137.58 139.58 3.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 25.2 t70 -74.24 -58.06 3.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -1.194 . . . . 0.0 109.448 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.15 -7.6 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 109.454 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -59.28 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.822 . . . . 0.0 109.193 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -73.28 -23.11 60.26 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -59.59 -22.75 62.22 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.313 0.578 . . . . 0.0 109.464 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.48 -42.49 78.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.75 -11.63 60.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.559 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -1.09 26.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.706 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.94 -16.33 34.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -84.24 -16.42 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.947 . . . . 0.0 109.495 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -88.49 -45.01 10.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.601 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.35 73.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 124' ' ' ALA . 6.7 pttt -73.66 -28.4 61.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.407 ' N ' ' HG3' ' A' ' 123' ' ' LYS . . . -87.06 -8.05 57.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.218 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 tp -81.43 -4.07 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -74.36 -26.86 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.547 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -63.7 -33.63 76.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.403 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.513 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 19.2 tp -81.64 -10.27 59.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.502 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -31.29 19.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.568 HG13 ' CD2' ' A' ' 61' ' ' PHE . 1.2 m -90.56 -12.75 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.513 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 2.0 tt -90.4 -23.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 0.0 110.055 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.409 ' O ' ' HE2' ' A' ' 135' ' ' LYS . 0.7 OUTLIER -77.4 -39.28 47.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.552 HD22 ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -82.67 3.19 30.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 110.415 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.532 ' N ' HD11 ' A' ' 133' ' ' LEU . 14.3 p -87.15 -12.98 45.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.913 -1.117 . . . . 0.0 109.669 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 132' ' ' GLU . 5.6 ptpt -71.34 -5.44 32.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -97.63 -43.42 7.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 109.608 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -44.7 -29.06 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.583 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.565 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.418 ' O ' HG21 ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 2' ' ' MET . 0.6 OUTLIER -160.75 153.77 21.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.839 . . . . 0.0 109.609 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.608 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 3.9 p90 -139.53 -145.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.348 -0.845 . . . . 0.0 108.926 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -134.7 152.5 51.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.606 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -115.9 138.28 51.32 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -143.39 72.61 1.37 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.321 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 78' ' ' VAL . 4.0 p -106.26 140.59 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' N ' HG21 ' A' ' 8' ' ' VAL . 3.2 m -140.84 147.42 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.339 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.3 p -143.78 42.9 1.47 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . 171.68 -87.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 109.582 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 13' ' ' GLN . 1.4 mt-10 -128.62 44.13 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER 70.81 61.95 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -145.6 99.21 3.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.616 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.515 ' HE3' ' CD2' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -175.12 -78.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 109.286 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.618 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -148.26 109.47 4.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 17' ' ' SER . 43.5 p -138.07 83.37 1.97 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 109.464 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.5 -153.47 11.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.47 152.47 30.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -1.169 . . . . 0.0 109.741 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.618 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -150.7 152.33 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 109.276 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 10.6 tt0 -109.84 -50.55 2.97 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.47 ' O ' HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -155.44 130.84 9.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -98.01 -152.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER 179.55 94.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.806 -1.184 . . . . 0.0 109.617 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 23' ' ' ILE . 22.2 t -99.05 134.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.418 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 22.2 m -123.36 112.22 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.359 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -157.57 159.97 30.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -31.48 71.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.163 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -98.54 71.7 2.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.74 152.86 9.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.26 26.45 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.686 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.06 156.93 21.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -100.35 -121.37 4.7 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.608 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 30.7 mm -154.42 135.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -1.225 . . . . 0.0 109.016 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.6 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -140.7 -172.44 0.32 Allowed Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.5 Cg_endo -77.88 76.12 4.48 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.776 1.651 . . . . 0.0 110.407 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.22 37.53 0.6 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 39' ' ' ALA . 15.8 t-80 -67.76 166.6 14.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.179 -1.189 . . . . 0.0 109.394 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . . . -53.68 160.77 1.86 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.9 77.84 3.78 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.738 2.292 . . . . 0.0 110.581 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 4.2 mm? -97.22 148.61 22.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.142 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.419 ' C ' HG21 ' A' ' 43' ' ' THR . 0.4 OUTLIER -158.5 31.59 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.419 HG21 ' C ' ' A' ' 42' ' ' LEU . 26.8 p -131.21 -145.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 109.239 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' O ' ' CG2' ' A' ' 45' ' ' ILE . . . -99.47 128.42 45.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.032 -1.043 . . . . 0.0 108.844 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.479 ' CG2' ' O ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -160.41 42.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 110.395 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.667 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.6 OUTLIER -130.82 45.73 1.9 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.917 -1.115 . . . . 0.0 110.723 179.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 79.52 3.31 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.047 1.831 . . . . 0.0 110.496 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 64' ' ' LEU . . . 158.62 -141.47 7.66 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.388 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' CG1' ' A' ' 130' ' ' VAL . 1.0 OUTLIER -110.02 179.91 3.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.404 -1.057 . . . . 0.0 109.587 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.546 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 1.7 tt -147.89 154.02 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.514 ' N ' HG12 ' A' ' 50' ' ' ILE . 1.3 tmt_? -144.8 152.35 40.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 8.3 mt -150.7 166.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 110.452 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 90.1 t -141.78 118.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.618 -0.677 . . . . 0.0 109.267 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 150.88 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 6.5 mp0 42.46 -147.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -109.67 -11.06 14.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.952 . . . . 0.0 109.419 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.04 -98.64 2.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 58' ' ' HIS . 2.6 m-70 -130.3 -66.51 0.77 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.55 165.86 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.97 143.31 50.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 0.0 109.436 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.558 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.7 OUTLIER -116.9 123.71 47.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.546 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.6 mt -137.38 -160.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.969 . . . . 0.0 109.316 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -174.38 131.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 0.0 109.32 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.515 ' CD2' ' HE3' ' A' ' 15' ' ' MET . 3.6 mm? -119.5 158.27 26.62 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -99.27 -19.71 16.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.521 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.96 45.73 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.54 -178.02 32.21 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 2.7 mp -102.79 122.94 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -1.125 . . . . 0.0 109.367 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 6.7 mp -99.53 175.34 5.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.696 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -168.78 129.3 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 39' ' ' ALA . 5.7 p -99.86 129.06 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.076 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.74 173.7 3.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.5 Cg_endo -81.04 56.02 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.07 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.89 -16.73 1.21 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.075 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 5' ' ' HIS . 15.5 m-80 -150.91 -175.65 5.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 0.0 109.468 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.53 ' CG2' HG23 ' A' ' 34' ' ' ILE . 38.0 t -144.25 146.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.237 -0.914 . . . . 0.0 109.361 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.496 HG21 ' CB ' ' A' ' 7' ' ' ASP . 1.2 p -138.07 174.24 10.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 8' ' ' VAL . 1.2 p -178.25 119.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.298 -0.876 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.62 124.51 48.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.033 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.456 ' CB ' HD13 ' A' ' 64' ' ' LEU . . . -128.73 -152.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.78 -39.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.489 HG21 ' N ' ' A' ' 83' ' ' ALA . 28.4 m -104.24 151.73 23.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 109.754 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.489 ' N ' HG21 ' A' ' 82' ' ' THR . . . -165.68 167.51 17.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.321 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 84' ' ' ILE . 16.3 mt -130.68 -28.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 69.37 45.71 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.418 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 74.04 -112.13 3.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.78 27.08 9.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.42 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -49.43 -40.72 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.669 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.86 -88.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.772 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.07 164.84 20.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.45 ' HG3' HD13 ' A' ' 131' ' ' ILE . 25.9 tt0 -106.26 -72.8 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.54 -17.1 34.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -81.64 3.75 24.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.591 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.09 26.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 108.693 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 mtm -71.08 -26.54 63.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.507 -0.745 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.58 -24.21 67.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.323 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.24 -42.75 22.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.327 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG3' HD11 ' A' ' 125' ' ' ILE . 4.4 tttt -58.44 -43.51 88.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -26.55 65.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.307 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -89.94 7.68 36.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -90.5 -35.62 14.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -34.9 72.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 106' ' ' SER . 0.4 OUTLIER -62.58 -34.88 77.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -48.72 65.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.448 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mt -89.56 27.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 107' ' ' SER . 0.5 OUTLIER -68.92 92.86 0.52 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 106' ' ' SER . 39.5 m 61.47 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.633 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.44 118.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -95.68 73.42 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.514 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.27 132.02 4.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.5 m-20 -67.23 -149.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -1.148 . . . . 0.0 109.398 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.537 ' CA ' ' HB1' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -35.96 -31.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.301 0.572 . . . . 0.0 109.708 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 111' ' ' ASP . 22.5 t70 -38.18 -93.15 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.665 -0.647 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -63.42 -20.15 65.31 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 112' ' ' VAL . . . -55.74 -26.22 44.44 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.419 0.628 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -82.13 -31.92 30.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.384 -0.822 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -13.31 61.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.646 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 t -83.24 9.34 10.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.16 10.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.432 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.451 ' HG3' HD23 ' A' ' 121' ' ' LEU . 23.2 pt-20 -67.6 -12.49 60.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 120' ' ' GLU . 3.9 mm? -82.57 -36.21 26.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.918 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.94 46.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -69.85 -14.05 62.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.369 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.16 -8.49 57.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.343 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.411 HD11 ' HG3' ' A' ' 98' ' ' LYS . 27.3 mm -87.66 -17.9 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.51 -26.49 68.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -60.3 -34.22 73.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 109.492 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 27.9 tp -90.03 -11.84 40.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -60.84 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.564 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.558 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 16.2 m -55.42 -51.15 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.015 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 3.9 tt -60.19 -26.95 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.15 -38.66 85.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 109.942 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 133' ' ' LEU . 1.2 pp -90.22 -16.2 29.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.04 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 131' ' ' ILE . 20.0 p -61.25 -38.89 88.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -60.41 -33.95 73.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.993 . . . . 0.0 109.419 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.48 1.0 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.03 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.459 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.563 ' O ' ' CG2' ' A' ' 3' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 21' ' ' GLU . 6.5 t 52.07 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.591 1.186 . . . . 0.0 111.075 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.6 ' CE2' HG23 ' A' ' 34' ' ' ILE . 9.2 p90 -110.75 -168.37 1.3 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -111.06 137.57 48.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.155 -0.966 . . . . 0.0 108.655 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.618 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -125.61 162.68 24.42 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.912 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.58 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.94 101.35 2.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.728 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 16' ' ' PHE . 7.3 p -99.79 124.66 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 2.3 t -136.93 146.73 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.2 m -123.59 -145.88 0.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -40.04 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 110.039 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -153.38 65.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -156.05 138.68 15.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -92.4 138.32 31.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.465 ' HE1' ' HB3' ' A' ' 83' ' ' ALA . 1.1 mmt -124.99 -60.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.618 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 49.7 t80 -131.09 133.41 45.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.467 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 p -163.0 97.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.262 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.02 -151.03 19.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.502 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 12.5 mt -70.23 161.94 29.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.191 -1.182 . . . . 0.0 109.302 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.615 HG23 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -178.59 153.93 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.258 -177.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 3' ' ' THR . 1.5 pp20? -152.25 -36.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.942 -1.099 . . . . 0.0 110.677 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.517 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.74 71.21 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.848 -1.158 . . . . 0.0 110.891 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 9.5 pt -102.81 142.29 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.099 -1.0 . . . . 0.0 108.699 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.535 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 20.0 pt20 -149.27 126.55 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.055 -1.028 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -99.11 114.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.6 m -99.78 108.42 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.52 -91.82 1.26 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.58 -67.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -1.089 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.64 132.09 33.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.55 -178.29 35.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -174.74 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.125 . . . . 0.0 109.591 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 12.8 mt -151.27 142.96 23.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.629 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -101.79 -99.69 2.44 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.6 HG23 ' CE2' ' A' ' 4' ' ' TYR . 7.2 mm -156.75 140.47 7.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.429 -1.042 . . . . 0.0 109.139 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -128.76 178.06 1.84 Allowed Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 33.1 Cg_endo -75.43 75.78 3.77 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.058 1.838 . . . . 0.0 110.172 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.5 38.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -107.9 175.33 5.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.209 . . . . 0.0 109.583 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.99 167.24 14.7 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.269 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.438 ' HA ' HG11 ' A' ' 71' ' ' VAL . 36.3 Cg_endo -78.61 81.99 2.61 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.535 2.157 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 69' ' ' LEU . 1.4 pp -90.17 142.27 27.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.727 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 70' ' ' GLU . 3.4 mt -128.13 69.94 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.293 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -110.3 -160.5 0.72 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.459 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -101.01 172.73 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 69' ' ' LEU . 1.7 tt -99.96 126.98 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 156.15 70.52 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.98 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.15 175.71 10.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.56 2.173 . . . . 0.0 110.314 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 113.96 -132.92 10.84 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.456 ' HE2' HG11 ' A' ' 130' ' ' VAL . 6.0 ptm -129.53 -177.11 4.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -1.204 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -151.96 131.3 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 109.816 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -98.41 127.26 44.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.562 HG13 ' CB ' ' A' ' 23' ' ' ILE . 1.2 tt -134.3 145.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.077 -1.014 . . . . 0.0 110.91 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 38.9 t -127.75 113.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HG2' ' CE1' ' A' ' 16' ' ' PHE . 17.6 mtmt -66.32 157.14 32.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -0.762 . . . . 0.0 109.886 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.537 ' CG ' HG22 ' A' ' 3' ' ' THR . 18.2 tt0 -60.29 -65.02 0.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.345 -0.847 . . . . 0.0 109.531 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.04 102.98 8.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 58' ' ' HIS . . . 159.47 -103.42 0.23 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.482 ' CD2' ' C ' ' A' ' 57' ' ' GLY . 51.8 m-70 -148.51 159.96 43.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -1.194 . . . . 0.0 109.702 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.497 ' CB ' ' HA ' ' A' ' 53' ' ' VAL . 1.9 pt-20 -101.3 136.05 41.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HB3' ' NH2' ' A' ' 85' ' ' ARG . 8.9 mt-10 -134.01 150.64 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.943 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 1.2 p90 -109.2 131.02 55.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.459 ' HA ' ' HG3' ' A' ' 85' ' ' ARG . 1.7 mt -101.95 -175.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.436 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.498 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 6.2 t80 -152.37 136.84 16.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.068 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.92 179.99 7.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -161.3 113.16 1.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.435 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.79 132.97 6.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.27 -161.79 28.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 82.2 mt -139.46 143.2 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -1.155 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.519 HD13 ' CD1' ' A' ' 41' ' ' LEU . 1.4 pp -123.72 138.5 54.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.42 ' HB2' HD22 ' A' ' 42' ' ' LEU . 2.8 pt-20 -142.72 149.89 39.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 40' ' ' PRO . 4.4 p -109.54 133.4 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.76 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.518 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -101.45 175.43 2.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.408 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.0 Cg_endo -76.76 77.59 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.62 2.213 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.85 12.58 31.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.524 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 68.3 m-80 -153.9 -172.29 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -1.086 . . . . 0.0 109.343 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 75' ' ' ASN . 3.1 t -166.13 150.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.09 -1.006 . . . . 0.0 108.935 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.468 HG21 ' CB ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -158.5 142.26 15.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 0.0 109.315 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 69' ' ' LEU . 3.5 m -151.06 137.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.187 -0.946 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 1.1 mp -106.77 160.66 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.848 . . . . 0.0 109.194 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.461 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -149.76 175.88 11.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.8 -52.21 3.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.4 t -102.18 -176.68 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.367 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 15' ' ' MET . . . -168.51 80.88 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 63' ' ' TYR . 3.6 mp -108.51 72.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.494 ' NH2' ' HB3' ' A' ' 60' ' ' GLU . 22.9 ttt180 -42.84 154.11 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -45.95 -51.75 10.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -106.71 49.4 0.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -1.141 . . . . 0.0 109.539 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -27.69 14.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -123.36 -175.02 3.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.367 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 10.7 t70 -54.29 179.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.342 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.83 -34.8 7.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.95 -25.24 27.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -72.29 -7.44 49.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.59 -24.63 20.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.179 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -31.55 37.67 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 109.484 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -5.56 27.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.68 -22.93 42.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.465 ' CG ' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -82.34 -41.58 19.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.2 mtp-105 -61.3 -27.18 68.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.86 -21.76 26.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.95 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.12 -26.32 33.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.347 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 106' ' ' SER . 16.3 tt0 -60.97 -30.55 70.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.837 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -56.11 -30.88 62.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -89.5 -47.68 7.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.883 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 107' ' ' SER . 11.7 mt -86.83 14.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 107' ' ' SER . 71.2 p -48.69 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 77.03 167.76 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.565 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -166.94 134.52 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.15 -89.01 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.468 ' O ' ' OD2' ' A' ' 113' ' ' ASP . . . -167.78 174.41 42.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 1.2 m-20 63.65 105.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -1.202 . . . . 0.0 109.312 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 15.6 m 40.99 26.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -90.83 -89.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.177 -0.952 . . . . 0.0 108.893 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.451 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 26.7 t80 -73.93 -20.47 60.36 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.83 -53.17 58.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.51 -39.78 94.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.355 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.462 ' HB2' HG22 ' A' ' 105' ' ' ILE . . . -67.03 -16.35 64.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.589 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -74.52 -23.1 58.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.44 -41.15 11.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.977 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 6.2 pt-20 -75.77 -32.15 59.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.442 ' O ' HG12 ' A' ' 125' ' ' ILE . 51.1 tp -87.24 -51.84 5.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 109.614 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 118' ' ' SER . . . -52.72 -39.78 62.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -57.84 -36.12 71.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.781 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 123' ' ' LYS . . . -75.92 -22.54 55.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.563 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.465 HD13 ' CG ' ' A' ' 98' ' ' LYS . 14.0 mm -79.79 -3.61 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.619 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.81 -32.74 74.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -19.28 64.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.0 tp -83.99 -17.5 40.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -90.37 -28.99 18.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.733 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.576 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 5.0 m -89.19 -26.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 109.461 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 132' ' ' GLU . 3.1 tt -66.97 -46.86 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -52.65 -26.29 13.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -44.98 28.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 135' ' ' LYS . 79.5 p -61.1 -14.88 27.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -45.42 -41.65 9.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.367 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -97.08 -41.77 8.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.442 ' O ' ' OXT' ' A' ' 138' ' ' MET . . . -44.19 -61.98 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.442 ' OXT' ' O ' ' A' ' 137' ' ' ALA . 2.8 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' THR . 6.3 mtp . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.506 ' CG2' ' HG3' ' A' ' 21' ' ' GLU . 1.3 p 49.98 176.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.398 -0.814 . . . . 0.0 109.906 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.595 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 1.3 p90 179.42 -171.66 0.15 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.559 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.0 t60 -111.62 149.68 31.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 109.025 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -137.92 158.48 44.26 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 178.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 6.5 t0 -144.98 92.65 2.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 6' ' ' LEU . 3.4 p -113.2 118.69 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.918 . . . . 0.0 109.408 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 t -130.9 145.08 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.454 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 39.5 t -178.05 66.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 10' ' ' SER . . . 178.09 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER 42.54 27.38 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.653 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.88 -150.59 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.512 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -134.39 102.84 5.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' A' ' 62' ' ' ILE . 1.4 mmt -76.01 -78.69 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.259 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.625 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 34.7 t80 -125.66 124.76 41.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.165 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 17' ' ' SER . 52.6 p -154.4 83.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.7 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.01 -153.59 17.37 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' C ' HG13 ' A' ' 20' ' ' VAL . 13.6 mt -65.02 167.7 7.5 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.151 -1.205 . . . . 0.0 108.745 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.625 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -173.85 173.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 120.87 -1.144 . . . . 0.0 109.496 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.9 tt0 -118.19 -46.37 2.61 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.4 137.3 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.433 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 18.7 pt -99.42 -156.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -177.13 95.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.509 -1.369 . . . . 0.0 110.378 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.528 HG22 ' CG ' ' A' ' 46' ' ' LYS . 76.4 t -99.23 141.75 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.46 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 25.6 m -145.53 119.81 9.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.274 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -145.54 -163.39 10.18 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -42.66 42.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -1.078 . . . . 0.0 109.592 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 163.26 21.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.917 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.79 138.57 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -141.31 45.72 1.74 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -1.13 . . . . 0.0 109.213 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mt -144.85 164.58 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.785 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -112.59 -112.33 3.16 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.595 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 15.9 mm -153.33 138.04 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -1.153 . . . . 0.0 109.459 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -149.23 171.87 5.82 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.0 Cg_endo -70.3 83.03 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.566 1.511 . . . . 0.0 109.486 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.73 35.12 0.46 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.7 t-80 -81.97 151.26 27.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -1.12 . . . . 0.0 109.526 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . -42.94 154.8 0.28 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.409 -0.807 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 76.01 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.583 2.188 . . . . 0.0 110.559 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.03 162.13 13.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.311 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.68 35.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.634 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 68' ' ' ILE . 30.0 p -130.68 -145.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.901 . . . . 0.0 109.375 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -99.32 120.41 39.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 69' ' ' LEU . 1.1 pp -166.7 -169.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.163 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.63 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER 71.66 49.46 0.28 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 111.059 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.63 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 146.17 17.22 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.15 1.9 . . . . 0.0 110.418 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 115.58 -142.88 17.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.318 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -99.56 -155.22 0.5 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -1.079 . . . . 0.0 109.198 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.537 ' CG2' ' O ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -173.76 111.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 110.383 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 50' ' ' ILE . 15.7 mtm180 -99.46 166.63 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -152.62 167.63 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.601 -1.312 . . . . 0.0 111.246 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 52' ' ' ILE . 13.6 t -143.99 104.73 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLN . 1.3 ttpt -66.37 120.51 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.692 -0.63 . . . . 0.0 109.868 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' LYS . 82.0 mt-30 43.26 -161.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.363 -0.835 . . . . 0.0 109.373 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -68.71 88.41 0.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 54' ' ' LYS . . . 121.27 -171.21 14.86 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 61.5 160.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.383 -1.069 . . . . 0.0 109.607 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -171.35 147.41 2.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.401 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -132.8 154.67 50.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 130' ' ' VAL . 0.9 OUTLIER -112.08 133.62 54.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 109.373 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 78.0 mt -151.94 167.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 109.261 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.52 ' N ' HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.65 149.66 37.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 109.576 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -157.67 152.69 25.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.16 -79.56 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 109.723 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 129.4 9.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.32 144.6 7.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 43' ' ' THR . 79.3 mt -99.48 118.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -1.108 . . . . 0.0 108.965 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 1.3 tt -112.49 153.37 27.54 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -145.65 152.41 39.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.28 139.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.0 109.872 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.521 ' HG2' ' CD ' ' A' ' 73' ' ' PRO . 0.9 OUTLIER -122.27 172.33 5.33 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.462 -0.774 . . . . 0.0 109.038 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.521 ' CD ' ' HG2' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -78.62 91.15 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.513 2.142 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.22 -10.31 54.6 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -161.32 162.11 30.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.027 -1.278 . . . . 0.0 109.896 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG12 ' CG2' ' A' ' 34' ' ' ILE . 18.3 m -135.75 172.87 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.5 m -159.95 156.64 27.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.504 ' CG2' ' HB2' ' A' ' 69' ' ' LEU . 2.7 p -167.73 133.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mt -117.77 118.34 31.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.418 ' C ' ' OG ' ' A' ' 10' ' ' SER . . . -109.02 -165.97 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.361 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.23 -52.29 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.438 HG23 ' OH ' ' A' ' 63' ' ' TYR . 16.5 m -99.93 120.11 39.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.35 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -149.75 163.71 37.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.54 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.1 mt -149.03 119.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.285 -0.885 . . . . 0.0 109.25 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.46 ' CG ' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -67.58 95.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.37 -110.75 1.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.409 ' NE2' ' OE1' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -139.13 57.2 1.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 109.223 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -60.19 -45.16 94.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.61 -78.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -150.25 -155.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 109.608 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.471 ' HB2' HD11 ' A' ' 131' ' ' ILE . 1.3 pt-20 -151.93 -49.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.652 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.87 -10.14 59.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.359 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -8.48 59.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.52 -24.32 20.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.246 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -35.58 76.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -54.71 -33.34 60.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.17 75.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.112 -0.993 . . . . 0.0 109.86 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -18.06 60.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -70.06 -50.34 42.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.626 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -86.02 -9.19 57.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.573 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.404 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -76.81 -30.8 56.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 1.5 tm-20 -70.88 -22.46 62.28 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.306 -0.871 . . . . 0.0 109.347 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.74 -20.75 60.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -81.67 -36.75 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.519 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 8.4 mm -78.87 -26.91 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.1 p -80.81 -9.94 59.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.5 t -104.58 131.19 52.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.57 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 58.3 p -135.97 142.22 44.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.281 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.3 m-70 175.21 41.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.382 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.63 158.92 31.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -74.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -1.177 . . . . 0.0 109.562 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 17.6 m -100.84 19.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.393 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 9.7 t70 -59.83 -100.41 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.358 -0.839 . . . . 0.0 109.278 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 12.6 p90 -64.61 -22.22 66.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.903 -1.123 . . . . 0.0 108.223 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.84 -33.65 56.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -88.3 -24.7 23.1 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -68.08 -21.12 64.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -26.3 61.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.444 ' O ' ' HE3' ' A' ' 123' ' ' LYS . . . -90.18 -38.18 13.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -78.85 -5.79 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.519 ' HG ' ' CD1' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -90.15 -51.3 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.593 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.31 -28.87 70.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.179 -0.951 . . . . 0.0 109.459 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 119' ' ' ALA . 14.8 mtmt -70.23 -23.66 62.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.66 62.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.868 . . . . 0.0 109.733 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.3 mp -80.08 -1.24 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.4 -24.57 63.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.454 ' O ' HG22 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -69.76 -45.76 67.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.62 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.4 OUTLIER -65.99 -15.51 63.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.638 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 125' ' ' ILE . 14.2 mmt180 -81.85 -25.75 34.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.501 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 31.6 m -88.09 -20.36 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 128' ' ' LEU . 7.7 pt -91.01 -44.62 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 0.0 110.047 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 5.0 mm-40 -61.81 -24.21 66.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.233 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 6.5 mp -89.09 -37.73 14.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -55.59 -40.93 72.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -61.39 -29.58 70.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.83 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -111.26 31.56 5.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 109.548 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.19 -3.56 8.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 109.654 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.339 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 20.6 ptp . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.19 0.519 . . . . 0.0 109.837 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -42.35 166.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.873 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CE1' ' HA ' ' A' ' 35' ' ' TYR . 5.0 p90 -148.79 -147.3 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 20.5 t-80 -133.9 140.71 46.99 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.05 -1.031 . . . . 0.0 109.641 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.608 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.067 . . . . 0.0 108.775 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -142.83 86.78 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.951 -1.093 . . . . 0.0 110.528 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.449 HG22 ' CB ' ' A' ' 15' ' ' MET . 5.0 m -99.9 148.78 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 79' ' ' LEU . 1.5 m -152.96 173.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.032 -1.043 . . . . 0.0 109.869 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -129.4 -153.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.92 -29.95 70.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' GLN . 6.3 mm-40 -116.74 26.51 9.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.003 . . . . 0.0 109.695 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 12' ' ' GLU . 19.8 mt-30 43.68 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.409 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 15' ' ' MET . 4.6 mm-40 -165.4 74.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.527 ' CE ' HG23 ' A' ' 62' ' ' ILE . 6.8 mtp -151.32 -73.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.643 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 47.7 t80 -159.75 136.84 9.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.267 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -160.17 105.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.461 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 144.99 -160.38 28.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.518 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 12.0 mt -56.09 174.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -1.191 . . . . 0.0 108.957 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.643 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 179.96 169.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.078 . . . . 0.0 109.65 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.0 tt0 -122.5 -41.9 2.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.314 -0.866 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.68 130.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -98.77 -165.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HB3' ' CB ' ' A' ' 51' ' ' ARG . 4.5 tp60 -168.89 84.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.665 -1.272 . . . . 0.0 110.233 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.3 141.86 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.445 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 10.2 m -138.16 129.69 27.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 109.03 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.92 -81.38 0.1 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -38.78 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -1.173 . . . . 0.0 109.769 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -123.41 163.69 20.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 80.4 -82.06 1.51 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 44.1 tt0 73.88 53.11 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -1.089 . . . . 0.0 109.732 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -145.54 156.64 43.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -99.22 -115.17 3.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.584 HG21 ' CE2' ' A' ' 4' ' ' TYR . 29.5 mm -153.11 145.81 14.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -154.91 -171.0 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.7 Cg_endo -78.63 73.93 5.68 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.678 1.586 . . . . 0.0 109.671 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.09 54.7 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.547 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 11.8 t-160 -85.63 50.84 2.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -1.132 . . . . 0.0 109.648 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 38' ' ' HIS . . . 55.56 167.03 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 109.627 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.46 78.92 3.47 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.621 2.214 . . . . 0.0 110.229 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -95.05 144.4 25.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.16 36.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.6 p -121.26 -134.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . . . -99.6 168.73 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.883 -1.136 . . . . 0.0 109.333 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.448 ' HB ' HD21 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -112.9 136.23 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -65.46 147.01 98.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.569 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 35.3 Cg_endo -77.71 133.97 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.688 2.259 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.508 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 174.25 -144.89 7.78 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.512 ' HE2' ' CA ' ' A' ' 130' ' ' VAL . 3.8 ptm -105.73 -164.68 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -1.114 . . . . 0.0 109.481 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.537 HD11 HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -168.57 123.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.995 -1.066 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -111.28 159.69 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -154.06 158.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.28 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.481 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 47.2 t -142.15 102.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -54.94 159.42 2.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 -179.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 54' ' ' LYS . 1.4 tm0? -35.85 -38.83 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.586 . . . . 0.0 110.022 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -103.06 -159.58 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -64.62 -163.77 0.79 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 4.1 t60 79.46 124.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.412 -1.052 . . . . 0.0 109.732 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.85 140.73 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 108.872 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HB2' HG23 ' A' ' 52' ' ' ILE . 2.0 mp0 -109.68 152.34 25.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.109 . . . . 0.0 109.746 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 130' ' ' VAL . 2.3 m-85 -124.22 132.29 53.59 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.527 HG23 ' CE ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -149.54 -176.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.615 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.545 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -162.84 130.88 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 108.928 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.48 -166.34 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.87 . . . . 0.0 109.334 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.466 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 1.9 m -143.04 -93.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.69 154.63 17.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.0 -173.27 42.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.1 mt -122.09 131.99 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.339 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 45' ' ' ILE . 0.6 OUTLIER -112.88 -172.4 2.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.961 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 179.78 142.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.58 132.55 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 109.917 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HG3' ' HA ' ' A' ' 76' ' ' VAL . 1.2 mt-30 -119.78 173.42 3.61 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 0.0 109.081 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.35 110.6 2.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.525 2.15 . . . . 0.0 110.829 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 78.51 11.86 84.85 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 19.6 p-10 -179.8 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.284 . . . . 0.0 109.838 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 6' ' ' LEU . 4.5 m -129.75 178.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.106 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.9 m -160.86 160.48 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.95 -1.094 . . . . 0.0 109.954 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.428 ' HB ' ' CB ' ' A' ' 69' ' ' LEU . 1.8 p -177.02 138.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 1.3 mp -124.31 153.27 42.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.04 -1.037 . . . . 0.0 109.95 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.95 166.06 26.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.433 -0.792 . . . . 0.0 109.047 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 81' ' ' ASP . 8.5 t70 -100.18 3.77 43.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 11.7 m -119.64 153.56 35.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' HB3' ' OG ' ' A' ' 10' ' ' SER . . . -168.57 113.42 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.474 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.545 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -104.62 -37.38 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.216 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 75.43 49.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 43.88 -109.58 0.26 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.517 ' CA ' HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -98.78 59.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -1.117 . . . . 0.0 109.886 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 33.3 t0 -47.42 -38.23 12.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.4 tp -163.65 127.6 2.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.13 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.09 172.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 109.319 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -128.56 -5.69 5.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 109.836 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.31 -11.34 41.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.944 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -81.57 -17.38 48.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.44 -7.74 52.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -0.978 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mtt -85.4 -10.93 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.6 -26.53 60.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.89 -1.94 34.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.58 -53.82 5.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -74.45 -29.56 61.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -82.75 -21.86 34.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -68.64 -29.37 67.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -17.66 51.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -88.79 -20.32 24.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 65.4 mt -83.08 4.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.661 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.4 m -47.83 -52.13 20.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.69 115.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.7 p -153.28 148.66 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.434 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.63 -63.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.529 ' N ' ' HB2' ' A' ' 113' ' ' ASP . . . 175.4 171.62 39.54 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.82 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 109.596 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 116' ' ' GLN . 14.3 m -88.19 20.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.529 ' HB2' ' N ' ' A' ' 110' ' ' GLY . 51.0 t0 -62.35 -100.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -15.36 58.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 108.473 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.83 -37.73 70.25 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.685 -0.634 . . . . 0.0 109.591 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 12.2 tt0 -84.24 -10.2 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.65 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.93 -20.84 24.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.65 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -64.37 -13.18 49.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 109.488 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.66 -60.97 1.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -59.08 -47.62 84.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -68.18 -59.74 2.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.802 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 118' ' ' SER . . . -56.26 -16.63 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.855 . . . . 0.0 109.829 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.409 ' CD ' ' HB2' ' A' ' 47' ' ' PRO . 7.6 ttpt -76.86 -36.2 56.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.18 -14.01 54.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.805 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 35.2 mm -87.84 -8.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.483 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -68.43 -30.64 69.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.459 ' O ' ' CG2' ' A' ' 131' ' ' ILE . 0.8 OUTLIER -84.07 -17.73 39.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.657 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -85.09 -30.51 24.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.433 ' O ' HD22 ' A' ' 133' ' ' LEU . 5.7 tpp180 -82.17 -33.94 29.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.54 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.15 -25.24 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.174 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.517 HG13 ' CA ' ' A' ' 87' ' ' GLN . 2.3 tt -90.95 -23.85 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 110.29 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -81.01 -34.62 32.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -84.67 0.17 51.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.955 -1.09 . . . . 0.0 110.099 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.545 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -80.97 -2.08 46.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -25.23 34.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -89.12 -9.05 52.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.12 -0.987 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.83 37.33 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.431 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.445 ' O ' HG22 ' A' ' 3' ' ' THR . 1.3 tpt . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.221 0.534 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.514 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -165.99 140.28 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.57 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 1.7 p90 -152.73 -142.69 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 19.2 t-80 -139.39 141.81 37.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.878 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.639 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -137.38 153.83 50.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.079 -1.013 . . . . 0.0 108.673 178.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 77' ' ' THR . 3.1 t70 -148.33 98.06 2.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.524 HG21 ' CG2' ' A' ' 78' ' ' VAL . 2.1 p -99.28 110.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.862 -1.149 . . . . 0.0 109.09 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.05 154.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.7 t -165.96 107.52 0.73 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.211 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . 77.07 34.36 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 55.04 39.63 31.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 22.5 mt-30 -87.67 -43.9 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.204 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER 72.21 84.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.126 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.44 ' SD ' HG13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -98.97 -93.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 108.78 179.26 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.692 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 32.8 t80 -94.03 110.09 21.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.006 . . . . 0.0 109.315 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' ' 7' ' ' ASP . 60.4 p -136.97 109.94 7.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 145.49 -169.52 27.03 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.492 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 19.8 mt -52.46 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.107 -1.231 . . . . 0.0 108.602 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.692 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -176.04 145.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.962 -1.086 . . . . 0.0 109.563 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -108.7 -48.61 3.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 67.3 mmtt -147.19 101.76 3.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.405 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.94 109.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.79 110.09 22.48 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.04 -1.037 . . . . 0.0 110.51 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 32' ' ' LEU . 7.4 p -99.67 147.81 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.457 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.416 ' N ' HG21 ' A' ' 25' ' ' VAL . 12.4 m -135.84 121.71 19.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -152.42 -177.67 26.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.91 150.59 34.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -1.132 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 64.8 76.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.14 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 99.66 179.65 30.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 175.02 38.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.238 . . . . 0.0 109.806 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.528 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 4.6 mt -92.41 150.03 21.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.47 177.94 29.88 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.57 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 16.4 mm -98.6 140.13 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.874 -1.368 . . . . 0.0 109.187 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -137.79 170.87 9.47 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.8 Cg_endo -72.63 80.02 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.862 1.708 . . . . 0.0 109.918 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.66 34.94 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.8 t-160 -83.23 142.67 30.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -1.208 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -46.74 157.71 0.45 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.185 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.73 87.4 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 110.359 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.9 155.44 17.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' CD1' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -157.62 75.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.502 ' CG2' ' N ' ' A' ' 44' ' ' ALA . 5.9 t -156.09 -146.08 0.17 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.885 . . . . 0.0 109.021 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 43' ' ' THR . . . -99.46 136.46 39.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.476 ' CG1' ' C ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -156.47 -169.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 109.76 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.625 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER 63.61 51.95 1.37 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.488 -0.757 . . . . 0.0 110.399 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.625 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.4 Cg_endo -80.19 65.99 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.208 1.938 . . . . 0.0 110.811 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.45 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 155.11 -127.49 2.08 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.298 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.475 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 4.6 ptm -108.61 -169.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 109.684 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.536 ' CD1' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -179.43 127.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.479 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -110.35 172.86 6.61 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 18.2 mt -155.14 166.49 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.019 -1.051 . . . . 0.0 109.601 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 42.8 t -138.89 107.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.263 -0.898 . . . . 0.0 109.903 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.531 ' CG ' ' N ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 157.68 -97.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 16' ' ' PHE . 11.6 tm0? -50.68 165.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 0.0 109.373 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.0 t-160 75.54 -145.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.185 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.422 ' H ' ' CG ' ' A' ' 56' ' ' HIS . . . -84.7 -86.43 0.92 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' HG3' ' A' ' 59' ' ' GLU . 99.8 m-70 -120.23 -18.8 7.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -169.73 152.45 4.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.211 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.15 161.01 22.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.541 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 2.8 m-85 -118.19 141.78 48.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.535 ' CG2' ' N ' ' A' ' 63' ' ' TYR . 2.3 mp -151.53 166.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.101 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.583 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -171.45 130.1 0.71 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.172 -0.955 . . . . 0.0 109.275 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mt -131.62 172.6 12.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.084 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -148.76 46.57 1.02 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.472 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 133.24 91.27 0.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -160.91 151.55 22.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 43' ' ' THR . 20.4 mt -105.72 119.7 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 78' ' ' VAL . 1.4 pp -109.06 -161.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.958 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' HG21 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -177.7 124.16 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 p -99.66 138.78 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.504 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.471 ' HG2' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -121.46 174.98 2.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.471 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.79 84.66 1.99 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.444 2.096 . . . . 0.0 110.515 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 132.77 -36.29 2.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 9.8 p30 -155.14 154.19 31.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -1.225 . . . . 0.0 109.83 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 77' ' ' THR . 1.4 p -134.3 165.84 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.876 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.525 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 98.7 m -153.55 145.56 23.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 0.0 109.63 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.524 ' CG2' HG21 ' A' ' 8' ' ' VAL . 2.6 m -122.74 147.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 0.0 109.441 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.4 114.09 20.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.673 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -137.17 172.2 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.314 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.73 -20.19 8.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 m -112.84 109.63 19.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' HB2' ' HE3' ' A' ' 15' ' ' MET . . . -129.45 146.48 51.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 55.3 mt -139.16 86.39 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.248 -0.907 . . . . 0.0 108.969 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' ILE . 26.3 ttt180 -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.01 107.54 0.57 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.44 79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -92.26 -34.35 14.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tp -162.99 131.82 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 53.21 -178.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 92' ' ' ALA . 11.1 pt-20 -170.2 -39.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.473 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -75.06 -27.16 59.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.355 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -84.01 8.07 16.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.394 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.05 -12.36 38.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 0.0 109.178 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -26.82 53.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.44 -0.787 . . . . 0.0 109.467 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -77.25 -22.28 52.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.38 72.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' CD ' HG12 ' A' ' 125' ' ' ILE . 22.0 tttp -79.54 -22.59 43.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -69.07 -48.93 61.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.81 8.1 18.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.481 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . . . -84.05 -24.13 30.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.164 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 33.2 tt0 -69.42 -24.18 63.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.85 . . . . 0.0 109.224 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.67 -47.12 83.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.84 74.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.499 HG22 ' CD1' ' A' ' 114' ' ' TYR . 14.6 mt -84.12 -11.23 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.0 m -48.98 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.666 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -164.6 -38.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.217 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.0 m 48.05 68.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 -67.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 111' ' ' ASP . . . 125.75 -47.36 1.02 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -43.1 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -1.1 . . . . 0.0 109.133 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.421 ' HB ' ' CG ' ' A' ' 116' ' ' GLN . 22.6 m -143.56 36.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.12 -96.47 0.11 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.711 -0.618 . . . . 0.0 109.375 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.499 ' CD1' HG22 ' A' ' 105' ' ' ILE . 2.4 m-85 -60.03 -19.2 51.49 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.32 -54.18 15.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.421 ' CG ' ' HB ' ' A' ' 112' ' ' VAL . 50.6 mm-40 -87.95 -0.72 57.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.687 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 114' ' ' TYR . . . -90.88 -25.5 19.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.672 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.455 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 1.1 p -64.01 -18.63 64.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.706 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.25 -68.91 0.75 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 121' ' ' LEU . 11.1 pt-20 -55.14 -44.64 75.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 110.046 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.504 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -62.62 -61.01 2.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -59.49 -14.35 12.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.788 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.457 ' O ' ' HB1' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -66.04 -33.89 76.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.768 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.25 70.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 109.564 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.509 HG12 ' CD ' ' A' ' 98' ' ' LYS . 3.6 mp -77.29 -1.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.961 . . . . 0.0 109.715 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 123' ' ' LYS . . . -74.51 -20.56 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.071 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.466 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.5 pt20 -87.22 -24.12 24.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.459 HD22 ' O ' ' A' ' 128' ' ' LEU . 2.2 tt -72.17 -9.36 58.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 0.0 109.424 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -84.61 -34.1 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.693 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.4 m -62.7 -27.6 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.504 ' N ' HG21 ' A' ' 130' ' ' VAL . 96.8 mt -62.34 -39.59 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -65.08 -18.34 65.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 4.8 mp -89.03 -34.97 16.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -70.66 -20.88 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -81.02 -6.49 58.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -143.25 23.4 1.84 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -96.24 -20.82 18.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.446 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 55' ' ' GLN . 1.4 t -43.63 154.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.503 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.624 ' CE2' HG21 ' A' ' 34' ' ' ILE . 3.5 p90 -144.34 -159.65 1.02 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.562 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.1 t60 -114.05 144.79 42.55 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.603 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -103.15 130.97 50.49 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.162 -0.961 . . . . 0.0 109.136 178.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.528 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -137.44 88.85 2.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.418 ' O ' HG11 ' A' ' 8' ' ' VAL . 2.2 p -114.01 116.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.468 HG13 ' HG3' ' A' ' 14' ' ' GLN . 16.3 m -124.28 172.19 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' CG ' ' A' ' 13' ' ' GLN . 15.0 m -124.81 -150.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.403 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -43.24 65.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.616 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -164.91 49.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 109.691 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.462 ' CG ' ' HB2' ' A' ' 10' ' ' SER . 0.1 OUTLIER -151.15 155.54 39.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.468 ' HG3' HG13 ' A' ' 9' ' ' VAL . 2.0 mt-30 -111.49 161.58 16.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.815 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.431 ' HE3' HG21 ' A' ' 62' ' ' ILE . 32.3 mtp -140.88 -46.55 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.274 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.603 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -138.75 110.95 7.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.653 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 17' ' ' SER . 19.6 p -139.43 86.48 2.12 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . -177.6 -149.98 8.22 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.484 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 35.7 mt -82.45 175.25 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 109.529 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.591 ' CG2' ' N ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER 176.4 171.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.085 -1.009 . . . . 0.0 108.82 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.591 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.4 tt0 -166.87 -34.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.584 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -116.42 75.66 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.561 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -99.61 143.6 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.266 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.516 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 19.7 tt0 -149.78 158.33 44.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.005 -1.06 . . . . 0.0 109.927 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 49' ' ' MET . 6.9 p -131.03 149.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.403 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -120.51 89.16 3.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.407 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.06 -77.7 0.56 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 p -150.38 -86.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.37 -28.6 22.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.96 73.06 1.8 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.24 29.97 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -1.115 . . . . 0.0 109.474 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.4 mt -130.86 144.75 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.66 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.5 -97.59 2.15 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.624 HG21 ' CE2' ' A' ' 4' ' ' TYR . 5.0 mm -155.72 161.74 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -1.041 . . . . 0.0 109.422 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -165.12 175.1 2.66 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -71.88 118.62 5.72 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.836 1.69 . . . . 0.0 109.222 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.97 24.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.575 ' CE1' HG22 ' A' ' 71' ' ' VAL . 19.3 p80 -86.9 -171.0 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.798 0.809 . . . . 0.0 110.79 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.611 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . . . -54.74 -172.89 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 39' ' ' ALA . 33.1 Cg_endo -76.79 -179.68 5.62 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.913 1.742 . . . . 0.0 110.271 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' HA ' ' HB ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -90.6 37.64 0.92 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.193 -0.942 . . . . 0.0 110.913 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tp -147.5 116.54 6.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.574 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 t -175.74 -173.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.417 -0.802 . . . . 0.0 109.199 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.75 150.58 52.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.072 -1.018 . . . . 0.0 109.822 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.596 ' CD1' ' CB ' ' A' ' 69' ' ' LEU . 1.7 mp -102.17 112.64 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.497 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 1.0 OUTLIER -65.01 174.72 1.21 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 123' ' ' LYS . 33.8 Cg_endo -77.14 142.63 21.86 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.574 2.182 . . . . 0.0 110.55 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 152.15 -156.39 26.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.473 ' O ' HG21 ' A' ' 25' ' ' VAL . 13.5 ptm -103.6 -168.31 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -1.172 . . . . 0.0 109.35 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 7.6 mt -155.82 126.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.798 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -117.9 110.54 17.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.561 HG12 ' CB ' ' A' ' 23' ' ' ILE . 29.4 mt -118.33 168.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.117 -0.989 . . . . 0.0 110.52 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 38.1 t -135.27 120.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.4 ttmt -64.03 147.45 52.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.464 ' HB2' ' OG1' ' A' ' 3' ' ' THR . 6.3 tm0? -65.05 -49.05 71.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.444 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -53.26 -62.59 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 85.43 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -170.66 176.84 4.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -1.054 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -145.55 128.38 16.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 133.19 32.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.564 ' CZ ' HD13 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -116.23 145.31 43.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.958 . . . . 0.0 109.618 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.431 HG21 ' HE3' ' A' ' 15' ' ' MET . 3.2 mp -121.85 171.93 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 127' ' ' GLN . 8.2 t80 -141.34 152.7 44.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.29 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -172.92 -166.9 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.498 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 61.7 m -154.81 21.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.48 150.0 5.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.25 159.91 9.5 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.461 ' O ' HG21 ' A' ' 78' ' ' VAL . 2.0 mp -107.9 140.69 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.105 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.596 ' CB ' ' CD1' ' A' ' 45' ' ' ILE . 2.6 tt -121.05 156.9 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.09 -1.006 . . . . 0.0 109.635 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.457 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -158.21 146.45 18.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG22 ' CE1' ' A' ' 38' ' ' HIS . 2.2 t -103.31 159.27 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 110.132 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.607 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -126.19 -171.13 0.22 Allowed Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.9 Cg_endo -79.55 40.61 0.97 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.645 1.564 . . . . 0.0 111.294 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 145.49 34.23 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.94 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 5.2 p-10 166.19 133.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.284 . . . . 0.0 109.974 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 71' ' ' VAL . 6.6 t -99.62 157.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.285 -0.884 . . . . 0.0 108.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 23.0 m -154.3 137.07 15.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.252 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.509 HG21 ' N ' ' A' ' 79' ' ' LEU . 1.5 p -141.32 141.72 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.599 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.509 ' N ' HG21 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -111.24 107.67 17.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.2 162.58 12.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.733 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.96 -47.02 7.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.5 m -100.82 136.03 41.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 109.549 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' C ' HD13 ' A' ' 84' ' ' ILE . . . -151.24 134.13 15.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.514 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.571 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 1.1 mp -111.86 -37.94 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.84 . . . . 0.0 108.959 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 77.26 84.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 42.18 -111.61 0.34 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.456 ' O ' ' CG ' ' A' ' 87' ' ' GLN . 1.4 tt0 -117.98 62.12 0.76 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.284 -1.127 . . . . 0.0 109.509 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 85' ' ' ARG . 13.0 t70 -85.77 -11.3 53.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -149.26 144.69 26.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 54.16 171.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.18 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.417 ' HG3' ' CD1' ' A' ' 131' ' ' ILE . 81.6 tt0 -168.15 -80.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.95 58.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.269 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -6.01 51.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.17 -27.37 19.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.942 . . . . 0.0 108.988 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 mtt -67.2 -40.53 86.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.443 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -33.11 75.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.469 ' HB2' HD12 ' A' ' 128' ' ' LEU . 1.3 tmmt? -62.37 -14.36 39.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.79 -53.05 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.482 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -65.23 -15.16 62.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.63 -28.36 26.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.348 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 103' ' ' GLU . 24.8 tt0 -76.33 -48.61 19.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 102' ' ' GLU . 38.6 tt0 -45.43 -29.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -71.22 -56.74 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 mt -87.36 16.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.927 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -65.96 91.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.433 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 71.6 143.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.0 OUTLIER 171.25 166.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.234 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -130.43 132.17 45.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.63 166.49 16.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 3.2 m-20 -97.41 -54.34 3.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -1.194 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 21.2 m -122.6 -18.05 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.814 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 112' ' ' VAL . 1.4 m-20 -46.4 -95.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.565 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -13.08 60.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.175 -0.953 . . . . 0.0 108.47 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -73.28 -5.0 36.65 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -85.31 -30.93 23.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.61 -16.62 61.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -21.94 63.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.36 -27.42 25.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.653 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -81.81 -27.84 33.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.673 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.431 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -76.2 -58.57 3.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -45.7 -25.05 0.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HD3' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -66.56 -50.36 63.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.831 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.56 71.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 125' ' ' ILE . 37.6 mm -59.97 -14.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.861 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.5 -47.19 64.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.573 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -73.91 -23.02 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' A' ' 98' ' ' LYS . 3.2 tt -74.94 -13.54 60.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.73 -48.19 7.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.752 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.54 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.9 m -62.69 -38.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -64.57 -18.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.31 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 135' ' ' LYS . 0.1 OUTLIER -82.22 -18.49 42.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.564 HD13 ' CZ ' ' A' ' 61' ' ' PHE . 1.1 pp -90.09 -24.83 21.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.413 ' HA ' ' HB1' ' A' ' 137' ' ' ALA . 10.7 t -69.72 -5.57 25.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.516 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.51 ' HE2' ' CG ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -53.19 -20.97 4.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.51 ' CG ' ' HE2' ' A' ' 135' ' ' LYS . 14.8 mttt -113.85 -12.75 12.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.38 -58.0 2.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 ptp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.419 179.879 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.473 ' O ' ' HB ' ' A' ' 3' ' ' THR . 3.8 mtt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.549 ' CB ' ' HB2' ' A' ' 21' ' ' GLU . 9.1 t 174.47 128.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.638 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 21.8 p90 -107.68 -161.57 0.79 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.582 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.1 t-80 -117.26 144.59 44.67 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 109.052 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.623 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -135.59 161.4 35.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.306 -1.496 . . . . 0.0 109.194 178.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -149.49 94.55 2.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.486 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.85 112.27 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.183 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.35 156.82 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 1.6 t -157.71 84.14 0.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . 57.56 21.79 7.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 1.3 pt-20 175.13 88.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -59.49 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.31 48.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.472 ' HB3' HG22 ' A' ' 62' ' ' ILE . 9.2 mtt -136.52 -52.47 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.427 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.623 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 33.9 t80 -166.53 129.25 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.494 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 79.4 p -161.6 94.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.422 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.22 -146.8 11.84 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 11.4 mt -68.24 167.92 13.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -1.142 . . . . 0.0 109.257 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 177.9 155.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 108.794 -177.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 6.4 tt0 -151.06 -44.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.537 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -105.97 76.49 1.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 111.494 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.552 ' CB ' HG13 ' A' ' 52' ' ' ILE . 6.5 pt -102.97 147.81 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.51 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 37.4 tt0 -145.71 127.24 15.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.786 -1.196 . . . . 0.0 110.333 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 t -104.71 133.09 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.44 -0.787 . . . . 0.0 108.963 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -124.46 129.55 50.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.467 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.23 -128.36 1.29 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -108.39 -18.52 13.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -1.168 . . . . 0.0 109.566 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.34 149.14 27.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.75 -74.44 1.32 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER 60.87 -175.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -1.099 . . . . 0.0 109.908 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 31' ' ' GLU . 14.3 mt 61.11 138.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 109.749 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.51 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.89 -102.1 2.42 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.638 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 10.5 mm -154.24 141.7 12.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.315 -1.109 . . . . 0.0 109.154 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -124.69 177.7 1.72 Allowed Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -75.11 76.51 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.04 1.827 . . . . 0.0 110.425 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.37 41.04 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -99.49 144.81 28.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -1.136 . . . . 0.0 109.565 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.508 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -55.64 175.65 0.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.46 106.2 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.709 2.273 . . . . 0.0 110.443 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 122.61 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.404 HD23 ' OE1' ' A' ' 70' ' ' GLU . 2.9 mt -136.21 71.65 1.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 p -137.69 -154.91 0.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.494 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.01 167.51 10.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.448 HG12 ' HB3' ' A' ' 69' ' ' LEU . 1.2 mt -103.57 -147.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.114 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -168.88 167.79 5.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.998 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 65' ' ' SER . 35.7 Cg_endo -78.88 122.42 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.745 2.297 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 176.85 -161.06 28.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.476 ' HB2' ' HB ' ' A' ' 130' ' ' VAL . 2.3 ppp? -107.87 176.08 5.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -1.081 . . . . 0.0 109.222 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.521 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -164.38 126.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.995 -1.066 . . . . 0.0 110.064 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -99.14 169.43 9.4 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CD1' HD23 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -161.31 158.27 2.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.415 -1.428 . . . . 0.0 110.692 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.537 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 39.7 t -139.21 100.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -58.2 159.82 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.518 ' CG ' HG23 ' A' ' 3' ' ' THR . 4.1 tm0? -42.08 -52.09 4.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 109.619 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -57.98 178.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.18 82.37 1.68 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.46 -167.59 2.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 9.2 pt-20 -166.68 141.27 4.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.25 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' HG23 ' A' ' 52' ' ' ILE . 1.7 mm-40 -116.2 167.63 10.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.718 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE2' HG21 ' A' ' 130' ' ' VAL . 6.0 m-85 -129.24 119.15 23.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.049 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.521 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -126.79 179.93 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.132 -0.98 . . . . 0.0 109.871 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.567 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -173.79 142.62 0.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.12 178.92 8.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.746 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' PRO . 14.0 p -104.99 -25.47 12.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.64 178.19 37.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.11 -133.5 3.72 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -144.4 130.43 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.24 . . . . 0.0 109.31 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HA ' ' CG1' ' A' ' 78' ' ' VAL . 2.3 pp -109.13 125.91 52.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.786 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' O ' HG21 ' A' ' 76' ' ' VAL . 22.8 tt0 -125.17 129.14 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.065 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.47 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 7.1 p -99.24 155.46 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.832 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.509 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -138.21 170.83 9.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.432 -0.792 . . . . 0.0 109.442 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.47 71.76 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.659 2.239 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.19 -1.35 7.72 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.234 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 38.2 p-10 -172.88 175.26 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.933 -1.333 . . . . 0.0 109.865 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -161.14 162.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.502 HG21 ' N ' ' A' ' 78' ' ' VAL . 29.4 m -158.54 149.36 20.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.418 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' N ' HG21 ' A' ' 77' ' ' THR . 7.0 m -135.86 157.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 112.88 16.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.711 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.61 159.18 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.93 -48.87 16.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.7 t -102.04 -178.56 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.419 ' C ' ' HE2' ' A' ' 15' ' ' MET . . . -170.13 85.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.567 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.1 mp -104.09 67.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.21 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 84' ' ' ILE . 1.2 ptt180 -42.23 139.42 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.495 -0.753 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.485 ' C ' ' CG ' ' A' ' 87' ' ' GLN . . . -47.36 148.81 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.485 ' CG ' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 58.61 25.1 12.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -1.222 . . . . 0.0 109.043 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 87' ' ' GLN . 17.6 p-10 -41.04 -46.39 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.04 -61.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.874 . . . . 0.0 109.343 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.08 172.2 13.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.3 OUTLIER -140.31 -87.27 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.359 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -19.29 56.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -77.17 -8.43 57.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.36 -8.32 51.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.959 . . . . 0.0 109.203 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -23.37 58.86 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.377 -0.827 . . . . 0.0 109.527 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -85.37 5.41 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.626 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.1 -12.44 38.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -29.52 65.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.542 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -90.23 -32.66 16.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.39 -8.11 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.202 -0.937 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.09 -30.67 20.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -0.989 . . . . 0.0 109.384 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.56 -33.4 72.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.525 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.57 -35.29 73.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -75.27 -20.6 59.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 32.3 mt -90.33 21.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 55.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -119.8 145.77 46.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.381 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.428 ' HA ' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p -128.95 138.29 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.686 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.6 -68.78 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.26 -100.14 0.14 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.533 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.1 OUTLIER -72.14 156.76 38.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.457 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 14.8 m 40.88 37.91 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.682 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 11.2 t70 -88.14 -96.3 0.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.192 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.37 -19.38 63.84 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.39 -41.79 84.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -90.12 -16.63 29.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.348 -0.845 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.38 -32.14 43.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.4 t -55.71 -21.75 20.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 109.587 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.85 -29.28 18.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.28 -24.75 63.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 125' ' ' ILE . 8.8 tt -82.51 -50.92 8.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.54 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.44 1.73 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.829 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.09 -61.76 1.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -78.3 -20.48 51.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 125' ' ' ILE . 1.3 mp -75.72 -12.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 109.163 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.7 78.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.285 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.549 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -78.66 -7.62 57.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 5.8 tp -78.26 -26.76 47.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.468 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.421 ' O ' HD21 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -87.94 -25.25 23.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.752 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.585 HG21 ' CE2' ' A' ' 61' ' ' PHE . 2.3 p -80.53 -25.7 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.643 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.478 ' HA ' HG22 ' A' ' 134' ' ' THR . 2.1 tt -90.58 -24.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.232 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 -44.94 46.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.095 -1.003 . . . . 0.0 110.198 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.421 HD21 ' O ' ' A' ' 129' ' ' ARG . 2.6 pp -68.56 -11.03 59.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 110.038 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 131' ' ' ILE . 57.4 p -53.28 -41.88 66.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.569 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -41.76 64.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -94.57 40.66 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.379 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.12 6.75 36.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.847 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.542 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.7 mtp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.522 ' CB ' ' HG3' ' A' ' 55' ' ' GLN . 70.9 p -132.39 161.7 32.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.905 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.616 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 4.0 p90 -163.61 -143.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.574 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 2.4 t-80 -139.69 149.45 43.69 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.656 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 1.6 pp -142.67 159.25 42.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.685 -1.259 . . . . 0.0 108.631 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.43 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.8 t0 -135.49 87.0 2.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.895 -1.128 . . . . 0.0 109.678 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 14.7 p -99.04 100.44 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.22 -0.925 . . . . 0.0 109.604 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 HG23 ' HG2' ' A' ' 13' ' ' GLN . 55.2 t -108.95 149.03 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.865 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.44 ' N ' HG11 ' A' ' 9' ' ' VAL . 2.4 p -162.58 144.9 10.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.74 -96.98 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.717 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.55 38.98 3.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.056 -1.028 . . . . 0.0 109.567 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.86 -153.71 0.34 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.251 -0.905 . . . . 0.0 109.457 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.422 ' O ' ' SD ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 70.46 61.5 0.21 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.519 -0.738 . . . . 0.0 109.491 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.523 ' CG ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.72 -70.28 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.519 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 34.9 t80 -162.8 131.95 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -160.82 105.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.278 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.566 ' HA2' ' CD2' ' A' ' 5' ' ' HIS . . . 146.67 -158.62 27.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.641 ' N ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -48.39 -179.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.068 -1.254 . . . . 0.0 109.474 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.677 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 170.37 115.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.549 -1.344 . . . . 0.0 109.74 179.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 1.5 tt0 -67.93 -44.7 76.27 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.5 mtpt -179.5 143.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.995 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 23.5 pt -105.34 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -178.92 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 109.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.482 ' CG1' ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.24 127.61 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.992 . . . . 0.0 109.513 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -130.64 140.6 50.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.83 54.11 0.04 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.476 ' HB3' ' CB ' ' A' ' 46' ' ' LYS . 89.4 p -174.17 -159.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 109.438 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.29 48.18 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -167.11 -144.07 3.99 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.3 OUTLIER 166.98 74.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' HG21 ' A' ' 25' ' ' VAL . 12.6 mt -153.07 178.24 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.877 . . . . 0.0 109.67 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.484 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -128.68 -112.36 1.63 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.784 -2.127 . . . . 0.0 107.784 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.616 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 12.7 mm -154.1 138.25 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 109.124 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -138.28 176.9 2.37 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.6 Cg_endo -74.06 8.11 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.995 1.797 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.6 10.77 5.23 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' ALA . 40.1 t60 -54.33 123.75 13.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -1.215 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.554 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -49.17 178.56 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 34.9 Cg_endo -77.72 81.36 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.465 2.11 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.433 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -98.71 137.61 37.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.663 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.06 72.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.412 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 p -144.27 -146.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.51 169.92 8.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.454 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.521 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -130.49 173.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 109.251 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -111.18 173.07 3.07 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.7 Cg_endo -78.31 -177.94 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.735 2.29 . . . . 0.0 110.474 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 126' ' ' ALA . . . 133.38 -159.12 23.51 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.517 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 4.6 ppp? -113.28 172.78 6.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.255 -1.144 . . . . 0.0 109.126 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.517 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 5.1 tt -146.75 146.81 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.052 -1.03 . . . . 0.0 110.922 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.46 160.28 23.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -153.71 158.98 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.458 -1.401 . . . . 0.0 110.926 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.77 102.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -52.09 141.33 18.64 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.122 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.574 ' OE1' ' CG ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -39.91 -59.1 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.574 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 3.4 m170 -122.36 31.58 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.739 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.35 -108.15 3.16 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -151.9 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -1.127 . . . . 0.0 109.139 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER 179.65 147.67 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.551 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.91 161.39 31.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.104 -0.998 . . . . 0.0 109.782 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -117.64 125.31 50.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.272 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.523 HG22 ' CG ' ' A' ' 15' ' ' MET . 5.2 mt -136.8 166.58 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.331 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.594 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.92 146.18 25.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.1 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -172.81 4.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.519 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.428 ' OG ' ' HB ' ' A' ' 82' ' ' THR . 62.8 m -115.65 14.38 16.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.83 151.45 25.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . -165.85 -106.64 0.19 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 9.1 mt -139.2 122.27 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 108.97 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -106.58 133.48 51.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.782 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -133.5 143.64 48.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.019 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 40' ' ' PRO . 14.7 p -109.94 139.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.917 -1.114 . . . . 0.0 109.494 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -127.87 176.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 108.862 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.0 Cg_endo -79.22 88.91 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.514 2.142 . . . . 0.0 111.103 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 101.07 -3.43 55.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.4 OUTLIER -164.37 155.3 15.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.242 . . . . 0.0 109.72 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 6' ' ' LEU . 35.5 m -133.16 175.74 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 108.845 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 7' ' ' ASP . 17.6 m -156.63 104.58 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.282 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 3.5 m -114.47 115.8 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 108.963 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.416 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -100.21 173.2 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.132 -0.98 . . . . 0.0 110.034 -179.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.447 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -157.69 -157.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 0.0 109.182 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.22 -30.78 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.95 . . . . 0.0 109.805 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.428 ' HB ' ' OG ' ' A' ' 65' ' ' SER . 5.5 m -110.01 153.2 24.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.412 ' C ' ' CD1' ' A' ' 84' ' ' ILE . . . -152.64 119.75 5.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.793 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.594 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 2.6 mp -139.07 95.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.29 -0.881 . . . . 0.0 108.907 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 84' ' ' ILE . 13.5 ttm180 -41.24 161.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.394 -0.816 . . . . 0.0 109.898 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -51.1 -26.32 12.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -151.7 93.41 1.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -1.153 . . . . 0.0 109.637 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -94.14 -57.88 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -83.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 109.475 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.13 165.97 17.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.43 -19.94 11.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.945 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 -25.59 32.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -65.51 -13.9 59.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.71 -32.0 16.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.379 -0.825 . . . . 0.0 109.29 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.409 ' HA ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -56.01 -40.61 73.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.802 . . . . 0.0 109.681 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.91 -16.5 53.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.54 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 100' ' ' LYS . . . -64.37 -27.76 69.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.654 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -55.71 29.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.549 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -19.92 62.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.907 . . . . 0.0 109.554 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.95 -34.28 77.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.61 -20.81 23.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.401 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.02 -16.67 64.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -80.53 -30.37 37.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -32.36 32.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.518 ' CG2' ' HB2' ' A' ' 118' ' ' SER . 25.6 mt -88.98 22.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 t -60.84 -24.94 66.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 m -140.02 167.08 22.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.215 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.08 134.1 3.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.618 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -156.14 179.47 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.89 -178.89 35.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 12.4 m-20 -98.41 127.62 44.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.518 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.29 28.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 109.672 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 111' ' ' ASP . 15.5 t70 -84.88 -93.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.45 -13.6 60.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.1 62.73 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.433 ' HG3' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -74.81 -45.95 40.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.498 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.45 -23.3 65.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.496 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 105' ' ' ILE . 8.6 p -70.6 -5.78 31.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.5 -12.23 52.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.41 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -73.71 -12.52 60.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -70.1 -60.79 2.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.69 -10.44 27.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.539 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -34.4 36.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.209 -0.932 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -82.4 -14.96 54.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 121' ' ' LEU . 48.0 mm -73.04 -8.16 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.485 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . . . -73.35 -35.23 65.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -0.907 . . . . 0.0 109.642 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.522 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 8.5 mt-30 -69.83 -23.26 63.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.464 ' HA ' HG12 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -69.47 -20.48 63.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.379 -0.825 . . . . 0.0 109.809 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -85.02 -40.63 16.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.557 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . 20.8 m -68.01 -16.95 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.669 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 127' ' ' GLN . 4.9 pt -90.97 -31.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -80.05 -30.87 39.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.743 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.5 mp -79.81 -40.22 29.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.758 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.9 p -63.16 -34.16 77.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.68 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -74.18 -15.98 61.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.542 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.04 29.6 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.668 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.41 -78.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.935 . . . . 0.0 109.53 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.0 mtm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.226 0.536 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.428 HG21 ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -104.86 -148.15 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.652 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.714 ' HB3' HG12 ' A' ' 20' ' ' VAL 0.253 0.7 OUTLIER -142.25 -169.71 3.01 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 124.107 1.908 . . . . 0.0 115.576 -175.438 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 7.3 t-80 -170.8 95.98 0.21 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 102.319 -3.215 . . . . 0.0 102.319 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.639 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -91.52 147.83 22.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.522 -1.361 . . . . 0.0 108.638 -176.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -155.76 69.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.847 -1.158 . . . . 0.0 110.015 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 78' ' ' VAL . 1.7 p -102.74 112.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 108.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 3.9 m -103.97 144.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.802 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.455 ' HB2' ' CB ' ' A' ' 13' ' ' GLN . 55.9 m -107.35 53.11 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 109.265 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . 72.03 77.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.361 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.38 31.6 12.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 10' ' ' SER . 1.9 tp60 -114.79 -28.18 7.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 46.07 88.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -85.82 -84.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 109.537 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.707 ' CZ ' HG11 ' A' ' 20' ' ' VAL . 1.1 t80 -101.05 112.09 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 94.6 p -128.72 85.84 2.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.131 -0.981 . . . . 0.0 109.658 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . 168.33 148.15 5.62 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.597 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.681 ' CD2' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -35.63 161.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.886 0.851 . . . . 0.0 111.656 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -158.51 -160.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 O-C-N 121.684 -0.635 . . . . 0.0 109.988 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.613 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 2.3 tt0 -160.33 -32.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.734 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.6 mmmt -141.21 85.2 1.96 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.782 -1.199 . . . . 0.0 110.309 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.557 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.57 142.68 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -127.41 143.91 51.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.762 -1.211 . . . . 0.0 110.309 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.443 HG22 HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -133.44 116.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.176 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -122.69 125.35 45.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.07 -40.27 0.18 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 159.87 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -1.192 . . . . 0.0 109.646 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -48.09 -43.03 30.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.55 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.44 -51.53 47.17 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.84 20.37 11.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -1.191 . . . . 0.0 109.414 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 153.93 40.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.716 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.39 171.03 23.85 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.557 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 16.6 mm -101.82 112.39 34.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.858 -1.378 . . . . 0.0 109.136 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.598 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -122.92 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.5 Cg_endo -76.89 5.56 4.83 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.551 1.501 . . . . 0.0 110.44 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.84 17.84 2.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.446 ' CG ' HD12 ' A' ' 34' ' ' ILE . 16.7 t60 -44.81 146.53 0.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -1.092 . . . . 0.0 109.541 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.0 10.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.669 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.53 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.4 Cg_endo -77.55 77.58 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.637 2.225 . . . . 0.0 110.222 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -98.42 159.03 15.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.718 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.431 HD11 ' C ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -157.43 32.04 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.424 ' O ' HG13 ' A' ' 68' ' ' ILE . 44.1 p -114.96 -144.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.389 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.79 164.91 11.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.015 . . . . 0.0 109.155 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.566 ' CD1' ' CB ' ' A' ' 69' ' ' LEU . 5.4 mt -128.99 149.88 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.99 . . . . 0.0 109.554 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' N ' HG21 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -70.24 167.86 22.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -78.99 136.58 13.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.744 2.296 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.62 -161.96 26.43 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.452 ' SD ' ' HB ' ' A' ' 130' ' ' VAL . 8.3 ptm -117.4 -164.23 0.98 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -1.133 . . . . 0.0 109.192 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.526 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -174.68 147.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.085 . . . . 0.0 109.982 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -129.17 126.37 39.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 23' ' ' ILE . 30.6 mt -123.53 166.36 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.874 -1.141 . . . . 0.0 111.037 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 34.2 t -132.23 119.26 39.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -71.05 129.49 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.653 . . . . 0.0 109.315 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 11.5 tt0 52.68 -90.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 54' ' ' LYS . 3.3 t-160 -171.1 60.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.77 -68.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -76.5 179.73 5.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -1.101 . . . . 0.0 109.399 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -156.5 153.68 29.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.844 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 156.44 36.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.251 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.55 ' CE2' ' O ' ' A' ' 130' ' ' VAL . 4.4 m-85 -119.24 124.97 48.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.544 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.469 ' CG1' HD13 ' A' ' 50' ' ' ILE . 5.3 mm -128.71 178.29 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.307 -0.871 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -173.24 125.98 0.43 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.458 ' CD2' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -113.36 -177.61 3.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.514 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 1.2 t -149.56 18.19 0.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.932 . . . . 0.0 109.384 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.13 156.72 6.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.14 -169.67 25.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.499 ' O ' ' CG2' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -115.94 118.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -1.123 . . . . 0.0 109.369 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.566 ' CB ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -101.91 153.12 20.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.208 -0.933 . . . . 0.0 109.922 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.473 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 41.6 tt0 -152.15 134.46 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 12.6 p -99.92 139.77 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.006 -1.059 . . . . 0.0 110.248 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.515 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.59 174.53 3.28 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.4 Cg_endo -78.62 103.4 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.32 2.014 . . . . 0.0 110.821 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 75.42 45.64 17.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 2.2 t30 159.91 115.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.468 -1.019 . . . . 0.0 109.177 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 ' HB ' HD12 ' A' ' 6' ' ' LEU . 23.5 t -102.2 146.53 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 108.875 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.2 m -147.59 136.68 22.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.802 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.531 HG12 ' CG2' ' A' ' 8' ' ' VAL . 1.4 p -150.4 142.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 108.991 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 4.6 mp -105.21 159.26 16.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -163.73 -174.36 3.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.333 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.68 -39.03 3.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 1.8 m -99.46 149.18 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.254 -0.904 . . . . 0.0 109.196 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -159.81 141.83 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.549 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 46.8 mt -132.67 126.14 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.328 -0.858 . . . . 0.0 108.793 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 86' ' ' GLY . 3.0 tpt180 -92.37 91.98 7.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.034 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 39.06 -102.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.4 ' HG2' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -94.26 81.81 4.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -1.161 . . . . 0.0 109.593 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.65 -53.33 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.098 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 2.8 mp -92.11 31.92 1.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.066 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 131' ' ' ILE . 18.2 m-20 62.21 -179.55 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.372 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.438 ' HG2' HD12 ' A' ' 131' ' ' ILE . 1.6 mt-10 -108.63 -36.59 6.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.0 -12.75 57.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 48.1 ttp180 -82.28 -26.77 32.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.44 -13.53 40.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 108.9 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 mtt -70.34 -20.79 62.96 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 109.48 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -68.8 -18.98 64.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.53 -54.97 3.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.094 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.479 ' HG2' ' CG1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.2 -39.47 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.104 -179.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -36.04 82.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 110.005 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -4.57 58.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 109.876 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.29 -20.97 22.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.714 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.423 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 5.6 tp10 -73.68 -36.8 65.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.34 -22.96 64.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -51.72 26.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.511 ' CD1' HD11 ' A' ' 121' ' ' LEU . 91.1 mt -89.14 22.84 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.98 -54.74 7.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -98.77 132.95 43.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -162.75 138.87 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.65 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.431 ' N ' ' CD2' ' A' ' 109' ' ' HIS . 0.5 OUTLIER -168.33 169.08 10.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.63 -173.53 28.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 5.0 t0 -101.17 135.26 42.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.272 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.59 28.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 6.9 t70 -79.24 -95.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.418 -0.801 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -69.76 -21.72 63.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.29 73.55 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -46.39 85.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.85 -11.22 58.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.9 t -82.77 6.03 19.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.907 . . . . 0.0 109.592 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.21 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 109.558 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -77.03 -18.51 58.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.44 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.511 HD11 ' CD1' ' A' ' 105' ' ' ILE . 9.0 tt -71.77 -63.32 1.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.05 -18.94 4.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.702 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -45.27 -38.32 5.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.79 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -90.55 -23.71 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 0.0 110.127 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 125' ' ' ILE . 2.2 mp -77.08 -1.06 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.83 -24.15 60.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.01 -1.056 . . . . 0.0 109.166 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.512 ' CB ' HD11 ' A' ' 84' ' ' ILE . 3.7 pt20 -90.06 -32.13 16.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.32 -20.84 65.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.678 -179.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 133' ' ' LEU . 2.0 mtt180 -90.15 -48.09 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.55 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -62.27 -28.97 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.511 ' CD1' ' O ' ' A' ' 90' ' ' ASP . 4.8 tt -90.74 -29.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.249 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 17.0 mm-40 -72.86 -34.01 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.389 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 129' ' ' ARG . 2.9 pp -83.62 10.92 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.992 . . . . 0.0 109.727 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 130' ' ' VAL . 76.3 p -83.05 -9.68 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -84.76 -47.94 9.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.752 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.5 OUTLIER -80.18 -2.81 46.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.705 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.57 -22.4 54.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.11 -0.994 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.437 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.464 ' O ' ' HB ' ' A' ' 3' ' ' THR . 4.5 mtm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.196 0.522 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.541 ' CB ' ' HB2' ' A' ' 21' ' ' GLU . 12.2 t 178.05 124.88 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.54 ' OH ' ' CD1' ' A' ' 23' ' ' ILE . 30.0 p90 -100.74 -159.41 0.73 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.567 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -122.77 144.02 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 108.823 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.603 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -135.21 167.67 20.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.532 178.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.592 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.49 97.75 2.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.499 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 19.3 m -99.49 148.54 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 108.695 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' CG2' ' C ' ' A' ' 8' ' ' VAL . 1.9 t -155.88 126.59 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.477 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.77 104.53 13.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.842 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.22 -95.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.716 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -139.26 56.91 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.607 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 169.99 13.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 111.52 22.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.6 mtt -116.76 -80.87 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.958 . . . . 0.0 109.842 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 32.5 t80 -130.16 147.08 51.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.744 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 p -175.07 92.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 158.79 -147.38 14.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.554 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 8.9 mt -64.17 172.61 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -1.194 . . . . 0.0 108.982 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.616 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 173.47 149.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.816 -1.177 . . . . 0.0 109.438 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.541 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -142.75 -47.12 0.32 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 4.6 tttp -93.94 126.37 39.11 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.207 -0.933 . . . . 0.0 109.088 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.604 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -154.97 66.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.577 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 18.6 tt0 -98.51 132.29 44.06 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.819 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' ' 26' ' ' THR . 2.7 p -119.94 140.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.503 ' N ' HG21 ' A' ' 25' ' ' VAL . 16.4 m -114.57 132.23 56.41 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 109.591 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.2 -107.94 0.63 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -150.8 159.51 44.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.463 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 51.01 42.83 28.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 148.32 -172.58 28.54 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 1.1 pt-20 179.61 -155.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.415 -1.05 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 31' ' ' GLU . 15.4 mt 60.34 130.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.347 -0.846 . . . . 0.0 109.633 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 23' ' ' ILE . . . -99.85 -84.03 1.77 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.591 ' C ' ' CD1' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -162.97 161.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.376 -1.073 . . . . 0.0 109.535 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -154.14 173.43 4.73 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -178.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 33.9 Cg_endo -75.88 94.56 1.01 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.309 2.006 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.12 -12.78 2.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' HD13 ' A' ' 34' ' ' ILE . 3.9 t-80 -60.71 -178.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.73 167.73 9.48 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.682 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 71' ' ' VAL . 35.6 Cg_endo -78.89 77.84 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.746 2.298 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.4 mt -99.68 155.31 17.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.398 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.69 99.7 5.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.529 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -135.71 -168.73 2.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.91 -172.02 2.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 69' ' ' LEU . 2.0 mp -110.8 116.88 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.648 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.51 166.1 9.99 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.201 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.38 120.41 4.86 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.622 2.215 . . . . 0.0 110.536 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.5 -155.94 27.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.456 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 1.7 ppp? -119.11 174.86 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -1.12 . . . . 0.0 109.267 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 1.5 tt -153.45 131.55 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.095 -1.003 . . . . 0.0 110.344 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.27 21.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.566 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -142.48 143.51 25.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.758 -1.214 . . . . 0.0 110.618 -178.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 37.2 t -127.53 104.07 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.71 136.37 57.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 46.16 -99.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.32 21.49 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -137.4 -65.26 0.05 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -69.87 142.1 53.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.45 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.3 131.63 25.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.862 . . . . 0.0 109.361 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.01 153.81 36.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.763 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.412 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 14.3 m-85 -100.45 155.55 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 62' ' ' ILE . 50.5 mt -154.8 160.7 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.562 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -163.63 152.95 14.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.91 . . . . 0.0 108.927 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.497 ' N ' HD22 ' A' ' 64' ' ' LEU . 2.5 pt? -179.88 162.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.469 ' CB ' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -143.39 36.11 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.4 114.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.11 -177.54 35.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 78' ' ' VAL . 2.2 mp -129.61 135.36 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -1.153 . . . . 0.0 109.28 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.563 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 1.2 tt -121.5 145.13 48.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -135.87 129.66 32.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG22 ' CG2' ' A' ' 76' ' ' VAL . 4.3 p -100.08 123.72 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.483 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -101.75 174.11 3.12 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.2 Cg_endo -78.24 72.45 6.25 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.631 2.221 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.51 -14.33 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.189 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 78.7 m-20 -145.53 -176.16 5.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.305 . . . . 0.0 109.893 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 77' ' ' THR . 12.1 t -158.66 165.82 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.542 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -169.63 140.06 2.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.975 . . . . 0.0 109.604 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 68' ' ' ILE . 1.7 p -153.31 140.42 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.39 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mt -116.41 150.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.45 13.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 -39.47 4.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 m -108.9 136.72 47.97 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 0.0 109.197 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -158.4 163.33 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.088 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.562 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 43.7 mt -142.92 116.87 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.54 109.62 21.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.594 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.64 -146.38 31.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.469 ' OE1' HG12 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -107.97 34.43 3.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -1.098 . . . . 0.0 108.798 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 87' ' ' GLN . 4.5 t0 -44.71 -29.67 0.81 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.407 -0.808 . . . . 0.0 109.68 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -120.7 111.35 17.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.617 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 21.2 m-20 60.24 157.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 -83.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -16.95 60.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.497 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.91 0.1 32.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.41 -5.75 55.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.415 ' HB2' ' HE1' ' A' ' 95' ' ' MET . 0.1 OUTLIER -81.21 -22.64 38.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.79 -28.6 19.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.624 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.45 ' O ' ' HB1' ' A' ' 101' ' ' ALA . . . -71.46 -20.02 62.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.74 -26.16 27.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.36 11.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -62.11 -26.94 68.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.17 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 97' ' ' ALA . . . -79.74 -44.62 20.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.323 -0.861 . . . . 0.0 109.106 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -54.03 -38.16 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.288 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.412 ' OE1' ' CA ' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -46.54 -42.32 15.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -72.46 -38.12 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.4 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.6 mt -87.94 22.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -55.91 27.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.86 136.8 54.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 59.7 p -131.23 -179.41 5.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -178.63 -171.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.89 176.46 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 111' ' ' ASP . 25.5 t0 -83.74 -73.94 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -103.61 13.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.02 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 16.1 t80 -71.29 -16.92 62.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.165 -0.959 . . . . 0.0 108.601 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.0 66.77 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -47.97 75.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.37 -6.08 37.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.71 -11.06 54.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.562 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 123' ' ' LYS . . . -85.03 -29.28 25.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.615 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -28.43 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -81.32 -61.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.65 -38.63 2.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 109.743 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.469 ' HD3' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -45.75 -59.35 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.46 -21.64 63.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.752 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 121' ' ' LEU . 20.3 mm -71.42 -4.2 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' A' ' 49' ' ' MET . . . -84.42 -9.91 57.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.653 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.448 ' O ' HG21 ' A' ' 131' ' ' ILE . 4.2 tt0 -82.65 -26.4 32.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.936 . . . . 0.0 109.651 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 61.8 tp -75.52 -8.98 58.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -43.93 10.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.933 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.412 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.9 m -69.74 -24.72 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.928 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -89.52 -48.13 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.87 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 131' ' ' ILE . 13.0 pt-20 -54.66 -24.32 21.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.322 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -80.66 -43.06 21.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 0.0 109.78 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 41.7 p -43.11 -34.85 1.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.645 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -67.78 -49.67 61.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -96.51 45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.11 -36.23 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.606 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.585 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.2 ptt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.532 ' HA ' ' HB3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 54.2 103.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.593 ' CZ ' HG23 ' A' ' 34' ' ' ILE . 27.3 p90 -99.24 -152.08 0.4 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -129.68 146.63 51.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 2.5 pp -133.31 169.67 16.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.312 -1.493 . . . . 0.0 109.252 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.491 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 21.6 t70 -146.0 100.53 3.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 9.1 p -105.57 105.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.083 -1.011 . . . . 0.0 109.745 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.361 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.505 ' HB3' ' CB ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -166.95 73.11 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.746 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . 72.32 5.38 5.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 39.6 mt-10 -156.58 76.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 12' ' ' GLU . 3.3 pt20 -56.01 -164.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.723 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER 72.11 32.04 1.84 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.534 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.514 ' CE ' ' CG2' ' A' ' 62' ' ' ILE . 16.0 mtt -106.18 -79.96 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 109.249 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.662 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 37.5 t80 -146.25 117.78 8.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -145.05 108.65 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.115 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 143.5 -163.32 27.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.645 ' N ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -43.93 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.695 -0.885 . . . . 0.0 110.879 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.643 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 167.05 150.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -147.78 -39.18 0.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.8 -1.187 . . . . 0.0 110.471 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 1.8 mptt -116.95 78.57 1.22 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.937 -1.102 . . . . 0.0 111.324 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.57 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 7.8 pt -101.14 160.93 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 50' ' ' ILE . 4.2 tt0 -162.78 116.28 1.67 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.706 -1.246 . . . . 0.0 110.184 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.93 111.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 108.988 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.427 HG21 ' OE1' ' A' ' 31' ' ' GLU . 97.7 m -100.15 110.84 23.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.438 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -136.19 -116.53 1.57 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -118.24 124.03 46.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -1.139 . . . . 0.0 109.57 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.0 tt0 76.44 111.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.35 164.76 39.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 1.2 tt0 -163.54 64.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.145 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 23.4 mt -149.58 140.8 23.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.091 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.91 -105.06 2.65 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.806 -2.117 . . . . 0.0 107.806 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.593 HG23 ' CZ ' ' A' ' 4' ' ' TYR . 7.6 mm -153.85 143.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.289 -1.124 . . . . 0.0 109.278 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -142.18 173.63 4.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -72.63 94.45 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.954 1.769 . . . . 0.0 109.752 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.15 4.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.519 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.0 t-80 -71.75 166.06 22.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -89.67 176.23 3.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.253 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 34.9 Cg_endo -76.82 100.7 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.516 2.144 . . . . 0.0 110.374 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.508 ' N ' HG13 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -93.21 140.29 29.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.592 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.76 48.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 p -118.71 -146.61 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.385 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -100.34 176.3 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 69' ' ' LEU . 1.6 tp -102.29 151.23 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 141.52 47.44 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.958 . . . . 0.0 109.607 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.3 Cg_endo -79.38 -179.8 5.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.554 2.169 . . . . 0.0 110.321 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 101.58 -129.0 9.75 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.418 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.9 ptm -119.42 177.79 4.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.155 . . . . 0.0 109.236 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 1.2 tt -152.84 130.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.075 -1.016 . . . . 0.0 110.003 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.53 HG13 ' CB ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -148.59 158.8 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.65 -1.281 . . . . 0.0 111.076 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 25.0 t -139.35 99.72 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HD3' ' CB ' ' A' ' 58' ' ' HIS . 6.0 ptmt -65.91 153.35 42.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.513 ' HA ' HG22 ' A' ' 3' ' ' THR . 1.5 tt0 -41.62 -52.88 3.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.488 -0.758 . . . . 0.0 110.137 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -43.67 -51.04 7.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.868 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.21 -38.71 1.44 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.459 ' CB ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -48.65 129.1 16.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -1.235 . . . . 0.0 109.313 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.45 123.59 48.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.329 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -122.95 144.83 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 109.424 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 1.6 p90 -114.62 135.85 53.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.514 ' CG2' ' CE ' ' A' ' 15' ' ' MET . 2.7 mm -108.43 -155.87 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.83 . . . . 0.0 109.07 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 48' ' ' GLY . 5.3 t80 -168.0 125.18 1.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.66 178.04 6.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 0.0 109.021 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 9.04 4.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.745 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 80' ' ' ALA . . . 138.25 144.73 4.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.48 -155.47 23.35 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 28.7 mt -133.8 133.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -1.181 . . . . 0.0 109.42 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HB3' HD11 ' A' ' 45' ' ' ILE . 1.1 pp -114.05 -169.71 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -179.91 149.08 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.262 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 41' ' ' LEU . 11.0 p -100.34 141.15 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.498 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 24.8 mt-30 -126.91 160.55 58.58 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.2 Cg_endo -75.32 90.76 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.355 2.036 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.31 6.92 41.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -175.18 -176.87 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -1.177 . . . . 0.0 109.816 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 6' ' ' LEU . 28.6 m -157.96 150.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -135.32 167.97 20.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.909 -1.119 . . . . 0.0 109.834 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 p -175.15 120.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.068 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.34 141.4 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.749 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 10' ' ' SER . . . -127.39 -179.9 5.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.203 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -98.51 -2.05 39.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.54 HG21 ' CD1' ' A' ' 84' ' ' ILE . 1.9 m -155.2 143.67 20.41 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.175 -0.953 . . . . 0.0 109.136 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . . . -146.29 98.61 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.603 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.54 ' CD1' HG21 ' A' ' 82' ' ' THR . 2.1 mp -115.3 84.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.324 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 84' ' ' ILE . 6.5 ttm180 -44.1 164.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -49.64 -64.8 3.19 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -93.45 37.81 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.188 . . . . 0.0 109.628 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -48.46 -48.93 37.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.23 -58.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 0.0 109.172 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.45 107.68 12.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.398 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.448 ' HA ' HD13 ' A' ' 131' ' ' ILE . 47.8 mt-10 -101.72 -70.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.644 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.46 -17.6 36.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.616 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -81.6 -1.02 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.27 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.17 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.483 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -69.39 -37.79 77.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -34.81 11.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.52 -54.46 35.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.352 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -22.8 15.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -75.13 -60.93 2.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -64.17 -12.38 39.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.66 -36.42 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -57.55 -16.83 11.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -57.68 6.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.604 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -11.51 60.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.494 HD12 ' CG ' ' A' ' 121' ' ' LEU . 14.1 mm -76.09 -8.44 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.528 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -46.14 -65.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 0.0 109.331 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 165.85 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -151.39 -50.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 179.94 -72.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.18 -155.23 26.5 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 1.6 m-20 56.99 -101.5 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -1.086 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 116' ' ' GLN . 3.4 m -119.69 -15.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.871 -1.143 . . . . 0.0 109.285 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.8 OUTLIER -47.6 -95.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 118' ' ' SER . 19.3 t80 -74.26 -22.15 59.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -62.52 -20.76 64.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.517 ' CG ' ' O ' ' A' ' 112' ' ' VAL . 33.7 mm-40 -85.71 -52.99 5.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.872 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.507 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . . . -74.53 -1.41 21.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 36.4 t -90.19 -35.65 15.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.769 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.61 -28.57 18.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.868 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.507 ' CG ' ' HA ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -82.09 -8.55 59.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.494 ' CG ' HD12 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -86.06 -48.47 8.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.54 -17.12 18.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -37.66 88.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.465 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.84 -12.37 59.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -83.36 -8.04 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.52 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -68.29 -46.39 70.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 109.305 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 131' ' ' ILE . 12.1 tm0? -67.31 -23.53 65.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.483 ' CD2' ' HG2' ' A' ' 95' ' ' MET . 5.6 mp -74.5 -16.8 60.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 4.1 mtp85 -89.82 -50.69 5.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.78 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 27.4 m -60.54 -34.93 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.558 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 131' ' ' ILE . 3.4 tt -61.44 -36.09 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.337 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 129' ' ' ARG . 2.8 mt-10 -49.89 -27.46 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.218 -0.927 . . . . 0.0 109.363 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mp -75.16 -61.55 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.435 ' HA ' ' HB1' ' A' ' 137' ' ' ALA . 4.9 p -45.56 -31.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -58.53 -66.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.69 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -15.3 56.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.844 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 134' ' ' THR . . . -72.09 -34.8 68.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.239 0.543 . . . . 0.0 109.582 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.501 HG21 ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER 57.11 159.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.6 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 1.4 p90 -158.11 -144.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.49 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 24.1 t-80 -131.51 134.84 46.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.734 -1.229 . . . . 0.0 111.013 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.632 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -106.14 124.28 49.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -136.88 71.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.735 -1.228 . . . . 0.0 109.974 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 78' ' ' VAL . 2.1 p -102.46 124.91 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.38 -172.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.462 ' OG ' ' HB1' ' A' ' 83' ' ' ALA . 6.2 p -166.54 107.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 10' ' ' SER . . . 60.08 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 64.34 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -150.2 104.01 3.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.69 105.04 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.44 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.7 mmt -87.32 -89.1 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.888 . . . . 0.0 109.479 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.632 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -110.14 111.79 23.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 85.7 p -136.13 78.83 1.74 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' N ' ' CE1' ' A' ' 5' ' ' HIS . . . -177.47 174.16 46.73 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 30.9 mt -50.22 163.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -162.27 163.76 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.335 -0.853 . . . . 0.0 108.967 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.501 ' CG ' HG21 ' A' ' 3' ' ' THR . 0.0 OUTLIER -125.29 -39.18 2.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' O ' HG21 ' A' ' 52' ' ' ILE . 2.1 ttmt -156.15 109.07 2.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.031 -1.043 . . . . 0.0 110.369 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.546 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -101.28 146.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.532 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -120.73 141.58 50.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.0 109.988 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 50' ' ' ILE . 13.4 t -136.77 133.49 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 84.8 m -140.94 111.49 6.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 109.842 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 46' ' ' LYS . . . -120.73 -104.91 1.99 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.53 -67.05 1.02 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -117.99 139.15 51.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.097 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.43 69.33 1.41 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.49 77.07 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -1.066 . . . . 0.0 109.596 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mt -113.83 153.43 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 23' ' ' ILE . . . -99.81 172.0 24.34 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 12.9 mm -98.09 134.52 36.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.911 -1.346 . . . . 0.0 108.822 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.557 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -132.3 169.86 12.82 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.0 Cg_endo -72.7 87.6 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.018 1.812 . . . . 0.0 109.923 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 38' ' ' HIS . . . 138.42 -4.4 3.09 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' ALA . 70.3 t60 -42.84 132.72 3.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 0.0 109.501 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.522 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -48.73 176.4 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.1 Cg_endo -77.66 81.31 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.519 2.146 . . . . 0.0 110.291 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -96.75 155.95 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.722 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.84 34.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.403 -0.811 . . . . 0.0 108.907 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 22.4 p -99.56 -147.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 109.486 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.54 164.15 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 46' ' ' LYS . 48.0 mt -105.98 163.04 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 109.273 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 45' ' ' ILE . 8.4 mptt -96.06 151.88 38.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 0.0 109.826 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.483 ' CA ' ' O ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.56 127.71 7.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.82 2.347 . . . . 0.0 110.444 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 174.28 -149.92 11.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.475 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.9 ptm -109.54 -177.04 3.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -1.162 . . . . 0.0 109.405 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 24' ' ' GLN . 47.7 mt -155.08 140.04 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.442 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.496 ' N ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.37 115.38 17.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' A' ' 23' ' ' ILE . 14.1 mt -117.79 169.75 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 111.176 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.441 HG21 ' HG2' ' A' ' 59' ' ' GLU . 53.2 t -137.8 100.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -60.5 126.03 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -0.91 . . . . 0.0 110.154 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 23.1 mt-30 45.82 -92.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' LYS . 14.1 t-160 -164.12 49.87 0.13 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.84 -99.87 0.31 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -74.75 172.08 12.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -1.169 . . . . 0.0 109.874 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.441 ' HG2' HG21 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -127.34 167.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.046 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -133.04 144.86 50.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.489 ' C ' ' CD1' ' A' ' 62' ' ' ILE . 7.3 m-85 -111.21 134.68 52.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.141 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.489 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 2.8 mp -140.78 147.48 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 109.677 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -144.89 151.48 38.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.395 -0.815 . . . . 0.0 109.006 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.94 -173.87 2.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.483 ' O ' ' CA ' ' A' ' 47' ' ' PRO . 70.6 m -112.18 -81.72 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.49 168.09 24.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.35 -176.95 42.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.98 156.58 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.184 -1.186 . . . . 0.0 109.37 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -131.68 169.75 15.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.0 125.93 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 108.848 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 71' ' ' VAL . 11.6 p -99.85 146.77 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.492 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 6.3 mt-30 -131.42 163.78 47.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.036 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.8 Cg_endo -77.4 106.29 2.19 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.43 2.087 . . . . 0.0 110.599 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.55 58.32 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.49 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 -179.73 166.35 1.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -1.199 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 6' ' ' LEU . 10.2 m -139.02 167.93 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.829 . . . . 0.0 109.262 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 46.1 m -165.77 134.8 3.24 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.869 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.509 ' CG2' HG22 ' A' ' 8' ' ' VAL . 4.3 m -137.25 138.11 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 143.41 30.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.66 -179.17 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.4 -39.52 2.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.247 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.48 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 32.6 m -104.31 120.7 41.76 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.185 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.462 ' HB1' ' OG ' ' A' ' 10' ' ' SER . . . -135.9 87.33 2.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 109.771 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.486 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.1 mp -100.01 92.2 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 108.919 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' GLY . 1.2 ttt180 -41.95 153.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.786 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -43.26 -35.57 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 15.6 mt-30 -78.95 -69.92 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.0 109.382 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 84.53 -44.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 164.57 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.111 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 22.8 m-20 -119.05 -172.69 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -123.58 -70.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 -11.04 60.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.444 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -83.55 4.33 28.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.709 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.78 -21.2 23.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 108.996 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.494 ' CG ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -73.63 -25.14 60.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.484 -0.76 . . . . 0.0 109.406 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -17.17 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.68 -44.03 35.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.714 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -19.38 43.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 109.508 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -77.99 -37.03 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -79.65 -18.73 50.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' O ' HG12 ' A' ' 105' ' ' ILE . . . -89.18 -34.44 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.99 -31.02 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.468 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.24 -54.7 40.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.83 -16.24 60.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 101' ' ' ALA . 21.8 mm -87.25 16.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 109.524 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 107' ' ' SER . 15.0 m -91.93 -147.76 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 106' ' ' SER . 2.8 m 56.31 108.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.586 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.51 108.36 10.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 173.27 56.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.2 163.21 33.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.464 ' O ' ' HB1' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -1.217 . . . . 0.0 109.607 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 13.2 m -96.17 17.18 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.437 ' C ' ' OD1' ' A' ' 113' ' ' ASP . 39.5 t0 -63.27 -100.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 109.027 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 75.0 t80 -64.06 -20.47 65.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.998 -1.064 . . . . 0.0 108.252 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 111' ' ' ASP . . . -64.3 -39.36 93.76 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 1.2 tp-100 -86.5 -7.27 58.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.44 -36.95 32.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.9 m -52.54 -37.24 57.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -52.92 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.36 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -67.69 -8.66 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.466 ' O ' HD11 ' A' ' 125' ' ' ILE . 15.7 tp -83.95 -50.34 8.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.91 8.52 10.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.876 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -72.87 -37.86 67.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.612 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.92 28.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.466 HD11 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -70.49 -5.9 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' MET . . . -73.66 -23.98 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 0.0 109.286 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -82.73 -4.99 58.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.494 HD13 ' CG ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -84.02 -34.0 24.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -43.62 55.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 109.644 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.446 ' O ' HG21 ' A' ' 134' ' ' THR . 18.6 m -54.66 -17.85 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.931 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.409 ' O ' ' OG1' ' A' ' 134' ' ' THR . 38.5 mt -88.84 -66.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 131' ' ' ILE . 57.5 mm-40 -43.66 -34.84 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.119 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -73.73 -54.6 7.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.861 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 130' ' ' VAL . 7.9 p -44.02 -30.23 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -57.44 -53.74 54.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 3.49 48.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.544 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.17 44.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 0.0 109.37 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.479 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.44 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.2 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.74 -152.78 0.11 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.114 -0.991 . . . . 0.0 109.515 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.716 ' HB3' ' CG1' ' A' ' 20' ' ' VAL 0.277 1.1 m-85 -137.7 -178.23 5.15 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 124.451 2.072 . . . . 0.0 115.914 -175.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.566 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 7.1 t-80 -151.45 88.1 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.769 -3.378 . . . . 0.0 102.98 173.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.621 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -93.33 133.64 36.37 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.629 -1.294 . . . . 0.0 108.22 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -146.13 82.53 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.625 -1.297 . . . . 0.0 109.95 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 15' ' ' MET . 2.4 p -110.6 102.63 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.85 155.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.953 . . . . 0.0 109.441 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.472 ' CB ' ' HB1' ' A' ' 83' ' ' ALA . 89.2 p -105.26 -156.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.82 -47.32 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -160.21 60.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.414 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.52 118.95 1.4 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -77.95 117.14 19.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.465 ' HE3' ' CG2' ' A' ' 62' ' ' ILE . 5.9 mtt -86.82 -73.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.795 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.2 t80 -116.17 113.44 23.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 110.321 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 89.2 p -138.6 91.04 2.5 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.05 -172.81 45.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 55' ' ' GLN . 20.8 mt -72.02 154.59 41.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -1.229 . . . . 0.0 109.321 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.795 HG13 ' CZ ' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -153.81 -175.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.097 -1.002 . . . . 0.0 109.165 -178.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.57 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 9.9 tt0 -146.56 -40.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.779 -1.2 . . . . 0.0 110.208 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -139.31 91.16 2.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -98.87 159.96 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.071 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.466 ' O ' HG21 ' A' ' 50' ' ' ILE . 44.7 mt-30 -146.81 166.98 25.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 110.184 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.498 HG22 ' CG2' ' A' ' 45' ' ' ILE . 3.1 p -160.26 143.53 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 109.043 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.456 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 18.6 m -129.86 129.38 43.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA2' ' NZ ' ' A' ' 123' ' ' LYS . . . 126.27 14.28 3.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -116.25 -153.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.32 98.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 0.0 109.329 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.09 -93.81 1.43 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -177.48 28.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -1.152 . . . . 0.0 109.744 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.512 ' HB3' ' NE2' ' A' ' 38' ' ' HIS . 16.5 mt -70.64 145.92 50.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.069 -1.019 . . . . 0.0 109.278 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.06 -122.87 4.81 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.549 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 24.1 mm -151.59 123.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.168 -1.195 . . . . 0.0 109.315 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -136.88 -171.13 0.26 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 32.2 Cg_endo -76.64 84.57 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.479 1.453 . . . . 0.0 110.0 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 50.73 0.54 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.607 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 16.0 t-80 -84.95 46.95 1.32 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -1.067 . . . . 0.0 109.702 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.533 ' O ' ' CG1' ' A' ' 71' ' ' VAL . . . 56.17 160.57 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 110.097 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.93 66.21 8.82 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.835 2.356 . . . . 0.0 110.429 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB3' HD12 ' A' ' 69' ' ' LEU . 1.4 mm? -77.75 139.35 39.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 70' ' ' GLU . 17.5 tp -154.59 66.5 0.69 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -136.1 -95.28 0.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.93 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.426 ' N ' ' OG1' ' A' ' 43' ' ' THR . . . -150.99 164.52 36.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 109.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 46' ' ' LYS . 2.7 mt -113.17 4.16 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.103 -0.998 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' CB ' ' CD ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 48.16 179.81 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.715 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -80.26 119.49 3.85 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.528 2.152 . . . . 0.0 110.238 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -165.29 -153.2 7.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 130' ' ' VAL . 3.2 ppp? -128.61 -173.43 2.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.335 -1.097 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.521 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 8.4 mt -151.11 147.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.507 ' N ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -136.41 123.48 21.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 32.1 mt -128.4 168.56 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.798 -1.189 . . . . 0.0 111.246 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 51.5 t -139.15 153.08 24.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 80.78 -73.56 0.05 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.732 -0.605 . . . . 0.0 109.578 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 56' ' ' HIS . 0.3 OUTLIER 42.99 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.37 -0.831 . . . . 0.0 109.569 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.526 ' CB ' ' OE1' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -158.07 40.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.89 -1.131 . . . . 0.0 109.804 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -36.09 0.44 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.515 ' CE1' ' OE1' ' A' ' 59' ' ' GLU . 1.4 t-80 -169.35 -149.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.29 . . . . 0.0 109.54 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 58' ' ' HIS . 1.5 pt-20 -101.49 160.5 14.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.79 139.59 11.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.582 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.3 p90 -110.23 152.54 25.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.885 . . . . 0.0 109.623 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.465 ' CG2' ' HE3' ' A' ' 15' ' ' MET . 9.1 mt -127.9 144.57 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.258 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' HB3' ' A' ' 127' ' ' GLN . 19.6 t80 -113.75 130.38 56.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 80' ' ' ALA . 3.6 mt -121.33 173.89 7.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -125.44 -37.23 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.863 . . . . 0.0 109.416 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.21 144.62 4.47 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 168.25 -173.59 43.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.531 HG21 ' N ' ' A' ' 69' ' ' LEU . 60.6 mt -99.36 152.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -1.075 . . . . 0.0 109.075 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.531 ' N ' HG21 ' A' ' 68' ' ' ILE . 3.3 pp -132.0 157.33 44.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.917 -1.115 . . . . 0.0 110.586 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 8.4 pt-20 -150.66 114.89 5.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 39' ' ' ALA . 10.0 p -104.04 151.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.889 -1.132 . . . . 0.0 110.709 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.524 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 3.6 mm-40 -136.43 179.28 1.41 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -79.48 102.23 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.395 2.063 . . . . 0.0 110.847 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 79.97 34.72 29.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.566 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 7.9 t30 171.18 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -1.175 . . . . 0.0 109.355 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.534 ' CG2' HD12 ' A' ' 6' ' ' LEU . 2.5 m -112.89 152.65 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 7' ' ' ASP . 88.0 m -152.67 136.02 15.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 109.282 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 69' ' ' LEU . 3.1 m -144.83 147.54 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 109.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.77 142.7 46.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 64' ' ' LEU . . . -139.09 179.61 6.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -100.43 -34.18 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.611 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -118.41 147.9 43.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 0.0 109.741 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' A' ' 10' ' ' SER . . . -143.29 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.421 -0.799 . . . . 0.0 109.107 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.585 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 2.0 mt -98.93 52.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HG2' ' N ' ' A' ' 86' ' ' GLY . 48.9 ttt180 -42.16 147.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 85' ' ' ARG . . . -42.92 -32.49 1.45 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -111.21 64.66 0.61 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -1.181 . . . . 0.0 109.579 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.12 -83.01 0.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.84 -169.73 3.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.75 73.48 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.68 -68.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.11 -19.85 62.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.87 -2.03 24.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.96 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 108.913 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.3 mtp -85.75 -35.08 20.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.468 -0.77 . . . . 0.0 109.324 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -84.75 -27.32 27.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.22 -54.26 49.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -51.93 -21.61 3.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -80.06 -57.32 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 109.722 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.46 -19.56 48.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.409 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -85.72 -43.71 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -56.55 -34.53 67.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.439 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.67 -50.82 72.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -18.29 64.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.541 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 105' ' ' ILE . 21.4 mt -80.61 -25.83 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -101.42 102.68 13.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.503 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.1 m -154.01 -41.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -0.948 . . . . 0.0 109.726 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.405 ' O ' ' CE2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -155.9 -166.49 2.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.695 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.76 -86.88 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.64 177.91 8.88 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.529 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -113.14 126.5 55.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.324 -1.103 . . . . 0.0 109.333 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.11 29.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 0.0 109.564 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 111' ' ' ASP . 21.2 t70 -84.07 -94.41 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 108' ' ' SER . 20.8 p90 -74.32 -22.99 59.0 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.88 46.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.88 -34.7 51.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.436 -0.79 . . . . 0.0 109.108 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.46 -20.5 54.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.257 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.5 m -65.31 -39.35 92.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.361 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.27 -13.28 36.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.891 . . . . 0.0 109.328 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.19 -32.04 38.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 101' ' ' ALA . 17.6 mt -83.74 -39.33 20.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -57.34 -23.67 50.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.69 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.515 ' NZ ' ' HA2' ' A' ' 27' ' ' GLY . 11.1 mmtt -79.8 -30.45 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.15 62.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 109.555 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.475 HD11 ' HA ' ' A' ' 122' ' ' ALA . 3.3 mt -80.53 1.74 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.595 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.75 62.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.269 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.586 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.8 pt20 -79.12 -11.0 59.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.465 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 0.6 OUTLIER -73.08 -30.24 63.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.965 . . . . 0.0 109.795 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -48.81 14.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.1 m -61.49 -40.4 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.912 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 91' ' ' GLU . 9.3 tt -65.3 -43.41 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 131' ' ' ILE . 3.1 mm-40 -53.83 -26.19 23.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -0.879 . . . . 0.0 109.1 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -48.88 20.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.18 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 1.8 p -53.65 -20.12 4.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -76.25 -55.89 5.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 7.34 24.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.41 -52.17 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.5 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER 55.69 92.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.205 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.678 ' CZ ' ' CG2' ' A' ' 34' ' ' ILE . 32.3 p90 -82.3 -143.18 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 109.099 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -140.26 133.27 29.39 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.203 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.609 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -123.43 150.16 44.16 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.761 -1.212 . . . . 0.0 108.113 178.152 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.529 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.3 OUTLIER -140.5 88.09 2.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 15' ' ' MET . 5.0 p -99.91 132.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -142.89 159.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.4 p -100.34 -146.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -0.838 . . . . 0.0 109.525 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 81' ' ' ASP . . . -81.75 -10.39 59.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.743 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' GLN . 14.5 mt-10 -118.34 24.21 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 41.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.78 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.94 92.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.659 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.517 ' CE ' HG23 ' A' ' 62' ' ' ILE . 1.7 mtt -161.97 -88.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.852 . . . . 0.0 108.934 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.691 ' CE2' ' CG1' ' A' ' 20' ' ' VAL . 68.8 t80 -135.3 144.82 46.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.3 p -165.07 82.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.411 -0.806 . . . . 0.0 109.525 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.6 -178.96 42.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.51 ' O ' HG11 ' A' ' 20' ' ' VAL . 7.6 mt -71.01 139.45 50.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.076 -1.249 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.691 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m -144.27 148.11 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.41 -0.806 . . . . 0.0 110.643 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.95 -42.05 4.79 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.593 -0.692 . . . . 0.0 109.849 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.88 109.43 9.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.967 -1.083 . . . . 0.0 110.486 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.9 mm -105.4 -173.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.023 -1.048 . . . . 0.0 109.081 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -176.05 98.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.948 -1.095 . . . . 0.0 109.965 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 2.1 p -104.32 137.98 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.352 -0.842 . . . . 0.0 109.069 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.518 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 31.6 m -124.21 115.52 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' A' ' 46' ' ' LYS . . . -108.94 -68.06 0.61 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.6 t -170.6 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -1.152 . . . . 0.0 109.375 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -95.0 66.94 3.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.465 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.0 82.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -115.87 89.23 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.537 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 mt -106.81 151.35 25.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.26 172.6 25.5 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 107.243 -2.343 . . . . 0.0 107.243 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.678 ' CG2' ' CZ ' ' A' ' 4' ' ' TYR . 18.8 mm -99.21 128.53 50.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.585 -1.538 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -129.98 170.75 10.23 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.0 Cg_endo -70.78 81.91 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.772 1.648 . . . . 0.0 109.676 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' HIS . . . 168.27 -27.07 0.14 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.532 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -42.2 163.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -1.091 . . . . 0.0 109.461 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.549 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 164.26 -52.0 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.052 -1.03 . . . . 0.0 110.492 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 39' ' ' ALA . 36.6 Cg_endo -79.32 23.63 0.64 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.607 2.204 . . . . 0.0 111.828 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HG ' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -100.57 110.92 23.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.804 -1.185 . . . . 0.0 109.612 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mt -148.41 80.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.925 . . . . 0.0 109.357 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 44' ' ' ALA . 5.1 t -147.06 -146.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.516 ' N ' ' CG2' ' A' ' 43' ' ' THR . . . -103.98 -176.61 3.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 109.472 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 69' ' ' LEU . 1.4 mt -132.55 166.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 17.3 mmtt -116.4 166.29 12.95 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -78.27 118.22 4.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.606 2.204 . . . . 0.0 110.559 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 63' ' ' TYR . . . -168.17 -145.59 4.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 3.7 ppp? -122.14 -172.64 2.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -1.126 . . . . 0.0 109.448 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.42 157.92 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.586 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.591 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 6.3 ttp180 -149.98 134.9 17.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.111 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -114.44 161.0 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 110.318 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.524 ' O ' ' CG1' ' A' ' 53' ' ' VAL . 41.1 t -126.47 65.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 9.5 mtmt -43.54 124.49 3.55 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.19 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.436 ' HG3' ' N ' ' A' ' 56' ' ' HIS . 6.5 tp-100 46.65 -93.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.7 . . . . 0.0 109.657 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' LYS . 2.3 t-160 -165.32 122.12 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.53 -72.77 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.59 138.53 55.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -157.21 162.37 39.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.348 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -156.55 177.1 11.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 2.8 p90 -146.17 154.49 41.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.808 -1.182 . . . . 0.0 110.052 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.517 HG23 ' CE ' ' A' ' 15' ' ' MET . 2.5 mm -133.0 -161.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.603 ' CD2' ' HB ' ' A' ' 84' ' ' ILE . 42.0 t80 -157.61 114.69 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HE2' ' A' ' 15' ' ' MET . 1.4 pt? -113.64 176.97 4.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 47.5 m -125.19 45.7 2.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 80' ' ' ALA . . . 93.04 -167.4 29.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 134.53 -139.42 10.85 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.4 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 3.7 mt -132.22 147.9 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.07 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.469 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.5 pp -130.6 131.6 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.989 -1.069 . . . . 0.0 110.15 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 77' ' ' THR . 5.0 pt-20 -134.15 128.83 34.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' HG13 ' A' ' 76' ' ' VAL . 5.6 p -99.65 128.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.036 -1.04 . . . . 0.0 110.036 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.475 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.1 mt-30 -106.79 172.53 3.79 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 108.876 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.5 Cg_endo -78.75 112.52 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.577 2.185 . . . . 0.0 110.441 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 79.16 20.92 68.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.8 p-10 171.45 158.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG13 ' CG2' ' A' ' 71' ' ' VAL . 34.5 m -140.99 160.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.023 . . . . 0.0 109.436 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -152.04 143.53 23.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.555 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 8' ' ' VAL . 2.8 m -151.65 156.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 mp -122.71 166.18 15.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 66' ' ' GLY . . . -146.0 -149.47 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.434 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 1.4 m-20 -139.37 -55.47 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.567 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -111.58 148.17 33.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.679 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -140.2 146.57 38.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.508 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.603 ' HB ' ' CD2' ' A' ' 63' ' ' TYR . 43.8 mt -126.17 -25.85 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 0.0 109.718 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HA ' HG21 ' A' ' 62' ' ' ILE . 8.1 ttt180 66.08 153.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.318 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -47.57 -29.7 5.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.456 ' OE1' ' HB ' ' A' ' 134' ' ' THR . 1.2 mt-30 -165.57 81.3 0.32 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.189 -1.183 . . . . 0.0 109.675 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 9.9 t70 -73.62 -26.67 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 174.64 -50.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.211 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.32 119.84 31.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.918 . . . . 0.0 109.642 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 92' ' ' ALA . 14.8 pt-20 -131.04 -38.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.247 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -77.25 -16.52 58.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 109.408 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.04 2.72 53.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.31 -16.39 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 108.981 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -52.4 5.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.458 -0.776 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 99' ' ' ARG . 2.3 mt-10 -56.27 -31.42 63.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -58.07 -53.07 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -53.47 -31.34 45.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.93 -43.5 83.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.307 -0.871 . . . . 0.0 109.545 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 12.0 pttm -84.11 -4.87 59.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.466 ' CB ' HD13 ' A' ' 121' ' ' LEU . . . -90.35 -7.73 52.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.508 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -86.35 -25.76 25.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 109.661 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -43.5 91.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -81.12 -15.1 56.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.464 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.463 ' CG1' HD11 ' A' ' 121' ' ' LEU . 18.8 mm -88.71 -19.42 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t -86.12 63.18 7.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.547 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -171.15 169.14 6.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.56 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.8 t -175.08 100.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -157.58 76.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.66 169.81 25.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.57 -49.42 21.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -1.127 . . . . 0.0 109.309 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 18.3 m -118.7 33.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.559 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.17 -97.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.069 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 3.4 t80 -67.39 -14.11 62.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.65 74.91 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.63 -0.669 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -83.94 -5.65 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.682 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.0 -18.67 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.5 m -76.6 -29.86 56.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.732 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.92 -32.42 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.635 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' GLN . 6.3 mm-40 -75.78 -36.25 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.5 HD22 ' CD1' ' A' ' 125' ' ' ILE . 2.8 tt -73.38 -61.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.96 -27.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.683 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 121' ' ' LEU . 16.5 tttt -63.24 -54.27 40.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -12.66 61.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.5 ' CD1' HD22 ' A' ' 121' ' ' LEU . 49.2 mm -82.23 2.18 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.95 -39.33 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.487 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.423 ' HG3' ' CG2' ' A' ' 84' ' ' ILE . 1.6 tm0? -76.58 -7.17 54.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.414 ' C ' HG21 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -81.72 -21.11 38.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.554 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -85.69 -33.9 21.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 109.592 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.3 m -75.4 -33.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 132' ' ' GLU . 2.1 tt -61.68 -44.63 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 131' ' ' ILE . 77.5 mm-40 -44.85 -35.24 2.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.041 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 130' ' ' VAL . 4.5 mp -64.89 -55.46 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -0.81 . . . . 0.0 109.245 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.456 ' HB ' ' OE1' ' A' ' 87' ' ' GLN . 30.9 p -50.08 -29.14 8.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.481 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 2.8 mmtt -65.73 -54.96 20.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -88.83 21.4 3.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 133' ' ' LEU . . . -123.65 42.5 3.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.388 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.244 0.545 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -109.93 -147.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.888 . . . . 0.0 109.649 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.796 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.61 -179.75 5.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.34 2.019 . . . . 0.0 115.884 -175.797 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.504 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 8.7 t-80 -153.96 89.65 1.32 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 110.123 -3.217 . . . . 0.0 103.445 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.643 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -92.77 126.77 38.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.683 -1.261 . . . . 0.0 107.992 -177.562 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 7.3 t70 -133.36 75.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.593 -1.317 . . . . 0.0 109.912 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.492 HG21 ' N ' ' A' ' 9' ' ' VAL . 1.4 p -111.13 147.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.26 -0.9 . . . . 0.0 108.948 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.51 ' HB ' ' N ' ' A' ' 14' ' ' GLN . 14.1 m -150.16 155.94 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.078 -1.014 . . . . 0.0 109.624 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.462 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -172.2 157.19 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.281 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 10' ' ' SER . . . 61.48 -89.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.414 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 22.13 3.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.387 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.5 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER 46.34 75.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 110.051 179.651 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.51 ' N ' ' HB ' ' A' ' 9' ' ' VAL . 9.1 tt0 164.98 100.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.475 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -124.47 -73.21 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.064 179.286 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.668 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.1 t80 -127.17 112.79 15.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.047 -1.033 . . . . 0.0 110.082 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 92.0 p -134.6 85.52 2.19 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.48 -160.73 23.12 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.461 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 12.5 mt -93.24 159.67 15.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.25 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.796 HG11 ' HB3' ' A' ' 4' ' ' TYR . 1.8 m -155.32 -167.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.885 -1.135 . . . . 0.0 110.663 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.588 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -155.35 -33.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 178.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 10.1 mmtm -142.97 88.4 2.04 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.961 -1.087 . . . . 0.0 110.211 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.548 ' CG2' HG23 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -99.24 138.78 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.696 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -122.95 165.93 15.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 110.346 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.533 ' CB ' HG12 ' A' ' 50' ' ' ILE . 11.5 p -171.53 154.98 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 2.1 t 179.76 154.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.829 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.5 -89.78 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 158.41 43.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 59.0 74.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' C ' ' HG2' ' A' ' 46' ' ' LYS . . . 91.8 141.69 10.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -137.05 55.39 1.83 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.171 . . . . 0.0 109.752 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' HG11 ' A' ' 25' ' ' VAL . 4.9 mt -115.09 157.07 24.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.21 171.63 24.61 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.571 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 12.7 mm -99.81 127.16 52.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.854 -1.38 . . . . 0.0 108.986 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -134.46 170.26 11.73 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -70.11 88.24 0.58 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.586 1.524 . . . . 0.0 109.538 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.73 18.98 2.58 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.591 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 6.8 t-160 -60.14 146.96 41.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -1.191 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.489 ' N ' ' CD2' ' A' ' 38' ' ' HIS . . . -40.59 147.04 0.41 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.98 69.14 8.04 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.695 2.263 . . . . 0.0 111.047 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.6 mt -91.07 126.57 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.121 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.4 24.12 12.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.57 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -105.56 -92.81 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.393 -0.817 . . . . 0.0 109.336 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -130.12 172.72 11.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.935 . . . . 0.0 109.161 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.31 -149.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 2.2 mptp? -121.35 125.38 26.91 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.481 ' CB ' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.24 -159.36 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.433 2.089 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 97.85 -137.08 13.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.459 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.6 ppp? -102.62 -178.91 3.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -1.117 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.533 HG12 ' CB ' ' A' ' 25' ' ' VAL . 14.2 mt -157.63 140.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 110.193 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.5 ' N ' HG21 ' A' ' 50' ' ' ILE . 7.5 mmt85 -131.16 112.31 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 12.6 mt -117.48 164.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 0.0 111.312 -178.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.18 112.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' HIS . 20.4 mttm -65.96 149.89 49.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.792 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 3' ' ' THR . 34.5 tt0 -52.11 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.338 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 48.7 t-80 71.45 95.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.36 178.34 29.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -63.07 -166.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -1.224 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 10.2 pt-20 -131.12 147.45 52.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -125.52 138.29 53.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CZ ' HD13 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -109.08 139.41 44.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.819 . . . . 0.0 109.677 -179.613 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.459 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 19.1 mt -121.2 160.48 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.288 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 127' ' ' GLN . 1.4 t80 -139.38 151.49 46.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.268 -0.895 . . . . 0.0 109.014 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 1.3 pt? 179.93 -170.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.481 ' HA ' ' CB ' ' A' ' 47' ' ' PRO . 4.9 m -135.21 -169.22 2.33 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.33 -0.856 . . . . 0.0 109.204 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 65' ' ' SER . . . 42.24 -141.07 1.76 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.16 119.24 2.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.504 ' O ' HD21 ' A' ' 69' ' ' LEU . 5.4 tt -151.89 130.28 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -1.102 . . . . 0.0 109.065 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.746 ' CG ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 178.18 -140.0 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 -179.493 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' CD1' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -146.3 142.64 28.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.366 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG21 ' CG2' ' A' ' 76' ' ' VAL . 7.6 p -109.53 126.99 66.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.464 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -105.39 173.86 3.01 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -77.92 4.02 6.48 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.524 2.149 . . . . 0.0 109.974 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . -167.16 39.27 0.24 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.504 ' OD1' ' ND1' ' A' ' 5' ' ' HIS . 5.0 t30 167.98 94.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 109.472 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.511 ' CG2' HG21 ' A' ' 71' ' ' VAL . 5.0 t -100.78 116.12 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.215 -0.928 . . . . 0.0 109.267 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.666 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 6.4 t -118.45 158.64 24.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.906 . . . . 0.0 109.686 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.746 ' HA ' ' CG ' ' A' ' 69' ' ' LEU . 3.5 p 179.44 141.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.742 0.782 . . . . 0.0 110.288 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -115.64 145.63 42.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' SER . . . -123.53 -165.25 1.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.492 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.32 -43.83 4.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 17.8 m -106.32 151.85 24.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.79 93.7 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 6.1 mt -106.63 66.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.335 -0.853 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 84' ' ' ILE . 13.0 ttp180 -44.79 161.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 87' ' ' GLN . . . -51.45 147.49 10.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 13.2 pt20 38.58 38.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.63 -0.924 . . . . 0.0 109.886 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -45.09 -48.55 11.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.59 -57.4 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.8 -167.09 1.75 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.412 ' CB ' HD11 ' A' ' 131' ' ' ILE . 16.1 pt-20 -144.78 -38.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.583 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.67 67.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -8.03 52.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.4 -14.61 32.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.26 -18.53 26.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.407 -0.808 . . . . 0.0 109.41 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -1.51 36.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.43 ' O ' ' HB1' ' A' ' 101' ' ' ALA . . . -80.37 -38.51 30.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 109.318 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.42 -27.81 56.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -70.38 -43.62 69.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.86 -23.0 39.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.233 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 97' ' ' ALA . . . -81.46 -22.14 38.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.213 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 31.9 tt0 -66.08 -19.32 65.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -27.5 21.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.408 ' O ' ' OH ' ' A' ' 114' ' ' TYR . 1.6 m-70 -77.12 -45.9 25.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 121' ' ' LEU . 88.0 mt -87.61 12.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' ILE . 2.6 m -44.37 -60.85 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.0 p -90.34 -160.85 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.29 128.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.029 -1.045 . . . . 0.0 109.616 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -160.82 93.37 0.98 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 109.377 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.46 ' O ' ' HB1' ' A' ' 115' ' ' ALA . . . 165.2 143.85 3.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.09 -41.61 67.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 14.5 m -137.46 -31.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER -41.61 -92.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.743 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.408 ' OH ' ' O ' ' A' ' 104' ' ' HIS . 15.4 t80 -77.92 -21.4 51.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 110' ' ' GLY . . . -61.27 -18.05 56.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 8.7 mt-30 -84.99 -35.93 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.16 -10.02 27.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 105' ' ' ILE . 18.1 m -71.42 -49.22 43.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.591 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.49 61.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.716 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.37 -47.48 76.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.522 ' HB2' ' CD1' ' A' ' 105' ' ' ILE . 47.9 tp -52.2 -51.76 56.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.717 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.38 64.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.758 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -78.11 -13.96 59.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.96 42.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.5 mp -88.21 -2.09 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.45 -24.55 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 109.282 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.585 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 2.1 pt20 -74.89 -32.63 61.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.451 HD22 ' OE2' ' A' ' 132' ' ' GLU . 4.3 tt -84.2 -6.76 59.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -26.13 47.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 2.3 m -86.46 -31.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.513 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.431 ' HA ' HG22 ' A' ' 134' ' ' THR . 3.2 pt -72.03 -4.03 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.37 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.451 ' OE2' HD22 ' A' ' 128' ' ' LEU . 1.7 mm-40 -78.21 -34.08 49.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.699 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.577 HD13 ' CZ ' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -87.31 2.98 48.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.155 -0.966 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 131' ' ' ILE . 70.6 p -83.2 -16.15 47.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.019 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -71.81 -25.77 62.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.37 -0.831 . . . . 0.0 109.225 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.01 39.54 3.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.403 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -112.09 -7.09 14.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.466 -179.859 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.403 ' C ' ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.328 0.585 . . . . 0.0 109.579 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.425 HG21 ' HG3' ' A' ' 21' ' ' GLU . 38.1 p -141.88 155.45 45.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.235 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.586 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -148.49 -148.45 0.26 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.596 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -131.35 144.57 51.34 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 2.3 pp -135.67 154.4 51.3 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.491 -1.381 . . . . 0.0 109.278 178.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -140.03 115.19 9.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 -179.448 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 64' ' ' LEU . 2.1 p -111.71 94.02 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.179 -0.951 . . . . 0.0 108.74 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.431 HG23 ' HG3' ' A' ' 14' ' ' GLN . 23.4 t -99.73 155.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.705 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.468 ' OG ' ' N ' ' A' ' 11' ' ' ALA . 3.8 p -124.15 -149.99 0.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.42 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' N ' ' OG ' ' A' ' 10' ' ' SER . . . -52.69 -38.06 59.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.88 32.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.313 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -134.66 67.53 1.5 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 9' ' ' VAL . 23.6 tt0 -44.65 155.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 109.811 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.516 ' CB ' HG22 ' A' ' 62' ' ' ILE . 4.1 mmt -134.15 -96.81 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.776 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 3.5 t80 -70.09 130.95 43.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.919 -1.113 . . . . 0.0 108.717 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -157.23 110.24 2.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 138.91 -160.64 25.78 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.79 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -1.214 . . . . 0.0 109.51 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.776 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 170.41 162.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.592 -1.318 . . . . 0.0 107.959 179.827 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -130.03 -37.57 1.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.454 -1.404 . . . . 0.0 110.433 -179.082 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 1.3 mtmt -155.29 93.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.767 -1.208 . . . . 0.0 110.764 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.551 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -98.92 153.93 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.253 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.485 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -156.16 134.55 11.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.623 -1.298 . . . . 0.0 110.259 -179.636 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.12 129.68 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 m -106.6 114.24 28.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -141.23 -123.15 1.91 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 t -125.11 138.23 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 47.41 78.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.264 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.05 111.78 1.72 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.22 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.832 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.68 138.89 44.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.613 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.17 -100.9 2.27 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 178.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.586 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 28.8 mm -155.61 153.81 7.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.333 -1.098 . . . . 0.0 109.671 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -155.5 -176.47 0.61 Allowed Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.821 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.8 Cg_endo -80.02 69.68 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.062 1.841 . . . . 0.0 109.844 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.38 35.52 0.37 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.441 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 12.2 t-80 -72.06 -74.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 0.0 109.627 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 71' ' ' VAL . . . 167.89 166.67 0.14 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.35 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HA ' HG12 ' A' ' 71' ' ' VAL . 35.2 Cg_endo -77.68 79.12 3.3 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.68 2.253 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.468 HD21 ' N ' ' A' ' 41' ' ' LEU . 4.0 mm? -92.85 133.17 36.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.837 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.63 52.28 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.175 179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.5 p -126.1 -138.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -99.68 -163.45 1.03 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.0 109.566 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.474 ' CD1' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -120.57 135.59 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.38 134.38 93.38 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.493 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.2 Cg_endo -79.22 159.85 26.42 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.551 2.167 . . . . 0.0 110.29 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.51 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 125.18 -142.74 14.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.423 ' HE1' ' HB3' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -108.32 -172.02 1.98 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -1.14 . . . . 0.0 109.129 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 24' ' ' GLN . 0.8 OUTLIER -161.6 141.17 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.986 -1.071 . . . . 0.0 110.145 -179.562 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -131.34 139.7 49.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 HG12 ' CB ' ' A' ' 23' ' ' ILE . 12.1 mt -130.67 172.51 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.999 -1.063 . . . . 0.0 109.997 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 41.4 t -138.34 104.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.695 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 146.21 -99.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.078 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 1.1 tt0 44.28 -157.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -81.52 -18.88 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.289 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.19 -140.24 10.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -118.38 -22.13 7.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -1.205 . . . . 0.0 109.54 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -146.46 126.19 13.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.703 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' OE1' ' HA ' ' A' ' 60' ' ' GLU . 2.3 mm-40 -103.63 142.39 34.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.016 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -133.49 106.32 7.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.516 HG22 ' CB ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -124.47 -166.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.091 179.617 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.592 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -172.67 126.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.31 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' A' ' 8' ' ' VAL . 3.1 mt -119.6 -173.52 2.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.406 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 p -152.73 34.42 0.49 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.268 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.92 172.2 13.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.55 -164.95 25.12 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 11.9 tt -109.51 154.38 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -1.184 . . . . 0.0 109.621 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.455 ' CD2' ' C ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -133.87 132.06 39.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.197 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -136.13 131.46 34.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.226 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 39' ' ' ALA . 9.8 p -100.82 137.56 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.527 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.8 mm-40 -124.65 176.73 2.16 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -78.85 106.72 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.489 2.126 . . . . 0.0 110.757 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 70.69 31.93 67.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.461 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 10.8 p-10 174.63 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.627 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 34' ' ' ILE . 6.4 p -124.69 149.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.426 HG21 ' N ' ' A' ' 78' ' ' VAL . 22.1 m -146.86 142.18 27.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.255 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.474 HG23 ' CD1' ' A' ' 45' ' ' ILE . 4.8 m -145.03 141.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.24 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 79' ' ' LEU . 6.0 mp -103.05 158.76 16.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -152.6 -165.72 2.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -120.65 -38.98 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -115.29 171.86 7.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.78 133.43 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.592 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 61.5 mt -144.14 152.68 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.125 -0.984 . . . . 0.0 109.491 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.464 ' N ' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -96.08 178.11 5.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.349 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.433 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -76.83 2.32 60.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.42 46.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 109.536 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -48.89 -58.07 5.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 -67.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.78 -168.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 131' ' ' ILE . 4.3 pt-20 -172.42 -34.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.53 -19.54 55.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.16 3.35 20.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.0 108.879 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.5 mtp -79.2 -23.95 43.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.677 . . . . 0.0 109.546 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 20.6 mt-10 -68.23 -19.39 64.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.569 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.43 -40.93 20.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -39.26 80.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.506 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.35 82.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 96' ' ' GLU . 16.1 mttt -89.69 -0.35 57.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 121' ' ' LEU . . . -86.56 -55.46 3.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.324 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.8 -42.08 77.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.246 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.6 -43.27 75.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.633 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 98.9 mt -89.97 24.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.275 -0.89 . . . . 0.0 109.335 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 107' ' ' SER . 16.6 m -61.09 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 72.27 168.68 0.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.228 -0.92 . . . . 0.0 109.279 -179.945 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 t -152.29 154.72 36.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.545 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -154.62 150.35 27.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.424 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 111' ' ' ASP . . . 115.74 20.3 5.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.8 OUTLIER 52.32 100.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -1.135 . . . . 0.0 109.348 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 25.8 m 40.7 34.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 109.661 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 20.6 t0 -87.23 -95.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.085 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.67 -12.26 61.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.01 63.43 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.62 -0.675 . . . . 0.0 109.42 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.97 -27.07 60.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.442 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.76 -7.74 58.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.446 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.4 m -81.01 -30.66 34.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.543 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.18 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -84.18 -13.31 53.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.503 ' CD1' ' HB3' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -74.9 -24.97 58.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.02 -6.39 56.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -14.58 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -88.9 -10.61 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.389 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.7 mp -81.36 -2.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.51 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -90.49 -21.33 21.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.677 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 124' ' ' ALA . 12.0 pt20 -69.17 -35.78 76.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.456 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 125' ' ' ILE . 0.9 OUTLIER -84.2 11.04 8.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.431 ' HG3' ' HA ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -89.72 -51.27 5.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 62' ' ' ILE . 22.6 m -52.3 -19.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.774 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 91' ' ' GLU . 7.3 mt -86.29 -58.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' ILE . 39.2 mm-40 -42.15 -40.02 2.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.778 . . . . 0.0 110.121 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 mp -74.2 -52.04 13.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.007 . . . . 0.0 109.73 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 131' ' ' ILE . 6.6 p -46.89 -24.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -70.91 -55.93 7.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.837 . . . . 0.0 109.594 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.74 20.17 13.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.35 63.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.295 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.537 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.211 0.529 . . . . 0.0 109.636 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.548 ' CG2' ' HB2' ' A' ' 21' ' ' GLU . 2.1 p -42.47 125.0 3.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' ' 34' ' ' ILE . 27.1 p90 -118.64 -171.67 2.13 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.8 OUTLIER -111.97 147.46 35.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.035 -1.041 . . . . 0.0 109.076 179.834 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.611 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -137.06 162.8 32.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.964 -1.085 . . . . 0.0 109.132 178.66 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 10.9 t0 -154.64 96.95 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.478 ' O ' HG11 ' A' ' 8' ' ' VAL . 2.5 p -109.69 112.25 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.115 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.47 167.61 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.063 -1.023 . . . . 0.0 109.925 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.39 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.399 -0.813 . . . . 0.0 109.436 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 65.91 109.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 21.3 mm-40 62.38 79.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLU . 9.8 mp0 -43.8 111.97 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.466 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -171.52 53.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.321 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.48 ' CE ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -133.81 -88.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.611 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.7 t80 -139.96 126.03 19.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.055 -1.028 . . . . 0.0 109.355 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.3 p -159.67 82.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -0.96 . . . . 0.0 109.235 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.53 -145.04 6.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.454 ' C ' HG13 ' A' ' 20' ' ' VAL . 11.4 mt -69.99 159.49 33.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -1.116 . . . . 0.0 109.583 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.599 HG23 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -175.91 164.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 -178.124 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' ' 3' ' ' THR . 47.0 tt0 -139.1 -56.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.108 -0.995 . . . . 0.0 110.236 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -130.64 111.21 12.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.043 -1.036 . . . . 0.0 110.711 -178.985 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -99.18 -162.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -166.36 159.03 14.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.74 -1.225 . . . . 0.0 109.904 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.485 HG21 ' HA2' ' A' ' 33' ' ' GLY . 1.3 t -154.52 116.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 81.6 m -111.47 110.56 21.06 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 109.231 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -154.76 45.68 0.55 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.61 169.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -1.158 . . . . 0.0 109.546 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.65 43.3 31.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.98 167.34 19.81 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -164.7 66.01 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -1.214 . . . . 0.0 109.375 -179.914 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mt -131.2 147.36 52.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.827 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.74 -102.9 2.45 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.62 HG21 ' CE2' ' A' ' 4' ' ' TYR . 3.5 mm -153.61 159.1 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.276 -1.132 . . . . 0.0 108.979 178.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -151.28 174.74 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.505 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' CB ' ' HB3' ' A' ' 2' ' ' MET . 32.5 Cg_endo -74.85 76.91 3.2 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.174 1.916 . . . . 0.0 109.95 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.64 49.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.544 ' CE1' HD13 ' A' ' 41' ' ' LEU . 14.9 t-80 -109.48 2.65 20.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 0.0 109.792 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 38' ' ' HIS . . . 66.92 155.78 0.14 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.986 . . . . 0.0 109.44 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.33 87.65 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.676 2.251 . . . . 0.0 110.655 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD13 ' CE1' ' A' ' 38' ' ' HIS . 7.3 mt -99.05 138.67 35.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.472 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' A' ' 70' ' ' GLU . 74.3 mt -119.9 86.94 2.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.0 p -131.25 -155.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.401 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -100.33 171.7 7.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.398 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 tt -100.21 169.84 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -115.5 142.46 28.86 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.92 . . . . 0.0 109.349 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.5 146.05 21.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.514 2.143 . . . . 0.0 110.298 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 144.63 -148.22 19.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.3 ppp? -101.46 174.35 6.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -1.119 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.544 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -148.48 151.39 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.982 -1.074 . . . . 0.0 109.88 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.5 ttt180 -121.03 172.65 7.79 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -164.22 144.85 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.711 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.635 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 34.4 t -134.09 118.01 27.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.648 -0.657 . . . . 0.0 109.302 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 139.97 -86.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.532 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.6 tt0 41.33 -94.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.412 -0.805 . . . . 0.0 109.65 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 19.1 t-160 -132.11 -36.56 1.16 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.17 42.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -173.34 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.337 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' ILE . 10.8 pt-20 -126.86 145.84 50.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.102 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -136.93 167.92 20.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.574 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.9 OUTLIER -134.07 136.47 43.99 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.463 -0.773 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -109.48 -157.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 109.031 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 127' ' ' GLN . 4.2 t80 -172.62 129.15 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.157 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.99 -164.36 2.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -165.4 130.61 2.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.4 158.7 3.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.14 177.5 14.91 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.412 HG21 ' N ' ' A' ' 69' ' ' LEU . 41.1 mt -122.85 142.86 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -1.116 . . . . 0.0 109.309 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.441 ' O ' HD21 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -106.55 132.84 52.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.864 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.48 ' HG2' ' CD2' ' A' ' 42' ' ' LEU . 1.5 tt0 -134.44 112.56 11.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 108.895 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.456 HG22 ' HB ' ' A' ' 76' ' ' VAL . 4.0 p -99.65 158.51 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -139.78 169.25 12.53 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.32 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 73.44 5.75 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.702 2.268 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.33 -14.74 5.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 14.5 p30 -165.43 166.09 18.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 77' ' ' THR . 1.3 p -153.73 145.63 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 109.327 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.524 ' N ' HG21 ' A' ' 76' ' ' VAL . 4.3 m -137.78 142.35 40.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.138 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 8' ' ' VAL . 2.5 m -142.61 143.4 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 109.225 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -116.99 147.0 42.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -138.55 -174.37 3.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.39 -46.81 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 65' ' ' SER . 7.5 t -100.38 -176.1 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HB2' ' CE ' ' A' ' 15' ' ' MET . . . -178.94 76.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.422 HG21 ' CB ' ' A' ' 88' ' ' ASP . 3.8 mp -106.18 77.01 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.296 -0.877 . . . . 0.0 109.744 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 86' ' ' GLY . 4.9 ttt-85 -45.77 152.11 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 131' ' ' ILE . . . -42.11 -45.59 5.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -74.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.265 . . . . 0.0 109.31 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 89' ' ' LEU . 27.8 t70 50.01 39.03 17.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.825 . . . . 0.0 109.563 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 59.61 151.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 0.0 109.603 179.826 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.37 -166.48 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 109.617 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -177.06 -51.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 109.147 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.75 -28.19 58.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -69.81 -6.53 32.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 128' ' ' LEU . . . -89.3 -22.44 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 108.743 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -29.79 33.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.534 -0.728 . . . . 0.0 109.047 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -32.63 74.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.455 -0.778 . . . . 0.0 109.402 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.6 -63.68 1.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -57.77 -29.52 64.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.354 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -66.35 -32.68 74.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -22.36 32.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . . . -85.55 -15.66 41.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 108.923 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -72.55 -17.32 61.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.12 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.443 ' HA ' ' OG ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -87.4 -34.59 18.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -68.57 -38.85 81.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.551 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.519 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 94.2 mt -73.46 -16.98 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -91.37 24.45 2.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 108' ' ' SER . 0.7 OUTLIER -150.82 178.14 9.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 75.95 175.59 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -154.83 -165.14 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.391 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 178.68 25.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.14 -55.16 3.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.3 m -118.9 9.46 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.47 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.997 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 108' ' ' SER . 23.4 p90 -67.11 -19.9 65.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.988 -1.07 . . . . 0.0 108.161 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.36 -26.88 54.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -78.64 -31.32 46.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.5 -24.24 56.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.9 -4.19 36.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.09 -38.58 27.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 109.472 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.98 0.82 46.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.652 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.519 ' HG ' ' CD1' ' A' ' 105' ' ' ILE . 0.1 OUTLIER -79.37 -46.92 16.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.43 -9.32 32.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -71.68 -22.97 61.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.634 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.25 -3.51 58.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.682 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -89.56 -8.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.364 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.27 -36.42 63.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 109.274 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.3 pt20 -90.33 1.52 56.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.415 ' HA ' HG23 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -90.13 -26.45 20.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -21.34 33.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.742 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.574 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 30.2 m -88.05 -28.98 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.538 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -88.46 -13.63 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -33.45 33.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 110.013 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.572 HD23 ' CE2' ' A' ' 61' ' ' PHE . 1.6 pp -84.12 1.32 44.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 0.7 OUTLIER -88.86 -35.31 16.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.209 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.6 pttt -79.1 -22.64 44.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.256 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.1 -7.03 54.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.394 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.79 3.05 55.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 109.578 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.436 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.248 0.547 . . . . 0.0 109.532 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 2' ' ' MET . 0.2 OUTLIER 62.66 131.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.313 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.627 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 4.3 p90 -130.82 -154.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 9.9 t-80 -127.64 138.51 52.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.354 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.585 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -134.81 160.01 39.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.986 -1.072 . . . . 0.0 109.015 179.349 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.481 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 15.4 t70 -149.81 101.59 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 0.0 110.08 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' O ' HG11 ' A' ' 8' ' ' VAL . 13.7 p -102.46 123.78 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.189 -0.944 . . . . 0.0 109.121 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 t -135.81 148.61 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -140.11 -142.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.045 179.87 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.29 30.25 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.694 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 13' ' ' GLN . 1.3 pm0 -170.53 78.89 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.278 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 3.3 mt-30 -42.48 103.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 109.67 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 5.6 tt0 175.15 59.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.7 mmm -143.49 -82.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.157 -0.965 . . . . 0.0 109.945 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.619 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 27.5 t80 -145.81 143.55 29.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.116 -0.99 . . . . 0.0 109.276 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.444 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 13.8 p -175.19 88.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.84 -145.35 10.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.496 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 14.8 mt -68.7 165.15 20.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.19 -1.182 . . . . 0.0 109.066 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.619 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -173.82 152.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.042 -1.036 . . . . 0.0 109.135 -177.907 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 54' ' ' LYS . 3.0 tt0 -114.73 -69.85 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.119 -0.988 . . . . 0.0 110.65 -178.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.5 tptt -125.93 107.98 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.744 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.588 ' CB ' HG13 ' A' ' 52' ' ' ILE . 1.3 pp -108.9 118.82 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.64 125.51 45.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.541 -1.349 . . . . 0.0 110.298 -178.46 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 23' ' ' ILE . 1.5 t -112.86 120.75 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.166 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.9 m -124.14 110.12 14.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.77 -145.53 5.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 1.4 m -98.56 135.28 40.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -1.223 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.6 tt0 71.33 101.61 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.121 -0.987 . . . . 0.0 109.233 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.03 171.38 20.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 179.84 60.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.974 -1.31 . . . . 0.0 110.304 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -94.46 153.2 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.012 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.65 171.83 24.35 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.627 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 15.0 mm -99.11 126.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.039 -1.271 . . . . 0.0 108.434 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -124.21 170.63 8.41 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.1 Cg_endo -72.31 90.91 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.841 1.694 . . . . 0.0 109.933 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.26 2.25 4.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -49.3 136.64 15.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -1.202 . . . . 0.0 109.492 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.436 ' O ' HG12 ' A' ' 71' ' ' VAL . . . -54.07 171.29 0.27 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -77.37 83.46 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.697 2.265 . . . . 0.0 110.522 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.26 141.31 32.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 109.46 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.67 89.98 1.81 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 68' ' ' ILE . 11.9 p -150.13 -138.52 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.257 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 67' ' ' GLY . . . -100.06 171.13 8.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.215 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 0.1 OUTLIER -99.89 174.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.227 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -111.43 143.91 29.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.78 121.86 5.65 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.51 2.14 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.528 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 168.22 -156.15 27.44 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 5.9 ptm -108.55 -177.33 3.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -158.69 136.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.952 -1.092 . . . . 0.0 110.722 -179.524 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.86 174.87 5.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.588 HG13 ' CB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -164.95 152.87 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.652 -1.28 . . . . 0.0 109.886 -179.414 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 53.2 t -136.29 99.96 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER 155.89 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 8.8 tt0 50.34 23.78 1.33 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 109.826 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 43.5 63.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.594 179.965 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.49 -59.59 0.27 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 -158.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 109.542 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -110.04 158.64 18.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -156.95 165.2 36.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.589 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 3.5 p90 -128.19 127.7 43.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.96 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -177.84 128.8 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 108.924 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.84 -166.06 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -119.89 -90.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.401 ' C ' HG12 ' A' ' 45' ' ' ILE . . . -125.58 -131.47 3.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . 104.49 -166.63 15.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' A' ' 45' ' ' ILE . 16.7 tt -113.61 133.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -1.199 . . . . 0.0 109.459 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -114.82 116.46 28.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.462 ' O ' HG21 ' A' ' 76' ' ' VAL . 2.7 pt-20 -114.34 127.75 56.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 108.88 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.465 HG21 ' HB ' ' A' ' 76' ' ' VAL . 14.1 p -99.8 144.81 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.12 -0.987 . . . . 0.0 109.884 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -123.69 172.89 5.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.384 -0.822 . . . . 0.0 109.103 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' CD ' ' HG2' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -78.16 93.95 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.611 2.208 . . . . 0.0 110.635 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.06 -17.0 45.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -156.92 152.85 27.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 109.324 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG21 ' N ' ' A' ' 77' ' ' THR . 2.0 p -138.14 144.02 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.01 . . . . 0.0 109.617 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.516 ' N ' HG21 ' A' ' 76' ' ' VAL . 11.9 p -131.07 146.78 52.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.375 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 69' ' ' LEU . 4.9 m -149.33 146.1 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -124.36 151.47 44.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.29 -0.881 . . . . 0.0 109.341 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.465 ' N ' ' HG ' ' A' ' 79' ' ' LEU . . . -144.46 -164.8 1.99 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.37 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -117.06 -24.25 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.502 ' CG2' ' N ' ' A' ' 83' ' ' ALA . 20.5 m -110.8 165.47 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 82' ' ' THR . . . -175.15 67.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.76 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.47 ' O ' HG21 ' A' ' 84' ' ' ILE . 2.8 mp -101.43 72.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.276 -0.89 . . . . 0.0 108.922 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -44.35 167.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.88 . . . . 0.0 109.445 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.47 -46.29 58.38 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.404 ' HG2' HG23 ' A' ' 134' ' ' THR . 0.2 OUTLIER -53.27 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -1.162 . . . . 0.0 109.406 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' LEU . 34.7 t70 55.24 17.87 2.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.532 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 42.38 37.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB2' ' OD2' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -146.42 168.7 20.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -152.41 -82.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.812 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.72 -25.9 68.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -64.86 -24.86 67.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.934 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.98 -17.05 26.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.005 . . . . 0.0 109.207 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.522 ' HA ' ' CD1' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -80.8 -48.47 12.42 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 -179.586 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -72.19 -9.69 58.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.846 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.62 -19.96 47.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.79 -1.62 58.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.05 -36.78 19.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -61.02 -20.61 62.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.08 -21.61 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.63 -44.86 95.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 -6.15 43.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -90.1 -41.61 11.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 121' ' ' LEU . 3.2 mt -86.98 13.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.145 -0.972 . . . . 0.0 109.827 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -103.89 74.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.292 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.9 p -155.7 -153.47 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t 173.61 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -165.55 -54.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.819 . . . . 0.0 109.447 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.02 143.85 15.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 19.7 t70 -64.35 -24.67 67.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -112.89 18.9 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.86 -92.35 0.06 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.427 -0.795 . . . . 0.0 109.219 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -73.5 -23.61 60.07 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -56.77 -36.98 70.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -87.6 -15.51 37.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.803 . . . . 0.0 109.231 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.98 -31.72 69.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -51.96 -26.01 9.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.91 -35.97 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -65.11 -50.5 65.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.663 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.471 ' HB2' HD12 ' A' ' 105' ' ' ILE . 36.4 tp -55.31 -53.57 54.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -43.68 -35.89 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -49.99 74.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.661 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.64 -10.77 59.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.561 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 121' ' ' LEU . 20.4 mm -89.0 -11.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.445 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.528 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -72.4 -35.05 68.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -81.2 -10.22 59.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.522 ' CD1' ' HA ' ' A' ' 95' ' ' MET . 0.3 OUTLIER -83.14 -29.24 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.436 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -77.04 -39.76 48.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 109.597 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.589 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.6 m -74.18 -36.41 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.488 ' CD1' ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -67.21 -19.48 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.422 179.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.449 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 6.1 tm-20 -71.95 -16.05 62.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.925 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.11 -47.99 7.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.404 HG23 ' HG2' ' A' ' 87' ' ' GLN . 3.7 p -60.67 -31.11 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.611 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -63.43 -28.88 70.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.828 -179.817 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.457 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -109.31 0.6 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 0.0 109.587 -179.992 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.11 8.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 6.9 tpt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.605 179.981 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' THR . 1.5 ttm . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.206 0.527 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.517 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER 52.76 171.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.584 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 2.1 p90 179.62 -179.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.5 t60 -105.32 149.51 25.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.216 -0.927 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.594 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -138.5 164.77 28.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.001 178.825 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.56 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 2.2 t70 -154.88 81.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 78' ' ' VAL . 2.7 p -104.36 110.55 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.14 -170.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . 80.3 p -143.22 -166.7 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.419 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.37 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.453 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -140.55 65.07 1.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.89 . . . . 0.0 109.448 -179.933 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -147.32 172.1 14.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -91.65 152.01 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.554 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.508 ' HE1' ' CB ' ' A' ' 83' ' ' ALA . 1.7 mtt -154.05 -76.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.475 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.65 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 30.6 t80 -168.14 134.83 2.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 9.1 p -165.73 98.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 156.9 -153.8 25.0 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' C ' HG13 ' A' ' 20' ' ' VAL . 12.5 mt -65.18 162.15 17.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -1.211 . . . . 0.0 108.747 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.65 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -172.59 171.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.571 -178.538 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 5.0 tt0 -120.24 -47.97 2.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.074 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -172.44 133.1 0.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.042 179.873 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.556 ' CG2' HD21 ' A' ' 6' ' ' LEU . 3.0 pt -108.37 129.56 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 20.0 mt-30 -99.5 95.71 7.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.108 . . . . 0.0 109.511 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.509 ' CG2' HD13 ' A' ' 23' ' ' ILE . 3.8 t -99.14 151.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.688 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 9.0 t -160.94 140.44 10.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 108.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' N ' ' HB2' ' A' ' 31' ' ' GLU . . . -111.8 -166.8 18.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 t -48.08 -66.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -66.74 -13.86 61.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.084 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 112.65 151.49 11.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.688 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -142.82 155.3 44.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -1.217 . . . . 0.0 109.716 179.421 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.53 175.98 10.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.883 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.31 171.49 14.12 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.584 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 16.7 mm -99.89 143.86 13.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.808 -1.407 . . . . 0.0 108.927 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.599 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 1.8 p90 -155.66 169.42 10.39 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.599 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -69.58 83.18 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.553 1.502 . . . . 0.0 109.627 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.07 33.58 0.46 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 32.4 t60 -77.95 3.97 13.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -1.161 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . 76.53 175.39 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 0.0 109.847 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -78.2 76.24 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.722 2.281 . . . . 0.0 110.412 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.491 ' HG ' ' NE2' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -93.36 122.2 35.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.4 75.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 1.8 p -139.21 -147.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -106.3 169.37 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -111.04 171.86 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.755 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -115.3 165.52 14.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 36.0 Cg_endo -78.27 117.08 4.01 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.694 2.262 . . . . 0.0 110.323 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -172.53 -153.01 8.98 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.446 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 9.7 ptm -114.19 178.03 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 109.268 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 2.0 tt -151.78 153.4 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.029 -1.045 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' N ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -123.27 176.77 5.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.662 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.25 141.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.005 -179.242 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 55.1 t -128.79 113.55 29.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' HIS . 24.3 mmtt -64.33 142.77 58.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 -179.113 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 56' ' ' HIS . 1.1 tt0 -43.5 -28.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.191 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 45.6 t-80 178.98 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 109.305 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.23 -107.59 0.52 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 5.2 t-80 -106.41 172.06 7.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -156.52 136.49 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.196 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -164.52 -173.85 3.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.64 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.1 p90 -125.2 144.11 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.418 -0.801 . . . . 0.0 109.493 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 HG21 ' HG2' ' A' ' 85' ' ' ARG . 2.4 mm -116.17 -147.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 108.986 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 1.5 t80 -174.92 130.98 0.31 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 108.841 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.39 177.05 7.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.72 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.427 ' HB2' ' CG2' ' A' ' 82' ' ' THR . 6.4 t -109.04 -52.36 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' ALA . . . -166.68 -155.27 8.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 128.49 -158.92 21.88 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.485 ' CA ' HD12 ' A' ' 45' ' ' ILE . 14.5 tt -127.38 125.8 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -1.083 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 0.6 OUTLIER -99.69 144.0 29.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -141.08 134.01 29.08 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.506 HG21 ' N ' ' A' ' 72' ' ' GLN . 7.1 p -99.8 155.86 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.131 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.589 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.04 -177.84 0.75 Allowed Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.776 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -79.88 93.31 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.323 2.015 . . . . 0.0 110.618 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.29 56.3 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -126.83 160.74 30.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 34' ' ' ILE . 14.7 t -134.96 153.3 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.205 -0.934 . . . . 0.0 109.038 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.411 ' N ' HG11 ' A' ' 76' ' ' VAL . 4.1 m -158.73 127.55 5.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.061 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 1.2 p -140.32 126.28 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.93 131.5 49.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.103 -0.998 . . . . 0.0 109.673 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 66' ' ' GLY . . . -117.1 -156.7 0.64 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.286 -0.883 . . . . 0.0 109.266 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -145.85 13.76 1.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.427 ' CG2' ' HB2' ' A' ' 65' ' ' SER . 3.1 m -148.98 135.87 19.79 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.227 -0.92 . . . . 0.0 109.322 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.508 ' CB ' ' HE1' ' A' ' 15' ' ' MET . . . -144.83 107.07 4.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.274 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 98.6 mt -110.19 -29.62 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.4 ' HG2' HG21 ' A' ' 62' ' ' ILE . 2.3 mtp-105 62.77 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.248 -0.907 . . . . 0.0 109.636 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.538 ' CA ' ' CG2' ' A' ' 130' ' ' VAL . . . -66.81 -11.49 57.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ASP . 4.7 mt-30 -90.97 -50.24 5.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -1.139 . . . . 0.0 109.167 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.538 ' HB2' ' CG2' ' A' ' 84' ' ' ILE . 56.7 t0 43.6 47.05 6.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.828 . . . . 0.0 109.583 179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 90' ' ' ASP . 11.0 mt 48.8 -91.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.408 -0.808 . . . . 0.0 109.784 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 88' ' ' ASP . 6.1 m-20 -53.94 -168.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 0.0 109.719 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -153.82 -69.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.49 -17.97 62.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 0.0 109.831 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -22.12 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -19.5 23.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 109.248 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.478 ' CG ' HD13 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -77.74 -29.02 50.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.625 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.8 -2.27 46.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.03 -36.42 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.109 -0.994 . . . . 0.0 109.53 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -58.61 -36.39 73.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.786 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -75.77 -31.9 59.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.694 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -90.03 4.67 49.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.848 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.75 -4.43 57.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 109.58 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 3.3 tp10 -89.49 -47.82 7.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -60.94 -17.09 49.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.975 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -86.76 -30.16 21.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.028 -1.045 . . . . 0.0 109.835 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 99.4 mt -89.88 10.78 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.59 30.88 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.423 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 152.04 51.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.578 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 5.9 p -138.38 129.51 27.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 108' ' ' SER . 6.8 t60 178.39 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 147.06 152.0 5.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.2 -51.24 16.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.3 24.99 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.67 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.22 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.578 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 10.2 p90 -72.28 -25.07 61.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.97 -26.75 38.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -31.6 17.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -68.29 -19.28 64.69 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.822 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 p -67.71 -32.01 72.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.575 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.97 -14.7 59.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.518 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mm-40 -82.35 -28.94 31.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 125' ' ' ILE . 8.6 mt -90.27 -39.78 12.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.596 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.77 -44.24 93.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.695 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -59.82 -28.43 67.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -67.25 -30.32 70.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.537 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 125' ' ' ILE . 2.2 mp -70.95 -8.05 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.23 -31.4 19.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.256 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -78.6 -13.43 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.259 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.478 HD13 ' CG ' ' A' ' 95' ' ' MET . 6.4 tt -76.84 -19.4 57.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.391 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -82.18 -28.22 32.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.769 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.568 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.6 m -86.07 -27.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.955 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.434 ' N ' HG21 ' A' ' 130' ' ' VAL . 5.0 tt -69.53 -28.91 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.799 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 14.9 mm-40 -65.59 -15.69 62.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 133' ' ' LEU . 7.4 mp -90.29 -40.94 11.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.644 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.521 HG22 ' CE1' ' A' ' 61' ' ' PHE . 2.2 p -71.92 -3.12 20.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -76.74 -23.52 53.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -120.99 40.41 3.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.369 179.647 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.09 -18.82 13.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.533 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.493 -179.959 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.29 0.566 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.39 130.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.639 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 3.4 p90 -131.32 -143.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -141.35 150.0 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 0.0 108.99 -179.361 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.702 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -112.52 132.07 55.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.175 -0.953 . . . . 0.0 109.04 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -129.76 72.42 1.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.823 -1.173 . . . . 0.0 109.791 179.832 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 3.7 p -109.1 118.2 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.214 -0.929 . . . . 0.0 109.211 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 13.2 m -129.75 159.59 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.03 169.42 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -55.48 118.84 4.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.337 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 3.4 mt-10 58.81 44.02 17.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.206 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -177.78 168.56 2.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.7 pt20 -147.97 174.38 11.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.458 ' HE1' ' HB3' ' A' ' 83' ' ' ALA . 3.9 mmt -144.65 -75.45 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.944 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.1 t80 -109.5 113.09 25.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 110.294 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.432 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 32.8 p -136.36 90.6 2.58 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.26 -0.9 . . . . 0.0 109.708 178.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 5' ' ' HIS . . . 168.99 -158.64 31.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.89 -164.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.933 -1.333 . . . . 0.0 109.291 179.483 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.598 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 172.43 164.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 0.0 108.461 179.162 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.531 ' HB2' ' CA ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -123.73 -40.07 2.35 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.432 ' O ' HG21 ' A' ' 52' ' ' ILE . 25.8 ttpt -159.4 113.51 2.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 110.558 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.546 ' CG2' HG22 ' A' ' 52' ' ' ILE . 13.0 pt -98.81 -164.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -179.76 97.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.667 -1.271 . . . . 0.0 110.221 179.691 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 32' ' ' LEU . 3.1 p -99.26 140.42 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.306 -0.872 . . . . 0.0 108.717 179.279 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 23.8 m -131.97 103.6 6.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -133.26 -47.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER 165.05 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -1.168 . . . . 0.0 109.555 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.63 125.36 33.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.463 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.76 -52.69 4.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.02 19.17 4.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.759 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.43 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -128.22 160.7 31.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.602 179.873 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.49 -112.73 3.37 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.404 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.639 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 31.2 mm -155.0 149.18 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.26 -1.141 . . . . 0.0 109.481 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -153.34 -172.86 0.33 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.955 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.0 Cg_endo -78.46 81.21 2.81 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.687 1.592 . . . . 0.0 110.423 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 25.7 1.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 39' ' ' ALA . 28.3 t60 -56.89 145.01 31.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.241 . . . . 0.0 109.477 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -49.27 176.25 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.18 87.51 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.645 2.23 . . . . 0.0 110.424 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.19 126.19 46.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.384 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.93 73.09 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -149.3 -144.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.051 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.58 -171.45 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.001 . . . . 0.0 109.183 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 3.1 mt -132.45 172.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.678 -179.89 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -123.45 174.28 3.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.288 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -77.43 144.22 22.63 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.513 2.142 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 165.84 -157.28 29.68 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.466 ' HE1' ' N ' ' A' ' 50' ' ' ILE . 1.4 ptm -111.29 -177.74 3.28 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.509 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 3.1 tp -160.28 115.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.455 ' C ' ' CG1' ' A' ' 52' ' ' ILE . 25.2 ttp180 -110.24 154.88 22.78 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.546 HG22 ' CG2' ' A' ' 23' ' ' ILE . 15.9 mt -154.65 170.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.193 . . . . 0.0 111.011 -178.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.43 111.32 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' HIS . 4.3 ttpt -62.65 105.71 0.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.584 -0.697 . . . . 0.0 110.193 -179.116 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CA ' ' HB2' ' A' ' 21' ' ' GLU . 3.5 tt0 40.59 -93.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.735 . . . . 0.0 110.023 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 28.6 t-80 -150.15 81.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.998 . . . . 0.0 109.487 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.64 -97.51 0.11 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 59' ' ' GLU . 47.7 t60 -86.39 170.99 11.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -1.167 . . . . 0.0 109.584 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 6.8 mt-10 -125.47 164.1 21.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.338 -0.851 . . . . 0.0 109.183 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -122.67 130.62 53.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.111 -0.993 . . . . 0.0 109.756 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.403 ' C ' ' CG1' ' A' ' 62' ' ' ILE . 2.1 m-85 -108.83 132.87 53.58 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.509 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.5 mt -150.73 -179.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.978 -1.076 . . . . 0.0 110.01 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.572 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -159.77 152.66 21.64 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.923 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 65' ' ' SER . 1.2 pp -146.93 -174.55 4.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.97 -179.541 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -133.86 -48.98 0.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.47 164.04 31.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 45' ' ' ILE . . . 156.88 -172.76 34.52 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.6 mp -111.18 131.28 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -1.137 . . . . 0.0 109.061 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . 1.3 tt -115.78 137.55 51.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -0.872 . . . . 0.0 109.408 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 12.7 pt-20 -146.37 143.25 28.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.487 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . 6.1 p -99.62 147.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.675 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.463 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -126.87 170.43 9.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 179.958 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.68 77.73 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.643 2.229 . . . . 0.0 110.926 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.44 0.65 16.02 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.225 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 72' ' ' GLN . 1.8 p30 -174.89 166.87 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.005 -1.291 . . . . 0.0 109.756 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG1' ' HA ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -135.15 161.99 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 109.129 179.833 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.403 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 17.4 m -156.11 136.75 13.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.557 ' CG2' ' CG2' ' A' ' 8' ' ' VAL . 7.4 m -138.95 148.4 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.455 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -115.01 120.89 41.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 -179.886 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.77 -174.97 3.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.1 -51.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.8 m -100.27 126.82 46.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.458 ' HB3' ' HE1' ' A' ' 15' ' ' MET . . . -138.53 150.2 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.982 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.572 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 69.6 mt -132.68 122.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.352 -0.843 . . . . 0.0 108.901 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -72.88 89.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.951 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.15 -123.8 12.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' HB3' HG12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -100.88 52.97 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -1.096 . . . . 0.0 109.676 -179.674 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.88 -37.53 70.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.37 174.04 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.17 44.06 30.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 87' ' ' GLN . 68.2 mt-10 -77.12 -80.56 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.45 -7.77 53.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.315 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -86.86 8.76 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.902 . . . . 0.0 109.51 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.454 ' HB2' HD11 ' A' ' 128' ' ' LEU . . . -90.19 -37.58 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.037 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -38.94 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 5.1 mm-40 -71.0 -18.18 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.06 62.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.76 -18.91 9.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 109.702 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -74.15 -45.68 47.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.78 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -79.33 -19.63 49.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.621 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.61 -20.73 25.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.132 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.474 ' O ' ' OG ' ' A' ' 106' ' ' SER . 34.7 tt0 -71.39 -28.03 63.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.572 ' HG3' ' CD2' ' A' ' 104' ' ' HIS . 7.2 pt-20 -59.27 -31.06 68.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.669 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.572 ' CD2' ' HG3' ' A' ' 103' ' ' GLU . 25.3 m170 -82.24 -40.72 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 7.4 mt -85.74 12.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' SER . 58.0 m -110.58 117.69 34.22 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 81.65 171.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.827 -0.546 . . . . 0.0 109.537 179.884 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 77.67 173.33 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 109.13 -179.539 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.481 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 4.8 p-80 -170.13 125.56 0.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.61 169.23 40.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.51 -40.23 85.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -1.096 . . . . 0.0 109.327 179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 113' ' ' ASP . 23.2 m -124.92 -9.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 112' ' ' VAL . 2.0 m-20 -48.02 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.168 179.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.527 ' C ' ' CD1' ' A' ' 114' ' ' TYR . 5.8 p90 -75.93 -21.2 57.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.017 -1.052 . . . . 0.0 108.294 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.81 -18.28 62.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.631 -0.668 . . . . 0.0 109.355 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 3.0 mt-30 -70.23 -36.06 74.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 120' ' ' GLU . . . -72.86 -24.7 60.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -65.96 -25.98 67.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.339 -0.851 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.3 -33.32 25.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.653 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 117' ' ' ALA . 1.2 pp20? -85.61 -8.3 58.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.482 HD11 ' CD1' ' A' ' 105' ' ' ILE . 9.0 tt -84.14 -59.13 2.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.536 ' HA ' ' CG1' ' A' ' 125' ' ' ILE . . . -46.54 -27.79 1.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -51.22 70.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.918 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.19 59.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.536 ' CG1' ' HA ' ' A' ' 122' ' ' ALA . 33.5 mm -76.6 -8.12 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.962 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.72 -2.86 58.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.168 -0.958 . . . . 0.0 109.615 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.433 ' OE1' ' CD1' ' A' ' 84' ' ' ILE . 1.6 mt-30 -87.63 -37.89 16.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.232 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 94' ' ' ALA . 4.6 tp -81.19 -24.54 37.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.855 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' LEU . 16.5 mmm180 -62.5 -43.51 98.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -68.66 -9.99 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.71 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.461 HG12 ' HB3' ' A' ' 87' ' ' GLN . 63.0 mt -90.62 -56.15 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 21.1 mm-40 -68.67 -9.19 48.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -87.65 -48.69 7.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 10.4 t -69.08 -7.57 37.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -55.64 -53.64 54.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.554 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -87.46 -12.74 45.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -46.83 -37.83 9.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.306 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.397 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.503 ' HG2' ' CG ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.109 0.481 . . . . 0.0 109.746 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.529 ' CB ' ' HB2' ' A' ' 21' ' ' GLU . 8.9 t 173.7 129.31 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.71 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.601 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 13.8 p90 -112.84 -162.55 0.8 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.4 t60 -117.27 142.36 47.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 108.548 178.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.631 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -130.43 156.79 44.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.415 178.43 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.489 ' CB ' HG21 ' A' ' 77' ' ' THR . 0.7 OUTLIER -143.03 90.2 2.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 16' ' ' PHE . 7.3 m -108.37 147.7 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.31 151.19 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m -119.94 125.68 49.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 56.0 27.78 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER 66.07 72.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -165.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 82.74 1.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.435 ' SD ' ' CG2' ' A' ' 62' ' ' ILE . 7.4 mmt -105.88 -92.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.631 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 34.4 t80 -121.07 138.99 53.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.084 -1.01 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 p -169.06 100.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.94 -151.41 23.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.512 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 10.9 mt -64.22 170.48 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.598 HG23 ' CD2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER 172.92 160.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 108.39 -177.608 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 8.6 tt0 -156.32 -58.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.916 -1.115 . . . . 0.0 110.623 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.533 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -91.42 74.72 6.03 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.395 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 2.9 pt -99.89 143.67 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 35.8 tt0 -150.63 121.85 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.789 -1.194 . . . . 0.0 109.674 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 46' ' ' LYS . 9.7 p -99.84 159.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 5.9 m -138.46 111.79 8.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.216 -0.927 . . . . 0.0 109.204 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.53 -99.62 0.52 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -134.56 -0.12 2.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -1.169 . . . . 0.0 110.214 -179.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 tm-20 -164.05 128.66 2.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.93 -53.64 0.61 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 16.8 mt-10 48.85 23.61 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -1.174 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 35' ' ' TYR . 1.7 mt -148.13 161.09 42.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.493 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -111.73 -103.83 2.72 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.601 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 9.2 mm -154.54 140.59 11.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.41 -1.053 . . . . 0.0 109.238 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -121.5 -178.89 0.66 Allowed Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.345 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 34.3 Cg_endo -77.54 96.09 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.262 1.975 . . . . 0.0 110.4 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.88 15.25 5.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.475 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 40.2 t-80 -72.74 171.98 11.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -1.146 . . . . 0.0 109.447 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.411 ' H ' ' CG ' ' A' ' 38' ' ' HIS . . . -85.89 156.49 58.09 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.353 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.02 78.0 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.682 2.254 . . . . 0.0 110.782 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -97.84 149.04 22.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.983 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.74 133.47 13.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 179.97 -92.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.84 . . . . 0.0 109.436 179.48 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 43' ' ' THR . . . -131.29 160.9 33.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -100.42 132.42 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -65.33 136.41 96.37 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 -179.837 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.467 ' CB ' ' OG ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -80.18 160.51 23.4 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.446 2.097 . . . . 0.0 110.44 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 126.58 -131.64 7.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ptm -121.94 178.3 4.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -1.056 . . . . 0.0 109.009 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -156.23 131.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.618 -1.301 . . . . 0.0 110.96 -179.604 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -98.84 129.67 45.23 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.518 HG13 ' CB ' ' A' ' 23' ' ' ILE . 2.1 tt -130.82 152.38 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.887 -1.133 . . . . 0.0 110.898 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 46.8 t -131.19 107.56 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' GLN . 4.4 ttpt -67.29 119.51 12.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.735 . . . . 0.0 109.646 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' LYS . 3.4 tt0 41.19 -152.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.423 -0.798 . . . . 0.0 109.742 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -88.91 67.24 8.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 161.62 163.6 14.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.7 m170 57.88 159.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.184 -1.186 . . . . 0.0 109.347 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 0.3 OUTLIER 179.97 118.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.53 157.08 45.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 -179.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.4 OUTLIER -113.58 136.44 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 -179.904 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 50' ' ' ILE . 5.3 mp -112.58 167.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.592 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 14.4 t80 -128.48 140.83 51.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.32 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -168.83 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.467 ' OG ' ' CB ' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -179.47 132.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 -179.966 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 80' ' ' ALA . . . 72.79 142.97 0.51 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.57 165.06 11.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.73 123.85 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -1.108 . . . . 0.0 109.22 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.498 ' CD2' ' C ' ' A' ' 69' ' ' LEU . 1.2 tt -108.09 153.73 22.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.0 110.036 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 77' ' ' THR . 4.4 pt-20 -156.14 111.0 2.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 76' ' ' VAL . 4.4 p -99.85 159.08 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 2.0 mt-30 -143.11 172.97 4.97 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.7 Cg_endo -80.26 62.11 8.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.627 2.218 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.63 -14.74 1.06 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.6 p-10 -167.21 168.65 13.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.996 -1.296 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 77' ' ' THR . 0.9 OUTLIER -155.49 162.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.413 -0.804 . . . . 0.0 109.063 -179.891 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.489 HG21 ' CB ' ' A' ' 7' ' ' ASP . 6.4 p -154.18 156.05 36.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -166.43 130.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.962 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.96 112.0 23.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 66' ' ' GLY . . . -106.07 -175.27 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.63 -9.26 9.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.456 ' HB ' ' N ' ' A' ' 65' ' ' SER . 16.7 m -109.35 142.04 40.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -161.39 132.85 5.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.911 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.592 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 18.9 mt -128.8 -36.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.368 -0.833 . . . . 0.0 109.143 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 75.34 134.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.172 -179.763 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -39.16 96.6 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 85' ' ' ARG . 39.3 tt0 63.85 74.36 0.42 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -1.112 . . . . 0.0 109.942 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 8.9 t70 -52.3 -35.09 49.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.086 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER 166.47 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.076 179.875 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 75.12 153.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.487 ' CB ' HD12 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.66 -29.36 3.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.56 -33.64 20.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 9.3 ttt180 -63.67 -22.72 67.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 0.0 109.466 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.74 -25.11 23.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.274 -0.891 . . . . 0.0 108.712 179.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.5 mtm -66.29 -20.74 66.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.505 -0.747 . . . . 0.0 109.373 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.441 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 2.3 tm-20 -80.05 -22.38 42.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.93 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.15 72.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.405 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.34 -26.81 61.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.211 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.443 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -81.94 -26.68 33.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HG3' ' OE1' ' A' ' 96' ' ' GLU . 8.3 mttt -83.25 -27.32 29.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 109.624 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.87 -19.69 31.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.395 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 16.1 tp10 -77.34 -38.22 50.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.924 . . . . 0.0 109.334 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -72.49 -43.61 63.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -28.05 67.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 98.8 mt -90.24 26.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.203 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 t -97.32 -14.35 21.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.707 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.6 p -126.01 110.91 14.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.502 ' CB ' ' HB2' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -158.0 155.73 29.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 109.271 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.7 -76.95 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 111' ' ' ASP . . . 179.05 -175.74 47.48 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 0.2 OUTLIER 77.84 -78.03 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -1.079 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.3 m -135.51 8.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.15 -91.24 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.409 -0.807 . . . . 0.0 108.884 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.502 ' HB2' ' CB ' ' A' ' 108' ' ' SER . 49.5 t80 -72.12 -17.49 61.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.22 82.21 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 5.9 mm-40 -90.68 -32.5 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.494 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -67.37 -24.77 65.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -32.23 53.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.441 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.24 -25.98 22.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 8.8 mm-40 -62.87 -46.31 88.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB2' ' CD1' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -58.03 -52.56 65.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.463 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -18.85 60.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 -179.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -29.46 64.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.96 -24.67 21.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.812 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 121' ' ' LEU . 24.7 mm -80.62 7.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.54 -34.07 15.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.466 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 2.6 pt20 -80.86 -25.01 37.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.903 . . . . 0.0 109.618 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.466 ' N ' ' HG2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -71.23 -15.84 62.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.25 -52.49 4.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 21.6 m -56.61 -29.33 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.942 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.487 HD12 ' CB ' ' A' ' 91' ' ' GLU . 12.0 tt -64.36 -42.96 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.005 . . . . 0.0 109.735 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -60.39 -23.77 64.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.578 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.28 -49.62 16.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.792 -179.677 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.444 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 8.8 t -70.66 -17.81 62.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -53.04 52.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -5.26 59.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 134' ' ' THR . . . -60.27 -34.09 73.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.519 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.3 0.572 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.534 ' CG2' ' HG3' ' A' ' 21' ' ' GLU . 7.6 p -45.52 135.87 6.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.6 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 5.3 p90 -132.8 178.36 6.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.063 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.3 t60 -103.79 149.1 25.34 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.623 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -138.55 156.72 47.24 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.442 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -145.68 94.09 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.98 -1.075 . . . . 0.0 110.261 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 6.5 p -107.61 96.32 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 108.779 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.42 ' CG2' HD22 ' A' ' 79' ' ' LEU . 28.7 m -118.26 162.22 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.961 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.41 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 3.5 t -102.63 -158.27 0.66 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.343 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -68.38 -50.27 54.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 4.2 mt-10 -141.59 67.61 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 14' ' ' GLN . 1.8 mm-40 171.61 68.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 13' ' ' GLN . 14.7 pt20 -43.71 158.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.66 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.503 ' HE2' ' CG2' ' A' ' 62' ' ' ILE . 12.3 mmm -126.83 -73.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.176 -0.952 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.67 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 40.9 t80 -114.68 93.45 4.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.9 p -124.04 95.71 4.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -159.73 32.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' C ' HG11 ' A' ' 20' ' ' VAL . 12.6 mt -66.78 160.73 25.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -1.173 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.67 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -164.36 160.26 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.969 -178.5 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.534 ' HG3' ' CG2' ' A' ' 3' ' ' THR . 0.1 OUTLIER -130.63 -34.85 1.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.516 -0.74 . . . . 0.0 109.35 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.4 ttpp -155.1 97.84 1.96 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.096 -1.002 . . . . 0.0 110.515 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.543 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.31 156.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 11.9 tt0 -151.96 134.47 15.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -108.78 142.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -130.41 113.04 13.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.51 -111.95 1.48 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.712 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 m -107.97 -62.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -1.179 . . . . 0.0 109.466 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.64 -17.8 14.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.56 119.37 5.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -129.26 34.62 4.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -1.194 . . . . 0.0 109.798 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.406 HD21 ' CE1' ' A' ' 35' ' ' TYR . 6.5 mt -138.61 139.29 38.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.013 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.11 -101.46 2.29 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 20.4 mm -155.59 152.7 8.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -154.44 -176.0 0.56 Allowed Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.746 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 36.2 Cg_endo -81.7 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.359 2.04 . . . . 0.0 110.183 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.49 38.64 0.02 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 10.4 t-160 -82.47 10.02 8.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -1.08 . . . . 0.0 109.594 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 38' ' ' HIS . . . 75.86 173.47 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.314 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -78.16 76.97 4.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.581 2.188 . . . . 0.0 110.485 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.01 130.04 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.183 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.2 tp -148.77 69.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -140.29 -95.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.729 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 43' ' ' THR . . . -156.87 167.96 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.544 HD11 HG22 ' A' ' 45' ' ' ILE . 3.4 mt -110.07 167.25 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 68.4 mmtt -100.11 159.45 29.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.09 163.95 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.858 2.372 . . . . 0.0 110.423 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 130.78 -146.25 17.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.512 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 24.8 ptm -103.19 -176.77 3.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -1.112 . . . . 0.0 109.085 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -158.52 118.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 109.544 -179.81 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.36 131.28 46.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 109.367 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 23' ' ' ILE . 35.5 mt -132.73 163.08 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.107 -0.995 . . . . 0.0 109.784 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.592 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 39.2 t -134.95 154.62 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.616 -0.677 . . . . 0.0 109.64 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.4 tmtm? 92.0 -79.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.466 ' OE1' ' HG2' ' A' ' 60' ' ' GLU . 14.6 tt0 51.44 -99.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.818 -1.176 . . . . 0.0 109.606 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -165.28 50.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.922 -1.111 . . . . 0.0 109.275 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.543 ' C ' ' CD2' ' A' ' 58' ' ' HIS . . . 146.73 -44.61 0.82 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 57' ' ' GLY . 44.3 m-70 -150.93 -176.64 5.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.406 -1.055 . . . . 0.0 109.235 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.6 mp0 -106.9 162.31 13.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 109.124 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' OE1' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -162.64 171.28 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.968 -1.082 . . . . 0.0 110.016 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.7 OUTLIER -121.1 176.3 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 109.656 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.2 mt -152.94 -160.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.78 . . . . 0.0 109.0 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 48' ' ' GLY . 3.8 t80 -172.36 128.87 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.21 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -158.63 -169.74 2.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 109.708 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.491 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -86.98 -59.75 2.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.55 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.14 -63.92 0.33 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.59 -152.3 52.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.414 HG21 ' O ' ' A' ' 43' ' ' THR . 75.1 mt -102.71 137.99 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.141 . . . . 0.0 109.217 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.537 ' HB2' ' CG1' ' A' ' 45' ' ' ILE . 1.7 tt -119.37 152.6 36.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.0 109.576 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 6.0 mt-10 -149.65 138.33 20.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 109.229 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 40' ' ' PRO . 9.6 p -100.52 140.51 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.793 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.521 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 5.6 mt-30 -124.19 174.76 3.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.4 Cg_endo -78.12 80.92 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.342 2.028 . . . . 0.0 111.022 -179.389 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 102.5 25.3 7.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 7.0 p-10 171.15 138.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -1.208 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.509 ' CG2' HG23 ' A' ' 34' ' ' ILE . 28.3 m -126.61 172.48 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 108.908 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.468 HG21 ' N ' ' A' ' 78' ' ' VAL . 55.3 m -163.11 157.19 20.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.212 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.468 ' N ' HG21 ' A' ' 77' ' ' THR . 2.4 p -161.82 135.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 108.95 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.42 HD22 ' CG2' ' A' ' 9' ' ' VAL . 2.0 mt -116.37 122.9 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.082 -1.012 . . . . 0.0 109.779 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.14 -168.06 1.33 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.235 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.57 -12.02 8.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.447 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.2 m -112.19 147.83 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.45 ' HB3' ' HE3' ' A' ' 15' ' ' MET . . . -158.25 70.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 109.728 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.518 HD11 ' CE1' ' A' ' 63' ' ' TYR . 8.6 mt -99.0 56.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HB3' HG21 ' A' ' 62' ' ' ILE . 7.2 ptt180 -46.21 154.6 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 87' ' ' GLN . . . -58.37 148.98 36.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' NE2' ' HB ' ' A' ' 134' ' ' THR . 35.1 mt-30 69.29 6.15 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -1.122 . . . . 0.0 109.645 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.13 -34.43 73.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.68 151.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 93' ' ' ARG . 66.0 t0 56.99 103.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.311 -0.868 . . . . 0.0 109.585 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.427 ' HA ' HD13 ' A' ' 131' ' ' ILE . 33.6 mt-10 -110.11 -53.98 2.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.5 -20.7 26.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.504 ' CB ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -86.76 -9.35 56.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.968 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . . . -90.41 -12.22 38.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.209 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -25.97 32.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 109.683 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 12.5 pt-20 -77.07 -14.33 59.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.38 -47.92 53.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 109.54 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -21.91 19.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -39.67 24.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -90.08 0.46 57.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.529 ' CB ' ' CD1' ' A' ' 121' ' ' LEU . . . -90.33 -32.18 16.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.72 -26.22 68.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.75 -37.43 82.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -68.96 -16.24 63.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 107' ' ' SER . 11.4 mm -89.14 19.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.165 -0.96 . . . . 0.0 109.744 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -47.52 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.634 -179.937 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' ILE . 2.5 m -43.66 137.18 3.09 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.4 p -166.41 158.93 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.499 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.17 166.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.14 138.35 5.23 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -72.16 -72.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.329 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 113' ' ' ASP . 32.2 m -111.61 12.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 112' ' ' VAL . 29.6 t0 -49.86 -99.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -68.45 -15.8 63.68 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.873 -1.142 . . . . 0.0 108.514 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.84 -16.0 62.58 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.601 -0.687 . . . . 0.0 109.5 179.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -88.83 -27.92 20.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 121' ' ' LEU . . . -82.67 -14.29 54.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -23.39 61.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.61 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.57 -23.9 24.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.25 -10.38 54.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.529 ' CD1' ' CB ' ' A' ' 101' ' ' ALA . 3.1 mm? -86.3 -63.62 1.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.644 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.18 -18.67 4.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.86 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -54.59 -41.04 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.23 -36.3 18.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -64.6 -10.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.427 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.53 -35.46 75.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.476 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.423 ' HA ' ' CG2' ' A' ' 130' ' ' VAL . 1.6 pp0? -81.09 5.33 16.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.448 ' CD2' ' O ' ' A' ' 128' ' ' LEU . 2.3 tt -86.14 -36.23 19.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -34.74 62.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.161 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.581 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 35.5 m -72.38 -36.56 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 128' ' ' LEU . 3.6 tt -68.26 -31.37 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -75.29 -16.55 60.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.475 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -71.03 -42.1 69.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.647 -179.95 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.515 ' HB ' ' NE2' ' A' ' 87' ' ' GLN . 9.7 t -74.1 -14.13 60.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -60.09 -35.72 75.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.11 -0.994 . . . . 0.0 109.176 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -95.75 -3.98 44.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.252 179.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 134' ' ' THR . . . -58.49 -57.09 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.474 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.3 ptp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.444 179.797 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.2 mtm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.274 0.559 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -162.04 177.17 9.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 2.4 p90 -166.05 -149.09 0.1 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.7 t60 -133.05 147.54 52.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 108.886 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.656 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -140.23 169.96 16.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.194 178.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.575 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.75 103.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.896 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.404 ' O ' HG11 ' A' ' 8' ' ' VAL . 3.6 p -116.39 102.94 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.981 . . . . 0.0 109.515 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 14' ' ' GLN . 15.0 t -111.55 156.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.466 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 15.4 t -122.13 78.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 109.655 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 10' ' ' SER . . . 69.14 -85.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.77 30.88 4.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.507 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.69 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.451 ' HA ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.27 144.99 11.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 -179.853 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.423 ' HE3' ' HB3' ' A' ' 85' ' ' ARG . 13.9 mtt -127.96 -77.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.262 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 34.7 t80 -103.49 123.83 47.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 17' ' ' SER . 14.8 p -152.12 103.04 2.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.0 -155.32 26.05 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 8.5 mt -61.33 178.69 0.26 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.119 -1.224 . . . . 0.0 108.937 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.645 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 175.88 113.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.784 -1.197 . . . . 0.0 109.888 -177.871 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 6.6 tt0 -76.17 -43.04 44.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.085 179.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -165.94 134.51 3.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.987 -1.071 . . . . 0.0 110.586 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 39.0 pt -98.71 -148.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -176.1 132.99 0.25 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.259 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.483 HG22 ' HA2' ' A' ' 33' ' ' GLY . 4.1 t -140.25 131.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.976 -1.078 . . . . 0.0 109.324 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.7 m -132.61 113.89 13.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.519 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.76 -119.64 2.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.6 p -122.65 -6.63 8.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.01 -91.86 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.92 142.8 34.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.98 63.1 1.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -1.219 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD11 ' OH ' ' A' ' 35' ' ' TYR . 8.9 mt -141.26 162.36 35.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 109.595 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.495 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -106.05 -116.64 4.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.617 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 17.5 mm -153.05 141.1 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.531 -0.982 . . . . 0.0 108.373 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -139.37 172.99 5.6 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.745 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -73.26 85.29 1.25 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.034 1.823 . . . . 0.0 109.975 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.57 20.16 2.19 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 59.1 t60 -55.0 139.61 40.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -1.233 . . . . 0.0 109.381 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -43.68 162.15 0.19 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.322 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.481 ' HA ' HG13 ' A' ' 71' ' ' VAL . 34.2 Cg_endo -76.85 75.68 4.41 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.501 2.134 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.15 140.35 30.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.05 107.55 4.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 109.236 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 44' ' ' ALA . 11.8 t -175.25 -139.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 43' ' ' THR . . . -99.67 179.2 4.61 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.883 -1.136 . . . . 0.0 109.403 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 1.3 tp -111.84 118.82 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.464 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.78 144.83 44.34 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.8 Cg_endo -78.5 172.7 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.661 2.241 . . . . 0.0 110.436 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.47 -153.98 19.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.515 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 4.7 ppp? -102.83 -178.93 3.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -1.124 . . . . 0.0 109.289 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 51' ' ' ARG . 3.9 mt -154.33 165.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.128 -0.982 . . . . 0.0 110.235 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.538 ' N ' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -152.85 151.03 29.94 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.357 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 21.5 mt -153.39 163.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.745 -1.222 . . . . 0.0 110.769 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 59' ' ' GLU . 67.3 t -139.84 109.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' HIS . 14.8 tttm -64.86 119.8 11.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.634 -0.666 . . . . 0.0 109.537 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.58 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 52.0 tt0 42.75 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.75 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.58 ' CD2' ' HG2' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -154.87 56.49 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 -179.941 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -130.44 -98.25 0.81 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 176.92 4.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -1.092 . . . . 0.0 109.372 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.3 pt-20 -121.95 146.02 47.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 147.54 34.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 134' ' ' THR . 8.9 m-85 -102.85 155.58 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.671 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' A' ' 52' ' ' ILE . 65.5 mt -153.47 145.84 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.598 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.536 ' CD2' ' HB ' ' A' ' 84' ' ' ILE . 4.0 t80 -147.47 133.08 18.79 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -167.79 168.17 12.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 110.107 -179.58 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.461 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 1.4 m -150.19 92.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.379 -0.826 . . . . 0.0 109.296 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.94 105.09 1.77 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . -177.2 -178.48 46.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.501 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 4.1 mm -118.79 135.71 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -1.176 . . . . 0.0 109.414 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 1.5 tt -112.89 152.27 29.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -0.899 . . . . 0.0 109.578 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.411 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.0 tt0 -161.12 133.16 5.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 40' ' ' PRO . 13.5 p -99.89 140.64 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.579 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.3 mt-30 -120.6 -178.77 0.62 Allowed Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -79.63 82.58 2.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.4 2.067 . . . . 0.0 111.005 -179.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.47 -9.62 64.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HB2' ' OE1' ' A' ' 72' ' ' GLN . 10.0 m-20 -131.85 160.89 34.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -1.217 . . . . 0.0 109.695 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.426 HG23 HG22 ' A' ' 34' ' ' ILE . 12.5 t -137.64 152.3 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -151.04 162.63 40.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -179.34 139.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.426 -0.796 . . . . 0.0 109.103 179.857 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 79' ' ' LEU . 6.0 mp -106.23 174.05 6.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -164.21 165.49 21.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.265 -0.897 . . . . 0.0 109.589 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -108.27 -45.42 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.313 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.4 110.49 5.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 109.689 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.536 ' HB ' ' CD2' ' A' ' 63' ' ' TYR . 3.3 mt -137.75 73.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.057 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.423 ' HB3' ' HE3' ' A' ' 15' ' ' MET . 8.9 ptp180 -43.93 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.532 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -44.06 -58.01 4.56 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -47.91 -87.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -1.196 . . . . 0.0 109.329 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 18.8 t70 68.26 19.0 9.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 0.2 OUTLIER 71.97 34.26 1.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.627 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.76 161.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -138.45 -65.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.631 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.67 -12.22 51.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 109.719 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.17 9.05 13.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.626 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.28 19.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.335 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -18.02 63.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.827 . . . . 0.0 109.519 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -77.93 -18.67 55.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.34 62.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.629 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -79.81 -22.77 42.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.22 -48.48 20.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.733 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -30.32 67.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.152 -0.967 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.22 26.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.65 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' LYS . 3.0 tt0 -80.3 -38.26 31.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.17 -32.0 70.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.138 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -27.87 67.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.314 -0.866 . . . . 0.0 109.296 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.6 mt -88.97 21.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 109.647 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 107' ' ' SER . 19.3 p -57.35 -63.51 1.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.4 OUTLIER 168.01 94.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 -153.51 0.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.97 166.53 13.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.85 152.59 8.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.49 -56.47 3.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -1.112 . . . . 0.0 109.37 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.34 23.0 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 37.4 t0 -75.73 -95.79 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.206 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -71.19 -20.58 62.26 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.45 75.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -70.77 -34.12 71.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.93 -22.88 67.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.0 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.2 t -53.59 -40.76 65.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.374 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . -73.65 -38.79 64.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.02 -20.36 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.422 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.45 ' O ' HG12 ' A' ' 125' ' ' ILE . 7.2 tp -78.08 -65.34 0.99 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HA ' HG12 ' A' ' 125' ' ' ILE . . . -49.39 -29.69 6.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 119' ' ' ALA . 2.3 mptt -65.88 -43.69 87.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.87 -20.98 64.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 121' ' ' LEU . 10.5 mm -70.2 -14.02 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.43 -18.73 47.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.433 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.455 ' O ' HG22 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.537 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.9 OUTLIER -74.72 -13.05 60.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.602 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -84.45 -39.75 18.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 49' ' ' MET . 2.7 m -70.58 -22.25 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 127' ' ' GLN . 23.4 pt -87.55 -32.61 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HG2' HG13 ' A' ' 131' ' ' ILE . 18.8 mm-40 -83.1 -17.84 41.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -85.33 -46.78 10.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.962 . . . . 0.0 109.499 179.867 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 61' ' ' PHE . 11.1 t -75.16 -13.18 60.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.406 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.48 -27.38 1.72 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.398 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -82.76 -38.03 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.823 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.68 -71.85 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.668 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.432 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.468 ' O ' HG21 ' A' ' 3' ' ' THR . 13.6 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -177.77 143.38 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.977 . . . . 0.0 109.684 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.639 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 1.8 p90 -137.7 -145.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.713 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 35.6 t-80 -131.37 140.46 49.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.926 -1.109 . . . . 0.0 110.493 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.616 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -109.96 127.65 54.9 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.327 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -135.73 63.64 1.59 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.956 -1.09 . . . . 0.0 109.307 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.483 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 1.9 p -99.64 131.04 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.211 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.7 144.68 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.451 ' HB3' ' HB1' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -153.05 -157.42 0.79 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 109.222 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 12' ' ' GLU . . . -43.51 122.85 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 108.985 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.5 mt-10 76.35 78.98 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.818 . . . . 0.0 108.989 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 12' ' ' GLU . 23.3 tm0? -41.47 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 172.64 47.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.772 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -93.7 -93.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.967 . . . . 0.0 109.346 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.1 t80 -134.04 111.44 10.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.034 . . . . 0.0 109.959 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.412 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 51.4 p -136.3 71.87 1.43 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.901 . . . . 0.0 109.38 178.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . -169.39 167.97 40.91 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 18' ' ' GLY . 18.8 mt -46.18 167.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.409 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -167.64 168.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.967 . . . . 0.0 109.549 -179.318 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.5 tt0 -120.17 -37.35 3.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 52' ' ' ILE . 41.6 tttp -167.92 124.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.929 -1.107 . . . . 0.0 110.721 179.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.553 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 19.5 pt -99.09 -159.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 1.2 tt0 -177.04 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.865 -1.147 . . . . 0.0 109.789 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.459 HG11 HG13 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -99.34 99.78 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 109.588 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 5.8 t -100.14 129.49 46.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.868 . . . . 0.0 109.329 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.28 -90.34 0.51 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 p -134.45 -43.5 0.77 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -1.177 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -101.72 -78.0 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.555 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.81 114.43 6.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 25.25 11.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.446 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.6 mt -122.15 157.65 31.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.502 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -99.83 -109.51 3.06 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.639 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 22.8 mm -153.82 155.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 109.319 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -150.66 175.19 2.97 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.334 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.7 Cg_endo -74.05 82.28 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.12 1.88 . . . . 0.0 110.057 179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.37 26.78 2.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.1 t-160 -55.21 -89.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -1.097 . . . . 0.0 109.553 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.475 ' N ' ' CG ' ' A' ' 38' ' ' HIS . . . -172.5 168.98 2.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.478 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 36.2 Cg_endo -78.43 70.02 7.42 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.671 2.248 . . . . 0.0 110.703 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 2.9 mm? -84.58 142.06 30.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.188 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mt -151.85 49.38 0.8 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.086 -1.008 . . . . 0.0 109.558 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -126.51 -152.51 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.46 179.72 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 1.2 mt -128.55 168.7 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 167.67 8.92 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.533 ' CA ' ' O ' ' A' ' 65' ' ' SER . 35.6 Cg_endo -78.01 135.56 14.04 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.661 2.241 . . . . 0.0 110.381 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 177.31 -158.36 23.8 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.8 ptm -100.43 173.97 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.087 . . . . 0.0 109.102 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 24' ' ' GLN . 2.4 tt -148.41 103.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -99.3 147.26 25.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.535 HG22 ' CG2' ' A' ' 23' ' ' ILE . 12.6 mt -149.48 167.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.021 -1.05 . . . . 0.0 110.868 -178.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -137.85 106.46 3.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -70.27 127.53 33.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.562 -179.387 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER 45.51 -158.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.68 82.79 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 142.75 146.09 4.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 22.1 t-80 75.2 162.09 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -170.34 132.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 0.0 109.32 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.22 138.17 51.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.246 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 12.1 p90 -123.19 129.1 50.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.093 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 0.9 OUTLIER -112.64 -146.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.35 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.611 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 1.3 t80 -169.98 141.98 2.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.018 . . . . 0.0 109.133 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 pp -142.41 -175.98 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.533 ' O ' ' CA ' ' A' ' 47' ' ' PRO . 23.1 t -117.32 -46.54 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.34 -143.93 3.79 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' LEU . . . 116.92 174.55 17.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.06 129.34 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.116 . . . . 0.0 109.472 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.527 HD21 ' CG1' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -100.56 118.23 36.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.47 -179.898 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.515 ' N ' HD23 ' A' ' 69' ' ' LEU . 15.0 tt0 -122.93 141.48 51.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.128 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.488 HG21 ' N ' ' A' ' 72' ' ' GLN . 12.2 p -101.53 150.69 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.733 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 4.1 mt-30 -137.23 173.83 5.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.58 110.12 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.456 2.104 . . . . 0.0 110.669 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 69.15 37.73 82.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.556 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.5 p30 165.37 162.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.265 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HA ' ' HG3' ' A' ' 72' ' ' GLN . 32.8 m -142.34 163.32 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.53 -0.731 . . . . 0.0 109.099 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 40.7 m -160.2 132.81 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 109.742 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 69' ' ' LEU . 3.0 m -127.52 153.79 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 109.339 179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' CA ' ' A' ' 67' ' ' GLY . 1.2 mp -111.97 121.61 45.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.016 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 10' ' ' SER . . . -133.72 168.41 18.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.178 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.13 -17.7 5.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 110.133 -179.737 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.458 HG21 ' N ' ' A' ' 83' ' ' ALA . 17.2 m -113.22 142.74 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.807 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.503 ' N ' ' HB1' ' A' ' 11' ' ' ALA . . . -150.47 132.99 15.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.068 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.611 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 57.6 mt -115.29 -40.46 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' GLY . 7.8 ttp180 69.77 133.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -41.58 -40.8 3.0 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 18.3 mt-30 -73.41 -61.94 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -1.216 . . . . 0.0 109.393 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 27.4 t70 62.69 12.83 5.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.785 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 tp 57.56 38.53 27.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 177.5 159.23 0.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.517 ' CG ' HD12 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -153.19 -50.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.064 -1.022 . . . . 0.0 109.855 -179.686 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.44 72.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -79.07 -17.49 55.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 109.847 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . . . -90.51 -12.0 38.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.296 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -24.12 47.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.55 -15.03 58.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.9 87.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.92 -37.19 13.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 109.724 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -50.89 15.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.965 . . . . 0.0 109.691 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -17.75 14.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 121' ' ' LEU . . . -89.52 -32.25 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.975 . . . . 0.0 109.643 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.445 ' O ' ' CG2' ' A' ' 105' ' ' ILE . 35.4 tp10 -73.99 -27.07 60.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -35.08 67.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 2.47 39.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.466 HD13 ' CB ' ' A' ' 117' ' ' ALA . 1.7 tp -69.52 -19.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 p -89.71 -29.39 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.672 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -60.58 92.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.427 ' HB3' ' HA ' ' A' ' 113' ' ' ASP . 10.9 m -162.59 -148.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.399 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -140.66 -150.16 0.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.973 . . . . 0.0 109.678 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -77.22 0.35 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 2.0 m-20 -80.51 177.0 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -1.161 . . . . 0.0 109.726 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.37 33.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.64 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.427 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 51.1 t0 -83.89 -96.78 0.06 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.059 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.62 -18.25 65.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.36 87.68 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.357 0.599 . . . . 0.0 109.394 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 22.0 mt-30 -88.41 -16.99 31.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.466 ' CB ' HD13 ' A' ' 105' ' ' ILE . . . -72.96 -27.14 61.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.2 t -60.22 -16.6 34.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -81.69 -61.11 2.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.75 -9.02 48.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.642 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.453 HD12 HD11 ' A' ' 105' ' ' ILE . 11.8 tp -89.12 -60.71 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -78.26 5.65 9.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.036 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' ALA . 4.1 tttt -73.28 -45.79 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.59 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.08 -6.75 41.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 122' ' ' ALA . 2.0 mp -84.73 -14.48 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . . . -67.15 -32.46 73.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 128' ' ' LEU . 10.8 pt20 -82.5 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.1 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.451 ' HA ' HG23 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -74.67 -13.31 60.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.374 179.919 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -89.65 -53.74 4.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.597 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 34.4 m -67.77 -27.91 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.72 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.517 HD12 ' CG ' ' A' ' 91' ' ' GLU . 3.8 tt -65.11 -38.35 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' N ' ' CG2' ' A' ' 131' ' ' ILE . 4.8 mm-40 -67.23 -8.3 30.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -86.26 -44.22 12.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.843 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.465 ' HA ' ' HB1' ' A' ' 137' ' ' ALA . 13.8 t -82.33 -9.55 59.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -55.3 -45.68 76.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 137' ' ' ALA . 1.3 ptmt -85.75 -16.61 38.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.689 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 134' ' ' THR . . . -43.78 -39.49 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 mtp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.505 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.296 0.57 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.85 36.38 0.78 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.454 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 1.6 t -152.75 158.45 42.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.743 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.608 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 2.2 p90 -159.58 175.09 13.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 2.3 t-160 -99.41 124.79 44.85 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 108.742 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.673 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -114.7 159.91 19.98 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.709 178.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.464 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.26 90.17 1.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.993 -1.067 . . . . 0.0 110.204 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 16' ' ' PHE . 1.8 p -100.13 132.15 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.077 -1.014 . . . . 0.0 109.25 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 m -152.76 171.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -141.18 72.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.654 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 61.82 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 55.22 58.23 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.556 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -147.45 154.24 40.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.79 76.91 1.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.458 ' SD ' HG22 ' A' ' 62' ' ' ILE . 5.7 mmt -79.72 -63.65 1.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 109.888 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.673 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 18.6 t80 -135.24 121.86 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.445 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -152.84 103.17 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.316 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' O ' HG11 ' A' ' 20' ' ' VAL . . . 158.91 -164.21 33.59 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.5 ' C ' HG11 ' A' ' 20' ' ' VAL . 9.1 mt -56.6 155.88 6.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.057 -1.261 . . . . 0.0 108.709 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.665 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -168.44 116.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.021 -1.049 . . . . 0.0 109.99 -177.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 2.6 mt-10 -66.5 -47.53 72.71 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 108.761 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 17.6 tttt -172.95 144.44 1.28 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.124 -0.985 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 44.3 pt -98.26 -145.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.535 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.12 127.27 0.36 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 109.481 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.0 t -116.53 133.27 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.411 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 31.0 m -129.09 91.84 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.42 168.22 21.07 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.6 -50.98 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 109.488 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.28 99.51 7.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.386 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.99 140.95 4.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -152.13 26.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.77 150.97 41.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.067 -1.021 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -99.54 -114.92 3.63 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.608 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 17.9 mm -149.58 152.64 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.098 -1.237 . . . . 0.0 109.327 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.544 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -151.58 171.82 6.11 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.4 Cg_endo -73.23 78.24 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.028 1.819 . . . . 0.0 110.2 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.32 36.1 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.568 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 11.4 t-160 -87.11 28.99 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -1.224 . . . . 0.0 109.831 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 71' ' ' VAL . . . 58.99 158.32 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.065 -1.022 . . . . 0.0 109.554 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.8 78.7 3.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.777 2.318 . . . . 0.0 110.682 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.553 HD11 ' CE1' ' A' ' 38' ' ' HIS . 25.3 mt -100.35 173.43 6.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -171.16 57.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' HD22 ' A' ' 69' ' ' LEU . 71.4 p -114.62 -136.9 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.25 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -104.39 164.21 11.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.928 -1.107 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 46' ' ' LYS . 3.0 mt -109.1 9.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.791 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER 55.54 158.33 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.672 . . . . 0.0 110.176 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.69 -175.66 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.733 2.289 . . . . 0.0 110.287 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 116.06 -161.05 13.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.453 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 15.9 ptm -102.91 179.57 4.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 109.248 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -150.85 138.87 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.032 -1.043 . . . . 0.0 110.646 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.514 ' HG2' ' N ' ' A' ' 52' ' ' ILE . 66.3 ttt180 -119.67 161.32 20.89 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.561 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 36.1 mt -157.23 167.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.72 -1.238 . . . . 0.0 110.876 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.453 ' N ' HG23 ' A' ' 52' ' ' ILE . 24.5 t -142.64 107.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HB3' ' HA3' ' A' ' 57' ' ' GLY . 15.6 tttm -68.67 149.89 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 110.326 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -54.27 -52.58 60.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 8.69 33.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 54' ' ' LYS . . . -108.38 178.01 21.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.42 ' O ' ' HB3' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -84.82 -77.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.586 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 58' ' ' HIS . 17.0 pt-20 -179.59 139.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 109.84 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -138.21 156.8 47.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 6.1 p90 -128.65 125.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.493 ' C ' ' CG2' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -100.46 -146.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.228 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -175.51 132.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.034 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 63' ' ' TYR . 1.1 mt -139.07 -171.82 3.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -139.79 -64.78 0.48 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.79 136.54 8.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.34 165.62 33.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 79' ' ' LEU . 1.1 pp -101.65 -176.24 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -1.197 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.52 ' CB ' HG13 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -148.62 169.38 20.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 110.364 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.72 111.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 39' ' ' ALA . 6.2 p -99.53 144.6 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.441 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.534 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.48 178.34 1.04 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.534 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 36.3 Cg_endo -79.05 81.55 2.77 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.501 2.134 . . . . 0.0 110.922 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.15 -21.72 5.46 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 4.3 p30 -159.39 135.71 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.239 . . . . 0.0 109.864 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' N ' ' A' ' 77' ' ' THR . 9.6 p -99.18 168.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 109.271 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.508 ' N ' HG23 ' A' ' 76' ' ' VAL . 99.3 m -164.12 137.67 5.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.257 -0.902 . . . . 0.0 109.063 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.52 HG13 ' CB ' ' A' ' 69' ' ' LEU . 4.6 m -140.83 165.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.57 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' A' ' 68' ' ' ILE . 1.5 mt -131.6 149.49 52.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.866 . . . . 0.0 109.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.25 176.68 10.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 109.52 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.94 -56.58 2.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.5 m -105.08 123.13 47.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' CE ' ' A' ' 15' ' ' MET . . . -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.579 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 13.7 mt -101.61 150.7 5.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.213 -0.93 . . . . 0.0 109.461 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 87' ' ' GLN . 8.3 ttm180 -119.74 155.85 31.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.479 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 87' ' ' GLN . . . -44.45 93.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 2.4 mt-30 162.32 -72.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.083 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 90' ' ' ASP . 1.3 p30 40.71 50.63 2.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 89' ' ' LEU . 86.0 mt 43.17 -93.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 88' ' ' ASP . 8.0 p-10 -49.48 159.64 0.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 109.329 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.526 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 27.6 mt-10 -141.26 -56.68 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.65 -14.34 54.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -76.58 -10.56 59.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' HB1' ' A' ' 97' ' ' ALA . . . -89.01 -21.71 23.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.961 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -27.67 68.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.44 -0.787 . . . . 0.0 109.376 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.72 -15.2 61.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . . . -68.04 -45.66 73.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -61.2 -17.03 51.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -89.9 -40.17 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -75.73 -12.25 60.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.942 . . . . 0.0 109.292 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.434 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -86.89 -15.36 39.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.132 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -46.67 67.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.365 -0.834 . . . . 0.0 109.407 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -49.51 -23.26 1.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' TYR . 54.1 m80 -86.7 -36.89 18.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 114' ' ' TYR . 17.5 mt -79.04 -6.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 p -101.06 -16.54 17.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.523 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.36 130.73 37.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.711 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.09 131.47 51.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 21.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.779 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.98 -176.63 33.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.421 ' OD1' ' CG1' ' A' ' 112' ' ' VAL . 1.3 p30 -81.12 -29.37 34.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.144 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.3 m -119.37 22.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.81 -99.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -0.817 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.47 ' HB2' ' HA ' ' A' ' 105' ' ' ILE . 17.6 p90 -65.3 -18.9 65.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.021 -1.049 . . . . 0.0 108.214 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.08 80.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -77.15 -17.5 58.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.341 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.27 -17.85 53.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.2 t -62.01 -28.81 69.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -75.87 -27.89 57.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -85.52 -8.22 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.923 . . . . 0.0 109.494 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.444 HD11 ' CD1' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -90.41 -57.93 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -22.29 65.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -87.07 -19.53 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.85 -34.61 33.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.478 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 125' ' ' ILE . 2.8 mp -75.89 -6.09 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.378 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.46 76.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.572 ' HG2' ' CG ' ' A' ' 63' ' ' TYR . 5.1 tm0? -81.39 -14.29 57.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.524 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 34.6 tp -78.73 -25.02 44.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.0 109.69 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -45.71 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.939 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.58 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 35.7 m -70.41 -32.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 91' ' ' GLU . 2.2 tt -78.24 -25.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.094 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 128' ' ' LEU . 1.4 mm-40 -74.66 -22.13 59.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.104 -0.997 . . . . 0.0 110.243 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.571 HD13 ' CZ ' ' A' ' 61' ' ' PHE . 1.4 pp -90.54 0.45 57.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.995 -1.066 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.5 t -89.07 4.6 47.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.665 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -30.08 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.597 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 11.56 23.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.16 -47.27 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.452 -179.874 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.477 ' HE3' ' O ' ' A' ' 3' ' ' THR . 2.1 ttp -159.81 144.29 14.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.477 ' O ' ' HE3' ' A' ' 2' ' ' MET . 65.9 p -50.94 164.74 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 109.604 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.588 ' CE2' HG21 ' A' ' 34' ' ' ILE . 1.3 p90 -142.22 -144.86 0.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.714 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 12.7 t-80 -129.62 126.71 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.79 -1.194 . . . . 0.0 111.221 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.62 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -99.75 130.9 46.01 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.6 OUTLIER -139.49 75.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 109.746 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' HA ' HG11 ' A' ' 78' ' ' VAL . 2.4 p -104.01 111.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.57 -178.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.493 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -158.01 111.95 2.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.762 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.71 -89.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.735 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -134.71 62.23 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.66 142.64 12.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.478 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.486 ' CG ' ' O ' ' A' ' 14' ' ' GLN . 6.1 pt20 -106.55 107.68 18.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.452 ' HE3' ' HG2' ' A' ' 85' ' ' ARG . 6.6 mtt -79.66 -60.68 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -130.84 111.07 11.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.923 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.452 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.5 p -136.97 92.19 2.7 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.69 -161.27 32.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.2 mt -76.82 159.13 30.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.035 -1.274 . . . . 0.0 109.799 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -157.15 162.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.227 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -122.29 -37.52 2.8 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.448 ' O ' HG21 ' A' ' 52' ' ' ILE . 7.9 ttpp -160.77 110.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.98 . . . . 0.0 110.661 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.541 HG22 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.2 152.11 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 25' ' ' VAL . 1.9 tt0 -134.45 145.32 48.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.075 . . . . 0.0 109.964 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.492 ' N ' ' HG2' ' A' ' 24' ' ' GLN . 3.1 t -131.95 125.46 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.434 -0.791 . . . . 0.0 108.96 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.425 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 88.8 m -116.06 97.86 6.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.353 -0.842 . . . . 0.0 109.395 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -103.24 -100.02 2.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 m -128.83 -81.0 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.53 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.78 166.29 3.7 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -156.54 32.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.242 -1.152 . . . . 0.0 109.597 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -102.7 150.08 23.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.529 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.45 -112.42 3.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.588 HG21 ' CE2' ' A' ' 4' ' ' TYR . 19.5 mm -154.32 147.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -1.141 . . . . 0.0 109.537 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -157.13 -172.77 0.34 Allowed Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 36.3 Cg_endo -81.11 31.15 0.51 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.0 1.8 . . . . 0.0 110.71 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.07 26.48 0.2 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.526 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 57.1 t60 -70.12 -4.85 23.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -1.084 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 38' ' ' HIS . . . 77.05 168.24 0.12 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.502 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 36.1 Cg_endo -78.1 74.19 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.626 2.218 . . . . 0.0 110.524 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.428 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.52 142.65 27.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.307 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' HG ' ' C ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -139.84 32.54 2.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.407 ' O ' HG21 ' A' ' 68' ' ' ILE . 5.3 t -100.67 -156.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.178 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -108.01 -177.35 3.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.032 -1.042 . . . . 0.0 109.663 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 1.3 mp -126.48 177.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -108.08 167.13 9.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.394 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.479 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 35.4 Cg_endo -78.16 140.75 17.95 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.619 2.213 . . . . 0.0 110.516 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 168.43 -162.79 36.58 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.464 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.1 ptm -100.66 -170.65 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 109.211 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 50' ' ' ILE . 19.1 mt -158.09 140.63 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.987 . . . . 0.0 110.296 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' N ' HG21 ' A' ' 50' ' ' ILE . 2.1 ttp180 -130.49 119.19 22.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 23' ' ' ILE . 18.8 mt -123.46 170.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.116 . . . . 0.0 110.965 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.6 t -134.57 101.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -61.17 119.9 9.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 0.0 109.633 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' LYS . 31.1 mt-30 43.22 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -152.19 66.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 109.558 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.38 -128.01 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -69.28 -165.74 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 51.3 mp0 -129.95 -178.94 4.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 59.8 mm-40 -129.51 137.29 50.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -111.69 98.41 7.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 108.834 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 63' ' ' TYR . 4.0 mt -111.04 161.57 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 109.998 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.488 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 1.2 t80 -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -165.83 -171.09 1.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.829 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.451 ' N ' ' HB ' ' A' ' 82' ' ' THR . 3.1 t -160.48 139.76 10.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.782 . . . . 0.0 109.27 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' SER . . . 63.08 125.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.98 159.81 11.23 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 15.0 mt -106.65 123.7 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.554 ' CD2' ' N ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -101.61 127.88 48.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.554 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 4.0 pt-20 -131.08 146.11 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.502 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 12.1 p -102.27 163.92 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.052 -1.03 . . . . 0.0 109.928 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.441 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 2.4 mt-30 -141.32 172.58 5.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 0.0 109.338 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.5 79.91 3.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.577 2.185 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.68 -12.55 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.495 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 4.8 p30 -149.28 172.4 14.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -1.181 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG21 ' N ' ' A' ' 77' ' ' THR . 2.8 p -145.66 151.45 14.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.482 ' N ' HG21 ' A' ' 76' ' ' VAL . 68.3 p -136.58 172.92 12.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.511 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -178.97 127.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 109.151 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -104.91 134.66 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.885 . . . . 0.0 109.265 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.437 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -129.6 -179.91 5.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.0 109.625 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.55 -29.17 5.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.343 -0.848 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 51.9 m -103.12 119.97 39.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.72 98.73 3.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.488 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 96.3 mt -109.71 -27.87 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.56 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 84' ' ' ILE . 22.1 mtm180 61.32 126.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.475 ' CA ' ' CG2' ' A' ' 130' ' ' VAL . . . -44.3 -29.7 1.76 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 88' ' ' ASP . 67.3 mt-30 -71.25 -64.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -1.122 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASP . 14.0 t0 44.4 41.32 4.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.58 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 88' ' ' ASP . 2.1 t70 -115.75 99.87 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' CB ' HG23 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -96.39 0.06 50.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.51 -14.17 62.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.385 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -82.88 -2.79 55.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.39 -23.62 21.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 0.0 108.856 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -29.44 63.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.45 -0.781 . . . . 0.0 109.235 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.13 -57.87 9.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.45 69.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.2 tttt -55.16 -41.08 71.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.427 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -60.68 -51.83 67.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -76.58 -0.36 22.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.701 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -85.64 -30.7 23.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.127 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 4.7 tp10 -80.55 -26.03 38.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -82.15 -13.61 56.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.97 -31.51 20.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.495 HG22 HD11 ' A' ' 105' ' ' ILE . 37.3 mt -77.85 -1.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.317 -0.864 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.3 m -105.83 78.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.29 167.9 2.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.3 m 64.85 -152.22 0.28 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 108' ' ' SER . 12.0 t-80 174.34 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.257 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.94 169.61 40.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.85 -59.42 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.2 16.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.96 -96.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.502 ' C ' ' CD1' ' A' ' 114' ' ' TYR . 13.7 p90 -74.14 -15.77 61.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 108.53 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.11 -19.83 65.69 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.62 -14.71 62.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.491 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.0 -6.67 57.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.502 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.26 -16.61 42.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.95 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -5.03 55.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.629 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.25 -52.28 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.35 94.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.542 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -61.08 -32.46 72.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.887 . . . . 0.0 109.633 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.24 -8.58 50.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 109.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 tp -88.89 5.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 109.354 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.35 -13.27 55.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.445 ' O ' HG21 ' A' ' 130' ' ' VAL . 24.2 pt20 -89.69 -13.39 37.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.477 ' O ' HG12 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -89.63 -29.5 18.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -73.13 -19.73 61.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.585 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 10.2 m -90.12 -27.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.727 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 128' ' ' LEU . 22.1 pt -75.57 -16.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.35 -47.74 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -45.17 95.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 130' ' ' VAL . 12.3 p -49.17 -26.54 2.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -57.81 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -110.07 50.42 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.23 -48.66 1.96 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.371 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.393 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -132.29 94.2 3.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.465 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -174.01 156.16 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.775 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.584 ' OH ' ' CG2' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -143.55 -142.28 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.205 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.531 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 17.5 t-80 -134.73 131.23 37.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.852 -1.155 . . . . 0.0 110.993 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.646 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -99.11 131.84 44.85 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.171 -0.956 . . . . 0.0 108.714 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.489 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -142.42 75.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.85 -1.156 . . . . 0.0 109.68 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.476 ' HA ' HG21 ' A' ' 78' ' ' VAL . 1.4 p -105.11 117.14 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.34 164.24 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -128.8 -159.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.363 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.93 -74.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 109.388 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -136.95 53.69 1.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.77 109.92 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -65.2 154.64 37.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.302 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.516 ' CE ' ' HB3' ' A' ' 83' ' ' ALA . 3.8 mmt -118.84 -58.64 1.94 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.753 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.646 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.56 111.2 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.957 . . . . 0.0 109.677 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 95.0 p -131.93 78.02 1.79 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 20' ' ' VAL . . . -174.7 167.08 39.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.4 mt -50.73 166.67 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.205 -1.174 . . . . 0.0 109.278 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.608 ' CG2' ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -167.09 169.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -144.94 -63.63 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 109.517 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.525 ' O ' HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -90.43 103.45 16.13 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 0.0 108.657 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.608 ' CG1' ' CG2' ' A' ' 20' ' ' VAL . 3.1 mp -115.48 156.46 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.0 109.142 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -151.76 131.38 13.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.117 . . . . 0.0 109.741 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 t -145.57 127.15 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.332 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -148.34 127.73 13.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -137.49 -92.46 0.29 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -138.3 -40.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.0 109.445 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.05 -91.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.87 -172.5 5.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -164.58 41.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.134 -1.215 . . . . 0.0 109.777 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.95 165.2 26.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.879 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.84 174.39 26.62 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 27.0 mm -99.21 160.96 3.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.636 -1.508 . . . . 0.0 109.515 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.619 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -162.59 171.21 6.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.4 Cg_endo -70.13 83.96 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.37 1.38 . . . . 0.0 109.618 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.34 14.36 0.83 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.58 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 43.1 t60 -53.88 157.85 2.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.84 -1.388 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -58.46 173.87 0.39 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.332 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.457 ' CD ' ' CB ' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.83 63.6 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.614 2.209 . . . . 0.0 110.602 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' ' NE2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -59.42 160.61 6.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.882 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.524 ' O ' ' CA ' ' A' ' 70' ' ' GLU . 85.5 mt -115.97 -92.08 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.983 . . . . 0.0 110.649 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 68' ' ' ILE . 7.1 p -122.66 27.2 7.91 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 121.596 -0.69 . . . . 0.0 110.242 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 69' ' ' LEU . . . -113.64 119.35 37.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.868 -1.145 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 5.2 tt -112.4 176.49 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.417 -0.802 . . . . 0.0 109.174 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -120.4 130.98 24.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.973 -1.08 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 36.4 Cg_endo -79.34 -164.51 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.547 2.165 . . . . 0.0 110.384 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 90.32 -133.77 11.98 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.489 ' N ' ' HB3' ' A' ' 126' ' ' ALA . 5.1 ppp? -114.57 174.8 5.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -1.085 . . . . 0.0 109.41 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -149.99 116.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.368 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -104.94 123.61 48.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.815 . . . . 0.0 108.959 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.562 HG22 ' CG2' ' A' ' 23' ' ' ILE . 2.6 mt -129.98 -176.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.001 -1.062 . . . . 0.0 109.916 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 22' ' ' LYS . 6.8 t -158.14 109.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -57.57 114.01 2.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.578 -0.701 . . . . 0.0 110.398 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.466 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 40.59 61.93 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.771 . . . . 0.0 110.151 179.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 43.08 44.8 4.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.779 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.57 -122.29 2.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -52.05 146.98 7.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.306 -1.114 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.61 123.04 47.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.099 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -128.04 121.16 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.339 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.586 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.0 p90 -113.28 147.83 36.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.222 -0.923 . . . . 0.0 109.908 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.481 ' CG2' ' SD ' ' A' ' 15' ' ' MET . 1.7 mt -120.07 -158.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.424 -0.797 . . . . 0.0 109.139 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 7.6 t80 -172.44 133.32 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.447 HD21 ' CB ' ' A' ' 80' ' ' ALA . 2.1 mp -140.43 -174.54 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -128.12 5.16 5.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.49 160.04 8.32 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.458 ' O ' HG21 ' A' ' 45' ' ' ILE . . . 162.16 -175.5 38.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 43' ' ' THR . 1.4 pt -103.16 137.8 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -1.12 . . . . 0.0 109.258 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.529 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' CA ' ' O ' ' A' ' 42' ' ' LEU . 15.2 pt-20 -126.59 139.41 53.21 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 39' ' ' ALA . 9.2 p -100.51 142.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.461 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.4 mm100 -124.74 158.75 61.27 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 109.097 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -76.95 86.47 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.603 2.202 . . . . 0.0 110.477 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.64 2.28 10.61 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.519 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 175.7 175.68 0.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -1.178 . . . . 0.0 109.213 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 5' ' ' HIS . 2.3 p -150.63 148.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.167 -0.958 . . . . 0.0 109.132 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.429 HG23 ' HB3' ' A' ' 7' ' ' ASP . 7.5 p -140.86 142.86 34.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 109.573 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.52 ' HB ' ' CD1' ' A' ' 45' ' ' ILE . 3.0 m -148.36 138.28 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.425 ' CD2' ' C ' ' A' ' 79' ' ' LEU . 1.2 tt -114.49 135.74 53.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.447 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -122.2 179.42 4.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -115.39 -11.28 11.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.494 HG21 ' N ' ' A' ' 83' ' ' ALA . 9.3 m -127.53 161.4 28.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.516 ' HB3' ' CE ' ' A' ' 15' ' ' MET . . . -167.57 122.32 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.586 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 48.3 mt -117.37 -45.22 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.288 -0.882 . . . . 0.0 109.267 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.485 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 3.0 ttt180 74.6 147.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.436 -0.79 . . . . 0.0 109.646 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.443 ' HA2' HG22 ' A' ' 130' ' ' VAL . . . -58.12 -21.87 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ASP . 57.8 mt-30 -81.45 -63.67 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.448 ' HB3' ' CG2' ' A' ' 84' ' ' ILE . 2.8 p30 40.35 30.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.62 -0.675 . . . . 0.0 109.867 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ASP . 1.2 mp 50.48 -179.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 91' ' ' GLU . 4.9 m-20 43.96 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.437 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 1.3 mt-10 172.97 -30.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.488 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 -17.4 48.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.85 . . . . 0.0 109.561 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 4.5 29.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.673 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' O ' ' CD1' ' A' ' 128' ' ' LEU . . . -90.84 -30.35 17.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.459 ' HA ' HD12 ' A' ' 128' ' ' LEU . 4.8 mtt -73.32 -5.06 37.22 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.361 -0.837 . . . . 0.0 109.596 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.06 1.61 56.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.636 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . . . -89.34 -42.51 11.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.653 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -19.55 63.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -89.89 -26.99 20.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 9.1 pttt -89.3 -11.3 43.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.621 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 105' ' ' ILE . . . -90.47 -58.49 2.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.613 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.53 63.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.715 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -52.83 -38.34 61.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 109.889 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -88.38 -26.33 22.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.603 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 107' ' ' SER . 12.0 mt -88.24 22.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 109.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.2 m -54.99 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER 67.37 118.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.0 t -137.74 118.98 14.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 109' ' ' HIS . 52.2 t-80 -113.28 56.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 111' ' ' ASP . . . -138.48 125.7 3.25 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 68.8 m-20 -44.88 -80.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -1.201 . . . . 0.0 109.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 113' ' ' ASP . 20.6 m -117.53 -10.0 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.414 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.5 OUTLIER -48.02 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.335 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -70.94 -14.88 62.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.043 -1.036 . . . . 0.0 108.26 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -66.26 -23.36 66.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.569 -0.707 . . . . 0.0 109.264 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.42 -54.17 13.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.327 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.9 -20.21 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.19 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -79.01 -44.24 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.16 68.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.381 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.54 -20.7 64.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.464 ' O ' HD11 ' A' ' 125' ' ' ILE . 7.6 mt -90.0 -24.0 21.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.416 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -59.75 -16.77 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.586 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.3 96.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -70.66 -5.97 33.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -85.79 -13.16 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.149 -0.97 . . . . 0.0 109.289 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.489 ' HB3' ' N ' ' A' ' 49' ' ' MET . . . -87.36 -24.56 24.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.293 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -83.55 -15.48 49.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.414 -0.804 . . . . 0.0 109.489 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.459 HD12 ' HA ' ' A' ' 95' ' ' MET . 0.7 OUTLIER -80.19 -22.74 41.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.601 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.449 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 1.9 ttp180 -85.24 -35.31 21.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.785 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.586 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 18.3 m -76.34 -28.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.459 ' O ' ' OG1' ' A' ' 134' ' ' THR . 7.1 tt -76.9 -38.45 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 109.267 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.96 -23.86 48.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.07 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.579 HD11 ' CE2' ' A' ' 61' ' ' PHE . 41.4 mt -76.4 -37.63 56.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.25 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 72.0 p -59.29 -16.75 23.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.775 . . . . 0.0 109.65 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -76.18 -44.08 39.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -14.12 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.36 -80.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.491 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mmt -84.98 167.6 15.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -133.88 174.58 10.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.58 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 1.1 p90 -148.39 -136.03 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.4 OUTLIER -151.05 138.37 19.4 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.817 -1.177 . . . . 0.0 110.423 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.608 ' HB2' ' CE2' ' A' ' 16' ' ' PHE . 0.4 OUTLIER -102.18 148.06 25.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 1.1 t0 -144.92 72.02 1.32 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.017 -1.052 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.52 ' HB ' ' CG1' ' A' ' 78' ' ' VAL . 2.9 p -106.81 138.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.352 -0.842 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.452 ' N ' HG21 ' A' ' 8' ' ' VAL . 32.8 m -145.88 173.26 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.687 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.9 t -170.25 113.76 0.47 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.056 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 65.96 26.48 10.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.075 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.1 mm-40 63.46 24.09 13.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.517 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 12.4 tt0 -78.07 -22.49 48.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.144 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 6.3 mt-30 63.46 100.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.522 ' HE3' ' CB ' ' A' ' 83' ' ' ALA . 16.7 mmm -101.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -135.67 111.66 9.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.623 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 17' ' ' SER . 27.6 p -135.32 77.69 1.69 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.47 179.98 48.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.0 mt -60.26 161.91 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -1.193 . . . . 0.0 109.492 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.582 HG13 ' CZ ' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -157.75 159.3 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.81 . . . . 0.0 108.829 -179.225 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.468 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.1 -52.75 2.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -0.937 . . . . 0.0 110.138 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -141.02 108.12 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.769 -1.207 . . . . 0.0 111.28 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -103.13 155.91 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.483 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 2.0 tm0? -146.76 115.61 6.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.416 -1.427 . . . . 0.0 110.724 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.535 ' CG2' ' HG2' ' A' ' 46' ' ' LYS . 3.3 t -103.92 133.62 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.233 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.464 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 54.7 m -125.01 102.72 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.549 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -123.07 -110.06 1.98 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 t -132.37 -77.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -1.16 . . . . 0.0 109.63 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.81 -24.75 67.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.74 151.37 18.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -142.81 11.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -1.076 . . . . 0.0 109.315 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.4 mt -116.64 156.45 27.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -100.03 -114.59 3.65 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.58 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 15.9 mm -154.98 143.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -1.049 . . . . 0.0 109.245 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -154.35 -172.13 0.31 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -78.94 8.86 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.805 1.67 . . . . 0.0 110.423 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.91 11.42 3.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 84.6 t60 -53.26 156.22 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.629 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.48 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -70.08 173.22 4.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.668 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -77.75 76.05 4.48 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.758 2.305 . . . . 0.0 110.386 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.3 140.29 34.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.607 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -155.51 29.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 109.563 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.3 p -121.76 -139.54 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.219 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' A' ' 45' ' ' ILE . . . -99.79 119.97 38.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -160.74 -166.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.757 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.667 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 13.3 mttt 71.5 46.41 0.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.8 Cg_endo -80.32 152.67 20.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 94.01 -152.71 20.84 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.696 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.527 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 7.2 ptm -99.56 -171.67 2.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -1.024 . . . . 0.0 109.503 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 50' ' ' ILE . 40.9 mt -150.0 156.18 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.44 ' NH1' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 4.6 mt -121.26 162.8 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 110.476 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 74.9 t -133.38 118.95 33.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 154.71 -98.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 56' ' ' HIS . 1.9 tt0 37.75 47.44 0.84 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.6 t-160 81.8 -68.89 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.606 -0.684 . . . . 0.0 109.494 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -161.54 77.94 0.17 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.458 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 168.19 -160.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.149 . . . . 0.0 109.489 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.19 158.42 43.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.288 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -147.23 115.96 6.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.683 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.612 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 14.1 p90 -103.24 140.55 37.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.449 HG22 ' HB3' ' A' ' 15' ' ' MET . 0.7 OUTLIER -115.58 -156.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.945 . . . . 0.0 109.566 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 49' ' ' MET . 8.9 t80 -177.46 111.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.195 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.415 HD13 HD13 ' A' ' 50' ' ' ILE . 1.6 mp -134.85 -179.91 5.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 109.336 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -71.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.82 62.83 0.63 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.37 -179.62 50.63 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 10.0 mm -101.45 118.37 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.515 ' HB2' ' CG1' ' A' ' 45' ' ' ILE . 4.1 mm? -99.47 157.69 16.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.36 133.01 11.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 108.993 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' O ' HG11 ' A' ' 71' ' ' VAL . 12.7 p -99.69 136.26 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.655 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.479 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -119.03 173.59 3.34 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.38 -0.825 . . . . 0.0 109.456 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.2 Cg_endo -78.23 73.3 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.621 2.214 . . . . 0.0 110.515 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.6 3.67 32.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.418 ' O ' HG21 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -151.67 -175.3 5.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' HD13 ' A' ' 6' ' ' LEU . 4.5 t -158.64 146.78 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.263 -0.898 . . . . 0.0 109.034 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.435 HG21 ' HB3' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -138.22 157.5 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -168.46 135.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.83 109.02 12.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.75 179.34 4.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.623 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -105.17 -42.76 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.43 HG22 HD13 ' A' ' 84' ' ' ILE . 14.8 m -109.42 100.4 9.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.522 ' CB ' ' HE3' ' A' ' 15' ' ' MET . . . -122.38 94.33 4.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.189 -0.945 . . . . 0.0 109.379 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' HA ' ' OD2' ' A' ' 88' ' ' ASP . 3.3 mp -100.1 84.54 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.518 ' N ' ' OD2' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -66.36 133.7 51.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.62 -121.58 11.0 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.406 ' CD ' ' OE1' ' A' ' 91' ' ' GLU . 11.6 pt20 -124.32 53.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -1.106 . . . . 0.0 109.565 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 85' ' ' ARG . 1.6 p30 -63.09 -13.37 35.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.4 mt -114.57 -90.89 0.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 m-20 -117.1 -179.9 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' CB ' HD13 ' A' ' 131' ' ' ILE . 4.9 pt-20 -145.77 -43.54 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.863 . . . . 0.0 109.215 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.27 -18.46 39.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -0.828 . . . . 0.0 109.462 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.3 3.62 51.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -13.43 34.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.196 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.34 -18.04 34.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.374 -0.829 . . . . 0.0 109.364 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.8 -14.95 57.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.51 -5.71 58.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 109.598 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.413 ' HG2' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -89.85 -24.23 21.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.436 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -89.21 -21.44 23.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 109.401 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.32 -31.93 29.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.524 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . . . -90.36 -39.66 12.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.0 -11.64 59.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.331 -0.856 . . . . 0.0 109.535 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 99' ' ' ARG . 15.5 tt0 -90.28 -37.41 14.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.6 -30.63 46.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 107' ' ' SER . 31.3 mt -89.18 4.3 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.649 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 107' ' ' SER . 1.3 t -45.65 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER 77.25 121.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.429 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.1 141.29 18.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -111.28 -173.4 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.49 117.6 0.75 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -48.97 -69.91 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 19.9 m -121.03 12.17 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 18.4 t0 -66.22 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -0.868 . . . . 0.0 109.211 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 32.1 t80 -75.72 -5.5 45.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.54 -7.91 59.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -78.31 -29.43 47.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.603 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -78.24 -6.39 54.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.096 -1.002 . . . . 0.0 109.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.76 -8.8 59.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.577 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.73 -34.87 17.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 123' ' ' LYS . 8.7 pt-20 -75.3 -27.42 59.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -79.29 -41.86 27.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.433 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.74 -11.67 59.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.246 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.56 -32.7 65.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.95 -26.99 54.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 125' ' ' ILE . 3.0 mp -81.84 2.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.91 . . . . 0.0 109.479 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.58 -26.68 60.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.471 ' OE1' ' CE2' ' A' ' 63' ' ' TYR . 12.6 mt-30 -74.56 -5.11 40.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.453 HD22 ' O ' ' A' ' 128' ' ' LEU . 6.7 tt -79.78 -19.19 49.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -90.06 -49.5 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.612 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 5.0 m -66.85 -38.64 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 109.588 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.516 HD11 HG23 ' A' ' 131' ' ' ILE . 2.6 tt -54.97 -39.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.539 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -43.59 -38.3 2.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.468 HD23 ' CD2' ' A' ' 61' ' ' PHE . 9.0 mp -62.75 -51.55 66.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.148 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.9 p -50.84 -31.59 17.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.613 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 19.5 mttt -62.3 -42.9 99.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.54 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 20.6 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.455 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.18 -55.14 5.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.498 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER 66.72 167.46 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER 53.94 117.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.75 0.786 . . . . 0.0 110.47 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.611 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 3.3 p90 -130.69 -153.41 0.56 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.186 -0.946 . . . . 0.0 108.641 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.476 ' ND1' ' N ' ' A' ' 6' ' ' LEU . 21.6 t-80 -129.53 144.56 51.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.943 -1.098 . . . . 0.0 109.852 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.601 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -138.21 164.19 29.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.225 -0.922 . . . . 0.0 108.958 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.57 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 8.3 t0 -160.02 94.69 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.98 -1.075 . . . . 0.0 109.964 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.493 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 5.0 m -104.34 147.3 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 108.958 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.493 ' CG2' ' C ' ' A' ' 8' ' ' VAL . 1.7 t -154.74 177.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.2 p -138.62 -160.89 1.11 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.27 -51.27 8.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.53 66.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.708 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -147.01 139.38 24.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.18 132.07 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.49 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.463 ' CE ' ' HB2' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -127.45 -72.88 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.647 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 47.9 t80 -151.41 112.83 4.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.26 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.404 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 56.9 p -141.74 92.84 2.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.44 -153.1 21.26 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 21.4 mt -67.12 177.07 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.058 -1.26 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.647 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 177.17 159.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.13 -0.981 . . . . 0.0 108.658 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.512 ' HG3' ' CG2' ' A' ' 3' ' ' THR . 1.0 OUTLIER -129.75 -71.36 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.03 113.93 26.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.116 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.561 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -125.45 141.01 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.474 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 2.2 pt20 -145.54 129.66 17.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 109.885 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.9 128.4 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -111.73 116.56 30.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.51 -144.07 3.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLU . 89.3 p -77.39 122.65 25.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.121 . . . . 0.0 109.592 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 28' ' ' SER . 1.4 tp10 60.07 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.687 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.14 169.07 38.91 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -171.38 46.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -1.138 . . . . 0.0 109.319 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.402 HD12 ' OH ' ' A' ' 35' ' ' TYR . 8.8 mt -150.21 146.82 27.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.68 -99.49 2.24 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.611 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 20.5 mm -156.53 151.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.514 -0.992 . . . . 0.0 109.241 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.537 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -148.47 173.9 3.84 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.8 Cg_endo -73.26 81.77 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.908 1.739 . . . . 0.0 110.01 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.24 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -48.88 164.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.243 . . . . 0.0 109.413 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 71' ' ' VAL . . . -78.28 170.62 15.38 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.332 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.491 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.2 Cg_endo -77.19 73.93 5.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.581 2.188 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 41' ' ' LEU . 4.0 mm? -78.37 161.56 27.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 2.8 pp -169.08 36.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 108.972 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.1 -95.37 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.565 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.452 ' N ' ' OG1' ' A' ' 43' ' ' THR . . . -137.44 162.49 33.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.922 -1.111 . . . . 0.0 109.869 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.465 ' HB ' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -100.95 139.87 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -75.01 139.18 72.83 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.725 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.6 -162.04 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.716 2.277 . . . . 0.0 110.365 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.06 -141.12 15.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.407 ' HE2' HG11 ' A' ' 130' ' ' VAL . 12.8 ptm -108.78 174.41 5.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -1.144 . . . . 0.0 109.012 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -154.67 119.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.934 -1.104 . . . . 0.0 110.282 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.476 ' N ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.52 150.92 21.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.574 ' CD1' ' CD2' ' A' ' 6' ' ' LEU . 5.4 tt -143.84 167.9 12.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.617 -1.302 . . . . 0.0 111.384 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 53' ' ' VAL . 38.8 t -134.56 90.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -53.81 121.76 8.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.325 -0.859 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.532 ' HA ' ' CG2' ' A' ' 3' ' ' THR . 1.3 tt0 45.38 -158.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.171 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -77.67 103.78 7.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.944 . . . . 0.0 109.115 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 103.3 178.77 26.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 t-160 62.45 129.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -1.229 . . . . 0.0 109.448 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.2 mp0 -134.31 134.14 41.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' CB ' HG23 ' A' ' 52' ' ' ILE . 3.1 tt0 -104.85 170.48 7.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 0.0 109.596 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.619 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -133.07 122.86 24.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.169 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.5 mp -137.89 169.22 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.078 -1.013 . . . . 0.0 109.863 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -158.21 144.07 17.05 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.98 -164.26 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 110.035 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 33.6 p -105.1 -144.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.435 -0.791 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 80' ' ' ALA . . . -96.02 -135.19 8.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 128.44 -167.32 20.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 78' ' ' VAL . 19.6 tt -105.04 125.1 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 109.062 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.481 ' C ' ' CD1' ' A' ' 69' ' ' LEU . 2.4 pp -113.51 167.91 10.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.244 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 0.8 OUTLIER -161.79 123.63 2.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 9.9 p -99.95 145.01 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.984 -1.072 . . . . 0.0 110.418 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.519 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.18 175.58 2.49 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -76.96 75.8 4.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.509 2.139 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.03 -35.6 2.35 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 2.3 p30 -143.66 149.81 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.254 . . . . 0.0 109.85 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 6' ' ' LEU . 6.3 p -127.09 145.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.879 . . . . 0.0 109.413 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.518 ' N ' HG21 ' A' ' 76' ' ' VAL . 19.3 p -132.85 155.06 49.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' HB ' ' A' ' 45' ' ' ILE . 2.1 p -162.74 153.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 108.952 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.458 ' N ' HG21 ' A' ' 78' ' ' VAL . 6.4 mt -129.74 160.98 31.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 109.808 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 66' ' ' GLY . . . -149.91 -148.51 0.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 80' ' ' ALA . 11.0 m-20 -128.22 -33.39 2.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.667 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.479 HG23 ' N ' ' A' ' 83' ' ' ALA . 48.3 m -112.5 164.22 13.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.479 ' N ' HG23 ' A' ' 82' ' ' THR . . . -172.08 86.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 109.63 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.469 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.2 mp -105.67 134.17 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -0.915 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.7 ttt85 -58.51 153.86 15.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -51.52 -33.82 33.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.43 44.23 1.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.679 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.9 -32.75 72.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.79 -159.99 0.71 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.44 ' CB ' ' HB2' ' A' ' 93' ' ' ARG . 29.8 m-20 -62.21 179.48 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.33 -60.82 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.4 -12.65 59.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.44 ' HB2' ' CB ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -85.57 0.39 52.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.676 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.62 -1.75 57.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -0.998 . . . . 0.0 109.469 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.01 -22.56 21.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.779 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -80.71 -9.5 59.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.568 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.05 -24.42 35.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HB3' HD13 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -88.11 -27.5 21.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 3.9 ttm180 -67.35 -42.39 83.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -33.86 35.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.9 -14.02 59.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 26.5 tp10 -78.8 -23.01 45.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 2.9 tm-20 -54.37 -30.4 51.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 -46.08 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 105' ' ' ILE . 34.4 mt -52.14 -40.67 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.701 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 107' ' ' SER . 0.3 OUTLIER -92.98 58.18 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 108' ' ' SER . 6.2 p 178.8 155.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.664 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER 76.6 173.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.72 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 -171.52 3.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.795 . . . . 0.0 109.252 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.64 162.71 15.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.3 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -1.117 . . . . 0.0 109.472 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 15.5 m 39.97 33.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.425 -0.797 . . . . 0.0 110.031 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.16 -96.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 109.118 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -73.51 -15.84 61.3 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.013 -1.054 . . . . 0.0 108.401 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.06 -35.17 79.81 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.44 -11.84 61.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -0.782 . . . . 0.0 109.219 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HB2' HG12 ' A' ' 105' ' ' ILE . . . -76.77 -12.13 59.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 109.647 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -19.94 41.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.651 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.1 48.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.02 -32.77 22.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.659 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.457 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.75 -66.26 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.686 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -44.34 -25.46 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.835 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.9 ttmt -63.43 -53.14 56.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.73 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.3 -27.86 66.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.697 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.2 mm -75.15 -5.5 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 109.747 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.98 -1.67 40.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.442 ' O ' HG21 ' A' ' 130' ' ' VAL . 16.0 tt0 -89.81 -28.73 19.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.471 ' O ' HG12 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -69.33 -15.91 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -80.63 -27.26 37.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.619 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.7 m -89.58 -28.61 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.553 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.489 ' N ' HG21 ' A' ' 130' ' ' VAL . 25.9 pt -66.56 -20.43 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.805 . . . . 0.0 109.537 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -78.27 -26.06 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.453 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -87.39 -47.68 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.948 . . . . 0.0 109.543 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 133' ' ' LEU . 28.5 p -43.82 -27.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -48.34 -67.03 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.0 26.88 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 0.0 109.769 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 133' ' ' LEU . . . -100.4 -36.58 9.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mmm . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.56 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' THR . 3.3 tpp -130.55 137.23 49.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.612 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.513 HG21 ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER 57.89 147.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.777 . . . . 0.0 109.845 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.581 ' CE2' HG21 ' A' ' 34' ' ' ILE . 1.9 p90 -152.2 -164.42 1.96 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.23 -0.919 . . . . 0.0 108.953 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.8 t60 -116.87 145.16 43.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.119 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.618 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -137.49 152.01 49.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.7 OUTLIER -149.2 91.71 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.092 . . . . 0.0 110.034 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.518 HG12 ' CD1' ' A' ' 6' ' ' LEU . 3.3 m -100.66 141.3 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.288 -0.883 . . . . 0.0 109.012 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.416 HG12 ' C ' ' A' ' 8' ' ' VAL . 6.4 m -152.89 176.8 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.444 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -120.45 -150.2 0.45 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.37 -32.06 18.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -147.18 55.29 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HG3' ' OG ' ' A' ' 10' ' ' SER . 17.1 pt20 175.93 122.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 15' ' ' MET . 15.5 mt-30 -96.37 165.52 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.922 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.442 ' HE3' ' CB ' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -141.91 -91.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 109.111 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 31.7 t80 -96.01 120.55 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.212 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.406 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 29.9 p -152.53 80.35 1.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.54 20.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.501 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 24.4 mt -62.94 175.0 0.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.011 -1.287 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.62 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 179.5 160.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 108.993 -177.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.547 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 2.8 tm-20 -122.25 -51.18 1.99 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 110.087 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 18.3 tttp -153.74 122.56 6.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.134 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.565 ' CG2' ' CG1' ' A' ' 52' ' ' ILE . 11.2 pt -106.64 -170.13 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' CG ' ' CB ' ' A' ' 51' ' ' ARG . 5.0 pt20 -179.95 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.619 -1.3 . . . . 0.0 110.274 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 49' ' ' MET . 1.5 p -101.19 133.65 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.36 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -120.7 135.32 55.16 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.281 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . 179.47 -76.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -158.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -1.121 . . . . 0.0 109.507 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -67.77 -82.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . -51.8 117.98 6.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.18 64.28 1.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -112.98 160.81 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.386 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -111.37 -111.46 3.24 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.581 HG21 ' CE2' ' A' ' 4' ' ' TYR . 23.5 mm -156.11 140.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.981 . . . . 0.0 108.806 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.608 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -146.6 -172.05 0.3 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.608 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 35.7 Cg_endo -80.96 42.76 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.23 1.953 . . . . 0.0 110.606 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.46 34.09 0.04 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -74.58 145.31 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -1.13 . . . . 0.0 109.606 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.55 165.89 1.1 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.788 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.494 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.2 Cg_endo -78.62 73.38 5.93 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.685 2.257 . . . . 0.0 110.466 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.91 147.86 25.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.287 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -156.87 44.22 0.38 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.469 ' O ' HG21 ' A' ' 68' ' ' ILE . 32.0 p -123.69 -110.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -101.4 155.39 18.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.822 -1.174 . . . . 0.0 109.584 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.7 tt -104.56 177.08 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -86.43 113.38 52.22 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 109.636 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 45' ' ' ILE . 35.5 Cg_endo -78.61 122.15 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.483 2.122 . . . . 0.0 110.353 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.48 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 162.42 -127.72 1.76 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 1.7 ppp? -113.48 167.7 10.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.257 -1.143 . . . . 0.0 109.024 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 1.5 tt -150.39 149.31 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.931 -1.106 . . . . 0.0 110.393 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.542 ' CB ' ' CG ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -116.49 177.96 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.89 153.86 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.828 -1.17 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 18.1 t -137.97 149.51 24.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.57 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 10.1 tppt? 90.06 -112.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.581 ' HG3' ' CE1' ' A' ' 16' ' ' PHE . 18.8 tt0 53.62 58.32 5.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.547 -1.345 . . . . 0.0 109.155 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 56.1 m170 58.53 43.03 19.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.266 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 71.48 86.18 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.466 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 167.2 125.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.588 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.54 133.76 53.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.115 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.78 168.59 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CD2' HG13 ' A' ' 130' ' ' VAL . 0.8 OUTLIER -125.51 134.06 52.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.292 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 2.0 mt -101.73 -147.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.189 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.581 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 9.1 t80 -178.75 122.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 109.23 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.451 ' CD2' ' CB ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -120.21 161.57 20.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.81 -14.04 14.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.6 161.99 9.96 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 156.69 -167.46 33.63 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.469 HG21 ' O ' ' A' ' 43' ' ' THR . 7.2 mt -101.72 170.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -1.073 . . . . 0.0 109.158 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB2' ' CG1' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -155.0 163.87 39.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.697 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -157.44 134.64 10.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 109.202 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 14.5 p -100.39 152.73 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.783 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.452 ' N ' HG21 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -131.6 170.51 11.1 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 109.245 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -77.54 103.62 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.485 2.123 . . . . 0.0 110.325 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . 83.84 1.53 89.86 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 74' ' ' GLY . 13.4 m-80 -152.63 170.09 21.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -1.214 . . . . 0.0 109.391 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 75' ' ' ASN . 6.1 t -150.79 144.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.246 -0.909 . . . . 0.0 109.266 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -151.6 138.46 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.071 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.471 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 3.2 m -139.71 158.28 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.05 149.97 40.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.19 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.489 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -147.96 -175.84 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.851 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -123.32 -31.42 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.636 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.496 ' CG2' HD13 ' A' ' 84' ' ' ILE . 14.7 m -112.5 162.86 15.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' N ' ' CG2' ' A' ' 82' ' ' THR . . . -161.83 81.93 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.679 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.581 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -99.9 70.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.937 . . . . 0.0 109.326 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 84' ' ' ILE . 0.7 OUTLIER -44.04 161.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 131' ' ' ILE . . . -48.62 -59.04 6.92 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -116.9 60.0 0.75 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -1.144 . . . . 0.0 109.497 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -50.63 -63.63 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -142.87 -88.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.66 179.15 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -149.61 -39.74 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.16 32.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -78.31 -8.28 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.25 28.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.3 mtt -71.43 -6.73 42.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.516 -0.74 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 4.6 mt-10 -81.44 -40.65 23.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.53 -65.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -45.16 -31.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -59.53 -56.81 17.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.124 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.39 3.99 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 110.028 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.77 -46.3 10.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 109.638 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -65.56 -33.59 76.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.829 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -15.19 58.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.104 -0.998 . . . . 0.0 109.769 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -80.31 -65.18 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.84 -15.03 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 107' ' ' SER . 28.0 t -78.25 78.97 4.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 109.463 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 106' ' ' SER . 2.2 p 176.9 129.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' SER . 16.5 m 54.52 104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.421 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.54 -154.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 137.58 139.58 3.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 25.2 t70 -74.24 -58.06 3.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -1.194 . . . . 0.0 109.448 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.15 -7.6 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 109.454 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -59.28 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.822 . . . . 0.0 109.193 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -73.28 -23.11 60.26 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -59.59 -22.75 62.22 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.313 0.578 . . . . 0.0 109.464 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.48 -42.49 78.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.75 -11.63 60.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.559 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -1.09 26.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.706 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.94 -16.33 34.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -84.24 -16.42 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.947 . . . . 0.0 109.495 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -88.49 -45.01 10.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.601 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.35 73.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 124' ' ' ALA . 6.7 pttt -73.66 -28.4 61.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.407 ' N ' ' HG3' ' A' ' 123' ' ' LYS . . . -87.06 -8.05 57.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.218 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 tp -81.43 -4.07 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -74.36 -26.86 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.547 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -63.7 -33.63 76.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.403 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.513 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 19.2 tp -81.64 -10.27 59.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.502 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -31.29 19.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.568 HG13 ' CD2' ' A' ' 61' ' ' PHE . 1.2 m -90.56 -12.75 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.513 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 2.0 tt -90.4 -23.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 0.0 110.055 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.409 ' O ' ' HE2' ' A' ' 135' ' ' LYS . 0.7 OUTLIER -77.4 -39.28 47.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.552 HD22 ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -82.67 3.19 30.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 110.415 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.532 ' N ' HD11 ' A' ' 133' ' ' LEU . 14.3 p -87.15 -12.98 45.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.913 -1.117 . . . . 0.0 109.669 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 132' ' ' GLU . 5.6 ptpt -71.34 -5.44 32.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -97.63 -43.42 7.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 109.608 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -44.7 -29.06 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.583 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.565 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.418 ' O ' HG21 ' A' ' 3' ' ' THR . 0.0 OUTLIER -101.35 28.76 5.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.382 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.418 HG21 ' O ' ' A' ' 2' ' ' MET . 0.6 OUTLIER -160.75 153.77 21.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.839 . . . . 0.0 109.609 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.608 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 3.9 p90 -139.53 -145.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.348 -0.845 . . . . 0.0 108.926 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -134.7 152.5 51.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.606 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -115.9 138.28 51.32 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -143.39 72.61 1.37 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.321 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 78' ' ' VAL . 4.0 p -106.26 140.59 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' N ' HG21 ' A' ' 8' ' ' VAL . 3.2 m -140.84 147.42 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.339 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.3 p -143.78 42.9 1.47 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . 171.68 -87.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 109.582 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 13' ' ' GLN . 1.4 mt-10 -128.62 44.13 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER 70.81 61.95 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -145.6 99.21 3.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.616 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.515 ' HE3' ' CD2' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -175.12 -78.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 109.286 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.618 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -148.26 109.47 4.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 17' ' ' SER . 43.5 p -138.07 83.37 1.97 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 109.464 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.5 -153.47 11.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.47 152.47 30.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -1.169 . . . . 0.0 109.741 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.618 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -150.7 152.33 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 109.276 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 10.6 tt0 -109.84 -50.55 2.97 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.47 ' O ' HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -155.44 130.84 9.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -98.01 -152.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER 179.55 94.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.806 -1.184 . . . . 0.0 109.617 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 ' CD1' ' A' ' 23' ' ' ILE . 22.2 t -99.05 134.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.418 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 22.2 m -123.36 112.22 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.359 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -157.57 159.97 30.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -31.48 71.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.163 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -98.54 71.7 2.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.74 152.86 9.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.26 26.45 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.686 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.06 156.93 21.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -100.35 -121.37 4.7 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.608 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 30.7 mm -154.42 135.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -1.225 . . . . 0.0 109.016 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.6 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -140.7 -172.44 0.32 Allowed Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.6 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.5 Cg_endo -77.88 76.12 4.48 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.776 1.651 . . . . 0.0 110.407 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.22 37.53 0.6 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 39' ' ' ALA . 15.8 t-80 -67.76 166.6 14.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.179 -1.189 . . . . 0.0 109.394 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . . . -53.68 160.77 1.86 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.9 77.84 3.78 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.738 2.292 . . . . 0.0 110.581 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 39' ' ' ALA . 4.2 mm? -97.22 148.61 22.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.142 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.419 ' C ' HG21 ' A' ' 43' ' ' THR . 0.4 OUTLIER -158.5 31.59 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.419 HG21 ' C ' ' A' ' 42' ' ' LEU . 26.8 p -131.21 -145.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 109.239 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' O ' ' CG2' ' A' ' 45' ' ' ILE . . . -99.47 128.42 45.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.032 -1.043 . . . . 0.0 108.844 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.479 ' CG2' ' O ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -160.41 42.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 110.395 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.667 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.6 OUTLIER -130.82 45.73 1.9 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.917 -1.115 . . . . 0.0 110.723 179.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 79.52 3.31 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.047 1.831 . . . . 0.0 110.496 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 64' ' ' LEU . . . 158.62 -141.47 7.66 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.388 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' CG1' ' A' ' 130' ' ' VAL . 1.0 OUTLIER -110.02 179.91 3.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.404 -1.057 . . . . 0.0 109.587 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.546 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 1.7 tt -147.89 154.02 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.514 ' N ' HG12 ' A' ' 50' ' ' ILE . 1.3 tmt_? -144.8 152.35 40.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 8.3 mt -150.7 166.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 110.452 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 90.1 t -141.78 118.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.618 -0.677 . . . . 0.0 109.267 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 150.88 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 6.5 mp0 42.46 -147.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -109.67 -11.06 14.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.952 . . . . 0.0 109.419 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.04 -98.64 2.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 58' ' ' HIS . 2.6 m-70 -130.3 -66.51 0.77 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.55 165.86 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.97 143.31 50.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 0.0 109.436 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.558 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.7 OUTLIER -116.9 123.71 47.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.546 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.6 mt -137.38 -160.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.969 . . . . 0.0 109.316 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.557 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -174.38 131.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 0.0 109.32 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.515 ' CD2' ' HE3' ' A' ' 15' ' ' MET . 3.6 mm? -119.5 158.27 26.62 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -99.27 -19.71 16.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.521 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.96 45.73 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.54 -178.02 32.21 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 2.7 mp -102.79 122.94 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -1.125 . . . . 0.0 109.367 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.482 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 6.7 mp -99.53 175.34 5.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.696 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -168.78 129.3 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 39' ' ' ALA . 5.7 p -99.86 129.06 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.076 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.74 173.7 3.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.5 Cg_endo -81.04 56.02 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.07 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.89 -16.73 1.21 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.075 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 5' ' ' HIS . 15.5 m-80 -150.91 -175.65 5.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 0.0 109.468 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.53 ' CG2' HG23 ' A' ' 34' ' ' ILE . 38.0 t -144.25 146.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.237 -0.914 . . . . 0.0 109.361 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.496 HG21 ' CB ' ' A' ' 7' ' ' ASP . 1.2 p -138.07 174.24 10.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.529 ' CG1' ' HB ' ' A' ' 8' ' ' VAL . 1.2 p -178.25 119.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.298 -0.876 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.62 124.51 48.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.033 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.456 ' CB ' HD13 ' A' ' 64' ' ' LEU . . . -128.73 -152.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.78 -39.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.489 HG21 ' N ' ' A' ' 83' ' ' ALA . 28.4 m -104.24 151.73 23.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 109.754 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.489 ' N ' HG21 ' A' ' 82' ' ' THR . . . -165.68 167.51 17.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.321 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 84' ' ' ILE . 16.3 mt -130.68 -28.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 69.37 45.71 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.418 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 84' ' ' ILE . . . 74.04 -112.13 3.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.78 27.08 9.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.42 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -49.43 -40.72 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.669 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.86 -88.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.772 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.07 164.84 20.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.45 ' HG3' HD13 ' A' ' 131' ' ' ILE . 25.9 tt0 -106.26 -72.8 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.54 -17.1 34.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -81.64 3.75 24.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.591 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.09 26.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 108.693 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 mtm -71.08 -26.54 63.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.507 -0.745 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.58 -24.21 67.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.323 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.24 -42.75 22.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.327 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG3' HD11 ' A' ' 125' ' ' ILE . 4.4 tttt -58.44 -43.51 88.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -26.55 65.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.307 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -89.94 7.68 36.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -90.5 -35.62 14.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -34.9 72.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 106' ' ' SER . 0.4 OUTLIER -62.58 -34.88 77.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -48.72 65.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.448 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mt -89.56 27.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 107' ' ' SER . 0.5 OUTLIER -68.92 92.86 0.52 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 106' ' ' SER . 39.5 m 61.47 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.633 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.44 118.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -95.68 73.42 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.514 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.27 132.02 4.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.5 m-20 -67.23 -149.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -1.148 . . . . 0.0 109.398 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.537 ' CA ' ' HB1' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -35.96 -31.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.301 0.572 . . . . 0.0 109.708 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 111' ' ' ASP . 22.5 t70 -38.18 -93.15 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.665 -0.647 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -63.42 -20.15 65.31 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.537 ' HB1' ' CA ' ' A' ' 112' ' ' VAL . . . -55.74 -26.22 44.44 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.419 0.628 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -82.13 -31.92 30.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.384 -0.822 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -13.31 61.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.646 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 t -83.24 9.34 10.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.16 10.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.432 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.451 ' HG3' HD23 ' A' ' 121' ' ' LEU . 23.2 pt-20 -67.6 -12.49 60.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.451 HD23 ' HG3' ' A' ' 120' ' ' GLU . 3.9 mm? -82.57 -36.21 26.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.918 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.94 46.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -69.85 -14.05 62.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.369 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.16 -8.49 57.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.343 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.411 HD11 ' HG3' ' A' ' 98' ' ' LYS . 27.3 mm -87.66 -17.9 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.51 -26.49 68.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -60.3 -34.22 73.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 109.492 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.52 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 27.9 tp -90.03 -11.84 40.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -60.84 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.564 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.558 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 16.2 m -55.42 -51.15 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.015 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' A' ' 128' ' ' LEU . 3.9 tt -60.19 -26.95 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.15 -38.66 85.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 109.942 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.477 ' C ' ' CD1' ' A' ' 133' ' ' LEU . 1.2 pp -90.22 -16.2 29.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.04 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 131' ' ' ILE . 20.0 p -61.25 -38.89 88.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -60.41 -33.95 73.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.993 . . . . 0.0 109.419 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.48 1.0 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.03 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 109.427 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.459 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.563 ' O ' ' CG2' ' A' ' 3' ' ' THR . 0.1 OUTLIER -50.73 176.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -0.871 . . . . 0.0 109.472 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 21' ' ' GLU . 6.5 t 52.07 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.591 1.186 . . . . 0.0 111.075 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.6 ' CE2' HG23 ' A' ' 34' ' ' ILE . 9.2 p90 -110.75 -168.37 1.3 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -111.06 137.57 48.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.155 -0.966 . . . . 0.0 108.655 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.618 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -125.61 162.68 24.42 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.912 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.58 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.94 101.35 2.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.728 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 16' ' ' PHE . 7.3 p -99.79 124.66 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 2.3 t -136.93 146.73 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.2 m -123.59 -145.88 0.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -40.04 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 110.039 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -153.38 65.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -156.05 138.68 15.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -92.4 138.32 31.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.465 ' HE1' ' HB3' ' A' ' 83' ' ' ALA . 1.1 mmt -124.99 -60.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.618 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 49.7 t80 -131.09 133.41 45.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.467 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 p -163.0 97.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.262 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.02 -151.03 19.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.502 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 12.5 mt -70.23 161.94 29.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.191 -1.182 . . . . 0.0 109.302 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.615 HG23 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -178.59 153.93 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.258 -177.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 3' ' ' THR . 1.5 pp20? -152.25 -36.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.942 -1.099 . . . . 0.0 110.677 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.517 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -106.74 71.21 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.848 -1.158 . . . . 0.0 110.891 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 9.5 pt -102.81 142.29 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.099 -1.0 . . . . 0.0 108.699 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.535 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 20.0 pt20 -149.27 126.55 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.055 -1.028 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -99.11 114.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 51.6 m -99.78 108.42 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.52 -91.82 1.26 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.58 -67.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -1.089 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.64 132.09 33.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.55 -178.29 35.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -174.74 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.125 . . . . 0.0 109.591 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 12.8 mt -151.27 142.96 23.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.629 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -101.79 -99.69 2.44 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.6 HG23 ' CE2' ' A' ' 4' ' ' TYR . 7.2 mm -156.75 140.47 7.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.429 -1.042 . . . . 0.0 109.139 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -128.76 178.06 1.84 Allowed Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 33.1 Cg_endo -75.43 75.78 3.77 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.058 1.838 . . . . 0.0 110.172 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.5 38.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -107.9 175.33 5.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.209 . . . . 0.0 109.583 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.99 167.24 14.7 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.269 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.438 ' HA ' HG11 ' A' ' 71' ' ' VAL . 36.3 Cg_endo -78.61 81.99 2.61 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.535 2.157 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' CD1' HD13 ' A' ' 69' ' ' LEU . 1.4 pp -90.17 142.27 27.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.727 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 70' ' ' GLU . 3.4 mt -128.13 69.94 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.293 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -110.3 -160.5 0.72 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.459 ' O ' HD22 ' A' ' 69' ' ' LEU . . . -101.01 172.73 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 69' ' ' LEU . 1.7 tt -99.96 126.98 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 156.15 70.52 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.98 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.15 175.71 10.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.56 2.173 . . . . 0.0 110.314 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 113.96 -132.92 10.84 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.456 ' HE2' HG11 ' A' ' 130' ' ' VAL . 6.0 ptm -129.53 -177.11 4.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -1.204 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -151.96 131.3 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 109.816 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -98.41 127.26 44.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.562 HG13 ' CB ' ' A' ' 23' ' ' ILE . 1.2 tt -134.3 145.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.077 -1.014 . . . . 0.0 110.91 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.517 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 38.9 t -127.75 113.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HG2' ' CE1' ' A' ' 16' ' ' PHE . 17.6 mtmt -66.32 157.14 32.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -0.762 . . . . 0.0 109.886 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.537 ' CG ' HG22 ' A' ' 3' ' ' THR . 18.2 tt0 -60.29 -65.02 0.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.345 -0.847 . . . . 0.0 109.531 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.04 102.98 8.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 58' ' ' HIS . . . 159.47 -103.42 0.23 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.482 ' CD2' ' C ' ' A' ' 57' ' ' GLY . 51.8 m-70 -148.51 159.96 43.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -1.194 . . . . 0.0 109.702 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.497 ' CB ' ' HA ' ' A' ' 53' ' ' VAL . 1.9 pt-20 -101.3 136.05 41.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HB3' ' NH2' ' A' ' 85' ' ' ARG . 8.9 mt-10 -134.01 150.64 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.943 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 1.2 p90 -109.2 131.02 55.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.459 ' HA ' ' HG3' ' A' ' 85' ' ' ARG . 1.7 mt -101.95 -175.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.436 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.498 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 6.2 t80 -152.37 136.84 16.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.068 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.92 179.99 7.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -161.3 113.16 1.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.435 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.79 132.97 6.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.27 -161.79 28.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 82.2 mt -139.46 143.2 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -1.155 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.519 HD13 ' CD1' ' A' ' 41' ' ' LEU . 1.4 pp -123.72 138.5 54.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.42 ' HB2' HD22 ' A' ' 42' ' ' LEU . 2.8 pt-20 -142.72 149.89 39.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 40' ' ' PRO . 4.4 p -109.54 133.4 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.76 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.518 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -101.45 175.43 2.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.408 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.0 Cg_endo -76.76 77.59 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.62 2.213 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.85 12.58 31.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.524 ' O ' ' CG2' ' A' ' 76' ' ' VAL . 68.3 m-80 -153.9 -172.29 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -1.086 . . . . 0.0 109.343 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 75' ' ' ASN . 3.1 t -166.13 150.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.09 -1.006 . . . . 0.0 108.935 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.468 HG21 ' CB ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -158.5 142.26 15.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 0.0 109.315 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 69' ' ' LEU . 3.5 m -151.06 137.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.187 -0.946 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 1.1 mp -106.77 160.66 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.848 . . . . 0.0 109.194 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.461 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -149.76 175.88 11.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.8 -52.21 3.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.4 t -102.18 -176.68 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.367 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB3' ' HE1' ' A' ' 15' ' ' MET . . . -168.51 80.88 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.496 ' HB ' ' CE1' ' A' ' 63' ' ' TYR . 3.6 mp -108.51 72.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.494 ' NH2' ' HB3' ' A' ' 60' ' ' GLU . 22.9 ttt180 -42.84 154.11 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -45.95 -51.75 10.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -106.71 49.4 0.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -1.141 . . . . 0.0 109.539 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -27.69 14.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -123.36 -175.02 3.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.367 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 10.7 t70 -54.29 179.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.342 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -105.83 -34.8 7.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.95 -25.24 27.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -72.29 -7.44 49.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.59 -24.63 20.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.179 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -31.55 37.67 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 109.484 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -5.56 27.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.68 -22.93 42.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.465 ' CG ' HD13 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -82.34 -41.58 19.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.2 mtp-105 -61.3 -27.18 68.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.86 -21.76 26.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.95 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.12 -26.32 33.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.347 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 106' ' ' SER . 16.3 tt0 -60.97 -30.55 70.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.837 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -56.11 -30.88 62.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -89.5 -47.68 7.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.883 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 107' ' ' SER . 11.7 mt -86.83 14.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 107' ' ' SER . 71.2 p -48.69 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 77.03 167.76 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.565 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -166.94 134.52 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.15 -89.01 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.468 ' O ' ' OD2' ' A' ' 113' ' ' ASP . . . -167.78 174.41 42.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 1.2 m-20 63.65 105.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -1.202 . . . . 0.0 109.312 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 15.6 m 40.99 26.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -90.83 -89.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.177 -0.952 . . . . 0.0 108.893 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.451 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 26.7 t80 -73.93 -20.47 60.36 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.83 -53.17 58.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.51 -39.78 94.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.355 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.462 ' HB2' HG22 ' A' ' 105' ' ' ILE . . . -67.03 -16.35 64.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.589 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.53 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -74.52 -23.1 58.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.44 -41.15 11.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.977 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 6.2 pt-20 -75.77 -32.15 59.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.442 ' O ' HG12 ' A' ' 125' ' ' ILE . 51.1 tp -87.24 -51.84 5.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 109.614 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 118' ' ' SER . . . -52.72 -39.78 62.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -57.84 -36.12 71.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.781 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 123' ' ' LYS . . . -75.92 -22.54 55.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.563 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.465 HD13 ' CG ' ' A' ' 98' ' ' LYS . 14.0 mm -79.79 -3.61 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.619 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.81 -32.74 74.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -19.28 64.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 14.0 tp -83.99 -17.5 40.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -90.37 -28.99 18.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.733 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.576 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 5.0 m -89.19 -26.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 109.461 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 132' ' ' GLU . 3.1 tt -66.97 -46.86 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.455 ' N ' HG22 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -52.65 -26.29 13.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -44.98 28.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 135' ' ' LYS . 79.5 p -61.1 -14.88 27.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -45.42 -41.65 9.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.367 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -97.08 -41.77 8.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.442 ' O ' ' OXT' ' A' ' 138' ' ' MET . . . -44.19 -61.98 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.442 ' OXT' ' O ' ' A' ' 137' ' ' ALA . 2.8 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' THR . 6.3 mtp -77.65 -170.63 1.89 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.506 ' CG2' ' HG3' ' A' ' 21' ' ' GLU . 1.3 p 49.98 176.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.398 -0.814 . . . . 0.0 109.906 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.595 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 1.3 p90 179.42 -171.66 0.15 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.559 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.0 t60 -111.62 149.68 31.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 109.025 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.594 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -137.92 158.48 44.26 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 178.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 6.5 t0 -144.98 92.65 2.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG13 HD12 ' A' ' 6' ' ' LEU . 3.4 p -113.2 118.69 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.918 . . . . 0.0 109.408 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 t -130.9 145.08 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.454 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 39.5 t -178.05 66.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 10' ' ' SER . . . 178.09 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER 42.54 27.38 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.653 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.88 -150.59 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.512 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -134.39 102.84 5.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.444 ' HB3' ' CD1' ' A' ' 62' ' ' ILE . 1.4 mmt -76.01 -78.69 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.259 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.625 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 34.7 t80 -125.66 124.76 41.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.165 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 17' ' ' SER . 52.6 p -154.4 83.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.7 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.01 -153.59 17.37 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' C ' HG13 ' A' ' 20' ' ' VAL . 13.6 mt -65.02 167.7 7.5 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.151 -1.205 . . . . 0.0 108.745 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.625 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -173.85 173.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 120.87 -1.144 . . . . 0.0 109.496 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.9 tt0 -118.19 -46.37 2.61 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HE3' HG22 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.4 137.3 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.433 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 18.7 pt -99.42 -156.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -177.13 95.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.509 -1.369 . . . . 0.0 110.378 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.528 HG22 ' CG ' ' A' ' 46' ' ' LYS . 76.4 t -99.23 141.75 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.46 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 25.6 m -145.53 119.81 9.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.274 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -145.54 -163.39 10.18 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -42.66 42.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -1.078 . . . . 0.0 109.592 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 163.26 21.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.917 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.79 138.57 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -141.31 45.72 1.74 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -1.13 . . . . 0.0 109.213 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mt -144.85 164.58 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.785 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -112.59 -112.33 3.16 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.595 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 15.9 mm -153.33 138.04 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -1.153 . . . . 0.0 109.459 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.599 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -149.23 171.87 5.82 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.0 Cg_endo -70.3 83.03 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.566 1.511 . . . . 0.0 109.486 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.73 35.12 0.46 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.7 t-80 -81.97 151.26 27.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -1.12 . . . . 0.0 109.526 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . -42.94 154.8 0.28 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.409 -0.807 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 76.01 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.583 2.188 . . . . 0.0 110.559 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.03 162.13 13.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.311 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.68 35.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.634 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 68' ' ' ILE . 30.0 p -130.68 -145.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.901 . . . . 0.0 109.375 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -99.32 120.41 39.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 69' ' ' LEU . 1.1 pp -166.7 -169.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.163 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.63 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER 71.66 49.46 0.28 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 111.059 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.63 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 146.17 17.22 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.15 1.9 . . . . 0.0 110.418 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 115.58 -142.88 17.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.318 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.417 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -99.56 -155.22 0.5 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -1.079 . . . . 0.0 109.198 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.537 ' CG2' ' O ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -173.76 111.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 110.383 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.495 ' O ' HD12 ' A' ' 50' ' ' ILE . 15.7 mtm180 -99.46 166.63 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -152.62 167.63 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.601 -1.312 . . . . 0.0 111.246 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.457 ' N ' HG22 ' A' ' 52' ' ' ILE . 13.6 t -143.99 104.73 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLN . 1.3 ttpt -66.37 120.51 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.692 -0.63 . . . . 0.0 109.868 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 54' ' ' LYS . 82.0 mt-30 43.26 -161.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.363 -0.835 . . . . 0.0 109.373 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -68.71 88.41 0.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 54' ' ' LYS . . . 121.27 -171.21 14.86 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 61.5 160.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.383 -1.069 . . . . 0.0 109.607 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -171.35 147.41 2.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.401 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -132.8 154.67 50.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.501 ' CE2' ' HA ' ' A' ' 130' ' ' VAL . 0.9 OUTLIER -112.08 133.62 54.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 109.373 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.532 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 78.0 mt -151.94 167.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 109.261 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.52 ' N ' HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.65 149.66 37.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 109.576 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -157.67 152.69 25.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.16 -79.56 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 109.723 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 129.4 9.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.32 144.6 7.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 43' ' ' THR . 79.3 mt -99.48 118.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -1.108 . . . . 0.0 108.965 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 1.3 tt -112.49 153.37 27.54 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -145.65 152.41 39.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.28 139.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.0 109.872 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.521 ' HG2' ' CD ' ' A' ' 73' ' ' PRO . 0.9 OUTLIER -122.27 172.33 5.33 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.462 -0.774 . . . . 0.0 109.038 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.521 ' CD ' ' HG2' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -78.62 91.15 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.513 2.142 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.22 -10.31 54.6 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -161.32 162.11 30.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.027 -1.278 . . . . 0.0 109.896 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG12 ' CG2' ' A' ' 34' ' ' ILE . 18.3 m -135.75 172.87 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.5 m -159.95 156.64 27.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.504 ' CG2' ' HB2' ' A' ' 69' ' ' LEU . 2.7 p -167.73 133.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mt -117.77 118.34 31.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.418 ' C ' ' OG ' ' A' ' 10' ' ' SER . . . -109.02 -165.97 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.361 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.23 -52.29 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.438 HG23 ' OH ' ' A' ' 63' ' ' TYR . 16.5 m -99.93 120.11 39.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.35 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -149.75 163.71 37.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.54 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.1 mt -149.03 119.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.285 -0.885 . . . . 0.0 109.25 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.46 ' CG ' ' O ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -67.58 95.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.37 -110.75 1.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.409 ' NE2' ' OE1' ' A' ' 91' ' ' GLU . 0.1 OUTLIER -139.13 57.2 1.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 109.223 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -60.19 -45.16 94.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.61 -78.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -150.25 -155.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 109.608 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.471 ' HB2' HD11 ' A' ' 131' ' ' ILE . 1.3 pt-20 -151.93 -49.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.652 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.87 -10.14 59.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.359 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -8.48 59.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.52 -24.32 20.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.246 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -35.58 76.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -54.71 -33.34 60.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.17 75.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.112 -0.993 . . . . 0.0 109.86 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -18.06 60.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -70.06 -50.34 42.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.626 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -86.02 -9.19 57.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.573 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.404 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -76.81 -30.8 56.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 1.5 tm-20 -70.88 -22.46 62.28 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.306 -0.871 . . . . 0.0 109.347 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.74 -20.75 60.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -81.67 -36.75 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.519 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 8.4 mm -78.87 -26.91 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.1 p -80.81 -9.94 59.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.5 t -104.58 131.19 52.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.57 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 58.3 p -135.97 142.22 44.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.281 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.3 m-70 175.21 41.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.382 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.63 158.92 31.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -74.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -1.177 . . . . 0.0 109.562 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 17.6 m -100.84 19.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.393 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 9.7 t70 -59.83 -100.41 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.358 -0.839 . . . . 0.0 109.278 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 12.6 p90 -64.61 -22.22 66.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.903 -1.123 . . . . 0.0 108.223 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.84 -33.65 56.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -88.3 -24.7 23.1 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -68.08 -21.12 64.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -26.3 61.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.444 ' O ' ' HE3' ' A' ' 123' ' ' LYS . . . -90.18 -38.18 13.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -78.85 -5.79 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.519 ' HG ' ' CD1' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -90.15 -51.3 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.593 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.31 -28.87 70.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.179 -0.951 . . . . 0.0 109.459 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HE3' ' O ' ' A' ' 119' ' ' ALA . 14.8 mtmt -70.23 -23.66 62.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.66 62.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.868 . . . . 0.0 109.733 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.3 mp -80.08 -1.24 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.4 -24.57 63.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.454 ' O ' HG22 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -69.76 -45.76 67.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.62 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.4 OUTLIER -65.99 -15.51 63.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.638 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 125' ' ' ILE . 14.2 mmt180 -81.85 -25.75 34.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.501 ' HA ' ' CE2' ' A' ' 61' ' ' PHE . 31.6 m -88.09 -20.36 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 128' ' ' LEU . 7.7 pt -91.01 -44.62 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 0.0 110.047 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 5.0 mm-40 -61.81 -24.21 66.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.233 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 6.5 mp -89.09 -37.73 14.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -55.59 -40.93 72.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -61.39 -29.58 70.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.83 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -111.26 31.56 5.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 109.548 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.19 -3.56 8.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 109.654 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.339 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.519 ' CG ' ' O ' ' A' ' 1' ' ' ALA . 20.6 ptp 40.68 -155.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.482 -0.762 . . . . 0.0 109.837 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -42.35 166.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.873 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.597 ' CE1' ' HA ' ' A' ' 35' ' ' TYR . 5.0 p90 -148.79 -147.3 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 20.5 t-80 -133.9 140.71 46.99 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.05 -1.031 . . . . 0.0 109.641 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.608 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.067 . . . . 0.0 108.775 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -142.83 86.78 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.951 -1.093 . . . . 0.0 110.528 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.449 HG22 ' CB ' ' A' ' 15' ' ' MET . 5.0 m -99.9 148.78 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 79' ' ' LEU . 1.5 m -152.96 173.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.032 -1.043 . . . . 0.0 109.869 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.44 ' OG ' ' HB3' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -129.4 -153.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.92 -29.95 70.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' GLN . 6.3 mm-40 -116.74 26.51 9.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.003 . . . . 0.0 109.695 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 12' ' ' GLU . 19.8 mt-30 43.68 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.409 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 15' ' ' MET . 4.6 mm-40 -165.4 74.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.527 ' CE ' HG23 ' A' ' 62' ' ' ILE . 6.8 mtp -151.32 -73.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.643 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 47.7 t80 -159.75 136.84 9.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.267 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -160.17 105.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.461 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 144.99 -160.38 28.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.518 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 12.0 mt -56.09 174.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -1.191 . . . . 0.0 108.957 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.643 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 179.96 169.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.078 . . . . 0.0 109.65 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.0 tt0 -122.5 -41.9 2.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.314 -0.866 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.68 130.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -98.77 -165.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.44 ' HB3' ' CB ' ' A' ' 51' ' ' ARG . 4.5 tp60 -168.89 84.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.665 -1.272 . . . . 0.0 110.233 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.3 141.86 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.445 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 10.2 m -138.16 129.69 27.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 109.03 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.92 -81.38 0.1 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -38.78 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -1.173 . . . . 0.0 109.769 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -123.41 163.69 20.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 80.4 -82.06 1.51 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 44.1 tt0 73.88 53.11 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -1.089 . . . . 0.0 109.732 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -145.54 156.64 43.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -99.22 -115.17 3.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.584 HG21 ' CE2' ' A' ' 4' ' ' TYR . 29.5 mm -153.11 145.81 14.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -154.91 -171.0 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.7 Cg_endo -78.63 73.93 5.68 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.678 1.586 . . . . 0.0 109.671 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.09 54.7 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.547 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 11.8 t-160 -85.63 50.84 2.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -1.132 . . . . 0.0 109.648 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 38' ' ' HIS . . . 55.56 167.03 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 109.627 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.46 78.92 3.47 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.621 2.214 . . . . 0.0 110.229 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -95.05 144.4 25.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.16 36.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.6 p -121.26 -134.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . . . -99.6 168.73 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.883 -1.136 . . . . 0.0 109.333 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.448 ' HB ' HD21 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -112.9 136.23 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -65.46 147.01 98.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.569 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 35.3 Cg_endo -77.71 133.97 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.688 2.259 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.508 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 174.25 -144.89 7.78 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.512 ' HE2' ' CA ' ' A' ' 130' ' ' VAL . 3.8 ptm -105.73 -164.68 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -1.114 . . . . 0.0 109.481 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.537 HD11 HG22 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -168.57 123.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.995 -1.066 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -111.28 159.69 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -154.06 158.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.28 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.481 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 47.2 t -142.15 102.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -54.94 159.42 2.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 -179.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 54' ' ' LYS . 1.4 tm0? -35.85 -38.83 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.586 . . . . 0.0 110.022 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -103.06 -159.58 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -64.62 -163.77 0.79 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 4.1 t60 79.46 124.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.412 -1.052 . . . . 0.0 109.732 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.85 140.73 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 108.872 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HB2' HG23 ' A' ' 52' ' ' ILE . 2.0 mp0 -109.68 152.34 25.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.109 . . . . 0.0 109.746 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 130' ' ' VAL . 2.3 m-85 -124.22 132.29 53.59 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.527 HG23 ' CE ' ' A' ' 15' ' ' MET . 0.0 OUTLIER -149.54 -176.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.615 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.545 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -162.84 130.88 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 108.928 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.48 -166.34 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.87 . . . . 0.0 109.334 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.466 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 1.9 m -143.04 -93.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.69 154.63 17.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.0 -173.27 42.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.1 mt -122.09 131.99 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.339 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 45' ' ' ILE . 0.6 OUTLIER -112.88 -172.4 2.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.961 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 179.78 142.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 p -107.58 132.55 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 109.917 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.468 ' HG3' ' HA ' ' A' ' 76' ' ' VAL . 1.2 mt-30 -119.78 173.42 3.61 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 0.0 109.081 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.35 110.6 2.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.525 2.15 . . . . 0.0 110.829 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 78.51 11.86 84.85 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 19.6 p-10 -179.8 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.284 . . . . 0.0 109.838 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 6' ' ' LEU . 4.5 m -129.75 178.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.106 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.9 m -160.86 160.48 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.95 -1.094 . . . . 0.0 109.954 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.428 ' HB ' ' CB ' ' A' ' 69' ' ' LEU . 1.8 p -177.02 138.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 1.3 mp -124.31 153.27 42.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.04 -1.037 . . . . 0.0 109.95 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.95 166.06 26.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.433 -0.792 . . . . 0.0 109.047 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 81' ' ' ASP . 8.5 t70 -100.18 3.77 43.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 11.7 m -119.64 153.56 35.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' HB3' ' OG ' ' A' ' 10' ' ' SER . . . -168.57 113.42 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.474 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.545 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -104.62 -37.38 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.216 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 75.43 49.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 43.88 -109.58 0.26 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.517 ' CA ' HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -98.78 59.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -1.117 . . . . 0.0 109.886 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 33.3 t0 -47.42 -38.23 12.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.4 tp -163.65 127.6 2.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.13 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.09 172.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 109.319 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -128.56 -5.69 5.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 109.836 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.31 -11.34 41.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.944 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -81.57 -17.38 48.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.44 -7.74 52.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -0.978 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mtt -85.4 -10.93 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.6 -26.53 60.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.89 -1.94 34.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.58 -53.82 5.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -74.45 -29.56 61.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -82.75 -21.86 34.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -68.64 -29.37 67.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -17.66 51.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -88.79 -20.32 24.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 65.4 mt -83.08 4.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.661 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.4 m -47.83 -52.13 20.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.69 115.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.7 p -153.28 148.66 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.434 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.63 -63.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.529 ' N ' ' HB2' ' A' ' 113' ' ' ASP . . . 175.4 171.62 39.54 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.82 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 109.596 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 116' ' ' GLN . 14.3 m -88.19 20.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.529 ' HB2' ' N ' ' A' ' 110' ' ' GLY . 51.0 t0 -62.35 -100.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -15.36 58.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 108.473 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.83 -37.73 70.25 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.685 -0.634 . . . . 0.0 109.591 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 12.2 tt0 -84.24 -10.2 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.65 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.93 -20.84 24.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.65 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -64.37 -13.18 49.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 109.488 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.66 -60.97 1.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -59.08 -47.62 84.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -68.18 -59.74 2.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.802 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 118' ' ' SER . . . -56.26 -16.63 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.855 . . . . 0.0 109.829 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.409 ' CD ' ' HB2' ' A' ' 47' ' ' PRO . 7.6 ttpt -76.86 -36.2 56.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.18 -14.01 54.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.805 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 35.2 mm -87.84 -8.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.483 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -68.43 -30.64 69.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.459 ' O ' ' CG2' ' A' ' 131' ' ' ILE . 0.8 OUTLIER -84.07 -17.73 39.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.657 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -85.09 -30.51 24.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.433 ' O ' HD22 ' A' ' 133' ' ' LEU . 5.7 tpp180 -82.17 -33.94 29.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.54 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.15 -25.24 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.174 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.517 HG13 ' CA ' ' A' ' 87' ' ' GLN . 2.3 tt -90.95 -23.85 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 110.29 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -81.01 -34.62 32.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -84.67 0.17 51.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.955 -1.09 . . . . 0.0 110.099 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.545 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -80.97 -2.08 46.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -25.23 34.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -89.12 -9.05 52.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.12 -0.987 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.83 37.33 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.431 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 1.3 tpt 178.62 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.253 -0.905 . . . . 0.0 109.609 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.514 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -165.99 140.28 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.57 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 1.7 p90 -152.73 -142.69 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 19.2 t-80 -139.39 141.81 37.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.878 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.639 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 0.9 OUTLIER -137.38 153.83 50.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.079 -1.013 . . . . 0.0 108.673 178.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 77' ' ' THR . 3.1 t70 -148.33 98.06 2.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.524 HG21 ' CG2' ' A' ' 78' ' ' VAL . 2.1 p -99.28 110.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.862 -1.149 . . . . 0.0 109.09 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.05 154.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 1.7 t -165.96 107.52 0.73 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.211 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . 77.07 34.36 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 55.04 39.63 31.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 22.5 mt-30 -87.67 -43.9 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.204 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER 72.21 84.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.126 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.44 ' SD ' HG13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -98.97 -93.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 108.78 179.26 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.692 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 32.8 t80 -94.03 110.09 21.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.006 . . . . 0.0 109.315 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' ' 7' ' ' ASP . 60.4 p -136.97 109.94 7.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 145.49 -169.52 27.03 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.492 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 19.8 mt -52.46 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.107 -1.231 . . . . 0.0 108.602 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.692 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -176.04 145.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.962 -1.086 . . . . 0.0 109.563 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -108.7 -48.61 3.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 67.3 mmtt -147.19 101.76 3.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.405 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.94 109.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.79 110.09 22.48 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.04 -1.037 . . . . 0.0 110.51 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 32' ' ' LEU . 7.4 p -99.67 147.81 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.457 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.416 ' N ' HG21 ' A' ' 25' ' ' VAL . 12.4 m -135.84 121.71 19.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -152.42 -177.67 26.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.91 150.59 34.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -1.132 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 64.8 76.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.14 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 99.66 179.65 30.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 175.02 38.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.238 . . . . 0.0 109.806 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.528 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 4.6 mt -92.41 150.03 21.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.47 177.94 29.88 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.57 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 16.4 mm -98.6 140.13 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.874 -1.368 . . . . 0.0 109.187 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -137.79 170.87 9.47 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.8 Cg_endo -72.63 80.02 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.862 1.708 . . . . 0.0 109.918 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.66 34.94 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.8 t-160 -83.23 142.67 30.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -1.208 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -46.74 157.71 0.45 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.185 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.73 87.4 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 110.359 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.9 155.44 17.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' CD1' ' O ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -157.62 75.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.502 ' CG2' ' N ' ' A' ' 44' ' ' ALA . 5.9 t -156.09 -146.08 0.17 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.885 . . . . 0.0 109.021 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 43' ' ' THR . . . -99.46 136.46 39.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.476 ' CG1' ' C ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -156.47 -169.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 109.76 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.625 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER 63.61 51.95 1.37 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.488 -0.757 . . . . 0.0 110.399 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.625 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.4 Cg_endo -80.19 65.99 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.208 1.938 . . . . 0.0 110.811 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.45 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 155.11 -127.49 2.08 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.298 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.475 ' HA ' ' HB2' ' A' ' 63' ' ' TYR . 4.6 ptm -108.61 -169.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 109.684 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.536 ' CD1' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -179.43 127.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.479 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -110.35 172.86 6.61 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 18.2 mt -155.14 166.49 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.019 -1.051 . . . . 0.0 109.601 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 42.8 t -138.89 107.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.263 -0.898 . . . . 0.0 109.903 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' CG ' ' N ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 157.68 -97.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 16' ' ' PHE . 11.6 tm0? -50.68 165.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 0.0 109.373 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.0 t-160 75.54 -145.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.185 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.422 ' H ' ' CG ' ' A' ' 56' ' ' HIS . . . -84.7 -86.43 0.92 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' HG3' ' A' ' 59' ' ' GLU . 99.8 m-70 -120.23 -18.8 7.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -169.73 152.45 4.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.211 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.15 161.01 22.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 2.8 m-85 -118.19 141.78 48.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.535 ' CG2' ' N ' ' A' ' 63' ' ' TYR . 2.3 mp -151.53 166.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.101 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.583 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -171.45 130.1 0.71 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.172 -0.955 . . . . 0.0 109.275 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.5 mt -131.62 172.6 12.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.084 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -148.76 46.57 1.02 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.472 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 133.24 91.27 0.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -160.91 151.55 22.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 43' ' ' THR . 20.4 mt -105.72 119.7 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 78' ' ' VAL . 1.4 pp -109.06 -161.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.958 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' HG21 ' A' ' 76' ' ' VAL . 1.0 OUTLIER -177.7 124.16 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 p -99.66 138.78 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.504 -178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.471 ' HG2' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -121.46 174.98 2.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.471 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.79 84.66 1.99 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.444 2.096 . . . . 0.0 110.515 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 132.77 -36.29 2.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.483 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 9.8 p30 -155.14 154.19 31.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -1.225 . . . . 0.0 109.83 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.525 ' CG2' ' N ' ' A' ' 77' ' ' THR . 1.4 p -134.3 165.84 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.876 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.525 ' N ' ' CG2' ' A' ' 76' ' ' VAL . 98.7 m -153.55 145.56 23.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 0.0 109.63 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.524 ' CG2' HG21 ' A' ' 8' ' ' VAL . 2.6 m -122.74 147.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 0.0 109.441 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.4 114.09 20.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.673 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -137.17 172.2 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.314 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.73 -20.19 8.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 m -112.84 109.63 19.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' HB2' ' HE3' ' A' ' 15' ' ' MET . . . -129.45 146.48 51.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 55.3 mt -139.16 86.39 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.248 -0.907 . . . . 0.0 108.969 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' ILE . 26.3 ttt180 -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.01 107.54 0.57 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.44 79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -92.26 -34.35 14.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 tp -162.99 131.82 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 53.21 -178.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 92' ' ' ALA . 11.1 pt-20 -170.2 -39.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.473 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -75.06 -27.16 59.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.355 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -84.01 8.07 16.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.394 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.05 -12.36 38.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 0.0 109.178 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -26.82 53.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.44 -0.787 . . . . 0.0 109.467 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -77.25 -22.28 52.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.38 72.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' CD ' HG12 ' A' ' 125' ' ' ILE . 22.0 tttp -79.54 -22.59 43.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -69.07 -48.93 61.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.81 8.1 18.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.481 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . . . -84.05 -24.13 30.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.164 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 33.2 tt0 -69.42 -24.18 63.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.85 . . . . 0.0 109.224 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.67 -47.12 83.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.84 74.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.499 HG22 ' CD1' ' A' ' 114' ' ' TYR . 14.6 mt -84.12 -11.23 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.0 m -48.98 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.666 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -164.6 -38.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.217 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.0 m 48.05 68.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 -67.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 111' ' ' ASP . . . 125.75 -47.36 1.02 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -43.1 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -1.1 . . . . 0.0 109.133 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.421 ' HB ' ' CG ' ' A' ' 116' ' ' GLN . 22.6 m -143.56 36.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.12 -96.47 0.11 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.711 -0.618 . . . . 0.0 109.375 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.499 ' CD1' HG22 ' A' ' 105' ' ' ILE . 2.4 m-85 -60.03 -19.2 51.49 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.32 -54.18 15.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.421 ' CG ' ' HB ' ' A' ' 112' ' ' VAL . 50.6 mm-40 -87.95 -0.72 57.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.687 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 114' ' ' TYR . . . -90.88 -25.5 19.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.672 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.455 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 1.1 p -64.01 -18.63 64.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.706 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.25 -68.91 0.75 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.504 ' CG ' ' N ' ' A' ' 121' ' ' LEU . 11.1 pt-20 -55.14 -44.64 75.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 110.046 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.504 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -62.62 -61.01 2.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -59.49 -14.35 12.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.788 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.457 ' O ' ' HB1' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -66.04 -33.89 76.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.768 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.25 70.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 109.564 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.509 HG12 ' CD ' ' A' ' 98' ' ' LYS . 3.6 mp -77.29 -1.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.961 . . . . 0.0 109.715 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 123' ' ' LYS . . . -74.51 -20.56 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.071 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.466 ' O ' HG23 ' A' ' 130' ' ' VAL . 1.5 pt20 -87.22 -24.12 24.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.459 HD22 ' O ' ' A' ' 128' ' ' LEU . 2.2 tt -72.17 -9.36 58.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 0.0 109.424 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -84.61 -34.1 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.693 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.4 m -62.7 -27.6 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.504 ' N ' HG21 ' A' ' 130' ' ' VAL . 96.8 mt -62.34 -39.59 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -65.08 -18.34 65.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 133' ' ' LEU . 4.8 mp -89.03 -34.97 16.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -70.66 -20.88 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -81.02 -6.49 58.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -143.25 23.4 1.84 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -96.24 -20.82 18.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.446 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -172.03 174.28 4.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.288 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 55' ' ' GLN . 1.4 t -43.63 154.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.503 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.624 ' CE2' HG21 ' A' ' 34' ' ' ILE . 3.5 p90 -144.34 -159.65 1.02 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.562 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.1 t60 -114.05 144.79 42.55 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.603 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -103.15 130.97 50.49 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.162 -0.961 . . . . 0.0 109.136 178.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -137.44 88.85 2.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.418 ' O ' HG11 ' A' ' 8' ' ' VAL . 2.2 p -114.01 116.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.468 HG13 ' HG3' ' A' ' 14' ' ' GLN . 16.3 m -124.28 172.19 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' CG ' ' A' ' 13' ' ' GLN . 15.0 m -124.81 -150.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.403 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -43.24 65.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.616 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -164.91 49.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 109.691 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.462 ' CG ' ' HB2' ' A' ' 10' ' ' SER . 0.1 OUTLIER -151.15 155.54 39.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.468 ' HG3' HG13 ' A' ' 9' ' ' VAL . 2.0 mt-30 -111.49 161.58 16.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.815 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.431 ' HE3' HG21 ' A' ' 62' ' ' ILE . 32.3 mtp -140.88 -46.55 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.274 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.603 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -138.75 110.95 7.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.653 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.458 ' O ' ' OG ' ' A' ' 17' ' ' SER . 19.6 p -139.43 86.48 2.12 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . -177.6 -149.98 8.22 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.484 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 35.7 mt -82.45 175.25 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 109.529 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.591 ' CG2' ' N ' ' A' ' 21' ' ' GLU . 0.1 OUTLIER 176.4 171.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.085 -1.009 . . . . 0.0 108.82 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.591 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.4 tt0 -166.87 -34.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.584 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -116.42 75.66 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.561 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -99.61 143.6 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.266 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.516 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 19.7 tt0 -149.78 158.33 44.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.005 -1.06 . . . . 0.0 109.927 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 49' ' ' MET . 6.9 p -131.03 149.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.403 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -120.51 89.16 3.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.407 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.06 -77.7 0.56 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 p -150.38 -86.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.37 -28.6 22.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.96 73.06 1.8 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.24 29.97 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -1.115 . . . . 0.0 109.474 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.4 mt -130.86 144.75 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.66 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.5 -97.59 2.15 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.624 HG21 ' CE2' ' A' ' 4' ' ' TYR . 5.0 mm -155.72 161.74 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -1.041 . . . . 0.0 109.422 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.559 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -165.12 175.1 2.66 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.552 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -71.88 118.62 5.72 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.836 1.69 . . . . 0.0 109.222 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.97 24.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.575 ' CE1' HG22 ' A' ' 71' ' ' VAL . 19.3 p80 -86.9 -171.0 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.798 0.809 . . . . 0.0 110.79 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.611 ' CB ' ' CD ' ' A' ' 40' ' ' PRO . . . -54.74 -172.89 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 39' ' ' ALA . 33.1 Cg_endo -76.79 -179.68 5.62 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.913 1.742 . . . . 0.0 110.271 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' HA ' ' HB ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -90.6 37.64 0.92 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.193 -0.942 . . . . 0.0 110.913 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tp -147.5 116.54 6.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.574 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 t -175.74 -173.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.417 -0.802 . . . . 0.0 109.199 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.75 150.58 52.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.072 -1.018 . . . . 0.0 109.822 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.596 ' CD1' ' CB ' ' A' ' 69' ' ' LEU . 1.7 mp -102.17 112.64 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.497 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 1.0 OUTLIER -65.01 174.72 1.21 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 123' ' ' LYS . 33.8 Cg_endo -77.14 142.63 21.86 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.574 2.182 . . . . 0.0 110.55 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 152.15 -156.39 26.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.473 ' O ' HG21 ' A' ' 25' ' ' VAL . 13.5 ptm -103.6 -168.31 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -1.172 . . . . 0.0 109.35 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 7.6 mt -155.82 126.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.798 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -117.9 110.54 17.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.561 HG12 ' CB ' ' A' ' 23' ' ' ILE . 29.4 mt -118.33 168.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.117 -0.989 . . . . 0.0 110.52 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' A' ' 52' ' ' ILE . 38.1 t -135.27 120.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.4 ttmt -64.03 147.45 52.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.464 ' HB2' ' OG1' ' A' ' 3' ' ' THR . 6.3 tm0? -65.05 -49.05 71.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.444 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -53.26 -62.59 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 85.43 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -170.66 176.84 4.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -1.054 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -145.55 128.38 16.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 133.19 32.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.564 ' CZ ' HD13 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -116.23 145.31 43.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.958 . . . . 0.0 109.618 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG21 ' HE3' ' A' ' 15' ' ' MET . 3.2 mp -121.85 171.93 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CD2' ' HB2' ' A' ' 127' ' ' GLN . 8.2 t80 -141.34 152.7 44.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.29 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -172.92 -166.9 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.498 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 61.7 m -154.81 21.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.48 150.0 5.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.25 159.91 9.5 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.461 ' O ' HG21 ' A' ' 78' ' ' VAL . 2.0 mp -107.9 140.69 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.105 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.596 ' CB ' ' CD1' ' A' ' 45' ' ' ILE . 2.6 tt -121.05 156.9 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.09 -1.006 . . . . 0.0 109.635 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.457 ' N ' ' CD2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -158.21 146.45 18.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG22 ' CE1' ' A' ' 38' ' ' HIS . 2.2 t -103.31 159.27 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 110.132 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.607 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -126.19 -171.13 0.22 Allowed Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.9 Cg_endo -79.55 40.61 0.97 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.645 1.564 . . . . 0.0 111.294 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 145.49 34.23 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.94 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 5.2 p-10 166.19 133.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.284 . . . . 0.0 109.974 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' CG1' HG21 ' A' ' 71' ' ' VAL . 6.6 t -99.62 157.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.285 -0.884 . . . . 0.0 108.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 23.0 m -154.3 137.07 15.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.252 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.509 HG21 ' N ' ' A' ' 79' ' ' LEU . 1.5 p -141.32 141.72 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.599 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.509 ' N ' HG21 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -111.24 107.67 17.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.2 162.58 12.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.733 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.96 -47.02 7.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.5 m -100.82 136.03 41.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 109.549 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' C ' HD13 ' A' ' 84' ' ' ILE . . . -151.24 134.13 15.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.514 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.571 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 1.1 mp -111.86 -37.94 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.84 . . . . 0.0 108.959 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 77.26 84.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 42.18 -111.61 0.34 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.456 ' O ' ' CG ' ' A' ' 87' ' ' GLN . 1.4 tt0 -117.98 62.12 0.76 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.284 -1.127 . . . . 0.0 109.509 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 85' ' ' ARG . 13.0 t70 -85.77 -11.3 53.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -149.26 144.69 26.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 54.16 171.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.18 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.417 ' HG3' ' CD1' ' A' ' 131' ' ' ILE . 81.6 tt0 -168.15 -80.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.95 58.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.269 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -6.01 51.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.17 -27.37 19.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.942 . . . . 0.0 108.988 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 mtt -67.2 -40.53 86.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.443 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -33.11 75.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.469 ' HB2' HD12 ' A' ' 128' ' ' LEU . 1.3 tmmt? -62.37 -14.36 39.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.79 -53.05 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.482 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -65.23 -15.16 62.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.63 -28.36 26.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.348 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 103' ' ' GLU . 24.8 tt0 -76.33 -48.61 19.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 102' ' ' GLU . 38.6 tt0 -45.43 -29.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -71.22 -56.74 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 mt -87.36 16.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.927 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -65.96 91.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.433 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 71.6 143.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.0 OUTLIER 171.25 166.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.234 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -130.43 132.17 45.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.63 166.49 16.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 3.2 m-20 -97.41 -54.34 3.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -1.194 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 21.2 m -122.6 -18.05 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.814 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 112' ' ' VAL . 1.4 m-20 -46.4 -95.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.565 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -13.08 60.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.175 -0.953 . . . . 0.0 108.47 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -73.28 -5.0 36.65 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -85.31 -30.93 23.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.61 -16.62 61.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -21.94 63.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.36 -27.42 25.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.653 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -81.81 -27.84 33.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.673 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.431 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -76.2 -58.57 3.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -45.7 -25.05 0.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HD3' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -66.56 -50.36 63.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.831 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.56 71.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 125' ' ' ILE . 37.6 mm -59.97 -14.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.861 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.5 -47.19 64.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.573 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -73.91 -23.02 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' A' ' 98' ' ' LYS . 3.2 tt -74.94 -13.54 60.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.73 -48.19 7.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.752 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.54 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.9 m -62.69 -38.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.49 ' CD1' ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -64.57 -18.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.31 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 135' ' ' LYS . 0.1 OUTLIER -82.22 -18.49 42.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.564 HD13 ' CZ ' ' A' ' 61' ' ' PHE . 1.1 pp -90.09 -24.83 21.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.413 ' HA ' ' HB1' ' A' ' 137' ' ' ALA . 10.7 t -69.72 -5.57 25.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.516 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.51 ' HE2' ' CG ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -53.19 -20.97 4.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.51 ' CG ' ' HE2' ' A' ' 135' ' ' LYS . 14.8 mttt -113.85 -12.75 12.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.38 -58.0 2.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 ptp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.419 179.879 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' O ' HG21 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.473 ' O ' ' HB ' ' A' ' 3' ' ' THR . 3.8 mtt 44.8 53.33 7.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.458 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.549 ' CB ' ' HB2' ' A' ' 21' ' ' GLU . 9.1 t 174.47 128.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.638 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 21.8 p90 -107.68 -161.57 0.79 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.582 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.1 t-80 -117.26 144.59 44.67 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 109.052 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.623 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -135.59 161.4 35.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.306 -1.496 . . . . 0.0 109.194 178.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -149.49 94.55 2.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.486 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.85 112.27 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.183 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.35 156.82 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 12' ' ' GLU . 1.6 t -157.71 84.14 0.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . 57.56 21.79 7.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 1.3 pt-20 175.13 88.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -59.49 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.31 48.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.472 ' HB3' HG22 ' A' ' 62' ' ' ILE . 9.2 mtt -136.52 -52.47 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.427 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.623 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 33.9 t80 -166.53 129.25 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.494 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 79.4 p -161.6 94.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.422 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.22 -146.8 11.84 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 11.4 mt -68.24 167.92 13.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -1.142 . . . . 0.0 109.257 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.6 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 177.9 155.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 108.794 -177.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 6.4 tt0 -151.06 -44.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.537 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -105.97 76.49 1.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 111.494 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.552 ' CB ' HG13 ' A' ' 52' ' ' ILE . 6.5 pt -102.97 147.81 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.51 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 37.4 tt0 -145.71 127.24 15.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.786 -1.196 . . . . 0.0 110.333 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 t -104.71 133.09 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.44 -0.787 . . . . 0.0 108.963 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -124.46 129.55 50.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.467 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.23 -128.36 1.29 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -108.39 -18.52 13.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -1.168 . . . . 0.0 109.566 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.34 149.14 27.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.75 -74.44 1.32 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER 60.87 -175.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -1.099 . . . . 0.0 109.908 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 31' ' ' GLU . 14.3 mt 61.11 138.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 109.749 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.51 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.89 -102.1 2.42 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.638 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 10.5 mm -154.24 141.7 12.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.315 -1.109 . . . . 0.0 109.154 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -124.69 177.7 1.72 Allowed Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -75.11 76.51 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.04 1.827 . . . . 0.0 110.425 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.37 41.04 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -99.49 144.81 28.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -1.136 . . . . 0.0 109.565 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -55.64 175.65 0.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.46 106.2 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.709 2.273 . . . . 0.0 110.443 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.11 122.61 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.404 HD23 ' OE1' ' A' ' 70' ' ' GLU . 2.9 mt -136.21 71.65 1.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 p -137.69 -154.91 0.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.494 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.01 167.51 10.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.448 HG12 ' HB3' ' A' ' 69' ' ' LEU . 1.2 mt -103.57 -147.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.114 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -168.88 167.79 5.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.998 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.449 ' HB3' ' O ' ' A' ' 65' ' ' SER . 35.7 Cg_endo -78.88 122.42 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.745 2.297 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 176.85 -161.06 28.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.476 ' HB2' ' HB ' ' A' ' 130' ' ' VAL . 2.3 ppp? -107.87 176.08 5.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -1.081 . . . . 0.0 109.222 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.521 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -164.38 126.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.995 -1.066 . . . . 0.0 110.064 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -99.14 169.43 9.4 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.565 ' CD1' HD23 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -161.31 158.27 2.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.415 -1.428 . . . . 0.0 110.692 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.537 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 39.7 t -139.21 100.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -58.2 159.82 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.518 ' CG ' HG23 ' A' ' 3' ' ' THR . 4.1 tm0? -42.08 -52.09 4.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 109.619 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -57.98 178.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.18 82.37 1.68 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.46 -167.59 2.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 9.2 pt-20 -166.68 141.27 4.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.25 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' HG23 ' A' ' 52' ' ' ILE . 1.7 mm-40 -116.2 167.63 10.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.718 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE2' HG21 ' A' ' 130' ' ' VAL . 6.0 m-85 -129.24 119.15 23.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.049 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.521 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -126.79 179.93 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.132 -0.98 . . . . 0.0 109.871 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.567 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -173.79 142.62 0.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.12 178.92 8.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.746 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 47' ' ' PRO . 14.0 p -104.99 -25.47 12.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.64 178.19 37.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.11 -133.5 3.72 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -144.4 130.43 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.24 . . . . 0.0 109.31 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HA ' ' CG1' ' A' ' 78' ' ' VAL . 2.3 pp -109.13 125.91 52.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.786 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' O ' HG21 ' A' ' 76' ' ' VAL . 22.8 tt0 -125.17 129.14 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.065 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' HA ' ' HB ' ' A' ' 76' ' ' VAL . 7.1 p -99.24 155.46 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.832 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.509 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -138.21 170.83 9.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.432 -0.792 . . . . 0.0 109.442 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.47 71.76 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.659 2.239 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.19 -1.35 7.72 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.234 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 38.2 p-10 -172.88 175.26 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.933 -1.333 . . . . 0.0 109.865 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -161.14 162.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.502 HG21 ' N ' ' A' ' 78' ' ' VAL . 29.4 m -158.54 149.36 20.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.418 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' N ' HG21 ' A' ' 77' ' ' THR . 7.0 m -135.86 157.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 112.88 16.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.711 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.61 159.18 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.93 -48.87 16.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.7 t -102.04 -178.56 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.419 ' C ' ' HE2' ' A' ' 15' ' ' MET . . . -170.13 85.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.567 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.1 mp -104.09 67.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.21 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 84' ' ' ILE . 1.2 ptt180 -42.23 139.42 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.495 -0.753 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' C ' ' CG ' ' A' ' 87' ' ' GLN . . . -47.36 148.81 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.485 ' CG ' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER 58.61 25.1 12.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -1.222 . . . . 0.0 109.043 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 87' ' ' GLN . 17.6 p-10 -41.04 -46.39 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.04 -61.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.874 . . . . 0.0 109.343 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.08 172.2 13.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.3 OUTLIER -140.31 -87.27 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.359 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -19.29 56.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -77.17 -8.43 57.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.36 -8.32 51.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.959 . . . . 0.0 109.203 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -23.37 58.86 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.377 -0.827 . . . . 0.0 109.527 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -85.37 5.41 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.626 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.1 -12.44 38.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -29.52 65.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.542 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -90.23 -32.66 16.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.39 -8.11 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.202 -0.937 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.09 -30.67 20.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -0.989 . . . . 0.0 109.384 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.56 -33.4 72.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.525 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.57 -35.29 73.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -75.27 -20.6 59.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 32.3 mt -90.33 21.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 55.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -119.8 145.77 46.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.381 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.428 ' HA ' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p -128.95 138.29 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.686 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.6 -68.78 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.26 -100.14 0.14 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.533 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.1 OUTLIER -72.14 156.76 38.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.457 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 14.8 m 40.88 37.91 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.682 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 11.2 t70 -88.14 -96.3 0.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.192 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.37 -19.38 63.84 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.39 -41.79 84.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -90.12 -16.63 29.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.348 -0.845 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.38 -32.14 43.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.4 t -55.71 -21.75 20.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 109.587 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.85 -29.28 18.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.28 -24.75 63.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.461 ' O ' HD12 ' A' ' 125' ' ' ILE . 8.8 tt -82.51 -50.92 8.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.54 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.44 1.73 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.829 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.09 -61.76 1.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -78.3 -20.48 51.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 125' ' ' ILE . 1.3 mp -75.72 -12.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 109.163 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.7 78.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.285 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.549 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -78.66 -7.62 57.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 5.8 tp -78.26 -26.76 47.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.468 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.421 ' O ' HD21 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -87.94 -25.25 23.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.752 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG21 ' CE2' ' A' ' 61' ' ' PHE . 2.3 p -80.53 -25.7 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.643 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.478 ' HA ' HG22 ' A' ' 134' ' ' THR . 2.1 tt -90.58 -24.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.232 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 -44.94 46.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.095 -1.003 . . . . 0.0 110.198 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.421 HD21 ' O ' ' A' ' 129' ' ' ARG . 2.6 pp -68.56 -11.03 59.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 110.038 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 131' ' ' ILE . 57.4 p -53.28 -41.88 66.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.569 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -41.76 64.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -94.57 40.66 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.379 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.12 6.75 36.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.847 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.542 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.292 0.568 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.7 mtp 53.71 58.34 5.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.324 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.522 ' CB ' ' HG3' ' A' ' 55' ' ' GLN . 70.9 p -132.39 161.7 32.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.905 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.616 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 4.0 p90 -163.61 -143.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.574 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . 2.4 t-80 -139.69 149.45 43.69 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.656 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 1.6 pp -142.67 159.25 42.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.685 -1.259 . . . . 0.0 108.631 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.43 ' HB3' HG22 ' A' ' 77' ' ' THR . 9.8 t0 -135.49 87.0 2.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.895 -1.128 . . . . 0.0 109.678 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 14.7 p -99.04 100.44 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.22 -0.925 . . . . 0.0 109.604 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG23 ' HG2' ' A' ' 13' ' ' GLN . 55.2 t -108.95 149.03 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.865 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.44 ' N ' HG11 ' A' ' 9' ' ' VAL . 2.4 p -162.58 144.9 10.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.74 -96.98 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.717 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.55 38.98 3.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.056 -1.028 . . . . 0.0 109.567 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.86 -153.71 0.34 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.251 -0.905 . . . . 0.0 109.457 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.422 ' O ' ' SD ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 70.46 61.5 0.21 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.519 -0.738 . . . . 0.0 109.491 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.523 ' CG ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.72 -70.28 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.519 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.677 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 34.9 t80 -162.8 131.95 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -160.82 105.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.278 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.566 ' HA2' ' CD2' ' A' ' 5' ' ' HIS . . . 146.67 -158.62 27.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.641 ' N ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -48.39 -179.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.068 -1.254 . . . . 0.0 109.474 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.677 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 170.37 115.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.549 -1.344 . . . . 0.0 109.74 179.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 1.5 tt0 -67.93 -44.7 76.27 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.5 mtpt -179.5 143.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.995 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 23.5 pt -105.34 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -178.92 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 109.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.482 ' CG1' ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.24 127.61 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.992 . . . . 0.0 109.513 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -130.64 140.6 50.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.83 54.11 0.04 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.476 ' HB3' ' CB ' ' A' ' 46' ' ' LYS . 89.4 p -174.17 -159.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 109.438 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.29 48.18 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -167.11 -144.07 3.99 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.3 OUTLIER 166.98 74.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' HG21 ' A' ' 25' ' ' VAL . 12.6 mt -153.07 178.24 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.877 . . . . 0.0 109.67 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.484 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -128.68 -112.36 1.63 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.784 -2.127 . . . . 0.0 107.784 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.616 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 12.7 mm -154.1 138.25 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 109.124 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -138.28 176.9 2.37 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.586 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.6 Cg_endo -74.06 8.11 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.995 1.797 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.6 10.77 5.23 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' ALA . 40.1 t60 -54.33 123.75 13.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -1.215 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -49.17 178.56 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 34.9 Cg_endo -77.72 81.36 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.465 2.11 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.433 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -98.71 137.61 37.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.663 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.06 72.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.412 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 p -144.27 -146.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.51 169.92 8.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.454 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.521 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -130.49 173.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 109.251 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' CB ' ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -111.18 173.07 3.07 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.7 Cg_endo -78.31 -177.94 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.735 2.29 . . . . 0.0 110.474 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.485 ' HA2' ' HB3' ' A' ' 126' ' ' ALA . . . 133.38 -159.12 23.51 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.517 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 4.6 ppp? -113.28 172.78 6.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.255 -1.144 . . . . 0.0 109.126 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.517 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 5.1 tt -146.75 146.81 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.052 -1.03 . . . . 0.0 110.922 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.46 160.28 23.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -153.71 158.98 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.458 -1.401 . . . . 0.0 110.926 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.77 102.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -52.09 141.33 18.64 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.122 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.574 ' OE1' ' CG ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -39.91 -59.1 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.574 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 3.4 m170 -122.36 31.58 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.739 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.35 -108.15 3.16 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -151.9 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -1.127 . . . . 0.0 109.139 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER 179.65 147.67 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.551 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.91 161.39 31.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.104 -0.998 . . . . 0.0 109.782 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -117.64 125.31 50.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.272 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.523 HG22 ' CG ' ' A' ' 15' ' ' MET . 5.2 mt -136.8 166.58 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.331 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.594 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.92 146.18 25.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.1 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -172.81 4.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.519 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.428 ' OG ' ' HB ' ' A' ' 82' ' ' THR . 62.8 m -115.65 14.38 16.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.83 151.45 25.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . -165.85 -106.64 0.19 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 9.1 mt -139.2 122.27 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 108.97 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.521 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -106.58 133.48 51.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.782 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -133.5 143.64 48.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.019 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 40' ' ' PRO . 14.7 p -109.94 139.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.917 -1.114 . . . . 0.0 109.494 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -127.87 176.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 108.862 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.0 Cg_endo -79.22 88.91 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.514 2.142 . . . . 0.0 111.103 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 101.07 -3.43 55.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.4 OUTLIER -164.37 155.3 15.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.242 . . . . 0.0 109.72 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 6' ' ' LEU . 35.5 m -133.16 175.74 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 108.845 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.43 HG22 ' HB3' ' A' ' 7' ' ' ASP . 17.6 m -156.63 104.58 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.282 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 3.5 m -114.47 115.8 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 108.963 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.416 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -100.21 173.2 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.132 -0.98 . . . . 0.0 110.034 -179.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.447 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -157.69 -157.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 0.0 109.182 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.22 -30.78 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.95 . . . . 0.0 109.805 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.428 ' HB ' ' OG ' ' A' ' 65' ' ' SER . 5.5 m -110.01 153.2 24.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' C ' ' CD1' ' A' ' 84' ' ' ILE . . . -152.64 119.75 5.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.793 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.594 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 2.6 mp -139.07 95.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.29 -0.881 . . . . 0.0 108.907 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 84' ' ' ILE . 13.5 ttm180 -41.24 161.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.394 -0.816 . . . . 0.0 109.898 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.413 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -51.1 -26.32 12.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -151.7 93.41 1.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -1.153 . . . . 0.0 109.637 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -94.14 -57.88 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -83.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 109.475 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.13 165.97 17.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.43 -19.94 11.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.945 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 -25.59 32.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -65.51 -13.9 59.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.71 -32.0 16.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.379 -0.825 . . . . 0.0 109.29 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.409 ' HA ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -56.01 -40.61 73.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.802 . . . . 0.0 109.681 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.91 -16.5 53.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.54 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 100' ' ' LYS . . . -64.37 -27.76 69.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.654 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -55.71 29.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.549 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -19.92 62.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.907 . . . . 0.0 109.554 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.95 -34.28 77.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.61 -20.81 23.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.401 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.02 -16.67 64.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -80.53 -30.37 37.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -32.36 32.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.518 ' CG2' ' HB2' ' A' ' 118' ' ' SER . 25.6 mt -88.98 22.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 t -60.84 -24.94 66.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 m -140.02 167.08 22.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.215 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.08 134.1 3.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.618 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -156.14 179.47 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.89 -178.89 35.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.522 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 12.4 m-20 -98.41 127.62 44.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.518 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.29 28.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 109.672 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 111' ' ' ASP . 15.5 t70 -84.88 -93.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.45 -13.6 60.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.1 62.73 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.433 ' HG3' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -74.81 -45.95 40.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.498 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.45 -23.3 65.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.496 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 105' ' ' ILE . 8.6 p -70.6 -5.78 31.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.5 -12.23 52.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.41 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -73.71 -12.52 60.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.451 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -70.1 -60.79 2.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.69 -10.44 27.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.539 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -34.4 36.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.209 -0.932 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -82.4 -14.96 54.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 121' ' ' LEU . 48.0 mm -73.04 -8.16 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.485 ' HB3' ' HA2' ' A' ' 48' ' ' GLY . . . -73.35 -35.23 65.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -0.907 . . . . 0.0 109.642 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.522 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 8.5 mt-30 -69.83 -23.26 63.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.464 ' HA ' HG12 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -69.47 -20.48 63.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.379 -0.825 . . . . 0.0 109.809 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -85.02 -40.63 16.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.557 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . 20.8 m -68.01 -16.95 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.669 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 127' ' ' GLN . 4.9 pt -90.97 -31.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.471 ' N ' HG13 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -80.05 -30.87 39.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.743 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.5 mp -79.81 -40.22 29.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.758 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.9 p -63.16 -34.16 77.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.68 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -74.18 -15.98 61.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.542 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.04 29.6 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.668 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.41 -78.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.935 . . . . 0.0 109.53 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.0 mtm -146.22 109.33 4.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.648 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.428 HG21 ' HG3' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -104.86 -148.15 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.652 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.714 ' HB3' HG12 ' A' ' 20' ' ' VAL 0.253 0.7 OUTLIER -142.25 -169.71 3.01 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 124.107 1.908 . . . . 0.0 115.576 -175.438 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 7.3 t-80 -170.8 95.98 0.21 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 102.319 -3.215 . . . . 0.0 102.319 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.639 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -91.52 147.83 22.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.522 -1.361 . . . . 0.0 108.638 -176.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.477 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -155.76 69.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.847 -1.158 . . . . 0.0 110.015 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' CG2' HG12 ' A' ' 78' ' ' VAL . 1.7 p -102.74 112.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 108.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 3.9 m -103.97 144.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.802 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.455 ' HB2' ' CB ' ' A' ' 13' ' ' GLN . 55.9 m -107.35 53.11 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 109.265 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . 72.03 77.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.361 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.38 31.6 12.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 10' ' ' SER . 1.9 tp60 -114.79 -28.18 7.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 46.07 88.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -85.82 -84.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 109.537 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.707 ' CZ ' HG11 ' A' ' 20' ' ' VAL . 1.1 t80 -101.05 112.09 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 94.6 p -128.72 85.84 2.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.131 -0.981 . . . . 0.0 109.658 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . 168.33 148.15 5.62 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.597 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.681 ' CD2' ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -35.63 161.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.886 0.851 . . . . 0.0 111.656 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -158.51 -160.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 O-C-N 121.684 -0.635 . . . . 0.0 109.988 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.613 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 2.3 tt0 -160.33 -32.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.734 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.6 mmmt -141.21 85.2 1.96 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.782 -1.199 . . . . 0.0 110.309 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.557 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.57 142.68 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.324 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -127.41 143.91 51.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.762 -1.211 . . . . 0.0 110.309 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.443 HG22 HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -133.44 116.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.176 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -122.69 125.35 45.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.07 -40.27 0.18 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 159.87 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -1.192 . . . . 0.0 109.646 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -48.09 -43.03 30.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.55 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.44 -51.53 47.17 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.84 20.37 11.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -1.191 . . . . 0.0 109.414 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 153.93 40.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.716 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.39 171.03 23.85 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.557 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 16.6 mm -101.82 112.39 34.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.858 -1.378 . . . . 0.0 109.136 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.598 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -122.92 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.598 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.5 Cg_endo -76.89 5.56 4.83 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.551 1.501 . . . . 0.0 110.44 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.84 17.84 2.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.446 ' CG ' HD12 ' A' ' 34' ' ' ILE . 16.7 t60 -44.81 146.53 0.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -1.092 . . . . 0.0 109.541 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.0 10.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.669 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.53 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.4 Cg_endo -77.55 77.58 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.637 2.225 . . . . 0.0 110.222 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -98.42 159.03 15.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.718 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.431 HD11 ' C ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -157.43 32.04 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.424 ' O ' HG13 ' A' ' 68' ' ' ILE . 44.1 p -114.96 -144.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.389 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.79 164.91 11.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.015 . . . . 0.0 109.155 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.566 ' CD1' ' CB ' ' A' ' 69' ' ' LEU . 5.4 mt -128.99 149.88 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.99 . . . . 0.0 109.554 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' N ' HG21 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -70.24 167.86 22.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -78.99 136.58 13.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.744 2.296 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.62 -161.96 26.43 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.452 ' SD ' ' HB ' ' A' ' 130' ' ' VAL . 8.3 ptm -117.4 -164.23 0.98 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -1.133 . . . . 0.0 109.192 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.526 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -174.68 147.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.085 . . . . 0.0 109.982 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -129.17 126.37 39.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 23' ' ' ILE . 30.6 mt -123.53 166.36 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.874 -1.141 . . . . 0.0 111.037 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 34.2 t -132.23 119.26 39.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -71.05 129.49 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.653 . . . . 0.0 109.315 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 11.5 tt0 52.68 -90.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 54' ' ' LYS . 3.3 t-160 -171.1 60.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.77 -68.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -76.5 179.73 5.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -1.101 . . . . 0.0 109.399 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -156.5 153.68 29.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.844 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 156.44 36.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.251 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.55 ' CE2' ' O ' ' A' ' 130' ' ' VAL . 4.4 m-85 -119.24 124.97 48.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.544 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.469 ' CG1' HD13 ' A' ' 50' ' ' ILE . 5.3 mm -128.71 178.29 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.307 -0.871 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.549 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -173.24 125.98 0.43 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.458 ' CD2' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -113.36 -177.61 3.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.514 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 1.2 t -149.56 18.19 0.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.932 . . . . 0.0 109.384 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.13 156.72 6.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.14 -169.67 25.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.499 ' O ' ' CG2' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -115.94 118.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -1.123 . . . . 0.0 109.369 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.566 ' CB ' ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -101.91 153.12 20.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.208 -0.933 . . . . 0.0 109.922 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 41.6 tt0 -152.15 134.46 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 40' ' ' PRO . 12.6 p -99.92 139.77 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.006 -1.059 . . . . 0.0 110.248 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.515 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.59 174.53 3.28 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.4 Cg_endo -78.62 103.4 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.32 2.014 . . . . 0.0 110.821 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 75.42 45.64 17.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 2.2 t30 159.91 115.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.468 -1.019 . . . . 0.0 109.177 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 ' HB ' HD12 ' A' ' 6' ' ' LEU . 23.5 t -102.2 146.53 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 108.875 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.2 m -147.59 136.68 22.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.802 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.531 HG12 ' CG2' ' A' ' 8' ' ' VAL . 1.4 p -150.4 142.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 108.991 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 4.6 mp -105.21 159.26 16.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -163.73 -174.36 3.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.333 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.68 -39.03 3.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 1.8 m -99.46 149.18 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.254 -0.904 . . . . 0.0 109.196 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -159.81 141.83 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.549 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 46.8 mt -132.67 126.14 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.328 -0.858 . . . . 0.0 108.793 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 86' ' ' GLY . 3.0 tpt180 -92.37 91.98 7.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.034 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 39.06 -102.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.4 ' HG2' HD13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -94.26 81.81 4.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -1.161 . . . . 0.0 109.593 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.65 -53.33 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.098 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 2.8 mp -92.11 31.92 1.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.066 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 131' ' ' ILE . 18.2 m-20 62.21 -179.55 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.372 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.438 ' HG2' HD12 ' A' ' 131' ' ' ILE . 1.6 mt-10 -108.63 -36.59 6.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.0 -12.75 57.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.493 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 48.1 ttp180 -82.28 -26.77 32.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.44 -13.53 40.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 108.9 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 mtt -70.34 -20.79 62.96 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 109.48 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -68.8 -18.98 64.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.53 -54.97 3.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.094 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.479 ' HG2' ' CG1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.2 -39.47 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.104 -179.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -36.04 82.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 110.005 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -4.57 58.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 109.876 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.29 -20.97 22.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.714 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.423 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 5.6 tp10 -73.68 -36.8 65.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.34 -22.96 64.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -51.72 26.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.511 ' CD1' HD11 ' A' ' 121' ' ' LEU . 91.1 mt -89.14 22.84 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.98 -54.74 7.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -98.77 132.95 43.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -162.75 138.87 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.65 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.431 ' N ' ' CD2' ' A' ' 109' ' ' HIS . 0.5 OUTLIER -168.33 169.08 10.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.63 -173.53 28.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.531 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 5.0 t0 -101.17 135.26 42.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.272 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.59 28.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 6.9 t70 -79.24 -95.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.418 -0.801 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -69.76 -21.72 63.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.29 73.55 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -46.39 85.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.85 -11.22 58.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.9 t -82.77 6.03 19.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.907 . . . . 0.0 109.592 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.21 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 109.558 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -77.03 -18.51 58.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.44 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.511 HD11 ' CD1' ' A' ' 105' ' ' ILE . 9.0 tt -71.77 -63.32 1.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.05 -18.94 4.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.702 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -45.27 -38.32 5.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.79 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -90.55 -23.71 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 0.0 110.127 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 125' ' ' ILE . 2.2 mp -77.08 -1.06 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.83 -24.15 60.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.01 -1.056 . . . . 0.0 109.166 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.512 ' CB ' HD11 ' A' ' 84' ' ' ILE . 3.7 pt20 -90.06 -32.13 16.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.427 HD12 ' HB2' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.32 -20.84 65.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.678 -179.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.458 ' O ' HD21 ' A' ' 133' ' ' LEU . 2.0 mtt180 -90.15 -48.09 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.55 ' O ' ' CE2' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -62.27 -28.97 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.511 ' CD1' ' O ' ' A' ' 90' ' ' ASP . 4.8 tt -90.74 -29.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.249 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 17.0 mm-40 -72.86 -34.01 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.389 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 129' ' ' ARG . 2.9 pp -83.62 10.92 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.992 . . . . 0.0 109.727 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 130' ' ' VAL . 76.3 p -83.05 -9.68 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.475 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -84.76 -47.94 9.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.752 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.475 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.5 OUTLIER -80.18 -2.81 46.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.705 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.57 -22.4 54.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.11 -0.994 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.437 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.464 ' O ' ' HB ' ' A' ' 3' ' ' THR . 4.5 mtm -96.16 98.04 10.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.623 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.541 ' CB ' ' HB2' ' A' ' 21' ' ' GLU . 12.2 t 178.05 124.88 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.54 ' OH ' ' CD1' ' A' ' 23' ' ' ILE . 30.0 p90 -100.74 -159.41 0.73 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.567 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -122.77 144.02 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 108.823 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.603 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -135.21 167.67 20.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.532 178.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.592 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.49 97.75 2.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.499 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 19.3 m -99.49 148.54 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 108.695 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' CG2' ' C ' ' A' ' 8' ' ' VAL . 1.9 t -155.88 126.59 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.477 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.77 104.53 13.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.842 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.22 -95.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.716 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -139.26 56.91 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.607 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 169.99 13.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 111.52 22.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 4.6 mtt -116.76 -80.87 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.958 . . . . 0.0 109.842 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 32.5 t80 -130.16 147.08 51.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.744 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 p -175.07 92.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 158.79 -147.38 14.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.554 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 8.9 mt -64.17 172.61 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -1.194 . . . . 0.0 108.982 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.616 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 173.47 149.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.816 -1.177 . . . . 0.0 109.438 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.541 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -142.75 -47.12 0.32 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 4.6 tttp -93.94 126.37 39.11 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.207 -0.933 . . . . 0.0 109.088 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.604 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -154.97 66.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.577 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 18.6 tt0 -98.51 132.29 44.06 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.819 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' ' 26' ' ' THR . 2.7 p -119.94 140.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.503 ' N ' HG21 ' A' ' 25' ' ' VAL . 16.4 m -114.57 132.23 56.41 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 109.591 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.2 -107.94 0.63 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -150.8 159.51 44.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.463 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 51.01 42.83 28.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 148.32 -172.58 28.54 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 1.1 pt-20 179.61 -155.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.415 -1.05 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 31' ' ' GLU . 15.4 mt 60.34 130.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.347 -0.846 . . . . 0.0 109.633 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 23' ' ' ILE . . . -99.85 -84.03 1.77 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.591 ' C ' ' CD1' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -162.97 161.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.376 -1.073 . . . . 0.0 109.535 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -154.14 173.43 4.73 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -178.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 33.9 Cg_endo -75.88 94.56 1.01 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.309 2.006 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.12 -12.78 2.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' HD13 ' A' ' 34' ' ' ILE . 3.9 t-80 -60.71 -178.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -104.73 167.73 9.48 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.682 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HA ' HG12 ' A' ' 71' ' ' VAL . 35.6 Cg_endo -78.89 77.84 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.746 2.298 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.4 mt -99.68 155.31 17.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.398 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.69 99.7 5.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.529 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -135.71 -168.73 2.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.91 -172.02 2.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 69' ' ' LEU . 2.0 mp -110.8 116.88 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.648 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.51 166.1 9.99 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.201 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.38 120.41 4.86 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.622 2.215 . . . . 0.0 110.536 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.5 -155.94 27.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.456 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 1.7 ppp? -119.11 174.86 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -1.12 . . . . 0.0 109.267 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 25' ' ' VAL . 1.5 tt -153.45 131.55 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.095 -1.003 . . . . 0.0 110.344 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.27 21.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.566 ' CG1' ' CG2' ' A' ' 23' ' ' ILE . 1.0 OUTLIER -142.48 143.51 25.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.758 -1.214 . . . . 0.0 110.618 -178.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.479 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 37.2 t -127.53 104.07 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.71 136.37 57.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 46.16 -99.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.32 21.49 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -137.4 -65.26 0.05 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -69.87 142.1 53.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.45 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.3 131.63 25.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.862 . . . . 0.0 109.361 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -121.01 153.81 36.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.763 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.412 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 14.3 m-85 -100.45 155.55 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 62' ' ' ILE . 50.5 mt -154.8 160.7 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.562 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -163.63 152.95 14.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.91 . . . . 0.0 108.927 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.497 ' N ' HD22 ' A' ' 64' ' ' LEU . 2.5 pt? -179.88 162.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.469 ' CB ' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -143.39 36.11 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.4 114.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.11 -177.54 35.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 78' ' ' VAL . 2.2 mp -129.61 135.36 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -1.153 . . . . 0.0 109.28 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.563 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 1.2 tt -121.5 145.13 48.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -135.87 129.66 32.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG22 ' CG2' ' A' ' 76' ' ' VAL . 4.3 p -100.08 123.72 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.483 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -101.75 174.11 3.12 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.483 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.2 Cg_endo -78.24 72.45 6.25 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.631 2.221 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.51 -14.33 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.189 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 78.7 m-20 -145.53 -176.16 5.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.305 . . . . 0.0 109.893 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 77' ' ' THR . 12.1 t -158.66 165.82 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.542 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -169.63 140.06 2.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.975 . . . . 0.0 109.604 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 68' ' ' ILE . 1.7 p -153.31 140.42 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.39 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mt -116.41 150.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.45 13.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 -39.47 4.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 m -108.9 136.72 47.97 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 0.0 109.197 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -158.4 163.33 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.088 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.562 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 43.7 mt -142.92 116.87 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.54 109.62 21.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.594 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.64 -146.38 31.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.469 ' OE1' HG12 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -107.97 34.43 3.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -1.098 . . . . 0.0 108.798 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 87' ' ' GLN . 4.5 t0 -44.71 -29.67 0.81 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.407 -0.808 . . . . 0.0 109.68 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -120.7 111.35 17.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.617 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 21.2 m-20 60.24 157.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 -83.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -16.95 60.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.497 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.91 0.1 32.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.41 -5.75 55.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.415 ' HB2' ' HE1' ' A' ' 95' ' ' MET . 0.1 OUTLIER -81.21 -22.64 38.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.79 -28.6 19.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.624 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.45 ' O ' ' HB1' ' A' ' 101' ' ' ALA . . . -71.46 -20.02 62.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.74 -26.16 27.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.36 11.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -62.11 -26.94 68.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.17 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 97' ' ' ALA . . . -79.74 -44.62 20.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.323 -0.861 . . . . 0.0 109.106 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -54.03 -38.16 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.288 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.412 ' OE1' ' CA ' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -46.54 -42.32 15.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -72.46 -38.12 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.4 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.6 mt -87.94 22.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 109.581 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -55.91 27.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.86 136.8 54.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 59.7 p -131.23 -179.41 5.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -178.63 -171.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.89 176.46 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 111' ' ' ASP . 25.5 t0 -83.74 -73.94 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -103.61 13.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.02 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 16.1 t80 -71.29 -16.92 62.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.165 -0.959 . . . . 0.0 108.601 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.0 66.77 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -47.97 75.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.37 -6.08 37.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.71 -11.06 54.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.562 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 123' ' ' LYS . . . -85.03 -29.28 25.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.615 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -28.43 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.45 ' CD2' ' HB3' ' A' ' 101' ' ' ALA . 0.9 OUTLIER -81.32 -61.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.65 -38.63 2.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 109.743 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.469 ' HD3' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -45.75 -59.35 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.46 -21.64 63.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.752 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 121' ' ' LEU . 20.3 mm -71.42 -4.2 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.438 ' HB3' ' HG3' ' A' ' 49' ' ' MET . . . -84.42 -9.91 57.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.653 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.448 ' O ' HG21 ' A' ' 131' ' ' ILE . 4.2 tt0 -82.65 -26.4 32.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.936 . . . . 0.0 109.651 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 128' ' ' LEU . 61.8 tp -75.52 -8.98 58.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -43.93 10.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.933 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.412 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.9 m -69.74 -24.72 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.928 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -89.52 -48.13 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.87 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.509 ' N ' HG22 ' A' ' 131' ' ' ILE . 13.0 pt-20 -54.66 -24.32 21.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.322 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -80.66 -43.06 21.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 0.0 109.78 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 41.7 p -43.11 -34.85 1.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.645 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -67.78 -49.67 61.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -96.51 45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.11 -36.23 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.606 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.585 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.362 0.601 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.2 ptt? -175.17 -171.11 0.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.532 ' HA ' ' HB3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 54.2 103.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.593 ' CZ ' HG23 ' A' ' 34' ' ' ILE . 27.3 p90 -99.24 -152.08 0.4 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.625 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -129.68 146.63 51.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.662 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 2.5 pp -133.31 169.67 16.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.312 -1.493 . . . . 0.0 109.252 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.491 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 21.6 t70 -146.0 100.53 3.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 9.1 p -105.57 105.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.083 -1.011 . . . . 0.0 109.745 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.361 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.505 ' HB3' ' CB ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -166.95 73.11 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.746 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . 72.32 5.38 5.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 39.6 mt-10 -156.58 76.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 12' ' ' GLU . 3.3 pt20 -56.01 -164.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.723 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER 72.11 32.04 1.84 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.534 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.514 ' CE ' ' CG2' ' A' ' 62' ' ' ILE . 16.0 mtt -106.18 -79.96 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 109.249 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.662 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 37.5 t80 -146.25 117.78 8.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -145.05 108.65 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.115 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 143.5 -163.32 27.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.645 ' N ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -43.93 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.695 -0.885 . . . . 0.0 110.879 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.643 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 167.05 150.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -147.78 -39.18 0.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.8 -1.187 . . . . 0.0 110.471 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 1.8 mptt -116.95 78.57 1.22 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.937 -1.102 . . . . 0.0 111.324 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.57 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 7.8 pt -101.14 160.93 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.465 ' O ' HG13 ' A' ' 50' ' ' ILE . 4.2 tt0 -162.78 116.28 1.67 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.706 -1.246 . . . . 0.0 110.184 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.93 111.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 108.988 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.427 HG21 ' OE1' ' A' ' 31' ' ' GLU . 97.7 m -100.15 110.84 23.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.438 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -136.19 -116.53 1.57 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -118.24 124.03 46.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -1.139 . . . . 0.0 109.57 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.0 tt0 76.44 111.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.35 164.76 39.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 1.2 tt0 -163.54 64.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.145 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 23.4 mt -149.58 140.8 23.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.091 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.91 -105.06 2.65 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.806 -2.117 . . . . 0.0 107.806 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.593 HG23 ' CZ ' ' A' ' 4' ' ' TYR . 7.6 mm -153.85 143.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.289 -1.124 . . . . 0.0 109.278 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -142.18 173.63 4.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -72.63 94.45 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.954 1.769 . . . . 0.0 109.752 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.15 4.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.519 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.0 t-80 -71.75 166.06 22.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -89.67 176.23 3.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.253 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 34.9 Cg_endo -76.82 100.7 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.516 2.144 . . . . 0.0 110.374 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.508 ' N ' HG13 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -93.21 140.29 29.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.592 -179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.76 48.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 p -118.71 -146.61 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.385 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -100.34 176.3 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 69' ' ' LEU . 1.6 tp -102.29 151.23 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 141.52 47.44 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.958 . . . . 0.0 109.607 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.3 Cg_endo -79.38 -179.8 5.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.554 2.169 . . . . 0.0 110.321 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 101.58 -129.0 9.75 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.418 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.9 ptm -119.42 177.79 4.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.155 . . . . 0.0 109.236 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 61' ' ' PHE . 1.2 tt -152.84 130.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.075 -1.016 . . . . 0.0 110.003 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.53 HG13 ' CB ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -148.59 158.8 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.65 -1.281 . . . . 0.0 111.076 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 22' ' ' LYS . 25.0 t -139.35 99.72 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HD3' ' CB ' ' A' ' 58' ' ' HIS . 6.0 ptmt -65.91 153.35 42.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.513 ' HA ' HG22 ' A' ' 3' ' ' THR . 1.5 tt0 -41.62 -52.88 3.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.488 -0.758 . . . . 0.0 110.137 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -43.67 -51.04 7.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.868 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.21 -38.71 1.44 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.459 ' CB ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -48.65 129.1 16.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -1.235 . . . . 0.0 109.313 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.45 123.59 48.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.329 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -122.95 144.83 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 109.424 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 1.6 p90 -114.62 135.85 53.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.514 ' CG2' ' CE ' ' A' ' 15' ' ' MET . 2.7 mm -108.43 -155.87 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.83 . . . . 0.0 109.07 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.577 ' CD2' ' O ' ' A' ' 48' ' ' GLY . 5.3 t80 -168.0 125.18 1.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.66 178.04 6.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 0.0 109.021 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 9.04 4.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.745 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 80' ' ' ALA . . . 138.25 144.73 4.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.48 -155.47 23.35 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 28.7 mt -133.8 133.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -1.181 . . . . 0.0 109.42 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.467 ' HB3' HD11 ' A' ' 45' ' ' ILE . 1.1 pp -114.05 -169.71 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -179.91 149.08 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.262 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.508 HG13 ' N ' ' A' ' 41' ' ' LEU . 11.0 p -100.34 141.15 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.498 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 24.8 mt-30 -126.91 160.55 58.58 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.2 Cg_endo -75.32 90.76 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.355 2.036 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.31 6.92 41.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -175.18 -176.87 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -1.177 . . . . 0.0 109.816 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 6' ' ' LEU . 28.6 m -157.96 150.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -135.32 167.97 20.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.909 -1.119 . . . . 0.0 109.834 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 p -175.15 120.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.068 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.34 141.4 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.749 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 10' ' ' SER . . . -127.39 -179.9 5.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.203 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -98.51 -2.05 39.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.54 HG21 ' CD1' ' A' ' 84' ' ' ILE . 1.9 m -155.2 143.67 20.41 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.175 -0.953 . . . . 0.0 109.136 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . . . -146.29 98.61 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.603 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.54 ' CD1' HG21 ' A' ' 82' ' ' THR . 2.1 mp -115.3 84.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.324 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 84' ' ' ILE . 6.5 ttm180 -44.1 164.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -49.64 -64.8 3.19 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -93.45 37.81 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.188 . . . . 0.0 109.628 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -48.46 -48.93 37.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.23 -58.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 0.0 109.172 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.45 107.68 12.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.398 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.448 ' HA ' HD13 ' A' ' 131' ' ' ILE . 47.8 mt-10 -101.72 -70.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.644 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.46 -17.6 36.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.616 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -81.6 -1.02 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.27 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.17 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.483 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -69.39 -37.79 77.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -34.81 11.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.52 -54.46 35.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.352 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -22.8 15.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -75.13 -60.93 2.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -64.17 -12.38 39.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.66 -36.42 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -57.55 -16.83 11.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -57.68 6.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.604 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -11.51 60.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.494 HD12 ' CG ' ' A' ' 121' ' ' LEU . 14.1 mm -76.09 -8.44 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.528 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -46.14 -65.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 0.0 109.331 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 165.85 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -151.39 -50.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 179.94 -72.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.18 -155.23 26.5 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 1.6 m-20 56.99 -101.5 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -1.086 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 116' ' ' GLN . 3.4 m -119.69 -15.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.871 -1.143 . . . . 0.0 109.285 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.8 OUTLIER -47.6 -95.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 118' ' ' SER . 19.3 t80 -74.26 -22.15 59.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -62.52 -20.76 64.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.517 ' CG ' ' O ' ' A' ' 112' ' ' VAL . 33.7 mm-40 -85.71 -52.99 5.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.872 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.507 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . . . -74.53 -1.41 21.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 36.4 t -90.19 -35.65 15.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.769 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.61 -28.57 18.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.868 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.507 ' CG ' ' HA ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -82.09 -8.55 59.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.802 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.494 ' CG ' HD12 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -86.06 -48.47 8.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.54 -17.12 18.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -37.66 88.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.465 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.84 -12.37 59.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -83.36 -8.04 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.52 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -68.29 -46.39 70.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 109.305 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 131' ' ' ILE . 12.1 tm0? -67.31 -23.53 65.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.483 ' CD2' ' HG2' ' A' ' 95' ' ' MET . 5.6 mp -74.5 -16.8 60.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 4.1 mtp85 -89.82 -50.69 5.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.78 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 27.4 m -60.54 -34.93 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.558 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 131' ' ' ILE . 3.4 tt -61.44 -36.09 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.337 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 129' ' ' ARG . 2.8 mt-10 -49.89 -27.46 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.218 -0.927 . . . . 0.0 109.363 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mp -75.16 -61.55 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.435 ' HA ' ' HB1' ' A' ' 137' ' ' ALA . 4.9 p -45.56 -31.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -58.53 -66.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.69 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -15.3 56.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.844 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 134' ' ' THR . . . -72.09 -34.8 68.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -85.83 -175.75 5.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.582 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.501 HG21 ' CG ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER 57.11 159.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.6 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 1.4 p90 -158.11 -144.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.49 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 24.1 t-80 -131.51 134.84 46.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.734 -1.229 . . . . 0.0 111.013 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.632 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -106.14 124.28 49.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -136.88 71.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.735 -1.228 . . . . 0.0 109.974 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 78' ' ' VAL . 2.1 p -102.46 124.91 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.38 -172.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.462 ' OG ' ' HB1' ' A' ' 83' ' ' ALA . 6.2 p -166.54 107.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 10' ' ' SER . . . 60.08 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 64.34 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -150.2 104.01 3.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.69 105.04 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.44 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.7 mmt -87.32 -89.1 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.888 . . . . 0.0 109.479 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.632 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -110.14 111.79 23.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 85.7 p -136.13 78.83 1.74 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' N ' ' CE1' ' A' ' 5' ' ' HIS . . . -177.47 174.16 46.73 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 30.9 mt -50.22 163.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.59 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -162.27 163.76 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.335 -0.853 . . . . 0.0 108.967 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.501 ' CG ' HG21 ' A' ' 3' ' ' THR . 0.0 OUTLIER -125.29 -39.18 2.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' O ' HG21 ' A' ' 52' ' ' ILE . 2.1 ttmt -156.15 109.07 2.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.031 -1.043 . . . . 0.0 110.369 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.546 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -101.28 146.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.532 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -120.73 141.58 50.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.0 109.988 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.486 ' HA ' HG12 ' A' ' 50' ' ' ILE . 13.4 t -136.77 133.49 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 84.8 m -140.94 111.49 6.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 109.842 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 46' ' ' LYS . . . -120.73 -104.91 1.99 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.53 -67.05 1.02 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -117.99 139.15 51.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.097 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.43 69.33 1.41 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.49 77.07 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -1.066 . . . . 0.0 109.596 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mt -113.83 153.43 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 23' ' ' ILE . . . -99.81 172.0 24.34 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 12.9 mm -98.09 134.52 36.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.911 -1.346 . . . . 0.0 108.822 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.557 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -132.3 169.86 12.82 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.0 Cg_endo -72.7 87.6 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.018 1.812 . . . . 0.0 109.923 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 38' ' ' HIS . . . 138.42 -4.4 3.09 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' ALA . 70.3 t60 -42.84 132.72 3.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 0.0 109.501 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.522 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -48.73 176.4 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.522 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.1 Cg_endo -77.66 81.31 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.519 2.146 . . . . 0.0 110.291 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -96.75 155.95 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.722 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.84 34.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.403 -0.811 . . . . 0.0 108.907 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.454 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 22.4 p -99.56 -147.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 109.486 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.54 164.15 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 46' ' ' LYS . 48.0 mt -105.98 163.04 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 109.273 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 45' ' ' ILE . 8.4 mptt -96.06 151.88 38.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 0.0 109.826 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.483 ' CA ' ' O ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.56 127.71 7.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.82 2.347 . . . . 0.0 110.444 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 174.28 -149.92 11.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.475 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.9 ptm -109.54 -177.04 3.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -1.162 . . . . 0.0 109.405 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 24' ' ' GLN . 47.7 mt -155.08 140.04 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.442 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.496 ' N ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -129.37 115.38 17.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' A' ' 23' ' ' ILE . 14.1 mt -117.79 169.75 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 111.176 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.441 HG21 ' HG2' ' A' ' 59' ' ' GLU . 53.2 t -137.8 100.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -60.5 126.03 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -0.91 . . . . 0.0 110.154 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 23.1 mt-30 45.82 -92.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' LYS . 14.1 t-160 -164.12 49.87 0.13 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.84 -99.87 0.31 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -74.75 172.08 12.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -1.169 . . . . 0.0 109.874 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.441 ' HG2' HG21 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -127.34 167.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.046 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -133.04 144.86 50.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.489 ' C ' ' CD1' ' A' ' 62' ' ' ILE . 7.3 m-85 -111.21 134.68 52.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.141 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.489 ' CD1' ' C ' ' A' ' 61' ' ' PHE . 2.8 mp -140.78 147.48 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 109.677 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -144.89 151.48 38.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.395 -0.815 . . . . 0.0 109.006 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.94 -173.87 2.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.483 ' O ' ' CA ' ' A' ' 47' ' ' PRO . 70.6 m -112.18 -81.72 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.49 168.09 24.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.35 -176.95 42.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.98 156.58 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.184 -1.186 . . . . 0.0 109.37 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -131.68 169.75 15.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.0 125.93 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 108.848 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' O ' HG11 ' A' ' 71' ' ' VAL . 11.6 p -99.85 146.77 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.492 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 6.3 mt-30 -131.42 163.78 47.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.036 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.8 Cg_endo -77.4 106.29 2.19 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.43 2.087 . . . . 0.0 110.599 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.55 58.32 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.49 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 -179.73 166.35 1.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -1.199 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 6' ' ' LEU . 10.2 m -139.02 167.93 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.829 . . . . 0.0 109.262 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 46.1 m -165.77 134.8 3.24 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.869 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.509 ' CG2' HG22 ' A' ' 8' ' ' VAL . 4.3 m -137.25 138.11 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 143.41 30.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.66 -179.17 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.4 -39.52 2.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.247 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.48 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 32.6 m -104.31 120.7 41.76 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.185 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.462 ' HB1' ' OG ' ' A' ' 10' ' ' SER . . . -135.9 87.33 2.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 109.771 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.486 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.1 mp -100.01 92.2 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 108.919 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' GLY . 1.2 ttt180 -41.95 153.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.786 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -43.26 -35.57 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 15.6 mt-30 -78.95 -69.92 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.0 109.382 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 84.53 -44.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 164.57 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.111 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 22.8 m-20 -119.05 -172.69 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -123.58 -70.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 -11.04 60.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.444 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -83.55 4.33 28.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.709 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.78 -21.2 23.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 108.996 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.494 ' CG ' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -73.63 -25.14 60.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.484 -0.76 . . . . 0.0 109.406 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -17.17 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.68 -44.03 35.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.714 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -19.38 43.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 109.508 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -77.99 -37.03 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 pttm -79.65 -18.73 50.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' O ' HG12 ' A' ' 105' ' ' ILE . . . -89.18 -34.44 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.99 -31.02 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.468 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.24 -54.7 40.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.83 -16.24 60.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 101' ' ' ALA . 21.8 mm -87.25 16.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 109.524 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 107' ' ' SER . 15.0 m -91.93 -147.76 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 106' ' ' SER . 2.8 m 56.31 108.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.586 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.51 108.36 10.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 173.27 56.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.2 163.21 33.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.464 ' O ' ' HB1' ' A' ' 115' ' ' ALA . 0.4 OUTLIER -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -1.217 . . . . 0.0 109.607 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.427 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 13.2 m -96.17 17.18 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.437 ' C ' ' OD1' ' A' ' 113' ' ' ASP . 39.5 t0 -63.27 -100.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 109.027 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 75.0 t80 -64.06 -20.47 65.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.998 -1.064 . . . . 0.0 108.252 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 111' ' ' ASP . . . -64.3 -39.36 93.76 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 1.2 tp-100 -86.5 -7.27 58.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -80.44 -36.95 32.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.9 m -52.54 -37.24 57.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -52.92 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.36 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -67.69 -8.66 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.466 ' O ' HD11 ' A' ' 125' ' ' ILE . 15.7 tp -83.95 -50.34 8.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.91 8.52 10.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.876 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -72.87 -37.86 67.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.612 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.92 28.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.466 HD11 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -70.49 -5.9 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' A' ' 49' ' ' MET . . . -73.66 -23.98 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 0.0 109.286 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -82.73 -4.99 58.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.494 HD13 ' CG ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -84.02 -34.0 24.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -43.62 55.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 109.644 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.446 ' O ' HG21 ' A' ' 134' ' ' THR . 18.6 m -54.66 -17.85 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.931 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.409 ' O ' ' OG1' ' A' ' 134' ' ' THR . 38.5 mt -88.84 -66.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 131' ' ' ILE . 57.5 mm-40 -43.66 -34.84 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.119 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -73.73 -54.6 7.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.861 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 130' ' ' VAL . 7.9 p -44.02 -30.23 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -57.44 -53.74 54.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 3.49 48.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.544 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.17 44.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 0.0 109.37 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.479 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.44 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.2 ttm -100.89 121.5 41.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 109.39 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.74 -152.78 0.11 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.114 -0.991 . . . . 0.0 109.515 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.716 ' HB3' ' CG1' ' A' ' 20' ' ' VAL 0.277 1.1 m-85 -137.7 -178.23 5.15 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 124.451 2.072 . . . . 0.0 115.914 -175.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.566 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 7.1 t-80 -151.45 88.1 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.769 -3.378 . . . . 0.0 102.98 173.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.621 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -93.33 133.64 36.37 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.629 -1.294 . . . . 0.0 108.22 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 0.3 OUTLIER -146.13 82.53 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.625 -1.297 . . . . 0.0 109.95 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 15' ' ' MET . 2.4 p -110.6 102.63 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.85 155.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.953 . . . . 0.0 109.441 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.472 ' CB ' ' HB1' ' A' ' 83' ' ' ALA . 89.2 p -105.26 -156.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.82 -47.32 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -160.21 60.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.414 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.52 118.95 1.4 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -77.95 117.14 19.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.465 ' HE3' ' CG2' ' A' ' 62' ' ' ILE . 5.9 mtt -86.82 -73.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.795 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.2 t80 -116.17 113.44 23.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 110.321 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 89.2 p -138.6 91.04 2.5 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.05 -172.81 45.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 55' ' ' GLN . 20.8 mt -72.02 154.59 41.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -1.229 . . . . 0.0 109.321 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.795 HG13 ' CZ ' ' A' ' 16' ' ' PHE . 0.7 OUTLIER -153.81 -175.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.097 -1.002 . . . . 0.0 109.165 -178.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.57 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 9.9 tt0 -146.56 -40.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.779 -1.2 . . . . 0.0 110.208 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -139.31 91.16 2.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -98.87 159.96 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.071 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.466 ' O ' HG21 ' A' ' 50' ' ' ILE . 44.7 mt-30 -146.81 166.98 25.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 110.184 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.498 HG22 ' CG2' ' A' ' 45' ' ' ILE . 3.1 p -160.26 143.53 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 109.043 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.456 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 18.6 m -129.86 129.38 43.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA2' ' NZ ' ' A' ' 123' ' ' LYS . . . 126.27 14.28 3.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -116.25 -153.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.32 98.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 0.0 109.329 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.09 -93.81 1.43 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -177.48 28.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -1.152 . . . . 0.0 109.744 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.512 ' HB3' ' NE2' ' A' ' 38' ' ' HIS . 16.5 mt -70.64 145.92 50.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.069 -1.019 . . . . 0.0 109.278 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.06 -122.87 4.81 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.549 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 24.1 mm -151.59 123.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.168 -1.195 . . . . 0.0 109.315 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -136.88 -171.13 0.26 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 32.2 Cg_endo -76.64 84.57 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.479 1.453 . . . . 0.0 110.0 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 50.73 0.54 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.607 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 16.0 t-80 -84.95 46.95 1.32 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -1.067 . . . . 0.0 109.702 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.533 ' O ' ' CG1' ' A' ' 71' ' ' VAL . . . 56.17 160.57 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 110.097 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.93 66.21 8.82 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.835 2.356 . . . . 0.0 110.429 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' HB3' HD12 ' A' ' 69' ' ' LEU . 1.4 mm? -77.75 139.35 39.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 70' ' ' GLU . 17.5 tp -154.59 66.5 0.69 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -136.1 -95.28 0.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.93 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.426 ' N ' ' OG1' ' A' ' 43' ' ' THR . . . -150.99 164.52 36.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 109.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.499 ' O ' ' O ' ' A' ' 46' ' ' LYS . 2.7 mt -113.17 4.16 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.103 -0.998 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' CB ' ' CD ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 48.16 179.81 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.715 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.545 ' CD ' ' CB ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -80.26 119.49 3.85 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.528 2.152 . . . . 0.0 110.238 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -165.29 -153.2 7.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 130' ' ' VAL . 3.2 ppp? -128.61 -173.43 2.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.335 -1.097 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.521 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 8.4 mt -151.11 147.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' N ' HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -136.41 123.48 21.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.585 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 32.1 mt -128.4 168.56 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.798 -1.189 . . . . 0.0 111.246 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 51.5 t -139.15 153.08 24.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 80.78 -73.56 0.05 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.732 -0.605 . . . . 0.0 109.578 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 56' ' ' HIS . 0.3 OUTLIER 42.99 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.37 -0.831 . . . . 0.0 109.569 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.526 ' CB ' ' OE1' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -158.07 40.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.89 -1.131 . . . . 0.0 109.804 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -36.09 0.44 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.515 ' CE1' ' OE1' ' A' ' 59' ' ' GLU . 1.4 t-80 -169.35 -149.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.29 . . . . 0.0 109.54 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 58' ' ' HIS . 1.5 pt-20 -101.49 160.5 14.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.79 139.59 11.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.582 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.3 p90 -110.23 152.54 25.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.885 . . . . 0.0 109.623 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.465 ' CG2' ' HE3' ' A' ' 15' ' ' MET . 9.1 mt -127.9 144.57 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.258 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' CD2' ' HB3' ' A' ' 127' ' ' GLN . 19.6 t80 -113.75 130.38 56.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.488 HD23 ' CB ' ' A' ' 80' ' ' ALA . 3.6 mt -121.33 173.89 7.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -125.44 -37.23 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.863 . . . . 0.0 109.416 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.21 144.62 4.47 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 168.25 -173.59 43.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.531 HG21 ' N ' ' A' ' 69' ' ' LEU . 60.6 mt -99.36 152.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -1.075 . . . . 0.0 109.075 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.531 ' N ' HG21 ' A' ' 68' ' ' ILE . 3.3 pp -132.0 157.33 44.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.917 -1.115 . . . . 0.0 110.586 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 8.4 pt-20 -150.66 114.89 5.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 39' ' ' ALA . 10.0 p -104.04 151.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.889 -1.132 . . . . 0.0 110.709 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.524 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 3.6 mm-40 -136.43 179.28 1.41 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -79.48 102.23 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.395 2.063 . . . . 0.0 110.847 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 79.97 34.72 29.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.566 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 7.9 t30 171.18 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -1.175 . . . . 0.0 109.355 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' CG2' HD12 ' A' ' 6' ' ' LEU . 2.5 m -112.89 152.65 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 7' ' ' ASP . 88.0 m -152.67 136.02 15.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 109.282 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.464 HG13 ' HB2' ' A' ' 69' ' ' LEU . 3.1 m -144.83 147.54 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 109.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.77 142.7 46.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.488 ' CB ' HD23 ' A' ' 64' ' ' LEU . . . -139.09 179.61 6.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -100.43 -34.18 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.611 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -118.41 147.9 43.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 0.0 109.741 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB1' ' CB ' ' A' ' 10' ' ' SER . . . -143.29 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.421 -0.799 . . . . 0.0 109.107 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.585 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 2.0 mt -98.93 52.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HG2' ' N ' ' A' ' 86' ' ' GLY . 48.9 ttt180 -42.16 147.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 85' ' ' ARG . . . -42.92 -32.49 1.45 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -111.21 64.66 0.61 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -1.181 . . . . 0.0 109.579 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.12 -83.01 0.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.84 -169.73 3.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.75 73.48 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.68 -68.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.11 -19.85 62.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.87 -2.03 24.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.96 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 108.913 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.3 mtp -85.75 -35.08 20.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.468 -0.77 . . . . 0.0 109.324 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -84.75 -27.32 27.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.22 -54.26 49.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -51.93 -21.61 3.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -80.06 -57.32 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 109.722 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.46 -19.56 48.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.409 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -85.72 -43.71 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -56.55 -34.53 67.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.439 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.67 -50.82 72.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -18.29 64.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.541 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 105' ' ' ILE . 21.4 mt -80.61 -25.83 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -101.42 102.68 13.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.503 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.1 m -154.01 -41.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -0.948 . . . . 0.0 109.726 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.405 ' O ' ' CE2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -155.9 -166.49 2.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.695 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.76 -86.88 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.64 177.91 8.88 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.529 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -113.14 126.5 55.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.324 -1.103 . . . . 0.0 109.333 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.11 29.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 0.0 109.564 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 111' ' ' ASP . 21.2 t70 -84.07 -94.41 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 108' ' ' SER . 20.8 p90 -74.32 -22.99 59.0 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.88 46.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.88 -34.7 51.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.436 -0.79 . . . . 0.0 109.108 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.46 -20.5 54.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.257 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.5 m -65.31 -39.35 92.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.361 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.27 -13.28 36.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.891 . . . . 0.0 109.328 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.19 -32.04 38.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 101' ' ' ALA . 17.6 mt -83.74 -39.33 20.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.475 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -57.34 -23.67 50.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.69 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.515 ' NZ ' ' HA2' ' A' ' 27' ' ' GLY . 11.1 mmtt -79.8 -30.45 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.15 62.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 109.555 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.475 HD11 ' HA ' ' A' ' 122' ' ' ALA . 3.3 mt -80.53 1.74 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.595 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.75 62.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.269 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.586 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.8 pt20 -79.12 -11.0 59.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.465 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 0.6 OUTLIER -73.08 -30.24 63.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.965 . . . . 0.0 109.795 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -48.81 14.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.1 m -61.49 -40.4 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.912 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 91' ' ' GLU . 9.3 tt -65.3 -43.41 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.503 ' N ' HG22 ' A' ' 131' ' ' ILE . 3.1 mm-40 -53.83 -26.19 23.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -0.879 . . . . 0.0 109.1 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -48.88 20.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.18 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 1.8 p -53.65 -20.12 4.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -76.25 -55.89 5.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 7.34 24.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.41 -52.17 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.5 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.8 mmt -133.36 138.07 46.15 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 0.0 109.313 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER 55.69 92.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.205 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.678 ' CZ ' ' CG2' ' A' ' 34' ' ' ILE . 32.3 p90 -82.3 -143.18 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 109.099 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -140.26 133.27 29.39 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.203 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.609 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -123.43 150.16 44.16 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.761 -1.212 . . . . 0.0 108.113 178.152 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.529 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.3 OUTLIER -140.5 88.09 2.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 15' ' ' MET . 5.0 p -99.91 132.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -142.89 159.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.4 p -100.34 -146.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -0.838 . . . . 0.0 109.525 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 81' ' ' ASP . . . -81.75 -10.39 59.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.743 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' GLN . 14.5 mt-10 -118.34 24.21 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 41.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.78 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.94 92.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.659 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.517 ' CE ' HG23 ' A' ' 62' ' ' ILE . 1.7 mtt -161.97 -88.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.852 . . . . 0.0 108.934 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.691 ' CE2' ' CG1' ' A' ' 20' ' ' VAL . 68.8 t80 -135.3 144.82 46.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.3 p -165.07 82.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.411 -0.806 . . . . 0.0 109.525 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.6 -178.96 42.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.51 ' O ' HG11 ' A' ' 20' ' ' VAL . 7.6 mt -71.01 139.45 50.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.076 -1.249 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.691 ' CG1' ' CE2' ' A' ' 16' ' ' PHE . 2.5 m -144.27 148.11 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.41 -0.806 . . . . 0.0 110.643 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.95 -42.05 4.79 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.593 -0.692 . . . . 0.0 109.849 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.518 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.88 109.43 9.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.967 -1.083 . . . . 0.0 110.486 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 3.9 mm -105.4 -173.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.023 -1.048 . . . . 0.0 109.081 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -176.05 98.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.948 -1.095 . . . . 0.0 109.965 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 2.1 p -104.32 137.98 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.352 -0.842 . . . . 0.0 109.069 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.518 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 31.6 m -124.21 115.52 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' A' ' 46' ' ' LYS . . . -108.94 -68.06 0.61 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.6 t -170.6 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -1.152 . . . . 0.0 109.375 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -95.0 66.94 3.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.465 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.0 82.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -115.87 89.23 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.537 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 mt -106.81 151.35 25.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.26 172.6 25.5 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 107.243 -2.343 . . . . 0.0 107.243 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.678 ' CG2' ' CZ ' ' A' ' 4' ' ' TYR . 18.8 mm -99.21 128.53 50.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.585 -1.538 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -129.98 170.75 10.23 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.0 Cg_endo -70.78 81.91 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.772 1.648 . . . . 0.0 109.676 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' HIS . . . 168.27 -27.07 0.14 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.532 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -42.2 163.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -1.091 . . . . 0.0 109.461 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' N ' ' CD ' ' A' ' 40' ' ' PRO . . . 164.26 -52.0 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.052 -1.03 . . . . 0.0 110.492 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 39' ' ' ALA . 36.6 Cg_endo -79.32 23.63 0.64 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.607 2.204 . . . . 0.0 111.828 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HG ' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -100.57 110.92 23.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.804 -1.185 . . . . 0.0 109.612 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mt -148.41 80.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.925 . . . . 0.0 109.357 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 44' ' ' ALA . 5.1 t -147.06 -146.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.516 ' N ' ' CG2' ' A' ' 43' ' ' THR . . . -103.98 -176.61 3.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 109.472 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 69' ' ' LEU . 1.4 mt -132.55 166.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.468 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 17.3 mmtt -116.4 166.29 12.95 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -78.27 118.22 4.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.606 2.204 . . . . 0.0 110.559 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 63' ' ' TYR . . . -168.17 -145.59 4.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.477 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 3.7 ppp? -122.14 -172.64 2.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -1.126 . . . . 0.0 109.448 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.42 157.92 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.586 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.591 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 6.3 ttp180 -149.98 134.9 17.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.111 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.635 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -114.44 161.0 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 110.318 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.524 ' O ' ' CG1' ' A' ' 53' ' ' VAL . 41.1 t -126.47 65.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 9.5 mtmt -43.54 124.49 3.55 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.19 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.436 ' HG3' ' N ' ' A' ' 56' ' ' HIS . 6.5 tp-100 46.65 -93.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.7 . . . . 0.0 109.657 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' LYS . 2.3 t-160 -165.32 122.12 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.53 -72.77 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.59 138.53 55.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -157.21 162.37 39.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.348 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -156.55 177.1 11.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 2.8 p90 -146.17 154.49 41.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.808 -1.182 . . . . 0.0 110.052 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.517 HG23 ' CE ' ' A' ' 15' ' ' MET . 2.5 mm -133.0 -161.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.603 ' CD2' ' HB ' ' A' ' 84' ' ' ILE . 42.0 t80 -157.61 114.69 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HE2' ' A' ' 15' ' ' MET . 1.4 pt? -113.64 176.97 4.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 47.5 m -125.19 45.7 2.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 80' ' ' ALA . . . 93.04 -167.4 29.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 134.53 -139.42 10.85 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.4 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 3.7 mt -132.22 147.9 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.07 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.469 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.5 pp -130.6 131.6 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.989 -1.069 . . . . 0.0 110.15 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 77' ' ' THR . 5.0 pt-20 -134.15 128.83 34.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.48 ' CG2' HG13 ' A' ' 76' ' ' VAL . 5.6 p -99.65 128.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.036 -1.04 . . . . 0.0 110.036 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.475 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.1 mt-30 -106.79 172.53 3.79 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 108.876 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.5 Cg_endo -78.75 112.52 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.577 2.185 . . . . 0.0 110.441 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 79.16 20.92 68.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.8 p-10 171.45 158.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG13 ' CG2' ' A' ' 71' ' ' VAL . 34.5 m -140.99 160.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.023 . . . . 0.0 109.436 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -152.04 143.53 23.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.555 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 8' ' ' VAL . 2.8 m -151.65 156.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.3 mp -122.71 166.18 15.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 66' ' ' GLY . . . -146.0 -149.47 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' HA ' ' HB1' ' A' ' 11' ' ' ALA . 1.4 m-20 -139.37 -55.47 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.567 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -111.58 148.17 33.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.679 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -140.2 146.57 38.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.508 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.603 ' HB ' ' CD2' ' A' ' 63' ' ' TYR . 43.8 mt -126.17 -25.85 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 0.0 109.718 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HA ' HG21 ' A' ' 62' ' ' ILE . 8.1 ttt180 66.08 153.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.318 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -47.57 -29.7 5.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.456 ' OE1' ' HB ' ' A' ' 134' ' ' THR . 1.2 mt-30 -165.57 81.3 0.32 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.189 -1.183 . . . . 0.0 109.675 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 9.9 t70 -73.62 -26.67 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER 174.64 -50.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.211 -179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.32 119.84 31.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.918 . . . . 0.0 109.642 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 92' ' ' ALA . 14.8 pt-20 -131.04 -38.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.247 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -77.25 -16.52 58.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 109.408 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.04 2.72 53.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.31 -16.39 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 108.981 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -52.4 5.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.458 -0.776 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 99' ' ' ARG . 2.3 mt-10 -56.27 -31.42 63.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -58.07 -53.07 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -53.47 -31.34 45.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.93 -43.5 83.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.307 -0.871 . . . . 0.0 109.545 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 12.0 pttm -84.11 -4.87 59.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.466 ' CB ' HD13 ' A' ' 121' ' ' LEU . . . -90.35 -7.73 52.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.508 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -86.35 -25.76 25.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 109.661 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -43.5 91.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -81.12 -15.1 56.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.464 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.463 ' CG1' HD11 ' A' ' 121' ' ' LEU . 18.8 mm -88.71 -19.42 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t -86.12 63.18 7.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.547 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -171.15 169.14 6.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.56 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.8 t -175.08 100.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -157.58 76.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.66 169.81 25.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.57 -49.42 21.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -1.127 . . . . 0.0 109.309 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 18.3 m -118.7 33.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.559 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.17 -97.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.069 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 3.4 t80 -67.39 -14.11 62.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.65 74.91 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.63 -0.669 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -83.94 -5.65 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.682 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.0 -18.67 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.5 m -76.6 -29.86 56.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.732 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.92 -32.42 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.635 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 116' ' ' GLN . 6.3 mm-40 -75.78 -36.25 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.5 HD22 ' CD1' ' A' ' 125' ' ' ILE . 2.8 tt -73.38 -61.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.96 -27.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.683 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 121' ' ' LEU . 16.5 tttt -63.24 -54.27 40.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -12.66 61.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.5 ' CD1' HD22 ' A' ' 121' ' ' LEU . 49.2 mm -82.23 2.18 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.95 -39.33 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.487 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.423 ' HG3' ' CG2' ' A' ' 84' ' ' ILE . 1.6 tm0? -76.58 -7.17 54.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.414 ' C ' HG21 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -81.72 -21.11 38.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.554 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -85.69 -33.9 21.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 109.592 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.3 m -75.4 -33.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 132' ' ' GLU . 2.1 tt -61.68 -44.63 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.48 ' N ' HG22 ' A' ' 131' ' ' ILE . 77.5 mm-40 -44.85 -35.24 2.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.041 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 130' ' ' VAL . 4.5 mp -64.89 -55.46 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -0.81 . . . . 0.0 109.245 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.456 ' HB ' ' OE1' ' A' ' 87' ' ' GLN . 30.9 p -50.08 -29.14 8.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.481 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 2.8 mmtt -65.73 -54.96 20.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -88.83 21.4 3.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 133' ' ' LEU . . . -123.65 42.5 3.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.388 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.268 0.556 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -116.29 40.97 2.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.926 . . . . 0.0 109.554 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -109.93 -147.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.888 . . . . 0.0 109.649 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.796 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.61 -179.75 5.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.34 2.019 . . . . 0.0 115.884 -175.797 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.504 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 8.7 t-80 -153.96 89.65 1.32 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 110.123 -3.217 . . . . 0.0 103.445 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.643 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -92.77 126.77 38.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.683 -1.261 . . . . 0.0 107.992 -177.562 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 7.3 t70 -133.36 75.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.593 -1.317 . . . . 0.0 109.912 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.492 HG21 ' N ' ' A' ' 9' ' ' VAL . 1.4 p -111.13 147.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.26 -0.9 . . . . 0.0 108.948 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.51 ' HB ' ' N ' ' A' ' 14' ' ' GLN . 14.1 m -150.16 155.94 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.078 -1.014 . . . . 0.0 109.624 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.462 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -172.2 157.19 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.281 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 10' ' ' SER . . . 61.48 -89.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.414 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 22.13 3.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.387 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.5 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 0.1 OUTLIER 46.34 75.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 110.051 179.651 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.51 ' N ' ' HB ' ' A' ' 9' ' ' VAL . 9.1 tt0 164.98 100.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.475 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -124.47 -73.21 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.064 179.286 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.668 ' CZ ' HG13 ' A' ' 20' ' ' VAL . 1.1 t80 -127.17 112.79 15.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.047 -1.033 . . . . 0.0 110.082 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 92.0 p -134.6 85.52 2.19 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.48 -160.73 23.12 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.461 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 12.5 mt -93.24 159.67 15.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.25 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.796 HG11 ' HB3' ' A' ' 4' ' ' TYR . 1.8 m -155.32 -167.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.885 -1.135 . . . . 0.0 110.663 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.588 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -155.35 -33.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 178.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 10.1 mmtm -142.97 88.4 2.04 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.961 -1.087 . . . . 0.0 110.211 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.548 ' CG2' HG23 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -99.24 138.78 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.696 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 0.9 OUTLIER -122.95 165.93 15.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 110.346 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.533 ' CB ' HG12 ' A' ' 50' ' ' ILE . 11.5 p -171.53 154.98 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 2.1 t 179.76 154.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.829 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.5 -89.78 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 158.41 43.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 59.0 74.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' C ' ' HG2' ' A' ' 46' ' ' LYS . . . 91.8 141.69 10.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -137.05 55.39 1.83 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.171 . . . . 0.0 109.752 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' HG11 ' A' ' 25' ' ' VAL . 4.9 mt -115.09 157.07 24.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.21 171.63 24.61 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 178.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.571 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 12.7 mm -99.81 127.16 52.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.854 -1.38 . . . . 0.0 108.986 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.637 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -134.46 170.26 11.73 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -70.11 88.24 0.58 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.586 1.524 . . . . 0.0 109.538 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.73 18.98 2.58 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.591 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 6.8 t-160 -60.14 146.96 41.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -1.191 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.489 ' N ' ' CD2' ' A' ' 38' ' ' HIS . . . -40.59 147.04 0.41 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.98 69.14 8.04 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.695 2.263 . . . . 0.0 111.047 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.6 mt -91.07 126.57 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.121 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.4 24.12 12.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.57 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -105.56 -92.81 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.393 -0.817 . . . . 0.0 109.336 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -130.12 172.72 11.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.935 . . . . 0.0 109.161 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -117.31 -149.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 2.2 mptp? -121.35 125.38 26.91 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' CB ' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.24 -159.36 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.433 2.089 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 97.85 -137.08 13.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.459 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.6 ppp? -102.62 -178.91 3.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -1.117 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.533 HG12 ' CB ' ' A' ' 25' ' ' VAL . 14.2 mt -157.63 140.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 110.193 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.5 ' N ' HG21 ' A' ' 50' ' ' ILE . 7.5 mmt85 -131.16 112.31 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.562 ' HA ' ' O ' ' A' ' 22' ' ' LYS . 12.6 mt -117.48 164.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 0.0 111.312 -178.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.18 112.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' HIS . 20.4 mttm -65.96 149.89 49.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.792 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 3' ' ' THR . 34.5 tt0 -52.11 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.338 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 48.7 t-80 71.45 95.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.36 178.34 29.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -63.07 -166.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -1.224 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 10.2 pt-20 -131.12 147.45 52.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -125.52 138.29 53.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CZ ' HD13 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -109.08 139.41 44.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.819 . . . . 0.0 109.677 -179.613 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.459 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 19.1 mt -121.2 160.48 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.288 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 127' ' ' GLN . 1.4 t80 -139.38 151.49 46.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.268 -0.895 . . . . 0.0 109.014 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 64' ' ' LEU . 1.3 pt? 179.93 -170.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.481 ' HA ' ' CB ' ' A' ' 47' ' ' PRO . 4.9 m -135.21 -169.22 2.33 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.33 -0.856 . . . . 0.0 109.204 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 65' ' ' SER . . . 42.24 -141.07 1.76 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.16 119.24 2.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.504 ' O ' HD21 ' A' ' 69' ' ' LEU . 5.4 tt -151.89 130.28 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -1.102 . . . . 0.0 109.065 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.746 ' CG ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 178.18 -140.0 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 -179.493 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' CD1' ' A' ' 69' ' ' LEU . 0.4 OUTLIER -146.3 142.64 28.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.366 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG21 ' CG2' ' A' ' 76' ' ' VAL . 7.6 p -109.53 126.99 66.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.464 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -105.39 173.86 3.01 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -77.92 4.02 6.48 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.524 2.149 . . . . 0.0 109.974 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . -167.16 39.27 0.24 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.504 ' OD1' ' ND1' ' A' ' 5' ' ' HIS . 5.0 t30 167.98 94.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 109.472 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.511 ' CG2' HG21 ' A' ' 71' ' ' VAL . 5.0 t -100.78 116.12 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.215 -0.928 . . . . 0.0 109.267 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.666 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 6.4 t -118.45 158.64 24.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.906 . . . . 0.0 109.686 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.746 ' HA ' ' CG ' ' A' ' 69' ' ' LEU . 3.5 p 179.44 141.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.742 0.782 . . . . 0.0 110.288 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -115.64 145.63 42.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' SER . . . -123.53 -165.25 1.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.492 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.32 -43.83 4.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 17.8 m -106.32 151.85 24.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.79 93.7 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.583 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 6.1 mt -106.63 66.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.335 -0.853 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 84' ' ' ILE . 13.0 ttp180 -44.79 161.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 87' ' ' GLN . . . -51.45 147.49 10.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 13.2 pt20 38.58 38.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.63 -0.924 . . . . 0.0 109.886 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -45.09 -48.55 11.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.59 -57.4 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.8 -167.09 1.75 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.412 ' CB ' HD11 ' A' ' 131' ' ' ILE . 16.1 pt-20 -144.78 -38.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.583 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.67 67.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -8.03 52.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.4 -14.61 32.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.26 -18.53 26.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.407 -0.808 . . . . 0.0 109.41 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -1.51 36.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.43 ' O ' ' HB1' ' A' ' 101' ' ' ALA . . . -80.37 -38.51 30.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 109.318 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.42 -27.81 56.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -70.38 -43.62 69.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.86 -23.0 39.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.233 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 97' ' ' ALA . . . -81.46 -22.14 38.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.213 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 31.9 tt0 -66.08 -19.32 65.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -27.5 21.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.408 ' O ' ' OH ' ' A' ' 114' ' ' TYR . 1.6 m-70 -77.12 -45.9 25.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 121' ' ' LEU . 88.0 mt -87.61 12.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' ILE . 2.6 m -44.37 -60.85 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.0 p -90.34 -160.85 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.29 128.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.029 -1.045 . . . . 0.0 109.616 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -160.82 93.37 0.98 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 109.377 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.46 ' O ' ' HB1' ' A' ' 115' ' ' ALA . . . 165.2 143.85 3.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.09 -41.61 67.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 14.5 m -137.46 -31.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER -41.61 -92.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.743 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.408 ' OH ' ' O ' ' A' ' 104' ' ' HIS . 15.4 t80 -77.92 -21.4 51.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 110' ' ' GLY . . . -61.27 -18.05 56.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 8.7 mt-30 -84.99 -35.93 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.16 -10.02 27.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 105' ' ' ILE . 18.1 m -71.42 -49.22 43.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.591 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.49 61.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.716 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.37 -47.48 76.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.522 ' HB2' ' CD1' ' A' ' 105' ' ' ILE . 47.9 tp -52.2 -51.76 56.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.717 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.38 64.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.758 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -78.11 -13.96 59.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.96 42.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.58 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.5 mp -88.21 -2.09 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.45 -24.55 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 109.282 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.585 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 2.1 pt20 -74.89 -32.63 61.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.451 HD22 ' OE2' ' A' ' 132' ' ' GLU . 4.3 tt -84.2 -6.76 59.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -26.13 47.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 2.3 m -86.46 -31.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.513 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.431 ' HA ' HG22 ' A' ' 134' ' ' THR . 3.2 pt -72.03 -4.03 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.37 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.451 ' OE2' HD22 ' A' ' 128' ' ' LEU . 1.7 mm-40 -78.21 -34.08 49.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.699 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.577 HD13 ' CZ ' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -87.31 2.98 48.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.155 -0.966 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.431 HG22 ' HA ' ' A' ' 131' ' ' ILE . 70.6 p -83.2 -16.15 47.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.019 179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -71.81 -25.77 62.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.37 -0.831 . . . . 0.0 109.225 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.01 39.54 3.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.403 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -112.09 -7.09 14.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.466 -179.859 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.403 ' C ' ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -64.1 179.04 0.59 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.945 . . . . 0.0 109.579 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.425 HG21 ' HG3' ' A' ' 21' ' ' GLU . 38.1 p -141.88 155.45 45.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.235 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.586 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -148.49 -148.45 0.26 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.596 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -131.35 144.57 51.34 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 2.3 pp -135.67 154.4 51.3 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.491 -1.381 . . . . 0.0 109.278 178.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.433 ' HA ' ' O ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -140.03 115.19 9.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 -179.448 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 64' ' ' LEU . 2.1 p -111.71 94.02 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.179 -0.951 . . . . 0.0 108.74 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.431 HG23 ' HG3' ' A' ' 14' ' ' GLN . 23.4 t -99.73 155.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.705 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.468 ' OG ' ' N ' ' A' ' 11' ' ' ALA . 3.8 p -124.15 -149.99 0.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.42 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' N ' ' OG ' ' A' ' 10' ' ' SER . . . -52.69 -38.06 59.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.88 32.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.313 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -134.66 67.53 1.5 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 9' ' ' VAL . 23.6 tt0 -44.65 155.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 109.811 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.516 ' CB ' HG22 ' A' ' 62' ' ' ILE . 4.1 mmt -134.15 -96.81 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.776 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 3.5 t80 -70.09 130.95 43.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.919 -1.113 . . . . 0.0 108.717 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -157.23 110.24 2.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 138.91 -160.64 25.78 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -53.79 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -1.214 . . . . 0.0 109.51 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.776 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 170.41 162.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.592 -1.318 . . . . 0.0 107.959 179.827 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -130.03 -37.57 1.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.454 -1.404 . . . . 0.0 110.433 -179.082 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 1.3 mtmt -155.29 93.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.767 -1.208 . . . . 0.0 110.764 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.551 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -98.92 153.93 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.253 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.485 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -156.16 134.55 11.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.623 -1.298 . . . . 0.0 110.259 -179.636 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.12 129.68 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 m -106.6 114.24 28.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -141.23 -123.15 1.91 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 t -125.11 138.23 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 47.41 78.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.264 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.05 111.78 1.72 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.22 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.832 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.68 138.89 44.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.613 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.17 -100.9 2.27 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 178.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.586 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 28.8 mm -155.61 153.81 7.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.333 -1.098 . . . . 0.0 109.671 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.596 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -155.5 -176.47 0.61 Allowed Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.821 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.586 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.8 Cg_endo -80.02 69.68 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.062 1.841 . . . . 0.0 109.844 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.38 35.52 0.37 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.441 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 12.2 t-80 -72.06 -74.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 0.0 109.627 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.48 ' O ' HG12 ' A' ' 71' ' ' VAL . . . 167.89 166.67 0.14 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.35 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HA ' HG12 ' A' ' 71' ' ' VAL . 35.2 Cg_endo -77.68 79.12 3.3 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.68 2.253 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.468 HD21 ' N ' ' A' ' 41' ' ' LEU . 4.0 mm? -92.85 133.17 36.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.837 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.63 52.28 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.175 179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.5 p -126.1 -138.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -99.68 -163.45 1.03 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.0 109.566 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.474 ' CD1' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -120.57 135.59 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.38 134.38 93.38 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.493 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.2 Cg_endo -79.22 159.85 26.42 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.551 2.167 . . . . 0.0 110.29 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.51 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 125.18 -142.74 14.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.423 ' HE1' ' HB3' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -108.32 -172.02 1.98 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -1.14 . . . . 0.0 109.129 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 24' ' ' GLN . 0.8 OUTLIER -161.6 141.17 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.986 -1.071 . . . . 0.0 110.145 -179.562 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.509 ' HG3' ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -131.34 139.7 49.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 HG12 ' CB ' ' A' ' 23' ' ' ILE . 12.1 mt -130.67 172.51 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.999 -1.063 . . . . 0.0 109.997 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 41.4 t -138.34 104.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.695 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 146.21 -99.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.078 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 1.1 tt0 44.28 -157.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -81.52 -18.88 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.289 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.19 -140.24 10.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -118.38 -22.13 7.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -1.205 . . . . 0.0 109.54 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -146.46 126.19 13.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.703 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' OE1' ' HA ' ' A' ' 60' ' ' GLU . 2.3 mm-40 -103.63 142.39 34.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.016 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.509 ' CZ ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -133.49 106.32 7.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG22 ' CB ' ' A' ' 15' ' ' MET . 0.6 OUTLIER -124.47 -166.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.091 179.617 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.592 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -172.67 126.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.31 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.517 ' CD1' HG22 ' A' ' 8' ' ' VAL . 3.1 mt -119.6 -173.52 2.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.406 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 p -152.73 34.42 0.49 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.268 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.92 172.2 13.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.55 -164.95 25.12 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 11.9 tt -109.51 154.38 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -1.184 . . . . 0.0 109.621 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' CD2' ' C ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -133.87 132.06 39.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.197 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -136.13 131.46 34.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.226 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 39' ' ' ALA . 9.8 p -100.82 137.56 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.527 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.8 mm-40 -124.65 176.73 2.16 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -78.85 106.72 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.489 2.126 . . . . 0.0 110.757 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 70.69 31.93 67.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.461 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 10.8 p-10 174.63 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.627 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG12 HG23 ' A' ' 34' ' ' ILE . 6.4 p -124.69 149.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.426 HG21 ' N ' ' A' ' 78' ' ' VAL . 22.1 m -146.86 142.18 27.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.255 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.474 HG23 ' CD1' ' A' ' 45' ' ' ILE . 4.8 m -145.03 141.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.24 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 79' ' ' LEU . 6.0 mp -103.05 158.76 16.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -152.6 -165.72 2.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -120.65 -38.98 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -115.29 171.86 7.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -173.78 133.43 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.592 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 61.5 mt -144.14 152.68 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.125 -0.984 . . . . 0.0 109.491 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.464 ' N ' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -96.08 178.11 5.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.349 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.433 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -76.83 2.32 60.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.42 46.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 109.536 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -48.89 -58.07 5.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 -67.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.78 -168.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 131' ' ' ILE . 4.3 pt-20 -172.42 -34.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.53 -19.54 55.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.16 3.35 20.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.0 108.879 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 5.5 mtp -79.2 -23.95 43.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.677 . . . . 0.0 109.546 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 20.6 mt-10 -68.23 -19.39 64.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.569 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.43 -40.93 20.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -39.26 80.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.506 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.35 82.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 96' ' ' GLU . 16.1 mttt -89.69 -0.35 57.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 121' ' ' LEU . . . -86.56 -55.46 3.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.324 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.8 -42.08 77.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.246 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.6 -43.27 75.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.633 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 98.9 mt -89.97 24.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.275 -0.89 . . . . 0.0 109.335 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 107' ' ' SER . 16.6 m -61.09 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 72.27 168.68 0.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.228 -0.92 . . . . 0.0 109.279 -179.945 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 t -152.29 154.72 36.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.545 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -154.62 150.35 27.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.424 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 111' ' ' ASP . . . 115.74 20.3 5.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.53 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 0.8 OUTLIER 52.32 100.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -1.135 . . . . 0.0 109.348 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 25.8 m 40.7 34.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 109.661 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 20.6 t0 -87.23 -95.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.085 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.67 -12.26 61.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.01 63.43 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.62 -0.675 . . . . 0.0 109.42 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.97 -27.07 60.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.442 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.76 -7.74 58.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.446 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.4 m -81.01 -30.66 34.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.543 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.18 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -84.18 -13.31 53.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.503 ' CD1' ' HB3' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -74.9 -24.97 58.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.02 -6.39 56.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -14.58 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -88.9 -10.61 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.389 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.499 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.7 mp -81.36 -2.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.51 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -90.49 -21.33 21.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.677 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 124' ' ' ALA . 12.0 pt20 -69.17 -35.78 76.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.456 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 125' ' ' ILE . 0.9 OUTLIER -84.2 11.04 8.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.431 ' HG3' ' HA ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -89.72 -51.27 5.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 62' ' ' ILE . 22.6 m -52.3 -19.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.774 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 91' ' ' GLU . 7.3 mt -86.29 -58.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' ILE . 39.2 mm-40 -42.15 -40.02 2.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.778 . . . . 0.0 110.121 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 mp -74.2 -52.04 13.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.007 . . . . 0.0 109.73 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 131' ' ' ILE . 6.6 p -46.89 -24.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -70.91 -55.93 7.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.837 . . . . 0.0 109.594 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.74 20.17 13.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.35 63.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.295 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.537 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -155.93 63.44 0.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.548 ' CG2' ' HB2' ' A' ' 21' ' ' GLU . 2.1 p -42.47 125.0 3.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.62 ' CE2' HG21 ' A' ' 34' ' ' ILE . 27.1 p90 -118.64 -171.67 2.13 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.8 OUTLIER -111.97 147.46 35.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.035 -1.041 . . . . 0.0 109.076 179.834 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.611 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -137.06 162.8 32.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.964 -1.085 . . . . 0.0 109.132 178.66 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.549 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 10.9 t0 -154.64 96.95 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.478 ' O ' HG11 ' A' ' 8' ' ' VAL . 2.5 p -109.69 112.25 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.115 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.47 167.61 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.063 -1.023 . . . . 0.0 109.925 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -179.39 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.399 -0.813 . . . . 0.0 109.436 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 65.91 109.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 21.3 mm-40 62.38 79.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLU . 9.8 mp0 -43.8 111.97 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.466 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -171.52 53.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.321 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.48 ' CE ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -133.81 -88.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.611 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.7 t80 -139.96 126.03 19.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.055 -1.028 . . . . 0.0 109.355 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.3 p -159.67 82.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -0.96 . . . . 0.0 109.235 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.53 -145.04 6.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.454 ' C ' HG13 ' A' ' 20' ' ' VAL . 11.4 mt -69.99 159.49 33.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -1.116 . . . . 0.0 109.583 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.599 HG23 ' CD2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -175.91 164.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 -178.124 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' ' 3' ' ' THR . 47.0 tt0 -139.1 -56.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.108 -0.995 . . . . 0.0 110.236 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -130.64 111.21 12.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.043 -1.036 . . . . 0.0 110.711 -178.985 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -99.18 -162.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -166.36 159.03 14.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.74 -1.225 . . . . 0.0 109.904 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.485 HG21 ' HA2' ' A' ' 33' ' ' GLY . 1.3 t -154.52 116.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 81.6 m -111.47 110.56 21.06 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 109.231 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -154.76 45.68 0.55 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.61 169.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -1.158 . . . . 0.0 109.546 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.65 43.3 31.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.98 167.34 19.81 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -164.7 66.01 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -1.214 . . . . 0.0 109.375 -179.914 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mt -131.2 147.36 52.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.827 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.74 -102.9 2.45 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.62 HG21 ' CE2' ' A' ' 4' ' ' TYR . 3.5 mm -153.61 159.1 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.276 -1.132 . . . . 0.0 108.979 178.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -151.28 174.74 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.505 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' CB ' ' HB3' ' A' ' 2' ' ' MET . 32.5 Cg_endo -74.85 76.91 3.2 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.174 1.916 . . . . 0.0 109.95 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.64 49.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.544 ' CE1' HD13 ' A' ' 41' ' ' LEU . 14.9 t-80 -109.48 2.65 20.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 0.0 109.792 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 38' ' ' HIS . . . 66.92 155.78 0.14 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.986 . . . . 0.0 109.44 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.33 87.65 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.676 2.251 . . . . 0.0 110.655 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD13 ' CE1' ' A' ' 38' ' ' HIS . 7.3 mt -99.05 138.67 35.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.472 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.48 ' CD2' ' HG2' ' A' ' 70' ' ' GLU . 74.3 mt -119.9 86.94 2.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 17.0 p -131.25 -155.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.401 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -100.33 171.7 7.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.398 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 tt -100.21 169.84 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -115.5 142.46 28.86 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.92 . . . . 0.0 109.349 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.438 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.5 146.05 21.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.514 2.143 . . . . 0.0 110.298 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 144.63 -148.22 19.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.457 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 5.3 ppp? -101.46 174.35 6.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -1.119 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.544 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -148.48 151.39 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.982 -1.074 . . . . 0.0 109.88 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.5 ttt180 -121.03 172.65 7.79 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -164.22 144.85 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.711 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.635 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 34.4 t -134.09 118.01 27.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.648 -0.657 . . . . 0.0 109.302 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 139.97 -86.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.532 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.6 tt0 41.33 -94.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.412 -0.805 . . . . 0.0 109.65 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 19.1 t-160 -132.11 -36.56 1.16 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.17 42.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -173.34 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.337 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' ILE . 10.8 pt-20 -126.86 145.84 50.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.102 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -136.93 167.92 20.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.574 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.9 OUTLIER -134.07 136.47 43.99 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.463 -0.773 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -109.48 -157.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 109.031 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 127' ' ' GLN . 4.2 t80 -172.62 129.15 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.157 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.99 -164.36 2.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -165.4 130.61 2.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.4 158.7 3.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.14 177.5 14.91 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.412 HG21 ' N ' ' A' ' 69' ' ' LEU . 41.1 mt -122.85 142.86 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -1.116 . . . . 0.0 109.309 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.441 ' O ' HD21 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -106.55 132.84 52.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.864 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.48 ' HG2' ' CD2' ' A' ' 42' ' ' LEU . 1.5 tt0 -134.44 112.56 11.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 108.895 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.456 HG22 ' HB ' ' A' ' 76' ' ' VAL . 4.0 p -99.65 158.51 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -139.78 169.25 12.53 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.32 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 73.44 5.75 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.702 2.268 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.33 -14.74 5.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.506 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 14.5 p30 -165.43 166.09 18.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 77' ' ' THR . 1.3 p -153.73 145.63 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 109.327 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.524 ' N ' HG21 ' A' ' 76' ' ' VAL . 4.3 m -137.78 142.35 40.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.138 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 8' ' ' VAL . 2.5 m -142.61 143.4 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 109.225 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -116.99 147.0 42.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -138.55 -174.37 3.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.39 -46.81 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 65' ' ' SER . 7.5 t -100.38 -176.1 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HB2' ' CE ' ' A' ' 15' ' ' MET . . . -178.94 76.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.422 HG21 ' CB ' ' A' ' 88' ' ' ASP . 3.8 mp -106.18 77.01 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.296 -0.877 . . . . 0.0 109.744 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 86' ' ' GLY . 4.9 ttt-85 -45.77 152.11 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' O ' ' HB ' ' A' ' 131' ' ' ILE . . . -42.11 -45.59 5.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -74.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.265 . . . . 0.0 109.31 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 89' ' ' LEU . 27.8 t70 50.01 39.03 17.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.825 . . . . 0.0 109.563 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 59.61 151.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 0.0 109.603 179.826 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.37 -166.48 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 109.617 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -177.06 -51.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 109.147 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.75 -28.19 58.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -69.81 -6.53 32.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 128' ' ' LEU . . . -89.3 -22.44 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 108.743 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -29.79 33.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.534 -0.728 . . . . 0.0 109.047 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -32.63 74.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.455 -0.778 . . . . 0.0 109.402 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.6 -63.68 1.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.9 ttpt -57.77 -29.52 64.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.354 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -66.35 -32.68 74.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -22.36 32.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . . . -85.55 -15.66 41.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 108.923 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -72.55 -17.32 61.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.12 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.443 ' HA ' ' OG ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -87.4 -34.59 18.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -68.57 -38.85 81.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.551 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.519 ' CD1' ' HG ' ' A' ' 121' ' ' LEU . 94.2 mt -73.46 -16.98 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -91.37 24.45 2.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 108' ' ' SER . 0.7 OUTLIER -150.82 178.14 9.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 75.95 175.59 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -154.83 -165.14 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.391 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 178.68 25.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.14 -55.16 3.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.3 m -118.9 9.46 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.47 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.997 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 108' ' ' SER . 23.4 p90 -67.11 -19.9 65.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.988 -1.07 . . . . 0.0 108.161 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.36 -26.88 54.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.45 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -78.64 -31.32 46.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.5 -24.24 56.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.9 -4.19 36.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.09 -38.58 27.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 109.472 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.98 0.82 46.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.652 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.519 ' HG ' ' CD1' ' A' ' 105' ' ' ILE . 0.1 OUTLIER -79.37 -46.92 16.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.43 -9.32 32.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -71.68 -22.97 61.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.634 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.25 -3.51 58.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.682 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -89.56 -8.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.364 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.27 -36.42 63.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 109.274 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.552 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.3 pt20 -90.33 1.52 56.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.415 ' HA ' HG23 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -90.13 -26.45 20.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -21.34 33.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.742 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.574 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 30.2 m -88.05 -28.98 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.538 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -88.46 -13.63 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -33.45 33.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 110.013 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.572 HD23 ' CE2' ' A' ' 61' ' ' PHE . 1.6 pp -84.12 1.32 44.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 0.7 OUTLIER -88.86 -35.31 16.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.209 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.6 pttt -79.1 -22.64 44.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.256 179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.1 -7.03 54.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.394 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.79 3.05 55.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 109.578 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.436 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -56.47 138.61 51.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.532 179.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 2' ' ' MET . 0.2 OUTLIER 62.66 131.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.313 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.627 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 4.3 p90 -130.82 -154.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 9.9 t-80 -127.64 138.51 52.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.354 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.585 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.5 OUTLIER -134.81 160.01 39.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.986 -1.072 . . . . 0.0 109.015 179.349 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.481 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 15.4 t70 -149.81 101.59 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 0.0 110.08 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' O ' HG11 ' A' ' 8' ' ' VAL . 13.7 p -102.46 123.78 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.189 -0.944 . . . . 0.0 109.121 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 t -135.81 148.61 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -140.11 -142.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.045 179.87 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.29 30.25 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.694 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 13' ' ' GLN . 1.3 pm0 -170.53 78.89 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.278 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 3.3 mt-30 -42.48 103.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 109.67 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 5.6 tt0 175.15 59.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.7 mmm -143.49 -82.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.157 -0.965 . . . . 0.0 109.945 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.619 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 27.5 t80 -145.81 143.55 29.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.116 -0.99 . . . . 0.0 109.276 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.444 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 13.8 p -175.19 88.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.84 -145.35 10.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.496 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 14.8 mt -68.7 165.15 20.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.19 -1.182 . . . . 0.0 109.066 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.619 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -173.82 152.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.042 -1.036 . . . . 0.0 109.135 -177.907 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 54' ' ' LYS . 3.0 tt0 -114.73 -69.85 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.119 -0.988 . . . . 0.0 110.65 -178.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.5 tptt -125.93 107.98 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.744 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.588 ' CB ' HG13 ' A' ' 52' ' ' ILE . 1.3 pp -108.9 118.82 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.64 125.51 45.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.541 -1.349 . . . . 0.0 110.298 -178.46 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.406 ' CG2' HD13 ' A' ' 23' ' ' ILE . 1.5 t -112.86 120.75 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.166 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.9 m -124.14 110.12 14.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.77 -145.53 5.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 1.4 m -98.56 135.28 40.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -1.223 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.6 tt0 71.33 101.61 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.121 -0.987 . . . . 0.0 109.233 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.03 171.38 20.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 179.84 60.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.974 -1.31 . . . . 0.0 110.304 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -94.46 153.2 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.012 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.65 171.83 24.35 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.627 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 15.0 mm -99.11 126.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.039 -1.271 . . . . 0.0 108.434 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -124.21 170.63 8.41 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.1 Cg_endo -72.31 90.91 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.841 1.694 . . . . 0.0 109.933 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.26 2.25 4.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -49.3 136.64 15.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -1.202 . . . . 0.0 109.492 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.436 ' O ' HG12 ' A' ' 71' ' ' VAL . . . -54.07 171.29 0.27 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -77.37 83.46 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.697 2.265 . . . . 0.0 110.522 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.26 141.31 32.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 109.46 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.67 89.98 1.81 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 68' ' ' ILE . 11.9 p -150.13 -138.52 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.257 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 67' ' ' GLY . . . -100.06 171.13 8.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.215 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 0.1 OUTLIER -99.89 174.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.227 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -111.43 143.91 29.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.78 121.86 5.65 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.51 2.14 . . . . 0.0 110.402 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.528 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 168.22 -156.15 27.44 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.421 ' HB3' ' O ' ' A' ' 126' ' ' ALA . 5.9 ptm -108.55 -177.33 3.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -158.69 136.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.952 -1.092 . . . . 0.0 110.722 -179.524 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.86 174.87 5.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.588 HG13 ' CB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -164.95 152.87 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.652 -1.28 . . . . 0.0 109.886 -179.414 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 53.2 t -136.29 99.96 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER 155.89 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 8.8 tt0 50.34 23.78 1.33 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 109.826 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 43.5 63.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.594 179.965 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.49 -59.59 0.27 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 -158.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 109.542 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -110.04 158.64 18.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -156.95 165.2 36.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.589 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 3.5 p90 -128.19 127.7 43.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.96 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -177.84 128.8 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 108.924 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.84 -166.06 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -119.89 -90.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' C ' HG12 ' A' ' 45' ' ' ILE . . . -125.58 -131.47 3.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . 104.49 -166.63 15.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.445 ' C ' ' CD1' ' A' ' 45' ' ' ILE . 16.7 tt -113.61 133.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -1.199 . . . . 0.0 109.459 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -114.82 116.46 28.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.462 ' O ' HG21 ' A' ' 76' ' ' VAL . 2.7 pt-20 -114.34 127.75 56.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 108.88 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.465 HG21 ' HB ' ' A' ' 76' ' ' VAL . 14.1 p -99.8 144.81 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.12 -0.987 . . . . 0.0 109.884 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.529 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -123.69 172.89 5.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.384 -0.822 . . . . 0.0 109.103 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' CD ' ' HG2' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -78.16 93.95 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.611 2.208 . . . . 0.0 110.635 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.06 -17.0 45.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -156.92 152.85 27.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 109.324 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG21 ' N ' ' A' ' 77' ' ' THR . 2.0 p -138.14 144.02 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.01 . . . . 0.0 109.617 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.516 ' N ' HG21 ' A' ' 76' ' ' VAL . 11.9 p -131.07 146.78 52.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.375 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.486 ' CG1' ' HG ' ' A' ' 69' ' ' LEU . 4.9 m -149.33 146.1 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -124.36 151.47 44.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.29 -0.881 . . . . 0.0 109.341 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.465 ' N ' ' HG ' ' A' ' 79' ' ' LEU . . . -144.46 -164.8 1.99 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.37 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -117.06 -24.25 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.502 ' CG2' ' N ' ' A' ' 83' ' ' ALA . 20.5 m -110.8 165.47 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' CG2' ' A' ' 82' ' ' THR . . . -175.15 67.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.76 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.47 ' O ' HG21 ' A' ' 84' ' ' ILE . 2.8 mp -101.43 72.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.276 -0.89 . . . . 0.0 108.922 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -44.35 167.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.88 . . . . 0.0 109.445 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -52.47 -46.29 58.38 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.404 ' HG2' HG23 ' A' ' 134' ' ' THR . 0.2 OUTLIER -53.27 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -1.162 . . . . 0.0 109.406 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' LEU . 34.7 t70 55.24 17.87 2.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.532 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 42.38 37.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB2' ' OD2' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -146.42 168.7 20.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -152.41 -82.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.812 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.72 -25.9 68.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -64.86 -24.86 67.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.934 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.98 -17.05 26.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.005 . . . . 0.0 109.207 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.522 ' HA ' ' CD1' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -80.8 -48.47 12.42 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 -179.586 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -72.19 -9.69 58.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.846 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.62 -19.96 47.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.79 -1.62 58.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.05 -36.78 19.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -61.02 -20.61 62.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.08 -21.61 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.63 -44.86 95.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 -6.15 43.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -90.1 -41.61 11.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 121' ' ' LEU . 3.2 mt -86.98 13.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.145 -0.972 . . . . 0.0 109.827 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -103.89 74.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.292 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.9 p -155.7 -153.47 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t 173.61 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -165.55 -54.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.819 . . . . 0.0 109.447 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.02 143.85 15.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.464 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 19.7 t70 -64.35 -24.67 67.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -112.89 18.9 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.86 -92.35 0.06 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.427 -0.795 . . . . 0.0 109.219 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -73.5 -23.61 60.07 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 111' ' ' ASP . . . -56.77 -36.98 70.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -87.6 -15.51 37.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.803 . . . . 0.0 109.231 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.98 -31.72 69.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -51.96 -26.01 9.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.91 -35.97 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -65.11 -50.5 65.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.663 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.471 ' HB2' HD12 ' A' ' 105' ' ' ILE . 36.4 tp -55.31 -53.57 54.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -43.68 -35.89 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -49.99 74.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.661 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.64 -10.77 59.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.561 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 121' ' ' LEU . 20.4 mm -89.0 -11.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.445 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.528 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -72.4 -35.05 68.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -81.2 -10.22 59.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.522 ' CD1' ' HA ' ' A' ' 95' ' ' MET . 0.3 OUTLIER -83.14 -29.24 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.436 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -77.04 -39.76 48.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 109.597 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.589 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.6 m -74.18 -36.41 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.488 ' CD1' ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -67.21 -19.48 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.422 179.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.449 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 6.1 tm-20 -71.95 -16.05 62.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.925 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.11 -47.99 7.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.404 HG23 ' HG2' ' A' ' 87' ' ' GLN . 3.7 p -60.67 -31.11 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.611 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -63.43 -28.88 70.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.828 -179.817 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.457 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -109.31 0.6 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 0.0 109.587 -179.992 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.11 8.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 6.9 tpt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.605 179.981 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' THR . 1.5 ttm -148.81 132.77 17.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 109.58 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.517 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER 52.76 171.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.584 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 2.1 p90 179.62 -179.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.5 t60 -105.32 149.51 25.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.216 -0.927 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.594 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -138.5 164.77 28.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.001 178.825 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.56 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 2.2 t70 -154.88 81.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 78' ' ' VAL . 2.7 p -104.36 110.55 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.14 -170.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . 80.3 p -143.22 -166.7 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.419 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.37 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.453 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -140.55 65.07 1.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.89 . . . . 0.0 109.448 -179.933 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -147.32 172.1 14.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -91.65 152.01 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.554 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.508 ' HE1' ' CB ' ' A' ' 83' ' ' ALA . 1.7 mtt -154.05 -76.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.475 179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.65 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 30.6 t80 -168.14 134.83 2.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 9.1 p -165.73 98.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 20' ' ' VAL . . . 156.9 -153.8 25.0 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' C ' HG13 ' A' ' 20' ' ' VAL . 12.5 mt -65.18 162.15 17.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -1.211 . . . . 0.0 108.747 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.65 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -172.59 171.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.571 -178.538 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 5.0 tt0 -120.24 -47.97 2.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.074 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -172.44 133.1 0.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.042 179.873 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.556 ' CG2' HD21 ' A' ' 6' ' ' LEU . 3.0 pt -108.37 129.56 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.444 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 20.0 mt-30 -99.5 95.71 7.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.108 . . . . 0.0 109.511 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.509 ' CG2' HD13 ' A' ' 23' ' ' ILE . 3.8 t -99.14 151.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.688 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 9.0 t -160.94 140.44 10.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 108.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' N ' ' HB2' ' A' ' 31' ' ' GLU . . . -111.8 -166.8 18.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 t -48.08 -66.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -66.74 -13.86 61.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.084 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 112.65 151.49 11.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.688 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -142.82 155.3 44.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -1.217 . . . . 0.0 109.716 179.421 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.53 175.98 10.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.883 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.31 171.49 14.12 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.584 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 16.7 mm -99.89 143.86 13.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.808 -1.407 . . . . 0.0 108.927 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.599 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 1.8 p90 -155.66 169.42 10.39 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.599 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -69.58 83.18 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.553 1.502 . . . . 0.0 109.627 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.07 33.58 0.46 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 32.4 t60 -77.95 3.97 13.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -1.161 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.524 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . 76.53 175.39 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 0.0 109.847 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -78.2 76.24 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.722 2.281 . . . . 0.0 110.412 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.491 ' HG ' ' NE2' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -93.36 122.2 35.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.4 75.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 1.8 p -139.21 -147.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -106.3 169.37 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 0.0 OUTLIER -111.04 171.86 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.755 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -115.3 165.52 14.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 36.0 Cg_endo -78.27 117.08 4.01 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.694 2.262 . . . . 0.0 110.323 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -172.53 -153.01 8.98 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.446 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 9.7 ptm -114.19 178.03 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 109.268 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 2.0 tt -151.78 153.4 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.029 -1.045 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' N ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -123.27 176.77 5.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.662 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 HG13 ' CB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.25 141.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.005 -179.242 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 55.1 t -128.79 113.55 29.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 58' ' ' HIS . 24.3 mmtt -64.33 142.77 58.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 -179.113 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 56' ' ' HIS . 1.1 tt0 -43.5 -28.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.191 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 45.6 t-80 178.98 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 109.305 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.23 -107.59 0.52 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 5.2 t-80 -106.41 172.06 7.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -156.52 136.49 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.196 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -164.52 -173.85 3.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.64 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.1 p90 -125.2 144.11 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.418 -0.801 . . . . 0.0 109.493 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 HG21 ' HG2' ' A' ' 85' ' ' ARG . 2.4 mm -116.17 -147.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 108.986 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 1.5 t80 -174.92 130.98 0.31 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 108.841 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.39 177.05 7.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.72 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.427 ' HB2' ' CG2' ' A' ' 82' ' ' THR . 6.4 t -109.04 -52.36 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' ALA . . . -166.68 -155.27 8.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 128.49 -158.92 21.88 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.485 ' CA ' HD12 ' A' ' 45' ' ' ILE . 14.5 tt -127.38 125.8 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -1.083 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' A' ' 45' ' ' ILE . 0.6 OUTLIER -99.69 144.0 29.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -141.08 134.01 29.08 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.506 HG21 ' N ' ' A' ' 72' ' ' GLN . 7.1 p -99.8 155.86 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.131 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.589 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.04 -177.84 0.75 Allowed Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.776 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -79.88 93.31 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.323 2.015 . . . . 0.0 110.618 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.29 56.3 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -126.83 160.74 30.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 34' ' ' ILE . 14.7 t -134.96 153.3 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.205 -0.934 . . . . 0.0 109.038 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.411 ' N ' HG11 ' A' ' 76' ' ' VAL . 4.1 m -158.73 127.55 5.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.061 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 1.2 p -140.32 126.28 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.93 131.5 49.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.103 -0.998 . . . . 0.0 109.673 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 66' ' ' GLY . . . -117.1 -156.7 0.64 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.286 -0.883 . . . . 0.0 109.266 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -145.85 13.76 1.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.427 ' CG2' ' HB2' ' A' ' 65' ' ' SER . 3.1 m -148.98 135.87 19.79 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.227 -0.92 . . . . 0.0 109.322 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.508 ' CB ' ' HE1' ' A' ' 15' ' ' MET . . . -144.83 107.07 4.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.274 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 98.6 mt -110.19 -29.62 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.4 ' HG2' HG21 ' A' ' 62' ' ' ILE . 2.3 mtp-105 62.77 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.248 -0.907 . . . . 0.0 109.636 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.538 ' CA ' ' CG2' ' A' ' 130' ' ' VAL . . . -66.81 -11.49 57.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ASP . 4.7 mt-30 -90.97 -50.24 5.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -1.139 . . . . 0.0 109.167 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.538 ' HB2' ' CG2' ' A' ' 84' ' ' ILE . 56.7 t0 43.6 47.05 6.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.828 . . . . 0.0 109.583 179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 90' ' ' ASP . 11.0 mt 48.8 -91.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.408 -0.808 . . . . 0.0 109.784 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 88' ' ' ASP . 6.1 m-20 -53.94 -168.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 0.0 109.719 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -153.82 -69.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.49 -17.97 62.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 0.0 109.831 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -22.12 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -19.5 23.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 109.248 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.478 ' CG ' HD13 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -77.74 -29.02 50.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.625 -179.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.8 -2.27 46.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.03 -36.42 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.109 -0.994 . . . . 0.0 109.53 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -58.61 -36.39 73.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.786 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -75.77 -31.9 59.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.694 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -90.03 4.67 49.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.848 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.75 -4.43 57.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 109.58 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 3.3 tp10 -89.49 -47.82 7.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -60.94 -17.09 49.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.975 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -86.76 -30.16 21.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.028 -1.045 . . . . 0.0 109.835 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 99.4 mt -89.88 10.78 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.59 30.88 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.423 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 152.04 51.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.578 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 5.9 p -138.38 129.51 27.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 108' ' ' SER . 6.8 t60 178.39 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 147.06 152.0 5.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.2 -51.24 16.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.3 24.99 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.67 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.22 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.578 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 10.2 p90 -72.28 -25.07 61.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.97 -26.75 38.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -31.6 17.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -68.29 -19.28 64.69 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.822 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 p -67.71 -32.01 72.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.575 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.97 -14.7 59.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.518 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mm-40 -82.35 -28.94 31.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.42 ' O ' ' CD1' ' A' ' 125' ' ' ILE . 8.6 mt -90.27 -39.78 12.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.596 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.77 -44.24 93.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.695 -179.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -59.82 -28.43 67.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -67.25 -30.32 70.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.537 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.523 HD13 ' N ' ' A' ' 125' ' ' ILE . 2.2 mp -70.95 -8.05 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.23 -31.4 19.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.256 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.462 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -78.6 -13.43 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.259 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.478 HD13 ' CG ' ' A' ' 95' ' ' MET . 6.4 tt -76.84 -19.4 57.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.391 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -82.18 -28.22 32.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.769 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.568 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.6 m -86.07 -27.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.955 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.434 ' N ' HG21 ' A' ' 130' ' ' VAL . 5.0 tt -69.53 -28.91 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.799 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 14.9 mm-40 -65.59 -15.69 62.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 133' ' ' LEU . 7.4 mp -90.29 -40.94 11.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.644 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.521 HG22 ' CE1' ' A' ' 61' ' ' PHE . 2.2 p -71.92 -3.12 20.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -76.74 -23.52 53.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -120.99 40.41 3.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.369 179.647 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.09 -18.82 13.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.533 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.493 -179.959 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -44.74 130.66 7.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.617 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.39 130.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.639 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 3.4 p90 -131.32 -143.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.592 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -141.35 150.0 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 0.0 108.99 -179.361 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.702 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -112.52 132.07 55.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.175 -0.953 . . . . 0.0 109.04 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -129.76 72.42 1.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.823 -1.173 . . . . 0.0 109.791 179.832 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 3.7 p -109.1 118.2 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.214 -0.929 . . . . 0.0 109.211 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 13.2 m -129.75 159.59 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.03 169.42 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . -55.48 118.84 4.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.337 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 3.4 mt-10 58.81 44.02 17.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.206 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -177.78 168.56 2.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.7 pt20 -147.97 174.38 11.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.458 ' HE1' ' HB3' ' A' ' 83' ' ' ALA . 3.9 mmt -144.65 -75.45 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.944 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.1 t80 -109.5 113.09 25.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 110.294 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.432 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 32.8 p -136.36 90.6 2.58 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.26 -0.9 . . . . 0.0 109.708 178.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 5' ' ' HIS . . . 168.99 -158.64 31.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.602 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.89 -164.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.933 -1.333 . . . . 0.0 109.291 179.483 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.598 ' HB ' ' CE2' ' A' ' 16' ' ' PHE . 0.2 OUTLIER 172.43 164.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 0.0 108.461 179.162 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.531 ' HB2' ' CA ' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -123.73 -40.07 2.35 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' O ' HG21 ' A' ' 52' ' ' ILE . 25.8 ttpt -159.4 113.51 2.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 110.558 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.546 ' CG2' HG22 ' A' ' 52' ' ' ILE . 13.0 pt -98.81 -164.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -179.76 97.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.667 -1.271 . . . . 0.0 110.221 179.691 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 32' ' ' LEU . 3.1 p -99.26 140.42 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.306 -0.872 . . . . 0.0 108.717 179.279 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 23.8 m -131.97 103.6 6.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -133.26 -47.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER 165.05 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -1.168 . . . . 0.0 109.555 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.63 125.36 33.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.463 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.76 -52.69 4.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.02 19.17 4.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.759 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.43 ' O ' HG11 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -128.22 160.7 31.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.602 179.873 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.49 -112.73 3.37 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.404 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.639 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 31.2 mm -155.0 149.18 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.26 -1.141 . . . . 0.0 109.481 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.616 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -153.34 -172.86 0.33 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.955 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.0 Cg_endo -78.46 81.21 2.81 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.687 1.592 . . . . 0.0 110.423 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 25.7 1.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 39' ' ' ALA . 28.3 t60 -56.89 145.01 31.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.241 . . . . 0.0 109.477 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.527 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -49.27 176.25 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.18 87.51 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.645 2.23 . . . . 0.0 110.424 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.19 126.19 46.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.384 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.93 73.09 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -149.3 -144.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.051 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.58 -171.45 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.001 . . . . 0.0 109.183 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 3.1 mt -132.45 172.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.678 -179.89 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -123.45 174.28 3.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.288 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -77.43 144.22 22.63 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.513 2.142 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 165.84 -157.28 29.68 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.466 ' HE1' ' N ' ' A' ' 50' ' ' ILE . 1.4 ptm -111.29 -177.74 3.28 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.509 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 3.1 tp -160.28 115.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.455 ' C ' ' CG1' ' A' ' 52' ' ' ILE . 25.2 ttp180 -110.24 154.88 22.78 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.546 HG22 ' CG2' ' A' ' 23' ' ' ILE . 15.9 mt -154.65 170.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.193 . . . . 0.0 111.011 -178.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.43 111.32 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' HIS . 4.3 ttpt -62.65 105.71 0.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.584 -0.697 . . . . 0.0 110.193 -179.116 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.531 ' CA ' ' HB2' ' A' ' 21' ' ' GLU . 3.5 tt0 40.59 -93.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.735 . . . . 0.0 110.023 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 28.6 t-80 -150.15 81.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.998 . . . . 0.0 109.487 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.64 -97.51 0.11 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 59' ' ' GLU . 47.7 t60 -86.39 170.99 11.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -1.167 . . . . 0.0 109.584 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 6.8 mt-10 -125.47 164.1 21.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.338 -0.851 . . . . 0.0 109.183 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -122.67 130.62 53.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.111 -0.993 . . . . 0.0 109.756 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.403 ' C ' ' CG1' ' A' ' 62' ' ' ILE . 2.1 m-85 -108.83 132.87 53.58 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.509 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.5 mt -150.73 -179.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.978 -1.076 . . . . 0.0 110.01 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.572 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -159.77 152.66 21.64 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.923 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 65' ' ' SER . 1.2 pp -146.93 -174.55 4.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.97 -179.541 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -133.86 -48.98 0.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.47 164.04 31.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 45' ' ' ILE . . . 156.88 -172.76 34.52 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.6 mp -111.18 131.28 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -1.137 . . . . 0.0 109.061 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . 1.3 tt -115.78 137.55 51.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -0.872 . . . . 0.0 109.408 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 12.7 pt-20 -146.37 143.25 28.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.487 ' HA ' ' CG1' ' A' ' 76' ' ' VAL . 6.1 p -99.62 147.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.675 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.463 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -126.87 170.43 9.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 179.958 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.68 77.73 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.643 2.229 . . . . 0.0 110.926 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.44 0.65 16.02 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.225 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 72' ' ' GLN . 1.8 p30 -174.89 166.87 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.005 -1.291 . . . . 0.0 109.756 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.487 ' CG1' ' HA ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -135.15 161.99 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 109.129 179.833 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.403 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 17.4 m -156.11 136.75 13.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.557 ' CG2' ' CG2' ' A' ' 8' ' ' VAL . 7.4 m -138.95 148.4 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.455 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -115.01 120.89 41.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 -179.886 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.77 -174.97 3.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.1 -51.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.8 m -100.27 126.82 46.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.458 ' HB3' ' HE1' ' A' ' 15' ' ' MET . . . -138.53 150.2 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.982 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.572 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 69.6 mt -132.68 122.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.352 -0.843 . . . . 0.0 108.901 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -72.88 89.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.951 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.15 -123.8 12.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' HB3' HG12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -100.88 52.97 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -1.096 . . . . 0.0 109.676 -179.674 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.88 -37.53 70.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.37 174.04 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.17 44.06 30.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 87' ' ' GLN . 68.2 mt-10 -77.12 -80.56 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.45 -7.77 53.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.315 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -86.86 8.76 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.902 . . . . 0.0 109.51 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.454 ' HB2' HD11 ' A' ' 128' ' ' LEU . . . -90.19 -37.58 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.037 179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -38.94 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 5.1 mm-40 -71.0 -18.18 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.06 62.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.76 -18.91 9.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 109.702 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -74.15 -45.68 47.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.78 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -79.33 -19.63 49.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.621 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.61 -20.73 25.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.132 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.474 ' O ' ' OG ' ' A' ' 106' ' ' SER . 34.7 tt0 -71.39 -28.03 63.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.572 ' HG3' ' CD2' ' A' ' 104' ' ' HIS . 7.2 pt-20 -59.27 -31.06 68.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.669 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.572 ' CD2' ' HG3' ' A' ' 103' ' ' GLU . 25.3 m170 -82.24 -40.72 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 7.4 mt -85.74 12.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' SER . 58.0 m -110.58 117.69 34.22 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 81.65 171.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.827 -0.546 . . . . 0.0 109.537 179.884 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 77.67 173.33 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 109.13 -179.539 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.481 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 4.8 p-80 -170.13 125.56 0.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.61 169.23 40.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.51 -40.23 85.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -1.096 . . . . 0.0 109.327 179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 113' ' ' ASP . 23.2 m -124.92 -9.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 112' ' ' VAL . 2.0 m-20 -48.02 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.168 179.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.527 ' C ' ' CD1' ' A' ' 114' ' ' TYR . 5.8 p90 -75.93 -21.2 57.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.017 -1.052 . . . . 0.0 108.294 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.81 -18.28 62.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.631 -0.668 . . . . 0.0 109.355 179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 3.0 mt-30 -70.23 -36.06 74.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.449 ' O ' ' HG3' ' A' ' 120' ' ' GLU . . . -72.86 -24.7 60.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -65.96 -25.98 67.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.339 -0.851 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.3 -33.32 25.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.653 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 117' ' ' ALA . 1.2 pp20? -85.61 -8.3 58.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.482 HD11 ' CD1' ' A' ' 105' ' ' ILE . 9.0 tt -84.14 -59.13 2.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.536 ' HA ' ' CG1' ' A' ' 125' ' ' ILE . . . -46.54 -27.79 1.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -51.22 70.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.918 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.19 59.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.536 ' CG1' ' HA ' ' A' ' 122' ' ' ALA . 33.5 mm -76.6 -8.12 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.962 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.72 -2.86 58.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.168 -0.958 . . . . 0.0 109.615 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.433 ' OE1' ' CD1' ' A' ' 84' ' ' ILE . 1.6 mt-30 -87.63 -37.89 16.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.232 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 94' ' ' ALA . 4.6 tp -81.19 -24.54 37.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.855 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' LEU . 16.5 mmm180 -62.5 -43.51 98.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 28.1 m -68.66 -9.99 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.71 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.461 HG12 ' HB3' ' A' ' 87' ' ' GLN . 63.0 mt -90.62 -56.15 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 21.1 mm-40 -68.67 -9.19 48.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -87.65 -48.69 7.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.406 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 10.4 t -69.08 -7.57 37.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -55.64 -53.64 54.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.554 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -87.46 -12.74 45.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -46.83 -37.83 9.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.306 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.397 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.503 ' HG2' ' CG ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER 177.84 56.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.746 -179.895 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.529 ' CB ' ' HB2' ' A' ' 21' ' ' GLU . 8.9 t 173.7 129.31 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.71 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.601 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 13.8 p90 -112.84 -162.55 0.8 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.4 t60 -117.27 142.36 47.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 108.548 178.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.631 ' HG ' ' CD2' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -130.43 156.79 44.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.415 178.43 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.489 ' CB ' HG21 ' A' ' 77' ' ' THR . 0.7 OUTLIER -143.03 90.2 2.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 16' ' ' PHE . 7.3 m -108.37 147.7 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -169.31 151.19 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m -119.94 125.68 49.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 56.0 27.78 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER 66.07 72.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -165.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 82.74 1.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.435 ' SD ' ' CG2' ' A' ' 62' ' ' ILE . 7.4 mmt -105.88 -92.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.631 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 34.4 t80 -121.07 138.99 53.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.084 -1.01 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 p -169.06 100.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.94 -151.41 23.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.512 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 10.9 mt -64.22 170.48 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.598 HG23 ' CD2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER 172.92 160.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 108.39 -177.608 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 8.6 tt0 -156.32 -58.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.916 -1.115 . . . . 0.0 110.623 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.533 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -91.42 74.72 6.03 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.395 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' CG2' ' CG2' ' A' ' 20' ' ' VAL . 2.9 pt -99.89 143.67 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.493 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 35.8 tt0 -150.63 121.85 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.789 -1.194 . . . . 0.0 109.674 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 46' ' ' LYS . 9.7 p -99.84 159.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 5.9 m -138.46 111.79 8.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.216 -0.927 . . . . 0.0 109.204 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.53 -99.62 0.52 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -134.56 -0.12 2.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -1.169 . . . . 0.0 110.214 -179.674 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 tm-20 -164.05 128.66 2.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.93 -53.64 0.61 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 16.8 mt-10 48.85 23.61 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -1.174 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.558 HD21 ' CE1' ' A' ' 35' ' ' TYR . 1.7 mt -148.13 161.09 42.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.493 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -111.73 -103.83 2.72 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.601 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 9.2 mm -154.54 140.59 11.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.41 -1.053 . . . . 0.0 109.238 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -121.5 -178.89 0.66 Allowed Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.345 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.567 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 34.3 Cg_endo -77.54 96.09 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.262 1.975 . . . . 0.0 110.4 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.88 15.25 5.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.475 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 40.2 t-80 -72.74 171.98 11.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -1.146 . . . . 0.0 109.447 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.411 ' H ' ' CG ' ' A' ' 38' ' ' HIS . . . -85.89 156.49 58.09 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.353 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -77.02 78.0 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.682 2.254 . . . . 0.0 110.782 -179.917 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -97.84 149.04 22.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.983 179.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.74 133.47 13.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER 179.97 -92.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.84 . . . . 0.0 109.436 179.48 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 43' ' ' THR . . . -131.29 160.9 33.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.465 HD11 ' HB2' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -100.42 132.42 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -65.33 136.41 96.37 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 -179.837 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' CB ' ' OG ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -80.18 160.51 23.4 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.446 2.097 . . . . 0.0 110.44 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 126.58 -131.64 7.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ptm -121.94 178.3 4.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -1.056 . . . . 0.0 109.009 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 24' ' ' GLN . 0.6 OUTLIER -156.23 131.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.618 -1.301 . . . . 0.0 110.96 -179.604 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -98.84 129.67 45.23 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.518 HG13 ' CB ' ' A' ' 23' ' ' ILE . 2.1 tt -130.82 152.38 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.887 -1.133 . . . . 0.0 110.898 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.533 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 46.8 t -131.19 107.56 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' GLN . 4.4 ttpt -67.29 119.51 12.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.735 . . . . 0.0 109.646 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' LYS . 3.4 tt0 41.19 -152.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.423 -0.798 . . . . 0.0 109.742 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -88.91 67.24 8.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 161.62 163.6 14.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.7 m170 57.88 159.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.184 -1.186 . . . . 0.0 109.347 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 0.3 OUTLIER 179.97 118.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.53 157.08 45.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 -179.631 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.4 OUTLIER -113.58 136.44 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 -179.904 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 50' ' ' ILE . 5.3 mp -112.58 167.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.592 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 14.4 t80 -128.48 140.83 51.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.32 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -168.83 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.467 ' OG ' ' CB ' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -179.47 132.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 -179.966 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 80' ' ' ALA . . . 72.79 142.97 0.51 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.57 165.06 11.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.73 123.85 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -1.108 . . . . 0.0 109.22 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.498 ' CD2' ' C ' ' A' ' 69' ' ' LEU . 1.2 tt -108.09 153.73 22.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.0 110.036 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 77' ' ' THR . 4.4 pt-20 -156.14 111.0 2.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 HG22 ' HB ' ' A' ' 76' ' ' VAL . 4.4 p -99.85 159.08 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 2.0 mt-30 -143.11 172.97 4.97 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.7 Cg_endo -80.26 62.11 8.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.627 2.218 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.63 -14.74 1.06 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.6 p-10 -167.21 168.65 13.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.996 -1.296 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 77' ' ' THR . 0.9 OUTLIER -155.49 162.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.413 -0.804 . . . . 0.0 109.063 -179.891 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.489 HG21 ' CB ' ' A' ' 7' ' ' ASP . 6.4 p -154.18 156.05 36.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -166.43 130.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.962 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.96 112.0 23.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 66' ' ' GLY . . . -106.07 -175.27 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.63 -9.26 9.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.456 ' HB ' ' N ' ' A' ' 65' ' ' SER . 16.7 m -109.35 142.04 40.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -161.39 132.85 5.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.911 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.592 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 18.9 mt -128.8 -36.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.368 -0.833 . . . . 0.0 109.143 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 75.34 134.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.172 -179.763 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -39.16 96.6 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 85' ' ' ARG . 39.3 tt0 63.85 74.36 0.42 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -1.112 . . . . 0.0 109.942 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 8.9 t70 -52.3 -35.09 49.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.086 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER 166.47 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.076 179.875 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 75.12 153.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.487 ' CB ' HD12 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.66 -29.36 3.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.56 -33.64 20.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.463 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 9.3 ttt180 -63.67 -22.72 67.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 0.0 109.466 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.74 -25.11 23.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.274 -0.891 . . . . 0.0 108.712 179.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.5 mtm -66.29 -20.74 66.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.505 -0.747 . . . . 0.0 109.373 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.441 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 2.3 tm-20 -80.05 -22.38 42.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.93 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.15 72.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.405 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.34 -26.81 61.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.211 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.443 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -81.94 -26.68 33.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HG3' ' OE1' ' A' ' 96' ' ' GLU . 8.3 mttt -83.25 -27.32 29.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 109.624 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.87 -19.69 31.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.395 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 16.1 tp10 -77.34 -38.22 50.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.924 . . . . 0.0 109.334 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -72.49 -43.61 63.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -28.05 67.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.524 ' CG2' ' O ' ' A' ' 105' ' ' ILE . 98.8 mt -90.24 26.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.203 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 t -97.32 -14.35 21.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.707 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.6 p -126.01 110.91 14.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.502 ' CB ' ' HB2' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -158.0 155.73 29.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 109.271 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.7 -76.95 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 111' ' ' ASP . . . 179.05 -175.74 47.48 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 0.2 OUTLIER 77.84 -78.03 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -1.079 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.3 m -135.51 8.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.15 -91.24 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.409 -0.807 . . . . 0.0 108.884 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.502 ' HB2' ' CB ' ' A' ' 108' ' ' SER . 49.5 t80 -72.12 -17.49 61.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.22 82.21 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 5.9 mm-40 -90.68 -32.5 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.494 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -67.37 -24.77 65.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -32.23 53.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.441 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.24 -25.98 22.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 8.8 mm-40 -62.87 -46.31 88.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB2' ' CD1' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -58.03 -52.56 65.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.463 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -18.85 60.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 -179.686 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -29.46 64.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.96 -24.67 21.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.812 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 121' ' ' LEU . 24.7 mm -80.62 7.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.54 -34.07 15.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.466 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 2.6 pt20 -80.86 -25.01 37.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.903 . . . . 0.0 109.618 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.466 ' N ' ' HG2' ' A' ' 127' ' ' GLN . 0.1 OUTLIER -71.23 -15.84 62.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.25 -52.49 4.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 21.6 m -56.61 -29.33 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.942 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.487 HD12 ' CB ' ' A' ' 91' ' ' GLU . 12.0 tt -64.36 -42.96 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.005 . . . . 0.0 109.735 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -60.39 -23.77 64.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.578 -179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.28 -49.62 16.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.792 -179.677 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.444 ' O ' ' HB1' ' A' ' 137' ' ' ALA . 8.8 t -70.66 -17.81 62.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -53.04 52.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -5.26 59.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 134' ' ' THR . . . -60.27 -34.09 73.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.519 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.227 0.537 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.6 143.27 16.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.534 ' CG2' ' HG3' ' A' ' 21' ' ' GLU . 7.6 p -45.52 135.87 6.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.6 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 5.3 p90 -132.8 178.36 6.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.063 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.3 t60 -103.79 149.1 25.34 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.623 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 0.6 OUTLIER -138.55 156.72 47.24 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.442 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' OD1' ' CE1' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -145.68 94.09 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.98 -1.075 . . . . 0.0 110.261 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.432 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 6.5 p -107.61 96.32 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 108.779 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.42 ' CG2' HD22 ' A' ' 79' ' ' LEU . 28.7 m -118.26 162.22 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.961 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.41 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 3.5 t -102.63 -158.27 0.66 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.343 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -68.38 -50.27 54.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 4.2 mt-10 -141.59 67.61 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 14' ' ' GLN . 1.8 mm-40 171.61 68.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 13' ' ' GLN . 14.7 pt20 -43.71 158.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.66 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.503 ' HE2' ' CG2' ' A' ' 62' ' ' ILE . 12.3 mmm -126.83 -73.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.176 -0.952 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.67 ' CE1' ' HB ' ' A' ' 20' ' ' VAL . 40.9 t80 -114.68 93.45 4.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.9 p -124.04 95.71 4.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -159.73 32.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' C ' HG11 ' A' ' 20' ' ' VAL . 12.6 mt -66.78 160.73 25.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -1.173 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.67 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -164.36 160.26 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.969 -178.5 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.534 ' HG3' ' CG2' ' A' ' 3' ' ' THR . 0.1 OUTLIER -130.63 -34.85 1.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.516 -0.74 . . . . 0.0 109.35 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.4 ttpp -155.1 97.84 1.96 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.096 -1.002 . . . . 0.0 110.515 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.543 ' CB ' HG12 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -99.31 156.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.497 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 11.9 tt0 -151.96 134.47 15.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -108.78 142.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -130.41 113.04 13.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.51 -111.95 1.48 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.712 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 m -107.97 -62.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -1.179 . . . . 0.0 109.466 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.64 -17.8 14.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.56 119.37 5.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -129.26 34.62 4.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -1.194 . . . . 0.0 109.798 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.406 HD21 ' CE1' ' A' ' 35' ' ' TYR . 6.5 mt -138.61 139.29 38.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.013 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.11 -101.46 2.29 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 20.4 mm -155.59 152.7 8.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.613 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -154.44 -176.0 0.56 Allowed Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.746 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 36.2 Cg_endo -81.7 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.359 2.04 . . . . 0.0 110.183 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.49 38.64 0.02 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 39' ' ' ALA . 10.4 t-160 -82.47 10.02 8.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -1.08 . . . . 0.0 109.594 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 38' ' ' HIS . . . 75.86 173.47 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.314 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -78.16 76.97 4.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.581 2.188 . . . . 0.0 110.485 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.01 130.04 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.183 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.2 tp -148.77 69.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -140.29 -95.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.729 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.458 ' N ' ' OG1' ' A' ' 43' ' ' THR . . . -156.87 167.96 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.544 HD11 HG22 ' A' ' 45' ' ' ILE . 3.4 mt -110.07 167.25 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 68.4 mmtt -100.11 159.45 29.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.491 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.09 163.95 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.858 2.372 . . . . 0.0 110.423 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 130.78 -146.25 17.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.512 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 24.8 ptm -103.19 -176.77 3.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -1.112 . . . . 0.0 109.085 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -158.52 118.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 109.544 -179.81 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.36 131.28 46.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 109.367 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 23' ' ' ILE . 35.5 mt -132.73 163.08 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.107 -0.995 . . . . 0.0 109.784 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.592 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 39.2 t -134.95 154.62 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.616 -0.677 . . . . 0.0 109.64 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.4 tmtm? 92.0 -79.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.466 ' OE1' ' HG2' ' A' ' 60' ' ' GLU . 14.6 tt0 51.44 -99.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.818 -1.176 . . . . 0.0 109.606 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -165.28 50.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.922 -1.111 . . . . 0.0 109.275 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.543 ' C ' ' CD2' ' A' ' 58' ' ' HIS . . . 146.73 -44.61 0.82 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 57' ' ' GLY . 44.3 m-70 -150.93 -176.64 5.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.406 -1.055 . . . . 0.0 109.235 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 5.6 mp0 -106.9 162.31 13.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 109.124 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.466 ' HG2' ' OE1' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -162.64 171.28 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.968 -1.082 . . . . 0.0 110.016 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.7 OUTLIER -121.1 176.3 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 109.656 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.2 mt -152.94 -160.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.78 . . . . 0.0 109.0 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 48' ' ' GLY . 3.8 t80 -172.36 128.87 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.21 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -158.63 -169.74 2.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 109.708 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.491 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -86.98 -59.75 2.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.55 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.14 -63.92 0.33 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.59 -152.3 52.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.414 HG21 ' O ' ' A' ' 43' ' ' THR . 75.1 mt -102.71 137.99 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.141 . . . . 0.0 109.217 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.537 ' HB2' ' CG1' ' A' ' 45' ' ' ILE . 1.7 tt -119.37 152.6 36.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.0 109.576 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 6.0 mt-10 -149.65 138.33 20.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 109.229 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 40' ' ' PRO . 9.6 p -100.52 140.51 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.793 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.521 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 5.6 mt-30 -124.19 174.76 3.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.4 Cg_endo -78.12 80.92 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.342 2.028 . . . . 0.0 111.022 -179.389 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 102.5 25.3 7.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 7.0 p-10 171.15 138.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -1.208 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.509 ' CG2' HG23 ' A' ' 34' ' ' ILE . 28.3 m -126.61 172.48 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 108.908 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.468 HG21 ' N ' ' A' ' 78' ' ' VAL . 55.3 m -163.11 157.19 20.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.212 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.468 ' N ' HG21 ' A' ' 77' ' ' THR . 2.4 p -161.82 135.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 108.95 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.42 HD22 ' CG2' ' A' ' 9' ' ' VAL . 2.0 mt -116.37 122.9 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.082 -1.012 . . . . 0.0 109.779 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.14 -168.06 1.33 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.235 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.57 -12.02 8.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.447 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.2 m -112.19 147.83 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.45 ' HB3' ' HE3' ' A' ' 15' ' ' MET . . . -158.25 70.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 109.728 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.518 HD11 ' CE1' ' A' ' 63' ' ' TYR . 8.6 mt -99.0 56.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HB3' HG21 ' A' ' 62' ' ' ILE . 7.2 ptt180 -46.21 154.6 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 87' ' ' GLN . . . -58.37 148.98 36.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' NE2' ' HB ' ' A' ' 134' ' ' THR . 35.1 mt-30 69.29 6.15 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -1.122 . . . . 0.0 109.645 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -70.13 -34.43 73.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.68 151.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 93' ' ' ARG . 66.0 t0 56.99 103.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.311 -0.868 . . . . 0.0 109.585 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.427 ' HA ' HD13 ' A' ' 131' ' ' ILE . 33.6 mt-10 -110.11 -53.98 2.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.5 -20.7 26.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.504 ' CB ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -86.76 -9.35 56.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.968 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . . . -90.41 -12.22 38.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.209 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -25.97 32.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 109.683 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 12.5 pt-20 -77.07 -14.33 59.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.38 -47.92 53.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 109.54 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -21.91 19.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -39.67 24.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -90.08 0.46 57.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.529 ' CB ' ' CD1' ' A' ' 121' ' ' LEU . . . -90.33 -32.18 16.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.72 -26.22 68.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.75 -37.43 82.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -68.96 -16.24 63.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 107' ' ' SER . 11.4 mm -89.14 19.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.165 -0.96 . . . . 0.0 109.744 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -47.52 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.634 -179.937 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' ILE . 2.5 m -43.66 137.18 3.09 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.4 p -166.41 158.93 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.499 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.17 166.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.14 138.35 5.23 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -72.16 -72.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.329 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 113' ' ' ASP . 32.2 m -111.61 12.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 112' ' ' VAL . 29.6 t0 -49.86 -99.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -68.45 -15.8 63.68 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.873 -1.142 . . . . 0.0 108.514 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.84 -16.0 62.58 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.601 -0.687 . . . . 0.0 109.5 179.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -88.83 -27.92 20.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 121' ' ' LEU . . . -82.67 -14.29 54.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -23.39 61.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.61 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.57 -23.9 24.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.25 -10.38 54.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.529 ' CD1' ' CB ' ' A' ' 101' ' ' ALA . 3.1 mm? -86.3 -63.62 1.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.644 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.18 -18.67 4.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.86 -179.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -54.59 -41.04 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.23 -36.3 18.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -64.6 -10.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.427 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.53 -35.46 75.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.476 179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.423 ' HA ' ' CG2' ' A' ' 130' ' ' VAL . 1.6 pp0? -81.09 5.33 16.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.448 ' CD2' ' O ' ' A' ' 128' ' ' LEU . 2.3 tt -86.14 -36.23 19.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -34.74 62.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.161 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.581 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 35.5 m -72.38 -36.56 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 128' ' ' LEU . 3.6 tt -68.26 -31.37 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -75.29 -16.55 60.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.475 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -71.03 -42.1 69.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.647 -179.95 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.515 ' HB ' ' NE2' ' A' ' 87' ' ' GLN . 9.7 t -74.1 -14.13 60.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -60.09 -35.72 75.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.11 -0.994 . . . . 0.0 109.176 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -95.75 -3.98 44.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.252 179.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 134' ' ' THR . . . -58.49 -57.09 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.474 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.3 ptp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.444 179.797 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.2 mtm -152.59 141.49 21.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.47 ' OG1' ' N ' ' A' ' 4' ' ' TYR . 0.0 OUTLIER -162.04 177.17 9.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.617 ' CZ ' HG21 ' A' ' 34' ' ' ILE . 2.4 p90 -166.05 -149.09 0.1 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.7 t60 -133.05 147.54 52.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 108.886 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.656 ' HG ' ' CD1' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -140.23 169.96 16.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.194 178.975 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.575 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.75 103.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.896 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.404 ' O ' HG11 ' A' ' 8' ' ' VAL . 3.6 p -116.39 102.94 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.981 . . . . 0.0 109.515 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 14' ' ' GLN . 15.0 t -111.55 156.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.466 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 15.4 t -122.13 78.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 109.655 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 10' ' ' SER . . . 69.14 -85.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.77 30.88 4.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.507 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.69 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.451 ' HA ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.27 144.99 11.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 -179.853 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.423 ' HE3' ' HB3' ' A' ' 85' ' ' ARG . 13.9 mtt -127.96 -77.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.262 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 34.7 t80 -103.49 123.83 47.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.431 ' O ' ' OG ' ' A' ' 17' ' ' SER . 14.8 p -152.12 103.04 2.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.0 -155.32 26.05 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' C ' ' CG1' ' A' ' 20' ' ' VAL . 8.5 mt -61.33 178.69 0.26 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.119 -1.224 . . . . 0.0 108.937 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.645 ' HB ' ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER 175.88 113.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.784 -1.197 . . . . 0.0 109.888 -177.871 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 6.6 tt0 -76.17 -43.04 44.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.085 179.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -165.94 134.51 3.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.987 -1.071 . . . . 0.0 110.586 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 39.0 pt -98.71 -148.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.493 ' N ' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -176.1 132.99 0.25 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.259 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.483 HG22 ' HA2' ' A' ' 33' ' ' GLY . 4.1 t -140.25 131.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.976 -1.078 . . . . 0.0 109.324 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.7 m -132.61 113.89 13.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.519 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.76 -119.64 2.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.6 p -122.65 -6.63 8.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.01 -91.86 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.92 142.8 34.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.98 63.1 1.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -1.219 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD11 ' OH ' ' A' ' 35' ' ' TYR . 8.9 mt -141.26 162.36 35.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 109.595 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.495 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -106.05 -116.64 4.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.617 HG21 ' CZ ' ' A' ' 4' ' ' TYR . 17.5 mm -153.05 141.1 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.531 -0.982 . . . . 0.0 108.373 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -139.37 172.99 5.6 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.745 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -73.26 85.29 1.25 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.034 1.823 . . . . 0.0 109.975 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.57 20.16 2.19 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 59.1 t60 -55.0 139.61 40.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -1.233 . . . . 0.0 109.381 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 38' ' ' HIS . . . -43.68 162.15 0.19 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.322 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.481 ' HA ' HG13 ' A' ' 71' ' ' VAL . 34.2 Cg_endo -76.85 75.68 4.41 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.501 2.134 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.15 140.35 30.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.05 107.55 4.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 109.236 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 44' ' ' ALA . 11.8 t -175.25 -139.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.483 ' N ' ' CG2' ' A' ' 43' ' ' THR . . . -99.67 179.2 4.61 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.883 -1.136 . . . . 0.0 109.403 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 1.3 tp -111.84 118.82 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.464 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.78 144.83 44.34 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.8 Cg_endo -78.5 172.7 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.661 2.241 . . . . 0.0 110.436 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.47 -153.98 19.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.515 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 4.7 ppp? -102.83 -178.93 3.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -1.124 . . . . 0.0 109.289 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 51' ' ' ARG . 3.9 mt -154.33 165.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.128 -0.982 . . . . 0.0 110.235 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.538 ' N ' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -152.85 151.03 29.94 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.357 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.58 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 21.5 mt -153.39 163.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.745 -1.222 . . . . 0.0 110.769 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 59' ' ' GLU . 67.3 t -139.84 109.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' HIS . 14.8 tttm -64.86 119.8 11.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.634 -0.666 . . . . 0.0 109.537 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.58 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 52.0 tt0 42.75 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.75 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.58 ' CD2' ' HG2' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -154.87 56.49 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 -179.941 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -130.44 -98.25 0.81 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 176.92 4.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -1.092 . . . . 0.0 109.372 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.3 pt-20 -121.95 146.02 47.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 147.54 34.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.561 ' CZ ' ' HB ' ' A' ' 134' ' ' THR . 8.9 m-85 -102.85 155.58 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.671 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' A' ' 52' ' ' ILE . 65.5 mt -153.47 145.84 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.598 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.536 ' CD2' ' HB ' ' A' ' 84' ' ' ILE . 4.0 t80 -147.47 133.08 18.79 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -167.79 168.17 12.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 110.107 -179.58 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.461 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 1.4 m -150.19 92.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.379 -0.826 . . . . 0.0 109.296 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.94 105.09 1.77 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . -177.2 -178.48 46.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.501 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 4.1 mm -118.79 135.71 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -1.176 . . . . 0.0 109.414 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.531 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 1.5 tt -112.89 152.27 29.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -0.899 . . . . 0.0 109.578 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.411 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.0 tt0 -161.12 133.16 5.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 40' ' ' PRO . 13.5 p -99.89 140.64 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.579 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.3 mt-30 -120.6 -178.77 0.62 Allowed Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -79.63 82.58 2.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.4 2.067 . . . . 0.0 111.005 -179.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.47 -9.62 64.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.464 ' HB2' ' OE1' ' A' ' 72' ' ' GLN . 10.0 m-20 -131.85 160.89 34.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -1.217 . . . . 0.0 109.695 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.426 HG23 HG22 ' A' ' 34' ' ' ILE . 12.5 t -137.64 152.3 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -151.04 162.63 40.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -179.34 139.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.426 -0.796 . . . . 0.0 109.103 179.857 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 79' ' ' LEU . 6.0 mp -106.23 174.05 6.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -164.21 165.49 21.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.265 -0.897 . . . . 0.0 109.589 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -108.27 -45.42 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.313 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.4 110.49 5.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 109.689 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.536 ' HB ' ' CD2' ' A' ' 63' ' ' TYR . 3.3 mt -137.75 73.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.057 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.423 ' HB3' ' HE3' ' A' ' 15' ' ' MET . 8.9 ptp180 -43.93 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.532 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -44.06 -58.01 4.56 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -47.91 -87.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -1.196 . . . . 0.0 109.329 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 18.8 t70 68.26 19.0 9.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 0.2 OUTLIER 71.97 34.26 1.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.627 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.76 161.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -138.45 -65.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.631 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.67 -12.22 51.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 109.719 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.17 9.05 13.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.626 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.28 19.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.335 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.17 -18.02 63.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.827 . . . . 0.0 109.519 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -77.93 -18.67 55.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.34 62.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.629 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -79.81 -22.77 42.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.22 -48.48 20.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.733 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -30.32 67.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.152 -0.967 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.22 26.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.65 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' LYS . 3.0 tt0 -80.3 -38.26 31.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.17 -32.0 70.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.138 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -27.87 67.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.314 -0.866 . . . . 0.0 109.296 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.6 mt -88.97 21.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 109.647 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 107' ' ' SER . 19.3 p -57.35 -63.51 1.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.4 OUTLIER 168.01 94.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 -153.51 0.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.97 166.53 13.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.85 152.59 8.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.49 -56.47 3.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -1.112 . . . . 0.0 109.37 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.34 23.0 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 37.4 t0 -75.73 -95.79 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.206 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -71.19 -20.58 62.26 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.45 75.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -70.77 -34.12 71.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.93 -22.88 67.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.0 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.2 t -53.59 -40.76 65.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.374 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . -73.65 -38.79 64.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.02 -20.36 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.422 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.45 ' O ' HG12 ' A' ' 125' ' ' ILE . 7.2 tp -78.08 -65.34 0.99 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.446 ' HA ' HG12 ' A' ' 125' ' ' ILE . . . -49.39 -29.69 6.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 119' ' ' ALA . 2.3 mptt -65.88 -43.69 87.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.87 -20.98 64.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 121' ' ' LEU . 10.5 mm -70.2 -14.02 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.43 -18.73 47.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.433 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.455 ' O ' HG22 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.537 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.9 OUTLIER -74.72 -13.05 60.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.602 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -84.45 -39.75 18.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 49' ' ' MET . 2.7 m -70.58 -22.25 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 127' ' ' GLN . 23.4 pt -87.55 -32.61 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HG2' HG13 ' A' ' 131' ' ' ILE . 18.8 mm-40 -83.1 -17.84 41.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.475 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -85.33 -46.78 10.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.962 . . . . 0.0 109.499 179.867 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.561 ' HB ' ' CZ ' ' A' ' 61' ' ' PHE . 11.1 t -75.16 -13.18 60.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.406 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.48 -27.38 1.72 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.398 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -82.76 -38.03 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.823 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.68 -71.85 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.668 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.432 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.23 0.538 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.468 ' O ' HG21 ' A' ' 3' ' ' THR . 13.6 mtp -84.94 93.76 8.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.528 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.468 HG21 ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -177.77 143.38 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.977 . . . . 0.0 109.684 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.639 ' CE2' ' CG2' ' A' ' 34' ' ' ILE . 1.8 p90 -137.7 -145.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.713 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.556 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 35.6 t-80 -131.37 140.46 49.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.926 -1.109 . . . . 0.0 110.493 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.616 ' CB ' ' CD2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -109.96 127.65 54.9 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.327 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' N ' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -135.73 63.64 1.59 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.956 -1.09 . . . . 0.0 109.307 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.483 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 1.9 p -99.64 131.04 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.211 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.7 144.68 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.451 ' HB3' ' HB1' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -153.05 -157.42 0.79 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 109.222 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 12' ' ' GLU . . . -43.51 122.85 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 108.985 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.5 mt-10 76.35 78.98 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.818 . . . . 0.0 108.989 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 12' ' ' GLU . 23.3 tm0? -41.47 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 172.64 47.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.772 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -93.7 -93.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.967 . . . . 0.0 109.346 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.616 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.1 t80 -134.04 111.44 10.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.034 . . . . 0.0 109.959 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.412 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 51.4 p -136.3 71.87 1.43 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.901 . . . . 0.0 109.38 178.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . -169.39 167.97 40.91 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 18' ' ' GLY . 18.8 mt -46.18 167.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.409 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.573 ' HB ' ' CZ ' ' A' ' 16' ' ' PHE . 0.2 OUTLIER -167.64 168.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.967 . . . . 0.0 109.549 -179.318 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.5 tt0 -120.17 -37.35 3.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 52' ' ' ILE . 41.6 tttp -167.92 124.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.929 -1.107 . . . . 0.0 110.721 179.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.553 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 19.5 pt -99.09 -159.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 1.2 tt0 -177.04 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.865 -1.147 . . . . 0.0 109.789 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.459 HG11 HG13 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -99.34 99.78 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 109.588 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.445 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 5.8 t -100.14 129.49 46.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.868 . . . . 0.0 109.329 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.28 -90.34 0.51 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 p -134.45 -43.5 0.77 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -1.177 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -101.72 -78.0 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.555 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.81 114.43 6.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 25.25 11.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.446 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.6 mt -122.15 157.65 31.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.502 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -99.83 -109.51 3.06 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.639 ' CG2' ' CE2' ' A' ' 4' ' ' TYR . 22.8 mm -153.82 155.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 109.319 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -150.66 175.19 2.97 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.334 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.7 Cg_endo -74.05 82.28 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.12 1.88 . . . . 0.0 110.057 179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.37 26.78 2.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.1 t-160 -55.21 -89.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -1.097 . . . . 0.0 109.553 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.475 ' N ' ' CG ' ' A' ' 38' ' ' HIS . . . -172.5 168.98 2.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.478 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 36.2 Cg_endo -78.43 70.02 7.42 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.671 2.248 . . . . 0.0 110.703 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 2.9 mm? -84.58 142.06 30.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.188 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mt -151.85 49.38 0.8 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.086 -1.008 . . . . 0.0 109.558 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -126.51 -152.51 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.46 179.72 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.513 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 1.2 mt -128.55 168.7 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 167.67 8.92 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.533 ' CA ' ' O ' ' A' ' 65' ' ' SER . 35.6 Cg_endo -78.01 135.56 14.04 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.661 2.241 . . . . 0.0 110.381 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 177.31 -158.36 23.8 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.8 ptm -100.43 173.97 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.087 . . . . 0.0 109.102 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 24' ' ' GLN . 2.4 tt -148.41 103.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -99.3 147.26 25.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.535 HG22 ' CG2' ' A' ' 23' ' ' ILE . 12.6 mt -149.48 167.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.021 -1.05 . . . . 0.0 110.868 -178.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.5 t -137.85 106.46 3.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -70.27 127.53 33.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.562 -179.387 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER 45.51 -158.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.68 82.79 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 142.75 146.09 4.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 22.1 t-80 75.2 162.09 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -170.34 132.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 0.0 109.32 179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.22 138.17 51.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.246 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 12.1 p90 -123.19 129.1 50.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.093 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 62' ' ' ILE . 0.9 OUTLIER -112.64 -146.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.35 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.611 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 1.3 t80 -169.98 141.98 2.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.018 . . . . 0.0 109.133 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 pp -142.41 -175.98 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.533 ' O ' ' CA ' ' A' ' 47' ' ' PRO . 23.1 t -117.32 -46.54 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.34 -143.93 3.79 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' LEU . . . 116.92 174.55 17.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.06 129.34 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.116 . . . . 0.0 109.472 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.527 HD21 ' CG1' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -100.56 118.23 36.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.47 -179.898 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.515 ' N ' HD23 ' A' ' 69' ' ' LEU . 15.0 tt0 -122.93 141.48 51.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.128 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG21 ' N ' ' A' ' 72' ' ' GLN . 12.2 p -101.53 150.69 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.733 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 4.1 mt-30 -137.23 173.83 5.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.58 110.12 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.456 2.104 . . . . 0.0 110.669 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 69.15 37.73 82.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.556 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.5 p30 165.37 162.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.265 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HA ' ' HG3' ' A' ' 72' ' ' GLN . 32.8 m -142.34 163.32 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.53 -0.731 . . . . 0.0 109.099 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 40.7 m -160.2 132.81 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 109.742 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 69' ' ' LEU . 3.0 m -127.52 153.79 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 109.339 179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' CA ' ' A' ' 67' ' ' GLY . 1.2 mp -111.97 121.61 45.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.016 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 10' ' ' SER . . . -133.72 168.41 18.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.178 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.13 -17.7 5.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 110.133 -179.737 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.458 HG21 ' N ' ' A' ' 83' ' ' ALA . 17.2 m -113.22 142.74 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.807 -179.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.503 ' N ' ' HB1' ' A' ' 11' ' ' ALA . . . -150.47 132.99 15.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.068 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.611 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 57.6 mt -115.29 -40.46 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' GLY . 7.8 ttp180 69.77 133.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -41.58 -40.8 3.0 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.823 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 18.3 mt-30 -73.41 -61.94 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -1.216 . . . . 0.0 109.393 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 87' ' ' GLN . 27.4 t70 62.69 12.83 5.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.785 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 tp 57.56 38.53 27.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 177.5 159.23 0.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.517 ' CG ' HD12 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -153.19 -50.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.064 -1.022 . . . . 0.0 109.855 -179.686 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.44 72.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -79.07 -17.49 55.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 109.847 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.409 ' HB3' ' OE1' ' A' ' 127' ' ' GLN . . . -90.51 -12.0 38.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.296 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -78.02 -24.12 47.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.55 -15.03 58.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.9 87.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.92 -37.19 13.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 109.724 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -50.89 15.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.965 . . . . 0.0 109.691 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -17.75 14.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 121' ' ' LEU . . . -89.52 -32.25 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.975 . . . . 0.0 109.643 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.445 ' O ' ' CG2' ' A' ' 105' ' ' ILE . 35.4 tp10 -73.99 -27.07 60.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -35.08 67.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 2.47 39.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.466 HD13 ' CB ' ' A' ' 117' ' ' ALA . 1.7 tp -69.52 -19.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 p -89.71 -29.39 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.672 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -60.58 92.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.427 ' HB3' ' HA ' ' A' ' 113' ' ' ASP . 10.9 m -162.59 -148.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.399 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -140.66 -150.16 0.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.973 . . . . 0.0 109.678 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -77.22 0.35 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 112' ' ' VAL . 2.0 m-20 -80.51 177.0 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -1.161 . . . . 0.0 109.726 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.37 33.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.64 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.427 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 51.1 t0 -83.89 -96.78 0.06 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.059 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.62 -18.25 65.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.36 87.68 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.357 0.599 . . . . 0.0 109.394 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 22.0 mt-30 -88.41 -16.99 31.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.466 ' CB ' HD13 ' A' ' 105' ' ' ILE . . . -72.96 -27.14 61.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.2 t -60.22 -16.6 34.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -81.69 -61.11 2.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.75 -9.02 48.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.642 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.453 HD12 HD11 ' A' ' 105' ' ' ILE . 11.8 tp -89.12 -60.71 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -78.26 5.65 9.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.036 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 119' ' ' ALA . 4.1 tttt -73.28 -45.79 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.59 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.08 -6.75 41.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 122' ' ' ALA . 2.0 mp -84.73 -14.48 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 63' ' ' TYR . . . -67.15 -32.46 73.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.432 ' HG3' ' N ' ' A' ' 128' ' ' LEU . 10.8 pt20 -82.5 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.1 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.451 ' HA ' HG23 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -74.67 -13.31 60.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.374 179.919 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -89.65 -53.74 4.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.597 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 34.4 m -67.77 -27.91 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.72 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.517 HD12 ' CG ' ' A' ' 91' ' ' GLU . 3.8 tt -65.11 -38.35 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' N ' ' CG2' ' A' ' 131' ' ' ILE . 4.8 mm-40 -67.23 -8.3 30.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -86.26 -44.22 12.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.843 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.465 ' HA ' ' HB1' ' A' ' 137' ' ' ALA . 13.8 t -82.33 -9.55 59.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -55.3 -45.68 76.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 137' ' ' ALA . 1.3 ptmt -85.75 -16.61 38.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.689 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 134' ' ' THR . . . -43.78 -39.49 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 mtp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.505 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 1.6 t -152.75 158.45 42.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.743 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.729 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.2 p90 -159.58 175.09 13.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 2.3 t-160 -99.41 124.79 44.85 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 108.742 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.061 HD23 HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -114.7 159.91 19.98 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.709 178.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.923 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.26 90.17 1.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.993 -1.067 . . . . 0.0 110.204 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 16' ' ' PHE . 1.8 p -100.13 132.15 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.077 -1.014 . . . . 0.0 109.25 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 m -152.76 171.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.62 ' OG ' ' HB3' ' A' ' 80' ' ' ALA . 3.1 m -141.18 72.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 61.82 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 55.22 58.23 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.556 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -147.45 154.24 40.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.79 76.91 1.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.699 ' HB3' HD13 ' A' ' 62' ' ' ILE . 5.7 mmt -79.72 -63.65 1.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 109.888 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.688 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 18.6 t80 -135.24 121.86 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.445 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -152.84 103.17 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.316 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 158.91 -164.21 33.59 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.436 ' C ' HG12 ' A' ' 20' ' ' VAL . 9.1 mt -56.6 155.88 6.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.057 -1.261 . . . . 0.0 108.709 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.061 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -168.44 116.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.021 -1.049 . . . . 0.0 109.99 -177.522 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 2.6 mt-10 -66.5 -47.53 72.71 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 108.761 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 17.6 tttt -172.95 144.44 1.28 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.124 -0.985 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.667 ' CG2' HD22 ' A' ' 6' ' ' LEU . 44.3 pt -98.26 -145.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.658 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.12 127.27 0.36 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 109.481 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.685 HG23 ' HA2' ' A' ' 33' ' ' GLY . 12.0 t -116.53 133.27 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 31.0 m -129.09 91.84 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.42 168.22 21.07 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.6 -50.98 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 109.488 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.28 99.51 7.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.386 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.99 140.95 4.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -152.13 26.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.77 150.97 41.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.067 -1.021 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.685 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.54 -114.92 3.63 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.729 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 17.9 mm -149.58 152.64 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.098 -1.237 . . . . 0.0 109.327 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.57 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -151.58 171.82 6.11 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.083 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.4 Cg_endo -73.23 78.24 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.028 1.819 . . . . 0.0 110.2 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.32 36.1 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CE1' HD12 ' A' ' 41' ' ' LEU . 11.4 t-160 -87.11 28.99 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -1.224 . . . . 0.0 109.831 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 71' ' ' VAL . . . 58.99 158.32 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.065 -1.022 . . . . 0.0 109.554 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.8 78.7 3.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.777 2.318 . . . . 0.0 110.682 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.598 HD12 ' CE1' ' A' ' 38' ' ' HIS . 25.3 mt -100.35 173.43 6.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -171.16 57.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.4 p -114.62 -136.9 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.25 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -104.39 164.21 11.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.928 -1.107 . . . . 0.0 109.324 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.0 mt -109.1 9.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.791 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER 55.54 158.33 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.672 . . . . 0.0 110.176 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.69 -175.66 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.733 2.289 . . . . 0.0 110.287 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 116.06 -161.05 13.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.472 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 15.9 ptm -102.91 179.57 4.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 109.248 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.866 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.4 OUTLIER -150.85 138.87 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.032 -1.043 . . . . 0.0 110.646 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG2' ' N ' ' A' ' 52' ' ' ILE . 66.3 ttt180 -119.67 161.32 20.89 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 53' ' ' VAL . 36.1 mt -157.23 167.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.72 -1.238 . . . . 0.0 110.876 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.592 ' N ' HG22 ' A' ' 52' ' ' ILE . 24.5 t -142.64 107.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB3' ' HA3' ' A' ' 57' ' ' GLY . 15.6 tttm -68.67 149.89 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 110.326 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.405 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 2.2 tt0 -54.27 -52.58 60.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 8.69 33.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 54' ' ' LYS . . . -108.38 178.01 21.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -84.82 -77.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.586 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' HIS . 17.0 pt-20 -179.59 139.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 109.84 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -138.21 156.8 47.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 1.068 ' CE2' HD11 ' A' ' 133' ' ' LEU . 6.1 p90 -128.65 125.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.883 HG23 ' HG3' ' A' ' 85' ' ' ARG . 1.0 OUTLIER -100.46 -146.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.228 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.788 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -175.51 132.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.034 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HG ' ' C ' ' A' ' 63' ' ' TYR . 1.1 mt -139.07 -171.82 3.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -139.79 -64.78 0.48 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.79 136.54 8.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.34 165.62 33.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 79' ' ' LEU . 1.1 pp -101.65 -176.24 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -1.197 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.568 ' HB2' HG12 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -148.62 169.38 20.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 110.364 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.72 111.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 6.2 p -99.53 144.6 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.441 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.554 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.48 178.34 1.04 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 36.3 Cg_endo -79.05 81.55 2.77 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.501 2.134 . . . . 0.0 110.922 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.15 -21.72 5.46 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 4.3 p30 -159.39 135.71 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.239 . . . . 0.0 109.864 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 77' ' ' THR . 9.6 p -99.18 168.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 109.271 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 76' ' ' VAL . 99.3 m -164.12 137.67 5.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.257 -0.902 . . . . 0.0 109.063 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' ' 69' ' ' LEU . 4.6 m -140.83 165.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.57 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.51 ' HB2' HD11 ' A' ' 68' ' ' ILE . 1.5 mt -131.6 149.49 52.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.866 . . . . 0.0 109.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB3' ' OG ' ' A' ' 10' ' ' SER . . . -148.25 176.68 10.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 109.52 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.94 -56.58 2.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.5 m -105.08 123.13 47.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.508 ' O ' ' HE2' ' A' ' 15' ' ' MET . . . -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.788 HD12 ' CE1' ' A' ' 63' ' ' TYR . 13.7 mt -101.61 150.7 5.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.213 -0.93 . . . . 0.0 109.461 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.883 ' HG3' HG23 ' A' ' 62' ' ' ILE . 8.3 ttm180 -119.74 155.85 31.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.479 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 87' ' ' GLN . . . -44.45 93.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 2.4 mt-30 162.32 -72.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.083 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.542 ' OD2' ' NE2' ' A' ' 127' ' ' GLN . 1.3 p30 40.71 50.63 2.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASP . 86.0 mt 43.17 -93.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 88' ' ' ASP . 8.0 p-10 -49.48 159.64 0.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 109.329 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HA ' HD11 ' A' ' 131' ' ' ILE . 27.6 mt-10 -141.26 -56.68 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.65 -14.34 54.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -76.58 -10.56 59.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.01 -21.71 23.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.961 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.4 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.39 -27.67 68.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.44 -0.787 . . . . 0.0 109.376 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.72 -15.2 61.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . . . -68.04 -45.66 73.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -61.2 -17.03 51.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -89.9 -40.17 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -75.73 -12.25 60.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.942 . . . . 0.0 109.292 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.89 -15.36 39.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.132 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -46.67 67.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.365 -0.834 . . . . 0.0 109.407 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -49.51 -23.26 1.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 114' ' ' TYR . 54.1 m80 -86.7 -36.89 18.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 105' ' ' ILE . 17.5 mt -79.04 -6.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 p -101.06 -16.54 17.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.523 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.36 130.73 37.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.711 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.09 131.47 51.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 21.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.779 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.98 -176.63 33.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.968 ' OD1' HG13 ' A' ' 112' ' ' VAL . 1.3 p30 -81.12 -29.37 34.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.144 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.968 HG13 ' OD1' ' A' ' 111' ' ' ASP . 4.3 m -119.37 22.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.81 -99.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -0.817 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.485 ' HB2' ' HA ' ' A' ' 105' ' ' ILE . 17.6 p90 -65.3 -18.9 65.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.021 -1.049 . . . . 0.0 108.214 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -58.89 -39.08 80.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -77.15 -17.5 58.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.341 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.27 -17.85 53.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.2 t -62.01 -28.81 69.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -75.87 -27.89 57.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -85.52 -8.22 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.923 . . . . 0.0 109.494 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -90.41 -57.93 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -22.29 65.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -87.07 -19.53 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.85 -34.61 33.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.478 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 125' ' ' ILE . 2.8 mp -75.89 -6.09 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.378 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.46 76.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.595 ' HG2' ' CG ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -81.39 -14.29 57.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.535 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 34.6 tp -78.73 -25.02 44.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.0 109.69 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -45.71 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.939 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.652 ' HA ' HD23 ' A' ' 133' ' ' LEU . 35.7 m -70.41 -32.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.885 ' O ' HG22 ' A' ' 134' ' ' THR . 2.2 tt -78.24 -25.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.094 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 128' ' ' LEU . 1.4 mm-40 -74.66 -22.13 59.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.104 -0.997 . . . . 0.0 110.243 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 1.068 HD11 ' CE2' ' A' ' 61' ' ' PHE . 1.4 pp -90.54 0.45 57.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.995 -1.066 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.885 HG22 ' O ' ' A' ' 131' ' ' ILE . 7.5 t -89.07 4.6 47.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.665 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -71.46 -30.08 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.597 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 11.56 23.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.16 -47.27 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.452 -179.874 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 ttp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.326 0.584 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.548 HG22 ' CG ' ' A' ' 21' ' ' GLU . 65.9 p -50.94 164.74 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 109.604 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.674 ' CE2' HG22 ' A' ' 34' ' ' ILE . 1.3 p90 -142.22 -144.86 0.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.714 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.743 ' O ' HG12 ' A' ' 76' ' ' VAL . 12.7 t-80 -129.62 126.71 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.79 -1.194 . . . . 0.0 111.221 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.025 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -99.75 130.9 46.01 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -139.49 75.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 109.746 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.4 p -104.01 111.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.668 HG12 ' HA ' ' A' ' 14' ' ' GLN . 2.7 m -116.57 -178.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.493 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -158.01 111.95 2.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.762 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.71 -89.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.735 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -134.71 62.23 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.66 142.64 12.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.478 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.668 ' HA ' HG12 ' A' ' 9' ' ' VAL . 6.1 pt20 -106.55 107.68 18.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.552 ' HE2' ' HG2' ' A' ' 85' ' ' ARG . 6.6 mtt -79.66 -60.68 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.641 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -130.84 111.07 11.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.923 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.5 p -136.97 92.19 2.7 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.69 -161.27 32.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 19' ' ' LEU . 36.2 mt -76.82 159.13 30.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.035 -1.274 . . . . 0.0 109.799 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.15 162.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.227 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' CG ' HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -122.29 -37.52 2.8 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.9 ttpp -160.77 110.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.98 . . . . 0.0 110.661 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.025 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.2 152.11 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.8 ' O ' HG23 ' A' ' 50' ' ' ILE . 1.9 tt0 -134.45 145.32 48.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.075 . . . . 0.0 109.964 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.875 HG23 ' HA2' ' A' ' 33' ' ' GLY . 3.1 t -131.95 125.46 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.434 -0.791 . . . . 0.0 108.96 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 88.8 m -116.06 97.86 6.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.353 -0.842 . . . . 0.0 109.395 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -103.24 -100.02 2.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 m -128.83 -81.0 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.53 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.78 166.29 3.7 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -156.54 32.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.242 -1.152 . . . . 0.0 109.597 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -102.7 150.08 23.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.529 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.875 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.45 -112.42 3.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.691 HG21 HG11 ' A' ' 76' ' ' VAL . 19.5 mm -154.32 147.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -1.141 . . . . 0.0 109.537 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -157.13 -172.77 0.34 Allowed Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 36.3 Cg_endo -81.11 31.15 0.51 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.0 1.8 . . . . 0.0 110.71 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.07 26.48 0.2 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.72 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 57.1 t60 -70.12 -4.85 23.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -1.084 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 77.05 168.24 0.12 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.1 Cg_endo -78.1 74.19 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.626 2.218 . . . . 0.0 110.524 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.52 142.65 27.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.307 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' HG ' ' C ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -139.84 32.54 2.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.608 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.3 t -100.67 -156.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.178 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.608 ' N ' HG23 ' A' ' 43' ' ' THR . . . -108.01 -177.35 3.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.032 -1.042 . . . . 0.0 109.663 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.851 HD11 ' N ' ' A' ' 69' ' ' LEU . 1.3 mp -126.48 177.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.68 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -108.08 167.13 9.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.394 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.504 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 35.4 Cg_endo -78.16 140.75 17.95 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.619 2.213 . . . . 0.0 110.516 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 168.43 -162.79 36.58 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.487 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.1 ptm -100.66 -170.65 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 109.211 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.8 HG23 ' O ' ' A' ' 24' ' ' GLN . 19.1 mt -158.09 140.63 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.987 . . . . 0.0 110.296 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.49 119.19 22.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.713 HG23 ' CA ' ' A' ' 23' ' ' ILE . 18.8 mt -123.46 170.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.116 . . . . 0.0 110.965 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.704 HG22 ' HG3' ' A' ' 59' ' ' GLU . 28.6 t -134.57 101.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -61.17 119.9 9.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 0.0 109.633 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' LYS . 31.1 mt-30 43.22 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -152.19 66.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 109.558 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.38 -128.01 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -69.28 -165.74 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.704 ' HG3' HG22 ' A' ' 53' ' ' VAL . 51.3 mp0 -129.95 -178.94 4.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 59.8 mm-40 -129.51 137.29 50.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.593 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -111.69 98.41 7.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 108.834 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 63' ' ' TYR . 4.0 mt -111.04 161.57 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 109.998 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.698 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.2 t80 -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -165.83 -171.09 1.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.829 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.47 ' CB ' ' HB3' ' A' ' 47' ' ' PRO . 3.1 t -160.48 139.76 10.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.782 . . . . 0.0 109.27 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' SER . . . 63.08 125.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.98 159.81 11.23 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 15.0 mt -106.65 123.7 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.076 HD22 ' N ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -101.61 127.88 48.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 1.076 ' N ' HD22 ' A' ' 69' ' ' LEU . 4.0 pt-20 -131.08 146.11 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 39' ' ' ALA . 12.1 p -102.27 163.92 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.052 -1.03 . . . . 0.0 109.928 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.521 ' N ' HG22 ' A' ' 71' ' ' VAL . 1.6 mt-30 -141.32 172.58 5.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 0.0 109.338 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.5 79.91 3.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.577 2.185 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.68 -12.55 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.513 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 4.8 p30 -149.28 172.4 14.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -1.181 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 5' ' ' HIS . 2.8 p -145.66 151.45 14.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 68.3 p -136.58 172.92 12.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -178.97 127.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 109.151 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -104.91 134.66 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.885 . . . . 0.0 109.265 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 64' ' ' LEU . . . -129.6 -179.91 5.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.0 109.625 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.55 -29.17 5.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.343 -0.848 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 51.9 m -103.12 119.97 39.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.72 98.73 3.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 63' ' ' TYR . 96.3 mt -109.71 -27.87 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.56 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.552 ' HG2' ' HE2' ' A' ' 15' ' ' MET . 22.1 mtm180 61.32 126.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.527 ' CA ' HG21 ' A' ' 130' ' ' VAL . . . -44.3 -29.7 1.76 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 88' ' ' ASP . 67.3 mt-30 -71.25 -64.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -1.122 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASP . 14.0 t0 44.4 41.32 4.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.58 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 88' ' ' ASP . 2.1 t70 -115.75 99.87 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.768 ' HB3' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -96.39 0.06 50.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.51 -14.17 62.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.385 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -82.88 -2.79 55.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.39 -23.62 21.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 0.0 108.856 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.653 ' HG2' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -57.1 -29.44 63.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.45 -0.781 . . . . 0.0 109.235 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.13 -57.87 9.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.45 69.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.877 ' HG3' HD11 ' A' ' 125' ' ' ILE . 25.2 tttt -55.16 -41.08 71.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -60.68 -51.83 67.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -76.58 -0.36 22.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.701 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -85.64 -30.7 23.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.127 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 4.7 tp10 -80.55 -26.03 38.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -82.15 -13.61 56.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.97 -31.51 20.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.58 ' O ' HG22 ' A' ' 105' ' ' ILE . 37.3 mt -77.85 -1.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.317 -0.864 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.3 m -105.83 78.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.29 167.9 2.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.3 m 64.85 -152.22 0.28 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 108' ' ' SER . 12.0 t-80 174.34 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.257 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.94 169.61 40.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.85 -59.42 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.2 16.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.96 -96.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.502 ' C ' ' CD1' ' A' ' 114' ' ' TYR . 13.7 p90 -74.14 -15.77 61.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 108.53 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.11 -19.83 65.69 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.62 -14.71 62.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.491 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.0 -6.67 57.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.502 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.26 -16.61 42.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.95 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -5.03 55.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.629 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.72 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.25 -52.28 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.35 94.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.542 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -61.08 -32.46 72.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.887 . . . . 0.0 109.633 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.24 -8.58 50.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 109.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.877 HD11 ' HG3' ' A' ' 98' ' ' LYS . 1.3 tp -88.89 5.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 109.354 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.35 -13.27 55.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.804 ' O ' HG23 ' A' ' 131' ' ' ILE . 24.2 pt20 -89.69 -13.39 37.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 95' ' ' MET . 0.2 OUTLIER -89.63 -29.5 18.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -73.13 -19.73 61.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 10.2 m -90.12 -27.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.727 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 127' ' ' GLN . 22.1 pt -75.57 -16.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.35 -47.74 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -61.59 -45.17 95.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.568 HG23 ' CD2' ' A' ' 61' ' ' PHE . 12.3 p -49.17 -26.54 2.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -57.81 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -110.07 50.42 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 133' ' ' LEU . . . -123.23 -48.66 1.96 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.371 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.393 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.473 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -174.01 156.16 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.775 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.628 ' HE1' HD11 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -143.55 -142.28 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.205 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.815 ' O ' HG12 ' A' ' 76' ' ' VAL . 17.5 t-80 -134.73 131.23 37.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.852 -1.155 . . . . 0.0 110.993 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.906 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -99.11 131.84 44.85 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.171 -0.956 . . . . 0.0 108.714 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.956 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -142.42 75.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.85 -1.156 . . . . 0.0 109.68 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.854 HG13 ' HB2' ' A' ' 15' ' ' MET . 1.4 p -105.11 117.14 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.34 164.24 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -128.8 -159.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.363 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.93 -74.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 109.388 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -136.95 53.69 1.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.77 109.92 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -65.2 154.64 37.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.302 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.854 ' HB2' HG13 ' A' ' 8' ' ' VAL . 3.8 mmt -118.84 -58.64 1.94 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.753 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.646 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.56 111.2 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.957 . . . . 0.0 109.677 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 95.0 p -131.93 78.02 1.79 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 20' ' ' VAL . . . -174.7 167.08 39.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' C ' HG12 ' A' ' 20' ' ' VAL . 54.4 mt -50.73 166.67 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.205 -1.174 . . . . 0.0 109.278 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.906 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -167.09 169.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -144.94 -63.63 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 109.517 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -90.43 103.45 16.13 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 0.0 108.657 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.881 ' HA ' HG23 ' A' ' 52' ' ' ILE . 3.1 mp -115.48 156.46 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.0 109.142 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -151.76 131.38 13.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.117 . . . . 0.0 109.741 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.552 HG13 ' HB ' ' A' ' 50' ' ' ILE . 1.1 t -145.57 127.15 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.332 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -148.34 127.73 13.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -137.49 -92.46 0.29 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -138.3 -40.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.0 109.445 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.05 -91.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.87 -172.5 5.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 32' ' ' LEU . 2.2 mt-10 -164.58 41.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.134 -1.215 . . . . 0.0 109.777 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -136.95 165.2 26.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.879 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.84 174.39 26.62 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 27.0 mm -99.21 160.96 3.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.636 -1.508 . . . . 0.0 109.515 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.648 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -162.59 171.21 6.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.4 Cg_endo -70.13 83.96 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.37 1.38 . . . . 0.0 109.618 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.34 14.36 0.83 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.991 ' NE2' HD23 ' A' ' 41' ' ' LEU . 43.1 t60 -53.88 157.85 2.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.84 -1.388 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.875 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -58.46 173.87 0.39 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.332 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.875 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.83 63.6 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.614 2.209 . . . . 0.0 110.602 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.991 HD23 ' NE2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -59.42 160.61 6.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.882 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.524 ' O ' ' CA ' ' A' ' 70' ' ' GLU . 85.5 mt -115.97 -92.08 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.983 . . . . 0.0 110.649 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.633 ' O ' HG22 ' A' ' 68' ' ' ILE . 7.1 p -122.66 27.2 7.91 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 121.596 -0.69 . . . . 0.0 110.242 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 69' ' ' LEU . . . -113.64 119.35 37.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.868 -1.145 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 67' ' ' GLY . 5.2 tt -112.4 176.49 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.417 -0.802 . . . . 0.0 109.174 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -120.4 130.98 24.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.973 -1.08 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.457 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 36.4 Cg_endo -79.34 -164.51 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.547 2.165 . . . . 0.0 110.384 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 90.32 -133.77 11.98 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.546 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.1 ppp? -114.57 174.8 5.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -1.085 . . . . 0.0 109.41 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.957 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.4 OUTLIER -149.99 116.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.368 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -104.94 123.61 48.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.815 . . . . 0.0 108.959 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 23' ' ' ILE . 2.6 mt -129.98 -176.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.001 -1.062 . . . . 0.0 109.916 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.652 ' H ' HG22 ' A' ' 52' ' ' ILE . 6.8 t -158.14 109.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -57.57 114.01 2.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.578 -0.701 . . . . 0.0 110.398 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.499 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 40.59 61.93 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.771 . . . . 0.0 110.151 179.437 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.44 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 43.08 44.8 4.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.779 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.57 -122.29 2.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -52.05 146.98 7.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.306 -1.114 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.61 123.04 47.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.099 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -128.04 121.16 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.339 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.595 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.0 p90 -113.28 147.83 36.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.222 -0.923 . . . . 0.0 109.908 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.957 ' H ' HG23 ' A' ' 50' ' ' ILE . 1.7 mt -120.07 -158.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.424 -0.797 . . . . 0.0 109.139 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.661 ' CE1' HD12 ' A' ' 84' ' ' ILE . 7.6 t80 -172.44 133.32 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.458 HD22 ' HB2' ' A' ' 80' ' ' ALA . 2.1 mp -140.43 -174.54 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -128.12 5.16 5.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.49 160.04 8.32 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.862 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 162.16 -175.5 38.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 43' ' ' THR . 1.4 pt -103.16 137.8 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -1.12 . . . . 0.0 109.258 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.798 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' CA ' ' O ' ' A' ' 42' ' ' LEU . 15.2 pt-20 -126.59 139.41 53.21 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 40' ' ' PRO . 9.2 p -100.51 142.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.472 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.4 mm100 -124.74 158.75 61.27 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 109.097 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -76.95 86.47 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.603 2.202 . . . . 0.0 110.477 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.64 2.28 10.61 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.541 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 175.7 175.68 0.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -1.178 . . . . 0.0 109.213 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 5' ' ' HIS . 2.3 p -150.63 148.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.167 -0.958 . . . . 0.0 109.132 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.956 HG22 ' HB3' ' A' ' 7' ' ' ASP . 7.5 p -140.86 142.86 34.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 109.573 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.763 ' HB ' HD12 ' A' ' 45' ' ' ILE . 3.0 m -148.36 138.28 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.634 ' C ' HD23 ' A' ' 79' ' ' LEU . 1.2 tt -114.49 135.74 53.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.458 ' HB2' HD22 ' A' ' 64' ' ' LEU . . . -122.2 179.42 4.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -115.39 -11.28 11.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 83' ' ' ALA . 9.3 m -127.53 161.4 28.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 82' ' ' THR . . . -167.57 122.32 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 63' ' ' TYR . 48.3 mt -117.37 -45.22 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.288 -0.882 . . . . 0.0 109.267 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.485 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 3.0 ttt180 74.6 147.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.436 -0.79 . . . . 0.0 109.646 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.674 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -58.12 -21.87 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ASP . 57.8 mt-30 -81.45 -63.67 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.469 ' HB3' ' CG2' ' A' ' 84' ' ' ILE . 2.8 p30 40.35 30.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.62 -0.675 . . . . 0.0 109.867 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ASP . 1.2 mp 50.48 -179.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 91' ' ' GLU . 4.9 m-20 43.96 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.901 ' HA ' HD11 ' A' ' 131' ' ' ILE . 1.3 mt-10 172.97 -30.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.488 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 -17.4 48.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.85 . . . . 0.0 109.561 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 4.5 29.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.673 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' O ' ' CD1' ' A' ' 128' ' ' LEU . . . -90.84 -30.35 17.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.423 ' HA ' HD11 ' A' ' 128' ' ' LEU . 4.8 mtt -73.32 -5.06 37.22 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.361 -0.837 . . . . 0.0 109.596 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.06 1.61 56.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.636 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -89.34 -42.51 11.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.653 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -19.55 63.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -89.89 -26.99 20.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 9.1 pttt -89.3 -11.3 43.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.621 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 105' ' ' ILE . . . -90.47 -58.49 2.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.613 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.53 63.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.715 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -52.83 -38.34 61.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 109.889 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -88.38 -26.33 22.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.603 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 121' ' ' LEU . 12.0 mt -88.24 22.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 109.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.2 m -54.99 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER 67.37 118.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.0 t -137.74 118.98 14.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 109' ' ' HIS . 52.2 t-80 -113.28 56.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 115' ' ' ALA . . . -138.48 125.7 3.25 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 68.8 m-20 -44.88 -80.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -1.201 . . . . 0.0 109.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.629 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 20.6 m -117.53 -10.0 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.414 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.5 OUTLIER -48.02 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.335 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -70.94 -14.88 62.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.043 -1.036 . . . . 0.0 108.26 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -66.26 -23.36 66.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.569 -0.707 . . . . 0.0 109.264 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.42 -54.17 13.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.327 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.9 -20.21 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.19 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -44.24 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.16 68.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.381 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.54 -20.7 64.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 125' ' ' ILE . 7.6 mt -90.0 -24.0 21.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -59.75 -16.77 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.586 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.3 96.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -70.66 -5.97 33.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -85.79 -13.16 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.149 -0.97 . . . . 0.0 109.289 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -87.36 -24.56 24.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.293 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -83.55 -15.48 49.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.414 -0.804 . . . . 0.0 109.489 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -80.19 -22.74 41.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.601 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 1.9 ttp180 -85.24 -35.31 21.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.785 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.674 HG23 ' HA2' ' A' ' 86' ' ' GLY . 18.3 m -76.34 -28.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.901 HD11 ' HA ' ' A' ' 91' ' ' GLU . 7.1 tt -76.9 -38.45 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 109.267 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.466 ' N ' HG23 ' A' ' 131' ' ' ILE . 7.4 mm-40 -56.96 -23.86 48.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.07 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 41.4 mt -76.4 -37.63 56.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.25 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 72.0 p -59.29 -16.75 23.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.775 . . . . 0.0 109.65 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -76.18 -44.08 39.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -14.12 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.36 -80.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.491 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -133.88 174.58 10.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.723 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.1 p90 -148.39 -136.03 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.4 OUTLIER -151.05 138.37 19.4 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.817 -1.177 . . . . 0.0 110.423 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -102.18 148.06 25.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 77' ' ' THR . 1.1 t0 -144.92 72.02 1.32 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.017 -1.052 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 15' ' ' MET . 2.9 p -106.81 138.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.352 -0.842 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.568 ' CG2' HD23 ' A' ' 79' ' ' LEU . 32.8 m -145.88 173.26 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.687 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 45.9 t -170.25 113.76 0.47 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.056 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 65.96 26.48 10.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.075 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.1 mm-40 63.46 24.09 13.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.517 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.424 ' OE1' ' SD ' ' A' ' 15' ' ' MET . 12.4 tt0 -78.07 -22.49 48.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.144 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 6.3 mt-30 63.46 100.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.759 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 16.7 mmm -101.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.685 ' HD2' HD23 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -135.67 111.66 9.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.623 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 17' ' ' SER . 27.6 p -135.32 77.69 1.69 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.47 179.98 48.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 5' ' ' HIS . 12.0 mt -60.26 161.91 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -1.193 . . . . 0.0 109.492 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -157.75 159.3 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.81 . . . . 0.0 108.829 -179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.1 -52.75 2.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -0.937 . . . . 0.0 110.138 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -141.02 108.12 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.769 -1.207 . . . . 0.0 111.28 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.853 HD12 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -103.13 155.91 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 2.0 tm0? -146.76 115.61 6.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.416 -1.427 . . . . 0.0 110.724 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.994 HG21 ' HG2' ' A' ' 46' ' ' LYS . 3.3 t -103.92 133.62 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.233 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 54.7 m -125.01 102.72 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.549 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -123.07 -110.06 1.98 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 t -132.37 -77.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -1.16 . . . . 0.0 109.63 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.81 -24.75 67.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.74 151.37 18.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -142.81 11.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -1.076 . . . . 0.0 109.315 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.4 mt -116.64 156.45 27.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.562 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -100.03 -114.59 3.65 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.723 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 15.9 mm -154.98 143.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -1.049 . . . . 0.0 109.245 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -154.35 -172.13 0.31 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -78.94 8.86 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.805 1.67 . . . . 0.0 110.423 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.91 11.42 3.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 84.6 t60 -53.26 156.22 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.629 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -70.08 173.22 4.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.668 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -77.75 76.05 4.48 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.758 2.305 . . . . 0.0 110.386 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -100.3 140.29 34.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.607 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -155.51 29.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 109.563 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.3 p -121.76 -139.54 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.219 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.79 119.97 38.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -160.74 -166.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.757 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.994 ' HG2' HG21 ' A' ' 25' ' ' VAL . 13.3 mttt 71.5 46.41 0.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.8 Cg_endo -80.32 152.67 20.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 94.01 -152.71 20.84 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.696 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.548 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 7.2 ptm -99.56 -171.67 2.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -1.024 . . . . 0.0 109.503 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.805 HG12 HG22 ' A' ' 25' ' ' VAL . 40.9 mt -150.0 156.18 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.718 HG23 ' CA ' ' A' ' 23' ' ' ILE . 4.6 mt -121.26 162.8 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 110.476 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 74.9 t -133.38 118.95 33.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 154.71 -98.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 56' ' ' HIS . 1.9 tt0 37.75 47.44 0.84 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.6 t-160 81.8 -68.89 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.606 -0.684 . . . . 0.0 109.494 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -161.54 77.94 0.17 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.458 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 168.19 -160.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.149 . . . . 0.0 109.489 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.19 158.42 43.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.288 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -147.23 115.96 6.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.683 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.698 ' CD2' HD22 ' A' ' 133' ' ' LEU . 14.1 p90 -103.24 140.55 37.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.58 -156.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.945 . . . . 0.0 109.566 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 127' ' ' GLN . 8.9 t80 -177.46 111.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.195 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mp -134.85 -179.91 5.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 109.336 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -71.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.82 62.83 0.63 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.37 -179.62 50.63 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 78' ' ' VAL . 10.0 mm -101.45 118.37 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.946 HD13 ' HB ' ' A' ' 78' ' ' VAL . 4.1 mm? -99.47 157.69 16.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.36 133.01 11.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 108.993 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.529 HG11 ' HA ' ' A' ' 40' ' ' PRO . 12.7 p -99.69 136.26 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.655 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.494 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -119.03 173.59 3.34 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.38 -0.825 . . . . 0.0 109.456 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.2 Cg_endo -78.23 73.3 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.621 2.214 . . . . 0.0 110.515 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.6 3.67 32.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -151.67 -175.3 5.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 75' ' ' ASN . 4.5 t -158.64 146.78 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.263 -0.898 . . . . 0.0 109.034 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.85 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -138.22 157.5 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.946 ' HB ' HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -168.46 135.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.568 HD23 ' CG2' ' A' ' 9' ' ' VAL . 1.2 mt -125.83 109.02 12.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.75 179.34 4.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.623 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -105.17 -42.76 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 84' ' ' ILE . 14.8 m -109.42 100.4 9.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.759 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -122.38 94.33 4.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.189 -0.945 . . . . 0.0 109.379 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.959 HG23 ' OD1' ' A' ' 88' ' ' ASP . 3.3 mp -100.1 84.54 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.518 ' N ' ' OD2' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -66.36 133.7 51.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.62 -121.58 11.0 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.406 ' CD ' ' OE1' ' A' ' 91' ' ' GLU . 11.6 pt20 -124.32 53.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -1.106 . . . . 0.0 109.565 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.959 ' OD1' HG23 ' A' ' 84' ' ' ILE . 1.6 p30 -63.09 -13.37 35.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 89' ' ' LEU . 14.4 mt -114.57 -90.89 0.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 m-20 -117.1 -179.9 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.606 ' HB2' HD11 ' A' ' 131' ' ' ILE . 4.9 pt-20 -145.77 -43.54 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.863 . . . . 0.0 109.215 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.27 -18.46 39.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -0.828 . . . . 0.0 109.462 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.3 3.62 51.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -13.43 34.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.196 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.446 ' HG2' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.34 -18.04 34.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.374 -0.829 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.8 -14.95 57.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' O ' HD11 ' A' ' 125' ' ' ILE . . . -81.51 -5.71 58.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG2' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -89.85 -24.23 21.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -89.21 -21.44 23.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 109.401 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.32 -31.93 29.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.796 ' HB2' HD22 ' A' ' 121' ' ' LEU . . . -90.36 -39.66 12.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.0 -11.64 59.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.331 -0.856 . . . . 0.0 109.535 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 99' ' ' ARG . 15.5 tt0 -90.28 -37.41 14.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.6 -30.63 46.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.628 HD13 ' OG ' ' A' ' 118' ' ' SER . 31.3 mt -89.18 4.3 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.649 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 107' ' ' SER . 1.3 t -45.65 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER 77.25 121.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.429 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.1 141.29 18.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -111.28 -173.4 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.49 117.6 0.75 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -48.97 -69.91 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 19.9 m -121.03 12.17 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 18.4 t0 -66.22 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -0.868 . . . . 0.0 109.211 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' A' ' 114' ' ' TYR . 32.1 t80 -75.72 -5.5 45.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.54 -7.91 59.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -78.31 -29.43 47.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.603 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -78.24 -6.39 54.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.096 -1.002 . . . . 0.0 109.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.628 ' OG ' HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -79.76 -8.8 59.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.577 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.73 -34.87 17.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 123' ' ' LYS . 8.7 pt-20 -75.3 -27.42 59.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.796 HD22 ' HB2' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -79.29 -41.86 27.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.433 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.499 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -76.74 -11.67 59.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.246 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.56 -32.7 65.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.95 -26.99 54.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.0 mp -81.84 2.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.91 . . . . 0.0 109.479 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.563 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . . . -74.58 -26.68 60.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.621 ' NE2' ' CE2' ' A' ' 63' ' ' TYR . 40.5 mt-30 -74.56 -5.11 40.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 128' ' ' LEU . 6.7 tt -79.78 -19.19 49.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -90.06 -49.5 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.625 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 5.0 m -66.85 -38.64 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 109.588 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 91' ' ' GLU . 2.6 tt -54.97 -39.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.539 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -43.59 -38.3 2.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' A' ' 61' ' ' PHE . 9.0 mp -62.75 -51.55 66.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.148 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 134' ' ' THR . 18.9 p -50.84 -31.59 17.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 19.5 mttt -62.3 -42.9 99.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.54 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 20.6 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.455 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.18 -55.14 5.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.498 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.804 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 53.94 117.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.75 0.786 . . . . 0.0 110.47 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.695 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.3 p90 -130.69 -153.41 0.56 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.186 -0.946 . . . . 0.0 108.641 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 21.6 t-80 -129.53 144.56 51.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.943 -1.098 . . . . 0.0 109.852 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.086 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -138.21 164.19 29.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.225 -0.922 . . . . 0.0 108.958 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 1.066 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 t0 -160.02 94.69 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.98 -1.075 . . . . 0.0 109.964 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 6' ' ' LEU . 5.0 m -104.34 147.3 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 108.958 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 10' ' ' SER . 1.7 t -154.74 177.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 1.2 p -138.62 -160.89 1.11 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.27 -51.27 8.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.53 66.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.708 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -147.01 139.38 24.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.18 132.07 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.49 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.854 ' SD ' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -127.45 -72.88 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.642 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 47.9 t80 -151.41 112.83 4.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.26 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.404 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 56.9 p -141.74 92.84 2.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.44 -153.1 21.26 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' C ' HG12 ' A' ' 20' ' ' VAL . 21.4 mt -67.12 177.07 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.058 -1.26 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.086 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 177.17 159.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.13 -0.981 . . . . 0.0 108.658 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.804 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -129.75 -71.36 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.03 113.93 26.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.116 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.764 HG22 ' CG1' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -125.45 141.01 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.483 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 2.2 pt20 -145.54 129.66 17.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 109.885 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.773 HG22 ' CG1' ' A' ' 50' ' ' ILE . 3.3 t -109.9 128.4 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -111.73 116.56 30.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.51 -144.07 3.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLU . 89.3 p -77.39 122.65 25.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.121 . . . . 0.0 109.592 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 28' ' ' SER . 1.4 tp10 60.07 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.687 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.14 169.07 38.91 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -171.38 46.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -1.138 . . . . 0.0 109.319 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.565 HD13 ' OH ' ' A' ' 35' ' ' TYR . 8.8 mt -150.21 146.82 27.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.68 -99.49 2.24 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.695 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 20.5 mm -156.53 151.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.514 -0.992 . . . . 0.0 109.241 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.565 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.47 173.9 3.84 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.8 Cg_endo -73.26 81.77 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.908 1.739 . . . . 0.0 110.01 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.24 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -48.88 164.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.243 . . . . 0.0 109.413 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.828 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -78.28 170.62 15.38 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.332 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.828 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.19 73.93 5.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.581 2.188 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 41' ' ' LEU . 4.0 mm? -78.37 161.56 27.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.8 pp -169.08 36.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 108.972 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.1 -95.37 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.565 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.612 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -137.44 162.49 33.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.922 -1.111 . . . . 0.0 109.869 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.684 HD13 HG11 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -100.95 139.87 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' O ' HG11 ' A' ' 25' ' ' VAL . 13.3 mmtm -75.01 139.18 72.83 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.725 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.6 -162.04 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.716 2.277 . . . . 0.0 110.365 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.06 -141.12 15.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 ptm -108.78 174.41 5.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -1.144 . . . . 0.0 109.012 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.773 ' CG1' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -154.67 119.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.934 -1.104 . . . . 0.0 110.282 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.741 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.52 150.92 21.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.957 HD11 ' CD2' ' A' ' 6' ' ' LEU . 5.4 tt -143.84 167.9 12.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.617 -1.302 . . . . 0.0 111.384 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 38.8 t -134.56 90.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -53.81 121.76 8.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.325 -0.859 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.691 ' HA ' HG22 ' A' ' 3' ' ' THR . 1.3 tt0 45.38 -158.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.171 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -77.67 103.78 7.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.944 . . . . 0.0 109.115 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 103.3 178.77 26.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 t-160 62.45 129.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -1.229 . . . . 0.0 109.448 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.2 mp0 -134.31 134.14 41.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 52' ' ' ILE . 3.1 tt0 -104.85 170.48 7.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 0.0 109.596 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.631 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -133.07 122.86 24.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.169 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.5 mp -137.89 169.22 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.078 -1.013 . . . . 0.0 109.863 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -158.21 144.07 17.05 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.98 -164.26 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 110.035 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 33.6 p -105.1 -144.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.435 -0.791 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -96.02 -135.19 8.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 128.44 -167.32 20.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' ILE . 19.6 tt -105.04 125.1 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 109.062 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 70' ' ' GLU . 2.4 pp -113.51 167.91 10.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.244 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.789 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -161.79 123.63 2.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' ' 76' ' ' VAL . 9.9 p -99.95 145.01 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.984 -1.072 . . . . 0.0 110.418 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.532 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.18 175.58 2.49 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -76.96 75.8 4.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.509 2.139 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.03 -35.6 2.35 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 9.6 p-10 -143.66 149.81 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.254 . . . . 0.0 109.85 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' ' 71' ' ' VAL . 6.3 p -127.09 145.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.879 . . . . 0.0 109.413 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 7' ' ' ASP . 19.3 p -132.85 155.06 49.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.684 HG11 HD13 ' A' ' 45' ' ' ILE . 2.1 p -162.74 153.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 108.952 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.419 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 6.4 mt -129.74 160.98 31.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 109.808 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -149.91 -148.51 0.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 80' ' ' ALA . 11.0 m-20 -128.22 -33.39 2.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.667 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 83' ' ' ALA . 48.3 m -112.5 164.22 13.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.854 ' HB1' ' SD ' ' A' ' 15' ' ' MET . . . -172.08 86.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 109.63 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.2 mp -105.67 134.17 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -0.915 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.7 ttt85 -58.51 153.86 15.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -51.52 -33.82 33.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.43 44.23 1.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.679 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.9 -32.75 72.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.79 -159.99 0.71 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' HB2' ' A' ' 93' ' ' ARG . 29.8 m-20 -62.21 179.48 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.33 -60.82 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.4 -12.65 59.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.462 ' HB2' ' CB ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -85.57 0.39 52.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.676 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.62 -1.75 57.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -0.998 . . . . 0.0 109.469 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.01 -22.56 21.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.779 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -80.71 -9.5 59.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.568 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.05 -24.42 35.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -27.5 21.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -67.35 -42.39 83.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -33.86 35.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.9 -14.02 59.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.864 ' OE1' HD12 ' A' ' 105' ' ' ILE . 26.5 tp10 -78.8 -23.01 45.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 2.9 tm-20 -54.37 -30.4 51.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 -46.08 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.864 HD12 ' OE1' ' A' ' 102' ' ' GLU . 34.4 mt -52.14 -40.67 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.701 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 107' ' ' SER . 0.3 OUTLIER -92.98 58.18 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 108' ' ' SER . 6.2 p 178.8 155.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.664 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER 76.6 173.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.72 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.98 -171.52 3.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.795 . . . . 0.0 109.252 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.64 162.71 15.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -1.117 . . . . 0.0 109.472 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 111' ' ' ASP . 15.5 m 39.97 33.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.425 -0.797 . . . . 0.0 110.031 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.16 -96.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 109.118 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -73.51 -15.84 61.3 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.013 -1.054 . . . . 0.0 108.401 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.06 -35.17 79.81 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.44 -11.84 61.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -0.782 . . . . 0.0 109.219 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.77 -12.13 59.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 109.647 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -19.94 41.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.651 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.1 48.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.02 -32.77 22.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.659 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.75 -66.26 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.686 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -44.34 -25.46 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.835 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.9 ttmt -63.43 -53.14 56.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.73 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.3 -27.86 66.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.697 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.2 mm -75.15 -5.5 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 109.747 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -79.98 -1.67 40.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.821 ' O ' HG23 ' A' ' 131' ' ' ILE . 16.0 tt0 -89.81 -28.73 19.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -69.33 -15.91 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -80.63 -27.26 37.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.631 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.7 m -89.58 -28.61 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.553 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 127' ' ' GLN . 25.9 pt -66.56 -20.43 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.805 . . . . 0.0 109.537 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -78.27 -26.06 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -87.39 -47.68 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.948 . . . . 0.0 109.543 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 28.5 p -43.82 -27.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -48.34 -67.03 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.0 26.88 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 0.0 109.769 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -100.4 -36.58 9.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mmm . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.56 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' THR . 3.3 tpp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.205 0.526 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER 57.89 147.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.777 . . . . 0.0 109.845 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.774 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.9 p90 -152.2 -164.42 1.96 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.23 -0.919 . . . . 0.0 108.953 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.8 t60 -116.87 145.16 43.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.119 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.011 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -137.49 152.01 49.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.863 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.7 OUTLIER -149.2 91.71 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.092 . . . . 0.0 110.034 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 6' ' ' LEU . 3.3 m -100.66 141.3 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.288 -0.883 . . . . 0.0 109.012 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 8' ' ' VAL . 6.4 m -152.89 176.8 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.461 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -120.45 -150.2 0.45 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.37 -32.06 18.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -147.18 55.29 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.461 ' HG3' ' OG ' ' A' ' 10' ' ' SER . 17.1 pt20 175.93 122.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 15' ' ' MET . 15.5 mt-30 -96.37 165.52 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.922 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.554 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -141.91 -91.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 109.111 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.637 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 31.7 t80 -96.01 120.55 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.212 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.406 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 29.9 p -152.53 80.35 1.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.54 20.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.74 ' C ' HG12 ' A' ' 20' ' ' VAL . 24.4 mt -62.94 175.0 0.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.011 -1.287 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.011 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 179.5 160.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 108.993 -177.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.576 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 2.8 tm-20 -122.25 -51.18 1.99 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 110.087 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.512 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 18.3 tttp -153.74 122.56 6.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.134 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.038 HG22 ' CG1' ' A' ' 52' ' ' ILE . 11.2 pt -106.64 -170.13 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' CG ' ' CB ' ' A' ' 51' ' ' ARG . 5.0 pt20 -179.95 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.619 -1.3 . . . . 0.0 110.274 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 46' ' ' LYS . 1.5 p -101.19 133.65 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.36 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -120.7 135.32 55.16 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.281 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . 179.47 -76.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -158.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -1.121 . . . . 0.0 109.507 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -67.77 -82.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . -51.8 117.98 6.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.18 64.28 1.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -112.98 160.81 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.386 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -111.37 -111.46 3.24 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.774 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 23.5 mm -156.11 140.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.981 . . . . 0.0 108.806 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.62 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -146.6 -172.05 0.3 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 35.7 Cg_endo -80.96 42.76 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.23 1.953 . . . . 0.0 110.606 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.46 34.09 0.04 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -74.58 145.31 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -1.13 . . . . 0.0 109.606 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.701 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -55.55 165.89 1.1 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.788 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.701 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -78.62 73.38 5.93 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.685 2.257 . . . . 0.0 110.466 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -99.91 147.86 25.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.287 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -156.87 44.22 0.38 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.0 p -123.69 -110.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.568 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -101.4 155.39 18.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.822 -1.174 . . . . 0.0 109.584 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.47 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.7 tt -104.56 177.08 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.518 ' O ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -86.43 113.38 52.22 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 109.636 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.483 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 35.5 Cg_endo -78.61 122.15 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.483 2.122 . . . . 0.0 110.353 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.48 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 162.42 -127.72 1.76 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.68 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.7 ppp? -113.48 167.7 10.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.257 -1.143 . . . . 0.0 109.024 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.858 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.5 tt -150.39 149.31 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.931 -1.106 . . . . 0.0 110.393 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.542 ' CB ' ' CG ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -116.49 177.96 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.038 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.89 153.86 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.828 -1.17 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 18.1 t -137.97 149.51 24.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HB2' ' CB ' ' A' ' 21' ' ' GLU . 10.1 tppt? 90.06 -112.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HG3' ' CE1' ' A' ' 16' ' ' PHE . 18.8 tt0 53.62 58.32 5.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.547 -1.345 . . . . 0.0 109.155 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.427 ' NE2' HD12 ' A' ' 19' ' ' LEU . 56.1 m170 58.53 43.03 19.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.266 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 71.48 86.18 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.466 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 167.2 125.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.588 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.54 133.76 53.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.115 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.78 168.59 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.961 ' CZ ' HD21 ' A' ' 133' ' ' LEU . 0.8 OUTLIER -125.51 134.06 52.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.292 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.858 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.0 mt -101.73 -147.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.189 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 9.1 t80 -178.75 122.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 109.23 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.451 ' CD2' ' CB ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -120.21 161.57 20.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.81 -14.04 14.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.6 161.99 9.96 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 156.69 -167.46 33.63 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 69' ' ' LEU . 7.2 mt -101.72 170.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -1.073 . . . . 0.0 109.158 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -155.0 163.87 39.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.697 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -157.44 134.64 10.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 109.202 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.664 HG23 HG22 ' A' ' 76' ' ' VAL . 14.5 p -100.39 152.73 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.783 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -131.6 170.51 11.1 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 109.245 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -77.54 103.62 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.485 2.123 . . . . 0.0 110.325 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . 83.84 1.53 89.86 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 74' ' ' GLY . 13.4 m-80 -152.63 170.09 21.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -1.214 . . . . 0.0 109.391 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 34' ' ' ILE . 6.1 t -150.79 144.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.246 -0.909 . . . . 0.0 109.266 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -151.6 138.46 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.071 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 3.2 m -139.71 158.28 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.05 149.97 40.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.19 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.521 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -147.96 -175.84 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.851 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -123.32 -31.42 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.636 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 83' ' ' ALA . 14.7 m -112.5 162.86 15.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -161.83 81.93 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.679 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -99.9 70.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.937 . . . . 0.0 109.326 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.701 ' HD2' HG23 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -44.04 161.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -48.62 -59.04 6.92 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -116.9 60.0 0.75 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -1.144 . . . . 0.0 109.497 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -50.63 -63.63 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 89' ' ' LEU . 84.4 mt -142.87 -88.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.66 179.15 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.863 ' HA ' HD11 ' A' ' 131' ' ' ILE . 30.5 mt-10 -149.61 -39.74 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.16 32.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -78.31 -8.28 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.25 28.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.3 mtt -71.43 -6.73 42.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.516 -0.74 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 4.6 mt-10 -81.44 -40.65 23.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.53 -65.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.679 ' HG2' HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -45.16 -31.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -59.53 -56.81 17.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.124 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.39 3.99 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 110.028 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.77 -46.3 10.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 109.638 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -65.56 -33.59 76.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.829 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -15.19 58.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.104 -0.998 . . . . 0.0 109.769 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -80.31 -65.18 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.84 -15.03 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 107' ' ' SER . 28.0 t -78.25 78.97 4.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 109.463 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 106' ' ' SER . 2.2 p 176.9 129.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' SER . 16.5 m 54.52 104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.421 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.54 -154.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 137.58 139.58 3.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 25.2 t70 -74.24 -58.06 3.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -1.194 . . . . 0.0 109.448 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.15 -7.6 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 109.454 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -59.28 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.822 . . . . 0.0 109.193 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -73.28 -23.11 60.26 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -59.59 -22.75 62.22 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.313 0.578 . . . . 0.0 109.464 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.48 -42.49 78.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.75 -11.63 60.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.559 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -1.09 26.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.706 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.94 -16.33 34.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -84.24 -16.42 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.947 . . . . 0.0 109.495 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -88.49 -45.01 10.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.601 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.35 73.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 124' ' ' ALA . 6.7 pttt -73.66 -28.4 61.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -87.06 -8.05 57.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.218 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.679 HD11 ' HG2' ' A' ' 98' ' ' LYS . 1.5 tp -81.43 -4.07 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.68 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -74.36 -26.86 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -63.7 -33.63 76.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.403 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 131' ' ' ILE . 19.2 tp -81.64 -10.27 59.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.502 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -31.29 19.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.779 ' O ' HG23 ' A' ' 134' ' ' THR . 1.2 m -90.56 -12.75 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.0 tt -90.4 -23.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 0.0 110.055 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 135' ' ' LYS . 0.7 OUTLIER -77.4 -39.28 47.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -82.67 3.19 30.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 110.415 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 130' ' ' VAL . 14.3 p -87.15 -12.98 45.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.913 -1.117 . . . . 0.0 109.669 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 132' ' ' GLU . 5.6 ptpt -71.34 -5.44 32.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -97.63 -43.42 7.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 109.608 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -44.7 -29.06 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.583 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.565 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.573 ' O ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.773 HG22 ' HA ' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -160.75 153.77 21.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.839 . . . . 0.0 109.609 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.712 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.9 p90 -139.53 -145.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.348 -0.845 . . . . 0.0 108.926 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -134.7 152.5 51.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -115.9 138.28 51.32 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.866 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.5 OUTLIER -143.39 72.61 1.37 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.321 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 15' ' ' MET . 4.0 p -106.26 140.59 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.84 147.42 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.339 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 1.3 p -143.78 42.9 1.47 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 171.68 -87.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 109.582 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 13' ' ' GLN . 1.4 mt-10 -128.62 44.13 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER 70.81 61.95 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -145.6 99.21 3.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.616 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.862 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -175.12 -78.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 109.286 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -148.26 109.47 4.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.5 p -138.07 83.37 1.97 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 109.464 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.5 -153.47 11.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.47 152.47 30.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -1.169 . . . . 0.0 109.741 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.7 152.33 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 109.276 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.773 ' HA ' HG22 ' A' ' 3' ' ' THR . 10.6 tt0 -109.84 -50.55 2.97 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -155.44 130.84 9.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.744 ' CD1' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -98.01 -152.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.019 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.556 ' H ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER 179.55 94.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.806 -1.184 . . . . 0.0 109.617 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.744 HG23 ' CD1' ' A' ' 23' ' ' ILE . 22.2 t -99.05 134.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 22.2 m -123.36 112.22 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.359 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -157.57 159.97 30.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -31.48 71.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.163 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' CB ' ' HG3' ' A' ' 47' ' ' PRO . 1.9 tt0 -98.54 71.7 2.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.74 152.86 9.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.26 26.45 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.686 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.06 156.93 21.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.665 ' HA2' HD11 ' A' ' 23' ' ' ILE . . . -100.35 -121.37 4.7 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.045 ' CG2' HG21 ' A' ' 76' ' ' VAL . 30.7 mm -154.42 135.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -1.225 . . . . 0.0 109.016 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -140.7 -172.44 0.32 Allowed Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 34.5 Cg_endo -77.88 76.12 4.48 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.776 1.651 . . . . 0.0 110.407 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.22 37.53 0.6 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 39' ' ' ALA . 15.8 t-80 -67.76 166.6 14.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.179 -1.189 . . . . 0.0 109.394 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -53.68 160.77 1.86 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.6 Cg_endo -77.9 77.84 3.78 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.738 2.292 . . . . 0.0 110.581 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 4.2 mm? -97.22 148.61 22.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.142 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.5 31.59 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 68' ' ' ILE . 26.8 p -131.21 -145.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 109.239 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.47 128.42 45.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.032 -1.043 . . . . 0.0 108.844 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -160.41 42.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 110.395 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.699 ' CD ' HD11 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -130.82 45.73 1.9 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.917 -1.115 . . . . 0.0 110.723 179.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.695 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 79.52 3.31 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.047 1.831 . . . . 0.0 110.496 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 64' ' ' LEU . . . 158.62 -141.47 7.66 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.388 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' CG1' ' A' ' 130' ' ' VAL . 1.0 OUTLIER -110.02 179.91 3.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.404 -1.057 . . . . 0.0 109.587 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 1.7 tt -147.89 154.02 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.531 ' N ' HG12 ' A' ' 50' ' ' ILE . 1.3 tmt_? -144.8 152.35 40.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 8.3 mt -150.7 166.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 110.452 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 90.1 t -141.78 118.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.618 -0.677 . . . . 0.0 109.267 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 150.88 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 6.5 mp0 42.46 -147.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -109.67 -11.06 14.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.952 . . . . 0.0 109.419 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.04 -98.64 2.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -130.3 -66.51 0.77 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.55 165.86 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.97 143.31 50.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 0.0 109.436 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.64 ' HZ ' HD11 ' A' ' 133' ' ' LEU . 0.7 OUTLIER -116.9 123.71 47.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.707 HG21 ' HG2' ' A' ' 15' ' ' MET . 1.6 mt -137.38 -160.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.969 . . . . 0.0 109.316 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.602 ' H ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -174.38 131.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 0.0 109.32 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.544 HD22 ' C ' ' A' ' 63' ' ' TYR . 3.6 mm? -119.5 158.27 26.62 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -99.27 -19.71 16.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.521 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.96 45.73 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 80' ' ' ALA . . . -72.54 -178.02 32.21 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 43' ' ' THR . 2.7 mp -102.79 122.94 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -1.125 . . . . 0.0 109.367 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.699 HD11 ' CD ' ' A' ' 46' ' ' LYS . 6.7 mp -99.53 175.34 5.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.696 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -168.78 129.3 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.7 p -99.86 129.06 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.076 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.542 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.74 173.7 3.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.5 Cg_endo -81.04 56.02 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.07 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.89 -16.73 1.21 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.075 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' A' ' 5' ' ' HIS . 15.5 m-80 -150.91 -175.65 5.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 0.0 109.468 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.045 HG21 ' CG2' ' A' ' 34' ' ' ILE . 38.0 t -144.25 146.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.237 -0.914 . . . . 0.0 109.361 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.866 HG22 ' HB3' ' A' ' 7' ' ' ASP . 1.2 p -138.07 174.24 10.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 8' ' ' VAL . 1.2 p -178.25 119.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.298 -0.876 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.593 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -102.62 124.51 48.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.033 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.442 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . . . -128.73 -152.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.78 -39.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.4 m -104.24 151.73 23.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 109.754 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -165.68 167.51 17.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.321 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.454 HG13 ' CE1' ' A' ' 63' ' ' TYR . 16.3 mt -130.68 -28.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 69.37 45.71 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.418 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.04 -112.13 3.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.78 27.08 9.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.42 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 85' ' ' ARG . 32.1 t70 -49.43 -40.72 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.669 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.86 -88.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.772 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.07 164.84 20.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.26 -72.8 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.54 -17.1 34.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -81.64 3.75 24.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.591 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.09 26.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 108.693 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 mtm -71.08 -26.54 63.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.507 -0.745 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.58 -24.21 67.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.323 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.24 -42.75 22.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.327 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -58.44 -43.51 88.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -26.55 65.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.307 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -89.94 7.68 36.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.812 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -90.5 -35.62 14.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -34.9 72.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 106' ' ' SER . 0.4 OUTLIER -62.58 -34.88 77.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -48.72 65.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.448 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mt -89.56 27.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 107' ' ' SER . 0.5 OUTLIER -68.92 92.86 0.52 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 106' ' ' SER . 39.5 m 61.47 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.633 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.44 118.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -95.68 73.42 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.514 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.27 132.02 4.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.5 m-20 -67.23 -149.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -1.148 . . . . 0.0 109.398 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.831 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -35.96 -31.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.301 0.572 . . . . 0.0 109.708 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 111' ' ' ASP . 22.5 t70 -38.18 -93.15 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.665 -0.647 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -63.42 -20.15 65.31 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -55.74 -26.22 44.44 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.419 0.628 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -82.13 -31.92 30.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.384 -0.822 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -13.31 61.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.646 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 t -83.24 9.34 10.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.16 10.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.432 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.629 ' HG3' HD22 ' A' ' 121' ' ' LEU . 23.2 pt-20 -67.6 -12.49 60.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.812 HD12 ' HB1' ' A' ' 101' ' ' ALA . 3.9 mm? -82.57 -36.21 26.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.918 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.94 46.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -69.85 -14.05 62.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.369 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.16 -8.49 57.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.343 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.66 -17.9 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.51 -26.49 68.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -60.3 -34.22 73.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 109.492 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.526 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 27.9 tp -90.03 -11.84 40.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -60.84 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.564 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 134' ' ' THR . 16.2 m -55.42 -51.15 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.015 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 130' ' ' VAL . 3.9 tt -60.19 -26.95 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.15 -38.66 85.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 109.942 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 133' ' ' LEU . 1.2 pp -90.22 -16.2 29.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.04 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 130' ' ' VAL . 20.0 p -61.25 -38.89 88.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -60.41 -33.95 73.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.993 . . . . 0.0 109.419 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.48 1.0 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 133' ' ' LEU . . . -77.26 -36.03 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 109.427 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.459 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.813 ' O ' HG22 ' A' ' 3' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.813 HG22 ' O ' ' A' ' 2' ' ' MET . 6.5 t 52.07 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.591 1.186 . . . . 0.0 111.075 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.956 ' CE2' HG22 ' A' ' 34' ' ' ILE . 9.2 p90 -110.75 -168.37 1.3 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -111.06 137.57 48.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.155 -0.966 . . . . 0.0 108.655 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.052 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -125.61 162.68 24.42 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.912 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 1.045 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.94 101.35 2.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.728 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 16' ' ' PHE . 7.3 p -99.79 124.66 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 2.3 t -136.93 146.73 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.2 m -123.59 -145.88 0.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -40.04 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 110.039 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -153.38 65.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -156.05 138.68 15.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -92.4 138.32 31.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.758 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 1.1 mmt -124.99 -60.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.653 ' HB2' HD11 ' A' ' 62' ' ' ILE . 49.7 t80 -131.09 133.41 45.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.467 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 p -163.0 97.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.262 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 165.02 -151.03 19.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.732 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -70.23 161.94 29.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.191 -1.182 . . . . 0.0 109.302 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.052 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -178.59 153.93 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.258 -177.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 3' ' ' THR . 1.5 pp20? -152.25 -36.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.942 -1.099 . . . . 0.0 110.677 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -106.74 71.21 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.848 -1.158 . . . . 0.0 110.891 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.953 HG22 ' CG1' ' A' ' 52' ' ' ILE . 9.5 pt -102.81 142.29 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.099 -1.0 . . . . 0.0 108.699 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.546 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 20.0 pt20 -149.27 126.55 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.055 -1.028 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -99.11 114.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . 51.6 m -99.78 108.42 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.52 -91.82 1.26 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.58 -67.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -1.089 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.64 132.09 33.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.55 -178.29 35.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -174.74 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.125 . . . . 0.0 109.591 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 12.8 mt -151.27 142.96 23.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.629 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -101.79 -99.69 2.44 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.956 HG22 ' CE2' ' A' ' 4' ' ' TYR . 7.2 mm -156.75 140.47 7.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.429 -1.042 . . . . 0.0 109.139 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -128.76 178.06 1.84 Allowed Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 33.1 Cg_endo -75.43 75.78 3.77 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.058 1.838 . . . . 0.0 110.172 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.5 38.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -107.9 175.33 5.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.209 . . . . 0.0 109.583 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -92.99 167.24 14.7 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.269 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.73 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.61 81.99 2.61 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.535 2.157 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.943 HD11 HD11 ' A' ' 69' ' ' LEU . 1.4 pp -90.17 142.27 27.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.727 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mt -128.13 69.94 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.293 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -110.3 -160.5 0.72 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -101.01 172.73 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.706 ' HA ' HD23 ' A' ' 69' ' ' LEU . 1.7 tt -99.96 126.98 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 156.15 70.52 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.98 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.15 175.71 10.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.56 2.173 . . . . 0.0 110.314 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 113.96 -132.92 10.84 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.669 ' SD ' HG13 ' A' ' 130' ' ' VAL . 6.0 ptm -129.53 -177.11 4.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -1.204 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.8 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -151.96 131.3 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 109.816 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -98.41 127.26 44.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.953 ' CG1' HG22 ' A' ' 23' ' ' ILE . 1.2 tt -134.3 145.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.077 -1.014 . . . . 0.0 110.91 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.757 HG22 ' HB3' ' A' ' 59' ' ' GLU . 38.9 t -127.75 113.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 16' ' ' PHE . 17.6 mtmt -66.32 157.14 32.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -0.762 . . . . 0.0 109.886 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.764 ' CG ' HG21 ' A' ' 3' ' ' THR . 18.2 tt0 -60.29 -65.02 0.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.345 -0.847 . . . . 0.0 109.531 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.04 102.98 8.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.47 -103.42 0.23 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -148.51 159.96 43.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -1.194 . . . . 0.0 109.702 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.757 ' HB3' HG22 ' A' ' 53' ' ' VAL . 1.9 pt-20 -101.3 136.05 41.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 52' ' ' ILE . 8.9 mt-10 -134.01 150.64 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.943 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 1.2 p90 -109.2 131.02 55.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.8 ' H ' HG23 ' A' ' 50' ' ' ILE . 1.7 mt -101.95 -175.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.436 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.682 ' H ' HG22 ' A' ' 62' ' ' ILE . 6.2 t80 -152.37 136.84 16.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.068 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -161.92 179.99 7.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -161.3 113.16 1.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.435 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.79 132.97 6.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.27 -161.79 28.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 82.2 mt -139.46 143.2 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -1.155 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.943 HD11 HD11 ' A' ' 41' ' ' LEU . 1.4 pp -123.72 138.5 54.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 2.8 pt-20 -142.72 149.89 39.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 40' ' ' PRO . 4.4 p -109.54 133.4 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.76 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.534 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -101.45 175.43 2.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.408 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.0 Cg_endo -76.76 77.59 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.62 2.213 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.85 12.58 31.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.819 ' O ' HG23 ' A' ' 76' ' ' VAL . 68.3 m-80 -153.9 -172.29 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -1.086 . . . . 0.0 109.343 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 75' ' ' ASN . 3.1 t -166.13 150.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.09 -1.006 . . . . 0.0 108.935 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -158.5 142.26 15.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 0.0 109.315 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 69' ' ' LEU . 3.5 m -151.06 137.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.187 -0.946 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 1.1 mp -106.77 160.66 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.848 . . . . 0.0 109.194 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.492 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -149.76 175.88 11.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.8 -52.21 3.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.4 t -102.18 -176.68 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.367 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.758 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -168.51 80.88 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.6 mp -108.51 72.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.52 ' NH2' ' HB3' ' A' ' 60' ' ' GLU . 22.9 ttt180 -42.84 154.11 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -45.95 -51.75 10.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -106.71 49.4 0.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -1.141 . . . . 0.0 109.539 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -27.69 14.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -123.36 -175.02 3.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.367 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 10.7 t70 -54.29 179.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.342 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.791 ' HB3' HD11 ' A' ' 131' ' ' ILE . 32.7 mt-10 -105.83 -34.8 7.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.95 -25.24 27.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -72.29 -7.44 49.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 127' ' ' GLN . . . -90.59 -24.63 20.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.179 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -31.55 37.67 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 109.484 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -5.56 27.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.68 -22.93 42.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HG2' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -82.34 -41.58 19.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.2 mtp-105 -61.3 -27.18 68.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.86 -21.76 26.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.95 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.12 -26.32 33.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.347 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 106' ' ' SER . 16.3 tt0 -60.97 -30.55 70.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.837 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -56.11 -30.88 62.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -89.5 -47.68 7.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.883 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.065 HD13 ' HB1' ' A' ' 117' ' ' ALA . 11.7 mt -86.83 14.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 107' ' ' SER . 71.2 p -48.69 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 77.03 167.76 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.565 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -166.94 134.52 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.15 -89.01 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.468 ' O ' ' OD2' ' A' ' 113' ' ' ASP . . . -167.78 174.41 42.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 112' ' ' VAL . 1.2 m-20 63.65 105.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -1.202 . . . . 0.0 109.312 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 111' ' ' ASP . 15.6 m 40.99 26.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -90.83 -89.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.177 -0.952 . . . . 0.0 108.893 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 26.7 t80 -73.93 -20.47 60.36 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.83 -53.17 58.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.51 -39.78 94.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.355 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 1.065 ' HB1' HD13 ' A' ' 105' ' ' ILE . . . -67.03 -16.35 64.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.589 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.561 ' O ' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -74.52 -23.1 58.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.44 -41.15 11.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.977 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 6.2 pt-20 -75.77 -32.15 59.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 105' ' ' ILE . 51.1 tp -87.24 -51.84 5.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 109.614 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -52.72 -39.78 62.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -57.84 -36.12 71.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.781 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 123' ' ' LYS . . . -75.92 -22.54 55.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.563 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.0 mm -79.79 -3.61 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.619 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.495 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -64.81 -32.74 74.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -69.08 -19.28 64.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.411 ' N ' ' HG2' ' A' ' 127' ' ' GLN . 14.0 tp -83.99 -17.5 40.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -90.37 -28.99 18.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.733 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.669 HG13 ' SD ' ' A' ' 49' ' ' MET . 5.0 m -89.19 -26.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 109.461 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.791 HD11 ' HB3' ' A' ' 91' ' ' GLU . 3.1 tt -66.97 -46.86 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.576 ' N ' HG23 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -52.65 -26.29 13.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -44.98 28.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 79.5 p -61.1 -14.88 27.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -45.42 -41.65 9.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.367 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -97.08 -41.77 8.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -44.19 -61.98 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.442 ' OXT' ' O ' ' A' ' 137' ' ' ALA . 2.8 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' THR . 6.3 mtp . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.556 HG22 ' HG3' ' A' ' 21' ' ' GLU . 1.3 p 49.98 176.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.398 -0.814 . . . . 0.0 109.906 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.725 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.3 p90 179.42 -171.66 0.15 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.559 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.0 t60 -111.62 149.68 31.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 109.025 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.012 HD23 HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -137.92 158.48 44.26 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 178.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.856 ' N ' HD12 ' A' ' 6' ' ' LEU . 6.5 t0 -144.98 92.65 2.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.4 p -113.2 118.69 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.918 . . . . 0.0 109.408 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 t -130.9 145.08 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.693 ' CB ' ' HB3' ' A' ' 80' ' ' ALA . 39.5 t -178.05 66.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 178.09 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER 42.54 27.38 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.653 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -148.88 -150.59 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.512 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -134.39 102.84 5.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.651 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.4 mmt -76.01 -78.69 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.259 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.612 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 34.7 t80 -125.66 124.76 41.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.165 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 17' ' ' SER . 52.6 p -154.4 83.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.7 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.01 -153.59 17.37 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.643 ' C ' HG12 ' A' ' 20' ' ' VAL . 13.6 mt -65.02 167.7 7.5 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.151 -1.205 . . . . 0.0 108.745 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.012 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -173.85 173.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 120.87 -1.144 . . . . 0.0 109.496 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.9 tt0 -118.19 -46.37 2.61 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HE2' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.4 137.3 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.433 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.984 ' HB ' HD11 ' A' ' 50' ' ' ILE . 18.7 pt -99.42 -156.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -177.13 95.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.509 -1.369 . . . . 0.0 110.378 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.537 HG11 ' C ' ' A' ' 46' ' ' LYS . 76.4 t -99.23 141.75 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 25.6 m -145.53 119.81 9.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.274 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -145.54 -163.39 10.18 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -42.66 42.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -1.078 . . . . 0.0 109.592 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 163.26 21.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.917 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.79 138.57 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -141.31 45.72 1.74 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -1.13 . . . . 0.0 109.213 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.412 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 5.9 mt -144.85 164.58 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.785 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -112.59 -112.33 3.16 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 76' ' ' VAL . 15.9 mm -153.33 138.04 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -1.153 . . . . 0.0 109.459 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.618 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -149.23 171.87 5.82 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.0 Cg_endo -70.3 83.03 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.566 1.511 . . . . 0.0 109.486 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.73 35.12 0.46 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.632 ' CD2' ' CD1' ' A' ' 34' ' ' ILE . 22.3 t60 -81.97 151.26 27.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -1.12 . . . . 0.0 109.526 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . -42.94 154.8 0.28 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.409 -0.807 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 76.01 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.583 2.188 . . . . 0.0 110.559 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -97.03 162.13 13.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.311 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.68 35.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.634 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 68' ' ' ILE . 30.0 p -130.68 -145.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.901 . . . . 0.0 109.375 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.32 120.41 39.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 44' ' ' ALA . 1.1 pp -166.7 -169.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.163 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.657 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER 71.66 49.46 0.28 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 111.059 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.657 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 146.17 17.22 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.15 1.9 . . . . 0.0 110.418 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 115.58 -142.88 17.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.318 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -99.56 -155.22 0.5 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -1.079 . . . . 0.0 109.198 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.984 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -173.76 111.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 110.383 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 50' ' ' ILE . 15.7 mtm180 -99.46 166.63 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.881 HD11 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -152.62 167.63 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.601 -1.312 . . . . 0.0 111.246 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.481 ' N ' HG23 ' A' ' 52' ' ' ILE . 13.6 t -143.99 104.73 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLN . 1.3 ttpt -66.37 120.51 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.692 -0.63 . . . . 0.0 109.868 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 82.0 mt-30 43.26 -161.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.363 -0.835 . . . . 0.0 109.373 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -68.71 88.41 0.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 54' ' ' LYS . . . 121.27 -171.21 14.86 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 61.5 160.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.383 -1.069 . . . . 0.0 109.607 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -171.35 147.41 2.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.401 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -132.8 154.67 50.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' ' 130' ' ' VAL . 0.9 OUTLIER -112.08 133.62 54.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 109.373 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 15' ' ' MET . 78.0 mt -151.94 167.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 109.261 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.61 ' N ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.65 149.66 37.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 109.576 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER -157.67 152.69 25.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.16 -79.56 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 109.723 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 129.4 9.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.32 144.6 7.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 43' ' ' THR . 79.3 mt -99.48 118.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -1.108 . . . . 0.0 108.965 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.671 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.3 tt -112.49 153.37 27.54 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -145.65 152.41 39.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.28 139.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.0 109.872 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.525 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.9 OUTLIER -122.27 172.33 5.33 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.462 -0.774 . . . . 0.0 109.038 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -78.62 91.15 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.513 2.142 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.22 -10.31 54.6 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -161.32 162.11 30.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.027 -1.278 . . . . 0.0 109.896 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 34' ' ' ILE . 18.3 m -135.75 172.87 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 78' ' ' VAL . 32.5 m -159.95 156.64 27.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.504 ' CG2' ' HB2' ' A' ' 69' ' ' LEU . 2.7 p -167.73 133.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mt -117.77 118.34 31.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.693 ' HB3' ' CB ' ' A' ' 10' ' ' SER . . . -109.02 -165.97 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.361 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.23 -52.29 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 m -99.93 120.11 39.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.35 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . -149.75 163.71 37.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.54 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.1 mt -149.03 119.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.285 -0.885 . . . . 0.0 109.25 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -67.58 95.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.37 -110.75 1.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.738 ' HB3' HG22 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -139.13 57.2 1.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 109.223 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -60.19 -45.16 94.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.61 -78.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -150.25 -155.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 109.608 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.471 ' HB2' HD12 ' A' ' 131' ' ' ILE . 1.3 pt-20 -151.93 -49.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.652 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.87 -10.14 59.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.359 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -8.48 59.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.52 -24.32 20.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.246 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -35.58 76.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -54.71 -33.34 60.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.17 75.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.112 -0.993 . . . . 0.0 109.86 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -18.06 60.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -70.06 -50.34 42.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.626 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -86.02 -9.19 57.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.573 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.908 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -76.81 -30.8 56.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 1.5 tm-20 -70.88 -22.46 62.28 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.306 -0.871 . . . . 0.0 109.347 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.74 -20.75 60.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -81.67 -36.75 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.714 HD11 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mm -78.87 -26.91 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.1 p -80.81 -9.94 59.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.5 t -104.58 131.19 52.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.57 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 58.3 p -135.97 142.22 44.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.281 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.3 m-70 175.21 41.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.382 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.63 158.92 31.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -74.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -1.177 . . . . 0.0 109.562 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 17.6 m -100.84 19.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.393 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 9.7 t70 -59.83 -100.41 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.358 -0.839 . . . . 0.0 109.278 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 12.6 p90 -64.61 -22.22 66.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.903 -1.123 . . . . 0.0 108.223 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -53.84 -33.65 56.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -88.3 -24.7 23.1 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -68.08 -21.12 64.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -26.3 61.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HE3' ' A' ' 123' ' ' LYS . . . -90.18 -38.18 13.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -78.85 -5.79 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.908 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -90.15 -51.3 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.593 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.31 -28.87 70.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.179 -0.951 . . . . 0.0 109.459 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 119' ' ' ALA . 14.8 mtmt -70.23 -23.66 62.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.66 62.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.868 . . . . 0.0 109.733 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.3 mp -80.08 -1.24 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.4 -24.57 63.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.766 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -69.76 -45.76 67.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.62 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.541 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.4 OUTLIER -65.99 -15.51 63.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.638 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 133' ' ' LEU . 14.2 mmt180 -81.85 -25.75 34.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 127' ' ' GLN . 31.6 m -88.09 -20.36 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.738 HG22 ' HB3' ' A' ' 87' ' ' GLN . 7.7 pt -91.01 -44.62 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 0.0 110.047 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 5.0 mm-40 -61.81 -24.21 66.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.233 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 133' ' ' LEU . 6.5 mp -89.09 -37.73 14.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -55.59 -40.93 72.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -61.39 -29.58 70.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.83 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -111.26 31.56 5.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 109.548 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.19 -3.56 8.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 109.654 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.339 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 20.6 ptp . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.19 0.519 . . . . 0.0 109.837 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.693 HG21 ' CG ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -42.35 166.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.873 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.738 ' CE2' HG22 ' A' ' 34' ' ' ILE . 5.0 p90 -148.79 -147.3 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 20.5 t-80 -133.9 140.71 46.99 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.05 -1.031 . . . . 0.0 109.641 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.04 HD21 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.067 . . . . 0.0 108.775 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.818 ' N ' HD12 ' A' ' 6' ' ' LEU . 36.1 t0 -142.83 86.78 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.951 -1.093 . . . . 0.0 110.528 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 6' ' ' LEU . 5.0 m -99.9 148.78 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 8' ' ' VAL . 1.5 m -152.96 173.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.032 -1.043 . . . . 0.0 109.869 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.662 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -129.4 -153.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.92 -29.95 70.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' GLN . 6.3 mm-40 -116.74 26.51 9.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.003 . . . . 0.0 109.695 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 12' ' ' GLU . 19.8 mt-30 43.68 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.409 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 15' ' ' MET . 4.6 mm-40 -165.4 74.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.722 ' HB2' HG23 ' A' ' 8' ' ' VAL . 6.8 mtp -151.32 -73.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.647 ' CD1' HD13 ' A' ' 52' ' ' ILE . 47.7 t80 -159.75 136.84 9.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.267 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -160.17 105.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 144.99 -160.38 28.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.753 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.0 mt -56.09 174.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -1.191 . . . . 0.0 108.957 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.024 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 179.96 169.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.078 . . . . 0.0 109.65 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.0 tt0 -122.5 -41.9 2.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.314 -0.866 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HG3' ' HB ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -175.68 130.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.947 ' CG2' HD22 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -98.77 -165.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.584 ' N ' HD12 ' A' ' 23' ' ' ILE . 4.5 tp60 -168.89 84.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.665 -1.272 . . . . 0.0 110.233 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.3 141.86 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.445 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 10.2 m -138.16 129.69 27.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 109.03 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.92 -81.38 0.1 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -38.78 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -1.173 . . . . 0.0 109.769 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -123.41 163.69 20.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 80.4 -82.06 1.51 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 44.1 tt0 73.88 53.11 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -1.089 . . . . 0.0 109.732 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -145.54 156.64 43.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -99.22 -115.17 3.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.738 HG22 ' CE2' ' A' ' 4' ' ' TYR . 29.5 mm -153.11 145.81 14.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -154.91 -171.0 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.7 Cg_endo -78.63 73.93 5.68 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.678 1.586 . . . . 0.0 109.671 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.09 54.7 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.547 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 11.8 t-160 -85.63 50.84 2.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -1.132 . . . . 0.0 109.648 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 55.56 167.03 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 109.627 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.2 Cg_endo -78.46 78.92 3.47 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.621 2.214 . . . . 0.0 110.229 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -95.05 144.4 25.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.16 36.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.6 p -121.26 -134.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . . . -99.6 168.73 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.883 -1.136 . . . . 0.0 109.333 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.528 HD12 HD22 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -112.9 136.23 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -65.46 147.01 98.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.569 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 35.3 Cg_endo -77.71 133.97 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.688 2.259 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.508 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 174.25 -144.89 7.78 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.938 ' HE2' HG23 ' A' ' 130' ' ' VAL . 3.8 ptm -105.73 -164.68 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -1.114 . . . . 0.0 109.481 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.57 123.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.995 -1.066 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.609 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -111.28 159.69 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.04 HD11 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -154.06 158.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.28 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.481 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 47.2 t -142.15 102.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -54.94 159.42 2.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 -179.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.693 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.4 tm0? -35.85 -38.83 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.586 . . . . 0.0 110.022 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -103.06 -159.58 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -64.62 -163.77 0.79 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 4.1 t60 79.46 124.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.412 -1.052 . . . . 0.0 109.732 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.85 140.73 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 108.872 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.0 mp0 -109.68 152.34 25.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.109 . . . . 0.0 109.746 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 1.003 ' CD2' HG22 ' A' ' 130' ' ' VAL . 2.3 m-85 -124.22 132.29 53.59 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD12 HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -149.54 -176.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.615 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CD1' HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -162.84 130.88 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 108.928 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.48 -166.34 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.87 . . . . 0.0 109.334 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.462 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 1.9 m -143.04 -93.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.69 154.63 17.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.0 -173.27 42.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.1 mt -122.09 131.99 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.339 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -112.88 -172.4 2.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.961 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 179.78 142.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 71' ' ' VAL . 9.2 p -107.58 132.55 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 109.917 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.513 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.2 mt-30 -119.78 173.42 3.61 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 0.0 109.081 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.35 110.6 2.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.525 2.15 . . . . 0.0 110.829 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 78.51 11.86 84.85 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 19.6 p-10 -179.8 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.284 . . . . 0.0 109.838 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 6' ' ' LEU . 4.5 m -129.75 178.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.106 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 78' ' ' VAL . 98.9 m -160.86 160.48 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.95 -1.094 . . . . 0.0 109.954 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' CG1' HG12 ' A' ' 8' ' ' VAL . 1.8 p -177.02 138.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.777 ' N ' HD12 ' A' ' 79' ' ' LEU . 1.3 mp -124.31 153.27 42.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.04 -1.037 . . . . 0.0 109.95 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.95 166.06 26.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.433 -0.792 . . . . 0.0 109.047 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 81' ' ' ASP . 8.5 t70 -100.18 3.77 43.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 11.7 m -119.64 153.56 35.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB2' ' CB ' ' A' ' 10' ' ' SER . . . -168.57 113.42 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.474 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.575 HD13 ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -104.62 -37.38 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.216 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 75.43 49.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 130' ' ' VAL . . . 43.88 -109.58 0.26 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CA ' HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -98.78 59.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -1.117 . . . . 0.0 109.886 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 33.3 t0 -47.42 -38.23 12.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.4 tp -163.65 127.6 2.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.13 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.09 172.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 109.319 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.674 ' HA ' HD11 ' A' ' 131' ' ' ILE . 2.4 mt-10 -128.56 -5.69 5.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 109.836 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.31 -11.34 41.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.944 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -81.57 -17.38 48.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.44 -7.74 52.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -0.978 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mtt -85.4 -10.93 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.6 -26.53 60.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.89 -1.94 34.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HD2' HD12 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -84.58 -53.82 5.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -74.45 -29.56 61.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.75 -21.86 34.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -68.64 -29.37 67.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -17.66 51.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -88.79 -20.32 24.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 121' ' ' LEU . 65.4 mt -83.08 4.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.661 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.4 m -47.83 -52.13 20.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.69 115.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.7 p -153.28 148.66 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.434 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.63 -63.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.543 ' N ' ' HB2' ' A' ' 113' ' ' ASP . . . 175.4 171.62 39.54 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.82 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 109.596 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 14.3 m -88.19 20.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.543 ' HB2' ' N ' ' A' ' 110' ' ' GLY . 51.0 t0 -62.35 -100.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -15.36 58.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 108.473 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -71.83 -37.73 70.25 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.685 -0.634 . . . . 0.0 109.591 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 12.2 tt0 -84.24 -10.2 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.65 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.93 -20.84 24.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.65 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -64.37 -13.18 49.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 109.488 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.66 -60.97 1.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -59.08 -47.62 84.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.974 ' HB2' HD11 ' A' ' 105' ' ' ILE . 0.7 OUTLIER -68.18 -59.74 2.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.802 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -56.26 -16.63 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.855 . . . . 0.0 109.829 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.423 ' CD ' ' HB2' ' A' ' 47' ' ' PRO . 7.6 ttpt -76.86 -36.2 56.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.18 -14.01 54.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.805 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.607 HD12 ' HD2' ' A' ' 98' ' ' LYS . 35.2 mm -87.84 -8.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.49 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -68.43 -30.64 69.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.599 ' O ' HG22 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -84.07 -17.73 39.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.657 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -85.09 -30.51 24.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.483 ' O ' HD23 ' A' ' 133' ' ' LEU . 5.7 tpp180 -82.17 -33.94 29.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.54 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 1.003 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.15 -25.24 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.174 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.3 tt -90.95 -23.85 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 110.29 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -81.01 -34.62 32.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.9 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -84.67 0.17 51.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.955 -1.09 . . . . 0.0 110.099 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.542 HG23 ' CD2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -80.97 -2.08 46.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -25.23 34.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -89.12 -9.05 52.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.12 -0.987 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.83 37.33 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.431 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 3' ' ' THR . 1.3 tpt . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.221 0.534 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 2' ' ' MET . 0.4 OUTLIER -165.99 140.28 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.776 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.7 p90 -152.73 -142.69 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 75' ' ' ASN . 19.2 t-80 -139.39 141.81 37.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.878 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.031 HD23 HG21 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -137.38 153.83 50.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.079 -1.013 . . . . 0.0 108.673 178.619 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.766 ' N ' HD12 ' A' ' 6' ' ' LEU . 3.1 t70 -148.33 98.06 2.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.989 ' HA ' HG22 ' A' ' 78' ' ' VAL . 2.1 p -99.28 110.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.862 -1.149 . . . . 0.0 109.09 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.05 154.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.713 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.7 t -165.96 107.52 0.73 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.211 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 77.07 34.36 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 55.04 39.63 31.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 22.5 mt-30 -87.67 -43.9 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.204 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER 72.21 84.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.126 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' HG13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -98.97 -93.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 108.78 179.26 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.698 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 32.8 t80 -94.03 110.09 21.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.006 . . . . 0.0 109.315 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.496 ' HB2' ' OD1' ' A' ' 7' ' ' ASP . 60.4 p -136.97 109.94 7.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . 145.49 -169.52 27.03 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.72 ' C ' HG12 ' A' ' 20' ' ' VAL . 19.8 mt -52.46 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.107 -1.231 . . . . 0.0 108.602 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.031 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -176.04 145.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.962 -1.086 . . . . 0.0 109.563 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -108.7 -48.61 3.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 67.3 mmtt -147.19 101.76 3.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.405 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.943 HG13 HD11 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -99.94 109.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.79 110.09 22.48 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.04 -1.037 . . . . 0.0 110.51 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.839 HG21 ' HG3' ' A' ' 46' ' ' LYS . 7.4 p -99.67 147.81 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.457 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -135.84 121.71 19.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -152.42 -177.67 26.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.91 150.59 34.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -1.132 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 64.8 76.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.14 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 99.66 179.65 30.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 175.02 38.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.238 . . . . 0.0 109.806 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.528 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 4.6 mt -92.41 150.03 21.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.672 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.47 177.94 29.88 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.776 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 16.4 mm -98.6 140.13 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.874 -1.368 . . . . 0.0 109.187 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -137.79 170.87 9.47 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.8 Cg_endo -72.63 80.02 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.862 1.708 . . . . 0.0 109.918 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.66 34.94 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.435 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 11.8 t60 -83.23 142.67 30.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -1.208 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -46.74 157.71 0.45 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.185 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.73 87.4 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 110.359 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 71' ' ' VAL . 2.4 mm? -99.9 155.44 17.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -157.62 75.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.773 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.9 t -156.09 -146.08 0.17 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.885 . . . . 0.0 109.021 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.773 ' N ' HG23 ' A' ' 43' ' ' THR . . . -99.46 136.46 39.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.969 HD12 HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -156.47 -169.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 109.76 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.839 ' HG3' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 63.61 51.95 1.37 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.488 -0.757 . . . . 0.0 110.399 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.4 Cg_endo -80.19 65.99 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.208 1.938 . . . . 0.0 110.811 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.45 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 155.11 -127.49 2.08 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.298 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 4.6 ptm -108.61 -169.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 109.684 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.943 HD11 HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -179.43 127.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.477 ' C ' HG13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -110.35 172.86 6.61 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.826 HD13 HD21 ' A' ' 6' ' ' LEU . 18.2 mt -155.14 166.49 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.019 -1.051 . . . . 0.0 109.601 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 42.8 t -138.89 107.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.263 -0.898 . . . . 0.0 109.903 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 157.68 -97.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 16' ' ' PHE . 11.6 tm0? -50.68 165.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 0.0 109.373 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.0 t-160 75.54 -145.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.185 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.7 -86.43 0.92 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -120.23 -18.8 7.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -169.73 152.45 4.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.211 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.15 161.01 22.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 2.8 m-85 -118.19 141.78 48.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.912 ' HB ' HG23 ' A' ' 50' ' ' ILE . 2.3 mp -151.53 166.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.101 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -171.45 130.1 0.71 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.172 -0.955 . . . . 0.0 109.275 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 80' ' ' ALA . 10.5 mt -131.62 172.6 12.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.084 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -148.76 46.57 1.02 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.472 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 133.24 91.27 0.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -160.91 151.55 22.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' THR . 20.4 mt -105.72 119.7 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.969 HD21 HD12 ' A' ' 45' ' ' ILE . 1.4 pp -109.06 -161.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.958 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.576 ' N ' HD12 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -177.7 124.16 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 76' ' ' VAL . 13.4 p -99.66 138.78 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.504 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HG2' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -121.46 174.98 2.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.508 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.79 84.66 1.99 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.444 2.096 . . . . 0.0 110.515 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 132.77 -36.29 2.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 5' ' ' HIS . 9.8 p30 -155.14 154.19 31.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -1.225 . . . . 0.0 109.83 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.637 ' HB ' HG23 ' A' ' 71' ' ' VAL . 1.4 p -134.3 165.84 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.876 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.532 ' N ' HG22 ' A' ' 76' ' ' VAL . 98.7 m -153.55 145.56 23.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 0.0 109.63 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.989 HG22 ' HA ' ' A' ' 8' ' ' VAL . 2.6 m -122.74 147.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 0.0 109.441 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.4 114.09 20.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.673 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -137.17 172.2 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.314 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.73 -20.19 8.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 m -112.84 109.63 19.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -129.45 146.48 51.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.679 HD12 ' CE1' ' A' ' 63' ' ' TYR . 55.3 mt -139.16 86.39 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.248 -0.907 . . . . 0.0 108.969 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' ILE . 26.3 ttt180 -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.01 107.54 0.57 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.44 79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.421 ' O ' HD12 ' A' ' 89' ' ' LEU . 11.8 t70 -92.26 -34.35 14.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 88' ' ' ASP . 1.7 tp -162.99 131.82 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 53.21 -178.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.628 ' HB2' HD13 ' A' ' 131' ' ' ILE . 11.1 pt-20 -170.2 -39.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -75.06 -27.16 59.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.355 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -84.01 8.07 16.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.394 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.05 -12.36 38.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 0.0 109.178 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -26.82 53.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.44 -0.787 . . . . 0.0 109.467 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -77.25 -22.28 52.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.38 72.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' CD ' HG12 ' A' ' 125' ' ' ILE . 22.0 tttp -79.54 -22.59 43.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -69.07 -48.93 61.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.81 8.1 18.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.855 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -84.05 -24.13 30.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.164 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 33.2 tt0 -69.42 -24.18 63.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.85 . . . . 0.0 109.224 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.67 -47.12 83.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.84 74.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.762 HD11 ' HG ' ' A' ' 121' ' ' LEU . 14.6 mt -84.12 -11.23 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.0 m -48.98 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.666 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -164.6 -38.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.217 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.0 m 48.05 68.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 -67.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 111' ' ' ASP . . . 125.75 -47.36 1.02 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -43.1 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -1.1 . . . . 0.0 109.133 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.429 ' HB ' ' CG ' ' A' ' 116' ' ' GLN . 22.6 m -143.56 36.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.12 -96.47 0.11 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.711 -0.618 . . . . 0.0 109.375 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.609 ' CD1' HG21 ' A' ' 105' ' ' ILE . 2.4 m-85 -60.03 -19.2 51.49 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.32 -54.18 15.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.429 ' CG ' ' HB ' ' A' ' 112' ' ' VAL . 50.6 mm-40 -87.95 -0.72 57.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.687 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -90.88 -25.5 19.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.672 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 p -64.01 -18.63 64.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.706 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.25 -68.91 0.75 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 11.1 pt-20 -55.14 -44.64 75.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 110.046 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.855 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -62.62 -61.01 2.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.49 -14.35 12.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.788 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -33.89 76.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.25 70.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 109.564 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.6 mp -77.29 -1.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.961 . . . . 0.0 109.715 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.645 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -74.51 -20.56 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.071 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.883 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.5 pt20 -87.22 -24.12 24.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.619 HD23 ' C ' ' A' ' 128' ' ' LEU . 2.2 tt -72.17 -9.36 58.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 0.0 109.424 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.417 ' O ' HD13 ' A' ' 133' ' ' LEU . 10.0 mmt85 -84.61 -34.1 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.693 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 127' ' ' GLN . 33.4 m -62.7 -27.6 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 91' ' ' GLU . 96.8 mt -62.34 -39.59 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -65.08 -18.34 65.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 133' ' ' LEU . 4.8 mp -89.03 -34.97 16.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -70.66 -20.88 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -81.02 -6.49 58.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -143.25 23.4 1.84 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -96.24 -20.82 18.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.475 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.505 HG21 ' HG3' ' A' ' 55' ' ' GLN . 1.4 t -43.63 154.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.503 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.692 ' CE2' HG22 ' A' ' 34' ' ' ILE . 3.5 p90 -144.34 -159.65 1.02 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.562 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.1 t60 -114.05 144.79 42.55 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.947 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -103.15 130.97 50.49 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.162 -0.961 . . . . 0.0 109.136 178.356 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -137.44 88.85 2.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.2 p -114.01 116.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG12 ' HG3' ' A' ' 14' ' ' GLN . 16.3 m -124.28 172.19 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB2' ' CG ' ' A' ' 13' ' ' GLN . 15.0 m -124.81 -150.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.403 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -43.24 65.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.616 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -164.91 49.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 109.691 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.458 ' CG ' ' HB2' ' A' ' 10' ' ' SER . 0.1 OUTLIER -151.15 155.54 39.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.0 mt-30 -111.49 161.58 16.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.815 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.488 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 32.3 mtp -140.88 -46.55 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.274 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.626 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -138.75 110.95 7.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.653 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 17' ' ' SER . 19.6 p -139.43 86.48 2.12 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . -177.6 -149.98 8.22 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.731 ' C ' HG12 ' A' ' 20' ' ' VAL . 35.7 mt -82.45 175.25 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 109.529 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.947 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER 176.4 171.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.085 -1.009 . . . . 0.0 108.82 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.591 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.4 tt0 -166.87 -34.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.584 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -116.42 75.66 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.814 HD13 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -99.61 143.6 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.266 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 19.7 tt0 -149.78 158.33 44.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.005 -1.06 . . . . 0.0 109.927 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 30' ' ' GLY . 6.9 p -131.03 149.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -120.51 89.16 3.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.407 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -119.06 -77.7 0.56 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 p -150.38 -86.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.37 -28.6 22.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -90.96 73.06 1.8 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.24 29.97 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -1.115 . . . . 0.0 109.474 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.65 HD13 ' OH ' ' A' ' 35' ' ' TYR . 12.4 mt -130.86 144.75 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.66 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.5 -97.59 2.15 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.713 HD12 ' ND1' ' A' ' 38' ' ' HIS . 5.0 mm -155.72 161.74 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -1.041 . . . . 0.0 109.422 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.65 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -165.12 175.1 2.66 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -71.88 118.62 5.72 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.836 1.69 . . . . 0.0 109.222 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.97 24.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.8 ' CE1' HG21 ' A' ' 71' ' ' VAL . 19.3 p80 -86.9 -171.0 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.798 0.809 . . . . 0.0 110.79 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 1.053 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -54.74 -172.89 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 1.053 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 33.1 Cg_endo -76.79 -179.68 5.62 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.913 1.742 . . . . 0.0 110.271 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.527 ' CA ' ' H ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -90.6 37.64 0.92 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.193 -0.942 . . . . 0.0 110.913 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tp -147.5 116.54 6.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.574 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 t -175.74 -173.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.417 -0.802 . . . . 0.0 109.199 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.75 150.58 52.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.072 -1.018 . . . . 0.0 109.822 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.704 HD13 ' HB2' ' A' ' 69' ' ' LEU . 1.7 mp -102.17 112.64 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 1.0 OUTLIER -65.01 174.72 1.21 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 33.8 Cg_endo -77.14 142.63 21.86 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.574 2.182 . . . . 0.0 110.55 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 152.15 -156.39 26.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.5 ptm -103.6 -168.31 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -1.172 . . . . 0.0 109.35 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 7.6 mt -155.82 126.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.798 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -117.9 110.54 17.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.752 ' CD1' HD12 ' A' ' 23' ' ' ILE . 29.4 mt -118.33 168.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.117 -0.989 . . . . 0.0 110.52 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.593 ' N ' HG22 ' A' ' 52' ' ' ILE . 38.1 t -135.27 120.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.4 ttmt -64.03 147.45 52.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.505 ' HG3' HG21 ' A' ' 3' ' ' THR . 6.3 tm0? -65.05 -49.05 71.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.444 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -53.26 -62.59 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 85.43 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -170.66 176.84 4.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -1.054 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 53' ' ' VAL . 5.3 mt-10 -145.55 128.38 16.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 133.19 32.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -116.23 145.31 43.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.958 . . . . 0.0 109.618 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 63' ' ' TYR . 3.2 mp -121.85 171.93 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.637 ' CE1' HD13 ' A' ' 84' ' ' ILE . 8.2 t80 -141.34 152.7 44.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.29 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.482 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -172.92 -166.9 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.498 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 61.7 m -154.81 21.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 159.48 150.0 5.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.25 159.91 9.5 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.883 ' O ' HG23 ' A' ' 78' ' ' VAL . 2.0 mp -107.9 140.69 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.105 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 69' ' ' LEU . 2.6 tt -121.05 156.9 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.09 -1.006 . . . . 0.0 109.635 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.658 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -158.21 146.45 18.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.11 HG22 HG22 ' A' ' 76' ' ' VAL . 2.2 t -103.31 159.27 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 110.132 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.607 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -126.19 -171.13 0.22 Allowed Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.9 Cg_endo -79.55 40.61 0.97 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.645 1.564 . . . . 0.0 111.294 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 145.49 34.23 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.94 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 5.2 p-10 166.19 133.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.284 . . . . 0.0 109.974 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.11 HG22 HG22 ' A' ' 71' ' ' VAL . 6.6 t -99.62 157.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.285 -0.884 . . . . 0.0 108.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 23.0 m -154.3 137.07 15.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.252 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.5 p -141.32 141.72 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.599 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.24 107.67 17.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 66' ' ' GLY . . . -102.2 162.58 12.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.733 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.96 -47.02 7.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.5 m -100.82 136.03 41.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 109.549 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.698 ' C ' HD12 ' A' ' 84' ' ' ILE . . . -151.24 134.13 15.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.514 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.727 HG21 ' HG3' ' A' ' 127' ' ' GLN . 1.1 mp -111.86 -37.94 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.84 . . . . 0.0 108.959 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 77.26 84.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 42.18 -111.61 0.34 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 87' ' ' GLN . 1.4 tt0 -117.98 62.12 0.76 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.284 -1.127 . . . . 0.0 109.509 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 85' ' ' ARG . 13.0 t70 -85.77 -11.3 53.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -149.26 144.69 26.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 54.16 171.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.18 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HG3' HD11 ' A' ' 131' ' ' ILE . 81.6 tt0 -168.15 -80.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.95 58.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.269 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -6.01 51.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.17 -27.37 19.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.942 . . . . 0.0 108.988 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 mtt -67.2 -40.53 86.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.443 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -33.11 75.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 128' ' ' LEU . 1.3 tmmt? -62.37 -14.36 39.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.79 -53.05 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.482 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -65.23 -15.16 62.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.612 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -84.63 -28.36 26.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.348 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 103' ' ' GLU . 24.8 tt0 -76.33 -48.61 19.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 102' ' ' GLU . 38.6 tt0 -45.43 -29.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -71.22 -56.74 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 mt -87.36 16.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.927 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -65.96 91.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.433 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 71.6 143.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.0 OUTLIER 171.25 166.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.234 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -130.43 132.17 45.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.63 166.49 16.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 3.2 m-20 -97.41 -54.34 3.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -1.194 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 113' ' ' ASP . 21.2 m -122.6 -18.05 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.814 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 112' ' ' VAL . 1.4 m-20 -46.4 -95.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.565 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -13.08 60.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.175 -0.953 . . . . 0.0 108.47 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -73.28 -5.0 36.65 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -85.31 -30.93 23.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.61 -16.62 61.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -21.94 63.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.36 -27.42 25.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.653 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -81.81 -27.84 33.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.673 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.612 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -76.2 -58.57 3.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -45.7 -25.05 0.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HD3' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -66.56 -50.36 63.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.831 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.56 71.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.441 HD12 ' HG3' ' A' ' 98' ' ' LYS . 37.6 mm -59.97 -14.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.861 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -69.5 -47.19 64.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.727 ' HG3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.91 -23.02 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 128' ' ' LEU . 3.2 tt -74.94 -13.54 60.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.73 -48.19 7.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.752 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.9 m -62.69 -38.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -64.57 -18.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.31 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 135' ' ' LYS . 0.1 OUTLIER -82.22 -18.49 42.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 1.1 pp -90.09 -24.83 21.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 131' ' ' ILE . 10.7 t -69.72 -5.57 25.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.516 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.533 ' HE2' ' CG ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -53.19 -20.97 4.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.533 ' CG ' ' HE2' ' A' ' 135' ' ' LYS . 14.8 mttt -113.85 -12.75 12.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.38 -58.0 2.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 ptp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.419 179.879 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.483 ' O ' ' HB ' ' A' ' 3' ' ' THR . 3.8 mtt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 3' ' ' THR . 9.1 t 174.47 128.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 1.053 ' CE2' HG22 ' A' ' 34' ' ' ILE . 21.8 p90 -107.68 -161.57 0.79 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.1 t-80 -117.26 144.59 44.67 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 109.052 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.086 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -135.59 161.4 35.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.306 -1.496 . . . . 0.0 109.194 178.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.966 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -149.49 94.55 2.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.486 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.6 p -99.85 112.27 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.183 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.35 156.82 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 1.6 t -157.71 84.14 0.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . 57.56 21.79 7.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 1.3 pt-20 175.13 88.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -59.49 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.31 48.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.649 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 9.2 mtt -136.52 -52.47 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.427 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.636 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 33.9 t80 -166.53 129.25 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.494 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 79.4 p -161.6 94.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.422 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.22 -146.8 11.84 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.749 ' C ' HG12 ' A' ' 20' ' ' VAL . 11.4 mt -68.24 167.92 13.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -1.142 . . . . 0.0 109.257 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.086 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 177.9 155.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 108.794 -177.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 6.4 tt0 -151.06 -44.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.549 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -105.97 76.49 1.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 111.494 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.879 HG22 HG12 ' A' ' 52' ' ' ILE . 6.5 pt -102.97 147.81 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.518 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 37.4 tt0 -145.71 127.24 15.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.786 -1.196 . . . . 0.0 110.333 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.514 HG23 ' HA2' ' A' ' 33' ' ' GLY . 5.4 t -104.71 133.09 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.44 -0.787 . . . . 0.0 108.963 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -124.46 129.55 50.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.467 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.23 -128.36 1.29 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -108.39 -18.52 13.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -1.168 . . . . 0.0 109.566 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.34 149.14 27.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.75 -74.44 1.32 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER 60.87 -175.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -1.099 . . . . 0.0 109.908 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 31' ' ' GLU . 14.3 mt 61.11 138.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 109.749 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.518 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.89 -102.1 2.42 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.053 HG22 ' CE2' ' A' ' 4' ' ' TYR . 10.5 mm -154.24 141.7 12.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.315 -1.109 . . . . 0.0 109.154 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -124.69 177.7 1.72 Allowed Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -75.11 76.51 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.04 1.827 . . . . 0.0 110.425 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.37 41.04 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.469 ' CD2' ' CD1' ' A' ' 34' ' ' ILE . 70.2 t60 -99.49 144.81 28.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -1.136 . . . . 0.0 109.565 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.955 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -55.64 175.65 0.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.955 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.46 106.2 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.709 2.273 . . . . 0.0 110.443 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.482 ' H ' HG11 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -100.11 122.61 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.57 HD21 ' HG3' ' A' ' 70' ' ' GLU . 2.9 mt -136.21 71.65 1.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 p -137.69 -154.91 0.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.494 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.01 167.51 10.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.728 HD11 ' HB ' ' A' ' 78' ' ' VAL . 1.2 mt -103.57 -147.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.114 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -168.88 167.79 5.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.998 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.7 Cg_endo -78.88 122.42 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.745 2.297 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 176.85 -161.06 28.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.685 ' HE1' HG23 ' A' ' 130' ' ' VAL . 2.3 ppp? -107.87 176.08 5.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -1.081 . . . . 0.0 109.222 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -164.38 126.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.995 -1.066 . . . . 0.0 110.064 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -99.14 169.43 9.4 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.879 HG12 HG22 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -161.31 158.27 2.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.415 -1.428 . . . . 0.0 110.692 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.549 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 39.7 t -139.21 100.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -58.2 159.82 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 3' ' ' THR . 4.1 tm0? -42.08 -52.09 4.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 109.619 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -57.98 178.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.18 82.37 1.68 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.46 -167.59 2.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 9.2 pt-20 -166.68 141.27 4.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.25 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.589 ' H ' HG22 ' A' ' 52' ' ' ILE . 1.7 mm-40 -116.2 167.63 10.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.718 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 1.011 ' CD2' HG22 ' A' ' 130' ' ' VAL . 6.0 m-85 -129.24 119.15 23.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.049 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.675 HG22 ' H ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -126.79 179.93 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.132 -0.98 . . . . 0.0 109.871 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.775 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -173.79 142.62 0.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -147.12 178.92 8.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.746 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 14.0 p -104.99 -25.47 12.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.64 178.19 37.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.11 -133.5 3.72 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -144.4 130.43 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.24 . . . . 0.0 109.31 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.887 ' HA ' HG12 ' A' ' 78' ' ' VAL . 2.3 pp -109.13 125.91 52.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.786 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HG3' HD21 ' A' ' 42' ' ' LEU . 22.8 tt0 -125.17 129.14 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.065 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 ' HA ' ' A' ' 40' ' ' PRO . 7.1 p -99.24 155.46 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.832 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.509 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -138.21 170.83 9.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.432 -0.792 . . . . 0.0 109.442 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.47 71.76 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.659 2.239 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.19 -1.35 7.72 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.234 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 38.2 p-10 -172.88 175.26 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.933 -1.333 . . . . 0.0 109.865 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG13 ' HA ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -161.14 162.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 7' ' ' ASP . 29.4 m -158.54 149.36 20.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.418 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.887 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -135.86 157.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 112.88 16.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.711 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.61 159.18 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.93 -48.87 16.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.7 t -102.04 -178.56 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -170.13 85.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 84' ' ' ILE . 3.1 mp -104.09 67.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.21 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.578 ' HB3' ' HE2' ' A' ' 15' ' ' MET . 1.2 ptt180 -42.23 139.42 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.495 -0.753 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.485 ' C ' ' CG ' ' A' ' 87' ' ' GLN . . . -47.36 148.81 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.827 ' OE1' HG21 ' A' ' 134' ' ' THR . 0.0 OUTLIER 58.61 25.1 12.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -1.222 . . . . 0.0 109.043 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 87' ' ' GLN . 17.6 p-10 -41.04 -46.39 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -159.04 -61.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.874 . . . . 0.0 109.343 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.08 172.2 13.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.662 ' HA ' HD11 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -140.31 -87.27 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.359 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -19.29 56.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -77.17 -8.43 57.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.36 -8.32 51.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.959 . . . . 0.0 109.203 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.414 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.48 -23.37 58.86 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.377 -0.827 . . . . 0.0 109.527 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -85.37 5.41 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.626 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -90.1 -12.44 38.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -29.52 65.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.542 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -90.23 -32.66 16.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.39 -8.11 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.202 -0.937 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 97' ' ' ALA . . . -87.09 -30.67 20.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -0.989 . . . . 0.0 109.384 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.564 ' HA ' HD12 ' A' ' 105' ' ' ILE . 1.9 tt0 -69.56 -33.4 72.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.525 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.57 -35.29 73.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -75.27 -20.6 59.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 105' ' ' ILE . 32.3 mt -90.33 21.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 55.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -119.8 145.77 46.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.381 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.439 ' HA ' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p -128.95 138.29 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.686 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.6 -68.78 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.26 -100.14 0.14 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.607 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -72.14 156.76 38.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.457 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 111' ' ' ASP . 14.8 m 40.88 37.91 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.682 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 11.2 t70 -88.14 -96.3 0.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.192 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.37 -19.38 63.84 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.39 -41.79 84.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -90.12 -16.63 29.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.348 -0.845 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 105' ' ' ILE . . . -79.38 -32.14 43.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.4 t -55.71 -21.75 20.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 109.587 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.85 -29.28 18.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.28 -24.75 63.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.497 ' O ' HD13 ' A' ' 125' ' ' ILE . 8.8 tt -82.51 -50.92 8.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.54 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.44 1.73 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.829 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.09 -61.76 1.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -78.3 -20.48 51.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.3 mp -75.72 -12.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 109.163 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.775 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -68.67 -41.7 78.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -78.66 -7.62 57.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 5.8 tp -78.26 -26.76 47.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.468 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.512 ' O ' HD23 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -87.94 -25.25 23.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.752 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 1.011 HG22 ' CD2' ' A' ' 61' ' ' PHE . 2.3 p -80.53 -25.7 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.643 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.1 tt -90.58 -24.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.232 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 -44.94 46.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.095 -1.003 . . . . 0.0 110.198 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 129' ' ' ARG . 2.6 pp -68.56 -11.03 59.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 110.038 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.827 HG21 ' OE1' ' A' ' 87' ' ' GLN . 57.4 p -53.28 -41.88 66.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.569 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -41.76 64.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -94.57 40.66 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.379 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.12 6.75 36.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.847 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.542 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.7 mtp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.553 HG21 ' CG ' ' A' ' 55' ' ' GLN . 70.9 p -132.39 161.7 32.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.905 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.746 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 4.0 p90 -163.61 -143.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.772 ' HA ' HG12 ' A' ' 20' ' ' VAL . 2.4 t-80 -139.69 149.45 43.69 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.072 HD23 HG21 ' A' ' 20' ' ' VAL . 1.6 pp -142.67 159.25 42.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.685 -1.259 . . . . 0.0 108.631 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 77' ' ' THR . 9.8 t0 -135.49 87.0 2.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.895 -1.128 . . . . 0.0 109.678 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' ' 16' ' ' PHE . 14.7 p -99.04 100.44 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.22 -0.925 . . . . 0.0 109.604 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 13' ' ' GLN . 55.2 t -108.95 149.03 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.865 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 2.4 p -162.58 144.9 10.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.74 -96.98 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.717 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.55 38.98 3.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.056 -1.028 . . . . 0.0 109.567 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.582 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.86 -153.71 0.34 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.251 -0.905 . . . . 0.0 109.457 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.422 ' O ' ' SD ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 70.46 61.5 0.21 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.519 -0.738 . . . . 0.0 109.491 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.641 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -143.72 -70.28 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.519 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.804 ' HB3' HG12 ' A' ' 8' ' ' VAL . 34.9 t80 -162.8 131.95 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -160.82 105.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.278 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 5' ' ' HIS . . . 146.67 -158.62 27.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.804 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -48.39 -179.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.068 -1.254 . . . . 0.0 109.474 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.072 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 170.37 115.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.549 -1.344 . . . . 0.0 109.74 179.32 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 1.5 tt0 -67.93 -44.7 76.27 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.5 mtpt -179.5 143.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.995 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.94 HG22 ' CG1' ' A' ' 52' ' ' ILE . 23.5 pt -105.34 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.501 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -178.92 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 109.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.24 127.61 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.992 . . . . 0.0 109.513 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -130.64 140.6 50.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.83 54.11 0.04 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.493 ' HB3' ' CB ' ' A' ' 46' ' ' LYS . 89.4 p -174.17 -159.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 109.438 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.29 48.18 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -167.11 -144.07 3.99 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.3 OUTLIER 166.98 74.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.792 HD13 ' OH ' ' A' ' 35' ' ' TYR . 12.6 mt -153.07 178.24 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.877 . . . . 0.0 109.67 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -128.68 -112.36 1.63 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.784 -2.127 . . . . 0.0 107.784 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.746 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 12.7 mm -154.1 138.25 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 109.124 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.792 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -138.28 176.9 2.37 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.6 Cg_endo -74.06 8.11 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.995 1.797 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.6 10.77 5.23 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' ALA . 40.1 t60 -54.33 123.75 13.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -1.215 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -49.17 178.56 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 34.9 Cg_endo -77.72 81.36 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.465 2.11 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -98.71 137.61 37.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.663 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.06 72.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.412 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 p -144.27 -146.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.51 169.92 8.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.454 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -130.49 173.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 109.251 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' CB ' ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -111.18 173.07 3.07 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.7 Cg_endo -78.31 -177.94 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.735 2.29 . . . . 0.0 110.474 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.38 -159.12 23.51 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.539 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 4.6 ppp? -113.28 172.78 6.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.255 -1.144 . . . . 0.0 109.126 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 62' ' ' ILE . 5.1 tt -146.75 146.81 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.052 -1.03 . . . . 0.0 110.922 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.46 160.28 23.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.94 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -153.71 158.98 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.458 -1.401 . . . . 0.0 110.926 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.77 102.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -52.09 141.33 18.64 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.122 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.574 ' OE1' ' CG ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -39.91 -59.1 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.574 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -122.36 31.58 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.739 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.35 -108.15 3.16 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -151.9 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -1.127 . . . . 0.0 109.139 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER 179.65 147.67 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.551 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.8 mt-10 -130.91 161.39 31.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.104 -0.998 . . . . 0.0 109.782 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -117.64 125.31 50.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.272 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 50' ' ' ILE . 5.2 mt -136.8 166.58 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.331 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.856 ' HE1' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.92 146.18 25.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.1 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -172.81 4.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.519 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' A' ' 82' ' ' THR . 62.8 m -115.65 14.38 16.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.83 151.45 25.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . -165.85 -106.64 0.19 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 9.1 mt -139.2 122.27 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 108.97 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.657 ' HB2' HD13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -106.58 133.48 51.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.782 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -133.5 143.64 48.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.019 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.671 ' HA ' HG12 ' A' ' 76' ' ' VAL . 14.7 p -109.94 139.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.917 -1.114 . . . . 0.0 109.494 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.579 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -127.87 176.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 108.862 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.0 Cg_endo -79.22 88.91 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.514 2.142 . . . . 0.0 111.103 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 101.07 -3.43 55.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.4 OUTLIER -164.37 155.3 15.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.242 . . . . 0.0 109.72 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.685 HG22 ' HA ' ' A' ' 6' ' ' LEU . 35.5 m -133.16 175.74 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 108.845 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 7' ' ' ASP . 17.6 m -156.63 104.58 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.282 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.5 m -114.47 115.8 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 108.963 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -100.21 173.2 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.132 -0.98 . . . . 0.0 110.034 -179.312 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -157.69 -157.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 0.0 109.182 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.22 -30.78 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.95 . . . . 0.0 109.805 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.432 ' HB ' ' OG ' ' A' ' 65' ' ' SER . 5.5 m -110.01 153.2 24.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.889 ' C ' HD12 ' A' ' 84' ' ' ILE . . . -152.64 119.75 5.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.793 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.889 HD12 ' C ' ' A' ' 83' ' ' ALA . 2.6 mp -139.07 95.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.29 -0.881 . . . . 0.0 108.907 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 84' ' ' ILE . 13.5 ttm180 -41.24 161.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.394 -0.816 . . . . 0.0 109.898 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -51.1 -26.32 12.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -151.7 93.41 1.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -1.153 . . . . 0.0 109.637 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -94.14 -57.88 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -83.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 109.475 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.13 165.97 17.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.43 -19.94 11.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.945 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 -25.59 32.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -65.51 -13.9 59.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.71 -32.0 16.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.379 -0.825 . . . . 0.0 109.29 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.488 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -56.01 -40.61 73.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.802 . . . . 0.0 109.681 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.91 -16.5 53.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.54 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 100' ' ' LYS . . . -64.37 -27.76 69.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.654 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -55.71 29.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.549 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -19.92 62.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.907 . . . . 0.0 109.554 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.95 -34.28 77.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.784 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -89.61 -20.81 23.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.401 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.02 -16.67 64.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -80.53 -30.37 37.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -32.36 32.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 118' ' ' SER . 25.6 mt -88.98 22.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 t -60.84 -24.94 66.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 m -140.02 167.08 22.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.215 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.08 134.1 3.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.618 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -156.14 179.47 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.89 -178.89 35.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.571 ' O ' HG22 ' A' ' 112' ' ' VAL . 12.4 m-20 -98.41 127.62 44.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.518 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.29 28.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 109.672 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 111' ' ' ASP . 15.5 t70 -84.88 -93.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.45 -13.6 60.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.1 62.73 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.468 ' HG3' ' HB ' ' A' ' 112' ' ' VAL . 3.8 mm-40 -74.81 -45.95 40.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.498 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.45 -23.3 65.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.496 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.543 ' HB2' ' CG2' ' A' ' 105' ' ' ILE . 8.6 p -70.6 -5.78 31.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.5 -12.23 52.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.41 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -73.71 -12.52 60.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -70.1 -60.79 2.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.69 -10.44 27.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.539 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -34.4 36.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.209 -0.932 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -82.4 -14.96 54.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 48.0 mm -73.04 -8.16 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -73.35 -35.23 65.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -0.907 . . . . 0.0 109.642 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 34.2 mt-30 -69.83 -23.26 63.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -69.47 -20.48 63.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.379 -0.825 . . . . 0.0 109.809 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -85.02 -40.63 16.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.566 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . 20.8 m -68.01 -16.95 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.669 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 127' ' ' GLN . 4.9 pt -90.97 -31.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.484 ' HG2' HG13 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -80.05 -30.87 39.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.743 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.5 mp -79.81 -40.22 29.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.758 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 130' ' ' VAL . 17.9 p -63.16 -34.16 77.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.68 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -74.18 -15.98 61.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.542 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.04 29.6 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.668 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.41 -78.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.935 . . . . 0.0 109.53 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.0 mtm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.226 0.536 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -104.86 -148.15 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.652 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 1.23 ' CG ' HG22 ' A' ' 20' ' ' VAL 0.253 0.7 OUTLIER -142.25 -169.71 3.01 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 124.107 1.908 . . . . 0.0 115.576 -175.438 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 7.3 t-80 -170.8 95.98 0.21 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 102.319 -3.215 . . . . 0.0 102.319 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.89 HD23 HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.52 147.83 22.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.522 -1.361 . . . . 0.0 108.638 -176.474 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -155.76 69.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.847 -1.158 . . . . 0.0 110.015 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 64' ' ' LEU . 1.7 p -102.74 112.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 108.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 3.9 m -103.97 144.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.802 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.843 ' OG ' ' HB2' ' A' ' 83' ' ' ALA . 55.9 m -107.35 53.11 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 109.265 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 72.03 77.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.361 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.38 31.6 12.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.462 ' CB ' ' HB2' ' A' ' 10' ' ' SER . 1.9 tp60 -114.79 -28.18 7.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 46.07 88.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.647 ' HE1' ' O ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -85.82 -84.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 109.537 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.725 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 1.1 t80 -101.05 112.09 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 94.6 p -128.72 85.84 2.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.131 -0.981 . . . . 0.0 109.658 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 168.33 148.15 5.62 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.597 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -35.63 161.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.886 0.851 . . . . 0.0 111.656 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.23 HG22 ' CG ' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -158.51 -160.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 O-C-N 121.684 -0.635 . . . . 0.0 109.988 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.833 ' N ' HG23 ' A' ' 20' ' ' VAL . 2.3 tt0 -160.33 -32.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.734 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.6 mmmt -141.21 85.2 1.96 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.782 -1.199 . . . . 0.0 110.309 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.87 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.57 142.68 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.324 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -127.41 143.91 51.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.762 -1.211 . . . . 0.0 110.309 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -133.44 116.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.176 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -122.69 125.35 45.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.07 -40.27 0.18 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 159.87 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -1.192 . . . . 0.0 109.646 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -48.09 -43.03 30.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.55 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.44 -51.53 47.17 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.84 20.37 11.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -1.191 . . . . 0.0 109.414 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 153.93 40.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.716 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.39 171.03 23.85 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.949 HG22 ' OH ' ' A' ' 4' ' ' TYR . 16.6 mm -101.82 112.39 34.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.858 -1.378 . . . . 0.0 109.136 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -122.92 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 33.5 Cg_endo -76.89 5.56 4.83 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.551 1.501 . . . . 0.0 110.44 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.84 17.84 2.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.452 ' CG ' HD13 ' A' ' 34' ' ' ILE . 16.7 t60 -44.81 146.53 0.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -1.092 . . . . 0.0 109.541 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.0 10.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.669 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.563 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.4 Cg_endo -77.55 77.58 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.637 2.225 . . . . 0.0 110.222 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 41' ' ' LEU . 1.6 mm? -98.42 159.03 15.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.718 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.43 32.04 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.417 ' O ' HG13 ' A' ' 68' ' ' ILE . 44.1 p -114.96 -144.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.389 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.79 164.91 11.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.015 . . . . 0.0 109.155 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.895 ' CD1' HD13 ' A' ' 69' ' ' LEU . 5.4 mt -128.99 149.88 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.99 . . . . 0.0 109.554 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' HD2' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -70.24 167.86 22.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -78.99 136.58 13.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.744 2.296 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.62 -161.96 26.43 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.626 ' C ' HG22 ' A' ' 50' ' ' ILE . 8.3 ptm -117.4 -164.23 0.98 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -1.133 . . . . 0.0 109.192 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.918 HD12 ' HB ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -174.68 147.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.085 . . . . 0.0 109.982 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -129.17 126.37 39.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.654 HG23 ' CA ' ' A' ' 23' ' ' ILE . 30.6 mt -123.53 166.36 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.874 -1.141 . . . . 0.0 111.037 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.54 ' N ' HG22 ' A' ' 52' ' ' ILE . 34.2 t -132.23 119.26 39.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -71.05 129.49 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.653 . . . . 0.0 109.315 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 11.5 tt0 52.68 -90.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 54' ' ' LYS . 3.3 t-160 -171.1 60.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.77 -68.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -76.5 179.73 5.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -1.101 . . . . 0.0 109.399 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -156.5 153.68 29.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.844 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 156.44 36.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.251 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 1.029 ' CD2' HG22 ' A' ' 130' ' ' VAL . 4.4 m-85 -119.24 124.97 48.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.544 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.918 ' HB ' HD12 ' A' ' 50' ' ' ILE . 5.3 mm -128.71 178.29 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.307 -0.871 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.637 ' H ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -173.24 125.98 0.43 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -113.36 -177.61 3.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.514 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 1.2 t -149.56 18.19 0.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.932 . . . . 0.0 109.384 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.13 156.72 6.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.14 -169.67 25.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -115.94 118.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -1.123 . . . . 0.0 109.369 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.895 HD13 ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -101.91 153.12 20.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.208 -0.933 . . . . 0.0 109.922 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 41.6 tt0 -152.15 134.46 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG23 HG22 ' A' ' 76' ' ' VAL . 12.6 p -99.92 139.77 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.006 -1.059 . . . . 0.0 110.248 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.59 174.53 3.28 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.4 Cg_endo -78.62 103.4 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.32 2.014 . . . . 0.0 110.821 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 75.42 45.64 17.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 2.2 t30 159.91 115.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.468 -1.019 . . . . 0.0 109.177 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.663 HG22 HG23 ' A' ' 71' ' ' VAL . 23.5 t -102.2 146.53 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 108.875 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 7' ' ' ASP . 22.2 m -147.59 136.68 22.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.802 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.776 HG13 HG23 ' A' ' 8' ' ' VAL . 1.4 p -150.4 142.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 108.991 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 4.6 mp -105.21 159.26 16.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -163.73 -174.36 3.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.333 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.68 -39.03 3.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 1.8 m -99.46 149.18 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.254 -0.904 . . . . 0.0 109.196 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.843 ' HB2' ' OG ' ' A' ' 10' ' ' SER . . . -159.81 141.83 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.647 ' O ' ' HE1' ' A' ' 15' ' ' MET . 46.8 mt -132.67 126.14 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.328 -0.858 . . . . 0.0 108.793 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 86' ' ' GLY . 3.0 tpt180 -92.37 91.98 7.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.034 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 39.06 -102.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HG2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -94.26 81.81 4.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -1.161 . . . . 0.0 109.593 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.65 -53.33 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.098 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 2.8 mp -92.11 31.92 1.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.066 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 131' ' ' ILE . 18.2 m-20 62.21 -179.55 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.372 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.443 ' HG2' HD11 ' A' ' 131' ' ' ILE . 1.6 mt-10 -108.63 -36.59 6.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.0 -12.75 57.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 48.1 ttp180 -82.28 -26.77 32.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.44 -13.53 40.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 108.9 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.487 ' HA ' HD11 ' A' ' 128' ' ' LEU . 3.4 mtt -70.34 -20.79 62.96 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -68.8 -18.98 64.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.53 -54.97 3.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.094 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HG2' ' CG1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.2 -39.47 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.104 -179.344 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -36.04 82.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 110.005 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -4.57 58.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 109.876 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -90.29 -20.97 22.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.714 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 5.6 tp10 -73.68 -36.8 65.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.34 -22.96 64.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -51.72 26.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 105' ' ' ILE . 91.1 mt -89.14 22.84 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.98 -54.74 7.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -98.77 132.95 43.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -162.75 138.87 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.65 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -168.33 169.08 10.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.63 -173.53 28.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 112' ' ' VAL . 5.0 t0 -101.17 135.26 42.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.272 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.59 28.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 6.9 t70 -79.24 -95.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.418 -0.801 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -69.76 -21.72 63.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.169 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.29 73.55 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -46.39 85.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.85 -11.22 58.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.9 t -82.77 6.03 19.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.907 . . . . 0.0 109.592 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.21 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 109.558 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -77.03 -18.51 58.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.44 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.647 HD11 ' HB1' ' A' ' 101' ' ' ALA . 9.0 tt -71.77 -63.32 1.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.05 -18.94 4.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.702 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -45.27 -38.32 5.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.79 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -90.55 -23.71 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 0.0 110.127 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 125' ' ' ILE . 2.2 mp -77.08 -1.06 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.83 -24.15 60.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.01 -1.056 . . . . 0.0 109.166 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.776 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.8 pt20 -90.06 -32.13 16.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -63.32 -20.84 65.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.678 -179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.467 ' O ' HD23 ' A' ' 133' ' ' LEU . 2.0 mtt180 -90.15 -48.09 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 1.029 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -62.27 -28.97 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 127' ' ' GLN . 4.8 tt -90.74 -29.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.249 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 17.0 mm-40 -72.86 -34.01 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.389 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 133' ' ' LEU . 2.9 pp -83.62 10.92 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.992 . . . . 0.0 109.727 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 130' ' ' VAL . 76.3 p -83.05 -9.68 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -84.76 -47.94 9.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.752 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.491 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.5 OUTLIER -80.18 -2.81 46.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.705 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.57 -22.4 54.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.11 -0.994 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.437 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.47 ' O ' ' HB ' ' A' ' 3' ' ' THR . 4.5 mtm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.196 0.522 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 3' ' ' THR . 12.2 t 178.05 124.88 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.62 ' OH ' HG22 ' A' ' 34' ' ' ILE . 30.0 p90 -100.74 -159.41 0.73 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.77 144.02 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 108.823 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.062 HD12 ' N ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -135.21 167.67 20.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.532 178.618 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 1.062 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.49 97.75 2.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.907 HG12 ' CG1' ' A' ' 78' ' ' VAL . 19.3 m -99.49 148.54 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 108.695 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 8' ' ' VAL . 1.9 t -155.88 126.59 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.477 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.77 104.53 13.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.842 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.22 -95.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.716 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -139.26 56.91 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.607 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 169.99 13.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 111.52 22.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.566 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 4.6 mtt -116.76 -80.87 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.958 . . . . 0.0 109.842 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.5 t80 -130.16 147.08 51.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.744 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 p -175.07 92.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.79 -147.38 14.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.77 ' C ' HG12 ' A' ' 20' ' ' VAL . 8.9 mt -64.17 172.61 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -1.194 . . . . 0.0 108.982 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.051 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 173.47 149.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.816 -1.177 . . . . 0.0 109.438 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -142.75 -47.12 0.32 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.645 ' C ' HD13 ' A' ' 23' ' ' ILE . 4.6 tttp -93.94 126.37 39.11 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.207 -0.933 . . . . 0.0 109.088 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.913 HG22 ' CG1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -154.97 66.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.607 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 18.6 tt0 -98.51 132.29 44.06 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.819 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 49' ' ' MET . 2.7 p -119.94 140.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.4 m -114.57 132.23 56.41 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 109.591 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.2 -107.94 0.63 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -150.8 159.51 44.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.463 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 51.01 42.83 28.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 148.32 -172.58 28.54 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 1.1 pt-20 179.61 -155.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.415 -1.05 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 35' ' ' TYR . 15.4 mt 60.34 130.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.347 -0.846 . . . . 0.0 109.633 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.85 -84.03 1.77 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.62 HG22 ' OH ' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -162.97 161.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.376 -1.073 . . . . 0.0 109.535 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -154.14 173.43 4.73 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -178.675 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.525 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 33.9 Cg_endo -75.88 94.56 1.01 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.309 2.006 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.12 -12.78 2.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.488 ' ND1' HD11 ' A' ' 34' ' ' ILE . 3.9 t-80 -60.71 -178.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -104.73 167.73 9.48 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.682 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.6 Cg_endo -78.89 77.84 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.746 2.298 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HE1' ' A' ' 38' ' ' HIS . 21.4 mt -99.68 155.31 17.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.398 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.412 HD12 ' CD ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -126.69 99.7 5.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.529 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -135.71 -168.73 2.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.647 ' C ' HD12 ' A' ' 45' ' ' ILE . . . -101.91 -172.02 2.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.995 HD11 ' CB ' ' A' ' 69' ' ' LEU . 2.0 mp -110.8 116.88 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.648 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.51 166.1 9.99 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.201 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.38 120.41 4.86 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.622 2.215 . . . . 0.0 110.536 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.5 -155.94 27.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.878 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.7 ppp? -119.11 174.86 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -1.12 . . . . 0.0 109.267 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 50' ' ' ILE . 1.5 tt -153.45 131.55 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.095 -1.003 . . . . 0.0 110.344 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.27 21.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.913 ' CG1' HG22 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -142.48 143.51 25.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.758 -1.214 . . . . 0.0 110.618 -178.277 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 37.2 t -127.53 104.07 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.71 136.37 57.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.16 -99.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.32 21.49 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -137.4 -65.26 0.05 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -69.87 142.1 53.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.45 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.3 131.63 25.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.862 . . . . 0.0 109.361 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 52' ' ' ILE . 1.2 tt0 -121.01 153.81 36.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.763 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 14.3 m-85 -100.45 155.55 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 16' ' ' PHE . 50.5 mt -154.8 160.7 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.568 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -163.63 152.95 14.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.91 . . . . 0.0 108.927 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 64' ' ' LEU . 2.5 pt? -179.88 162.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.495 ' CB ' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -143.39 36.11 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.4 114.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.11 -177.54 35.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.2 mp -129.61 135.36 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -1.153 . . . . 0.0 109.28 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.995 ' CB ' HD11 ' A' ' 45' ' ' ILE . 1.2 tt -121.5 145.13 48.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' CD ' HD12 ' A' ' 42' ' ' LEU . 47.5 tt0 -135.87 129.66 32.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 40' ' ' PRO . 4.3 p -100.08 123.72 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.498 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -101.75 174.11 3.12 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.2 Cg_endo -78.24 72.45 6.25 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.631 2.221 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.51 -14.33 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.189 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' VAL . 78.7 m-20 -145.53 -176.16 5.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.305 . . . . 0.0 109.893 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 75' ' ' ASN . 12.1 t -158.66 165.82 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.542 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -169.63 140.06 2.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.975 . . . . 0.0 109.604 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.907 ' CG1' HG12 ' A' ' 8' ' ' VAL . 1.7 p -153.31 140.42 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.39 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mt -116.41 150.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.45 13.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 -39.47 4.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 m -108.9 136.72 47.97 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 0.0 109.197 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.566 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -158.4 163.33 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.088 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 43.7 mt -142.92 116.87 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.54 109.62 21.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.594 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.64 -146.38 31.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' OE1' HG12 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -107.97 34.43 3.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -1.098 . . . . 0.0 108.798 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 87' ' ' GLN . 4.5 t0 -44.71 -29.67 0.81 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.407 -0.808 . . . . 0.0 109.68 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -120.7 111.35 17.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.617 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 21.2 m-20 60.24 157.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 -83.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -16.95 60.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.497 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.91 0.1 32.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.41 -5.75 55.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.427 ' HG3' HD11 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -81.21 -22.64 38.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.79 -28.6 19.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.624 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.46 -20.02 62.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.674 ' HG3' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -84.74 -26.16 27.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.36 11.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -62.11 -26.94 68.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.17 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.74 -44.62 20.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.323 -0.861 . . . . 0.0 109.106 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -54.03 -38.16 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.288 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.412 ' OE1' ' CA ' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -46.54 -42.32 15.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -72.46 -38.12 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.4 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 121' ' ' LEU . 11.6 mt -87.94 22.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -55.91 27.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.86 136.8 54.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 59.7 p -131.23 -179.41 5.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -178.63 -171.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.89 176.46 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 25.5 t0 -83.74 -73.94 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -103.61 13.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.02 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 16.1 t80 -71.29 -16.92 62.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.165 -0.959 . . . . 0.0 108.601 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.0 66.77 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -47.97 75.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.37 -6.08 37.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.71 -11.06 54.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.562 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 123' ' ' LYS . . . -85.03 -29.28 25.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.615 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -28.43 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.619 HD13 HD11 ' A' ' 105' ' ' ILE . 0.9 OUTLIER -81.32 -61.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.65 -38.63 2.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 109.743 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HD3' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -45.75 -59.35 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.46 -21.64 63.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.752 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.674 HG23 ' HG3' ' A' ' 98' ' ' LYS . 20.3 mm -71.42 -4.2 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 49' ' ' MET . . . -84.42 -9.91 57.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.653 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.562 ' CD ' HD13 ' A' ' 84' ' ' ILE . 4.2 tt0 -82.65 -26.4 32.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.936 . . . . 0.0 109.651 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 61.8 tp -75.52 -8.98 58.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -43.93 10.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.933 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 134' ' ' THR . 33.9 m -69.74 -24.72 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.928 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.67 HD13 ' C ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -89.52 -48.13 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.87 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 131' ' ' ILE . 13.0 pt-20 -54.66 -24.32 21.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.322 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -80.66 -43.06 21.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 0.0 109.78 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 130' ' ' VAL . 41.7 p -43.11 -34.85 1.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.645 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -67.78 -49.67 61.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -96.51 45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.11 -36.23 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.606 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.585 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.2 ptt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.852 HG23 ' HG2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 54.2 103.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.921 ' CE2' HG22 ' A' ' 34' ' ' ILE . 27.3 p90 -99.24 -152.08 0.4 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.763 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -129.68 146.63 51.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.087 HD23 HG21 ' A' ' 20' ' ' VAL . 2.5 pp -133.31 169.67 16.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.312 -1.493 . . . . 0.0 109.252 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.842 ' N ' HD12 ' A' ' 6' ' ' LEU . 21.6 t70 -146.0 100.53 3.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.1 p -105.57 105.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.083 -1.011 . . . . 0.0 109.745 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.361 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.746 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -166.95 73.11 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.746 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 72.32 5.38 5.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 39.6 mt-10 -156.58 76.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 12' ' ' GLU . 3.3 pt20 -56.01 -164.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.723 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER 72.11 32.04 1.84 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.534 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.807 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 16.0 mtt -106.18 -79.96 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 109.249 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.675 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 37.5 t80 -146.25 117.78 8.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -145.05 108.65 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.115 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 143.5 -163.32 27.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.815 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -43.93 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.695 -0.885 . . . . 0.0 110.879 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.087 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 167.05 150.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.852 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -147.78 -39.18 0.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.8 -1.187 . . . . 0.0 110.471 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 1.8 mptt -116.95 78.57 1.22 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.937 -1.102 . . . . 0.0 111.324 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.897 HG22 HG12 ' A' ' 52' ' ' ILE . 7.8 pt -101.14 160.93 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 4.2 tt0 -162.78 116.28 1.67 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.706 -1.246 . . . . 0.0 110.184 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -99.93 111.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 108.988 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.444 HG23 ' CD ' ' A' ' 31' ' ' GLU . 97.7 m -100.15 110.84 23.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.438 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -136.19 -116.53 1.57 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -118.24 124.03 46.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -1.139 . . . . 0.0 109.57 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.0 tt0 76.44 111.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.35 164.76 39.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 1.2 tt0 -163.54 64.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.145 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 23.4 mt -149.58 140.8 23.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.091 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.91 -105.06 2.65 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.806 -2.117 . . . . 0.0 107.806 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.921 HG22 ' CE2' ' A' ' 4' ' ' TYR . 7.6 mm -153.85 143.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.289 -1.124 . . . . 0.0 109.278 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -142.18 173.63 4.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.317 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -72.63 94.45 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.954 1.769 . . . . 0.0 109.752 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.15 4.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.519 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.0 t-80 -71.75 166.06 22.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.996 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -89.67 176.23 3.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.253 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 1.008 ' HA ' HG11 ' A' ' 71' ' ' VAL . 34.9 Cg_endo -76.82 100.7 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.516 2.144 . . . . 0.0 110.374 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 140.29 29.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.592 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.76 48.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 p -118.71 -146.61 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.385 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.581 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -100.34 176.3 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.644 HD11 HG21 ' A' ' 25' ' ' VAL . 1.6 tp -102.29 151.23 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 141.52 47.44 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.958 . . . . 0.0 109.607 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.3 Cg_endo -79.38 -179.8 5.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.554 2.169 . . . . 0.0 110.321 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 101.58 -129.0 9.75 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.441 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.9 ptm -119.42 177.79 4.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.155 . . . . 0.0 109.236 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.2 tt -152.84 130.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.075 -1.016 . . . . 0.0 110.003 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.08 HD11 HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -148.59 158.8 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.65 -1.281 . . . . 0.0 111.076 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 59' ' ' GLU . 25.0 t -139.35 99.72 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HD3' ' CB ' ' A' ' 58' ' ' HIS . 6.0 ptmt -65.91 153.35 42.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.639 ' CB ' HG21 ' A' ' 3' ' ' THR . 0.6 OUTLIER -41.62 -52.88 3.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.488 -0.758 . . . . 0.0 110.137 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -43.67 -51.04 7.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.868 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.21 -38.71 1.44 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.461 ' CB ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -48.65 129.1 16.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -1.235 . . . . 0.0 109.313 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.59 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -105.45 123.59 48.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.329 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 52' ' ' ILE . 1.3 tm-20 -122.95 144.83 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 1.6 p90 -114.62 135.85 53.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.701 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.7 mm -108.43 -155.87 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.83 . . . . 0.0 109.07 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' H ' HG22 ' A' ' 62' ' ' ILE . 5.3 t80 -168.0 125.18 1.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.66 178.04 6.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 0.0 109.021 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 9.04 4.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.745 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.25 144.73 4.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.48 -155.47 23.35 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 28.7 mt -133.8 133.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -1.181 . . . . 0.0 109.42 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 70' ' ' GLU . 1.1 pp -114.05 -169.71 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.719 ' N ' HD12 ' A' ' 69' ' ' LEU . 3.4 pt-20 -179.91 149.08 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.262 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.008 HG11 ' HA ' ' A' ' 40' ' ' PRO . 11.0 p -100.34 141.15 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.517 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 24.8 mt-30 -126.91 160.55 58.58 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.2 Cg_endo -75.32 90.76 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.355 2.036 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.31 6.92 41.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.482 ' C ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -175.18 -176.87 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -1.177 . . . . 0.0 109.816 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 6' ' ' LEU . 28.6 m -157.96 150.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.595 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -135.32 167.97 20.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.909 -1.119 . . . . 0.0 109.834 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 8' ' ' VAL . 1.7 p -175.15 120.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.068 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.34 141.4 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.749 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.746 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -127.39 -179.9 5.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.203 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -98.51 -2.05 39.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.566 HG23 ' CD1' ' A' ' 84' ' ' ILE . 1.9 m -155.2 143.67 20.41 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.175 -0.953 . . . . 0.0 109.136 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.807 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -146.29 98.61 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.603 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 84' ' ' ILE . 2.1 mp -115.3 84.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.324 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 84' ' ' ILE . 6.5 ttm180 -44.1 164.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -49.64 -64.8 3.19 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB3' HG21 ' A' ' 134' ' ' THR . 1.3 pt20 -93.45 37.81 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.188 . . . . 0.0 109.628 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -48.46 -48.93 37.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.23 -58.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 0.0 109.172 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.45 107.68 12.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.398 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HB3' HD11 ' A' ' 131' ' ' ILE . 47.8 mt-10 -101.72 -70.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.644 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.46 -17.6 36.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.616 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -81.6 -1.02 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.27 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.17 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.64 ' HG2' HD21 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -69.39 -37.79 77.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -34.81 11.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.52 -54.46 35.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.352 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -22.8 15.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -75.13 -60.93 2.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -64.17 -12.38 39.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.717 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -87.66 -36.42 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -57.55 -16.83 11.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -57.68 6.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.604 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -11.51 60.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.645 HD11 ' CG ' ' A' ' 121' ' ' LEU . 14.1 mm -76.09 -8.44 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.528 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -46.14 -65.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 0.0 109.331 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 165.85 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -151.39 -50.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 179.94 -72.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.18 -155.23 26.5 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 1.6 m-20 56.99 -101.5 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -1.086 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 116' ' ' GLN . 3.4 m -119.69 -15.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.871 -1.143 . . . . 0.0 109.285 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.8 OUTLIER -47.6 -95.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 118' ' ' SER . 19.3 t80 -74.26 -22.15 59.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -62.52 -20.76 64.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.517 ' CG ' ' O ' ' A' ' 112' ' ' VAL . 33.7 mm-40 -85.71 -52.99 5.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.872 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . . . -74.53 -1.41 21.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 36.4 t -90.19 -35.65 15.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.769 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.61 -28.57 18.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.868 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' CG ' ' HA ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -82.09 -8.55 59.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.717 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -86.06 -48.47 8.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.54 -17.12 18.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -64.96 -37.66 88.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.465 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.84 -12.37 59.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -83.36 -8.04 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.541 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -68.29 -46.39 70.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 109.305 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.4 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.1 tm0? -67.31 -23.53 65.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.64 HD21 ' HG2' ' A' ' 95' ' ' MET . 5.6 mp -74.5 -16.8 60.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.46 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 4.1 mtp85 -89.82 -50.69 5.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.78 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 27.4 m -60.54 -34.93 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.558 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.442 HD11 ' HB3' ' A' ' 91' ' ' GLU . 3.4 tt -61.44 -36.09 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.337 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 129' ' ' ARG . 2.8 mt-10 -49.89 -27.46 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.218 -0.927 . . . . 0.0 109.363 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mp -75.16 -61.55 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 87' ' ' GLN . 4.9 p -45.56 -31.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -58.53 -66.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.69 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -15.3 56.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.844 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.8 68.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.239 0.543 . . . . 0.0 109.582 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 57.11 159.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.713 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.4 p90 -158.11 -144.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.683 ' O ' HG22 ' A' ' 76' ' ' VAL . 24.1 t-80 -131.51 134.84 46.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.734 -1.229 . . . . 0.0 111.013 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.85 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -106.14 124.28 49.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -136.88 71.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.735 -1.228 . . . . 0.0 109.974 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.729 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.1 p -102.46 124.91 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.38 -172.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.2 p -166.54 107.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 60.08 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 64.34 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -150.2 104.01 3.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.69 105.04 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.7 mmt -87.32 -89.1 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.888 . . . . 0.0 109.479 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.654 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -110.14 111.79 23.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 85.7 p -136.13 78.83 1.74 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' N ' ' CE1' ' A' ' 5' ' ' HIS . . . -177.47 174.16 46.73 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 30.9 mt -50.22 163.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.879 ' O ' HG22 ' A' ' 3' ' ' THR . 0.2 OUTLIER -162.27 163.76 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.335 -0.853 . . . . 0.0 108.967 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.758 ' CG ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -125.29 -39.18 2.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 2.1 ttmt -156.15 109.07 2.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.031 -1.043 . . . . 0.0 110.369 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.85 HG21 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -101.28 146.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.939 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -120.73 141.58 50.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.0 109.988 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 50' ' ' ILE . 13.4 t -136.77 133.49 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 84.8 m -140.94 111.49 6.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 109.842 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 46' ' ' LYS . . . -120.73 -104.91 1.99 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.53 -67.05 1.02 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -117.99 139.15 51.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.097 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.43 69.33 1.41 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.49 77.07 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -1.066 . . . . 0.0 109.596 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mt -113.83 153.43 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 23' ' ' ILE . . . -99.81 172.0 24.34 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.713 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 12.9 mm -98.09 134.52 36.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.911 -1.346 . . . . 0.0 108.822 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.579 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -132.3 169.86 12.82 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.0 Cg_endo -72.7 87.6 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.018 1.812 . . . . 0.0 109.923 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 38' ' ' HIS . . . 138.42 -4.4 3.09 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' ALA . 70.3 t60 -42.84 132.72 3.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 0.0 109.501 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.994 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -48.73 176.4 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.994 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.1 Cg_endo -77.66 81.31 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.519 2.146 . . . . 0.0 110.291 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -96.75 155.95 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.722 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.84 34.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.403 -0.811 . . . . 0.0 108.907 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 22.4 p -99.56 -147.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 109.486 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -100.54 164.15 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 46' ' ' LYS . 48.0 mt -105.98 163.04 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 109.273 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.544 ' N ' HG22 ' A' ' 45' ' ' ILE . 8.4 mptt -96.06 151.88 38.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 0.0 109.826 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.56 127.71 7.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.82 2.347 . . . . 0.0 110.444 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 174.28 -149.92 11.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.499 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.9 ptm -109.54 -177.04 3.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -1.162 . . . . 0.0 109.405 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.939 HG23 ' O ' ' A' ' 24' ' ' GLN . 47.7 mt -155.08 140.04 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.442 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 115.38 17.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.737 HG23 ' CA ' ' A' ' 23' ' ' ILE . 14.1 mt -117.79 169.75 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 111.176 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' N ' HG22 ' A' ' 52' ' ' ILE . 53.2 t -137.8 100.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -60.5 126.03 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -0.91 . . . . 0.0 110.154 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 23.1 mt-30 45.82 -92.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -164.12 49.87 0.13 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.84 -99.87 0.31 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -74.75 172.08 12.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -1.169 . . . . 0.0 109.874 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -127.34 167.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.046 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -133.04 144.86 50.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.983 ' C ' HD12 ' A' ' 62' ' ' ILE . 7.3 m-85 -111.21 134.68 52.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.141 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.983 HD12 ' C ' ' A' ' 61' ' ' PHE . 2.8 mp -140.78 147.48 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 109.677 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -144.89 151.48 38.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.395 -0.815 . . . . 0.0 109.006 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.94 -173.87 2.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.5 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 70.6 m -112.18 -81.72 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.49 168.09 24.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.35 -176.95 42.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 69' ' ' LEU . 4.7 mp -99.98 156.58 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.184 -1.186 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -131.68 169.75 15.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.0 125.93 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 108.848 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 76' ' ' VAL . 11.6 p -99.85 146.77 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.526 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 26.4 mt-30 -131.42 163.78 47.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.036 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.8 Cg_endo -77.4 106.29 2.19 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.43 2.087 . . . . 0.0 110.599 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.55 58.32 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.509 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 -179.73 166.35 1.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -1.199 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 5' ' ' HIS . 10.2 m -139.02 167.93 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.829 . . . . 0.0 109.262 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 7' ' ' ASP . 46.1 m -165.77 134.8 3.24 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.869 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.729 ' CG2' HG23 ' A' ' 8' ' ' VAL . 4.3 m -137.25 138.11 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 143.41 30.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.66 -179.17 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.4 -39.52 2.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.247 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.48 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 32.6 m -104.31 120.7 41.76 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.185 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.9 87.33 2.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 109.771 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 88' ' ' ASP . 3.1 mp -100.01 92.2 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 108.919 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' GLY . 1.2 ttt180 -41.95 153.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.786 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.609 ' HA2' HG21 ' A' ' 130' ' ' VAL . . . -43.26 -35.57 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 15.6 mt-30 -78.95 -69.92 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.0 109.382 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.758 ' HB2' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER 84.53 -44.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 164.57 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.111 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 22.8 m-20 -119.05 -172.69 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -123.58 -70.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 -11.04 60.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -83.55 4.33 28.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.709 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.78 -21.2 23.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 108.996 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.597 ' CG ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -73.63 -25.14 60.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.484 -0.76 . . . . 0.0 109.406 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -17.17 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.68 -44.03 35.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.714 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HG3' HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.01 -19.38 43.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 109.508 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.447 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -77.99 -37.03 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 2.8 pttm -79.65 -18.73 50.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 109.496 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 105' ' ' ILE . . . -89.18 -34.44 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.99 -31.02 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.468 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.24 -54.7 40.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.83 -16.24 60.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 105' ' ' ILE . 21.8 mm -87.25 16.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 109.524 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 107' ' ' SER . 15.0 m -91.93 -147.76 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 106' ' ' SER . 2.8 m 56.31 108.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.586 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.51 108.36 10.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 173.27 56.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.2 163.21 33.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -1.217 . . . . 0.0 109.607 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.497 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 13.2 m -96.17 17.18 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.437 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 39.5 t0 -63.27 -100.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 109.027 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 75.0 t80 -64.06 -20.47 65.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.998 -1.064 . . . . 0.0 108.252 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -64.3 -39.36 93.76 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 1.2 tp-100 -86.5 -7.27 58.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 105' ' ' ILE . . . -80.44 -36.95 32.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.9 m -52.54 -37.24 57.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -52.92 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.36 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -67.69 -8.66 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.687 ' O ' HD13 ' A' ' 125' ' ' ILE . 15.7 tp -83.95 -50.34 8.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.91 8.52 10.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.876 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -72.87 -37.86 67.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.612 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.92 28.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -70.49 -5.9 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' MET . . . -73.66 -23.98 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 0.0 109.286 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -82.73 -4.99 58.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.597 HD11 ' CG ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -84.02 -34.0 24.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -43.62 55.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 109.644 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.609 HG21 ' HA2' ' A' ' 86' ' ' GLY . 18.6 m -54.66 -17.85 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.931 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' ' C ' ' A' ' 132' ' ' GLU . 38.5 mt -88.84 -66.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 131' ' ' ILE . 57.5 mm-40 -43.66 -34.84 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.119 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -73.73 -54.6 7.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.861 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.582 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 7.9 p -44.02 -30.23 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -57.44 -53.74 54.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 3.49 48.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.544 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -104.17 44.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 0.0 109.37 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.479 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.482 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.2 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.92 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.74 -152.78 0.11 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.114 -0.991 . . . . 0.0 109.515 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 1.142 ' CG ' HG22 ' A' ' 20' ' ' VAL 0.277 1.1 m-85 -137.7 -178.23 5.15 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 124.451 2.072 . . . . 0.0 115.914 -175.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.587 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 7.1 t-80 -151.45 88.1 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.769 -3.378 . . . . 0.0 102.98 173.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -93.33 133.64 36.37 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.629 -1.294 . . . . 0.0 108.22 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 77' ' ' THR . 0.3 OUTLIER -146.13 82.53 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.625 -1.297 . . . . 0.0 109.95 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.73 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.4 p -110.6 102.63 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.85 155.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.953 . . . . 0.0 109.441 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.966 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 89.2 p -105.26 -156.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.82 -47.32 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -160.21 60.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.414 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.52 118.95 1.4 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -77.95 117.14 19.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.532 ' HE1' HG22 ' A' ' 62' ' ' ILE . 5.9 mtt -86.82 -73.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.2 t80 -116.17 113.44 23.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 110.321 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 89.2 p -138.6 91.04 2.5 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.05 -172.81 45.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 55' ' ' GLN . 20.8 mt -72.02 154.59 41.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -1.229 . . . . 0.0 109.321 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.142 HG22 ' CG ' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -153.81 -175.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.097 -1.002 . . . . 0.0 109.165 -178.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.666 ' N ' HG23 ' A' ' 20' ' ' VAL . 9.9 tt0 -146.56 -40.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.779 -1.2 . . . . 0.0 110.208 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -139.31 91.16 2.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.799 HD13 HD21 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -98.87 159.96 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.071 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.747 ' O ' HG23 ' A' ' 50' ' ' ILE . 44.7 mt-30 -146.81 166.98 25.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 110.184 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.715 HG12 ' HA2' ' A' ' 33' ' ' GLY . 3.1 p -160.26 143.53 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 109.043 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 18.6 m -129.86 129.38 43.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' HA2' ' NZ ' ' A' ' 123' ' ' LYS . . . 126.27 14.28 3.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -116.25 -153.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.32 98.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 0.0 109.329 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.09 -93.81 1.43 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 26' ' ' THR . 8.6 tt0 -177.48 28.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -1.152 . . . . 0.0 109.744 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB3' ' NE2' ' A' ' 38' ' ' HIS . 16.5 mt -70.64 145.92 50.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.069 -1.019 . . . . 0.0 109.278 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.715 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.06 -122.87 4.81 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.084 HG22 ' OH ' ' A' ' 4' ' ' TYR . 24.1 mm -151.59 123.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.168 -1.195 . . . . 0.0 109.315 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -136.88 -171.13 0.26 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 32.2 Cg_endo -76.64 84.57 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.479 1.453 . . . . 0.0 110.0 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 50.73 0.54 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.607 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 16.0 t-80 -84.95 46.95 1.32 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -1.067 . . . . 0.0 109.702 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.607 ' O ' HG11 ' A' ' 71' ' ' VAL . . . 56.17 160.57 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 110.097 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.93 66.21 8.82 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.835 2.356 . . . . 0.0 110.429 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 69' ' ' LEU . 1.4 mm? -77.75 139.35 39.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 69' ' ' LEU . 17.5 tp -154.59 66.5 0.69 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -136.1 -95.28 0.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.93 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' H ' HG23 ' A' ' 43' ' ' THR . . . -150.99 164.52 36.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 109.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.645 HG13 HD23 ' A' ' 69' ' ' LEU . 2.7 mt -113.17 4.16 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.103 -0.998 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' CG ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 48.16 179.81 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.715 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -80.26 119.49 3.85 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.528 2.152 . . . . 0.0 110.238 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -165.29 -153.2 7.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 130' ' ' VAL . 3.2 ppp? -128.61 -173.43 2.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.335 -1.097 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.747 HG23 ' O ' ' A' ' 24' ' ' GLN . 8.4 mt -151.11 147.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.41 123.48 21.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.246 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.59 HG23 ' CA ' ' A' ' 23' ' ' ILE . 32.1 mt -128.4 168.56 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.798 -1.189 . . . . 0.0 111.246 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.586 ' N ' HG22 ' A' ' 52' ' ' ILE . 51.5 t -139.15 153.08 24.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 80.78 -73.56 0.05 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.732 -0.605 . . . . 0.0 109.578 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 56' ' ' HIS . 0.3 OUTLIER 42.99 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.37 -0.831 . . . . 0.0 109.569 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.526 ' CB ' ' OE1' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -158.07 40.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.89 -1.131 . . . . 0.0 109.804 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -36.09 0.44 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.515 ' CE1' ' OE1' ' A' ' 59' ' ' GLU . 1.4 t-80 -169.35 -149.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.29 . . . . 0.0 109.54 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 58' ' ' HIS . 1.5 pt-20 -101.49 160.5 14.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.79 139.59 11.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.3 p90 -110.23 152.54 25.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.885 . . . . 0.0 109.623 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 16' ' ' PHE . 9.1 mt -127.9 144.57 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.258 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE1' HD12 ' A' ' 84' ' ' ILE . 19.6 t80 -113.75 130.38 56.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 8' ' ' VAL . 3.6 mt -121.33 173.89 7.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -125.44 -37.23 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.863 . . . . 0.0 109.416 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.21 144.62 4.47 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 168.25 -173.59 43.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 43' ' ' THR . 60.6 mt -99.36 152.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -1.075 . . . . 0.0 109.075 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.731 ' C ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -132.0 157.33 44.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.917 -1.115 . . . . 0.0 110.586 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' HD12 ' A' ' 69' ' ' LEU . 8.4 pt-20 -150.66 114.89 5.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.773 HG23 HG12 ' A' ' 76' ' ' VAL . 10.0 p -104.04 151.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.889 -1.132 . . . . 0.0 110.709 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.583 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.6 mm-40 -136.43 179.28 1.41 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -79.48 102.23 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.395 2.063 . . . . 0.0 110.847 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 75' ' ' ASN . . . 79.97 34.72 29.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.587 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 7.9 t30 171.18 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -1.175 . . . . 0.0 109.355 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.811 HG22 HD22 ' A' ' 6' ' ' LEU . 2.5 m -112.89 152.65 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 7' ' ' ASP . 88.0 m -152.67 136.02 15.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 109.282 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.73 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.1 m -144.83 147.54 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 109.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.77 142.7 46.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.461 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -139.09 179.61 6.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -100.43 -34.18 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.611 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -118.41 147.9 43.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 0.0 109.741 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.966 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -143.29 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.421 -0.799 . . . . 0.0 109.107 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.636 HD12 ' CE1' ' A' ' 63' ' ' TYR . 2.0 mt -98.93 52.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HG2' ' N ' ' A' ' 86' ' ' GLY . 48.9 ttt180 -42.16 147.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 85' ' ' ARG . . . -42.92 -32.49 1.45 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -111.21 64.66 0.61 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -1.181 . . . . 0.0 109.579 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.12 -83.01 0.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.84 -169.73 3.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.75 73.48 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.68 -68.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.11 -19.85 62.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.87 -2.03 24.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.96 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 108.913 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.3 mtp -85.75 -35.08 20.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.468 -0.77 . . . . 0.0 109.324 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -84.75 -27.32 27.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.22 -54.26 49.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -51.93 -21.61 3.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -80.06 -57.32 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 109.722 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.46 -19.56 48.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.869 ' HB1' HD13 ' A' ' 121' ' ' LEU . . . -85.72 -43.71 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -56.55 -34.53 67.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.439 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.67 -50.82 72.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -18.29 64.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.541 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 121' ' ' LEU . 21.4 mt -80.61 -25.83 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -101.42 102.68 13.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.503 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.1 m -154.01 -41.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -0.948 . . . . 0.0 109.726 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.405 ' O ' ' CE2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -155.9 -166.49 2.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.695 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.76 -86.88 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.64 177.91 8.88 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -113.14 126.5 55.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.324 -1.103 . . . . 0.0 109.333 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.11 29.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 0.0 109.564 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 111' ' ' ASP . 21.2 t70 -84.07 -94.41 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 108' ' ' SER . 20.8 p90 -74.32 -22.99 59.0 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.88 46.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.88 -34.7 51.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.436 -0.79 . . . . 0.0 109.108 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.46 -20.5 54.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.257 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.5 m -65.31 -39.35 92.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.361 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.27 -13.28 36.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.891 . . . . 0.0 109.328 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.19 -32.04 38.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.869 HD13 ' HB1' ' A' ' 101' ' ' ALA . 17.6 mt -83.74 -39.33 20.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.34 -23.67 50.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.69 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.539 ' NZ ' ' HA2' ' A' ' 27' ' ' GLY . 11.1 mmtt -79.8 -30.45 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.15 62.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 109.555 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.3 mt -80.53 1.74 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.595 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.75 62.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.269 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.599 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.8 pt20 -79.12 -11.0 59.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 0.6 OUTLIER -73.08 -30.24 63.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.965 . . . . 0.0 109.795 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -48.81 14.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.1 m -61.49 -40.4 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.912 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.545 HG23 ' N ' ' A' ' 132' ' ' GLU . 9.3 tt -65.3 -43.41 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 131' ' ' ILE . 3.1 mm-40 -53.83 -26.19 23.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -0.879 . . . . 0.0 109.1 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -48.88 20.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.18 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.8 p -53.65 -20.12 4.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -76.25 -55.89 5.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 7.34 24.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.41 -52.17 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.5 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER 55.69 92.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.205 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.87 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 32.3 p90 -82.3 -143.18 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 109.099 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -140.26 133.27 29.39 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.203 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.888 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -123.43 150.16 44.16 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.761 -1.212 . . . . 0.0 108.113 178.152 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.789 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -140.5 88.09 2.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.65 HG23 ' CG2' ' A' ' 78' ' ' VAL . 5.0 p -99.91 132.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -142.89 159.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.236 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 87.4 p -100.34 -146.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -0.838 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.75 -10.39 59.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.743 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' GLN . 14.5 mt-10 -118.34 24.21 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.454 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 41.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.78 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.94 92.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.659 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.927 ' HG2' HG21 ' A' ' 62' ' ' ILE . 1.7 mtt -161.97 -88.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.852 . . . . 0.0 108.934 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.691 ' CE2' ' CG1' ' A' ' 20' ' ' VAL . 68.8 t80 -135.3 144.82 46.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.3 p -165.07 82.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.411 -0.806 . . . . 0.0 109.525 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.6 -178.96 42.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 7.6 mt -71.01 139.45 50.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.076 -1.249 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.01 ' CG2' HD11 ' A' ' 23' ' ' ILE . 2.5 m -144.27 148.11 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.41 -0.806 . . . . 0.0 110.643 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.95 -42.05 4.79 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.593 -0.692 . . . . 0.0 109.849 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.529 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.88 109.43 9.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.967 -1.083 . . . . 0.0 110.486 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.086 HG23 HG22 ' A' ' 52' ' ' ILE . 3.9 mm -105.4 -173.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.023 -1.048 . . . . 0.0 109.081 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.63 ' H ' HG22 ' A' ' 23' ' ' ILE . 16.0 tt0 -176.05 98.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.948 -1.095 . . . . 0.0 109.965 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 2.1 p -104.32 137.98 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.352 -0.842 . . . . 0.0 109.069 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.527 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 31.6 m -124.21 115.52 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 46' ' ' LYS . . . -108.94 -68.06 0.61 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.6 t -170.6 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -1.152 . . . . 0.0 109.375 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -95.0 66.94 3.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.465 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.0 82.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -115.87 89.23 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.537 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 mt -106.81 151.35 25.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.26 172.6 25.5 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 107.243 -2.343 . . . . 0.0 107.243 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.87 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 18.8 mm -99.21 128.53 50.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.585 -1.538 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.607 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -129.98 170.75 10.23 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.0 Cg_endo -70.78 81.91 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.772 1.648 . . . . 0.0 109.676 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' HIS . . . 168.27 -27.07 0.14 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.725 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -42.2 163.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -1.091 . . . . 0.0 109.461 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . . . 164.26 -52.0 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.052 -1.03 . . . . 0.0 110.492 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 36.6 Cg_endo -79.32 23.63 0.64 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.607 2.204 . . . . 0.0 111.828 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.53 ' HG ' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -100.57 110.92 23.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.804 -1.185 . . . . 0.0 109.612 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 42' ' ' LEU . 3.5 mt -148.41 80.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.925 . . . . 0.0 109.357 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.774 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.1 t -147.06 -146.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.774 ' N ' HG23 ' A' ' 43' ' ' THR . . . -103.98 -176.61 3.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 109.472 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.875 HD11 ' O ' ' A' ' 68' ' ' ILE . 1.4 mt -132.55 166.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 17.3 mmtt -116.4 166.29 12.95 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -78.27 118.22 4.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.606 2.204 . . . . 0.0 110.559 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 63' ' ' TYR . . . -168.17 -145.59 4.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.526 ' HE3' HG12 ' A' ' 130' ' ' VAL . 3.7 ppp? -122.14 -172.64 2.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -1.126 . . . . 0.0 109.448 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.966 HD13 ' N ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.42 157.92 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.586 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.966 ' N ' HD13 ' A' ' 50' ' ' ILE . 6.3 ttp180 -149.98 134.9 17.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.111 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.086 HG22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -114.44 161.0 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 110.318 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.785 HG12 ' O ' ' A' ' 53' ' ' VAL . 41.1 t -126.47 65.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 9.5 mtmt -43.54 124.49 3.55 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.19 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 56' ' ' HIS . 6.5 tp-100 46.65 -93.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.7 . . . . 0.0 109.657 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' LYS . 2.3 t-160 -165.32 122.12 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.53 -72.77 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.59 138.53 55.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -157.21 162.37 39.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.348 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -156.55 177.1 11.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.755 ' O ' HD13 ' A' ' 62' ' ' ILE . 2.8 p90 -146.17 154.49 41.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.808 -1.182 . . . . 0.0 110.052 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.927 HG21 ' HG2' ' A' ' 15' ' ' MET . 2.5 mm -133.0 -161.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.62 ' HE1' ' HB3' ' A' ' 126' ' ' ALA . 42.0 t80 -157.61 114.69 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 64' ' ' LEU . 1.4 pt? -113.64 176.97 4.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 m -125.19 45.7 2.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.04 -167.4 29.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 134.53 -139.42 10.85 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.875 ' O ' HD11 ' A' ' 45' ' ' ILE . 3.7 mt -132.22 147.9 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.07 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.536 ' C ' HD12 ' A' ' 69' ' ' LEU . 2.5 pp -130.6 131.6 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.989 -1.069 . . . . 0.0 110.15 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 77' ' ' THR . 5.0 pt-20 -134.15 128.83 34.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.855 HG23 HG12 ' A' ' 76' ' ' VAL . 5.6 p -99.65 128.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.036 -1.04 . . . . 0.0 110.036 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.1 mt-30 -106.79 172.53 3.79 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 108.876 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.5 Cg_endo -78.75 112.52 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.577 2.185 . . . . 0.0 110.441 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 79.16 20.92 68.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.8 p-10 171.45 158.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.855 HG12 HG23 ' A' ' 71' ' ' VAL . 34.5 m -140.99 160.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.023 . . . . 0.0 109.436 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.555 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -152.04 143.53 23.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.555 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG2' HG23 ' A' ' 8' ' ' VAL . 2.8 m -151.65 156.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 79' ' ' LEU . 6.3 mp -122.71 166.18 15.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 10' ' ' SER . . . -146.0 -149.47 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -139.37 -55.47 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.567 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -111.58 148.17 33.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.679 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -140.2 146.57 38.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.508 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HB ' ' CD2' ' A' ' 63' ' ' TYR . 43.8 mt -126.17 -25.85 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 0.0 109.718 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 66.08 153.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.318 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -47.57 -29.7 5.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' OE1' ' HB ' ' A' ' 134' ' ' THR . 1.2 mt-30 -165.57 81.3 0.32 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.189 -1.183 . . . . 0.0 109.675 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 9.9 t70 -73.62 -26.67 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 174.64 -50.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.211 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.32 119.84 31.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.918 . . . . 0.0 109.642 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 92' ' ' ALA . 14.8 pt-20 -131.04 -38.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.247 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -77.25 -16.52 58.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 109.408 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.04 2.72 53.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.31 -16.39 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 108.981 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -52.4 5.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.458 -0.776 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 99' ' ' ARG . 2.3 mt-10 -56.27 -31.42 63.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -58.07 -53.07 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -53.47 -31.34 45.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.448 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.93 -43.5 83.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.307 -0.871 . . . . 0.0 109.545 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 12.0 pttm -84.11 -4.87 59.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -90.35 -7.73 52.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.508 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -86.35 -25.76 25.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 109.661 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -43.5 91.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -81.12 -15.1 56.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.464 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.747 HG13 HD13 ' A' ' 121' ' ' LEU . 18.8 mm -88.71 -19.42 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t -86.12 63.18 7.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.547 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -171.15 169.14 6.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.56 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 114' ' ' TYR . 29.8 t -175.08 100.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -157.58 76.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.66 169.81 25.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.57 -49.42 21.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -1.127 . . . . 0.0 109.309 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 18.3 m -118.7 33.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.559 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.17 -97.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.069 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 3.4 t80 -67.39 -14.11 62.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.65 74.91 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.63 -0.669 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -83.94 -5.65 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.682 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.0 -18.67 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.5 m -76.6 -29.86 56.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.732 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.92 -32.42 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.635 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 116' ' ' GLN . 6.3 mm-40 -75.78 -36.25 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 101' ' ' ALA . 2.8 tt -73.38 -61.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.96 -27.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.683 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 121' ' ' LEU . 16.5 tttt -63.24 -54.27 40.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -12.66 61.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.672 ' CG1' HD23 ' A' ' 121' ' ' LEU . 49.2 mm -82.23 2.18 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.62 ' HB3' ' HE1' ' A' ' 63' ' ' TYR . . . -83.95 -39.33 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.487 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.416 ' HG3' ' CG2' ' A' ' 84' ' ' ILE . 1.6 tm0? -76.58 -7.17 54.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.416 ' C ' HG22 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -81.72 -21.11 38.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.554 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -85.69 -33.9 21.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 109.592 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.3 m -75.4 -33.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 132' ' ' GLU . 2.1 tt -61.68 -44.63 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 131' ' ' ILE . 77.5 mm-40 -44.85 -35.24 2.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.041 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 4.5 mp -64.89 -55.46 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -0.81 . . . . 0.0 109.245 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.461 ' HB ' ' OE1' ' A' ' 87' ' ' GLN . 30.9 p -50.08 -29.14 8.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.481 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 2.8 mmtt -65.73 -54.96 20.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -88.83 21.4 3.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.65 42.5 3.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.388 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.244 0.545 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.002 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -109.93 -147.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.888 . . . . 0.0 109.649 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 1.192 ' CG ' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.61 -179.75 5.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.34 2.019 . . . . 0.0 115.884 -175.797 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.504 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 8.7 t-80 -153.96 89.65 1.32 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 110.123 -3.217 . . . . 0.0 103.445 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.983 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -92.77 126.77 38.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.683 -1.261 . . . . 0.0 107.992 -177.562 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 77' ' ' THR . 7.3 t70 -133.36 75.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.593 -1.317 . . . . 0.0 109.912 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 15' ' ' MET . 1.4 p -111.13 147.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.26 -0.9 . . . . 0.0 108.948 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.516 ' HB ' ' N ' ' A' ' 14' ' ' GLN . 14.1 m -150.16 155.94 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.078 -1.014 . . . . 0.0 109.624 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -172.2 157.19 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.281 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 61.48 -89.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.414 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 22.13 3.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.387 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER 46.34 75.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 110.051 179.651 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.516 ' N ' ' HB ' ' A' ' 9' ' ' VAL . 9.1 tt0 164.98 100.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.544 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -124.47 -73.21 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.064 179.286 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.688 ' CE2' HG11 ' A' ' 20' ' ' VAL . 1.1 t80 -127.17 112.79 15.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.047 -1.033 . . . . 0.0 110.082 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 92.0 p -134.6 85.52 2.19 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.48 -160.73 23.12 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.467 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -93.24 159.67 15.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.25 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.192 HG22 ' CG ' ' A' ' 4' ' ' TYR . 1.8 m -155.32 -167.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.885 -1.135 . . . . 0.0 110.663 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.779 ' N ' HG23 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -155.35 -33.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 178.981 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 10.1 mmtm -142.97 88.4 2.04 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.961 -1.087 . . . . 0.0 110.211 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.983 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.24 138.78 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.696 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.986 ' O ' HG23 ' A' ' 50' ' ' ILE . 5.0 mt-30 -122.95 165.93 15.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 110.346 -178.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.546 ' CB ' HG12 ' A' ' 50' ' ' ILE . 11.5 p -171.53 154.98 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 2.1 t 179.76 154.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.829 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.5 -89.78 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 158.41 43.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 59.0 74.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' C ' ' HG2' ' A' ' 46' ' ' LYS . . . 91.8 141.69 10.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -137.05 55.39 1.83 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.171 . . . . 0.0 109.752 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.09 157.07 24.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.21 171.63 24.61 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.914 HG22 ' OH ' ' A' ' 4' ' ' TYR . 12.7 mm -99.81 127.16 52.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.854 -1.38 . . . . 0.0 108.986 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.651 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -134.46 170.26 11.73 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.651 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -70.11 88.24 0.58 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.586 1.524 . . . . 0.0 109.538 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.73 18.98 2.58 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 6.7 t60 -60.14 146.96 41.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -1.191 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.617 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -40.59 147.04 0.41 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -78.98 69.14 8.04 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.695 2.263 . . . . 0.0 111.047 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.6 mt -91.07 126.57 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.121 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.4 24.12 12.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.57 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -105.56 -92.81 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.393 -0.817 . . . . 0.0 109.336 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.808 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -130.12 172.72 11.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.935 . . . . 0.0 109.161 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.808 HD13 ' C ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -117.31 -149.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' O ' HG21 ' A' ' 25' ' ' VAL . 2.2 mptp? -121.35 125.38 26.91 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.24 -159.36 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.433 2.089 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 97.85 -137.08 13.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.6 ppp? -102.62 -178.91 3.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -1.117 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.986 HG23 ' O ' ' A' ' 24' ' ' GLN . 14.2 mt -157.63 140.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 110.193 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 7.5 mmt85 -131.16 112.31 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.694 HG23 ' CA ' ' A' ' 23' ' ' ILE . 12.6 mt -117.48 164.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 0.0 111.312 -178.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 59' ' ' GLU . 41.8 t -133.18 112.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' HIS . 20.4 mttm -65.96 149.89 49.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.792 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.557 ' HB2' HG21 ' A' ' 3' ' ' THR . 34.5 tt0 -52.11 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.338 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 48.7 t-80 71.45 95.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.36 178.34 29.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -63.07 -166.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -1.224 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HB3' HG22 ' A' ' 53' ' ' VAL . 10.2 pt-20 -131.12 147.45 52.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -125.52 138.29 53.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.911 ' CE1' HD11 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -109.08 139.41 44.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.819 . . . . 0.0 109.677 -179.613 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 19.1 mt -121.2 160.48 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.288 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.742 ' HE1' HD12 ' A' ' 84' ' ' ILE . 1.4 t80 -139.38 151.49 46.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.268 -0.895 . . . . 0.0 109.014 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.726 ' N ' HD23 ' A' ' 64' ' ' LEU . 1.3 pt? 179.93 -170.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.511 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 4.9 m -135.21 -169.22 2.33 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.33 -0.856 . . . . 0.0 109.204 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 65' ' ' SER . . . 42.24 -141.07 1.76 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.16 119.24 2.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 5.4 tt -151.89 130.28 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -1.102 . . . . 0.0 109.065 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 178.18 -140.0 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 -179.493 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.622 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -146.3 142.64 28.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.366 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 76' ' ' VAL . 7.6 p -109.53 126.99 66.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.48 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -105.39 173.86 3.01 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -77.92 4.02 6.48 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.524 2.149 . . . . 0.0 109.974 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . -167.16 39.27 0.24 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.504 ' OD1' ' ND1' ' A' ' 5' ' ' HIS . 5.0 t30 167.98 94.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 109.472 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.839 HG22 HG23 ' A' ' 71' ' ' VAL . 5.0 t -100.78 116.12 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.215 -0.928 . . . . 0.0 109.267 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.688 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 6.4 t -118.45 158.64 24.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.906 . . . . 0.0 109.686 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.764 ' HA ' ' CG ' ' A' ' 69' ' ' LEU . 3.5 p 179.44 141.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.742 0.782 . . . . 0.0 110.288 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.657 ' C ' HD23 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -115.64 145.63 42.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.53 -165.25 1.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.32 -43.83 4.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 17.8 m -106.32 151.85 24.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.79 93.7 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.742 HD12 ' HE1' ' A' ' 63' ' ' TYR . 6.1 mt -106.63 66.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.335 -0.853 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 84' ' ' ILE . 13.0 ttp180 -44.79 161.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 87' ' ' GLN . . . -51.45 147.49 10.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.859 ' H ' HG22 ' A' ' 131' ' ' ILE . 13.2 pt20 38.58 38.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.63 -0.924 . . . . 0.0 109.886 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -45.09 -48.55 11.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.59 -57.4 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.8 -167.09 1.75 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.616 ' CB ' HD12 ' A' ' 131' ' ' ILE . 16.1 pt-20 -144.78 -38.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.583 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.67 67.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -8.03 52.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.4 -14.61 32.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.26 -18.53 26.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.407 -0.808 . . . . 0.0 109.41 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -1.51 36.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.51 30.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 109.318 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HA ' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -76.42 -27.81 56.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -70.38 -43.62 69.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.86 -23.0 39.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.233 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.615 ' CB ' HD13 ' A' ' 121' ' ' LEU . . . -81.46 -22.14 38.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.213 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 31.9 tt0 -66.08 -19.32 65.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -27.5 21.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.406 ' O ' ' OH ' ' A' ' 114' ' ' TYR . 1.6 m-70 -77.12 -45.9 25.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.731 ' O ' HG22 ' A' ' 105' ' ' ILE . 88.0 mt -87.61 12.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' ILE . 2.6 m -44.37 -60.85 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.0 p -90.34 -160.85 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.29 128.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.029 -1.045 . . . . 0.0 109.616 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -160.82 93.37 0.98 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 109.377 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.854 ' O ' ' HB2' ' A' ' 115' ' ' ALA . . . 165.2 143.85 3.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.09 -41.61 67.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 14.5 m -137.46 -31.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER -41.61 -92.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.743 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 104' ' ' HIS . 15.4 t80 -77.92 -21.4 51.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -61.27 -18.05 56.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 8.7 mt-30 -84.99 -35.93 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.16 -10.02 27.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.1 m -71.42 -49.22 43.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.591 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.49 61.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.716 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.37 -47.48 76.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' CB ' ' A' ' 101' ' ' ALA . 47.9 tp -52.2 -51.76 56.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.717 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.38 64.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.758 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -78.11 -13.96 59.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.96 42.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.5 mp -88.21 -2.09 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.704 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -88.45 -24.55 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.598 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 8.4 pt20 -74.89 -32.63 61.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 4.3 tt -84.2 -6.76 59.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -26.13 47.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.439 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 2.3 m -86.46 -31.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.513 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.859 HG22 ' H ' ' A' ' 87' ' ' GLN . 3.2 pt -72.03 -4.03 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.37 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.7 mm-40 -78.21 -34.08 49.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.699 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.911 HD11 ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -87.31 2.98 48.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.155 -0.966 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -83.2 -16.15 47.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.019 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -71.81 -25.77 62.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.37 -0.831 . . . . 0.0 109.225 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.01 39.54 3.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.403 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -112.09 -7.09 14.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.466 -179.859 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.428 ' C ' ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.328 0.585 . . . . 0.0 109.579 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.646 HG22 ' HG3' ' A' ' 21' ' ' GLU . 38.1 p -141.88 155.45 45.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.235 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.635 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -148.49 -148.45 0.26 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.83 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -131.35 144.57 51.34 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.055 HD23 HG21 ' A' ' 20' ' ' VAL . 2.3 pp -135.67 154.4 51.3 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.491 -1.381 . . . . 0.0 109.278 178.453 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.567 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -140.03 115.19 9.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 -179.448 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.601 ' CG2' HD21 ' A' ' 64' ' ' LEU . 2.1 p -111.71 94.02 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.179 -0.951 . . . . 0.0 108.74 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.695 HG22 ' HG3' ' A' ' 14' ' ' GLN . 23.4 t -99.73 155.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.705 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 3.8 p -124.15 -149.99 0.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.42 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 81' ' ' ASP . . . -52.69 -38.06 59.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.88 32.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.313 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -134.66 67.53 1.5 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.695 ' HG3' HG22 ' A' ' 9' ' ' VAL . 23.6 tt0 -44.65 155.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 109.811 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.565 ' HB2' HG13 ' A' ' 8' ' ' VAL . 4.1 mmt -134.15 -96.81 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.846 ' HB3' HD11 ' A' ' 6' ' ' LEU . 3.5 t80 -70.09 130.95 43.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.919 -1.113 . . . . 0.0 108.717 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -157.23 110.24 2.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 138.91 -160.64 25.78 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.75 ' C ' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -53.79 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -1.214 . . . . 0.0 109.51 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.055 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 170.41 162.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.592 -1.318 . . . . 0.0 107.959 179.827 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HG3' HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -130.03 -37.57 1.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.454 -1.404 . . . . 0.0 110.433 -179.082 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 1.3 mtmt -155.29 93.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.767 -1.208 . . . . 0.0 110.764 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.743 ' CA ' HG23 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -98.92 153.93 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.253 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -156.16 134.55 11.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.623 -1.298 . . . . 0.0 110.259 -179.636 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.6 t -108.12 129.68 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 m -106.6 114.24 28.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -141.23 -123.15 1.91 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 t -125.11 138.23 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 47.41 78.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.264 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.05 111.78 1.72 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.22 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.832 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.68 138.89 44.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.613 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.17 -100.9 2.27 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 178.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.853 HG13 HG21 ' A' ' 76' ' ' VAL . 28.8 mm -155.61 153.81 7.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.333 -1.098 . . . . 0.0 109.671 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -155.5 -176.47 0.61 Allowed Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.821 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 34.8 Cg_endo -80.02 69.68 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.062 1.841 . . . . 0.0 109.844 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.38 35.52 0.37 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 12.2 t-80 -72.06 -74.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 0.0 109.627 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 167.89 166.67 0.14 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.35 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.68 79.12 3.3 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.68 2.253 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 4.0 mm? -92.85 133.17 36.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.837 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -138.63 52.28 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.175 179.826 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.5 p -126.1 -138.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -99.68 -163.45 1.03 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.0 109.566 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.561 ' CD1' HG21 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -120.57 135.59 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' CD ' ' H ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.38 134.38 93.38 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.493 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.2 Cg_endo -79.22 159.85 26.42 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.551 2.167 . . . . 0.0 110.29 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 125.18 -142.74 14.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.408 ' CE ' ' HB3' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -108.32 -172.02 1.98 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -1.14 . . . . 0.0 109.129 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.509 HD13 HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -161.6 141.17 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.986 -1.071 . . . . 0.0 110.145 -179.562 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HG3' ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -131.34 139.7 49.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.743 HG23 ' CA ' ' A' ' 23' ' ' ILE . 12.1 mt -130.67 172.51 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.999 -1.063 . . . . 0.0 109.997 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 41.4 t -138.34 104.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.695 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 146.21 -99.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.078 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 1.1 tt0 44.28 -157.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -81.52 -18.88 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.289 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.19 -140.24 10.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -118.38 -22.13 7.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -1.205 . . . . 0.0 109.54 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -146.46 126.19 13.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.703 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 60' ' ' GLU . 2.3 mm-40 -103.63 142.39 34.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.016 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CZ ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -133.49 106.32 7.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.674 ' O ' HG11 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -124.47 -166.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.091 179.617 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.737 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -172.67 126.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.31 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 8' ' ' VAL . 3.1 mt -119.6 -173.52 2.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.406 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 p -152.73 34.42 0.49 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.268 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.92 172.2 13.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.55 -164.95 25.12 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 79' ' ' LEU . 11.9 tt -109.51 154.38 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -1.184 . . . . 0.0 109.621 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.726 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -133.87 132.06 39.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.197 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -136.13 131.46 34.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.226 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 40' ' ' PRO . 9.8 p -100.82 137.56 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.59 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.8 mm-40 -124.65 176.73 2.16 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -78.85 106.72 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.489 2.126 . . . . 0.0 110.757 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 70.69 31.93 67.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.464 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 10.8 p-10 174.63 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.627 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.853 HG21 HG13 ' A' ' 34' ' ' ILE . 6.4 p -124.69 149.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -146.86 142.18 27.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.255 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 45' ' ' ILE . 4.8 m -145.03 141.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.24 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 68' ' ' ILE . 6.0 mp -103.05 158.76 16.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 10' ' ' SER . . . -152.6 -165.72 2.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -120.65 -38.98 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -115.29 171.86 7.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -173.78 133.43 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.737 HD12 ' CE1' ' A' ' 63' ' ' TYR . 61.5 mt -144.14 152.68 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.125 -0.984 . . . . 0.0 109.491 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.433 ' O ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -96.08 178.11 5.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.349 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -76.83 2.32 60.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.42 46.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 109.536 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -48.89 -58.07 5.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 -67.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.78 -168.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.859 ' HB2' HG21 ' A' ' 131' ' ' ILE . 4.3 pt-20 -172.42 -34.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.53 -19.54 55.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.16 3.35 20.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 128' ' ' LEU . . . -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.0 108.879 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.556 ' HG3' HD13 ' A' ' 128' ' ' LEU . 5.5 mtp -79.2 -23.95 43.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.677 . . . . 0.0 109.546 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 20.6 mt-10 -68.23 -19.39 64.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.569 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.43 -40.93 20.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -39.26 80.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.506 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.35 82.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 96' ' ' GLU . 16.1 mttt -89.69 -0.35 57.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.945 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -86.56 -55.46 3.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.324 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.8 -42.08 77.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.246 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.6 -43.27 75.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.633 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 105' ' ' ILE . 98.9 mt -89.97 24.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.275 -0.89 . . . . 0.0 109.335 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 107' ' ' SER . 16.6 m -61.09 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 72.27 168.68 0.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.228 -0.92 . . . . 0.0 109.279 -179.945 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 t -152.29 154.72 36.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.545 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -154.62 150.35 27.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.424 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' ASP . . . 115.74 20.3 5.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.531 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.8 OUTLIER 52.32 100.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -1.135 . . . . 0.0 109.348 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 111' ' ' ASP . 25.8 m 40.7 34.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 109.661 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 20.6 t0 -87.23 -95.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.085 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.67 -12.26 61.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.01 63.43 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.62 -0.675 . . . . 0.0 109.42 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.97 -27.07 60.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.442 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.76 -7.74 58.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.446 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.466 ' OG ' HG23 ' A' ' 105' ' ' ILE . 38.4 m -81.01 -30.66 34.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.18 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -84.18 -13.31 53.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.945 HD12 ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -74.9 -24.97 58.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.447 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -79.02 -6.39 56.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -14.58 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -88.9 -10.61 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.389 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 125' ' ' ILE . 1.7 mp -81.36 -2.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.512 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -90.49 -21.33 21.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.677 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 124' ' ' ALA . 20.1 pt20 -69.17 -35.78 76.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.456 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -84.2 11.04 8.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.437 ' HG3' ' HA ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -89.72 -51.27 5.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.674 HG11 ' O ' ' A' ' 62' ' ' ILE . 22.6 m -52.3 -19.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.774 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.859 HG21 ' HB2' ' A' ' 91' ' ' GLU . 7.3 mt -86.29 -58.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' ILE . 39.2 mm-40 -42.15 -40.02 2.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.778 . . . . 0.0 110.121 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 mp -74.2 -52.04 13.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.007 . . . . 0.0 109.73 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 130' ' ' VAL . 6.6 p -46.89 -24.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -70.91 -55.93 7.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.837 . . . . 0.0 109.594 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.74 20.17 13.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.35 63.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.295 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.556 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.211 0.529 . . . . 0.0 109.636 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.066 HG22 ' HB2' ' A' ' 21' ' ' GLU . 2.1 p -42.47 125.0 3.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.745 ' CE2' HG22 ' A' ' 34' ' ' ILE . 27.1 p90 -118.64 -171.67 2.13 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.515 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -111.97 147.46 35.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.035 -1.041 . . . . 0.0 109.076 179.834 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.104 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -137.06 162.8 32.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.964 -1.085 . . . . 0.0 109.132 178.66 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 1.009 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.9 t0 -154.64 96.95 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 78' ' ' VAL . 2.5 p -109.69 112.25 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.115 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.47 167.61 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.063 -1.023 . . . . 0.0 109.925 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -179.39 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.399 -0.813 . . . . 0.0 109.436 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 65.91 109.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 21.3 mm-40 62.38 79.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLU . 9.8 mp0 -43.8 111.97 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.466 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.61 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -171.52 53.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.321 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.621 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -133.81 -88.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.627 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.7 t80 -139.96 126.03 19.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.055 -1.028 . . . . 0.0 109.355 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.3 p -159.67 82.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -0.96 . . . . 0.0 109.235 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.53 -145.04 6.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.675 ' C ' HG12 ' A' ' 20' ' ' VAL . 11.4 mt -69.99 159.49 33.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -1.116 . . . . 0.0 109.583 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.104 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -175.91 164.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 -178.124 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 1.066 ' HB2' HG22 ' A' ' 3' ' ' THR . 47.0 tt0 -139.1 -56.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.108 -0.995 . . . . 0.0 110.236 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.553 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -130.64 111.21 12.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.043 -1.036 . . . . 0.0 110.711 -178.985 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.828 HG22 ' CG1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -99.18 -162.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.507 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -166.36 159.03 14.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.74 -1.225 . . . . 0.0 109.904 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.547 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.3 t -154.52 116.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 81.6 m -111.47 110.56 21.06 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 109.231 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -154.76 45.68 0.55 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.61 169.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -1.158 . . . . 0.0 109.546 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.65 43.3 31.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.98 167.34 19.81 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -164.7 66.01 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -1.214 . . . . 0.0 109.375 -179.914 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.504 HD13 ' OH ' ' A' ' 35' ' ' TYR . 5.7 mt -131.2 147.36 52.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.827 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.74 -102.9 2.45 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.745 HG22 ' CE2' ' A' ' 4' ' ' TYR . 3.5 mm -153.61 159.1 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.276 -1.132 . . . . 0.0 108.979 178.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -151.28 174.74 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.505 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.5 Cg_endo -74.85 76.91 3.2 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.174 1.916 . . . . 0.0 109.95 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.64 49.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 14.9 t-80 -109.48 2.65 20.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 0.0 109.792 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 38' ' ' HIS . . . 66.92 155.78 0.14 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.986 . . . . 0.0 109.44 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.33 87.65 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.676 2.251 . . . . 0.0 110.655 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 38' ' ' HIS . 7.3 mt -99.05 138.67 35.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.472 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.504 ' CD2' ' HG2' ' A' ' 70' ' ' GLU . 74.3 mt -119.9 86.94 2.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' ILE . 17.0 p -131.25 -155.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.401 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -100.33 171.7 7.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.398 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 67' ' ' GLY . 3.4 tt -100.21 169.84 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -115.5 142.46 28.86 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.92 . . . . 0.0 109.349 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.5 146.05 21.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.514 2.143 . . . . 0.0 110.298 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 144.63 -148.22 19.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.473 ' HE1' HG12 ' A' ' 130' ' ' VAL . 5.3 ppp? -101.46 174.35 6.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -1.119 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.969 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.5 OUTLIER -148.48 151.39 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.982 -1.074 . . . . 0.0 109.88 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.5 ttt180 -121.03 172.65 7.79 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.828 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -164.22 144.85 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.711 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.635 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 34.4 t -134.09 118.01 27.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.648 -0.657 . . . . 0.0 109.302 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 139.97 -86.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.528 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.6 tt0 41.33 -94.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.412 -0.805 . . . . 0.0 109.65 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 2.1 t60 -132.11 -36.56 1.16 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.17 42.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -173.34 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.337 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' ILE . 10.8 pt-20 -126.86 145.84 50.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.102 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -136.93 167.92 20.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -134.07 136.47 43.99 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.463 -0.773 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.969 ' H ' HG23 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -109.48 -157.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 109.031 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.75 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 4.2 t80 -172.62 129.15 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.157 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.99 -164.36 2.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.528 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.3 OUTLIER -165.4 130.61 2.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.4 158.7 3.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.552 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 126.14 177.5 14.91 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 43' ' ' THR . 41.1 mt -122.85 142.86 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -1.116 . . . . 0.0 109.309 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.598 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -106.55 132.84 52.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.864 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 tt0 -134.44 112.56 11.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 108.895 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.501 HG23 ' HB ' ' A' ' 76' ' ' VAL . 4.0 p -99.65 158.51 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -139.78 169.25 12.53 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.32 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 73.44 5.75 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.702 2.268 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.33 -14.74 5.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 14.5 p30 -165.43 166.09 18.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 70' ' ' GLU . 1.3 p -153.73 145.63 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 109.327 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.609 HG23 ' HB3' ' A' ' 7' ' ' ASP . 4.3 m -137.78 142.35 40.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.138 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 8' ' ' VAL . 2.5 m -142.61 143.4 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 109.225 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -116.99 147.0 42.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -138.55 -174.37 3.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.39 -46.81 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 65' ' ' SER . 7.5 t -100.38 -176.1 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.621 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -178.94 76.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 84' ' ' ILE . 3.8 mp -106.18 77.01 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.296 -0.877 . . . . 0.0 109.744 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 86' ' ' GLY . 4.9 ttt-85 -45.77 152.11 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.572 ' CA ' HG23 ' A' ' 130' ' ' VAL . . . -42.11 -45.59 5.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -74.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.265 . . . . 0.0 109.31 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' CG ' HG23 ' A' ' 84' ' ' ILE . 27.8 t70 50.01 39.03 17.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.825 . . . . 0.0 109.563 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 59.61 151.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 0.0 109.603 179.826 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.37 -166.48 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 109.617 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.535 ' CB ' HD11 ' A' ' 131' ' ' ILE . 6.7 pt-20 -177.06 -51.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 109.147 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.75 -28.19 58.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -69.81 -6.53 32.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 128' ' ' LEU . . . -89.3 -22.44 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 108.743 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -29.79 33.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.534 -0.728 . . . . 0.0 109.047 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -32.63 74.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.455 -0.778 . . . . 0.0 109.402 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.6 -63.68 1.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.499 ' HG3' HD11 ' A' ' 125' ' ' ILE . 5.9 ttpt -57.77 -29.52 64.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.354 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -66.35 -32.68 74.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -22.36 32.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.999 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -85.55 -15.66 41.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 108.923 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -72.55 -17.32 61.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.12 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -87.4 -34.59 18.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -68.57 -38.85 81.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.551 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.786 HD11 ' HG ' ' A' ' 121' ' ' LEU . 94.2 mt -73.46 -16.98 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -91.37 24.45 2.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 108' ' ' SER . 0.7 OUTLIER -150.82 178.14 9.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 75.95 175.59 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -154.83 -165.14 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.391 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 178.68 25.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.14 -55.16 3.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.661 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 11.3 m -118.9 9.46 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.47 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.997 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 108' ' ' SER . 23.4 p90 -67.11 -19.9 65.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.988 -1.07 . . . . 0.0 108.161 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -56.36 -26.88 54.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -78.64 -31.32 46.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.5 -24.24 56.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.9 -4.19 36.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.09 -38.58 27.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 109.472 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.98 0.82 46.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.652 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.999 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -79.37 -46.92 16.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.43 -9.32 32.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -71.68 -22.97 61.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.634 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.25 -3.51 58.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.682 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -89.56 -8.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.364 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.75 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -74.27 -36.42 63.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 109.274 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.556 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.3 pt20 -90.33 1.52 56.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -90.13 -26.45 20.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -21.34 33.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.742 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.583 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 30.2 m -88.05 -28.98 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.538 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -88.46 -13.63 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -33.45 33.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 110.013 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 133' ' ' LEU . 1.6 pp -84.12 1.32 44.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 0.7 OUTLIER -88.86 -35.31 16.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.209 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 7.6 pttt -79.1 -22.64 44.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.256 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -90.1 -7.03 54.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.394 179.895 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.79 3.05 55.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 109.578 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.436 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.248 0.547 . . . . 0.0 109.532 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.745 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER 62.66 131.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.313 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.839 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 4.3 p90 -130.82 -154.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 9.9 t-80 -127.64 138.51 52.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.354 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.053 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -134.81 160.01 39.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.986 -1.072 . . . . 0.0 109.015 179.349 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.98 ' N ' HD12 ' A' ' 6' ' ' LEU . 15.4 t70 -149.81 101.59 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 0.0 110.08 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 8' ' ' VAL . 13.7 p -102.46 123.78 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.189 -0.944 . . . . 0.0 109.121 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 t -135.81 148.61 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.635 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -140.11 -142.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.045 179.87 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.29 30.25 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.694 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.549 ' CD ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pm0 -170.53 78.89 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.278 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' GLU . 3.3 mt-30 -42.48 103.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 109.67 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 5.6 tt0 175.15 59.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.621 ' HB3' HG21 ' A' ' 62' ' ' ILE . 5.7 mmm -143.49 -82.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.157 -0.965 . . . . 0.0 109.945 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 62' ' ' ILE . 27.5 t80 -145.81 143.55 29.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.116 -0.99 . . . . 0.0 109.276 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.444 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 13.8 p -175.19 88.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.84 -145.35 10.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.722 ' C ' HG12 ' A' ' 20' ' ' VAL . 14.8 mt -68.7 165.15 20.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.19 -1.182 . . . . 0.0 109.066 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.053 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -173.82 152.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.042 -1.036 . . . . 0.0 109.135 -177.907 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.745 ' HG3' HG23 ' A' ' 3' ' ' THR . 3.0 tt0 -114.73 -69.85 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.119 -0.988 . . . . 0.0 110.65 -178.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.5 tptt -125.93 107.98 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.744 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.978 HG22 HG12 ' A' ' 52' ' ' ILE . 1.3 pp -108.9 118.82 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.64 125.51 45.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.541 -1.349 . . . . 0.0 110.298 -178.46 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.5 t -112.86 120.75 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.166 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.9 m -124.14 110.12 14.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -128.77 -145.53 5.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 1.4 m -98.56 135.28 40.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -1.223 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.6 tt0 71.33 101.61 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.121 -0.987 . . . . 0.0 109.233 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.03 171.38 20.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 179.84 60.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.974 -1.31 . . . . 0.0 110.304 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -94.46 153.2 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.012 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.65 171.83 24.35 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.839 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 15.0 mm -99.11 126.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.039 -1.271 . . . . 0.0 108.434 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -124.21 170.63 8.41 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.971 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.1 Cg_endo -72.31 90.91 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.841 1.694 . . . . 0.0 109.933 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.26 2.25 4.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -49.3 136.64 15.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -1.202 . . . . 0.0 109.492 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -54.07 171.29 0.27 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -77.37 83.46 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.697 2.265 . . . . 0.0 110.522 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -99.26 141.31 32.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 109.46 -179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.67 89.98 1.81 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 68' ' ' ILE . 11.9 p -150.13 -138.52 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.257 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.608 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -100.06 171.13 8.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.215 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.913 HD11 ' C ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -99.89 174.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.227 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 2.5 mttt -111.43 143.91 29.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -77.78 121.86 5.65 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.51 2.14 . . . . 0.0 110.402 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.531 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 168.22 -156.15 27.44 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.594 ' N ' ' HB1' ' A' ' 126' ' ' ALA . 5.9 ptm -108.55 -177.33 3.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.642 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -158.69 136.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.952 -1.092 . . . . 0.0 110.722 -179.524 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.86 174.87 5.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.978 HG12 HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -164.95 152.87 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.652 -1.28 . . . . 0.0 109.886 -179.414 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 53.2 t -136.29 99.96 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER 155.89 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 8.8 tt0 50.34 23.78 1.33 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 109.826 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 43.5 63.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.594 179.965 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.49 -59.59 0.27 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 -158.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 109.542 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -110.04 158.64 18.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.9 mt-10 -156.95 165.2 36.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 3.5 p90 -128.19 127.7 43.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -99.96 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.715 ' HE1' ' HB3' ' A' ' 126' ' ' ALA . 23.2 t80 -177.84 128.8 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 108.924 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.84 -166.06 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -119.89 -90.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' C ' HG12 ' A' ' 45' ' ' ILE . . . -125.58 -131.47 3.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 104.49 -166.63 15.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.913 ' C ' HD11 ' A' ' 45' ' ' ILE . 16.7 tt -113.61 133.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -1.199 . . . . 0.0 109.459 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.987 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -114.82 116.46 28.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.7 pt-20 -114.34 127.75 56.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 108.88 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.62 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.1 p -99.8 144.81 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.12 -0.987 . . . . 0.0 109.884 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.543 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -123.69 172.89 5.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.384 -0.822 . . . . 0.0 109.103 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -78.16 93.95 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.611 2.208 . . . . 0.0 110.635 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.06 -17.0 45.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -156.92 152.85 27.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 109.324 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 70' ' ' GLU . 2.0 p -138.14 144.02 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.01 . . . . 0.0 109.617 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.879 HG22 ' HB3' ' A' ' 7' ' ' ASP . 11.9 p -131.07 146.78 52.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.375 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 69' ' ' LEU . 4.9 m -149.33 146.1 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.512 ' C ' HD23 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -124.36 151.47 44.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.29 -0.881 . . . . 0.0 109.341 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.494 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -144.46 -164.8 1.99 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.37 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -117.06 -24.25 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 83' ' ' ALA . 20.5 m -110.8 165.47 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.635 ' HB2' ' CB ' ' A' ' 10' ' ' SER . . . -175.15 67.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.76 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 82' ' ' THR . 2.8 mp -101.43 72.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.276 -0.89 . . . . 0.0 108.922 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -44.35 167.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.88 . . . . 0.0 109.445 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.424 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -52.47 -46.29 58.38 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.27 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -1.162 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' LEU . 34.7 t70 55.24 17.87 2.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.532 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 42.38 37.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.42 ' HB2' ' OD2' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -146.42 168.7 20.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -152.41 -82.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.812 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.72 -25.9 68.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -64.86 -24.86 67.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.934 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.98 -17.05 26.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.005 . . . . 0.0 109.207 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.978 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -80.8 -48.47 12.42 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 -179.586 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -72.19 -9.69 58.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.846 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.62 -19.96 47.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -87.79 -1.62 58.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.05 -36.78 19.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -61.02 -20.61 62.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.559 ' O ' HD12 ' A' ' 105' ' ' ILE . . . -90.08 -21.61 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.63 -44.86 95.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 -6.15 43.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -90.1 -41.61 11.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.711 ' O ' HG22 ' A' ' 105' ' ' ILE . 3.2 mt -86.98 13.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.145 -0.972 . . . . 0.0 109.827 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -103.89 74.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.292 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.9 p -155.7 -153.47 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t 173.61 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -165.55 -54.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.819 . . . . 0.0 109.447 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.02 143.85 15.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 19.7 t70 -64.35 -24.67 67.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -112.89 18.9 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.86 -92.35 0.06 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.427 -0.795 . . . . 0.0 109.219 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -73.5 -23.61 60.07 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -56.77 -36.98 70.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -87.6 -15.51 37.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.803 . . . . 0.0 109.231 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.98 -31.72 69.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -51.96 -26.01 9.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.91 -35.97 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -65.11 -50.5 65.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.663 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 125' ' ' ILE . 36.4 tp -55.31 -53.57 54.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -43.68 -35.89 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -49.99 74.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.661 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.64 -10.77 59.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.561 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.583 HD11 HD11 ' A' ' 121' ' ' LEU . 20.4 mm -89.0 -11.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.445 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.715 ' HB3' ' HE1' ' A' ' 63' ' ' TYR . . . -72.4 -35.05 68.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -81.2 -10.22 59.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.978 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.3 OUTLIER -83.14 -29.24 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.436 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -77.04 -39.76 48.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 109.597 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.597 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.6 m -74.18 -36.41 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -67.21 -19.48 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.422 179.934 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.452 ' C ' ' HG2' ' A' ' 135' ' ' LYS . 6.1 tm-20 -71.95 -16.05 62.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.925 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.11 -47.99 7.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.7 p -60.67 -31.11 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -63.43 -28.88 70.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.828 -179.817 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -109.31 0.6 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 0.0 109.587 -179.992 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.11 8.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 6.9 tpt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.605 179.981 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' THR . 1.5 ttm . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.206 0.527 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.537 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER 52.76 171.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.744 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.1 p90 179.62 -179.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.5 t60 -105.32 149.51 25.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.216 -0.927 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.048 HD12 ' N ' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -138.5 164.77 28.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.001 178.825 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 1.048 ' N ' HD12 ' A' ' 6' ' ' LEU . 2.2 t70 -154.88 81.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.667 HG23 HG13 ' A' ' 78' ' ' VAL . 2.7 p -104.36 110.55 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.14 -170.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . 80.3 p -143.22 -166.7 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.419 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.37 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.453 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -140.55 65.07 1.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.89 . . . . 0.0 109.448 -179.933 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -147.32 172.1 14.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -91.65 152.01 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.554 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.7 mtt -154.05 -76.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.475 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 30.6 t80 -168.14 134.83 2.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 9.1 p -165.73 98.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 156.9 -153.8 25.0 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.657 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -65.18 162.15 17.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -1.211 . . . . 0.0 108.747 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.044 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -172.59 171.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.571 -178.538 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 5.0 tt0 -120.24 -47.97 2.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.074 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -172.44 133.1 0.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.042 179.873 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.865 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 pt -108.37 129.56 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.672 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 20.0 mt-30 -99.5 95.71 7.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.108 . . . . 0.0 109.511 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 50' ' ' ILE . 3.8 t -99.14 151.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.692 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 9.0 t -160.94 140.44 10.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 108.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' HB2' ' A' ' 31' ' ' GLU . . . -111.8 -166.8 18.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 t -48.08 -66.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -66.74 -13.86 61.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.084 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.412 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 112.65 151.49 11.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.692 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -142.82 155.3 44.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -1.217 . . . . 0.0 109.716 179.421 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.53 175.98 10.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.883 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.31 171.49 14.12 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.744 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 16.7 mm -99.89 143.86 13.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.808 -1.407 . . . . 0.0 108.927 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.626 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 1.8 p90 -155.66 169.42 10.39 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -69.58 83.18 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.553 1.502 . . . . 0.0 109.627 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.07 33.58 0.46 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.701 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 32.4 t60 -77.95 3.97 13.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -1.161 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 76.53 175.39 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 0.0 109.847 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -78.2 76.24 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.722 2.281 . . . . 0.0 110.412 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.567 ' H ' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -93.36 122.2 35.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.4 75.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.8 p -139.21 -147.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -106.3 169.37 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -111.04 171.86 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.755 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -115.3 165.52 14.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 36.0 Cg_endo -78.27 117.08 4.01 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.694 2.262 . . . . 0.0 110.323 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -172.53 -153.01 8.98 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.549 ' HB2' HG11 ' A' ' 130' ' ' VAL . 9.7 ptm -114.19 178.03 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 109.268 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.798 HG23 ' H ' ' A' ' 62' ' ' ILE . 2.0 tt -151.78 153.4 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.029 -1.045 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' N ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -123.27 176.77 5.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.662 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.826 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.25 141.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.005 -179.242 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 55.1 t -128.79 113.55 29.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.681 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 58' ' ' HIS . 24.3 mmtt -64.33 142.77 58.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 -179.113 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.1 tt0 -43.5 -28.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.191 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 45.6 t-80 178.98 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 109.305 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.23 -107.59 0.52 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 5.2 t-80 -106.41 172.06 7.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -156.52 136.49 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.196 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -164.52 -173.85 3.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.64 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.1 p90 -125.2 144.11 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.418 -0.801 . . . . 0.0 109.493 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.798 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.4 mm -116.17 -147.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 108.986 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.878 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.5 t80 -174.92 130.98 0.31 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 108.841 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.39 177.05 7.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.72 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.545 ' HB2' HG21 ' A' ' 82' ' ' THR . 6.4 t -109.04 -52.36 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.68 -155.27 8.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 128.49 -158.92 21.88 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.597 ' C ' HD11 ' A' ' 45' ' ' ILE . 14.5 tt -127.38 125.8 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -1.083 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.573 ' HB2' HD12 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -99.69 144.0 29.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -141.08 134.01 29.08 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.567 HG11 ' H ' ' A' ' 41' ' ' LEU . 7.1 p -99.8 155.86 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.131 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.589 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.04 -177.84 0.75 Allowed Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.776 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -79.88 93.31 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.323 2.015 . . . . 0.0 110.618 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.29 56.3 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -126.83 160.74 30.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.622 HG21 ' CG2' ' A' ' 34' ' ' ILE . 14.7 t -134.96 153.3 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.205 -0.934 . . . . 0.0 109.038 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.731 HG23 ' HB3' ' A' ' 7' ' ' ASP . 4.1 m -158.73 127.55 5.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.061 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.667 HG13 HG23 ' A' ' 8' ' ' VAL . 1.2 p -140.32 126.28 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.93 131.5 49.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.103 -0.998 . . . . 0.0 109.673 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.462 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -117.1 -156.7 0.64 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.286 -0.883 . . . . 0.0 109.266 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -145.85 13.76 1.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.545 HG21 ' HB2' ' A' ' 65' ' ' SER . 3.1 m -148.98 135.87 19.79 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.227 -0.92 . . . . 0.0 109.322 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.83 107.07 4.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.274 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.878 HD12 ' CE1' ' A' ' 63' ' ' TYR . 98.6 mt -110.19 -29.62 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.634 HH21 HD12 ' A' ' 62' ' ' ILE . 2.3 mtp-105 62.77 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.248 -0.907 . . . . 0.0 109.636 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.757 ' CA ' HG23 ' A' ' 130' ' ' VAL . . . -66.81 -11.49 57.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ASP . 20.0 mt-30 -90.97 -50.24 5.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -1.139 . . . . 0.0 109.167 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.693 ' HB2' HG22 ' A' ' 84' ' ' ILE . 56.7 t0 43.6 47.05 6.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.828 . . . . 0.0 109.583 179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 90' ' ' ASP . 11.0 mt 48.8 -91.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.408 -0.808 . . . . 0.0 109.784 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 88' ' ' ASP . 6.1 m-20 -53.94 -168.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 0.0 109.719 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -153.82 -69.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.49 -17.97 62.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 0.0 109.831 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -22.12 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -19.5 23.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 109.248 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -29.02 50.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.625 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.8 -2.27 46.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.03 -36.42 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.109 -0.994 . . . . 0.0 109.53 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -58.61 -36.39 73.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.786 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -75.77 -31.9 59.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.694 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -90.03 4.67 49.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.848 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 121' ' ' LEU . . . -89.75 -4.43 57.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 109.58 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 3.3 tp10 -89.49 -47.82 7.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -60.94 -17.09 49.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.975 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -86.76 -30.16 21.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.028 -1.045 . . . . 0.0 109.835 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 105' ' ' ILE . 99.4 mt -89.88 10.78 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.59 30.88 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.423 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 152.04 51.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.59 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 5.9 p -138.38 129.51 27.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 t60 178.39 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 147.06 152.0 5.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.2 -51.24 16.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.3 24.99 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.67 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.22 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.59 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 10.2 p90 -72.28 -25.07 61.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.97 -26.75 38.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -31.6 17.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -68.29 -19.28 64.69 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.822 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 p -67.71 -32.01 72.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.575 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.97 -14.7 59.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.518 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.436 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mm-40 -82.35 -28.94 31.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.547 HD13 ' HB1' ' A' ' 101' ' ' ALA . 8.6 mt -90.27 -39.78 12.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.596 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.415 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -59.77 -44.24 93.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.695 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -59.82 -28.43 67.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -67.25 -30.32 70.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.537 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.597 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.2 mp -70.95 -8.05 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.23 -31.4 19.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.256 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -78.6 -13.43 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.259 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.561 ' C ' HD23 ' A' ' 128' ' ' LEU . 6.4 tt -76.84 -19.4 57.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.391 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -82.18 -28.22 32.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.769 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.757 HG23 ' CA ' ' A' ' 86' ' ' GLY . 27.6 m -86.07 -27.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.955 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.0 tt -69.53 -28.91 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.799 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 14.9 mm-40 -65.59 -15.69 62.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 7.4 mp -90.29 -40.94 11.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.644 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 61' ' ' PHE . 2.2 p -71.92 -3.12 20.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -76.74 -23.52 53.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -120.99 40.41 3.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.369 179.647 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.09 -18.82 13.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.533 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.493 -179.959 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.29 0.566 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.651 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER 64.39 130.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.4 p90 -131.32 -143.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.843 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -141.35 150.0 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 0.0 108.99 -179.361 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.915 ' CD2' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -112.52 132.07 55.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.175 -0.953 . . . . 0.0 109.04 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -129.76 72.42 1.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.823 -1.173 . . . . 0.0 109.791 179.832 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.842 HG23 HG23 ' A' ' 78' ' ' VAL . 3.7 p -109.1 118.2 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.214 -0.929 . . . . 0.0 109.211 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 13.2 m -129.75 159.59 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.03 169.42 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.48 118.84 4.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 58.81 44.02 17.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.206 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -177.78 168.56 2.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.7 pt20 -147.97 174.38 11.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.765 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 3.9 mmt -144.65 -75.45 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.944 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.1 t80 -109.5 113.09 25.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 110.294 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.433 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 32.8 p -136.36 90.6 2.58 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.26 -0.9 . . . . 0.0 109.708 178.928 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 5' ' ' HIS . . . 168.99 -158.64 31.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.787 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.89 -164.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.933 -1.333 . . . . 0.0 109.291 179.483 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 5' ' ' HIS . 0.2 OUTLIER 172.43 164.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 0.0 108.461 179.162 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.651 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER -123.73 -40.07 2.35 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 25.8 ttpt -159.4 113.51 2.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 110.558 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.915 HG21 ' CD2' ' A' ' 6' ' ' LEU . 13.0 pt -98.81 -164.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.689 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -179.76 97.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.667 -1.271 . . . . 0.0 110.221 179.691 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.607 HG12 ' HA2' ' A' ' 33' ' ' GLY . 3.1 p -99.26 140.42 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.306 -0.872 . . . . 0.0 108.717 179.279 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.493 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 23.8 m -131.97 103.6 6.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -133.26 -47.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER 165.05 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -1.168 . . . . 0.0 109.555 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.63 125.36 33.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.463 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.76 -52.69 4.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.02 19.17 4.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.759 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.682 HD23 ' OH ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -128.22 160.7 31.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.602 179.873 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.49 -112.73 3.37 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.404 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.689 HG12 HD11 ' A' ' 23' ' ' ILE . 31.2 mm -155.0 149.18 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.26 -1.141 . . . . 0.0 109.481 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.682 ' OH ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -153.34 -172.86 0.33 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.955 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.0 Cg_endo -78.46 81.21 2.81 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.687 1.592 . . . . 0.0 110.423 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 25.7 1.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 39' ' ' ALA . 28.3 t60 -56.89 145.01 31.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.241 . . . . 0.0 109.477 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.96 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -49.27 176.25 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.96 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.18 87.51 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.645 2.23 . . . . 0.0 110.424 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.19 126.19 46.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.384 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.93 73.09 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -149.3 -144.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.051 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.58 -171.45 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.001 . . . . 0.0 109.183 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 3.1 mt -132.45 172.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.678 -179.89 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -123.45 174.28 3.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.288 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -77.43 144.22 22.63 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.513 2.142 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 165.84 -157.28 29.68 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.425 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.4 ptm -111.29 -177.74 3.28 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 24' ' ' GLN . 3.1 tp -160.28 115.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.455 ' C ' ' CG1' ' A' ' 52' ' ' ILE . 25.2 ttp180 -110.24 154.88 22.78 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.865 ' CG2' HG22 ' A' ' 23' ' ' ILE . 15.9 mt -154.65 170.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.193 . . . . 0.0 111.011 -178.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.557 ' N ' HG22 ' A' ' 52' ' ' ILE . 41.4 t -132.43 111.32 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' HIS . 4.3 ttpt -62.65 105.71 0.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.584 -0.697 . . . . 0.0 110.193 -179.116 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CA ' ' HB2' ' A' ' 21' ' ' GLU . 13.0 tt0 40.59 -93.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.735 . . . . 0.0 110.023 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 28.6 t-80 -150.15 81.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.998 . . . . 0.0 109.487 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.64 -97.51 0.11 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.39 170.99 11.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -1.167 . . . . 0.0 109.584 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 6.8 mt-10 -125.47 164.1 21.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.338 -0.851 . . . . 0.0 109.183 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -122.67 130.62 53.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.111 -0.993 . . . . 0.0 109.756 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.403 ' C ' ' CG1' ' A' ' 62' ' ' ILE . 2.1 m-85 -108.83 132.87 53.58 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 63' ' ' TYR . 1.5 mt -150.73 -179.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.978 -1.076 . . . . 0.0 110.01 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.578 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -159.77 152.66 21.64 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.923 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 65' ' ' SER . 1.2 pp -146.93 -174.55 4.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.97 -179.541 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.479 ' N ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -133.86 -48.98 0.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.47 164.04 31.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 156.88 -172.76 34.52 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.6 mp -111.18 131.28 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -1.137 . . . . 0.0 109.061 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.859 ' HA ' HG12 ' A' ' 78' ' ' VAL . 1.3 tt -115.78 137.55 51.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -0.872 . . . . 0.0 109.408 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 12.7 pt-20 -146.37 143.25 28.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 1.007 ' HA ' HG12 ' A' ' 76' ' ' VAL . 6.1 p -99.62 147.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.675 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -126.87 170.43 9.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 179.958 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.68 77.73 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.643 2.229 . . . . 0.0 110.926 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.44 0.65 16.02 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.225 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 72' ' ' GLN . 1.8 p30 -174.89 166.87 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.005 -1.291 . . . . 0.0 109.756 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.007 HG12 ' HA ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -135.15 161.99 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 109.129 179.833 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 17.4 m -156.11 136.75 13.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.859 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.4 m -138.95 148.4 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.479 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -115.01 120.89 41.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 -179.886 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.77 -174.97 3.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.1 -51.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.8 m -100.27 126.82 46.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.765 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -138.53 150.2 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.982 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 69.6 mt -132.68 122.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.352 -0.843 . . . . 0.0 108.901 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -72.88 89.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.951 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.15 -123.8 12.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HB3' HG12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -100.88 52.97 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -1.096 . . . . 0.0 109.676 -179.674 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.88 -37.53 70.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.37 174.04 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.17 44.06 30.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 87' ' ' GLN . 68.2 mt-10 -77.12 -80.56 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.45 -7.77 53.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.315 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -86.86 8.76 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.902 . . . . 0.0 109.51 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.19 -37.58 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -38.94 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 5.1 mm-40 -71.0 -18.18 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.06 62.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.76 -18.91 9.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 109.702 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -74.15 -45.68 47.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.78 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -79.33 -19.63 49.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.621 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.61 -20.73 25.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.132 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HG2' ' OG ' ' A' ' 106' ' ' SER . 34.7 tt0 -71.39 -28.03 63.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.4 ' HG3' ' ND1' ' A' ' 104' ' ' HIS . 7.2 pt-20 -59.27 -31.06 68.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.669 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.4 ' ND1' ' HG3' ' A' ' 103' ' ' GLU . 14.1 m-70 -82.24 -40.72 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 105' ' ' ILE . 7.4 mt -85.74 12.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' SER . 58.0 m -110.58 117.69 34.22 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 81.65 171.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.827 -0.546 . . . . 0.0 109.537 179.884 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 77.67 173.33 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 109.13 -179.539 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 4.8 p-80 -170.13 125.56 0.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.61 169.23 40.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 3.7 m-20 -67.51 -40.23 85.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -1.096 . . . . 0.0 109.327 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 113' ' ' ASP . 23.2 m -124.92 -9.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 112' ' ' VAL . 2.0 m-20 -48.02 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.168 179.804 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.527 ' CD1' ' C ' ' A' ' 114' ' ' TYR . 5.8 p90 -75.93 -21.2 57.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.017 -1.052 . . . . 0.0 108.294 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -62.81 -18.28 62.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.631 -0.668 . . . . 0.0 109.355 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 3.0 mt-30 -70.23 -36.06 74.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.653 ' HB3' HG13 ' A' ' 105' ' ' ILE . . . -72.86 -24.7 60.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -65.96 -25.98 67.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.339 -0.851 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.3 -33.32 25.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.653 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 117' ' ' ALA . 1.2 pp20? -85.61 -8.3 58.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 122' ' ' ALA . 9.0 tt -84.14 -59.13 2.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.548 ' HA ' ' CG1' ' A' ' 125' ' ' ILE . . . -46.54 -27.79 1.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -51.22 70.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.918 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.19 59.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.548 ' CG1' ' HA ' ' A' ' 122' ' ' ALA . 33.5 mm -76.6 -8.12 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.962 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -88.72 -2.86 58.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.168 -0.958 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.496 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.6 mt-30 -87.63 -37.89 16.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.232 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 131' ' ' ILE . 4.6 tp -81.19 -24.54 37.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.855 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' LEU . 16.5 mmm180 -62.5 -43.51 98.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 127' ' ' GLN . 28.1 m -68.66 -9.99 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.71 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 87' ' ' GLN . 63.0 mt -90.62 -56.15 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 21.1 mm-40 -68.67 -9.19 48.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -87.65 -48.69 7.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.544 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 10.4 t -69.08 -7.57 37.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -55.64 -53.64 54.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.554 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -87.46 -12.74 45.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -46.83 -37.83 9.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.306 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.397 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.504 ' HG2' ' CG ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.109 0.481 . . . . 0.0 109.746 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 3' ' ' THR . 8.9 t 173.7 129.31 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.71 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 1.035 ' CE2' HG22 ' A' ' 34' ' ' ILE . 13.8 p90 -112.84 -162.55 0.8 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.486 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER -117.27 142.36 47.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 108.548 178.756 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.042 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -130.43 156.79 44.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.415 178.43 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.891 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -143.03 90.2 2.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.951 HG13 HD13 ' A' ' 6' ' ' LEU . 7.3 m -108.37 147.7 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -169.31 151.19 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 2.4 m -119.94 125.68 49.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 56.0 27.78 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER 66.07 72.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -165.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 82.74 1.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.621 ' SD ' HG23 ' A' ' 62' ' ' ILE . 7.4 mmt -105.88 -92.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HB3' HG22 ' A' ' 8' ' ' VAL . 34.4 t80 -121.07 138.99 53.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.084 -1.01 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 p -169.06 100.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 154.94 -151.41 23.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.786 ' C ' HG12 ' A' ' 20' ' ' VAL . 10.9 mt -64.22 170.48 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.042 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 172.92 160.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 108.39 -177.608 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.537 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 8.6 tt0 -156.32 -58.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.916 -1.115 . . . . 0.0 110.623 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.544 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -91.42 74.72 6.03 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.395 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.665 HG22 ' CG1' ' A' ' 52' ' ' ILE . 2.9 pt -99.89 143.67 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.269 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 35.8 tt0 -150.63 121.85 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.789 -1.194 . . . . 0.0 109.674 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.84 159.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 5.9 m -138.46 111.79 8.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.216 -0.927 . . . . 0.0 109.204 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.53 -99.62 0.52 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -134.56 -0.12 2.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -1.169 . . . . 0.0 110.214 -179.674 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 tm-20 -164.05 128.66 2.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.93 -53.64 0.61 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 16.8 mt-10 48.85 23.61 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -1.174 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.576 HD22 ' OH ' ' A' ' 35' ' ' TYR . 1.7 mt -148.13 161.09 42.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -111.73 -103.83 2.72 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.035 HG22 ' CE2' ' A' ' 4' ' ' TYR . 9.2 mm -154.54 140.59 11.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.41 -1.053 . . . . 0.0 109.238 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -121.5 -178.89 0.66 Allowed Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.345 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 34.3 Cg_endo -77.54 96.09 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.262 1.975 . . . . 0.0 110.4 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.88 15.25 5.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.475 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 40.2 t-80 -72.74 171.98 11.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -1.146 . . . . 0.0 109.447 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -85.89 156.49 58.09 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.353 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 71' ' ' VAL . 34.0 Cg_endo -77.02 78.0 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.682 2.254 . . . . 0.0 110.782 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 71' ' ' VAL . 1.2 mm? -97.84 149.04 22.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.983 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.51 ' C ' HG22 ' A' ' 43' ' ' THR . 0.8 OUTLIER -152.74 133.47 13.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 179.97 -92.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.84 . . . . 0.0 109.436 179.48 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.503 ' H ' HG23 ' A' ' 43' ' ' THR . . . -131.29 160.9 33.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.925 HD13 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -100.42 132.42 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -65.33 136.41 96.37 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 -179.837 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.467 ' CB ' ' OG ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -80.18 160.51 23.4 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.446 2.097 . . . . 0.0 110.44 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 126.58 -131.64 7.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ptm -121.94 178.3 4.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -1.056 . . . . 0.0 109.009 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -156.23 131.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.618 -1.301 . . . . 0.0 110.96 -179.604 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -98.84 129.67 45.23 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.943 HD11 ' CD2' ' A' ' 6' ' ' LEU . 2.1 tt -130.82 152.38 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.887 -1.133 . . . . 0.0 110.898 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 46.8 t -131.19 107.56 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' GLN . 4.4 ttpt -67.29 119.51 12.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.735 . . . . 0.0 109.646 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' LYS . 3.4 tt0 41.19 -152.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.423 -0.798 . . . . 0.0 109.742 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -88.91 67.24 8.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 161.62 163.6 14.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.3 m-70 57.88 159.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.184 -1.186 . . . . 0.0 109.347 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.3 OUTLIER 179.97 118.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -132.53 157.08 45.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.603 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.4 OUTLIER -113.58 136.44 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 -179.904 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 50' ' ' ILE . 5.3 mp -112.58 167.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.602 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 14.4 t80 -128.48 140.83 51.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.32 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -168.83 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.467 ' OG ' ' CB ' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -179.47 132.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 -179.966 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.642 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 72.79 142.97 0.51 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.57 165.06 11.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.73 123.85 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -1.108 . . . . 0.0 109.22 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.806 HD12 HD12 ' A' ' 45' ' ' ILE . 1.2 tt -108.09 153.73 22.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.0 110.036 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 77' ' ' THR . 4.4 pt-20 -156.14 111.0 2.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG23 ' HB ' ' A' ' 76' ' ' VAL . 4.4 p -99.85 159.08 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 2.0 mt-30 -143.11 172.97 4.97 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.7 Cg_endo -80.26 62.11 8.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.627 2.218 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.63 -14.74 1.06 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 1.9 p30 -167.21 168.65 13.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.996 -1.296 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -155.49 162.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.413 -0.804 . . . . 0.0 109.063 -179.891 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 7' ' ' ASP . 6.4 p -154.18 156.05 36.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG21 HD13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -166.43 130.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.962 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.96 112.0 23.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.642 ' HB1' ' O ' ' A' ' 66' ' ' GLY . . . -106.07 -175.27 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.63 -9.26 9.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 65' ' ' SER . 16.7 m -109.35 142.04 40.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -161.39 132.85 5.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.911 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.602 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 18.9 mt -128.8 -36.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.368 -0.833 . . . . 0.0 109.143 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 75.34 134.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.172 -179.763 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -39.16 96.6 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 85' ' ' ARG . 8.2 tt0 63.85 74.36 0.42 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -1.112 . . . . 0.0 109.942 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 8.9 t70 -52.3 -35.09 49.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.086 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER 166.47 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.076 179.875 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 75.12 153.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' CB ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.66 -29.36 3.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.56 -33.64 20.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.476 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 9.3 ttt180 -63.67 -22.72 67.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 0.0 109.466 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.74 -25.11 23.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.274 -0.891 . . . . 0.0 108.712 179.63 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.538 ' HA ' HD11 ' A' ' 128' ' ' LEU . 2.5 mtm -66.29 -20.74 66.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.505 -0.747 . . . . 0.0 109.373 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 2.3 tm-20 -80.05 -22.38 42.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.93 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.15 72.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.405 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.34 -26.81 61.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.211 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -81.94 -26.68 33.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HG3' ' OE1' ' A' ' 96' ' ' GLU . 8.3 mttt -83.25 -27.32 29.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 109.624 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.87 -19.69 31.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.395 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 16.1 tp10 -77.34 -38.22 50.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.924 . . . . 0.0 109.334 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -72.49 -43.61 63.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -28.05 67.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.801 ' O ' HG22 ' A' ' 105' ' ' ILE . 98.8 mt -90.24 26.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.203 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 t -97.32 -14.35 21.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.707 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.6 p -126.01 110.91 14.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -158.0 155.73 29.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 109.271 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.7 -76.95 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 111' ' ' ASP . . . 179.05 -175.74 47.48 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 0.2 OUTLIER 77.84 -78.03 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -1.079 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.3 m -135.51 8.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.15 -91.24 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.409 -0.807 . . . . 0.0 108.884 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 108' ' ' SER . 49.5 t80 -72.12 -17.49 61.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.22 82.21 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 5.9 mm-40 -90.68 -32.5 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.494 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -67.37 -24.77 65.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -32.23 53.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.441 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.24 -25.98 22.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 8.8 mm-40 -62.87 -46.31 88.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -58.03 -52.56 65.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.463 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -18.85 60.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 -179.686 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -29.46 64.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.96 -24.67 21.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.812 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 125' ' ' ILE . 24.7 mm -80.62 7.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.54 -34.07 15.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 2.6 pt20 -80.86 -25.01 37.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.903 . . . . 0.0 109.618 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -71.23 -15.84 62.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.25 -52.49 4.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.603 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 21.6 m -56.61 -29.33 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.942 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 132' ' ' GLU . 12.0 tt -64.36 -42.96 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.005 . . . . 0.0 109.735 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 131' ' ' ILE . 6.6 mm-40 -60.39 -23.77 64.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.28 -49.62 16.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.792 -179.677 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 8.8 t -70.66 -17.81 62.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -53.04 52.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -5.26 59.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -60.27 -34.09 73.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.519 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.3 0.572 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.629 HG22 ' CG ' ' A' ' 21' ' ' GLU . 7.6 p -45.52 135.87 6.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.701 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 5.3 p90 -132.8 178.36 6.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.063 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.3 t60 -103.79 149.1 25.34 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.121 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -138.55 156.72 47.24 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.442 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.859 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.68 94.09 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.98 -1.075 . . . . 0.0 110.261 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.707 HG12 ' HB3' ' A' ' 16' ' ' PHE . 6.5 p -107.61 96.32 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 108.779 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.561 HG23 HD23 ' A' ' 79' ' ' LEU . 28.7 m -118.26 162.22 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.961 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 t -102.63 -158.27 0.66 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.343 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -68.38 -50.27 54.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 4.2 mt-10 -141.59 67.61 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 1.8 mm-40 171.61 68.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 13' ' ' GLN . 14.7 pt20 -43.71 158.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.66 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.94 ' HB3' HG21 ' A' ' 62' ' ' ILE . 12.3 mmm -126.83 -73.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.176 -0.952 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.707 ' HB3' HG12 ' A' ' 8' ' ' VAL . 40.9 t80 -114.68 93.45 4.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.9 p -124.04 95.71 4.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -159.73 32.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.405 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.6 mt -66.78 160.73 25.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -1.173 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.121 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -164.36 160.26 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.969 -178.5 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.629 ' CG ' HG22 ' A' ' 3' ' ' THR . 0.1 OUTLIER -130.63 -34.85 1.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.516 -0.74 . . . . 0.0 109.35 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.4 ttpp -155.1 97.84 1.96 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.096 -1.002 . . . . 0.0 110.515 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.31 156.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.52 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 11.9 tt0 -151.96 134.47 15.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.538 HG23 ' HA2' ' A' ' 33' ' ' GLY . 36.5 t -108.78 142.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -130.41 113.04 13.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.51 -111.95 1.48 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.712 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 m -107.97 -62.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -1.179 . . . . 0.0 109.466 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.64 -17.8 14.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.56 119.37 5.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -129.26 34.62 4.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -1.194 . . . . 0.0 109.798 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.69 HD23 ' OH ' ' A' ' 35' ' ' TYR . 6.5 mt -138.61 139.29 38.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.013 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.11 -101.46 2.29 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.709 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.861 HG21 HG21 ' A' ' 76' ' ' VAL . 20.4 mm -155.59 152.7 8.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.69 ' OH ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -154.44 -176.0 0.56 Allowed Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.746 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 36.2 Cg_endo -81.7 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.359 2.04 . . . . 0.0 110.183 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.49 38.64 0.02 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.71 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 10.4 t-160 -82.47 10.02 8.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -1.08 . . . . 0.0 109.594 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.873 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 75.86 173.47 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.314 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.873 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -78.16 76.97 4.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.581 2.188 . . . . 0.0 110.485 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -90.01 130.04 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.183 179.804 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.2 tp -148.77 69.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -140.29 -95.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.729 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.507 ' H ' HG23 ' A' ' 43' ' ' THR . . . -156.87 167.96 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.808 ' CD1' HG21 ' A' ' 78' ' ' VAL . 3.4 mt -110.07 167.25 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 68.4 mmtt -100.11 159.45 29.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.09 163.95 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.858 2.372 . . . . 0.0 110.423 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 130.78 -146.25 17.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.669 ' HB2' HG11 ' A' ' 130' ' ' VAL . 24.8 ptm -103.19 -176.77 3.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -1.112 . . . . 0.0 109.085 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -158.52 118.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 109.544 -179.81 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.36 131.28 46.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 109.367 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 23' ' ' ILE . 35.5 mt -132.73 163.08 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.107 -0.995 . . . . 0.0 109.784 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.592 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 39.2 t -134.95 154.62 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.616 -0.677 . . . . 0.0 109.64 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.4 tmtm? 92.0 -79.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.492 ' OE1' ' HG2' ' A' ' 60' ' ' GLU . 14.6 tt0 51.44 -99.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.818 -1.176 . . . . 0.0 109.606 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -165.28 50.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.922 -1.111 . . . . 0.0 109.275 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.73 -44.61 0.82 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -150.93 -176.64 5.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.406 -1.055 . . . . 0.0 109.235 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.566 ' HG2' HG13 ' A' ' 53' ' ' VAL . 5.6 mp0 -106.9 162.31 13.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 109.124 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HG2' ' OE1' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -162.64 171.28 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.968 -1.082 . . . . 0.0 110.016 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.592 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.7 OUTLIER -121.1 176.3 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 109.656 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.94 HG21 ' HB3' ' A' ' 15' ' ' MET . 1.2 mt -152.94 -160.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.78 . . . . 0.0 109.0 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.804 ' C ' HD13 ' A' ' 64' ' ' LEU . 3.8 t80 -172.36 128.87 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.21 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.888 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -158.63 -169.74 2.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 109.708 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -86.98 -59.75 2.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.55 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.14 -63.92 0.33 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.59 -152.3 52.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.843 ' O ' HG23 ' A' ' 78' ' ' VAL . 75.1 mt -102.71 137.99 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.141 . . . . 0.0 109.217 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.732 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.7 tt -119.37 152.6 36.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.0 109.576 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 6.0 mt-10 -149.65 138.33 20.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 109.229 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.597 ' HA ' HG12 ' A' ' 76' ' ' VAL . 9.6 p -100.52 140.51 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.793 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 5.6 mt-30 -124.19 174.76 3.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.4 Cg_endo -78.12 80.92 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.342 2.028 . . . . 0.0 111.022 -179.389 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 102.5 25.3 7.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 7.0 p-10 171.15 138.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -1.208 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.861 HG21 HG21 ' A' ' 34' ' ' ILE . 28.3 m -126.61 172.48 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 108.908 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 78' ' ' VAL . 55.3 m -163.11 157.19 20.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.212 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 68' ' ' ILE . 2.4 p -161.82 135.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 108.95 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.561 HD23 HG23 ' A' ' 9' ' ' VAL . 2.0 mt -116.37 122.9 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.082 -1.012 . . . . 0.0 109.779 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.14 -168.06 1.33 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.235 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.57 -12.02 8.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.447 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.2 m -112.19 147.83 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -158.25 70.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 109.728 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.652 HD12 ' CE1' ' A' ' 63' ' ' TYR . 8.6 mt -99.0 56.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 88' ' ' ASP . 7.2 ptt180 -46.21 154.6 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.42 ' C ' ' HG3' ' A' ' 87' ' ' GLN . . . -58.37 148.98 36.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.816 ' CD ' HG21 ' A' ' 134' ' ' THR . 12.9 mt-30 69.29 6.15 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -1.122 . . . . 0.0 109.645 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 12.0 t70 -70.13 -34.43 73.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.68 151.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 93' ' ' ARG . 66.0 t0 56.99 103.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.311 -0.868 . . . . 0.0 109.585 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.11 -53.98 2.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.5 -20.7 26.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.504 ' CB ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -86.76 -9.35 56.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.968 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . . . -90.41 -12.22 38.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.209 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -25.97 32.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 109.683 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 12.5 pt-20 -77.07 -14.33 59.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.38 -47.92 53.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 109.54 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -21.91 19.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -39.67 24.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -90.08 0.46 57.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.973 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -90.33 -32.18 16.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.72 -26.22 68.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.75 -37.43 82.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -68.96 -16.24 63.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 107' ' ' SER . 11.4 mm -89.14 19.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.165 -0.96 . . . . 0.0 109.744 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -47.52 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.634 -179.937 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' ILE . 2.5 m -43.66 137.18 3.09 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.4 p -166.41 158.93 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.499 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.17 166.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.14 138.35 5.23 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -72.16 -72.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.329 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.704 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 32.2 m -111.61 12.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 112' ' ' VAL . 29.6 t0 -49.86 -99.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -68.45 -15.8 63.68 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.873 -1.142 . . . . 0.0 108.514 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -64.84 -16.0 62.58 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.601 -0.687 . . . . 0.0 109.5 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -88.83 -27.92 20.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -82.67 -14.29 54.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -23.39 61.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.61 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.57 -23.9 24.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.25 -10.38 54.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.973 HD12 ' HB1' ' A' ' 101' ' ' ALA . 3.1 mm? -86.3 -63.62 1.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.644 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 125' ' ' ILE . . . -54.18 -18.67 4.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -54.59 -41.04 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.23 -36.3 18.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -64.6 -10.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.427 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.512 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -69.53 -35.46 75.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.476 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.518 ' HA ' HG22 ' A' ' 130' ' ' VAL . 1.6 pp0? -81.09 5.33 16.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 128' ' ' LEU . 2.3 tt -86.14 -36.23 19.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -34.74 62.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.161 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 49' ' ' MET . 35.5 m -72.38 -36.56 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 128' ' ' LEU . 3.6 tt -68.26 -31.37 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -75.29 -16.55 60.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -71.03 -42.1 69.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.647 -179.95 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.816 HG21 ' CD ' ' A' ' 87' ' ' GLN . 9.7 t -74.1 -14.13 60.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -60.09 -35.72 75.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.11 -0.994 . . . . 0.0 109.176 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -95.75 -3.98 44.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.252 179.703 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -58.49 -57.09 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.474 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.3 ptp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.444 179.797 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.447 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.2 mtm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.274 0.559 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -162.04 177.17 9.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.829 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.4 p90 -166.05 -149.09 0.1 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.557 ' HA ' HG12 ' A' ' 20' ' ' VAL . 1.2 t-80 -133.05 147.54 52.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 108.886 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.037 HD23 HG21 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -140.23 169.96 16.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.194 178.975 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 1.027 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.75 103.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.896 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.6 p -116.39 102.94 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.981 . . . . 0.0 109.515 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG13 ' HA ' ' A' ' 14' ' ' GLN . 15.0 t -111.55 156.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.589 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 15.4 t -122.13 78.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 109.655 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 69.14 -85.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.77 30.88 4.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.507 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.69 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.741 ' HA ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.27 144.99 11.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 -179.853 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.593 ' SD ' HG23 ' A' ' 62' ' ' ILE . 13.9 mtt -127.96 -77.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.262 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.672 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 34.7 t80 -103.49 123.83 47.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 17' ' ' SER . 14.8 p -152.12 103.04 2.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.0 -155.32 26.05 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' C ' HG12 ' A' ' 20' ' ' VAL . 8.5 mt -61.33 178.69 0.26 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.119 -1.224 . . . . 0.0 108.937 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.037 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 175.88 113.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.784 -1.197 . . . . 0.0 109.888 -177.871 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 6.6 tt0 -76.17 -43.04 44.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.085 179.242 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -165.94 134.51 3.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.987 -1.071 . . . . 0.0 110.586 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.872 HD11 HG12 ' A' ' 34' ' ' ILE . 39.0 pt -98.71 -148.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -176.1 132.99 0.25 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.259 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.476 HG23 ' HA2' ' A' ' 33' ' ' GLY . 4.1 t -140.25 131.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.976 -1.078 . . . . 0.0 109.324 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.7 m -132.61 113.89 13.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.519 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.76 -119.64 2.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.6 p -122.65 -6.63 8.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.01 -91.86 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.92 142.8 34.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.98 63.1 1.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -1.219 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' A' ' 32' ' ' LEU . 8.9 mt -141.26 162.36 35.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 109.595 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -106.05 -116.64 4.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.882 HG21 HG21 ' A' ' 76' ' ' VAL . 17.5 mm -153.05 141.1 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.531 -0.982 . . . . 0.0 108.373 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -139.37 172.99 5.6 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.745 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -73.26 85.29 1.25 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.034 1.823 . . . . 0.0 109.975 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.57 20.16 2.19 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 59.1 t60 -55.0 139.61 40.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -1.233 . . . . 0.0 109.381 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -43.68 162.15 0.19 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.322 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 34.2 Cg_endo -76.85 75.68 4.41 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.501 2.134 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.15 140.35 30.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.05 107.55 4.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 109.236 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.731 HG23 ' N ' ' A' ' 44' ' ' ALA . 11.8 t -175.25 -139.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.731 ' N ' HG23 ' A' ' 43' ' ' THR . . . -99.67 179.2 4.61 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.883 -1.136 . . . . 0.0 109.403 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 45' ' ' ILE . 1.3 tp -111.84 118.82 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.464 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -54.78 144.83 44.34 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.852 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.8 Cg_endo -78.5 172.7 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.661 2.241 . . . . 0.0 110.436 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.47 -153.98 19.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.864 ' HB2' HG13 ' A' ' 130' ' ' VAL . 4.7 ppp? -102.83 -178.93 3.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -1.124 . . . . 0.0 109.289 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 51' ' ' ARG . 3.9 mt -154.33 165.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.128 -0.982 . . . . 0.0 110.235 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.538 ' N ' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -152.85 151.03 29.94 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.357 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.656 ' CG2' HG22 ' A' ' 23' ' ' ILE . 21.5 mt -153.39 163.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.745 -1.222 . . . . 0.0 110.769 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' N ' HG22 ' A' ' 52' ' ' ILE . 67.3 t -139.84 109.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' HIS . 14.8 tttm -64.86 119.8 11.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.634 -0.666 . . . . 0.0 109.537 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 52.0 tt0 42.75 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.75 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -154.87 56.49 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 -179.941 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -130.44 -98.25 0.81 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 176.92 4.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -1.092 . . . . 0.0 109.372 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.3 pt-20 -121.95 146.02 47.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 147.54 34.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 134' ' ' THR . 8.9 m-85 -102.85 155.58 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.671 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.593 HG23 ' SD ' ' A' ' 15' ' ' MET . 65.5 mt -153.47 145.84 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.598 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.542 ' CD2' ' HB ' ' A' ' 84' ' ' ILE . 4.0 t80 -147.47 133.08 18.79 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.802 ' C ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -167.79 168.17 12.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 110.107 -179.58 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.605 ' N ' HD22 ' A' ' 64' ' ' LEU . 1.4 m -150.19 92.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.379 -0.826 . . . . 0.0 109.296 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.94 105.09 1.77 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.544 ' C ' HD13 ' A' ' 68' ' ' ILE . . . -177.2 -178.48 46.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.864 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.1 mm -118.79 135.71 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -1.176 . . . . 0.0 109.414 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.617 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.5 tt -112.89 152.27 29.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -0.899 . . . . 0.0 109.578 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.41 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.0 tt0 -161.12 133.16 5.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 40' ' ' PRO . 13.5 p -99.89 140.64 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.579 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.3 mt-30 -120.6 -178.77 0.62 Allowed Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -79.63 82.58 2.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.4 2.067 . . . . 0.0 111.005 -179.586 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.47 -9.62 64.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HB2' ' OE1' ' A' ' 72' ' ' GLN . 10.0 m-20 -131.85 160.89 34.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -1.217 . . . . 0.0 109.695 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 34' ' ' ILE . 12.5 t -137.64 152.3 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -151.04 162.63 40.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -179.34 139.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.426 -0.796 . . . . 0.0 109.103 179.857 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 6.0 mp -106.23 174.05 6.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -164.21 165.49 21.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.265 -0.897 . . . . 0.0 109.589 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -108.27 -45.42 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.313 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.4 110.49 5.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 109.689 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.788 HG23 ' CG ' ' A' ' 88' ' ' ASP . 3.3 mt -137.75 73.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.057 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' GLY . 8.9 ptp180 -43.93 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.532 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.531 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -44.06 -58.01 4.56 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -47.91 -87.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -1.196 . . . . 0.0 109.329 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.788 ' CG ' HG23 ' A' ' 84' ' ' ILE . 18.8 t70 68.26 19.0 9.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 0.2 OUTLIER 71.97 34.26 1.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.627 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.76 161.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -138.45 -65.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.631 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.67 -12.22 51.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 109.719 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.17 9.05 13.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.626 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.28 19.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.335 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.17 -18.02 63.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.827 . . . . 0.0 109.519 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -77.93 -18.67 55.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.34 62.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.629 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -79.81 -22.77 42.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.22 -48.48 20.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.733 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -30.32 67.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.152 -0.967 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.22 26.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.65 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' LYS . 3.0 tt0 -80.3 -38.26 31.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.17 -32.0 70.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.138 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -27.87 67.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.314 -0.866 . . . . 0.0 109.296 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 121' ' ' LEU . 25.6 mt -88.97 21.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 109.647 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 107' ' ' SER . 19.3 p -57.35 -63.51 1.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.4 OUTLIER 168.01 94.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 -153.51 0.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.97 166.53 13.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.85 152.59 8.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.49 -56.47 3.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -1.112 . . . . 0.0 109.37 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.34 23.0 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 37.4 t0 -75.73 -95.79 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.206 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -71.19 -20.58 62.26 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.45 75.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.225 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -70.77 -34.12 71.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.93 -22.88 67.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.0 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.2 t -53.59 -40.76 65.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.374 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . -73.65 -38.79 64.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.02 -20.36 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.422 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 105' ' ' ILE . 7.2 tp -78.08 -65.34 0.99 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 125' ' ' ILE . . . -49.39 -29.69 6.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 119' ' ' ALA . 2.3 mptt -65.88 -43.69 87.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.87 -20.98 64.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 122' ' ' ALA . 10.5 mm -70.2 -14.02 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.43 -18.73 47.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.433 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.581 ' O ' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.537 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.462 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.9 OUTLIER -74.72 -13.05 60.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.602 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -84.45 -39.75 18.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.864 HG13 ' HB2' ' A' ' 49' ' ' MET . 2.7 m -70.58 -22.25 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 127' ' ' GLN . 23.4 pt -87.55 -32.61 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HG2' HG13 ' A' ' 131' ' ' ILE . 18.8 mm-40 -83.1 -17.84 41.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.657 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -85.33 -46.78 10.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.962 . . . . 0.0 109.499 179.867 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 61' ' ' PHE . 11.1 t -75.16 -13.18 60.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.406 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.48 -27.38 1.72 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.398 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -82.76 -38.03 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.823 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.68 -71.85 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.668 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.432 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 3' ' ' THR . 13.6 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -177.77 143.38 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.977 . . . . 0.0 109.684 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.67 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.8 p90 -137.7 -145.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.713 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.838 ' O ' HG22 ' A' ' 76' ' ' VAL . 35.6 t-80 -131.37 140.46 49.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.926 -1.109 . . . . 0.0 110.493 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.853 HD21 HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -109.96 127.65 54.9 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.327 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' HB3' ' OG1' ' A' ' 77' ' ' THR . 0.2 OUTLIER -135.73 63.64 1.59 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.956 -1.09 . . . . 0.0 109.307 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.838 HG23 ' CG2' ' A' ' 78' ' ' VAL . 1.9 p -99.64 131.04 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.211 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.7 144.68 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -153.05 -157.42 0.79 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 109.222 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 81' ' ' ASP . . . -43.51 122.85 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 108.985 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.5 mt-10 76.35 78.98 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.818 . . . . 0.0 108.989 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 12' ' ' GLU . 23.3 tm0? -41.47 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 172.64 47.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.772 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -93.7 -93.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.967 . . . . 0.0 109.346 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.621 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.1 t80 -134.04 111.44 10.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.034 . . . . 0.0 109.959 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.413 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 51.4 p -136.3 71.87 1.43 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.901 . . . . 0.0 109.38 178.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . -169.39 167.97 40.91 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 19' ' ' LEU . 18.8 mt -46.18 167.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.409 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.765 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -167.64 168.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.967 . . . . 0.0 109.549 -179.318 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.5 tt0 -120.17 -37.35 3.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -167.92 124.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.929 -1.107 . . . . 0.0 110.721 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.853 HG21 HD21 ' A' ' 6' ' ' LEU . 19.5 pt -99.09 -159.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.744 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 1.2 tt0 -177.04 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.865 -1.147 . . . . 0.0 109.789 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -99.34 99.78 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 109.588 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 26' ' ' THR . 5.8 t -100.14 129.49 46.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.868 . . . . 0.0 109.329 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.28 -90.34 0.51 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 p -134.45 -43.5 0.77 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -1.177 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -101.72 -78.0 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.555 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.81 114.43 6.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 25.25 11.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.446 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.437 HD13 ' OH ' ' A' ' 35' ' ' TYR . 11.6 mt -122.15 157.65 31.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.542 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -99.83 -109.51 3.06 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.67 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 22.8 mm -153.82 155.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 109.319 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -150.66 175.19 2.97 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.334 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.7 Cg_endo -74.05 82.28 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.12 1.88 . . . . 0.0 110.057 179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.37 26.78 2.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.586 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.1 t-160 -55.21 -89.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -1.097 . . . . 0.0 109.553 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -172.5 168.98 2.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.829 ' HA ' HG11 ' A' ' 71' ' ' VAL . 36.2 Cg_endo -78.43 70.02 7.42 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.671 2.248 . . . . 0.0 110.703 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.499 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 2.9 mm? -84.58 142.06 30.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.188 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.646 HD21 ' OE1' ' A' ' 70' ' ' GLU . 1.2 mt -151.85 49.38 0.8 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.086 -1.008 . . . . 0.0 109.558 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -126.51 -152.51 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.46 179.72 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 1.2 mt -128.55 168.7 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 167.67 8.92 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.533 ' CA ' ' O ' ' A' ' 65' ' ' SER . 35.6 Cg_endo -78.01 135.56 14.04 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.661 2.241 . . . . 0.0 110.381 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 177.31 -158.36 23.8 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.489 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.8 ptm -100.43 173.97 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.087 . . . . 0.0 109.102 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.767 HG23 ' H ' ' A' ' 62' ' ' ILE . 2.4 tt -148.41 103.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -99.3 147.26 25.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.773 ' CG2' HG22 ' A' ' 23' ' ' ILE . 12.6 mt -149.48 167.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.021 -1.05 . . . . 0.0 110.868 -178.825 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 59' ' ' GLU . 66.5 t -137.85 106.46 3.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -70.27 127.53 33.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.562 -179.387 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER 45.51 -158.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.68 82.79 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 142.75 146.09 4.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 22.1 t-80 75.2 162.09 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.644 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.8 pt-20 -170.34 132.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.22 138.17 51.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.246 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.93 ' C ' HD13 ' A' ' 62' ' ' ILE . 12.1 p90 -123.19 129.1 50.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.093 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -112.64 -146.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.35 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.839 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.3 t80 -169.98 141.98 2.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.018 . . . . 0.0 109.133 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 pp -142.41 -175.98 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.533 ' O ' ' CA ' ' A' ' 47' ' ' PRO . 23.1 t -117.32 -46.54 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.34 -143.93 3.79 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' LEU . . . 116.92 174.55 17.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.06 129.34 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.116 . . . . 0.0 109.472 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.965 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -100.56 118.23 36.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.47 -179.898 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.902 ' N ' HD22 ' A' ' 69' ' ' LEU . 15.0 tt0 -122.93 141.48 51.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.128 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.829 HG11 ' HA ' ' A' ' 40' ' ' PRO . 12.2 p -101.53 150.69 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.733 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.548 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 2.5 mt-30 -137.23 173.83 5.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.58 110.12 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.456 2.104 . . . . 0.0 110.669 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 69.15 37.73 82.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.58 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.5 p30 165.37 162.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.265 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 5' ' ' HIS . 32.8 m -142.34 163.32 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.53 -0.731 . . . . 0.0 109.099 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 40.7 m -160.2 132.81 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 109.742 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.838 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.0 m -127.52 153.79 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 109.339 179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' CA ' ' A' ' 67' ' ' GLY . 1.2 mp -111.97 121.61 45.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.016 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -133.72 168.41 18.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.178 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -126.13 -17.7 5.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 110.133 -179.737 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -113.22 142.74 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.807 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -150.47 132.99 15.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.068 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.839 HD12 ' CE1' ' A' ' 63' ' ' TYR . 57.6 mt -115.29 -40.46 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' GLY . 7.8 ttp180 69.77 133.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -41.58 -40.8 3.0 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.823 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 18.3 mt-30 -73.41 -61.94 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -1.216 . . . . 0.0 109.393 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.482 ' HB2' HG22 ' A' ' 84' ' ' ILE . 27.4 t70 62.69 12.83 5.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.785 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 tp 57.56 38.53 27.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 177.5 159.23 0.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.729 ' CB ' HD11 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -153.19 -50.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.064 -1.022 . . . . 0.0 109.855 -179.686 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.44 72.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -79.07 -17.49 55.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 109.847 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.763 ' HB1' ' OE1' ' A' ' 127' ' ' GLN . . . -90.51 -12.0 38.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.296 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.695 ' HG2' HD21 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -78.02 -24.12 47.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.55 -15.03 58.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.9 87.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.92 -37.19 13.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 109.724 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -50.89 15.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.965 . . . . 0.0 109.691 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -17.75 14.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 121' ' ' LEU . . . -89.52 -32.25 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.975 . . . . 0.0 109.643 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.737 ' O ' HG22 ' A' ' 105' ' ' ILE . 35.4 tp10 -73.99 -27.07 60.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -35.08 67.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 2.47 39.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 102' ' ' GLU . 1.7 tp -69.52 -19.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 p -89.71 -29.39 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.672 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -60.58 92.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 113' ' ' ASP . 10.9 m -162.59 -148.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.399 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 1.4 t-160 -140.66 -150.16 0.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.973 . . . . 0.0 109.678 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -77.22 0.35 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 112' ' ' VAL . 2.0 m-20 -80.51 177.0 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -1.161 . . . . 0.0 109.726 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.37 33.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.64 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 51.1 t0 -83.89 -96.78 0.06 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.059 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.62 -18.25 65.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.36 87.68 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.357 0.599 . . . . 0.0 109.394 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 22.0 mt-30 -88.41 -16.99 31.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.626 ' HB1' HD12 ' A' ' 105' ' ' ILE . . . -72.96 -27.14 61.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.2 t -60.22 -16.6 34.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -81.69 -61.11 2.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.75 -9.02 48.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.642 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 105' ' ' ILE . 11.8 tp -89.12 -60.71 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.8 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -78.26 5.65 9.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.036 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 119' ' ' ALA . 4.1 tttt -73.28 -45.79 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.59 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.08 -6.75 41.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' A' ' 122' ' ' ALA . 2.0 mp -84.73 -14.48 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.646 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -67.15 -32.46 73.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLN . . . . . 0.763 ' OE1' ' HB1' ' A' ' 94' ' ' ALA . 10.8 pt20 -82.5 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.1 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.695 HD21 ' HG2' ' A' ' 95' ' ' MET . 0.6 OUTLIER -74.67 -13.31 60.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.374 179.919 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -89.65 -53.74 4.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.701 HG23 ' HA2' ' A' ' 86' ' ' GLY . 34.4 m -67.77 -27.91 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.72 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.729 HD11 ' CB ' ' A' ' 91' ' ' GLU . 3.8 tt -65.11 -38.35 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.453 ' N ' HG23 ' A' ' 131' ' ' ILE . 4.8 mm-40 -67.23 -8.3 30.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -86.26 -44.22 12.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.843 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.8 t -82.33 -9.55 59.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -55.3 -45.68 76.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 137' ' ' ALA . 1.3 ptmt -85.75 -16.61 38.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.689 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.78 -39.49 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 mtp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.505 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.296 0.57 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.85 36.38 0.78 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 1.6 t -152.75 158.45 42.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.743 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.729 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.2 p90 -159.58 175.09 13.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 2.3 t-160 -99.41 124.79 44.85 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 108.742 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.061 HD23 HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -114.7 159.91 19.98 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.709 178.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.923 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.26 90.17 1.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.993 -1.067 . . . . 0.0 110.204 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 16' ' ' PHE . 1.8 p -100.13 132.15 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.077 -1.014 . . . . 0.0 109.25 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 m -152.76 171.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.62 ' OG ' ' HB3' ' A' ' 80' ' ' ALA . 3.1 m -141.18 72.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 61.82 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 55.22 58.23 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.556 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -147.45 154.24 40.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.79 76.91 1.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.699 ' HB3' HD13 ' A' ' 62' ' ' ILE . 5.7 mmt -79.72 -63.65 1.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 109.888 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.688 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 18.6 t80 -135.24 121.86 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.445 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -152.84 103.17 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.316 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 158.91 -164.21 33.59 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.436 ' C ' HG12 ' A' ' 20' ' ' VAL . 9.1 mt -56.6 155.88 6.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.057 -1.261 . . . . 0.0 108.709 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.061 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -168.44 116.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.021 -1.049 . . . . 0.0 109.99 -177.522 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 2.6 mt-10 -66.5 -47.53 72.71 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 108.761 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 17.6 tttt -172.95 144.44 1.28 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.124 -0.985 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.667 ' CG2' HD22 ' A' ' 6' ' ' LEU . 44.3 pt -98.26 -145.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.658 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.12 127.27 0.36 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 109.481 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.685 HG23 ' HA2' ' A' ' 33' ' ' GLY . 12.0 t -116.53 133.27 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 31.0 m -129.09 91.84 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.42 168.22 21.07 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.6 -50.98 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 109.488 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.28 99.51 7.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.386 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.99 140.95 4.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -152.13 26.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.77 150.97 41.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.067 -1.021 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.685 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.54 -114.92 3.63 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.729 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 17.9 mm -149.58 152.64 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.098 -1.237 . . . . 0.0 109.327 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.57 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -151.58 171.82 6.11 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.083 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.4 Cg_endo -73.23 78.24 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.028 1.819 . . . . 0.0 110.2 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.32 36.1 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CE1' HD12 ' A' ' 41' ' ' LEU . 11.4 t-160 -87.11 28.99 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -1.224 . . . . 0.0 109.831 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 71' ' ' VAL . . . 58.99 158.32 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.065 -1.022 . . . . 0.0 109.554 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.8 78.7 3.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.777 2.318 . . . . 0.0 110.682 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.598 HD12 ' CE1' ' A' ' 38' ' ' HIS . 25.3 mt -100.35 173.43 6.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -171.16 57.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.4 p -114.62 -136.9 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.25 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -104.39 164.21 11.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.928 -1.107 . . . . 0.0 109.324 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.0 mt -109.1 9.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.791 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER 55.54 158.33 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.672 . . . . 0.0 110.176 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.69 -175.66 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.733 2.289 . . . . 0.0 110.287 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 116.06 -161.05 13.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.472 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 15.9 ptm -102.91 179.57 4.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 109.248 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.866 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.4 OUTLIER -150.85 138.87 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.032 -1.043 . . . . 0.0 110.646 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG2' ' N ' ' A' ' 52' ' ' ILE . 66.3 ttt180 -119.67 161.32 20.89 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 53' ' ' VAL . 36.1 mt -157.23 167.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.72 -1.238 . . . . 0.0 110.876 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.592 ' N ' HG22 ' A' ' 52' ' ' ILE . 24.5 t -142.64 107.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB3' ' HA3' ' A' ' 57' ' ' GLY . 15.6 tttm -68.67 149.89 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 110.326 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.405 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 2.2 tt0 -54.27 -52.58 60.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 8.69 33.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 54' ' ' LYS . . . -108.38 178.01 21.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -84.82 -77.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.586 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' HIS . 17.0 pt-20 -179.59 139.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 109.84 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -138.21 156.8 47.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.068 ' CE2' HD11 ' A' ' 133' ' ' LEU . 6.1 p90 -128.65 125.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.883 HG23 ' HG3' ' A' ' 85' ' ' ARG . 1.0 OUTLIER -100.46 -146.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.228 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.788 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -175.51 132.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.034 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HG ' ' C ' ' A' ' 63' ' ' TYR . 1.1 mt -139.07 -171.82 3.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -139.79 -64.78 0.48 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.79 136.54 8.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.34 165.62 33.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 79' ' ' LEU . 1.1 pp -101.65 -176.24 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -1.197 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.568 ' HB2' HG12 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -148.62 169.38 20.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 110.364 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.72 111.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 6.2 p -99.53 144.6 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.441 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.554 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.48 178.34 1.04 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 36.3 Cg_endo -79.05 81.55 2.77 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.501 2.134 . . . . 0.0 110.922 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.15 -21.72 5.46 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 4.3 p30 -159.39 135.71 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.239 . . . . 0.0 109.864 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 77' ' ' THR . 9.6 p -99.18 168.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 109.271 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 76' ' ' VAL . 99.3 m -164.12 137.67 5.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.257 -0.902 . . . . 0.0 109.063 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' ' 69' ' ' LEU . 4.6 m -140.83 165.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.57 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.51 ' HB2' HD11 ' A' ' 68' ' ' ILE . 1.5 mt -131.6 149.49 52.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.866 . . . . 0.0 109.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB3' ' OG ' ' A' ' 10' ' ' SER . . . -148.25 176.68 10.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 109.52 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.94 -56.58 2.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.5 m -105.08 123.13 47.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.508 ' O ' ' HE2' ' A' ' 15' ' ' MET . . . -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.788 HD12 ' CE1' ' A' ' 63' ' ' TYR . 13.7 mt -101.61 150.7 5.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.213 -0.93 . . . . 0.0 109.461 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.883 ' HG3' HG23 ' A' ' 62' ' ' ILE . 8.3 ttm180 -119.74 155.85 31.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.479 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 87' ' ' GLN . . . -44.45 93.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 2.4 mt-30 162.32 -72.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.083 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.542 ' OD2' ' NE2' ' A' ' 127' ' ' GLN . 1.3 p30 40.71 50.63 2.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASP . 86.0 mt 43.17 -93.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 88' ' ' ASP . 8.0 p-10 -49.48 159.64 0.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 109.329 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HA ' HD11 ' A' ' 131' ' ' ILE . 27.6 mt-10 -141.26 -56.68 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.65 -14.34 54.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -76.58 -10.56 59.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.01 -21.71 23.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.961 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.4 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.39 -27.67 68.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.44 -0.787 . . . . 0.0 109.376 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.72 -15.2 61.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . . . -68.04 -45.66 73.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -61.2 -17.03 51.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -89.9 -40.17 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -75.73 -12.25 60.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.942 . . . . 0.0 109.292 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.89 -15.36 39.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.132 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -46.67 67.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.365 -0.834 . . . . 0.0 109.407 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -49.51 -23.26 1.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 114' ' ' TYR . 54.1 m80 -86.7 -36.89 18.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 105' ' ' ILE . 17.5 mt -79.04 -6.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 p -101.06 -16.54 17.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.523 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.36 130.73 37.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.711 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.09 131.47 51.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 21.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.779 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.98 -176.63 33.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.968 ' OD1' HG13 ' A' ' 112' ' ' VAL . 1.3 p30 -81.12 -29.37 34.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.144 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.968 HG13 ' OD1' ' A' ' 111' ' ' ASP . 4.3 m -119.37 22.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.81 -99.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -0.817 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.485 ' HB2' ' HA ' ' A' ' 105' ' ' ILE . 17.6 p90 -65.3 -18.9 65.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.021 -1.049 . . . . 0.0 108.214 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -58.89 -39.08 80.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -77.15 -17.5 58.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.341 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.27 -17.85 53.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.2 t -62.01 -28.81 69.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -75.87 -27.89 57.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -85.52 -8.22 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.923 . . . . 0.0 109.494 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -90.41 -57.93 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -22.29 65.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -87.07 -19.53 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.85 -34.61 33.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.478 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 125' ' ' ILE . 2.8 mp -75.89 -6.09 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.378 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.46 76.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.595 ' HG2' ' CG ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -81.39 -14.29 57.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.535 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 34.6 tp -78.73 -25.02 44.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.0 109.69 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -45.71 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.939 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.652 ' HA ' HD23 ' A' ' 133' ' ' LEU . 35.7 m -70.41 -32.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.885 ' O ' HG22 ' A' ' 134' ' ' THR . 2.2 tt -78.24 -25.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.094 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 128' ' ' LEU . 1.4 mm-40 -74.66 -22.13 59.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.104 -0.997 . . . . 0.0 110.243 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 1.068 HD11 ' CE2' ' A' ' 61' ' ' PHE . 1.4 pp -90.54 0.45 57.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.995 -1.066 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.885 HG22 ' O ' ' A' ' 131' ' ' ILE . 7.5 t -89.07 4.6 47.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.665 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -71.46 -30.08 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.597 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 11.56 23.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.16 -47.27 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.452 -179.874 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 ttp -159.81 144.29 14.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.548 HG22 ' CG ' ' A' ' 21' ' ' GLU . 65.9 p -50.94 164.74 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 109.604 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.674 ' CE2' HG22 ' A' ' 34' ' ' ILE . 1.3 p90 -142.22 -144.86 0.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.714 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.743 ' O ' HG12 ' A' ' 76' ' ' VAL . 12.7 t-80 -129.62 126.71 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.79 -1.194 . . . . 0.0 111.221 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.025 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -99.75 130.9 46.01 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -139.49 75.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 109.746 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.4 p -104.01 111.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.668 HG12 ' HA ' ' A' ' 14' ' ' GLN . 2.7 m -116.57 -178.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.493 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -158.01 111.95 2.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.762 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.71 -89.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.735 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -134.71 62.23 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.66 142.64 12.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.478 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.668 ' HA ' HG12 ' A' ' 9' ' ' VAL . 6.1 pt20 -106.55 107.68 18.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.552 ' HE2' ' HG2' ' A' ' 85' ' ' ARG . 6.6 mtt -79.66 -60.68 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.641 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -130.84 111.07 11.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.923 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.5 p -136.97 92.19 2.7 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.69 -161.27 32.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 19' ' ' LEU . 36.2 mt -76.82 159.13 30.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.035 -1.274 . . . . 0.0 109.799 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.15 162.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.227 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' CG ' HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -122.29 -37.52 2.8 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.9 ttpp -160.77 110.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.98 . . . . 0.0 110.661 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.025 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.2 152.11 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.8 ' O ' HG23 ' A' ' 50' ' ' ILE . 1.9 tt0 -134.45 145.32 48.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.075 . . . . 0.0 109.964 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.875 HG23 ' HA2' ' A' ' 33' ' ' GLY . 3.1 t -131.95 125.46 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.434 -0.791 . . . . 0.0 108.96 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 88.8 m -116.06 97.86 6.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.353 -0.842 . . . . 0.0 109.395 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -103.24 -100.02 2.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 m -128.83 -81.0 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.53 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.78 166.29 3.7 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -156.54 32.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.242 -1.152 . . . . 0.0 109.597 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -102.7 150.08 23.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.529 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.875 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.45 -112.42 3.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.691 HG21 HG11 ' A' ' 76' ' ' VAL . 19.5 mm -154.32 147.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -1.141 . . . . 0.0 109.537 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -157.13 -172.77 0.34 Allowed Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 36.3 Cg_endo -81.11 31.15 0.51 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.0 1.8 . . . . 0.0 110.71 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.07 26.48 0.2 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.72 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 57.1 t60 -70.12 -4.85 23.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -1.084 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 77.05 168.24 0.12 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.1 Cg_endo -78.1 74.19 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.626 2.218 . . . . 0.0 110.524 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.52 142.65 27.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.307 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.432 ' HG ' ' C ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -139.84 32.54 2.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.608 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.3 t -100.67 -156.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.178 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.608 ' N ' HG23 ' A' ' 43' ' ' THR . . . -108.01 -177.35 3.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.032 -1.042 . . . . 0.0 109.663 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.851 HD11 ' N ' ' A' ' 69' ' ' LEU . 1.3 mp -126.48 177.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.68 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -108.08 167.13 9.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.394 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.504 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 35.4 Cg_endo -78.16 140.75 17.95 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.619 2.213 . . . . 0.0 110.516 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 168.43 -162.79 36.58 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.487 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.1 ptm -100.66 -170.65 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 109.211 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.8 HG23 ' O ' ' A' ' 24' ' ' GLN . 19.1 mt -158.09 140.63 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.987 . . . . 0.0 110.296 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.49 119.19 22.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.713 HG23 ' CA ' ' A' ' 23' ' ' ILE . 18.8 mt -123.46 170.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.116 . . . . 0.0 110.965 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.704 HG22 ' HG3' ' A' ' 59' ' ' GLU . 28.6 t -134.57 101.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -61.17 119.9 9.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 0.0 109.633 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' LYS . 31.1 mt-30 43.22 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -152.19 66.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 109.558 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.38 -128.01 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -69.28 -165.74 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.704 ' HG3' HG22 ' A' ' 53' ' ' VAL . 51.3 mp0 -129.95 -178.94 4.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 59.8 mm-40 -129.51 137.29 50.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.593 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -111.69 98.41 7.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 108.834 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 63' ' ' TYR . 4.0 mt -111.04 161.57 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 109.998 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.698 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.2 t80 -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -165.83 -171.09 1.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.829 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.47 ' CB ' ' HB3' ' A' ' 47' ' ' PRO . 3.1 t -160.48 139.76 10.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.782 . . . . 0.0 109.27 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' SER . . . 63.08 125.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.98 159.81 11.23 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 15.0 mt -106.65 123.7 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.076 HD22 ' N ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -101.61 127.88 48.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 1.076 ' N ' HD22 ' A' ' 69' ' ' LEU . 4.0 pt-20 -131.08 146.11 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 39' ' ' ALA . 12.1 p -102.27 163.92 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.052 -1.03 . . . . 0.0 109.928 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.521 ' N ' HG22 ' A' ' 71' ' ' VAL . 1.6 mt-30 -141.32 172.58 5.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 0.0 109.338 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.5 79.91 3.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.577 2.185 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.68 -12.55 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.513 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 4.8 p30 -149.28 172.4 14.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -1.181 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 5' ' ' HIS . 2.8 p -145.66 151.45 14.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 68.3 p -136.58 172.92 12.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -178.97 127.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 109.151 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -104.91 134.66 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.885 . . . . 0.0 109.265 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 64' ' ' LEU . . . -129.6 -179.91 5.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.0 109.625 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.55 -29.17 5.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.343 -0.848 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 51.9 m -103.12 119.97 39.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.72 98.73 3.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 63' ' ' TYR . 96.3 mt -109.71 -27.87 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.56 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.552 ' HG2' ' HE2' ' A' ' 15' ' ' MET . 22.1 mtm180 61.32 126.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.527 ' CA ' HG21 ' A' ' 130' ' ' VAL . . . -44.3 -29.7 1.76 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 88' ' ' ASP . 67.3 mt-30 -71.25 -64.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -1.122 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASP . 14.0 t0 44.4 41.32 4.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.58 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 88' ' ' ASP . 2.1 t70 -115.75 99.87 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.768 ' HB3' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -96.39 0.06 50.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.51 -14.17 62.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.385 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -82.88 -2.79 55.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.39 -23.62 21.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 0.0 108.856 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.653 ' HG2' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -57.1 -29.44 63.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.45 -0.781 . . . . 0.0 109.235 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.13 -57.87 9.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.45 69.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.877 ' HG3' HD11 ' A' ' 125' ' ' ILE . 25.2 tttt -55.16 -41.08 71.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -60.68 -51.83 67.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -76.58 -0.36 22.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.701 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -85.64 -30.7 23.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.127 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 4.7 tp10 -80.55 -26.03 38.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -82.15 -13.61 56.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.97 -31.51 20.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.58 ' O ' HG22 ' A' ' 105' ' ' ILE . 37.3 mt -77.85 -1.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.317 -0.864 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.3 m -105.83 78.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.29 167.9 2.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.3 m 64.85 -152.22 0.28 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 108' ' ' SER . 12.0 t-80 174.34 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.257 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.94 169.61 40.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.85 -59.42 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.2 16.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.96 -96.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.502 ' C ' ' CD1' ' A' ' 114' ' ' TYR . 13.7 p90 -74.14 -15.77 61.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 108.53 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.11 -19.83 65.69 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.62 -14.71 62.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.491 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.0 -6.67 57.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.502 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.26 -16.61 42.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.95 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -5.03 55.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.629 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.72 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.25 -52.28 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.35 94.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.542 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -61.08 -32.46 72.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.887 . . . . 0.0 109.633 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.24 -8.58 50.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 109.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.877 HD11 ' HG3' ' A' ' 98' ' ' LYS . 1.3 tp -88.89 5.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 109.354 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.35 -13.27 55.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.804 ' O ' HG23 ' A' ' 131' ' ' ILE . 24.2 pt20 -89.69 -13.39 37.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 95' ' ' MET . 0.2 OUTLIER -89.63 -29.5 18.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -73.13 -19.73 61.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 10.2 m -90.12 -27.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.727 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 127' ' ' GLN . 22.1 pt -75.57 -16.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.35 -47.74 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -61.59 -45.17 95.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.568 HG23 ' CD2' ' A' ' 61' ' ' PHE . 12.3 p -49.17 -26.54 2.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -57.81 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -110.07 50.42 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 133' ' ' LEU . . . -123.23 -48.66 1.96 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.371 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.393 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.473 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -132.29 94.2 3.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.465 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -174.01 156.16 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.775 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.628 ' HE1' HD11 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -143.55 -142.28 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.205 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.815 ' O ' HG12 ' A' ' 76' ' ' VAL . 17.5 t-80 -134.73 131.23 37.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.852 -1.155 . . . . 0.0 110.993 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.906 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -99.11 131.84 44.85 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.171 -0.956 . . . . 0.0 108.714 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.956 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -142.42 75.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.85 -1.156 . . . . 0.0 109.68 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.854 HG13 ' HB2' ' A' ' 15' ' ' MET . 1.4 p -105.11 117.14 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.34 164.24 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -128.8 -159.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.363 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.93 -74.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 109.388 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -136.95 53.69 1.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.77 109.92 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -65.2 154.64 37.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.302 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.854 ' HB2' HG13 ' A' ' 8' ' ' VAL . 3.8 mmt -118.84 -58.64 1.94 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.753 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.646 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.56 111.2 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.957 . . . . 0.0 109.677 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 95.0 p -131.93 78.02 1.79 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 20' ' ' VAL . . . -174.7 167.08 39.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' C ' HG12 ' A' ' 20' ' ' VAL . 54.4 mt -50.73 166.67 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.205 -1.174 . . . . 0.0 109.278 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.906 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -167.09 169.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -144.94 -63.63 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 109.517 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -90.43 103.45 16.13 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 0.0 108.657 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.881 ' HA ' HG23 ' A' ' 52' ' ' ILE . 3.1 mp -115.48 156.46 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.0 109.142 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -151.76 131.38 13.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.117 . . . . 0.0 109.741 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.552 HG13 ' HB ' ' A' ' 50' ' ' ILE . 1.1 t -145.57 127.15 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.332 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -148.34 127.73 13.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -137.49 -92.46 0.29 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -138.3 -40.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.0 109.445 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.05 -91.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.87 -172.5 5.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 32' ' ' LEU . 2.2 mt-10 -164.58 41.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.134 -1.215 . . . . 0.0 109.777 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -136.95 165.2 26.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.879 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.84 174.39 26.62 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 27.0 mm -99.21 160.96 3.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.636 -1.508 . . . . 0.0 109.515 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.648 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -162.59 171.21 6.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.4 Cg_endo -70.13 83.96 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.37 1.38 . . . . 0.0 109.618 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.34 14.36 0.83 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.991 ' NE2' HD23 ' A' ' 41' ' ' LEU . 43.1 t60 -53.88 157.85 2.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.84 -1.388 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.875 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -58.46 173.87 0.39 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.332 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.875 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.83 63.6 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.614 2.209 . . . . 0.0 110.602 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.991 HD23 ' NE2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -59.42 160.61 6.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.882 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.524 ' O ' ' CA ' ' A' ' 70' ' ' GLU . 85.5 mt -115.97 -92.08 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.983 . . . . 0.0 110.649 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.633 ' O ' HG22 ' A' ' 68' ' ' ILE . 7.1 p -122.66 27.2 7.91 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 121.596 -0.69 . . . . 0.0 110.242 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 69' ' ' LEU . . . -113.64 119.35 37.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.868 -1.145 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 67' ' ' GLY . 5.2 tt -112.4 176.49 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.417 -0.802 . . . . 0.0 109.174 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -120.4 130.98 24.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.973 -1.08 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.457 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 36.4 Cg_endo -79.34 -164.51 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.547 2.165 . . . . 0.0 110.384 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 90.32 -133.77 11.98 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.546 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.1 ppp? -114.57 174.8 5.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -1.085 . . . . 0.0 109.41 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.957 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.4 OUTLIER -149.99 116.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.368 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -104.94 123.61 48.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.815 . . . . 0.0 108.959 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 23' ' ' ILE . 2.6 mt -129.98 -176.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.001 -1.062 . . . . 0.0 109.916 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.652 ' H ' HG22 ' A' ' 52' ' ' ILE . 6.8 t -158.14 109.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -57.57 114.01 2.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.578 -0.701 . . . . 0.0 110.398 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.499 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 40.59 61.93 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.771 . . . . 0.0 110.151 179.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.44 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 43.08 44.8 4.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.779 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.57 -122.29 2.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -52.05 146.98 7.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.306 -1.114 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.61 123.04 47.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.099 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -128.04 121.16 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.339 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.595 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.0 p90 -113.28 147.83 36.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.222 -0.923 . . . . 0.0 109.908 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.957 ' H ' HG23 ' A' ' 50' ' ' ILE . 1.7 mt -120.07 -158.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.424 -0.797 . . . . 0.0 109.139 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.661 ' CE1' HD12 ' A' ' 84' ' ' ILE . 7.6 t80 -172.44 133.32 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.458 HD22 ' HB2' ' A' ' 80' ' ' ALA . 2.1 mp -140.43 -174.54 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -128.12 5.16 5.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.49 160.04 8.32 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.862 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 162.16 -175.5 38.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 43' ' ' THR . 1.4 pt -103.16 137.8 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -1.12 . . . . 0.0 109.258 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.798 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' CA ' ' O ' ' A' ' 42' ' ' LEU . 15.2 pt-20 -126.59 139.41 53.21 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 40' ' ' PRO . 9.2 p -100.51 142.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.472 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.4 mm100 -124.74 158.75 61.27 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 109.097 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -76.95 86.47 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.603 2.202 . . . . 0.0 110.477 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.64 2.28 10.61 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.541 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 175.7 175.68 0.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -1.178 . . . . 0.0 109.213 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 5' ' ' HIS . 2.3 p -150.63 148.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.167 -0.958 . . . . 0.0 109.132 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.956 HG22 ' HB3' ' A' ' 7' ' ' ASP . 7.5 p -140.86 142.86 34.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 109.573 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.763 ' HB ' HD12 ' A' ' 45' ' ' ILE . 3.0 m -148.36 138.28 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.634 ' C ' HD23 ' A' ' 79' ' ' LEU . 1.2 tt -114.49 135.74 53.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.458 ' HB2' HD22 ' A' ' 64' ' ' LEU . . . -122.2 179.42 4.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -115.39 -11.28 11.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 83' ' ' ALA . 9.3 m -127.53 161.4 28.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 82' ' ' THR . . . -167.57 122.32 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 63' ' ' TYR . 48.3 mt -117.37 -45.22 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.288 -0.882 . . . . 0.0 109.267 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.485 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 3.0 ttt180 74.6 147.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.436 -0.79 . . . . 0.0 109.646 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.674 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -58.12 -21.87 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ASP . 57.8 mt-30 -81.45 -63.67 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.469 ' HB3' ' CG2' ' A' ' 84' ' ' ILE . 2.8 p30 40.35 30.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.62 -0.675 . . . . 0.0 109.867 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ASP . 1.2 mp 50.48 -179.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 91' ' ' GLU . 4.9 m-20 43.96 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.901 ' HA ' HD11 ' A' ' 131' ' ' ILE . 1.3 mt-10 172.97 -30.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.488 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 -17.4 48.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.85 . . . . 0.0 109.561 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 4.5 29.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.673 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' O ' ' CD1' ' A' ' 128' ' ' LEU . . . -90.84 -30.35 17.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.423 ' HA ' HD11 ' A' ' 128' ' ' LEU . 4.8 mtt -73.32 -5.06 37.22 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.361 -0.837 . . . . 0.0 109.596 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.06 1.61 56.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.636 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -89.34 -42.51 11.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.653 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -19.55 63.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -89.89 -26.99 20.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 9.1 pttt -89.3 -11.3 43.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.621 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 105' ' ' ILE . . . -90.47 -58.49 2.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.613 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.53 63.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.715 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -52.83 -38.34 61.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 109.889 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -88.38 -26.33 22.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.603 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 121' ' ' LEU . 12.0 mt -88.24 22.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 109.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.2 m -54.99 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER 67.37 118.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.0 t -137.74 118.98 14.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 109' ' ' HIS . 52.2 t-80 -113.28 56.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 115' ' ' ALA . . . -138.48 125.7 3.25 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 68.8 m-20 -44.88 -80.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -1.201 . . . . 0.0 109.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.629 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 20.6 m -117.53 -10.0 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.414 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.5 OUTLIER -48.02 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.335 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -70.94 -14.88 62.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.043 -1.036 . . . . 0.0 108.26 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -66.26 -23.36 66.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.569 -0.707 . . . . 0.0 109.264 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.42 -54.17 13.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.327 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.9 -20.21 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.19 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -44.24 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.16 68.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.381 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.54 -20.7 64.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 125' ' ' ILE . 7.6 mt -90.0 -24.0 21.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -59.75 -16.77 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.586 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.3 96.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -70.66 -5.97 33.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -85.79 -13.16 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.149 -0.97 . . . . 0.0 109.289 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -87.36 -24.56 24.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.293 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -83.55 -15.48 49.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.414 -0.804 . . . . 0.0 109.489 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -80.19 -22.74 41.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.601 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 1.9 ttp180 -85.24 -35.31 21.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.785 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.674 HG23 ' HA2' ' A' ' 86' ' ' GLY . 18.3 m -76.34 -28.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.901 HD11 ' HA ' ' A' ' 91' ' ' GLU . 7.1 tt -76.9 -38.45 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 109.267 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.466 ' N ' HG23 ' A' ' 131' ' ' ILE . 7.4 mm-40 -56.96 -23.86 48.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.07 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 41.4 mt -76.4 -37.63 56.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.25 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 72.0 p -59.29 -16.75 23.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.775 . . . . 0.0 109.65 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -76.18 -44.08 39.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -14.12 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.36 -80.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.491 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mmt -84.98 167.6 15.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -133.88 174.58 10.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.723 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.1 p90 -148.39 -136.03 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.4 OUTLIER -151.05 138.37 19.4 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.817 -1.177 . . . . 0.0 110.423 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -102.18 148.06 25.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 77' ' ' THR . 1.1 t0 -144.92 72.02 1.32 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.017 -1.052 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 15' ' ' MET . 2.9 p -106.81 138.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.352 -0.842 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.568 ' CG2' HD23 ' A' ' 79' ' ' LEU . 32.8 m -145.88 173.26 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.687 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 45.9 t -170.25 113.76 0.47 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.056 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 65.96 26.48 10.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.075 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.1 mm-40 63.46 24.09 13.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.517 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.424 ' OE1' ' SD ' ' A' ' 15' ' ' MET . 12.4 tt0 -78.07 -22.49 48.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.144 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 6.3 mt-30 63.46 100.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.759 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 16.7 mmm -101.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.685 ' HD2' HD23 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -135.67 111.66 9.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.623 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 17' ' ' SER . 27.6 p -135.32 77.69 1.69 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.47 179.98 48.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 5' ' ' HIS . 12.0 mt -60.26 161.91 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -1.193 . . . . 0.0 109.492 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -157.75 159.3 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.81 . . . . 0.0 108.829 -179.225 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.1 -52.75 2.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -0.937 . . . . 0.0 110.138 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -141.02 108.12 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.769 -1.207 . . . . 0.0 111.28 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.853 HD12 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -103.13 155.91 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 2.0 tm0? -146.76 115.61 6.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.416 -1.427 . . . . 0.0 110.724 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.994 HG21 ' HG2' ' A' ' 46' ' ' LYS . 3.3 t -103.92 133.62 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.233 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 54.7 m -125.01 102.72 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.549 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -123.07 -110.06 1.98 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 t -132.37 -77.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -1.16 . . . . 0.0 109.63 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.81 -24.75 67.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.74 151.37 18.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -142.81 11.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -1.076 . . . . 0.0 109.315 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.4 mt -116.64 156.45 27.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.562 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -100.03 -114.59 3.65 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.723 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 15.9 mm -154.98 143.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -1.049 . . . . 0.0 109.245 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -154.35 -172.13 0.31 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -78.94 8.86 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.805 1.67 . . . . 0.0 110.423 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.91 11.42 3.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 84.6 t60 -53.26 156.22 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.629 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -70.08 173.22 4.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.668 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -77.75 76.05 4.48 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.758 2.305 . . . . 0.0 110.386 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -100.3 140.29 34.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.607 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -155.51 29.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 109.563 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.3 p -121.76 -139.54 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.219 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.79 119.97 38.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -160.74 -166.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.757 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.994 ' HG2' HG21 ' A' ' 25' ' ' VAL . 13.3 mttt 71.5 46.41 0.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.8 Cg_endo -80.32 152.67 20.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 94.01 -152.71 20.84 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.696 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.548 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 7.2 ptm -99.56 -171.67 2.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -1.024 . . . . 0.0 109.503 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.805 HG12 HG22 ' A' ' 25' ' ' VAL . 40.9 mt -150.0 156.18 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.718 HG23 ' CA ' ' A' ' 23' ' ' ILE . 4.6 mt -121.26 162.8 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 110.476 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 74.9 t -133.38 118.95 33.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 154.71 -98.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 56' ' ' HIS . 1.9 tt0 37.75 47.44 0.84 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.6 t-160 81.8 -68.89 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.606 -0.684 . . . . 0.0 109.494 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -161.54 77.94 0.17 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.458 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 168.19 -160.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.149 . . . . 0.0 109.489 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.19 158.42 43.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.288 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -147.23 115.96 6.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.683 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.698 ' CD2' HD22 ' A' ' 133' ' ' LEU . 14.1 p90 -103.24 140.55 37.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.58 -156.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.945 . . . . 0.0 109.566 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.621 ' CE2' ' NE2' ' A' ' 127' ' ' GLN . 8.9 t80 -177.46 111.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.195 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mp -134.85 -179.91 5.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 109.336 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -71.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.82 62.83 0.63 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.37 -179.62 50.63 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 78' ' ' VAL . 10.0 mm -101.45 118.37 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.946 HD13 ' HB ' ' A' ' 78' ' ' VAL . 4.1 mm? -99.47 157.69 16.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.36 133.01 11.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 108.993 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.529 HG11 ' HA ' ' A' ' 40' ' ' PRO . 12.7 p -99.69 136.26 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.655 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.494 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -119.03 173.59 3.34 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.38 -0.825 . . . . 0.0 109.456 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.2 Cg_endo -78.23 73.3 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.621 2.214 . . . . 0.0 110.515 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.6 3.67 32.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -151.67 -175.3 5.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 75' ' ' ASN . 4.5 t -158.64 146.78 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.263 -0.898 . . . . 0.0 109.034 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.85 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -138.22 157.5 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.946 ' HB ' HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -168.46 135.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.568 HD23 ' CG2' ' A' ' 9' ' ' VAL . 1.2 mt -125.83 109.02 12.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.75 179.34 4.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.623 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -105.17 -42.76 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 84' ' ' ILE . 14.8 m -109.42 100.4 9.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.759 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -122.38 94.33 4.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.189 -0.945 . . . . 0.0 109.379 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.959 HG23 ' OD1' ' A' ' 88' ' ' ASP . 3.3 mp -100.1 84.54 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.518 ' N ' ' OD2' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -66.36 133.7 51.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.62 -121.58 11.0 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.406 ' CD ' ' OE1' ' A' ' 91' ' ' GLU . 11.6 pt20 -124.32 53.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -1.106 . . . . 0.0 109.565 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.959 ' OD1' HG23 ' A' ' 84' ' ' ILE . 1.6 p30 -63.09 -13.37 35.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 89' ' ' LEU . 14.4 mt -114.57 -90.89 0.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 m-20 -117.1 -179.9 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.606 ' HB2' HD11 ' A' ' 131' ' ' ILE . 4.9 pt-20 -145.77 -43.54 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.863 . . . . 0.0 109.215 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.27 -18.46 39.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -0.828 . . . . 0.0 109.462 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.3 3.62 51.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -13.43 34.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.196 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.446 ' HG2' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.34 -18.04 34.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.374 -0.829 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.8 -14.95 57.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.495 ' O ' HD11 ' A' ' 125' ' ' ILE . . . -81.51 -5.71 58.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG2' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -89.85 -24.23 21.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -89.21 -21.44 23.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 109.401 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.32 -31.93 29.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.796 ' HB2' HD22 ' A' ' 121' ' ' LEU . . . -90.36 -39.66 12.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.0 -11.64 59.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.331 -0.856 . . . . 0.0 109.535 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 99' ' ' ARG . 15.5 tt0 -90.28 -37.41 14.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.6 -30.63 46.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.628 HD13 ' OG ' ' A' ' 118' ' ' SER . 31.3 mt -89.18 4.3 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.649 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 107' ' ' SER . 1.3 t -45.65 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER 77.25 121.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.429 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.1 141.29 18.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -111.28 -173.4 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.49 117.6 0.75 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -48.97 -69.91 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 19.9 m -121.03 12.17 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 18.4 t0 -66.22 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -0.868 . . . . 0.0 109.211 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' A' ' 114' ' ' TYR . 32.1 t80 -75.72 -5.5 45.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.54 -7.91 59.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -78.31 -29.43 47.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.603 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -78.24 -6.39 54.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.096 -1.002 . . . . 0.0 109.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.628 ' OG ' HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -79.76 -8.8 59.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.577 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.73 -34.87 17.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 123' ' ' LYS . 8.7 pt-20 -75.3 -27.42 59.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.796 HD22 ' HB2' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -79.29 -41.86 27.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.433 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.499 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -76.74 -11.67 59.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.246 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.56 -32.7 65.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.95 -26.99 54.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.0 mp -81.84 2.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.91 . . . . 0.0 109.479 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.563 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . . . -74.58 -26.68 60.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.621 ' NE2' ' CE2' ' A' ' 63' ' ' TYR . 40.5 mt-30 -74.56 -5.11 40.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 128' ' ' LEU . 6.7 tt -79.78 -19.19 49.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -90.06 -49.5 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.625 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 5.0 m -66.85 -38.64 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 109.588 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 91' ' ' GLU . 2.6 tt -54.97 -39.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.539 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -43.59 -38.3 2.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' A' ' 61' ' ' PHE . 9.0 mp -62.75 -51.55 66.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.148 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 134' ' ' THR . 18.9 p -50.84 -31.59 17.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 19.5 mttt -62.3 -42.9 99.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.54 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 20.6 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.455 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.18 -55.14 5.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.498 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER 66.72 167.46 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.804 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 53.94 117.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.75 0.786 . . . . 0.0 110.47 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.695 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.3 p90 -130.69 -153.41 0.56 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.186 -0.946 . . . . 0.0 108.641 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 21.6 t-80 -129.53 144.56 51.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.943 -1.098 . . . . 0.0 109.852 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.086 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -138.21 164.19 29.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.225 -0.922 . . . . 0.0 108.958 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 1.066 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 t0 -160.02 94.69 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.98 -1.075 . . . . 0.0 109.964 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 6' ' ' LEU . 5.0 m -104.34 147.3 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 108.958 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 10' ' ' SER . 1.7 t -154.74 177.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 1.2 p -138.62 -160.89 1.11 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.27 -51.27 8.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.53 66.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.708 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -147.01 139.38 24.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.18 132.07 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.49 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.854 ' SD ' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -127.45 -72.88 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.642 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 47.9 t80 -151.41 112.83 4.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.26 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.404 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 56.9 p -141.74 92.84 2.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.44 -153.1 21.26 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' C ' HG12 ' A' ' 20' ' ' VAL . 21.4 mt -67.12 177.07 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.058 -1.26 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.086 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 177.17 159.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.13 -0.981 . . . . 0.0 108.658 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.804 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -129.75 -71.36 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.03 113.93 26.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.116 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.764 HG22 ' CG1' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -125.45 141.01 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.483 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 2.2 pt20 -145.54 129.66 17.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 109.885 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.773 HG22 ' CG1' ' A' ' 50' ' ' ILE . 3.3 t -109.9 128.4 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -111.73 116.56 30.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.51 -144.07 3.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLU . 89.3 p -77.39 122.65 25.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.121 . . . . 0.0 109.592 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 28' ' ' SER . 1.4 tp10 60.07 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.687 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.14 169.07 38.91 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -171.38 46.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -1.138 . . . . 0.0 109.319 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.565 HD13 ' OH ' ' A' ' 35' ' ' TYR . 8.8 mt -150.21 146.82 27.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.68 -99.49 2.24 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.695 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 20.5 mm -156.53 151.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.514 -0.992 . . . . 0.0 109.241 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.565 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.47 173.9 3.84 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.8 Cg_endo -73.26 81.77 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.908 1.739 . . . . 0.0 110.01 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.24 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -48.88 164.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.243 . . . . 0.0 109.413 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.828 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -78.28 170.62 15.38 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.332 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.828 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.19 73.93 5.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.581 2.188 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 41' ' ' LEU . 4.0 mm? -78.37 161.56 27.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.8 pp -169.08 36.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 108.972 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.1 -95.37 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.565 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.612 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -137.44 162.49 33.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.922 -1.111 . . . . 0.0 109.869 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.684 HD13 HG11 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -100.95 139.87 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' O ' HG11 ' A' ' 25' ' ' VAL . 13.3 mmtm -75.01 139.18 72.83 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.725 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.6 -162.04 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.716 2.277 . . . . 0.0 110.365 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.06 -141.12 15.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 ptm -108.78 174.41 5.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -1.144 . . . . 0.0 109.012 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.773 ' CG1' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -154.67 119.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.934 -1.104 . . . . 0.0 110.282 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.741 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.52 150.92 21.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.957 HD11 ' CD2' ' A' ' 6' ' ' LEU . 5.4 tt -143.84 167.9 12.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.617 -1.302 . . . . 0.0 111.384 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 38.8 t -134.56 90.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -53.81 121.76 8.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.325 -0.859 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.691 ' HA ' HG22 ' A' ' 3' ' ' THR . 1.3 tt0 45.38 -158.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.171 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -77.67 103.78 7.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.944 . . . . 0.0 109.115 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 103.3 178.77 26.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 t-160 62.45 129.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -1.229 . . . . 0.0 109.448 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.2 mp0 -134.31 134.14 41.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 52' ' ' ILE . 3.1 tt0 -104.85 170.48 7.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 0.0 109.596 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.631 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -133.07 122.86 24.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.169 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.5 mp -137.89 169.22 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.078 -1.013 . . . . 0.0 109.863 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -158.21 144.07 17.05 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.98 -164.26 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 110.035 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 33.6 p -105.1 -144.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.435 -0.791 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -96.02 -135.19 8.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 128.44 -167.32 20.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' ILE . 19.6 tt -105.04 125.1 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 109.062 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 70' ' ' GLU . 2.4 pp -113.51 167.91 10.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.244 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.789 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -161.79 123.63 2.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' ' 76' ' ' VAL . 9.9 p -99.95 145.01 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.984 -1.072 . . . . 0.0 110.418 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.532 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.18 175.58 2.49 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -76.96 75.8 4.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.509 2.139 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.03 -35.6 2.35 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 9.6 p-10 -143.66 149.81 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.254 . . . . 0.0 109.85 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' ' 71' ' ' VAL . 6.3 p -127.09 145.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.879 . . . . 0.0 109.413 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 7' ' ' ASP . 19.3 p -132.85 155.06 49.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.684 HG11 HD13 ' A' ' 45' ' ' ILE . 2.1 p -162.74 153.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 108.952 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.419 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 6.4 mt -129.74 160.98 31.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 109.808 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -149.91 -148.51 0.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 80' ' ' ALA . 11.0 m-20 -128.22 -33.39 2.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.667 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 83' ' ' ALA . 48.3 m -112.5 164.22 13.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.854 ' HB1' ' SD ' ' A' ' 15' ' ' MET . . . -172.08 86.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 109.63 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.2 mp -105.67 134.17 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -0.915 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.7 ttt85 -58.51 153.86 15.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -51.52 -33.82 33.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.43 44.23 1.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.679 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.9 -32.75 72.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.79 -159.99 0.71 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' HB2' ' A' ' 93' ' ' ARG . 29.8 m-20 -62.21 179.48 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.33 -60.82 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.4 -12.65 59.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.462 ' HB2' ' CB ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -85.57 0.39 52.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.676 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.62 -1.75 57.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -0.998 . . . . 0.0 109.469 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.01 -22.56 21.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.779 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -80.71 -9.5 59.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.568 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.05 -24.42 35.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -27.5 21.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -67.35 -42.39 83.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -33.86 35.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.9 -14.02 59.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.864 ' OE1' HD12 ' A' ' 105' ' ' ILE . 26.5 tp10 -78.8 -23.01 45.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 2.9 tm-20 -54.37 -30.4 51.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 -46.08 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.864 HD12 ' OE1' ' A' ' 102' ' ' GLU . 34.4 mt -52.14 -40.67 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.701 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 107' ' ' SER . 0.3 OUTLIER -92.98 58.18 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 108' ' ' SER . 6.2 p 178.8 155.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.664 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER 76.6 173.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.72 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.98 -171.52 3.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.795 . . . . 0.0 109.252 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.64 162.71 15.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -1.117 . . . . 0.0 109.472 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 111' ' ' ASP . 15.5 m 39.97 33.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.425 -0.797 . . . . 0.0 110.031 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.16 -96.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 109.118 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -73.51 -15.84 61.3 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.013 -1.054 . . . . 0.0 108.401 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.06 -35.17 79.81 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.44 -11.84 61.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -0.782 . . . . 0.0 109.219 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.77 -12.13 59.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 109.647 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -19.94 41.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.651 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.1 48.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.02 -32.77 22.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.659 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.75 -66.26 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.686 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -44.34 -25.46 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.835 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.9 ttmt -63.43 -53.14 56.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.73 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.3 -27.86 66.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.697 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.2 mm -75.15 -5.5 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 109.747 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -79.98 -1.67 40.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.821 ' O ' HG23 ' A' ' 131' ' ' ILE . 16.0 tt0 -89.81 -28.73 19.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -69.33 -15.91 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -80.63 -27.26 37.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.631 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.7 m -89.58 -28.61 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.553 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 127' ' ' GLN . 25.9 pt -66.56 -20.43 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.805 . . . . 0.0 109.537 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -78.27 -26.06 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -87.39 -47.68 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.948 . . . . 0.0 109.543 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 28.5 p -43.82 -27.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -48.34 -67.03 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.0 26.88 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 0.0 109.769 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -100.4 -36.58 9.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mmm . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.56 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' THR . 3.3 tpp -130.55 137.23 49.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.612 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER 57.89 147.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.777 . . . . 0.0 109.845 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.774 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.9 p90 -152.2 -164.42 1.96 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.23 -0.919 . . . . 0.0 108.953 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.8 t60 -116.87 145.16 43.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.119 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.011 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -137.49 152.01 49.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.863 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.7 OUTLIER -149.2 91.71 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.092 . . . . 0.0 110.034 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 6' ' ' LEU . 3.3 m -100.66 141.3 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.288 -0.883 . . . . 0.0 109.012 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 8' ' ' VAL . 6.4 m -152.89 176.8 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.461 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -120.45 -150.2 0.45 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.37 -32.06 18.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -147.18 55.29 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.461 ' HG3' ' OG ' ' A' ' 10' ' ' SER . 17.1 pt20 175.93 122.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 15' ' ' MET . 15.5 mt-30 -96.37 165.52 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.922 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.554 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -141.91 -91.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 109.111 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.637 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 31.7 t80 -96.01 120.55 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.212 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.406 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 29.9 p -152.53 80.35 1.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.54 20.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.74 ' C ' HG12 ' A' ' 20' ' ' VAL . 24.4 mt -62.94 175.0 0.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.011 -1.287 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.011 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 179.5 160.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 108.993 -177.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.576 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 2.8 tm-20 -122.25 -51.18 1.99 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 110.087 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.512 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 18.3 tttp -153.74 122.56 6.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.134 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.038 HG22 ' CG1' ' A' ' 52' ' ' ILE . 11.2 pt -106.64 -170.13 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' CG ' ' CB ' ' A' ' 51' ' ' ARG . 5.0 pt20 -179.95 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.619 -1.3 . . . . 0.0 110.274 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 46' ' ' LYS . 1.5 p -101.19 133.65 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.36 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -120.7 135.32 55.16 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.281 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . 179.47 -76.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -158.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -1.121 . . . . 0.0 109.507 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -67.77 -82.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . -51.8 117.98 6.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.18 64.28 1.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -112.98 160.81 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.386 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -111.37 -111.46 3.24 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.774 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 23.5 mm -156.11 140.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.981 . . . . 0.0 108.806 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.62 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -146.6 -172.05 0.3 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 35.7 Cg_endo -80.96 42.76 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.23 1.953 . . . . 0.0 110.606 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.46 34.09 0.04 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -74.58 145.31 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -1.13 . . . . 0.0 109.606 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.701 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -55.55 165.89 1.1 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.788 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.701 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -78.62 73.38 5.93 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.685 2.257 . . . . 0.0 110.466 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -99.91 147.86 25.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.287 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -156.87 44.22 0.38 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.0 p -123.69 -110.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.568 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -101.4 155.39 18.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.822 -1.174 . . . . 0.0 109.584 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.47 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.7 tt -104.56 177.08 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.518 ' O ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -86.43 113.38 52.22 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 109.636 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.483 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 35.5 Cg_endo -78.61 122.15 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.483 2.122 . . . . 0.0 110.353 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.48 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 162.42 -127.72 1.76 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.68 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.7 ppp? -113.48 167.7 10.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.257 -1.143 . . . . 0.0 109.024 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.858 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.5 tt -150.39 149.31 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.931 -1.106 . . . . 0.0 110.393 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.542 ' CB ' ' CG ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -116.49 177.96 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.038 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.89 153.86 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.828 -1.17 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 18.1 t -137.97 149.51 24.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HB2' ' CB ' ' A' ' 21' ' ' GLU . 10.1 tppt? 90.06 -112.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HG3' ' CE1' ' A' ' 16' ' ' PHE . 18.8 tt0 53.62 58.32 5.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.547 -1.345 . . . . 0.0 109.155 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.427 ' NE2' HD12 ' A' ' 19' ' ' LEU . 56.1 m170 58.53 43.03 19.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.266 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 71.48 86.18 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.466 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 167.2 125.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.588 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.54 133.76 53.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.115 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.78 168.59 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.961 ' CZ ' HD21 ' A' ' 133' ' ' LEU . 0.8 OUTLIER -125.51 134.06 52.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.292 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.858 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.0 mt -101.73 -147.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.189 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 9.1 t80 -178.75 122.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 109.23 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.451 ' CD2' ' CB ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -120.21 161.57 20.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.81 -14.04 14.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.6 161.99 9.96 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 156.69 -167.46 33.63 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 69' ' ' LEU . 7.2 mt -101.72 170.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -1.073 . . . . 0.0 109.158 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -155.0 163.87 39.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.697 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -157.44 134.64 10.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 109.202 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.664 HG23 HG22 ' A' ' 76' ' ' VAL . 14.5 p -100.39 152.73 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.783 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -131.6 170.51 11.1 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 109.245 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -77.54 103.62 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.485 2.123 . . . . 0.0 110.325 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . 83.84 1.53 89.86 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 74' ' ' GLY . 13.4 m-80 -152.63 170.09 21.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -1.214 . . . . 0.0 109.391 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 34' ' ' ILE . 6.1 t -150.79 144.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.246 -0.909 . . . . 0.0 109.266 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -151.6 138.46 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.071 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 3.2 m -139.71 158.28 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.05 149.97 40.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.19 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.521 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -147.96 -175.84 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.851 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -123.32 -31.42 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.636 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 83' ' ' ALA . 14.7 m -112.5 162.86 15.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -161.83 81.93 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.679 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -99.9 70.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.937 . . . . 0.0 109.326 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.701 ' HD2' HG23 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -44.04 161.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -48.62 -59.04 6.92 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -116.9 60.0 0.75 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -1.144 . . . . 0.0 109.497 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -50.63 -63.63 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 89' ' ' LEU . 84.4 mt -142.87 -88.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.66 179.15 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.863 ' HA ' HD11 ' A' ' 131' ' ' ILE . 30.5 mt-10 -149.61 -39.74 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.16 32.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -78.31 -8.28 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.25 28.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.3 mtt -71.43 -6.73 42.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.516 -0.74 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 4.6 mt-10 -81.44 -40.65 23.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.53 -65.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.679 ' HG2' HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -45.16 -31.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -59.53 -56.81 17.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.124 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.39 3.99 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 110.028 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.77 -46.3 10.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 109.638 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -65.56 -33.59 76.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.829 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -15.19 58.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.104 -0.998 . . . . 0.0 109.769 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -80.31 -65.18 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.84 -15.03 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 107' ' ' SER . 28.0 t -78.25 78.97 4.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 109.463 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 106' ' ' SER . 2.2 p 176.9 129.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' SER . 16.5 m 54.52 104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.421 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.54 -154.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 137.58 139.58 3.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 25.2 t70 -74.24 -58.06 3.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -1.194 . . . . 0.0 109.448 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.15 -7.6 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 109.454 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -59.28 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.822 . . . . 0.0 109.193 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -73.28 -23.11 60.26 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -59.59 -22.75 62.22 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.313 0.578 . . . . 0.0 109.464 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.48 -42.49 78.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.75 -11.63 60.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.559 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -1.09 26.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.706 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.94 -16.33 34.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -84.24 -16.42 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.947 . . . . 0.0 109.495 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -88.49 -45.01 10.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.601 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.35 73.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 124' ' ' ALA . 6.7 pttt -73.66 -28.4 61.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -87.06 -8.05 57.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.218 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.679 HD11 ' HG2' ' A' ' 98' ' ' LYS . 1.5 tp -81.43 -4.07 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.68 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -74.36 -26.86 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -63.7 -33.63 76.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.403 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 131' ' ' ILE . 19.2 tp -81.64 -10.27 59.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.502 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -31.29 19.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.779 ' O ' HG23 ' A' ' 134' ' ' THR . 1.2 m -90.56 -12.75 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.0 tt -90.4 -23.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 0.0 110.055 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 135' ' ' LYS . 0.7 OUTLIER -77.4 -39.28 47.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -82.67 3.19 30.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 110.415 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 130' ' ' VAL . 14.3 p -87.15 -12.98 45.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.913 -1.117 . . . . 0.0 109.669 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 132' ' ' GLU . 5.6 ptpt -71.34 -5.44 32.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -97.63 -43.42 7.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 109.608 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -44.7 -29.06 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.583 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.565 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.573 ' O ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -101.35 28.76 5.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.382 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.773 HG22 ' HA ' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -160.75 153.77 21.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.839 . . . . 0.0 109.609 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.712 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.9 p90 -139.53 -145.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.348 -0.845 . . . . 0.0 108.926 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -134.7 152.5 51.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -115.9 138.28 51.32 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.866 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.5 OUTLIER -143.39 72.61 1.37 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.321 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 15' ' ' MET . 4.0 p -106.26 140.59 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.84 147.42 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.339 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 1.3 p -143.78 42.9 1.47 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 171.68 -87.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 109.582 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 13' ' ' GLN . 1.4 mt-10 -128.62 44.13 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER 70.81 61.95 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -145.6 99.21 3.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.616 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.862 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -175.12 -78.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 109.286 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -148.26 109.47 4.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.5 p -138.07 83.37 1.97 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 109.464 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.5 -153.47 11.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.47 152.47 30.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -1.169 . . . . 0.0 109.741 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.7 152.33 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 109.276 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.773 ' HA ' HG22 ' A' ' 3' ' ' THR . 10.6 tt0 -109.84 -50.55 2.97 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -155.44 130.84 9.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.744 ' CD1' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -98.01 -152.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.019 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.556 ' H ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER 179.55 94.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.806 -1.184 . . . . 0.0 109.617 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.744 HG23 ' CD1' ' A' ' 23' ' ' ILE . 22.2 t -99.05 134.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 22.2 m -123.36 112.22 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.359 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -157.57 159.97 30.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -31.48 71.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.163 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' CB ' ' HG3' ' A' ' 47' ' ' PRO . 1.9 tt0 -98.54 71.7 2.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.74 152.86 9.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.26 26.45 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.686 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.06 156.93 21.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.665 ' HA2' HD11 ' A' ' 23' ' ' ILE . . . -100.35 -121.37 4.7 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.045 ' CG2' HG21 ' A' ' 76' ' ' VAL . 30.7 mm -154.42 135.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -1.225 . . . . 0.0 109.016 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -140.7 -172.44 0.32 Allowed Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 34.5 Cg_endo -77.88 76.12 4.48 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.776 1.651 . . . . 0.0 110.407 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.22 37.53 0.6 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 39' ' ' ALA . 15.8 t-80 -67.76 166.6 14.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.179 -1.189 . . . . 0.0 109.394 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -53.68 160.77 1.86 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.6 Cg_endo -77.9 77.84 3.78 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.738 2.292 . . . . 0.0 110.581 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 4.2 mm? -97.22 148.61 22.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.142 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.5 31.59 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 68' ' ' ILE . 26.8 p -131.21 -145.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 109.239 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.47 128.42 45.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.032 -1.043 . . . . 0.0 108.844 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -160.41 42.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 110.395 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.699 ' CD ' HD11 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -130.82 45.73 1.9 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.917 -1.115 . . . . 0.0 110.723 179.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.695 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 79.52 3.31 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.047 1.831 . . . . 0.0 110.496 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 64' ' ' LEU . . . 158.62 -141.47 7.66 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.388 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' CG1' ' A' ' 130' ' ' VAL . 1.0 OUTLIER -110.02 179.91 3.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.404 -1.057 . . . . 0.0 109.587 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 1.7 tt -147.89 154.02 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.531 ' N ' HG12 ' A' ' 50' ' ' ILE . 1.3 tmt_? -144.8 152.35 40.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 8.3 mt -150.7 166.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 110.452 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 90.1 t -141.78 118.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.618 -0.677 . . . . 0.0 109.267 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 150.88 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 6.5 mp0 42.46 -147.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -109.67 -11.06 14.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.952 . . . . 0.0 109.419 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.04 -98.64 2.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -130.3 -66.51 0.77 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.55 165.86 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.97 143.31 50.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 0.0 109.436 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.64 ' HZ ' HD11 ' A' ' 133' ' ' LEU . 0.7 OUTLIER -116.9 123.71 47.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.707 HG21 ' HG2' ' A' ' 15' ' ' MET . 1.6 mt -137.38 -160.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.969 . . . . 0.0 109.316 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.602 ' H ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -174.38 131.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 0.0 109.32 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.544 HD22 ' C ' ' A' ' 63' ' ' TYR . 3.6 mm? -119.5 158.27 26.62 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -99.27 -19.71 16.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.521 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.96 45.73 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 80' ' ' ALA . . . -72.54 -178.02 32.21 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 43' ' ' THR . 2.7 mp -102.79 122.94 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -1.125 . . . . 0.0 109.367 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.699 HD11 ' CD ' ' A' ' 46' ' ' LYS . 6.7 mp -99.53 175.34 5.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.696 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -168.78 129.3 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.7 p -99.86 129.06 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.076 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.542 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.74 173.7 3.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.5 Cg_endo -81.04 56.02 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.07 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.89 -16.73 1.21 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.075 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' A' ' 5' ' ' HIS . 15.5 m-80 -150.91 -175.65 5.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 0.0 109.468 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.045 HG21 ' CG2' ' A' ' 34' ' ' ILE . 38.0 t -144.25 146.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.237 -0.914 . . . . 0.0 109.361 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.866 HG22 ' HB3' ' A' ' 7' ' ' ASP . 1.2 p -138.07 174.24 10.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 8' ' ' VAL . 1.2 p -178.25 119.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.298 -0.876 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.593 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -102.62 124.51 48.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.033 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.442 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . . . -128.73 -152.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.78 -39.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.4 m -104.24 151.73 23.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 109.754 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -165.68 167.51 17.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.321 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.454 HG13 ' CE1' ' A' ' 63' ' ' TYR . 16.3 mt -130.68 -28.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 69.37 45.71 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.418 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.04 -112.13 3.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.78 27.08 9.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.42 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 85' ' ' ARG . 32.1 t70 -49.43 -40.72 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.669 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.86 -88.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.772 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.07 164.84 20.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.26 -72.8 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.54 -17.1 34.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -81.64 3.75 24.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.591 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.09 26.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 108.693 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 mtm -71.08 -26.54 63.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.507 -0.745 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.58 -24.21 67.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.323 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.24 -42.75 22.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.327 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -58.44 -43.51 88.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -26.55 65.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.307 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -89.94 7.68 36.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.812 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -90.5 -35.62 14.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -34.9 72.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 106' ' ' SER . 0.4 OUTLIER -62.58 -34.88 77.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -48.72 65.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.448 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mt -89.56 27.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 107' ' ' SER . 0.5 OUTLIER -68.92 92.86 0.52 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 106' ' ' SER . 39.5 m 61.47 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.633 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.44 118.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -95.68 73.42 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.514 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.27 132.02 4.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.5 m-20 -67.23 -149.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -1.148 . . . . 0.0 109.398 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.831 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -35.96 -31.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.301 0.572 . . . . 0.0 109.708 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 111' ' ' ASP . 22.5 t70 -38.18 -93.15 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.665 -0.647 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -63.42 -20.15 65.31 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -55.74 -26.22 44.44 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.419 0.628 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -82.13 -31.92 30.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.384 -0.822 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -13.31 61.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.646 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 t -83.24 9.34 10.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.16 10.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.432 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.629 ' HG3' HD22 ' A' ' 121' ' ' LEU . 23.2 pt-20 -67.6 -12.49 60.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.812 HD12 ' HB1' ' A' ' 101' ' ' ALA . 3.9 mm? -82.57 -36.21 26.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.918 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.94 46.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -69.85 -14.05 62.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.369 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.16 -8.49 57.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.343 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.66 -17.9 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.51 -26.49 68.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -60.3 -34.22 73.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 109.492 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.526 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 27.9 tp -90.03 -11.84 40.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -60.84 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.564 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 134' ' ' THR . 16.2 m -55.42 -51.15 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.015 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 130' ' ' VAL . 3.9 tt -60.19 -26.95 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.15 -38.66 85.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 109.942 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 133' ' ' LEU . 1.2 pp -90.22 -16.2 29.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.04 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 130' ' ' VAL . 20.0 p -61.25 -38.89 88.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -60.41 -33.95 73.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.993 . . . . 0.0 109.419 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.48 1.0 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 133' ' ' LEU . . . -77.26 -36.03 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 109.427 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.459 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.813 ' O ' HG22 ' A' ' 3' ' ' THR . 0.1 OUTLIER -50.73 176.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -0.871 . . . . 0.0 109.472 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.813 HG22 ' O ' ' A' ' 2' ' ' MET . 6.5 t 52.07 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.591 1.186 . . . . 0.0 111.075 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.956 ' CE2' HG22 ' A' ' 34' ' ' ILE . 9.2 p90 -110.75 -168.37 1.3 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 76' ' ' VAL . 0.1 OUTLIER -111.06 137.57 48.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.155 -0.966 . . . . 0.0 108.655 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.052 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -125.61 162.68 24.42 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.912 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 1.045 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.94 101.35 2.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.728 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 16' ' ' PHE . 7.3 p -99.79 124.66 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 2.3 t -136.93 146.73 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.2 m -123.59 -145.88 0.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -40.04 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 110.039 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -153.38 65.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -156.05 138.68 15.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -92.4 138.32 31.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.758 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 1.1 mmt -124.99 -60.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.653 ' HB2' HD11 ' A' ' 62' ' ' ILE . 49.7 t80 -131.09 133.41 45.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.467 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 p -163.0 97.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.262 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 165.02 -151.03 19.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.732 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -70.23 161.94 29.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.191 -1.182 . . . . 0.0 109.302 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.052 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -178.59 153.93 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.258 -177.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 3' ' ' THR . 1.5 pp20? -152.25 -36.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.942 -1.099 . . . . 0.0 110.677 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -106.74 71.21 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.848 -1.158 . . . . 0.0 110.891 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.953 HG22 ' CG1' ' A' ' 52' ' ' ILE . 9.5 pt -102.81 142.29 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.099 -1.0 . . . . 0.0 108.699 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.546 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 20.0 pt20 -149.27 126.55 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.055 -1.028 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -99.11 114.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . 51.6 m -99.78 108.42 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.52 -91.82 1.26 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.58 -67.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -1.089 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.64 132.09 33.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.55 -178.29 35.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -174.74 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.125 . . . . 0.0 109.591 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 12.8 mt -151.27 142.96 23.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.629 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -101.79 -99.69 2.44 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.956 HG22 ' CE2' ' A' ' 4' ' ' TYR . 7.2 mm -156.75 140.47 7.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.429 -1.042 . . . . 0.0 109.139 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -128.76 178.06 1.84 Allowed Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 33.1 Cg_endo -75.43 75.78 3.77 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.058 1.838 . . . . 0.0 110.172 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.5 38.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -107.9 175.33 5.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.209 . . . . 0.0 109.583 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -92.99 167.24 14.7 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.269 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.73 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.61 81.99 2.61 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.535 2.157 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.943 HD11 HD11 ' A' ' 69' ' ' LEU . 1.4 pp -90.17 142.27 27.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.727 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mt -128.13 69.94 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.293 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -110.3 -160.5 0.72 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -101.01 172.73 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.706 ' HA ' HD23 ' A' ' 69' ' ' LEU . 1.7 tt -99.96 126.98 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 156.15 70.52 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.98 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.15 175.71 10.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.56 2.173 . . . . 0.0 110.314 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 113.96 -132.92 10.84 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.669 ' SD ' HG13 ' A' ' 130' ' ' VAL . 6.0 ptm -129.53 -177.11 4.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -1.204 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.8 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -151.96 131.3 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 109.816 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -98.41 127.26 44.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.953 ' CG1' HG22 ' A' ' 23' ' ' ILE . 1.2 tt -134.3 145.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.077 -1.014 . . . . 0.0 110.91 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.757 HG22 ' HB3' ' A' ' 59' ' ' GLU . 38.9 t -127.75 113.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 16' ' ' PHE . 17.6 mtmt -66.32 157.14 32.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -0.762 . . . . 0.0 109.886 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.764 ' CG ' HG21 ' A' ' 3' ' ' THR . 18.2 tt0 -60.29 -65.02 0.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.345 -0.847 . . . . 0.0 109.531 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.04 102.98 8.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.47 -103.42 0.23 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -148.51 159.96 43.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -1.194 . . . . 0.0 109.702 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.757 ' HB3' HG22 ' A' ' 53' ' ' VAL . 1.9 pt-20 -101.3 136.05 41.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 52' ' ' ILE . 8.9 mt-10 -134.01 150.64 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.943 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 1.2 p90 -109.2 131.02 55.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.8 ' H ' HG23 ' A' ' 50' ' ' ILE . 1.7 mt -101.95 -175.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.436 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.682 ' H ' HG22 ' A' ' 62' ' ' ILE . 6.2 t80 -152.37 136.84 16.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.068 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -161.92 179.99 7.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -161.3 113.16 1.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.435 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.79 132.97 6.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.27 -161.79 28.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 82.2 mt -139.46 143.2 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -1.155 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.943 HD11 HD11 ' A' ' 41' ' ' LEU . 1.4 pp -123.72 138.5 54.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 2.8 pt-20 -142.72 149.89 39.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 40' ' ' PRO . 4.4 p -109.54 133.4 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.76 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.534 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -101.45 175.43 2.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.408 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.0 Cg_endo -76.76 77.59 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.62 2.213 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.85 12.58 31.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.819 ' O ' HG23 ' A' ' 76' ' ' VAL . 68.3 m-80 -153.9 -172.29 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -1.086 . . . . 0.0 109.343 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 75' ' ' ASN . 3.1 t -166.13 150.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.09 -1.006 . . . . 0.0 108.935 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -158.5 142.26 15.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 0.0 109.315 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 69' ' ' LEU . 3.5 m -151.06 137.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.187 -0.946 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 1.1 mp -106.77 160.66 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.848 . . . . 0.0 109.194 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.492 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -149.76 175.88 11.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.8 -52.21 3.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.4 t -102.18 -176.68 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.367 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.758 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -168.51 80.88 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.6 mp -108.51 72.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.52 ' NH2' ' HB3' ' A' ' 60' ' ' GLU . 22.9 ttt180 -42.84 154.11 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -45.95 -51.75 10.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -106.71 49.4 0.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -1.141 . . . . 0.0 109.539 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -27.69 14.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -123.36 -175.02 3.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.367 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 10.7 t70 -54.29 179.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.342 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.791 ' HB3' HD11 ' A' ' 131' ' ' ILE . 32.7 mt-10 -105.83 -34.8 7.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.95 -25.24 27.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -72.29 -7.44 49.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 127' ' ' GLN . . . -90.59 -24.63 20.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.179 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -31.55 37.67 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 109.484 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -5.56 27.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.68 -22.93 42.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HG2' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -82.34 -41.58 19.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.2 mtp-105 -61.3 -27.18 68.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.86 -21.76 26.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.95 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.12 -26.32 33.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.347 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 106' ' ' SER . 16.3 tt0 -60.97 -30.55 70.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.837 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -56.11 -30.88 62.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -89.5 -47.68 7.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.883 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.065 HD13 ' HB1' ' A' ' 117' ' ' ALA . 11.7 mt -86.83 14.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 107' ' ' SER . 71.2 p -48.69 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 77.03 167.76 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.565 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -166.94 134.52 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.15 -89.01 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.468 ' O ' ' OD2' ' A' ' 113' ' ' ASP . . . -167.78 174.41 42.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 112' ' ' VAL . 1.2 m-20 63.65 105.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -1.202 . . . . 0.0 109.312 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 111' ' ' ASP . 15.6 m 40.99 26.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -90.83 -89.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.177 -0.952 . . . . 0.0 108.893 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 26.7 t80 -73.93 -20.47 60.36 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.83 -53.17 58.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.51 -39.78 94.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.355 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 1.065 ' HB1' HD13 ' A' ' 105' ' ' ILE . . . -67.03 -16.35 64.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.589 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.561 ' O ' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -74.52 -23.1 58.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.44 -41.15 11.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.977 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 6.2 pt-20 -75.77 -32.15 59.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 105' ' ' ILE . 51.1 tp -87.24 -51.84 5.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 109.614 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -52.72 -39.78 62.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -57.84 -36.12 71.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.781 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 123' ' ' LYS . . . -75.92 -22.54 55.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.563 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.0 mm -79.79 -3.61 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.619 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.495 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -64.81 -32.74 74.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -69.08 -19.28 64.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.411 ' N ' ' HG2' ' A' ' 127' ' ' GLN . 14.0 tp -83.99 -17.5 40.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -90.37 -28.99 18.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.733 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.669 HG13 ' SD ' ' A' ' 49' ' ' MET . 5.0 m -89.19 -26.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 109.461 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.791 HD11 ' HB3' ' A' ' 91' ' ' GLU . 3.1 tt -66.97 -46.86 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.576 ' N ' HG23 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -52.65 -26.29 13.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -44.98 28.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 79.5 p -61.1 -14.88 27.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -45.42 -41.65 9.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.367 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -97.08 -41.77 8.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -44.19 -61.98 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.442 ' OXT' ' O ' ' A' ' 137' ' ' ALA . 2.8 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' THR . 6.3 mtp -77.65 -170.63 1.89 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.556 HG22 ' HG3' ' A' ' 21' ' ' GLU . 1.3 p 49.98 176.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.398 -0.814 . . . . 0.0 109.906 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.725 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.3 p90 179.42 -171.66 0.15 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.559 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.0 t60 -111.62 149.68 31.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 109.025 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.012 HD23 HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -137.92 158.48 44.26 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 178.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.856 ' N ' HD12 ' A' ' 6' ' ' LEU . 6.5 t0 -144.98 92.65 2.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.4 p -113.2 118.69 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.918 . . . . 0.0 109.408 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 t -130.9 145.08 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.693 ' CB ' ' HB3' ' A' ' 80' ' ' ALA . 39.5 t -178.05 66.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 178.09 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER 42.54 27.38 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.653 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.8 OUTLIER -148.88 -150.59 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.512 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -134.39 102.84 5.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.651 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.4 mmt -76.01 -78.69 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.259 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.612 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 34.7 t80 -125.66 124.76 41.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.165 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 17' ' ' SER . 52.6 p -154.4 83.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.7 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.01 -153.59 17.37 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.643 ' C ' HG12 ' A' ' 20' ' ' VAL . 13.6 mt -65.02 167.7 7.5 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.151 -1.205 . . . . 0.0 108.745 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.012 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -173.85 173.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 120.87 -1.144 . . . . 0.0 109.496 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.9 tt0 -118.19 -46.37 2.61 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HE2' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.4 137.3 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.433 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.984 ' HB ' HD11 ' A' ' 50' ' ' ILE . 18.7 pt -99.42 -156.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -177.13 95.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.509 -1.369 . . . . 0.0 110.378 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.537 HG11 ' C ' ' A' ' 46' ' ' LYS . 76.4 t -99.23 141.75 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 25.6 m -145.53 119.81 9.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.274 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -145.54 -163.39 10.18 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -42.66 42.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -1.078 . . . . 0.0 109.592 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 163.26 21.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.917 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.79 138.57 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -141.31 45.72 1.74 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -1.13 . . . . 0.0 109.213 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.412 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 5.9 mt -144.85 164.58 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.785 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -112.59 -112.33 3.16 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 76' ' ' VAL . 15.9 mm -153.33 138.04 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -1.153 . . . . 0.0 109.459 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.618 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -149.23 171.87 5.82 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.0 Cg_endo -70.3 83.03 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.566 1.511 . . . . 0.0 109.486 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.73 35.12 0.46 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.632 ' CD2' ' CD1' ' A' ' 34' ' ' ILE . 22.3 t60 -81.97 151.26 27.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -1.12 . . . . 0.0 109.526 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . -42.94 154.8 0.28 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.409 -0.807 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 76.01 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.583 2.188 . . . . 0.0 110.559 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -97.03 162.13 13.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.311 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.68 35.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.634 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 68' ' ' ILE . 30.0 p -130.68 -145.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.901 . . . . 0.0 109.375 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.32 120.41 39.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 44' ' ' ALA . 1.1 pp -166.7 -169.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.163 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.657 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER 71.66 49.46 0.28 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 111.059 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.657 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 146.17 17.22 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.15 1.9 . . . . 0.0 110.418 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 115.58 -142.88 17.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.318 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -99.56 -155.22 0.5 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -1.079 . . . . 0.0 109.198 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.984 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -173.76 111.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 110.383 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 50' ' ' ILE . 15.7 mtm180 -99.46 166.63 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.881 HD11 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -152.62 167.63 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.601 -1.312 . . . . 0.0 111.246 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.481 ' N ' HG23 ' A' ' 52' ' ' ILE . 13.6 t -143.99 104.73 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLN . 1.3 ttpt -66.37 120.51 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.692 -0.63 . . . . 0.0 109.868 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 82.0 mt-30 43.26 -161.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.363 -0.835 . . . . 0.0 109.373 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -68.71 88.41 0.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 54' ' ' LYS . . . 121.27 -171.21 14.86 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 61.5 160.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.383 -1.069 . . . . 0.0 109.607 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -171.35 147.41 2.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.401 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -132.8 154.67 50.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' ' 130' ' ' VAL . 0.9 OUTLIER -112.08 133.62 54.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 109.373 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 15' ' ' MET . 78.0 mt -151.94 167.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 109.261 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.61 ' N ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.65 149.66 37.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 109.576 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER -157.67 152.69 25.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.16 -79.56 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 109.723 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 129.4 9.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.32 144.6 7.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 43' ' ' THR . 79.3 mt -99.48 118.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -1.108 . . . . 0.0 108.965 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.671 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.3 tt -112.49 153.37 27.54 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -145.65 152.41 39.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.28 139.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.0 109.872 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.525 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.9 OUTLIER -122.27 172.33 5.33 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.462 -0.774 . . . . 0.0 109.038 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -78.62 91.15 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.513 2.142 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.22 -10.31 54.6 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -161.32 162.11 30.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.027 -1.278 . . . . 0.0 109.896 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 34' ' ' ILE . 18.3 m -135.75 172.87 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 78' ' ' VAL . 32.5 m -159.95 156.64 27.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.504 ' CG2' ' HB2' ' A' ' 69' ' ' LEU . 2.7 p -167.73 133.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mt -117.77 118.34 31.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.693 ' HB3' ' CB ' ' A' ' 10' ' ' SER . . . -109.02 -165.97 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.361 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.23 -52.29 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 m -99.93 120.11 39.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.35 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . -149.75 163.71 37.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.54 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.1 mt -149.03 119.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.285 -0.885 . . . . 0.0 109.25 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -67.58 95.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.37 -110.75 1.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.738 ' HB3' HG22 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -139.13 57.2 1.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 109.223 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -60.19 -45.16 94.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.61 -78.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -150.25 -155.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 109.608 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.471 ' HB2' HD12 ' A' ' 131' ' ' ILE . 1.3 pt-20 -151.93 -49.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.652 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.87 -10.14 59.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.359 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -8.48 59.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.52 -24.32 20.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.246 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -35.58 76.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -54.71 -33.34 60.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.17 75.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.112 -0.993 . . . . 0.0 109.86 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -18.06 60.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -70.06 -50.34 42.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.626 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -86.02 -9.19 57.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.573 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.908 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -76.81 -30.8 56.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 1.5 tm-20 -70.88 -22.46 62.28 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.306 -0.871 . . . . 0.0 109.347 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.74 -20.75 60.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -81.67 -36.75 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.714 HD11 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mm -78.87 -26.91 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.1 p -80.81 -9.94 59.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.5 t -104.58 131.19 52.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.57 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 58.3 p -135.97 142.22 44.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.281 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.3 m-70 175.21 41.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.382 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.63 158.92 31.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -74.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -1.177 . . . . 0.0 109.562 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 17.6 m -100.84 19.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.393 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 9.7 t70 -59.83 -100.41 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.358 -0.839 . . . . 0.0 109.278 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 12.6 p90 -64.61 -22.22 66.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.903 -1.123 . . . . 0.0 108.223 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -53.84 -33.65 56.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -88.3 -24.7 23.1 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -68.08 -21.12 64.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -26.3 61.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HE3' ' A' ' 123' ' ' LYS . . . -90.18 -38.18 13.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -78.85 -5.79 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.908 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -90.15 -51.3 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.593 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.31 -28.87 70.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.179 -0.951 . . . . 0.0 109.459 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 119' ' ' ALA . 14.8 mtmt -70.23 -23.66 62.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.66 62.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.868 . . . . 0.0 109.733 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.3 mp -80.08 -1.24 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.4 -24.57 63.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.766 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -69.76 -45.76 67.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.62 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.541 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.4 OUTLIER -65.99 -15.51 63.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.638 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 133' ' ' LEU . 14.2 mmt180 -81.85 -25.75 34.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 127' ' ' GLN . 31.6 m -88.09 -20.36 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.738 HG22 ' HB3' ' A' ' 87' ' ' GLN . 7.7 pt -91.01 -44.62 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 0.0 110.047 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 5.0 mm-40 -61.81 -24.21 66.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.233 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 133' ' ' LEU . 6.5 mp -89.09 -37.73 14.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -55.59 -40.93 72.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -61.39 -29.58 70.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.83 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -111.26 31.56 5.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 109.548 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.19 -3.56 8.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 109.654 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.339 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.519 ' CG ' ' O ' ' A' ' 1' ' ' ALA . 20.6 ptp 40.68 -155.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.482 -0.762 . . . . 0.0 109.837 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.693 HG21 ' CG ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -42.35 166.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.873 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.738 ' CE2' HG22 ' A' ' 34' ' ' ILE . 5.0 p90 -148.79 -147.3 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 20.5 t-80 -133.9 140.71 46.99 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.05 -1.031 . . . . 0.0 109.641 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.04 HD21 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.067 . . . . 0.0 108.775 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.818 ' N ' HD12 ' A' ' 6' ' ' LEU . 36.1 t0 -142.83 86.78 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.951 -1.093 . . . . 0.0 110.528 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 6' ' ' LEU . 5.0 m -99.9 148.78 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 8' ' ' VAL . 1.5 m -152.96 173.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.032 -1.043 . . . . 0.0 109.869 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.662 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -129.4 -153.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.92 -29.95 70.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' GLN . 6.3 mm-40 -116.74 26.51 9.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.003 . . . . 0.0 109.695 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 12' ' ' GLU . 19.8 mt-30 43.68 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.409 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 15' ' ' MET . 4.6 mm-40 -165.4 74.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.722 ' HB2' HG23 ' A' ' 8' ' ' VAL . 6.8 mtp -151.32 -73.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.647 ' CD1' HD13 ' A' ' 52' ' ' ILE . 47.7 t80 -159.75 136.84 9.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.267 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -160.17 105.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 144.99 -160.38 28.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.0 mt -56.09 174.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -1.191 . . . . 0.0 108.957 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.024 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 179.96 169.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.078 . . . . 0.0 109.65 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.0 tt0 -122.5 -41.9 2.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.314 -0.866 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HG3' ' HB ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -175.68 130.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.947 ' CG2' HD22 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -98.77 -165.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.584 ' N ' HD12 ' A' ' 23' ' ' ILE . 4.5 tp60 -168.89 84.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.665 -1.272 . . . . 0.0 110.233 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.3 141.86 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.445 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 10.2 m -138.16 129.69 27.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 109.03 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.92 -81.38 0.1 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -38.78 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -1.173 . . . . 0.0 109.769 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -123.41 163.69 20.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 80.4 -82.06 1.51 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 44.1 tt0 73.88 53.11 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -1.089 . . . . 0.0 109.732 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -145.54 156.64 43.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -99.22 -115.17 3.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.738 HG22 ' CE2' ' A' ' 4' ' ' TYR . 29.5 mm -153.11 145.81 14.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -154.91 -171.0 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.7 Cg_endo -78.63 73.93 5.68 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.678 1.586 . . . . 0.0 109.671 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.09 54.7 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.547 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 11.8 t-160 -85.63 50.84 2.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -1.132 . . . . 0.0 109.648 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 55.56 167.03 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 109.627 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.2 Cg_endo -78.46 78.92 3.47 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.621 2.214 . . . . 0.0 110.229 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -95.05 144.4 25.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.16 36.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.6 p -121.26 -134.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . . . -99.6 168.73 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.883 -1.136 . . . . 0.0 109.333 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.528 HD12 HD22 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -112.9 136.23 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -65.46 147.01 98.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.569 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 35.3 Cg_endo -77.71 133.97 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.688 2.259 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.508 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 174.25 -144.89 7.78 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.938 ' HE2' HG23 ' A' ' 130' ' ' VAL . 3.8 ptm -105.73 -164.68 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -1.114 . . . . 0.0 109.481 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.57 123.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.995 -1.066 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.609 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -111.28 159.69 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.04 HD11 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -154.06 158.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.28 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.481 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 47.2 t -142.15 102.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -54.94 159.42 2.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 -179.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.693 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.4 tm0? -35.85 -38.83 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.586 . . . . 0.0 110.022 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -103.06 -159.58 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -64.62 -163.77 0.79 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 4.1 t60 79.46 124.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.412 -1.052 . . . . 0.0 109.732 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.85 140.73 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 108.872 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.0 mp0 -109.68 152.34 25.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.109 . . . . 0.0 109.746 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.003 ' CD2' HG22 ' A' ' 130' ' ' VAL . 2.3 m-85 -124.22 132.29 53.59 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD12 HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -149.54 -176.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.615 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CD1' HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -162.84 130.88 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 108.928 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.48 -166.34 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.87 . . . . 0.0 109.334 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.462 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 1.9 m -143.04 -93.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.69 154.63 17.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.0 -173.27 42.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.1 mt -122.09 131.99 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.339 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -112.88 -172.4 2.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.961 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 179.78 142.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 71' ' ' VAL . 9.2 p -107.58 132.55 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 109.917 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.513 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.2 mt-30 -119.78 173.42 3.61 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 0.0 109.081 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.35 110.6 2.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.525 2.15 . . . . 0.0 110.829 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 78.51 11.86 84.85 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 19.6 p-10 -179.8 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.284 . . . . 0.0 109.838 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 6' ' ' LEU . 4.5 m -129.75 178.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.106 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 78' ' ' VAL . 98.9 m -160.86 160.48 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.95 -1.094 . . . . 0.0 109.954 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' CG1' HG12 ' A' ' 8' ' ' VAL . 1.8 p -177.02 138.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.777 ' N ' HD12 ' A' ' 79' ' ' LEU . 1.3 mp -124.31 153.27 42.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.04 -1.037 . . . . 0.0 109.95 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.95 166.06 26.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.433 -0.792 . . . . 0.0 109.047 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 81' ' ' ASP . 8.5 t70 -100.18 3.77 43.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 11.7 m -119.64 153.56 35.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB2' ' CB ' ' A' ' 10' ' ' SER . . . -168.57 113.42 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.474 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.575 HD13 ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -104.62 -37.38 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.216 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 75.43 49.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 130' ' ' VAL . . . 43.88 -109.58 0.26 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CA ' HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -98.78 59.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -1.117 . . . . 0.0 109.886 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 33.3 t0 -47.42 -38.23 12.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.4 tp -163.65 127.6 2.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.13 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.09 172.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 109.319 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.674 ' HA ' HD11 ' A' ' 131' ' ' ILE . 2.4 mt-10 -128.56 -5.69 5.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 109.836 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.31 -11.34 41.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.944 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -81.57 -17.38 48.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.44 -7.74 52.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -0.978 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mtt -85.4 -10.93 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.6 -26.53 60.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.89 -1.94 34.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HD2' HD12 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -84.58 -53.82 5.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -74.45 -29.56 61.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.75 -21.86 34.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -68.64 -29.37 67.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -17.66 51.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -88.79 -20.32 24.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 121' ' ' LEU . 65.4 mt -83.08 4.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.661 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.4 m -47.83 -52.13 20.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.69 115.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.7 p -153.28 148.66 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.434 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.63 -63.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.543 ' N ' ' HB2' ' A' ' 113' ' ' ASP . . . 175.4 171.62 39.54 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.82 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 109.596 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 14.3 m -88.19 20.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.543 ' HB2' ' N ' ' A' ' 110' ' ' GLY . 51.0 t0 -62.35 -100.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -15.36 58.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 108.473 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -71.83 -37.73 70.25 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.685 -0.634 . . . . 0.0 109.591 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 12.2 tt0 -84.24 -10.2 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.65 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.93 -20.84 24.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.65 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -64.37 -13.18 49.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 109.488 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.66 -60.97 1.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -59.08 -47.62 84.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.974 ' HB2' HD11 ' A' ' 105' ' ' ILE . 0.7 OUTLIER -68.18 -59.74 2.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.802 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -56.26 -16.63 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.855 . . . . 0.0 109.829 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.423 ' CD ' ' HB2' ' A' ' 47' ' ' PRO . 7.6 ttpt -76.86 -36.2 56.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.18 -14.01 54.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.805 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.607 HD12 ' HD2' ' A' ' 98' ' ' LYS . 35.2 mm -87.84 -8.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.49 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -68.43 -30.64 69.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.599 ' O ' HG22 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -84.07 -17.73 39.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.657 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -85.09 -30.51 24.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.483 ' O ' HD23 ' A' ' 133' ' ' LEU . 5.7 tpp180 -82.17 -33.94 29.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.54 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.003 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.15 -25.24 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.174 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.3 tt -90.95 -23.85 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 110.29 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -81.01 -34.62 32.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.9 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -84.67 0.17 51.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.955 -1.09 . . . . 0.0 110.099 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.542 HG23 ' CD2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -80.97 -2.08 46.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -25.23 34.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -89.12 -9.05 52.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.12 -0.987 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.83 37.33 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.431 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 3' ' ' THR . 1.3 tpt 178.62 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.253 -0.905 . . . . 0.0 109.609 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 2' ' ' MET . 0.4 OUTLIER -165.99 140.28 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.776 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.7 p90 -152.73 -142.69 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 75' ' ' ASN . 19.2 t-80 -139.39 141.81 37.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.878 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.031 HD23 HG21 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -137.38 153.83 50.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.079 -1.013 . . . . 0.0 108.673 178.619 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.766 ' N ' HD12 ' A' ' 6' ' ' LEU . 3.1 t70 -148.33 98.06 2.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.989 ' HA ' HG22 ' A' ' 78' ' ' VAL . 2.1 p -99.28 110.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.862 -1.149 . . . . 0.0 109.09 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.05 154.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.713 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.7 t -165.96 107.52 0.73 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.211 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 77.07 34.36 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 55.04 39.63 31.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 22.5 mt-30 -87.67 -43.9 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.204 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER 72.21 84.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.126 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' HG13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -98.97 -93.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 108.78 179.26 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.698 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 32.8 t80 -94.03 110.09 21.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.006 . . . . 0.0 109.315 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.496 ' HB2' ' OD1' ' A' ' 7' ' ' ASP . 60.4 p -136.97 109.94 7.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . 145.49 -169.52 27.03 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.72 ' C ' HG12 ' A' ' 20' ' ' VAL . 19.8 mt -52.46 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.107 -1.231 . . . . 0.0 108.602 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.031 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -176.04 145.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.962 -1.086 . . . . 0.0 109.563 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -108.7 -48.61 3.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 67.3 mmtt -147.19 101.76 3.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.405 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.943 HG13 HD11 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -99.94 109.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.79 110.09 22.48 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.04 -1.037 . . . . 0.0 110.51 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.839 HG21 ' HG3' ' A' ' 46' ' ' LYS . 7.4 p -99.67 147.81 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.457 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -135.84 121.71 19.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -152.42 -177.67 26.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.91 150.59 34.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -1.132 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 64.8 76.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.14 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 99.66 179.65 30.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 175.02 38.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.238 . . . . 0.0 109.806 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.528 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 4.6 mt -92.41 150.03 21.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.672 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.47 177.94 29.88 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.776 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 16.4 mm -98.6 140.13 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.874 -1.368 . . . . 0.0 109.187 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -137.79 170.87 9.47 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.8 Cg_endo -72.63 80.02 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.862 1.708 . . . . 0.0 109.918 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.66 34.94 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.435 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 11.8 t60 -83.23 142.67 30.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -1.208 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -46.74 157.71 0.45 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.185 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.73 87.4 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 110.359 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 71' ' ' VAL . 2.4 mm? -99.9 155.44 17.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -157.62 75.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.773 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.9 t -156.09 -146.08 0.17 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.885 . . . . 0.0 109.021 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.773 ' N ' HG23 ' A' ' 43' ' ' THR . . . -99.46 136.46 39.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.969 HD12 HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -156.47 -169.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 109.76 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.839 ' HG3' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 63.61 51.95 1.37 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.488 -0.757 . . . . 0.0 110.399 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.4 Cg_endo -80.19 65.99 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.208 1.938 . . . . 0.0 110.811 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.45 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 155.11 -127.49 2.08 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.298 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 4.6 ptm -108.61 -169.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 109.684 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.943 HD11 HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -179.43 127.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.477 ' C ' HG13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -110.35 172.86 6.61 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.826 HD13 HD21 ' A' ' 6' ' ' LEU . 18.2 mt -155.14 166.49 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.019 -1.051 . . . . 0.0 109.601 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 42.8 t -138.89 107.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.263 -0.898 . . . . 0.0 109.903 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 157.68 -97.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 16' ' ' PHE . 11.6 tm0? -50.68 165.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 0.0 109.373 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.0 t-160 75.54 -145.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.185 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.7 -86.43 0.92 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -120.23 -18.8 7.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -169.73 152.45 4.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.211 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.15 161.01 22.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 2.8 m-85 -118.19 141.78 48.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.912 ' HB ' HG23 ' A' ' 50' ' ' ILE . 2.3 mp -151.53 166.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.101 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -171.45 130.1 0.71 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.172 -0.955 . . . . 0.0 109.275 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 80' ' ' ALA . 10.5 mt -131.62 172.6 12.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.084 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -148.76 46.57 1.02 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.472 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 133.24 91.27 0.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -160.91 151.55 22.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' THR . 20.4 mt -105.72 119.7 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.969 HD21 HD12 ' A' ' 45' ' ' ILE . 1.4 pp -109.06 -161.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.958 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.576 ' N ' HD12 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -177.7 124.16 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 76' ' ' VAL . 13.4 p -99.66 138.78 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.504 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HG2' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -121.46 174.98 2.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.508 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.79 84.66 1.99 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.444 2.096 . . . . 0.0 110.515 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 132.77 -36.29 2.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 5' ' ' HIS . 9.8 p30 -155.14 154.19 31.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -1.225 . . . . 0.0 109.83 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.637 ' HB ' HG23 ' A' ' 71' ' ' VAL . 1.4 p -134.3 165.84 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.876 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.532 ' N ' HG22 ' A' ' 76' ' ' VAL . 98.7 m -153.55 145.56 23.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 0.0 109.63 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.989 HG22 ' HA ' ' A' ' 8' ' ' VAL . 2.6 m -122.74 147.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 0.0 109.441 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.4 114.09 20.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.673 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -137.17 172.2 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.314 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.73 -20.19 8.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 m -112.84 109.63 19.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -129.45 146.48 51.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.679 HD12 ' CE1' ' A' ' 63' ' ' TYR . 55.3 mt -139.16 86.39 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.248 -0.907 . . . . 0.0 108.969 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' ILE . 26.3 ttt180 -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.01 107.54 0.57 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.44 79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.421 ' O ' HD12 ' A' ' 89' ' ' LEU . 11.8 t70 -92.26 -34.35 14.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 88' ' ' ASP . 1.7 tp -162.99 131.82 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 53.21 -178.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.628 ' HB2' HD13 ' A' ' 131' ' ' ILE . 11.1 pt-20 -170.2 -39.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -75.06 -27.16 59.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.355 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -84.01 8.07 16.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.394 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.05 -12.36 38.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 0.0 109.178 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -26.82 53.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.44 -0.787 . . . . 0.0 109.467 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -77.25 -22.28 52.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.38 72.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' CD ' HG12 ' A' ' 125' ' ' ILE . 22.0 tttp -79.54 -22.59 43.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -69.07 -48.93 61.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.81 8.1 18.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.855 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -84.05 -24.13 30.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.164 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 33.2 tt0 -69.42 -24.18 63.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.85 . . . . 0.0 109.224 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.67 -47.12 83.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.84 74.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.762 HD11 ' HG ' ' A' ' 121' ' ' LEU . 14.6 mt -84.12 -11.23 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.0 m -48.98 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.666 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -164.6 -38.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.217 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.0 m 48.05 68.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 -67.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 111' ' ' ASP . . . 125.75 -47.36 1.02 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -43.1 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -1.1 . . . . 0.0 109.133 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.429 ' HB ' ' CG ' ' A' ' 116' ' ' GLN . 22.6 m -143.56 36.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.12 -96.47 0.11 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.711 -0.618 . . . . 0.0 109.375 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.609 ' CD1' HG21 ' A' ' 105' ' ' ILE . 2.4 m-85 -60.03 -19.2 51.49 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.32 -54.18 15.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.429 ' CG ' ' HB ' ' A' ' 112' ' ' VAL . 50.6 mm-40 -87.95 -0.72 57.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.687 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -90.88 -25.5 19.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.672 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 p -64.01 -18.63 64.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.706 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.25 -68.91 0.75 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 11.1 pt-20 -55.14 -44.64 75.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 110.046 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.855 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -62.62 -61.01 2.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.49 -14.35 12.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.788 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -33.89 76.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.25 70.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 109.564 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.6 mp -77.29 -1.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.961 . . . . 0.0 109.715 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.645 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -74.51 -20.56 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.071 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.883 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.5 pt20 -87.22 -24.12 24.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.619 HD23 ' C ' ' A' ' 128' ' ' LEU . 2.2 tt -72.17 -9.36 58.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 0.0 109.424 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.417 ' O ' HD13 ' A' ' 133' ' ' LEU . 10.0 mmt85 -84.61 -34.1 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.693 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 127' ' ' GLN . 33.4 m -62.7 -27.6 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 91' ' ' GLU . 96.8 mt -62.34 -39.59 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -65.08 -18.34 65.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 133' ' ' LEU . 4.8 mp -89.03 -34.97 16.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -70.66 -20.88 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -81.02 -6.49 58.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -143.25 23.4 1.84 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -96.24 -20.82 18.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.475 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -172.03 174.28 4.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.288 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.505 HG21 ' HG3' ' A' ' 55' ' ' GLN . 1.4 t -43.63 154.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.503 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.692 ' CE2' HG22 ' A' ' 34' ' ' ILE . 3.5 p90 -144.34 -159.65 1.02 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.562 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.1 t60 -114.05 144.79 42.55 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.947 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -103.15 130.97 50.49 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.162 -0.961 . . . . 0.0 109.136 178.356 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -137.44 88.85 2.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.2 p -114.01 116.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG12 ' HG3' ' A' ' 14' ' ' GLN . 16.3 m -124.28 172.19 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB2' ' CG ' ' A' ' 13' ' ' GLN . 15.0 m -124.81 -150.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.403 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -43.24 65.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.616 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -164.91 49.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 109.691 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.458 ' CG ' ' HB2' ' A' ' 10' ' ' SER . 0.1 OUTLIER -151.15 155.54 39.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.0 mt-30 -111.49 161.58 16.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.815 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.488 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 32.3 mtp -140.88 -46.55 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.274 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.626 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -138.75 110.95 7.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.653 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 17' ' ' SER . 19.6 p -139.43 86.48 2.12 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . -177.6 -149.98 8.22 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.731 ' C ' HG12 ' A' ' 20' ' ' VAL . 35.7 mt -82.45 175.25 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 109.529 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.947 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER 176.4 171.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.085 -1.009 . . . . 0.0 108.82 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.591 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.4 tt0 -166.87 -34.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.584 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -116.42 75.66 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.814 HD13 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -99.61 143.6 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.266 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 19.7 tt0 -149.78 158.33 44.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.005 -1.06 . . . . 0.0 109.927 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 30' ' ' GLY . 6.9 p -131.03 149.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -120.51 89.16 3.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.407 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -119.06 -77.7 0.56 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 p -150.38 -86.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.37 -28.6 22.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -90.96 73.06 1.8 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.24 29.97 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -1.115 . . . . 0.0 109.474 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.65 HD13 ' OH ' ' A' ' 35' ' ' TYR . 12.4 mt -130.86 144.75 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.66 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.5 -97.59 2.15 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.713 HD12 ' ND1' ' A' ' 38' ' ' HIS . 5.0 mm -155.72 161.74 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -1.041 . . . . 0.0 109.422 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.65 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -165.12 175.1 2.66 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -71.88 118.62 5.72 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.836 1.69 . . . . 0.0 109.222 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.97 24.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.8 ' CE1' HG21 ' A' ' 71' ' ' VAL . 19.3 p80 -86.9 -171.0 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.798 0.809 . . . . 0.0 110.79 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 1.053 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -54.74 -172.89 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 1.053 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 33.1 Cg_endo -76.79 -179.68 5.62 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.913 1.742 . . . . 0.0 110.271 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.527 ' CA ' ' H ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -90.6 37.64 0.92 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.193 -0.942 . . . . 0.0 110.913 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tp -147.5 116.54 6.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.574 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 t -175.74 -173.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.417 -0.802 . . . . 0.0 109.199 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.75 150.58 52.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.072 -1.018 . . . . 0.0 109.822 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.704 HD13 ' HB2' ' A' ' 69' ' ' LEU . 1.7 mp -102.17 112.64 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 1.0 OUTLIER -65.01 174.72 1.21 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 33.8 Cg_endo -77.14 142.63 21.86 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.574 2.182 . . . . 0.0 110.55 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 152.15 -156.39 26.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.5 ptm -103.6 -168.31 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -1.172 . . . . 0.0 109.35 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 7.6 mt -155.82 126.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.798 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -117.9 110.54 17.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.752 ' CD1' HD12 ' A' ' 23' ' ' ILE . 29.4 mt -118.33 168.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.117 -0.989 . . . . 0.0 110.52 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.593 ' N ' HG22 ' A' ' 52' ' ' ILE . 38.1 t -135.27 120.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.4 ttmt -64.03 147.45 52.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.505 ' HG3' HG21 ' A' ' 3' ' ' THR . 6.3 tm0? -65.05 -49.05 71.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.444 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -53.26 -62.59 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 85.43 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -170.66 176.84 4.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -1.054 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 53' ' ' VAL . 5.3 mt-10 -145.55 128.38 16.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 133.19 32.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -116.23 145.31 43.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.958 . . . . 0.0 109.618 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 63' ' ' TYR . 3.2 mp -121.85 171.93 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' CE1' HD13 ' A' ' 84' ' ' ILE . 8.2 t80 -141.34 152.7 44.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.29 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.482 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -172.92 -166.9 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.498 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 61.7 m -154.81 21.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 159.48 150.0 5.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.25 159.91 9.5 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.883 ' O ' HG23 ' A' ' 78' ' ' VAL . 2.0 mp -107.9 140.69 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.105 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 69' ' ' LEU . 2.6 tt -121.05 156.9 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.09 -1.006 . . . . 0.0 109.635 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.658 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -158.21 146.45 18.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.11 HG22 HG22 ' A' ' 76' ' ' VAL . 2.2 t -103.31 159.27 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 110.132 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.607 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -126.19 -171.13 0.22 Allowed Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.9 Cg_endo -79.55 40.61 0.97 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.645 1.564 . . . . 0.0 111.294 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 145.49 34.23 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.94 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 5.2 p-10 166.19 133.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.284 . . . . 0.0 109.974 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.11 HG22 HG22 ' A' ' 71' ' ' VAL . 6.6 t -99.62 157.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.285 -0.884 . . . . 0.0 108.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 23.0 m -154.3 137.07 15.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.252 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.5 p -141.32 141.72 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.599 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.24 107.67 17.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 66' ' ' GLY . . . -102.2 162.58 12.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.733 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.96 -47.02 7.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.5 m -100.82 136.03 41.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 109.549 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.698 ' C ' HD12 ' A' ' 84' ' ' ILE . . . -151.24 134.13 15.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.514 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.727 HG21 ' HG3' ' A' ' 127' ' ' GLN . 1.1 mp -111.86 -37.94 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.84 . . . . 0.0 108.959 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 77.26 84.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 42.18 -111.61 0.34 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 87' ' ' GLN . 1.4 tt0 -117.98 62.12 0.76 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.284 -1.127 . . . . 0.0 109.509 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 85' ' ' ARG . 13.0 t70 -85.77 -11.3 53.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -149.26 144.69 26.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 54.16 171.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.18 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HG3' HD11 ' A' ' 131' ' ' ILE . 81.6 tt0 -168.15 -80.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.95 58.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.269 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -6.01 51.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.17 -27.37 19.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.942 . . . . 0.0 108.988 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 mtt -67.2 -40.53 86.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.443 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -33.11 75.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 128' ' ' LEU . 1.3 tmmt? -62.37 -14.36 39.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.79 -53.05 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.482 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -65.23 -15.16 62.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.612 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -84.63 -28.36 26.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.348 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 103' ' ' GLU . 24.8 tt0 -76.33 -48.61 19.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 102' ' ' GLU . 38.6 tt0 -45.43 -29.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -71.22 -56.74 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 mt -87.36 16.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.927 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -65.96 91.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.433 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 71.6 143.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.0 OUTLIER 171.25 166.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.234 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -130.43 132.17 45.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.63 166.49 16.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 3.2 m-20 -97.41 -54.34 3.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -1.194 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 113' ' ' ASP . 21.2 m -122.6 -18.05 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.814 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 112' ' ' VAL . 1.4 m-20 -46.4 -95.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.565 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -13.08 60.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.175 -0.953 . . . . 0.0 108.47 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -73.28 -5.0 36.65 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -85.31 -30.93 23.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.61 -16.62 61.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -21.94 63.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.36 -27.42 25.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.653 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -81.81 -27.84 33.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.673 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.612 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -76.2 -58.57 3.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -45.7 -25.05 0.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HD3' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -66.56 -50.36 63.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.831 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.56 71.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.441 HD12 ' HG3' ' A' ' 98' ' ' LYS . 37.6 mm -59.97 -14.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.861 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -69.5 -47.19 64.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.727 ' HG3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.91 -23.02 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 128' ' ' LEU . 3.2 tt -74.94 -13.54 60.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.73 -48.19 7.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.752 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.9 m -62.69 -38.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -64.57 -18.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.31 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 135' ' ' LYS . 0.1 OUTLIER -82.22 -18.49 42.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 1.1 pp -90.09 -24.83 21.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 131' ' ' ILE . 10.7 t -69.72 -5.57 25.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.516 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.533 ' HE2' ' CG ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -53.19 -20.97 4.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.533 ' CG ' ' HE2' ' A' ' 135' ' ' LYS . 14.8 mttt -113.85 -12.75 12.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.38 -58.0 2.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 ptp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.419 179.879 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.483 ' O ' ' HB ' ' A' ' 3' ' ' THR . 3.8 mtt 44.8 53.33 7.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.458 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 3' ' ' THR . 9.1 t 174.47 128.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 1.053 ' CE2' HG22 ' A' ' 34' ' ' ILE . 21.8 p90 -107.68 -161.57 0.79 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.1 t-80 -117.26 144.59 44.67 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 109.052 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.086 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -135.59 161.4 35.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.306 -1.496 . . . . 0.0 109.194 178.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.966 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -149.49 94.55 2.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.486 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.6 p -99.85 112.27 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.183 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.35 156.82 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 1.6 t -157.71 84.14 0.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . 57.56 21.79 7.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 1.3 pt-20 175.13 88.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -59.49 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.31 48.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.649 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 9.2 mtt -136.52 -52.47 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.427 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.636 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 33.9 t80 -166.53 129.25 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.494 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 79.4 p -161.6 94.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.422 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.22 -146.8 11.84 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.749 ' C ' HG12 ' A' ' 20' ' ' VAL . 11.4 mt -68.24 167.92 13.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -1.142 . . . . 0.0 109.257 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.086 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 177.9 155.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 108.794 -177.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 6.4 tt0 -151.06 -44.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.549 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -105.97 76.49 1.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 111.494 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.879 HG22 HG12 ' A' ' 52' ' ' ILE . 6.5 pt -102.97 147.81 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.518 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 37.4 tt0 -145.71 127.24 15.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.786 -1.196 . . . . 0.0 110.333 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.514 HG23 ' HA2' ' A' ' 33' ' ' GLY . 5.4 t -104.71 133.09 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.44 -0.787 . . . . 0.0 108.963 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -124.46 129.55 50.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.467 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.23 -128.36 1.29 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -108.39 -18.52 13.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -1.168 . . . . 0.0 109.566 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.34 149.14 27.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.75 -74.44 1.32 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER 60.87 -175.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -1.099 . . . . 0.0 109.908 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 31' ' ' GLU . 14.3 mt 61.11 138.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 109.749 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.518 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.89 -102.1 2.42 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.053 HG22 ' CE2' ' A' ' 4' ' ' TYR . 10.5 mm -154.24 141.7 12.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.315 -1.109 . . . . 0.0 109.154 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -124.69 177.7 1.72 Allowed Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -75.11 76.51 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.04 1.827 . . . . 0.0 110.425 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.37 41.04 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.469 ' CD2' ' CD1' ' A' ' 34' ' ' ILE . 70.2 t60 -99.49 144.81 28.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -1.136 . . . . 0.0 109.565 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.955 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -55.64 175.65 0.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.955 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.46 106.2 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.709 2.273 . . . . 0.0 110.443 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.482 ' H ' HG11 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -100.11 122.61 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD21 ' HG3' ' A' ' 70' ' ' GLU . 2.9 mt -136.21 71.65 1.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 p -137.69 -154.91 0.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.494 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.01 167.51 10.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.728 HD11 ' HB ' ' A' ' 78' ' ' VAL . 1.2 mt -103.57 -147.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.114 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -168.88 167.79 5.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.998 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.7 Cg_endo -78.88 122.42 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.745 2.297 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 176.85 -161.06 28.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.685 ' HE1' HG23 ' A' ' 130' ' ' VAL . 2.3 ppp? -107.87 176.08 5.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -1.081 . . . . 0.0 109.222 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -164.38 126.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.995 -1.066 . . . . 0.0 110.064 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -99.14 169.43 9.4 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.879 HG12 HG22 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -161.31 158.27 2.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.415 -1.428 . . . . 0.0 110.692 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.549 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 39.7 t -139.21 100.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -58.2 159.82 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 3' ' ' THR . 4.1 tm0? -42.08 -52.09 4.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 109.619 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -57.98 178.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.18 82.37 1.68 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.46 -167.59 2.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 9.2 pt-20 -166.68 141.27 4.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.25 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.589 ' H ' HG22 ' A' ' 52' ' ' ILE . 1.7 mm-40 -116.2 167.63 10.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.718 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.011 ' CD2' HG22 ' A' ' 130' ' ' VAL . 6.0 m-85 -129.24 119.15 23.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.049 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.675 HG22 ' H ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -126.79 179.93 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.132 -0.98 . . . . 0.0 109.871 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.775 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -173.79 142.62 0.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -147.12 178.92 8.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.746 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 14.0 p -104.99 -25.47 12.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.64 178.19 37.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.11 -133.5 3.72 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -144.4 130.43 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.24 . . . . 0.0 109.31 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.887 ' HA ' HG12 ' A' ' 78' ' ' VAL . 2.3 pp -109.13 125.91 52.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.786 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HG3' HD21 ' A' ' 42' ' ' LEU . 22.8 tt0 -125.17 129.14 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.065 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 ' HA ' ' A' ' 40' ' ' PRO . 7.1 p -99.24 155.46 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.832 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.509 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -138.21 170.83 9.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.432 -0.792 . . . . 0.0 109.442 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.47 71.76 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.659 2.239 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.19 -1.35 7.72 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.234 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 38.2 p-10 -172.88 175.26 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.933 -1.333 . . . . 0.0 109.865 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG13 ' HA ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -161.14 162.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 7' ' ' ASP . 29.4 m -158.54 149.36 20.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.418 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.887 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -135.86 157.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 112.88 16.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.711 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.61 159.18 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.93 -48.87 16.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.7 t -102.04 -178.56 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -170.13 85.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 84' ' ' ILE . 3.1 mp -104.09 67.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.21 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.578 ' HB3' ' HE2' ' A' ' 15' ' ' MET . 1.2 ptt180 -42.23 139.42 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.495 -0.753 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' C ' ' CG ' ' A' ' 87' ' ' GLN . . . -47.36 148.81 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.827 ' OE1' HG21 ' A' ' 134' ' ' THR . 0.0 OUTLIER 58.61 25.1 12.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -1.222 . . . . 0.0 109.043 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 87' ' ' GLN . 17.6 p-10 -41.04 -46.39 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -159.04 -61.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.874 . . . . 0.0 109.343 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.08 172.2 13.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.662 ' HA ' HD11 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -140.31 -87.27 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.359 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -19.29 56.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -77.17 -8.43 57.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.36 -8.32 51.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.959 . . . . 0.0 109.203 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.414 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.48 -23.37 58.86 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.377 -0.827 . . . . 0.0 109.527 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -85.37 5.41 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.626 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -90.1 -12.44 38.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -29.52 65.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.542 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -90.23 -32.66 16.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.39 -8.11 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.202 -0.937 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 97' ' ' ALA . . . -87.09 -30.67 20.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -0.989 . . . . 0.0 109.384 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.564 ' HA ' HD12 ' A' ' 105' ' ' ILE . 1.9 tt0 -69.56 -33.4 72.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.525 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.57 -35.29 73.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -75.27 -20.6 59.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 105' ' ' ILE . 32.3 mt -90.33 21.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 55.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -119.8 145.77 46.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.381 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.439 ' HA ' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p -128.95 138.29 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.686 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.6 -68.78 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.26 -100.14 0.14 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.607 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -72.14 156.76 38.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.457 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 111' ' ' ASP . 14.8 m 40.88 37.91 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.682 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 11.2 t70 -88.14 -96.3 0.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.192 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.37 -19.38 63.84 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.39 -41.79 84.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -90.12 -16.63 29.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.348 -0.845 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 105' ' ' ILE . . . -79.38 -32.14 43.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.4 t -55.71 -21.75 20.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 109.587 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.85 -29.28 18.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.28 -24.75 63.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.497 ' O ' HD13 ' A' ' 125' ' ' ILE . 8.8 tt -82.51 -50.92 8.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.54 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.44 1.73 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.829 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.09 -61.76 1.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -78.3 -20.48 51.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.3 mp -75.72 -12.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 109.163 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.775 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -68.67 -41.7 78.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -78.66 -7.62 57.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 5.8 tp -78.26 -26.76 47.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.468 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.512 ' O ' HD23 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -87.94 -25.25 23.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.752 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.011 HG22 ' CD2' ' A' ' 61' ' ' PHE . 2.3 p -80.53 -25.7 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.643 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.1 tt -90.58 -24.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.232 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 -44.94 46.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.095 -1.003 . . . . 0.0 110.198 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 129' ' ' ARG . 2.6 pp -68.56 -11.03 59.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 110.038 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.827 HG21 ' OE1' ' A' ' 87' ' ' GLN . 57.4 p -53.28 -41.88 66.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.569 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -41.76 64.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -94.57 40.66 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.379 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.12 6.75 36.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.847 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.542 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.292 0.568 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.7 mtp 53.71 58.34 5.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.324 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.553 HG21 ' CG ' ' A' ' 55' ' ' GLN . 70.9 p -132.39 161.7 32.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.905 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.746 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 4.0 p90 -163.61 -143.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.772 ' HA ' HG12 ' A' ' 20' ' ' VAL . 2.4 t-80 -139.69 149.45 43.69 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.072 HD23 HG21 ' A' ' 20' ' ' VAL . 1.6 pp -142.67 159.25 42.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.685 -1.259 . . . . 0.0 108.631 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 77' ' ' THR . 9.8 t0 -135.49 87.0 2.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.895 -1.128 . . . . 0.0 109.678 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' ' 16' ' ' PHE . 14.7 p -99.04 100.44 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.22 -0.925 . . . . 0.0 109.604 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 13' ' ' GLN . 55.2 t -108.95 149.03 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.865 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 2.4 p -162.58 144.9 10.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.74 -96.98 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.717 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.55 38.98 3.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.056 -1.028 . . . . 0.0 109.567 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.582 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.86 -153.71 0.34 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.251 -0.905 . . . . 0.0 109.457 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.422 ' O ' ' SD ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 70.46 61.5 0.21 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.519 -0.738 . . . . 0.0 109.491 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.641 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -143.72 -70.28 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.519 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.804 ' HB3' HG12 ' A' ' 8' ' ' VAL . 34.9 t80 -162.8 131.95 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -160.82 105.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.278 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 5' ' ' HIS . . . 146.67 -158.62 27.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.804 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -48.39 -179.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.068 -1.254 . . . . 0.0 109.474 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.072 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 170.37 115.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.549 -1.344 . . . . 0.0 109.74 179.32 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 1.5 tt0 -67.93 -44.7 76.27 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.5 mtpt -179.5 143.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.995 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.94 HG22 ' CG1' ' A' ' 52' ' ' ILE . 23.5 pt -105.34 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.501 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -178.92 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 109.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.24 127.61 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.992 . . . . 0.0 109.513 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -130.64 140.6 50.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.83 54.11 0.04 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.493 ' HB3' ' CB ' ' A' ' 46' ' ' LYS . 89.4 p -174.17 -159.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 109.438 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.29 48.18 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -167.11 -144.07 3.99 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.3 OUTLIER 166.98 74.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.792 HD13 ' OH ' ' A' ' 35' ' ' TYR . 12.6 mt -153.07 178.24 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.877 . . . . 0.0 109.67 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -128.68 -112.36 1.63 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.784 -2.127 . . . . 0.0 107.784 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.746 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 12.7 mm -154.1 138.25 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 109.124 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.792 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -138.28 176.9 2.37 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.6 Cg_endo -74.06 8.11 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.995 1.797 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.6 10.77 5.23 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' ALA . 40.1 t60 -54.33 123.75 13.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -1.215 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -49.17 178.56 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 34.9 Cg_endo -77.72 81.36 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.465 2.11 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -98.71 137.61 37.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.663 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.06 72.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.412 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 p -144.27 -146.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.51 169.92 8.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.454 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -130.49 173.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 109.251 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' CB ' ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -111.18 173.07 3.07 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.7 Cg_endo -78.31 -177.94 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.735 2.29 . . . . 0.0 110.474 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.38 -159.12 23.51 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.539 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 4.6 ppp? -113.28 172.78 6.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.255 -1.144 . . . . 0.0 109.126 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 62' ' ' ILE . 5.1 tt -146.75 146.81 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.052 -1.03 . . . . 0.0 110.922 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.46 160.28 23.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.94 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -153.71 158.98 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.458 -1.401 . . . . 0.0 110.926 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.77 102.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -52.09 141.33 18.64 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.122 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.574 ' OE1' ' CG ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -39.91 -59.1 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.574 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -122.36 31.58 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.739 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.35 -108.15 3.16 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -151.9 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -1.127 . . . . 0.0 109.139 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER 179.65 147.67 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.551 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.8 mt-10 -130.91 161.39 31.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.104 -0.998 . . . . 0.0 109.782 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -117.64 125.31 50.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.272 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 50' ' ' ILE . 5.2 mt -136.8 166.58 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.331 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.856 ' HE1' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.92 146.18 25.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.1 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -172.81 4.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.519 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' A' ' 82' ' ' THR . 62.8 m -115.65 14.38 16.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.83 151.45 25.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . -165.85 -106.64 0.19 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 9.1 mt -139.2 122.27 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 108.97 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.657 ' HB2' HD13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -106.58 133.48 51.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.782 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -133.5 143.64 48.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.019 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.671 ' HA ' HG12 ' A' ' 76' ' ' VAL . 14.7 p -109.94 139.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.917 -1.114 . . . . 0.0 109.494 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.579 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -127.87 176.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 108.862 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.0 Cg_endo -79.22 88.91 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.514 2.142 . . . . 0.0 111.103 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 101.07 -3.43 55.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.4 OUTLIER -164.37 155.3 15.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.242 . . . . 0.0 109.72 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.685 HG22 ' HA ' ' A' ' 6' ' ' LEU . 35.5 m -133.16 175.74 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 108.845 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 7' ' ' ASP . 17.6 m -156.63 104.58 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.282 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.5 m -114.47 115.8 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 108.963 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -100.21 173.2 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.132 -0.98 . . . . 0.0 110.034 -179.312 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -157.69 -157.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 0.0 109.182 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.22 -30.78 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.95 . . . . 0.0 109.805 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.432 ' HB ' ' OG ' ' A' ' 65' ' ' SER . 5.5 m -110.01 153.2 24.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.889 ' C ' HD12 ' A' ' 84' ' ' ILE . . . -152.64 119.75 5.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.793 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.889 HD12 ' C ' ' A' ' 83' ' ' ALA . 2.6 mp -139.07 95.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.29 -0.881 . . . . 0.0 108.907 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 84' ' ' ILE . 13.5 ttm180 -41.24 161.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.394 -0.816 . . . . 0.0 109.898 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -51.1 -26.32 12.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -151.7 93.41 1.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -1.153 . . . . 0.0 109.637 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -94.14 -57.88 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -83.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 109.475 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.13 165.97 17.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.43 -19.94 11.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.945 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 -25.59 32.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -65.51 -13.9 59.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.71 -32.0 16.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.379 -0.825 . . . . 0.0 109.29 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.488 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -56.01 -40.61 73.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.802 . . . . 0.0 109.681 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.91 -16.5 53.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.54 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 100' ' ' LYS . . . -64.37 -27.76 69.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.654 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -55.71 29.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.549 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -19.92 62.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.907 . . . . 0.0 109.554 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.95 -34.28 77.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.784 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -89.61 -20.81 23.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.401 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.02 -16.67 64.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -80.53 -30.37 37.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -32.36 32.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 118' ' ' SER . 25.6 mt -88.98 22.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 t -60.84 -24.94 66.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 m -140.02 167.08 22.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.215 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.08 134.1 3.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.618 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -156.14 179.47 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.89 -178.89 35.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.571 ' O ' HG22 ' A' ' 112' ' ' VAL . 12.4 m-20 -98.41 127.62 44.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.518 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.29 28.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 109.672 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 111' ' ' ASP . 15.5 t70 -84.88 -93.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.45 -13.6 60.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.1 62.73 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.468 ' HG3' ' HB ' ' A' ' 112' ' ' VAL . 3.8 mm-40 -74.81 -45.95 40.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.498 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.45 -23.3 65.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.496 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.543 ' HB2' ' CG2' ' A' ' 105' ' ' ILE . 8.6 p -70.6 -5.78 31.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.5 -12.23 52.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.41 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -73.71 -12.52 60.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -70.1 -60.79 2.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.69 -10.44 27.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.539 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -34.4 36.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.209 -0.932 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -82.4 -14.96 54.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 48.0 mm -73.04 -8.16 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -73.35 -35.23 65.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -0.907 . . . . 0.0 109.642 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 34.2 mt-30 -69.83 -23.26 63.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -69.47 -20.48 63.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.379 -0.825 . . . . 0.0 109.809 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -85.02 -40.63 16.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.566 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . 20.8 m -68.01 -16.95 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.669 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 127' ' ' GLN . 4.9 pt -90.97 -31.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.484 ' HG2' HG13 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -80.05 -30.87 39.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.743 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.5 mp -79.81 -40.22 29.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.758 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 130' ' ' VAL . 17.9 p -63.16 -34.16 77.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.68 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -74.18 -15.98 61.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.542 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.04 29.6 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.668 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.41 -78.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.935 . . . . 0.0 109.53 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.0 mtm -146.22 109.33 4.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.648 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -104.86 -148.15 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.652 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 1.23 ' CG ' HG22 ' A' ' 20' ' ' VAL 0.253 0.7 OUTLIER -142.25 -169.71 3.01 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 124.107 1.908 . . . . 0.0 115.576 -175.438 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 7.3 t-80 -170.8 95.98 0.21 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 102.319 -3.215 . . . . 0.0 102.319 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.89 HD23 HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.52 147.83 22.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.522 -1.361 . . . . 0.0 108.638 -176.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -155.76 69.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.847 -1.158 . . . . 0.0 110.015 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 64' ' ' LEU . 1.7 p -102.74 112.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 108.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 3.9 m -103.97 144.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.802 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.843 ' OG ' ' HB2' ' A' ' 83' ' ' ALA . 55.9 m -107.35 53.11 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 109.265 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 72.03 77.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.361 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.38 31.6 12.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.462 ' CB ' ' HB2' ' A' ' 10' ' ' SER . 1.9 tp60 -114.79 -28.18 7.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 46.07 88.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.647 ' HE1' ' O ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -85.82 -84.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 109.537 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.725 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 1.1 t80 -101.05 112.09 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 94.6 p -128.72 85.84 2.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.131 -0.981 . . . . 0.0 109.658 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 168.33 148.15 5.62 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.597 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -35.63 161.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.886 0.851 . . . . 0.0 111.656 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.23 HG22 ' CG ' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -158.51 -160.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 O-C-N 121.684 -0.635 . . . . 0.0 109.988 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.833 ' N ' HG23 ' A' ' 20' ' ' VAL . 2.3 tt0 -160.33 -32.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.734 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.6 mmmt -141.21 85.2 1.96 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.782 -1.199 . . . . 0.0 110.309 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.87 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.57 142.68 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.324 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -127.41 143.91 51.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.762 -1.211 . . . . 0.0 110.309 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -133.44 116.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.176 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -122.69 125.35 45.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.07 -40.27 0.18 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 159.87 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -1.192 . . . . 0.0 109.646 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -48.09 -43.03 30.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.55 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.44 -51.53 47.17 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.84 20.37 11.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -1.191 . . . . 0.0 109.414 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 153.93 40.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.716 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.39 171.03 23.85 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.949 HG22 ' OH ' ' A' ' 4' ' ' TYR . 16.6 mm -101.82 112.39 34.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.858 -1.378 . . . . 0.0 109.136 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -122.92 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 33.5 Cg_endo -76.89 5.56 4.83 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.551 1.501 . . . . 0.0 110.44 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.84 17.84 2.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.452 ' CG ' HD13 ' A' ' 34' ' ' ILE . 16.7 t60 -44.81 146.53 0.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -1.092 . . . . 0.0 109.541 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.0 10.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.669 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.563 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.4 Cg_endo -77.55 77.58 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.637 2.225 . . . . 0.0 110.222 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 41' ' ' LEU . 1.6 mm? -98.42 159.03 15.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.718 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.43 32.04 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.417 ' O ' HG13 ' A' ' 68' ' ' ILE . 44.1 p -114.96 -144.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.389 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.79 164.91 11.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.015 . . . . 0.0 109.155 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.895 ' CD1' HD13 ' A' ' 69' ' ' LEU . 5.4 mt -128.99 149.88 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.99 . . . . 0.0 109.554 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' HD2' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -70.24 167.86 22.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -78.99 136.58 13.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.744 2.296 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.62 -161.96 26.43 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.626 ' C ' HG22 ' A' ' 50' ' ' ILE . 8.3 ptm -117.4 -164.23 0.98 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -1.133 . . . . 0.0 109.192 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.918 HD12 ' HB ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -174.68 147.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.085 . . . . 0.0 109.982 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -129.17 126.37 39.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.654 HG23 ' CA ' ' A' ' 23' ' ' ILE . 30.6 mt -123.53 166.36 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.874 -1.141 . . . . 0.0 111.037 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.54 ' N ' HG22 ' A' ' 52' ' ' ILE . 34.2 t -132.23 119.26 39.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -71.05 129.49 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.653 . . . . 0.0 109.315 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 11.5 tt0 52.68 -90.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 54' ' ' LYS . 3.3 t-160 -171.1 60.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.77 -68.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -76.5 179.73 5.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -1.101 . . . . 0.0 109.399 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -156.5 153.68 29.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.844 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 156.44 36.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.251 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.029 ' CD2' HG22 ' A' ' 130' ' ' VAL . 4.4 m-85 -119.24 124.97 48.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.544 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.918 ' HB ' HD12 ' A' ' 50' ' ' ILE . 5.3 mm -128.71 178.29 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.307 -0.871 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' H ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -173.24 125.98 0.43 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -113.36 -177.61 3.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.514 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 1.2 t -149.56 18.19 0.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.932 . . . . 0.0 109.384 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.13 156.72 6.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.14 -169.67 25.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -115.94 118.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -1.123 . . . . 0.0 109.369 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.895 HD13 ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -101.91 153.12 20.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.208 -0.933 . . . . 0.0 109.922 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 41.6 tt0 -152.15 134.46 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG23 HG22 ' A' ' 76' ' ' VAL . 12.6 p -99.92 139.77 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.006 -1.059 . . . . 0.0 110.248 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.59 174.53 3.28 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.4 Cg_endo -78.62 103.4 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.32 2.014 . . . . 0.0 110.821 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 75.42 45.64 17.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 2.2 t30 159.91 115.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.468 -1.019 . . . . 0.0 109.177 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.663 HG22 HG23 ' A' ' 71' ' ' VAL . 23.5 t -102.2 146.53 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 108.875 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 7' ' ' ASP . 22.2 m -147.59 136.68 22.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.802 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.776 HG13 HG23 ' A' ' 8' ' ' VAL . 1.4 p -150.4 142.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 108.991 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 4.6 mp -105.21 159.26 16.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -163.73 -174.36 3.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.333 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.68 -39.03 3.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 1.8 m -99.46 149.18 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.254 -0.904 . . . . 0.0 109.196 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.843 ' HB2' ' OG ' ' A' ' 10' ' ' SER . . . -159.81 141.83 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.647 ' O ' ' HE1' ' A' ' 15' ' ' MET . 46.8 mt -132.67 126.14 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.328 -0.858 . . . . 0.0 108.793 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 86' ' ' GLY . 3.0 tpt180 -92.37 91.98 7.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.034 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 39.06 -102.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HG2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -94.26 81.81 4.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -1.161 . . . . 0.0 109.593 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.65 -53.33 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.098 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 2.8 mp -92.11 31.92 1.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.066 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 131' ' ' ILE . 18.2 m-20 62.21 -179.55 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.372 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.443 ' HG2' HD11 ' A' ' 131' ' ' ILE . 1.6 mt-10 -108.63 -36.59 6.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.0 -12.75 57.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 48.1 ttp180 -82.28 -26.77 32.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.44 -13.53 40.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 108.9 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.487 ' HA ' HD11 ' A' ' 128' ' ' LEU . 3.4 mtt -70.34 -20.79 62.96 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -68.8 -18.98 64.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.53 -54.97 3.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.094 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HG2' ' CG1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.2 -39.47 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.104 -179.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -36.04 82.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 110.005 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -4.57 58.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 109.876 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -90.29 -20.97 22.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.714 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 5.6 tp10 -73.68 -36.8 65.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.34 -22.96 64.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -51.72 26.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 105' ' ' ILE . 91.1 mt -89.14 22.84 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.98 -54.74 7.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -98.77 132.95 43.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -162.75 138.87 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.65 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -168.33 169.08 10.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.63 -173.53 28.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 112' ' ' VAL . 5.0 t0 -101.17 135.26 42.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.272 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.59 28.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 6.9 t70 -79.24 -95.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.418 -0.801 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -69.76 -21.72 63.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.169 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.29 73.55 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -46.39 85.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.85 -11.22 58.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.9 t -82.77 6.03 19.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.907 . . . . 0.0 109.592 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.21 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 109.558 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -77.03 -18.51 58.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.44 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.647 HD11 ' HB1' ' A' ' 101' ' ' ALA . 9.0 tt -71.77 -63.32 1.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.05 -18.94 4.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.702 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -45.27 -38.32 5.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.79 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -90.55 -23.71 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 0.0 110.127 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 125' ' ' ILE . 2.2 mp -77.08 -1.06 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.83 -24.15 60.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.01 -1.056 . . . . 0.0 109.166 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.776 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.8 pt20 -90.06 -32.13 16.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -63.32 -20.84 65.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.678 -179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.467 ' O ' HD23 ' A' ' 133' ' ' LEU . 2.0 mtt180 -90.15 -48.09 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 1.029 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -62.27 -28.97 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 127' ' ' GLN . 4.8 tt -90.74 -29.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.249 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 17.0 mm-40 -72.86 -34.01 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.389 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 133' ' ' LEU . 2.9 pp -83.62 10.92 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.992 . . . . 0.0 109.727 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 130' ' ' VAL . 76.3 p -83.05 -9.68 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -84.76 -47.94 9.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.752 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.491 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.5 OUTLIER -80.18 -2.81 46.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.705 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.57 -22.4 54.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.11 -0.994 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.437 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.47 ' O ' ' HB ' ' A' ' 3' ' ' THR . 4.5 mtm -96.16 98.04 10.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.623 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 3' ' ' THR . 12.2 t 178.05 124.88 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.62 ' OH ' HG22 ' A' ' 34' ' ' ILE . 30.0 p90 -100.74 -159.41 0.73 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -122.77 144.02 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 108.823 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.062 HD12 ' N ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -135.21 167.67 20.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.532 178.618 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 1.062 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.49 97.75 2.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.907 HG12 ' CG1' ' A' ' 78' ' ' VAL . 19.3 m -99.49 148.54 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 108.695 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 8' ' ' VAL . 1.9 t -155.88 126.59 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.477 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.77 104.53 13.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.842 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.22 -95.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.716 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -139.26 56.91 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.607 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 169.99 13.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 111.52 22.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.566 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 4.6 mtt -116.76 -80.87 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.958 . . . . 0.0 109.842 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.5 t80 -130.16 147.08 51.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.744 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 p -175.07 92.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.79 -147.38 14.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.77 ' C ' HG12 ' A' ' 20' ' ' VAL . 8.9 mt -64.17 172.61 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -1.194 . . . . 0.0 108.982 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.051 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 173.47 149.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.816 -1.177 . . . . 0.0 109.438 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -142.75 -47.12 0.32 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.645 ' C ' HD13 ' A' ' 23' ' ' ILE . 4.6 tttp -93.94 126.37 39.11 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.207 -0.933 . . . . 0.0 109.088 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.913 HG22 ' CG1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -154.97 66.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.607 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 18.6 tt0 -98.51 132.29 44.06 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.819 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 49' ' ' MET . 2.7 p -119.94 140.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.4 m -114.57 132.23 56.41 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 109.591 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.2 -107.94 0.63 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -150.8 159.51 44.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.463 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 51.01 42.83 28.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 148.32 -172.58 28.54 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 1.1 pt-20 179.61 -155.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.415 -1.05 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 35' ' ' TYR . 15.4 mt 60.34 130.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.347 -0.846 . . . . 0.0 109.633 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.85 -84.03 1.77 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.62 HG22 ' OH ' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -162.97 161.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.376 -1.073 . . . . 0.0 109.535 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -154.14 173.43 4.73 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -178.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.525 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 33.9 Cg_endo -75.88 94.56 1.01 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.309 2.006 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.12 -12.78 2.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.488 ' ND1' HD11 ' A' ' 34' ' ' ILE . 3.9 t-80 -60.71 -178.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -104.73 167.73 9.48 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.682 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.6 Cg_endo -78.89 77.84 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.746 2.298 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HE1' ' A' ' 38' ' ' HIS . 21.4 mt -99.68 155.31 17.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.398 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.412 HD12 ' CD ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -126.69 99.7 5.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.529 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -135.71 -168.73 2.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.647 ' C ' HD12 ' A' ' 45' ' ' ILE . . . -101.91 -172.02 2.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.995 HD11 ' CB ' ' A' ' 69' ' ' LEU . 2.0 mp -110.8 116.88 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.648 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.51 166.1 9.99 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.201 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.38 120.41 4.86 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.622 2.215 . . . . 0.0 110.536 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.5 -155.94 27.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.878 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.7 ppp? -119.11 174.86 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -1.12 . . . . 0.0 109.267 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 50' ' ' ILE . 1.5 tt -153.45 131.55 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.095 -1.003 . . . . 0.0 110.344 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.27 21.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.913 ' CG1' HG22 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -142.48 143.51 25.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.758 -1.214 . . . . 0.0 110.618 -178.277 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 37.2 t -127.53 104.07 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.71 136.37 57.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.16 -99.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.32 21.49 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -137.4 -65.26 0.05 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -69.87 142.1 53.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.45 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.3 131.63 25.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.862 . . . . 0.0 109.361 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 52' ' ' ILE . 1.2 tt0 -121.01 153.81 36.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.763 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 14.3 m-85 -100.45 155.55 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 16' ' ' PHE . 50.5 mt -154.8 160.7 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.568 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -163.63 152.95 14.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.91 . . . . 0.0 108.927 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 64' ' ' LEU . 2.5 pt? -179.88 162.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.495 ' CB ' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -143.39 36.11 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.4 114.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.11 -177.54 35.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.2 mp -129.61 135.36 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -1.153 . . . . 0.0 109.28 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.995 ' CB ' HD11 ' A' ' 45' ' ' ILE . 1.2 tt -121.5 145.13 48.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' CD ' HD12 ' A' ' 42' ' ' LEU . 47.5 tt0 -135.87 129.66 32.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 40' ' ' PRO . 4.3 p -100.08 123.72 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.498 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -101.75 174.11 3.12 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.2 Cg_endo -78.24 72.45 6.25 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.631 2.221 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.51 -14.33 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.189 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' VAL . 78.7 m-20 -145.53 -176.16 5.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.305 . . . . 0.0 109.893 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 75' ' ' ASN . 12.1 t -158.66 165.82 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.542 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -169.63 140.06 2.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.975 . . . . 0.0 109.604 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.907 ' CG1' HG12 ' A' ' 8' ' ' VAL . 1.7 p -153.31 140.42 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.39 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mt -116.41 150.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.45 13.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 -39.47 4.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 m -108.9 136.72 47.97 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 0.0 109.197 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.566 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -158.4 163.33 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.088 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 43.7 mt -142.92 116.87 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.54 109.62 21.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.594 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.64 -146.38 31.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.492 ' OE1' HG12 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -107.97 34.43 3.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -1.098 . . . . 0.0 108.798 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 87' ' ' GLN . 4.5 t0 -44.71 -29.67 0.81 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.407 -0.808 . . . . 0.0 109.68 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -120.7 111.35 17.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.617 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 21.2 m-20 60.24 157.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 -83.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -16.95 60.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.497 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.91 0.1 32.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.41 -5.75 55.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.427 ' HG3' HD11 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -81.21 -22.64 38.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.79 -28.6 19.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.624 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.46 -20.02 62.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.674 ' HG3' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -84.74 -26.16 27.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.36 11.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -62.11 -26.94 68.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.17 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.74 -44.62 20.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.323 -0.861 . . . . 0.0 109.106 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -54.03 -38.16 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.288 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.412 ' OE1' ' CA ' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -46.54 -42.32 15.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -72.46 -38.12 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.4 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 121' ' ' LEU . 11.6 mt -87.94 22.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -55.91 27.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.86 136.8 54.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 59.7 p -131.23 -179.41 5.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -178.63 -171.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.89 176.46 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 25.5 t0 -83.74 -73.94 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -103.61 13.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.02 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 16.1 t80 -71.29 -16.92 62.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.165 -0.959 . . . . 0.0 108.601 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.0 66.77 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -47.97 75.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.37 -6.08 37.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.71 -11.06 54.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.562 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 123' ' ' LYS . . . -85.03 -29.28 25.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.615 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -28.43 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.619 HD13 HD11 ' A' ' 105' ' ' ILE . 0.9 OUTLIER -81.32 -61.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.65 -38.63 2.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 109.743 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HD3' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -45.75 -59.35 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.46 -21.64 63.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.752 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.674 HG23 ' HG3' ' A' ' 98' ' ' LYS . 20.3 mm -71.42 -4.2 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 49' ' ' MET . . . -84.42 -9.91 57.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.653 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.562 ' CD ' HD13 ' A' ' 84' ' ' ILE . 4.2 tt0 -82.65 -26.4 32.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.936 . . . . 0.0 109.651 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 61.8 tp -75.52 -8.98 58.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -43.93 10.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.933 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 134' ' ' THR . 33.9 m -69.74 -24.72 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.928 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.67 HD13 ' C ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -89.52 -48.13 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.87 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 131' ' ' ILE . 13.0 pt-20 -54.66 -24.32 21.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.322 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -80.66 -43.06 21.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 0.0 109.78 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 130' ' ' VAL . 41.7 p -43.11 -34.85 1.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.645 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -67.78 -49.67 61.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -96.51 45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.11 -36.23 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.606 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.585 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.362 0.601 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.2 ptt? -175.17 -171.11 0.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.852 HG23 ' HG2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 54.2 103.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.921 ' CE2' HG22 ' A' ' 34' ' ' ILE . 27.3 p90 -99.24 -152.08 0.4 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.763 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -129.68 146.63 51.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.087 HD23 HG21 ' A' ' 20' ' ' VAL . 2.5 pp -133.31 169.67 16.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.312 -1.493 . . . . 0.0 109.252 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.842 ' N ' HD12 ' A' ' 6' ' ' LEU . 21.6 t70 -146.0 100.53 3.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.1 p -105.57 105.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.083 -1.011 . . . . 0.0 109.745 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.361 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.746 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -166.95 73.11 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.746 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 72.32 5.38 5.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 39.6 mt-10 -156.58 76.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 12' ' ' GLU . 3.3 pt20 -56.01 -164.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.723 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER 72.11 32.04 1.84 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.534 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.807 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 16.0 mtt -106.18 -79.96 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 109.249 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.675 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 37.5 t80 -146.25 117.78 8.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -145.05 108.65 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.115 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 143.5 -163.32 27.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.815 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -43.93 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.695 -0.885 . . . . 0.0 110.879 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.087 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 167.05 150.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.852 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -147.78 -39.18 0.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.8 -1.187 . . . . 0.0 110.471 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 1.8 mptt -116.95 78.57 1.22 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.937 -1.102 . . . . 0.0 111.324 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.897 HG22 HG12 ' A' ' 52' ' ' ILE . 7.8 pt -101.14 160.93 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 4.2 tt0 -162.78 116.28 1.67 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.706 -1.246 . . . . 0.0 110.184 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -99.93 111.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 108.988 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.444 HG23 ' CD ' ' A' ' 31' ' ' GLU . 97.7 m -100.15 110.84 23.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.438 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -136.19 -116.53 1.57 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -118.24 124.03 46.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -1.139 . . . . 0.0 109.57 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.0 tt0 76.44 111.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.35 164.76 39.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 1.2 tt0 -163.54 64.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.145 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 23.4 mt -149.58 140.8 23.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.091 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.91 -105.06 2.65 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.806 -2.117 . . . . 0.0 107.806 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.921 HG22 ' CE2' ' A' ' 4' ' ' TYR . 7.6 mm -153.85 143.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.289 -1.124 . . . . 0.0 109.278 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -142.18 173.63 4.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.317 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -72.63 94.45 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.954 1.769 . . . . 0.0 109.752 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.15 4.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.519 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.0 t-80 -71.75 166.06 22.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.996 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -89.67 176.23 3.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.253 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 1.008 ' HA ' HG11 ' A' ' 71' ' ' VAL . 34.9 Cg_endo -76.82 100.7 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.516 2.144 . . . . 0.0 110.374 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 140.29 29.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.592 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.76 48.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 p -118.71 -146.61 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.385 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.581 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -100.34 176.3 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.644 HD11 HG21 ' A' ' 25' ' ' VAL . 1.6 tp -102.29 151.23 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 141.52 47.44 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.958 . . . . 0.0 109.607 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.3 Cg_endo -79.38 -179.8 5.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.554 2.169 . . . . 0.0 110.321 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 101.58 -129.0 9.75 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.441 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.9 ptm -119.42 177.79 4.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.155 . . . . 0.0 109.236 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.2 tt -152.84 130.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.075 -1.016 . . . . 0.0 110.003 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.08 HD11 HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -148.59 158.8 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.65 -1.281 . . . . 0.0 111.076 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 59' ' ' GLU . 25.0 t -139.35 99.72 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HD3' ' CB ' ' A' ' 58' ' ' HIS . 6.0 ptmt -65.91 153.35 42.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.639 ' CB ' HG21 ' A' ' 3' ' ' THR . 0.6 OUTLIER -41.62 -52.88 3.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.488 -0.758 . . . . 0.0 110.137 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -43.67 -51.04 7.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.868 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.21 -38.71 1.44 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.461 ' CB ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -48.65 129.1 16.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -1.235 . . . . 0.0 109.313 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.59 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -105.45 123.59 48.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.329 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 52' ' ' ILE . 1.3 tm-20 -122.95 144.83 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 1.6 p90 -114.62 135.85 53.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.701 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.7 mm -108.43 -155.87 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.83 . . . . 0.0 109.07 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' H ' HG22 ' A' ' 62' ' ' ILE . 5.3 t80 -168.0 125.18 1.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.66 178.04 6.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 0.0 109.021 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 9.04 4.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.745 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.25 144.73 4.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.48 -155.47 23.35 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 28.7 mt -133.8 133.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -1.181 . . . . 0.0 109.42 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 70' ' ' GLU . 1.1 pp -114.05 -169.71 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.719 ' N ' HD12 ' A' ' 69' ' ' LEU . 3.4 pt-20 -179.91 149.08 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.262 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.008 HG11 ' HA ' ' A' ' 40' ' ' PRO . 11.0 p -100.34 141.15 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.517 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 24.8 mt-30 -126.91 160.55 58.58 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.2 Cg_endo -75.32 90.76 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.355 2.036 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.31 6.92 41.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.482 ' C ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -175.18 -176.87 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -1.177 . . . . 0.0 109.816 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 6' ' ' LEU . 28.6 m -157.96 150.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.595 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -135.32 167.97 20.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.909 -1.119 . . . . 0.0 109.834 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 8' ' ' VAL . 1.7 p -175.15 120.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.068 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.34 141.4 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.749 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.746 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -127.39 -179.9 5.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.203 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -98.51 -2.05 39.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.566 HG23 ' CD1' ' A' ' 84' ' ' ILE . 1.9 m -155.2 143.67 20.41 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.175 -0.953 . . . . 0.0 109.136 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.807 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -146.29 98.61 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.603 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 84' ' ' ILE . 2.1 mp -115.3 84.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.324 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 84' ' ' ILE . 6.5 ttm180 -44.1 164.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -49.64 -64.8 3.19 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB3' HG21 ' A' ' 134' ' ' THR . 1.3 pt20 -93.45 37.81 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.188 . . . . 0.0 109.628 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -48.46 -48.93 37.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.23 -58.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 0.0 109.172 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.45 107.68 12.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.398 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HB3' HD11 ' A' ' 131' ' ' ILE . 47.8 mt-10 -101.72 -70.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.644 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.46 -17.6 36.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.616 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -81.6 -1.02 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.27 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.17 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.64 ' HG2' HD21 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -69.39 -37.79 77.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -34.81 11.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.52 -54.46 35.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.352 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -22.8 15.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -75.13 -60.93 2.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -64.17 -12.38 39.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.717 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -87.66 -36.42 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -57.55 -16.83 11.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -57.68 6.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.604 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -11.51 60.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.645 HD11 ' CG ' ' A' ' 121' ' ' LEU . 14.1 mm -76.09 -8.44 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.528 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -46.14 -65.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 0.0 109.331 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 165.85 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -151.39 -50.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 179.94 -72.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.18 -155.23 26.5 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 1.6 m-20 56.99 -101.5 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -1.086 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 116' ' ' GLN . 3.4 m -119.69 -15.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.871 -1.143 . . . . 0.0 109.285 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.8 OUTLIER -47.6 -95.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 118' ' ' SER . 19.3 t80 -74.26 -22.15 59.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -62.52 -20.76 64.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.517 ' CG ' ' O ' ' A' ' 112' ' ' VAL . 33.7 mm-40 -85.71 -52.99 5.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.872 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . . . -74.53 -1.41 21.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 36.4 t -90.19 -35.65 15.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.769 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.61 -28.57 18.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.868 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' CG ' ' HA ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -82.09 -8.55 59.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.802 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.717 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -86.06 -48.47 8.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.54 -17.12 18.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -64.96 -37.66 88.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.465 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.84 -12.37 59.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -83.36 -8.04 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.541 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -68.29 -46.39 70.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 109.305 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.4 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.1 tm0? -67.31 -23.53 65.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.64 HD21 ' HG2' ' A' ' 95' ' ' MET . 5.6 mp -74.5 -16.8 60.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.46 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 4.1 mtp85 -89.82 -50.69 5.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.78 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 27.4 m -60.54 -34.93 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.558 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.442 HD11 ' HB3' ' A' ' 91' ' ' GLU . 3.4 tt -61.44 -36.09 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.337 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 129' ' ' ARG . 2.8 mt-10 -49.89 -27.46 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.218 -0.927 . . . . 0.0 109.363 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mp -75.16 -61.55 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 87' ' ' GLN . 4.9 p -45.56 -31.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -58.53 -66.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.69 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -15.3 56.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.844 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.8 68.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -85.83 -175.75 5.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.582 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 57.11 159.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.713 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.4 p90 -158.11 -144.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.683 ' O ' HG22 ' A' ' 76' ' ' VAL . 24.1 t-80 -131.51 134.84 46.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.734 -1.229 . . . . 0.0 111.013 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -106.14 124.28 49.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -136.88 71.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.735 -1.228 . . . . 0.0 109.974 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.729 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.1 p -102.46 124.91 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.38 -172.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.2 p -166.54 107.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 60.08 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 64.34 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -150.2 104.01 3.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.69 105.04 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.7 mmt -87.32 -89.1 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.888 . . . . 0.0 109.479 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.654 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -110.14 111.79 23.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 85.7 p -136.13 78.83 1.74 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' N ' ' CE1' ' A' ' 5' ' ' HIS . . . -177.47 174.16 46.73 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 30.9 mt -50.22 163.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.879 ' O ' HG22 ' A' ' 3' ' ' THR . 0.2 OUTLIER -162.27 163.76 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.335 -0.853 . . . . 0.0 108.967 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.758 ' CG ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -125.29 -39.18 2.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 2.1 ttmt -156.15 109.07 2.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.031 -1.043 . . . . 0.0 110.369 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.85 HG21 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -101.28 146.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.939 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -120.73 141.58 50.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.0 109.988 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 50' ' ' ILE . 13.4 t -136.77 133.49 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 84.8 m -140.94 111.49 6.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 109.842 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 46' ' ' LYS . . . -120.73 -104.91 1.99 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.53 -67.05 1.02 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -117.99 139.15 51.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.097 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.43 69.33 1.41 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.49 77.07 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -1.066 . . . . 0.0 109.596 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mt -113.83 153.43 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 23' ' ' ILE . . . -99.81 172.0 24.34 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.713 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 12.9 mm -98.09 134.52 36.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.911 -1.346 . . . . 0.0 108.822 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.579 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -132.3 169.86 12.82 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.0 Cg_endo -72.7 87.6 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.018 1.812 . . . . 0.0 109.923 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 38' ' ' HIS . . . 138.42 -4.4 3.09 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' ALA . 70.3 t60 -42.84 132.72 3.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 0.0 109.501 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.994 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -48.73 176.4 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.994 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.1 Cg_endo -77.66 81.31 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.519 2.146 . . . . 0.0 110.291 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -96.75 155.95 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.722 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.84 34.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.403 -0.811 . . . . 0.0 108.907 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 22.4 p -99.56 -147.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 109.486 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -100.54 164.15 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 46' ' ' LYS . 48.0 mt -105.98 163.04 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 109.273 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.544 ' N ' HG22 ' A' ' 45' ' ' ILE . 8.4 mptt -96.06 151.88 38.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 0.0 109.826 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.56 127.71 7.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.82 2.347 . . . . 0.0 110.444 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 174.28 -149.92 11.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.499 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.9 ptm -109.54 -177.04 3.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -1.162 . . . . 0.0 109.405 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.939 HG23 ' O ' ' A' ' 24' ' ' GLN . 47.7 mt -155.08 140.04 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.442 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 115.38 17.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.737 HG23 ' CA ' ' A' ' 23' ' ' ILE . 14.1 mt -117.79 169.75 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 111.176 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' N ' HG22 ' A' ' 52' ' ' ILE . 53.2 t -137.8 100.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -60.5 126.03 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -0.91 . . . . 0.0 110.154 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 23.1 mt-30 45.82 -92.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -164.12 49.87 0.13 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.84 -99.87 0.31 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -74.75 172.08 12.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -1.169 . . . . 0.0 109.874 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -127.34 167.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.046 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -133.04 144.86 50.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.983 ' C ' HD12 ' A' ' 62' ' ' ILE . 7.3 m-85 -111.21 134.68 52.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.141 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.983 HD12 ' C ' ' A' ' 61' ' ' PHE . 2.8 mp -140.78 147.48 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 109.677 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -144.89 151.48 38.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.395 -0.815 . . . . 0.0 109.006 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.94 -173.87 2.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.5 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 70.6 m -112.18 -81.72 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.49 168.09 24.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.35 -176.95 42.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 69' ' ' LEU . 4.7 mp -99.98 156.58 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.184 -1.186 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -131.68 169.75 15.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.0 125.93 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 108.848 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 76' ' ' VAL . 11.6 p -99.85 146.77 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.526 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 26.4 mt-30 -131.42 163.78 47.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.036 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.8 Cg_endo -77.4 106.29 2.19 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.43 2.087 . . . . 0.0 110.599 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.55 58.32 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.509 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 -179.73 166.35 1.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -1.199 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 5' ' ' HIS . 10.2 m -139.02 167.93 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.829 . . . . 0.0 109.262 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 7' ' ' ASP . 46.1 m -165.77 134.8 3.24 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.869 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.729 ' CG2' HG23 ' A' ' 8' ' ' VAL . 4.3 m -137.25 138.11 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 143.41 30.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.66 -179.17 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.4 -39.52 2.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.247 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.48 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 32.6 m -104.31 120.7 41.76 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.185 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.9 87.33 2.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 109.771 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 88' ' ' ASP . 3.1 mp -100.01 92.2 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 108.919 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' GLY . 1.2 ttt180 -41.95 153.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.786 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.609 ' HA2' HG21 ' A' ' 130' ' ' VAL . . . -43.26 -35.57 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 15.6 mt-30 -78.95 -69.92 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.0 109.382 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.758 ' HB2' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER 84.53 -44.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 164.57 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.111 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 22.8 m-20 -119.05 -172.69 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -123.58 -70.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 -11.04 60.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -83.55 4.33 28.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.709 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.78 -21.2 23.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 108.996 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.597 ' CG ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -73.63 -25.14 60.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.484 -0.76 . . . . 0.0 109.406 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -17.17 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.68 -44.03 35.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.714 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HG3' HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.01 -19.38 43.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 109.508 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.447 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -77.99 -37.03 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 2.8 pttm -79.65 -18.73 50.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 109.496 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 105' ' ' ILE . . . -89.18 -34.44 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.99 -31.02 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.468 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.24 -54.7 40.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.83 -16.24 60.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 105' ' ' ILE . 21.8 mm -87.25 16.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 109.524 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 107' ' ' SER . 15.0 m -91.93 -147.76 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 106' ' ' SER . 2.8 m 56.31 108.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.586 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.51 108.36 10.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 173.27 56.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.2 163.21 33.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -1.217 . . . . 0.0 109.607 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.497 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 13.2 m -96.17 17.18 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.437 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 39.5 t0 -63.27 -100.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 109.027 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 75.0 t80 -64.06 -20.47 65.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.998 -1.064 . . . . 0.0 108.252 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -64.3 -39.36 93.76 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 1.2 tp-100 -86.5 -7.27 58.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 105' ' ' ILE . . . -80.44 -36.95 32.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.9 m -52.54 -37.24 57.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -52.92 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.36 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -67.69 -8.66 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.687 ' O ' HD13 ' A' ' 125' ' ' ILE . 15.7 tp -83.95 -50.34 8.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.91 8.52 10.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.876 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -72.87 -37.86 67.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.612 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.92 28.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -70.49 -5.9 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' MET . . . -73.66 -23.98 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 0.0 109.286 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -82.73 -4.99 58.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.597 HD11 ' CG ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -84.02 -34.0 24.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -43.62 55.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 109.644 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.609 HG21 ' HA2' ' A' ' 86' ' ' GLY . 18.6 m -54.66 -17.85 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.931 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' ' C ' ' A' ' 132' ' ' GLU . 38.5 mt -88.84 -66.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 131' ' ' ILE . 57.5 mm-40 -43.66 -34.84 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.119 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -73.73 -54.6 7.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.861 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.582 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 7.9 p -44.02 -30.23 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -57.44 -53.74 54.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 3.49 48.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.544 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -104.17 44.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 0.0 109.37 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.479 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.482 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.2 ttm -100.89 121.5 41.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 109.39 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.92 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.74 -152.78 0.11 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.114 -0.991 . . . . 0.0 109.515 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 1.142 ' CG ' HG22 ' A' ' 20' ' ' VAL 0.277 1.1 m-85 -137.7 -178.23 5.15 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 124.451 2.072 . . . . 0.0 115.914 -175.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.587 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 7.1 t-80 -151.45 88.1 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.769 -3.378 . . . . 0.0 102.98 173.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -93.33 133.64 36.37 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.629 -1.294 . . . . 0.0 108.22 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 77' ' ' THR . 0.3 OUTLIER -146.13 82.53 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.625 -1.297 . . . . 0.0 109.95 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.73 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.4 p -110.6 102.63 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.85 155.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.953 . . . . 0.0 109.441 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.966 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 89.2 p -105.26 -156.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.82 -47.32 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -160.21 60.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.414 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.52 118.95 1.4 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -77.95 117.14 19.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.532 ' HE1' HG22 ' A' ' 62' ' ' ILE . 5.9 mtt -86.82 -73.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.2 t80 -116.17 113.44 23.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 110.321 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 89.2 p -138.6 91.04 2.5 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.05 -172.81 45.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 55' ' ' GLN . 20.8 mt -72.02 154.59 41.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -1.229 . . . . 0.0 109.321 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.142 HG22 ' CG ' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -153.81 -175.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.097 -1.002 . . . . 0.0 109.165 -178.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.666 ' N ' HG23 ' A' ' 20' ' ' VAL . 9.9 tt0 -146.56 -40.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.779 -1.2 . . . . 0.0 110.208 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -139.31 91.16 2.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.799 HD13 HD21 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -98.87 159.96 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.071 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.747 ' O ' HG23 ' A' ' 50' ' ' ILE . 44.7 mt-30 -146.81 166.98 25.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 110.184 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.715 HG12 ' HA2' ' A' ' 33' ' ' GLY . 3.1 p -160.26 143.53 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 109.043 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 18.6 m -129.86 129.38 43.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' HA2' ' NZ ' ' A' ' 123' ' ' LYS . . . 126.27 14.28 3.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -116.25 -153.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.32 98.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 0.0 109.329 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.09 -93.81 1.43 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 26' ' ' THR . 8.6 tt0 -177.48 28.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -1.152 . . . . 0.0 109.744 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB3' ' NE2' ' A' ' 38' ' ' HIS . 16.5 mt -70.64 145.92 50.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.069 -1.019 . . . . 0.0 109.278 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.715 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.06 -122.87 4.81 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.084 HG22 ' OH ' ' A' ' 4' ' ' TYR . 24.1 mm -151.59 123.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.168 -1.195 . . . . 0.0 109.315 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -136.88 -171.13 0.26 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 32.2 Cg_endo -76.64 84.57 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.479 1.453 . . . . 0.0 110.0 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 50.73 0.54 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.607 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 16.0 t-80 -84.95 46.95 1.32 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -1.067 . . . . 0.0 109.702 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.607 ' O ' HG11 ' A' ' 71' ' ' VAL . . . 56.17 160.57 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 110.097 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.93 66.21 8.82 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.835 2.356 . . . . 0.0 110.429 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 69' ' ' LEU . 1.4 mm? -77.75 139.35 39.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 69' ' ' LEU . 17.5 tp -154.59 66.5 0.69 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -136.1 -95.28 0.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.93 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' H ' HG23 ' A' ' 43' ' ' THR . . . -150.99 164.52 36.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 109.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.645 HG13 HD23 ' A' ' 69' ' ' LEU . 2.7 mt -113.17 4.16 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.103 -0.998 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' CG ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 48.16 179.81 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.715 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -80.26 119.49 3.85 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.528 2.152 . . . . 0.0 110.238 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -165.29 -153.2 7.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 130' ' ' VAL . 3.2 ppp? -128.61 -173.43 2.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.335 -1.097 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.747 HG23 ' O ' ' A' ' 24' ' ' GLN . 8.4 mt -151.11 147.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.41 123.48 21.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.246 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.59 HG23 ' CA ' ' A' ' 23' ' ' ILE . 32.1 mt -128.4 168.56 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.798 -1.189 . . . . 0.0 111.246 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.586 ' N ' HG22 ' A' ' 52' ' ' ILE . 51.5 t -139.15 153.08 24.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 80.78 -73.56 0.05 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.732 -0.605 . . . . 0.0 109.578 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 56' ' ' HIS . 0.3 OUTLIER 42.99 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.37 -0.831 . . . . 0.0 109.569 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.526 ' CB ' ' OE1' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -158.07 40.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.89 -1.131 . . . . 0.0 109.804 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -36.09 0.44 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.515 ' CE1' ' OE1' ' A' ' 59' ' ' GLU . 1.4 t-80 -169.35 -149.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.29 . . . . 0.0 109.54 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 58' ' ' HIS . 1.5 pt-20 -101.49 160.5 14.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.79 139.59 11.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.3 p90 -110.23 152.54 25.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.885 . . . . 0.0 109.623 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 16' ' ' PHE . 9.1 mt -127.9 144.57 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.258 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE1' HD12 ' A' ' 84' ' ' ILE . 19.6 t80 -113.75 130.38 56.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 8' ' ' VAL . 3.6 mt -121.33 173.89 7.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -125.44 -37.23 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.863 . . . . 0.0 109.416 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.21 144.62 4.47 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 168.25 -173.59 43.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 43' ' ' THR . 60.6 mt -99.36 152.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -1.075 . . . . 0.0 109.075 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.731 ' C ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -132.0 157.33 44.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.917 -1.115 . . . . 0.0 110.586 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' HD12 ' A' ' 69' ' ' LEU . 8.4 pt-20 -150.66 114.89 5.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.773 HG23 HG12 ' A' ' 76' ' ' VAL . 10.0 p -104.04 151.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.889 -1.132 . . . . 0.0 110.709 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.583 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.6 mm-40 -136.43 179.28 1.41 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -79.48 102.23 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.395 2.063 . . . . 0.0 110.847 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 75' ' ' ASN . . . 79.97 34.72 29.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.587 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 7.9 t30 171.18 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -1.175 . . . . 0.0 109.355 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.811 HG22 HD22 ' A' ' 6' ' ' LEU . 2.5 m -112.89 152.65 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 7' ' ' ASP . 88.0 m -152.67 136.02 15.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 109.282 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.73 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.1 m -144.83 147.54 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 109.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.77 142.7 46.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.461 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -139.09 179.61 6.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -100.43 -34.18 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.611 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -118.41 147.9 43.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 0.0 109.741 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.966 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -143.29 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.421 -0.799 . . . . 0.0 109.107 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.636 HD12 ' CE1' ' A' ' 63' ' ' TYR . 2.0 mt -98.93 52.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HG2' ' N ' ' A' ' 86' ' ' GLY . 48.9 ttt180 -42.16 147.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 85' ' ' ARG . . . -42.92 -32.49 1.45 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -111.21 64.66 0.61 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -1.181 . . . . 0.0 109.579 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.12 -83.01 0.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.84 -169.73 3.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.75 73.48 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.68 -68.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.11 -19.85 62.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.87 -2.03 24.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.96 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 108.913 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.3 mtp -85.75 -35.08 20.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.468 -0.77 . . . . 0.0 109.324 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -84.75 -27.32 27.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.22 -54.26 49.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -51.93 -21.61 3.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -80.06 -57.32 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 109.722 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.46 -19.56 48.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.869 ' HB1' HD13 ' A' ' 121' ' ' LEU . . . -85.72 -43.71 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -56.55 -34.53 67.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.439 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.67 -50.82 72.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -18.29 64.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.541 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 121' ' ' LEU . 21.4 mt -80.61 -25.83 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -101.42 102.68 13.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.503 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.1 m -154.01 -41.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -0.948 . . . . 0.0 109.726 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.405 ' O ' ' CE2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -155.9 -166.49 2.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.695 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.76 -86.88 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.64 177.91 8.88 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -113.14 126.5 55.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.324 -1.103 . . . . 0.0 109.333 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.11 29.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 0.0 109.564 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 111' ' ' ASP . 21.2 t70 -84.07 -94.41 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 108' ' ' SER . 20.8 p90 -74.32 -22.99 59.0 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.88 46.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.88 -34.7 51.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.436 -0.79 . . . . 0.0 109.108 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.46 -20.5 54.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.257 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.5 m -65.31 -39.35 92.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.361 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.27 -13.28 36.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.891 . . . . 0.0 109.328 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.19 -32.04 38.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.869 HD13 ' HB1' ' A' ' 101' ' ' ALA . 17.6 mt -83.74 -39.33 20.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.34 -23.67 50.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.69 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.539 ' NZ ' ' HA2' ' A' ' 27' ' ' GLY . 11.1 mmtt -79.8 -30.45 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.15 62.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 109.555 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.3 mt -80.53 1.74 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.595 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.75 62.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.269 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.599 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.8 pt20 -79.12 -11.0 59.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 0.6 OUTLIER -73.08 -30.24 63.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.965 . . . . 0.0 109.795 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -48.81 14.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.1 m -61.49 -40.4 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.912 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.545 HG23 ' N ' ' A' ' 132' ' ' GLU . 9.3 tt -65.3 -43.41 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 131' ' ' ILE . 3.1 mm-40 -53.83 -26.19 23.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -0.879 . . . . 0.0 109.1 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -48.88 20.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.18 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.8 p -53.65 -20.12 4.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -76.25 -55.89 5.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 7.34 24.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.41 -52.17 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.5 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.8 mmt -133.36 138.07 46.15 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 0.0 109.313 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER 55.69 92.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.205 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.87 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 32.3 p90 -82.3 -143.18 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 109.099 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -140.26 133.27 29.39 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.203 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.888 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -123.43 150.16 44.16 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.761 -1.212 . . . . 0.0 108.113 178.152 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.789 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -140.5 88.09 2.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.65 HG23 ' CG2' ' A' ' 78' ' ' VAL . 5.0 p -99.91 132.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -142.89 159.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.236 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 87.4 p -100.34 -146.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -0.838 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.75 -10.39 59.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.743 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' GLN . 14.5 mt-10 -118.34 24.21 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.454 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 41.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.78 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.94 92.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.659 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.927 ' HG2' HG21 ' A' ' 62' ' ' ILE . 1.7 mtt -161.97 -88.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.852 . . . . 0.0 108.934 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.691 ' CE2' ' CG1' ' A' ' 20' ' ' VAL . 68.8 t80 -135.3 144.82 46.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.3 p -165.07 82.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.411 -0.806 . . . . 0.0 109.525 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.6 -178.96 42.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 7.6 mt -71.01 139.45 50.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.076 -1.249 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.01 ' CG2' HD11 ' A' ' 23' ' ' ILE . 2.5 m -144.27 148.11 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.41 -0.806 . . . . 0.0 110.643 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.95 -42.05 4.79 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.593 -0.692 . . . . 0.0 109.849 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.529 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.88 109.43 9.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.967 -1.083 . . . . 0.0 110.486 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.086 HG23 HG22 ' A' ' 52' ' ' ILE . 3.9 mm -105.4 -173.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.023 -1.048 . . . . 0.0 109.081 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.63 ' H ' HG22 ' A' ' 23' ' ' ILE . 16.0 tt0 -176.05 98.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.948 -1.095 . . . . 0.0 109.965 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 2.1 p -104.32 137.98 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.352 -0.842 . . . . 0.0 109.069 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.527 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 31.6 m -124.21 115.52 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 46' ' ' LYS . . . -108.94 -68.06 0.61 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.6 t -170.6 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -1.152 . . . . 0.0 109.375 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -95.0 66.94 3.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.465 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.0 82.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -115.87 89.23 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.537 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 mt -106.81 151.35 25.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.26 172.6 25.5 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 107.243 -2.343 . . . . 0.0 107.243 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.87 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 18.8 mm -99.21 128.53 50.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.585 -1.538 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.607 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -129.98 170.75 10.23 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.0 Cg_endo -70.78 81.91 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.772 1.648 . . . . 0.0 109.676 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' HIS . . . 168.27 -27.07 0.14 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.725 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -42.2 163.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -1.091 . . . . 0.0 109.461 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . . . 164.26 -52.0 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.052 -1.03 . . . . 0.0 110.492 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 36.6 Cg_endo -79.32 23.63 0.64 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.607 2.204 . . . . 0.0 111.828 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.53 ' HG ' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -100.57 110.92 23.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.804 -1.185 . . . . 0.0 109.612 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 42' ' ' LEU . 3.5 mt -148.41 80.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.925 . . . . 0.0 109.357 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.774 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.1 t -147.06 -146.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.774 ' N ' HG23 ' A' ' 43' ' ' THR . . . -103.98 -176.61 3.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 109.472 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.875 HD11 ' O ' ' A' ' 68' ' ' ILE . 1.4 mt -132.55 166.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 17.3 mmtt -116.4 166.29 12.95 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -78.27 118.22 4.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.606 2.204 . . . . 0.0 110.559 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 63' ' ' TYR . . . -168.17 -145.59 4.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.526 ' HE3' HG12 ' A' ' 130' ' ' VAL . 3.7 ppp? -122.14 -172.64 2.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -1.126 . . . . 0.0 109.448 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.966 HD13 ' N ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.42 157.92 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.586 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.966 ' N ' HD13 ' A' ' 50' ' ' ILE . 6.3 ttp180 -149.98 134.9 17.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.111 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.086 HG22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -114.44 161.0 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 110.318 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.785 HG12 ' O ' ' A' ' 53' ' ' VAL . 41.1 t -126.47 65.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 9.5 mtmt -43.54 124.49 3.55 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.19 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 56' ' ' HIS . 6.5 tp-100 46.65 -93.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.7 . . . . 0.0 109.657 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' LYS . 2.3 t-160 -165.32 122.12 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.53 -72.77 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.59 138.53 55.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -157.21 162.37 39.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.348 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -156.55 177.1 11.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.755 ' O ' HD13 ' A' ' 62' ' ' ILE . 2.8 p90 -146.17 154.49 41.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.808 -1.182 . . . . 0.0 110.052 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.927 HG21 ' HG2' ' A' ' 15' ' ' MET . 2.5 mm -133.0 -161.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.62 ' HE1' ' HB3' ' A' ' 126' ' ' ALA . 42.0 t80 -157.61 114.69 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 64' ' ' LEU . 1.4 pt? -113.64 176.97 4.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 m -125.19 45.7 2.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.04 -167.4 29.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 134.53 -139.42 10.85 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.875 ' O ' HD11 ' A' ' 45' ' ' ILE . 3.7 mt -132.22 147.9 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.07 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.536 ' C ' HD12 ' A' ' 69' ' ' LEU . 2.5 pp -130.6 131.6 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.989 -1.069 . . . . 0.0 110.15 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 77' ' ' THR . 5.0 pt-20 -134.15 128.83 34.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.855 HG23 HG12 ' A' ' 76' ' ' VAL . 5.6 p -99.65 128.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.036 -1.04 . . . . 0.0 110.036 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.1 mt-30 -106.79 172.53 3.79 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 108.876 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.5 Cg_endo -78.75 112.52 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.577 2.185 . . . . 0.0 110.441 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 79.16 20.92 68.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.8 p-10 171.45 158.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.855 HG12 HG23 ' A' ' 71' ' ' VAL . 34.5 m -140.99 160.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.023 . . . . 0.0 109.436 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.555 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -152.04 143.53 23.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.555 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG2' HG23 ' A' ' 8' ' ' VAL . 2.8 m -151.65 156.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 79' ' ' LEU . 6.3 mp -122.71 166.18 15.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 10' ' ' SER . . . -146.0 -149.47 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -139.37 -55.47 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.567 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -111.58 148.17 33.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.679 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -140.2 146.57 38.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.508 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HB ' ' CD2' ' A' ' 63' ' ' TYR . 43.8 mt -126.17 -25.85 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 0.0 109.718 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 66.08 153.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.318 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -47.57 -29.7 5.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' OE1' ' HB ' ' A' ' 134' ' ' THR . 1.2 mt-30 -165.57 81.3 0.32 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.189 -1.183 . . . . 0.0 109.675 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 9.9 t70 -73.62 -26.67 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 174.64 -50.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.211 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.32 119.84 31.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.918 . . . . 0.0 109.642 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 92' ' ' ALA . 14.8 pt-20 -131.04 -38.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.247 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -77.25 -16.52 58.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 109.408 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.04 2.72 53.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.31 -16.39 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 108.981 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -52.4 5.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.458 -0.776 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 99' ' ' ARG . 2.3 mt-10 -56.27 -31.42 63.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -58.07 -53.07 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -53.47 -31.34 45.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.448 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.93 -43.5 83.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.307 -0.871 . . . . 0.0 109.545 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 12.0 pttm -84.11 -4.87 59.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -90.35 -7.73 52.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.508 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -86.35 -25.76 25.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 109.661 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -43.5 91.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -81.12 -15.1 56.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.464 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.747 HG13 HD13 ' A' ' 121' ' ' LEU . 18.8 mm -88.71 -19.42 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t -86.12 63.18 7.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.547 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -171.15 169.14 6.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.56 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 114' ' ' TYR . 29.8 t -175.08 100.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -157.58 76.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.66 169.81 25.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.57 -49.42 21.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -1.127 . . . . 0.0 109.309 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 18.3 m -118.7 33.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.559 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.17 -97.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.069 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 3.4 t80 -67.39 -14.11 62.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.65 74.91 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.63 -0.669 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -83.94 -5.65 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.682 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.0 -18.67 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.5 m -76.6 -29.86 56.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.732 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.92 -32.42 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.635 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 116' ' ' GLN . 6.3 mm-40 -75.78 -36.25 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 101' ' ' ALA . 2.8 tt -73.38 -61.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.96 -27.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.683 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 121' ' ' LEU . 16.5 tttt -63.24 -54.27 40.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -12.66 61.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.672 ' CG1' HD23 ' A' ' 121' ' ' LEU . 49.2 mm -82.23 2.18 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.62 ' HB3' ' HE1' ' A' ' 63' ' ' TYR . . . -83.95 -39.33 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.487 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.416 ' HG3' ' CG2' ' A' ' 84' ' ' ILE . 1.6 tm0? -76.58 -7.17 54.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.416 ' C ' HG22 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -81.72 -21.11 38.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.554 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -85.69 -33.9 21.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 109.592 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.3 m -75.4 -33.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 132' ' ' GLU . 2.1 tt -61.68 -44.63 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 131' ' ' ILE . 77.5 mm-40 -44.85 -35.24 2.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.041 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 4.5 mp -64.89 -55.46 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -0.81 . . . . 0.0 109.245 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.461 ' HB ' ' OE1' ' A' ' 87' ' ' GLN . 30.9 p -50.08 -29.14 8.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.481 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 2.8 mmtt -65.73 -54.96 20.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -88.83 21.4 3.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.65 42.5 3.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.388 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.268 0.556 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -116.29 40.97 2.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.926 . . . . 0.0 109.554 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.002 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -109.93 -147.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.888 . . . . 0.0 109.649 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 1.192 ' CG ' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.61 -179.75 5.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.34 2.019 . . . . 0.0 115.884 -175.797 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.504 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 8.7 t-80 -153.96 89.65 1.32 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 110.123 -3.217 . . . . 0.0 103.445 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.983 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -92.77 126.77 38.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.683 -1.261 . . . . 0.0 107.992 -177.562 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 77' ' ' THR . 7.3 t70 -133.36 75.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.593 -1.317 . . . . 0.0 109.912 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 15' ' ' MET . 1.4 p -111.13 147.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.26 -0.9 . . . . 0.0 108.948 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.516 ' HB ' ' N ' ' A' ' 14' ' ' GLN . 14.1 m -150.16 155.94 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.078 -1.014 . . . . 0.0 109.624 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -172.2 157.19 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.281 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 61.48 -89.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.414 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 22.13 3.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.387 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER 46.34 75.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 110.051 179.651 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.516 ' N ' ' HB ' ' A' ' 9' ' ' VAL . 9.1 tt0 164.98 100.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.544 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -124.47 -73.21 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.064 179.286 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.688 ' CE2' HG11 ' A' ' 20' ' ' VAL . 1.1 t80 -127.17 112.79 15.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.047 -1.033 . . . . 0.0 110.082 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 92.0 p -134.6 85.52 2.19 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.48 -160.73 23.12 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.467 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -93.24 159.67 15.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.25 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.192 HG22 ' CG ' ' A' ' 4' ' ' TYR . 1.8 m -155.32 -167.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.885 -1.135 . . . . 0.0 110.663 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.779 ' N ' HG23 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -155.35 -33.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 178.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 10.1 mmtm -142.97 88.4 2.04 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.961 -1.087 . . . . 0.0 110.211 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.983 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.24 138.78 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.696 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.986 ' O ' HG23 ' A' ' 50' ' ' ILE . 5.0 mt-30 -122.95 165.93 15.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 110.346 -178.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.546 ' CB ' HG12 ' A' ' 50' ' ' ILE . 11.5 p -171.53 154.98 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 2.1 t 179.76 154.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.829 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.5 -89.78 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 158.41 43.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 59.0 74.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' C ' ' HG2' ' A' ' 46' ' ' LYS . . . 91.8 141.69 10.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -137.05 55.39 1.83 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.171 . . . . 0.0 109.752 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.09 157.07 24.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.21 171.63 24.61 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.914 HG22 ' OH ' ' A' ' 4' ' ' TYR . 12.7 mm -99.81 127.16 52.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.854 -1.38 . . . . 0.0 108.986 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.651 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -134.46 170.26 11.73 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.651 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -70.11 88.24 0.58 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.586 1.524 . . . . 0.0 109.538 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.73 18.98 2.58 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 6.7 t60 -60.14 146.96 41.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -1.191 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.617 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -40.59 147.04 0.41 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -78.98 69.14 8.04 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.695 2.263 . . . . 0.0 111.047 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.6 mt -91.07 126.57 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.121 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.4 24.12 12.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.57 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -105.56 -92.81 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.393 -0.817 . . . . 0.0 109.336 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.808 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -130.12 172.72 11.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.935 . . . . 0.0 109.161 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.808 HD13 ' C ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -117.31 -149.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' O ' HG21 ' A' ' 25' ' ' VAL . 2.2 mptp? -121.35 125.38 26.91 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.24 -159.36 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.433 2.089 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 97.85 -137.08 13.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.6 ppp? -102.62 -178.91 3.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -1.117 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.986 HG23 ' O ' ' A' ' 24' ' ' GLN . 14.2 mt -157.63 140.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 110.193 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 7.5 mmt85 -131.16 112.31 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.694 HG23 ' CA ' ' A' ' 23' ' ' ILE . 12.6 mt -117.48 164.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 0.0 111.312 -178.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 59' ' ' GLU . 41.8 t -133.18 112.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' HIS . 20.4 mttm -65.96 149.89 49.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.792 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.557 ' HB2' HG21 ' A' ' 3' ' ' THR . 34.5 tt0 -52.11 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.338 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 48.7 t-80 71.45 95.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.36 178.34 29.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -63.07 -166.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -1.224 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HB3' HG22 ' A' ' 53' ' ' VAL . 10.2 pt-20 -131.12 147.45 52.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -125.52 138.29 53.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.911 ' CE1' HD11 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -109.08 139.41 44.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.819 . . . . 0.0 109.677 -179.613 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 19.1 mt -121.2 160.48 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.288 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.742 ' HE1' HD12 ' A' ' 84' ' ' ILE . 1.4 t80 -139.38 151.49 46.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.268 -0.895 . . . . 0.0 109.014 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.726 ' N ' HD23 ' A' ' 64' ' ' LEU . 1.3 pt? 179.93 -170.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.511 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 4.9 m -135.21 -169.22 2.33 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.33 -0.856 . . . . 0.0 109.204 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 65' ' ' SER . . . 42.24 -141.07 1.76 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.16 119.24 2.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 5.4 tt -151.89 130.28 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -1.102 . . . . 0.0 109.065 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 178.18 -140.0 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 -179.493 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.622 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -146.3 142.64 28.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.366 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 76' ' ' VAL . 7.6 p -109.53 126.99 66.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.48 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -105.39 173.86 3.01 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -77.92 4.02 6.48 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.524 2.149 . . . . 0.0 109.974 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . -167.16 39.27 0.24 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.504 ' OD1' ' ND1' ' A' ' 5' ' ' HIS . 5.0 t30 167.98 94.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 109.472 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.839 HG22 HG23 ' A' ' 71' ' ' VAL . 5.0 t -100.78 116.12 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.215 -0.928 . . . . 0.0 109.267 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.688 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 6.4 t -118.45 158.64 24.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.906 . . . . 0.0 109.686 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.764 ' HA ' ' CG ' ' A' ' 69' ' ' LEU . 3.5 p 179.44 141.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.742 0.782 . . . . 0.0 110.288 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.657 ' C ' HD23 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -115.64 145.63 42.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.53 -165.25 1.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.32 -43.83 4.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 17.8 m -106.32 151.85 24.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.79 93.7 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.742 HD12 ' HE1' ' A' ' 63' ' ' TYR . 6.1 mt -106.63 66.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.335 -0.853 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 84' ' ' ILE . 13.0 ttp180 -44.79 161.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 87' ' ' GLN . . . -51.45 147.49 10.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.859 ' H ' HG22 ' A' ' 131' ' ' ILE . 13.2 pt20 38.58 38.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.63 -0.924 . . . . 0.0 109.886 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -45.09 -48.55 11.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.59 -57.4 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.8 -167.09 1.75 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.616 ' CB ' HD12 ' A' ' 131' ' ' ILE . 16.1 pt-20 -144.78 -38.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.583 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.67 67.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -8.03 52.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.4 -14.61 32.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.26 -18.53 26.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.407 -0.808 . . . . 0.0 109.41 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -1.51 36.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.51 30.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 109.318 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HA ' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -76.42 -27.81 56.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -70.38 -43.62 69.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.86 -23.0 39.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.233 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.615 ' CB ' HD13 ' A' ' 121' ' ' LEU . . . -81.46 -22.14 38.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.213 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 31.9 tt0 -66.08 -19.32 65.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -27.5 21.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.406 ' O ' ' OH ' ' A' ' 114' ' ' TYR . 1.6 m-70 -77.12 -45.9 25.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.731 ' O ' HG22 ' A' ' 105' ' ' ILE . 88.0 mt -87.61 12.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' ILE . 2.6 m -44.37 -60.85 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.0 p -90.34 -160.85 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.29 128.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.029 -1.045 . . . . 0.0 109.616 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -160.82 93.37 0.98 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 109.377 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.854 ' O ' ' HB2' ' A' ' 115' ' ' ALA . . . 165.2 143.85 3.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.09 -41.61 67.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 14.5 m -137.46 -31.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER -41.61 -92.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.743 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 104' ' ' HIS . 15.4 t80 -77.92 -21.4 51.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -61.27 -18.05 56.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 8.7 mt-30 -84.99 -35.93 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.16 -10.02 27.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.1 m -71.42 -49.22 43.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.591 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.49 61.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.716 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.37 -47.48 76.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' CB ' ' A' ' 101' ' ' ALA . 47.9 tp -52.2 -51.76 56.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.717 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.38 64.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.758 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -78.11 -13.96 59.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.96 42.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.5 mp -88.21 -2.09 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.704 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -88.45 -24.55 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.598 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 8.4 pt20 -74.89 -32.63 61.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 4.3 tt -84.2 -6.76 59.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -26.13 47.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.439 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 2.3 m -86.46 -31.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.513 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.859 HG22 ' H ' ' A' ' 87' ' ' GLN . 3.2 pt -72.03 -4.03 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.37 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.7 mm-40 -78.21 -34.08 49.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.699 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.911 HD11 ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -87.31 2.98 48.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.155 -0.966 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -83.2 -16.15 47.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.019 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -71.81 -25.77 62.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.37 -0.831 . . . . 0.0 109.225 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.01 39.54 3.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.403 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -112.09 -7.09 14.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.466 -179.859 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.428 ' C ' ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -64.1 179.04 0.59 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.945 . . . . 0.0 109.579 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.646 HG22 ' HG3' ' A' ' 21' ' ' GLU . 38.1 p -141.88 155.45 45.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.235 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.635 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -148.49 -148.45 0.26 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.83 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -131.35 144.57 51.34 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.055 HD23 HG21 ' A' ' 20' ' ' VAL . 2.3 pp -135.67 154.4 51.3 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.491 -1.381 . . . . 0.0 109.278 178.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.567 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -140.03 115.19 9.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 -179.448 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.601 ' CG2' HD21 ' A' ' 64' ' ' LEU . 2.1 p -111.71 94.02 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.179 -0.951 . . . . 0.0 108.74 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.695 HG22 ' HG3' ' A' ' 14' ' ' GLN . 23.4 t -99.73 155.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.705 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 3.8 p -124.15 -149.99 0.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.42 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 81' ' ' ASP . . . -52.69 -38.06 59.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.88 32.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.313 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -134.66 67.53 1.5 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.695 ' HG3' HG22 ' A' ' 9' ' ' VAL . 23.6 tt0 -44.65 155.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 109.811 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.565 ' HB2' HG13 ' A' ' 8' ' ' VAL . 4.1 mmt -134.15 -96.81 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.846 ' HB3' HD11 ' A' ' 6' ' ' LEU . 3.5 t80 -70.09 130.95 43.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.919 -1.113 . . . . 0.0 108.717 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -157.23 110.24 2.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 138.91 -160.64 25.78 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.75 ' C ' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -53.79 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -1.214 . . . . 0.0 109.51 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.055 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 170.41 162.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.592 -1.318 . . . . 0.0 107.959 179.827 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HG3' HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -130.03 -37.57 1.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.454 -1.404 . . . . 0.0 110.433 -179.082 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 1.3 mtmt -155.29 93.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.767 -1.208 . . . . 0.0 110.764 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.743 ' CA ' HG23 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -98.92 153.93 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.253 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -156.16 134.55 11.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.623 -1.298 . . . . 0.0 110.259 -179.636 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.6 t -108.12 129.68 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 m -106.6 114.24 28.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -141.23 -123.15 1.91 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 t -125.11 138.23 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 47.41 78.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.264 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.05 111.78 1.72 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.22 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.832 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.68 138.89 44.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.613 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.17 -100.9 2.27 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 178.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.853 HG13 HG21 ' A' ' 76' ' ' VAL . 28.8 mm -155.61 153.81 7.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.333 -1.098 . . . . 0.0 109.671 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -155.5 -176.47 0.61 Allowed Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.821 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 34.8 Cg_endo -80.02 69.68 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.062 1.841 . . . . 0.0 109.844 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.38 35.52 0.37 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 12.2 t-80 -72.06 -74.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 0.0 109.627 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 167.89 166.67 0.14 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.35 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.68 79.12 3.3 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.68 2.253 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 4.0 mm? -92.85 133.17 36.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.837 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -138.63 52.28 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.175 179.826 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.5 p -126.1 -138.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -99.68 -163.45 1.03 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.0 109.566 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.561 ' CD1' HG21 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -120.57 135.59 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' CD ' ' H ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.38 134.38 93.38 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.493 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.2 Cg_endo -79.22 159.85 26.42 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.551 2.167 . . . . 0.0 110.29 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 125.18 -142.74 14.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.408 ' CE ' ' HB3' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -108.32 -172.02 1.98 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -1.14 . . . . 0.0 109.129 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.509 HD13 HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -161.6 141.17 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.986 -1.071 . . . . 0.0 110.145 -179.562 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HG3' ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -131.34 139.7 49.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.743 HG23 ' CA ' ' A' ' 23' ' ' ILE . 12.1 mt -130.67 172.51 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.999 -1.063 . . . . 0.0 109.997 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 41.4 t -138.34 104.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.695 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 146.21 -99.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.078 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 1.1 tt0 44.28 -157.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -81.52 -18.88 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.289 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.19 -140.24 10.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -118.38 -22.13 7.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -1.205 . . . . 0.0 109.54 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -146.46 126.19 13.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.703 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 60' ' ' GLU . 2.3 mm-40 -103.63 142.39 34.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.016 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CZ ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -133.49 106.32 7.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.674 ' O ' HG11 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -124.47 -166.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.091 179.617 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.737 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -172.67 126.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.31 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 8' ' ' VAL . 3.1 mt -119.6 -173.52 2.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.406 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 p -152.73 34.42 0.49 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.268 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.92 172.2 13.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.55 -164.95 25.12 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 79' ' ' LEU . 11.9 tt -109.51 154.38 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -1.184 . . . . 0.0 109.621 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.726 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -133.87 132.06 39.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.197 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -136.13 131.46 34.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.226 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 40' ' ' PRO . 9.8 p -100.82 137.56 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.59 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.8 mm-40 -124.65 176.73 2.16 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -78.85 106.72 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.489 2.126 . . . . 0.0 110.757 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 70.69 31.93 67.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.464 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 10.8 p-10 174.63 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.627 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.853 HG21 HG13 ' A' ' 34' ' ' ILE . 6.4 p -124.69 149.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -146.86 142.18 27.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.255 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 45' ' ' ILE . 4.8 m -145.03 141.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.24 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 68' ' ' ILE . 6.0 mp -103.05 158.76 16.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 10' ' ' SER . . . -152.6 -165.72 2.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -120.65 -38.98 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -115.29 171.86 7.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -173.78 133.43 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.737 HD12 ' CE1' ' A' ' 63' ' ' TYR . 61.5 mt -144.14 152.68 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.125 -0.984 . . . . 0.0 109.491 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.433 ' O ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -96.08 178.11 5.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.349 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -76.83 2.32 60.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.42 46.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 109.536 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -48.89 -58.07 5.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 -67.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.78 -168.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.859 ' HB2' HG21 ' A' ' 131' ' ' ILE . 4.3 pt-20 -172.42 -34.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.53 -19.54 55.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.16 3.35 20.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 128' ' ' LEU . . . -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.0 108.879 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.556 ' HG3' HD13 ' A' ' 128' ' ' LEU . 5.5 mtp -79.2 -23.95 43.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.677 . . . . 0.0 109.546 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 20.6 mt-10 -68.23 -19.39 64.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.569 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.43 -40.93 20.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -39.26 80.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.506 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.35 82.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 96' ' ' GLU . 16.1 mttt -89.69 -0.35 57.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.945 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -86.56 -55.46 3.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.324 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.8 -42.08 77.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.246 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.6 -43.27 75.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.633 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 105' ' ' ILE . 98.9 mt -89.97 24.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.275 -0.89 . . . . 0.0 109.335 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 107' ' ' SER . 16.6 m -61.09 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 72.27 168.68 0.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.228 -0.92 . . . . 0.0 109.279 -179.945 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 t -152.29 154.72 36.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.545 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -154.62 150.35 27.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.424 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' ASP . . . 115.74 20.3 5.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.531 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.8 OUTLIER 52.32 100.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -1.135 . . . . 0.0 109.348 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 111' ' ' ASP . 25.8 m 40.7 34.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 109.661 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 20.6 t0 -87.23 -95.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.085 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.67 -12.26 61.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.01 63.43 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.62 -0.675 . . . . 0.0 109.42 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.97 -27.07 60.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.442 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.76 -7.74 58.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.446 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.466 ' OG ' HG23 ' A' ' 105' ' ' ILE . 38.4 m -81.01 -30.66 34.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.18 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -84.18 -13.31 53.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.945 HD12 ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -74.9 -24.97 58.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.447 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -79.02 -6.39 56.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -14.58 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -88.9 -10.61 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.389 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 125' ' ' ILE . 1.7 mp -81.36 -2.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.512 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -90.49 -21.33 21.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.677 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 124' ' ' ALA . 20.1 pt20 -69.17 -35.78 76.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.456 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -84.2 11.04 8.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.437 ' HG3' ' HA ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -89.72 -51.27 5.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.674 HG11 ' O ' ' A' ' 62' ' ' ILE . 22.6 m -52.3 -19.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.774 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.859 HG21 ' HB2' ' A' ' 91' ' ' GLU . 7.3 mt -86.29 -58.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' ILE . 39.2 mm-40 -42.15 -40.02 2.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.778 . . . . 0.0 110.121 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 mp -74.2 -52.04 13.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.007 . . . . 0.0 109.73 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 130' ' ' VAL . 6.6 p -46.89 -24.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -70.91 -55.93 7.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.837 . . . . 0.0 109.594 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.74 20.17 13.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.35 63.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.295 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.556 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -155.93 63.44 0.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.066 HG22 ' HB2' ' A' ' 21' ' ' GLU . 2.1 p -42.47 125.0 3.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.745 ' CE2' HG22 ' A' ' 34' ' ' ILE . 27.1 p90 -118.64 -171.67 2.13 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.515 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER -111.97 147.46 35.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.035 -1.041 . . . . 0.0 109.076 179.834 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.104 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -137.06 162.8 32.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.964 -1.085 . . . . 0.0 109.132 178.66 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 1.009 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.9 t0 -154.64 96.95 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 78' ' ' VAL . 2.5 p -109.69 112.25 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.115 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.47 167.61 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.063 -1.023 . . . . 0.0 109.925 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -179.39 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.399 -0.813 . . . . 0.0 109.436 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 65.91 109.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 21.3 mm-40 62.38 79.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLU . 9.8 mp0 -43.8 111.97 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.466 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.61 ' O ' ' NE2' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -171.52 53.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.321 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.621 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -133.81 -88.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.627 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.7 t80 -139.96 126.03 19.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.055 -1.028 . . . . 0.0 109.355 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.3 p -159.67 82.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -0.96 . . . . 0.0 109.235 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.53 -145.04 6.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.675 ' C ' HG12 ' A' ' 20' ' ' VAL . 11.4 mt -69.99 159.49 33.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -1.116 . . . . 0.0 109.583 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.104 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -175.91 164.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 -178.124 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 1.066 ' HB2' HG22 ' A' ' 3' ' ' THR . 47.0 tt0 -139.1 -56.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.108 -0.995 . . . . 0.0 110.236 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.553 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -130.64 111.21 12.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.043 -1.036 . . . . 0.0 110.711 -178.985 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.828 HG22 ' CG1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -99.18 -162.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.507 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -166.36 159.03 14.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.74 -1.225 . . . . 0.0 109.904 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.547 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.3 t -154.52 116.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 81.6 m -111.47 110.56 21.06 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 109.231 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -154.76 45.68 0.55 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.61 169.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -1.158 . . . . 0.0 109.546 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.65 43.3 31.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.98 167.34 19.81 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -164.7 66.01 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -1.214 . . . . 0.0 109.375 -179.914 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD13 ' OH ' ' A' ' 35' ' ' TYR . 5.7 mt -131.2 147.36 52.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.827 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.74 -102.9 2.45 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.745 HG22 ' CE2' ' A' ' 4' ' ' TYR . 3.5 mm -153.61 159.1 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.276 -1.132 . . . . 0.0 108.979 178.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -151.28 174.74 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.505 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.5 Cg_endo -74.85 76.91 3.2 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.174 1.916 . . . . 0.0 109.95 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.64 49.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 14.9 t-80 -109.48 2.65 20.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 0.0 109.792 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 38' ' ' HIS . . . 66.92 155.78 0.14 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.986 . . . . 0.0 109.44 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.33 87.65 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.676 2.251 . . . . 0.0 110.655 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 38' ' ' HIS . 7.3 mt -99.05 138.67 35.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.472 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.504 ' CD2' ' HG2' ' A' ' 70' ' ' GLU . 74.3 mt -119.9 86.94 2.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' ILE . 17.0 p -131.25 -155.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.401 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -100.33 171.7 7.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.398 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 67' ' ' GLY . 3.4 tt -100.21 169.84 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -115.5 142.46 28.86 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.92 . . . . 0.0 109.349 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.5 146.05 21.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.514 2.143 . . . . 0.0 110.298 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 144.63 -148.22 19.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.473 ' HE1' HG12 ' A' ' 130' ' ' VAL . 5.3 ppp? -101.46 174.35 6.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -1.119 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.969 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.5 OUTLIER -148.48 151.39 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.982 -1.074 . . . . 0.0 109.88 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.5 ttt180 -121.03 172.65 7.79 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.828 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -164.22 144.85 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.711 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.635 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 34.4 t -134.09 118.01 27.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.648 -0.657 . . . . 0.0 109.302 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 139.97 -86.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.528 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.6 tt0 41.33 -94.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.412 -0.805 . . . . 0.0 109.65 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 2.1 t60 -132.11 -36.56 1.16 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.17 42.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -173.34 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.337 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' ILE . 10.8 pt-20 -126.86 145.84 50.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.102 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -136.93 167.92 20.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -134.07 136.47 43.99 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.463 -0.773 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.969 ' H ' HG23 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -109.48 -157.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 109.031 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.75 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 4.2 t80 -172.62 129.15 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.157 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.99 -164.36 2.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.528 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.3 OUTLIER -165.4 130.61 2.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.4 158.7 3.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.552 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 126.14 177.5 14.91 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 43' ' ' THR . 41.1 mt -122.85 142.86 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -1.116 . . . . 0.0 109.309 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.598 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -106.55 132.84 52.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.864 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 tt0 -134.44 112.56 11.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 108.895 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.501 HG23 ' HB ' ' A' ' 76' ' ' VAL . 4.0 p -99.65 158.51 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -139.78 169.25 12.53 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.32 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 73.44 5.75 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.702 2.268 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.33 -14.74 5.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 14.5 p30 -165.43 166.09 18.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 70' ' ' GLU . 1.3 p -153.73 145.63 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 109.327 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.609 HG23 ' HB3' ' A' ' 7' ' ' ASP . 4.3 m -137.78 142.35 40.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.138 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 8' ' ' VAL . 2.5 m -142.61 143.4 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 109.225 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -116.99 147.0 42.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -138.55 -174.37 3.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.39 -46.81 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 65' ' ' SER . 7.5 t -100.38 -176.1 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.621 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -178.94 76.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 84' ' ' ILE . 3.8 mp -106.18 77.01 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.296 -0.877 . . . . 0.0 109.744 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 86' ' ' GLY . 4.9 ttt-85 -45.77 152.11 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.572 ' CA ' HG23 ' A' ' 130' ' ' VAL . . . -42.11 -45.59 5.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -74.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.265 . . . . 0.0 109.31 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' CG ' HG23 ' A' ' 84' ' ' ILE . 27.8 t70 50.01 39.03 17.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.825 . . . . 0.0 109.563 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 59.61 151.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 0.0 109.603 179.826 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.37 -166.48 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 109.617 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.535 ' CB ' HD11 ' A' ' 131' ' ' ILE . 6.7 pt-20 -177.06 -51.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 109.147 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.75 -28.19 58.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -69.81 -6.53 32.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 128' ' ' LEU . . . -89.3 -22.44 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 108.743 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -29.79 33.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.534 -0.728 . . . . 0.0 109.047 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -32.63 74.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.455 -0.778 . . . . 0.0 109.402 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.6 -63.68 1.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.499 ' HG3' HD11 ' A' ' 125' ' ' ILE . 5.9 ttpt -57.77 -29.52 64.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.354 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -66.35 -32.68 74.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -22.36 32.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.999 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -85.55 -15.66 41.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 108.923 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -72.55 -17.32 61.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.12 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -87.4 -34.59 18.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -68.57 -38.85 81.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.551 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.786 HD11 ' HG ' ' A' ' 121' ' ' LEU . 94.2 mt -73.46 -16.98 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -91.37 24.45 2.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 108' ' ' SER . 0.7 OUTLIER -150.82 178.14 9.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 75.95 175.59 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -154.83 -165.14 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.391 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 178.68 25.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.14 -55.16 3.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.661 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 11.3 m -118.9 9.46 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.47 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.997 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 108' ' ' SER . 23.4 p90 -67.11 -19.9 65.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.988 -1.07 . . . . 0.0 108.161 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -56.36 -26.88 54.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -78.64 -31.32 46.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.5 -24.24 56.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.9 -4.19 36.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.09 -38.58 27.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 109.472 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.98 0.82 46.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.652 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.999 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -79.37 -46.92 16.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.43 -9.32 32.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -71.68 -22.97 61.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.634 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.25 -3.51 58.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.682 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -89.56 -8.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.364 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.75 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -74.27 -36.42 63.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 109.274 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.556 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.3 pt20 -90.33 1.52 56.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -90.13 -26.45 20.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -21.34 33.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.742 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.583 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 30.2 m -88.05 -28.98 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.538 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -88.46 -13.63 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -33.45 33.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 110.013 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 133' ' ' LEU . 1.6 pp -84.12 1.32 44.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 0.7 OUTLIER -88.86 -35.31 16.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.209 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 7.6 pttt -79.1 -22.64 44.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.256 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -90.1 -7.03 54.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.394 179.895 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.79 3.05 55.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 109.578 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.436 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -56.47 138.61 51.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.532 179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.745 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER 62.66 131.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.313 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.839 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 4.3 p90 -130.82 -154.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 9.9 t-80 -127.64 138.51 52.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.354 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.053 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -134.81 160.01 39.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.986 -1.072 . . . . 0.0 109.015 179.349 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.98 ' N ' HD12 ' A' ' 6' ' ' LEU . 15.4 t70 -149.81 101.59 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 0.0 110.08 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 8' ' ' VAL . 13.7 p -102.46 123.78 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.189 -0.944 . . . . 0.0 109.121 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 t -135.81 148.61 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.635 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -140.11 -142.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.045 179.87 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.29 30.25 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.694 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.549 ' CD ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pm0 -170.53 78.89 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.278 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' GLU . 3.3 mt-30 -42.48 103.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 109.67 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 5.6 tt0 175.15 59.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.621 ' HB3' HG21 ' A' ' 62' ' ' ILE . 5.7 mmm -143.49 -82.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.157 -0.965 . . . . 0.0 109.945 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 62' ' ' ILE . 27.5 t80 -145.81 143.55 29.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.116 -0.99 . . . . 0.0 109.276 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.444 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 13.8 p -175.19 88.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.84 -145.35 10.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.722 ' C ' HG12 ' A' ' 20' ' ' VAL . 14.8 mt -68.7 165.15 20.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.19 -1.182 . . . . 0.0 109.066 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.053 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -173.82 152.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.042 -1.036 . . . . 0.0 109.135 -177.907 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.745 ' HG3' HG23 ' A' ' 3' ' ' THR . 3.0 tt0 -114.73 -69.85 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.119 -0.988 . . . . 0.0 110.65 -178.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.5 tptt -125.93 107.98 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.744 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.978 HG22 HG12 ' A' ' 52' ' ' ILE . 1.3 pp -108.9 118.82 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.64 125.51 45.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.541 -1.349 . . . . 0.0 110.298 -178.46 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.5 t -112.86 120.75 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.166 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.9 m -124.14 110.12 14.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -128.77 -145.53 5.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 1.4 m -98.56 135.28 40.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -1.223 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.6 tt0 71.33 101.61 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.121 -0.987 . . . . 0.0 109.233 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.03 171.38 20.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 179.84 60.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.974 -1.31 . . . . 0.0 110.304 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -94.46 153.2 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.012 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.65 171.83 24.35 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.839 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 15.0 mm -99.11 126.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.039 -1.271 . . . . 0.0 108.434 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -124.21 170.63 8.41 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.971 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.1 Cg_endo -72.31 90.91 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.841 1.694 . . . . 0.0 109.933 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.26 2.25 4.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -49.3 136.64 15.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -1.202 . . . . 0.0 109.492 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -54.07 171.29 0.27 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -77.37 83.46 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.697 2.265 . . . . 0.0 110.522 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -99.26 141.31 32.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 109.46 -179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.67 89.98 1.81 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 68' ' ' ILE . 11.9 p -150.13 -138.52 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.257 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.608 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -100.06 171.13 8.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.215 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.913 HD11 ' C ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -99.89 174.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.227 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 2.5 mttt -111.43 143.91 29.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -77.78 121.86 5.65 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.51 2.14 . . . . 0.0 110.402 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.531 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 168.22 -156.15 27.44 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.594 ' N ' ' HB1' ' A' ' 126' ' ' ALA . 5.9 ptm -108.55 -177.33 3.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.642 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -158.69 136.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.952 -1.092 . . . . 0.0 110.722 -179.524 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.86 174.87 5.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.978 HG12 HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -164.95 152.87 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.652 -1.28 . . . . 0.0 109.886 -179.414 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 53.2 t -136.29 99.96 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER 155.89 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 8.8 tt0 50.34 23.78 1.33 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 109.826 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 43.5 63.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.594 179.965 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.49 -59.59 0.27 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 -158.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 109.542 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -110.04 158.64 18.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.9 mt-10 -156.95 165.2 36.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 3.5 p90 -128.19 127.7 43.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -99.96 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.715 ' HE1' ' HB3' ' A' ' 126' ' ' ALA . 23.2 t80 -177.84 128.8 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 108.924 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.84 -166.06 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -119.89 -90.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' C ' HG12 ' A' ' 45' ' ' ILE . . . -125.58 -131.47 3.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 104.49 -166.63 15.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.913 ' C ' HD11 ' A' ' 45' ' ' ILE . 16.7 tt -113.61 133.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -1.199 . . . . 0.0 109.459 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.987 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -114.82 116.46 28.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.7 pt-20 -114.34 127.75 56.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 108.88 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.62 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.1 p -99.8 144.81 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.12 -0.987 . . . . 0.0 109.884 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.543 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -123.69 172.89 5.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.384 -0.822 . . . . 0.0 109.103 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -78.16 93.95 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.611 2.208 . . . . 0.0 110.635 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.06 -17.0 45.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -156.92 152.85 27.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 109.324 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 70' ' ' GLU . 2.0 p -138.14 144.02 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.01 . . . . 0.0 109.617 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.879 HG22 ' HB3' ' A' ' 7' ' ' ASP . 11.9 p -131.07 146.78 52.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.375 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 69' ' ' LEU . 4.9 m -149.33 146.1 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.512 ' C ' HD23 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -124.36 151.47 44.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.29 -0.881 . . . . 0.0 109.341 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.494 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -144.46 -164.8 1.99 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.37 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -117.06 -24.25 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 83' ' ' ALA . 20.5 m -110.8 165.47 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.635 ' HB2' ' CB ' ' A' ' 10' ' ' SER . . . -175.15 67.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.76 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 82' ' ' THR . 2.8 mp -101.43 72.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.276 -0.89 . . . . 0.0 108.922 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -44.35 167.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.88 . . . . 0.0 109.445 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.424 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -52.47 -46.29 58.38 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.27 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -1.162 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' LEU . 34.7 t70 55.24 17.87 2.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.532 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 42.38 37.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.42 ' HB2' ' OD2' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -146.42 168.7 20.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -152.41 -82.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.812 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.72 -25.9 68.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -64.86 -24.86 67.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.934 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.98 -17.05 26.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.005 . . . . 0.0 109.207 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.978 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -80.8 -48.47 12.42 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 -179.586 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -72.19 -9.69 58.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.846 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.62 -19.96 47.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -87.79 -1.62 58.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.05 -36.78 19.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -61.02 -20.61 62.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.559 ' O ' HD12 ' A' ' 105' ' ' ILE . . . -90.08 -21.61 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.63 -44.86 95.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 -6.15 43.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -90.1 -41.61 11.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.711 ' O ' HG22 ' A' ' 105' ' ' ILE . 3.2 mt -86.98 13.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.145 -0.972 . . . . 0.0 109.827 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -103.89 74.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.292 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.9 p -155.7 -153.47 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t 173.61 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -165.55 -54.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.819 . . . . 0.0 109.447 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.02 143.85 15.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 19.7 t70 -64.35 -24.67 67.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -112.89 18.9 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.86 -92.35 0.06 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.427 -0.795 . . . . 0.0 109.219 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -73.5 -23.61 60.07 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -56.77 -36.98 70.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -87.6 -15.51 37.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.803 . . . . 0.0 109.231 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.98 -31.72 69.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -51.96 -26.01 9.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.91 -35.97 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -65.11 -50.5 65.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.663 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 125' ' ' ILE . 36.4 tp -55.31 -53.57 54.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -43.68 -35.89 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -49.99 74.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.661 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.64 -10.77 59.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.561 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.583 HD11 HD11 ' A' ' 121' ' ' LEU . 20.4 mm -89.0 -11.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.445 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.715 ' HB3' ' HE1' ' A' ' 63' ' ' TYR . . . -72.4 -35.05 68.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -81.2 -10.22 59.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.978 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.3 OUTLIER -83.14 -29.24 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.436 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -77.04 -39.76 48.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 109.597 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.597 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.6 m -74.18 -36.41 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -67.21 -19.48 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.422 179.934 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.452 ' C ' ' HG2' ' A' ' 135' ' ' LYS . 6.1 tm-20 -71.95 -16.05 62.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.925 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.11 -47.99 7.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.7 p -60.67 -31.11 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -63.43 -28.88 70.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.828 -179.817 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -109.31 0.6 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 0.0 109.587 -179.992 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.11 8.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 6.9 tpt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.605 179.981 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' THR . 1.5 ttm -148.81 132.77 17.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 109.58 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.537 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER 52.76 171.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.744 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.1 p90 179.62 -179.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.5 t60 -105.32 149.51 25.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.216 -0.927 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.048 HD12 ' N ' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -138.5 164.77 28.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.001 178.825 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 1.048 ' N ' HD12 ' A' ' 6' ' ' LEU . 2.2 t70 -154.88 81.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.667 HG23 HG13 ' A' ' 78' ' ' VAL . 2.7 p -104.36 110.55 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.14 -170.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . 80.3 p -143.22 -166.7 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.419 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.37 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.453 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -140.55 65.07 1.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.89 . . . . 0.0 109.448 -179.933 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -147.32 172.1 14.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -91.65 152.01 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.554 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.7 mtt -154.05 -76.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.475 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 30.6 t80 -168.14 134.83 2.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 9.1 p -165.73 98.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 156.9 -153.8 25.0 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.657 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -65.18 162.15 17.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -1.211 . . . . 0.0 108.747 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.044 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -172.59 171.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.571 -178.538 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 5.0 tt0 -120.24 -47.97 2.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.074 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -172.44 133.1 0.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.042 179.873 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.865 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 pt -108.37 129.56 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.672 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 20.0 mt-30 -99.5 95.71 7.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.108 . . . . 0.0 109.511 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 50' ' ' ILE . 3.8 t -99.14 151.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.692 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 9.0 t -160.94 140.44 10.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 108.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' HB2' ' A' ' 31' ' ' GLU . . . -111.8 -166.8 18.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 t -48.08 -66.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -66.74 -13.86 61.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.084 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 112.65 151.49 11.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.692 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -142.82 155.3 44.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -1.217 . . . . 0.0 109.716 179.421 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.53 175.98 10.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.883 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.31 171.49 14.12 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.744 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 16.7 mm -99.89 143.86 13.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.808 -1.407 . . . . 0.0 108.927 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.626 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 1.8 p90 -155.66 169.42 10.39 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -69.58 83.18 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.553 1.502 . . . . 0.0 109.627 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.07 33.58 0.46 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.701 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 32.4 t60 -77.95 3.97 13.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -1.161 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 76.53 175.39 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 0.0 109.847 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -78.2 76.24 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.722 2.281 . . . . 0.0 110.412 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.567 ' H ' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -93.36 122.2 35.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.4 75.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.8 p -139.21 -147.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -106.3 169.37 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -111.04 171.86 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.755 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -115.3 165.52 14.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 36.0 Cg_endo -78.27 117.08 4.01 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.694 2.262 . . . . 0.0 110.323 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -172.53 -153.01 8.98 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.549 ' HB2' HG11 ' A' ' 130' ' ' VAL . 9.7 ptm -114.19 178.03 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 109.268 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.798 HG23 ' H ' ' A' ' 62' ' ' ILE . 2.0 tt -151.78 153.4 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.029 -1.045 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' N ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -123.27 176.77 5.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.662 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.826 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.25 141.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.005 -179.242 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 55.1 t -128.79 113.55 29.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.681 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 58' ' ' HIS . 24.3 mmtt -64.33 142.77 58.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 -179.113 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.469 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.1 tt0 -43.5 -28.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.191 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 45.6 t-80 178.98 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 109.305 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.23 -107.59 0.52 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 5.2 t-80 -106.41 172.06 7.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -156.52 136.49 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.196 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -164.52 -173.85 3.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.64 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.1 p90 -125.2 144.11 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.418 -0.801 . . . . 0.0 109.493 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.798 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.4 mm -116.17 -147.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 108.986 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.878 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.5 t80 -174.92 130.98 0.31 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 108.841 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.39 177.05 7.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.72 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.545 ' HB2' HG21 ' A' ' 82' ' ' THR . 6.4 t -109.04 -52.36 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.68 -155.27 8.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 128.49 -158.92 21.88 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.597 ' C ' HD11 ' A' ' 45' ' ' ILE . 14.5 tt -127.38 125.8 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -1.083 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.573 ' HB2' HD12 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -99.69 144.0 29.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -141.08 134.01 29.08 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.567 HG11 ' H ' ' A' ' 41' ' ' LEU . 7.1 p -99.8 155.86 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.131 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.589 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.04 -177.84 0.75 Allowed Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.776 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -79.88 93.31 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.323 2.015 . . . . 0.0 110.618 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.29 56.3 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -126.83 160.74 30.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.622 HG21 ' CG2' ' A' ' 34' ' ' ILE . 14.7 t -134.96 153.3 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.205 -0.934 . . . . 0.0 109.038 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.731 HG23 ' HB3' ' A' ' 7' ' ' ASP . 4.1 m -158.73 127.55 5.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.061 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.667 HG13 HG23 ' A' ' 8' ' ' VAL . 1.2 p -140.32 126.28 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.93 131.5 49.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.103 -0.998 . . . . 0.0 109.673 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.462 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -117.1 -156.7 0.64 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.286 -0.883 . . . . 0.0 109.266 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -145.85 13.76 1.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.545 HG21 ' HB2' ' A' ' 65' ' ' SER . 3.1 m -148.98 135.87 19.79 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.227 -0.92 . . . . 0.0 109.322 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.83 107.07 4.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.274 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.878 HD12 ' CE1' ' A' ' 63' ' ' TYR . 98.6 mt -110.19 -29.62 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.634 HH21 HD12 ' A' ' 62' ' ' ILE . 2.3 mtp-105 62.77 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.248 -0.907 . . . . 0.0 109.636 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.757 ' CA ' HG23 ' A' ' 130' ' ' VAL . . . -66.81 -11.49 57.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ASP . 20.0 mt-30 -90.97 -50.24 5.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -1.139 . . . . 0.0 109.167 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.693 ' HB2' HG22 ' A' ' 84' ' ' ILE . 56.7 t0 43.6 47.05 6.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.828 . . . . 0.0 109.583 179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 90' ' ' ASP . 11.0 mt 48.8 -91.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.408 -0.808 . . . . 0.0 109.784 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 88' ' ' ASP . 6.1 m-20 -53.94 -168.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 0.0 109.719 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -153.82 -69.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.49 -17.97 62.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 0.0 109.831 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -22.12 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -19.5 23.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 109.248 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -29.02 50.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.625 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.8 -2.27 46.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.03 -36.42 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.109 -0.994 . . . . 0.0 109.53 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -58.61 -36.39 73.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.786 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -75.77 -31.9 59.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.694 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -90.03 4.67 49.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.848 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 121' ' ' LEU . . . -89.75 -4.43 57.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 109.58 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 3.3 tp10 -89.49 -47.82 7.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -60.94 -17.09 49.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.975 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -86.76 -30.16 21.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.028 -1.045 . . . . 0.0 109.835 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 105' ' ' ILE . 99.4 mt -89.88 10.78 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.59 30.88 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.423 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 152.04 51.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.59 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 5.9 p -138.38 129.51 27.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 t60 178.39 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 147.06 152.0 5.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.2 -51.24 16.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.3 24.99 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.67 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.22 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.59 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 10.2 p90 -72.28 -25.07 61.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.97 -26.75 38.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -31.6 17.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -68.29 -19.28 64.69 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.822 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 p -67.71 -32.01 72.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.575 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.97 -14.7 59.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.518 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.436 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mm-40 -82.35 -28.94 31.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.547 HD13 ' HB1' ' A' ' 101' ' ' ALA . 8.6 mt -90.27 -39.78 12.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.596 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.415 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -59.77 -44.24 93.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.695 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -59.82 -28.43 67.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -67.25 -30.32 70.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.537 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.597 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.2 mp -70.95 -8.05 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.23 -31.4 19.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.256 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -78.6 -13.43 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.259 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.561 ' C ' HD23 ' A' ' 128' ' ' LEU . 6.4 tt -76.84 -19.4 57.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.391 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -82.18 -28.22 32.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.769 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.757 HG23 ' CA ' ' A' ' 86' ' ' GLY . 27.6 m -86.07 -27.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.955 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.0 tt -69.53 -28.91 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.799 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 14.9 mm-40 -65.59 -15.69 62.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 7.4 mp -90.29 -40.94 11.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.644 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 61' ' ' PHE . 2.2 p -71.92 -3.12 20.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -76.74 -23.52 53.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -120.99 40.41 3.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.369 179.647 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.09 -18.82 13.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.533 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.493 -179.959 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -44.74 130.66 7.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.617 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.651 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER 64.39 130.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.4 p90 -131.32 -143.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.843 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -141.35 150.0 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 0.0 108.99 -179.361 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.915 ' CD2' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -112.52 132.07 55.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.175 -0.953 . . . . 0.0 109.04 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -129.76 72.42 1.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.823 -1.173 . . . . 0.0 109.791 179.832 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.842 HG23 HG23 ' A' ' 78' ' ' VAL . 3.7 p -109.1 118.2 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.214 -0.929 . . . . 0.0 109.211 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 13.2 m -129.75 159.59 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.03 169.42 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.48 118.84 4.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 58.81 44.02 17.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.206 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -177.78 168.56 2.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.7 pt20 -147.97 174.38 11.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.765 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 3.9 mmt -144.65 -75.45 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.944 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.1 t80 -109.5 113.09 25.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 110.294 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.433 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 32.8 p -136.36 90.6 2.58 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.26 -0.9 . . . . 0.0 109.708 178.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 5' ' ' HIS . . . 168.99 -158.64 31.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.787 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.89 -164.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.933 -1.333 . . . . 0.0 109.291 179.483 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 5' ' ' HIS . 0.2 OUTLIER 172.43 164.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 0.0 108.461 179.162 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER -123.73 -40.07 2.35 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 25.8 ttpt -159.4 113.51 2.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 110.558 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.915 HG21 ' CD2' ' A' ' 6' ' ' LEU . 13.0 pt -98.81 -164.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.689 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -179.76 97.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.667 -1.271 . . . . 0.0 110.221 179.691 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.607 HG12 ' HA2' ' A' ' 33' ' ' GLY . 3.1 p -99.26 140.42 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.306 -0.872 . . . . 0.0 108.717 179.279 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.493 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 23.8 m -131.97 103.6 6.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -133.26 -47.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER 165.05 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -1.168 . . . . 0.0 109.555 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.63 125.36 33.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.463 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.76 -52.69 4.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.02 19.17 4.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.759 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.682 HD23 ' OH ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -128.22 160.7 31.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.602 179.873 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.49 -112.73 3.37 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.404 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.689 HG12 HD11 ' A' ' 23' ' ' ILE . 31.2 mm -155.0 149.18 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.26 -1.141 . . . . 0.0 109.481 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.682 ' OH ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -153.34 -172.86 0.33 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.955 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.0 Cg_endo -78.46 81.21 2.81 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.687 1.592 . . . . 0.0 110.423 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 25.7 1.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 39' ' ' ALA . 28.3 t60 -56.89 145.01 31.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.241 . . . . 0.0 109.477 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.96 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -49.27 176.25 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.96 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.18 87.51 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.645 2.23 . . . . 0.0 110.424 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.19 126.19 46.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.384 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.93 73.09 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -149.3 -144.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.051 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.58 -171.45 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.001 . . . . 0.0 109.183 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 3.1 mt -132.45 172.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.678 -179.89 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -123.45 174.28 3.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.288 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -77.43 144.22 22.63 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.513 2.142 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 165.84 -157.28 29.68 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.425 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.4 ptm -111.29 -177.74 3.28 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 24' ' ' GLN . 3.1 tp -160.28 115.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.455 ' C ' ' CG1' ' A' ' 52' ' ' ILE . 25.2 ttp180 -110.24 154.88 22.78 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.865 ' CG2' HG22 ' A' ' 23' ' ' ILE . 15.9 mt -154.65 170.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.193 . . . . 0.0 111.011 -178.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.557 ' N ' HG22 ' A' ' 52' ' ' ILE . 41.4 t -132.43 111.32 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' HIS . 4.3 ttpt -62.65 105.71 0.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.584 -0.697 . . . . 0.0 110.193 -179.116 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CA ' ' HB2' ' A' ' 21' ' ' GLU . 13.0 tt0 40.59 -93.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.735 . . . . 0.0 110.023 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 28.6 t-80 -150.15 81.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.998 . . . . 0.0 109.487 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.64 -97.51 0.11 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.39 170.99 11.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -1.167 . . . . 0.0 109.584 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 6.8 mt-10 -125.47 164.1 21.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.338 -0.851 . . . . 0.0 109.183 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -122.67 130.62 53.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.111 -0.993 . . . . 0.0 109.756 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.403 ' C ' ' CG1' ' A' ' 62' ' ' ILE . 2.1 m-85 -108.83 132.87 53.58 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 63' ' ' TYR . 1.5 mt -150.73 -179.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.978 -1.076 . . . . 0.0 110.01 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.578 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -159.77 152.66 21.64 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.923 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 65' ' ' SER . 1.2 pp -146.93 -174.55 4.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.97 -179.541 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.479 ' N ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -133.86 -48.98 0.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.47 164.04 31.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 156.88 -172.76 34.52 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.6 mp -111.18 131.28 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -1.137 . . . . 0.0 109.061 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.859 ' HA ' HG12 ' A' ' 78' ' ' VAL . 1.3 tt -115.78 137.55 51.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -0.872 . . . . 0.0 109.408 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 12.7 pt-20 -146.37 143.25 28.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.007 ' HA ' HG12 ' A' ' 76' ' ' VAL . 6.1 p -99.62 147.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.675 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -126.87 170.43 9.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 179.958 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.68 77.73 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.643 2.229 . . . . 0.0 110.926 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.44 0.65 16.02 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.225 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 72' ' ' GLN . 1.8 p30 -174.89 166.87 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.005 -1.291 . . . . 0.0 109.756 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.007 HG12 ' HA ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -135.15 161.99 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 109.129 179.833 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 17.4 m -156.11 136.75 13.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.859 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.4 m -138.95 148.4 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.479 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -115.01 120.89 41.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 -179.886 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.77 -174.97 3.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.1 -51.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.8 m -100.27 126.82 46.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.765 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -138.53 150.2 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.982 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 69.6 mt -132.68 122.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.352 -0.843 . . . . 0.0 108.901 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -72.88 89.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.951 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.15 -123.8 12.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HB3' HG12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -100.88 52.97 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -1.096 . . . . 0.0 109.676 -179.674 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.88 -37.53 70.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.37 174.04 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.17 44.06 30.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 87' ' ' GLN . 68.2 mt-10 -77.12 -80.56 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.45 -7.77 53.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.315 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -86.86 8.76 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.902 . . . . 0.0 109.51 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.19 -37.58 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -38.94 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 5.1 mm-40 -71.0 -18.18 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.06 62.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.76 -18.91 9.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 109.702 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -74.15 -45.68 47.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.78 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -79.33 -19.63 49.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.621 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.61 -20.73 25.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.132 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HG2' ' OG ' ' A' ' 106' ' ' SER . 34.7 tt0 -71.39 -28.03 63.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.4 ' HG3' ' ND1' ' A' ' 104' ' ' HIS . 7.2 pt-20 -59.27 -31.06 68.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.669 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.4 ' ND1' ' HG3' ' A' ' 103' ' ' GLU . 14.1 m-70 -82.24 -40.72 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 105' ' ' ILE . 7.4 mt -85.74 12.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' SER . 58.0 m -110.58 117.69 34.22 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 81.65 171.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.827 -0.546 . . . . 0.0 109.537 179.884 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 77.67 173.33 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 109.13 -179.539 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 4.8 p-80 -170.13 125.56 0.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.61 169.23 40.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 3.7 m-20 -67.51 -40.23 85.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -1.096 . . . . 0.0 109.327 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 113' ' ' ASP . 23.2 m -124.92 -9.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 112' ' ' VAL . 2.0 m-20 -48.02 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.168 179.804 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.527 ' CD1' ' C ' ' A' ' 114' ' ' TYR . 5.8 p90 -75.93 -21.2 57.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.017 -1.052 . . . . 0.0 108.294 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -62.81 -18.28 62.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.631 -0.668 . . . . 0.0 109.355 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 3.0 mt-30 -70.23 -36.06 74.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.653 ' HB3' HG13 ' A' ' 105' ' ' ILE . . . -72.86 -24.7 60.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -65.96 -25.98 67.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.339 -0.851 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.3 -33.32 25.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.653 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 117' ' ' ALA . 1.2 pp20? -85.61 -8.3 58.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 122' ' ' ALA . 9.0 tt -84.14 -59.13 2.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.548 ' HA ' ' CG1' ' A' ' 125' ' ' ILE . . . -46.54 -27.79 1.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -51.22 70.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.918 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.19 59.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.548 ' CG1' ' HA ' ' A' ' 122' ' ' ALA . 33.5 mm -76.6 -8.12 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.962 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -88.72 -2.86 58.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.168 -0.958 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.496 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.6 mt-30 -87.63 -37.89 16.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.232 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 131' ' ' ILE . 4.6 tp -81.19 -24.54 37.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.855 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' LEU . 16.5 mmm180 -62.5 -43.51 98.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 127' ' ' GLN . 28.1 m -68.66 -9.99 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.71 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 87' ' ' GLN . 63.0 mt -90.62 -56.15 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 21.1 mm-40 -68.67 -9.19 48.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -87.65 -48.69 7.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.544 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 10.4 t -69.08 -7.57 37.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -55.64 -53.64 54.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.554 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -87.46 -12.74 45.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -46.83 -37.83 9.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.306 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.397 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.504 ' HG2' ' CG ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER 177.84 56.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.746 -179.895 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 3' ' ' THR . 8.9 t 173.7 129.31 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.71 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 1.035 ' CE2' HG22 ' A' ' 34' ' ' ILE . 13.8 p90 -112.84 -162.55 0.8 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.486 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER -117.27 142.36 47.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 108.548 178.756 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.042 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -130.43 156.79 44.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.415 178.43 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.891 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -143.03 90.2 2.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.951 HG13 HD13 ' A' ' 6' ' ' LEU . 7.3 m -108.37 147.7 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -169.31 151.19 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 2.4 m -119.94 125.68 49.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 56.0 27.78 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER 66.07 72.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -165.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 82.74 1.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.621 ' SD ' HG23 ' A' ' 62' ' ' ILE . 7.4 mmt -105.88 -92.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HB3' HG22 ' A' ' 8' ' ' VAL . 34.4 t80 -121.07 138.99 53.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.084 -1.01 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 p -169.06 100.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 154.94 -151.41 23.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.786 ' C ' HG12 ' A' ' 20' ' ' VAL . 10.9 mt -64.22 170.48 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.042 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 172.92 160.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 108.39 -177.608 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.537 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 8.6 tt0 -156.32 -58.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.916 -1.115 . . . . 0.0 110.623 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.544 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -91.42 74.72 6.03 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.395 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.665 HG22 ' CG1' ' A' ' 52' ' ' ILE . 2.9 pt -99.89 143.67 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.269 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 35.8 tt0 -150.63 121.85 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.789 -1.194 . . . . 0.0 109.674 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.84 159.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 5.9 m -138.46 111.79 8.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.216 -0.927 . . . . 0.0 109.204 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.53 -99.62 0.52 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -134.56 -0.12 2.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -1.169 . . . . 0.0 110.214 -179.674 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 tm-20 -164.05 128.66 2.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.93 -53.64 0.61 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 16.8 mt-10 48.85 23.61 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -1.174 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.576 HD22 ' OH ' ' A' ' 35' ' ' TYR . 1.7 mt -148.13 161.09 42.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -111.73 -103.83 2.72 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.035 HG22 ' CE2' ' A' ' 4' ' ' TYR . 9.2 mm -154.54 140.59 11.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.41 -1.053 . . . . 0.0 109.238 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -121.5 -178.89 0.66 Allowed Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.345 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 34.3 Cg_endo -77.54 96.09 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.262 1.975 . . . . 0.0 110.4 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.88 15.25 5.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.475 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 40.2 t-80 -72.74 171.98 11.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -1.146 . . . . 0.0 109.447 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -85.89 156.49 58.09 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.353 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 71' ' ' VAL . 34.0 Cg_endo -77.02 78.0 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.682 2.254 . . . . 0.0 110.782 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 71' ' ' VAL . 1.2 mm? -97.84 149.04 22.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.983 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.51 ' C ' HG22 ' A' ' 43' ' ' THR . 0.8 OUTLIER -152.74 133.47 13.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 179.97 -92.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.84 . . . . 0.0 109.436 179.48 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.503 ' H ' HG23 ' A' ' 43' ' ' THR . . . -131.29 160.9 33.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.925 HD13 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -100.42 132.42 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -65.33 136.41 96.37 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 -179.837 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' CB ' ' OG ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -80.18 160.51 23.4 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.446 2.097 . . . . 0.0 110.44 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 126.58 -131.64 7.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ptm -121.94 178.3 4.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -1.056 . . . . 0.0 109.009 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -156.23 131.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.618 -1.301 . . . . 0.0 110.96 -179.604 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -98.84 129.67 45.23 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.943 HD11 ' CD2' ' A' ' 6' ' ' LEU . 2.1 tt -130.82 152.38 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.887 -1.133 . . . . 0.0 110.898 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 46.8 t -131.19 107.56 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' GLN . 4.4 ttpt -67.29 119.51 12.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.735 . . . . 0.0 109.646 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' LYS . 3.4 tt0 41.19 -152.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.423 -0.798 . . . . 0.0 109.742 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -88.91 67.24 8.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 161.62 163.6 14.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.3 m-70 57.88 159.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.184 -1.186 . . . . 0.0 109.347 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.3 OUTLIER 179.97 118.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -132.53 157.08 45.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.603 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.4 OUTLIER -113.58 136.44 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 -179.904 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 50' ' ' ILE . 5.3 mp -112.58 167.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.602 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 14.4 t80 -128.48 140.83 51.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.32 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -168.83 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.467 ' OG ' ' CB ' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -179.47 132.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 -179.966 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.642 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 72.79 142.97 0.51 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.57 165.06 11.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.73 123.85 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -1.108 . . . . 0.0 109.22 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.806 HD12 HD12 ' A' ' 45' ' ' ILE . 1.2 tt -108.09 153.73 22.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.0 110.036 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 77' ' ' THR . 4.4 pt-20 -156.14 111.0 2.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG23 ' HB ' ' A' ' 76' ' ' VAL . 4.4 p -99.85 159.08 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 2.0 mt-30 -143.11 172.97 4.97 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.7 Cg_endo -80.26 62.11 8.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.627 2.218 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.63 -14.74 1.06 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 1.9 p30 -167.21 168.65 13.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.996 -1.296 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -155.49 162.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.413 -0.804 . . . . 0.0 109.063 -179.891 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 7' ' ' ASP . 6.4 p -154.18 156.05 36.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG21 HD13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -166.43 130.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.962 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.96 112.0 23.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.642 ' HB1' ' O ' ' A' ' 66' ' ' GLY . . . -106.07 -175.27 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.63 -9.26 9.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 65' ' ' SER . 16.7 m -109.35 142.04 40.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -161.39 132.85 5.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.911 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.602 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 18.9 mt -128.8 -36.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.368 -0.833 . . . . 0.0 109.143 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 75.34 134.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.172 -179.763 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -39.16 96.6 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 85' ' ' ARG . 8.2 tt0 63.85 74.36 0.42 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -1.112 . . . . 0.0 109.942 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 8.9 t70 -52.3 -35.09 49.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.086 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER 166.47 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.076 179.875 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 75.12 153.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' CB ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.66 -29.36 3.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.56 -33.64 20.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.476 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 9.3 ttt180 -63.67 -22.72 67.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 0.0 109.466 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.74 -25.11 23.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.274 -0.891 . . . . 0.0 108.712 179.63 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.538 ' HA ' HD11 ' A' ' 128' ' ' LEU . 2.5 mtm -66.29 -20.74 66.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.505 -0.747 . . . . 0.0 109.373 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 2.3 tm-20 -80.05 -22.38 42.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.93 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.15 72.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.405 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.34 -26.81 61.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.211 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -81.94 -26.68 33.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HG3' ' OE1' ' A' ' 96' ' ' GLU . 8.3 mttt -83.25 -27.32 29.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 109.624 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.87 -19.69 31.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.395 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 16.1 tp10 -77.34 -38.22 50.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.924 . . . . 0.0 109.334 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -72.49 -43.61 63.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -28.05 67.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.801 ' O ' HG22 ' A' ' 105' ' ' ILE . 98.8 mt -90.24 26.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.203 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 t -97.32 -14.35 21.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.707 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.6 p -126.01 110.91 14.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -158.0 155.73 29.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 109.271 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.7 -76.95 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 111' ' ' ASP . . . 179.05 -175.74 47.48 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 0.2 OUTLIER 77.84 -78.03 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -1.079 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.3 m -135.51 8.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.15 -91.24 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.409 -0.807 . . . . 0.0 108.884 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 108' ' ' SER . 49.5 t80 -72.12 -17.49 61.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.22 82.21 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 5.9 mm-40 -90.68 -32.5 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.494 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -67.37 -24.77 65.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -32.23 53.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.441 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.24 -25.98 22.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 8.8 mm-40 -62.87 -46.31 88.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -58.03 -52.56 65.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.463 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -18.85 60.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 -179.686 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -29.46 64.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.96 -24.67 21.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.812 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 125' ' ' ILE . 24.7 mm -80.62 7.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.54 -34.07 15.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 2.6 pt20 -80.86 -25.01 37.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.903 . . . . 0.0 109.618 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -71.23 -15.84 62.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.25 -52.49 4.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 21.6 m -56.61 -29.33 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.942 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 132' ' ' GLU . 12.0 tt -64.36 -42.96 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.005 . . . . 0.0 109.735 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 131' ' ' ILE . 6.6 mm-40 -60.39 -23.77 64.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.28 -49.62 16.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.792 -179.677 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 8.8 t -70.66 -17.81 62.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -53.04 52.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -5.26 59.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -60.27 -34.09 73.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.519 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.227 0.537 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.6 143.27 16.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.629 HG22 ' CG ' ' A' ' 21' ' ' GLU . 7.6 p -45.52 135.87 6.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.701 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 5.3 p90 -132.8 178.36 6.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.063 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.3 t60 -103.79 149.1 25.34 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.121 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -138.55 156.72 47.24 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.442 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.859 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.68 94.09 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.98 -1.075 . . . . 0.0 110.261 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.707 HG12 ' HB3' ' A' ' 16' ' ' PHE . 6.5 p -107.61 96.32 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 108.779 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.561 HG23 HD23 ' A' ' 79' ' ' LEU . 28.7 m -118.26 162.22 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.961 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 t -102.63 -158.27 0.66 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.343 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -68.38 -50.27 54.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 4.2 mt-10 -141.59 67.61 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 1.8 mm-40 171.61 68.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 13' ' ' GLN . 14.7 pt20 -43.71 158.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.66 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.94 ' HB3' HG21 ' A' ' 62' ' ' ILE . 12.3 mmm -126.83 -73.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.176 -0.952 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.707 ' HB3' HG12 ' A' ' 8' ' ' VAL . 40.9 t80 -114.68 93.45 4.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.9 p -124.04 95.71 4.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -159.73 32.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.405 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.6 mt -66.78 160.73 25.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -1.173 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.121 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -164.36 160.26 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.969 -178.5 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.629 ' CG ' HG22 ' A' ' 3' ' ' THR . 0.1 OUTLIER -130.63 -34.85 1.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.516 -0.74 . . . . 0.0 109.35 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.4 ttpp -155.1 97.84 1.96 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.096 -1.002 . . . . 0.0 110.515 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.31 156.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.52 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 11.9 tt0 -151.96 134.47 15.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.538 HG23 ' HA2' ' A' ' 33' ' ' GLY . 36.5 t -108.78 142.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -130.41 113.04 13.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.51 -111.95 1.48 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.712 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 m -107.97 -62.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -1.179 . . . . 0.0 109.466 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.64 -17.8 14.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.56 119.37 5.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -129.26 34.62 4.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -1.194 . . . . 0.0 109.798 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.69 HD23 ' OH ' ' A' ' 35' ' ' TYR . 6.5 mt -138.61 139.29 38.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.013 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.11 -101.46 2.29 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.709 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.861 HG21 HG21 ' A' ' 76' ' ' VAL . 20.4 mm -155.59 152.7 8.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.69 ' OH ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -154.44 -176.0 0.56 Allowed Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.746 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 36.2 Cg_endo -81.7 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.359 2.04 . . . . 0.0 110.183 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.49 38.64 0.02 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.71 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 10.4 t-160 -82.47 10.02 8.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -1.08 . . . . 0.0 109.594 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.873 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 75.86 173.47 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.314 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.873 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -78.16 76.97 4.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.581 2.188 . . . . 0.0 110.485 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -90.01 130.04 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.183 179.804 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.2 tp -148.77 69.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -140.29 -95.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.729 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.507 ' H ' HG23 ' A' ' 43' ' ' THR . . . -156.87 167.96 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.808 ' CD1' HG21 ' A' ' 78' ' ' VAL . 3.4 mt -110.07 167.25 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 68.4 mmtt -100.11 159.45 29.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.09 163.95 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.858 2.372 . . . . 0.0 110.423 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 130.78 -146.25 17.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.669 ' HB2' HG11 ' A' ' 130' ' ' VAL . 24.8 ptm -103.19 -176.77 3.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -1.112 . . . . 0.0 109.085 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -158.52 118.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 109.544 -179.81 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.36 131.28 46.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 109.367 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 23' ' ' ILE . 35.5 mt -132.73 163.08 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.107 -0.995 . . . . 0.0 109.784 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.592 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 39.2 t -134.95 154.62 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.616 -0.677 . . . . 0.0 109.64 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.4 tmtm? 92.0 -79.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.492 ' OE1' ' HG2' ' A' ' 60' ' ' GLU . 14.6 tt0 51.44 -99.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.818 -1.176 . . . . 0.0 109.606 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -165.28 50.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.922 -1.111 . . . . 0.0 109.275 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 146.73 -44.61 0.82 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -150.93 -176.64 5.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.406 -1.055 . . . . 0.0 109.235 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.566 ' HG2' HG13 ' A' ' 53' ' ' VAL . 5.6 mp0 -106.9 162.31 13.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 109.124 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HG2' ' OE1' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -162.64 171.28 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.968 -1.082 . . . . 0.0 110.016 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.592 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.7 OUTLIER -121.1 176.3 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 109.656 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.94 HG21 ' HB3' ' A' ' 15' ' ' MET . 1.2 mt -152.94 -160.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.78 . . . . 0.0 109.0 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.804 ' C ' HD13 ' A' ' 64' ' ' LEU . 3.8 t80 -172.36 128.87 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.21 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.888 ' N ' HD13 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -158.63 -169.74 2.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 109.708 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -86.98 -59.75 2.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.55 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.14 -63.92 0.33 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.59 -152.3 52.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.843 ' O ' HG23 ' A' ' 78' ' ' VAL . 75.1 mt -102.71 137.99 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.141 . . . . 0.0 109.217 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.732 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.7 tt -119.37 152.6 36.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.0 109.576 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 6.0 mt-10 -149.65 138.33 20.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 109.229 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.597 ' HA ' HG12 ' A' ' 76' ' ' VAL . 9.6 p -100.52 140.51 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.793 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 5.6 mt-30 -124.19 174.76 3.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.4 Cg_endo -78.12 80.92 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.342 2.028 . . . . 0.0 111.022 -179.389 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 102.5 25.3 7.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 7.0 p-10 171.15 138.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -1.208 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.861 HG21 HG21 ' A' ' 34' ' ' ILE . 28.3 m -126.61 172.48 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 108.908 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 78' ' ' VAL . 55.3 m -163.11 157.19 20.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.212 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 68' ' ' ILE . 2.4 p -161.82 135.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 108.95 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.561 HD23 HG23 ' A' ' 9' ' ' VAL . 2.0 mt -116.37 122.9 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.082 -1.012 . . . . 0.0 109.779 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.14 -168.06 1.33 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.235 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.57 -12.02 8.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.447 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.2 m -112.19 147.83 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -158.25 70.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 109.728 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.652 HD12 ' CE1' ' A' ' 63' ' ' TYR . 8.6 mt -99.0 56.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 88' ' ' ASP . 7.2 ptt180 -46.21 154.6 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.42 ' C ' ' HG3' ' A' ' 87' ' ' GLN . . . -58.37 148.98 36.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.816 ' CD ' HG21 ' A' ' 134' ' ' THR . 12.9 mt-30 69.29 6.15 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -1.122 . . . . 0.0 109.645 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 12.0 t70 -70.13 -34.43 73.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.68 151.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 93' ' ' ARG . 66.0 t0 56.99 103.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.311 -0.868 . . . . 0.0 109.585 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.11 -53.98 2.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.5 -20.7 26.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.504 ' CB ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -86.76 -9.35 56.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.968 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . . . -90.41 -12.22 38.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.209 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -25.97 32.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 109.683 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 12.5 pt-20 -77.07 -14.33 59.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.38 -47.92 53.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 109.54 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -21.91 19.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -39.67 24.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -90.08 0.46 57.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.973 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -90.33 -32.18 16.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.72 -26.22 68.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.75 -37.43 82.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -68.96 -16.24 63.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 107' ' ' SER . 11.4 mm -89.14 19.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.165 -0.96 . . . . 0.0 109.744 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -47.52 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.634 -179.937 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' ILE . 2.5 m -43.66 137.18 3.09 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.4 p -166.41 158.93 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.499 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.17 166.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.14 138.35 5.23 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -72.16 -72.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.329 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.704 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 32.2 m -111.61 12.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 112' ' ' VAL . 29.6 t0 -49.86 -99.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -68.45 -15.8 63.68 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.873 -1.142 . . . . 0.0 108.514 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -64.84 -16.0 62.58 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.601 -0.687 . . . . 0.0 109.5 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -88.83 -27.92 20.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -82.67 -14.29 54.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -23.39 61.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.61 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.57 -23.9 24.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.25 -10.38 54.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.973 HD12 ' HB1' ' A' ' 101' ' ' ALA . 3.1 mm? -86.3 -63.62 1.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.644 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 125' ' ' ILE . . . -54.18 -18.67 4.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -54.59 -41.04 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.23 -36.3 18.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -64.6 -10.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.427 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.512 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -69.53 -35.46 75.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.476 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.518 ' HA ' HG22 ' A' ' 130' ' ' VAL . 1.6 pp0? -81.09 5.33 16.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.835 HD23 ' O ' ' A' ' 128' ' ' LEU . 2.3 tt -86.14 -36.23 19.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -34.74 62.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.161 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 49' ' ' MET . 35.5 m -72.38 -36.56 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 128' ' ' LEU . 3.6 tt -68.26 -31.37 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -75.29 -16.55 60.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -71.03 -42.1 69.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.647 -179.95 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.816 HG21 ' CD ' ' A' ' 87' ' ' GLN . 9.7 t -74.1 -14.13 60.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -60.09 -35.72 75.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.11 -0.994 . . . . 0.0 109.176 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -95.75 -3.98 44.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.252 179.703 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -58.49 -57.09 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.474 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.3 ptp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.444 179.797 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.447 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.2 mtm -152.59 141.49 21.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -162.04 177.17 9.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.829 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.4 p90 -166.05 -149.09 0.1 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.557 ' HA ' HG12 ' A' ' 20' ' ' VAL . 1.2 t-80 -133.05 147.54 52.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 108.886 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.037 HD23 HG21 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -140.23 169.96 16.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.194 178.975 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 1.027 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.75 103.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.896 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.6 p -116.39 102.94 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.981 . . . . 0.0 109.515 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG13 ' HA ' ' A' ' 14' ' ' GLN . 15.0 t -111.55 156.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.589 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 15.4 t -122.13 78.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 109.655 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 69.14 -85.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.77 30.88 4.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.507 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.69 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.741 ' HA ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.27 144.99 11.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 -179.853 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.593 ' SD ' HG23 ' A' ' 62' ' ' ILE . 13.9 mtt -127.96 -77.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.262 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.672 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 34.7 t80 -103.49 123.83 47.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 17' ' ' SER . 14.8 p -152.12 103.04 2.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.0 -155.32 26.05 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' C ' HG12 ' A' ' 20' ' ' VAL . 8.5 mt -61.33 178.69 0.26 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.119 -1.224 . . . . 0.0 108.937 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.037 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 175.88 113.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.784 -1.197 . . . . 0.0 109.888 -177.871 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 6.6 tt0 -76.17 -43.04 44.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.085 179.242 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -165.94 134.51 3.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.987 -1.071 . . . . 0.0 110.586 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.872 HD11 HG12 ' A' ' 34' ' ' ILE . 39.0 pt -98.71 -148.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -176.1 132.99 0.25 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.259 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.476 HG23 ' HA2' ' A' ' 33' ' ' GLY . 4.1 t -140.25 131.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.976 -1.078 . . . . 0.0 109.324 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.7 m -132.61 113.89 13.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.519 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.76 -119.64 2.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.6 p -122.65 -6.63 8.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.01 -91.86 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.92 142.8 34.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.98 63.1 1.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -1.219 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' A' ' 32' ' ' LEU . 8.9 mt -141.26 162.36 35.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 109.595 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -106.05 -116.64 4.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.882 HG21 HG21 ' A' ' 76' ' ' VAL . 17.5 mm -153.05 141.1 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.531 -0.982 . . . . 0.0 108.373 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -139.37 172.99 5.6 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.745 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -73.26 85.29 1.25 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.034 1.823 . . . . 0.0 109.975 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.57 20.16 2.19 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 59.1 t60 -55.0 139.61 40.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -1.233 . . . . 0.0 109.381 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -43.68 162.15 0.19 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.322 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 34.2 Cg_endo -76.85 75.68 4.41 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.501 2.134 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.15 140.35 30.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.05 107.55 4.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 109.236 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.731 HG23 ' N ' ' A' ' 44' ' ' ALA . 11.8 t -175.25 -139.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.731 ' N ' HG23 ' A' ' 43' ' ' THR . . . -99.67 179.2 4.61 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.883 -1.136 . . . . 0.0 109.403 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 45' ' ' ILE . 1.3 tp -111.84 118.82 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.464 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -54.78 144.83 44.34 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.852 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.8 Cg_endo -78.5 172.7 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.661 2.241 . . . . 0.0 110.436 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.47 -153.98 19.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.864 ' HB2' HG13 ' A' ' 130' ' ' VAL . 4.7 ppp? -102.83 -178.93 3.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -1.124 . . . . 0.0 109.289 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 51' ' ' ARG . 3.9 mt -154.33 165.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.128 -0.982 . . . . 0.0 110.235 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.538 ' N ' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -152.85 151.03 29.94 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.357 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.656 ' CG2' HG22 ' A' ' 23' ' ' ILE . 21.5 mt -153.39 163.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.745 -1.222 . . . . 0.0 110.769 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' N ' HG22 ' A' ' 52' ' ' ILE . 67.3 t -139.84 109.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' HIS . 14.8 tttm -64.86 119.8 11.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.634 -0.666 . . . . 0.0 109.537 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 52.0 tt0 42.75 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.75 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.532 ' O ' ' CG ' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -154.87 56.49 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 -179.941 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -130.44 -98.25 0.81 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 176.92 4.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -1.092 . . . . 0.0 109.372 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.3 pt-20 -121.95 146.02 47.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 147.54 34.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 134' ' ' THR . 8.9 m-85 -102.85 155.58 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.671 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.593 HG23 ' SD ' ' A' ' 15' ' ' MET . 65.5 mt -153.47 145.84 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.598 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.542 ' CD2' ' HB ' ' A' ' 84' ' ' ILE . 4.0 t80 -147.47 133.08 18.79 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.802 ' C ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -167.79 168.17 12.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 110.107 -179.58 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.605 ' N ' HD22 ' A' ' 64' ' ' LEU . 1.4 m -150.19 92.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.379 -0.826 . . . . 0.0 109.296 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.94 105.09 1.77 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.544 ' C ' HD13 ' A' ' 68' ' ' ILE . . . -177.2 -178.48 46.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.864 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.1 mm -118.79 135.71 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -1.176 . . . . 0.0 109.414 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.617 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.5 tt -112.89 152.27 29.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -0.899 . . . . 0.0 109.578 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.41 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.0 tt0 -161.12 133.16 5.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 40' ' ' PRO . 13.5 p -99.89 140.64 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.579 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.3 mt-30 -120.6 -178.77 0.62 Allowed Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -79.63 82.58 2.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.4 2.067 . . . . 0.0 111.005 -179.586 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.47 -9.62 64.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HB2' ' OE1' ' A' ' 72' ' ' GLN . 10.0 m-20 -131.85 160.89 34.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -1.217 . . . . 0.0 109.695 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 34' ' ' ILE . 12.5 t -137.64 152.3 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -151.04 162.63 40.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -179.34 139.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.426 -0.796 . . . . 0.0 109.103 179.857 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 6.0 mp -106.23 174.05 6.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -164.21 165.49 21.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.265 -0.897 . . . . 0.0 109.589 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -108.27 -45.42 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.313 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.4 110.49 5.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 109.689 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.788 HG23 ' CG ' ' A' ' 88' ' ' ASP . 3.3 mt -137.75 73.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.057 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' GLY . 8.9 ptp180 -43.93 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.532 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.531 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -44.06 -58.01 4.56 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -47.91 -87.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -1.196 . . . . 0.0 109.329 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.788 ' CG ' HG23 ' A' ' 84' ' ' ILE . 18.8 t70 68.26 19.0 9.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 0.2 OUTLIER 71.97 34.26 1.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.627 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.76 161.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -138.45 -65.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.631 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.67 -12.22 51.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 109.719 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.17 9.05 13.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.626 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.28 19.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.335 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.17 -18.02 63.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.827 . . . . 0.0 109.519 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -77.93 -18.67 55.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.34 62.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.629 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -79.81 -22.77 42.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.22 -48.48 20.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.733 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -30.32 67.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.152 -0.967 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.22 26.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.65 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' LYS . 3.0 tt0 -80.3 -38.26 31.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.17 -32.0 70.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.138 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -27.87 67.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.314 -0.866 . . . . 0.0 109.296 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 121' ' ' LEU . 25.6 mt -88.97 21.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 109.647 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 107' ' ' SER . 19.3 p -57.35 -63.51 1.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.4 OUTLIER 168.01 94.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 -153.51 0.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.97 166.53 13.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.85 152.59 8.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.49 -56.47 3.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -1.112 . . . . 0.0 109.37 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.34 23.0 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 37.4 t0 -75.73 -95.79 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.206 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -71.19 -20.58 62.26 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.45 75.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.225 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -70.77 -34.12 71.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.93 -22.88 67.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.0 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.2 t -53.59 -40.76 65.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.374 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . -73.65 -38.79 64.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.02 -20.36 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.422 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 105' ' ' ILE . 7.2 tp -78.08 -65.34 0.99 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 125' ' ' ILE . . . -49.39 -29.69 6.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 119' ' ' ALA . 2.3 mptt -65.88 -43.69 87.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.87 -20.98 64.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 122' ' ' ALA . 10.5 mm -70.2 -14.02 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.43 -18.73 47.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.433 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.581 ' O ' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.537 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.462 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.9 OUTLIER -74.72 -13.05 60.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.602 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -84.45 -39.75 18.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.864 HG13 ' HB2' ' A' ' 49' ' ' MET . 2.7 m -70.58 -22.25 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 127' ' ' GLN . 23.4 pt -87.55 -32.61 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HG2' HG13 ' A' ' 131' ' ' ILE . 18.8 mm-40 -83.1 -17.84 41.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.657 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -85.33 -46.78 10.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.962 . . . . 0.0 109.499 179.867 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 61' ' ' PHE . 11.1 t -75.16 -13.18 60.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.406 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.48 -27.38 1.72 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.398 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -82.76 -38.03 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.823 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.68 -71.85 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.668 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.432 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.23 0.538 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 3' ' ' THR . 13.6 mtp -84.94 93.76 8.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.528 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -177.77 143.38 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.977 . . . . 0.0 109.684 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.67 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.8 p90 -137.7 -145.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.713 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.838 ' O ' HG22 ' A' ' 76' ' ' VAL . 35.6 t-80 -131.37 140.46 49.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.926 -1.109 . . . . 0.0 110.493 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.853 HD21 HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -109.96 127.65 54.9 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.327 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' HB3' ' OG1' ' A' ' 77' ' ' THR . 0.2 OUTLIER -135.73 63.64 1.59 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.956 -1.09 . . . . 0.0 109.307 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.838 HG23 ' CG2' ' A' ' 78' ' ' VAL . 1.9 p -99.64 131.04 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.211 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.7 144.68 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -153.05 -157.42 0.79 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 109.222 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 81' ' ' ASP . . . -43.51 122.85 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 108.985 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.5 mt-10 76.35 78.98 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.818 . . . . 0.0 108.989 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 12' ' ' GLU . 23.3 tm0? -41.47 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 172.64 47.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.772 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -93.7 -93.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.967 . . . . 0.0 109.346 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.621 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.1 t80 -134.04 111.44 10.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.034 . . . . 0.0 109.959 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.413 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 51.4 p -136.3 71.87 1.43 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.901 . . . . 0.0 109.38 178.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . -169.39 167.97 40.91 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 19' ' ' LEU . 18.8 mt -46.18 167.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.409 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.765 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -167.64 168.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.967 . . . . 0.0 109.549 -179.318 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.5 tt0 -120.17 -37.35 3.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -167.92 124.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.929 -1.107 . . . . 0.0 110.721 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.853 HG21 HD21 ' A' ' 6' ' ' LEU . 19.5 pt -99.09 -159.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.744 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 1.2 tt0 -177.04 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.865 -1.147 . . . . 0.0 109.789 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -99.34 99.78 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 109.588 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 26' ' ' THR . 5.8 t -100.14 129.49 46.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.868 . . . . 0.0 109.329 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.28 -90.34 0.51 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 p -134.45 -43.5 0.77 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -1.177 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -101.72 -78.0 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.555 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.81 114.43 6.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 25.25 11.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.446 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.437 HD13 ' OH ' ' A' ' 35' ' ' TYR . 11.6 mt -122.15 157.65 31.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.542 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -99.83 -109.51 3.06 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.67 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 22.8 mm -153.82 155.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 109.319 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -150.66 175.19 2.97 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.334 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.7 Cg_endo -74.05 82.28 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.12 1.88 . . . . 0.0 110.057 179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.37 26.78 2.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.586 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.1 t-160 -55.21 -89.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -1.097 . . . . 0.0 109.553 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -172.5 168.98 2.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.829 ' HA ' HG11 ' A' ' 71' ' ' VAL . 36.2 Cg_endo -78.43 70.02 7.42 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.671 2.248 . . . . 0.0 110.703 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.499 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 2.9 mm? -84.58 142.06 30.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.188 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.646 HD21 ' OE1' ' A' ' 70' ' ' GLU . 1.2 mt -151.85 49.38 0.8 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.086 -1.008 . . . . 0.0 109.558 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -126.51 -152.51 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.46 179.72 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 1.2 mt -128.55 168.7 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 167.67 8.92 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.533 ' CA ' ' O ' ' A' ' 65' ' ' SER . 35.6 Cg_endo -78.01 135.56 14.04 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.661 2.241 . . . . 0.0 110.381 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 177.31 -158.36 23.8 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.489 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.8 ptm -100.43 173.97 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.087 . . . . 0.0 109.102 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.767 HG23 ' H ' ' A' ' 62' ' ' ILE . 2.4 tt -148.41 103.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -99.3 147.26 25.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.773 ' CG2' HG22 ' A' ' 23' ' ' ILE . 12.6 mt -149.48 167.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.021 -1.05 . . . . 0.0 110.868 -178.825 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 59' ' ' GLU . 66.5 t -137.85 106.46 3.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -70.27 127.53 33.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.562 -179.387 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER 45.51 -158.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.68 82.79 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 142.75 146.09 4.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 22.1 t-80 75.2 162.09 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.644 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.8 pt-20 -170.34 132.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.22 138.17 51.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.246 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.93 ' C ' HD13 ' A' ' 62' ' ' ILE . 12.1 p90 -123.19 129.1 50.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.093 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -112.64 -146.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.35 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.839 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.3 t80 -169.98 141.98 2.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.018 . . . . 0.0 109.133 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 pp -142.41 -175.98 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.533 ' O ' ' CA ' ' A' ' 47' ' ' PRO . 23.1 t -117.32 -46.54 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.34 -143.93 3.79 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' LEU . . . 116.92 174.55 17.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.06 129.34 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.116 . . . . 0.0 109.472 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.965 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -100.56 118.23 36.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.47 -179.898 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.902 ' N ' HD22 ' A' ' 69' ' ' LEU . 15.0 tt0 -122.93 141.48 51.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.128 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.829 HG11 ' HA ' ' A' ' 40' ' ' PRO . 12.2 p -101.53 150.69 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.733 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.548 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 2.5 mt-30 -137.23 173.83 5.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.58 110.12 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.456 2.104 . . . . 0.0 110.669 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 69.15 37.73 82.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.58 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.5 p30 165.37 162.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.265 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 5' ' ' HIS . 32.8 m -142.34 163.32 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.53 -0.731 . . . . 0.0 109.099 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 40.7 m -160.2 132.81 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 109.742 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.838 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.0 m -127.52 153.79 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 109.339 179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' CA ' ' A' ' 67' ' ' GLY . 1.2 mp -111.97 121.61 45.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.016 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -133.72 168.41 18.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.178 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -126.13 -17.7 5.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 110.133 -179.737 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -113.22 142.74 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.807 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -150.47 132.99 15.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.068 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.839 HD12 ' CE1' ' A' ' 63' ' ' TYR . 57.6 mt -115.29 -40.46 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' GLY . 7.8 ttp180 69.77 133.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -41.58 -40.8 3.0 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.823 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 18.3 mt-30 -73.41 -61.94 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -1.216 . . . . 0.0 109.393 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.482 ' HB2' HG22 ' A' ' 84' ' ' ILE . 27.4 t70 62.69 12.83 5.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.785 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 tp 57.56 38.53 27.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 177.5 159.23 0.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.729 ' CB ' HD11 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -153.19 -50.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.064 -1.022 . . . . 0.0 109.855 -179.686 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.44 72.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -79.07 -17.49 55.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 109.847 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.763 ' HB1' ' OE1' ' A' ' 127' ' ' GLN . . . -90.51 -12.0 38.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.296 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.695 ' HG2' HD21 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -78.02 -24.12 47.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.55 -15.03 58.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.9 87.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.92 -37.19 13.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 109.724 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -50.89 15.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.965 . . . . 0.0 109.691 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -17.75 14.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 121' ' ' LEU . . . -89.52 -32.25 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.975 . . . . 0.0 109.643 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.737 ' O ' HG22 ' A' ' 105' ' ' ILE . 35.4 tp10 -73.99 -27.07 60.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -35.08 67.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 2.47 39.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 102' ' ' GLU . 1.7 tp -69.52 -19.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 p -89.71 -29.39 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.672 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -60.58 92.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 113' ' ' ASP . 10.9 m -162.59 -148.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.399 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 1.4 t-160 -140.66 -150.16 0.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.973 . . . . 0.0 109.678 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -77.22 0.35 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 112' ' ' VAL . 2.0 m-20 -80.51 177.0 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -1.161 . . . . 0.0 109.726 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.37 33.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.64 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 51.1 t0 -83.89 -96.78 0.06 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.059 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.62 -18.25 65.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.36 87.68 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.357 0.599 . . . . 0.0 109.394 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 22.0 mt-30 -88.41 -16.99 31.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.626 ' HB1' HD12 ' A' ' 105' ' ' ILE . . . -72.96 -27.14 61.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.2 t -60.22 -16.6 34.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -81.69 -61.11 2.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.75 -9.02 48.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.642 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 105' ' ' ILE . 11.8 tp -89.12 -60.71 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.8 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -78.26 5.65 9.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.036 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 119' ' ' ALA . 4.1 tttt -73.28 -45.79 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.59 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.08 -6.75 41.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' A' ' 122' ' ' ALA . 2.0 mp -84.73 -14.48 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.646 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -67.15 -32.46 73.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLN . . . . . 0.763 ' OE1' ' HB1' ' A' ' 94' ' ' ALA . 10.8 pt20 -82.5 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.1 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.695 HD21 ' HG2' ' A' ' 95' ' ' MET . 0.6 OUTLIER -74.67 -13.31 60.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.374 179.919 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -89.65 -53.74 4.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.701 HG23 ' HA2' ' A' ' 86' ' ' GLY . 34.4 m -67.77 -27.91 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.72 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.729 HD11 ' CB ' ' A' ' 91' ' ' GLU . 3.8 tt -65.11 -38.35 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.453 ' N ' HG23 ' A' ' 131' ' ' ILE . 4.8 mm-40 -67.23 -8.3 30.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -86.26 -44.22 12.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.843 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.8 t -82.33 -9.55 59.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -55.3 -45.68 76.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 137' ' ' ALA . 1.3 ptmt -85.75 -16.61 38.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.689 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.78 -39.49 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 mtp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.505 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 1.6 t -152.75 158.45 42.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.743 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.729 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.2 p90 -159.58 175.09 13.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 2.3 t-160 -99.41 124.79 44.85 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 108.742 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.061 HD23 HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -114.7 159.91 19.98 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.709 178.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.923 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.26 90.17 1.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.993 -1.067 . . . . 0.0 110.204 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 16' ' ' PHE . 1.8 p -100.13 132.15 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.077 -1.014 . . . . 0.0 109.25 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 m -152.76 171.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.62 ' OG ' ' HB3' ' A' ' 80' ' ' ALA . 3.1 m -141.18 72.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 61.82 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 55.22 58.23 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.556 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -147.45 154.24 40.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.79 76.91 1.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.699 ' HB3' HD13 ' A' ' 62' ' ' ILE . 5.7 mmt -79.72 -63.65 1.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 109.888 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.688 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 18.6 t80 -135.24 121.86 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.445 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -152.84 103.17 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.316 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 158.91 -164.21 33.59 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.436 ' C ' HG12 ' A' ' 20' ' ' VAL . 9.1 mt -56.6 155.88 6.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.057 -1.261 . . . . 0.0 108.709 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.061 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -168.44 116.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.021 -1.049 . . . . 0.0 109.99 -177.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 2.6 mt-10 -66.5 -47.53 72.71 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 108.761 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 17.6 tttt -172.95 144.44 1.28 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.124 -0.985 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.667 ' CG2' HD22 ' A' ' 6' ' ' LEU . 44.3 pt -98.26 -145.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.658 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.12 127.27 0.36 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 109.481 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.685 HG23 ' HA2' ' A' ' 33' ' ' GLY . 12.0 t -116.53 133.27 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 31.0 m -129.09 91.84 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.42 168.22 21.07 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.6 -50.98 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 109.488 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.28 99.51 7.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.386 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.99 140.95 4.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -152.13 26.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.77 150.97 41.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.067 -1.021 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.685 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.54 -114.92 3.63 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.729 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 17.9 mm -149.58 152.64 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.098 -1.237 . . . . 0.0 109.327 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.57 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -151.58 171.82 6.11 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.4 Cg_endo -73.23 78.24 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.028 1.819 . . . . 0.0 110.2 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.32 36.1 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CE1' HD12 ' A' ' 41' ' ' LEU . 11.4 t-160 -87.11 28.99 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -1.224 . . . . 0.0 109.831 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 71' ' ' VAL . . . 58.99 158.32 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.065 -1.022 . . . . 0.0 109.554 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.8 78.7 3.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.777 2.318 . . . . 0.0 110.682 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.598 HD12 ' CE1' ' A' ' 38' ' ' HIS . 25.3 mt -100.35 173.43 6.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -171.16 57.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.4 p -114.62 -136.9 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.25 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -104.39 164.21 11.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.928 -1.107 . . . . 0.0 109.324 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.0 mt -109.1 9.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.791 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER 55.54 158.33 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.672 . . . . 0.0 110.176 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.69 -175.66 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.733 2.289 . . . . 0.0 110.287 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 116.06 -161.05 13.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.472 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 15.9 ptm -102.91 179.57 4.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 109.248 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.866 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.4 OUTLIER -150.85 138.87 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.032 -1.043 . . . . 0.0 110.646 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG2' ' N ' ' A' ' 52' ' ' ILE . 66.3 ttt180 -119.67 161.32 20.89 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 53' ' ' VAL . 36.1 mt -157.23 167.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.72 -1.238 . . . . 0.0 110.876 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.592 ' N ' HG22 ' A' ' 52' ' ' ILE . 24.5 t -142.64 107.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB3' ' HA3' ' A' ' 57' ' ' GLY . 15.6 tttm -68.67 149.89 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 110.326 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.405 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 2.2 tt0 -54.27 -52.58 60.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 8.69 33.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 54' ' ' LYS . . . -108.38 178.01 21.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -84.82 -77.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.586 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' HIS . 17.0 pt-20 -179.59 139.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 109.84 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -138.21 156.8 47.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 1.068 ' CE2' HD11 ' A' ' 133' ' ' LEU . 6.1 p90 -128.65 125.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.883 HG23 ' HG3' ' A' ' 85' ' ' ARG . 1.0 OUTLIER -100.46 -146.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.228 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.788 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -175.51 132.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.034 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HG ' ' C ' ' A' ' 63' ' ' TYR . 1.1 mt -139.07 -171.82 3.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -139.79 -64.78 0.48 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.79 136.54 8.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.34 165.62 33.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 79' ' ' LEU . 1.1 pp -101.65 -176.24 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -1.197 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.568 ' HB2' HG12 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -148.62 169.38 20.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 110.364 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.72 111.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 6.2 p -99.53 144.6 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.441 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.554 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.48 178.34 1.04 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 36.3 Cg_endo -79.05 81.55 2.77 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.501 2.134 . . . . 0.0 110.922 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.15 -21.72 5.46 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 4.3 p30 -159.39 135.71 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.239 . . . . 0.0 109.864 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 77' ' ' THR . 9.6 p -99.18 168.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 109.271 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 76' ' ' VAL . 99.3 m -164.12 137.67 5.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.257 -0.902 . . . . 0.0 109.063 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' ' 69' ' ' LEU . 4.6 m -140.83 165.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.57 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.51 ' HB2' HD11 ' A' ' 68' ' ' ILE . 1.5 mt -131.6 149.49 52.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.866 . . . . 0.0 109.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB3' ' OG ' ' A' ' 10' ' ' SER . . . -148.25 176.68 10.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 109.52 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.94 -56.58 2.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.5 m -105.08 123.13 47.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.508 ' O ' ' HE2' ' A' ' 15' ' ' MET . . . -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.788 HD12 ' CE1' ' A' ' 63' ' ' TYR . 13.7 mt -101.61 150.7 5.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.213 -0.93 . . . . 0.0 109.461 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.883 ' HG3' HG23 ' A' ' 62' ' ' ILE . 8.3 ttm180 -119.74 155.85 31.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.479 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 87' ' ' GLN . . . -44.45 93.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 2.4 mt-30 162.32 -72.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.083 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 90' ' ' ASP . 1.3 p30 40.71 50.63 2.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASP . 86.0 mt 43.17 -93.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 88' ' ' ASP . 8.0 p-10 -49.48 159.64 0.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 109.329 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HA ' HD11 ' A' ' 131' ' ' ILE . 27.6 mt-10 -141.26 -56.68 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.65 -14.34 54.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -76.58 -10.56 59.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.01 -21.71 23.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.961 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.4 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.39 -27.67 68.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.44 -0.787 . . . . 0.0 109.376 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.72 -15.2 61.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . . . -68.04 -45.66 73.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -61.2 -17.03 51.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -89.9 -40.17 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -75.73 -12.25 60.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.942 . . . . 0.0 109.292 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.89 -15.36 39.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.132 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -46.67 67.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.365 -0.834 . . . . 0.0 109.407 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -49.51 -23.26 1.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 114' ' ' TYR . 54.1 m80 -86.7 -36.89 18.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 105' ' ' ILE . 17.5 mt -79.04 -6.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 p -101.06 -16.54 17.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.523 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.36 130.73 37.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.711 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.09 131.47 51.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 21.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.779 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.98 -176.63 33.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.968 ' OD1' HG13 ' A' ' 112' ' ' VAL . 1.3 p30 -81.12 -29.37 34.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.144 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.968 HG13 ' OD1' ' A' ' 111' ' ' ASP . 4.3 m -119.37 22.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.81 -99.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -0.817 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.485 ' HB2' ' HA ' ' A' ' 105' ' ' ILE . 17.6 p90 -65.3 -18.9 65.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.021 -1.049 . . . . 0.0 108.214 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -58.89 -39.08 80.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -77.15 -17.5 58.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.341 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.27 -17.85 53.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.2 t -62.01 -28.81 69.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -75.87 -27.89 57.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -85.52 -8.22 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.923 . . . . 0.0 109.494 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -90.41 -57.93 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -22.29 65.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -87.07 -19.53 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.85 -34.61 33.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.478 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 125' ' ' ILE . 2.8 mp -75.89 -6.09 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.378 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.46 76.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.595 ' HG2' ' CG ' ' A' ' 63' ' ' TYR . 5.1 tm0? -81.39 -14.29 57.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.535 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 34.6 tp -78.73 -25.02 44.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.0 109.69 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -45.71 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.939 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.652 ' HA ' HD23 ' A' ' 133' ' ' LEU . 35.7 m -70.41 -32.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.885 ' O ' HG22 ' A' ' 134' ' ' THR . 2.2 tt -78.24 -25.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.094 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 128' ' ' LEU . 1.4 mm-40 -74.66 -22.13 59.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.104 -0.997 . . . . 0.0 110.243 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 1.068 HD11 ' CE2' ' A' ' 61' ' ' PHE . 1.4 pp -90.54 0.45 57.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.995 -1.066 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.885 HG22 ' O ' ' A' ' 131' ' ' ILE . 7.5 t -89.07 4.6 47.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.665 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -71.46 -30.08 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.597 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 11.56 23.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.16 -47.27 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.452 -179.874 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 ttp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.326 0.584 . . . . 0.0 109.601 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.548 HG22 ' CG ' ' A' ' 21' ' ' GLU . 65.9 p -50.94 164.74 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 109.604 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.674 ' CE2' HG22 ' A' ' 34' ' ' ILE . 1.3 p90 -142.22 -144.86 0.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.714 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.743 ' O ' HG12 ' A' ' 76' ' ' VAL . 12.7 t-80 -129.62 126.71 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.79 -1.194 . . . . 0.0 111.221 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.025 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -99.75 130.9 46.01 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -139.49 75.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 109.746 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.4 p -104.01 111.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.668 HG12 ' HA ' ' A' ' 14' ' ' GLN . 2.7 m -116.57 -178.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.493 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -158.01 111.95 2.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.762 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.71 -89.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.735 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -134.71 62.23 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.66 142.64 12.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.478 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.668 ' HA ' HG12 ' A' ' 9' ' ' VAL . 6.1 pt20 -106.55 107.68 18.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.552 ' HE2' ' HG2' ' A' ' 85' ' ' ARG . 6.6 mtt -79.66 -60.68 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.641 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -130.84 111.07 11.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.923 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.5 p -136.97 92.19 2.7 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.69 -161.27 32.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 19' ' ' LEU . 36.2 mt -76.82 159.13 30.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.035 -1.274 . . . . 0.0 109.799 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.15 162.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.227 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.548 ' CG ' HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -122.29 -37.52 2.8 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.9 ttpp -160.77 110.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.98 . . . . 0.0 110.661 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.025 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.2 152.11 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.8 ' O ' HG23 ' A' ' 50' ' ' ILE . 1.9 tt0 -134.45 145.32 48.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.075 . . . . 0.0 109.964 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.875 HG23 ' HA2' ' A' ' 33' ' ' GLY . 3.1 t -131.95 125.46 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.434 -0.791 . . . . 0.0 108.96 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 88.8 m -116.06 97.86 6.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.353 -0.842 . . . . 0.0 109.395 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -103.24 -100.02 2.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 m -128.83 -81.0 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.53 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.78 166.29 3.7 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -156.54 32.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.242 -1.152 . . . . 0.0 109.597 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -102.7 150.08 23.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.529 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.875 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.45 -112.42 3.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.691 HG21 HG11 ' A' ' 76' ' ' VAL . 19.5 mm -154.32 147.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -1.141 . . . . 0.0 109.537 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -157.13 -172.77 0.34 Allowed Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 36.3 Cg_endo -81.11 31.15 0.51 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.0 1.8 . . . . 0.0 110.71 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.07 26.48 0.2 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.72 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 57.1 t60 -70.12 -4.85 23.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -1.084 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 77.05 168.24 0.12 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.1 Cg_endo -78.1 74.19 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.626 2.218 . . . . 0.0 110.524 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.52 142.65 27.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.307 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' HG ' ' C ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -139.84 32.54 2.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.608 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.3 t -100.67 -156.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.178 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.608 ' N ' HG23 ' A' ' 43' ' ' THR . . . -108.01 -177.35 3.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.032 -1.042 . . . . 0.0 109.663 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.851 HD11 ' N ' ' A' ' 69' ' ' LEU . 1.3 mp -126.48 177.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.68 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -108.08 167.13 9.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.394 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.504 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 35.4 Cg_endo -78.16 140.75 17.95 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.619 2.213 . . . . 0.0 110.516 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 168.43 -162.79 36.58 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.487 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.1 ptm -100.66 -170.65 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 109.211 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.8 HG23 ' O ' ' A' ' 24' ' ' GLN . 19.1 mt -158.09 140.63 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.987 . . . . 0.0 110.296 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.49 119.19 22.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.713 HG23 ' CA ' ' A' ' 23' ' ' ILE . 18.8 mt -123.46 170.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.116 . . . . 0.0 110.965 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.704 HG22 ' HG3' ' A' ' 59' ' ' GLU . 28.6 t -134.57 101.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -61.17 119.9 9.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 0.0 109.633 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' LYS . 31.1 mt-30 43.22 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -152.19 66.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 109.558 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.38 -128.01 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -69.28 -165.74 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.704 ' HG3' HG22 ' A' ' 53' ' ' VAL . 51.3 mp0 -129.95 -178.94 4.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 59.8 mm-40 -129.51 137.29 50.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.593 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -111.69 98.41 7.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 108.834 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 63' ' ' TYR . 4.0 mt -111.04 161.57 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 109.998 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.698 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.2 t80 -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -165.83 -171.09 1.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.829 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.47 ' CB ' ' HB3' ' A' ' 47' ' ' PRO . 3.1 t -160.48 139.76 10.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.782 . . . . 0.0 109.27 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' SER . . . 63.08 125.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.98 159.81 11.23 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 15.0 mt -106.65 123.7 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.076 HD22 ' N ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -101.61 127.88 48.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 1.076 ' N ' HD22 ' A' ' 69' ' ' LEU . 4.0 pt-20 -131.08 146.11 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 39' ' ' ALA . 12.1 p -102.27 163.92 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.052 -1.03 . . . . 0.0 109.928 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.521 ' N ' HG22 ' A' ' 71' ' ' VAL . 2.4 mt-30 -141.32 172.58 5.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 0.0 109.338 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.5 79.91 3.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.577 2.185 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.68 -12.55 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.513 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 4.8 p30 -149.28 172.4 14.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -1.181 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 5' ' ' HIS . 2.8 p -145.66 151.45 14.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 68.3 p -136.58 172.92 12.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -178.97 127.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 109.151 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -104.91 134.66 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.885 . . . . 0.0 109.265 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 64' ' ' LEU . . . -129.6 -179.91 5.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.0 109.625 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.55 -29.17 5.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.343 -0.848 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 51.9 m -103.12 119.97 39.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.72 98.73 3.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 63' ' ' TYR . 96.3 mt -109.71 -27.87 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.56 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.552 ' HG2' ' HE2' ' A' ' 15' ' ' MET . 22.1 mtm180 61.32 126.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.527 ' CA ' HG21 ' A' ' 130' ' ' VAL . . . -44.3 -29.7 1.76 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 88' ' ' ASP . 67.3 mt-30 -71.25 -64.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -1.122 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASP . 14.0 t0 44.4 41.32 4.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.58 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 88' ' ' ASP . 2.1 t70 -115.75 99.87 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.768 ' HB3' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -96.39 0.06 50.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.51 -14.17 62.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.385 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -82.88 -2.79 55.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.39 -23.62 21.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 0.0 108.856 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.653 ' HG2' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -57.1 -29.44 63.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.45 -0.781 . . . . 0.0 109.235 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.13 -57.87 9.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.45 69.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.877 ' HG3' HD11 ' A' ' 125' ' ' ILE . 25.2 tttt -55.16 -41.08 71.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -60.68 -51.83 67.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -76.58 -0.36 22.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.701 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -85.64 -30.7 23.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.127 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 4.7 tp10 -80.55 -26.03 38.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -82.15 -13.61 56.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.97 -31.51 20.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.58 ' O ' HG22 ' A' ' 105' ' ' ILE . 37.3 mt -77.85 -1.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.317 -0.864 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.3 m -105.83 78.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.29 167.9 2.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.3 m 64.85 -152.22 0.28 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 108' ' ' SER . 12.0 t-80 174.34 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.257 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.94 169.61 40.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.85 -59.42 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.2 16.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.96 -96.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.502 ' C ' ' CD1' ' A' ' 114' ' ' TYR . 13.7 p90 -74.14 -15.77 61.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 108.53 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.11 -19.83 65.69 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.62 -14.71 62.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.491 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.0 -6.67 57.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.502 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.26 -16.61 42.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.95 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -5.03 55.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.629 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.72 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.25 -52.28 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.35 94.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.542 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -61.08 -32.46 72.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.887 . . . . 0.0 109.633 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.24 -8.58 50.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 109.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.877 HD11 ' HG3' ' A' ' 98' ' ' LYS . 1.3 tp -88.89 5.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 109.354 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.35 -13.27 55.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.804 ' O ' HG23 ' A' ' 131' ' ' ILE . 24.2 pt20 -89.69 -13.39 37.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 95' ' ' MET . 0.2 OUTLIER -89.63 -29.5 18.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -73.13 -19.73 61.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 10.2 m -90.12 -27.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.727 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 127' ' ' GLN . 22.1 pt -75.57 -16.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.35 -47.74 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -61.59 -45.17 95.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.568 HG23 ' CD2' ' A' ' 61' ' ' PHE . 12.3 p -49.17 -26.54 2.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -57.81 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -110.07 50.42 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 133' ' ' LEU . . . -123.23 -48.66 1.96 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.371 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.393 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.473 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -174.01 156.16 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.775 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.628 ' HE1' HD11 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -143.55 -142.28 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.205 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.815 ' O ' HG12 ' A' ' 76' ' ' VAL . 17.5 t-80 -134.73 131.23 37.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.852 -1.155 . . . . 0.0 110.993 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.906 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -99.11 131.84 44.85 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.171 -0.956 . . . . 0.0 108.714 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.956 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -142.42 75.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.85 -1.156 . . . . 0.0 109.68 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.854 HG13 ' HB2' ' A' ' 15' ' ' MET . 1.4 p -105.11 117.14 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.34 164.24 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -128.8 -159.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.363 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.93 -74.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 109.388 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -136.95 53.69 1.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.77 109.92 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -65.2 154.64 37.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.302 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.854 ' HB2' HG13 ' A' ' 8' ' ' VAL . 3.8 mmt -118.84 -58.64 1.94 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.753 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.646 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.56 111.2 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.957 . . . . 0.0 109.677 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 95.0 p -131.93 78.02 1.79 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 20' ' ' VAL . . . -174.7 167.08 39.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.588 ' C ' HG12 ' A' ' 20' ' ' VAL . 54.4 mt -50.73 166.67 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.205 -1.174 . . . . 0.0 109.278 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.906 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -167.09 169.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -144.94 -63.63 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 109.517 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -90.43 103.45 16.13 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 0.0 108.657 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.881 ' HA ' HG23 ' A' ' 52' ' ' ILE . 3.1 mp -115.48 156.46 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.0 109.142 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.529 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -151.76 131.38 13.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.117 . . . . 0.0 109.741 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.552 HG13 ' HB ' ' A' ' 50' ' ' ILE . 1.1 t -145.57 127.15 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.332 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -148.34 127.73 13.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -137.49 -92.46 0.29 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -138.3 -40.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.0 109.445 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.05 -91.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.87 -172.5 5.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 32' ' ' LEU . 2.2 mt-10 -164.58 41.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.134 -1.215 . . . . 0.0 109.777 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -136.95 165.2 26.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.879 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.84 174.39 26.62 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 27.0 mm -99.21 160.96 3.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.636 -1.508 . . . . 0.0 109.515 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.648 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -162.59 171.21 6.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.4 Cg_endo -70.13 83.96 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.37 1.38 . . . . 0.0 109.618 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.34 14.36 0.83 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.991 ' NE2' HD23 ' A' ' 41' ' ' LEU . 43.1 t60 -53.88 157.85 2.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.84 -1.388 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.875 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -58.46 173.87 0.39 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.332 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.875 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.83 63.6 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.614 2.209 . . . . 0.0 110.602 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.991 HD23 ' NE2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -59.42 160.61 6.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.882 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.524 ' O ' ' CA ' ' A' ' 70' ' ' GLU . 85.5 mt -115.97 -92.08 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.983 . . . . 0.0 110.649 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.633 ' O ' HG22 ' A' ' 68' ' ' ILE . 7.1 p -122.66 27.2 7.91 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 121.596 -0.69 . . . . 0.0 110.242 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 69' ' ' LEU . . . -113.64 119.35 37.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.868 -1.145 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 67' ' ' GLY . 5.2 tt -112.4 176.49 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.417 -0.802 . . . . 0.0 109.174 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -120.4 130.98 24.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.973 -1.08 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.457 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 36.4 Cg_endo -79.34 -164.51 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.547 2.165 . . . . 0.0 110.384 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 90.32 -133.77 11.98 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.546 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.1 ppp? -114.57 174.8 5.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -1.085 . . . . 0.0 109.41 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.957 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.4 OUTLIER -149.99 116.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.368 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -104.94 123.61 48.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.815 . . . . 0.0 108.959 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 23' ' ' ILE . 2.6 mt -129.98 -176.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.001 -1.062 . . . . 0.0 109.916 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.652 ' H ' HG22 ' A' ' 52' ' ' ILE . 6.8 t -158.14 109.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -57.57 114.01 2.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.578 -0.701 . . . . 0.0 110.398 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.499 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 40.59 61.93 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.771 . . . . 0.0 110.151 179.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.44 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 43.08 44.8 4.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.779 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.57 -122.29 2.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -52.05 146.98 7.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.306 -1.114 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.61 123.04 47.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.099 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -128.04 121.16 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.339 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.595 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.0 p90 -113.28 147.83 36.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.222 -0.923 . . . . 0.0 109.908 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.957 ' H ' HG23 ' A' ' 50' ' ' ILE . 1.7 mt -120.07 -158.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.424 -0.797 . . . . 0.0 109.139 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.661 ' CE1' HD12 ' A' ' 84' ' ' ILE . 7.6 t80 -172.44 133.32 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.458 HD22 ' HB2' ' A' ' 80' ' ' ALA . 2.1 mp -140.43 -174.54 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -128.12 5.16 5.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.49 160.04 8.32 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.862 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 162.16 -175.5 38.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 43' ' ' THR . 1.4 pt -103.16 137.8 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -1.12 . . . . 0.0 109.258 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.798 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' CA ' ' O ' ' A' ' 42' ' ' LEU . 15.2 pt-20 -126.59 139.41 53.21 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 40' ' ' PRO . 9.2 p -100.51 142.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.472 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.4 mm100 -124.74 158.75 61.27 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 109.097 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -76.95 86.47 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.603 2.202 . . . . 0.0 110.477 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.64 2.28 10.61 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.541 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 175.7 175.68 0.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -1.178 . . . . 0.0 109.213 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 5' ' ' HIS . 2.3 p -150.63 148.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.167 -0.958 . . . . 0.0 109.132 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.956 HG22 ' HB3' ' A' ' 7' ' ' ASP . 7.5 p -140.86 142.86 34.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 109.573 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.763 ' HB ' HD12 ' A' ' 45' ' ' ILE . 3.0 m -148.36 138.28 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.634 ' C ' HD23 ' A' ' 79' ' ' LEU . 1.2 tt -114.49 135.74 53.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.458 ' HB2' HD22 ' A' ' 64' ' ' LEU . . . -122.2 179.42 4.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -115.39 -11.28 11.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 83' ' ' ALA . 9.3 m -127.53 161.4 28.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 82' ' ' THR . . . -167.57 122.32 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 63' ' ' TYR . 48.3 mt -117.37 -45.22 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.288 -0.882 . . . . 0.0 109.267 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.485 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 3.0 ttt180 74.6 147.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.436 -0.79 . . . . 0.0 109.646 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.674 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -58.12 -21.87 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ASP . 57.8 mt-30 -81.45 -63.67 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.469 ' HB3' ' CG2' ' A' ' 84' ' ' ILE . 2.8 p30 40.35 30.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.62 -0.675 . . . . 0.0 109.867 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ASP . 1.2 mp 50.48 -179.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 91' ' ' GLU . 4.9 m-20 43.96 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.901 ' HA ' HD11 ' A' ' 131' ' ' ILE . 1.3 mt-10 172.97 -30.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.488 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 -17.4 48.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.85 . . . . 0.0 109.561 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 4.5 29.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.673 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' O ' ' CD1' ' A' ' 128' ' ' LEU . . . -90.84 -30.35 17.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.423 ' HA ' HD11 ' A' ' 128' ' ' LEU . 4.8 mtt -73.32 -5.06 37.22 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.361 -0.837 . . . . 0.0 109.596 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.06 1.61 56.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.636 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -89.34 -42.51 11.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.653 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -19.55 63.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -89.89 -26.99 20.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 9.1 pttt -89.3 -11.3 43.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.621 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 105' ' ' ILE . . . -90.47 -58.49 2.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.613 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.53 63.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.715 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -52.83 -38.34 61.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 109.889 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -88.38 -26.33 22.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.603 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 121' ' ' LEU . 12.0 mt -88.24 22.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 109.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.2 m -54.99 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER 67.37 118.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.0 t -137.74 118.98 14.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 109' ' ' HIS . 52.2 t-80 -113.28 56.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 115' ' ' ALA . . . -138.48 125.7 3.25 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 68.8 m-20 -44.88 -80.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -1.201 . . . . 0.0 109.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.629 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 20.6 m -117.53 -10.0 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.414 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.5 OUTLIER -48.02 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.335 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -70.94 -14.88 62.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.043 -1.036 . . . . 0.0 108.26 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -66.26 -23.36 66.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.569 -0.707 . . . . 0.0 109.264 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.42 -54.17 13.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.327 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.9 -20.21 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.19 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -44.24 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.16 68.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.381 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.54 -20.7 64.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 125' ' ' ILE . 7.6 mt -90.0 -24.0 21.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -59.75 -16.77 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.586 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.3 96.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -70.66 -5.97 33.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -85.79 -13.16 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.149 -0.97 . . . . 0.0 109.289 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -87.36 -24.56 24.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.293 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -83.55 -15.48 49.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.414 -0.804 . . . . 0.0 109.489 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -80.19 -22.74 41.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.601 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 1.9 ttp180 -85.24 -35.31 21.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.785 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.674 HG23 ' HA2' ' A' ' 86' ' ' GLY . 18.3 m -76.34 -28.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.901 HD11 ' HA ' ' A' ' 91' ' ' GLU . 7.1 tt -76.9 -38.45 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 109.267 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.466 ' N ' HG23 ' A' ' 131' ' ' ILE . 7.4 mm-40 -56.96 -23.86 48.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.07 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 41.4 mt -76.4 -37.63 56.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.25 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 72.0 p -59.29 -16.75 23.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.775 . . . . 0.0 109.65 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -76.18 -44.08 39.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -14.12 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.36 -80.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.491 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -133.88 174.58 10.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.723 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.1 p90 -148.39 -136.03 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.4 OUTLIER -151.05 138.37 19.4 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.817 -1.177 . . . . 0.0 110.423 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -102.18 148.06 25.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 77' ' ' THR . 1.1 t0 -144.92 72.02 1.32 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.017 -1.052 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 15' ' ' MET . 2.9 p -106.81 138.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.352 -0.842 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.568 ' CG2' HD23 ' A' ' 79' ' ' LEU . 32.8 m -145.88 173.26 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.687 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 45.9 t -170.25 113.76 0.47 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.056 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 65.96 26.48 10.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.075 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.1 mm-40 63.46 24.09 13.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.517 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.424 ' OE1' ' SD ' ' A' ' 15' ' ' MET . 12.4 tt0 -78.07 -22.49 48.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.144 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 6.3 mt-30 63.46 100.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.759 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 16.7 mmm -101.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.685 ' HD2' HD23 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -135.67 111.66 9.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.623 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 17' ' ' SER . 27.6 p -135.32 77.69 1.69 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.47 179.98 48.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 5' ' ' HIS . 12.0 mt -60.26 161.91 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -1.193 . . . . 0.0 109.492 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.791 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -157.75 159.3 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.81 . . . . 0.0 108.829 -179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.1 -52.75 2.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -0.937 . . . . 0.0 110.138 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -141.02 108.12 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.769 -1.207 . . . . 0.0 111.28 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.853 HD12 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -103.13 155.91 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 2.0 tm0? -146.76 115.61 6.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.416 -1.427 . . . . 0.0 110.724 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.994 HG21 ' HG2' ' A' ' 46' ' ' LYS . 3.3 t -103.92 133.62 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.233 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 54.7 m -125.01 102.72 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.549 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -123.07 -110.06 1.98 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 t -132.37 -77.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -1.16 . . . . 0.0 109.63 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.81 -24.75 67.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.74 151.37 18.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -142.81 11.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -1.076 . . . . 0.0 109.315 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.4 mt -116.64 156.45 27.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.562 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -100.03 -114.59 3.65 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.723 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 15.9 mm -154.98 143.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -1.049 . . . . 0.0 109.245 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -154.35 -172.13 0.31 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -78.94 8.86 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.805 1.67 . . . . 0.0 110.423 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.91 11.42 3.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 84.6 t60 -53.26 156.22 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.629 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -70.08 173.22 4.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.668 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -77.75 76.05 4.48 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.758 2.305 . . . . 0.0 110.386 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -100.3 140.29 34.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.607 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -155.51 29.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 109.563 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.3 p -121.76 -139.54 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.219 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.79 119.97 38.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -160.74 -166.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.757 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.994 ' HG2' HG21 ' A' ' 25' ' ' VAL . 13.3 mttt 71.5 46.41 0.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.8 Cg_endo -80.32 152.67 20.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 94.01 -152.71 20.84 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.696 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.548 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 7.2 ptm -99.56 -171.67 2.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -1.024 . . . . 0.0 109.503 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.805 HG12 HG22 ' A' ' 25' ' ' VAL . 40.9 mt -150.0 156.18 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.718 HG23 ' CA ' ' A' ' 23' ' ' ILE . 4.6 mt -121.26 162.8 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 110.476 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 74.9 t -133.38 118.95 33.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 154.71 -98.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 56' ' ' HIS . 1.9 tt0 37.75 47.44 0.84 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.6 t-160 81.8 -68.89 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.606 -0.684 . . . . 0.0 109.494 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -161.54 77.94 0.17 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.458 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 168.19 -160.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.149 . . . . 0.0 109.489 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.19 158.42 43.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.288 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -147.23 115.96 6.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.683 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.698 ' CD2' HD22 ' A' ' 133' ' ' LEU . 14.1 p90 -103.24 140.55 37.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.58 -156.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.945 . . . . 0.0 109.566 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 126' ' ' ALA . 8.9 t80 -177.46 111.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.195 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mp -134.85 -179.91 5.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 109.336 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -71.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.82 62.83 0.63 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.37 -179.62 50.63 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 78' ' ' VAL . 10.0 mm -101.45 118.37 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.946 HD13 ' HB ' ' A' ' 78' ' ' VAL . 4.1 mm? -99.47 157.69 16.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.36 133.01 11.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 108.993 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.529 HG11 ' HA ' ' A' ' 40' ' ' PRO . 12.7 p -99.69 136.26 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.655 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.494 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -119.03 173.59 3.34 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.38 -0.825 . . . . 0.0 109.456 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.2 Cg_endo -78.23 73.3 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.621 2.214 . . . . 0.0 110.515 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.6 3.67 32.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -151.67 -175.3 5.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 75' ' ' ASN . 4.5 t -158.64 146.78 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.263 -0.898 . . . . 0.0 109.034 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.85 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -138.22 157.5 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.946 ' HB ' HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -168.46 135.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.568 HD23 ' CG2' ' A' ' 9' ' ' VAL . 1.2 mt -125.83 109.02 12.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.75 179.34 4.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.623 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -105.17 -42.76 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 84' ' ' ILE . 14.8 m -109.42 100.4 9.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.759 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -122.38 94.33 4.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.189 -0.945 . . . . 0.0 109.379 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.959 HG23 ' OD1' ' A' ' 88' ' ' ASP . 3.3 mp -100.1 84.54 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.518 ' N ' ' OD2' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -66.36 133.7 51.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.62 -121.58 11.0 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.406 ' CD ' ' OE1' ' A' ' 91' ' ' GLU . 11.6 pt20 -124.32 53.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -1.106 . . . . 0.0 109.565 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.959 ' OD1' HG23 ' A' ' 84' ' ' ILE . 1.6 p30 -63.09 -13.37 35.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 89' ' ' LEU . 14.4 mt -114.57 -90.89 0.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 m-20 -117.1 -179.9 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.606 ' HB2' HD11 ' A' ' 131' ' ' ILE . 4.9 pt-20 -145.77 -43.54 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.863 . . . . 0.0 109.215 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.27 -18.46 39.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -0.828 . . . . 0.0 109.462 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.3 3.62 51.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -13.43 34.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.196 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.446 ' HG2' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.34 -18.04 34.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.374 -0.829 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.8 -14.95 57.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.495 ' O ' HD11 ' A' ' 125' ' ' ILE . . . -81.51 -5.71 58.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG2' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -89.85 -24.23 21.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -89.21 -21.44 23.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 109.401 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.32 -31.93 29.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.796 ' HB2' HD22 ' A' ' 121' ' ' LEU . . . -90.36 -39.66 12.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.0 -11.64 59.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.331 -0.856 . . . . 0.0 109.535 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 99' ' ' ARG . 15.5 tt0 -90.28 -37.41 14.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.6 -30.63 46.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.628 HD13 ' OG ' ' A' ' 118' ' ' SER . 31.3 mt -89.18 4.3 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.649 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 107' ' ' SER . 1.3 t -45.65 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER 77.25 121.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.429 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.1 141.29 18.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -111.28 -173.4 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.49 117.6 0.75 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -48.97 -69.91 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 19.9 m -121.03 12.17 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 18.4 t0 -66.22 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -0.868 . . . . 0.0 109.211 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' A' ' 114' ' ' TYR . 32.1 t80 -75.72 -5.5 45.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.54 -7.91 59.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -78.31 -29.43 47.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.603 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -78.24 -6.39 54.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.096 -1.002 . . . . 0.0 109.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.628 ' OG ' HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -79.76 -8.8 59.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.577 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.73 -34.87 17.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 123' ' ' LYS . 8.7 pt-20 -75.3 -27.42 59.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.796 HD22 ' HB2' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -79.29 -41.86 27.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.433 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.499 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -76.74 -11.67 59.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.246 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.56 -32.7 65.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.95 -26.99 54.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.0 mp -81.84 2.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.91 . . . . 0.0 109.479 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.563 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . . . -74.58 -26.68 60.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.489 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.6 mt-30 -74.56 -5.11 40.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 128' ' ' LEU . 6.7 tt -79.78 -19.19 49.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -90.06 -49.5 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.625 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 5.0 m -66.85 -38.64 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 109.588 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 91' ' ' GLU . 2.6 tt -54.97 -39.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.539 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -43.59 -38.3 2.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' A' ' 61' ' ' PHE . 9.0 mp -62.75 -51.55 66.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.148 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 134' ' ' THR . 18.9 p -50.84 -31.59 17.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 19.5 mttt -62.3 -42.9 99.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.54 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 20.6 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.455 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.18 -55.14 5.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.498 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.804 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 53.94 117.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.75 0.786 . . . . 0.0 110.47 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.695 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.3 p90 -130.69 -153.41 0.56 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.186 -0.946 . . . . 0.0 108.641 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 21.6 t-80 -129.53 144.56 51.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.943 -1.098 . . . . 0.0 109.852 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.086 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -138.21 164.19 29.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.225 -0.922 . . . . 0.0 108.958 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 1.066 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 t0 -160.02 94.69 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.98 -1.075 . . . . 0.0 109.964 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 6' ' ' LEU . 5.0 m -104.34 147.3 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 108.958 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 10' ' ' SER . 1.7 t -154.74 177.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 1.2 p -138.62 -160.89 1.11 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.27 -51.27 8.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.53 66.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.708 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -147.01 139.38 24.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.18 132.07 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.49 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.854 ' SD ' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -127.45 -72.88 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.642 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 47.9 t80 -151.41 112.83 4.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.26 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.404 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 56.9 p -141.74 92.84 2.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.44 -153.1 21.26 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' C ' HG12 ' A' ' 20' ' ' VAL . 21.4 mt -67.12 177.07 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.058 -1.26 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.086 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 177.17 159.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.13 -0.981 . . . . 0.0 108.658 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.804 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -129.75 -71.36 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.03 113.93 26.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.116 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.764 HG22 ' CG1' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -125.45 141.01 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.483 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 2.2 pt20 -145.54 129.66 17.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 109.885 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.773 HG22 ' CG1' ' A' ' 50' ' ' ILE . 3.3 t -109.9 128.4 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -111.73 116.56 30.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.51 -144.07 3.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLU . 89.3 p -77.39 122.65 25.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.121 . . . . 0.0 109.592 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 28' ' ' SER . 1.4 tp10 60.07 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.687 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.14 169.07 38.91 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -171.38 46.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -1.138 . . . . 0.0 109.319 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.565 HD13 ' OH ' ' A' ' 35' ' ' TYR . 8.8 mt -150.21 146.82 27.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.68 -99.49 2.24 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.695 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 20.5 mm -156.53 151.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.514 -0.992 . . . . 0.0 109.241 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.565 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.47 173.9 3.84 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.8 Cg_endo -73.26 81.77 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.908 1.739 . . . . 0.0 110.01 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.24 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -48.88 164.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.243 . . . . 0.0 109.413 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.828 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -78.28 170.62 15.38 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.332 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.828 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.19 73.93 5.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.581 2.188 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 41' ' ' LEU . 4.0 mm? -78.37 161.56 27.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.8 pp -169.08 36.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 108.972 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.1 -95.37 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.565 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.612 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -137.44 162.49 33.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.922 -1.111 . . . . 0.0 109.869 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.684 HD13 HG11 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -100.95 139.87 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' O ' HG11 ' A' ' 25' ' ' VAL . 13.3 mmtm -75.01 139.18 72.83 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.725 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.6 -162.04 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.716 2.277 . . . . 0.0 110.365 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.06 -141.12 15.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 ptm -108.78 174.41 5.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -1.144 . . . . 0.0 109.012 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.773 ' CG1' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -154.67 119.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.934 -1.104 . . . . 0.0 110.282 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.741 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.52 150.92 21.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.957 HD11 ' CD2' ' A' ' 6' ' ' LEU . 5.4 tt -143.84 167.9 12.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.617 -1.302 . . . . 0.0 111.384 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 38.8 t -134.56 90.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -53.81 121.76 8.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.325 -0.859 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.691 ' HA ' HG22 ' A' ' 3' ' ' THR . 1.3 tt0 45.38 -158.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.171 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -77.67 103.78 7.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.944 . . . . 0.0 109.115 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 103.3 178.77 26.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 t-160 62.45 129.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -1.229 . . . . 0.0 109.448 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.2 mp0 -134.31 134.14 41.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 52' ' ' ILE . 3.1 tt0 -104.85 170.48 7.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 0.0 109.596 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.631 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -133.07 122.86 24.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.169 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.5 mp -137.89 169.22 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.078 -1.013 . . . . 0.0 109.863 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -158.21 144.07 17.05 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.98 -164.26 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 110.035 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 33.6 p -105.1 -144.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.435 -0.791 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -96.02 -135.19 8.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 128.44 -167.32 20.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' ILE . 19.6 tt -105.04 125.1 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 109.062 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 70' ' ' GLU . 2.4 pp -113.51 167.91 10.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.244 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.789 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -161.79 123.63 2.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' ' 76' ' ' VAL . 9.9 p -99.95 145.01 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.984 -1.072 . . . . 0.0 110.418 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.532 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.18 175.58 2.49 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -76.96 75.8 4.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.509 2.139 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.03 -35.6 2.35 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 2.3 p30 -143.66 149.81 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.254 . . . . 0.0 109.85 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' ' 71' ' ' VAL . 6.3 p -127.09 145.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.879 . . . . 0.0 109.413 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 7' ' ' ASP . 19.3 p -132.85 155.06 49.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.684 HG11 HD13 ' A' ' 45' ' ' ILE . 2.1 p -162.74 153.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 108.952 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.419 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 6.4 mt -129.74 160.98 31.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 109.808 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -149.91 -148.51 0.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 80' ' ' ALA . 11.0 m-20 -128.22 -33.39 2.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.667 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 83' ' ' ALA . 48.3 m -112.5 164.22 13.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.854 ' HB1' ' SD ' ' A' ' 15' ' ' MET . . . -172.08 86.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 109.63 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.478 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.2 mp -105.67 134.17 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -0.915 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.7 ttt85 -58.51 153.86 15.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -51.52 -33.82 33.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.43 44.23 1.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.679 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.9 -32.75 72.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.79 -159.99 0.71 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' HB2' ' A' ' 93' ' ' ARG . 29.8 m-20 -62.21 179.48 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.33 -60.82 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.4 -12.65 59.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.462 ' HB2' ' CB ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -85.57 0.39 52.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.676 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.62 -1.75 57.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -0.998 . . . . 0.0 109.469 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.01 -22.56 21.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.779 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -80.71 -9.5 59.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.568 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.05 -24.42 35.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -27.5 21.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -67.35 -42.39 83.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -33.86 35.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.9 -14.02 59.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.864 ' OE1' HD12 ' A' ' 105' ' ' ILE . 26.5 tp10 -78.8 -23.01 45.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 2.9 tm-20 -54.37 -30.4 51.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 -46.08 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.864 HD12 ' OE1' ' A' ' 102' ' ' GLU . 34.4 mt -52.14 -40.67 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.701 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 107' ' ' SER . 0.3 OUTLIER -92.98 58.18 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 108' ' ' SER . 6.2 p 178.8 155.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.664 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER 76.6 173.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.72 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 -171.52 3.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.795 . . . . 0.0 109.252 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.64 162.71 15.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -1.117 . . . . 0.0 109.472 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 111' ' ' ASP . 15.5 m 39.97 33.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.425 -0.797 . . . . 0.0 110.031 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.16 -96.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 109.118 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -73.51 -15.84 61.3 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.013 -1.054 . . . . 0.0 108.401 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.06 -35.17 79.81 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.44 -11.84 61.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -0.782 . . . . 0.0 109.219 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.77 -12.13 59.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 109.647 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -19.94 41.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.651 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.1 48.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.02 -32.77 22.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.659 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.75 -66.26 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.686 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -44.34 -25.46 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.835 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.9 ttmt -63.43 -53.14 56.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.73 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.3 -27.86 66.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.697 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.2 mm -75.15 -5.5 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 109.747 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -79.98 -1.67 40.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.821 ' O ' HG23 ' A' ' 131' ' ' ILE . 16.0 tt0 -89.81 -28.73 19.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -69.33 -15.91 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -80.63 -27.26 37.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.631 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.7 m -89.58 -28.61 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.553 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 127' ' ' GLN . 25.9 pt -66.56 -20.43 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.805 . . . . 0.0 109.537 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -78.27 -26.06 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -87.39 -47.68 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.948 . . . . 0.0 109.543 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 28.5 p -43.82 -27.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -48.34 -67.03 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.0 26.88 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 0.0 109.769 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -100.4 -36.58 9.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mmm . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.56 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' THR . 3.3 tpp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.205 0.526 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER 57.89 147.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.777 . . . . 0.0 109.845 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.774 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.9 p90 -152.2 -164.42 1.96 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.23 -0.919 . . . . 0.0 108.953 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.8 t60 -116.87 145.16 43.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.119 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.011 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -137.49 152.01 49.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.863 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.7 OUTLIER -149.2 91.71 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.092 . . . . 0.0 110.034 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 6' ' ' LEU . 3.3 m -100.66 141.3 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.288 -0.883 . . . . 0.0 109.012 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 8' ' ' VAL . 6.4 m -152.89 176.8 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.461 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -120.45 -150.2 0.45 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.37 -32.06 18.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -147.18 55.29 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.461 ' HG3' ' OG ' ' A' ' 10' ' ' SER . 17.1 pt20 175.93 122.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 15' ' ' MET . 15.5 mt-30 -96.37 165.52 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.922 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.554 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -141.91 -91.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 109.111 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.637 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 31.7 t80 -96.01 120.55 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.212 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.406 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 29.9 p -152.53 80.35 1.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.54 20.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.74 ' C ' HG12 ' A' ' 20' ' ' VAL . 24.4 mt -62.94 175.0 0.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.011 -1.287 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.011 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 179.5 160.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 108.993 -177.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.576 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 2.8 tm-20 -122.25 -51.18 1.99 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 110.087 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.512 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 18.3 tttp -153.74 122.56 6.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.134 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.038 HG22 ' CG1' ' A' ' 52' ' ' ILE . 11.2 pt -106.64 -170.13 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.542 ' CG ' ' CB ' ' A' ' 51' ' ' ARG . 5.0 pt20 -179.95 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.619 -1.3 . . . . 0.0 110.274 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 46' ' ' LYS . 1.5 p -101.19 133.65 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.36 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -120.7 135.32 55.16 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.281 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . 179.47 -76.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -158.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -1.121 . . . . 0.0 109.507 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -67.77 -82.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . -51.8 117.98 6.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.18 64.28 1.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -112.98 160.81 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.386 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -111.37 -111.46 3.24 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.774 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 23.5 mm -156.11 140.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.981 . . . . 0.0 108.806 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.62 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -146.6 -172.05 0.3 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 35.7 Cg_endo -80.96 42.76 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.23 1.953 . . . . 0.0 110.606 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.46 34.09 0.04 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -74.58 145.31 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -1.13 . . . . 0.0 109.606 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.701 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -55.55 165.89 1.1 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.788 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.701 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -78.62 73.38 5.93 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.685 2.257 . . . . 0.0 110.466 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -99.91 147.86 25.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.287 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -156.87 44.22 0.38 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.0 p -123.69 -110.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.568 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -101.4 155.39 18.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.822 -1.174 . . . . 0.0 109.584 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.47 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.7 tt -104.56 177.08 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.518 ' O ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -86.43 113.38 52.22 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 109.636 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.483 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 35.5 Cg_endo -78.61 122.15 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.483 2.122 . . . . 0.0 110.353 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.48 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 162.42 -127.72 1.76 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.68 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.7 ppp? -113.48 167.7 10.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.257 -1.143 . . . . 0.0 109.024 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.858 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.5 tt -150.39 149.31 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.931 -1.106 . . . . 0.0 110.393 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.542 ' CB ' ' CG ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -116.49 177.96 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.038 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.89 153.86 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.828 -1.17 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 18.1 t -137.97 149.51 24.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HB2' ' CB ' ' A' ' 21' ' ' GLU . 10.1 tppt? 90.06 -112.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HG3' ' CE1' ' A' ' 16' ' ' PHE . 18.8 tt0 53.62 58.32 5.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.547 -1.345 . . . . 0.0 109.155 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.427 ' NE2' HD12 ' A' ' 19' ' ' LEU . 56.1 m170 58.53 43.03 19.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.266 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 71.48 86.18 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.466 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 167.2 125.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.588 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.54 133.76 53.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.115 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.78 168.59 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.961 ' CZ ' HD21 ' A' ' 133' ' ' LEU . 0.8 OUTLIER -125.51 134.06 52.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.292 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.858 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.0 mt -101.73 -147.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.189 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 9.1 t80 -178.75 122.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 109.23 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.451 ' CD2' ' CB ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -120.21 161.57 20.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.81 -14.04 14.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.6 161.99 9.96 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 156.69 -167.46 33.63 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 69' ' ' LEU . 7.2 mt -101.72 170.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -1.073 . . . . 0.0 109.158 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -155.0 163.87 39.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.697 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -157.44 134.64 10.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 109.202 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.664 HG23 HG22 ' A' ' 76' ' ' VAL . 14.5 p -100.39 152.73 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.783 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.425 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -131.6 170.51 11.1 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 109.245 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -77.54 103.62 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.485 2.123 . . . . 0.0 110.325 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . 83.84 1.53 89.86 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 74' ' ' GLY . 13.4 m-80 -152.63 170.09 21.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -1.214 . . . . 0.0 109.391 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 34' ' ' ILE . 6.1 t -150.79 144.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.246 -0.909 . . . . 0.0 109.266 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -151.6 138.46 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.071 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 3.2 m -139.71 158.28 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.05 149.97 40.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.19 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.521 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -147.96 -175.84 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.851 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -123.32 -31.42 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.636 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 83' ' ' ALA . 14.7 m -112.5 162.86 15.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -161.83 81.93 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.679 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -99.9 70.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.937 . . . . 0.0 109.326 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.701 ' HD2' HG23 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -44.04 161.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -48.62 -59.04 6.92 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -116.9 60.0 0.75 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -1.144 . . . . 0.0 109.497 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -50.63 -63.63 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 89' ' ' LEU . 84.4 mt -142.87 -88.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.66 179.15 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.863 ' HA ' HD11 ' A' ' 131' ' ' ILE . 30.5 mt-10 -149.61 -39.74 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.16 32.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -78.31 -8.28 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.25 28.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.3 mtt -71.43 -6.73 42.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.516 -0.74 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 4.6 mt-10 -81.44 -40.65 23.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.53 -65.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.679 ' HG2' HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -45.16 -31.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -59.53 -56.81 17.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.124 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.39 3.99 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 110.028 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.77 -46.3 10.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 109.638 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -65.56 -33.59 76.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.829 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -15.19 58.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.104 -0.998 . . . . 0.0 109.769 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -80.31 -65.18 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.84 -15.03 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 107' ' ' SER . 28.0 t -78.25 78.97 4.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 109.463 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 106' ' ' SER . 2.2 p 176.9 129.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' SER . 16.5 m 54.52 104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.421 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.54 -154.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 137.58 139.58 3.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 25.2 t70 -74.24 -58.06 3.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -1.194 . . . . 0.0 109.448 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.15 -7.6 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 109.454 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -59.28 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.822 . . . . 0.0 109.193 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -73.28 -23.11 60.26 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -59.59 -22.75 62.22 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.313 0.578 . . . . 0.0 109.464 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.48 -42.49 78.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.75 -11.63 60.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.559 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -1.09 26.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.706 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.94 -16.33 34.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -84.24 -16.42 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.947 . . . . 0.0 109.495 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -88.49 -45.01 10.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.601 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.35 73.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 124' ' ' ALA . 6.7 pttt -73.66 -28.4 61.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -87.06 -8.05 57.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.218 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.679 HD11 ' HG2' ' A' ' 98' ' ' LYS . 1.5 tp -81.43 -4.07 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.68 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -74.36 -26.86 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -63.7 -33.63 76.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.403 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 131' ' ' ILE . 19.2 tp -81.64 -10.27 59.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.502 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -31.29 19.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.779 ' O ' HG23 ' A' ' 134' ' ' THR . 1.2 m -90.56 -12.75 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.0 tt -90.4 -23.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 0.0 110.055 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 135' ' ' LYS . 0.7 OUTLIER -77.4 -39.28 47.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -82.67 3.19 30.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 110.415 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 130' ' ' VAL . 14.3 p -87.15 -12.98 45.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.913 -1.117 . . . . 0.0 109.669 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 132' ' ' GLU . 5.6 ptpt -71.34 -5.44 32.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -97.63 -43.42 7.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 109.608 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -44.7 -29.06 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.583 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.565 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.573 ' O ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.773 HG22 ' HA ' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -160.75 153.77 21.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.839 . . . . 0.0 109.609 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.712 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.9 p90 -139.53 -145.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.348 -0.845 . . . . 0.0 108.926 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -134.7 152.5 51.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -115.9 138.28 51.32 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.866 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.5 OUTLIER -143.39 72.61 1.37 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.321 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 15' ' ' MET . 4.0 p -106.26 140.59 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.84 147.42 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.339 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 1.3 p -143.78 42.9 1.47 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 171.68 -87.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 109.582 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 13' ' ' GLN . 1.4 mt-10 -128.62 44.13 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER 70.81 61.95 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -145.6 99.21 3.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.616 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.862 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -175.12 -78.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 109.286 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -148.26 109.47 4.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.5 p -138.07 83.37 1.97 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 109.464 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.5 -153.47 11.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.47 152.47 30.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -1.169 . . . . 0.0 109.741 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.7 152.33 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 109.276 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.773 ' HA ' HG22 ' A' ' 3' ' ' THR . 10.6 tt0 -109.84 -50.55 2.97 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -155.44 130.84 9.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.744 ' CD1' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -98.01 -152.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.556 ' H ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER 179.55 94.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.806 -1.184 . . . . 0.0 109.617 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.744 HG23 ' CD1' ' A' ' 23' ' ' ILE . 22.2 t -99.05 134.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 22.2 m -123.36 112.22 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.359 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -157.57 159.97 30.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -31.48 71.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.163 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' CB ' ' HG3' ' A' ' 47' ' ' PRO . 1.9 tt0 -98.54 71.7 2.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.74 152.86 9.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.26 26.45 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.686 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.06 156.93 21.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.665 ' HA2' HD11 ' A' ' 23' ' ' ILE . . . -100.35 -121.37 4.7 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.045 ' CG2' HG21 ' A' ' 76' ' ' VAL . 30.7 mm -154.42 135.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -1.225 . . . . 0.0 109.016 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -140.7 -172.44 0.32 Allowed Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 34.5 Cg_endo -77.88 76.12 4.48 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.776 1.651 . . . . 0.0 110.407 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.22 37.53 0.6 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 39' ' ' ALA . 15.8 t-80 -67.76 166.6 14.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.179 -1.189 . . . . 0.0 109.394 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -53.68 160.77 1.86 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.6 Cg_endo -77.9 77.84 3.78 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.738 2.292 . . . . 0.0 110.581 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 4.2 mm? -97.22 148.61 22.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.142 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.5 31.59 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 68' ' ' ILE . 26.8 p -131.21 -145.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 109.239 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.47 128.42 45.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.032 -1.043 . . . . 0.0 108.844 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -160.41 42.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 110.395 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.699 ' CD ' HD11 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -130.82 45.73 1.9 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.917 -1.115 . . . . 0.0 110.723 179.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.695 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 79.52 3.31 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.047 1.831 . . . . 0.0 110.496 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 64' ' ' LEU . . . 158.62 -141.47 7.66 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.388 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' CG1' ' A' ' 130' ' ' VAL . 1.0 OUTLIER -110.02 179.91 3.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.404 -1.057 . . . . 0.0 109.587 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 1.7 tt -147.89 154.02 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.531 ' N ' HG12 ' A' ' 50' ' ' ILE . 1.3 tmt_? -144.8 152.35 40.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 8.3 mt -150.7 166.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 110.452 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 90.1 t -141.78 118.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.618 -0.677 . . . . 0.0 109.267 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 150.88 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 6.5 mp0 42.46 -147.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -109.67 -11.06 14.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.952 . . . . 0.0 109.419 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.04 -98.64 2.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 58' ' ' HIS . 2.6 m-70 -130.3 -66.51 0.77 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.55 165.86 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.97 143.31 50.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 0.0 109.436 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.64 ' HZ ' HD11 ' A' ' 133' ' ' LEU . 0.7 OUTLIER -116.9 123.71 47.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.707 HG21 ' HG2' ' A' ' 15' ' ' MET . 1.6 mt -137.38 -160.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.969 . . . . 0.0 109.316 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.602 ' H ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -174.38 131.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 0.0 109.32 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.544 HD22 ' C ' ' A' ' 63' ' ' TYR . 3.6 mm? -119.5 158.27 26.62 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -99.27 -19.71 16.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.521 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.96 45.73 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 80' ' ' ALA . . . -72.54 -178.02 32.21 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 43' ' ' THR . 2.7 mp -102.79 122.94 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -1.125 . . . . 0.0 109.367 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.699 HD11 ' CD ' ' A' ' 46' ' ' LYS . 6.7 mp -99.53 175.34 5.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.696 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -168.78 129.3 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.7 p -99.86 129.06 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.076 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.542 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.74 173.7 3.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.5 Cg_endo -81.04 56.02 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.07 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.89 -16.73 1.21 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.075 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' A' ' 5' ' ' HIS . 15.5 m-80 -150.91 -175.65 5.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 0.0 109.468 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.045 HG21 ' CG2' ' A' ' 34' ' ' ILE . 38.0 t -144.25 146.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.237 -0.914 . . . . 0.0 109.361 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.866 HG22 ' HB3' ' A' ' 7' ' ' ASP . 1.2 p -138.07 174.24 10.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 8' ' ' VAL . 1.2 p -178.25 119.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.298 -0.876 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.593 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -102.62 124.51 48.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.033 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.442 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . . . -128.73 -152.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.78 -39.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.4 m -104.24 151.73 23.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 109.754 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -165.68 167.51 17.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.321 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.454 HG13 ' CE1' ' A' ' 63' ' ' TYR . 16.3 mt -130.68 -28.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 69.37 45.71 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.418 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.04 -112.13 3.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.78 27.08 9.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.42 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 85' ' ' ARG . 32.1 t70 -49.43 -40.72 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.669 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.86 -88.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.772 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.07 164.84 20.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.26 -72.8 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.54 -17.1 34.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -81.64 3.75 24.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.591 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.09 26.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 108.693 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 mtm -71.08 -26.54 63.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.507 -0.745 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.58 -24.21 67.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.323 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.24 -42.75 22.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.327 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -58.44 -43.51 88.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -26.55 65.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.307 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -89.94 7.68 36.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.812 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -90.5 -35.62 14.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -34.9 72.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 106' ' ' SER . 0.4 OUTLIER -62.58 -34.88 77.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -48.72 65.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.448 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mt -89.56 27.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 107' ' ' SER . 0.5 OUTLIER -68.92 92.86 0.52 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 106' ' ' SER . 39.5 m 61.47 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.633 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.44 118.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -95.68 73.42 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.514 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.27 132.02 4.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.5 m-20 -67.23 -149.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -1.148 . . . . 0.0 109.398 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.831 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -35.96 -31.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.301 0.572 . . . . 0.0 109.708 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 111' ' ' ASP . 22.5 t70 -38.18 -93.15 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.665 -0.647 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -63.42 -20.15 65.31 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -55.74 -26.22 44.44 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.419 0.628 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -82.13 -31.92 30.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.384 -0.822 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -13.31 61.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.646 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 t -83.24 9.34 10.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.16 10.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.432 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.629 ' HG3' HD22 ' A' ' 121' ' ' LEU . 23.2 pt-20 -67.6 -12.49 60.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.812 HD12 ' HB1' ' A' ' 101' ' ' ALA . 3.9 mm? -82.57 -36.21 26.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.918 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.94 46.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -69.85 -14.05 62.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.369 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.16 -8.49 57.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.343 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.66 -17.9 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.51 -26.49 68.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -60.3 -34.22 73.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 109.492 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.526 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 27.9 tp -90.03 -11.84 40.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -60.84 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.564 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 134' ' ' THR . 16.2 m -55.42 -51.15 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.015 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 130' ' ' VAL . 3.9 tt -60.19 -26.95 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.15 -38.66 85.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 109.942 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 133' ' ' LEU . 1.2 pp -90.22 -16.2 29.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.04 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 130' ' ' VAL . 20.0 p -61.25 -38.89 88.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -60.41 -33.95 73.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.993 . . . . 0.0 109.419 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.48 1.0 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 133' ' ' LEU . . . -77.26 -36.03 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 109.427 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.459 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.813 ' O ' HG22 ' A' ' 3' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.813 HG22 ' O ' ' A' ' 2' ' ' MET . 6.5 t 52.07 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.591 1.186 . . . . 0.0 111.075 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.956 ' CE2' HG22 ' A' ' 34' ' ' ILE . 9.2 p90 -110.75 -168.37 1.3 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -111.06 137.57 48.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.155 -0.966 . . . . 0.0 108.655 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.052 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -125.61 162.68 24.42 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.912 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 1.045 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.94 101.35 2.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.728 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 16' ' ' PHE . 7.3 p -99.79 124.66 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 2.3 t -136.93 146.73 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.2 m -123.59 -145.88 0.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -40.04 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 110.039 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -153.38 65.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -156.05 138.68 15.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -92.4 138.32 31.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.758 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 1.1 mmt -124.99 -60.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.653 ' HB2' HD11 ' A' ' 62' ' ' ILE . 49.7 t80 -131.09 133.41 45.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.467 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 p -163.0 97.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.262 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 165.02 -151.03 19.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.732 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -70.23 161.94 29.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.191 -1.182 . . . . 0.0 109.302 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.052 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -178.59 153.93 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.258 -177.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 3' ' ' THR . 1.5 pp20? -152.25 -36.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.942 -1.099 . . . . 0.0 110.677 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -106.74 71.21 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.848 -1.158 . . . . 0.0 110.891 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.953 HG22 ' CG1' ' A' ' 52' ' ' ILE . 9.5 pt -102.81 142.29 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.099 -1.0 . . . . 0.0 108.699 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.546 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 20.0 pt20 -149.27 126.55 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.055 -1.028 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -99.11 114.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . 51.6 m -99.78 108.42 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.52 -91.82 1.26 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.58 -67.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -1.089 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.64 132.09 33.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.55 -178.29 35.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.453 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -174.74 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.125 . . . . 0.0 109.591 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 12.8 mt -151.27 142.96 23.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.629 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -101.79 -99.69 2.44 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.956 HG22 ' CE2' ' A' ' 4' ' ' TYR . 7.2 mm -156.75 140.47 7.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.429 -1.042 . . . . 0.0 109.139 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -128.76 178.06 1.84 Allowed Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 33.1 Cg_endo -75.43 75.78 3.77 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.058 1.838 . . . . 0.0 110.172 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.5 38.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -107.9 175.33 5.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.209 . . . . 0.0 109.583 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -92.99 167.24 14.7 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.269 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.73 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.61 81.99 2.61 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.535 2.157 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.943 HD11 HD11 ' A' ' 69' ' ' LEU . 1.4 pp -90.17 142.27 27.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.727 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mt -128.13 69.94 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.293 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -110.3 -160.5 0.72 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -101.01 172.73 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.706 ' HA ' HD23 ' A' ' 69' ' ' LEU . 1.7 tt -99.96 126.98 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 156.15 70.52 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.98 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.15 175.71 10.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.56 2.173 . . . . 0.0 110.314 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 113.96 -132.92 10.84 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.669 ' SD ' HG13 ' A' ' 130' ' ' VAL . 6.0 ptm -129.53 -177.11 4.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -1.204 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.8 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -151.96 131.3 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 109.816 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -98.41 127.26 44.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.953 ' CG1' HG22 ' A' ' 23' ' ' ILE . 1.2 tt -134.3 145.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.077 -1.014 . . . . 0.0 110.91 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.757 HG22 ' HB3' ' A' ' 59' ' ' GLU . 38.9 t -127.75 113.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 16' ' ' PHE . 17.6 mtmt -66.32 157.14 32.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -0.762 . . . . 0.0 109.886 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.764 ' CG ' HG21 ' A' ' 3' ' ' THR . 18.2 tt0 -60.29 -65.02 0.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.345 -0.847 . . . . 0.0 109.531 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.04 102.98 8.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 58' ' ' HIS . . . 159.47 -103.42 0.23 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.482 ' CD2' ' C ' ' A' ' 57' ' ' GLY . 51.8 m-70 -148.51 159.96 43.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -1.194 . . . . 0.0 109.702 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.757 ' HB3' HG22 ' A' ' 53' ' ' VAL . 1.9 pt-20 -101.3 136.05 41.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 52' ' ' ILE . 8.9 mt-10 -134.01 150.64 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.943 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 1.2 p90 -109.2 131.02 55.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.8 ' H ' HG23 ' A' ' 50' ' ' ILE . 1.7 mt -101.95 -175.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.436 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.682 ' H ' HG22 ' A' ' 62' ' ' ILE . 6.2 t80 -152.37 136.84 16.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.068 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -161.92 179.99 7.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -161.3 113.16 1.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.435 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.79 132.97 6.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.27 -161.79 28.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 82.2 mt -139.46 143.2 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -1.155 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.943 HD11 HD11 ' A' ' 41' ' ' LEU . 1.4 pp -123.72 138.5 54.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 2.8 pt-20 -142.72 149.89 39.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 40' ' ' PRO . 4.4 p -109.54 133.4 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.76 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.534 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -101.45 175.43 2.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.408 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.0 Cg_endo -76.76 77.59 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.62 2.213 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.85 12.58 31.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.819 ' O ' HG23 ' A' ' 76' ' ' VAL . 68.3 m-80 -153.9 -172.29 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -1.086 . . . . 0.0 109.343 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 75' ' ' ASN . 3.1 t -166.13 150.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.09 -1.006 . . . . 0.0 108.935 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -158.5 142.26 15.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 0.0 109.315 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 69' ' ' LEU . 3.5 m -151.06 137.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.187 -0.946 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 1.1 mp -106.77 160.66 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.848 . . . . 0.0 109.194 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.492 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -149.76 175.88 11.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.8 -52.21 3.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.4 t -102.18 -176.68 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.367 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.758 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -168.51 80.88 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.6 mp -108.51 72.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.52 ' NH2' ' HB3' ' A' ' 60' ' ' GLU . 22.9 ttt180 -42.84 154.11 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -45.95 -51.75 10.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -106.71 49.4 0.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -1.141 . . . . 0.0 109.539 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -27.69 14.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -123.36 -175.02 3.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.367 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 10.7 t70 -54.29 179.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.342 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.791 ' HB3' HD11 ' A' ' 131' ' ' ILE . 32.7 mt-10 -105.83 -34.8 7.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.95 -25.24 27.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -72.29 -7.44 49.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 127' ' ' GLN . . . -90.59 -24.63 20.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.179 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -31.55 37.67 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 109.484 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -5.56 27.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.68 -22.93 42.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HG2' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -82.34 -41.58 19.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.2 mtp-105 -61.3 -27.18 68.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.86 -21.76 26.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.95 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.12 -26.32 33.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.347 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 106' ' ' SER . 16.3 tt0 -60.97 -30.55 70.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.837 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -56.11 -30.88 62.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -89.5 -47.68 7.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.883 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.065 HD13 ' HB1' ' A' ' 117' ' ' ALA . 11.7 mt -86.83 14.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 107' ' ' SER . 71.2 p -48.69 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 77.03 167.76 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.565 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -166.94 134.52 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.15 -89.01 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.468 ' O ' ' OD2' ' A' ' 113' ' ' ASP . . . -167.78 174.41 42.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 112' ' ' VAL . 1.2 m-20 63.65 105.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -1.202 . . . . 0.0 109.312 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 111' ' ' ASP . 15.6 m 40.99 26.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -90.83 -89.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.177 -0.952 . . . . 0.0 108.893 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 26.7 t80 -73.93 -20.47 60.36 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.83 -53.17 58.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.51 -39.78 94.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.355 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 1.065 ' HB1' HD13 ' A' ' 105' ' ' ILE . . . -67.03 -16.35 64.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.589 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.561 ' O ' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -74.52 -23.1 58.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.44 -41.15 11.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.977 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 6.2 pt-20 -75.77 -32.15 59.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 105' ' ' ILE . 51.1 tp -87.24 -51.84 5.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 109.614 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -52.72 -39.78 62.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -57.84 -36.12 71.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.781 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 123' ' ' LYS . . . -75.92 -22.54 55.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.563 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.0 mm -79.79 -3.61 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.619 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.495 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -64.81 -32.74 74.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -69.08 -19.28 64.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.411 ' N ' ' HG2' ' A' ' 127' ' ' GLN . 14.0 tp -83.99 -17.5 40.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -90.37 -28.99 18.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.733 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.669 HG13 ' SD ' ' A' ' 49' ' ' MET . 5.0 m -89.19 -26.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 109.461 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.791 HD11 ' HB3' ' A' ' 91' ' ' GLU . 3.1 tt -66.97 -46.86 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.576 ' N ' HG23 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -52.65 -26.29 13.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -44.98 28.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 79.5 p -61.1 -14.88 27.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -45.42 -41.65 9.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.367 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -97.08 -41.77 8.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -44.19 -61.98 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.442 ' OXT' ' O ' ' A' ' 137' ' ' ALA . 2.8 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' THR . 6.3 mtp . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.556 HG22 ' HG3' ' A' ' 21' ' ' GLU . 1.3 p 49.98 176.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.398 -0.814 . . . . 0.0 109.906 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.725 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.3 p90 179.42 -171.66 0.15 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.559 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.0 t60 -111.62 149.68 31.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 109.025 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.012 HD23 HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -137.92 158.48 44.26 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 178.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.856 ' N ' HD12 ' A' ' 6' ' ' LEU . 6.5 t0 -144.98 92.65 2.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.4 p -113.2 118.69 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.918 . . . . 0.0 109.408 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 t -130.9 145.08 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.693 ' CB ' ' HB3' ' A' ' 80' ' ' ALA . 39.5 t -178.05 66.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 178.09 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER 42.54 27.38 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.653 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.88 -150.59 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.512 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -134.39 102.84 5.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.651 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.4 mmt -76.01 -78.69 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.259 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.612 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 34.7 t80 -125.66 124.76 41.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.165 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 17' ' ' SER . 52.6 p -154.4 83.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.7 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.01 -153.59 17.37 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.643 ' C ' HG12 ' A' ' 20' ' ' VAL . 13.6 mt -65.02 167.7 7.5 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.151 -1.205 . . . . 0.0 108.745 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.012 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -173.85 173.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 120.87 -1.144 . . . . 0.0 109.496 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.9 tt0 -118.19 -46.37 2.61 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HE2' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.4 137.3 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.433 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.984 ' HB ' HD11 ' A' ' 50' ' ' ILE . 18.7 pt -99.42 -156.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -177.13 95.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.509 -1.369 . . . . 0.0 110.378 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.537 HG11 ' C ' ' A' ' 46' ' ' LYS . 76.4 t -99.23 141.75 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 25.6 m -145.53 119.81 9.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.274 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -145.54 -163.39 10.18 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -42.66 42.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -1.078 . . . . 0.0 109.592 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 163.26 21.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.917 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.79 138.57 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -141.31 45.72 1.74 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -1.13 . . . . 0.0 109.213 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.412 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 5.9 mt -144.85 164.58 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.785 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -112.59 -112.33 3.16 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 76' ' ' VAL . 15.9 mm -153.33 138.04 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -1.153 . . . . 0.0 109.459 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.618 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -149.23 171.87 5.82 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.0 Cg_endo -70.3 83.03 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.566 1.511 . . . . 0.0 109.486 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.73 35.12 0.46 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.7 t-80 -81.97 151.26 27.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -1.12 . . . . 0.0 109.526 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . -42.94 154.8 0.28 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.409 -0.807 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 76.01 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.583 2.188 . . . . 0.0 110.559 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -97.03 162.13 13.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.311 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.68 35.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.634 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 68' ' ' ILE . 30.0 p -130.68 -145.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.901 . . . . 0.0 109.375 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.32 120.41 39.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 44' ' ' ALA . 1.1 pp -166.7 -169.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.163 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.657 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER 71.66 49.46 0.28 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 111.059 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.657 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 146.17 17.22 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.15 1.9 . . . . 0.0 110.418 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 115.58 -142.88 17.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.318 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -99.56 -155.22 0.5 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -1.079 . . . . 0.0 109.198 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.984 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -173.76 111.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 110.383 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 50' ' ' ILE . 15.7 mtm180 -99.46 166.63 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.881 HD11 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -152.62 167.63 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.601 -1.312 . . . . 0.0 111.246 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.481 ' N ' HG23 ' A' ' 52' ' ' ILE . 13.6 t -143.99 104.73 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLN . 1.3 ttpt -66.37 120.51 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.692 -0.63 . . . . 0.0 109.868 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 82.0 mt-30 43.26 -161.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.363 -0.835 . . . . 0.0 109.373 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -68.71 88.41 0.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 54' ' ' LYS . . . 121.27 -171.21 14.86 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 61.5 160.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.383 -1.069 . . . . 0.0 109.607 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -171.35 147.41 2.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.401 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -132.8 154.67 50.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' ' 130' ' ' VAL . 0.9 OUTLIER -112.08 133.62 54.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 109.373 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 15' ' ' MET . 78.0 mt -151.94 167.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 109.261 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.61 ' N ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.65 149.66 37.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 109.576 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER -157.67 152.69 25.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.16 -79.56 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 109.723 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 129.4 9.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.32 144.6 7.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 43' ' ' THR . 79.3 mt -99.48 118.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -1.108 . . . . 0.0 108.965 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.671 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.3 tt -112.49 153.37 27.54 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -145.65 152.41 39.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.28 139.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.0 109.872 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.525 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.9 OUTLIER -122.27 172.33 5.33 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.462 -0.774 . . . . 0.0 109.038 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -78.62 91.15 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.513 2.142 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.22 -10.31 54.6 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -161.32 162.11 30.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.027 -1.278 . . . . 0.0 109.896 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 34' ' ' ILE . 18.3 m -135.75 172.87 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 78' ' ' VAL . 32.5 m -159.95 156.64 27.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.504 ' CG2' ' HB2' ' A' ' 69' ' ' LEU . 2.7 p -167.73 133.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mt -117.77 118.34 31.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.693 ' HB3' ' CB ' ' A' ' 10' ' ' SER . . . -109.02 -165.97 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.361 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.23 -52.29 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 m -99.93 120.11 39.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.35 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . -149.75 163.71 37.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.54 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.1 mt -149.03 119.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.285 -0.885 . . . . 0.0 109.25 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -67.58 95.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.37 -110.75 1.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.738 ' HB3' HG22 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -139.13 57.2 1.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 109.223 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -60.19 -45.16 94.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.61 -78.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -150.25 -155.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 109.608 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.471 ' HB2' HD12 ' A' ' 131' ' ' ILE . 1.3 pt-20 -151.93 -49.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.652 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.87 -10.14 59.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.359 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -8.48 59.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.52 -24.32 20.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.246 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -35.58 76.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -54.71 -33.34 60.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.17 75.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.112 -0.993 . . . . 0.0 109.86 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -18.06 60.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -70.06 -50.34 42.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.626 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -86.02 -9.19 57.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.573 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.908 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -76.81 -30.8 56.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 1.5 tm-20 -70.88 -22.46 62.28 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.306 -0.871 . . . . 0.0 109.347 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.74 -20.75 60.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -81.67 -36.75 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.714 HD11 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mm -78.87 -26.91 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.1 p -80.81 -9.94 59.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.5 t -104.58 131.19 52.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.57 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 58.3 p -135.97 142.22 44.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.281 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.3 m-70 175.21 41.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.382 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.63 158.92 31.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -74.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -1.177 . . . . 0.0 109.562 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 17.6 m -100.84 19.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.393 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 9.7 t70 -59.83 -100.41 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.358 -0.839 . . . . 0.0 109.278 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 12.6 p90 -64.61 -22.22 66.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.903 -1.123 . . . . 0.0 108.223 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -53.84 -33.65 56.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -88.3 -24.7 23.1 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -68.08 -21.12 64.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -26.3 61.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HE3' ' A' ' 123' ' ' LYS . . . -90.18 -38.18 13.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -78.85 -5.79 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.908 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -90.15 -51.3 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.593 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.31 -28.87 70.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.179 -0.951 . . . . 0.0 109.459 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 119' ' ' ALA . 14.8 mtmt -70.23 -23.66 62.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.66 62.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.868 . . . . 0.0 109.733 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.3 mp -80.08 -1.24 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.4 -24.57 63.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.766 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -69.76 -45.76 67.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.62 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.541 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.4 OUTLIER -65.99 -15.51 63.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.638 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 133' ' ' LEU . 14.2 mmt180 -81.85 -25.75 34.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 127' ' ' GLN . 31.6 m -88.09 -20.36 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.738 HG22 ' HB3' ' A' ' 87' ' ' GLN . 7.7 pt -91.01 -44.62 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 0.0 110.047 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 5.0 mm-40 -61.81 -24.21 66.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.233 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 133' ' ' LEU . 6.5 mp -89.09 -37.73 14.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -55.59 -40.93 72.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -61.39 -29.58 70.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.83 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -111.26 31.56 5.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 109.548 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.19 -3.56 8.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 109.654 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.339 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 20.6 ptp . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.19 0.519 . . . . 0.0 109.837 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.693 HG21 ' CG ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -42.35 166.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.873 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.738 ' CE2' HG22 ' A' ' 34' ' ' ILE . 5.0 p90 -148.79 -147.3 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 20.5 t-80 -133.9 140.71 46.99 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.05 -1.031 . . . . 0.0 109.641 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.04 HD21 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.067 . . . . 0.0 108.775 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.818 ' N ' HD12 ' A' ' 6' ' ' LEU . 36.1 t0 -142.83 86.78 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.951 -1.093 . . . . 0.0 110.528 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 6' ' ' LEU . 5.0 m -99.9 148.78 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 8' ' ' VAL . 1.5 m -152.96 173.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.032 -1.043 . . . . 0.0 109.869 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.662 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -129.4 -153.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.92 -29.95 70.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' GLN . 6.3 mm-40 -116.74 26.51 9.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.003 . . . . 0.0 109.695 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 12' ' ' GLU . 19.8 mt-30 43.68 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.409 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 15' ' ' MET . 4.6 mm-40 -165.4 74.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.722 ' HB2' HG23 ' A' ' 8' ' ' VAL . 6.8 mtp -151.32 -73.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.647 ' CD1' HD13 ' A' ' 52' ' ' ILE . 47.7 t80 -159.75 136.84 9.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.267 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -160.17 105.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 144.99 -160.38 28.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.753 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.0 mt -56.09 174.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -1.191 . . . . 0.0 108.957 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.024 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 179.96 169.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.078 . . . . 0.0 109.65 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.0 tt0 -122.5 -41.9 2.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.314 -0.866 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HG3' ' HB ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -175.68 130.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.947 ' CG2' HD22 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -98.77 -165.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.584 ' N ' HD12 ' A' ' 23' ' ' ILE . 4.5 tp60 -168.89 84.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.665 -1.272 . . . . 0.0 110.233 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.3 141.86 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.445 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 10.2 m -138.16 129.69 27.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 109.03 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.92 -81.38 0.1 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -38.78 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -1.173 . . . . 0.0 109.769 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -123.41 163.69 20.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 80.4 -82.06 1.51 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 44.1 tt0 73.88 53.11 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -1.089 . . . . 0.0 109.732 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -145.54 156.64 43.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -99.22 -115.17 3.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.738 HG22 ' CE2' ' A' ' 4' ' ' TYR . 29.5 mm -153.11 145.81 14.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -154.91 -171.0 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.7 Cg_endo -78.63 73.93 5.68 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.678 1.586 . . . . 0.0 109.671 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.09 54.7 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.547 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 11.8 t-160 -85.63 50.84 2.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -1.132 . . . . 0.0 109.648 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 55.56 167.03 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 109.627 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.2 Cg_endo -78.46 78.92 3.47 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.621 2.214 . . . . 0.0 110.229 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -95.05 144.4 25.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.16 36.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.6 p -121.26 -134.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . . . -99.6 168.73 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.883 -1.136 . . . . 0.0 109.333 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.528 HD12 HD22 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -112.9 136.23 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -65.46 147.01 98.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.569 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 35.3 Cg_endo -77.71 133.97 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.688 2.259 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.508 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 174.25 -144.89 7.78 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.938 ' HE2' HG23 ' A' ' 130' ' ' VAL . 3.8 ptm -105.73 -164.68 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -1.114 . . . . 0.0 109.481 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.57 123.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.995 -1.066 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.609 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -111.28 159.69 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.04 HD11 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -154.06 158.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.28 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.481 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 47.2 t -142.15 102.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -54.94 159.42 2.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 -179.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.693 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.4 tm0? -35.85 -38.83 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.586 . . . . 0.0 110.022 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -103.06 -159.58 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -64.62 -163.77 0.79 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 4.1 t60 79.46 124.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.412 -1.052 . . . . 0.0 109.732 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.85 140.73 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 108.872 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.0 mp0 -109.68 152.34 25.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.109 . . . . 0.0 109.746 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 1.003 ' CD2' HG22 ' A' ' 130' ' ' VAL . 2.3 m-85 -124.22 132.29 53.59 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD12 HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -149.54 -176.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.615 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CD1' HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -162.84 130.88 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 108.928 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.48 -166.34 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.87 . . . . 0.0 109.334 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.462 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 1.9 m -143.04 -93.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.69 154.63 17.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.0 -173.27 42.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.1 mt -122.09 131.99 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.339 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -112.88 -172.4 2.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.961 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 179.78 142.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 71' ' ' VAL . 9.2 p -107.58 132.55 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 109.917 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.513 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.2 mt-30 -119.78 173.42 3.61 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 0.0 109.081 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.35 110.6 2.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.525 2.15 . . . . 0.0 110.829 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 78.51 11.86 84.85 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 19.6 p-10 -179.8 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.284 . . . . 0.0 109.838 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 6' ' ' LEU . 4.5 m -129.75 178.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.106 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 78' ' ' VAL . 98.9 m -160.86 160.48 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.95 -1.094 . . . . 0.0 109.954 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' CG1' HG12 ' A' ' 8' ' ' VAL . 1.8 p -177.02 138.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.777 ' N ' HD12 ' A' ' 79' ' ' LEU . 1.3 mp -124.31 153.27 42.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.04 -1.037 . . . . 0.0 109.95 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.95 166.06 26.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.433 -0.792 . . . . 0.0 109.047 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 81' ' ' ASP . 8.5 t70 -100.18 3.77 43.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 11.7 m -119.64 153.56 35.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB2' ' CB ' ' A' ' 10' ' ' SER . . . -168.57 113.42 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.474 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.575 HD13 ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -104.62 -37.38 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.216 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 75.43 49.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 130' ' ' VAL . . . 43.88 -109.58 0.26 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CA ' HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -98.78 59.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -1.117 . . . . 0.0 109.886 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 33.3 t0 -47.42 -38.23 12.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.4 tp -163.65 127.6 2.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.13 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.09 172.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 109.319 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.674 ' HA ' HD11 ' A' ' 131' ' ' ILE . 2.4 mt-10 -128.56 -5.69 5.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 109.836 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.31 -11.34 41.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.944 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -81.57 -17.38 48.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.44 -7.74 52.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -0.978 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mtt -85.4 -10.93 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.6 -26.53 60.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.89 -1.94 34.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HD2' HD12 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -84.58 -53.82 5.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -74.45 -29.56 61.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.75 -21.86 34.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -68.64 -29.37 67.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -17.66 51.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -88.79 -20.32 24.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 121' ' ' LEU . 65.4 mt -83.08 4.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.661 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.4 m -47.83 -52.13 20.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.69 115.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.7 p -153.28 148.66 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.434 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.63 -63.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.543 ' N ' ' HB2' ' A' ' 113' ' ' ASP . . . 175.4 171.62 39.54 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.82 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 109.596 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 14.3 m -88.19 20.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.543 ' HB2' ' N ' ' A' ' 110' ' ' GLY . 51.0 t0 -62.35 -100.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -15.36 58.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 108.473 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -71.83 -37.73 70.25 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.685 -0.634 . . . . 0.0 109.591 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 12.2 tt0 -84.24 -10.2 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.65 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.93 -20.84 24.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.65 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -64.37 -13.18 49.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 109.488 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.66 -60.97 1.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -59.08 -47.62 84.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.974 ' HB2' HD11 ' A' ' 105' ' ' ILE . 0.7 OUTLIER -68.18 -59.74 2.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.802 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -56.26 -16.63 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.855 . . . . 0.0 109.829 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.423 ' CD ' ' HB2' ' A' ' 47' ' ' PRO . 7.6 ttpt -76.86 -36.2 56.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.18 -14.01 54.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.805 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.607 HD12 ' HD2' ' A' ' 98' ' ' LYS . 35.2 mm -87.84 -8.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.49 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -68.43 -30.64 69.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.599 ' O ' HG22 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -84.07 -17.73 39.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.657 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -85.09 -30.51 24.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.483 ' O ' HD23 ' A' ' 133' ' ' LEU . 5.7 tpp180 -82.17 -33.94 29.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.54 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 1.003 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.15 -25.24 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.174 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.3 tt -90.95 -23.85 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 110.29 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -81.01 -34.62 32.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.9 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -84.67 0.17 51.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.955 -1.09 . . . . 0.0 110.099 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.542 HG23 ' CD2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -80.97 -2.08 46.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -25.23 34.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -89.12 -9.05 52.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.12 -0.987 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.83 37.33 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.431 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 3' ' ' THR . 1.3 tpt . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.221 0.534 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 2' ' ' MET . 0.4 OUTLIER -165.99 140.28 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.776 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.7 p90 -152.73 -142.69 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 75' ' ' ASN . 19.2 t-80 -139.39 141.81 37.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.878 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.031 HD23 HG21 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -137.38 153.83 50.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.079 -1.013 . . . . 0.0 108.673 178.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.766 ' N ' HD12 ' A' ' 6' ' ' LEU . 3.1 t70 -148.33 98.06 2.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.989 ' HA ' HG22 ' A' ' 78' ' ' VAL . 2.1 p -99.28 110.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.862 -1.149 . . . . 0.0 109.09 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.05 154.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.713 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.7 t -165.96 107.52 0.73 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.211 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 77.07 34.36 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 55.04 39.63 31.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 22.5 mt-30 -87.67 -43.9 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.204 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER 72.21 84.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.126 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' HG13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -98.97 -93.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 108.78 179.26 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.698 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 32.8 t80 -94.03 110.09 21.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.006 . . . . 0.0 109.315 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.496 ' HB2' ' OD1' ' A' ' 7' ' ' ASP . 60.4 p -136.97 109.94 7.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . 145.49 -169.52 27.03 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.72 ' C ' HG12 ' A' ' 20' ' ' VAL . 19.8 mt -52.46 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.107 -1.231 . . . . 0.0 108.602 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.031 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -176.04 145.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.962 -1.086 . . . . 0.0 109.563 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -108.7 -48.61 3.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 67.3 mmtt -147.19 101.76 3.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.405 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.943 HG13 HD11 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -99.94 109.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.79 110.09 22.48 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.04 -1.037 . . . . 0.0 110.51 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.839 HG21 ' HG3' ' A' ' 46' ' ' LYS . 7.4 p -99.67 147.81 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.457 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -135.84 121.71 19.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -152.42 -177.67 26.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.91 150.59 34.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -1.132 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 64.8 76.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.14 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 99.66 179.65 30.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 175.02 38.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.238 . . . . 0.0 109.806 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.528 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 4.6 mt -92.41 150.03 21.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.672 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.47 177.94 29.88 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.776 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 16.4 mm -98.6 140.13 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.874 -1.368 . . . . 0.0 109.187 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -137.79 170.87 9.47 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.8 Cg_endo -72.63 80.02 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.862 1.708 . . . . 0.0 109.918 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.66 34.94 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.435 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.8 t-160 -83.23 142.67 30.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -1.208 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -46.74 157.71 0.45 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.185 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.73 87.4 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 110.359 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 71' ' ' VAL . 2.4 mm? -99.9 155.44 17.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -157.62 75.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.773 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.9 t -156.09 -146.08 0.17 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.885 . . . . 0.0 109.021 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.773 ' N ' HG23 ' A' ' 43' ' ' THR . . . -99.46 136.46 39.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.969 HD12 HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -156.47 -169.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 109.76 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.839 ' HG3' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 63.61 51.95 1.37 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.488 -0.757 . . . . 0.0 110.399 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.4 Cg_endo -80.19 65.99 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.208 1.938 . . . . 0.0 110.811 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.45 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 155.11 -127.49 2.08 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.298 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 4.6 ptm -108.61 -169.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 109.684 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.943 HD11 HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -179.43 127.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.477 ' C ' HG13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -110.35 172.86 6.61 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.826 HD13 HD21 ' A' ' 6' ' ' LEU . 18.2 mt -155.14 166.49 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.019 -1.051 . . . . 0.0 109.601 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 42.8 t -138.89 107.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.263 -0.898 . . . . 0.0 109.903 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 157.68 -97.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 16' ' ' PHE . 11.6 tm0? -50.68 165.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 0.0 109.373 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.0 t-160 75.54 -145.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.185 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.7 -86.43 0.92 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -120.23 -18.8 7.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -169.73 152.45 4.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.211 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.15 161.01 22.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 2.8 m-85 -118.19 141.78 48.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.912 ' HB ' HG23 ' A' ' 50' ' ' ILE . 2.3 mp -151.53 166.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.101 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -171.45 130.1 0.71 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.172 -0.955 . . . . 0.0 109.275 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 80' ' ' ALA . 10.5 mt -131.62 172.6 12.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.084 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -148.76 46.57 1.02 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.472 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 133.24 91.27 0.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -160.91 151.55 22.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' THR . 20.4 mt -105.72 119.7 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.969 HD21 HD12 ' A' ' 45' ' ' ILE . 1.4 pp -109.06 -161.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.958 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.576 ' N ' HD12 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -177.7 124.16 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 76' ' ' VAL . 13.4 p -99.66 138.78 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.504 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HG2' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -121.46 174.98 2.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.508 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.79 84.66 1.99 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.444 2.096 . . . . 0.0 110.515 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 132.77 -36.29 2.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 5' ' ' HIS . 9.8 p30 -155.14 154.19 31.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -1.225 . . . . 0.0 109.83 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.637 ' HB ' HG23 ' A' ' 71' ' ' VAL . 1.4 p -134.3 165.84 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.876 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.532 ' N ' HG22 ' A' ' 76' ' ' VAL . 98.7 m -153.55 145.56 23.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 0.0 109.63 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.989 HG22 ' HA ' ' A' ' 8' ' ' VAL . 2.6 m -122.74 147.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 0.0 109.441 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.4 114.09 20.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.673 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -137.17 172.2 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.314 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.73 -20.19 8.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 m -112.84 109.63 19.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -129.45 146.48 51.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.679 HD12 ' CE1' ' A' ' 63' ' ' TYR . 55.3 mt -139.16 86.39 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.248 -0.907 . . . . 0.0 108.969 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' ILE . 26.3 ttt180 -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.01 107.54 0.57 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.44 79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.421 ' O ' HD12 ' A' ' 89' ' ' LEU . 11.8 t70 -92.26 -34.35 14.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 88' ' ' ASP . 1.7 tp -162.99 131.82 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 53.21 -178.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.628 ' HB2' HD13 ' A' ' 131' ' ' ILE . 11.1 pt-20 -170.2 -39.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -75.06 -27.16 59.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.355 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -84.01 8.07 16.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.394 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.05 -12.36 38.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 0.0 109.178 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -26.82 53.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.44 -0.787 . . . . 0.0 109.467 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -77.25 -22.28 52.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.38 72.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' CD ' HG12 ' A' ' 125' ' ' ILE . 22.0 tttp -79.54 -22.59 43.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -69.07 -48.93 61.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.81 8.1 18.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.855 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -84.05 -24.13 30.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.164 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 33.2 tt0 -69.42 -24.18 63.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.85 . . . . 0.0 109.224 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.67 -47.12 83.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.84 74.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.762 HD11 ' HG ' ' A' ' 121' ' ' LEU . 14.6 mt -84.12 -11.23 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.0 m -48.98 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.666 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -164.6 -38.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.217 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.0 m 48.05 68.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 -67.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 111' ' ' ASP . . . 125.75 -47.36 1.02 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -43.1 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -1.1 . . . . 0.0 109.133 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.429 ' HB ' ' CG ' ' A' ' 116' ' ' GLN . 22.6 m -143.56 36.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.12 -96.47 0.11 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.711 -0.618 . . . . 0.0 109.375 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.609 ' CD1' HG21 ' A' ' 105' ' ' ILE . 2.4 m-85 -60.03 -19.2 51.49 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.32 -54.18 15.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.429 ' CG ' ' HB ' ' A' ' 112' ' ' VAL . 50.6 mm-40 -87.95 -0.72 57.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.687 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -90.88 -25.5 19.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.672 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 p -64.01 -18.63 64.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.706 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.25 -68.91 0.75 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 11.1 pt-20 -55.14 -44.64 75.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 110.046 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.855 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -62.62 -61.01 2.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.49 -14.35 12.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.788 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -33.89 76.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.25 70.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 109.564 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.6 mp -77.29 -1.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.961 . . . . 0.0 109.715 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.645 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -74.51 -20.56 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.071 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.883 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.5 pt20 -87.22 -24.12 24.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.619 HD23 ' C ' ' A' ' 128' ' ' LEU . 2.2 tt -72.17 -9.36 58.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 0.0 109.424 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.417 ' O ' HD13 ' A' ' 133' ' ' LEU . 10.0 mmt85 -84.61 -34.1 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.693 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 127' ' ' GLN . 33.4 m -62.7 -27.6 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 91' ' ' GLU . 96.8 mt -62.34 -39.59 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -65.08 -18.34 65.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 133' ' ' LEU . 4.8 mp -89.03 -34.97 16.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -70.66 -20.88 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -81.02 -6.49 58.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -143.25 23.4 1.84 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -96.24 -20.82 18.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.475 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.505 HG21 ' HG3' ' A' ' 55' ' ' GLN . 1.4 t -43.63 154.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.503 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.692 ' CE2' HG22 ' A' ' 34' ' ' ILE . 3.5 p90 -144.34 -159.65 1.02 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.562 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.1 t60 -114.05 144.79 42.55 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.947 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -103.15 130.97 50.49 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.162 -0.961 . . . . 0.0 109.136 178.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -137.44 88.85 2.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.2 p -114.01 116.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG12 ' HG3' ' A' ' 14' ' ' GLN . 16.3 m -124.28 172.19 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB2' ' CG ' ' A' ' 13' ' ' GLN . 15.0 m -124.81 -150.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.403 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -43.24 65.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.616 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -164.91 49.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 109.691 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.458 ' CG ' ' HB2' ' A' ' 10' ' ' SER . 0.1 OUTLIER -151.15 155.54 39.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.0 mt-30 -111.49 161.58 16.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.815 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.488 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 32.3 mtp -140.88 -46.55 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.274 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.626 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -138.75 110.95 7.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.653 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 17' ' ' SER . 19.6 p -139.43 86.48 2.12 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . -177.6 -149.98 8.22 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.731 ' C ' HG12 ' A' ' 20' ' ' VAL . 35.7 mt -82.45 175.25 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 109.529 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.947 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER 176.4 171.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.085 -1.009 . . . . 0.0 108.82 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.591 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.4 tt0 -166.87 -34.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.584 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -116.42 75.66 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.814 HD13 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -99.61 143.6 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.266 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 19.7 tt0 -149.78 158.33 44.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.005 -1.06 . . . . 0.0 109.927 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 30' ' ' GLY . 6.9 p -131.03 149.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -120.51 89.16 3.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.407 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -119.06 -77.7 0.56 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 p -150.38 -86.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.37 -28.6 22.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -90.96 73.06 1.8 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.24 29.97 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -1.115 . . . . 0.0 109.474 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.65 HD13 ' OH ' ' A' ' 35' ' ' TYR . 12.4 mt -130.86 144.75 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.66 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.5 -97.59 2.15 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.713 HD12 ' ND1' ' A' ' 38' ' ' HIS . 5.0 mm -155.72 161.74 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -1.041 . . . . 0.0 109.422 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.65 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -165.12 175.1 2.66 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -71.88 118.62 5.72 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.836 1.69 . . . . 0.0 109.222 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.97 24.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.8 ' CE1' HG21 ' A' ' 71' ' ' VAL . 19.3 p80 -86.9 -171.0 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.798 0.809 . . . . 0.0 110.79 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 1.053 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -54.74 -172.89 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 1.053 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 33.1 Cg_endo -76.79 -179.68 5.62 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.913 1.742 . . . . 0.0 110.271 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.527 ' CA ' ' H ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -90.6 37.64 0.92 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.193 -0.942 . . . . 0.0 110.913 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tp -147.5 116.54 6.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.574 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 t -175.74 -173.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.417 -0.802 . . . . 0.0 109.199 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.75 150.58 52.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.072 -1.018 . . . . 0.0 109.822 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.704 HD13 ' HB2' ' A' ' 69' ' ' LEU . 1.7 mp -102.17 112.64 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 1.0 OUTLIER -65.01 174.72 1.21 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 33.8 Cg_endo -77.14 142.63 21.86 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.574 2.182 . . . . 0.0 110.55 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 152.15 -156.39 26.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.5 ptm -103.6 -168.31 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -1.172 . . . . 0.0 109.35 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 7.6 mt -155.82 126.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.798 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -117.9 110.54 17.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.752 ' CD1' HD12 ' A' ' 23' ' ' ILE . 29.4 mt -118.33 168.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.117 -0.989 . . . . 0.0 110.52 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.593 ' N ' HG22 ' A' ' 52' ' ' ILE . 38.1 t -135.27 120.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.4 ttmt -64.03 147.45 52.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.505 ' HG3' HG21 ' A' ' 3' ' ' THR . 6.3 tm0? -65.05 -49.05 71.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.444 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -53.26 -62.59 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 85.43 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -170.66 176.84 4.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -1.054 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 53' ' ' VAL . 5.3 mt-10 -145.55 128.38 16.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 133.19 32.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -116.23 145.31 43.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.958 . . . . 0.0 109.618 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 63' ' ' TYR . 3.2 mp -121.85 171.93 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.637 ' CE1' HD13 ' A' ' 84' ' ' ILE . 8.2 t80 -141.34 152.7 44.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.29 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.482 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -172.92 -166.9 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.498 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 61.7 m -154.81 21.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 159.48 150.0 5.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.25 159.91 9.5 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.883 ' O ' HG23 ' A' ' 78' ' ' VAL . 2.0 mp -107.9 140.69 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.105 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 69' ' ' LEU . 2.6 tt -121.05 156.9 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.09 -1.006 . . . . 0.0 109.635 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.658 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -158.21 146.45 18.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.11 HG22 HG22 ' A' ' 76' ' ' VAL . 2.2 t -103.31 159.27 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 110.132 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.607 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -126.19 -171.13 0.22 Allowed Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.9 Cg_endo -79.55 40.61 0.97 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.645 1.564 . . . . 0.0 111.294 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 145.49 34.23 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.94 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 5.2 p-10 166.19 133.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.284 . . . . 0.0 109.974 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.11 HG22 HG22 ' A' ' 71' ' ' VAL . 6.6 t -99.62 157.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.285 -0.884 . . . . 0.0 108.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 23.0 m -154.3 137.07 15.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.252 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.5 p -141.32 141.72 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.599 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.24 107.67 17.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 66' ' ' GLY . . . -102.2 162.58 12.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.733 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.96 -47.02 7.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.5 m -100.82 136.03 41.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 109.549 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.698 ' C ' HD12 ' A' ' 84' ' ' ILE . . . -151.24 134.13 15.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.514 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.727 HG21 ' HG3' ' A' ' 127' ' ' GLN . 1.1 mp -111.86 -37.94 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.84 . . . . 0.0 108.959 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 77.26 84.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 42.18 -111.61 0.34 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 87' ' ' GLN . 1.4 tt0 -117.98 62.12 0.76 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.284 -1.127 . . . . 0.0 109.509 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 85' ' ' ARG . 13.0 t70 -85.77 -11.3 53.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -149.26 144.69 26.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 54.16 171.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.18 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HG3' HD11 ' A' ' 131' ' ' ILE . 81.6 tt0 -168.15 -80.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.95 58.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.269 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -6.01 51.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.17 -27.37 19.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.942 . . . . 0.0 108.988 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 mtt -67.2 -40.53 86.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.443 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -33.11 75.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 128' ' ' LEU . 1.3 tmmt? -62.37 -14.36 39.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.79 -53.05 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.482 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -65.23 -15.16 62.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.612 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -84.63 -28.36 26.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.348 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 103' ' ' GLU . 24.8 tt0 -76.33 -48.61 19.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 102' ' ' GLU . 38.6 tt0 -45.43 -29.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -71.22 -56.74 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 mt -87.36 16.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.927 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -65.96 91.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.433 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 71.6 143.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.0 OUTLIER 171.25 166.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.234 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -130.43 132.17 45.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.63 166.49 16.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 3.2 m-20 -97.41 -54.34 3.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -1.194 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 113' ' ' ASP . 21.2 m -122.6 -18.05 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.814 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 112' ' ' VAL . 1.4 m-20 -46.4 -95.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.565 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -13.08 60.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.175 -0.953 . . . . 0.0 108.47 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -73.28 -5.0 36.65 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -85.31 -30.93 23.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.61 -16.62 61.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -21.94 63.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.36 -27.42 25.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.653 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -81.81 -27.84 33.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.673 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.612 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -76.2 -58.57 3.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -45.7 -25.05 0.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HD3' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -66.56 -50.36 63.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.831 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.56 71.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.441 HD12 ' HG3' ' A' ' 98' ' ' LYS . 37.6 mm -59.97 -14.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.861 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -69.5 -47.19 64.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.727 ' HG3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.91 -23.02 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 128' ' ' LEU . 3.2 tt -74.94 -13.54 60.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.73 -48.19 7.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.752 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.9 m -62.69 -38.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -64.57 -18.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.31 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 135' ' ' LYS . 0.1 OUTLIER -82.22 -18.49 42.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 1.1 pp -90.09 -24.83 21.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 131' ' ' ILE . 10.7 t -69.72 -5.57 25.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.516 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.533 ' HE2' ' CG ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -53.19 -20.97 4.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.533 ' CG ' ' HE2' ' A' ' 135' ' ' LYS . 14.8 mttt -113.85 -12.75 12.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.38 -58.0 2.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 ptp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.419 179.879 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.483 ' O ' ' HB ' ' A' ' 3' ' ' THR . 3.8 mtt . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 3' ' ' THR . 9.1 t 174.47 128.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 1.053 ' CE2' HG22 ' A' ' 34' ' ' ILE . 21.8 p90 -107.68 -161.57 0.79 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.1 t-80 -117.26 144.59 44.67 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 109.052 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.086 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -135.59 161.4 35.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.306 -1.496 . . . . 0.0 109.194 178.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.966 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -149.49 94.55 2.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.486 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.6 p -99.85 112.27 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.183 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.35 156.82 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 1.6 t -157.71 84.14 0.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . 57.56 21.79 7.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 1.3 pt-20 175.13 88.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -59.49 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.31 48.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.649 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 9.2 mtt -136.52 -52.47 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.427 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.636 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 33.9 t80 -166.53 129.25 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.494 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 79.4 p -161.6 94.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.422 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.22 -146.8 11.84 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.749 ' C ' HG12 ' A' ' 20' ' ' VAL . 11.4 mt -68.24 167.92 13.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -1.142 . . . . 0.0 109.257 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.086 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 177.9 155.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 108.794 -177.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 6.4 tt0 -151.06 -44.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.549 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -105.97 76.49 1.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 111.494 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.879 HG22 HG12 ' A' ' 52' ' ' ILE . 6.5 pt -102.97 147.81 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.518 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 37.4 tt0 -145.71 127.24 15.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.786 -1.196 . . . . 0.0 110.333 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.514 HG23 ' HA2' ' A' ' 33' ' ' GLY . 5.4 t -104.71 133.09 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.44 -0.787 . . . . 0.0 108.963 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -124.46 129.55 50.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.467 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.23 -128.36 1.29 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -108.39 -18.52 13.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -1.168 . . . . 0.0 109.566 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.34 149.14 27.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.75 -74.44 1.32 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER 60.87 -175.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -1.099 . . . . 0.0 109.908 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 31' ' ' GLU . 14.3 mt 61.11 138.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 109.749 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.518 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.89 -102.1 2.42 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.053 HG22 ' CE2' ' A' ' 4' ' ' TYR . 10.5 mm -154.24 141.7 12.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.315 -1.109 . . . . 0.0 109.154 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -124.69 177.7 1.72 Allowed Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -75.11 76.51 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.04 1.827 . . . . 0.0 110.425 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.37 41.04 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.415 ' HE1' HD23 ' A' ' 41' ' ' LEU . 38.9 t-80 -99.49 144.81 28.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -1.136 . . . . 0.0 109.565 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.955 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -55.64 175.65 0.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.955 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.46 106.2 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.709 2.273 . . . . 0.0 110.443 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.482 ' H ' HG11 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -100.11 122.61 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.57 HD21 ' HG3' ' A' ' 70' ' ' GLU . 2.9 mt -136.21 71.65 1.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 p -137.69 -154.91 0.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.494 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.01 167.51 10.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.728 HD11 ' HB ' ' A' ' 78' ' ' VAL . 1.2 mt -103.57 -147.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.114 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -168.88 167.79 5.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.998 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.7 Cg_endo -78.88 122.42 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.745 2.297 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 176.85 -161.06 28.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.685 ' HE1' HG23 ' A' ' 130' ' ' VAL . 2.3 ppp? -107.87 176.08 5.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -1.081 . . . . 0.0 109.222 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -164.38 126.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.995 -1.066 . . . . 0.0 110.064 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -99.14 169.43 9.4 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.879 HG12 HG22 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -161.31 158.27 2.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.415 -1.428 . . . . 0.0 110.692 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.549 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 39.7 t -139.21 100.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -58.2 159.82 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 3' ' ' THR . 4.1 tm0? -42.08 -52.09 4.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 109.619 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -57.98 178.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.18 82.37 1.68 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.46 -167.59 2.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 9.2 pt-20 -166.68 141.27 4.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.25 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.589 ' H ' HG22 ' A' ' 52' ' ' ILE . 1.7 mm-40 -116.2 167.63 10.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.718 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 1.011 ' CD2' HG22 ' A' ' 130' ' ' VAL . 6.0 m-85 -129.24 119.15 23.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.049 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.675 HG22 ' H ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -126.79 179.93 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.132 -0.98 . . . . 0.0 109.871 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.775 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -173.79 142.62 0.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -147.12 178.92 8.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.746 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 14.0 p -104.99 -25.47 12.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.64 178.19 37.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.11 -133.5 3.72 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -144.4 130.43 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.24 . . . . 0.0 109.31 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.887 ' HA ' HG12 ' A' ' 78' ' ' VAL . 2.3 pp -109.13 125.91 52.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.786 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HG3' HD21 ' A' ' 42' ' ' LEU . 22.8 tt0 -125.17 129.14 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.065 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 ' HA ' ' A' ' 40' ' ' PRO . 7.1 p -99.24 155.46 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.832 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.509 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -138.21 170.83 9.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.432 -0.792 . . . . 0.0 109.442 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.47 71.76 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.659 2.239 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.19 -1.35 7.72 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.234 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 38.2 p-10 -172.88 175.26 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.933 -1.333 . . . . 0.0 109.865 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.571 HG13 ' HA ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -161.14 162.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 7' ' ' ASP . 29.4 m -158.54 149.36 20.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.418 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.887 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -135.86 157.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 112.88 16.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.711 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.61 159.18 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.93 -48.87 16.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.7 t -102.04 -178.56 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -170.13 85.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 84' ' ' ILE . 3.1 mp -104.09 67.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.21 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.578 ' HB3' ' HE2' ' A' ' 15' ' ' MET . 1.2 ptt180 -42.23 139.42 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.495 -0.753 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.485 ' C ' ' CG ' ' A' ' 87' ' ' GLN . . . -47.36 148.81 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.827 ' OE1' HG21 ' A' ' 134' ' ' THR . 0.0 OUTLIER 58.61 25.1 12.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -1.222 . . . . 0.0 109.043 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 87' ' ' GLN . 17.6 p-10 -41.04 -46.39 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -159.04 -61.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.874 . . . . 0.0 109.343 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.08 172.2 13.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.662 ' HA ' HD11 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -140.31 -87.27 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.359 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -19.29 56.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -77.17 -8.43 57.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.36 -8.32 51.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.959 . . . . 0.0 109.203 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.414 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.48 -23.37 58.86 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.377 -0.827 . . . . 0.0 109.527 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -85.37 5.41 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.626 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -90.1 -12.44 38.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -29.52 65.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.542 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -90.23 -32.66 16.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.39 -8.11 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.202 -0.937 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 97' ' ' ALA . . . -87.09 -30.67 20.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -0.989 . . . . 0.0 109.384 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.564 ' HA ' HD12 ' A' ' 105' ' ' ILE . 1.9 tt0 -69.56 -33.4 72.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.525 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.57 -35.29 73.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -75.27 -20.6 59.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 105' ' ' ILE . 32.3 mt -90.33 21.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 55.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -119.8 145.77 46.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.381 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.439 ' HA ' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p -128.95 138.29 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.686 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.6 -68.78 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.26 -100.14 0.14 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.607 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -72.14 156.76 38.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.457 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 111' ' ' ASP . 14.8 m 40.88 37.91 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.682 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 11.2 t70 -88.14 -96.3 0.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.192 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.37 -19.38 63.84 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.39 -41.79 84.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -90.12 -16.63 29.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.348 -0.845 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 105' ' ' ILE . . . -79.38 -32.14 43.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.4 t -55.71 -21.75 20.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 109.587 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.85 -29.28 18.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.28 -24.75 63.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.497 ' O ' HD13 ' A' ' 125' ' ' ILE . 8.8 tt -82.51 -50.92 8.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.54 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.44 1.73 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.829 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.09 -61.76 1.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -78.3 -20.48 51.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.3 mp -75.72 -12.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 109.163 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.775 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -68.67 -41.7 78.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -78.66 -7.62 57.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 5.8 tp -78.26 -26.76 47.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.468 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.512 ' O ' HD23 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -87.94 -25.25 23.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.752 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 1.011 HG22 ' CD2' ' A' ' 61' ' ' PHE . 2.3 p -80.53 -25.7 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.643 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.1 tt -90.58 -24.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.232 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 -44.94 46.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.095 -1.003 . . . . 0.0 110.198 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 129' ' ' ARG . 2.6 pp -68.56 -11.03 59.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 110.038 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.827 HG21 ' OE1' ' A' ' 87' ' ' GLN . 57.4 p -53.28 -41.88 66.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.569 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -41.76 64.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -94.57 40.66 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.379 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.12 6.75 36.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.847 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.542 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.7 mtp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.553 HG21 ' CG ' ' A' ' 55' ' ' GLN . 70.9 p -132.39 161.7 32.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.905 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.746 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 4.0 p90 -163.61 -143.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.772 ' HA ' HG12 ' A' ' 20' ' ' VAL . 2.4 t-80 -139.69 149.45 43.69 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.072 HD23 HG21 ' A' ' 20' ' ' VAL . 1.6 pp -142.67 159.25 42.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.685 -1.259 . . . . 0.0 108.631 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 77' ' ' THR . 9.8 t0 -135.49 87.0 2.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.895 -1.128 . . . . 0.0 109.678 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' ' 16' ' ' PHE . 14.7 p -99.04 100.44 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.22 -0.925 . . . . 0.0 109.604 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 13' ' ' GLN . 55.2 t -108.95 149.03 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.865 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 2.4 p -162.58 144.9 10.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.74 -96.98 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.717 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.55 38.98 3.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.056 -1.028 . . . . 0.0 109.567 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.582 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.86 -153.71 0.34 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.251 -0.905 . . . . 0.0 109.457 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.422 ' O ' ' SD ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 70.46 61.5 0.21 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.519 -0.738 . . . . 0.0 109.491 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.641 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -143.72 -70.28 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.519 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.804 ' HB3' HG12 ' A' ' 8' ' ' VAL . 34.9 t80 -162.8 131.95 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -160.82 105.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.278 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 5' ' ' HIS . . . 146.67 -158.62 27.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.804 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -48.39 -179.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.068 -1.254 . . . . 0.0 109.474 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.072 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 170.37 115.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.549 -1.344 . . . . 0.0 109.74 179.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 1.5 tt0 -67.93 -44.7 76.27 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.5 mtpt -179.5 143.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.995 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.94 HG22 ' CG1' ' A' ' 52' ' ' ILE . 23.5 pt -105.34 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.501 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -178.92 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 109.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.24 127.61 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.992 . . . . 0.0 109.513 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -130.64 140.6 50.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.83 54.11 0.04 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.493 ' HB3' ' CB ' ' A' ' 46' ' ' LYS . 89.4 p -174.17 -159.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 109.438 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.29 48.18 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -167.11 -144.07 3.99 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.3 OUTLIER 166.98 74.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.792 HD13 ' OH ' ' A' ' 35' ' ' TYR . 12.6 mt -153.07 178.24 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.877 . . . . 0.0 109.67 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -128.68 -112.36 1.63 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.784 -2.127 . . . . 0.0 107.784 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.746 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 12.7 mm -154.1 138.25 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 109.124 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.792 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -138.28 176.9 2.37 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.6 Cg_endo -74.06 8.11 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.995 1.797 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.6 10.77 5.23 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' ALA . 40.1 t60 -54.33 123.75 13.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -1.215 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -49.17 178.56 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 34.9 Cg_endo -77.72 81.36 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.465 2.11 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -98.71 137.61 37.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.663 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.06 72.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.412 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 p -144.27 -146.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.51 169.92 8.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.454 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -130.49 173.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 109.251 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' CB ' ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -111.18 173.07 3.07 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.7 Cg_endo -78.31 -177.94 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.735 2.29 . . . . 0.0 110.474 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.38 -159.12 23.51 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.539 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 4.6 ppp? -113.28 172.78 6.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.255 -1.144 . . . . 0.0 109.126 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 62' ' ' ILE . 5.1 tt -146.75 146.81 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.052 -1.03 . . . . 0.0 110.922 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.46 160.28 23.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.94 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -153.71 158.98 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.458 -1.401 . . . . 0.0 110.926 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.77 102.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -52.09 141.33 18.64 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.122 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.574 ' OE1' ' CG ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -39.91 -59.1 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.574 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 3.4 m170 -122.36 31.58 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.739 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.35 -108.15 3.16 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -151.9 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -1.127 . . . . 0.0 109.139 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER 179.65 147.67 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.551 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.8 mt-10 -130.91 161.39 31.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.104 -0.998 . . . . 0.0 109.782 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -117.64 125.31 50.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.272 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 50' ' ' ILE . 5.2 mt -136.8 166.58 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.331 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.856 ' HE1' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.92 146.18 25.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.1 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -172.81 4.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.519 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' A' ' 82' ' ' THR . 62.8 m -115.65 14.38 16.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.83 151.45 25.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . -165.85 -106.64 0.19 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 9.1 mt -139.2 122.27 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 108.97 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.657 ' HB2' HD13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -106.58 133.48 51.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.782 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -133.5 143.64 48.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.019 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.671 ' HA ' HG12 ' A' ' 76' ' ' VAL . 14.7 p -109.94 139.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.917 -1.114 . . . . 0.0 109.494 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.579 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -127.87 176.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 108.862 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.0 Cg_endo -79.22 88.91 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.514 2.142 . . . . 0.0 111.103 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 101.07 -3.43 55.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.4 OUTLIER -164.37 155.3 15.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.242 . . . . 0.0 109.72 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.685 HG22 ' HA ' ' A' ' 6' ' ' LEU . 35.5 m -133.16 175.74 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 108.845 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 7' ' ' ASP . 17.6 m -156.63 104.58 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.282 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.5 m -114.47 115.8 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 108.963 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -100.21 173.2 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.132 -0.98 . . . . 0.0 110.034 -179.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -157.69 -157.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 0.0 109.182 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.22 -30.78 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.95 . . . . 0.0 109.805 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.432 ' HB ' ' OG ' ' A' ' 65' ' ' SER . 5.5 m -110.01 153.2 24.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.889 ' C ' HD12 ' A' ' 84' ' ' ILE . . . -152.64 119.75 5.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.793 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.889 HD12 ' C ' ' A' ' 83' ' ' ALA . 2.6 mp -139.07 95.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.29 -0.881 . . . . 0.0 108.907 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 84' ' ' ILE . 13.5 ttm180 -41.24 161.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.394 -0.816 . . . . 0.0 109.898 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -51.1 -26.32 12.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -151.7 93.41 1.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -1.153 . . . . 0.0 109.637 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -94.14 -57.88 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -83.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 109.475 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.13 165.97 17.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.43 -19.94 11.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.945 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 -25.59 32.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -65.51 -13.9 59.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.71 -32.0 16.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.379 -0.825 . . . . 0.0 109.29 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.488 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -56.01 -40.61 73.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.802 . . . . 0.0 109.681 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.91 -16.5 53.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.54 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 100' ' ' LYS . . . -64.37 -27.76 69.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.654 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -55.71 29.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.549 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -19.92 62.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.907 . . . . 0.0 109.554 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.95 -34.28 77.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.784 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -89.61 -20.81 23.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.401 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.02 -16.67 64.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -80.53 -30.37 37.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -32.36 32.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 118' ' ' SER . 25.6 mt -88.98 22.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 t -60.84 -24.94 66.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 m -140.02 167.08 22.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.215 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.08 134.1 3.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.618 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -156.14 179.47 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.89 -178.89 35.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.571 ' O ' HG22 ' A' ' 112' ' ' VAL . 12.4 m-20 -98.41 127.62 44.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.518 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.29 28.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 109.672 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 111' ' ' ASP . 15.5 t70 -84.88 -93.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.45 -13.6 60.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.1 62.73 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.468 ' HG3' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -74.81 -45.95 40.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.498 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.45 -23.3 65.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.496 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.543 ' HB2' ' CG2' ' A' ' 105' ' ' ILE . 8.6 p -70.6 -5.78 31.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.5 -12.23 52.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.41 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -73.71 -12.52 60.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -70.1 -60.79 2.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.69 -10.44 27.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.539 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -34.4 36.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.209 -0.932 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -82.4 -14.96 54.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 48.0 mm -73.04 -8.16 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -73.35 -35.23 65.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -0.907 . . . . 0.0 109.642 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 8.5 mt-30 -69.83 -23.26 63.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -69.47 -20.48 63.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.379 -0.825 . . . . 0.0 109.809 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -85.02 -40.63 16.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.566 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . 20.8 m -68.01 -16.95 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.669 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 127' ' ' GLN . 4.9 pt -90.97 -31.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.484 ' HG2' HG13 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -80.05 -30.87 39.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.743 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.5 mp -79.81 -40.22 29.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.758 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 130' ' ' VAL . 17.9 p -63.16 -34.16 77.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.68 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -74.18 -15.98 61.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.542 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.04 29.6 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.668 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.41 -78.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.935 . . . . 0.0 109.53 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.0 mtm . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.226 0.536 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -104.86 -148.15 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.652 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 1.23 ' CG ' HG22 ' A' ' 20' ' ' VAL 0.253 0.7 OUTLIER -142.25 -169.71 3.01 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 124.107 1.908 . . . . 0.0 115.576 -175.438 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 7.3 t-80 -170.8 95.98 0.21 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 102.319 -3.215 . . . . 0.0 102.319 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.89 HD23 HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.52 147.83 22.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.522 -1.361 . . . . 0.0 108.638 -176.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -155.76 69.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.847 -1.158 . . . . 0.0 110.015 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 64' ' ' LEU . 1.7 p -102.74 112.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 108.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 3.9 m -103.97 144.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.802 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.843 ' OG ' ' HB2' ' A' ' 83' ' ' ALA . 55.9 m -107.35 53.11 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 109.265 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 72.03 77.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.361 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.38 31.6 12.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.462 ' CB ' ' HB2' ' A' ' 10' ' ' SER . 1.9 tp60 -114.79 -28.18 7.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 46.07 88.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.647 ' HE1' ' O ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -85.82 -84.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 109.537 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.725 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 1.1 t80 -101.05 112.09 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 94.6 p -128.72 85.84 2.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.131 -0.981 . . . . 0.0 109.658 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 168.33 148.15 5.62 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.597 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -35.63 161.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.886 0.851 . . . . 0.0 111.656 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.23 HG22 ' CG ' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -158.51 -160.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 O-C-N 121.684 -0.635 . . . . 0.0 109.988 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.833 ' N ' HG23 ' A' ' 20' ' ' VAL . 2.3 tt0 -160.33 -32.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.734 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.6 mmmt -141.21 85.2 1.96 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.782 -1.199 . . . . 0.0 110.309 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.87 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.57 142.68 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -127.41 143.91 51.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.762 -1.211 . . . . 0.0 110.309 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -133.44 116.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.176 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -122.69 125.35 45.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.07 -40.27 0.18 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 159.87 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -1.192 . . . . 0.0 109.646 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -48.09 -43.03 30.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.55 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.44 -51.53 47.17 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.84 20.37 11.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -1.191 . . . . 0.0 109.414 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 153.93 40.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.716 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.39 171.03 23.85 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.949 HG22 ' OH ' ' A' ' 4' ' ' TYR . 16.6 mm -101.82 112.39 34.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.858 -1.378 . . . . 0.0 109.136 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -122.92 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 33.5 Cg_endo -76.89 5.56 4.83 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.551 1.501 . . . . 0.0 110.44 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.84 17.84 2.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.452 ' CG ' HD13 ' A' ' 34' ' ' ILE . 16.7 t60 -44.81 146.53 0.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -1.092 . . . . 0.0 109.541 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.0 10.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.669 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.563 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.4 Cg_endo -77.55 77.58 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.637 2.225 . . . . 0.0 110.222 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 41' ' ' LEU . 1.6 mm? -98.42 159.03 15.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.718 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.43 32.04 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.417 ' O ' HG13 ' A' ' 68' ' ' ILE . 44.1 p -114.96 -144.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.389 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.79 164.91 11.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.015 . . . . 0.0 109.155 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.895 ' CD1' HD13 ' A' ' 69' ' ' LEU . 5.4 mt -128.99 149.88 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.99 . . . . 0.0 109.554 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' HD2' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -70.24 167.86 22.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -78.99 136.58 13.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.744 2.296 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.62 -161.96 26.43 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.626 ' C ' HG22 ' A' ' 50' ' ' ILE . 8.3 ptm -117.4 -164.23 0.98 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -1.133 . . . . 0.0 109.192 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.918 HD12 ' HB ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -174.68 147.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.085 . . . . 0.0 109.982 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -129.17 126.37 39.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.654 HG23 ' CA ' ' A' ' 23' ' ' ILE . 30.6 mt -123.53 166.36 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.874 -1.141 . . . . 0.0 111.037 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.54 ' N ' HG22 ' A' ' 52' ' ' ILE . 34.2 t -132.23 119.26 39.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -71.05 129.49 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.653 . . . . 0.0 109.315 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 11.5 tt0 52.68 -90.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 54' ' ' LYS . 3.3 t-160 -171.1 60.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.77 -68.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -76.5 179.73 5.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -1.101 . . . . 0.0 109.399 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -156.5 153.68 29.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.844 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 156.44 36.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.251 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 1.029 ' CD2' HG22 ' A' ' 130' ' ' VAL . 4.4 m-85 -119.24 124.97 48.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.544 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.918 ' HB ' HD12 ' A' ' 50' ' ' ILE . 5.3 mm -128.71 178.29 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.307 -0.871 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.637 ' H ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -173.24 125.98 0.43 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -113.36 -177.61 3.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.514 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 1.2 t -149.56 18.19 0.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.932 . . . . 0.0 109.384 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.13 156.72 6.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.14 -169.67 25.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -115.94 118.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -1.123 . . . . 0.0 109.369 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.895 HD13 ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -101.91 153.12 20.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.208 -0.933 . . . . 0.0 109.922 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 41.6 tt0 -152.15 134.46 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG23 HG22 ' A' ' 76' ' ' VAL . 12.6 p -99.92 139.77 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.006 -1.059 . . . . 0.0 110.248 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.59 174.53 3.28 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.4 Cg_endo -78.62 103.4 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.32 2.014 . . . . 0.0 110.821 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 75.42 45.64 17.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 2.2 t30 159.91 115.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.468 -1.019 . . . . 0.0 109.177 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.663 HG22 HG23 ' A' ' 71' ' ' VAL . 23.5 t -102.2 146.53 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 108.875 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 7' ' ' ASP . 22.2 m -147.59 136.68 22.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.802 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.776 HG13 HG23 ' A' ' 8' ' ' VAL . 1.4 p -150.4 142.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 108.991 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 4.6 mp -105.21 159.26 16.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -163.73 -174.36 3.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.333 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.68 -39.03 3.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 1.8 m -99.46 149.18 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.254 -0.904 . . . . 0.0 109.196 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.843 ' HB2' ' OG ' ' A' ' 10' ' ' SER . . . -159.81 141.83 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.647 ' O ' ' HE1' ' A' ' 15' ' ' MET . 46.8 mt -132.67 126.14 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.328 -0.858 . . . . 0.0 108.793 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 86' ' ' GLY . 3.0 tpt180 -92.37 91.98 7.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.034 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 39.06 -102.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HG2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -94.26 81.81 4.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -1.161 . . . . 0.0 109.593 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.65 -53.33 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.098 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 2.8 mp -92.11 31.92 1.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.066 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 131' ' ' ILE . 18.2 m-20 62.21 -179.55 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.372 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.443 ' HG2' HD11 ' A' ' 131' ' ' ILE . 1.6 mt-10 -108.63 -36.59 6.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.0 -12.75 57.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 48.1 ttp180 -82.28 -26.77 32.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.44 -13.53 40.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 108.9 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.487 ' HA ' HD11 ' A' ' 128' ' ' LEU . 3.4 mtt -70.34 -20.79 62.96 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -68.8 -18.98 64.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.53 -54.97 3.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.094 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HG2' ' CG1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.2 -39.47 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.104 -179.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -36.04 82.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 110.005 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -4.57 58.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 109.876 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -90.29 -20.97 22.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.714 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 5.6 tp10 -73.68 -36.8 65.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.34 -22.96 64.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -51.72 26.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 105' ' ' ILE . 91.1 mt -89.14 22.84 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.98 -54.74 7.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -98.77 132.95 43.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -162.75 138.87 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.65 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.431 ' N ' ' CD2' ' A' ' 109' ' ' HIS . 0.5 OUTLIER -168.33 169.08 10.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.63 -173.53 28.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 112' ' ' VAL . 5.0 t0 -101.17 135.26 42.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.272 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.59 28.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 6.9 t70 -79.24 -95.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.418 -0.801 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -69.76 -21.72 63.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.29 73.55 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -46.39 85.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.85 -11.22 58.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.9 t -82.77 6.03 19.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.907 . . . . 0.0 109.592 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.21 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 109.558 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -77.03 -18.51 58.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.44 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.647 HD11 ' HB1' ' A' ' 101' ' ' ALA . 9.0 tt -71.77 -63.32 1.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.05 -18.94 4.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.702 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -45.27 -38.32 5.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.79 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -90.55 -23.71 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 0.0 110.127 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 125' ' ' ILE . 2.2 mp -77.08 -1.06 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.83 -24.15 60.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.01 -1.056 . . . . 0.0 109.166 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.776 ' O ' HG22 ' A' ' 131' ' ' ILE . 3.7 pt20 -90.06 -32.13 16.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -63.32 -20.84 65.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.678 -179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.467 ' O ' HD23 ' A' ' 133' ' ' LEU . 2.0 mtt180 -90.15 -48.09 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 1.029 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -62.27 -28.97 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 127' ' ' GLN . 4.8 tt -90.74 -29.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.249 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 17.0 mm-40 -72.86 -34.01 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.389 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 133' ' ' LEU . 2.9 pp -83.62 10.92 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.992 . . . . 0.0 109.727 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 130' ' ' VAL . 76.3 p -83.05 -9.68 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -84.76 -47.94 9.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.752 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.491 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.5 OUTLIER -80.18 -2.81 46.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.705 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.57 -22.4 54.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.11 -0.994 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.437 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.47 ' O ' ' HB ' ' A' ' 3' ' ' THR . 4.5 mtm . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.196 0.522 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 3' ' ' THR . 12.2 t 178.05 124.88 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.62 ' OH ' HG22 ' A' ' 34' ' ' ILE . 30.0 p90 -100.74 -159.41 0.73 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.567 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -122.77 144.02 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 108.823 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.062 HD12 ' N ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -135.21 167.67 20.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.532 178.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 1.062 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.49 97.75 2.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.907 HG12 ' CG1' ' A' ' 78' ' ' VAL . 19.3 m -99.49 148.54 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 108.695 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 8' ' ' VAL . 1.9 t -155.88 126.59 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.477 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.77 104.53 13.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.842 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.22 -95.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.716 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -139.26 56.91 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.607 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 169.99 13.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 111.52 22.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.566 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 4.6 mtt -116.76 -80.87 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.958 . . . . 0.0 109.842 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.5 t80 -130.16 147.08 51.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.744 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 p -175.07 92.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.79 -147.38 14.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.77 ' C ' HG12 ' A' ' 20' ' ' VAL . 8.9 mt -64.17 172.61 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -1.194 . . . . 0.0 108.982 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.051 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 173.47 149.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.816 -1.177 . . . . 0.0 109.438 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -142.75 -47.12 0.32 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.645 ' C ' HD13 ' A' ' 23' ' ' ILE . 4.6 tttp -93.94 126.37 39.11 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.207 -0.933 . . . . 0.0 109.088 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.913 HG22 ' CG1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -154.97 66.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.607 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 18.6 tt0 -98.51 132.29 44.06 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.819 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 49' ' ' MET . 2.7 p -119.94 140.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.4 m -114.57 132.23 56.41 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 109.591 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.2 -107.94 0.63 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -150.8 159.51 44.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.463 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 51.01 42.83 28.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 148.32 -172.58 28.54 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 1.1 pt-20 179.61 -155.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.415 -1.05 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 35' ' ' TYR . 15.4 mt 60.34 130.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.347 -0.846 . . . . 0.0 109.633 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.85 -84.03 1.77 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.62 HG22 ' OH ' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -162.97 161.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.376 -1.073 . . . . 0.0 109.535 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -154.14 173.43 4.73 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -178.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.525 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 33.9 Cg_endo -75.88 94.56 1.01 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.309 2.006 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.12 -12.78 2.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.488 ' ND1' HD11 ' A' ' 34' ' ' ILE . 3.9 t-80 -60.71 -178.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -104.73 167.73 9.48 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.682 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.6 Cg_endo -78.89 77.84 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.746 2.298 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HE1' ' A' ' 38' ' ' HIS . 21.4 mt -99.68 155.31 17.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.398 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.412 HD12 ' CD ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -126.69 99.7 5.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.529 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -135.71 -168.73 2.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.647 ' C ' HD12 ' A' ' 45' ' ' ILE . . . -101.91 -172.02 2.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.995 HD11 ' CB ' ' A' ' 69' ' ' LEU . 2.0 mp -110.8 116.88 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.648 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.51 166.1 9.99 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.201 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.38 120.41 4.86 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.622 2.215 . . . . 0.0 110.536 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.5 -155.94 27.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.878 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.7 ppp? -119.11 174.86 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -1.12 . . . . 0.0 109.267 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 50' ' ' ILE . 1.5 tt -153.45 131.55 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.095 -1.003 . . . . 0.0 110.344 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.27 21.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.913 ' CG1' HG22 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -142.48 143.51 25.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.758 -1.214 . . . . 0.0 110.618 -178.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 37.2 t -127.53 104.07 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.71 136.37 57.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.512 HE21 HD12 ' A' ' 19' ' ' LEU . 3.0 mm-40 46.16 -99.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.32 21.49 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -137.4 -65.26 0.05 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -69.87 142.1 53.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.45 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.3 131.63 25.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.862 . . . . 0.0 109.361 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 52' ' ' ILE . 1.2 tt0 -121.01 153.81 36.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.763 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 14.3 m-85 -100.45 155.55 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 16' ' ' PHE . 50.5 mt -154.8 160.7 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.568 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -163.63 152.95 14.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.91 . . . . 0.0 108.927 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 64' ' ' LEU . 2.5 pt? -179.88 162.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.495 ' CB ' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -143.39 36.11 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.4 114.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.11 -177.54 35.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.2 mp -129.61 135.36 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -1.153 . . . . 0.0 109.28 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.995 ' CB ' HD11 ' A' ' 45' ' ' ILE . 1.2 tt -121.5 145.13 48.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' CD ' HD12 ' A' ' 42' ' ' LEU . 47.5 tt0 -135.87 129.66 32.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 40' ' ' PRO . 4.3 p -100.08 123.72 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.498 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -101.75 174.11 3.12 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.2 Cg_endo -78.24 72.45 6.25 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.631 2.221 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.51 -14.33 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.189 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' VAL . 78.7 m-20 -145.53 -176.16 5.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.305 . . . . 0.0 109.893 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 75' ' ' ASN . 12.1 t -158.66 165.82 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.542 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -169.63 140.06 2.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.975 . . . . 0.0 109.604 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.907 ' CG1' HG12 ' A' ' 8' ' ' VAL . 1.7 p -153.31 140.42 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.39 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mt -116.41 150.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.45 13.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 -39.47 4.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 m -108.9 136.72 47.97 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 0.0 109.197 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.566 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -158.4 163.33 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.088 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 43.7 mt -142.92 116.87 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.54 109.62 21.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.594 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.64 -146.38 31.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.492 ' OE1' HG12 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -107.97 34.43 3.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -1.098 . . . . 0.0 108.798 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 87' ' ' GLN . 4.5 t0 -44.71 -29.67 0.81 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.407 -0.808 . . . . 0.0 109.68 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -120.7 111.35 17.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.617 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 21.2 m-20 60.24 157.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 -83.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -16.95 60.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.497 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.91 0.1 32.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.41 -5.75 55.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.427 ' HG3' HD11 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -81.21 -22.64 38.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.79 -28.6 19.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.624 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.46 -20.02 62.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.674 ' HG3' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -84.74 -26.16 27.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.36 11.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -62.11 -26.94 68.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.17 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.74 -44.62 20.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.323 -0.861 . . . . 0.0 109.106 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -54.03 -38.16 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.288 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.412 ' OE1' ' CA ' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -46.54 -42.32 15.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -72.46 -38.12 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.4 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 121' ' ' LEU . 11.6 mt -87.94 22.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -55.91 27.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.86 136.8 54.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 59.7 p -131.23 -179.41 5.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -178.63 -171.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.89 176.46 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 25.5 t0 -83.74 -73.94 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -103.61 13.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.02 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 16.1 t80 -71.29 -16.92 62.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.165 -0.959 . . . . 0.0 108.601 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.0 66.77 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -47.97 75.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.37 -6.08 37.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.71 -11.06 54.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.562 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 123' ' ' LYS . . . -85.03 -29.28 25.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.615 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -28.43 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.619 HD13 HD11 ' A' ' 105' ' ' ILE . 0.9 OUTLIER -81.32 -61.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.65 -38.63 2.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 109.743 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HD3' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -45.75 -59.35 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.46 -21.64 63.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.752 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.674 HG23 ' HG3' ' A' ' 98' ' ' LYS . 20.3 mm -71.42 -4.2 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 49' ' ' MET . . . -84.42 -9.91 57.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.653 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.562 ' CD ' HD13 ' A' ' 84' ' ' ILE . 4.2 tt0 -82.65 -26.4 32.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.936 . . . . 0.0 109.651 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 61.8 tp -75.52 -8.98 58.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -43.93 10.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.933 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 134' ' ' THR . 33.9 m -69.74 -24.72 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.928 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.67 HD13 ' C ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -89.52 -48.13 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.87 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 131' ' ' ILE . 13.0 pt-20 -54.66 -24.32 21.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.322 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -80.66 -43.06 21.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 0.0 109.78 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 130' ' ' VAL . 41.7 p -43.11 -34.85 1.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.645 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -67.78 -49.67 61.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -96.51 45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.11 -36.23 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.606 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.585 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.2 ptt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.852 HG23 ' HG2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 54.2 103.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.921 ' CE2' HG22 ' A' ' 34' ' ' ILE . 27.3 p90 -99.24 -152.08 0.4 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.763 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -129.68 146.63 51.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.087 HD23 HG21 ' A' ' 20' ' ' VAL . 2.5 pp -133.31 169.67 16.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.312 -1.493 . . . . 0.0 109.252 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.842 ' N ' HD12 ' A' ' 6' ' ' LEU . 21.6 t70 -146.0 100.53 3.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.1 p -105.57 105.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.083 -1.011 . . . . 0.0 109.745 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.361 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.746 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -166.95 73.11 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.746 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 72.32 5.38 5.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 39.6 mt-10 -156.58 76.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 12' ' ' GLU . 3.3 pt20 -56.01 -164.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.723 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER 72.11 32.04 1.84 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.534 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.807 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 16.0 mtt -106.18 -79.96 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 109.249 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.675 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 37.5 t80 -146.25 117.78 8.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -145.05 108.65 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.115 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 143.5 -163.32 27.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.815 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -43.93 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.695 -0.885 . . . . 0.0 110.879 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.087 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 167.05 150.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.852 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -147.78 -39.18 0.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.8 -1.187 . . . . 0.0 110.471 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 1.8 mptt -116.95 78.57 1.22 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.937 -1.102 . . . . 0.0 111.324 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.897 HG22 HG12 ' A' ' 52' ' ' ILE . 7.8 pt -101.14 160.93 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 4.2 tt0 -162.78 116.28 1.67 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.706 -1.246 . . . . 0.0 110.184 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -99.93 111.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 108.988 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.444 HG23 ' CD ' ' A' ' 31' ' ' GLU . 97.7 m -100.15 110.84 23.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.438 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -136.19 -116.53 1.57 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -118.24 124.03 46.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -1.139 . . . . 0.0 109.57 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.0 tt0 76.44 111.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.35 164.76 39.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 1.2 tt0 -163.54 64.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.145 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 23.4 mt -149.58 140.8 23.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.091 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.91 -105.06 2.65 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.806 -2.117 . . . . 0.0 107.806 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.921 HG22 ' CE2' ' A' ' 4' ' ' TYR . 7.6 mm -153.85 143.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.289 -1.124 . . . . 0.0 109.278 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -142.18 173.63 4.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -72.63 94.45 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.954 1.769 . . . . 0.0 109.752 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.15 4.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.519 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.0 t-80 -71.75 166.06 22.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.996 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -89.67 176.23 3.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.253 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 1.008 ' HA ' HG11 ' A' ' 71' ' ' VAL . 34.9 Cg_endo -76.82 100.7 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.516 2.144 . . . . 0.0 110.374 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 140.29 29.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.592 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.76 48.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 p -118.71 -146.61 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.385 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.581 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -100.34 176.3 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.644 HD11 HG21 ' A' ' 25' ' ' VAL . 1.6 tp -102.29 151.23 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 141.52 47.44 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.958 . . . . 0.0 109.607 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.3 Cg_endo -79.38 -179.8 5.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.554 2.169 . . . . 0.0 110.321 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 101.58 -129.0 9.75 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.441 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.9 ptm -119.42 177.79 4.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.155 . . . . 0.0 109.236 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.2 tt -152.84 130.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.075 -1.016 . . . . 0.0 110.003 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.08 HD11 HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -148.59 158.8 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.65 -1.281 . . . . 0.0 111.076 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 59' ' ' GLU . 25.0 t -139.35 99.72 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HD3' ' CB ' ' A' ' 58' ' ' HIS . 6.0 ptmt -65.91 153.35 42.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.639 ' CB ' HG21 ' A' ' 3' ' ' THR . 1.5 tt0 -41.62 -52.88 3.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.488 -0.758 . . . . 0.0 110.137 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -43.67 -51.04 7.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.868 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.21 -38.71 1.44 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.461 ' CB ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -48.65 129.1 16.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -1.235 . . . . 0.0 109.313 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.59 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -105.45 123.59 48.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.329 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 52' ' ' ILE . 1.3 tm-20 -122.95 144.83 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 1.6 p90 -114.62 135.85 53.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.701 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.7 mm -108.43 -155.87 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.83 . . . . 0.0 109.07 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' H ' HG22 ' A' ' 62' ' ' ILE . 5.3 t80 -168.0 125.18 1.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.66 178.04 6.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 0.0 109.021 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 9.04 4.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.745 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.25 144.73 4.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.48 -155.47 23.35 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 28.7 mt -133.8 133.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -1.181 . . . . 0.0 109.42 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 70' ' ' GLU . 1.1 pp -114.05 -169.71 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.719 ' N ' HD12 ' A' ' 69' ' ' LEU . 3.4 pt-20 -179.91 149.08 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.262 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.008 HG11 ' HA ' ' A' ' 40' ' ' PRO . 11.0 p -100.34 141.15 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.517 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 24.8 mt-30 -126.91 160.55 58.58 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.2 Cg_endo -75.32 90.76 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.355 2.036 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.31 6.92 41.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.482 ' C ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -175.18 -176.87 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -1.177 . . . . 0.0 109.816 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 6' ' ' LEU . 28.6 m -157.96 150.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.595 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -135.32 167.97 20.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.909 -1.119 . . . . 0.0 109.834 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 8' ' ' VAL . 1.7 p -175.15 120.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.068 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.34 141.4 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.749 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.746 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -127.39 -179.9 5.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.203 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -98.51 -2.05 39.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.566 HG23 ' CD1' ' A' ' 84' ' ' ILE . 1.9 m -155.2 143.67 20.41 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.175 -0.953 . . . . 0.0 109.136 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.807 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -146.29 98.61 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.603 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 84' ' ' ILE . 2.1 mp -115.3 84.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.324 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 84' ' ' ILE . 6.5 ttm180 -44.1 164.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -49.64 -64.8 3.19 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB3' HG21 ' A' ' 134' ' ' THR . 1.3 pt20 -93.45 37.81 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.188 . . . . 0.0 109.628 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -48.46 -48.93 37.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.23 -58.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 0.0 109.172 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.45 107.68 12.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.398 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HB3' HD11 ' A' ' 131' ' ' ILE . 47.8 mt-10 -101.72 -70.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.644 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.46 -17.6 36.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.616 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -81.6 -1.02 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.27 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.17 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.64 ' HG2' HD21 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -69.39 -37.79 77.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -34.81 11.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.52 -54.46 35.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.352 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -22.8 15.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -75.13 -60.93 2.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -64.17 -12.38 39.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.717 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -87.66 -36.42 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -57.55 -16.83 11.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -57.68 6.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.604 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -11.51 60.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.645 HD11 ' CG ' ' A' ' 121' ' ' LEU . 14.1 mm -76.09 -8.44 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.528 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -46.14 -65.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 0.0 109.331 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 165.85 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -151.39 -50.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 179.94 -72.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.18 -155.23 26.5 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 1.6 m-20 56.99 -101.5 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -1.086 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 116' ' ' GLN . 3.4 m -119.69 -15.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.871 -1.143 . . . . 0.0 109.285 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.8 OUTLIER -47.6 -95.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 118' ' ' SER . 19.3 t80 -74.26 -22.15 59.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -62.52 -20.76 64.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.517 ' CG ' ' O ' ' A' ' 112' ' ' VAL . 33.7 mm-40 -85.71 -52.99 5.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.872 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . . . -74.53 -1.41 21.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 36.4 t -90.19 -35.65 15.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.769 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.61 -28.57 18.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.868 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' CG ' ' HA ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -82.09 -8.55 59.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.717 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -86.06 -48.47 8.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.54 -17.12 18.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -64.96 -37.66 88.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.465 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.84 -12.37 59.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -83.36 -8.04 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.541 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -68.29 -46.39 70.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 109.305 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.4 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.1 tm0? -67.31 -23.53 65.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.64 HD21 ' HG2' ' A' ' 95' ' ' MET . 5.6 mp -74.5 -16.8 60.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.46 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 4.1 mtp85 -89.82 -50.69 5.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.78 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 27.4 m -60.54 -34.93 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.558 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.442 HD11 ' HB3' ' A' ' 91' ' ' GLU . 3.4 tt -61.44 -36.09 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.337 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 129' ' ' ARG . 2.8 mt-10 -49.89 -27.46 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.218 -0.927 . . . . 0.0 109.363 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mp -75.16 -61.55 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 87' ' ' GLN . 4.9 p -45.56 -31.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -58.53 -66.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.69 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -15.3 56.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.844 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.8 68.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.239 0.543 . . . . 0.0 109.582 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 57.11 159.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.713 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.4 p90 -158.11 -144.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.683 ' O ' HG22 ' A' ' 76' ' ' VAL . 24.1 t-80 -131.51 134.84 46.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.734 -1.229 . . . . 0.0 111.013 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.85 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -106.14 124.28 49.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -136.88 71.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.735 -1.228 . . . . 0.0 109.974 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.729 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.1 p -102.46 124.91 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.38 -172.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.2 p -166.54 107.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 60.08 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 64.34 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -150.2 104.01 3.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.69 105.04 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.7 mmt -87.32 -89.1 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.888 . . . . 0.0 109.479 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.654 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -110.14 111.79 23.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 85.7 p -136.13 78.83 1.74 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' N ' ' CE1' ' A' ' 5' ' ' HIS . . . -177.47 174.16 46.73 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 30.9 mt -50.22 163.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.879 ' O ' HG22 ' A' ' 3' ' ' THR . 0.2 OUTLIER -162.27 163.76 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.335 -0.853 . . . . 0.0 108.967 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.758 ' CG ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -125.29 -39.18 2.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 2.1 ttmt -156.15 109.07 2.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.031 -1.043 . . . . 0.0 110.369 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.85 HG21 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -101.28 146.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.939 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -120.73 141.58 50.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.0 109.988 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 50' ' ' ILE . 13.4 t -136.77 133.49 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 84.8 m -140.94 111.49 6.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 109.842 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 46' ' ' LYS . . . -120.73 -104.91 1.99 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.53 -67.05 1.02 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -117.99 139.15 51.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.097 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.43 69.33 1.41 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.49 77.07 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -1.066 . . . . 0.0 109.596 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mt -113.83 153.43 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 23' ' ' ILE . . . -99.81 172.0 24.34 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.713 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 12.9 mm -98.09 134.52 36.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.911 -1.346 . . . . 0.0 108.822 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.579 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -132.3 169.86 12.82 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.0 Cg_endo -72.7 87.6 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.018 1.812 . . . . 0.0 109.923 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 38' ' ' HIS . . . 138.42 -4.4 3.09 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' ALA . 70.3 t60 -42.84 132.72 3.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 0.0 109.501 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.994 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -48.73 176.4 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.994 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.1 Cg_endo -77.66 81.31 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.519 2.146 . . . . 0.0 110.291 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -96.75 155.95 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.722 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.84 34.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.403 -0.811 . . . . 0.0 108.907 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 22.4 p -99.56 -147.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 109.486 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -100.54 164.15 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 46' ' ' LYS . 48.0 mt -105.98 163.04 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 109.273 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.544 ' N ' HG22 ' A' ' 45' ' ' ILE . 8.4 mptt -96.06 151.88 38.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 0.0 109.826 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.56 127.71 7.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.82 2.347 . . . . 0.0 110.444 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 174.28 -149.92 11.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.499 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.9 ptm -109.54 -177.04 3.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -1.162 . . . . 0.0 109.405 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.939 HG23 ' O ' ' A' ' 24' ' ' GLN . 47.7 mt -155.08 140.04 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.442 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 115.38 17.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.737 HG23 ' CA ' ' A' ' 23' ' ' ILE . 14.1 mt -117.79 169.75 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 111.176 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' N ' HG22 ' A' ' 52' ' ' ILE . 53.2 t -137.8 100.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -60.5 126.03 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -0.91 . . . . 0.0 110.154 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 23.1 mt-30 45.82 -92.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' LYS . 14.1 t-160 -164.12 49.87 0.13 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.84 -99.87 0.31 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -74.75 172.08 12.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -1.169 . . . . 0.0 109.874 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -127.34 167.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.046 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -133.04 144.86 50.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.983 ' C ' HD12 ' A' ' 62' ' ' ILE . 7.3 m-85 -111.21 134.68 52.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.141 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.983 HD12 ' C ' ' A' ' 61' ' ' PHE . 2.8 mp -140.78 147.48 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 109.677 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -144.89 151.48 38.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.395 -0.815 . . . . 0.0 109.006 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.94 -173.87 2.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.5 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 70.6 m -112.18 -81.72 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.49 168.09 24.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.35 -176.95 42.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 69' ' ' LEU . 4.7 mp -99.98 156.58 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.184 -1.186 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -131.68 169.75 15.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.0 125.93 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 108.848 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 76' ' ' VAL . 11.6 p -99.85 146.77 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.526 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 6.3 mt-30 -131.42 163.78 47.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.036 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.8 Cg_endo -77.4 106.29 2.19 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.43 2.087 . . . . 0.0 110.599 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.55 58.32 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.509 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 -179.73 166.35 1.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -1.199 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 5' ' ' HIS . 10.2 m -139.02 167.93 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.829 . . . . 0.0 109.262 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 7' ' ' ASP . 46.1 m -165.77 134.8 3.24 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.869 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.729 ' CG2' HG23 ' A' ' 8' ' ' VAL . 4.3 m -137.25 138.11 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 143.41 30.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.66 -179.17 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.4 -39.52 2.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.247 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.48 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 32.6 m -104.31 120.7 41.76 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.185 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.9 87.33 2.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 109.771 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 88' ' ' ASP . 3.1 mp -100.01 92.2 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 108.919 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' GLY . 1.2 ttt180 -41.95 153.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.786 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.609 ' HA2' HG21 ' A' ' 130' ' ' VAL . . . -43.26 -35.57 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.539 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 15.6 mt-30 -78.95 -69.92 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.0 109.382 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.758 ' HB2' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER 84.53 -44.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 164.57 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.111 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 22.8 m-20 -119.05 -172.69 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -123.58 -70.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 -11.04 60.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -83.55 4.33 28.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.709 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.78 -21.2 23.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 108.996 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.597 ' CG ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -73.63 -25.14 60.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.484 -0.76 . . . . 0.0 109.406 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -17.17 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.68 -44.03 35.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.714 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HG3' HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.01 -19.38 43.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 109.508 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.447 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -77.99 -37.03 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 2.8 pttm -79.65 -18.73 50.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 109.496 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 105' ' ' ILE . . . -89.18 -34.44 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.99 -31.02 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.468 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.24 -54.7 40.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.83 -16.24 60.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 105' ' ' ILE . 21.8 mm -87.25 16.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 109.524 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 107' ' ' SER . 15.0 m -91.93 -147.76 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 106' ' ' SER . 2.8 m 56.31 108.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.586 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.51 108.36 10.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 173.27 56.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.2 163.21 33.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -1.217 . . . . 0.0 109.607 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.497 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 13.2 m -96.17 17.18 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.437 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 39.5 t0 -63.27 -100.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 109.027 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 75.0 t80 -64.06 -20.47 65.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.998 -1.064 . . . . 0.0 108.252 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -64.3 -39.36 93.76 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 1.2 tp-100 -86.5 -7.27 58.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 105' ' ' ILE . . . -80.44 -36.95 32.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.9 m -52.54 -37.24 57.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -52.92 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.36 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -67.69 -8.66 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.687 ' O ' HD13 ' A' ' 125' ' ' ILE . 15.7 tp -83.95 -50.34 8.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.91 8.52 10.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.876 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -72.87 -37.86 67.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.612 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.92 28.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -70.49 -5.9 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' MET . . . -73.66 -23.98 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 0.0 109.286 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -82.73 -4.99 58.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.597 HD11 ' CG ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -84.02 -34.0 24.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -43.62 55.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 109.644 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.609 HG21 ' HA2' ' A' ' 86' ' ' GLY . 18.6 m -54.66 -17.85 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.931 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' ' C ' ' A' ' 132' ' ' GLU . 38.5 mt -88.84 -66.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 131' ' ' ILE . 57.5 mm-40 -43.66 -34.84 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.119 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -73.73 -54.6 7.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.861 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.582 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 7.9 p -44.02 -30.23 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -57.44 -53.74 54.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 3.49 48.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.544 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -104.17 44.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 0.0 109.37 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.479 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.482 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.2 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.92 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.74 -152.78 0.11 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.114 -0.991 . . . . 0.0 109.515 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 1.142 ' CG ' HG22 ' A' ' 20' ' ' VAL 0.277 1.1 m-85 -137.7 -178.23 5.15 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 124.451 2.072 . . . . 0.0 115.914 -175.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.587 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 7.1 t-80 -151.45 88.1 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.769 -3.378 . . . . 0.0 102.98 173.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -93.33 133.64 36.37 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.629 -1.294 . . . . 0.0 108.22 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 77' ' ' THR . 0.3 OUTLIER -146.13 82.53 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.625 -1.297 . . . . 0.0 109.95 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.73 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.4 p -110.6 102.63 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.85 155.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.953 . . . . 0.0 109.441 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.966 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 89.2 p -105.26 -156.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.82 -47.32 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -160.21 60.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.414 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.52 118.95 1.4 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -77.95 117.14 19.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.532 ' HE1' HG22 ' A' ' 62' ' ' ILE . 5.9 mtt -86.82 -73.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.2 t80 -116.17 113.44 23.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 110.321 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 89.2 p -138.6 91.04 2.5 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.05 -172.81 45.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 55' ' ' GLN . 20.8 mt -72.02 154.59 41.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -1.229 . . . . 0.0 109.321 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.142 HG22 ' CG ' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -153.81 -175.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.097 -1.002 . . . . 0.0 109.165 -178.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.666 ' N ' HG23 ' A' ' 20' ' ' VAL . 9.9 tt0 -146.56 -40.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.779 -1.2 . . . . 0.0 110.208 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -139.31 91.16 2.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.799 HD13 HD21 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -98.87 159.96 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.071 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.747 ' O ' HG23 ' A' ' 50' ' ' ILE . 44.7 mt-30 -146.81 166.98 25.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 110.184 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.715 HG12 ' HA2' ' A' ' 33' ' ' GLY . 3.1 p -160.26 143.53 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 109.043 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 18.6 m -129.86 129.38 43.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' HA2' ' NZ ' ' A' ' 123' ' ' LYS . . . 126.27 14.28 3.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -116.25 -153.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.32 98.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 0.0 109.329 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.09 -93.81 1.43 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 26' ' ' THR . 8.6 tt0 -177.48 28.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -1.152 . . . . 0.0 109.744 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB3' ' NE2' ' A' ' 38' ' ' HIS . 16.5 mt -70.64 145.92 50.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.069 -1.019 . . . . 0.0 109.278 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.715 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.06 -122.87 4.81 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.084 HG22 ' OH ' ' A' ' 4' ' ' TYR . 24.1 mm -151.59 123.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.168 -1.195 . . . . 0.0 109.315 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -136.88 -171.13 0.26 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 32.2 Cg_endo -76.64 84.57 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.479 1.453 . . . . 0.0 110.0 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 50.73 0.54 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.607 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 16.0 t-80 -84.95 46.95 1.32 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -1.067 . . . . 0.0 109.702 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.607 ' O ' HG11 ' A' ' 71' ' ' VAL . . . 56.17 160.57 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 110.097 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.93 66.21 8.82 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.835 2.356 . . . . 0.0 110.429 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 69' ' ' LEU . 1.4 mm? -77.75 139.35 39.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 69' ' ' LEU . 17.5 tp -154.59 66.5 0.69 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -136.1 -95.28 0.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.93 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' H ' HG23 ' A' ' 43' ' ' THR . . . -150.99 164.52 36.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 109.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.645 HG13 HD23 ' A' ' 69' ' ' LEU . 2.7 mt -113.17 4.16 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.103 -0.998 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' CG ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 48.16 179.81 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.715 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -80.26 119.49 3.85 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.528 2.152 . . . . 0.0 110.238 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -165.29 -153.2 7.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 130' ' ' VAL . 3.2 ppp? -128.61 -173.43 2.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.335 -1.097 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.747 HG23 ' O ' ' A' ' 24' ' ' GLN . 8.4 mt -151.11 147.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.41 123.48 21.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.59 HG23 ' CA ' ' A' ' 23' ' ' ILE . 32.1 mt -128.4 168.56 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.798 -1.189 . . . . 0.0 111.246 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.586 ' N ' HG22 ' A' ' 52' ' ' ILE . 51.5 t -139.15 153.08 24.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 80.78 -73.56 0.05 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.732 -0.605 . . . . 0.0 109.578 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 56' ' ' HIS . 0.3 OUTLIER 42.99 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.37 -0.831 . . . . 0.0 109.569 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.526 ' CB ' ' OE1' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -158.07 40.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.89 -1.131 . . . . 0.0 109.804 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -36.09 0.44 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.515 ' CE1' ' OE1' ' A' ' 59' ' ' GLU . 1.4 t-80 -169.35 -149.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.29 . . . . 0.0 109.54 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 58' ' ' HIS . 1.5 pt-20 -101.49 160.5 14.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.79 139.59 11.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.3 p90 -110.23 152.54 25.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.885 . . . . 0.0 109.623 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 16' ' ' PHE . 9.1 mt -127.9 144.57 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.258 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE1' HD12 ' A' ' 84' ' ' ILE . 19.6 t80 -113.75 130.38 56.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 8' ' ' VAL . 3.6 mt -121.33 173.89 7.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -125.44 -37.23 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.863 . . . . 0.0 109.416 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.21 144.62 4.47 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 168.25 -173.59 43.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 43' ' ' THR . 60.6 mt -99.36 152.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -1.075 . . . . 0.0 109.075 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.731 ' C ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -132.0 157.33 44.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.917 -1.115 . . . . 0.0 110.586 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' HD12 ' A' ' 69' ' ' LEU . 8.4 pt-20 -150.66 114.89 5.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.773 HG23 HG12 ' A' ' 76' ' ' VAL . 10.0 p -104.04 151.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.889 -1.132 . . . . 0.0 110.709 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.583 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.6 mm-40 -136.43 179.28 1.41 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -79.48 102.23 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.395 2.063 . . . . 0.0 110.847 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 75' ' ' ASN . . . 79.97 34.72 29.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.587 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 7.9 t30 171.18 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -1.175 . . . . 0.0 109.355 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.811 HG22 HD22 ' A' ' 6' ' ' LEU . 2.5 m -112.89 152.65 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 7' ' ' ASP . 88.0 m -152.67 136.02 15.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 109.282 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.73 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.1 m -144.83 147.54 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 109.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.77 142.7 46.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.461 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -139.09 179.61 6.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -100.43 -34.18 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.611 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -118.41 147.9 43.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 0.0 109.741 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.966 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -143.29 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.421 -0.799 . . . . 0.0 109.107 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.636 HD12 ' CE1' ' A' ' 63' ' ' TYR . 2.0 mt -98.93 52.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HG2' ' N ' ' A' ' 86' ' ' GLY . 48.9 ttt180 -42.16 147.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 85' ' ' ARG . . . -42.92 -32.49 1.45 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -111.21 64.66 0.61 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -1.181 . . . . 0.0 109.579 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.12 -83.01 0.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.84 -169.73 3.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.75 73.48 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.68 -68.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.11 -19.85 62.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.87 -2.03 24.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.96 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 108.913 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.3 mtp -85.75 -35.08 20.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.468 -0.77 . . . . 0.0 109.324 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -84.75 -27.32 27.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.22 -54.26 49.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -51.93 -21.61 3.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -80.06 -57.32 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 109.722 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.46 -19.56 48.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.869 ' HB1' HD13 ' A' ' 121' ' ' LEU . . . -85.72 -43.71 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -56.55 -34.53 67.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.439 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.67 -50.82 72.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -18.29 64.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.541 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 121' ' ' LEU . 21.4 mt -80.61 -25.83 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -101.42 102.68 13.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.503 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.1 m -154.01 -41.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -0.948 . . . . 0.0 109.726 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.405 ' O ' ' CE2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -155.9 -166.49 2.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.695 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.76 -86.88 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.64 177.91 8.88 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -113.14 126.5 55.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.324 -1.103 . . . . 0.0 109.333 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.11 29.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 0.0 109.564 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 111' ' ' ASP . 21.2 t70 -84.07 -94.41 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 108' ' ' SER . 20.8 p90 -74.32 -22.99 59.0 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.88 46.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.88 -34.7 51.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.436 -0.79 . . . . 0.0 109.108 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.46 -20.5 54.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.257 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.5 m -65.31 -39.35 92.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.361 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.27 -13.28 36.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.891 . . . . 0.0 109.328 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.19 -32.04 38.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.869 HD13 ' HB1' ' A' ' 101' ' ' ALA . 17.6 mt -83.74 -39.33 20.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.34 -23.67 50.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.69 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.539 ' NZ ' ' HA2' ' A' ' 27' ' ' GLY . 11.1 mmtt -79.8 -30.45 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.15 62.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 109.555 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.3 mt -80.53 1.74 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.595 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.75 62.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.269 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.599 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.8 pt20 -79.12 -11.0 59.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 0.6 OUTLIER -73.08 -30.24 63.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.965 . . . . 0.0 109.795 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -48.81 14.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.1 m -61.49 -40.4 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.912 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.545 HG23 ' N ' ' A' ' 132' ' ' GLU . 9.3 tt -65.3 -43.41 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 131' ' ' ILE . 3.1 mm-40 -53.83 -26.19 23.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -0.879 . . . . 0.0 109.1 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -48.88 20.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.18 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.8 p -53.65 -20.12 4.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -76.25 -55.89 5.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 7.34 24.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.41 -52.17 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.5 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.488 1.475 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER 55.69 92.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.205 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.87 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 32.3 p90 -82.3 -143.18 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 109.099 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -140.26 133.27 29.39 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.203 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.888 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -123.43 150.16 44.16 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.761 -1.212 . . . . 0.0 108.113 178.152 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.789 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -140.5 88.09 2.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.65 HG23 ' CG2' ' A' ' 78' ' ' VAL . 5.0 p -99.91 132.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -142.89 159.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.236 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 87.4 p -100.34 -146.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -0.838 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.75 -10.39 59.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.743 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' GLN . 14.5 mt-10 -118.34 24.21 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.454 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 41.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.78 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.94 92.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.659 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.927 ' HG2' HG21 ' A' ' 62' ' ' ILE . 1.7 mtt -161.97 -88.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.852 . . . . 0.0 108.934 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.691 ' CE2' ' CG1' ' A' ' 20' ' ' VAL . 68.8 t80 -135.3 144.82 46.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.3 p -165.07 82.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.411 -0.806 . . . . 0.0 109.525 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.6 -178.96 42.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 7.6 mt -71.01 139.45 50.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.076 -1.249 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.01 ' CG2' HD11 ' A' ' 23' ' ' ILE . 2.5 m -144.27 148.11 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.41 -0.806 . . . . 0.0 110.643 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.95 -42.05 4.79 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.593 -0.692 . . . . 0.0 109.849 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.529 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.88 109.43 9.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.967 -1.083 . . . . 0.0 110.486 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.086 HG23 HG22 ' A' ' 52' ' ' ILE . 3.9 mm -105.4 -173.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.023 -1.048 . . . . 0.0 109.081 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.63 ' H ' HG22 ' A' ' 23' ' ' ILE . 4.0 tt0 -176.05 98.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.948 -1.095 . . . . 0.0 109.965 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 2.1 p -104.32 137.98 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.352 -0.842 . . . . 0.0 109.069 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.527 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 31.6 m -124.21 115.52 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 46' ' ' LYS . . . -108.94 -68.06 0.61 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.6 t -170.6 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -1.152 . . . . 0.0 109.375 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -95.0 66.94 3.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.465 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.0 82.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -115.87 89.23 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.537 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 mt -106.81 151.35 25.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.26 172.6 25.5 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 107.243 -2.343 . . . . 0.0 107.243 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.87 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 18.8 mm -99.21 128.53 50.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.585 -1.538 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.607 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -129.98 170.75 10.23 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.0 Cg_endo -70.78 81.91 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.772 1.648 . . . . 0.0 109.676 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' HIS . . . 168.27 -27.07 0.14 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.725 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -42.2 163.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -1.091 . . . . 0.0 109.461 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . . . 164.26 -52.0 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.052 -1.03 . . . . 0.0 110.492 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 36.6 Cg_endo -79.32 23.63 0.64 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.607 2.204 . . . . 0.0 111.828 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.53 ' HG ' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -100.57 110.92 23.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.804 -1.185 . . . . 0.0 109.612 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 42' ' ' LEU . 3.5 mt -148.41 80.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.925 . . . . 0.0 109.357 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.774 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.1 t -147.06 -146.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.774 ' N ' HG23 ' A' ' 43' ' ' THR . . . -103.98 -176.61 3.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 109.472 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.875 HD11 ' O ' ' A' ' 68' ' ' ILE . 1.4 mt -132.55 166.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 17.3 mmtt -116.4 166.29 12.95 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -78.27 118.22 4.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.606 2.204 . . . . 0.0 110.559 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 63' ' ' TYR . . . -168.17 -145.59 4.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.526 ' HE3' HG12 ' A' ' 130' ' ' VAL . 3.7 ppp? -122.14 -172.64 2.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -1.126 . . . . 0.0 109.448 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.966 HD13 ' N ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.42 157.92 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.586 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.966 ' N ' HD13 ' A' ' 50' ' ' ILE . 6.3 ttp180 -149.98 134.9 17.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.111 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.086 HG22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -114.44 161.0 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 110.318 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.785 HG12 ' O ' ' A' ' 53' ' ' VAL . 41.1 t -126.47 65.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 9.5 mtmt -43.54 124.49 3.55 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.19 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 56' ' ' HIS . 6.5 tp-100 46.65 -93.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.7 . . . . 0.0 109.657 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' LYS . 2.3 t-160 -165.32 122.12 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.53 -72.77 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.59 138.53 55.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -157.21 162.37 39.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.348 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -156.55 177.1 11.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.755 ' O ' HD13 ' A' ' 62' ' ' ILE . 2.8 p90 -146.17 154.49 41.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.808 -1.182 . . . . 0.0 110.052 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.927 HG21 ' HG2' ' A' ' 15' ' ' MET . 2.5 mm -133.0 -161.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.62 ' HE1' ' HB3' ' A' ' 126' ' ' ALA . 42.0 t80 -157.61 114.69 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 64' ' ' LEU . 1.4 pt? -113.64 176.97 4.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 m -125.19 45.7 2.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.04 -167.4 29.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 134.53 -139.42 10.85 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.875 ' O ' HD11 ' A' ' 45' ' ' ILE . 3.7 mt -132.22 147.9 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.07 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.536 ' C ' HD12 ' A' ' 69' ' ' LEU . 2.5 pp -130.6 131.6 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.989 -1.069 . . . . 0.0 110.15 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 77' ' ' THR . 5.0 pt-20 -134.15 128.83 34.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.855 HG23 HG12 ' A' ' 76' ' ' VAL . 5.6 p -99.65 128.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.036 -1.04 . . . . 0.0 110.036 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.1 mt-30 -106.79 172.53 3.79 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 108.876 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.5 Cg_endo -78.75 112.52 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.577 2.185 . . . . 0.0 110.441 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 79.16 20.92 68.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.8 p-10 171.45 158.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.855 HG12 HG23 ' A' ' 71' ' ' VAL . 34.5 m -140.99 160.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.023 . . . . 0.0 109.436 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.555 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -152.04 143.53 23.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.555 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG2' HG23 ' A' ' 8' ' ' VAL . 2.8 m -151.65 156.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 79' ' ' LEU . 6.3 mp -122.71 166.18 15.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 10' ' ' SER . . . -146.0 -149.47 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -139.37 -55.47 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.567 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -111.58 148.17 33.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.679 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -140.2 146.57 38.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.508 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HB ' ' CD2' ' A' ' 63' ' ' TYR . 43.8 mt -126.17 -25.85 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 0.0 109.718 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 66.08 153.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.318 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -47.57 -29.7 5.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.461 ' OE1' ' HB ' ' A' ' 134' ' ' THR . 1.2 mt-30 -165.57 81.3 0.32 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.189 -1.183 . . . . 0.0 109.675 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 9.9 t70 -73.62 -26.67 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 174.64 -50.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.211 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.32 119.84 31.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.918 . . . . 0.0 109.642 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 92' ' ' ALA . 14.8 pt-20 -131.04 -38.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.247 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -77.25 -16.52 58.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 109.408 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.04 2.72 53.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.31 -16.39 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 108.981 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -52.4 5.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.458 -0.776 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 99' ' ' ARG . 2.3 mt-10 -56.27 -31.42 63.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -58.07 -53.07 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -53.47 -31.34 45.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.448 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.93 -43.5 83.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.307 -0.871 . . . . 0.0 109.545 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 12.0 pttm -84.11 -4.87 59.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -90.35 -7.73 52.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.508 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -86.35 -25.76 25.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 109.661 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -43.5 91.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -81.12 -15.1 56.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.464 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.747 HG13 HD13 ' A' ' 121' ' ' LEU . 18.8 mm -88.71 -19.42 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t -86.12 63.18 7.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.547 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -171.15 169.14 6.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.56 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 114' ' ' TYR . 29.8 t -175.08 100.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -157.58 76.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.66 169.81 25.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.57 -49.42 21.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -1.127 . . . . 0.0 109.309 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 18.3 m -118.7 33.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.559 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.17 -97.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.069 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 3.4 t80 -67.39 -14.11 62.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.65 74.91 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.63 -0.669 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -83.94 -5.65 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.682 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.0 -18.67 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.5 m -76.6 -29.86 56.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.732 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.92 -32.42 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.635 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 116' ' ' GLN . 6.3 mm-40 -75.78 -36.25 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 101' ' ' ALA . 2.8 tt -73.38 -61.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.96 -27.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.683 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 121' ' ' LEU . 16.5 tttt -63.24 -54.27 40.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -12.66 61.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.672 ' CG1' HD23 ' A' ' 121' ' ' LEU . 49.2 mm -82.23 2.18 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.62 ' HB3' ' HE1' ' A' ' 63' ' ' TYR . . . -83.95 -39.33 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.487 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.416 ' HG3' ' CG2' ' A' ' 84' ' ' ILE . 1.6 tm0? -76.58 -7.17 54.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.416 ' C ' HG22 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -81.72 -21.11 38.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.554 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -85.69 -33.9 21.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 109.592 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.3 m -75.4 -33.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 132' ' ' GLU . 2.1 tt -61.68 -44.63 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 131' ' ' ILE . 77.5 mm-40 -44.85 -35.24 2.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.041 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 4.5 mp -64.89 -55.46 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -0.81 . . . . 0.0 109.245 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.461 ' HB ' ' OE1' ' A' ' 87' ' ' GLN . 30.9 p -50.08 -29.14 8.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.481 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 2.8 mmtt -65.73 -54.96 20.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -88.83 21.4 3.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.65 42.5 3.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.388 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.244 0.545 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.002 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -109.93 -147.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.888 . . . . 0.0 109.649 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 1.192 ' CG ' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.61 -179.75 5.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.34 2.019 . . . . 0.0 115.884 -175.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.504 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 8.7 t-80 -153.96 89.65 1.32 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 110.123 -3.217 . . . . 0.0 103.445 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.983 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -92.77 126.77 38.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.683 -1.261 . . . . 0.0 107.992 -177.562 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 77' ' ' THR . 7.3 t70 -133.36 75.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.593 -1.317 . . . . 0.0 109.912 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 15' ' ' MET . 1.4 p -111.13 147.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.26 -0.9 . . . . 0.0 108.948 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.516 ' HB ' ' N ' ' A' ' 14' ' ' GLN . 14.1 m -150.16 155.94 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.078 -1.014 . . . . 0.0 109.624 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -172.2 157.19 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.281 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 61.48 -89.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.414 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 22.13 3.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.387 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER 46.34 75.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 110.051 179.651 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.516 ' N ' ' HB ' ' A' ' 9' ' ' VAL . 9.1 tt0 164.98 100.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.544 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -124.47 -73.21 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.064 179.286 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.688 ' CE2' HG11 ' A' ' 20' ' ' VAL . 1.1 t80 -127.17 112.79 15.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.047 -1.033 . . . . 0.0 110.082 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 92.0 p -134.6 85.52 2.19 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.48 -160.73 23.12 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.467 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -93.24 159.67 15.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.25 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.192 HG22 ' CG ' ' A' ' 4' ' ' TYR . 1.8 m -155.32 -167.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.885 -1.135 . . . . 0.0 110.663 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.779 ' N ' HG23 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -155.35 -33.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 178.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 10.1 mmtm -142.97 88.4 2.04 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.961 -1.087 . . . . 0.0 110.211 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.983 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.24 138.78 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.696 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.986 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -122.95 165.93 15.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 110.346 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.546 ' CB ' HG12 ' A' ' 50' ' ' ILE . 11.5 p -171.53 154.98 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 2.1 t 179.76 154.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.829 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.5 -89.78 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 158.41 43.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 59.0 74.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' C ' ' HG2' ' A' ' 46' ' ' LYS . . . 91.8 141.69 10.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -137.05 55.39 1.83 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.171 . . . . 0.0 109.752 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.09 157.07 24.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.21 171.63 24.61 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.914 HG22 ' OH ' ' A' ' 4' ' ' TYR . 12.7 mm -99.81 127.16 52.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.854 -1.38 . . . . 0.0 108.986 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.651 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -134.46 170.26 11.73 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.651 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -70.11 88.24 0.58 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.586 1.524 . . . . 0.0 109.538 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.73 18.98 2.58 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 6.8 t-160 -60.14 146.96 41.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -1.191 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.617 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -40.59 147.04 0.41 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -78.98 69.14 8.04 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.695 2.263 . . . . 0.0 111.047 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.6 mt -91.07 126.57 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.121 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.4 24.12 12.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.57 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -105.56 -92.81 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.393 -0.817 . . . . 0.0 109.336 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.808 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -130.12 172.72 11.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.935 . . . . 0.0 109.161 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.808 HD13 ' C ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -117.31 -149.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' O ' HG21 ' A' ' 25' ' ' VAL . 2.2 mptp? -121.35 125.38 26.91 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.24 -159.36 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.433 2.089 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 97.85 -137.08 13.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.6 ppp? -102.62 -178.91 3.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -1.117 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.986 HG23 ' O ' ' A' ' 24' ' ' GLN . 14.2 mt -157.63 140.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 110.193 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 7.5 mmt85 -131.16 112.31 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.694 HG23 ' CA ' ' A' ' 23' ' ' ILE . 12.6 mt -117.48 164.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 0.0 111.312 -178.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 59' ' ' GLU . 41.8 t -133.18 112.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' HIS . 20.4 mttm -65.96 149.89 49.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.792 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.557 ' HB2' HG21 ' A' ' 3' ' ' THR . 34.5 tt0 -52.11 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.338 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 48.7 t-80 71.45 95.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.36 178.34 29.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -63.07 -166.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -1.224 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HB3' HG22 ' A' ' 53' ' ' VAL . 10.2 pt-20 -131.12 147.45 52.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -125.52 138.29 53.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.911 ' CE1' HD11 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -109.08 139.41 44.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.819 . . . . 0.0 109.677 -179.613 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 19.1 mt -121.2 160.48 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.288 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.742 ' HE1' HD12 ' A' ' 84' ' ' ILE . 1.4 t80 -139.38 151.49 46.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.268 -0.895 . . . . 0.0 109.014 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.726 ' N ' HD23 ' A' ' 64' ' ' LEU . 1.3 pt? 179.93 -170.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.511 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 4.9 m -135.21 -169.22 2.33 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.33 -0.856 . . . . 0.0 109.204 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 65' ' ' SER . . . 42.24 -141.07 1.76 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.16 119.24 2.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 5.4 tt -151.89 130.28 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -1.102 . . . . 0.0 109.065 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 178.18 -140.0 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 -179.493 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.622 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -146.3 142.64 28.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.366 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 76' ' ' VAL . 7.6 p -109.53 126.99 66.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.48 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -105.39 173.86 3.01 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -77.92 4.02 6.48 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.524 2.149 . . . . 0.0 109.974 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . -167.16 39.27 0.24 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.504 ' OD1' ' ND1' ' A' ' 5' ' ' HIS . 5.0 t30 167.98 94.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 109.472 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.839 HG22 HG23 ' A' ' 71' ' ' VAL . 5.0 t -100.78 116.12 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.215 -0.928 . . . . 0.0 109.267 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.688 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 6.4 t -118.45 158.64 24.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.906 . . . . 0.0 109.686 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.764 ' HA ' ' CG ' ' A' ' 69' ' ' LEU . 3.5 p 179.44 141.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.742 0.782 . . . . 0.0 110.288 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.657 ' C ' HD23 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -115.64 145.63 42.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.53 -165.25 1.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.32 -43.83 4.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 17.8 m -106.32 151.85 24.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.79 93.7 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.742 HD12 ' HE1' ' A' ' 63' ' ' TYR . 6.1 mt -106.63 66.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.335 -0.853 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 84' ' ' ILE . 13.0 ttp180 -44.79 161.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 87' ' ' GLN . . . -51.45 147.49 10.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.859 ' H ' HG22 ' A' ' 131' ' ' ILE . 13.2 pt20 38.58 38.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.63 -0.924 . . . . 0.0 109.886 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -45.09 -48.55 11.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.59 -57.4 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.8 -167.09 1.75 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.616 ' CB ' HD12 ' A' ' 131' ' ' ILE . 16.1 pt-20 -144.78 -38.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.583 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.67 67.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -8.03 52.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.4 -14.61 32.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.26 -18.53 26.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.407 -0.808 . . . . 0.0 109.41 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -1.51 36.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.51 30.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 109.318 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HA ' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -76.42 -27.81 56.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -70.38 -43.62 69.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.86 -23.0 39.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.233 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.615 ' CB ' HD13 ' A' ' 121' ' ' LEU . . . -81.46 -22.14 38.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.213 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 31.9 tt0 -66.08 -19.32 65.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -27.5 21.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.406 ' O ' ' OH ' ' A' ' 114' ' ' TYR . 1.6 m-70 -77.12 -45.9 25.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.731 ' O ' HG22 ' A' ' 105' ' ' ILE . 88.0 mt -87.61 12.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' ILE . 2.6 m -44.37 -60.85 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.0 p -90.34 -160.85 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.29 128.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.029 -1.045 . . . . 0.0 109.616 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -160.82 93.37 0.98 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 109.377 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.854 ' O ' ' HB2' ' A' ' 115' ' ' ALA . . . 165.2 143.85 3.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.09 -41.61 67.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 14.5 m -137.46 -31.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER -41.61 -92.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.743 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 104' ' ' HIS . 15.4 t80 -77.92 -21.4 51.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -61.27 -18.05 56.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 8.7 mt-30 -84.99 -35.93 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.16 -10.02 27.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.1 m -71.42 -49.22 43.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.591 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.49 61.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.716 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.37 -47.48 76.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' CB ' ' A' ' 101' ' ' ALA . 47.9 tp -52.2 -51.76 56.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.717 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.38 64.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.758 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -78.11 -13.96 59.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.96 42.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.5 mp -88.21 -2.09 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.704 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -88.45 -24.55 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.598 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 2.1 pt20 -74.89 -32.63 61.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 4.3 tt -84.2 -6.76 59.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -26.13 47.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.439 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 2.3 m -86.46 -31.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.513 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.859 HG22 ' H ' ' A' ' 87' ' ' GLN . 3.2 pt -72.03 -4.03 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.37 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.7 mm-40 -78.21 -34.08 49.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.699 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.911 HD11 ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -87.31 2.98 48.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.155 -0.966 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -83.2 -16.15 47.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.019 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -71.81 -25.77 62.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.37 -0.831 . . . . 0.0 109.225 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.01 39.54 3.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.403 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -112.09 -7.09 14.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.466 -179.859 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.428 ' C ' ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.328 0.585 . . . . 0.0 109.579 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.646 HG22 ' HG3' ' A' ' 21' ' ' GLU . 38.1 p -141.88 155.45 45.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.235 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.635 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -148.49 -148.45 0.26 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.83 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -131.35 144.57 51.34 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.055 HD23 HG21 ' A' ' 20' ' ' VAL . 2.3 pp -135.67 154.4 51.3 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.491 -1.381 . . . . 0.0 109.278 178.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.567 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -140.03 115.19 9.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 -179.448 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.601 ' CG2' HD21 ' A' ' 64' ' ' LEU . 2.1 p -111.71 94.02 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.179 -0.951 . . . . 0.0 108.74 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.695 HG22 ' HG3' ' A' ' 14' ' ' GLN . 23.4 t -99.73 155.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.705 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 3.8 p -124.15 -149.99 0.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.42 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 81' ' ' ASP . . . -52.69 -38.06 59.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.88 32.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.313 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -134.66 67.53 1.5 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.695 ' HG3' HG22 ' A' ' 9' ' ' VAL . 23.6 tt0 -44.65 155.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 109.811 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.565 ' HB2' HG13 ' A' ' 8' ' ' VAL . 4.1 mmt -134.15 -96.81 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.846 ' HB3' HD11 ' A' ' 6' ' ' LEU . 3.5 t80 -70.09 130.95 43.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.919 -1.113 . . . . 0.0 108.717 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -157.23 110.24 2.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 138.91 -160.64 25.78 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.75 ' C ' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -53.79 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -1.214 . . . . 0.0 109.51 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.055 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 170.41 162.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.592 -1.318 . . . . 0.0 107.959 179.827 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HG3' HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -130.03 -37.57 1.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.454 -1.404 . . . . 0.0 110.433 -179.082 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 1.3 mtmt -155.29 93.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.767 -1.208 . . . . 0.0 110.764 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.743 ' CA ' HG23 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -98.92 153.93 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.253 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -156.16 134.55 11.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.623 -1.298 . . . . 0.0 110.259 -179.636 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.6 t -108.12 129.68 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 m -106.6 114.24 28.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -141.23 -123.15 1.91 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 t -125.11 138.23 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 47.41 78.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.264 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.05 111.78 1.72 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.22 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.832 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.68 138.89 44.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.613 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.17 -100.9 2.27 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 178.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.853 HG13 HG21 ' A' ' 76' ' ' VAL . 28.8 mm -155.61 153.81 7.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.333 -1.098 . . . . 0.0 109.671 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -155.5 -176.47 0.61 Allowed Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.821 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 34.8 Cg_endo -80.02 69.68 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.062 1.841 . . . . 0.0 109.844 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.38 35.52 0.37 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 12.2 t-80 -72.06 -74.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 0.0 109.627 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 167.89 166.67 0.14 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.35 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.68 79.12 3.3 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.68 2.253 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 4.0 mm? -92.85 133.17 36.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.837 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -138.63 52.28 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.175 179.826 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.5 p -126.1 -138.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -99.68 -163.45 1.03 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.0 109.566 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.561 ' CD1' HG21 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -120.57 135.59 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' CD ' ' H ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.38 134.38 93.38 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.493 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.2 Cg_endo -79.22 159.85 26.42 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.551 2.167 . . . . 0.0 110.29 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 125.18 -142.74 14.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.408 ' CE ' ' HB3' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -108.32 -172.02 1.98 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -1.14 . . . . 0.0 109.129 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.509 HD13 HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -161.6 141.17 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.986 -1.071 . . . . 0.0 110.145 -179.562 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HG3' ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -131.34 139.7 49.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.743 HG23 ' CA ' ' A' ' 23' ' ' ILE . 12.1 mt -130.67 172.51 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.999 -1.063 . . . . 0.0 109.997 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 41.4 t -138.34 104.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.695 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 146.21 -99.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.078 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.485 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 1.1 tt0 44.28 -157.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -81.52 -18.88 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.289 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.19 -140.24 10.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -118.38 -22.13 7.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -1.205 . . . . 0.0 109.54 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -146.46 126.19 13.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.703 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 60' ' ' GLU . 2.3 mm-40 -103.63 142.39 34.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.016 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CZ ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -133.49 106.32 7.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.674 ' O ' HG11 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -124.47 -166.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.091 179.617 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.737 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -172.67 126.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.31 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 8' ' ' VAL . 3.1 mt -119.6 -173.52 2.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.406 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 p -152.73 34.42 0.49 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.268 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.92 172.2 13.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.55 -164.95 25.12 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 79' ' ' LEU . 11.9 tt -109.51 154.38 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -1.184 . . . . 0.0 109.621 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.726 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -133.87 132.06 39.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.197 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -136.13 131.46 34.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.226 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 40' ' ' PRO . 9.8 p -100.82 137.56 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.59 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.8 mm-40 -124.65 176.73 2.16 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -78.85 106.72 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.489 2.126 . . . . 0.0 110.757 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 70.69 31.93 67.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.464 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 10.8 p-10 174.63 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.627 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.853 HG21 HG13 ' A' ' 34' ' ' ILE . 6.4 p -124.69 149.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -146.86 142.18 27.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.255 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 45' ' ' ILE . 4.8 m -145.03 141.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.24 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 68' ' ' ILE . 6.0 mp -103.05 158.76 16.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 10' ' ' SER . . . -152.6 -165.72 2.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -120.65 -38.98 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -115.29 171.86 7.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -173.78 133.43 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.737 HD12 ' CE1' ' A' ' 63' ' ' TYR . 61.5 mt -144.14 152.68 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.125 -0.984 . . . . 0.0 109.491 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.433 ' O ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -96.08 178.11 5.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.349 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -76.83 2.32 60.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.42 46.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 109.536 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -48.89 -58.07 5.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 -67.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.78 -168.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.859 ' HB2' HG21 ' A' ' 131' ' ' ILE . 4.3 pt-20 -172.42 -34.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.53 -19.54 55.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.16 3.35 20.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 128' ' ' LEU . . . -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.0 108.879 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.556 ' HG3' HD13 ' A' ' 128' ' ' LEU . 5.5 mtp -79.2 -23.95 43.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.677 . . . . 0.0 109.546 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 20.6 mt-10 -68.23 -19.39 64.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.569 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.43 -40.93 20.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -39.26 80.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.506 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.35 82.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 96' ' ' GLU . 16.1 mttt -89.69 -0.35 57.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.945 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -86.56 -55.46 3.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.324 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.8 -42.08 77.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.246 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.6 -43.27 75.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.633 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 105' ' ' ILE . 98.9 mt -89.97 24.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.275 -0.89 . . . . 0.0 109.335 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 107' ' ' SER . 16.6 m -61.09 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 72.27 168.68 0.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.228 -0.92 . . . . 0.0 109.279 -179.945 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 t -152.29 154.72 36.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.545 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -154.62 150.35 27.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.424 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' ASP . . . 115.74 20.3 5.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.531 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.8 OUTLIER 52.32 100.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -1.135 . . . . 0.0 109.348 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 111' ' ' ASP . 25.8 m 40.7 34.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 109.661 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 20.6 t0 -87.23 -95.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.085 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.67 -12.26 61.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.01 63.43 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.62 -0.675 . . . . 0.0 109.42 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.97 -27.07 60.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.442 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.76 -7.74 58.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.446 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.466 ' OG ' HG23 ' A' ' 105' ' ' ILE . 38.4 m -81.01 -30.66 34.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.18 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -84.18 -13.31 53.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.945 HD12 ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -74.9 -24.97 58.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.447 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -79.02 -6.39 56.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -14.58 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -88.9 -10.61 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.389 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 125' ' ' ILE . 1.7 mp -81.36 -2.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.512 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -90.49 -21.33 21.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.677 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 124' ' ' ALA . 12.0 pt20 -69.17 -35.78 76.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.456 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -84.2 11.04 8.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.437 ' HG3' ' HA ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -89.72 -51.27 5.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.674 HG11 ' O ' ' A' ' 62' ' ' ILE . 22.6 m -52.3 -19.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.774 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.859 HG21 ' HB2' ' A' ' 91' ' ' GLU . 7.3 mt -86.29 -58.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' ILE . 39.2 mm-40 -42.15 -40.02 2.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.778 . . . . 0.0 110.121 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 mp -74.2 -52.04 13.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.007 . . . . 0.0 109.73 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 130' ' ' VAL . 6.6 p -46.89 -24.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -70.91 -55.93 7.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.837 . . . . 0.0 109.594 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.74 20.17 13.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.35 63.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.295 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.556 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.211 0.529 . . . . 0.0 109.636 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.066 HG22 ' HB2' ' A' ' 21' ' ' GLU . 2.1 p -42.47 125.0 3.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.745 ' CE2' HG22 ' A' ' 34' ' ' ILE . 27.1 p90 -118.64 -171.67 2.13 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.8 OUTLIER -111.97 147.46 35.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.035 -1.041 . . . . 0.0 109.076 179.834 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.104 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -137.06 162.8 32.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.964 -1.085 . . . . 0.0 109.132 178.66 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 1.009 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.9 t0 -154.64 96.95 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 78' ' ' VAL . 2.5 p -109.69 112.25 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.115 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.47 167.61 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.063 -1.023 . . . . 0.0 109.925 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -179.39 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.399 -0.813 . . . . 0.0 109.436 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 65.91 109.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 21.3 mm-40 62.38 79.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLU . 9.8 mp0 -43.8 111.97 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.466 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -171.52 53.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.321 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.621 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -133.81 -88.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.627 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.7 t80 -139.96 126.03 19.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.055 -1.028 . . . . 0.0 109.355 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.3 p -159.67 82.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -0.96 . . . . 0.0 109.235 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.53 -145.04 6.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.675 ' C ' HG12 ' A' ' 20' ' ' VAL . 11.4 mt -69.99 159.49 33.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -1.116 . . . . 0.0 109.583 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.104 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -175.91 164.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 -178.124 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 1.066 ' HB2' HG22 ' A' ' 3' ' ' THR . 47.0 tt0 -139.1 -56.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.108 -0.995 . . . . 0.0 110.236 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.553 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -130.64 111.21 12.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.043 -1.036 . . . . 0.0 110.711 -178.985 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.828 HG22 ' CG1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -99.18 -162.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.507 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -166.36 159.03 14.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.74 -1.225 . . . . 0.0 109.904 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.547 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.3 t -154.52 116.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 81.6 m -111.47 110.56 21.06 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 109.231 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -154.76 45.68 0.55 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.61 169.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -1.158 . . . . 0.0 109.546 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.65 43.3 31.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.98 167.34 19.81 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -164.7 66.01 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -1.214 . . . . 0.0 109.375 -179.914 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.504 HD13 ' OH ' ' A' ' 35' ' ' TYR . 5.7 mt -131.2 147.36 52.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.827 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.74 -102.9 2.45 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.745 HG22 ' CE2' ' A' ' 4' ' ' TYR . 3.5 mm -153.61 159.1 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.276 -1.132 . . . . 0.0 108.979 178.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -151.28 174.74 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.505 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.5 Cg_endo -74.85 76.91 3.2 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.174 1.916 . . . . 0.0 109.95 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.64 49.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 14.9 t-80 -109.48 2.65 20.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 0.0 109.792 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 38' ' ' HIS . . . 66.92 155.78 0.14 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.986 . . . . 0.0 109.44 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.33 87.65 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.676 2.251 . . . . 0.0 110.655 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 38' ' ' HIS . 7.3 mt -99.05 138.67 35.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.472 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.504 ' CD2' ' HG2' ' A' ' 70' ' ' GLU . 74.3 mt -119.9 86.94 2.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' ILE . 17.0 p -131.25 -155.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.401 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -100.33 171.7 7.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.398 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 67' ' ' GLY . 3.4 tt -100.21 169.84 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -115.5 142.46 28.86 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.92 . . . . 0.0 109.349 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.5 146.05 21.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.514 2.143 . . . . 0.0 110.298 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 144.63 -148.22 19.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.473 ' HE1' HG12 ' A' ' 130' ' ' VAL . 5.3 ppp? -101.46 174.35 6.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -1.119 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.969 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.5 OUTLIER -148.48 151.39 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.982 -1.074 . . . . 0.0 109.88 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.5 ttt180 -121.03 172.65 7.79 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.828 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -164.22 144.85 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.711 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.635 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 34.4 t -134.09 118.01 27.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.648 -0.657 . . . . 0.0 109.302 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 139.97 -86.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.528 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.6 tt0 41.33 -94.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.412 -0.805 . . . . 0.0 109.65 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 19.1 t-160 -132.11 -36.56 1.16 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.17 42.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -173.34 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.337 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' ILE . 10.8 pt-20 -126.86 145.84 50.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.102 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -136.93 167.92 20.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -134.07 136.47 43.99 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.463 -0.773 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.969 ' H ' HG23 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -109.48 -157.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 109.031 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.75 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 4.2 t80 -172.62 129.15 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.157 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.99 -164.36 2.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.528 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.3 OUTLIER -165.4 130.61 2.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.4 158.7 3.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.552 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 126.14 177.5 14.91 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 43' ' ' THR . 41.1 mt -122.85 142.86 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -1.116 . . . . 0.0 109.309 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.598 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -106.55 132.84 52.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.864 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 tt0 -134.44 112.56 11.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 108.895 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.501 HG23 ' HB ' ' A' ' 76' ' ' VAL . 4.0 p -99.65 158.51 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -139.78 169.25 12.53 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.32 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 73.44 5.75 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.702 2.268 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.33 -14.74 5.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 14.5 p30 -165.43 166.09 18.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 70' ' ' GLU . 1.3 p -153.73 145.63 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 109.327 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.609 HG23 ' HB3' ' A' ' 7' ' ' ASP . 4.3 m -137.78 142.35 40.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.138 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 8' ' ' VAL . 2.5 m -142.61 143.4 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 109.225 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -116.99 147.0 42.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -138.55 -174.37 3.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.39 -46.81 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 65' ' ' SER . 7.5 t -100.38 -176.1 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.621 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -178.94 76.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 84' ' ' ILE . 3.8 mp -106.18 77.01 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.296 -0.877 . . . . 0.0 109.744 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 86' ' ' GLY . 4.9 ttt-85 -45.77 152.11 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.572 ' CA ' HG23 ' A' ' 130' ' ' VAL . . . -42.11 -45.59 5.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -74.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.265 . . . . 0.0 109.31 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.51 ' CG ' HG23 ' A' ' 84' ' ' ILE . 27.8 t70 50.01 39.03 17.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.825 . . . . 0.0 109.563 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 59.61 151.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 0.0 109.603 179.826 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.37 -166.48 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 109.617 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.535 ' CB ' HD11 ' A' ' 131' ' ' ILE . 6.7 pt-20 -177.06 -51.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 109.147 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.75 -28.19 58.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -69.81 -6.53 32.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 128' ' ' LEU . . . -89.3 -22.44 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 108.743 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -29.79 33.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.534 -0.728 . . . . 0.0 109.047 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -32.63 74.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.455 -0.778 . . . . 0.0 109.402 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.6 -63.68 1.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.499 ' HG3' HD11 ' A' ' 125' ' ' ILE . 5.9 ttpt -57.77 -29.52 64.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.354 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -66.35 -32.68 74.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -22.36 32.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.999 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -85.55 -15.66 41.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 108.923 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -72.55 -17.32 61.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.12 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -87.4 -34.59 18.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -68.57 -38.85 81.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.551 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.786 HD11 ' HG ' ' A' ' 121' ' ' LEU . 94.2 mt -73.46 -16.98 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -91.37 24.45 2.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 108' ' ' SER . 0.7 OUTLIER -150.82 178.14 9.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 75.95 175.59 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -154.83 -165.14 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.391 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 178.68 25.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.14 -55.16 3.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.661 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 11.3 m -118.9 9.46 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.47 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.997 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 108' ' ' SER . 23.4 p90 -67.11 -19.9 65.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.988 -1.07 . . . . 0.0 108.161 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -56.36 -26.88 54.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -78.64 -31.32 46.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.5 -24.24 56.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.9 -4.19 36.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.09 -38.58 27.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 109.472 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.98 0.82 46.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.652 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.999 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -79.37 -46.92 16.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.43 -9.32 32.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -71.68 -22.97 61.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.634 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.25 -3.51 58.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.682 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -89.56 -8.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.364 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.75 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -74.27 -36.42 63.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 109.274 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.556 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.3 pt20 -90.33 1.52 56.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -90.13 -26.45 20.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -21.34 33.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.742 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.583 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 30.2 m -88.05 -28.98 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.538 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -88.46 -13.63 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -33.45 33.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 110.013 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 133' ' ' LEU . 1.6 pp -84.12 1.32 44.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 0.7 OUTLIER -88.86 -35.31 16.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.209 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 7.6 pttt -79.1 -22.64 44.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.256 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -90.1 -7.03 54.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.394 179.895 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.79 3.05 55.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 109.578 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.436 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.248 0.547 . . . . 0.0 109.532 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.745 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER 62.66 131.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.313 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.839 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 4.3 p90 -130.82 -154.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 9.9 t-80 -127.64 138.51 52.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.354 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.053 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -134.81 160.01 39.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.986 -1.072 . . . . 0.0 109.015 179.349 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.98 ' N ' HD12 ' A' ' 6' ' ' LEU . 15.4 t70 -149.81 101.59 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 0.0 110.08 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 8' ' ' VAL . 13.7 p -102.46 123.78 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.189 -0.944 . . . . 0.0 109.121 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 t -135.81 148.61 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.635 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -140.11 -142.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.045 179.87 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.29 30.25 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.694 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.549 ' CD ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pm0 -170.53 78.89 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.278 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' GLU . 3.3 mt-30 -42.48 103.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 109.67 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 5.6 tt0 175.15 59.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.621 ' HB3' HG21 ' A' ' 62' ' ' ILE . 5.7 mmm -143.49 -82.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.157 -0.965 . . . . 0.0 109.945 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 62' ' ' ILE . 27.5 t80 -145.81 143.55 29.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.116 -0.99 . . . . 0.0 109.276 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.444 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 13.8 p -175.19 88.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.84 -145.35 10.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.722 ' C ' HG12 ' A' ' 20' ' ' VAL . 14.8 mt -68.7 165.15 20.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.19 -1.182 . . . . 0.0 109.066 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.053 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -173.82 152.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.042 -1.036 . . . . 0.0 109.135 -177.907 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.745 ' HG3' HG23 ' A' ' 3' ' ' THR . 3.0 tt0 -114.73 -69.85 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.119 -0.988 . . . . 0.0 110.65 -178.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.5 tptt -125.93 107.98 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.744 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.978 HG22 HG12 ' A' ' 52' ' ' ILE . 1.3 pp -108.9 118.82 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.64 125.51 45.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.541 -1.349 . . . . 0.0 110.298 -178.46 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.468 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.5 t -112.86 120.75 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.166 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.9 m -124.14 110.12 14.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -128.77 -145.53 5.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 1.4 m -98.56 135.28 40.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -1.223 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.6 tt0 71.33 101.61 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.121 -0.987 . . . . 0.0 109.233 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.03 171.38 20.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 179.84 60.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.974 -1.31 . . . . 0.0 110.304 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -94.46 153.2 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.012 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.65 171.83 24.35 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.839 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 15.0 mm -99.11 126.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.039 -1.271 . . . . 0.0 108.434 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -124.21 170.63 8.41 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.1 Cg_endo -72.31 90.91 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.841 1.694 . . . . 0.0 109.933 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.26 2.25 4.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -49.3 136.64 15.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -1.202 . . . . 0.0 109.492 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -54.07 171.29 0.27 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -77.37 83.46 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.697 2.265 . . . . 0.0 110.522 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -99.26 141.31 32.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 109.46 -179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.67 89.98 1.81 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 68' ' ' ILE . 11.9 p -150.13 -138.52 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.257 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.608 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -100.06 171.13 8.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.215 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.913 HD11 ' C ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -99.89 174.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.227 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 2.5 mttt -111.43 143.91 29.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -77.78 121.86 5.65 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.51 2.14 . . . . 0.0 110.402 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.531 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 168.22 -156.15 27.44 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.594 ' N ' ' HB1' ' A' ' 126' ' ' ALA . 5.9 ptm -108.55 -177.33 3.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.642 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -158.69 136.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.952 -1.092 . . . . 0.0 110.722 -179.524 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.86 174.87 5.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.978 HG12 HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -164.95 152.87 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.652 -1.28 . . . . 0.0 109.886 -179.414 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 53.2 t -136.29 99.96 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER 155.89 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.476 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 8.8 tt0 50.34 23.78 1.33 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 109.826 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 43.5 63.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.594 179.965 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.49 -59.59 0.27 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 -158.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 109.542 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -110.04 158.64 18.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.9 mt-10 -156.95 165.2 36.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 3.5 p90 -128.19 127.7 43.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -99.96 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.715 ' HE1' ' HB3' ' A' ' 126' ' ' ALA . 23.2 t80 -177.84 128.8 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 108.924 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.84 -166.06 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -119.89 -90.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' C ' HG12 ' A' ' 45' ' ' ILE . . . -125.58 -131.47 3.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 104.49 -166.63 15.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.913 ' C ' HD11 ' A' ' 45' ' ' ILE . 16.7 tt -113.61 133.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -1.199 . . . . 0.0 109.459 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.987 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -114.82 116.46 28.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.7 pt-20 -114.34 127.75 56.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 108.88 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.62 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.1 p -99.8 144.81 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.12 -0.987 . . . . 0.0 109.884 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.543 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -123.69 172.89 5.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.384 -0.822 . . . . 0.0 109.103 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -78.16 93.95 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.611 2.208 . . . . 0.0 110.635 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.06 -17.0 45.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -156.92 152.85 27.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 109.324 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 70' ' ' GLU . 2.0 p -138.14 144.02 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.01 . . . . 0.0 109.617 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.879 HG22 ' HB3' ' A' ' 7' ' ' ASP . 11.9 p -131.07 146.78 52.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.375 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 69' ' ' LEU . 4.9 m -149.33 146.1 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.512 ' C ' HD23 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -124.36 151.47 44.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.29 -0.881 . . . . 0.0 109.341 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.494 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -144.46 -164.8 1.99 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.37 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -117.06 -24.25 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 83' ' ' ALA . 20.5 m -110.8 165.47 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.635 ' HB2' ' CB ' ' A' ' 10' ' ' SER . . . -175.15 67.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.76 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 82' ' ' THR . 2.8 mp -101.43 72.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.276 -0.89 . . . . 0.0 108.922 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -44.35 167.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.88 . . . . 0.0 109.445 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.424 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -52.47 -46.29 58.38 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.27 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -1.162 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' LEU . 34.7 t70 55.24 17.87 2.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.532 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 42.38 37.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.42 ' HB2' ' OD2' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -146.42 168.7 20.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -152.41 -82.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.812 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.72 -25.9 68.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -64.86 -24.86 67.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.934 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.98 -17.05 26.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.005 . . . . 0.0 109.207 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.978 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -80.8 -48.47 12.42 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 -179.586 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -72.19 -9.69 58.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.846 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.62 -19.96 47.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -87.79 -1.62 58.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.05 -36.78 19.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -61.02 -20.61 62.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.559 ' O ' HD12 ' A' ' 105' ' ' ILE . . . -90.08 -21.61 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.63 -44.86 95.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 -6.15 43.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -90.1 -41.61 11.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.711 ' O ' HG22 ' A' ' 105' ' ' ILE . 3.2 mt -86.98 13.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.145 -0.972 . . . . 0.0 109.827 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -103.89 74.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.292 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.9 p -155.7 -153.47 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t 173.61 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -165.55 -54.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.819 . . . . 0.0 109.447 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.02 143.85 15.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 19.7 t70 -64.35 -24.67 67.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -112.89 18.9 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.86 -92.35 0.06 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.427 -0.795 . . . . 0.0 109.219 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -73.5 -23.61 60.07 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -56.77 -36.98 70.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 116' ' ' GLN . 6.1 mm-40 -87.6 -15.51 37.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.803 . . . . 0.0 109.231 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.98 -31.72 69.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -51.96 -26.01 9.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.91 -35.97 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -65.11 -50.5 65.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.663 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 125' ' ' ILE . 36.4 tp -55.31 -53.57 54.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -43.68 -35.89 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -49.99 74.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.661 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.64 -10.77 59.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.561 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.583 HD11 HD11 ' A' ' 121' ' ' LEU . 20.4 mm -89.0 -11.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.445 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.715 ' HB3' ' HE1' ' A' ' 63' ' ' TYR . . . -72.4 -35.05 68.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -81.2 -10.22 59.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.978 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.3 OUTLIER -83.14 -29.24 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.436 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -77.04 -39.76 48.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 109.597 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.597 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.6 m -74.18 -36.41 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -67.21 -19.48 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.422 179.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.452 ' C ' ' HG2' ' A' ' 135' ' ' LYS . 6.1 tm-20 -71.95 -16.05 62.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.925 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.11 -47.99 7.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.7 p -60.67 -31.11 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -63.43 -28.88 70.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.828 -179.817 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -109.31 0.6 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 0.0 109.587 -179.992 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.11 8.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 6.9 tpt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.605 179.981 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' THR . 1.5 ttm . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.206 0.527 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.537 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER 52.76 171.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.744 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.1 p90 179.62 -179.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.5 t60 -105.32 149.51 25.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.216 -0.927 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.048 HD12 ' N ' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -138.5 164.77 28.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.001 178.825 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 1.048 ' N ' HD12 ' A' ' 6' ' ' LEU . 2.2 t70 -154.88 81.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.667 HG23 HG13 ' A' ' 78' ' ' VAL . 2.7 p -104.36 110.55 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.14 -170.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . 80.3 p -143.22 -166.7 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.419 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.37 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.453 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -140.55 65.07 1.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.89 . . . . 0.0 109.448 -179.933 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -147.32 172.1 14.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -91.65 152.01 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.554 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.7 mtt -154.05 -76.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.475 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 30.6 t80 -168.14 134.83 2.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 9.1 p -165.73 98.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 156.9 -153.8 25.0 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.657 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -65.18 162.15 17.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -1.211 . . . . 0.0 108.747 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.044 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -172.59 171.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.571 -178.538 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 5.0 tt0 -120.24 -47.97 2.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.074 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -172.44 133.1 0.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.042 179.873 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.865 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 pt -108.37 129.56 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 20.0 mt-30 -99.5 95.71 7.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.108 . . . . 0.0 109.511 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 50' ' ' ILE . 3.8 t -99.14 151.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.692 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 9.0 t -160.94 140.44 10.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 108.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' HB2' ' A' ' 31' ' ' GLU . . . -111.8 -166.8 18.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 t -48.08 -66.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -66.74 -13.86 61.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.084 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.412 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 112.65 151.49 11.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.692 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -142.82 155.3 44.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -1.217 . . . . 0.0 109.716 179.421 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.53 175.98 10.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.883 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.31 171.49 14.12 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.744 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 16.7 mm -99.89 143.86 13.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.808 -1.407 . . . . 0.0 108.927 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.626 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 1.8 p90 -155.66 169.42 10.39 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -69.58 83.18 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.553 1.502 . . . . 0.0 109.627 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.07 33.58 0.46 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.701 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 32.4 t60 -77.95 3.97 13.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -1.161 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 76.53 175.39 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 0.0 109.847 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -78.2 76.24 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.722 2.281 . . . . 0.0 110.412 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.567 ' H ' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -93.36 122.2 35.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.4 75.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.8 p -139.21 -147.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -106.3 169.37 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -111.04 171.86 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.755 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -115.3 165.52 14.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 36.0 Cg_endo -78.27 117.08 4.01 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.694 2.262 . . . . 0.0 110.323 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -172.53 -153.01 8.98 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.549 ' HB2' HG11 ' A' ' 130' ' ' VAL . 9.7 ptm -114.19 178.03 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 109.268 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.798 HG23 ' H ' ' A' ' 62' ' ' ILE . 2.0 tt -151.78 153.4 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.029 -1.045 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' N ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -123.27 176.77 5.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.662 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.826 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.25 141.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.005 -179.242 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 55.1 t -128.79 113.55 29.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 58' ' ' HIS . 24.3 mmtt -64.33 142.77 58.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 -179.113 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.1 tt0 -43.5 -28.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.191 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 45.6 t-80 178.98 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 109.305 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.23 -107.59 0.52 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 5.2 t-80 -106.41 172.06 7.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -156.52 136.49 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.196 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -164.52 -173.85 3.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.64 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.1 p90 -125.2 144.11 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.418 -0.801 . . . . 0.0 109.493 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.798 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.4 mm -116.17 -147.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 108.986 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.878 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.5 t80 -174.92 130.98 0.31 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 108.841 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.39 177.05 7.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.72 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.545 ' HB2' HG21 ' A' ' 82' ' ' THR . 6.4 t -109.04 -52.36 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.68 -155.27 8.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 128.49 -158.92 21.88 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.597 ' C ' HD11 ' A' ' 45' ' ' ILE . 14.5 tt -127.38 125.8 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -1.083 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.573 ' HB2' HD12 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -99.69 144.0 29.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -141.08 134.01 29.08 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.567 HG11 ' H ' ' A' ' 41' ' ' LEU . 7.1 p -99.8 155.86 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.131 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.589 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.04 -177.84 0.75 Allowed Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.776 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -79.88 93.31 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.323 2.015 . . . . 0.0 110.618 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.29 56.3 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -126.83 160.74 30.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.622 HG21 ' CG2' ' A' ' 34' ' ' ILE . 14.7 t -134.96 153.3 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.205 -0.934 . . . . 0.0 109.038 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.731 HG23 ' HB3' ' A' ' 7' ' ' ASP . 4.1 m -158.73 127.55 5.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.061 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.667 HG13 HG23 ' A' ' 8' ' ' VAL . 1.2 p -140.32 126.28 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.93 131.5 49.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.103 -0.998 . . . . 0.0 109.673 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.462 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -117.1 -156.7 0.64 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.286 -0.883 . . . . 0.0 109.266 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -145.85 13.76 1.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.545 HG21 ' HB2' ' A' ' 65' ' ' SER . 3.1 m -148.98 135.87 19.79 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.227 -0.92 . . . . 0.0 109.322 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.83 107.07 4.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.274 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.878 HD12 ' CE1' ' A' ' 63' ' ' TYR . 98.6 mt -110.19 -29.62 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.634 HH21 HD12 ' A' ' 62' ' ' ILE . 2.3 mtp-105 62.77 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.248 -0.907 . . . . 0.0 109.636 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.757 ' CA ' HG23 ' A' ' 130' ' ' VAL . . . -66.81 -11.49 57.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ASP . 4.7 mt-30 -90.97 -50.24 5.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -1.139 . . . . 0.0 109.167 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.693 ' HB2' HG22 ' A' ' 84' ' ' ILE . 56.7 t0 43.6 47.05 6.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.828 . . . . 0.0 109.583 179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 90' ' ' ASP . 11.0 mt 48.8 -91.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.408 -0.808 . . . . 0.0 109.784 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 88' ' ' ASP . 6.1 m-20 -53.94 -168.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 0.0 109.719 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -153.82 -69.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.49 -17.97 62.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 0.0 109.831 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -22.12 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -19.5 23.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 109.248 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -29.02 50.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.625 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.8 -2.27 46.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.03 -36.42 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.109 -0.994 . . . . 0.0 109.53 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -58.61 -36.39 73.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.786 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -75.77 -31.9 59.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.694 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -90.03 4.67 49.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.848 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 121' ' ' LEU . . . -89.75 -4.43 57.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 109.58 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 3.3 tp10 -89.49 -47.82 7.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -60.94 -17.09 49.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.975 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -86.76 -30.16 21.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.028 -1.045 . . . . 0.0 109.835 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 105' ' ' ILE . 99.4 mt -89.88 10.78 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.59 30.88 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.423 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 152.04 51.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.59 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 5.9 p -138.38 129.51 27.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 t60 178.39 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 147.06 152.0 5.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.2 -51.24 16.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.3 24.99 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.67 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.22 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.59 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 10.2 p90 -72.28 -25.07 61.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.97 -26.75 38.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -31.6 17.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -68.29 -19.28 64.69 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.822 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 p -67.71 -32.01 72.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.575 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.97 -14.7 59.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.518 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.436 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mm-40 -82.35 -28.94 31.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.547 HD13 ' HB1' ' A' ' 101' ' ' ALA . 8.6 mt -90.27 -39.78 12.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.596 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.415 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -59.77 -44.24 93.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.695 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -59.82 -28.43 67.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -67.25 -30.32 70.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.537 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.597 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.2 mp -70.95 -8.05 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.23 -31.4 19.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.256 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -78.6 -13.43 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.259 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.561 ' C ' HD23 ' A' ' 128' ' ' LEU . 6.4 tt -76.84 -19.4 57.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.391 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -82.18 -28.22 32.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.769 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.757 HG23 ' CA ' ' A' ' 86' ' ' GLY . 27.6 m -86.07 -27.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.955 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.0 tt -69.53 -28.91 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.799 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 14.9 mm-40 -65.59 -15.69 62.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 7.4 mp -90.29 -40.94 11.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.644 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 61' ' ' PHE . 2.2 p -71.92 -3.12 20.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -76.74 -23.52 53.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -120.99 40.41 3.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.369 179.647 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.09 -18.82 13.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.533 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.493 -179.959 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.29 0.566 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.651 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER 64.39 130.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.4 p90 -131.32 -143.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.843 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -141.35 150.0 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 0.0 108.99 -179.361 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.915 ' CD2' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -112.52 132.07 55.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.175 -0.953 . . . . 0.0 109.04 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -129.76 72.42 1.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.823 -1.173 . . . . 0.0 109.791 179.832 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.842 HG23 HG23 ' A' ' 78' ' ' VAL . 3.7 p -109.1 118.2 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.214 -0.929 . . . . 0.0 109.211 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 13.2 m -129.75 159.59 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.03 169.42 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.48 118.84 4.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 58.81 44.02 17.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.206 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -177.78 168.56 2.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.7 pt20 -147.97 174.38 11.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.765 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 3.9 mmt -144.65 -75.45 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.944 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.1 t80 -109.5 113.09 25.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 110.294 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.433 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 32.8 p -136.36 90.6 2.58 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.26 -0.9 . . . . 0.0 109.708 178.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 5' ' ' HIS . . . 168.99 -158.64 31.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.787 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.89 -164.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.933 -1.333 . . . . 0.0 109.291 179.483 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 5' ' ' HIS . 0.2 OUTLIER 172.43 164.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 0.0 108.461 179.162 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.651 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER -123.73 -40.07 2.35 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 25.8 ttpt -159.4 113.51 2.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 110.558 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.915 HG21 ' CD2' ' A' ' 6' ' ' LEU . 13.0 pt -98.81 -164.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.689 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -179.76 97.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.667 -1.271 . . . . 0.0 110.221 179.691 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.607 HG12 ' HA2' ' A' ' 33' ' ' GLY . 3.1 p -99.26 140.42 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.306 -0.872 . . . . 0.0 108.717 179.279 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.493 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 23.8 m -131.97 103.6 6.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -133.26 -47.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER 165.05 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -1.168 . . . . 0.0 109.555 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.63 125.36 33.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.463 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.76 -52.69 4.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.02 19.17 4.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.759 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.682 HD23 ' OH ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -128.22 160.7 31.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.602 179.873 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.49 -112.73 3.37 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.404 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.689 HG12 HD11 ' A' ' 23' ' ' ILE . 31.2 mm -155.0 149.18 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.26 -1.141 . . . . 0.0 109.481 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.682 ' OH ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -153.34 -172.86 0.33 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.955 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.0 Cg_endo -78.46 81.21 2.81 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.687 1.592 . . . . 0.0 110.423 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 25.7 1.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 39' ' ' ALA . 28.3 t60 -56.89 145.01 31.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.241 . . . . 0.0 109.477 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.96 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -49.27 176.25 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.96 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.18 87.51 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.645 2.23 . . . . 0.0 110.424 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.19 126.19 46.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.384 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.93 73.09 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -149.3 -144.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.051 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.58 -171.45 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.001 . . . . 0.0 109.183 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 3.1 mt -132.45 172.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.678 -179.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -123.45 174.28 3.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.288 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -77.43 144.22 22.63 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.513 2.142 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 165.84 -157.28 29.68 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.425 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.4 ptm -111.29 -177.74 3.28 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 24' ' ' GLN . 3.1 tp -160.28 115.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.455 ' C ' ' CG1' ' A' ' 52' ' ' ILE . 25.2 ttp180 -110.24 154.88 22.78 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.865 ' CG2' HG22 ' A' ' 23' ' ' ILE . 15.9 mt -154.65 170.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.193 . . . . 0.0 111.011 -178.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.557 ' N ' HG22 ' A' ' 52' ' ' ILE . 41.4 t -132.43 111.32 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' HIS . 4.3 ttpt -62.65 105.71 0.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.584 -0.697 . . . . 0.0 110.193 -179.116 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CA ' ' HB2' ' A' ' 21' ' ' GLU . 3.5 tt0 40.59 -93.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.735 . . . . 0.0 110.023 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 28.6 t-80 -150.15 81.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.998 . . . . 0.0 109.487 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.64 -97.51 0.11 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 59' ' ' GLU . 47.7 t60 -86.39 170.99 11.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -1.167 . . . . 0.0 109.584 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 6.8 mt-10 -125.47 164.1 21.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.338 -0.851 . . . . 0.0 109.183 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -122.67 130.62 53.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.111 -0.993 . . . . 0.0 109.756 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.403 ' C ' ' CG1' ' A' ' 62' ' ' ILE . 2.1 m-85 -108.83 132.87 53.58 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 63' ' ' TYR . 1.5 mt -150.73 -179.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.978 -1.076 . . . . 0.0 110.01 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.578 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -159.77 152.66 21.64 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.923 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 65' ' ' SER . 1.2 pp -146.93 -174.55 4.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.97 -179.541 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.479 ' N ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -133.86 -48.98 0.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.47 164.04 31.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 156.88 -172.76 34.52 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.6 mp -111.18 131.28 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -1.137 . . . . 0.0 109.061 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.859 ' HA ' HG12 ' A' ' 78' ' ' VAL . 1.3 tt -115.78 137.55 51.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -0.872 . . . . 0.0 109.408 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 12.7 pt-20 -146.37 143.25 28.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 1.007 ' HA ' HG12 ' A' ' 76' ' ' VAL . 6.1 p -99.62 147.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.675 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -126.87 170.43 9.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 179.958 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.68 77.73 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.643 2.229 . . . . 0.0 110.926 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.44 0.65 16.02 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.225 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 72' ' ' GLN . 1.8 p30 -174.89 166.87 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.005 -1.291 . . . . 0.0 109.756 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.007 HG12 ' HA ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -135.15 161.99 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 109.129 179.833 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 17.4 m -156.11 136.75 13.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.859 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.4 m -138.95 148.4 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.479 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -115.01 120.89 41.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 -179.886 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.77 -174.97 3.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.1 -51.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.8 m -100.27 126.82 46.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.765 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -138.53 150.2 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.982 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 69.6 mt -132.68 122.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.352 -0.843 . . . . 0.0 108.901 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -72.88 89.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.951 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.15 -123.8 12.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HB3' HG12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -100.88 52.97 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -1.096 . . . . 0.0 109.676 -179.674 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.88 -37.53 70.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.37 174.04 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.17 44.06 30.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 87' ' ' GLN . 68.2 mt-10 -77.12 -80.56 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.45 -7.77 53.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.315 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -86.86 8.76 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.902 . . . . 0.0 109.51 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.19 -37.58 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -38.94 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 5.1 mm-40 -71.0 -18.18 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.06 62.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.76 -18.91 9.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 109.702 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -74.15 -45.68 47.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.78 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -79.33 -19.63 49.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.621 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.61 -20.73 25.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.132 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HG2' ' OG ' ' A' ' 106' ' ' SER . 34.7 tt0 -71.39 -28.03 63.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.593 ' HG3' ' CD2' ' A' ' 104' ' ' HIS . 7.2 pt-20 -59.27 -31.06 68.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.669 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.593 ' CD2' ' HG3' ' A' ' 103' ' ' GLU . 25.3 m170 -82.24 -40.72 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 105' ' ' ILE . 7.4 mt -85.74 12.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' SER . 58.0 m -110.58 117.69 34.22 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 81.65 171.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.827 -0.546 . . . . 0.0 109.537 179.884 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 77.67 173.33 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 109.13 -179.539 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 4.8 p-80 -170.13 125.56 0.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.61 169.23 40.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 3.7 m-20 -67.51 -40.23 85.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -1.096 . . . . 0.0 109.327 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 113' ' ' ASP . 23.2 m -124.92 -9.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 112' ' ' VAL . 2.0 m-20 -48.02 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.168 179.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.527 ' CD1' ' C ' ' A' ' 114' ' ' TYR . 5.8 p90 -75.93 -21.2 57.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.017 -1.052 . . . . 0.0 108.294 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -62.81 -18.28 62.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.631 -0.668 . . . . 0.0 109.355 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 3.0 mt-30 -70.23 -36.06 74.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.653 ' HB3' HG13 ' A' ' 105' ' ' ILE . . . -72.86 -24.7 60.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -65.96 -25.98 67.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.339 -0.851 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.3 -33.32 25.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.653 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 117' ' ' ALA . 1.2 pp20? -85.61 -8.3 58.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 122' ' ' ALA . 9.0 tt -84.14 -59.13 2.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.548 ' HA ' ' CG1' ' A' ' 125' ' ' ILE . . . -46.54 -27.79 1.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -51.22 70.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.918 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.19 59.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.548 ' CG1' ' HA ' ' A' ' 122' ' ' ALA . 33.5 mm -76.6 -8.12 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.962 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -88.72 -2.86 58.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.168 -0.958 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.496 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.6 mt-30 -87.63 -37.89 16.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.232 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 131' ' ' ILE . 4.6 tp -81.19 -24.54 37.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.855 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' LEU . 16.5 mmm180 -62.5 -43.51 98.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 127' ' ' GLN . 28.1 m -68.66 -9.99 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.71 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 87' ' ' GLN . 63.0 mt -90.62 -56.15 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 21.1 mm-40 -68.67 -9.19 48.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -87.65 -48.69 7.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.544 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 10.4 t -69.08 -7.57 37.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -55.64 -53.64 54.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.554 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -87.46 -12.74 45.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -46.83 -37.83 9.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.306 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.397 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.504 ' HG2' ' CG ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.109 0.481 . . . . 0.0 109.746 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 3' ' ' THR . 8.9 t 173.7 129.31 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.71 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 1.035 ' CE2' HG22 ' A' ' 34' ' ' ILE . 13.8 p90 -112.84 -162.55 0.8 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.4 t60 -117.27 142.36 47.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 108.548 178.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.042 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -130.43 156.79 44.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.415 178.43 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.891 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -143.03 90.2 2.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.951 HG13 HD13 ' A' ' 6' ' ' LEU . 7.3 m -108.37 147.7 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -169.31 151.19 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 2.4 m -119.94 125.68 49.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 56.0 27.78 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER 66.07 72.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -165.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 82.74 1.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.621 ' SD ' HG23 ' A' ' 62' ' ' ILE . 7.4 mmt -105.88 -92.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HB3' HG22 ' A' ' 8' ' ' VAL . 34.4 t80 -121.07 138.99 53.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.084 -1.01 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 p -169.06 100.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 154.94 -151.41 23.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.786 ' C ' HG12 ' A' ' 20' ' ' VAL . 10.9 mt -64.22 170.48 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.042 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 172.92 160.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 108.39 -177.608 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.537 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 8.6 tt0 -156.32 -58.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.916 -1.115 . . . . 0.0 110.623 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.544 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -91.42 74.72 6.03 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.395 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.665 HG22 ' CG1' ' A' ' 52' ' ' ILE . 2.9 pt -99.89 143.67 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 35.8 tt0 -150.63 121.85 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.789 -1.194 . . . . 0.0 109.674 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.84 159.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 5.9 m -138.46 111.79 8.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.216 -0.927 . . . . 0.0 109.204 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.53 -99.62 0.52 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -134.56 -0.12 2.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -1.169 . . . . 0.0 110.214 -179.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 tm-20 -164.05 128.66 2.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.93 -53.64 0.61 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 16.8 mt-10 48.85 23.61 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -1.174 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.576 HD22 ' OH ' ' A' ' 35' ' ' TYR . 1.7 mt -148.13 161.09 42.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -111.73 -103.83 2.72 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.035 HG22 ' CE2' ' A' ' 4' ' ' TYR . 9.2 mm -154.54 140.59 11.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.41 -1.053 . . . . 0.0 109.238 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -121.5 -178.89 0.66 Allowed Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.345 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 34.3 Cg_endo -77.54 96.09 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.262 1.975 . . . . 0.0 110.4 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.88 15.25 5.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.475 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 40.2 t-80 -72.74 171.98 11.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -1.146 . . . . 0.0 109.447 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -85.89 156.49 58.09 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.353 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 71' ' ' VAL . 34.0 Cg_endo -77.02 78.0 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.682 2.254 . . . . 0.0 110.782 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 71' ' ' VAL . 1.2 mm? -97.84 149.04 22.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.983 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.51 ' C ' HG22 ' A' ' 43' ' ' THR . 0.8 OUTLIER -152.74 133.47 13.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 179.97 -92.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.84 . . . . 0.0 109.436 179.48 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.503 ' H ' HG23 ' A' ' 43' ' ' THR . . . -131.29 160.9 33.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.925 HD13 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -100.42 132.42 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -65.33 136.41 96.37 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 -179.837 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.467 ' CB ' ' OG ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -80.18 160.51 23.4 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.446 2.097 . . . . 0.0 110.44 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 126.58 -131.64 7.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ptm -121.94 178.3 4.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -1.056 . . . . 0.0 109.009 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -156.23 131.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.618 -1.301 . . . . 0.0 110.96 -179.604 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -98.84 129.67 45.23 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.943 HD11 ' CD2' ' A' ' 6' ' ' LEU . 2.1 tt -130.82 152.38 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.887 -1.133 . . . . 0.0 110.898 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 46.8 t -131.19 107.56 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' GLN . 4.4 ttpt -67.29 119.51 12.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.735 . . . . 0.0 109.646 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' LYS . 3.4 tt0 41.19 -152.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.423 -0.798 . . . . 0.0 109.742 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -88.91 67.24 8.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 161.62 163.6 14.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.7 m170 57.88 159.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.184 -1.186 . . . . 0.0 109.347 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.3 OUTLIER 179.97 118.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -132.53 157.08 45.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.603 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.4 OUTLIER -113.58 136.44 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 -179.904 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 50' ' ' ILE . 5.3 mp -112.58 167.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.602 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 14.4 t80 -128.48 140.83 51.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.32 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -168.83 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.467 ' OG ' ' CB ' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -179.47 132.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 -179.966 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.642 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 72.79 142.97 0.51 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.57 165.06 11.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.73 123.85 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -1.108 . . . . 0.0 109.22 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.806 HD12 HD12 ' A' ' 45' ' ' ILE . 1.2 tt -108.09 153.73 22.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.0 110.036 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 77' ' ' THR . 4.4 pt-20 -156.14 111.0 2.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG23 ' HB ' ' A' ' 76' ' ' VAL . 4.4 p -99.85 159.08 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 2.0 mt-30 -143.11 172.97 4.97 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.7 Cg_endo -80.26 62.11 8.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.627 2.218 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.63 -14.74 1.06 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.6 p-10 -167.21 168.65 13.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.996 -1.296 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -155.49 162.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.413 -0.804 . . . . 0.0 109.063 -179.891 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 7' ' ' ASP . 6.4 p -154.18 156.05 36.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG21 HD13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -166.43 130.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.962 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.96 112.0 23.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.642 ' HB1' ' O ' ' A' ' 66' ' ' GLY . . . -106.07 -175.27 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.63 -9.26 9.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 65' ' ' SER . 16.7 m -109.35 142.04 40.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -161.39 132.85 5.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.911 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.602 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 18.9 mt -128.8 -36.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.368 -0.833 . . . . 0.0 109.143 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 75.34 134.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.172 -179.763 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -39.16 96.6 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 85' ' ' ARG . 39.3 tt0 63.85 74.36 0.42 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -1.112 . . . . 0.0 109.942 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 8.9 t70 -52.3 -35.09 49.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.086 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER 166.47 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.076 179.875 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 75.12 153.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' CB ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.66 -29.36 3.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.56 -33.64 20.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.476 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 9.3 ttt180 -63.67 -22.72 67.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 0.0 109.466 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.74 -25.11 23.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.274 -0.891 . . . . 0.0 108.712 179.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.538 ' HA ' HD11 ' A' ' 128' ' ' LEU . 2.5 mtm -66.29 -20.74 66.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.505 -0.747 . . . . 0.0 109.373 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 2.3 tm-20 -80.05 -22.38 42.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.93 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.15 72.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.405 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.34 -26.81 61.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.211 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -81.94 -26.68 33.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HG3' ' OE1' ' A' ' 96' ' ' GLU . 8.3 mttt -83.25 -27.32 29.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 109.624 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.87 -19.69 31.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.395 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 16.1 tp10 -77.34 -38.22 50.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.924 . . . . 0.0 109.334 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -72.49 -43.61 63.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -28.05 67.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.801 ' O ' HG22 ' A' ' 105' ' ' ILE . 98.8 mt -90.24 26.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.203 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 t -97.32 -14.35 21.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.707 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.6 p -126.01 110.91 14.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -158.0 155.73 29.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 109.271 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.7 -76.95 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 111' ' ' ASP . . . 179.05 -175.74 47.48 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 0.2 OUTLIER 77.84 -78.03 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -1.079 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.3 m -135.51 8.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.15 -91.24 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.409 -0.807 . . . . 0.0 108.884 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 108' ' ' SER . 49.5 t80 -72.12 -17.49 61.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.22 82.21 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 5.9 mm-40 -90.68 -32.5 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.494 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -67.37 -24.77 65.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -32.23 53.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.441 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.24 -25.98 22.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 8.8 mm-40 -62.87 -46.31 88.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -58.03 -52.56 65.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.463 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -18.85 60.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 -179.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -29.46 64.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.96 -24.67 21.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.812 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 125' ' ' ILE . 24.7 mm -80.62 7.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.54 -34.07 15.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 2.6 pt20 -80.86 -25.01 37.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.903 . . . . 0.0 109.618 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -71.23 -15.84 62.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.25 -52.49 4.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.603 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 21.6 m -56.61 -29.33 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.942 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 132' ' ' GLU . 12.0 tt -64.36 -42.96 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.005 . . . . 0.0 109.735 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 131' ' ' ILE . 6.6 mm-40 -60.39 -23.77 64.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.28 -49.62 16.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.792 -179.677 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 8.8 t -70.66 -17.81 62.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -53.04 52.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -5.26 59.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -60.27 -34.09 73.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.519 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.3 0.572 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.629 HG22 ' CG ' ' A' ' 21' ' ' GLU . 7.6 p -45.52 135.87 6.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.701 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 5.3 p90 -132.8 178.36 6.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.063 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.3 t60 -103.79 149.1 25.34 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.121 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -138.55 156.72 47.24 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.442 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.859 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.68 94.09 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.98 -1.075 . . . . 0.0 110.261 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.707 HG12 ' HB3' ' A' ' 16' ' ' PHE . 6.5 p -107.61 96.32 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 108.779 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.561 HG23 HD23 ' A' ' 79' ' ' LEU . 28.7 m -118.26 162.22 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.961 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 t -102.63 -158.27 0.66 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.343 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -68.38 -50.27 54.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 4.2 mt-10 -141.59 67.61 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 1.8 mm-40 171.61 68.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 13' ' ' GLN . 14.7 pt20 -43.71 158.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.66 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.94 ' HB3' HG21 ' A' ' 62' ' ' ILE . 12.3 mmm -126.83 -73.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.176 -0.952 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.707 ' HB3' HG12 ' A' ' 8' ' ' VAL . 40.9 t80 -114.68 93.45 4.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.9 p -124.04 95.71 4.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -159.73 32.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.405 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.6 mt -66.78 160.73 25.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -1.173 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.121 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -164.36 160.26 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.969 -178.5 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.629 ' CG ' HG22 ' A' ' 3' ' ' THR . 0.1 OUTLIER -130.63 -34.85 1.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.516 -0.74 . . . . 0.0 109.35 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.4 ttpp -155.1 97.84 1.96 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.096 -1.002 . . . . 0.0 110.515 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.31 156.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.52 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 11.9 tt0 -151.96 134.47 15.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.538 HG23 ' HA2' ' A' ' 33' ' ' GLY . 36.5 t -108.78 142.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -130.41 113.04 13.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.51 -111.95 1.48 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 m -107.97 -62.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -1.179 . . . . 0.0 109.466 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.64 -17.8 14.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.56 119.37 5.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -129.26 34.62 4.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -1.194 . . . . 0.0 109.798 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.69 HD23 ' OH ' ' A' ' 35' ' ' TYR . 6.5 mt -138.61 139.29 38.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.013 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.11 -101.46 2.29 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.861 HG21 HG21 ' A' ' 76' ' ' VAL . 20.4 mm -155.59 152.7 8.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.69 ' OH ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -154.44 -176.0 0.56 Allowed Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.746 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 36.2 Cg_endo -81.7 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.359 2.04 . . . . 0.0 110.183 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.49 38.64 0.02 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.71 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 10.4 t-160 -82.47 10.02 8.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -1.08 . . . . 0.0 109.594 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.873 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 75.86 173.47 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.314 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.873 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -78.16 76.97 4.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.581 2.188 . . . . 0.0 110.485 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -90.01 130.04 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.183 179.804 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.2 tp -148.77 69.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -140.29 -95.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.729 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.507 ' H ' HG23 ' A' ' 43' ' ' THR . . . -156.87 167.96 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.808 ' CD1' HG21 ' A' ' 78' ' ' VAL . 3.4 mt -110.07 167.25 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 68.4 mmtt -100.11 159.45 29.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.09 163.95 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.858 2.372 . . . . 0.0 110.423 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 130.78 -146.25 17.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.669 ' HB2' HG11 ' A' ' 130' ' ' VAL . 24.8 ptm -103.19 -176.77 3.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -1.112 . . . . 0.0 109.085 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -158.52 118.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 109.544 -179.81 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.36 131.28 46.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 109.367 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 23' ' ' ILE . 35.5 mt -132.73 163.08 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.107 -0.995 . . . . 0.0 109.784 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.592 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 39.2 t -134.95 154.62 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.616 -0.677 . . . . 0.0 109.64 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.4 tmtm? 92.0 -79.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.492 ' OE1' ' HG2' ' A' ' 60' ' ' GLU . 14.6 tt0 51.44 -99.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.818 -1.176 . . . . 0.0 109.606 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -165.28 50.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.922 -1.111 . . . . 0.0 109.275 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.543 ' C ' ' CD2' ' A' ' 58' ' ' HIS . . . 146.73 -44.61 0.82 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 57' ' ' GLY . 44.3 m-70 -150.93 -176.64 5.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.406 -1.055 . . . . 0.0 109.235 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.566 ' HG2' HG13 ' A' ' 53' ' ' VAL . 5.6 mp0 -106.9 162.31 13.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 109.124 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HG2' ' OE1' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -162.64 171.28 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.968 -1.082 . . . . 0.0 110.016 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.592 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.7 OUTLIER -121.1 176.3 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 109.656 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.94 HG21 ' HB3' ' A' ' 15' ' ' MET . 1.2 mt -152.94 -160.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.78 . . . . 0.0 109.0 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.804 ' C ' HD13 ' A' ' 64' ' ' LEU . 3.8 t80 -172.36 128.87 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.21 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.888 HD13 ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -158.63 -169.74 2.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 109.708 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -86.98 -59.75 2.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.55 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.14 -63.92 0.33 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.59 -152.3 52.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.843 ' O ' HG23 ' A' ' 78' ' ' VAL . 75.1 mt -102.71 137.99 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.141 . . . . 0.0 109.217 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.732 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.7 tt -119.37 152.6 36.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.0 109.576 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 6.0 mt-10 -149.65 138.33 20.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 109.229 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.597 ' HA ' HG12 ' A' ' 76' ' ' VAL . 9.6 p -100.52 140.51 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.793 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 5.6 mt-30 -124.19 174.76 3.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.4 Cg_endo -78.12 80.92 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.342 2.028 . . . . 0.0 111.022 -179.389 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 102.5 25.3 7.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 7.0 p-10 171.15 138.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -1.208 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.861 HG21 HG21 ' A' ' 34' ' ' ILE . 28.3 m -126.61 172.48 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 108.908 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 78' ' ' VAL . 55.3 m -163.11 157.19 20.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.212 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 68' ' ' ILE . 2.4 p -161.82 135.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 108.95 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.561 HD23 HG23 ' A' ' 9' ' ' VAL . 2.0 mt -116.37 122.9 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.082 -1.012 . . . . 0.0 109.779 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.14 -168.06 1.33 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.235 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.57 -12.02 8.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.447 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.2 m -112.19 147.83 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -158.25 70.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 109.728 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.652 HD12 ' CE1' ' A' ' 63' ' ' TYR . 8.6 mt -99.0 56.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 88' ' ' ASP . 7.2 ptt180 -46.21 154.6 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.42 ' C ' ' HG3' ' A' ' 87' ' ' GLN . . . -58.37 148.98 36.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.816 ' CD ' HG21 ' A' ' 134' ' ' THR . 35.1 mt-30 69.29 6.15 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -1.122 . . . . 0.0 109.645 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 12.0 t70 -70.13 -34.43 73.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.68 151.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 93' ' ' ARG . 66.0 t0 56.99 103.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.311 -0.868 . . . . 0.0 109.585 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.11 -53.98 2.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.5 -20.7 26.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.504 ' CB ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -86.76 -9.35 56.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.968 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . . . -90.41 -12.22 38.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.209 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -25.97 32.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 109.683 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 12.5 pt-20 -77.07 -14.33 59.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.38 -47.92 53.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 109.54 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -21.91 19.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -39.67 24.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -90.08 0.46 57.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.973 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -90.33 -32.18 16.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.72 -26.22 68.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.75 -37.43 82.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -68.96 -16.24 63.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 107' ' ' SER . 11.4 mm -89.14 19.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.165 -0.96 . . . . 0.0 109.744 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -47.52 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.634 -179.937 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' ILE . 2.5 m -43.66 137.18 3.09 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.4 p -166.41 158.93 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.499 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.17 166.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.14 138.35 5.23 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -72.16 -72.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.329 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.704 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 32.2 m -111.61 12.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 112' ' ' VAL . 29.6 t0 -49.86 -99.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -68.45 -15.8 63.68 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.873 -1.142 . . . . 0.0 108.514 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -64.84 -16.0 62.58 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.601 -0.687 . . . . 0.0 109.5 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -88.83 -27.92 20.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -82.67 -14.29 54.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -23.39 61.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.61 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.57 -23.9 24.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.25 -10.38 54.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.973 HD12 ' HB1' ' A' ' 101' ' ' ALA . 3.1 mm? -86.3 -63.62 1.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.644 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 125' ' ' ILE . . . -54.18 -18.67 4.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -54.59 -41.04 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.23 -36.3 18.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -64.6 -10.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.427 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.512 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -69.53 -35.46 75.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.476 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.518 ' HA ' HG22 ' A' ' 130' ' ' VAL . 1.6 pp0? -81.09 5.33 16.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.835 ' O ' HD23 ' A' ' 128' ' ' LEU . 2.3 tt -86.14 -36.23 19.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -34.74 62.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.161 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 49' ' ' MET . 35.5 m -72.38 -36.56 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 128' ' ' LEU . 3.6 tt -68.26 -31.37 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -75.29 -16.55 60.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -71.03 -42.1 69.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.647 -179.95 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.816 HG21 ' CD ' ' A' ' 87' ' ' GLN . 9.7 t -74.1 -14.13 60.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -60.09 -35.72 75.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.11 -0.994 . . . . 0.0 109.176 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -95.75 -3.98 44.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.252 179.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -58.49 -57.09 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.474 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.3 ptp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.444 179.797 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.447 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.2 mtm . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.274 0.559 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -162.04 177.17 9.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.829 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.4 p90 -166.05 -149.09 0.1 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.557 ' HA ' HG12 ' A' ' 20' ' ' VAL . 2.7 t60 -133.05 147.54 52.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 108.886 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.037 HD23 HG21 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -140.23 169.96 16.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.194 178.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 1.027 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.75 103.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.896 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.6 p -116.39 102.94 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.981 . . . . 0.0 109.515 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG13 ' HA ' ' A' ' 14' ' ' GLN . 15.0 t -111.55 156.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.589 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 15.4 t -122.13 78.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 109.655 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 69.14 -85.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.77 30.88 4.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.507 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.69 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.741 ' HA ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.27 144.99 11.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 -179.853 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.593 ' SD ' HG23 ' A' ' 62' ' ' ILE . 13.9 mtt -127.96 -77.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.262 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.672 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 34.7 t80 -103.49 123.83 47.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 17' ' ' SER . 14.8 p -152.12 103.04 2.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.0 -155.32 26.05 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.761 ' C ' HG12 ' A' ' 20' ' ' VAL . 8.5 mt -61.33 178.69 0.26 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.119 -1.224 . . . . 0.0 108.937 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.037 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 175.88 113.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.784 -1.197 . . . . 0.0 109.888 -177.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 6.6 tt0 -76.17 -43.04 44.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.085 179.242 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -165.94 134.51 3.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.987 -1.071 . . . . 0.0 110.586 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.872 HD11 HG12 ' A' ' 34' ' ' ILE . 39.0 pt -98.71 -148.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -176.1 132.99 0.25 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.259 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.476 HG23 ' HA2' ' A' ' 33' ' ' GLY . 4.1 t -140.25 131.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.976 -1.078 . . . . 0.0 109.324 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.7 m -132.61 113.89 13.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.519 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.76 -119.64 2.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.6 p -122.65 -6.63 8.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.01 -91.86 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.92 142.8 34.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.98 63.1 1.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -1.219 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' A' ' 32' ' ' LEU . 8.9 mt -141.26 162.36 35.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 109.595 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -106.05 -116.64 4.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.882 HG21 HG21 ' A' ' 76' ' ' VAL . 17.5 mm -153.05 141.1 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.531 -0.982 . . . . 0.0 108.373 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -139.37 172.99 5.6 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.745 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -73.26 85.29 1.25 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.034 1.823 . . . . 0.0 109.975 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.57 20.16 2.19 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 59.1 t60 -55.0 139.61 40.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -1.233 . . . . 0.0 109.381 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -43.68 162.15 0.19 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.322 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 34.2 Cg_endo -76.85 75.68 4.41 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.501 2.134 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.15 140.35 30.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.05 107.55 4.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 109.236 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.731 HG23 ' N ' ' A' ' 44' ' ' ALA . 11.8 t -175.25 -139.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.731 ' N ' HG23 ' A' ' 43' ' ' THR . . . -99.67 179.2 4.61 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.883 -1.136 . . . . 0.0 109.403 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 45' ' ' ILE . 1.3 tp -111.84 118.82 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.464 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -54.78 144.83 44.34 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.852 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.8 Cg_endo -78.5 172.7 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.661 2.241 . . . . 0.0 110.436 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.47 -153.98 19.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.864 ' HB2' HG13 ' A' ' 130' ' ' VAL . 4.7 ppp? -102.83 -178.93 3.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -1.124 . . . . 0.0 109.289 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 51' ' ' ARG . 3.9 mt -154.33 165.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.128 -0.982 . . . . 0.0 110.235 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.538 ' N ' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -152.85 151.03 29.94 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.357 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.656 ' CG2' HG22 ' A' ' 23' ' ' ILE . 21.5 mt -153.39 163.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.745 -1.222 . . . . 0.0 110.769 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' N ' HG22 ' A' ' 52' ' ' ILE . 67.3 t -139.84 109.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' HIS . 14.8 tttm -64.86 119.8 11.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.634 -0.666 . . . . 0.0 109.537 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.58 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 52.0 tt0 42.75 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.75 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.58 ' CD2' ' HG2' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -154.87 56.49 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 -179.941 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -130.44 -98.25 0.81 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 176.92 4.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -1.092 . . . . 0.0 109.372 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.3 pt-20 -121.95 146.02 47.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 147.54 34.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 134' ' ' THR . 8.9 m-85 -102.85 155.58 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.671 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.593 HG23 ' SD ' ' A' ' 15' ' ' MET . 65.5 mt -153.47 145.84 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.598 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.542 ' CD2' ' HB ' ' A' ' 84' ' ' ILE . 4.0 t80 -147.47 133.08 18.79 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.802 ' C ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -167.79 168.17 12.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 110.107 -179.58 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.605 ' N ' HD22 ' A' ' 64' ' ' LEU . 1.4 m -150.19 92.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.379 -0.826 . . . . 0.0 109.296 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.94 105.09 1.77 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.544 ' C ' HD13 ' A' ' 68' ' ' ILE . . . -177.2 -178.48 46.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.864 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.1 mm -118.79 135.71 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -1.176 . . . . 0.0 109.414 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.617 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.5 tt -112.89 152.27 29.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -0.899 . . . . 0.0 109.578 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.41 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.0 tt0 -161.12 133.16 5.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 40' ' ' PRO . 13.5 p -99.89 140.64 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.579 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.3 mt-30 -120.6 -178.77 0.62 Allowed Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -79.63 82.58 2.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.4 2.067 . . . . 0.0 111.005 -179.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.47 -9.62 64.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HB2' ' OE1' ' A' ' 72' ' ' GLN . 10.0 m-20 -131.85 160.89 34.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -1.217 . . . . 0.0 109.695 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 34' ' ' ILE . 12.5 t -137.64 152.3 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -151.04 162.63 40.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -179.34 139.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.426 -0.796 . . . . 0.0 109.103 179.857 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 6.0 mp -106.23 174.05 6.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -164.21 165.49 21.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.265 -0.897 . . . . 0.0 109.589 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -108.27 -45.42 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.313 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.4 110.49 5.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 109.689 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.788 HG23 ' CG ' ' A' ' 88' ' ' ASP . 3.3 mt -137.75 73.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.057 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' GLY . 8.9 ptp180 -43.93 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.532 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.531 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -44.06 -58.01 4.56 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -47.91 -87.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -1.196 . . . . 0.0 109.329 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.788 ' CG ' HG23 ' A' ' 84' ' ' ILE . 18.8 t70 68.26 19.0 9.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 0.2 OUTLIER 71.97 34.26 1.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.627 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.76 161.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -138.45 -65.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.631 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.67 -12.22 51.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 109.719 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.17 9.05 13.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.626 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.28 19.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.335 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.17 -18.02 63.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.827 . . . . 0.0 109.519 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -77.93 -18.67 55.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.34 62.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.629 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -79.81 -22.77 42.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.22 -48.48 20.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.733 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -30.32 67.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.152 -0.967 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.22 26.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.65 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' LYS . 3.0 tt0 -80.3 -38.26 31.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.17 -32.0 70.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.138 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -27.87 67.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.314 -0.866 . . . . 0.0 109.296 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 121' ' ' LEU . 25.6 mt -88.97 21.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 109.647 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 107' ' ' SER . 19.3 p -57.35 -63.51 1.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.4 OUTLIER 168.01 94.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 -153.51 0.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.97 166.53 13.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.85 152.59 8.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.49 -56.47 3.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -1.112 . . . . 0.0 109.37 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.34 23.0 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 37.4 t0 -75.73 -95.79 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.206 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -71.19 -20.58 62.26 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.45 75.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -70.77 -34.12 71.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.93 -22.88 67.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.0 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.2 t -53.59 -40.76 65.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.374 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . -73.65 -38.79 64.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.02 -20.36 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.422 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 105' ' ' ILE . 7.2 tp -78.08 -65.34 0.99 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 125' ' ' ILE . . . -49.39 -29.69 6.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 119' ' ' ALA . 2.3 mptt -65.88 -43.69 87.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.87 -20.98 64.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 122' ' ' ALA . 10.5 mm -70.2 -14.02 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.43 -18.73 47.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.433 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.581 ' O ' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.537 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.462 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.9 OUTLIER -74.72 -13.05 60.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.602 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -84.45 -39.75 18.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.864 HG13 ' HB2' ' A' ' 49' ' ' MET . 2.7 m -70.58 -22.25 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 127' ' ' GLN . 23.4 pt -87.55 -32.61 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HG2' HG13 ' A' ' 131' ' ' ILE . 18.8 mm-40 -83.1 -17.84 41.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -85.33 -46.78 10.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.962 . . . . 0.0 109.499 179.867 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 61' ' ' PHE . 11.1 t -75.16 -13.18 60.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.406 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.48 -27.38 1.72 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.398 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -82.76 -38.03 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.823 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.68 -71.85 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.668 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.432 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 3' ' ' THR . 13.6 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -177.77 143.38 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.977 . . . . 0.0 109.684 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.67 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.8 p90 -137.7 -145.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.713 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.838 ' O ' HG22 ' A' ' 76' ' ' VAL . 35.6 t-80 -131.37 140.46 49.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.926 -1.109 . . . . 0.0 110.493 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.853 HD21 HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -109.96 127.65 54.9 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.327 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' HB3' ' OG1' ' A' ' 77' ' ' THR . 0.2 OUTLIER -135.73 63.64 1.59 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.956 -1.09 . . . . 0.0 109.307 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.838 HG23 ' CG2' ' A' ' 78' ' ' VAL . 1.9 p -99.64 131.04 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.211 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.7 144.68 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -153.05 -157.42 0.79 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 109.222 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 81' ' ' ASP . . . -43.51 122.85 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 108.985 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.5 mt-10 76.35 78.98 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.818 . . . . 0.0 108.989 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 12' ' ' GLU . 23.3 tm0? -41.47 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 172.64 47.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.772 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -93.7 -93.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.967 . . . . 0.0 109.346 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.621 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.1 t80 -134.04 111.44 10.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.034 . . . . 0.0 109.959 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.413 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 51.4 p -136.3 71.87 1.43 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.901 . . . . 0.0 109.38 178.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . -169.39 167.97 40.91 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 19' ' ' LEU . 18.8 mt -46.18 167.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.409 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.765 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -167.64 168.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.967 . . . . 0.0 109.549 -179.318 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.5 tt0 -120.17 -37.35 3.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -167.92 124.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.929 -1.107 . . . . 0.0 110.721 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.853 HG21 HD21 ' A' ' 6' ' ' LEU . 19.5 pt -99.09 -159.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 1.2 tt0 -177.04 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.865 -1.147 . . . . 0.0 109.789 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -99.34 99.78 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 109.588 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 26' ' ' THR . 5.8 t -100.14 129.49 46.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.868 . . . . 0.0 109.329 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.28 -90.34 0.51 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 p -134.45 -43.5 0.77 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -1.177 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -101.72 -78.0 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.555 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.81 114.43 6.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 25.25 11.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.446 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.437 HD13 ' OH ' ' A' ' 35' ' ' TYR . 11.6 mt -122.15 157.65 31.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.542 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -99.83 -109.51 3.06 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.67 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 22.8 mm -153.82 155.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 109.319 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -150.66 175.19 2.97 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.334 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.7 Cg_endo -74.05 82.28 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.12 1.88 . . . . 0.0 110.057 179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.37 26.78 2.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.586 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.1 t-160 -55.21 -89.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -1.097 . . . . 0.0 109.553 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -172.5 168.98 2.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.829 ' HA ' HG11 ' A' ' 71' ' ' VAL . 36.2 Cg_endo -78.43 70.02 7.42 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.671 2.248 . . . . 0.0 110.703 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.499 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 2.9 mm? -84.58 142.06 30.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.188 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.646 HD21 ' OE1' ' A' ' 70' ' ' GLU . 1.2 mt -151.85 49.38 0.8 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.086 -1.008 . . . . 0.0 109.558 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -126.51 -152.51 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.46 179.72 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 1.2 mt -128.55 168.7 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 167.67 8.92 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.533 ' CA ' ' O ' ' A' ' 65' ' ' SER . 35.6 Cg_endo -78.01 135.56 14.04 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.661 2.241 . . . . 0.0 110.381 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 177.31 -158.36 23.8 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.489 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.8 ptm -100.43 173.97 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.087 . . . . 0.0 109.102 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.767 HG23 ' H ' ' A' ' 62' ' ' ILE . 2.4 tt -148.41 103.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -99.3 147.26 25.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.773 ' CG2' HG22 ' A' ' 23' ' ' ILE . 12.6 mt -149.48 167.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.021 -1.05 . . . . 0.0 110.868 -178.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 59' ' ' GLU . 66.5 t -137.85 106.46 3.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -70.27 127.53 33.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.562 -179.387 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER 45.51 -158.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.68 82.79 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 142.75 146.09 4.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 22.1 t-80 75.2 162.09 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.644 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.8 pt-20 -170.34 132.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.22 138.17 51.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.246 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.93 ' C ' HD13 ' A' ' 62' ' ' ILE . 12.1 p90 -123.19 129.1 50.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.093 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -112.64 -146.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.35 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.839 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.3 t80 -169.98 141.98 2.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.018 . . . . 0.0 109.133 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 pp -142.41 -175.98 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.533 ' O ' ' CA ' ' A' ' 47' ' ' PRO . 23.1 t -117.32 -46.54 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.34 -143.93 3.79 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' LEU . . . 116.92 174.55 17.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.06 129.34 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.116 . . . . 0.0 109.472 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.965 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -100.56 118.23 36.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.47 -179.898 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.902 ' N ' HD22 ' A' ' 69' ' ' LEU . 15.0 tt0 -122.93 141.48 51.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.128 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.829 HG11 ' HA ' ' A' ' 40' ' ' PRO . 12.2 p -101.53 150.69 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.733 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.548 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 4.1 mt-30 -137.23 173.83 5.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.58 110.12 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.456 2.104 . . . . 0.0 110.669 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 69.15 37.73 82.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.58 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.5 p30 165.37 162.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.265 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 5' ' ' HIS . 32.8 m -142.34 163.32 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.53 -0.731 . . . . 0.0 109.099 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 40.7 m -160.2 132.81 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 109.742 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.838 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.0 m -127.52 153.79 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 109.339 179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' CA ' ' A' ' 67' ' ' GLY . 1.2 mp -111.97 121.61 45.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.016 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -133.72 168.41 18.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.178 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -126.13 -17.7 5.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 110.133 -179.737 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -113.22 142.74 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.807 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -150.47 132.99 15.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.068 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.839 HD12 ' CE1' ' A' ' 63' ' ' TYR . 57.6 mt -115.29 -40.46 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' GLY . 7.8 ttp180 69.77 133.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -41.58 -40.8 3.0 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 18.3 mt-30 -73.41 -61.94 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -1.216 . . . . 0.0 109.393 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.482 ' HB2' HG22 ' A' ' 84' ' ' ILE . 27.4 t70 62.69 12.83 5.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.785 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 tp 57.56 38.53 27.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 177.5 159.23 0.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.729 ' CB ' HD11 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -153.19 -50.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.064 -1.022 . . . . 0.0 109.855 -179.686 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.44 72.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -79.07 -17.49 55.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 109.847 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.763 ' HB1' ' OE1' ' A' ' 127' ' ' GLN . . . -90.51 -12.0 38.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.296 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.695 ' HG2' HD21 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -78.02 -24.12 47.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.55 -15.03 58.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.9 87.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.92 -37.19 13.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 109.724 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -50.89 15.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.965 . . . . 0.0 109.691 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -17.75 14.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 121' ' ' LEU . . . -89.52 -32.25 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.975 . . . . 0.0 109.643 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.737 ' O ' HG22 ' A' ' 105' ' ' ILE . 35.4 tp10 -73.99 -27.07 60.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -35.08 67.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 2.47 39.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 102' ' ' GLU . 1.7 tp -69.52 -19.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 p -89.71 -29.39 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.672 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -60.58 92.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 113' ' ' ASP . 10.9 m -162.59 -148.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.399 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 1.4 t-160 -140.66 -150.16 0.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.973 . . . . 0.0 109.678 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -77.22 0.35 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 112' ' ' VAL . 2.0 m-20 -80.51 177.0 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -1.161 . . . . 0.0 109.726 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.37 33.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.64 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 51.1 t0 -83.89 -96.78 0.06 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.059 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.62 -18.25 65.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.36 87.68 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.357 0.599 . . . . 0.0 109.394 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 22.0 mt-30 -88.41 -16.99 31.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.626 ' HB1' HD12 ' A' ' 105' ' ' ILE . . . -72.96 -27.14 61.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.2 t -60.22 -16.6 34.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -81.69 -61.11 2.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.75 -9.02 48.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.642 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 105' ' ' ILE . 11.8 tp -89.12 -60.71 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.8 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -78.26 5.65 9.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.036 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 119' ' ' ALA . 4.1 tttt -73.28 -45.79 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.59 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.08 -6.75 41.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' A' ' 122' ' ' ALA . 2.0 mp -84.73 -14.48 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.646 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -67.15 -32.46 73.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.763 ' OE1' ' HB1' ' A' ' 94' ' ' ALA . 10.8 pt20 -82.5 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.1 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.695 HD21 ' HG2' ' A' ' 95' ' ' MET . 0.6 OUTLIER -74.67 -13.31 60.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.374 179.919 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -89.65 -53.74 4.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.701 HG23 ' HA2' ' A' ' 86' ' ' GLY . 34.4 m -67.77 -27.91 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.72 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.729 HD11 ' CB ' ' A' ' 91' ' ' GLU . 3.8 tt -65.11 -38.35 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.453 ' N ' HG23 ' A' ' 131' ' ' ILE . 4.8 mm-40 -67.23 -8.3 30.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -86.26 -44.22 12.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.843 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.8 t -82.33 -9.55 59.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -55.3 -45.68 76.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 137' ' ' ALA . 1.3 ptmt -85.75 -16.61 38.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.689 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.78 -39.49 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 mtp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.505 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.296 0.57 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -148.85 36.38 0.78 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.455 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 1.6 t -152.75 158.45 42.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.743 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.729 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.2 p90 -159.58 175.09 13.65 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 2.3 t-160 -99.41 124.79 44.85 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.916 -1.115 . . . . 0.0 108.742 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.061 HD23 HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -114.7 159.91 19.98 Favored 'General case' 0 C--N 1.299 -1.587 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.709 178.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.923 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.26 90.17 1.64 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.993 -1.067 . . . . 0.0 110.204 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 16' ' ' PHE . 1.8 p -100.13 132.15 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.077 -1.014 . . . . 0.0 109.25 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 m -152.76 171.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.356 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.62 ' OG ' ' HB3' ' A' ' 80' ' ' ALA . 3.1 m -141.18 72.63 1.39 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.169 -0.957 . . . . 0.0 109.654 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 61.82 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.677 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 55.22 58.23 4.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.556 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' NE2' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -147.45 154.24 40.57 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 0.0 109.331 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.79 76.91 1.6 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.393 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.699 ' HB3' HD13 ' A' ' 62' ' ' ILE . 5.7 mmt -79.72 -63.65 1.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 0.0 109.888 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.688 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 18.6 t80 -135.24 121.86 20.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.445 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -152.84 103.17 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 0.0 109.316 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 158.91 -164.21 33.59 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.436 ' C ' HG12 ' A' ' 20' ' ' VAL . 9.1 mt -56.6 155.88 6.92 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.057 -1.261 . . . . 0.0 108.709 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.061 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -168.44 116.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.021 -1.049 . . . . 0.0 109.99 -177.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 2.6 mt-10 -66.5 -47.53 72.71 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 108.761 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 17.6 tttt -172.95 144.44 1.28 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.124 -0.985 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.667 ' CG2' HD22 ' A' ' 6' ' ' LEU . 44.3 pt -98.26 -145.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.658 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.12 127.27 0.36 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.943 -1.098 . . . . 0.0 109.481 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.685 HG23 ' HA2' ' A' ' 33' ' ' GLY . 12.0 t -116.53 133.27 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.221 -0.925 . . . . 0.0 109.181 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 31.0 m -129.09 91.84 3.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.494 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.42 168.22 21.07 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.6 -50.98 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.313 -1.11 . . . . 0.0 109.488 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.28 99.51 7.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -0.953 . . . . 0.0 109.386 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.99 140.95 4.24 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -152.13 26.72 0.61 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.105 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mt -121.77 150.97 41.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.067 -1.021 . . . . 0.0 109.485 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.685 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.54 -114.92 3.63 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.729 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 17.9 mm -149.58 152.64 11.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 121.098 -1.237 . . . . 0.0 109.327 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.57 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -151.58 171.82 6.11 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.4 Cg_endo -73.23 78.24 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.028 1.819 . . . . 0.0 110.2 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.32 36.1 0.15 Allowed Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.598 ' CE1' HD12 ' A' ' 41' ' ' LEU . 11.4 t-160 -87.11 28.99 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -1.224 . . . . 0.0 109.831 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 71' ' ' VAL . . . 58.99 158.32 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.065 -1.022 . . . . 0.0 109.554 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.8 78.7 3.6 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.777 2.318 . . . . 0.0 110.682 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.598 HD12 ' CE1' ' A' ' 38' ' ' HIS . 25.3 mt -100.35 173.43 6.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -171.16 57.2 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.316 -0.865 . . . . 0.0 109.416 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.405 ' O ' HD23 ' A' ' 69' ' ' LEU . 71.4 p -114.62 -136.9 0.37 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.25 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -104.39 164.21 11.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.928 -1.107 . . . . 0.0 109.324 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.603 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.0 mt -109.1 9.84 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.123 -0.986 . . . . 0.0 109.791 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.49 ' O ' ' O ' ' A' ' 45' ' ' ILE . 0.0 OUTLIER 55.54 158.33 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.672 . . . . 0.0 110.176 179.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.69 -175.66 2.84 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.733 2.289 . . . . 0.0 110.287 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 116.06 -161.05 13.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.472 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 15.9 ptm -102.91 179.57 4.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -1.11 . . . . 0.0 109.248 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.866 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.4 OUTLIER -150.85 138.87 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.032 -1.043 . . . . 0.0 110.646 -179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HG2' ' N ' ' A' ' 52' ' ' ILE . 66.3 ttt180 -119.67 161.32 20.89 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.592 HG22 ' N ' ' A' ' 53' ' ' VAL . 36.1 mt -157.23 167.84 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.72 -1.238 . . . . 0.0 110.876 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.592 ' N ' HG22 ' A' ' 52' ' ' ILE . 24.5 t -142.64 107.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB3' ' HA3' ' A' ' 57' ' ' GLY . 15.6 tttm -68.67 149.89 48.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.486 -0.759 . . . . 0.0 110.326 -178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.405 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 2.2 tt0 -54.27 -52.58 60.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.56 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.43 8.69 33.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.246 -0.909 . . . . 0.0 109.792 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 54' ' ' LYS . . . -108.38 178.01 21.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -84.82 -77.05 0.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -1.16 . . . . 0.0 109.586 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' HIS . 17.0 pt-20 -179.59 139.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 109.84 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -138.21 156.8 47.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.068 ' CE2' HD11 ' A' ' 133' ' ' LEU . 6.1 p90 -128.65 125.89 39.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.075 -1.016 . . . . 0.0 109.976 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.883 HG23 ' HG3' ' A' ' 85' ' ' ARG . 1.0 OUTLIER -100.46 -146.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.228 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.788 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -175.51 132.4 0.28 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.034 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HG ' ' C ' ' A' ' 63' ' ' TYR . 1.1 mt -139.07 -171.82 3.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -139.79 -64.78 0.48 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -135.79 136.54 8.52 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.34 165.62 33.33 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 79' ' ' LEU . 1.1 pp -101.65 -176.24 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -1.197 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.568 ' HB2' HG12 ' A' ' 78' ' ' VAL . 0.9 OUTLIER -148.62 169.38 20.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.102 -0.999 . . . . 0.0 110.364 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.72 111.65 1.18 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 6.2 p -99.53 144.6 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 110.441 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.554 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -117.48 178.34 1.04 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 36.3 Cg_endo -79.05 81.55 2.77 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.501 2.134 . . . . 0.0 110.922 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.15 -21.72 5.46 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 4.3 p30 -159.39 135.71 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.094 -1.239 . . . . 0.0 109.864 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 77' ' ' THR . 9.6 p -99.18 168.6 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.189 -0.945 . . . . 0.0 109.271 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 76' ' ' VAL . 99.3 m -164.12 137.67 5.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.257 -0.902 . . . . 0.0 109.063 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.568 HG12 ' HB2' ' A' ' 69' ' ' LEU . 4.6 m -140.83 165.32 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.57 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.51 ' HB2' HD11 ' A' ' 68' ' ' ILE . 1.5 mt -131.6 149.49 52.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.866 . . . . 0.0 109.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB3' ' OG ' ' A' ' 10' ' ' SER . . . -148.25 176.68 10.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 109.52 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -96.94 -56.58 2.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.371 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.5 m -105.08 123.13 47.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.136 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.508 ' O ' ' HE2' ' A' ' 15' ' ' MET . . . -134.04 93.95 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.698 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.788 HD12 ' CE1' ' A' ' 63' ' ' TYR . 13.7 mt -101.61 150.7 5.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.213 -0.93 . . . . 0.0 109.461 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.883 ' HG3' HG23 ' A' ' 62' ' ' ILE . 8.3 ttm180 -119.74 155.85 31.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.208 -0.932 . . . . 0.0 109.479 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.523 ' O ' ' CB ' ' A' ' 87' ' ' GLN . . . -44.45 93.51 0.01 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 2.4 mt-30 162.32 -72.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.36 -1.083 . . . . 0.0 109.485 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 90' ' ' ASP . 1.3 p30 40.71 50.63 2.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.528 -0.733 . . . . 0.0 109.726 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 88' ' ' ASP . 86.0 mt 43.17 -93.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 88' ' ' ASP . 8.0 p-10 -49.48 159.64 0.32 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -0.946 . . . . 0.0 109.329 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HA ' HD11 ' A' ' 131' ' ' ILE . 27.6 mt-10 -141.26 -56.68 0.49 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -0.906 . . . . 0.0 109.739 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.65 -14.34 54.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.561 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.7 ttt-85 -76.58 -10.56 59.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.471 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.01 -21.71 23.35 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.961 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.4 ' HG2' ' CD2' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -66.39 -27.67 68.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.44 -0.787 . . . . 0.0 109.376 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.72 -15.2 61.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.464 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . . . -68.04 -45.66 73.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.886 . . . . 0.0 109.406 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -61.2 -17.03 51.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.36 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 65.1 mtt85 -89.9 -40.17 12.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -0.916 . . . . 0.0 109.306 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -75.73 -12.25 60.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.942 . . . . 0.0 109.292 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.89 -15.36 39.23 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.284 -0.885 . . . . 0.0 109.132 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -46.67 67.76 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.365 -0.834 . . . . 0.0 109.407 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -49.51 -23.26 1.51 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' A' ' 114' ' ' TYR . 54.1 m80 -86.7 -36.89 18.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.194 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 105' ' ' ILE . 17.5 mt -79.04 -6.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 p -101.06 -16.54 17.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.523 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.36 130.73 37.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.711 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.09 131.47 51.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.481 -0.762 . . . . 0.0 109.325 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 21.76 1.31 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.967 . . . . 0.0 109.779 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.98 -176.63 33.39 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.968 ' OD1' HG13 ' A' ' 112' ' ' VAL . 1.3 p30 -81.12 -29.37 34.84 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.256 -1.144 . . . . 0.0 109.419 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.968 HG13 ' OD1' ' A' ' 111' ' ' ASP . 4.3 m -119.37 22.89 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.505 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.81 -99.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.392 -0.817 . . . . 0.0 109.265 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.485 ' HB2' ' HA ' ' A' ' 105' ' ' ILE . 17.6 p90 -65.3 -18.9 65.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.021 -1.049 . . . . 0.0 108.214 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -58.89 -39.08 80.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -77.15 -17.5 58.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.409 -0.807 . . . . 0.0 109.341 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -79.27 -17.85 53.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.3 -0.875 . . . . 0.0 109.568 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 34.2 t -62.01 -28.81 69.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.723 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 123' ' ' LYS . . . -75.87 -27.89 57.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 109.721 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 123' ' ' LYS . 0.9 OUTLIER -85.52 -8.22 58.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.923 . . . . 0.0 109.494 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -90.41 -57.93 2.67 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.989 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -22.29 65.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -87.07 -19.53 28.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.143 -0.973 . . . . 0.0 109.749 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -80.85 -34.61 33.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.185 -0.947 . . . . 0.0 109.478 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 125' ' ' ILE . 2.8 mp -75.89 -6.09 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.378 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.78 -33.46 76.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.659 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.595 ' HG2' ' CG ' ' A' ' 63' ' ' TYR . 5.1 tm0? -81.39 -14.29 57.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.221 -0.925 . . . . 0.0 109.579 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.535 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 34.6 tp -78.73 -25.02 44.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.0 109.69 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.21 -45.71 46.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.939 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.652 ' HA ' HD23 ' A' ' 133' ' ' LEU . 35.7 m -70.41 -32.11 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.885 ' O ' HG22 ' A' ' 134' ' ' THR . 2.2 tt -78.24 -25.42 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.094 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 128' ' ' LEU . 1.4 mm-40 -74.66 -22.13 59.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.104 -0.997 . . . . 0.0 110.243 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 1.068 HD11 ' CE2' ' A' ' 61' ' ' PHE . 1.4 pp -90.54 0.45 57.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.995 -1.066 . . . . 0.0 109.787 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.885 HG22 ' O ' ' A' ' 131' ' ' ILE . 7.5 t -89.07 4.6 47.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 0.0 109.665 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HD2' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -71.46 -30.08 65.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.945 . . . . 0.0 109.597 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 11.56 23.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.16 -47.27 24.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.452 -179.874 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 36' ' ' PRO . 2.1 ttp -159.81 144.29 14.88 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.601 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.548 HG22 ' CG ' ' A' ' 21' ' ' GLU . 65.9 p -50.94 164.74 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.395 -0.815 . . . . 0.0 109.604 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.674 ' CE2' HG22 ' A' ' 34' ' ' ILE . 1.3 p90 -142.22 -144.86 0.16 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.714 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.743 ' O ' HG12 ' A' ' 76' ' ' VAL . 12.7 t-80 -129.62 126.71 39.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.79 -1.194 . . . . 0.0 111.221 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.025 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -99.75 130.9 46.01 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -139.49 75.94 1.54 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 109.746 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.611 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.4 p -104.01 111.61 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.23 -0.919 . . . . 0.0 109.521 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.668 HG12 ' HA ' ' A' ' 14' ' ' GLN . 2.7 m -116.57 -178.4 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.493 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -158.01 111.95 2.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.762 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.71 -89.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.735 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -134.71 62.23 1.65 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.588 -179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.66 142.64 12.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.478 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.668 ' HA ' HG12 ' A' ' 9' ' ' VAL . 6.1 pt20 -106.55 107.68 18.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.552 ' HE2' ' HG2' ' A' ' 85' ' ' ARG . 6.6 mtt -79.66 -60.68 2.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.547 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.641 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -130.84 111.07 11.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.923 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' A' ' 17' ' ' SER . 22.5 p -136.97 92.19 2.7 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.228 -0.92 . . . . 0.0 109.345 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.69 -161.27 32.63 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 19' ' ' LEU . 36.2 mt -76.82 159.13 30.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.035 -1.274 . . . . 0.0 109.799 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.811 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.15 162.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.384 -0.823 . . . . 0.0 109.227 -179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.548 ' CG ' HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -122.29 -37.52 2.8 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.9 ttpp -160.77 110.68 1.73 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.133 -0.98 . . . . 0.0 110.661 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.025 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -104.2 152.11 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.8 ' O ' HG23 ' A' ' 50' ' ' ILE . 1.9 tt0 -134.45 145.32 48.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.075 . . . . 0.0 109.964 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.875 HG23 ' HA2' ' A' ' 33' ' ' GLY . 3.1 t -131.95 125.46 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.434 -0.791 . . . . 0.0 108.96 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.439 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 88.8 m -116.06 97.86 6.31 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.353 -0.842 . . . . 0.0 109.395 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -103.24 -100.02 2.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 m -128.83 -81.0 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.53 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.78 166.29 3.7 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -156.54 32.47 0.32 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.242 -1.152 . . . . 0.0 109.597 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mt -102.7 150.08 23.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.529 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.875 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.45 -112.42 3.33 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.691 HG21 HG11 ' A' ' 76' ' ' VAL . 19.5 mm -154.32 147.56 13.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.26 -1.141 . . . . 0.0 109.537 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -157.13 -172.77 0.34 Allowed Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 36.3 Cg_endo -81.11 31.15 0.51 Allowed 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.0 1.8 . . . . 0.0 110.71 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.07 26.48 0.2 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.72 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 57.1 t60 -70.12 -4.85 23.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -1.084 . . . . 0.0 109.718 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.765 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 77.05 168.24 0.12 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.765 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.1 Cg_endo -78.1 74.19 5.41 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.626 2.218 . . . . 0.0 110.524 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -95.52 142.65 27.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.307 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.432 ' HG ' ' C ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -139.84 32.54 2.0 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -0.887 . . . . 0.0 109.586 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.608 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.3 t -100.67 -156.69 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.178 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.608 ' N ' HG23 ' A' ' 43' ' ' THR . . . -108.01 -177.35 3.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.032 -1.042 . . . . 0.0 109.663 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.851 HD11 ' N ' ' A' ' 69' ' ' LEU . 1.3 mp -126.48 177.78 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.86 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.68 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -108.08 167.13 9.73 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.206 -0.934 . . . . 0.0 109.394 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.504 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 35.4 Cg_endo -78.16 140.75 17.95 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.619 2.213 . . . . 0.0 110.516 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 168.43 -162.79 36.58 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.487 ' O ' HG13 ' A' ' 50' ' ' ILE . 11.1 ptm -100.66 -170.65 1.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -1.161 . . . . 0.0 109.211 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.8 HG23 ' O ' ' A' ' 24' ' ' GLN . 19.1 mt -158.09 140.63 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.12 -0.987 . . . . 0.0 110.296 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -130.49 119.19 22.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.713 HG23 ' CA ' ' A' ' 23' ' ' ILE . 18.8 mt -123.46 170.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.914 -1.116 . . . . 0.0 110.965 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.704 HG22 ' HG3' ' A' ' 59' ' ' GLU . 28.6 t -134.57 101.12 3.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -61.17 119.9 9.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.433 -0.792 . . . . 0.0 109.633 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 54' ' ' LYS . 31.1 mt-30 43.22 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.327 -0.858 . . . . 0.0 109.625 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -152.19 66.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 0.0 109.558 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -148.38 -128.01 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -69.28 -165.74 0.08 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -1.184 . . . . 0.0 109.471 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.704 ' HG3' HG22 ' A' ' 53' ' ' VAL . 51.3 mp0 -129.95 -178.94 4.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.407 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 59.8 mm-40 -129.51 137.29 50.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.165 -0.959 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.593 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.6 OUTLIER -111.69 98.41 7.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 108.834 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 63' ' ' TYR . 4.0 mt -111.04 161.57 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.099 -1.001 . . . . 0.0 109.998 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.698 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.2 t80 -154.26 141.98 19.96 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.514 ' CB ' ' O ' ' A' ' 82' ' ' THR . 0.8 OUTLIER -165.83 -171.09 1.94 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 0.0 109.829 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.47 ' CB ' ' HB3' ' A' ' 47' ' ' PRO . 3.1 t -160.48 139.76 10.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.782 . . . . 0.0 109.27 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 65' ' ' SER . . . 63.08 125.59 0.01 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.98 159.81 11.23 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 15.0 mt -106.65 123.7 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.076 HD22 ' N ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -101.61 127.88 48.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 1.076 ' N ' HD22 ' A' ' 69' ' ' LEU . 4.0 pt-20 -131.08 146.11 52.25 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 39' ' ' ALA . 12.1 p -102.27 163.92 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.052 -1.03 . . . . 0.0 109.928 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.521 ' N ' HG22 ' A' ' 71' ' ' VAL . 2.4 mt-30 -141.32 172.58 5.87 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.311 -0.868 . . . . 0.0 109.338 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.5 79.91 3.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.577 2.185 . . . . 0.0 110.655 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 110.68 -12.55 30.07 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.513 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 4.8 p30 -149.28 172.4 14.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.191 -1.181 . . . . 0.0 109.531 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.743 HG12 ' O ' ' A' ' 5' ' ' HIS . 2.8 p -145.66 151.45 14.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 68.3 p -136.58 172.92 12.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.537 ' HB ' ' HA ' ' A' ' 69' ' ' LEU . 0.9 OUTLIER -178.97 127.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.412 -0.805 . . . . 0.0 109.151 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.8 mp -104.91 134.66 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.285 -0.885 . . . . 0.0 109.265 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.403 ' CB ' HD13 ' A' ' 64' ' ' LEU . . . -129.6 -179.91 5.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.0 109.625 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -119.55 -29.17 5.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.343 -0.848 . . . . 0.0 109.502 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.514 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 51.9 m -103.12 119.97 39.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.297 -0.877 . . . . 0.0 109.624 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.72 98.73 3.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.375 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.698 HD12 ' CE1' ' A' ' 63' ' ' TYR . 96.3 mt -109.71 -27.87 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.193 -0.942 . . . . 0.0 109.56 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.552 ' HG2' ' HE2' ' A' ' 15' ' ' MET . 22.1 mtm180 61.32 126.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 109.312 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.527 ' CA ' HG21 ' A' ' 130' ' ' VAL . . . -44.3 -29.7 1.76 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 88' ' ' ASP . 67.3 mt-30 -71.25 -64.23 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -1.122 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 90' ' ' ASP . 14.0 t0 44.4 41.32 4.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 56.58 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 88' ' ' ASP . 2.1 t70 -115.75 99.87 7.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.133 -0.979 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.768 ' HB3' HG21 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -96.39 0.06 50.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 109.626 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.51 -14.17 62.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.945 . . . . 0.0 109.385 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -82.88 -2.79 55.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.0 109.401 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.39 -23.62 21.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 0.0 108.856 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.653 ' HG2' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -57.1 -29.44 63.51 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.45 -0.781 . . . . 0.0 109.235 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -63.13 -57.87 9.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.38 -0.825 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -54.13 -42.45 69.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.877 ' HG3' HD11 ' A' ' 125' ' ' ILE . 25.2 tttt -55.16 -41.08 71.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.335 -0.853 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -60.68 -51.83 67.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -76.58 -0.36 22.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.701 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -85.64 -30.7 23.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.092 -1.005 . . . . 0.0 109.127 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 4.7 tp10 -80.55 -26.03 38.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.295 -0.878 . . . . 0.0 109.26 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -82.15 -13.61 56.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -86.97 -31.51 20.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.226 -0.921 . . . . 0.0 109.594 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.58 ' O ' HG22 ' A' ' 105' ' ' ILE . 37.3 mt -77.85 -1.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.317 -0.864 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.3 m -105.83 78.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.446 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.29 167.9 2.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 7.3 m 64.85 -152.22 0.28 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 108' ' ' SER . 12.0 t-80 174.34 101.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 109.257 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.94 169.61 40.94 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.85 -59.42 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -1.147 . . . . 0.0 109.471 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.6 m -112.2 16.35 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.925 . . . . 0.0 109.459 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -68.96 -96.41 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.351 -0.843 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.502 ' C ' ' CD1' ' A' ' 114' ' ' TYR . 13.7 p90 -74.14 -15.77 61.02 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 108.53 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.11 -19.83 65.69 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.61 -0.681 . . . . 0.0 109.311 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.62 -14.71 62.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.491 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -89.0 -6.67 57.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.861 . . . . 0.0 109.502 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.26 -16.61 42.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.99 -44.95 21.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.433 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.08 -5.03 55.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 109.629 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.72 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -86.25 -52.28 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.35 94.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.864 . . . . 0.0 109.542 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -61.08 -32.46 72.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.887 . . . . 0.0 109.633 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.24 -8.58 50.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.963 . . . . 0.0 109.735 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.877 HD11 ' HG3' ' A' ' 98' ' ' LYS . 1.3 tp -88.89 5.6 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.01 . . . . 0.0 109.354 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.35 -13.27 55.36 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.804 ' O ' HG23 ' A' ' 131' ' ' ILE . 24.2 pt20 -89.69 -13.39 37.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.653 HD11 ' HG2' ' A' ' 95' ' ' MET . 0.2 OUTLIER -89.63 -29.5 18.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.368 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -73.13 -19.73 61.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.126 -0.984 . . . . 0.0 109.489 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 10.2 m -90.12 -27.53 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.727 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 127' ' ' GLN . 22.1 pt -75.57 -16.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.623 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -86.35 -47.74 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 109.593 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.436 ' O ' ' HB2' ' A' ' 137' ' ' ALA . 0.2 OUTLIER -61.59 -45.17 95.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.581 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.568 HG23 ' CD2' ' A' ' 61' ' ' PHE . 12.3 p -49.17 -26.54 2.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.534 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -57.81 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.609 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -110.07 50.42 0.8 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 133' ' ' LEU . . . -123.23 -48.66 1.96 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.927 . . . . 0.0 109.371 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.393 179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.473 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -132.29 94.2 3.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.465 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 t -174.01 156.16 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.913 . . . . 0.0 109.775 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.628 ' HE1' HD11 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -143.55 -142.28 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.473 -0.767 . . . . 0.0 109.205 179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.815 ' O ' HG12 ' A' ' 76' ' ' VAL . 17.5 t-80 -134.73 131.23 37.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.852 -1.155 . . . . 0.0 110.993 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.906 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -99.11 131.84 44.85 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 121.171 -0.956 . . . . 0.0 108.714 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.956 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.3 OUTLIER -142.42 75.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.85 -1.156 . . . . 0.0 109.68 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.854 HG13 ' HB2' ' A' ' 15' ' ' MET . 1.4 p -105.11 117.14 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.395 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.34 164.24 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -128.8 -159.68 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.221 -0.925 . . . . 0.0 109.363 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.93 -74.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -0.92 . . . . 0.0 109.388 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -136.95 53.69 1.89 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 0.0 109.329 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.77 109.92 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.157 -0.964 . . . . 0.0 109.674 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -65.2 154.64 37.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 0.0 109.302 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.854 ' HB2' HG13 ' A' ' 8' ' ' VAL . 3.8 mmt -118.84 -58.64 1.94 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.753 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.646 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.56 111.2 5.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.168 -0.957 . . . . 0.0 109.677 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 95.0 p -131.93 78.02 1.79 Allowed 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.243 -0.911 . . . . 0.0 109.392 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 20' ' ' VAL . . . -174.7 167.08 39.18 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.588 ' C ' HG12 ' A' ' 20' ' ' VAL . 54.4 mt -50.73 166.67 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.205 -1.174 . . . . 0.0 109.278 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.906 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -167.09 169.82 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.606 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -144.94 -63.63 0.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.384 -0.823 . . . . 0.0 109.517 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -90.43 103.45 16.13 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.191 -0.943 . . . . 0.0 108.657 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.881 ' HA ' HG23 ' A' ' 52' ' ' ILE . 3.1 mp -115.48 156.46 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.0 109.142 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.529 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -151.76 131.38 13.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.117 . . . . 0.0 109.741 -179.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.552 HG13 ' HB ' ' A' ' 50' ' ' ILE . 1.1 t -145.57 127.15 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.332 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.8 m -148.34 127.73 13.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.18 -0.95 . . . . 0.0 109.456 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -137.49 -92.46 0.29 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 t -138.3 -40.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.0 109.445 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.05 -91.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.87 -172.5 5.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' HD12 ' A' ' 32' ' ' LEU . 2.2 mt-10 -164.58 41.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.134 -1.215 . . . . 0.0 109.777 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -136.95 165.2 26.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.138 -0.976 . . . . 0.0 109.879 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.84 174.39 26.62 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.584 ' CG2' ' OH ' ' A' ' 4' ' ' TYR . 27.0 mm -99.21 160.96 3.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.636 -1.508 . . . . 0.0 109.515 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.648 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.9 OUTLIER -162.59 171.21 6.72 Favored Pre-proline 0 C--N 1.297 -1.71 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -178.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.4 Cg_endo -70.13 83.96 0.74 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 121.37 1.38 . . . . 0.0 109.618 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.34 14.36 0.83 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.991 ' NE2' HD23 ' A' ' 41' ' ' LEU . 43.1 t60 -53.88 157.85 2.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.84 -1.388 . . . . 0.0 109.335 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.875 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -58.46 173.87 0.39 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.332 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.875 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.83 63.6 8.76 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.614 2.209 . . . . 0.0 110.602 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.991 HD23 ' NE2' ' A' ' 38' ' ' HIS . 0.6 OUTLIER -59.42 160.61 6.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.013 -1.055 . . . . 0.0 108.882 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.524 ' O ' ' CA ' ' A' ' 70' ' ' GLU . 85.5 mt -115.97 -92.08 0.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.983 . . . . 0.0 110.649 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.633 ' O ' HG22 ' A' ' 68' ' ' ILE . 7.1 p -122.66 27.2 7.91 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 121.596 -0.69 . . . . 0.0 110.242 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 69' ' ' LEU . . . -113.64 119.35 37.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.868 -1.145 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 67' ' ' GLY . 5.2 tt -112.4 176.49 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.417 -0.802 . . . . 0.0 109.174 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -120.4 130.98 24.59 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.973 -1.08 . . . . 0.0 109.597 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.457 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 36.4 Cg_endo -79.34 -164.51 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.547 2.165 . . . . 0.0 110.384 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 90.32 -133.77 11.98 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.546 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 5.1 ppp? -114.57 174.8 5.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.355 -1.085 . . . . 0.0 109.41 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.957 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.4 OUTLIER -149.99 116.91 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.368 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.2 OUTLIER -104.94 123.61 48.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.815 . . . . 0.0 108.959 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 23' ' ' ILE . 2.6 mt -129.98 -176.41 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.001 -1.062 . . . . 0.0 109.916 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.652 ' H ' HG22 ' A' ' 52' ' ' ILE . 6.8 t -158.14 109.88 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -57.57 114.01 2.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.578 -0.701 . . . . 0.0 110.398 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.499 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 40.59 61.93 1.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.466 -0.771 . . . . 0.0 110.151 179.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.44 ' HA ' ' CG1' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 43.08 44.8 4.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.779 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.57 -122.29 2.28 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -52.05 146.98 7.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.306 -1.114 . . . . 0.0 109.69 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -106.61 123.04 47.52 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.264 -0.898 . . . . 0.0 109.099 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -128.04 121.16 29.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.339 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.595 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.0 p90 -113.28 147.83 36.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.222 -0.923 . . . . 0.0 109.908 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.957 ' H ' HG23 ' A' ' 50' ' ' ILE . 1.7 mt -120.07 -158.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.424 -0.797 . . . . 0.0 109.139 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.661 ' CE1' HD12 ' A' ' 84' ' ' ILE . 7.6 t80 -172.44 133.32 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.296 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.458 HD22 ' HB2' ' A' ' 80' ' ' ALA . 2.1 mp -140.43 -174.54 3.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -0.951 . . . . 0.0 109.669 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -128.12 5.16 5.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.263 -0.898 . . . . 0.0 109.659 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.49 160.04 8.32 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.862 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 162.16 -175.5 38.64 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 43' ' ' THR . 1.4 pt -103.16 137.8 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -1.12 . . . . 0.0 109.258 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.798 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.891 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' CA ' ' O ' ' A' ' 42' ' ' LEU . 15.2 pt-20 -126.59 139.41 53.21 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 40' ' ' PRO . 9.2 p -100.51 142.1 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.07 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.472 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.4 mm100 -124.74 158.75 61.27 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.501 -0.749 . . . . 0.0 109.097 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -76.95 86.47 1.61 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.603 2.202 . . . . 0.0 110.477 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 121.64 2.28 10.61 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.541 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 175.7 175.68 0.25 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.197 -1.178 . . . . 0.0 109.213 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.815 HG12 ' O ' ' A' ' 5' ' ' HIS . 2.3 p -150.63 148.44 15.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.167 -0.958 . . . . 0.0 109.132 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.956 HG22 ' HB3' ' A' ' 7' ' ' ASP . 7.5 p -140.86 142.86 34.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.235 -0.916 . . . . 0.0 109.573 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.763 ' HB ' HD12 ' A' ' 45' ' ' ILE . 3.0 m -148.36 138.28 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.183 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.634 ' C ' HD23 ' A' ' 79' ' ' LEU . 1.2 tt -114.49 135.74 53.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.633 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.458 ' HB2' HD22 ' A' ' 64' ' ' LEU . . . -122.2 179.42 4.55 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.121 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -115.39 -11.28 11.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.966 . . . . 0.0 109.508 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.482 HG22 ' N ' ' A' ' 83' ' ' ALA . 9.3 m -127.53 161.4 28.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.482 ' N ' HG22 ' A' ' 82' ' ' THR . . . -167.57 122.32 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.161 -0.962 . . . . 0.0 109.731 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 63' ' ' TYR . 48.3 mt -117.37 -45.22 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.288 -0.882 . . . . 0.0 109.267 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.485 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 3.0 ttt180 74.6 147.33 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.436 -0.79 . . . . 0.0 109.646 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.674 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -58.12 -21.87 47.67 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 88' ' ' ASP . 57.8 mt-30 -81.45 -63.67 1.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.33 -1.1 . . . . 0.0 109.39 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.469 ' HB3' ' CG2' ' A' ' 84' ' ' ILE . 2.8 p30 40.35 30.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.62 -0.675 . . . . 0.0 109.867 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 88' ' ' ASP . 1.2 mp 50.48 -179.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.0 109.431 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' O ' ' CG ' ' A' ' 91' ' ' GLU . 4.9 m-20 43.96 -159.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.506 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.901 ' HA ' HD11 ' A' ' 131' ' ' ILE . 1.3 mt-10 172.97 -30.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.262 -0.899 . . . . 0.0 109.488 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.71 -17.4 48.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.85 . . . . 0.0 109.561 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 4.5 29.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.186 -0.946 . . . . 0.0 109.673 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' O ' ' CD1' ' A' ' 128' ' ' LEU . . . -90.84 -30.35 17.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.423 ' HA ' HD11 ' A' ' 128' ' ' LEU . 4.8 mtt -73.32 -5.06 37.22 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.361 -0.837 . . . . 0.0 109.596 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.06 1.61 56.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.636 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -89.34 -42.51 11.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.134 -0.979 . . . . 0.0 109.653 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -19.55 63.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.266 -0.896 . . . . 0.0 109.656 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -89.89 -26.99 20.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.615 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 9.1 pttt -89.3 -11.3 43.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.621 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 105' ' ' ILE . . . -90.47 -58.49 2.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 0.0 109.613 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.06 -31.53 63.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.715 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -52.83 -38.34 61.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.914 . . . . 0.0 109.889 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -88.38 -26.33 22.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.603 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.474 HD11 HD12 ' A' ' 121' ' ' LEU . 12.0 mt -88.24 22.31 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.224 -0.922 . . . . 0.0 109.693 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.2 m -54.99 91.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER 67.37 118.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.0 t -137.74 118.98 14.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 109' ' ' HIS . 52.2 t-80 -113.28 56.38 0.69 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.375 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 115' ' ' ALA . . . -138.48 125.7 3.25 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.513 ' O ' ' CB ' ' A' ' 115' ' ' ALA . 68.8 m-20 -44.88 -80.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.158 -1.201 . . . . 0.0 109.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.629 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 20.6 m -117.53 -10.0 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.414 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.5 OUTLIER -48.02 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.335 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -70.94 -14.88 62.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.043 -1.036 . . . . 0.0 108.26 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -66.26 -23.36 66.39 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.569 -0.707 . . . . 0.0 109.264 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.42 -54.17 13.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.917 . . . . 0.0 109.327 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.9 -20.21 61.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.282 -0.886 . . . . 0.0 109.19 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.01 -44.24 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.64 -27.16 68.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.381 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -62.54 -20.7 64.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 125' ' ' ILE . 7.6 mt -90.0 -24.0 21.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.307 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 125' ' ' ILE . . . -59.75 -16.77 30.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.586 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -43.3 96.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.196 -0.94 . . . . 0.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -70.66 -5.97 33.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -85.79 -13.16 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.149 -0.97 . . . . 0.0 109.289 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -87.36 -24.56 24.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.293 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.478 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -83.55 -15.48 49.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.414 -0.804 . . . . 0.0 109.489 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.423 ' CD1' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -80.19 -22.74 41.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.345 -0.847 . . . . 0.0 109.601 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.458 ' O ' ' HG ' ' A' ' 133' ' ' LEU . 1.9 ttp180 -85.24 -35.31 21.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.785 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.674 HG23 ' HA2' ' A' ' 86' ' ' GLY . 18.3 m -76.34 -28.58 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.673 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.901 HD11 ' HA ' ' A' ' 91' ' ' GLU . 7.1 tt -76.9 -38.45 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.118 -0.989 . . . . 0.0 109.267 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.466 ' N ' HG23 ' A' ' 131' ' ' ILE . 7.4 mm-40 -56.96 -23.86 48.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.07 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 41.4 mt -76.4 -37.63 56.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.25 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 72.0 p -59.29 -16.75 23.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.459 -0.775 . . . . 0.0 109.65 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -76.18 -44.08 39.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.119 -0.988 . . . . 0.0 109.611 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.05 -14.12 59.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 0.0 109.538 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -86.36 -80.92 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.491 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.1 mmt -84.98 167.6 15.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 4' ' ' TYR . 0.1 OUTLIER -133.88 174.58 10.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.707 -179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.723 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.1 p90 -148.39 -136.03 0.08 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.4 OUTLIER -151.05 138.37 19.4 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.817 -1.177 . . . . 0.0 110.423 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.853 HD21 HD12 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -102.18 148.06 25.88 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.85 ' HB3' HG22 ' A' ' 77' ' ' THR . 1.1 t0 -144.92 72.02 1.32 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.017 -1.052 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 15' ' ' MET . 2.9 p -106.81 138.31 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.352 -0.842 . . . . 0.0 109.278 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.568 ' CG2' HD23 ' A' ' 79' ' ' LEU . 32.8 m -145.88 173.26 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.146 -0.971 . . . . 0.0 109.687 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.539 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 45.9 t -170.25 113.76 0.47 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.246 -0.909 . . . . 0.0 109.056 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 65.96 26.48 10.94 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.075 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.1 mm-40 63.46 24.09 13.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.368 -0.832 . . . . 0.0 109.517 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.424 ' OE1' ' SD ' ' A' ' 15' ' ' MET . 12.4 tt0 -78.07 -22.49 48.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.144 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 6.3 mt-30 63.46 100.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.694 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.759 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 16.7 mmm -101.02 -64.3 1.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.685 ' HD2' HD23 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -135.67 111.66 9.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.623 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 17' ' ' SER . 27.6 p -135.32 77.69 1.69 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.47 179.98 48.51 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 5' ' ' HIS . 12.0 mt -60.26 161.91 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -1.193 . . . . 0.0 109.492 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.791 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -157.75 159.3 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.405 -0.81 . . . . 0.0 108.829 -179.225 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.475 ' O ' ' HD2' ' A' ' 22' ' ' LYS . 0.8 OUTLIER -116.1 -52.75 2.59 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.2 -0.937 . . . . 0.0 110.138 -179.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -141.02 108.12 5.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.769 -1.207 . . . . 0.0 111.28 -179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.853 HD12 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -103.13 155.91 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 2.0 tm0? -146.76 115.61 6.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.416 -1.427 . . . . 0.0 110.724 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.994 HG21 ' HG2' ' A' ' 46' ' ' LYS . 3.3 t -103.92 133.62 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 109.233 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 54.7 m -125.01 102.72 7.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.0 109.549 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -123.07 -110.06 1.98 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.4 t -132.37 -77.73 0.5 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -1.16 . . . . 0.0 109.63 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.81 -24.75 67.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.762 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -112.74 151.37 18.22 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -142.81 11.72 1.84 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -1.076 . . . . 0.0 109.315 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.4 mt -116.64 156.45 27.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.562 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -100.03 -114.59 3.65 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.723 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 15.9 mm -154.98 143.96 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.417 -1.049 . . . . 0.0 109.245 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.612 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -154.35 -172.13 0.31 Allowed Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -78.94 8.86 3.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 121.805 1.67 . . . . 0.0 110.423 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -137.91 11.42 3.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.474 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 84.6 t60 -53.26 156.22 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.629 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.921 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -70.08 173.22 4.55 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.668 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.921 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -77.75 76.05 4.48 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.758 2.305 . . . . 0.0 110.386 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -100.3 140.29 34.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.607 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 0.1 OUTLIER -155.51 29.05 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.335 -0.853 . . . . 0.0 109.563 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.3 p -121.76 -139.54 0.32 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.219 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.659 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.79 119.97 38.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.088 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.659 HG23 ' O ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -160.74 -166.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -0.918 . . . . 0.0 109.757 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.994 ' HG2' HG21 ' A' ' 25' ' ' VAL . 13.3 mttt 71.5 46.41 0.24 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.376 -0.828 . . . . 0.0 110.929 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.697 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.8 Cg_endo -80.32 152.67 20.88 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 110.546 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 94.01 -152.71 20.84 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.927 -1.13 . . . . 0.0 110.696 178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.548 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 7.2 ptm -99.56 -171.67 2.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.459 -1.024 . . . . 0.0 109.503 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.805 HG12 HG22 ' A' ' 25' ' ' VAL . 40.9 mt -150.0 156.18 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.107 -0.996 . . . . 0.0 110.281 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.455 ' NH1' ' HG2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -149.17 116.78 6.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.718 HG23 ' CA ' ' A' ' 23' ' ' ILE . 4.6 mt -121.26 162.8 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.046 -1.034 . . . . 0.0 110.476 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 74.9 t -133.38 118.95 33.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.66 -0.65 . . . . 0.0 109.463 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 154.71 -98.74 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.544 ' O ' ' CB ' ' A' ' 56' ' ' HIS . 1.9 tt0 37.75 47.44 0.84 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.373 -0.829 . . . . 0.0 110.047 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.544 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.6 t-160 81.8 -68.89 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.606 -0.684 . . . . 0.0 109.494 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -161.54 77.94 0.17 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.458 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 168.19 -160.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -1.149 . . . . 0.0 109.489 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.19 158.42 43.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.288 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -147.23 115.96 6.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 0.0 109.683 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.698 ' CD2' HD22 ' A' ' 133' ' ' LEU . 14.1 p90 -103.24 140.55 37.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.58 -156.21 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.189 -0.945 . . . . 0.0 109.566 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.563 ' CE1' ' HB3' ' A' ' 126' ' ' ALA . 8.9 t80 -177.46 111.42 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.195 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mp -134.85 -179.91 5.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.385 -0.822 . . . . 0.0 109.336 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.98 -71.56 0.71 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.252 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.82 62.83 0.63 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -85.37 -179.62 50.63 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 78' ' ' VAL . 10.0 mm -101.45 118.37 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.946 HD13 ' HB ' ' A' ' 78' ' ' VAL . 4.1 mm? -99.47 157.69 16.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.26 -0.9 . . . . 0.0 109.754 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -155.36 133.01 11.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.51 -0.744 . . . . 0.0 108.993 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.529 HG11 ' HA ' ' A' ' 40' ' ' PRO . 12.7 p -99.69 136.26 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.108 -0.995 . . . . 0.0 109.655 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.494 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -119.03 173.59 3.34 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.38 -0.825 . . . . 0.0 109.456 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.2 Cg_endo -78.23 73.3 5.86 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.621 2.214 . . . . 0.0 110.515 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.6 3.67 32.5 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -151.67 -175.3 5.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 75' ' ' ASN . 4.5 t -158.64 146.78 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.263 -0.898 . . . . 0.0 109.034 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.85 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -138.22 157.5 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 0.0 109.572 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.946 ' HB ' HD13 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -168.46 135.85 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.568 HD23 ' CG2' ' A' ' 9' ' ' VAL . 1.2 mt -125.83 109.02 12.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.75 179.34 4.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.623 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -105.17 -42.76 5.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 84' ' ' ILE . 14.8 m -109.42 100.4 9.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.759 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -122.38 94.33 4.26 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.189 -0.945 . . . . 0.0 109.379 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.959 HG23 ' OD1' ' A' ' 88' ' ' ASP . 3.3 mp -100.1 84.54 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.219 -0.925 . . . . 0.0 109.421 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.518 ' N ' ' OD2' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -66.36 133.7 51.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.676 -179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 50.62 -121.58 11.0 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.406 ' CD ' ' OE1' ' A' ' 91' ' ' GLU . 11.6 pt20 -124.32 53.66 1.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -1.106 . . . . 0.0 109.565 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.959 ' OD1' HG23 ' A' ' 84' ' ' ILE . 1.6 p30 -63.09 -13.37 35.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.367 -0.833 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 89' ' ' LEU . 14.4 mt -114.57 -90.89 0.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 1.4 m-20 -117.1 -179.9 3.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.592 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.606 ' HB2' HD11 ' A' ' 131' ' ' ILE . 4.9 pt-20 -145.77 -43.54 0.21 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.318 -0.863 . . . . 0.0 109.215 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.27 -18.46 39.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -0.828 . . . . 0.0 109.462 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.3 3.62 51.5 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -13.43 34.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.196 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.446 ' HG2' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -85.34 -18.04 34.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.374 -0.829 . . . . 0.0 109.364 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.8 -14.95 57.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.323 -0.861 . . . . 0.0 109.42 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.495 ' O ' HD11 ' A' ' 125' ' ' ILE . . . -81.51 -5.71 58.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 109.598 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.411 ' HG2' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -89.85 -24.23 21.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.707 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -89.21 -21.44 23.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 109.401 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.32 -31.93 29.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 109.576 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.796 ' HB2' HD22 ' A' ' 121' ' ' LEU . . . -90.36 -39.66 12.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.3 -0.875 . . . . 0.0 109.325 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.0 -11.64 59.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.331 -0.856 . . . . 0.0 109.535 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 99' ' ' ARG . 15.5 tt0 -90.28 -37.41 14.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.6 -30.63 46.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.628 HD13 ' OG ' ' A' ' 118' ' ' SER . 31.3 mt -89.18 4.3 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.649 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 107' ' ' SER . 1.3 t -45.65 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -0.862 . . . . 0.0 109.437 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER 77.25 121.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.429 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.1 141.29 18.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.173 -0.954 . . . . 0.0 109.434 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -111.28 -173.4 2.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 84.49 117.6 0.75 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -48.97 -69.91 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 109.369 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 19.9 m -121.03 12.17 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -0.868 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 18.4 t0 -66.22 -96.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.31 -0.868 . . . . 0.0 109.211 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' A' ' 114' ' ' TYR . 32.1 t80 -75.72 -5.5 45.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.052 -1.03 . . . . 0.0 108.704 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.54 -7.91 59.65 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.47 -0.769 . . . . 0.0 109.442 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -78.31 -29.43 47.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.9 . . . . 0.0 109.603 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 120' ' ' GLU . . . -78.24 -6.39 54.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.096 -1.002 . . . . 0.0 109.487 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.628 ' OG ' HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -79.76 -8.8 59.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.288 -0.883 . . . . 0.0 109.577 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.73 -34.87 17.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 0.0 109.581 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 123' ' ' LYS . 8.7 pt-20 -75.3 -27.42 59.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.214 -0.929 . . . . 0.0 109.531 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.796 HD22 ' HB2' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -79.29 -41.86 27.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.433 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.499 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -76.74 -11.67 59.87 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 109.246 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -56.56 -32.7 65.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.45 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.95 -26.99 54.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.656 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.0 mp -81.84 2.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.243 -0.91 . . . . 0.0 109.479 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.563 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . . . -74.58 -26.68 60.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.216 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.489 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.6 mt-30 -74.56 -5.11 40.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 128' ' ' LEU . 6.7 tt -79.78 -19.19 49.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.531 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -90.06 -49.5 6.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.577 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.625 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 5.0 m -66.85 -38.64 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.166 -0.959 . . . . 0.0 109.588 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 91' ' ' GLU . 2.6 tt -54.97 -39.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 109.539 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.48 ' N ' HG23 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -43.59 -38.3 2.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' A' ' 61' ' ' PHE . 9.0 mp -62.75 -51.55 66.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.148 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 134' ' ' THR . 18.9 p -50.84 -31.59 17.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.613 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 19.5 mttt -62.3 -42.9 99.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.0 109.54 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 20.6 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.455 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -77.18 -55.14 5.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 109.36 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.434 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.498 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER 66.72 167.46 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.426 -179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.804 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.6 OUTLIER 53.94 117.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.75 0.786 . . . . 0.0 110.47 179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.695 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.3 p90 -130.69 -153.41 0.56 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.186 -0.946 . . . . 0.0 108.641 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 21.6 t-80 -129.53 144.56 51.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.943 -1.098 . . . . 0.0 109.852 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.086 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -138.21 164.19 29.82 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.225 -0.922 . . . . 0.0 108.958 179.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.066 ' N ' HD12 ' A' ' 6' ' ' LEU . 8.3 t0 -160.02 94.69 1.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.98 -1.075 . . . . 0.0 109.964 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.519 HG13 ' CD1' ' A' ' 6' ' ' LEU . 5.0 m -104.34 147.3 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.305 -0.872 . . . . 0.0 108.958 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 10' ' ' SER . 1.7 t -154.74 177.98 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.627 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 1.2 p -138.62 -160.89 1.11 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.557 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.27 -51.27 8.46 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.53 66.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.708 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -147.01 139.38 24.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 109.386 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -78.18 132.07 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.242 -0.912 . . . . 0.0 109.49 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.854 ' SD ' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -127.45 -72.88 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.642 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 47.9 t80 -151.41 112.83 4.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 109.26 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.404 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 56.9 p -141.74 92.84 2.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.44 -153.1 21.26 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' C ' HG12 ' A' ' 20' ' ' VAL . 21.4 mt -67.12 177.07 1.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.058 -1.26 . . . . 0.0 109.273 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.086 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 177.17 159.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.13 -0.981 . . . . 0.0 108.658 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.804 ' HG3' HG23 ' A' ' 3' ' ' THR . 1.0 OUTLIER -129.75 -71.36 0.61 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.063 -1.023 . . . . 0.0 110.168 -179.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -112.03 113.93 26.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.133 -0.979 . . . . 0.0 110.116 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.764 HG22 ' CG1' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -125.45 141.01 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.483 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 2.2 pt20 -145.54 129.66 17.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.86 -1.15 . . . . 0.0 109.885 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.773 HG22 ' CG1' ' A' ' 50' ' ' ILE . 3.3 t -109.9 128.4 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.0 m -111.73 116.56 30.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.244 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -149.51 -144.07 3.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' GLU . 89.3 p -77.39 122.65 25.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -1.121 . . . . 0.0 109.592 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 28' ' ' SER . 1.4 tp10 60.07 147.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.687 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.14 169.07 38.91 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -171.38 46.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -1.138 . . . . 0.0 109.319 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.565 HD13 ' OH ' ' A' ' 35' ' ' TYR . 8.8 mt -150.21 146.82 27.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.88 . . . . 0.0 109.572 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -99.68 -99.49 2.24 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.695 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 20.5 mm -156.53 151.12 9.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.514 -0.992 . . . . 0.0 109.241 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.565 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.47 173.9 3.84 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.8 Cg_endo -73.26 81.77 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.908 1.739 . . . . 0.0 110.01 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.83 -11.24 1.67 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -48.88 164.72 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.086 -1.243 . . . . 0.0 109.413 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.828 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -78.28 170.62 15.38 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.332 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.828 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.19 73.93 5.27 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.581 2.188 . . . . 0.0 110.41 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 41' ' ' LEU . 4.0 mm? -78.37 161.56 27.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.8 pp -169.08 36.96 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 108.972 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.505 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -106.1 -95.37 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.565 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.612 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -137.44 162.49 33.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.922 -1.111 . . . . 0.0 109.869 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.684 HD13 HG11 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -100.95 139.87 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.378 -0.826 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' O ' HG11 ' A' ' 25' ' ' VAL . 13.3 mmtm -75.01 139.18 72.83 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.725 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.4 Cg_endo -79.6 -162.04 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.716 2.277 . . . . 0.0 110.365 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.06 -141.12 15.42 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 12.8 ptm -108.78 174.41 5.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -1.144 . . . . 0.0 109.012 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.773 ' CG1' HG22 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -154.67 119.9 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.934 -1.104 . . . . 0.0 110.282 -179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.741 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.52 150.92 21.72 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 178.685 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.957 HD11 ' CD2' ' A' ' 6' ' ' LEU . 5.4 tt -143.84 167.9 12.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.617 -1.302 . . . . 0.0 111.384 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 38.8 t -134.56 90.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 tttt -53.81 121.76 8.59 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.325 -0.859 . . . . 0.0 109.403 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.691 ' HA ' HG22 ' A' ' 3' ' ' THR . 1.3 tt0 45.38 -158.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.171 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -77.67 103.78 7.81 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.944 . . . . 0.0 109.115 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 103.3 178.77 26.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 t-160 62.45 129.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.11 -1.229 . . . . 0.0 109.448 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.2 mp0 -134.31 134.14 41.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 52' ' ' ILE . 3.1 tt0 -104.85 170.48 7.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 0.0 109.596 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.631 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -133.07 122.86 24.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.169 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.544 ' HB ' ' CG2' ' A' ' 50' ' ' ILE . 1.5 mp -137.89 169.22 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.078 -1.013 . . . . 0.0 109.863 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.3 OUTLIER -158.21 144.07 17.05 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -168.98 -164.26 0.47 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.105 -0.997 . . . . 0.0 110.035 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 33.6 p -105.1 -144.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.435 -0.791 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 80' ' ' ALA . . . -96.02 -135.19 8.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 128.44 -167.32 20.67 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' ILE . 19.6 tt -105.04 125.1 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.243 -1.151 . . . . 0.0 109.062 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.789 HD12 ' N ' ' A' ' 70' ' ' GLU . 2.4 pp -113.51 167.91 10.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.0 110.244 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.789 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -161.79 123.63 2.85 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' ' 76' ' ' VAL . 9.9 p -99.95 145.01 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.984 -1.072 . . . . 0.0 110.418 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.532 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.18 175.58 2.49 Favored Pre-proline 0 N--CA 1.488 1.469 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -76.96 75.8 4.41 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.509 2.139 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.03 -35.6 2.35 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 2.3 p30 -143.66 149.81 37.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.068 -1.254 . . . . 0.0 109.85 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.695 ' HB ' HG23 ' A' ' 71' ' ' VAL . 6.3 p -127.09 145.19 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.293 -0.879 . . . . 0.0 109.413 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.827 HG22 ' HB3' ' A' ' 7' ' ' ASP . 19.3 p -132.85 155.06 49.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 109.624 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.684 HG11 HD13 ' A' ' 45' ' ' ILE . 2.1 p -162.74 153.72 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 108.952 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.419 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 6.4 mt -129.74 160.98 31.75 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.095 -1.003 . . . . 0.0 109.808 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 66' ' ' GLY . . . -149.91 -148.51 0.27 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 80' ' ' ALA . 11.0 m-20 -128.22 -33.39 2.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.149 -0.969 . . . . 0.0 109.667 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 83' ' ' ALA . 48.3 m -112.5 164.22 13.55 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.854 ' HB1' ' SD ' ' A' ' 15' ' ' MET . . . -172.08 86.75 0.08 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 109.63 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.478 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 3.2 mp -105.67 134.17 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -0.915 . . . . 0.0 109.394 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.7 ttt85 -58.51 153.86 15.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 109.621 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -51.52 -33.82 33.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.43 44.23 1.86 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.172 -1.193 . . . . 0.0 109.679 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.9 -32.75 72.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.79 -159.99 0.71 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' CB ' ' HB2' ' A' ' 93' ' ' ARG . 29.8 m-20 -62.21 179.48 0.3 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.593 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -113.33 -60.82 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -0.874 . . . . 0.0 109.54 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.4 -12.65 59.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.678 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.462 ' HB2' ' CB ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -85.57 0.39 52.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.676 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.62 -1.75 57.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.103 -0.998 . . . . 0.0 109.469 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -90.01 -22.56 21.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.779 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -80.71 -9.5 59.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.568 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.05 -24.42 35.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.903 . . . . 0.0 109.634 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -27.5 21.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -67.35 -42.39 83.58 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -33.86 35.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.9 -14.02 59.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.864 ' OE1' HD12 ' A' ' 105' ' ' ILE . 26.5 tp10 -78.8 -23.01 45.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.365 -0.834 . . . . 0.0 109.568 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.46 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 2.9 tm-20 -54.37 -30.4 51.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 -46.08 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.578 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.864 HD12 ' OE1' ' A' ' 102' ' ' GLU . 34.4 mt -52.14 -40.67 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -0.89 . . . . 0.0 109.701 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 107' ' ' SER . 0.3 OUTLIER -92.98 58.18 2.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 108' ' ' SER . 6.2 p 178.8 155.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.126 -0.984 . . . . 0.0 109.664 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER 76.6 173.58 0.22 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.72 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.98 -171.52 3.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.427 -0.795 . . . . 0.0 109.252 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.64 162.71 15.86 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.3 OUTLIER -63.05 139.33 58.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -1.117 . . . . 0.0 109.472 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 111' ' ' ASP . 15.5 m 39.97 33.49 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.425 -0.797 . . . . 0.0 110.031 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -81.16 -96.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 109.118 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -73.51 -15.84 61.3 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.013 -1.054 . . . . 0.0 108.401 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.06 -35.17 79.81 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -69.44 -11.84 61.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -0.782 . . . . 0.0 109.219 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -76.77 -12.13 59.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 0.0 109.647 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.29 -19.94 41.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.651 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.61 -38.1 48.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 0.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -85.02 -32.77 22.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.906 . . . . 0.0 109.659 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 125' ' ' ILE . 0.8 OUTLIER -65.75 -66.26 0.57 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.686 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -44.34 -25.46 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.835 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 121' ' ' LEU . 8.9 ttmt -63.43 -53.14 56.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.981 . . . . 0.0 109.73 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.3 -27.86 66.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.697 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.2 mm -75.15 -5.5 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.196 -0.94 . . . . 0.0 109.747 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -79.98 -1.67 40.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.821 ' O ' HG23 ' A' ' 131' ' ' ILE . 16.0 tt0 -89.81 -28.73 19.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.215 -0.928 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.493 ' O ' HG12 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -69.33 -15.91 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -80.63 -27.26 37.29 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.631 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.7 m -89.58 -28.61 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 109.553 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.821 HG23 ' O ' ' A' ' 127' ' ' GLN . 25.9 pt -66.56 -20.43 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.805 . . . . 0.0 109.537 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.466 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -78.27 -26.06 47.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.571 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -87.39 -47.68 8.59 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.948 . . . . 0.0 109.543 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 28.5 p -43.82 -27.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -48.34 -67.03 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.867 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.0 26.88 8.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 0.0 109.769 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -100.4 -36.58 9.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.423 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.4 mmm . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.56 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.488 ' O ' ' O ' ' A' ' 3' ' ' THR . 3.3 tpp -130.55 137.23 49.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.612 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.488 ' O ' ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER 57.89 147.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.777 . . . . 0.0 109.845 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.774 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.9 p90 -152.2 -164.42 1.96 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.23 -0.919 . . . . 0.0 108.953 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.557 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.8 t60 -116.87 145.16 43.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 109.119 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.011 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -137.49 152.01 49.08 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.863 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.7 OUTLIER -149.2 91.71 1.87 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.953 -1.092 . . . . 0.0 110.034 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.562 HG13 ' CD1' ' A' ' 6' ' ' LEU . 3.3 m -100.66 141.3 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.288 -0.883 . . . . 0.0 109.012 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.431 HG13 ' C ' ' A' ' 8' ' ' VAL . 6.4 m -152.89 176.8 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.184 -0.947 . . . . 0.0 109.526 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.461 ' OG ' ' HG3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -120.45 -150.2 0.45 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.302 -0.874 . . . . 0.0 109.438 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.37 -32.06 18.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.884 . . . . 0.0 109.555 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -147.18 55.29 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.461 ' HG3' ' OG ' ' A' ' 10' ' ' SER . 17.1 pt20 175.93 122.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 15' ' ' MET . 15.5 mt-30 -96.37 165.52 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.922 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.554 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -141.91 -91.16 0.14 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.443 -0.786 . . . . 0.0 109.111 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.637 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 31.7 t80 -96.01 120.55 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.212 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.406 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 29.9 p -152.53 80.35 1.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.99 -157.54 20.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.74 ' C ' HG12 ' A' ' 20' ' ' VAL . 24.4 mt -62.94 175.0 0.93 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.011 -1.287 . . . . 0.0 108.868 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.011 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 179.5 160.5 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 108.993 -177.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.576 ' CB ' ' HB2' ' A' ' 54' ' ' LYS . 2.8 tm-20 -122.25 -51.18 1.99 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 0.0 110.087 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.512 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 18.3 tttp -153.74 122.56 6.37 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.712 -1.195 . . . . 0.0 111.134 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.038 HG22 ' CG1' ' A' ' 52' ' ' ILE . 11.2 pt -106.64 -170.13 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.542 ' CG ' ' CB ' ' A' ' 51' ' ' ARG . 5.0 pt20 -179.95 93.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.619 -1.3 . . . . 0.0 110.274 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.518 HG21 ' O ' ' A' ' 46' ' ' LYS . 1.5 p -101.19 133.65 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.36 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -120.7 135.32 55.16 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.281 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . 179.47 -76.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.39 -158.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.295 -1.121 . . . . 0.0 109.507 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -67.77 -82.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.283 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 46' ' ' LYS . . . -51.8 117.98 6.61 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -97.18 64.28 1.92 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.175 -1.191 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mt -112.98 160.81 17.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.897 . . . . 0.0 109.386 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -111.37 -111.46 3.24 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.385 -1.886 . . . . 0.0 108.385 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.774 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 23.5 mm -156.11 140.03 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.532 -0.981 . . . . 0.0 108.806 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.62 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -146.6 -172.05 0.3 Allowed Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 35.7 Cg_endo -80.96 42.76 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.23 1.953 . . . . 0.0 110.606 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.46 34.09 0.04 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -74.58 145.31 43.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -1.13 . . . . 0.0 109.606 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.701 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -55.55 165.89 1.1 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.347 -0.846 . . . . 0.0 109.788 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.701 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -78.62 73.38 5.93 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.685 2.257 . . . . 0.0 110.466 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -99.91 147.86 25.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.287 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.521 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.7 OUTLIER -156.87 44.22 0.38 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 109.527 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.0 p -123.69 -110.1 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.886 . . . . 0.0 109.572 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.568 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -101.4 155.39 18.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.822 -1.174 . . . . 0.0 109.584 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.47 ' O ' ' HD3' ' A' ' 47' ' ' PRO . 1.7 tt -104.56 177.08 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.337 -0.852 . . . . 0.0 109.434 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.518 ' O ' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -86.43 113.38 52.22 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.353 -0.842 . . . . 0.0 109.636 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.483 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 35.5 Cg_endo -78.61 122.15 5.39 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.483 2.122 . . . . 0.0 110.353 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.48 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 162.42 -127.72 1.76 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.68 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.7 ppp? -113.48 167.7 10.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.257 -1.143 . . . . 0.0 109.024 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.858 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.5 tt -150.39 149.31 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.931 -1.106 . . . . 0.0 110.393 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.542 ' CB ' ' CG ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -116.49 177.96 4.5 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.075 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.038 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.89 153.86 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.828 -1.17 . . . . 0.0 110.447 -179.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.57 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 18.1 t -137.97 149.51 24.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.576 ' HB2' ' CB ' ' A' ' 21' ' ' GLU . 10.1 tppt? 90.06 -112.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HG3' ' CE1' ' A' ' 16' ' ' PHE . 18.8 tt0 53.62 58.32 5.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.547 -1.345 . . . . 0.0 109.155 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.427 ' NE2' HD12 ' A' ' 19' ' ' LEU . 56.1 m170 58.53 43.03 19.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.266 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 71.48 86.18 0.17 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.466 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 167.2 125.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -1.121 . . . . 0.0 109.588 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.54 133.76 53.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.115 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.78 168.59 26.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.111 -0.993 . . . . 0.0 109.932 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.961 ' CZ ' HD21 ' A' ' 133' ' ' LEU . 0.8 OUTLIER -125.51 134.06 52.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.466 -0.771 . . . . 0.0 109.292 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.858 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.0 mt -101.73 -147.59 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.189 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.59 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 9.1 t80 -178.75 122.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.24 -0.913 . . . . 0.0 109.23 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.451 ' CD2' ' CB ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -120.21 161.57 20.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.81 -14.04 14.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.339 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 148.6 161.99 9.96 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 156.69 -167.46 33.63 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.471 HG22 ' H ' ' A' ' 69' ' ' LEU . 7.2 mt -101.72 170.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.376 -1.073 . . . . 0.0 109.158 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -155.0 163.87 39.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.697 -179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -157.44 134.64 10.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 109.202 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.664 HG23 HG22 ' A' ' 76' ' ' VAL . 14.5 p -100.39 152.73 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.188 -0.945 . . . . 0.0 109.783 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.425 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -131.6 170.51 11.1 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.426 -0.796 . . . . 0.0 109.245 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -77.54 103.62 1.75 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.485 2.123 . . . . 0.0 110.325 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.458 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . 83.84 1.53 89.86 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 74' ' ' GLY . 13.4 m-80 -152.63 170.09 21.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -1.214 . . . . 0.0 109.391 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.687 HG11 HG21 ' A' ' 34' ' ' ILE . 6.1 t -150.79 144.91 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.246 -0.909 . . . . 0.0 109.266 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.863 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -151.6 138.46 18.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.38 -0.825 . . . . 0.0 109.071 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 3.2 m -139.71 158.28 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.712 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.05 149.97 40.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.436 -0.79 . . . . 0.0 109.19 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.521 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -147.96 -175.84 5.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.216 -0.928 . . . . 0.0 109.851 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 0.5 OUTLIER -123.32 -31.42 3.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.636 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 83' ' ' ALA . 14.7 m -112.5 162.86 15.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.917 . . . . 0.0 109.392 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -161.83 81.93 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.679 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.59 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 4.9 mt -99.9 70.15 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.2 -0.937 . . . . 0.0 109.326 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.701 ' HD2' HG23 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -44.04 161.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.519 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.659 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -48.62 -59.04 6.92 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -116.9 60.0 0.75 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -1.144 . . . . 0.0 109.497 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -50.63 -63.63 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.439 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 89' ' ' LEU . 84.4 mt -142.87 -88.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.62 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -58.66 179.15 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.863 ' HA ' HD11 ' A' ' 131' ' ' ILE . 30.5 mt-10 -149.61 -39.74 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.86 -19.16 32.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -0.931 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -78.31 -8.28 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 109.527 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.81 -18.25 28.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.3 mtt -71.43 -6.73 42.5 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.516 -0.74 . . . . 0.0 109.329 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 4.6 mt-10 -81.44 -40.65 23.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -49.53 -65.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.679 ' HG2' HD11 ' A' ' 125' ' ' ILE . 0.5 OUTLIER -45.16 -31.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.929 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -59.53 -56.81 17.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.124 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.39 3.99 11.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -0.932 . . . . 0.0 110.028 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.77 -46.3 10.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.055 -1.028 . . . . 0.0 109.638 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -65.56 -33.59 76.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.323 -0.861 . . . . 0.0 109.829 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -15.19 58.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.104 -0.998 . . . . 0.0 109.769 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -80.31 -65.18 1.04 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -59.84 -15.03 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.744 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 107' ' ' SER . 28.0 t -78.25 78.97 4.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 109.463 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 106' ' ' SER . 2.2 p 176.9 129.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.34 -0.85 . . . . 0.0 109.33 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 107' ' ' SER . 16.5 m 54.52 104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.227 -0.921 . . . . 0.0 109.421 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.54 -154.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 137.58 139.58 3.91 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 25.2 t70 -74.24 -58.06 3.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.171 -1.194 . . . . 0.0 109.448 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.1 m -122.15 -7.6 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.902 . . . . 0.0 109.454 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -59.28 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.822 . . . . 0.0 109.193 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -73.28 -23.11 60.26 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -59.59 -22.75 62.22 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.313 0.578 . . . . 0.0 109.464 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -68.48 -42.49 78.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.862 . . . . 0.0 109.609 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.75 -11.63 60.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.559 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -1.09 26.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.706 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.94 -16.33 34.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.195 -0.941 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -84.24 -16.42 43.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.947 . . . . 0.0 109.495 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -88.49 -45.01 10.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 109.601 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.35 73.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.607 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.417 ' HG3' ' N ' ' A' ' 124' ' ' ALA . 6.7 pttt -73.66 -28.4 61.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.425 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -87.06 -8.05 57.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.218 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.679 HD11 ' HG2' ' A' ' 98' ' ' LYS . 1.5 tp -81.43 -4.07 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.217 -0.927 . . . . 0.0 109.547 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.68 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -74.36 -26.86 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -63.7 -33.63 76.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.403 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 131' ' ' ILE . 19.2 tp -81.64 -10.27 59.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 0.0 109.502 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.88 -31.29 19.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.433 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.779 ' O ' HG23 ' A' ' 134' ' ' THR . 1.2 m -90.56 -12.75 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.25 -0.906 . . . . 0.0 109.785 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.0 tt -90.4 -23.24 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.004 . . . . 0.0 110.055 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' A' ' 135' ' ' LYS . 0.7 OUTLIER -77.4 -39.28 47.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.25 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.961 HD21 ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -82.67 3.19 30.01 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.0 110.415 -179.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 130' ' ' VAL . 14.3 p -87.15 -12.98 45.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.913 -1.117 . . . . 0.0 109.669 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 132' ' ' GLU . 5.6 ptpt -71.34 -5.44 32.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -97.63 -43.42 7.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.129 -0.982 . . . . 0.0 109.608 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -44.7 -29.06 0.7 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.583 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.565 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.573 ' O ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -101.35 28.76 5.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.382 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.773 HG22 ' HA ' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -160.75 153.77 21.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.839 . . . . 0.0 109.609 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.712 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.9 p90 -139.53 -145.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.348 -0.845 . . . . 0.0 108.926 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.6 OUTLIER -134.7 152.5 51.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.856 -1.153 . . . . 0.0 109.503 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -115.9 138.28 51.32 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.493 -0.754 . . . . 0.0 109.591 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.866 ' HB3' HG22 ' A' ' 77' ' ' THR . 0.5 OUTLIER -143.39 72.61 1.37 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.321 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.862 HG13 ' HB3' ' A' ' 15' ' ' MET . 4.0 p -106.26 140.59 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.305 -0.872 . . . . 0.0 109.477 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.84 147.42 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.339 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 1.3 p -143.78 42.9 1.47 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.795 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 171.68 -87.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -0.973 . . . . 0.0 109.582 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 13' ' ' GLN . 1.4 mt-10 -128.62 44.13 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.418 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 12' ' ' GLU . 0.5 OUTLIER 70.81 61.95 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.272 -0.892 . . . . 0.0 109.265 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -145.6 99.21 3.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.302 -0.874 . . . . 0.0 109.616 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.862 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -175.12 -78.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 109.286 179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.62 ' CE2' ' HB ' ' A' ' 20' ' ' VAL . 1.0 OUTLIER -148.26 109.47 4.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.096 -1.003 . . . . 0.0 109.691 179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.5 p -138.07 83.37 1.97 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.358 -0.839 . . . . 0.0 109.464 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.5 -153.47 11.44 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.47 152.47 30.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -1.169 . . . . 0.0 109.741 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.719 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -150.7 152.33 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.483 -0.761 . . . . 0.0 109.276 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.773 ' HA ' HG22 ' A' ' 3' ' ' THR . 10.6 tt0 -109.84 -50.55 2.97 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER -155.44 130.84 9.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 110.058 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.744 ' CD1' HG23 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -98.01 -152.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.556 ' H ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER 179.55 94.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.806 -1.184 . . . . 0.0 109.617 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.744 HG23 ' CD1' ' A' ' 23' ' ' ILE . 22.2 t -99.05 134.13 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.424 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 22.2 m -123.36 112.22 17.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.391 -0.818 . . . . 0.0 109.359 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -157.57 159.97 30.25 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.08 -31.48 71.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -1.163 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' CB ' ' HG3' ' A' ' 47' ' ' PRO . 1.9 tt0 -98.54 71.7 2.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.74 152.86 9.78 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.26 26.45 0.6 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.686 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.06 156.93 21.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.161 -0.962 . . . . 0.0 109.63 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.665 ' HA2' HD11 ' A' ' 23' ' ' ILE . . . -100.35 -121.37 4.7 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.045 ' CG2' HG21 ' A' ' 76' ' ' VAL . 30.7 mm -154.42 135.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.117 -1.225 . . . . 0.0 109.016 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.616 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -140.7 -172.44 0.32 Allowed Pre-proline 0 C--N 1.297 -1.709 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 34.5 Cg_endo -77.88 76.12 4.48 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.776 1.651 . . . . 0.0 110.407 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.22 37.53 0.6 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' A' ' 39' ' ' ALA . 15.8 t-80 -67.76 166.6 14.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.179 -1.189 . . . . 0.0 109.394 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.548 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -53.68 160.77 1.86 Allowed Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.548 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.6 Cg_endo -77.9 77.84 3.78 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.738 2.292 . . . . 0.0 110.581 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 4.2 mm? -97.22 148.61 22.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.254 -0.904 . . . . 0.0 109.142 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.5 31.59 0.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 68' ' ' ILE . 26.8 p -131.21 -145.68 0.28 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.131 -0.98 . . . . 0.0 109.239 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.47 128.42 45.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.032 -1.043 . . . . 0.0 108.844 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.698 HG23 ' O ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -160.41 42.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.143 -0.973 . . . . 0.0 110.395 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.699 ' CD ' HD11 ' A' ' 69' ' ' LEU . 0.6 OUTLIER -130.82 45.73 1.9 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 120.917 -1.115 . . . . 0.0 110.723 179.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.695 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 79.52 3.31 Favored 'Trans proline' 0 C--N 1.317 -1.104 0 C-N-CA 122.047 1.831 . . . . 0.0 110.496 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 64' ' ' LEU . . . 158.62 -141.47 7.66 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.196 -1.478 . . . . 0.0 110.388 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.494 ' SD ' ' CG1' ' A' ' 130' ' ' VAL . 1.0 OUTLIER -110.02 179.91 3.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.404 -1.057 . . . . 0.0 109.587 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 1.7 tt -147.89 154.02 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.103 -0.998 . . . . 0.0 110.179 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.531 ' N ' HG12 ' A' ' 50' ' ' ILE . 1.3 tmt_? -144.8 152.35 40.2 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 8.3 mt -150.7 166.31 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.798 -1.189 . . . . 0.0 110.452 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.578 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 90.1 t -141.78 118.53 7.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 O-C-N 121.618 -0.677 . . . . 0.0 109.267 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 150.88 -97.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.538 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 6.5 mp0 42.46 -147.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -109.67 -11.06 14.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.178 -0.952 . . . . 0.0 109.419 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -107.04 -98.64 2.58 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.508 ' CD2' ' N ' ' A' ' 58' ' ' HIS . 2.6 m-70 -130.3 -66.51 0.77 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.55 165.86 29.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.946 . . . . 0.0 109.487 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.97 143.31 50.84 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.328 -0.858 . . . . 0.0 109.436 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.64 ' HZ ' HD11 ' A' ' 133' ' ' LEU . 0.7 OUTLIER -116.9 123.71 47.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.707 HG21 ' HG2' ' A' ' 15' ' ' MET . 1.6 mt -137.38 -160.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.149 -0.969 . . . . 0.0 109.316 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.602 ' H ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -174.38 131.92 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 0.0 109.32 -179.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.544 HD22 ' C ' ' A' ' 63' ' ' TYR . 3.6 mm? -119.5 158.27 26.62 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.216 -0.927 . . . . 0.0 109.188 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.1 p -99.27 -19.71 16.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -0.953 . . . . 0.0 109.521 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.96 45.73 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 80' ' ' ALA . . . -72.54 -178.02 32.21 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 43' ' ' THR . 2.7 mp -102.79 122.94 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -1.125 . . . . 0.0 109.367 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.699 HD11 ' CD ' ' A' ' 46' ' ' LYS . 6.7 mp -99.53 175.34 5.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.239 -0.913 . . . . 0.0 109.696 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -168.78 129.3 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.481 ' O ' HG13 ' A' ' 71' ' ' VAL . 5.7 p -99.86 129.06 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.153 -0.967 . . . . 0.0 110.076 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.542 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -105.74 173.7 3.07 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.5 Cg_endo -81.04 56.02 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.668 2.245 . . . . 0.0 111.07 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.89 -16.73 1.21 Allowed Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.671 -1.252 . . . . 0.0 110.075 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' A' ' 5' ' ' HIS . 15.5 m-80 -150.91 -175.65 5.22 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 0.0 109.468 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.045 HG21 ' CG2' ' A' ' 34' ' ' ILE . 38.0 t -144.25 146.41 20.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.237 -0.914 . . . . 0.0 109.361 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.866 HG22 ' HB3' ' A' ' 7' ' ' ASP . 1.2 p -138.07 174.24 10.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.547 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 8' ' ' VAL . 1.2 p -178.25 119.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.298 -0.876 . . . . 0.0 109.261 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.593 ' O ' HD23 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -102.62 124.51 48.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.033 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.442 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . . . -128.73 -152.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 109.576 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.78 -39.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.646 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.4 m -104.24 151.73 23.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.095 -1.003 . . . . 0.0 109.754 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -165.68 167.51 17.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.868 . . . . 0.0 109.321 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.454 HG13 ' CE1' ' A' ' 63' ' ' TYR . 16.3 mt -130.68 -28.05 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.201 -0.937 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER 69.37 45.71 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.418 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.04 -112.13 3.67 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.78 27.08 9.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.42 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 85' ' ' ARG . 32.1 t70 -49.43 -40.72 37.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.356 -0.84 . . . . 0.0 109.669 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.86 -88.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.269 -0.894 . . . . 0.0 109.772 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.07 164.84 20.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.69 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -106.26 -72.8 0.7 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 109.265 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.54 -17.1 34.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 109.416 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -81.64 3.75 24.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.853 . . . . 0.0 109.591 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.13 -20.09 26.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.105 -0.997 . . . . 0.0 108.693 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.4 mtm -71.08 -26.54 63.1 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.507 -0.745 . . . . 0.0 109.256 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.58 -24.21 67.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.299 -0.876 . . . . 0.0 109.323 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.24 -42.75 22.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.327 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -58.44 -43.51 88.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.288 -0.883 . . . . 0.0 109.379 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -26.55 65.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.875 . . . . 0.0 109.307 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -89.94 7.68 36.15 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.526 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.812 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -90.5 -35.62 14.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.172 -0.955 . . . . 0.0 109.631 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -34.9 72.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.384 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 106' ' ' SER . 0.4 OUTLIER -62.58 -34.88 77.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.322 -0.861 . . . . 0.0 109.533 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.72 -48.72 65.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.198 -0.939 . . . . 0.0 109.448 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mt -89.56 27.66 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.512 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 107' ' ' SER . 0.5 OUTLIER -68.92 92.86 0.52 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.53 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 106' ' ' SER . 39.5 m 61.47 143.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -0.915 . . . . 0.0 109.633 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.44 118.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.293 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -95.68 73.42 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -0.873 . . . . 0.0 109.514 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -145.27 132.02 4.48 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.5 m-20 -67.23 -149.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -1.148 . . . . 0.0 109.398 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.831 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 0.2 OUTLIER -35.96 -31.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.301 0.572 . . . . 0.0 109.708 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 111' ' ' ASP . 22.5 t70 -38.18 -93.15 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.665 -0.647 . . . . 0.0 110.332 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -63.42 -20.15 65.31 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -55.74 -26.22 44.44 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.419 0.628 . . . . 0.0 109.541 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -82.13 -31.92 30.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.384 -0.822 . . . . 0.0 109.638 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.83 -13.31 61.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.129 -0.982 . . . . 0.0 109.646 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 t -83.24 9.34 10.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.11 -43.16 10.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.185 -0.947 . . . . 0.0 109.432 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.629 ' HG3' HD22 ' A' ' 121' ' ' LEU . 23.2 pt-20 -67.6 -12.49 60.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.545 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.812 HD12 ' HB1' ' A' ' 101' ' ' ALA . 3.9 mm? -82.57 -36.21 26.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.918 . . . . 0.0 109.471 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.65 -38.94 46.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.252 -0.905 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -69.85 -14.05 62.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.921 . . . . 0.0 109.369 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -86.16 -8.49 57.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.343 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.3 mm -87.66 -17.9 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -64.51 -26.49 68.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.125 -0.985 . . . . 0.0 109.126 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -60.3 -34.22 73.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.883 . . . . 0.0 109.492 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.526 ' HA ' ' CG2' ' A' ' 131' ' ' ILE . 27.9 tp -90.03 -11.84 40.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.35 -60.84 2.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.915 . . . . 0.0 109.564 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.712 ' O ' HG23 ' A' ' 134' ' ' THR . 16.2 m -55.42 -51.15 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.015 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.573 ' N ' HG23 ' A' ' 130' ' ' VAL . 3.9 tt -60.19 -26.95 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 0.0 110.16 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.15 -38.66 85.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.085 -1.009 . . . . 0.0 109.942 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 133' ' ' LEU . 1.2 pp -90.22 -16.2 29.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.035 -1.04 . . . . 0.0 109.79 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 130' ' ' VAL . 20.0 p -61.25 -38.89 88.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.964 . . . . 0.0 109.532 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mtpp -60.41 -33.95 73.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.993 . . . . 0.0 109.419 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.48 1.0 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.311 -0.868 . . . . 0.0 109.608 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.49 ' HB2' HD12 ' A' ' 133' ' ' LEU . . . -77.26 -36.03 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -0.955 . . . . 0.0 109.427 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.459 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.813 ' O ' HG22 ' A' ' 3' ' ' THR . 0.1 OUTLIER -50.73 176.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.306 -0.871 . . . . 0.0 109.472 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.813 HG22 ' O ' ' A' ' 2' ' ' MET . 6.5 t 52.07 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 122.591 1.186 . . . . 0.0 111.075 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.956 ' CE2' HG22 ' A' ' 34' ' ' ILE . 9.2 p90 -110.75 -168.37 1.3 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.58 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -111.06 137.57 48.54 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.155 -0.966 . . . . 0.0 108.655 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.052 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -125.61 162.68 24.42 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.912 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.045 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.94 101.35 2.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.728 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.575 HG12 ' HB3' ' A' ' 16' ' ' PHE . 7.3 p -99.79 124.66 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 2.3 t -136.93 146.73 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.54 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 11' ' ' ALA . 1.2 m -123.59 -145.88 0.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -40.04 -75.8 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.404 -0.81 . . . . 0.0 110.039 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -153.38 65.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.183 -0.948 . . . . 0.0 109.507 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -156.05 138.68 15.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.391 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.6 mp0 -92.4 138.32 31.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.758 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 1.1 mmt -124.99 -60.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.653 ' HB2' HD11 ' A' ' 62' ' ' ILE . 49.7 t80 -131.09 133.41 45.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.467 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.5 p -163.0 97.29 0.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 0.0 109.262 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 165.02 -151.03 19.7 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.732 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -70.23 161.94 29.35 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.191 -1.182 . . . . 0.0 109.302 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.052 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -178.59 153.93 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.122 -0.986 . . . . 0.0 109.258 -177.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.583 ' HB3' ' HA ' ' A' ' 3' ' ' THR . 1.5 pp20? -152.25 -36.1 0.12 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.942 -1.099 . . . . 0.0 110.677 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -106.74 71.21 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.848 -1.158 . . . . 0.0 110.891 -178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.953 HG22 ' CG1' ' A' ' 52' ' ' ILE . 9.5 pt -102.81 142.29 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.099 -1.0 . . . . 0.0 108.699 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.546 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 20.0 pt20 -149.27 126.55 11.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.055 -1.028 . . . . 0.0 109.693 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -99.11 114.9 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 121.198 -0.939 . . . . 0.0 109.304 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.414 ' HA ' ' HG3' ' A' ' 31' ' ' GLU . 51.6 m -99.78 108.42 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.503 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.52 -91.82 1.26 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.58 -67.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.349 -1.089 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.64 132.09 33.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 109.371 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.55 -178.29 35.59 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -174.74 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.288 -1.125 . . . . 0.0 109.591 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 12.8 mt -151.27 142.96 23.71 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.629 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.546 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -101.79 -99.69 2.44 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.956 HG22 ' CE2' ' A' ' 4' ' ' TYR . 7.2 mm -156.75 140.47 7.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.429 -1.042 . . . . 0.0 109.139 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -128.76 178.06 1.84 Allowed Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 33.1 Cg_endo -75.43 75.78 3.77 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.058 1.838 . . . . 0.0 110.172 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.5 38.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -107.9 175.33 5.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.209 . . . . 0.0 109.583 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.73 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -92.99 167.24 14.7 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.269 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.73 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.3 Cg_endo -78.61 81.99 2.61 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.535 2.157 . . . . 0.0 110.502 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.943 HD11 HD11 ' A' ' 69' ' ' LEU . 1.4 pp -90.17 142.27 27.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.897 . . . . 0.0 109.727 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mt -128.13 69.94 1.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.458 -0.776 . . . . 0.0 109.293 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -110.3 -160.5 0.72 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.634 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -101.01 172.73 6.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.558 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.706 ' HA ' HD23 ' A' ' 69' ' ' LEU . 1.7 tt -99.96 126.98 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.233 -0.917 . . . . 0.0 109.495 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 156.15 70.52 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.98 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.15 175.71 10.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.56 2.173 . . . . 0.0 110.314 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 113.96 -132.92 10.84 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.669 ' SD ' HG13 ' A' ' 130' ' ' VAL . 6.0 ptm -129.53 -177.11 4.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -1.204 . . . . 0.0 109.476 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.8 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -151.96 131.3 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.083 -1.011 . . . . 0.0 109.816 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.4 OUTLIER -98.41 127.26 44.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.953 ' CG1' HG22 ' A' ' 23' ' ' ILE . 1.2 tt -134.3 145.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.077 -1.014 . . . . 0.0 110.91 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.757 HG22 ' HB3' ' A' ' 59' ' ' GLU . 38.9 t -127.75 113.53 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.486 ' HG2' ' CE1' ' A' ' 16' ' ' PHE . 17.6 mtmt -66.32 157.14 32.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -0.762 . . . . 0.0 109.886 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.764 ' CG ' HG21 ' A' ' 3' ' ' THR . 18.2 tt0 -60.29 -65.02 0.75 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.345 -0.847 . . . . 0.0 109.531 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.04 102.98 8.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.293 -0.879 . . . . 0.0 109.503 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' C ' ' CD2' ' A' ' 58' ' ' HIS . . . 159.47 -103.42 0.23 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.482 ' CD2' ' C ' ' A' ' 57' ' ' GLY . 51.8 m-70 -148.51 159.96 43.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.171 -1.194 . . . . 0.0 109.702 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.757 ' HB3' HG22 ' A' ' 53' ' ' VAL . 1.9 pt-20 -101.3 136.05 41.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.697 ' O ' HG22 ' A' ' 52' ' ' ILE . 8.9 mt-10 -134.01 150.64 51.25 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.064 -1.022 . . . . 0.0 109.943 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.584 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 1.2 p90 -109.2 131.02 55.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.8 ' H ' HG23 ' A' ' 50' ' ' ILE . 1.7 mt -101.95 -175.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.436 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.682 ' H ' HG22 ' A' ' 62' ' ' ILE . 6.2 t80 -152.37 136.84 16.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.306 -0.871 . . . . 0.0 109.068 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.487 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -161.92 179.99 7.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.089 -1.007 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -161.3 113.16 1.82 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.301 -0.874 . . . . 0.0 109.435 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.79 132.97 6.22 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.27 -161.79 28.17 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 82.2 mt -139.46 143.2 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.236 -1.155 . . . . 0.0 109.415 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.943 HD11 HD11 ' A' ' 41' ' ' LEU . 1.4 pp -123.72 138.5 54.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.475 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 2.8 pt-20 -142.72 149.89 39.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 40' ' ' PRO . 4.4 p -109.54 133.4 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 109.76 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.534 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -101.45 175.43 2.33 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.88 . . . . 0.0 109.408 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.0 Cg_endo -76.76 77.59 3.65 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.62 2.213 . . . . 0.0 110.193 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.85 12.58 31.8 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.819 ' O ' HG23 ' A' ' 76' ' ' VAL . 68.3 m-80 -153.9 -172.29 4.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.354 -1.086 . . . . 0.0 109.343 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 75' ' ' ASN . 3.1 t -166.13 150.03 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.09 -1.006 . . . . 0.0 108.935 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -158.5 142.26 15.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.896 . . . . 0.0 109.315 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 69' ' ' LEU . 3.5 m -151.06 137.87 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.187 -0.946 . . . . 0.0 109.825 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 1.1 mp -106.77 160.66 15.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.848 . . . . 0.0 109.194 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.492 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -149.76 175.88 11.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.098 -1.001 . . . . 0.0 109.879 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.8 -52.21 3.98 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.345 -0.847 . . . . 0.0 109.364 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.4 t -102.18 -176.68 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.367 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.758 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -168.51 80.88 0.15 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 0.0 109.707 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.64 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.6 mp -108.51 72.59 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.225 -0.922 . . . . 0.0 109.234 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.52 ' NH2' ' HB3' ' A' ' 60' ' ' GLU . 22.9 ttt180 -42.84 154.11 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -45.95 -51.75 10.57 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -106.71 49.4 0.8 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.26 -1.141 . . . . 0.0 109.539 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -27.69 14.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.292 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mt -123.36 -175.02 3.09 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.333 -0.854 . . . . 0.0 109.367 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 10.7 t70 -54.29 179.38 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.342 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.791 ' HB3' HD11 ' A' ' 131' ' ' ILE . 32.7 mt-10 -105.83 -34.8 7.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 109.433 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.95 -25.24 27.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.495 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -72.29 -7.44 49.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB1' ' HG3' ' A' ' 127' ' ' GLN . . . -90.59 -24.63 20.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.205 -0.934 . . . . 0.0 109.179 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -31.55 37.67 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 109.484 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -5.56 27.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.593 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.68 -22.93 42.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 109.53 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HG2' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -82.34 -41.58 19.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.913 . . . . 0.0 109.474 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.2 mtp-105 -61.3 -27.18 68.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -86.86 -21.76 26.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.179 -0.95 . . . . 0.0 109.484 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.12 -26.32 33.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.347 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 106' ' ' SER . 16.3 tt0 -60.97 -30.55 70.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.837 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -56.11 -30.88 62.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.393 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -89.5 -47.68 7.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.883 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.065 HD13 ' HB1' ' A' ' 117' ' ' ALA . 11.7 mt -86.83 14.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.171 -0.955 . . . . 0.0 109.619 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 107' ' ' SER . 71.2 p -48.69 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.529 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 77.03 167.76 0.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.565 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 114' ' ' TYR . 0.2 OUTLIER -166.94 134.52 2.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.906 . . . . 0.0 109.543 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.15 -89.01 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.886 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.468 ' O ' ' OD2' ' A' ' 113' ' ' ASP . . . -167.78 174.41 42.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 112' ' ' VAL . 1.2 m-20 63.65 105.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -1.202 . . . . 0.0 109.312 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 111' ' ' ASP . 15.6 m 40.99 26.41 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 111' ' ' ASP . 0.3 OUTLIER -90.83 -89.51 0.16 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.177 -0.952 . . . . 0.0 108.893 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 108' ' ' SER . 26.7 t80 -73.93 -20.47 60.36 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.83 -53.17 58.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -64.51 -39.78 94.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.355 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 1.065 ' HB1' HD13 ' A' ' 105' ' ' ILE . . . -67.03 -16.35 64.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.589 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.561 ' O ' ' HB3' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -74.52 -23.1 58.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.261 -0.9 . . . . 0.0 109.69 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.44 -41.15 11.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.977 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 123' ' ' LYS . 6.2 pt-20 -75.77 -32.15 59.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.137 -0.977 . . . . 0.0 110.05 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.547 HD22 HD12 ' A' ' 105' ' ' ILE . 51.1 tp -87.24 -51.84 5.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.096 -1.003 . . . . 0.0 109.614 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -52.72 -39.78 62.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.771 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -57.84 -36.12 71.85 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.781 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 123' ' ' LYS . . . -75.92 -22.54 55.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.563 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 121' ' ' LEU . 14.0 mm -79.79 -3.61 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.619 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.495 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -64.81 -32.74 74.57 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.272 -0.893 . . . . 0.0 109.471 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 1.0 OUTLIER -69.08 -19.28 64.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.411 ' N ' ' HG2' ' A' ' 127' ' ' GLN . 14.0 tp -83.99 -17.5 40.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.544 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -90.37 -28.99 18.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.733 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.669 HG13 ' SD ' ' A' ' 49' ' ' MET . 5.0 m -89.19 -26.87 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.068 -1.02 . . . . 0.0 109.461 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.791 HD11 ' HB3' ' A' ' 91' ' ' GLU . 3.1 tt -66.97 -46.86 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.3 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.576 ' N ' HG23 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -52.65 -26.29 13.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.161 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -44.98 28.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 79.5 p -61.1 -14.88 27.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.89 . . . . 0.0 109.549 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -45.42 -41.65 9.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 0.0 109.367 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -97.08 -41.77 8.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.51 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -44.19 -61.98 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.643 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.442 ' OXT' ' O ' ' A' ' 137' ' ' ALA . 2.8 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.647 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.475 ' O ' ' O ' ' A' ' 3' ' ' THR . 6.3 mtp -77.65 -170.63 1.89 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.556 HG22 ' HG3' ' A' ' 21' ' ' GLU . 1.3 p 49.98 176.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.398 -0.814 . . . . 0.0 109.906 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.725 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.3 p90 179.42 -171.66 0.15 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.559 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.0 t60 -111.62 149.68 31.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 109.025 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.012 HD23 HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -137.92 158.48 44.26 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 178.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.856 ' N ' HD12 ' A' ' 6' ' ' LEU . 6.5 t0 -144.98 92.65 2.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.711 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.4 p -113.2 118.69 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.23 -0.918 . . . . 0.0 109.408 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 t -130.9 145.08 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.693 ' CB ' ' HB3' ' A' ' 80' ' ' ALA . 39.5 t -178.05 66.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.693 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 10' ' ' SER . . . 178.09 45.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' ALA . 0.7 OUTLIER 42.54 27.38 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.313 -0.867 . . . . 0.0 109.653 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -148.88 -150.59 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -0.853 . . . . 0.0 109.512 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -134.39 102.84 5.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.489 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.651 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.4 mmt -76.01 -78.69 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.257 -0.902 . . . . 0.0 109.259 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.612 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 34.7 t80 -125.66 124.76 41.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.165 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 17' ' ' SER . 52.6 p -154.4 83.85 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.133 -0.979 . . . . 0.0 109.7 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.01 -153.59 17.37 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.643 ' C ' HG12 ' A' ' 20' ' ' VAL . 13.6 mt -65.02 167.7 7.5 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.151 -1.205 . . . . 0.0 108.745 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.012 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -173.85 173.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 120.87 -1.144 . . . . 0.0 109.496 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.9 tt0 -118.19 -46.37 2.61 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' HE2' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.4 137.3 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.433 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.984 ' HB ' HD11 ' A' ' 50' ' ' ILE . 18.7 pt -99.42 -156.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.8 OUTLIER -177.13 95.09 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.509 -1.369 . . . . 0.0 110.378 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.537 HG11 ' C ' ' A' ' 46' ' ' LYS . 76.4 t -99.23 141.75 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.94 -1.1 . . . . 0.0 109.627 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 25.6 m -145.53 119.81 9.56 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.274 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -145.54 -163.39 10.18 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.34 -42.66 42.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -1.078 . . . . 0.0 109.592 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.53 163.26 21.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.917 . . . . 0.0 109.573 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.79 138.57 0.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -141.31 45.72 1.74 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -1.13 . . . . 0.0 109.213 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.412 ' O ' ' HE2' ' A' ' 46' ' ' LYS . 5.9 mt -144.85 164.58 30.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 109.785 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' HG12 ' A' ' 34' ' ' ILE . . . -112.59 -112.33 3.16 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 76' ' ' VAL . 15.9 mm -153.33 138.04 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.24 -1.153 . . . . 0.0 109.459 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.618 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -149.23 171.87 5.82 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.0 Cg_endo -70.3 83.03 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.566 1.511 . . . . 0.0 109.486 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.73 35.12 0.46 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.437 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.7 t-80 -81.97 151.26 27.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.296 -1.12 . . . . 0.0 109.526 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' HIS . . . -42.94 154.8 0.28 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.409 -0.807 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 76.01 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.583 2.188 . . . . 0.0 110.559 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.9 OUTLIER -97.03 162.13 13.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.311 179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.68 35.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 0.0 109.634 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.65 ' O ' HG23 ' A' ' 68' ' ' ILE . 30.0 p -130.68 -145.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.259 -0.901 . . . . 0.0 109.375 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 45' ' ' ILE . . . -99.32 120.41 39.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.011 . . . . 0.0 109.033 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 44' ' ' ALA . 1.1 pp -166.7 -169.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.153 -0.967 . . . . 0.0 110.163 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.657 ' N ' ' HD3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER 71.66 49.46 0.28 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.624 -0.673 . . . . 0.0 111.059 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.657 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.6 Cg_endo -80.4 146.17 17.22 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 122.15 1.9 . . . . 0.0 110.418 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 115.58 -142.88 17.86 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.318 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -99.56 -155.22 0.5 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.365 -1.079 . . . . 0.0 109.198 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.984 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -173.76 111.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.996 -1.065 . . . . 0.0 110.383 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 50' ' ' ILE . 15.7 mtm180 -99.46 166.63 11.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.881 HD11 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -152.62 167.63 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 120.601 -1.312 . . . . 0.0 111.246 -178.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.481 ' N ' HG23 ' A' ' 52' ' ' ILE . 13.6 t -143.99 104.73 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 55' ' ' GLN . 1.3 ttpt -66.37 120.51 13.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.692 -0.63 . . . . 0.0 109.868 -179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 82.0 mt-30 43.26 -161.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.363 -0.835 . . . . 0.0 109.373 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -68.71 88.41 0.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 54' ' ' LYS . . . 121.27 -171.21 14.86 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 61.5 160.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.383 -1.069 . . . . 0.0 109.607 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -171.35 147.41 2.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.862 . . . . 0.0 109.401 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -132.8 154.67 50.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.6 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.513 ' CE2' ' HA ' ' A' ' 130' ' ' VAL . 0.9 OUTLIER -112.08 133.62 54.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.94 . . . . 0.0 109.373 179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.651 HD13 ' HB3' ' A' ' 15' ' ' MET . 78.0 mt -151.94 167.14 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -0.885 . . . . 0.0 109.261 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.61 ' N ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -143.65 149.66 37.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.017 -1.052 . . . . 0.0 109.576 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER -157.67 152.69 25.61 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.373 -0.829 . . . . 0.0 109.18 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.16 -79.56 0.59 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.1 -1.0 . . . . 0.0 109.723 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -91.81 129.4 9.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -175.32 144.6 7.34 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 43' ' ' THR . 79.3 mt -99.48 118.09 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -1.108 . . . . 0.0 108.965 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.671 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.3 tt -112.49 153.37 27.54 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.282 -0.886 . . . . 0.0 109.68 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -145.65 152.41 39.61 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -104.28 139.97 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.031 -1.043 . . . . 0.0 109.872 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.525 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.9 OUTLIER -122.27 172.33 5.33 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.462 -0.774 . . . . 0.0 109.038 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.525 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 35.6 Cg_endo -78.62 91.15 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.513 2.142 . . . . 0.0 110.854 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.22 -10.31 54.6 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.9 OUTLIER -161.32 162.11 30.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.027 -1.278 . . . . 0.0 109.896 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 34' ' ' ILE . 18.3 m -135.75 172.87 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.151 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.442 HG22 ' N ' ' A' ' 78' ' ' VAL . 32.5 m -159.95 156.64 27.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.15 -0.969 . . . . 0.0 109.524 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.504 ' CG2' ' HB2' ' A' ' 69' ' ' LEU . 2.7 p -167.73 133.34 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.267 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.2 mt -117.77 118.34 31.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.872 . . . . 0.0 109.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.693 ' HB3' ' CB ' ' A' ' 10' ' ' SER . . . -109.02 -165.97 1.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 0.0 109.361 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -125.23 -52.29 1.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -0.952 . . . . 0.0 109.511 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 m -99.93 120.11 39.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.35 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . -149.75 163.71 37.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.54 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.1 mt -149.03 119.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.285 -0.885 . . . . 0.0 109.25 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 85' ' ' ARG . 0.0 OUTLIER -67.58 95.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.158 -0.964 . . . . 0.0 109.482 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 55.37 -110.75 1.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.738 ' HB3' HG22 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -139.13 57.2 1.67 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.324 -1.103 . . . . 0.0 109.223 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -60.19 -45.16 94.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.671 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.61 -78.09 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.145 -0.972 . . . . 0.0 109.72 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -150.25 -155.21 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.195 -0.941 . . . . 0.0 109.608 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.471 ' HB2' HD12 ' A' ' 131' ' ' ILE . 1.3 pt-20 -151.93 -49.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.284 -0.885 . . . . 0.0 109.652 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.87 -10.14 59.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.229 -0.919 . . . . 0.0 109.359 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.22 -8.48 59.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 109.519 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.52 -24.32 20.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.163 -0.96 . . . . 0.0 109.246 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -35.58 76.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.457 ' O ' ' OE1' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -54.71 -33.34 60.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -68.9 -43.17 75.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.112 -0.993 . . . . 0.0 109.86 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -18.06 60.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.001 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -70.06 -50.34 42.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.011 . . . . 0.0 109.626 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -86.02 -9.19 57.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.573 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.908 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -76.81 -30.8 56.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 1.5 tm-20 -70.88 -22.46 62.28 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.306 -0.871 . . . . 0.0 109.347 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -73.74 -20.75 60.42 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.217 -0.927 . . . . 0.0 109.746 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -81.67 -36.75 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.905 . . . . 0.0 109.703 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.714 HD11 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mm -78.87 -26.91 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 94.1 p -80.81 -9.94 59.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.547 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.5 t -104.58 131.19 52.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.139 -0.976 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.57 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 58.3 p -135.97 142.22 44.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.905 . . . . 0.0 109.281 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.57 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.3 m-70 175.21 41.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -0.906 . . . . 0.0 109.382 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -169.63 158.92 31.46 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.66 -74.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -1.177 . . . . 0.0 109.562 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.606 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 17.6 m -100.84 19.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 109.393 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 9.7 t70 -59.83 -100.41 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.358 -0.839 . . . . 0.0 109.278 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.501 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 12.6 p90 -64.61 -22.22 66.92 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.903 -1.123 . . . . 0.0 108.223 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -53.84 -33.65 56.9 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.2 OUTLIER -88.3 -24.7 23.1 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -68.08 -21.12 64.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.472 -0.767 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.86 -26.3 61.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.331 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.467 ' O ' ' HE3' ' A' ' 123' ' ' LYS . . . -90.18 -38.18 13.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -78.85 -5.79 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.748 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.908 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -90.15 -51.3 5.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 109.593 -179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.31 -28.87 70.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.179 -0.951 . . . . 0.0 109.459 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' A' ' 119' ' ' ALA . 14.8 mtmt -70.23 -23.66 62.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.66 62.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.868 . . . . 0.0 109.733 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.3 mp -80.08 -1.24 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.103 -0.998 . . . . 0.0 109.554 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.4 -24.57 63.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.766 ' O ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -69.76 -45.76 67.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.62 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.541 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.4 OUTLIER -65.99 -15.51 63.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.638 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 133' ' ' LEU . 14.2 mmt180 -81.85 -25.75 34.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.502 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 127' ' ' GLN . 31.6 m -88.09 -20.36 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.738 HG22 ' HB3' ' A' ' 87' ' ' GLN . 7.7 pt -91.01 -44.62 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 0.0 110.047 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 5.0 mm-40 -61.81 -24.21 66.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.191 -0.943 . . . . 0.0 110.233 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.571 ' N ' HD12 ' A' ' 133' ' ' LEU . 6.5 mp -89.09 -37.73 14.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.78 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 130' ' ' VAL . 8.6 p -55.59 -40.93 72.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 109.652 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.9 ptmm? -61.39 -29.58 70.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.151 -0.968 . . . . 0.0 109.83 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -111.26 31.56 5.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.136 -0.978 . . . . 0.0 109.548 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -124.19 -3.56 8.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -0.902 . . . . 0.0 109.654 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.339 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.519 ' CG ' ' O ' ' A' ' 1' ' ' ALA . 20.6 ptp 40.68 -155.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.482 -0.762 . . . . 0.0 109.837 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.693 HG21 ' CG ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -42.35 166.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.873 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.738 ' CE2' HG22 ' A' ' 34' ' ' ILE . 5.0 p90 -148.79 -147.3 0.22 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.533 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 20.5 t-80 -133.9 140.71 46.99 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.05 -1.031 . . . . 0.0 109.641 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.04 HD21 HD11 ' A' ' 52' ' ' ILE . 0.5 OUTLIER -138.96 152.13 47.44 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.067 . . . . 0.0 108.775 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.818 ' N ' HD12 ' A' ' 6' ' ' LEU . 36.1 t0 -142.83 86.78 1.95 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.951 -1.093 . . . . 0.0 110.528 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.743 HG13 ' CD1' ' A' ' 6' ' ' LEU . 5.0 m -99.9 148.78 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 8' ' ' VAL . 1.5 m -152.96 173.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.032 -1.043 . . . . 0.0 109.869 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.662 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -129.4 -153.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.92 -29.95 70.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.282 -0.886 . . . . 0.0 109.833 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' GLN . 6.3 mm-40 -116.74 26.51 9.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.003 . . . . 0.0 109.695 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 12' ' ' GLU . 19.8 mt-30 43.68 92.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.409 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 15' ' ' MET . 4.6 mm-40 -165.4 74.96 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.722 ' HB2' HG23 ' A' ' 8' ' ' VAL . 6.8 mtp -151.32 -73.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.647 ' CD1' HD13 ' A' ' 52' ' ' ILE . 47.7 t80 -159.75 136.84 9.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.248 -0.908 . . . . 0.0 109.267 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.0 p -160.17 105.91 1.54 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 109.58 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 144.99 -160.38 28.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.0 mt -56.09 174.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.175 -1.191 . . . . 0.0 108.957 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.024 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 179.96 169.6 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.974 -1.078 . . . . 0.0 109.65 -178.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.511 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.0 tt0 -122.5 -41.9 2.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.314 -0.866 . . . . 0.0 109.281 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.423 ' HG3' ' HB ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -175.68 130.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 0.0 110.227 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.947 ' CG2' HD22 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -98.77 -165.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.584 ' N ' HD12 ' A' ' 23' ' ' ILE . 4.5 tp60 -168.89 84.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.665 -1.272 . . . . 0.0 110.233 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.7 p -99.3 141.86 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.004 . . . . 0.0 109.445 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 10.2 m -138.16 129.69 27.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.374 -0.829 . . . . 0.0 109.03 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -136.92 -81.38 0.1 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -38.78 0.33 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.207 -1.173 . . . . 0.0 109.769 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -123.41 163.69 20.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -0.959 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 80.4 -82.06 1.51 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 44.1 tt0 73.88 53.11 0.11 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.349 -1.089 . . . . 0.0 109.732 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.8 mt -145.54 156.64 43.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 0.0 109.317 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -99.22 -115.17 3.61 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.614 -1.795 . . . . 0.0 108.614 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.738 HG22 ' CE2' ' A' ' 4' ' ' TYR . 29.5 mm -153.11 145.81 14.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.142 -1.211 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -154.91 -171.0 0.26 Allowed Pre-proline 0 C--N 1.299 -1.59 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.611 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 33.7 Cg_endo -78.63 73.93 5.68 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 121.678 1.586 . . . . 0.0 109.671 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.09 54.7 0.1 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.547 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 11.8 t-160 -85.63 50.84 2.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -1.132 . . . . 0.0 109.648 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.728 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 55.56 167.03 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 109.627 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.728 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.2 Cg_endo -78.46 78.92 3.47 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.621 2.214 . . . . 0.0 110.229 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 41' ' ' LEU . 2.5 mm? -95.05 144.4 25.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.16 36.53 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 64.6 p -121.26 -134.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -0.871 . . . . 0.0 109.187 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' C ' ' CD2' ' A' ' 69' ' ' LEU . . . -99.6 168.73 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.883 -1.136 . . . . 0.0 109.333 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.528 HD12 HD22 ' A' ' 69' ' ' LEU . 0.5 OUTLIER -112.9 136.23 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.192 -0.942 . . . . 0.0 109.403 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -65.46 147.01 98.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 109.569 -179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.423 ' HB2' ' CD ' ' A' ' 123' ' ' LYS . 35.3 Cg_endo -77.71 133.97 13.2 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.688 2.259 . . . . 0.0 110.147 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.508 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 174.25 -144.89 7.78 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.938 ' HE2' HG23 ' A' ' 130' ' ' VAL . 3.8 ptm -105.73 -164.68 1.04 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.306 -1.114 . . . . 0.0 109.481 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -168.57 123.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.995 -1.066 . . . . 0.0 110.32 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.609 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -111.28 159.69 17.71 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.04 HD11 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -154.06 158.46 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 118.422 -1.311 . . . . 0.0 111.28 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.481 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 47.2 t -142.15 102.63 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER -54.94 159.42 2.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.318 -0.864 . . . . 0.0 109.588 -179.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.693 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.4 tm0? -35.85 -38.83 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.762 -0.586 . . . . 0.0 110.022 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -103.06 -159.58 0.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.145 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . -64.62 -163.77 0.79 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.533 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 4.1 t60 79.46 124.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.412 -1.052 . . . . 0.0 109.732 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.85 140.73 52.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 108.872 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.0 mp0 -109.68 152.34 25.72 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.925 -1.109 . . . . 0.0 109.746 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.003 ' CD2' HG22 ' A' ' 130' ' ' VAL . 2.3 m-85 -124.22 132.29 53.59 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD12 HG21 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -149.54 -176.82 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 109.615 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.575 ' CD1' HD13 ' A' ' 84' ' ' ILE . 0.4 OUTLIER -162.84 130.88 3.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 108.928 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.48 -166.34 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.87 . . . . 0.0 109.334 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.462 ' HB2' ' HB ' ' A' ' 82' ' ' THR . 1.9 m -143.04 -93.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.69 154.63 17.4 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.0 -173.27 42.27 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.1 mt -122.09 131.99 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -1.136 . . . . 0.0 109.339 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.528 HD22 HD12 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -112.88 -172.4 2.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.0 109.961 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 179.78 142.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 71' ' ' VAL . 9.2 p -107.58 132.55 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 109.917 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.513 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.2 mt-30 -119.78 173.42 3.61 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 0.0 109.081 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.35 110.6 2.89 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.525 2.15 . . . . 0.0 110.829 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 78.51 11.86 84.85 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 19.6 p-10 -179.8 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.017 -1.284 . . . . 0.0 109.838 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.742 HG22 ' HA ' ' A' ' 6' ' ' LEU . 4.5 m -129.75 178.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 0.0 109.106 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.498 HG22 ' N ' ' A' ' 78' ' ' VAL . 98.9 m -160.86 160.48 31.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.95 -1.094 . . . . 0.0 109.954 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' CG1' HG12 ' A' ' 8' ' ' VAL . 1.8 p -177.02 138.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.777 ' N ' HD12 ' A' ' 79' ' ' LEU . 1.3 mp -124.31 153.27 42.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.04 -1.037 . . . . 0.0 109.95 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.95 166.06 26.37 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.433 -0.792 . . . . 0.0 109.047 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 81' ' ' ASP . 8.5 t70 -100.18 3.77 43.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.169 -0.957 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 11.7 m -119.64 153.56 35.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.662 ' HB2' ' CB ' ' A' ' 10' ' ' SER . . . -168.57 113.42 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.474 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.575 HD13 ' CD1' ' A' ' 63' ' ' TYR . 1.0 OUTLIER -104.62 -37.38 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.231 -0.918 . . . . 0.0 109.216 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 75.43 49.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 130' ' ' VAL . . . 43.88 -109.58 0.26 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.523 ' CA ' HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -98.78 59.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -1.117 . . . . 0.0 109.886 -179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 33.3 t0 -47.42 -38.23 12.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.314 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.4 tp -163.65 127.6 2.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.13 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 56.09 172.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -0.95 . . . . 0.0 109.319 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.674 ' HA ' HD11 ' A' ' 131' ' ' ILE . 2.4 mt-10 -128.56 -5.69 5.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.226 -0.921 . . . . 0.0 109.836 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -90.31 -11.34 41.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.944 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -81.57 -17.38 48.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.888 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.44 -7.74 52.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.135 -0.978 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mtt -85.4 -10.93 55.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.613 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.6 -26.53 60.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.517 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.89 -1.94 34.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HD2' HD12 ' A' ' 125' ' ' ILE . 0.9 OUTLIER -84.58 -53.82 5.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.342 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -74.45 -29.56 61.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -65.62 -21.59 66.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.75 -21.86 34.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.253 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -68.64 -29.37 67.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.579 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -17.66 51.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.361 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -88.79 -20.32 24.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.492 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 121' ' ' LEU . 65.4 mt -83.08 4.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.661 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.4 m -47.83 -52.13 20.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.69 115.76 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -0.883 . . . . 0.0 109.342 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.7 p -153.28 148.66 27.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.434 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.63 -63.65 0.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.925 . . . . 0.0 109.518 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.543 ' N ' ' HB2' ' A' ' 113' ' ' ASP . . . 175.4 171.62 39.54 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 58.82 -90.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -1.115 . . . . 0.0 109.596 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 14.3 m -88.19 20.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.196 -0.94 . . . . 0.0 109.697 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.543 ' HB2' ' N ' ' A' ' 110' ' ' GLY . 51.0 t0 -62.35 -100.49 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.287 -0.883 . . . . 0.0 109.276 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -15.36 58.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.994 -1.066 . . . . 0.0 108.473 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -71.83 -37.73 70.25 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.685 -0.634 . . . . 0.0 109.591 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.464 ' HB2' ' HB ' ' A' ' 112' ' ' VAL . 12.2 tt0 -84.24 -10.2 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.65 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.93 -20.84 24.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 109.65 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.757 ' O ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -64.37 -13.18 49.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 109.488 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.66 -60.97 1.78 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.863 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -59.08 -47.62 84.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 110.049 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.974 ' HB2' HD11 ' A' ' 105' ' ' ILE . 0.7 OUTLIER -68.18 -59.74 2.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.802 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 118' ' ' SER . . . -56.26 -16.63 5.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.855 . . . . 0.0 109.829 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.423 ' CD ' ' HB2' ' A' ' 47' ' ' PRO . 7.6 ttpt -76.86 -36.2 56.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.731 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -83.18 -14.01 54.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.805 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.607 HD12 ' HD2' ' A' ' 98' ' ' LYS . 35.2 mm -87.84 -8.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.157 -0.964 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.49 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -68.43 -30.64 69.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.473 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.599 ' O ' HG22 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -84.07 -17.73 39.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.657 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 0.4 OUTLIER -85.09 -30.51 24.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.593 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.483 ' O ' HD23 ' A' ' 133' ' ' LEU . 5.7 tpp180 -82.17 -33.94 29.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.54 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.003 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.15 -25.24 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.348 -0.845 . . . . 0.0 109.174 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.674 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.3 tt -90.95 -23.85 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.434 -0.791 . . . . 0.0 110.29 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -81.01 -34.62 32.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.9 HD11 ' HZ ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -84.67 0.17 51.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.955 -1.09 . . . . 0.0 110.099 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.542 HG23 ' CD2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -80.97 -2.08 46.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.122 -0.987 . . . . 0.0 109.482 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -25.23 34.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.882 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -89.12 -9.05 52.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.12 -0.987 . . . . 0.0 109.578 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.83 37.33 1.53 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.684 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.431 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.666 ' O ' HG23 ' A' ' 3' ' ' THR . 1.3 tpt 178.62 40.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.253 -0.905 . . . . 0.0 109.609 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 2' ' ' MET . 0.4 OUTLIER -165.99 140.28 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.009 . . . . 0.0 109.792 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.776 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.7 p90 -152.73 -142.69 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 75' ' ' ASN . 19.2 t-80 -139.39 141.81 37.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.001 -1.062 . . . . 0.0 109.878 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.031 HD23 HG21 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -137.38 153.83 50.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.079 -1.013 . . . . 0.0 108.673 178.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.766 ' N ' HD12 ' A' ' 6' ' ' LEU . 3.1 t70 -148.33 98.06 2.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.989 ' HA ' HG22 ' A' ' 78' ' ' VAL . 2.1 p -99.28 110.14 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.862 -1.149 . . . . 0.0 109.09 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.05 154.66 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.711 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.713 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.7 t -165.96 107.52 0.73 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.326 -0.859 . . . . 0.0 109.211 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 77.07 34.36 0.41 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.311 -0.868 . . . . 0.0 109.384 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 55.04 39.63 31.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 109.605 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' O ' ' CB ' ' A' ' 14' ' ' GLN . 22.5 mt-30 -87.67 -43.9 11.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.923 . . . . 0.0 109.204 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER 72.21 84.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.126 179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.461 ' SD ' HG13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -98.97 -93.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 108.78 179.26 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.698 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 32.8 t80 -94.03 110.09 21.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.091 -1.006 . . . . 0.0 109.315 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.496 ' HB2' ' OD1' ' A' ' 7' ' ' ASP . 60.4 p -136.97 109.94 7.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . 145.49 -169.52 27.03 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.72 ' C ' HG12 ' A' ' 20' ' ' VAL . 19.8 mt -52.46 177.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.107 -1.231 . . . . 0.0 108.602 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.031 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -176.04 145.03 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.962 -1.086 . . . . 0.0 109.563 -178.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -108.7 -48.61 3.28 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.361 -0.837 . . . . 0.0 110.072 -179.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 67.3 mmtt -147.19 101.76 3.43 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.75 -1.18 . . . . 0.0 111.405 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.943 HG13 HD11 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -99.94 109.72 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.445 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.79 110.09 22.48 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.04 -1.037 . . . . 0.0 110.51 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.839 HG21 ' HG3' ' A' ' 46' ' ' LYS . 7.4 p -99.67 147.81 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.162 -0.961 . . . . 0.0 109.457 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.4 m -135.84 121.71 19.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.312 -0.867 . . . . 0.0 109.453 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -152.42 -177.67 26.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.91 150.59 34.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -1.132 . . . . 0.0 109.293 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 64.8 76.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.964 . . . . 0.0 109.14 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 99.66 179.65 30.69 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 30' ' ' GLY . 0.0 OUTLIER 175.02 38.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.238 . . . . 0.0 109.806 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.528 ' O ' ' CG1' ' A' ' 25' ' ' VAL . 4.6 mt -92.41 150.03 21.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.672 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.47 177.94 29.88 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 108.061 -2.016 . . . . 0.0 108.061 178.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.776 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 16.4 mm -98.6 140.13 19.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 120.874 -1.368 . . . . 0.0 109.187 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -137.79 170.87 9.47 Favored Pre-proline 0 C--N 1.299 -1.591 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.204 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.595 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.8 Cg_endo -72.63 80.02 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.862 1.708 . . . . 0.0 109.918 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.66 34.94 0.26 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.435 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.8 t-160 -83.23 142.67 30.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -1.208 . . . . 0.0 109.54 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.497 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -46.74 157.71 0.45 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.185 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.73 87.4 1.52 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 110.359 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 71' ' ' VAL . 2.4 mm? -99.9 155.44 17.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.49 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -157.62 75.2 0.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.773 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.9 t -156.09 -146.08 0.17 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.885 . . . . 0.0 109.021 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.773 ' N ' HG23 ' A' ' 43' ' ' THR . . . -99.46 136.46 39.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.969 HD12 HD21 ' A' ' 69' ' ' LEU . 0.8 OUTLIER -156.47 -169.35 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 109.76 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.839 ' HG3' HG21 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 63.61 51.95 1.37 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.488 -0.757 . . . . 0.0 110.399 -179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 37.4 Cg_endo -80.19 65.99 8.85 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.208 1.938 . . . . 0.0 110.811 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.45 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 155.11 -127.49 2.08 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.298 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' TYR . 4.6 ptm -108.61 -169.41 1.49 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -1.09 . . . . 0.0 109.684 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.943 HD11 HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -179.43 127.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 0.0 110.264 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.477 ' C ' HG13 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -110.35 172.86 6.61 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.826 HD13 HD21 ' A' ' 6' ' ' LEU . 18.2 mt -155.14 166.49 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.019 -1.051 . . . . 0.0 109.601 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 42.8 t -138.89 107.91 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.263 -0.898 . . . . 0.0 109.903 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 157.68 -97.21 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 16' ' ' PHE . 11.6 tm0? -50.68 165.45 0.1 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 0.0 109.373 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 2.0 t-160 75.54 -145.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.185 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.7 -86.43 0.92 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -120.23 -18.8 7.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.314 -1.109 . . . . 0.0 109.362 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -169.73 152.45 4.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.304 -0.873 . . . . 0.0 109.211 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.15 161.01 22.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.775 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 2.8 m-85 -118.19 141.78 48.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.373 -0.829 . . . . 0.0 109.568 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.912 ' HB ' HG23 ' A' ' 50' ' ' ILE . 2.3 mp -151.53 166.66 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.101 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -171.45 130.1 0.71 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.172 -0.955 . . . . 0.0 109.275 -179.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.895 HD22 ' HB3' ' A' ' 80' ' ' ALA . 10.5 mt -131.62 172.6 12.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.789 . . . . 0.0 109.084 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.7 m -148.76 46.57 1.02 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.002 . . . . 0.0 109.472 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 133.24 91.27 0.46 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 44' ' ' ALA . . . -160.91 151.55 22.0 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' THR . 20.4 mt -105.72 119.7 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.969 HD21 HD12 ' A' ' 45' ' ' ILE . 1.4 pp -109.06 -161.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.319 -0.863 . . . . 0.0 109.958 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.576 ' N ' HD12 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -177.7 124.16 0.12 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.637 HG23 ' HB ' ' A' ' 76' ' ' VAL . 13.4 p -99.66 138.78 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.504 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.508 ' HG2' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -121.46 174.98 2.7 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.508 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 35.9 Cg_endo -78.79 84.66 1.99 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.444 2.096 . . . . 0.0 110.515 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 132.77 -36.29 2.19 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.496 ' HB3' ' HB3' ' A' ' 5' ' ' HIS . 9.8 p30 -155.14 154.19 31.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -1.225 . . . . 0.0 109.83 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.637 ' HB ' HG23 ' A' ' 71' ' ' VAL . 1.4 p -134.3 165.84 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.876 . . . . 0.0 108.876 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.532 ' N ' HG22 ' A' ' 76' ' ' VAL . 98.7 m -153.55 145.56 23.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 0.0 109.63 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.989 HG22 ' HA ' ' A' ' 8' ' ' VAL . 2.6 m -122.74 147.82 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 0.0 109.441 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.4 114.09 20.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.673 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -137.17 172.2 13.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 0.0 109.314 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.73 -20.19 8.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 m -112.84 109.63 19.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -129.45 146.48 51.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.561 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.679 HD12 ' CE1' ' A' ' 63' ' ' TYR . 55.3 mt -139.16 86.39 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.248 -0.907 . . . . 0.0 108.969 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 84' ' ' ILE . 26.3 ttt180 -42.23 153.75 0.06 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -53.01 107.54 0.57 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.44 79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.277 -1.131 . . . . 0.0 109.461 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.421 ' O ' HD12 ' A' ' 89' ' ' LEU . 11.8 t70 -92.26 -34.35 14.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 109.348 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 88' ' ' ASP . 1.7 tp -162.99 131.82 4.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 109.28 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 53.21 -178.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.628 ' HB2' HD13 ' A' ' 131' ' ' ILE . 11.1 pt-20 -170.2 -39.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.487 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -75.06 -27.16 59.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.355 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -84.01 8.07 16.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.394 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.05 -12.36 38.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 0.0 109.178 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.17 -26.82 53.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.44 -0.787 . . . . 0.0 109.467 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -77.25 -22.28 52.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.0 -36.38 72.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' CD ' HG12 ' A' ' 125' ' ' ILE . 22.0 tttp -79.54 -22.59 43.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 109.353 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -69.07 -48.93 61.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.81 8.1 18.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.524 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.855 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -84.05 -24.13 30.57 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.166 -0.959 . . . . 0.0 109.164 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 102' ' ' GLU . 33.2 tt0 -69.42 -24.18 63.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.85 . . . . 0.0 109.224 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.67 -47.12 83.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.84 74.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.378 -0.826 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.762 HD11 ' HG ' ' A' ' 121' ' ' LEU . 14.6 mt -84.12 -11.23 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.384 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 68.0 m -48.98 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.666 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 105' ' ' ILE . 0.3 OUTLIER -164.6 -38.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.217 179.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.0 m 48.05 68.24 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.677 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.62 -67.45 0.89 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.442 ' O ' ' C ' ' A' ' 111' ' ' ASP . . . 125.75 -47.36 1.02 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -43.1 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -1.1 . . . . 0.0 109.133 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.429 ' HB ' ' CG ' ' A' ' 116' ' ' GLN . 22.6 m -143.56 36.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -90.12 -96.47 0.11 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.711 -0.618 . . . . 0.0 109.375 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.609 ' CD1' HG21 ' A' ' 105' ' ' ILE . 2.4 m-85 -60.03 -19.2 51.49 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.32 -54.18 15.86 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.429 ' CG ' ' HB ' ' A' ' 112' ' ' VAL . 50.6 mm-40 -87.95 -0.72 57.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.687 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . -90.88 -25.5 19.81 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.216 -0.927 . . . . 0.0 109.672 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.1 p -64.01 -18.63 64.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 109.706 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.25 -68.91 0.75 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.217 -0.927 . . . . 0.0 109.92 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 121' ' ' LEU . 11.1 pt-20 -55.14 -44.64 75.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.907 . . . . 0.0 110.046 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.855 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -62.62 -61.01 2.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.49 -14.35 12.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.788 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.04 -33.89 76.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.25 70.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -0.959 . . . . 0.0 109.564 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.6 mp -77.29 -1.71 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.163 -0.961 . . . . 0.0 109.715 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.645 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -74.51 -20.56 59.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.183 -0.948 . . . . 0.0 109.071 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.883 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.5 pt20 -87.22 -24.12 24.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.451 -0.78 . . . . 0.0 109.214 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.619 HD23 ' C ' ' A' ' 128' ' ' LEU . 2.2 tt -72.17 -9.36 58.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 0.0 109.424 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.417 ' O ' HD13 ' A' ' 133' ' ' LEU . 10.0 mmt85 -84.61 -34.1 23.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.185 -0.947 . . . . 0.0 109.693 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.883 HG22 ' O ' ' A' ' 127' ' ' GLN . 33.4 m -62.7 -27.6 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 109.539 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 91' ' ' GLU . 96.8 mt -62.34 -39.59 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.452 ' HA ' ' HG2' ' A' ' 135' ' ' LYS . 1.0 OUTLIER -65.08 -18.34 65.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.522 -179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.573 ' N ' ' CD1' ' A' ' 133' ' ' LEU . 4.8 mp -89.03 -34.97 16.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.192 -0.942 . . . . 0.0 109.519 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 79.1 p -70.66 -20.88 62.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 132' ' ' GLU . 0.1 OUTLIER -81.02 -6.49 58.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.773 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.1 mtmp? -143.25 23.4 1.84 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -96.24 -20.82 18.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.422 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.578 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.475 ' N ' ' HB3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -172.03 174.28 4.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.288 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.505 HG21 ' HG3' ' A' ' 55' ' ' GLN . 1.4 t -43.63 154.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.296 -0.878 . . . . 0.0 109.503 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.692 ' CE2' HG22 ' A' ' 34' ' ' ILE . 3.5 p90 -144.34 -159.65 1.02 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.562 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.1 t60 -114.05 144.79 42.55 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.947 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -103.15 130.97 50.49 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.162 -0.961 . . . . 0.0 109.136 178.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' H ' HD13 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -137.44 88.85 2.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.01 -1.056 . . . . 0.0 109.872 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.2 p -114.01 116.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.469 HG12 ' HG3' ' A' ' 14' ' ' GLN . 16.3 m -124.28 172.19 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.858 . . . . 0.0 109.753 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.458 ' HB2' ' CG ' ' A' ' 13' ' ' GLN . 15.0 m -124.81 -150.52 0.45 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.403 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.58 -43.24 65.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.616 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -164.91 49.3 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.083 -1.011 . . . . 0.0 109.691 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.458 ' CG ' ' HB2' ' A' ' 10' ' ' SER . 0.1 OUTLIER -151.15 155.54 39.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.32 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HG3' HG12 ' A' ' 9' ' ' VAL . 2.0 mt-30 -111.49 161.58 16.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.815 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.488 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 32.3 mtp -140.88 -46.55 0.4 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.393 -0.817 . . . . 0.0 109.274 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.626 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -138.75 110.95 7.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.95 . . . . 0.0 109.653 179.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 17' ' ' SER . 19.6 p -139.43 86.48 2.12 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.31 -0.869 . . . . 0.0 109.379 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . -177.6 -149.98 8.22 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.731 ' C ' HG12 ' A' ' 20' ' ' VAL . 35.7 mt -82.45 175.25 10.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.156 -1.202 . . . . 0.0 109.529 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.947 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.1 OUTLIER 176.4 171.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.085 -1.009 . . . . 0.0 108.82 -179.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.591 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 6.4 tt0 -166.87 -34.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.584 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -116.42 75.66 0.97 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.135 -0.978 . . . . 0.0 109.664 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.814 HD13 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -99.61 143.6 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.266 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 19.7 tt0 -149.78 158.33 44.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.005 -1.06 . . . . 0.0 109.927 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 30' ' ' GLY . 6.9 p -131.03 149.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.455 -0.778 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 0.2 OUTLIER -120.51 89.16 3.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.407 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -119.06 -77.7 0.56 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 p -150.38 -86.04 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -1.166 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.37 -28.6 22.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.0 109.402 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 25' ' ' VAL . . . -90.96 73.06 1.8 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -93.24 29.97 1.78 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -1.115 . . . . 0.0 109.474 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.65 HD13 ' OH ' ' A' ' 35' ' ' TYR . 12.4 mt -130.86 144.75 51.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.213 -0.929 . . . . 0.0 109.66 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.5 -97.59 2.15 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 107.603 -2.199 . . . . 0.0 107.603 178.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.713 HD12 ' ND1' ' A' ' 38' ' ' HIS . 5.0 mm -155.72 161.74 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.431 -1.041 . . . . 0.0 109.422 178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.65 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -165.12 175.1 2.66 Favored Pre-proline 0 N--CA 1.491 1.588 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -179.075 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.575 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -71.88 118.62 5.72 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.836 1.69 . . . . 0.0 109.222 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.02 31.97 24.72 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 107.342 -2.303 . . . . 0.0 107.342 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.8 ' CE1' HG21 ' A' ' 71' ' ' VAL . 19.3 p80 -86.9 -171.0 3.31 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.798 0.809 . . . . 0.0 110.79 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 1.053 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -54.74 -172.89 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 1.053 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 33.1 Cg_endo -76.79 -179.68 5.62 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.913 1.742 . . . . 0.0 110.271 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.527 ' CA ' ' H ' ' A' ' 71' ' ' VAL . 0.3 OUTLIER -90.6 37.64 0.92 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.193 -0.942 . . . . 0.0 110.913 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 tp -147.5 116.54 6.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.068 -1.02 . . . . 0.0 109.574 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.1 t -175.74 -173.73 0.63 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.417 -0.802 . . . . 0.0 109.199 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.75 150.58 52.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.072 -1.018 . . . . 0.0 109.822 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.704 HD13 ' HB2' ' A' ' 69' ' ' LEU . 1.7 mp -102.17 112.64 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.134 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.513 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 1.0 OUTLIER -65.01 174.72 1.21 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.279 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 33.8 Cg_endo -77.14 142.63 21.86 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.574 2.182 . . . . 0.0 110.55 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 152.15 -156.39 26.67 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.413 ' O ' HG13 ' A' ' 50' ' ' ILE . 13.5 ptm -103.6 -168.31 1.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.208 -1.172 . . . . 0.0 109.35 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 7.6 mt -155.82 126.6 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.146 -0.971 . . . . 0.0 109.798 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -117.9 110.54 17.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.752 ' CD1' HD12 ' A' ' 23' ' ' ILE . 29.4 mt -118.33 168.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.117 -0.989 . . . . 0.0 110.52 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.593 ' N ' HG22 ' A' ' 52' ' ' ILE . 38.1 t -135.27 120.96 30.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.4 ttmt -64.03 147.45 52.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.444 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.505 ' HG3' HG21 ' A' ' 3' ' ' THR . 6.3 tm0? -65.05 -49.05 71.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.444 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -53.26 -62.59 1.55 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.937 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.96 85.43 0.06 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -170.66 176.84 4.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -1.054 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 53' ' ' VAL . 5.3 mt-10 -145.55 128.38 16.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.26 133.19 32.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.716 ' CZ ' HD11 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -116.23 145.31 43.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.958 . . . . 0.0 109.618 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.55 HG22 ' H ' ' A' ' 63' ' ' TYR . 3.2 mp -121.85 171.93 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.322 -0.861 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' CE1' HD13 ' A' ' 84' ' ' ILE . 8.2 t80 -141.34 152.7 44.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.29 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.482 HD12 ' C ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -172.92 -166.9 0.39 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.498 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 61.7 m -154.81 21.53 0.45 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 159.48 150.0 5.7 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.25 159.91 9.5 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.883 ' O ' HG23 ' A' ' 78' ' ' VAL . 2.0 mp -107.9 140.69 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.105 . . . . 0.0 109.305 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.755 HD23 ' C ' ' A' ' 69' ' ' LEU . 2.6 tt -121.05 156.9 31.21 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.09 -1.006 . . . . 0.0 109.635 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.658 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -158.21 146.45 18.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.11 HG22 HG22 ' A' ' 76' ' ' VAL . 2.2 t -103.31 159.27 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.962 -1.086 . . . . 0.0 110.132 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.607 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -126.19 -171.13 0.22 Allowed Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 179.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.607 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.9 Cg_endo -79.55 40.61 0.97 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.645 1.564 . . . . 0.0 111.294 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 145.49 34.23 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.94 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 5.2 p-10 166.19 133.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.284 . . . . 0.0 109.974 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.11 HG22 HG22 ' A' ' 71' ' ' VAL . 6.6 t -99.62 157.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.285 -0.884 . . . . 0.0 108.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 23.0 m -154.3 137.07 15.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.252 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.883 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.5 p -141.32 141.72 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.599 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.24 107.67 17.06 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.268 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 66' ' ' GLY . . . -102.2 162.58 12.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.733 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -92.96 -47.02 7.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.618 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 55.5 m -100.82 136.03 41.33 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.227 -0.921 . . . . 0.0 109.549 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.698 ' C ' HD12 ' A' ' 84' ' ' ILE . . . -151.24 134.13 15.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.308 -0.87 . . . . 0.0 109.514 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.727 HG21 ' HG3' ' A' ' 127' ' ' GLN . 1.1 mp -111.86 -37.94 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.84 . . . . 0.0 108.959 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.511 ' CB ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER 77.26 84.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.467 -0.771 . . . . 0.0 109.809 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 42.18 -111.61 0.34 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.456 ' CG ' ' O ' ' A' ' 87' ' ' GLN . 1.4 tt0 -117.98 62.12 0.76 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.284 -1.127 . . . . 0.0 109.509 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 85' ' ' ARG . 13.0 t70 -85.77 -11.3 53.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 90' ' ' ASP . 0.5 OUTLIER -149.26 144.69 26.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.242 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER 54.16 171.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.169 -0.957 . . . . 0.0 109.18 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.678 ' HG3' HD11 ' A' ' 131' ' ' ILE . 81.6 tt0 -168.15 -80.2 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.442 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -79.69 -14.95 58.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.213 -0.929 . . . . 0.0 109.269 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -6.01 51.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.17 -27.37 19.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.194 -0.942 . . . . 0.0 108.988 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.4 mtt -67.2 -40.53 86.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.443 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.16 -33.11 75.02 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.433 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.67 75.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.897 . . . . 0.0 109.223 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 128' ' ' LEU . 1.3 tmmt? -62.37 -14.36 39.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 109.473 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.79 -53.05 4.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.92 . . . . 0.0 109.482 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -65.23 -15.16 62.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.612 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -84.63 -28.36 26.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.348 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 103' ' ' GLU . 24.8 tt0 -76.33 -48.61 19.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 102' ' ' GLU . 38.6 tt0 -45.43 -29.7 1.17 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.917 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -71.22 -56.74 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 mt -87.36 16.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.927 . . . . 0.0 109.507 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -65.96 91.21 0.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -0.953 . . . . 0.0 109.433 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 71.6 143.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.0 OUTLIER 171.25 166.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.234 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -130.43 132.17 45.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.537 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.63 166.49 16.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.579 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 3.2 m-20 -97.41 -54.34 3.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.171 -1.194 . . . . 0.0 109.537 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 113' ' ' ASP . 21.2 m -122.6 -18.05 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.239 -0.913 . . . . 0.0 109.814 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 112' ' ' VAL . 1.4 m-20 -46.4 -95.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.565 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -13.08 60.27 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.175 -0.953 . . . . 0.0 108.47 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -73.28 -5.0 36.65 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -85.31 -30.93 23.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -73.61 -16.62 61.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -21.94 63.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.676 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.36 -27.42 25.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.653 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -81.81 -27.84 33.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.673 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.612 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.2 OUTLIER -76.2 -58.57 3.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -45.7 -25.05 0.43 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.209 -0.932 . . . . 0.0 109.634 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.51 ' HD3' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -66.56 -50.36 63.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 109.831 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.61 -33.56 71.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 110.053 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.441 HD12 ' HG3' ' A' ' 98' ' ' LYS . 37.6 mm -59.97 -14.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.171 -0.956 . . . . 0.0 109.861 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.413 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -69.5 -47.19 64.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.727 ' HG3' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.91 -23.02 59.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.662 HD23 ' C ' ' A' ' 128' ' ' LEU . 3.2 tt -74.94 -13.54 60.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.61 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.73 -48.19 7.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.752 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 29.9 m -62.69 -38.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.792 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.855 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -64.57 -18.01 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.31 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 135' ' ' LYS . 0.1 OUTLIER -82.22 -18.49 42.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 0.0 109.942 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.716 HD11 ' CZ ' ' A' ' 61' ' ' PHE . 1.1 pp -90.09 -24.83 21.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.005 . . . . 0.0 109.413 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 131' ' ' ILE . 10.7 t -69.72 -5.57 25.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.516 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.533 ' HE2' ' CG ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -53.19 -20.97 4.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.743 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.533 ' CG ' ' HE2' ' A' ' 135' ' ' LYS . 14.8 mttt -113.85 -12.75 12.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 0.0 109.582 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.38 -58.0 2.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 ptp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.419 179.879 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.503 ' O ' HG22 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.483 ' O ' ' HB ' ' A' ' 3' ' ' THR . 3.8 mtt 44.8 53.33 7.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.224 -0.923 . . . . 0.0 109.458 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.574 ' O ' HG23 ' A' ' 3' ' ' THR . 9.1 t 174.47 128.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 1.053 ' CE2' HG22 ' A' ' 34' ' ' ILE . 21.8 p90 -107.68 -161.57 0.79 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 3.1 t-80 -117.26 144.59 44.67 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.194 -0.941 . . . . 0.0 109.052 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.086 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -135.59 161.4 35.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.306 -1.496 . . . . 0.0 109.194 178.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.966 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -149.49 94.55 2.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.486 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.597 HG12 ' HB3' ' A' ' 16' ' ' PHE . 2.6 p -99.85 112.27 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.183 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.35 156.82 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 109.621 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 1.6 t -157.71 84.14 0.89 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 12' ' ' GLU . . . 57.56 21.79 7.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -0.897 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 11' ' ' ALA . 1.3 pt-20 175.13 88.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -59.49 92.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.328 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.31 48.78 0.18 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.649 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 9.2 mtt -136.52 -52.47 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 109.427 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.636 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 33.9 t80 -166.53 129.25 1.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.494 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 79.4 p -161.6 94.1 0.95 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.422 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.22 -146.8 11.84 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.749 ' C ' HG12 ' A' ' 20' ' ' VAL . 11.4 mt -68.24 167.92 13.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.259 -1.142 . . . . 0.0 109.257 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.086 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 177.9 155.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.059 -1.026 . . . . 0.0 108.794 -177.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.556 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 6.4 tt0 -151.06 -44.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.099 . . . . 0.0 111.056 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.549 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -105.97 76.49 1.18 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.732 -1.23 . . . . 0.0 111.494 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.879 HG22 HG12 ' A' ' 52' ' ' ILE . 6.5 pt -102.97 147.81 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.518 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 37.4 tt0 -145.71 127.24 15.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.786 -1.196 . . . . 0.0 110.333 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.514 HG23 ' HA2' ' A' ' 33' ' ' GLY . 5.4 t -104.71 133.09 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.44 -0.787 . . . . 0.0 108.963 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 m -124.46 129.55 50.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.258 -0.901 . . . . 0.0 109.467 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.23 -128.36 1.29 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.6 p -108.39 -18.52 13.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -1.168 . . . . 0.0 109.566 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -153.34 149.14 27.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.75 -74.44 1.32 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER 60.87 -175.42 0.12 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -1.099 . . . . 0.0 109.908 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 31' ' ' GLU . 14.3 mt 61.11 138.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.466 -0.771 . . . . 0.0 109.749 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.518 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -99.89 -102.1 2.42 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.053 HG22 ' CE2' ' A' ' 4' ' ' TYR . 10.5 mm -154.24 141.7 12.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.315 -1.109 . . . . 0.0 109.154 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.641 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -124.69 177.7 1.72 Allowed Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 33.6 Cg_endo -75.11 76.51 3.42 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.04 1.827 . . . . 0.0 110.425 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 135.37 41.04 0.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.415 ' HE1' HD23 ' A' ' 41' ' ' LEU . 38.9 t-80 -99.49 144.81 28.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.269 -1.136 . . . . 0.0 109.565 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.955 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -55.64 175.65 0.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.478 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.955 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.46 106.2 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.709 2.273 . . . . 0.0 110.443 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.482 ' H ' HG11 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -100.11 122.61 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.512 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD21 ' HG3' ' A' ' 70' ' ' GLU . 2.9 mt -136.21 71.65 1.42 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.288 -0.883 . . . . 0.0 109.4 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.2 p -137.69 -154.91 0.56 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.494 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.01 167.51 10.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.56 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.728 HD11 ' HB ' ' A' ' 78' ' ' VAL . 1.2 mt -103.57 -147.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.114 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -168.88 167.79 5.65 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.104 -0.998 . . . . 0.0 109.711 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.459 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.7 Cg_endo -78.88 122.42 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.745 2.297 . . . . 0.0 110.398 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 176.85 -161.06 28.68 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.685 ' HE1' HG23 ' A' ' 130' ' ' VAL . 2.3 ppp? -107.87 176.08 5.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -1.081 . . . . 0.0 109.222 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.536 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -164.38 126.85 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.995 -1.066 . . . . 0.0 110.064 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 21.9 mtm-85 -99.14 169.43 9.4 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.879 HG12 HG22 ' A' ' 23' ' ' ILE . 0.7 OUTLIER -161.31 158.27 2.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.415 -1.428 . . . . 0.0 110.692 -178.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.549 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 39.7 t -139.21 100.75 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.6 OUTLIER -58.2 159.82 5.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.541 ' HG3' HG21 ' A' ' 3' ' ' THR . 4.1 tm0? -42.08 -52.09 4.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.483 -0.76 . . . . 0.0 109.619 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 5.0 m80 -57.98 178.2 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.18 82.37 1.68 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.46 -167.59 2.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -1.148 . . . . 0.0 109.532 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 9.2 pt-20 -166.68 141.27 4.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.25 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.589 ' H ' HG22 ' A' ' 52' ' ' ILE . 1.7 mm-40 -116.2 167.63 10.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.718 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.011 ' CD2' HG22 ' A' ' 130' ' ' VAL . 6.0 m-85 -129.24 119.15 23.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.428 -0.795 . . . . 0.0 109.049 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.675 HG22 ' H ' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -126.79 179.93 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.132 -0.98 . . . . 0.0 109.871 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.775 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 0.2 OUTLIER -173.79 142.62 0.91 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -147.12 178.92 8.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.746 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 14.0 p -104.99 -25.47 12.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.465 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 163.64 178.19 37.09 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.11 -133.5 3.72 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.9 mp -144.4 130.43 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.24 . . . . 0.0 109.31 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.887 ' HA ' HG12 ' A' ' 78' ' ' VAL . 2.3 pp -109.13 125.91 52.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.176 -0.952 . . . . 0.0 109.786 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HG3' HD21 ' A' ' 42' ' ' LEU . 22.8 tt0 -125.17 129.14 49.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.065 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 ' HA ' ' A' ' 40' ' ' PRO . 7.1 p -99.24 155.46 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.136 -0.977 . . . . 0.0 109.832 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.509 ' CB ' ' OD1' ' A' ' 75' ' ' ASN . 0.1 OUTLIER -138.21 170.83 9.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.432 -0.792 . . . . 0.0 109.442 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.47 71.76 6.66 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.659 2.239 . . . . 0.0 110.768 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.19 -1.35 7.72 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.234 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 38.2 p-10 -172.88 175.26 3.36 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.933 -1.333 . . . . 0.0 109.865 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.571 HG13 ' HA ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -161.14 162.65 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.223 -0.923 . . . . 0.0 108.966 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 7' ' ' ASP . 29.4 m -158.54 149.36 20.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.283 -0.886 . . . . 0.0 109.418 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.887 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.0 m -135.86 157.07 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.267 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.54 112.88 16.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.711 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -113.61 159.18 19.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.93 -48.87 16.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.467 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.7 t -102.04 -178.56 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 109.482 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -170.13 85.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.681 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.754 HG22 ' O ' ' A' ' 84' ' ' ILE . 3.1 mp -104.09 67.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 109.21 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.578 ' HB3' ' HE2' ' A' ' 15' ' ' MET . 1.2 ptt180 -42.23 139.42 1.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.495 -0.753 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' C ' ' CG ' ' A' ' 87' ' ' GLN . . . -47.36 148.81 3.07 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.827 ' OE1' HG21 ' A' ' 134' ' ' THR . 0.0 OUTLIER 58.61 25.1 12.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.122 -1.222 . . . . 0.0 109.043 -179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 87' ' ' GLN . 17.6 p-10 -41.04 -46.39 2.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -159.04 -61.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.301 -0.874 . . . . 0.0 109.343 179.715 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.08 172.2 13.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.662 ' HA ' HD11 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -140.31 -87.27 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.359 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.44 -19.29 56.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.518 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.9 ttt85 -77.17 -8.43 57.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.471 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.36 -8.32 51.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.166 -0.959 . . . . 0.0 109.203 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.414 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -74.48 -23.37 58.86 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.377 -0.827 . . . . 0.0 109.527 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -85.37 5.41 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.626 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 101' ' ' ALA . . . -90.1 -12.44 38.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -29.52 65.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.542 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.7 mtm-85 -90.23 -32.66 16.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.949 . . . . 0.0 109.665 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.39 -8.11 57.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.202 -0.937 . . . . 0.0 109.698 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 97' ' ' ALA . . . -87.09 -30.67 20.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.118 -0.989 . . . . 0.0 109.384 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.564 ' HA ' HD12 ' A' ' 105' ' ' ILE . 1.9 tt0 -69.56 -33.4 72.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.525 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -59.57 -35.29 73.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -75.27 -20.6 59.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 0.0 109.424 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 105' ' ' ILE . 32.3 mt -90.33 21.51 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.394 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.86 55.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -119.8 145.77 46.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.381 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.439 ' HA ' ' OD1' ' A' ' 113' ' ' ASP . 1.4 p -128.95 138.29 51.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.213 -0.929 . . . . 0.0 109.686 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.6 -68.78 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.908 . . . . 0.0 109.317 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 176.26 -100.14 0.14 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.607 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -72.14 156.76 38.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -1.103 . . . . 0.0 109.457 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 111' ' ' ASP . 14.8 m 40.88 37.91 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.508 -0.745 . . . . 0.0 109.682 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 108' ' ' SER . 11.2 t70 -88.14 -96.3 0.09 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.353 -0.842 . . . . 0.0 109.192 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -69.37 -19.38 63.84 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.39 -41.79 84.41 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -90.12 -16.63 29.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.348 -0.845 . . . . 0.0 109.455 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 105' ' ' ILE . . . -79.38 -32.14 43.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.658 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 38.4 t -55.71 -21.75 20.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.193 -0.942 . . . . 0.0 109.587 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.85 -29.28 18.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.555 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -59.28 -24.75 63.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.497 ' O ' HD13 ' A' ' 125' ' ' ILE . 8.8 tt -82.51 -50.92 8.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.279 -0.888 . . . . 0.0 109.54 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.44 1.73 15.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.829 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.09 -61.76 1.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -78.3 -20.48 51.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.3 mp -75.72 -12.74 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.934 . . . . 0.0 109.163 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.775 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -68.67 -41.7 78.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.147 -0.971 . . . . 0.0 109.285 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -78.66 -7.62 57.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 5.8 tp -78.26 -26.76 47.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.468 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.512 ' O ' HD23 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -87.94 -25.25 23.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.752 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.011 HG22 ' CD2' ' A' ' 61' ' ' PHE . 2.3 p -80.53 -25.7 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.643 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 91' ' ' GLU . 2.1 tt -90.58 -24.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 0.0 110.232 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -74.83 -44.94 46.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.095 -1.003 . . . . 0.0 110.198 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 129' ' ' ARG . 2.6 pp -68.56 -11.03 59.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 110.038 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.827 HG21 ' OE1' ' A' ' 87' ' ' GLN . 57.4 p -53.28 -41.88 66.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.569 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.72 -41.76 64.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -94.57 40.66 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.379 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -104.12 6.75 36.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.344 -0.847 . . . . 0.0 109.612 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.9 mpp? . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.542 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.292 0.568 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.7 mtp 53.71 58.34 5.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.324 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.553 HG21 ' CG ' ' A' ' 55' ' ' GLN . 70.9 p -132.39 161.7 32.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.149 -0.97 . . . . 0.0 109.905 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.746 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 4.0 p90 -163.61 -143.67 0.08 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.772 ' HA ' HG12 ' A' ' 20' ' ' VAL . 2.4 t-80 -139.69 149.45 43.69 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.072 HD23 HG21 ' A' ' 20' ' ' VAL . 1.6 pp -142.67 159.25 42.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.685 -1.259 . . . . 0.0 108.631 178.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 77' ' ' THR . 9.8 t0 -135.49 87.0 2.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.895 -1.128 . . . . 0.0 109.678 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.804 HG12 ' HB3' ' A' ' 16' ' ' PHE . 14.7 p -99.04 100.44 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.22 -0.925 . . . . 0.0 109.604 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 13' ' ' GLN . 55.2 t -108.95 149.03 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.317 -0.865 . . . . 0.0 109.388 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 2.4 p -162.58 144.9 10.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 0.0 109.75 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.74 -96.98 0.07 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.717 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.55 38.98 3.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.056 -1.028 . . . . 0.0 109.567 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.582 ' HG2' HG22 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 62.86 -153.71 0.34 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.251 -0.905 . . . . 0.0 109.457 -179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.422 ' O ' ' SD ' ' A' ' 15' ' ' MET . 0.0 OUTLIER 70.46 61.5 0.21 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.519 -0.738 . . . . 0.0 109.491 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.641 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -143.72 -70.28 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.195 -0.941 . . . . 0.0 109.519 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.804 ' HB3' HG12 ' A' ' 8' ' ' VAL . 34.9 t80 -162.8 131.95 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.587 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.3 p -160.82 105.12 1.37 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.353 -0.842 . . . . 0.0 109.278 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 5' ' ' HIS . . . 146.67 -158.62 27.77 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.804 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -48.39 -179.18 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.068 -1.254 . . . . 0.0 109.474 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.072 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 170.37 115.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.549 -1.344 . . . . 0.0 109.74 179.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 1.5 tt0 -67.93 -44.7 76.27 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.153 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 21' ' ' GLU . 2.5 mtpt -179.5 143.13 0.19 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.995 . . . . 0.0 110.769 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.94 HG22 ' CG1' ' A' ' 52' ' ' ILE . 23.5 pt -105.34 -155.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.501 ' N ' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -178.92 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.889 -1.132 . . . . 0.0 109.907 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.506 HG12 ' HB ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.24 127.61 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.112 -0.992 . . . . 0.0 109.513 179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -130.64 140.6 50.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 139.83 54.11 0.04 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.493 ' HB3' ' CB ' ' A' ' 46' ' ' LYS . 89.4 p -174.17 -159.44 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -1.145 . . . . 0.0 109.438 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.29 48.18 1.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.415 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 31' ' ' GLU . . . -167.11 -144.07 3.99 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 0.3 OUTLIER 166.98 74.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -1.142 . . . . 0.0 109.714 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.792 HD13 ' OH ' ' A' ' 35' ' ' TYR . 12.6 mt -153.07 178.24 9.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.877 . . . . 0.0 109.67 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -128.68 -112.36 1.63 Allowed Glycine 0 N--CA 1.485 1.901 0 N-CA-C 107.784 -2.127 . . . . 0.0 107.784 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.746 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 12.7 mm -154.1 138.25 9.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.293 -1.122 . . . . 0.0 109.124 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.792 ' OH ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -138.28 176.9 2.37 Favored Pre-proline 0 C--N 1.299 -1.628 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.6 Cg_endo -74.06 8.11 2.21 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.995 1.797 . . . . 0.0 110.962 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -132.6 10.77 5.23 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' ALA . 40.1 t60 -54.33 123.75 13.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.135 -1.215 . . . . 0.0 109.703 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 1.001 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -49.17 178.56 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.329 -0.857 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 1.001 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 34.9 Cg_endo -77.72 81.36 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.465 2.11 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.5 OUTLIER -98.71 137.61 37.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 109.663 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.06 72.96 0.85 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.32 -0.862 . . . . 0.0 109.412 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 p -144.27 -146.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.374 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.51 169.92 8.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -0.942 . . . . 0.0 109.454 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -130.49 173.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 109.251 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' CB ' ' HB3' ' A' ' 28' ' ' SER . 0.1 OUTLIER -111.18 173.07 3.07 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 -179.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.7 Cg_endo -78.31 -177.94 4.26 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.735 2.29 . . . . 0.0 110.474 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.38 -159.12 23.51 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.539 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 4.6 ppp? -113.28 172.78 6.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.255 -1.144 . . . . 0.0 109.126 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 62' ' ' ILE . 5.1 tt -146.75 146.81 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.052 -1.03 . . . . 0.0 110.922 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.46 160.28 23.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.94 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -153.71 158.98 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.458 -1.401 . . . . 0.0 110.926 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.77 102.07 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 55' ' ' GLN . 0.7 OUTLIER -52.09 141.33 18.64 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.482 -0.761 . . . . 0.0 110.122 -178.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.574 ' OE1' ' CG ' ' A' ' 56' ' ' HIS . 0.4 OUTLIER -39.91 -59.1 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.622 -0.674 . . . . 0.0 109.926 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.574 ' CG ' ' OE1' ' A' ' 55' ' ' GLN . 3.4 m170 -122.36 31.58 6.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.151 -0.968 . . . . 0.0 109.739 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -109.35 -108.15 3.16 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -151.9 -80.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -1.127 . . . . 0.0 109.139 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.3 OUTLIER 179.65 147.67 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.551 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.8 mt-10 -130.91 161.39 31.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.104 -0.998 . . . . 0.0 109.782 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -117.64 125.31 50.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.272 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 50' ' ' ILE . 5.2 mt -136.8 166.58 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.183 -0.948 . . . . 0.0 109.331 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.856 ' HE1' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -151.92 146.18 25.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -0.927 . . . . 0.0 109.1 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.34 -172.81 4.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 109.519 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' A' ' 82' ' ' THR . 62.8 m -115.65 14.38 16.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.83 151.45 25.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . -165.85 -106.64 0.19 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 9.1 mt -139.2 122.27 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -1.054 . . . . 0.0 108.97 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.657 ' HB2' HD13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -106.58 133.48 51.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 0.0 109.782 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -133.5 143.64 48.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.019 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.671 ' HA ' HG12 ' A' ' 76' ' ' VAL . 14.7 p -109.94 139.88 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.917 -1.114 . . . . 0.0 109.494 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.579 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -127.87 176.9 2.36 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 108.862 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.579 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.0 Cg_endo -79.22 88.91 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.514 2.142 . . . . 0.0 111.103 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 5' ' ' HIS . . . 101.07 -3.43 55.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.4 OUTLIER -164.37 155.3 15.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.088 -1.242 . . . . 0.0 109.72 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.685 HG22 ' HA ' ' A' ' 6' ' ' LEU . 35.5 m -133.16 175.74 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 0.0 108.845 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 7' ' ' ASP . 17.6 m -156.63 104.58 2.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.031 -1.043 . . . . 0.0 110.282 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.5 m -114.47 115.8 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 108.963 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -100.21 173.2 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.132 -0.98 . . . . 0.0 110.034 -179.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -157.69 -157.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 0.0 109.182 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -127.22 -30.78 2.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.95 . . . . 0.0 109.805 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.432 ' HB ' ' OG ' ' A' ' 65' ' ' SER . 5.5 m -110.01 153.2 24.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 0.0 109.421 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.889 ' C ' HD12 ' A' ' 84' ' ' ILE . . . -152.64 119.75 5.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.163 -0.961 . . . . 0.0 109.793 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.889 HD12 ' C ' ' A' ' 83' ' ' ALA . 2.6 mp -139.07 95.02 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.29 -0.881 . . . . 0.0 108.907 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 84' ' ' ILE . 13.5 ttm180 -41.24 161.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.394 -0.816 . . . . 0.0 109.898 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -51.1 -26.32 12.07 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -151.7 93.41 1.86 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -1.153 . . . . 0.0 109.637 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -94.14 -57.88 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.484 -0.76 . . . . 0.0 109.455 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -83.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 109.475 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.13 165.97 17.89 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.259 -0.901 . . . . 0.0 109.323 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -112.43 -19.94 11.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.945 . . . . 0.0 109.533 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -82.86 -25.59 32.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 109.491 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.1 ttp-105 -65.51 -13.9 59.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 0.0 109.492 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.71 -32.0 16.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.379 -0.825 . . . . 0.0 109.29 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.488 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -56.01 -40.61 73.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.802 . . . . 0.0 109.681 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.91 -16.5 53.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.228 -0.92 . . . . 0.0 109.54 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 100' ' ' LYS . . . -64.37 -27.76 69.23 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.654 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -55.71 29.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.179 -0.951 . . . . 0.0 109.549 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.85 -19.92 62.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.907 . . . . 0.0 109.554 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 97' ' ' ALA . 0.0 OUTLIER -62.95 -34.28 77.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.784 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -89.61 -20.81 23.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.401 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -67.02 -16.67 64.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -80.53 -30.37 37.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.56 -32.36 32.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.883 . . . . 0.0 109.437 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.543 ' CG2' ' HB2' ' A' ' 118' ' ' SER . 25.6 mt -88.98 22.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.9 t -60.84 -24.94 66.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.892 . . . . 0.0 109.244 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.0 m -140.02 167.08 22.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.215 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.08 134.1 3.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.235 -0.916 . . . . 0.0 109.618 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -156.14 179.47 9.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.405 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.89 -178.89 35.75 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.571 ' O ' HG22 ' A' ' 112' ' ' VAL . 12.4 m-20 -98.41 127.62 44.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.518 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.571 HG22 ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.29 28.03 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.487 -0.758 . . . . 0.0 109.672 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 111' ' ' ASP . 15.5 t70 -84.88 -93.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.45 -13.6 60.39 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.44 -28.1 62.73 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.682 -0.636 . . . . 0.0 109.369 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.468 ' HG3' ' HB ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -74.81 -45.95 40.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.257 -0.902 . . . . 0.0 109.498 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.45 -23.3 65.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.87 . . . . 0.0 109.496 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.543 ' HB2' ' CG2' ' A' ' 105' ' ' ILE . 8.6 p -70.6 -5.78 31.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.556 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -85.5 -12.23 52.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.41 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -73.71 -12.52 60.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.784 HD12 ' HB3' ' A' ' 101' ' ' ALA . 0.4 OUTLIER -70.1 -60.79 2.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.69 -10.44 27.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.539 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -34.4 36.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.209 -0.932 . . . . 0.0 109.666 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -82.4 -14.96 54.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.603 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 121' ' ' LEU . 48.0 mm -73.04 -8.16 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.58 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -73.35 -35.23 65.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -0.907 . . . . 0.0 109.642 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.548 ' HG3' ' CE2' ' A' ' 63' ' ' TYR . 8.5 mt-30 -69.83 -23.26 63.28 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.421 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -69.47 -20.48 63.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.379 -0.825 . . . . 0.0 109.809 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -85.02 -40.63 16.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 109.823 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.566 ' HA ' ' CD2' ' A' ' 61' ' ' PHE . 20.8 m -68.01 -16.95 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.24 -0.913 . . . . 0.0 109.669 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 127' ' ' GLN . 4.9 pt -90.97 -31.78 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.893 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.484 ' HG2' HG13 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -80.05 -30.87 39.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 109.743 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 7.5 mp -79.81 -40.22 29.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.758 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 130' ' ' VAL . 17.9 p -63.16 -34.16 77.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.68 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -74.18 -15.98 61.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.127 -0.983 . . . . 0.0 109.542 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.04 29.6 6.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.668 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -128.41 -78.05 0.57 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.203 -0.935 . . . . 0.0 109.53 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.0 mtm -146.22 109.33 4.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.648 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -104.86 -148.15 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.652 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 1.23 ' CG ' HG22 ' A' ' 20' ' ' VAL 0.253 0.7 OUTLIER -142.25 -169.71 3.01 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 124.107 1.908 . . . . 0.0 115.576 -175.438 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 7.3 t-80 -170.8 95.98 0.21 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 102.319 -3.215 . . . . 0.0 102.319 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.89 HD23 HG11 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.52 147.83 22.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.522 -1.361 . . . . 0.0 108.638 -176.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.497 ' O ' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -155.76 69.89 0.69 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.847 -1.158 . . . . 0.0 110.015 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 64' ' ' LEU . 1.7 p -102.74 112.39 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 108.938 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 79' ' ' LEU . 3.9 m -103.97 144.49 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.802 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.843 ' OG ' ' HB2' ' A' ' 83' ' ' ALA . 55.9 m -107.35 53.11 0.7 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 109.265 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 72.03 77.51 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.361 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 64.38 31.6 12.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.452 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.462 ' CB ' ' HB2' ' A' ' 10' ' ' SER . 1.9 tp60 -114.79 -28.18 7.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 46.07 88.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.647 ' HE1' ' O ' ' A' ' 84' ' ' ILE . 0.5 OUTLIER -85.82 -84.27 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.191 -0.943 . . . . 0.0 109.537 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.725 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 1.1 t80 -101.05 112.09 24.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.093 -1.004 . . . . 0.0 110.307 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 94.6 p -128.72 85.84 2.38 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.131 -0.981 . . . . 0.0 109.658 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 168.33 148.15 5.62 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.597 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.714 HD23 ' N ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -35.63 161.13 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.886 0.851 . . . . 0.0 111.656 179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.23 HG22 ' CG ' ' A' ' 4' ' ' TYR . 0.9 OUTLIER -158.51 -160.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.526 0 O-C-N 121.684 -0.635 . . . . 0.0 109.988 -179.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.833 ' N ' HG23 ' A' ' 20' ' ' VAL . 2.3 tt0 -160.33 -32.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.029 -1.044 . . . . 0.0 109.734 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.6 mmmt -141.21 85.2 1.96 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.782 -1.199 . . . . 0.0 110.309 179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.87 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.57 142.68 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.324 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.526 ' O ' ' CB ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -127.41 143.91 51.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.762 -1.211 . . . . 0.0 110.309 -179.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -133.44 116.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.176 179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.7 m -122.69 125.35 45.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.969 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.07 -40.27 0.18 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.42 159.87 18.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.174 -1.192 . . . . 0.0 109.646 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -48.09 -43.03 30.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.318 -0.864 . . . . 0.0 109.55 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -53.44 -51.53 47.17 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 65.84 20.37 11.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -1.191 . . . . 0.0 109.414 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 153.93 40.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 109.716 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.573 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.39 171.03 23.85 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.263 -1.935 . . . . 0.0 108.263 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.949 HG22 ' OH ' ' A' ' 4' ' ' TYR . 16.6 mm -101.82 112.39 34.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.858 -1.378 . . . . 0.0 109.136 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -122.92 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 33.5 Cg_endo -76.89 5.56 4.83 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 C-N-CA 121.551 1.501 . . . . 0.0 110.44 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.84 17.84 2.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.452 ' CG ' HD13 ' A' ' 34' ' ' ILE . 16.7 t60 -44.81 146.53 0.76 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -1.092 . . . . 0.0 109.541 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.41 151.0 10.9 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.921 . . . . 0.0 109.669 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.563 ' HA ' ' CG1' ' A' ' 71' ' ' VAL . 35.4 Cg_endo -77.55 77.58 3.82 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.637 2.225 . . . . 0.0 110.222 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 41' ' ' LEU . 1.6 mm? -98.42 159.03 15.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.718 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -157.43 32.04 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -0.813 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.417 ' O ' HG13 ' A' ' 68' ' ' ILE . 44.1 p -114.96 -144.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.389 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.79 164.91 11.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.076 -1.015 . . . . 0.0 109.155 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.895 ' CD1' HD13 ' A' ' 69' ' ' LEU . 5.4 mt -128.99 149.88 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.115 -0.99 . . . . 0.0 109.554 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG3' ' HD2' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -70.24 167.86 22.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.317 -0.864 . . . . 0.0 109.762 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.497 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -78.99 136.58 13.19 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.744 2.296 . . . . 0.0 110.251 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.62 -161.96 26.43 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.626 ' C ' HG22 ' A' ' 50' ' ' ILE . 8.3 ptm -117.4 -164.23 0.98 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -1.133 . . . . 0.0 109.192 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.918 HD12 ' HB ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -174.68 147.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.965 -1.085 . . . . 0.0 109.982 -179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.513 ' HG2' ' CE1' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -129.17 126.37 39.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.654 HG23 ' CA ' ' A' ' 23' ' ' ILE . 30.6 mt -123.53 166.36 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.874 -1.141 . . . . 0.0 111.037 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.54 ' N ' HG22 ' A' ' 52' ' ' ILE . 34.2 t -132.23 119.26 39.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -71.05 129.49 39.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.653 . . . . 0.0 109.315 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' GLU . 11.5 tt0 52.68 -90.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.951 . . . . 0.0 109.25 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 54' ' ' LYS . 3.3 t-160 -171.1 60.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.398 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.77 -68.35 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -76.5 179.73 5.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -1.101 . . . . 0.0 109.399 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -156.5 153.68 29.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -0.979 . . . . 0.0 109.844 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.3 156.44 36.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.251 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.029 ' CD2' HG22 ' A' ' 130' ' ' VAL . 4.4 m-85 -119.24 124.97 48.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.544 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.918 ' HB ' HD12 ' A' ' 50' ' ' ILE . 5.3 mm -128.71 178.29 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.307 -0.871 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.637 ' H ' HG22 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -173.24 125.98 0.43 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -113.36 -177.61 3.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.892 . . . . 0.0 109.514 -179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 1.2 t -149.56 18.19 0.92 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.932 . . . . 0.0 109.384 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.13 156.72 6.99 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 143.14 -169.67 25.66 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -115.94 118.59 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -1.123 . . . . 0.0 109.369 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.895 HD13 ' CD1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -101.91 153.12 20.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.208 -0.933 . . . . 0.0 109.922 -179.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 41.6 tt0 -152.15 134.46 15.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG23 HG22 ' A' ' 76' ' ' VAL . 12.6 p -99.92 139.77 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.006 -1.059 . . . . 0.0 110.248 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -122.59 174.53 3.28 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.4 Cg_endo -78.62 103.4 1.66 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.32 2.014 . . . . 0.0 110.821 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 75.42 45.64 17.92 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 2.2 t30 159.91 115.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.468 -1.019 . . . . 0.0 109.177 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.663 HG22 HG23 ' A' ' 71' ' ' VAL . 23.5 t -102.2 146.53 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 108.875 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 7' ' ' ASP . 22.2 m -147.59 136.68 22.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.802 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.776 HG13 HG23 ' A' ' 8' ' ' VAL . 1.4 p -150.4 142.79 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.377 -0.827 . . . . 0.0 108.991 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 4.6 mp -105.21 159.26 16.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.879 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -163.73 -174.36 3.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.333 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -117.68 -39.03 3.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.125 -0.984 . . . . 0.0 109.563 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 65' ' ' SER . 1.8 m -99.46 149.18 23.46 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.254 -0.904 . . . . 0.0 109.196 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.843 ' HB2' ' OG ' ' A' ' 10' ' ' SER . . . -159.81 141.83 13.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.777 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.647 ' O ' ' HE1' ' A' ' 15' ' ' MET . 46.8 mt -132.67 126.14 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.328 -0.858 . . . . 0.0 108.793 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.449 ' O ' ' C ' ' A' ' 86' ' ' GLY . 3.0 tpt180 -92.37 91.98 7.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.034 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . 39.06 -102.44 0.02 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HG2' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -94.26 81.81 4.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -1.161 . . . . 0.0 109.593 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.65 -53.33 2.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.409 -0.807 . . . . 0.0 109.098 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 2.8 mp -92.11 31.92 1.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.066 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 131' ' ' ILE . 18.2 m-20 62.21 -179.55 0.13 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.951 . . . . 0.0 109.372 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.443 ' HG2' HD11 ' A' ' 131' ' ' ILE . 1.6 mt-10 -108.63 -36.59 6.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.668 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.0 -12.75 57.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 48.1 ttp180 -82.28 -26.77 32.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.44 -13.53 40.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.893 . . . . 0.0 108.9 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.487 ' HA ' HD11 ' A' ' 128' ' ' LEU . 3.4 mtt -70.34 -20.79 62.96 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.415 -0.803 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -68.8 -18.98 64.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 109.802 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -90.53 -54.97 3.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 110.094 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HG2' ' CG1' ' A' ' 125' ' ' ILE . 0.0 OUTLIER -54.2 -39.47 66.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 110.104 -179.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -36.04 82.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.065 -1.022 . . . . 0.0 110.005 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -4.57 58.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 109.876 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.647 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -90.29 -20.97 22.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.714 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 5.6 tp10 -73.68 -36.8 65.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -68.34 -22.96 64.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.62 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -51.72 26.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 0.0 109.591 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 105' ' ' ILE . 91.1 mt -89.14 22.84 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.98 -54.74 7.83 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.4 m -98.77 132.95 43.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.51 ' HB2' ' CB ' ' A' ' 114' ' ' TYR . 0.1 OUTLIER -162.75 138.87 7.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.65 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.431 ' N ' ' CD2' ' A' ' 109' ' ' HIS . 0.5 OUTLIER -168.33 169.08 10.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.63 -173.53 28.46 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 112' ' ' VAL . 5.0 t0 -101.17 135.26 42.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.133 . . . . 0.0 109.272 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.59 28.57 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.509 -0.744 . . . . 0.0 109.422 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' TYR . 6.9 t70 -79.24 -95.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.418 -0.801 . . . . 0.0 109.281 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 0.1 OUTLIER -69.76 -21.72 63.42 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.32 -42.29 73.55 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.69 -46.39 85.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -67.85 -11.22 58.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.42 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.9 t -82.77 6.03 19.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.907 . . . . 0.0 109.592 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.28 -41.21 14.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 0.0 109.558 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 123' ' ' LYS . 0.7 OUTLIER -77.03 -18.51 58.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.44 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.647 HD11 ' HB1' ' A' ' 101' ' ' ALA . 9.0 tt -71.77 -63.32 1.15 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.05 -18.94 4.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -0.871 . . . . 0.0 109.702 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -45.27 -38.32 5.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.79 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -90.55 -23.71 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.137 -0.977 . . . . 0.0 110.127 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 125' ' ' ILE . 2.2 mp -77.08 -1.06 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.722 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.83 -24.15 60.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.01 -1.056 . . . . 0.0 109.166 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.776 ' O ' HG22 ' A' ' 131' ' ' ILE . 3.7 pt20 -90.06 -32.13 16.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -63.32 -20.84 65.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.283 -0.885 . . . . 0.0 109.678 -179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.467 ' O ' HD23 ' A' ' 133' ' ' LEU . 2.0 mtt180 -90.15 -48.09 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.226 -0.921 . . . . 0.0 109.924 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 1.029 HG22 ' CD2' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -62.27 -28.97 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.776 HG22 ' O ' ' A' ' 127' ' ' GLN . 4.8 tt -90.74 -29.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.896 . . . . 0.0 110.249 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 128' ' ' LEU . 17.0 mm-40 -72.86 -34.01 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.389 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.797 ' O ' HD12 ' A' ' 133' ' ' LEU . 2.9 pp -83.62 10.92 8.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.992 . . . . 0.0 109.727 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 130' ' ' VAL . 76.3 p -83.05 -9.68 59.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.491 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -84.76 -47.94 9.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.752 -179.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.491 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.5 OUTLIER -80.18 -2.81 46.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.196 -0.94 . . . . 0.0 109.705 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -76.57 -22.4 54.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.11 -0.994 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.437 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.47 ' O ' ' HB ' ' A' ' 3' ' ' THR . 4.5 mtm -96.16 98.04 10.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.151 -0.968 . . . . 0.0 109.623 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 3' ' ' THR . 12.2 t 178.05 124.88 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.62 ' OH ' HG22 ' A' ' 34' ' ' ILE . 30.0 p90 -100.74 -159.41 0.73 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.567 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -122.77 144.02 49.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.953 -1.092 . . . . 0.0 108.823 179.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.062 HD12 ' N ' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -135.21 167.67 20.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 109.532 178.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.062 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -150.49 97.75 2.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.922 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.907 HG12 ' CG1' ' A' ' 78' ' ' VAL . 19.3 m -99.49 148.54 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.248 -0.907 . . . . 0.0 108.695 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 8' ' ' VAL . 1.9 t -155.88 126.59 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.477 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.77 104.53 13.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.164 -0.96 . . . . 0.0 109.842 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.22 -95.0 0.05 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.716 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -139.26 56.91 1.67 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.154 -0.966 . . . . 0.0 109.607 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.73 169.99 13.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.182 -0.949 . . . . 0.0 109.62 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.63 111.52 22.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.358 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.566 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 4.6 mtt -116.76 -80.87 0.61 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.958 . . . . 0.0 109.842 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.617 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.5 t80 -130.16 147.08 51.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.744 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 p -175.07 92.98 0.07 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.79 -147.38 14.89 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.77 ' C ' HG12 ' A' ' 20' ' ' VAL . 8.9 mt -64.17 172.61 2.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -1.194 . . . . 0.0 108.982 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.051 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 173.47 149.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.816 -1.177 . . . . 0.0 109.438 -178.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.561 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -142.75 -47.12 0.32 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.645 ' C ' HD13 ' A' ' 23' ' ' ILE . 4.6 tttp -93.94 126.37 39.11 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.207 -0.933 . . . . 0.0 109.088 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.913 HG22 ' CG1' ' A' ' 52' ' ' ILE . 0.1 OUTLIER -154.97 66.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.607 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 18.6 tt0 -98.51 132.29 44.06 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.394 -0.816 . . . . 0.0 110.819 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 49' ' ' MET . 2.7 p -119.94 140.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.4 m -114.57 132.23 56.41 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.171 -0.956 . . . . 0.0 109.591 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -143.2 -107.94 0.63 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -150.8 159.51 44.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.213 -1.169 . . . . 0.0 109.463 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 51.01 42.83 28.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 31' ' ' GLU . . . 148.32 -172.58 28.54 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.474 ' O ' ' O ' ' A' ' 32' ' ' LEU . 1.1 pt-20 179.61 -155.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.415 -1.05 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 35' ' ' TYR . 15.4 mt 60.34 130.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.347 -0.846 . . . . 0.0 109.633 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.85 -84.03 1.77 Allowed Glycine 0 N--CA 1.48 1.615 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.62 HG22 ' OH ' ' A' ' 4' ' ' TYR . 0.6 OUTLIER -162.97 161.23 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.376 -1.073 . . . . 0.0 109.535 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -154.14 173.43 4.73 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -178.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.525 ' HD3' ' HG2' ' A' ' 21' ' ' GLU . 33.9 Cg_endo -75.88 94.56 1.01 Allowed 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.309 2.006 . . . . 0.0 110.371 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.12 -12.78 2.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.488 ' ND1' HD11 ' A' ' 34' ' ' ILE . 3.9 t-80 -60.71 -178.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.502 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -104.73 167.73 9.48 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 109.682 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.6 Cg_endo -78.89 77.84 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.746 2.298 . . . . 0.0 110.504 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.444 HD12 ' HE1' ' A' ' 38' ' ' HIS . 21.4 mt -99.68 155.31 17.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 0.0 109.398 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.412 HD12 ' CD ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -126.69 99.7 5.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 109.529 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 69.6 p -135.71 -168.73 2.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.647 ' C ' HD12 ' A' ' 45' ' ' ILE . . . -101.91 -172.02 2.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.283 -0.886 . . . . 0.0 109.439 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.995 HD11 ' CB ' ' A' ' 69' ' ' LEU . 2.0 mp -110.8 116.88 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.183 -0.948 . . . . 0.0 109.648 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.51 166.1 9.99 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.201 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.38 120.41 4.86 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.622 2.215 . . . . 0.0 110.536 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.5 -155.94 27.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.878 ' O ' HG23 ' A' ' 25' ' ' VAL . 1.7 ppp? -119.11 174.86 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -1.12 . . . . 0.0 109.267 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.545 ' O ' HG23 ' A' ' 50' ' ' ILE . 1.5 tt -153.45 131.55 2.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.095 -1.003 . . . . 0.0 110.344 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 151.27 21.2 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.913 ' CG1' HG22 ' A' ' 23' ' ' ILE . 1.0 OUTLIER -142.48 143.51 25.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.758 -1.214 . . . . 0.0 110.618 -178.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 37.2 t -127.53 104.07 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -63.71 136.37 57.41 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.529 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.512 HE21 HD12 ' A' ' 19' ' ' LEU . 3.0 mm-40 46.16 -99.62 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.578 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.32 21.49 0.19 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.623 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -137.4 -65.26 0.05 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -69.87 142.1 53.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.45 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -141.3 131.63 25.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.862 . . . . 0.0 109.361 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 52' ' ' ILE . 1.2 tt0 -121.01 153.81 36.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.869 . . . . 0.0 109.763 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 14.3 m-85 -100.45 155.55 17.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.88 . . . . 0.0 109.286 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 16' ' ' PHE . 50.5 mt -154.8 160.7 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.519 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.568 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -163.63 152.95 14.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.91 . . . . 0.0 108.927 -179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.687 ' N ' HD23 ' A' ' 64' ' ' LEU . 2.5 pt? -179.88 162.69 1.05 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.39 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.495 ' CB ' ' HD3' ' A' ' 123' ' ' LYS . 0.6 OUTLIER -143.39 36.11 1.34 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.571 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -176.4 114.82 0.5 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.11 -177.54 35.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 68' ' ' ILE . 2.2 mp -129.61 135.36 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -1.153 . . . . 0.0 109.28 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.995 ' CB ' HD11 ' A' ' 45' ' ' ILE . 1.2 tt -121.5 145.13 48.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' CD ' HD12 ' A' ' 42' ' ' LEU . 47.5 tt0 -135.87 129.66 32.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.64 HG13 ' HA ' ' A' ' 40' ' ' PRO . 4.3 p -100.08 123.72 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.498 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -101.75 174.11 3.12 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.2 Cg_endo -78.24 72.45 6.25 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.631 2.221 . . . . 0.0 110.912 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 127.51 -14.33 6.46 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.189 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.601 ' O ' HG23 ' A' ' 76' ' ' VAL . 78.7 m-20 -145.53 -176.16 5.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.305 . . . . 0.0 109.893 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 75' ' ' ASN . 12.1 t -158.66 165.82 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.422 -0.799 . . . . 0.0 108.927 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.542 ' N ' ' CG1' ' A' ' 76' ' ' VAL . 0.2 OUTLIER -169.63 140.06 2.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.975 . . . . 0.0 109.604 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.907 ' CG1' HG12 ' A' ' 8' ' ' VAL . 1.7 p -153.31 140.42 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.39 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mt -116.41 150.51 37.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.406 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.32 175.45 13.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 -39.47 4.09 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.26 -0.9 . . . . 0.0 109.401 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.0 m -108.9 136.72 47.97 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.227 -0.921 . . . . 0.0 109.197 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.566 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -158.4 163.33 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 110.088 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.568 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 43.7 mt -142.92 116.87 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.54 109.62 21.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.055 -1.028 . . . . 0.0 109.594 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.64 -146.38 31.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.492 ' OE1' HG12 ' A' ' 131' ' ' ILE . 0.4 OUTLIER -107.97 34.43 3.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -1.098 . . . . 0.0 108.798 179.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 87' ' ' GLN . 4.5 t0 -44.71 -29.67 0.81 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.407 -0.808 . . . . 0.0 109.68 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -120.7 111.35 17.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.169 -0.957 . . . . 0.0 109.617 -179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 21.2 m-20 60.24 157.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.39 -83.4 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -16.95 60.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.497 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.91 0.1 32.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 109.656 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.41 -5.75 55.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.0 109.457 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.427 ' HG3' HD11 ' A' ' 128' ' ' LEU . 0.1 OUTLIER -81.21 -22.64 38.66 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.79 -28.6 19.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.624 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.46 -20.02 62.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.264 -0.898 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.674 ' HG3' HG23 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -84.74 -26.16 27.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 0.0 109.78 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.02 -49.36 11.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -62.11 -26.94 68.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.298 -0.876 . . . . 0.0 109.17 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.74 -44.62 20.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.323 -0.861 . . . . 0.0 109.106 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -54.03 -38.16 64.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.296 -0.877 . . . . 0.0 109.288 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.412 ' OE1' ' CA ' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -46.54 -42.32 15.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -72.46 -38.12 68.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.4 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.619 HD11 HD13 ' A' ' 121' ' ' LEU . 11.6 mt -87.94 22.21 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.324 -0.86 . . . . 0.0 109.581 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.39 -55.91 27.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.916 . . . . 0.0 109.537 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.86 136.8 54.83 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.157 -0.964 . . . . 0.0 109.483 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.43 ' O ' ' CG ' ' A' ' 109' ' ' HIS . 59.7 p -131.23 -179.41 5.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -178.63 -171.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 53.89 176.46 0.09 OUTLIER Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 111' ' ' ASP . 25.5 t0 -83.74 -73.94 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -1.11 . . . . 0.0 109.347 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.4 m -103.61 13.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.325 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.02 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.3 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.467 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 16.1 t80 -71.29 -16.92 62.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.165 -0.959 . . . . 0.0 108.601 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.0 66.77 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.587 -0.696 . . . . 0.0 109.44 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.86 -47.97 75.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.307 -0.87 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.37 -6.08 37.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.71 -11.06 54.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 109.562 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 123' ' ' LYS . . . -85.03 -29.28 25.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.615 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -28.43 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.678 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.619 HD13 HD11 ' A' ' 105' ' ' ILE . 0.9 OUTLIER -81.32 -61.86 1.82 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.65 -38.63 2.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.865 . . . . 0.0 109.743 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.495 ' HD3' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -45.75 -59.35 2.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.595 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.46 -21.64 63.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.752 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.674 HG23 ' HG3' ' A' ' 98' ' ' LYS . 20.3 mm -71.42 -4.2 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 49' ' ' MET . . . -84.42 -9.91 57.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.653 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.562 ' CD ' HD13 ' A' ' 84' ' ' ILE . 4.2 tt0 -82.65 -26.4 32.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -0.936 . . . . 0.0 109.651 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 128' ' ' LEU . 61.8 tp -75.52 -8.98 58.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 109.541 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.23 -43.93 10.07 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.933 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 134' ' ' THR . 33.9 m -69.74 -24.72 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.21 -0.931 . . . . 0.0 109.928 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.67 HD13 ' C ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -89.52 -48.13 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.24 -0.913 . . . . 0.0 109.87 -179.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 131' ' ' ILE . 13.0 pt-20 -54.66 -24.32 21.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 109.322 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -80.66 -43.06 21.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 0.0 109.78 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 130' ' ' VAL . 41.7 p -43.11 -34.85 1.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.645 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -67.78 -49.67 61.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -96.51 45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.634 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -98.11 -36.23 10.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.949 . . . . 0.0 109.606 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.1 ttm . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.585 -179.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.362 0.601 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 4.2 ptt? -175.17 -171.11 0.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.852 HG23 ' HG2' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 54.2 103.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 109.596 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.921 ' CE2' HG22 ' A' ' 34' ' ' ILE . 27.3 p90 -99.24 -152.08 0.4 Allowed 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.763 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -129.68 146.63 51.44 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 178.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.087 HD23 HG21 ' A' ' 20' ' ' VAL . 2.5 pp -133.31 169.67 16.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.312 -1.493 . . . . 0.0 109.252 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.842 ' N ' HD12 ' A' ' 6' ' ' LEU . 21.6 t70 -146.0 100.53 3.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 8' ' ' VAL . 9.1 p -105.57 105.95 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.083 -1.011 . . . . 0.0 109.745 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.8 m -131.92 151.39 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.231 -0.918 . . . . 0.0 109.361 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.746 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -166.95 73.11 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.746 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 72.32 5.38 5.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.77 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.675 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . 39.6 mt-10 -156.58 76.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.215 -0.928 . . . . 0.0 109.321 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 12' ' ' GLU . 3.3 pt20 -56.01 -164.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.864 . . . . 0.0 109.723 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' CB ' ' O ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER 72.11 32.04 1.84 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 0.0 109.534 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.807 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 16.0 mtt -106.18 -79.96 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.198 -0.938 . . . . 0.0 109.249 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.675 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 37.5 t80 -146.25 117.78 8.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -145.05 108.65 4.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.115 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 143.5 -163.32 27.56 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.815 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -43.93 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.695 -0.885 . . . . 0.0 110.879 179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.087 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 167.05 150.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.852 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -147.78 -39.18 0.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.8 -1.187 . . . . 0.0 110.471 -179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 53' ' ' VAL . 1.8 mptt -116.95 78.57 1.22 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 120.937 -1.102 . . . . 0.0 111.324 -178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.897 HG22 HG12 ' A' ' 52' ' ' ILE . 7.8 pt -101.14 160.93 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 4.2 tt0 -162.78 116.28 1.67 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.706 -1.246 . . . . 0.0 110.184 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -99.93 111.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 108.988 179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.444 HG23 ' CD ' ' A' ' 31' ' ' GLU . 97.7 m -100.15 110.84 23.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.438 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -136.19 -116.53 1.57 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.729 -1.349 . . . . 0.0 109.729 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 0.4 OUTLIER -118.24 124.03 46.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -1.139 . . . . 0.0 109.57 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.0 tt0 76.44 111.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.35 164.76 39.31 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 1.2 tt0 -163.54 64.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.386 -1.067 . . . . 0.0 109.145 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 31' ' ' GLU . 23.4 mt -149.58 140.8 23.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.914 . . . . 0.0 110.091 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 24' ' ' GLN . . . -99.91 -105.06 2.65 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 107.806 -2.117 . . . . 0.0 107.806 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.921 HG22 ' CE2' ' A' ' 4' ' ' TYR . 7.6 mm -153.85 143.19 14.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.289 -1.124 . . . . 0.0 109.278 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.598 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -142.18 173.63 4.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -72.63 94.45 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.954 1.769 . . . . 0.0 109.752 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.33 -2.15 4.2 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.519 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 10.0 t-80 -71.75 166.06 22.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -1.164 . . . . 0.0 109.476 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.996 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -89.67 176.23 3.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 109.253 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 1.008 ' HA ' HG11 ' A' ' 71' ' ' VAL . 34.9 Cg_endo -76.82 100.7 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.516 2.144 . . . . 0.0 110.374 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.21 140.29 29.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.592 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.76 48.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 p -118.71 -146.61 0.39 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.385 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.581 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -100.34 176.3 5.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 109.592 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.644 HD11 HG21 ' A' ' 25' ' ' VAL . 1.6 tp -102.29 151.23 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.358 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.94 141.52 47.44 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.168 -0.958 . . . . 0.0 109.607 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.3 Cg_endo -79.38 -179.8 5.71 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.554 2.169 . . . . 0.0 110.321 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 101.58 -129.0 9.75 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.441 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.9 ptm -119.42 177.79 4.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -1.155 . . . . 0.0 109.236 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.701 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.2 tt -152.84 130.4 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.075 -1.016 . . . . 0.0 110.003 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -98.98 149.38 23.04 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.08 HD11 HD21 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -148.59 158.8 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.65 -1.281 . . . . 0.0 111.076 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 59' ' ' GLU . 25.0 t -139.35 99.72 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HD3' ' CB ' ' A' ' 58' ' ' HIS . 6.0 ptmt -65.91 153.35 42.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.495 -0.753 . . . . 0.0 109.931 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.639 ' CB ' HG21 ' A' ' 3' ' ' THR . 1.5 tt0 -41.62 -52.88 3.69 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.488 -0.758 . . . . 0.0 110.137 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -43.67 -51.04 7.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.13 -0.981 . . . . 0.0 109.868 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.21 -38.71 1.44 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.461 ' CB ' ' HD3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -48.65 129.1 16.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -1.235 . . . . 0.0 109.313 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.59 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -105.45 123.59 48.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.329 -179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 52' ' ' ILE . 1.3 tm-20 -122.95 144.83 48.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.223 -0.923 . . . . 0.0 109.424 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.587 ' CD2' ' HB ' ' A' ' 130' ' ' VAL . 1.6 p90 -114.62 135.85 53.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.589 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.701 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.7 mm -108.43 -155.87 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.373 -0.83 . . . . 0.0 109.07 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' H ' HG22 ' A' ' 62' ' ' ILE . 5.3 t80 -168.0 125.18 1.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 109.441 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.66 178.04 6.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.408 -0.808 . . . . 0.0 109.021 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -132.76 9.04 4.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.745 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 138.25 144.73 4.72 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.48 -155.47 23.35 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 28.7 mt -133.8 133.51 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.193 -1.181 . . . . 0.0 109.42 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 70' ' ' GLU . 1.1 pp -114.05 -169.71 1.57 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.719 ' N ' HD12 ' A' ' 69' ' ' LEU . 3.4 pt-20 -179.91 149.08 0.33 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.262 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.008 HG11 ' HA ' ' A' ' 40' ' ' PRO . 11.0 p -100.34 141.15 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 109.843 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.517 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 24.8 mt-30 -126.91 160.55 58.58 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.2 Cg_endo -75.32 90.76 1.09 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.355 2.036 . . . . 0.0 110.536 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.31 6.92 41.23 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.482 ' C ' HG13 ' A' ' 76' ' ' VAL . 0.2 OUTLIER -175.18 -176.87 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -1.177 . . . . 0.0 109.816 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.544 ' CG2' ' CB ' ' A' ' 6' ' ' LEU . 28.6 m -157.96 150.99 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.595 HG22 ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -135.32 167.97 20.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.909 -1.119 . . . . 0.0 109.834 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG13 ' HA ' ' A' ' 8' ' ' VAL . 1.7 p -175.15 120.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -0.83 . . . . 0.0 109.068 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.34 141.4 46.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.749 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.746 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -127.39 -179.9 5.13 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 109.203 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -98.51 -2.05 39.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 0.0 109.544 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.566 HG23 ' CD1' ' A' ' 84' ' ' ILE . 1.9 m -155.2 143.67 20.41 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.175 -0.953 . . . . 0.0 109.136 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.807 ' HB1' ' CE ' ' A' ' 15' ' ' MET . . . -146.29 98.61 3.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.603 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 84' ' ' ILE . 2.1 mp -115.3 84.65 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 109.324 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.411 ' O ' ' O ' ' A' ' 84' ' ' ILE . 6.5 ttm180 -44.1 164.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -49.64 -64.8 3.19 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.448 ' HB3' HG21 ' A' ' 134' ' ' THR . 1.3 pt20 -93.45 37.81 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -1.188 . . . . 0.0 109.628 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -48.46 -48.93 37.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.416 -0.803 . . . . 0.0 109.348 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -173.23 -58.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 0.0 109.172 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.45 107.68 12.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 0.0 109.398 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.442 ' HB3' HD11 ' A' ' 131' ' ' ILE . 47.8 mt-10 -101.72 -70.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.644 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -85.46 -17.6 36.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.616 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -81.6 -1.02 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.251 -0.906 . . . . 0.0 109.651 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.49 -18.27 25.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 109.17 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.64 ' HG2' HD21 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -69.39 -37.79 77.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.36 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -34.81 11.17 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.52 -54.46 35.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.352 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -22.8 15.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.257 -0.902 . . . . 0.0 109.435 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -75.13 -60.93 2.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.569 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -64.17 -12.38 39.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.446 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.717 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -87.66 -36.42 17.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.942 . . . . 0.0 109.285 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -57.55 -16.83 11.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.557 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -57.68 6.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.958 . . . . 0.0 109.604 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.41 -11.51 60.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.645 HD11 ' CG ' ' A' ' 121' ' ' LEU . 14.1 mm -76.09 -8.44 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.528 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -46.14 -65.97 0.47 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.199 -0.938 . . . . 0.0 109.331 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 165.85 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.481 179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.9 m -151.39 -50.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.393 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 179.94 -72.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.18 -155.23 26.5 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.632 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 1.6 m-20 56.99 -101.5 0.13 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -1.086 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.517 ' O ' ' CG ' ' A' ' 116' ' ' GLN . 3.4 m -119.69 -15.18 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.871 -1.143 . . . . 0.0 109.285 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.8 OUTLIER -47.6 -95.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.362 179.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 118' ' ' SER . 19.3 t80 -74.26 -22.15 59.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -62.52 -20.76 64.95 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.517 ' CG ' ' O ' ' A' ' 112' ' ' VAL . 33.7 mm-40 -85.71 -52.99 5.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.872 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.519 ' HA ' ' CG ' ' A' ' 120' ' ' GLU . . . -74.53 -1.41 21.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.756 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 114' ' ' TYR . 36.4 t -90.19 -35.65 15.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.128 -0.983 . . . . 0.0 109.769 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.61 -28.57 18.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.172 -0.955 . . . . 0.0 109.868 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' CG ' ' HA ' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -82.09 -8.55 59.66 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.145 -0.972 . . . . 0.0 109.55 -179.802 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.717 HD11 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -86.06 -48.47 8.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.182 -0.949 . . . . 0.0 109.465 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.54 -17.12 18.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.403 ' HD3' ' HB2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -64.96 -37.66 88.38 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.465 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.84 -12.37 59.97 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -83.36 -8.04 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.541 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -68.29 -46.39 70.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -0.925 . . . . 0.0 109.305 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.4 ' O ' HG22 ' A' ' 131' ' ' ILE . 12.1 tm0? -67.31 -23.53 65.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.64 HD21 ' HG2' ' A' ' 95' ' ' MET . 5.6 mp -74.5 -16.8 60.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.444 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.46 ' HA ' ' HG3' ' A' ' 132' ' ' GLU . 4.1 mtp85 -89.82 -50.69 5.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.78 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 27.4 m -60.54 -34.93 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.558 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.442 HD11 ' HB3' ' A' ' 91' ' ' GLU . 3.4 tt -61.44 -36.09 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 0.0 109.337 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.46 ' HG3' ' HA ' ' A' ' 129' ' ' ARG . 2.8 mt-10 -49.89 -27.46 5.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.218 -0.927 . . . . 0.0 109.363 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mp -75.16 -61.55 1.86 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.882 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.448 HG21 ' HB3' ' A' ' 87' ' ' GLN . 4.9 p -45.56 -31.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.344 -0.848 . . . . 0.0 109.661 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -58.53 -66.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.69 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.32 -15.3 56.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 109.844 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.8 68.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.589 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.408 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.453 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -85.83 -175.75 5.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -0.831 . . . . 0.0 109.582 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 57.11 159.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.713 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.4 p90 -158.11 -144.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.683 ' O ' HG22 ' A' ' 76' ' ' VAL . 24.1 t-80 -131.51 134.84 46.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.734 -1.229 . . . . 0.0 111.013 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -106.14 124.28 49.34 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -136.88 71.48 1.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.735 -1.228 . . . . 0.0 109.974 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.729 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.1 p -102.46 124.91 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.119 -0.988 . . . . 0.0 109.401 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 m -127.38 -172.28 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.604 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 6.2 p -166.54 107.77 0.68 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.316 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 60.08 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 0.0 109.318 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.03 64.34 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.486 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -150.2 104.01 3.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.826 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.69 105.04 2.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.446 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 2.7 mmt -87.32 -89.1 0.13 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.28 -0.888 . . . . 0.0 109.479 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.654 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -110.14 111.79 23.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.979 . . . . 0.0 109.89 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 85.7 p -136.13 78.83 1.74 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' N ' ' CE1' ' A' ' 5' ' ' HIS . . . -177.47 174.16 46.73 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 30.9 mt -50.22 163.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.253 -1.145 . . . . 0.0 109.61 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.879 ' O ' HG22 ' A' ' 3' ' ' THR . 0.2 OUTLIER -162.27 163.76 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.335 -0.853 . . . . 0.0 108.967 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.758 ' CG ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -125.29 -39.18 2.22 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.259 -0.9 . . . . 0.0 109.582 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 2.1 ttmt -156.15 109.07 2.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.031 -1.043 . . . . 0.0 110.369 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.85 HG21 HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -101.28 146.63 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 178.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.939 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -120.73 141.58 50.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.0 109.988 -179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 50' ' ' ILE . 13.4 t -136.77 133.49 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 84.8 m -140.94 111.49 6.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -0.999 . . . . 0.0 109.842 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 46' ' ' LYS . . . -120.73 -104.91 1.99 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.53 -67.05 1.02 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -117.99 139.15 51.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.097 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.43 69.33 1.41 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.49 77.07 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -1.066 . . . . 0.0 109.596 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.0 mt -113.83 153.43 29.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -0.893 . . . . 0.0 109.46 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 23' ' ' ILE . . . -99.81 172.0 24.34 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.844 -2.103 . . . . 0.0 107.844 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.713 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 12.9 mm -98.09 134.52 36.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 120.911 -1.346 . . . . 0.0 108.822 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.579 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -132.3 169.86 12.82 Favored Pre-proline 0 C--N 1.298 -1.637 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -178.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.0 Cg_endo -72.7 87.6 0.96 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.018 1.812 . . . . 0.0 109.923 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 38' ' ' HIS . . . 138.42 -4.4 3.09 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 39' ' ' ALA . 70.3 t60 -42.84 132.72 3.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 0.0 109.501 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.994 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -48.73 176.4 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.994 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.1 Cg_endo -77.66 81.31 2.7 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.519 2.146 . . . . 0.0 110.291 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HB2' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -96.75 155.95 16.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.882 . . . . 0.0 109.722 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.84 34.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.403 -0.811 . . . . 0.0 108.907 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 22.4 p -99.56 -147.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.334 -0.854 . . . . 0.0 109.486 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' C ' HD23 ' A' ' 69' ' ' LEU . . . -100.54 164.15 12.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.331 -0.856 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 46' ' ' LYS . 48.0 mt -105.98 163.04 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.922 . . . . 0.0 109.273 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.544 ' N ' HG22 ' A' ' 45' ' ' ILE . 8.4 mptt -96.06 151.88 38.54 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.076 -1.015 . . . . 0.0 109.826 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.56 127.71 7.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.82 2.347 . . . . 0.0 110.444 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 174.28 -149.92 11.12 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.499 ' O ' HG13 ' A' ' 50' ' ' ILE . 3.9 ptm -109.54 -177.04 3.18 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -1.162 . . . . 0.0 109.405 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.939 HG23 ' O ' ' A' ' 24' ' ' GLN . 47.7 mt -155.08 140.04 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.442 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.37 115.38 17.47 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.737 HG23 ' CA ' ' A' ' 23' ' ' ILE . 14.1 mt -117.79 169.75 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 111.176 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' N ' HG22 ' A' ' 52' ' ' ILE . 53.2 t -137.8 100.16 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 56' ' ' HIS . 0.1 OUTLIER -60.5 126.03 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.244 -0.91 . . . . 0.0 110.154 -179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 23.1 mt-30 45.82 -92.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.542 -0.724 . . . . 0.0 109.561 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' LYS . 14.1 t-160 -164.12 49.87 0.13 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.84 -99.87 0.31 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -74.75 172.08 12.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -1.169 . . . . 0.0 109.874 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -127.34 167.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.361 -0.837 . . . . 0.0 109.046 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -133.04 144.86 50.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.943 . . . . 0.0 109.74 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.983 ' C ' HD12 ' A' ' 62' ' ' ILE . 7.3 m-85 -111.21 134.68 52.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 109.141 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.983 HD12 ' C ' ' A' ' 61' ' ' PHE . 2.8 mp -140.78 147.48 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 0.0 109.677 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.523 ' C ' ' CD1' ' A' ' 63' ' ' TYR . 0.9 OUTLIER -144.89 151.48 38.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.395 -0.815 . . . . 0.0 109.006 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.94 -173.87 2.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.257 -0.902 . . . . 0.0 109.423 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.5 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 70.6 m -112.18 -81.72 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.283 -0.885 . . . . 0.0 109.417 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -137.49 168.09 24.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 167.35 -176.95 42.07 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 69' ' ' LEU . 4.7 mp -99.98 156.58 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.184 -1.186 . . . . 0.0 109.37 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -131.68 169.75 15.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.972 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.0 125.93 1.17 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.355 -0.841 . . . . 0.0 108.848 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 76' ' ' VAL . 11.6 p -99.85 146.77 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 109.988 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.526 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 6.3 mt-30 -131.42 163.78 47.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.036 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.8 Cg_endo -77.4 106.29 2.19 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.43 2.087 . . . . 0.0 110.599 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.89 2.55 58.32 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.509 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.2 p30 -179.73 166.35 1.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.161 -1.199 . . . . 0.0 109.436 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 5' ' ' HIS . 10.2 m -139.02 167.93 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.373 -0.829 . . . . 0.0 109.262 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 7' ' ' ASP . 46.1 m -165.77 134.8 3.24 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.186 -0.946 . . . . 0.0 109.869 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.729 ' CG2' HG23 ' A' ' 8' ' ' VAL . 4.3 m -137.25 138.11 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 143.41 30.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.581 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.66 -179.17 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 0.0 109.359 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -119.4 -39.52 2.88 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.281 -0.887 . . . . 0.0 109.247 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.48 ' CG2' ' CD1' ' A' ' 84' ' ' ILE . 32.6 m -104.31 120.7 41.76 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.234 -0.916 . . . . 0.0 109.185 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -135.9 87.33 2.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 109.771 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.758 HG23 ' HB2' ' A' ' 88' ' ' ASP . 3.1 mp -100.01 92.2 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 108.919 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' GLY . 1.2 ttt180 -41.95 153.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 109.786 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.609 ' HA2' HG21 ' A' ' 130' ' ' VAL . . . -43.26 -35.57 2.64 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.539 ' O ' ' CB ' ' A' ' 88' ' ' ASP . 15.6 mt-30 -78.95 -69.92 0.54 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.399 -1.059 . . . . 0.0 109.382 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.758 ' HB2' HG23 ' A' ' 84' ' ' ILE . 0.0 OUTLIER 84.53 -44.11 0.08 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 88' ' ' ASP . 0.3 OUTLIER 164.57 -50.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.391 -0.818 . . . . 0.0 109.111 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 22.8 m-20 -119.05 -172.69 2.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.428 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -123.58 -70.62 0.76 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.0 109.502 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.62 -11.04 60.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -83.55 4.33 28.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.243 -0.91 . . . . 0.0 109.709 -179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.78 -21.2 23.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 108.996 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.597 ' CG ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -73.63 -25.14 60.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.484 -0.76 . . . . 0.0 109.406 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.96 -17.17 22.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 0.0 109.589 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.68 -44.03 35.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.251 -0.906 . . . . 0.0 109.714 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HG3' HD11 ' A' ' 125' ' ' ILE . 0.0 OUTLIER -59.01 -19.38 43.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.987 . . . . 0.0 109.508 -179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.447 ' O ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -77.99 -37.03 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.569 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 97' ' ' ALA . 2.8 pttm -79.65 -18.73 50.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 109.496 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.454 ' O ' HG12 ' A' ' 105' ' ' ILE . . . -89.18 -34.44 16.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.518 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -50.99 -31.02 16.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.872 . . . . 0.0 109.468 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.24 -54.7 40.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.473 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.83 -16.24 60.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.65 ' O ' HG22 ' A' ' 105' ' ' ILE . 21.8 mm -87.25 16.56 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.394 -0.816 . . . . 0.0 109.524 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 107' ' ' SER . 15.0 m -91.93 -147.76 0.22 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 109.681 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 106' ' ' SER . 2.8 m 56.31 108.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.586 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.51 108.36 10.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 173.27 56.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.472 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -174.2 163.21 33.92 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -61.06 2.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -1.217 . . . . 0.0 109.607 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.497 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 13.2 m -96.17 17.18 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.335 -0.853 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.437 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 39.5 t0 -63.27 -100.33 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.454 -0.779 . . . . 0.0 109.027 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 75.0 t80 -64.06 -20.47 65.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.998 -1.064 . . . . 0.0 108.252 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -64.3 -39.36 93.76 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 1.2 tp-100 -86.5 -7.27 58.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.791 . . . . 0.0 109.341 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 105' ' ' ILE . . . -80.44 -36.95 32.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.487 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.9 m -52.54 -37.24 57.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.124 -0.985 . . . . 0.0 109.444 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.53 -52.92 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.36 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -67.69 -8.66 36.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 109.457 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.687 ' O ' HD13 ' A' ' 125' ' ' ILE . 15.7 tp -83.95 -50.34 8.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.507 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -81.91 8.52 10.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.167 -0.958 . . . . 0.0 109.876 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 15.8 ttpp -72.87 -37.86 67.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.612 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.11 -16.92 28.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.689 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -70.49 -5.9 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' MET . . . -73.66 -23.98 59.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.095 -1.003 . . . . 0.0 109.286 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -82.73 -4.99 58.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.597 HD11 ' CG ' ' A' ' 95' ' ' MET . 0.2 OUTLIER -84.02 -34.0 24.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -43.62 55.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 109.644 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.609 HG21 ' HA2' ' A' ' 86' ' ' GLY . 18.6 m -54.66 -17.85 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.931 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.404 ' O ' ' C ' ' A' ' 132' ' ' GLU . 38.5 mt -88.84 -66.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -0.97 . . . . 0.0 109.983 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 131' ' ' ILE . 57.5 mm-40 -43.66 -34.84 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.119 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -73.73 -54.6 7.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 109.861 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.582 ' HA ' ' HB3' ' A' ' 137' ' ' ALA . 7.9 p -44.02 -30.23 0.7 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 109.571 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -57.44 -53.74 54.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.915 . . . . 0.0 109.617 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 3.49 48.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.093 -1.004 . . . . 0.0 109.544 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 134' ' ' THR . . . -104.17 44.17 1.04 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 0.0 109.37 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.479 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.482 ' HB3' ' HB3' ' A' ' 36' ' ' PRO . 18.2 ttm -100.89 121.5 41.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 109.39 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.92 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -82.74 -152.78 0.11 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.114 -0.991 . . . . 0.0 109.515 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 1.142 ' CG ' HG22 ' A' ' 20' ' ' VAL 0.277 1.1 m-85 -137.7 -178.23 5.15 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 124.451 2.072 . . . . 0.0 115.914 -175.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.587 ' HB3' ' CB ' ' A' ' 75' ' ' ASN . 7.1 t-80 -151.45 88.1 1.41 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 109.769 -3.378 . . . . 0.0 102.98 173.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.031 ' HB2' HG11 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -93.33 133.64 36.37 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.629 -1.294 . . . . 0.0 108.22 -177.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.639 ' O ' HG23 ' A' ' 77' ' ' THR . 0.3 OUTLIER -146.13 82.53 1.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.625 -1.297 . . . . 0.0 109.95 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.73 HG23 ' CG2' ' A' ' 78' ' ' VAL . 2.4 p -110.6 102.63 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.316 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.7 m -105.85 155.26 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.176 -0.953 . . . . 0.0 109.441 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.966 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 89.2 p -105.26 -156.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.397 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.82 -47.32 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.491 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -160.21 60.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.414 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.52 118.95 1.4 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -77.95 117.14 19.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.879 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.532 ' HE1' HG22 ' A' ' 62' ' ' ILE . 5.9 mtt -86.82 -73.74 0.45 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.643 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.2 t80 -116.17 113.44 23.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 110.321 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 89.2 p -138.6 91.04 2.5 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.114 -0.991 . . . . 0.0 109.727 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.05 -172.81 45.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 55' ' ' GLN . 20.8 mt -72.02 154.59 41.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.11 -1.229 . . . . 0.0 109.321 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.142 HG22 ' CG ' ' A' ' 4' ' ' TYR . 0.7 OUTLIER -153.81 -175.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.097 -1.002 . . . . 0.0 109.165 -178.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.666 ' N ' HG23 ' A' ' 20' ' ' VAL . 9.9 tt0 -146.56 -40.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.779 -1.2 . . . . 0.0 110.208 178.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -139.31 91.16 2.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.878 -1.139 . . . . 0.0 110.087 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.799 HD13 HD21 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -98.87 159.96 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.071 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.747 ' O ' HG23 ' A' ' 50' ' ' ILE . 44.7 mt-30 -146.81 166.98 25.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.976 -1.078 . . . . 0.0 110.184 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.715 HG12 ' HA2' ' A' ' 33' ' ' GLY . 3.1 p -160.26 143.53 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.438 -0.789 . . . . 0.0 109.043 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 18.6 m -129.86 129.38 43.88 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' HA2' ' NZ ' ' A' ' 123' ' ' LYS . . . 126.27 14.28 3.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.844 -1.303 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -116.25 -153.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.115 -1.227 . . . . 0.0 109.47 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -56.32 98.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 0.0 109.329 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.09 -93.81 1.43 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HG3' HG23 ' A' ' 26' ' ' THR . 8.6 tt0 -177.48 28.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -1.152 . . . . 0.0 109.744 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB3' ' NE2' ' A' ' 38' ' ' HIS . 16.5 mt -70.64 145.92 50.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.069 -1.019 . . . . 0.0 109.278 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.715 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.06 -122.87 4.81 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 108.046 -2.022 . . . . 0.0 108.046 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.084 HG22 ' OH ' ' A' ' 4' ' ' TYR . 24.1 mm -151.59 123.45 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.168 -1.195 . . . . 0.0 109.315 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -136.88 -171.13 0.26 Allowed Pre-proline 0 N--CA 1.49 1.545 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.619 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 32.2 Cg_endo -76.64 84.57 1.87 Allowed 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 121.479 1.453 . . . . 0.0 110.0 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.92 50.73 0.54 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.607 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 16.0 t-80 -84.95 46.95 1.32 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.387 -1.067 . . . . 0.0 109.702 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.607 ' O ' HG11 ' A' ' 71' ' ' VAL . . . 56.17 160.57 0.07 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -0.973 . . . . 0.0 110.097 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 36.5 Cg_endo -79.93 66.21 8.82 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.835 2.356 . . . . 0.0 110.429 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 69' ' ' LEU . 1.4 mm? -77.75 139.35 39.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.15 -0.969 . . . . 0.0 109.302 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' ' 69' ' ' LEU . 17.5 tp -154.59 66.5 0.69 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.28 -0.888 . . . . 0.0 109.566 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -136.1 -95.28 0.24 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.93 . . . . 0.0 109.408 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' H ' HG23 ' A' ' 43' ' ' THR . . . -150.99 164.52 36.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.086 -1.009 . . . . 0.0 109.11 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.645 HG13 HD23 ' A' ' 69' ' ' LEU . 2.7 mt -113.17 4.16 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.103 -0.998 . . . . 0.0 110.192 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' CG ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER 48.16 179.81 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 109.715 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -80.26 119.49 3.85 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.528 2.152 . . . . 0.0 110.238 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -165.29 -153.2 7.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.404 ' CE ' ' CG1' ' A' ' 130' ' ' VAL . 3.2 ppp? -128.61 -173.43 2.96 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.335 -1.097 . . . . 0.0 109.564 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.747 HG23 ' O ' ' A' ' 24' ' ' GLN . 8.4 mt -151.11 147.9 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 0.0 109.826 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.439 ' O ' ' N ' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.41 123.48 21.6 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.59 HG23 ' CA ' ' A' ' 23' ' ' ILE . 32.1 mt -128.4 168.56 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.798 -1.189 . . . . 0.0 111.246 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.586 ' N ' HG22 ' A' ' 52' ' ' ILE . 51.5 t -139.15 153.08 24.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 80.78 -73.56 0.05 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.732 -0.605 . . . . 0.0 109.578 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 56' ' ' HIS . 0.3 OUTLIER 42.99 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.37 -0.831 . . . . 0.0 109.569 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.526 ' CB ' ' OE1' ' A' ' 55' ' ' GLN . 0.3 OUTLIER -158.07 40.32 0.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.89 -1.131 . . . . 0.0 109.804 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.37 -36.09 0.44 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.515 ' CE1' ' OE1' ' A' ' 59' ' ' GLU . 1.4 t-80 -169.35 -149.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.007 -1.29 . . . . 0.0 109.54 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' OE1' ' CE1' ' A' ' 58' ' ' HIS . 1.5 pt-20 -101.49 160.5 14.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.51 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.79 139.59 11.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.3 p90 -110.23 152.54 25.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.283 -0.885 . . . . 0.0 109.623 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 16' ' ' PHE . 9.1 mt -127.9 144.57 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.258 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.636 ' CE1' HD12 ' A' ' 84' ' ' ILE . 19.6 t80 -113.75 130.38 56.45 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.307 -0.871 . . . . 0.0 109.466 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD11 HG21 ' A' ' 8' ' ' VAL . 3.6 mt -121.33 173.89 7.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -125.44 -37.23 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.318 -0.863 . . . . 0.0 109.416 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 171.21 144.62 4.47 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 168.25 -173.59 43.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.402 HG23 ' O ' ' A' ' 43' ' ' THR . 60.6 mt -99.36 152.74 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -1.075 . . . . 0.0 109.075 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.731 ' C ' HD12 ' A' ' 69' ' ' LEU . 3.3 pp -132.0 157.33 44.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.917 -1.115 . . . . 0.0 110.586 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' HD12 ' A' ' 69' ' ' LEU . 8.4 pt-20 -150.66 114.89 5.1 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.773 HG23 HG12 ' A' ' 76' ' ' VAL . 10.0 p -104.04 151.77 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.889 -1.132 . . . . 0.0 110.709 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.583 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 3.6 mm-40 -136.43 179.28 1.41 Allowed Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -79.48 102.23 1.47 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.395 2.063 . . . . 0.0 110.847 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 75' ' ' ASN . . . 79.97 34.72 29.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.587 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 7.9 t30 171.18 110.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -1.175 . . . . 0.0 109.355 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.811 HG22 HD22 ' A' ' 6' ' ' LEU . 2.5 m -112.89 152.65 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.283 -0.886 . . . . 0.0 109.307 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 7' ' ' ASP . 88.0 m -152.67 136.02 15.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.375 -0.828 . . . . 0.0 109.282 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.73 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.1 m -144.83 147.54 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.197 -0.939 . . . . 0.0 109.501 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.1 mp -117.77 142.7 46.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.416 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.461 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -139.09 179.61 6.4 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.309 -0.87 . . . . 0.0 109.43 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -100.43 -34.18 10.05 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.611 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -118.41 147.9 43.09 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 0.0 109.741 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.966 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -143.29 91.94 2.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.421 -0.799 . . . . 0.0 109.107 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.636 HD12 ' CE1' ' A' ' 63' ' ' TYR . 2.0 mt -98.93 52.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.208 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HG2' ' N ' ' A' ' 86' ' ' GLY . 48.9 ttt180 -42.16 147.25 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 109.468 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 85' ' ' ARG . . . -42.92 -32.49 1.45 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -111.21 64.66 0.61 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.193 -1.181 . . . . 0.0 109.579 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.12 -83.01 0.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.328 -0.858 . . . . 0.0 109.46 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.84 -169.73 3.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.75 73.48 0.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.396 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.2 OUTLIER -100.68 -68.03 0.83 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.11 -19.85 62.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 109.633 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.87 -2.03 24.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.21 -18.96 26.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 0.0 108.913 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.3 mtp -85.75 -35.08 20.99 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.468 -0.77 . . . . 0.0 109.324 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -84.75 -27.32 27.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.35 -0.844 . . . . 0.0 109.384 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.22 -54.26 49.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.359 -0.838 . . . . 0.0 109.631 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -51.93 -21.61 3.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -0.94 . . . . 0.0 109.423 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -80.06 -57.32 3.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.863 . . . . 0.0 109.722 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -59.46 -19.56 48.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.869 ' HB1' HD13 ' A' ' 121' ' ' LEU . . . -85.72 -43.71 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.964 . . . . 0.0 109.369 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -56.55 -34.53 67.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.3 -0.875 . . . . 0.0 109.439 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.67 -50.82 72.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.312 -0.867 . . . . 0.0 109.507 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -18.29 64.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.541 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 121' ' ' LEU . 21.4 mt -80.61 -25.83 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.925 . . . . 0.0 109.498 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 t -101.42 102.68 13.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.503 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.1 m -154.01 -41.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.183 -0.948 . . . . 0.0 109.726 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.405 ' O ' ' CE2' ' A' ' 114' ' ' TYR . 0.0 OUTLIER -155.9 -166.49 2.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.195 -0.941 . . . . 0.0 109.695 -179.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.76 -86.88 0.58 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.404 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 66.64 177.91 8.88 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.2 OUTLIER -113.14 126.5 55.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.324 -1.103 . . . . 0.0 109.333 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 111' ' ' ASP . 19.4 m 41.11 29.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.378 -0.826 . . . . 0.0 109.564 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 111' ' ' ASP . 21.2 t70 -84.07 -94.41 0.07 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.454 -0.779 . . . . 0.0 109.128 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 108' ' ' SER . 20.8 p90 -74.32 -22.99 59.0 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.88 46.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -77.88 -34.7 51.47 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.436 -0.79 . . . . 0.0 109.108 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -77.46 -20.5 54.35 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.342 -0.849 . . . . 0.0 109.257 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.5 m -65.31 -39.35 92.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.328 -0.858 . . . . 0.0 109.361 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.27 -13.28 36.54 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.275 -0.891 . . . . 0.0 109.328 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.19 -32.04 38.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.365 -0.834 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.869 HD13 ' HB1' ' A' ' 101' ' ' ALA . 17.6 mt -83.74 -39.33 20.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.34 -23.67 50.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.69 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.539 ' NZ ' ' HA2' ' A' ' 27' ' ' GLY . 11.1 mmtt -79.8 -30.45 40.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 0.0 109.538 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.15 62.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.171 -0.956 . . . . 0.0 109.555 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 125' ' ' ILE . 3.3 mt -80.53 1.74 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.595 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.75 62.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.269 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.599 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.8 pt20 -79.12 -11.0 59.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 0.6 OUTLIER -73.08 -30.24 63.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.157 -0.965 . . . . 0.0 109.795 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -48.81 14.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.591 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.1 m -61.49 -40.4 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.912 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.545 HG23 ' N ' ' A' ' 132' ' ' GLU . 9.3 tt -65.3 -43.41 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.288 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.545 ' N ' HG23 ' A' ' 131' ' ' ILE . 3.1 mm-40 -53.83 -26.19 23.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -0.879 . . . . 0.0 109.1 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.51 -48.88 20.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.879 . . . . 0.0 109.18 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.8 p -53.65 -20.12 4.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.237 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -76.25 -55.89 5.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.92 7.34 24.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -68.41 -52.17 35.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.51 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.5 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 2.8 mmt -133.36 138.07 46.15 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.225 -0.922 . . . . 0.0 109.313 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.414 ' CG2' ' H ' ' A' ' 55' ' ' GLN . 0.2 OUTLIER 55.69 92.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -0.873 . . . . 0.0 109.205 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.87 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 32.3 p90 -82.3 -143.18 0.06 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 0.0 109.099 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.57 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.0 OUTLIER -140.26 133.27 29.39 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.203 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.888 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -123.43 150.16 44.16 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.761 -1.212 . . . . 0.0 108.113 178.152 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.789 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -140.5 88.09 2.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.964 -1.085 . . . . 0.0 110.224 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.65 HG23 ' CG2' ' A' ' 78' ' ' VAL . 5.0 p -99.91 132.27 45.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -142.89 159.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.065 -1.022 . . . . 0.0 109.971 -179.236 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.623 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 87.4 p -100.34 -146.79 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -0.838 . . . . 0.0 109.525 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.75 -10.39 59.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.743 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 13' ' ' GLN . 14.5 mt-10 -118.34 24.21 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.981 . . . . 0.0 109.633 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.454 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 41.8 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.78 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -177.94 92.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.659 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.927 ' HG2' HG21 ' A' ' 62' ' ' ILE . 1.7 mtt -161.97 -88.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.336 -0.852 . . . . 0.0 108.934 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.691 ' CE2' ' CG1' ' A' ' 20' ' ' VAL . 68.8 t80 -135.3 144.82 46.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.214 -0.929 . . . . 0.0 109.745 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.3 p -165.07 82.5 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.411 -0.806 . . . . 0.0 109.525 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.6 -178.96 42.33 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 4' ' ' TYR . 7.6 mt -71.01 139.45 50.51 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.076 -1.249 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.01 ' CG2' HD11 ' A' ' 23' ' ' ILE . 2.5 m -144.27 148.11 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.41 -0.806 . . . . 0.0 110.643 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.95 -42.05 4.79 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.593 -0.692 . . . . 0.0 109.849 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.529 ' O ' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -133.88 109.43 9.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.967 -1.083 . . . . 0.0 110.486 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.086 HG23 HG22 ' A' ' 52' ' ' ILE . 3.9 mm -105.4 -173.28 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.023 -1.048 . . . . 0.0 109.081 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.63 ' H ' HG22 ' A' ' 23' ' ' ILE . 4.0 tt0 -176.05 98.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.948 -1.095 . . . . 0.0 109.965 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 50' ' ' ILE . 2.1 p -104.32 137.98 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.352 -0.842 . . . . 0.0 109.069 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.527 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 31.6 m -124.21 115.52 21.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.339 -0.85 . . . . 0.0 109.574 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 46' ' ' LYS . . . -108.94 -68.06 0.61 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.6 t -170.6 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -1.152 . . . . 0.0 109.375 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -95.0 66.94 3.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.0 109.465 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.0 82.39 0.09 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -115.87 89.23 3.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.537 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.8 mt -106.81 151.35 25.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.877 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' O ' ' CE1' ' A' ' 35' ' ' TYR . . . -99.26 172.6 25.5 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 107.243 -2.343 . . . . 0.0 107.243 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.87 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 18.8 mm -99.21 128.53 50.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 120.585 -1.538 . . . . 0.0 109.385 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.607 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -129.98 170.75 10.23 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 30.0 Cg_endo -70.78 81.91 1.02 Allowed 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.772 1.648 . . . . 0.0 109.676 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 38' ' ' HIS . . . 168.27 -27.07 0.14 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.725 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 0.6 OUTLIER -42.2 163.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.346 -1.091 . . . . 0.0 109.461 179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.931 ' HB3' ' HD3' ' A' ' 40' ' ' PRO . . . 164.26 -52.0 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.052 -1.03 . . . . 0.0 110.492 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.931 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 36.6 Cg_endo -79.32 23.63 0.64 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.607 2.204 . . . . 0.0 111.828 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.53 ' HG ' ' NE2' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -100.57 110.92 23.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.804 -1.185 . . . . 0.0 109.612 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 42' ' ' LEU . 3.5 mt -148.41 80.82 1.46 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.925 . . . . 0.0 109.357 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.774 HG23 ' N ' ' A' ' 44' ' ' ALA . 5.1 t -147.06 -146.88 0.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.774 ' N ' HG23 ' A' ' 43' ' ' THR . . . -103.98 -176.61 3.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.115 -0.991 . . . . 0.0 109.472 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.875 HD11 ' O ' ' A' ' 68' ' ' ILE . 1.4 mt -132.55 166.18 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 17.3 mmtt -116.4 166.29 12.95 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 0.0 109.224 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -78.27 118.22 4.27 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.606 2.204 . . . . 0.0 110.559 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' CD1' ' A' ' 63' ' ' TYR . . . -168.17 -145.59 4.61 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.526 ' HE3' HG12 ' A' ' 130' ' ' VAL . 3.7 ppp? -122.14 -172.64 2.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.285 -1.126 . . . . 0.0 109.448 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.966 HD13 ' N ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.42 157.92 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 109.586 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.966 ' N ' HD13 ' A' ' 50' ' ' ILE . 6.3 ttp180 -149.98 134.9 17.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.388 -0.82 . . . . 0.0 109.111 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.086 HG22 HG23 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -114.44 161.0 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 110.318 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.785 HG12 ' O ' ' A' ' 53' ' ' VAL . 41.1 t -126.47 65.16 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 9.5 mtmt -43.54 124.49 3.55 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.19 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 56' ' ' HIS . 6.5 tp-100 46.65 -93.91 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.7 . . . . 0.0 109.657 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' LYS . 2.3 t-160 -165.32 122.12 1.47 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 0.0 109.458 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.53 -72.77 0.23 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.59 138.53 55.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -1.117 . . . . 0.0 109.595 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -157.21 162.37 39.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.343 -0.848 . . . . 0.0 109.348 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -156.55 177.1 11.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.17 -0.956 . . . . 0.0 109.354 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.755 ' O ' HD13 ' A' ' 62' ' ' ILE . 2.8 p90 -146.17 154.49 41.84 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.808 -1.182 . . . . 0.0 110.052 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.927 HG21 ' HG2' ' A' ' 15' ' ' MET . 2.5 mm -133.0 -161.52 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.62 ' HE1' ' HB3' ' A' ' 126' ' ' ALA . 42.0 t80 -157.61 114.69 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.117 -0.989 . . . . 0.0 109.513 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.77 ' H ' HD23 ' A' ' 64' ' ' LEU . 1.4 pt? -113.64 176.97 4.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.353 -0.842 . . . . 0.0 109.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 m -125.19 45.7 2.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.523 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.04 -167.4 29.25 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 134.53 -139.42 10.85 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.875 ' O ' HD11 ' A' ' 45' ' ' ILE . 3.7 mt -132.22 147.9 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.332 -1.099 . . . . 0.0 109.07 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.536 ' C ' HD12 ' A' ' 69' ' ' LEU . 2.5 pp -130.6 131.6 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.989 -1.069 . . . . 0.0 110.15 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 77' ' ' THR . 5.0 pt-20 -134.15 128.83 34.86 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.855 HG23 HG12 ' A' ' 76' ' ' VAL . 5.6 p -99.65 128.76 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.036 -1.04 . . . . 0.0 110.036 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.1 mt-30 -106.79 172.53 3.79 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.421 -0.799 . . . . 0.0 108.876 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.528 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.5 Cg_endo -78.75 112.52 3.14 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.577 2.185 . . . . 0.0 110.441 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 79.16 20.92 68.78 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.8 p-10 171.45 158.8 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -1.158 . . . . 0.0 109.205 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.855 HG12 HG23 ' A' ' 71' ' ' VAL . 34.5 m -140.99 160.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.062 -1.023 . . . . 0.0 109.436 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.555 ' CG2' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -152.04 143.53 23.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.924 . . . . 0.0 109.555 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG2' HG23 ' A' ' 8' ' ' VAL . 2.8 m -151.65 156.3 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.349 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 79' ' ' LEU . 6.3 mp -122.71 166.18 15.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.968 . . . . 0.0 109.538 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 10' ' ' SER . . . -146.0 -149.47 0.28 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -139.37 -55.47 0.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.567 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.8 m -111.58 148.17 33.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.206 -0.934 . . . . 0.0 109.679 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 63' ' ' TYR . . . -140.2 146.57 38.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.431 -0.793 . . . . 0.0 109.508 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.616 ' HB ' ' CD2' ' A' ' 63' ' ' TYR . 43.8 mt -126.17 -25.85 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 0.0 109.718 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 66.08 153.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.318 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -47.57 -29.7 5.84 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.461 ' OE1' ' HB ' ' A' ' 134' ' ' THR . 1.2 mt-30 -165.57 81.3 0.32 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.189 -1.183 . . . . 0.0 109.675 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 84' ' ' ILE . 9.9 t70 -73.62 -26.67 60.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.215 -0.928 . . . . 0.0 109.349 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 174.64 -50.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.382 -0.824 . . . . 0.0 109.211 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.32 119.84 31.69 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.232 -0.918 . . . . 0.0 109.642 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 92' ' ' ALA . 14.8 pt-20 -131.04 -38.63 1.23 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.247 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 91' ' ' GLU . . . -77.25 -16.52 58.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.315 -0.866 . . . . 0.0 109.408 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.04 2.72 53.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -0.872 . . . . 0.0 109.482 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.31 -16.39 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 108.981 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.74 -52.4 5.53 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.458 -0.776 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 99' ' ' ARG . 2.3 mt-10 -56.27 -31.42 63.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.465 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 100' ' ' LYS . . . -58.07 -53.07 62.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -53.47 -31.34 45.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.448 ' HD2' ' HA ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -66.93 -43.5 83.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.307 -0.871 . . . . 0.0 109.545 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 97' ' ' ALA . 12.0 pttm -84.11 -4.87 59.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.206 -0.934 . . . . 0.0 109.657 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 1.024 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -90.35 -7.73 52.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.198 -0.939 . . . . 0.0 109.508 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.7 OUTLIER -86.35 -25.76 25.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.238 -0.914 . . . . 0.0 109.661 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.16 -43.5 91.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.531 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -81.12 -15.1 56.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.464 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.747 HG13 HD13 ' A' ' 121' ' ' LEU . 18.8 mm -88.71 -19.42 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t -86.12 63.18 7.88 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.547 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 t -171.15 169.14 6.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.56 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 114' ' ' TYR . 29.8 t -175.08 100.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -157.58 76.27 0.81 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 0.0 109.471 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 161.66 169.81 25.49 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -74.57 -49.42 21.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -1.127 . . . . 0.0 109.309 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 18.3 m -118.7 33.81 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -0.879 . . . . 0.0 109.559 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.17 -97.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.069 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 114' ' ' TYR . 3.4 t80 -67.39 -14.11 62.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.33 -38.65 74.91 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.63 -0.669 . . . . 0.0 109.508 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -83.94 -5.65 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 109.682 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.0 -18.67 25.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.639 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.5 m -76.6 -29.86 56.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 0.0 109.732 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.92 -32.42 17.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.635 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 116' ' ' GLN . 6.3 mm-40 -75.78 -36.25 59.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 0.0 109.625 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.024 HD11 ' HB1' ' A' ' 101' ' ' ALA . 2.8 tt -73.38 -61.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.617 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -42.96 -27.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 109.683 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 121' ' ' LEU . 16.5 tttt -63.24 -54.27 40.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.239 -0.913 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -12.66 61.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.672 ' CG1' HD23 ' A' ' 121' ' ' LEU . 49.2 mm -82.23 2.18 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.581 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.62 ' HB3' ' HE1' ' A' ' 63' ' ' TYR . . . -83.95 -39.33 19.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.154 -0.966 . . . . 0.0 109.487 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.416 ' HG3' ' CG2' ' A' ' 84' ' ' ILE . 1.6 tm0? -76.58 -7.17 54.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.534 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.416 ' C ' HG22 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -81.72 -21.11 38.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.554 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -85.69 -33.9 21.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -0.952 . . . . 0.0 109.592 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.601 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 33.3 m -75.4 -33.99 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.526 HG23 ' N ' ' A' ' 132' ' ' GLU . 2.1 tt -61.68 -44.63 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.357 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 131' ' ' ILE . 77.5 mm-40 -44.85 -35.24 2.68 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 109.041 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 130' ' ' VAL . 4.5 mp -64.89 -55.46 19.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -0.81 . . . . 0.0 109.245 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.461 ' HB ' ' OE1' ' A' ' 87' ' ' GLN . 30.9 p -50.08 -29.14 8.33 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.856 . . . . 0.0 109.481 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 132' ' ' GLU . 2.8 mmtt -65.73 -54.96 20.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.242 -0.911 . . . . 0.0 109.519 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -88.83 21.4 3.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -123.65 42.5 3.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.611 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.388 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.268 0.556 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -116.29 40.97 2.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.218 -0.926 . . . . 0.0 109.554 -179.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.002 HG22 ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -109.93 -147.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.888 . . . . 0.0 109.649 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 1.192 ' CG ' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.61 -179.75 5.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 124.34 2.019 . . . . 0.0 115.884 -175.797 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.504 ' ND1' ' OD1' ' A' ' 75' ' ' ASN . 8.7 t-80 -153.96 89.65 1.32 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 110.123 -3.217 . . . . 0.0 103.445 174.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.983 HD21 HG21 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -92.77 126.77 38.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.683 -1.261 . . . . 0.0 107.992 -177.562 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' A' ' 77' ' ' THR . 7.3 t70 -133.36 75.58 1.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.593 -1.317 . . . . 0.0 109.912 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 15' ' ' MET . 1.4 p -111.13 147.35 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.26 -0.9 . . . . 0.0 108.948 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.516 ' HB ' ' N ' ' A' ' 14' ' ' GLN . 14.1 m -150.16 155.94 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.078 -1.014 . . . . 0.0 109.624 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -172.2 157.19 4.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.21 -0.931 . . . . 0.0 109.281 -179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 61.48 -89.3 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 109.414 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.3 22.13 3.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.98 . . . . 0.0 109.387 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER 46.34 75.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.366 -0.834 . . . . 0.0 110.051 179.651 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.516 ' N ' ' HB ' ' A' ' 9' ' ' VAL . 9.1 tt0 164.98 100.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 109.702 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.544 ' HB3' HG13 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -124.47 -73.21 0.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.064 179.286 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.688 ' CE2' HG11 ' A' ' 20' ' ' VAL . 1.1 t80 -127.17 112.79 15.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.047 -1.033 . . . . 0.0 110.082 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 6' ' ' LEU . 92.0 p -134.6 85.52 2.19 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.195 -0.941 . . . . 0.0 109.478 178.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.48 -160.73 23.12 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.467 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -93.24 159.67 15.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.075 -1.25 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.192 HG22 ' CG ' ' A' ' 4' ' ' TYR . 1.8 m -155.32 -167.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.885 -1.135 . . . . 0.0 110.663 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.779 ' N ' HG23 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -155.35 -33.39 0.09 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.641 178.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 10.1 mmtm -142.97 88.4 2.04 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.961 -1.087 . . . . 0.0 110.211 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.983 HG21 HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.24 138.78 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.696 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.986 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -122.95 165.93 15.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.03 -1.044 . . . . 0.0 110.346 -178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.546 ' CB ' HG12 ' A' ' 50' ' ' ILE . 11.5 p -171.53 154.98 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 2.1 t 179.76 154.9 0.54 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.123 -0.986 . . . . 0.0 109.829 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 170.5 -89.78 0.09 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 158.41 43.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 109.303 179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 59.0 74.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.155 -0.966 . . . . 0.0 109.392 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' C ' ' HG2' ' A' ' 46' ' ' LYS . . . 91.8 141.69 10.18 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -137.05 55.39 1.83 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -1.171 . . . . 0.0 109.752 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mt -115.09 157.07 24.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.822 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.21 171.63 24.61 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 178.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.914 HG22 ' OH ' ' A' ' 4' ' ' TYR . 12.7 mm -99.81 127.16 52.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 120.854 -1.38 . . . . 0.0 108.986 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.651 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -134.46 170.26 11.73 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.651 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -70.11 88.24 0.58 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.586 1.524 . . . . 0.0 109.538 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.73 18.98 2.58 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 6.8 t-160 -60.14 146.96 41.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.175 -1.191 . . . . 0.0 109.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.617 ' O ' HG11 ' A' ' 71' ' ' VAL . . . -40.59 147.04 0.41 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.51 -0.744 . . . . 0.0 109.666 -179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -78.98 69.14 8.04 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.695 2.263 . . . . 0.0 111.047 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.6 mt -91.07 126.57 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.009 . . . . 0.0 109.121 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.4 24.12 12.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.189 -0.944 . . . . 0.0 109.57 -179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 p -105.56 -92.81 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.393 -0.817 . . . . 0.0 109.336 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.808 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -130.12 172.72 11.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.935 . . . . 0.0 109.161 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.808 HD13 ' C ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -117.31 -149.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 -179.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' O ' HG21 ' A' ' 25' ' ' VAL . 2.2 mptp? -121.35 125.38 26.91 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.297 -0.877 . . . . 0.0 109.485 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.24 -159.36 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.433 2.089 . . . . 0.0 110.425 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 97.85 -137.08 13.08 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 50' ' ' ILE . 2.6 ppp? -102.62 -178.91 3.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -1.117 . . . . 0.0 109.383 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.986 HG23 ' O ' ' A' ' 24' ' ' GLN . 14.2 mt -157.63 140.63 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 110.193 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 7.5 mmt85 -131.16 112.31 12.73 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.694 HG23 ' CA ' ' A' ' 23' ' ' ILE . 12.6 mt -117.48 164.2 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 0.0 111.312 -178.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 59' ' ' GLU . 41.8 t -133.18 112.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' HIS . 20.4 mttm -65.96 149.89 49.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.517 -0.739 . . . . 0.0 109.792 -179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.557 ' HB2' HG21 ' A' ' 3' ' ' THR . 34.5 tt0 -52.11 95.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.332 -0.855 . . . . 0.0 109.338 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 55' ' ' GLN . 48.7 t-80 71.45 95.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.36 178.34 29.51 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -63.07 -166.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -1.224 . . . . 0.0 109.407 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HB3' HG22 ' A' ' 53' ' ' VAL . 10.2 pt-20 -131.12 147.45 52.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -125.52 138.29 53.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 108.964 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.911 ' CE1' HD11 ' A' ' 133' ' ' LEU . 0.5 OUTLIER -109.08 139.41 44.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.389 -0.819 . . . . 0.0 109.677 -179.613 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.466 ' O ' ' HB ' ' A' ' 50' ' ' ILE . 19.1 mt -121.2 160.48 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.352 -0.842 . . . . 0.0 109.288 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.742 ' HE1' HD12 ' A' ' 84' ' ' ILE . 1.4 t80 -139.38 151.49 46.37 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.268 -0.895 . . . . 0.0 109.014 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.726 ' N ' HD23 ' A' ' 64' ' ' LEU . 1.3 pt? 179.93 -170.1 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.345 -0.847 . . . . 0.0 109.479 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.511 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 4.9 m -135.21 -169.22 2.33 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.33 -0.856 . . . . 0.0 109.204 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 65' ' ' SER . . . 42.24 -141.07 1.76 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.16 119.24 2.42 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' ALA . 5.4 tt -151.89 130.28 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.326 -1.102 . . . . 0.0 109.065 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER 178.18 -140.0 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 -179.493 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.622 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -146.3 142.64 28.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.366 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.839 HG23 HG22 ' A' ' 76' ' ' VAL . 7.6 p -109.53 126.99 66.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.091 -1.006 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.48 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -105.39 173.86 3.01 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.487 -0.758 . . . . 0.0 109.293 179.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -77.92 4.02 6.48 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.524 2.149 . . . . 0.0 109.974 179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . -167.16 39.27 0.24 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.504 ' OD1' ' ND1' ' A' ' 5' ' ' HIS . 5.0 t30 167.98 94.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.237 -1.155 . . . . 0.0 109.472 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.839 HG22 HG23 ' A' ' 71' ' ' VAL . 5.0 t -100.78 116.12 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.215 -0.928 . . . . 0.0 109.267 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.688 ' O ' ' HB3' ' A' ' 69' ' ' LEU . 6.4 t -118.45 158.64 24.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.251 -0.906 . . . . 0.0 109.686 -179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.764 ' HA ' ' CG ' ' A' ' 69' ' ' LEU . 3.5 p 179.44 141.06 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 121.742 0.782 . . . . 0.0 110.288 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.657 ' C ' HD23 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -115.64 145.63 42.54 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.823 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.53 -165.25 1.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.0 109.492 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -106.32 -43.83 4.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 17.8 m -106.32 151.85 24.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.218 -0.926 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.79 93.7 1.98 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.742 HD12 ' HE1' ' A' ' 63' ' ' TYR . 6.1 mt -106.63 66.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.335 -0.853 . . . . 0.0 109.529 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' A' ' 84' ' ' ILE . 13.0 ttp180 -44.79 161.05 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.685 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 87' ' ' GLN . . . -51.45 147.49 10.33 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.859 ' H ' HG22 ' A' ' 131' ' ' ILE . 13.2 pt20 38.58 38.7 0.27 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.63 -0.924 . . . . 0.0 109.886 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -45.09 -48.55 11.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.362 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.59 -57.4 0.22 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -129.8 -167.09 1.75 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.154 -0.966 . . . . 0.0 109.448 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.616 ' CB ' HD12 ' A' ' 131' ' ' ILE . 16.1 pt-20 -144.78 -38.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.583 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.67 67.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.673 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -8.03 52.94 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.4 -14.61 32.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -89.26 -18.53 26.83 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.407 -0.808 . . . . 0.0 109.41 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.21 -1.51 36.74 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -80.37 -38.51 30.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 109.318 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HA ' HD11 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -76.42 -27.81 56.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 179.799 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -70.38 -43.62 69.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.295 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.86 -23.0 39.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.233 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.615 ' CB ' HD13 ' A' ' 121' ' ' LEU . . . -81.46 -22.14 38.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.213 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 102' ' ' GLU . 31.9 tt0 -66.08 -19.32 65.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.51 -27.5 21.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.406 ' O ' ' OH ' ' A' ' 114' ' ' TYR . 1.6 m-70 -77.12 -45.9 25.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.489 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.731 ' O ' HG22 ' A' ' 105' ' ' ILE . 88.0 mt -87.61 12.11 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 105' ' ' ILE . 2.6 m -44.37 -60.85 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.935 . . . . 0.0 109.128 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.0 p -90.34 -160.85 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 175.29 128.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.029 -1.045 . . . . 0.0 109.616 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -160.82 93.37 0.98 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 109.377 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.854 ' O ' ' HB2' ' A' ' 115' ' ' ALA . . . 165.2 143.85 3.86 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.09 -41.61 67.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.692 -179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 14.5 m -137.46 -31.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.042 -1.036 . . . . 0.0 110.352 -179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' A' ' 112' ' ' VAL . 0.6 OUTLIER -41.61 -92.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 109.828 -179.743 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 104' ' ' HIS . 15.4 t80 -77.92 -21.4 51.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 110' ' ' GLY . . . -61.27 -18.05 56.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 8.7 mt-30 -84.99 -35.93 21.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.392 -0.818 . . . . 0.0 109.352 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.16 -10.02 27.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.332 -0.855 . . . . 0.0 109.722 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 18.1 m -71.42 -49.22 43.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.591 -179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -58.14 -25.49 61.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.716 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.37 -47.48 76.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.643 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.615 HD13 ' CB ' ' A' ' 101' ' ' ALA . 47.9 tp -52.2 -51.76 56.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.717 -179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.1 -20.38 64.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.758 -179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -78.11 -13.96 59.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.96 42.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.588 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 125' ' ' ILE . 1.5 mp -88.21 -2.09 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.704 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -88.45 -24.55 22.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.975 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.598 ' HB3' ' CE1' ' A' ' 63' ' ' TYR . 2.1 pt20 -74.89 -32.63 61.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.533 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.448 ' O ' ' HG2' ' A' ' 132' ' ' GLU . 4.3 tt -84.2 -6.76 59.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.615 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -26.13 47.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.439 ' HB ' ' CD2' ' A' ' 61' ' ' PHE . 2.3 m -86.46 -31.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.513 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.859 HG22 ' H ' ' A' ' 87' ' ' GLN . 3.2 pt -72.03 -4.03 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.935 . . . . 0.0 109.37 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 128' ' ' LEU . 1.7 mm-40 -78.21 -34.08 49.58 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.171 -0.956 . . . . 0.0 109.699 -179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.911 HD11 ' CE1' ' A' ' 61' ' ' PHE . 0.7 OUTLIER -87.31 2.98 48.61 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.155 -0.966 . . . . 0.0 109.533 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 70.6 p -83.2 -16.15 47.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.019 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -71.81 -25.77 62.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.37 -0.831 . . . . 0.0 109.225 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.01 39.54 3.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 0.0 109.403 -179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -112.09 -7.09 14.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.466 -179.859 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.428 ' C ' ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -64.1 179.04 0.59 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.945 . . . . 0.0 109.579 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.646 HG22 ' HG3' ' A' ' 21' ' ' GLU . 38.1 p -141.88 155.45 45.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.235 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.635 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 0.9 OUTLIER -148.49 -148.45 0.26 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.83 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -131.35 144.57 51.34 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.055 HD23 HG21 ' A' ' 20' ' ' VAL . 2.3 pp -135.67 154.4 51.3 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 120.491 -1.381 . . . . 0.0 109.278 178.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.567 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -140.03 115.19 9.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 109.942 -179.448 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.601 ' CG2' HD21 ' A' ' 64' ' ' LEU . 2.1 p -111.71 94.02 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.179 -0.951 . . . . 0.0 108.74 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.695 HG22 ' HG3' ' A' ' 14' ' ' GLN . 23.4 t -99.73 155.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 0.0 109.705 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.544 ' HB3' ' HB2' ' A' ' 83' ' ' ALA . 3.8 p -124.15 -149.99 0.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 109.42 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 81' ' ' ASP . . . -52.69 -38.06 59.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -178.88 32.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.313 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -134.66 67.53 1.5 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.588 -179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.695 ' HG3' HG22 ' A' ' 9' ' ' VAL . 23.6 tt0 -44.65 155.24 0.1 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.368 -0.832 . . . . 0.0 109.811 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.565 ' HB2' HG13 ' A' ' 8' ' ' VAL . 4.1 mmt -134.15 -96.81 0.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.846 ' HB3' HD11 ' A' ' 6' ' ' LEU . 3.5 t80 -70.09 130.95 43.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.919 -1.113 . . . . 0.0 108.717 179.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.418 ' N ' ' CD1' ' A' ' 16' ' ' PHE . 4.7 p -157.23 110.24 2.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.5 179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' HIS . . . 138.91 -160.64 25.78 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.75 ' C ' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -53.79 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -1.214 . . . . 0.0 109.51 179.433 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.055 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER 170.41 162.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.592 -1.318 . . . . 0.0 107.959 179.827 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.646 ' HG3' HG22 ' A' ' 3' ' ' THR . 0.3 OUTLIER -130.03 -37.57 1.48 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.454 -1.404 . . . . 0.0 110.433 -179.082 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 1.3 mtmt -155.29 93.21 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.767 -1.208 . . . . 0.0 110.764 -179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.743 ' CA ' HG23 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -98.92 153.93 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.253 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -156.16 134.55 11.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.623 -1.298 . . . . 0.0 110.259 -179.636 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.525 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.6 t -108.12 129.68 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.8 m -106.6 114.24 28.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.237 -0.914 . . . . 0.0 109.397 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.493 ' CA ' ' O ' ' A' ' 47' ' ' PRO . . . -141.23 -123.15 1.91 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.2 t -125.11 138.23 54.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -1.157 . . . . 0.0 109.287 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 47.41 78.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.264 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.05 111.78 1.72 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.22 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.176 . . . . 0.0 109.832 -179.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.68 138.89 44.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.613 179.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.17 -100.9 2.27 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 178.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.853 HG13 HG21 ' A' ' 76' ' ' VAL . 28.8 mm -155.61 153.81 7.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.333 -1.098 . . . . 0.0 109.671 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.625 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -155.5 -176.47 0.61 Allowed Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.821 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 34.8 Cg_endo -80.02 69.68 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.062 1.841 . . . . 0.0 109.844 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.38 35.52 0.37 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.638 ' O ' ' HB2' ' A' ' 39' ' ' ALA . 12.2 t-80 -72.06 -74.99 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 0.0 109.627 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 167.89 166.67 0.14 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.35 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.2 Cg_endo -77.68 79.12 3.3 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.68 2.253 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' A' ' 39' ' ' ALA . 4.0 mm? -92.85 133.17 36.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.837 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -138.63 52.28 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.561 -0.712 . . . . 0.0 109.175 179.826 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.5 p -126.1 -138.15 0.27 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -99.68 -163.45 1.03 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.0 109.566 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.561 ' CD1' HG21 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -120.57 135.59 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' CD ' ' H ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -61.38 134.38 93.38 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.185 -0.947 . . . . 0.0 109.522 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.493 ' O ' ' CA ' ' A' ' 27' ' ' GLY . 36.2 Cg_endo -79.22 159.85 26.42 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.551 2.167 . . . . 0.0 110.29 179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 125.18 -142.74 14.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.408 ' CE ' ' HB3' ' A' ' 129' ' ' ARG . 0.8 OUTLIER -108.32 -172.02 1.98 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -1.14 . . . . 0.0 109.129 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.509 HD13 HD13 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -161.6 141.17 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.986 -1.071 . . . . 0.0 110.145 -179.562 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.534 ' HG3' ' CZ ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -131.34 139.7 49.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.743 HG23 ' CA ' ' A' ' 23' ' ' ILE . 12.1 mt -130.67 172.51 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.999 -1.063 . . . . 0.0 109.997 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.589 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 41.4 t -138.34 104.91 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.312 -0.867 . . . . 0.0 109.695 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.589 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 146.21 -99.87 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.078 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.485 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 1.1 tt0 44.28 -157.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.025 -1.047 . . . . 0.0 109.383 -179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -81.52 -18.88 43.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.289 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -104.19 -140.24 10.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -118.38 -22.13 7.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -1.205 . . . . 0.0 109.54 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -146.46 126.19 13.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.703 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 60' ' ' GLU . 2.3 mm-40 -103.63 142.39 34.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.016 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.534 ' CZ ' ' HG3' ' A' ' 51' ' ' ARG . 0.4 OUTLIER -133.49 106.32 7.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.767 -179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.674 ' O ' HG11 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -124.47 -166.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 0.0 109.091 179.617 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.737 ' CE1' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -172.67 126.4 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -0.972 . . . . 0.0 109.31 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 8' ' ' VAL . 3.1 mt -119.6 -173.52 2.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.837 . . . . 0.0 109.406 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 p -152.73 34.42 0.49 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.268 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 124.92 172.2 13.45 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.55 -164.95 25.12 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 79' ' ' LEU . 11.9 tt -109.51 154.38 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -1.184 . . . . 0.0 109.621 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.726 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -133.87 132.06 39.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.197 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -136.13 131.46 34.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.899 . . . . 0.0 109.226 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 40' ' ' PRO . 9.8 p -100.82 137.56 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.865 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.59 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 1.8 mm-40 -124.65 176.73 2.16 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.1 Cg_endo -78.85 106.72 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.489 2.126 . . . . 0.0 110.757 -179.408 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 70.69 31.93 67.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.464 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 10.8 p-10 174.63 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 109.627 179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.853 HG21 HG13 ' A' ' 34' ' ' ILE . 6.4 p -124.69 149.84 29.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.185 -0.947 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -146.86 142.18 27.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.255 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.561 HG21 ' CD1' ' A' ' 45' ' ' ILE . 4.8 m -145.03 141.85 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.24 -179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB2' HG22 ' A' ' 68' ' ' ILE . 6.0 mp -103.05 158.76 16.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 10' ' ' SER . . . -152.6 -165.72 2.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.357 -0.839 . . . . 0.0 109.33 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.3 OUTLIER -120.65 -38.98 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -0.971 . . . . 0.0 109.574 -179.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 t -115.29 171.86 7.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.464 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' A' ' 10' ' ' SER . . . -173.78 133.43 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.449 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.737 HD12 ' CE1' ' A' ' 63' ' ' TYR . 61.5 mt -144.14 152.68 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.125 -0.984 . . . . 0.0 109.491 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.433 ' O ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -96.08 178.11 5.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.349 179.88 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' A' ' 130' ' ' VAL . . . -76.83 2.32 60.05 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.42 46.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -1.213 . . . . 0.0 109.536 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -48.89 -58.07 5.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.482 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 -67.35 0.36 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.302 -0.874 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.78 -168.17 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.302 -0.874 . . . . 0.0 109.367 179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.859 ' HB2' HG21 ' A' ' 131' ' ' ILE . 4.3 pt-20 -172.42 -34.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.928 . . . . 0.0 109.732 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.53 -19.54 55.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -0.943 . . . . 0.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -80.16 3.35 20.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 128' ' ' LEU . . . -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.196 -0.94 . . . . 0.0 108.879 179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.556 ' HG3' HD13 ' A' ' 128' ' ' LEU . 5.5 mtp -79.2 -23.95 43.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.677 . . . . 0.0 109.546 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 20.6 mt-10 -68.23 -19.39 64.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.569 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.43 -40.93 20.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.584 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -39.26 80.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.202 -0.937 . . . . 0.0 109.506 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -36.35 82.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.583 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 96' ' ' GLU . 16.1 mttt -89.69 -0.35 57.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.922 . . . . 0.0 109.682 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.945 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -86.56 -55.46 3.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 109.324 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -68.8 -42.08 77.81 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.864 . . . . 0.0 109.246 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.6 -43.27 75.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.633 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -69.03 -23.85 64.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.572 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 105' ' ' ILE . 98.9 mt -89.97 24.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.275 -0.89 . . . . 0.0 109.335 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 107' ' ' SER . 16.6 m -61.09 92.8 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.364 -0.835 . . . . 0.0 109.469 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.3 OUTLIER 72.27 168.68 0.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.228 -0.92 . . . . 0.0 109.279 -179.945 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.9 t -152.29 154.72 36.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.545 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -154.62 150.35 27.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.424 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 113' ' ' ASP . . . 115.74 20.3 5.41 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.531 ' O ' HG22 ' A' ' 112' ' ' VAL . 0.8 OUTLIER 52.32 100.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -1.135 . . . . 0.0 109.348 179.933 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 111' ' ' ASP . 25.8 m 40.7 34.27 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.607 -0.683 . . . . 0.0 109.661 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 110' ' ' GLY . 20.6 t0 -87.23 -95.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.489 -0.757 . . . . 0.0 109.085 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -69.67 -12.26 61.5 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.01 63.43 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.62 -0.675 . . . . 0.0 109.42 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -73.97 -27.07 60.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -0.862 . . . . 0.0 109.442 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -78.76 -7.74 58.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.917 . . . . 0.0 109.446 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.466 ' OG ' HG23 ' A' ' 105' ' ' ILE . 38.4 m -81.01 -30.66 34.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.18 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 0.0 109.385 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -84.18 -13.31 53.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.945 HD12 ' HB1' ' A' ' 101' ' ' ALA . 0.3 OUTLIER -74.9 -24.97 58.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.381 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.447 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -79.02 -6.39 56.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.236 -0.915 . . . . 0.0 109.595 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -14.58 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 109.408 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' HG2' ' A' ' 127' ' ' GLN . . . -88.9 -10.61 47.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.905 . . . . 0.0 109.389 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 125' ' ' ILE . 1.7 mp -81.36 -2.73 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.512 ' CB ' ' HA2' ' A' ' 48' ' ' GLY . . . -90.49 -21.33 21.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.121 -0.987 . . . . 0.0 109.677 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 124' ' ' ALA . 12.0 pt20 -69.17 -35.78 76.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.456 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.722 ' HA ' HD12 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -84.2 11.04 8.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.617 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.437 ' HG3' ' HA ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -89.72 -51.27 5.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 0.0 109.655 -179.834 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.674 HG11 ' O ' ' A' ' 62' ' ' ILE . 22.6 m -52.3 -19.7 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.774 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.859 HG21 ' HB2' ' A' ' 91' ' ' GLU . 7.3 mt -86.29 -58.55 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.186 -0.946 . . . . 0.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 131' ' ' ILE . 39.2 mm-40 -42.15 -40.02 2.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.778 . . . . 0.0 110.121 -179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 4.9 mp -74.2 -52.04 13.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.088 -1.007 . . . . 0.0 109.73 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 130' ' ' VAL . 6.6 p -46.89 -24.41 0.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 0.0 109.523 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -70.91 -55.93 7.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.362 -0.837 . . . . 0.0 109.594 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.74 20.17 13.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 109.495 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -69.45 -22.35 63.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.295 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.556 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -155.93 63.44 0.58 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.892 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.066 HG22 ' HB2' ' A' ' 21' ' ' GLU . 2.1 p -42.47 125.0 3.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.58 179.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.745 ' CE2' HG22 ' A' ' 34' ' ' ILE . 27.1 p90 -118.64 -171.67 2.13 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 0.8 OUTLIER -111.97 147.46 35.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.035 -1.041 . . . . 0.0 109.076 179.834 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.104 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -137.06 162.8 32.36 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.964 -1.085 . . . . 0.0 109.132 178.66 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.009 ' N ' HD12 ' A' ' 6' ' ' LEU . 10.9 t0 -154.64 96.95 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 78' ' ' VAL . 2.5 p -109.69 112.25 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.238 -0.914 . . . . 0.0 109.115 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.47 167.61 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.063 -1.023 . . . . 0.0 109.925 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -179.39 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.399 -0.813 . . . . 0.0 109.436 179.941 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 65.91 109.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 109.429 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 21.3 mm-40 62.38 79.48 0.26 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLU . 9.8 mp0 -43.8 111.97 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.466 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.459 ' OE1' ' O ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -171.52 53.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.278 -0.889 . . . . 0.0 109.321 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.621 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -133.81 -88.29 0.4 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 -179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.627 ' CD2' ' HG ' ' A' ' 6' ' ' LEU . 32.7 t80 -139.96 126.03 19.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.055 -1.028 . . . . 0.0 109.355 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.3 p -159.67 82.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -0.96 . . . . 0.0 109.235 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.53 -145.04 6.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.675 ' C ' HG12 ' A' ' 20' ' ' VAL . 11.4 mt -69.99 159.49 33.68 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -1.116 . . . . 0.0 109.583 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.104 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -175.91 164.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 -178.124 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 1.066 ' HB2' HG22 ' A' ' 3' ' ' THR . 47.0 tt0 -139.1 -56.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.108 -0.995 . . . . 0.0 110.236 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.553 ' HE3' ' CD1' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -130.64 111.21 12.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.043 -1.036 . . . . 0.0 110.711 -178.985 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.828 HG22 ' CG1' ' A' ' 52' ' ' ILE . 0.9 OUTLIER -99.18 -162.42 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.507 ' O ' HG13 ' A' ' 50' ' ' ILE . 0.9 OUTLIER -166.36 159.03 14.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.74 -1.225 . . . . 0.0 109.904 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.547 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.3 t -154.52 116.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.196 -0.94 . . . . 0.0 109.089 179.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.433 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 81.6 m -111.47 110.56 21.06 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.457 -0.777 . . . . 0.0 109.231 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 47' ' ' PRO . . . -154.76 45.68 0.55 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.61 169.32 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -1.158 . . . . 0.0 109.546 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 53.65 43.3 31.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.337 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.98 167.34 19.81 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -164.7 66.01 0.14 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.136 -1.214 . . . . 0.0 109.375 -179.914 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD13 ' OH ' ' A' ' 35' ' ' TYR . 5.7 mt -131.2 147.36 52.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.827 179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.547 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.74 -102.9 2.45 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.745 HG22 ' CE2' ' A' ' 4' ' ' TYR . 3.5 mm -153.61 159.1 3.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.276 -1.132 . . . . 0.0 108.979 178.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.572 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -151.28 174.74 3.32 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.505 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.5 Cg_endo -74.85 76.91 3.2 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.174 1.916 . . . . 0.0 109.95 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.64 49.34 0.07 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 14.9 t-80 -109.48 2.65 20.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -1.182 . . . . 0.0 109.792 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 38' ' ' HIS . . . 66.92 155.78 0.14 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.986 . . . . 0.0 109.44 -179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.33 87.65 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.676 2.251 . . . . 0.0 110.655 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 38' ' ' HIS . 7.3 mt -99.05 138.67 35.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 109.472 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.504 ' CD2' ' HG2' ' A' ' 70' ' ' GLU . 74.3 mt -119.9 86.94 2.65 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.255 -0.903 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.561 ' O ' HG23 ' A' ' 68' ' ' ILE . 17.0 p -131.25 -155.0 0.66 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.401 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . . . -100.33 171.7 7.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.398 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.552 HG22 ' O ' ' A' ' 67' ' ' GLY . 3.4 tt -100.21 169.84 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -115.5 142.46 28.86 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.92 . . . . 0.0 109.349 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.9 Cg_endo -78.5 146.05 21.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.514 2.143 . . . . 0.0 110.298 -179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 144.63 -148.22 19.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.473 ' HE1' HG12 ' A' ' 130' ' ' VAL . 5.3 ppp? -101.46 174.35 6.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -1.119 . . . . 0.0 109.305 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.969 HG23 ' H ' ' A' ' 62' ' ' ILE . 0.5 OUTLIER -148.48 151.39 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.982 -1.074 . . . . 0.0 109.88 179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 23' ' ' ILE . 1.5 ttt180 -121.03 172.65 7.79 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.828 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -164.22 144.85 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.711 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.635 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 34.4 t -134.09 118.01 27.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.648 -0.657 . . . . 0.0 109.302 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.635 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER 139.97 -86.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.835 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.528 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 3.6 tt0 41.33 -94.64 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.412 -0.805 . . . . 0.0 109.65 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 19.1 t-160 -132.11 -36.56 1.16 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.237 -0.914 . . . . 0.0 109.415 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.17 42.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.59 -173.34 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.279 -1.13 . . . . 0.0 109.337 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 52' ' ' ILE . 10.8 pt-20 -126.86 145.84 50.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.102 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -136.93 167.92 20.56 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -134.07 136.47 43.99 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.463 -0.773 . . . . 0.0 109.733 -179.964 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.969 ' H ' HG23 ' A' ' 50' ' ' ILE . 0.8 OUTLIER -109.48 -157.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 109.031 179.671 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.75 ' HE2' ' HB3' ' A' ' 126' ' ' ALA . 4.2 t80 -172.62 129.15 0.53 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.157 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.99 -164.36 2.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.188 -0.945 . . . . 0.0 109.61 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.528 ' HB2' HG21 ' A' ' 82' ' ' THR . 0.3 OUTLIER -165.4 130.61 2.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.345 -0.847 . . . . 0.0 109.526 -179.977 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.4 158.7 3.25 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.552 ' O ' HG22 ' A' ' 45' ' ' ILE . . . 126.14 177.5 14.91 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 43' ' ' THR . 41.1 mt -122.85 142.86 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -1.116 . . . . 0.0 109.309 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.598 ' O ' HD23 ' A' ' 69' ' ' LEU . 1.0 OUTLIER -106.55 132.84 52.08 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.277 -0.89 . . . . 0.0 109.46 -179.864 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.742 ' O ' HG23 ' A' ' 76' ' ' VAL . 1.5 tt0 -134.44 112.56 11.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.417 -0.802 . . . . 0.0 108.895 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.501 HG23 ' HB ' ' A' ' 76' ' ' VAL . 4.0 p -99.65 158.51 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 0.0 109.945 -179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -139.78 169.25 12.53 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.0 109.32 179.912 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 73.44 5.75 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.702 2.268 . . . . 0.0 110.563 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.33 -14.74 5.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.515 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 14.5 p30 -165.43 166.09 18.72 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -1.148 . . . . 0.0 109.394 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 70' ' ' GLU . 1.3 p -153.73 145.63 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 109.327 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.609 HG23 ' HB3' ' A' ' 7' ' ' ASP . 4.3 m -137.78 142.35 40.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.269 -0.895 . . . . 0.0 109.138 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 8' ' ' VAL . 2.5 m -142.61 143.4 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 109.225 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.3 mp -116.99 147.0 42.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.0 109.685 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -138.55 -174.37 3.8 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.273 -0.892 . . . . 0.0 109.249 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -105.39 -46.81 4.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.576 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.528 HG21 ' HB2' ' A' ' 65' ' ' SER . 7.5 t -100.38 -176.1 3.11 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.634 -179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.621 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -178.94 76.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 84' ' ' ILE . 3.8 mp -106.18 77.01 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.296 -0.877 . . . . 0.0 109.744 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 86' ' ' GLY . 4.9 ttt-85 -45.77 152.11 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.572 ' CA ' HG23 ' A' ' 130' ' ' VAL . . . -42.11 -45.59 5.07 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -74.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.049 -1.265 . . . . 0.0 109.31 179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.51 ' CG ' HG23 ' A' ' 84' ' ' ILE . 27.8 t70 50.01 39.03 17.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.379 -0.825 . . . . 0.0 109.563 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 88' ' ' ASP . 0.4 OUTLIER 59.61 151.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 0.0 109.603 179.826 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 63.37 -166.48 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 0.0 109.617 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.535 ' CB ' HD11 ' A' ' 131' ' ' ILE . 6.7 pt-20 -177.06 -51.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.391 -0.818 . . . . 0.0 109.147 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.75 -28.19 58.39 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -69.81 -6.53 32.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 179.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' O ' HD11 ' A' ' 128' ' ' LEU . . . -89.3 -22.44 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 108.743 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -29.79 33.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.534 -0.728 . . . . 0.0 109.047 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.25 -32.63 74.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.455 -0.778 . . . . 0.0 109.402 179.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -57.6 -63.68 1.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.499 ' HG3' HD11 ' A' ' 125' ' ' ILE . 5.9 ttpt -57.77 -29.52 64.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.354 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.9 ttm-85 -66.35 -32.68 74.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -0.893 . . . . 0.0 109.426 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -22.36 32.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.212 -0.93 . . . . 0.0 109.457 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.999 ' HB1' HD21 ' A' ' 121' ' ' LEU . . . -85.55 -15.66 41.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 108.923 179.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -72.55 -17.32 61.73 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.399 -0.813 . . . . 0.0 109.12 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HA ' ' OG ' ' A' ' 106' ' ' SER . 0.0 OUTLIER -87.4 -34.59 18.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -68.57 -38.85 81.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.551 -179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.786 HD11 ' HG ' ' A' ' 121' ' ' LEU . 94.2 mt -73.46 -16.98 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 109.568 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 103' ' ' GLU . 0.3 OUTLIER -91.37 24.45 2.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.866 . . . . 0.0 109.454 179.927 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.509 ' O ' ' CB ' ' A' ' 108' ' ' SER . 0.7 OUTLIER -150.82 178.14 9.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.717 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 75.95 175.59 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -154.83 -165.14 1.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.296 -0.878 . . . . 0.0 109.391 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.96 178.68 25.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -92.14 -55.16 3.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -1.156 . . . . 0.0 109.451 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.661 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 11.3 m -118.9 9.46 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.47 -98.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 108.997 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' A' ' 108' ' ' SER . 23.4 p90 -67.11 -19.9 65.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.988 -1.07 . . . . 0.0 108.161 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -56.36 -26.88 54.24 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -78.64 -31.32 46.8 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.383 -0.823 . . . . 0.0 109.323 179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -75.5 -24.24 56.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.164 -0.96 . . . . 0.0 109.428 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.9 -4.19 36.53 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.653 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -81.09 -38.58 27.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 109.472 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.98 0.82 46.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.652 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.999 HD21 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -79.37 -46.92 16.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.43 -9.32 32.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.893 . . . . 0.0 109.527 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -71.68 -22.97 61.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.634 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.25 -3.51 58.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.182 -0.949 . . . . 0.0 109.682 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.561 ' CD1' ' N ' ' A' ' 125' ' ' ILE . 1.2 mp -89.56 -8.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 0.0 109.364 179.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.75 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -74.27 -36.42 63.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.082 -1.011 . . . . 0.0 109.274 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.556 ' HB3' ' CD2' ' A' ' 63' ' ' TYR . 1.3 pt20 -90.33 1.52 56.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -90.13 -26.45 20.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.163 -0.961 . . . . 0.0 109.61 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.01 -21.34 33.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.742 -179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.583 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 30.2 m -88.05 -28.98 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.538 -179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.985 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -88.46 -13.63 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -0.87 . . . . 0.0 109.51 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -33.45 33.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 110.013 -179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 133' ' ' LEU . 1.6 pp -84.12 1.32 44.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.004 -1.06 . . . . 0.0 109.586 -179.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 131' ' ' ILE . 0.7 OUTLIER -88.86 -35.31 16.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.17 -0.956 . . . . 0.0 109.209 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 7.6 pttt -79.1 -22.64 44.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.256 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -90.1 -7.03 54.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.338 -0.851 . . . . 0.0 109.394 179.895 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -90.79 3.05 55.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 109.578 -179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.436 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -56.47 138.61 51.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.532 179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.745 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER 62.66 131.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.192 -0.943 . . . . 0.0 109.313 -179.852 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.839 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 4.3 p90 -130.82 -154.73 0.65 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.287 -0.883 . . . . 0.0 109.292 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 75' ' ' ASN . 9.9 t-80 -127.64 138.51 52.86 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.14 -0.975 . . . . 0.0 109.354 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.053 HD23 HG21 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -134.81 160.01 39.54 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 120.986 -1.072 . . . . 0.0 109.015 179.349 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.98 ' N ' HD12 ' A' ' 6' ' ' LEU . 15.4 t70 -149.81 101.59 3.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.987 -1.071 . . . . 0.0 110.08 -179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 8' ' ' VAL . 13.7 p -102.46 123.78 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 O-C-N 121.189 -0.944 . . . . 0.0 109.121 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.9 t -135.81 148.61 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.134 -0.979 . . . . 0.0 109.836 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.635 ' CB ' ' HB2' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -140.11 -142.54 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.045 179.87 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.29 30.25 0.71 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.079 -1.013 . . . . 0.0 109.694 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.549 ' CD ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pm0 -170.53 78.89 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.0 109.278 -179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' GLU . 3.3 mt-30 -42.48 103.46 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 109.67 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 13' ' ' GLN . 5.6 tt0 175.15 59.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.621 ' HB3' HG21 ' A' ' 62' ' ' ILE . 5.7 mmm -143.49 -82.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.157 -0.965 . . . . 0.0 109.945 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HB2' HD11 ' A' ' 62' ' ' ILE . 27.5 t80 -145.81 143.55 29.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.116 -0.99 . . . . 0.0 109.276 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.444 ' CB ' ' OD1' ' A' ' 7' ' ' ASP . 13.8 p -175.19 88.54 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -0.919 . . . . 0.0 109.59 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.84 -145.35 10.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.722 ' C ' HG12 ' A' ' 20' ' ' VAL . 14.8 mt -68.7 165.15 20.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.19 -1.182 . . . . 0.0 109.066 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.053 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -173.82 152.15 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.042 -1.036 . . . . 0.0 109.135 -177.907 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.745 ' HG3' HG23 ' A' ' 3' ' ' THR . 3.0 tt0 -114.73 -69.85 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.119 -0.988 . . . . 0.0 110.65 -178.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.5 tptt -125.93 107.98 10.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.925 -1.109 . . . . 0.0 110.744 -178.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.978 HG22 HG12 ' A' ' 52' ' ' ILE . 1.3 pp -108.9 118.82 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -99.64 125.51 45.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.541 -1.349 . . . . 0.0 110.298 -178.46 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG23 ' HA2' ' A' ' 33' ' ' GLY . 1.5 t -112.86 120.75 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.007 -1.058 . . . . 0.0 109.166 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.9 m -124.14 110.12 14.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 47' ' ' PRO . . . -128.77 -145.53 5.99 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 29' ' ' GLU . 1.4 m -98.56 135.28 40.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -1.223 . . . . 0.0 109.26 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' CB ' ' O ' ' A' ' 28' ' ' SER . 6.6 tt0 71.33 101.61 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.121 -0.987 . . . . 0.0 109.233 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.03 171.38 20.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 179.84 60.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.974 -1.31 . . . . 0.0 110.304 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mt -94.46 153.2 18.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.012 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.65 171.83 24.35 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.839 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 15.0 mm -99.11 126.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.039 -1.271 . . . . 0.0 108.434 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -124.21 170.63 8.41 Favored Pre-proline 0 C--N 1.299 -1.603 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -178.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.616 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.1 Cg_endo -72.31 90.91 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.841 1.694 . . . . 0.0 109.933 179.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.26 2.25 4.18 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -49.3 136.64 15.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.156 -1.202 . . . . 0.0 109.492 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.864 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -54.07 171.29 0.27 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.864 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -77.37 83.46 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.697 2.265 . . . . 0.0 110.522 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -99.26 141.31 32.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 109.46 -179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.67 89.98 1.81 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.254 -0.904 . . . . 0.0 109.374 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' HG13 ' A' ' 68' ' ' ILE . 11.9 p -150.13 -138.52 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.257 -179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.608 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -100.06 171.13 8.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.215 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.913 HD11 ' C ' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -99.89 174.61 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -0.961 . . . . 0.0 109.227 179.954 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 2.5 mttt -111.43 143.91 29.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.345 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 35.2 Cg_endo -77.78 121.86 5.65 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.51 2.14 . . . . 0.0 110.402 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.531 ' HA2' ' CB ' ' A' ' 126' ' ' ALA . . . 168.22 -156.15 27.44 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.594 ' N ' ' HB1' ' A' ' 126' ' ' ALA . 5.9 ptm -108.55 -177.33 3.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.28 -1.13 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.642 HG23 ' H ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -158.69 136.35 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.952 -1.092 . . . . 0.0 110.722 -179.524 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -102.86 174.87 5.68 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.978 HG12 HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -164.95 152.87 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.652 -1.28 . . . . 0.0 109.886 -179.414 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 53.2 t -136.29 99.96 2.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER 155.89 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.476 ' N ' ' CG ' ' A' ' 54' ' ' LYS . 8.8 tt0 50.34 23.78 1.33 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 109.826 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER 43.5 63.84 1.42 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.594 179.965 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 163.49 -59.59 0.27 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.4 -158.17 0.5 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.17 -1.194 . . . . 0.0 109.542 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -110.04 158.64 18.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.895 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' H ' HG22 ' A' ' 52' ' ' ILE . 2.9 mt-10 -156.95 165.2 36.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.597 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 3.5 p90 -128.19 127.7 43.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.656 HD11 ' HB2' ' A' ' 16' ' ' PHE . 1.0 OUTLIER -99.96 -154.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.741 -179.847 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.715 ' HE1' ' HB3' ' A' ' 126' ' ' ALA . 23.2 t80 -177.84 128.8 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 108.924 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.84 -166.06 2.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.17 -0.956 . . . . 0.0 109.825 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 m -119.89 -90.79 0.57 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' C ' HG12 ' A' ' 45' ' ' ILE . . . -125.58 -131.47 3.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 104.49 -166.63 15.18 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.913 ' C ' HD11 ' A' ' 45' ' ' ILE . 16.7 tt -113.61 133.72 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -1.199 . . . . 0.0 109.459 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.987 ' O ' HD23 ' A' ' 69' ' ' LEU . 0.9 OUTLIER -114.82 116.46 28.62 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.398 -179.777 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.653 ' O ' HG23 ' A' ' 76' ' ' VAL . 2.7 pt-20 -114.34 127.75 56.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.0 108.88 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.62 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.1 p -99.8 144.81 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.12 -0.987 . . . . 0.0 109.884 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.543 ' CG ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -123.69 172.89 5.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.384 -0.822 . . . . 0.0 109.103 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -78.16 93.95 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.611 2.208 . . . . 0.0 110.635 -179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.06 -17.0 45.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.682 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.529 ' O ' ' CB ' ' A' ' 72' ' ' GLN . 0.7 OUTLIER -156.92 152.85 27.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -1.134 . . . . 0.0 109.324 179.999 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 70' ' ' GLU . 2.0 p -138.14 144.02 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.01 . . . . 0.0 109.617 -179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.879 HG22 ' HB3' ' A' ' 7' ' ' ASP . 11.9 p -131.07 146.78 52.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.319 -0.863 . . . . 0.0 109.375 179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 69' ' ' LEU . 4.9 m -149.33 146.1 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.512 ' C ' HD23 ' A' ' 79' ' ' LEU . 0.9 OUTLIER -124.36 151.47 44.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.29 -0.881 . . . . 0.0 109.341 179.925 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.494 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -144.46 -164.8 1.99 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.37 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -117.06 -24.25 7.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 83' ' ' ALA . 20.5 m -110.8 165.47 11.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.322 -0.861 . . . . 0.0 109.301 179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.635 ' HB2' ' CB ' ' A' ' 10' ' ' SER . . . -175.15 67.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.137 -0.977 . . . . 0.0 109.76 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.532 HD12 ' CG2' ' A' ' 82' ' ' THR . 2.8 mp -101.43 72.25 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.276 -0.89 . . . . 0.0 108.922 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -44.35 167.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.291 -0.88 . . . . 0.0 109.445 -179.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.424 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -52.47 -46.29 58.38 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -53.27 -80.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -1.162 . . . . 0.0 109.406 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 89' ' ' LEU . 34.7 t70 55.24 17.87 2.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.532 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 88' ' ' ASP . 0.7 OUTLIER 42.38 37.07 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.531 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.42 ' HB2' ' OD2' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -146.42 168.7 20.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -152.41 -82.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.196 -0.94 . . . . 0.0 109.812 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.72 -25.9 68.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.227 -0.921 . . . . 0.0 109.92 -179.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -64.86 -24.86 67.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.974 . . . . 0.0 109.934 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.98 -17.05 26.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.091 -1.005 . . . . 0.0 109.207 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.978 ' HA ' HD11 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -80.8 -48.47 12.42 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 -179.586 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -72.19 -9.69 58.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.846 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.62 -19.96 47.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 125' ' ' ILE . 0.3 OUTLIER -87.79 -1.62 58.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.269 -0.894 . . . . 0.0 109.532 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.05 -36.78 19.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.528 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -61.02 -20.61 62.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -0.913 . . . . 0.0 109.427 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.559 ' O ' HD12 ' A' ' 105' ' ' ILE . . . -90.08 -21.61 22.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.369 -0.832 . . . . 0.0 109.186 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.63 -44.86 95.22 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.0 109.406 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.08 -6.15 43.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -90.1 -41.61 11.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.229 -0.919 . . . . 0.0 109.828 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.711 ' O ' HG22 ' A' ' 105' ' ' ILE . 3.2 mt -86.98 13.8 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.145 -0.972 . . . . 0.0 109.827 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -103.89 74.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.292 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 52.9 p -155.7 -153.47 0.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.425 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.7 t 173.61 112.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 109.493 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -165.55 -54.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.819 . . . . 0.0 109.447 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -107.02 143.85 15.84 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.544 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 19.7 t70 -64.35 -24.67 67.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -1.125 . . . . 0.0 109.524 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.9 m -112.89 18.9 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.382 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.86 -92.35 0.06 Allowed 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.427 -0.795 . . . . 0.0 109.219 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -73.5 -23.61 60.07 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -56.77 -36.98 70.46 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' A' ' 116' ' ' GLN . 6.1 mm-40 -87.6 -15.51 37.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.416 -0.803 . . . . 0.0 109.231 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.98 -31.72 69.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.405 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -51.96 -26.01 9.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 0.0 109.74 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.91 -35.97 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.684 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -65.11 -50.5 65.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.663 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 125' ' ' ILE . 36.4 tp -55.31 -53.57 54.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.508 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 121' ' ' LEU . . . -43.68 -35.89 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.01 -49.99 74.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.661 -179.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.64 -10.77 59.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.561 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.583 HD11 HD11 ' A' ' 121' ' ' LEU . 20.4 mm -89.0 -11.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.445 179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.715 ' HB3' ' HE1' ' A' ' 63' ' ' TYR . . . -72.4 -35.05 68.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -81.2 -10.22 59.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.978 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.3 OUTLIER -83.14 -29.24 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.436 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -77.04 -39.76 48.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.843 . . . . 0.0 109.597 -179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.597 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 27.6 m -74.18 -36.41 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.957 HD13 ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -67.21 -19.48 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.422 179.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.452 ' C ' ' HG2' ' A' ' 135' ' ' LYS . 6.1 tm-20 -71.95 -16.05 62.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.925 . . . . 0.0 109.426 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mp -90.11 -47.99 7.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.433 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.7 p -60.67 -31.11 70.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.454 ' HG3' ' N ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -63.43 -28.88 70.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.341 -0.849 . . . . 0.0 109.828 -179.817 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' N ' ' HG3' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -109.31 0.6 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.108 -0.995 . . . . 0.0 109.587 -179.992 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -55.9 -18.11 8.17 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 6.9 tpt . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.605 179.981 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.467 ' O ' ' O ' ' A' ' 3' ' ' THR . 1.5 ttm -148.81 132.77 17.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 109.58 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.537 ' N ' ' HG3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER 52.76 171.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 179.846 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.744 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.1 p90 179.62 -179.21 0.42 Allowed 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.563 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.5 t60 -105.32 149.51 25.99 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.216 -0.927 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.048 HD12 ' N ' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -138.5 164.77 28.55 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.001 178.825 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.048 ' N ' HD12 ' A' ' 6' ' ' LEU . 2.2 t70 -154.88 81.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.526 179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.667 HG23 HG13 ' A' ' 78' ' ' VAL . 2.7 p -104.36 110.55 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.867 . . . . 0.0 109.48 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 33.2 m -119.14 -170.54 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.94 . . . . 0.0 109.688 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . 80.3 p -143.22 -166.7 2.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.419 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' SER . . . -44.37 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.179 -0.95 . . . . 0.0 109.453 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' CD ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -140.55 65.07 1.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.89 . . . . 0.0 109.448 -179.933 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -147.32 172.1 14.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 109.452 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -91.65 152.01 20.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.246 -0.909 . . . . 0.0 109.554 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.7 mtt -154.05 -76.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 109.475 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' CZ ' ' HB ' ' A' ' 20' ' ' VAL . 30.6 t80 -168.14 134.83 2.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 9.1 p -165.73 98.78 0.67 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 156.9 -153.8 25.0 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.657 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.5 mt -65.18 162.15 17.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.141 -1.211 . . . . 0.0 108.747 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.044 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -172.59 171.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.889 -1.132 . . . . 0.0 109.571 -178.538 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.518 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 5.0 tt0 -120.24 -47.97 2.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.074 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -172.44 133.1 0.62 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.042 179.873 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.865 HG21 HD22 ' A' ' 6' ' ' LEU . 3.0 pt -108.37 129.56 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 178.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.456 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 20.0 mt-30 -99.5 95.71 7.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.928 -1.108 . . . . 0.0 109.511 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 50' ' ' ILE . 3.8 t -99.14 151.59 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.692 ' HA ' ' CB ' ' A' ' 31' ' ' GLU . 9.0 t -160.94 140.44 10.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.424 -0.798 . . . . 0.0 108.949 -179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.447 ' N ' ' HB2' ' A' ' 31' ' ' GLU . . . -111.8 -166.8 18.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 t -48.08 -66.71 0.36 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 109.09 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -66.74 -13.86 61.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.084 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 112.65 151.49 11.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.692 ' CB ' ' HA ' ' A' ' 26' ' ' THR . 0.6 OUTLIER -142.82 155.3 44.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.131 -1.217 . . . . 0.0 109.716 179.421 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.53 175.98 10.06 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.883 -179.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.31 171.49 14.12 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.013 -2.035 . . . . 0.0 108.013 178.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.744 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 16.7 mm -99.89 143.86 13.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 120.808 -1.407 . . . . 0.0 108.927 179.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.626 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 1.8 p90 -155.66 169.42 10.39 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.626 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 29.7 Cg_endo -69.58 83.18 0.67 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.553 1.502 . . . . 0.0 109.627 179.613 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 131.07 33.58 0.46 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.701 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 32.4 t60 -77.95 3.97 13.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -1.161 . . . . 0.0 109.565 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.957 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 76.53 175.39 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.099 -1.0 . . . . 0.0 109.847 179.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.957 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.5 Cg_endo -78.2 76.24 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.722 2.281 . . . . 0.0 110.412 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.567 ' H ' HG11 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -93.36 122.2 35.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.467 -179.986 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.4 75.23 1.5 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 68' ' ' ILE . 1.8 p -139.21 -147.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' C ' HD13 ' A' ' 45' ' ' ILE . . . -106.3 169.37 8.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -111.04 171.86 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.755 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -115.3 165.52 14.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 46' ' ' LYS . 36.0 Cg_endo -78.27 117.08 4.01 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.694 2.262 . . . . 0.0 110.323 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . -172.53 -153.01 8.98 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.549 ' HB2' HG11 ' A' ' 130' ' ' VAL . 9.7 ptm -114.19 178.03 4.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 109.268 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.798 HG23 ' H ' ' A' ' 62' ' ' ILE . 2.0 tt -151.78 153.4 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.029 -1.045 . . . . 0.0 110.298 -179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' N ' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -123.27 176.77 5.92 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.662 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.826 ' CG1' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -171.25 141.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.005 -179.242 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 21' ' ' GLU . 55.1 t -128.79 113.55 29.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 58' ' ' HIS . 24.3 mmtt -64.33 142.77 58.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 -179.113 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.469 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.1 tt0 -43.5 -28.01 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.191 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 45.6 t-80 178.98 53.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.416 -0.803 . . . . 0.0 109.305 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.23 -107.59 0.52 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 5.2 t-80 -106.41 172.06 7.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -1.124 . . . . 0.0 109.697 -179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -156.52 136.49 12.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.196 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -164.52 -173.85 3.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.173 -0.955 . . . . 0.0 109.64 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 2.1 p90 -125.2 144.11 50.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.418 -0.801 . . . . 0.0 109.493 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.798 ' H ' HG23 ' A' ' 50' ' ' ILE . 2.4 mm -116.17 -147.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.357 -0.84 . . . . 0.0 108.986 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.878 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.5 t80 -174.92 130.98 0.31 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 108.841 179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.39 177.05 7.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.72 -179.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.545 ' HB2' HG21 ' A' ' 82' ' ' THR . 6.4 t -109.04 -52.36 2.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.38 -0.825 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -166.68 -155.27 8.85 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 128.49 -158.92 21.88 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.597 ' C ' HD11 ' A' ' 45' ' ' ILE . 14.5 tt -127.38 125.8 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.358 -1.083 . . . . 0.0 109.49 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.573 ' HB2' HD12 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -99.69 144.0 29.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -141.08 134.01 29.08 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.685 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.567 HG11 ' H ' ' A' ' 41' ' ' LEU . 7.1 p -99.8 155.86 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.131 -179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.589 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -132.04 -177.84 0.75 Allowed Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.776 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 34.7 Cg_endo -79.88 93.31 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.323 2.015 . . . . 0.0 110.618 -179.307 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.03 -15.29 56.3 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -126.83 160.74 30.03 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.226 -1.161 . . . . 0.0 109.513 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.622 HG21 ' CG2' ' A' ' 34' ' ' ILE . 14.7 t -134.96 153.3 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.205 -0.934 . . . . 0.0 109.038 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.731 HG23 ' HB3' ' A' ' 7' ' ' ASP . 4.1 m -158.73 127.55 5.42 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.061 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.667 HG13 HG23 ' A' ' 8' ' ' VAL . 1.2 p -140.32 126.28 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.93 131.5 49.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.103 -0.998 . . . . 0.0 109.673 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.462 ' HA ' ' HA3' ' A' ' 67' ' ' GLY . . . -117.1 -156.7 0.64 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.286 -0.883 . . . . 0.0 109.266 179.69 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -145.85 13.76 1.33 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.249 -0.907 . . . . 0.0 109.319 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.545 HG21 ' HB2' ' A' ' 65' ' ' SER . 3.1 m -148.98 135.87 19.79 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.227 -0.92 . . . . 0.0 109.322 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.83 107.07 4.34 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.274 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.878 HD12 ' CE1' ' A' ' 63' ' ' TYR . 98.6 mt -110.19 -29.62 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.347 -0.846 . . . . 0.0 109.684 -179.656 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.634 HH21 HD12 ' A' ' 62' ' ' ILE . 2.3 mtp-105 62.77 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.248 -0.907 . . . . 0.0 109.636 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.757 ' CA ' HG23 ' A' ' 130' ' ' VAL . . . -66.81 -11.49 57.84 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ASP . 4.7 mt-30 -90.97 -50.24 5.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -1.139 . . . . 0.0 109.167 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.693 ' HB2' HG22 ' A' ' 84' ' ' ILE . 56.7 t0 43.6 47.05 6.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.828 . . . . 0.0 109.583 179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 90' ' ' ASP . 11.0 mt 48.8 -91.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.408 -0.808 . . . . 0.0 109.784 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 88' ' ' ASP . 6.1 m-20 -53.94 -168.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.859 . . . . 0.0 109.719 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -153.82 -69.15 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.471 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.49 -17.97 62.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 0.0 109.831 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -22.12 65.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.46 -19.5 23.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.925 . . . . 0.0 109.248 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.74 -29.02 50.91 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.824 . . . . 0.0 109.625 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -80.8 -2.27 46.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.03 -36.42 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.109 -0.994 . . . . 0.0 109.53 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -58.61 -36.39 73.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.882 . . . . 0.0 109.786 -179.805 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -75.77 -31.9 59.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.188 -0.945 . . . . 0.0 109.694 -179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -90.03 4.67 49.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -0.973 . . . . 0.0 109.848 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.547 ' HB1' HD13 ' A' ' 121' ' ' LEU . . . -89.75 -4.43 57.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.177 -0.952 . . . . 0.0 109.58 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 3.3 tp10 -89.49 -47.82 7.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 109.719 -179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -60.94 -17.09 49.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 109.975 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -86.76 -30.16 21.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.028 -1.045 . . . . 0.0 109.835 -179.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 105' ' ' ILE . 99.4 mt -89.88 10.78 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.59 30.88 1.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.423 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 152.04 51.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -0.903 . . . . 0.0 109.515 -179.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.59 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 5.9 p -138.38 129.51 27.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.264 -0.897 . . . . 0.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 t60 178.39 59.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 147.06 152.0 5.55 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -74.2 -51.24 16.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -1.116 . . . . 0.0 109.403 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.9 m -107.3 24.99 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.67 -96.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.42 -0.8 . . . . 0.0 109.22 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.59 ' CE2' ' HA ' ' A' ' 108' ' ' SER . 10.2 p90 -72.28 -25.07 61.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.257 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.97 -26.75 38.81 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.14 -31.6 17.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -0.814 . . . . 0.0 109.362 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -68.29 -19.28 64.69 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.384 -0.822 . . . . 0.0 109.56 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 p -67.71 -32.01 72.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.575 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.97 -14.7 59.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.518 -179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.436 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mm-40 -82.35 -28.94 31.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.642 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.547 HD13 ' HB1' ' A' ' 101' ' ' ALA . 8.6 mt -90.27 -39.78 12.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.596 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.415 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -59.77 -44.24 93.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 109.695 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 pttp -59.82 -28.43 67.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.182 -0.949 . . . . 0.0 109.455 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 127' ' ' GLN . . . -67.25 -30.32 70.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 109.537 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.597 ' N ' HD12 ' A' ' 125' ' ' ILE . 2.2 mp -70.95 -8.05 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.23 -31.4 19.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.256 179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 124' ' ' ALA . 0.0 OUTLIER -78.6 -13.43 59.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.259 179.75 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.561 ' C ' HD23 ' A' ' 128' ' ' LEU . 6.4 tt -76.84 -19.4 57.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.896 . . . . 0.0 109.391 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -82.18 -28.22 32.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.378 -0.826 . . . . 0.0 109.769 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.757 HG23 ' CA ' ' A' ' 86' ' ' GLY . 27.6 m -86.07 -27.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.951 . . . . 0.0 109.955 -179.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.0 tt -69.53 -28.91 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.799 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.483 ' O ' ' CG ' ' A' ' 135' ' ' LYS . 14.9 mm-40 -65.59 -15.69 62.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 109.488 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 7.4 mp -90.29 -40.94 11.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.644 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.468 HG23 ' CZ ' ' A' ' 61' ' ' PHE . 2.2 p -71.92 -3.12 20.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.933 -179.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -76.74 -23.52 53.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.114 -0.991 . . . . 0.0 109.478 179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.513 ' CG ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -120.99 40.41 3.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.369 179.647 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -108.09 -18.82 13.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.533 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.2 ttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.493 -179.959 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -44.74 130.66 7.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.617 179.914 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.651 HG23 ' HG3' ' A' ' 21' ' ' GLU . 0.2 OUTLIER 64.39 130.14 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.209 -0.932 . . . . 0.0 109.423 179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.686 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 3.4 p90 -131.32 -143.47 0.24 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 0.0 109.576 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.843 ' HA ' HG12 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -141.35 150.0 41.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 0.0 108.99 -179.361 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.915 ' CD2' HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -112.52 132.07 55.28 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.175 -0.953 . . . . 0.0 109.04 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.498 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -129.76 72.42 1.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.823 -1.173 . . . . 0.0 109.791 179.832 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.842 HG23 HG23 ' A' ' 78' ' ' VAL . 3.7 p -109.1 118.2 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.214 -0.929 . . . . 0.0 109.211 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 13.2 m -129.75 159.59 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.943 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.03 169.42 8.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.332 -0.855 . . . . 0.0 109.609 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.48 118.84 4.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.337 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 58.81 44.02 17.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.878 . . . . 0.0 109.206 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -177.78 168.56 2.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.412 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 1.7 pt20 -147.97 174.38 11.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.765 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 3.9 mmt -144.65 -75.45 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.944 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.702 ' CD2' ' CB ' ' A' ' 6' ' ' LEU . 1.1 t80 -109.5 113.09 25.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 110.294 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.433 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 32.8 p -136.36 90.6 2.58 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.26 -0.9 . . . . 0.0 109.708 178.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' O ' ' CG ' ' A' ' 5' ' ' HIS . . . 168.99 -158.64 31.36 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.787 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -71.89 -164.05 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.933 -1.333 . . . . 0.0 109.291 179.483 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 5' ' ' HIS . 0.2 OUTLIER 172.43 164.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 0.0 108.461 179.162 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.651 ' HG3' HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER -123.73 -40.07 2.35 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.428 -0.795 . . . . 0.0 109.3 179.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 25.8 ttpt -159.4 113.51 2.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.975 -1.078 . . . . 0.0 110.558 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.915 HG21 ' CD2' ' A' ' 6' ' ' LEU . 13.0 pt -98.81 -164.38 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.689 ' O ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -179.76 97.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.667 -1.271 . . . . 0.0 110.221 179.691 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.607 HG12 ' HA2' ' A' ' 33' ' ' GLY . 3.1 p -99.26 140.42 18.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.306 -0.872 . . . . 0.0 108.717 179.279 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.493 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 23.8 m -131.97 103.6 6.39 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.695 -179.464 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 28' ' ' SER . . . -133.26 -47.61 0.1 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER 165.05 -51.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.214 -1.168 . . . . 0.0 109.555 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.63 125.36 33.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.463 -179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.76 -52.69 4.23 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 57.02 19.17 4.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.759 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.682 HD23 ' OH ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -128.22 160.7 31.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.082 -1.011 . . . . 0.0 109.602 179.873 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.607 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -99.49 -112.73 3.37 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.404 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.689 HG12 HD11 ' A' ' 23' ' ' ILE . 31.2 mm -155.0 149.18 12.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.26 -1.141 . . . . 0.0 109.481 179.281 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.682 ' OH ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -153.34 -172.86 0.33 Allowed Pre-proline 0 C--N 1.3 -1.562 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.955 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' CD ' ' CB ' ' A' ' 35' ' ' TYR . 34.0 Cg_endo -78.46 81.21 2.81 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 121.687 1.592 . . . . 0.0 110.423 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 25.7 1.82 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 39' ' ' ALA . 28.3 t60 -56.89 145.01 31.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.241 . . . . 0.0 109.477 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.96 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -49.27 176.25 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.38 179.978 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.96 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.4 Cg_endo -78.18 87.51 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.645 2.23 . . . . 0.0 110.424 -179.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.19 126.19 46.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.384 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.93 73.09 0.93 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.143 -0.973 . . . . 0.0 109.855 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -149.3 -144.78 0.16 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.0 109.051 179.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -99.58 -171.45 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.001 . . . . 0.0 109.183 179.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 3.1 mt -132.45 172.66 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.172 -0.955 . . . . 0.0 109.678 -179.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -123.45 174.28 3.68 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.288 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 46' ' ' LYS . 35.5 Cg_endo -77.43 144.22 22.63 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.513 2.142 . . . . 0.0 110.307 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 165.84 -157.28 29.68 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.425 ' HB3' ' HB1' ' A' ' 126' ' ' ALA . 1.4 ptm -111.29 -177.74 3.28 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -1.079 . . . . 0.0 109.498 -179.874 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.689 HD12 ' O ' ' A' ' 24' ' ' GLN . 3.1 tp -160.28 115.53 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.928 -1.108 . . . . 0.0 110.441 -179.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.455 ' C ' ' CG1' ' A' ' 52' ' ' ILE . 25.2 ttp180 -110.24 154.88 22.78 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.865 ' CG2' HG22 ' A' ' 23' ' ' ILE . 15.9 mt -154.65 170.32 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.193 . . . . 0.0 111.011 -178.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.557 ' N ' HG22 ' A' ' 52' ' ' ILE . 41.4 t -132.43 111.32 17.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 56' ' ' HIS . 4.3 ttpt -62.65 105.71 0.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.584 -0.697 . . . . 0.0 110.193 -179.116 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.527 ' CA ' ' HB2' ' A' ' 21' ' ' GLU . 3.5 tt0 40.59 -93.82 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.523 -0.735 . . . . 0.0 110.023 179.525 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 54' ' ' LYS . 28.6 t-80 -150.15 81.88 1.37 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.102 -0.998 . . . . 0.0 109.487 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.64 -97.51 0.11 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.448 ' CD2' ' O ' ' A' ' 59' ' ' GLU . 47.7 t60 -86.39 170.99 11.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -1.167 . . . . 0.0 109.584 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' ILE . 6.8 mt-10 -125.47 164.1 21.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.338 -0.851 . . . . 0.0 109.183 179.793 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -122.67 130.62 53.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.111 -0.993 . . . . 0.0 109.756 -179.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.403 ' C ' ' CG1' ' A' ' 62' ' ' ILE . 2.1 m-85 -108.83 132.87 53.58 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 63' ' ' TYR . 1.5 mt -150.73 -179.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.978 -1.076 . . . . 0.0 110.01 -179.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.578 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -159.77 152.66 21.64 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.923 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD12 ' N ' ' A' ' 65' ' ' SER . 1.2 pp -146.93 -174.55 4.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.046 -1.034 . . . . 0.0 109.97 -179.541 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.479 ' N ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -133.86 -48.98 0.81 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.47 164.04 31.87 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 79' ' ' LEU . . . 156.88 -172.76 34.52 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 1.6 mp -111.18 131.28 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -1.137 . . . . 0.0 109.061 179.863 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.859 ' HA ' HG12 ' A' ' 78' ' ' VAL . 1.3 tt -115.78 137.55 51.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.304 -0.872 . . . . 0.0 109.408 -179.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 12.7 pt-20 -146.37 143.25 28.95 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.007 ' HA ' HG12 ' A' ' 76' ' ' VAL . 6.1 p -99.62 147.01 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.675 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.488 ' HB3' ' OD1' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -126.87 170.43 9.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.902 . . . . 0.0 109.524 179.958 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' HD2' ' HG2' ' A' ' 72' ' ' GLN . 36.1 Cg_endo -78.68 77.73 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.643 2.229 . . . . 0.0 110.926 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.44 0.65 16.02 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.225 179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 72' ' ' GLN . 1.8 p30 -174.89 166.87 3.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.005 -1.291 . . . . 0.0 109.756 -179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.007 HG12 ' HA ' ' A' ' 71' ' ' VAL . 0.2 OUTLIER -135.15 161.99 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.852 . . . . 0.0 109.129 179.833 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 17.4 m -156.11 136.75 13.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.859 HG12 ' HA ' ' A' ' 69' ' ' LEU . 7.4 m -138.95 148.4 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.434 -0.791 . . . . 0.0 109.037 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.479 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -115.01 120.89 41.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 -179.886 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -123.77 -174.97 3.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.148 -0.97 . . . . 0.0 109.466 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.1 -51.4 2.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 -179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.8 m -100.27 126.82 46.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.295 -0.878 . . . . 0.0 109.22 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.765 ' HB1' ' HE3' ' A' ' 15' ' ' MET . . . -138.53 150.2 46.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.982 -179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.578 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 69.6 mt -132.68 122.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.352 -0.843 . . . . 0.0 108.901 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -72.88 89.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.951 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 49.15 -123.8 12.1 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.624 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.508 ' HB3' HG12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -100.88 52.97 0.85 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -1.096 . . . . 0.0 109.676 -179.674 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.88 -37.53 70.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.217 -0.927 . . . . 0.0 109.422 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.37 174.04 12.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.17 44.06 30.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.453 ' OE2' ' O ' ' A' ' 87' ' ' GLN . 68.2 mt-10 -77.12 -80.56 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.187 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.45 -7.77 53.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.222 -0.924 . . . . 0.0 109.315 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtt85 -86.86 8.76 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.258 -0.902 . . . . 0.0 109.51 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.19 -37.58 14.06 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.251 -0.906 . . . . 0.0 109.037 179.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -38.94 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 179.819 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 5.1 mm-40 -71.0 -18.18 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -63.47 -52.06 62.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.509 -179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -55.76 -18.91 9.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 109.702 -179.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -74.15 -45.68 47.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.78 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -79.33 -19.63 49.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.621 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.61 -20.73 25.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.132 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HG2' ' OG ' ' A' ' 106' ' ' SER . 34.7 tt0 -71.39 -28.03 63.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 109.195 179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.593 ' HG3' ' CD2' ' A' ' 104' ' ' HIS . 7.2 pt-20 -59.27 -31.06 68.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.669 179.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.593 ' CD2' ' HG3' ' A' ' 103' ' ' GLU . 25.3 m170 -82.24 -40.72 21.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 -179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.743 HG22 ' O ' ' A' ' 105' ' ' ILE . 7.4 mt -85.74 12.53 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.228 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' SER . 58.0 m -110.58 117.69 34.22 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -0.906 . . . . 0.0 109.444 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.1 OUTLIER 81.65 171.96 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.827 -0.546 . . . . 0.0 109.537 179.884 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.523 ' CB ' ' O ' ' A' ' 107' ' ' SER . 0.1 OUTLIER 77.67 173.33 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.422 -0.799 . . . . 0.0 109.13 -179.539 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 114' ' ' TYR . 4.8 p-80 -170.13 125.56 0.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.61 169.23 40.14 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 115' ' ' ALA . 3.7 m-20 -67.51 -40.23 85.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.337 -1.096 . . . . 0.0 109.327 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 113' ' ' ASP . 23.2 m -124.92 -9.73 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.574 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 112' ' ' VAL . 2.0 m-20 -48.02 -95.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.168 179.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.527 ' CD1' ' C ' ' A' ' 114' ' ' TYR . 5.8 p90 -75.93 -21.2 57.32 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.017 -1.052 . . . . 0.0 108.294 179.28 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 111' ' ' ASP . . . -62.81 -18.28 62.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.631 -0.668 . . . . 0.0 109.355 179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 3.0 mt-30 -70.23 -36.06 74.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.503 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.653 ' HB3' HG13 ' A' ' 105' ' ' ILE . . . -72.86 -24.7 60.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -0.869 . . . . 0.0 109.499 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.4 m -65.96 -25.98 67.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.339 -0.851 . . . . 0.0 109.605 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.3 -33.32 25.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.945 . . . . 0.0 109.653 -179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 117' ' ' ALA . 1.2 pp20? -85.61 -8.3 58.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 -179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 122' ' ' ALA . 9.0 tt -84.14 -59.13 2.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.548 ' HA ' ' CG1' ' A' ' 125' ' ' ILE . . . -46.54 -27.79 1.23 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.778 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.84 -51.22 70.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.918 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.19 59.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 -179.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.548 ' CG1' ' HA ' ' A' ' 122' ' ' ALA . 33.5 mm -76.6 -8.12 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.962 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 49' ' ' MET . . . -88.72 -2.86 58.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.168 -0.958 . . . . 0.0 109.615 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.496 ' O ' HG22 ' A' ' 130' ' ' VAL . 1.6 mt-30 -87.63 -37.89 16.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.194 -0.941 . . . . 0.0 109.232 179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HA ' HD12 ' A' ' 131' ' ' ILE . 4.6 tp -81.19 -24.54 37.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.333 -0.855 . . . . 0.0 109.461 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.478 ' O ' ' HB2' ' A' ' 133' ' ' LEU . 16.5 mmm180 -62.5 -43.51 98.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 127' ' ' GLN . 28.1 m -68.66 -9.99 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.234 -0.916 . . . . 0.0 109.71 -179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.508 HG12 ' HB3' ' A' ' 87' ' ' GLN . 63.0 mt -90.62 -56.15 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 109.588 -179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.435 ' HA ' ' OE1' ' A' ' 132' ' ' GLU . 21.1 mm-40 -68.67 -9.19 48.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 0.0 109.614 -179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -87.65 -48.69 7.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.464 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.544 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 10.4 t -69.08 -7.57 37.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 109.503 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -55.64 -53.64 54.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.554 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -87.46 -12.74 45.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.213 -0.93 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -46.83 -37.83 9.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.921 . . . . 0.0 109.306 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.397 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.504 ' HG2' ' CG ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER 177.84 56.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.746 -179.895 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 3' ' ' THR . 8.9 t 173.7 129.31 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.292 -0.88 . . . . 0.0 109.71 179.87 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 1.035 ' CE2' HG22 ' A' ' 34' ' ' ILE . 13.8 p90 -112.84 -162.55 0.8 Allowed 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 1.4 t60 -117.27 142.36 47.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 108.548 178.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.042 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -130.43 156.79 44.17 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 118.859 -1.136 . . . . 0.0 109.415 178.43 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.891 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -143.03 90.2 2.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.341 -0.85 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.951 HG13 HD13 ' A' ' 6' ' ' LEU . 7.3 m -108.37 147.7 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.249 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -169.31 151.19 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 0.0 109.538 -179.928 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 2.4 m -119.94 125.68 49.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' GLU . . . 56.0 27.78 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.2 OUTLIER 66.07 72.48 0.39 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.993 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.35 -165.65 1.36 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.92 82.74 1.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.621 ' SD ' HG23 ' A' ' 62' ' ' ILE . 7.4 mmt -105.88 -92.63 0.38 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.401 179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.656 ' HB3' HG22 ' A' ' 8' ' ' VAL . 34.4 t80 -121.07 138.99 53.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.084 -1.01 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 55.2 p -169.06 100.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 0.0 109.402 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 154.94 -151.41 23.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.84 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.786 ' C ' HG12 ' A' ' 20' ' ' VAL . 10.9 mt -64.22 170.48 3.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -1.179 . . . . 0.0 109.484 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.042 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 172.92 160.36 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.007 -1.058 . . . . 0.0 108.39 -177.608 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.537 ' HB2' ' CB ' ' A' ' 3' ' ' THR . 8.6 tt0 -156.32 -58.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.916 -1.115 . . . . 0.0 110.623 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.544 ' CB ' ' HB ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -91.42 74.72 6.03 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.089 -1.007 . . . . 0.0 111.054 -178.395 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.665 HG22 ' CG1' ' A' ' 52' ' ' ILE . 2.9 pt -99.89 143.67 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.503 ' HA ' ' N ' ' A' ' 33' ' ' GLY . 35.8 tt0 -150.63 121.85 7.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.789 -1.194 . . . . 0.0 109.674 -179.348 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.7 p -99.84 159.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.24 -0.912 . . . . 0.0 109.328 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 5.9 m -138.46 111.79 8.05 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.216 -0.927 . . . . 0.0 109.204 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.53 -99.62 0.52 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -134.56 -0.12 2.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.212 -1.169 . . . . 0.0 110.214 -179.674 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 3.7 tm-20 -164.05 128.66 2.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.009 -1.057 . . . . 0.0 109.607 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.93 -53.64 0.61 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' O ' ' HG ' ' A' ' 32' ' ' LEU . 16.8 mt-10 48.85 23.61 0.71 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -1.174 . . . . 0.0 109.559 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.576 HD22 ' OH ' ' A' ' 35' ' ' TYR . 1.7 mt -148.13 161.09 42.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.108 -0.995 . . . . 0.0 109.991 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' N ' ' HA ' ' A' ' 24' ' ' GLN . . . -111.73 -103.83 2.72 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.035 HG22 ' CE2' ' A' ' 4' ' ' TYR . 9.2 mm -154.54 140.59 11.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.41 -1.053 . . . . 0.0 109.238 179.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -121.5 -178.89 0.66 Allowed Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.345 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 35' ' ' TYR . 34.3 Cg_endo -77.54 96.09 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.262 1.975 . . . . 0.0 110.4 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.88 15.25 5.32 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.475 ' ND1' ' CD1' ' A' ' 34' ' ' ILE . 40.2 t-80 -72.74 171.98 11.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -1.146 . . . . 0.0 109.447 179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -85.89 156.49 58.09 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 0.0 109.353 179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.483 ' HA ' HG13 ' A' ' 71' ' ' VAL . 34.0 Cg_endo -77.02 78.0 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.682 2.254 . . . . 0.0 110.782 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.446 ' O ' HG12 ' A' ' 71' ' ' VAL . 1.2 mm? -97.84 149.04 22.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 108.983 179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.51 ' C ' HG22 ' A' ' 43' ' ' THR . 0.8 OUTLIER -152.74 133.47 13.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.113 -179.638 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 179.97 -92.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.357 -0.84 . . . . 0.0 109.436 179.48 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.503 ' H ' HG23 ' A' ' 43' ' ' THR . . . -131.29 160.9 33.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.138 -0.976 . . . . 0.0 109.37 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.925 HD13 HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -100.42 132.42 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.171 -0.956 . . . . 0.0 109.4 179.94 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -65.33 136.41 96.37 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 -179.837 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.467 ' CB ' ' OG ' ' A' ' 65' ' ' SER . 36.2 Cg_endo -80.18 160.51 23.4 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.446 2.097 . . . . 0.0 110.44 -179.778 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 126.58 -131.64 7.43 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.726 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ptm -121.94 178.3 4.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.404 -1.056 . . . . 0.0 109.009 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -156.23 131.16 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.618 -1.301 . . . . 0.0 110.96 -179.604 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.7 ttm180 -98.84 129.67 45.23 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.943 HD11 ' CD2' ' A' ' 6' ' ' LEU . 2.1 tt -130.82 152.38 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.887 -1.133 . . . . 0.0 110.898 -177.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.544 ' HB ' ' CB ' ' A' ' 22' ' ' LYS . 46.8 t -131.19 107.56 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 55' ' ' GLN . 4.4 ttpt -67.29 119.51 12.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.735 . . . . 0.0 109.646 -179.665 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 54' ' ' LYS . 3.4 tt0 41.19 -152.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.423 -0.798 . . . . 0.0 109.742 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -88.91 67.24 8.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.348 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 58' ' ' HIS . . . 161.62 163.6 14.85 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.45 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.7 m170 57.88 159.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.184 -1.186 . . . . 0.0 109.347 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.3 OUTLIER 179.97 118.59 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.616 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -132.53 157.08 45.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.139 -0.976 . . . . 0.0 109.668 -179.631 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.603 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.4 OUTLIER -113.58 136.44 52.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.861 . . . . 0.0 109.718 -179.904 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 50' ' ' ILE . 5.3 mp -112.58 167.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.382 -0.824 . . . . 0.0 109.103 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.602 ' CD1' ' HB ' ' A' ' 84' ' ' ILE . 14.4 t80 -128.48 140.83 51.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 109.32 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -167.56 -168.83 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 0.0 109.637 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.467 ' OG ' ' CB ' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -179.47 132.73 0.11 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.609 -179.966 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.642 ' O ' ' HB1' ' A' ' 80' ' ' ALA . . . 72.79 142.97 0.51 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' A' ' 80' ' ' ALA . . . 145.57 165.06 11.12 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.5 mp -100.73 123.85 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -1.108 . . . . 0.0 109.22 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.806 HD12 HD12 ' A' ' 45' ' ' ILE . 1.2 tt -108.09 153.73 22.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.0 110.036 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 77' ' ' THR . 4.4 pt-20 -156.14 111.0 2.88 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG23 ' HB ' ' A' ' 76' ' ' VAL . 4.4 p -99.85 159.08 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.018 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' CB ' ' HD2' ' A' ' 73' ' ' PRO . 2.0 mt-30 -143.11 172.97 4.97 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 72' ' ' GLN . 36.7 Cg_endo -80.26 62.11 8.42 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.627 2.218 . . . . 0.0 110.516 179.611 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.63 -14.74 1.06 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 5' ' ' HIS . 7.6 p-10 -167.21 168.65 13.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.996 -1.296 . . . . 0.0 109.959 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.661 HG13 ' HA ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -155.49 162.69 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.413 -0.804 . . . . 0.0 109.063 -179.891 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 7' ' ' ASP . 6.4 p -154.18 156.05 36.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.355 -0.841 . . . . 0.0 109.267 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG21 HD13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -166.43 130.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.39 -179.962 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.96 112.0 23.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.309 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.642 ' HB1' ' O ' ' A' ' 66' ' ' GLY . . . -106.07 -175.27 2.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.499 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.63 -9.26 9.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 65' ' ' SER . 16.7 m -109.35 142.04 40.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.152 -0.968 . . . . 0.0 109.332 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -161.39 132.85 5.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 0.0 109.911 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.602 ' HB ' ' CD1' ' A' ' 63' ' ' TYR . 18.9 mt -128.8 -36.63 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.368 -0.833 . . . . 0.0 109.143 179.591 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.496 ' O ' ' N ' ' A' ' 87' ' ' GLN . 0.0 OUTLIER 75.34 134.69 0.05 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.172 -179.763 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 85' ' ' ARG . . . -39.16 96.6 0.01 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' A' ' 85' ' ' ARG . 39.3 tt0 63.85 74.36 0.42 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -1.112 . . . . 0.0 109.942 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 89' ' ' LEU . 8.9 t70 -52.3 -35.09 49.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.086 179.518 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER 166.47 140.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.359 -0.838 . . . . 0.0 109.076 179.875 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.513 ' CB ' ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER 75.12 153.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 -179.77 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' CB ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -125.66 -29.36 3.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -86.56 -33.64 20.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 109.584 -179.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.476 ' HB2' ' OD2' ' A' ' 90' ' ' ASP . 9.3 ttt180 -63.67 -22.72 67.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 0.0 109.466 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -87.74 -25.11 23.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.274 -0.891 . . . . 0.0 108.712 179.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.538 ' HA ' HD11 ' A' ' 128' ' ' LEU . 2.5 mtm -66.29 -20.74 66.19 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.505 -0.747 . . . . 0.0 109.373 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' OE1' ' HG3' ' A' ' 100' ' ' LYS . 2.3 tm-20 -80.05 -22.38 42.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.211 -0.93 . . . . 0.0 109.46 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -32.15 72.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.858 . . . . 0.0 109.405 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -73.34 -26.81 61.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.356 -0.84 . . . . 0.0 109.211 179.859 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.426 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -81.94 -26.68 33.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HG3' ' OE1' ' A' ' 96' ' ' GLU . 8.3 mttt -83.25 -27.32 29.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.378 -0.826 . . . . 0.0 109.624 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.87 -19.69 31.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.395 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 102' ' ' GLU . 16.1 tp10 -77.34 -38.22 50.73 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.222 -0.924 . . . . 0.0 109.334 179.913 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -72.49 -43.61 63.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -28.05 67.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.801 ' O ' HG22 ' A' ' 105' ' ' ILE . 98.8 mt -90.24 26.88 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.203 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 t -97.32 -14.35 21.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.218 -0.926 . . . . 0.0 109.707 -179.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 96.6 p -126.01 110.91 14.11 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 109.773 -179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -158.0 155.73 29.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 109.271 179.916 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -107.7 -76.95 0.6 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 111' ' ' ASP . . . 179.05 -175.74 47.48 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.983 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 110' ' ' GLY . 0.2 OUTLIER 77.84 -78.03 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.365 -1.079 . . . . 0.0 109.619 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.3 m -135.51 8.71 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.15 -91.24 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.409 -0.807 . . . . 0.0 108.884 179.819 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.512 ' HB2' ' CB ' ' A' ' 108' ' ' SER . 49.5 t80 -72.12 -17.49 61.97 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.47 -36.22 82.21 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.637 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 5.9 mm-40 -90.68 -32.5 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.327 -0.858 . . . . 0.0 109.494 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.459 ' HA ' ' HG3' ' A' ' 120' ' ' GLU . . . -67.37 -24.77 65.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.299 -0.876 . . . . 0.0 109.693 -179.63 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.05 -32.23 53.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.157 -0.964 . . . . 0.0 109.441 -179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.24 -25.98 22.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.459 ' HG3' ' HA ' ' A' ' 117' ' ' ALA . 8.8 mm-40 -62.87 -46.31 88.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.0 109.376 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.528 ' HB2' ' CD1' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -58.03 -52.56 65.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.251 -0.906 . . . . 0.0 109.463 179.913 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.16 -18.85 60.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 -179.686 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -29.46 64.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 -179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -89.96 -24.67 21.21 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.154 -0.966 . . . . 0.0 109.812 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 125' ' ' ILE . 24.7 mm -80.62 7.1 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.837 -179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.54 -34.07 15.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 128' ' ' LEU . 2.6 pt20 -80.86 -25.01 37.96 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.254 -0.903 . . . . 0.0 109.618 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.538 HD11 ' HA ' ' A' ' 95' ' ' MET . 0.1 OUTLIER -71.23 -15.84 62.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.591 -179.864 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.25 -52.49 4.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.297 -0.877 . . . . 0.0 109.719 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' HB ' ' CD1' ' A' ' 61' ' ' PHE . 21.6 m -56.61 -29.33 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 0.0 109.942 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.522 HG23 ' N ' ' A' ' 132' ' ' GLU . 12.0 tt -64.36 -42.96 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.005 . . . . 0.0 109.735 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 131' ' ' ILE . 6.6 mm-40 -60.39 -23.77 64.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.3 OUTLIER -76.28 -49.62 16.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.792 -179.677 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.498 ' HA ' ' HB2' ' A' ' 137' ' ' ALA . 8.8 t -70.66 -17.81 62.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 -179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -53.04 52.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.629 -179.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.93 -5.26 59.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.562 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -60.27 -34.09 73.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.984 . . . . 0.0 109.504 179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.091 -0.957 . . . . 0.0 109.519 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.227 0.537 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.6 143.27 16.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.629 HG22 ' CG ' ' A' ' 21' ' ' GLU . 7.6 p -45.52 135.87 6.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 109.77 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.701 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 5.3 p90 -132.8 178.36 6.93 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.063 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.568 ' C ' ' CD2' ' A' ' 5' ' ' HIS . 2.3 t60 -103.79 149.1 25.34 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.912 -1.118 . . . . 0.0 109.79 -179.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.121 HD23 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -138.55 156.72 47.24 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.442 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.859 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.68 94.09 2.44 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.98 -1.075 . . . . 0.0 110.261 -179.583 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.707 HG12 ' HB3' ' A' ' 16' ' ' PHE . 6.5 p -107.61 96.32 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.281 -0.887 . . . . 0.0 108.779 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.561 HG23 HD23 ' A' ' 79' ' ' LEU . 28.7 m -118.26 162.22 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.961 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.454 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 3.5 t -102.63 -158.27 0.66 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.343 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 12' ' ' GLU . . . -68.38 -50.27 54.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 11' ' ' ALA . 4.2 mt-10 -141.59 67.61 1.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.443 179.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 12' ' ' GLU . 1.8 mm-40 171.61 68.13 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.437 -0.789 . . . . 0.0 109.156 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 13' ' ' GLN . 14.7 pt20 -43.71 158.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.863 . . . . 0.0 109.66 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.94 ' HB3' HG21 ' A' ' 62' ' ' ILE . 12.3 mmm -126.83 -73.69 0.61 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.176 -0.952 . . . . 0.0 109.334 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.707 ' HB3' HG12 ' A' ' 8' ' ' VAL . 40.9 t80 -114.68 93.45 4.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 109.515 179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 86.9 p -124.04 95.71 4.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.352 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -159.73 32.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.405 ' C ' HG12 ' A' ' 20' ' ' VAL . 12.6 mt -66.78 160.73 25.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -1.173 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.121 HG21 HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -164.36 160.26 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.204 -0.935 . . . . 0.0 109.969 -178.5 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.629 ' CG ' HG22 ' A' ' 3' ' ' THR . 0.1 OUTLIER -130.63 -34.85 1.52 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.516 -0.74 . . . . 0.0 109.35 -179.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.4 ttpp -155.1 97.84 1.96 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.096 -1.002 . . . . 0.0 110.515 -179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -99.31 156.94 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.374 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.52 ' HA ' ' HA3' ' A' ' 33' ' ' GLY . 11.9 tt0 -151.96 134.47 15.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.621 -1.299 . . . . 0.0 110.382 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.538 HG23 ' HA2' ' A' ' 33' ' ' GLY . 36.5 t -108.78 142.17 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 0.0 109.085 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.4 m -130.41 113.04 13.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.51 -111.95 1.48 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 m -107.97 -62.76 1.4 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.195 -1.179 . . . . 0.0 109.466 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.64 -17.8 14.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.44 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.56 119.37 5.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -129.26 34.62 4.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -1.194 . . . . 0.0 109.798 -179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.69 HD23 ' OH ' ' A' ' 35' ' ' TYR . 6.5 mt -138.61 139.29 38.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.08 -1.013 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' HG23 ' A' ' 25' ' ' VAL . . . -99.11 -101.46 2.29 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 107.843 -2.103 . . . . 0.0 107.843 178.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.861 HG21 HG21 ' A' ' 76' ' ' VAL . 20.4 mm -155.59 152.7 8.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.274 -1.133 . . . . 0.0 109.553 178.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.69 ' OH ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -154.44 -176.0 0.56 Allowed Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.746 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.629 ' HD2' ' HB3' ' A' ' 35' ' ' TYR . 36.2 Cg_endo -81.7 43.61 1.56 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.359 2.04 . . . . 0.0 110.183 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.49 38.64 0.02 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.71 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 10.4 t-160 -82.47 10.02 8.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -1.08 . . . . 0.0 109.594 -179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.873 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . 75.86 173.47 0.09 OUTLIER Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 0.0 109.314 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.873 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 35.3 Cg_endo -78.16 76.97 4.14 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.581 2.188 . . . . 0.0 110.485 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -90.01 130.04 36.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.183 179.804 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.2 tp -148.77 69.61 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.632 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -140.29 -95.05 0.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.357 179.729 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.507 ' H ' HG23 ' A' ' 43' ' ' THR . . . -156.87 167.96 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.037 -1.039 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.808 ' CD1' HG21 ' A' ' 78' ' ' VAL . 3.4 mt -110.07 167.25 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.334 -0.854 . . . . 0.0 109.282 179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 68.4 mmtt -100.11 159.45 29.78 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.212 -0.93 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 36.3 Cg_endo -79.09 163.95 25.09 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.858 2.372 . . . . 0.0 110.423 -179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 63' ' ' TYR . . . 130.78 -146.25 17.55 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.669 ' HB2' HG11 ' A' ' 130' ' ' VAL . 24.8 ptm -103.19 -176.77 3.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -1.112 . . . . 0.0 109.085 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.534 ' CG2' ' HB ' ' A' ' 62' ' ' ILE . 0.6 OUTLIER -158.52 118.45 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 109.544 -179.81 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.36 131.28 46.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -0.896 . . . . 0.0 109.367 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.549 HG12 ' CB ' ' A' ' 23' ' ' ILE . 35.5 mt -132.73 163.08 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.107 -0.995 . . . . 0.0 109.784 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.592 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 39.2 t -134.95 154.62 36.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.616 -0.677 . . . . 0.0 109.64 179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.592 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.4 tmtm? 92.0 -79.2 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.492 ' OE1' ' HG2' ' A' ' 60' ' ' GLU . 14.6 tt0 51.44 -99.38 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.818 -1.176 . . . . 0.0 109.606 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -165.28 50.45 0.1 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.922 -1.111 . . . . 0.0 109.275 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.543 ' C ' ' CD2' ' A' ' 58' ' ' HIS . . . 146.73 -44.61 0.82 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 57' ' ' GLY . 44.3 m-70 -150.93 -176.64 5.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.406 -1.055 . . . . 0.0 109.235 179.806 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.566 ' HG2' HG13 ' A' ' 53' ' ' VAL . 5.6 mp0 -106.9 162.31 13.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.253 -0.905 . . . . 0.0 109.124 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' HG2' ' OE1' ' A' ' 55' ' ' GLN . 0.9 OUTLIER -162.64 171.28 17.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.968 -1.082 . . . . 0.0 110.016 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.592 ' CD1' ' HB ' ' A' ' 130' ' ' VAL . 0.7 OUTLIER -121.1 176.3 5.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 109.656 -179.734 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.94 HG21 ' HB3' ' A' ' 15' ' ' MET . 1.2 mt -152.94 -160.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.451 -0.78 . . . . 0.0 109.0 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.804 ' C ' HD13 ' A' ' 64' ' ' LEU . 3.8 t80 -172.36 128.87 0.56 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.193 -0.942 . . . . 0.0 109.21 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.888 HD13 ' N ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -158.63 -169.74 2.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -0.954 . . . . 0.0 109.708 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . 0.3 OUTLIER -86.98 -59.75 2.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.0 109.55 179.972 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.14 -63.92 0.33 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.59 -152.3 52.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.843 ' O ' HG23 ' A' ' 78' ' ' VAL . 75.1 mt -102.71 137.99 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.141 . . . . 0.0 109.217 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.732 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.7 tt -119.37 152.6 36.52 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.136 -0.978 . . . . 0.0 109.576 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 6.0 mt-10 -149.65 138.33 20.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 109.229 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.597 ' HA ' HG12 ' A' ' 76' ' ' VAL . 9.6 p -100.52 140.51 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.136 -0.978 . . . . 0.0 109.793 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 5.6 mt-30 -124.19 174.76 3.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 34.4 Cg_endo -78.12 80.92 2.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.342 2.028 . . . . 0.0 111.022 -179.389 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 75' ' ' ASN . . . 102.5 25.3 7.81 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 75' ' ' ASN . 7.0 p-10 171.15 138.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -1.208 . . . . 0.0 109.803 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.861 HG21 HG21 ' A' ' 34' ' ' ILE . 28.3 m -126.61 172.48 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 108.908 179.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 78' ' ' VAL . 55.3 m -163.11 157.19 20.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 110.212 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 68' ' ' ILE . 2.4 p -161.82 135.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 108.95 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.561 HD23 HG23 ' A' ' 9' ' ' VAL . 2.0 mt -116.37 122.9 46.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.082 -1.012 . . . . 0.0 109.779 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -115.14 -168.06 1.33 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.324 -0.86 . . . . 0.0 109.235 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -121.57 -12.02 8.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.447 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.2 m -112.19 147.83 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.37 -0.831 . . . . 0.0 109.191 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -158.25 70.97 0.56 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 109.728 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.652 HD12 ' CE1' ' A' ' 63' ' ' TYR . 8.6 mt -99.0 56.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.431 179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 88' ' ' ASP . 7.2 ptt180 -46.21 154.6 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 0.0 109.599 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.42 ' C ' ' HG3' ' A' ' 87' ' ' GLN . . . -58.37 148.98 36.56 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.816 ' CD ' HG21 ' A' ' 134' ' ' THR . 35.1 mt-30 69.29 6.15 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.292 -1.122 . . . . 0.0 109.645 179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.429 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . 12.0 t70 -70.13 -34.43 73.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -178.68 151.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.0 109.715 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.504 ' OD1' ' CB ' ' A' ' 93' ' ' ARG . 66.0 t0 56.99 103.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.311 -0.868 . . . . 0.0 109.585 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.11 -53.98 2.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.324 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.5 -20.7 26.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.504 ' CB ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -86.76 -9.35 56.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 -179.968 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.424 ' N ' ' OD1' ' A' ' 90' ' ' ASP . . . -90.41 -12.22 38.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.209 179.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -25.97 32.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.328 -0.857 . . . . 0.0 109.683 -179.704 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 93' ' ' ARG . 12.5 pt-20 -77.07 -14.33 59.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.38 -47.92 53.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.175 -0.953 . . . . 0.0 109.54 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -21.91 19.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -39.67 24.16 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -0.975 . . . . 0.0 109.606 -179.854 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -90.08 0.46 57.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.261 -0.899 . . . . 0.0 109.65 -179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.973 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -90.33 -32.18 16.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.185 -0.947 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.72 -26.22 68.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.75 -37.43 82.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -68.96 -16.24 63.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 109.458 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 107' ' ' SER . 11.4 mm -89.14 19.77 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.165 -0.96 . . . . 0.0 109.744 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.402 ' O ' ' C ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -47.52 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.634 -179.937 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 105' ' ' ILE . 2.5 m -43.66 137.18 3.09 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.399 -0.813 . . . . 0.0 109.696 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 91.4 p -166.41 158.93 14.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.519 -0.738 . . . . 0.0 109.499 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.17 166.61 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.236 -0.915 . . . . 0.0 109.48 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.14 138.35 5.23 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -72.16 -72.3 0.24 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.329 179.833 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.704 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 32.2 m -111.61 12.5 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.397 -0.814 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 112' ' ' VAL . 29.6 t0 -49.86 -99.1 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 109.543 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -68.45 -15.8 63.68 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.873 -1.142 . . . . 0.0 108.514 179.472 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . . . -64.84 -16.0 62.58 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.601 -0.687 . . . . 0.0 109.5 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -88.83 -27.92 20.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.374 179.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.654 ' O ' HD23 ' A' ' 121' ' ' LEU . . . -82.67 -14.29 54.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.463 -179.916 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -23.39 61.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.285 -0.884 . . . . 0.0 109.61 -179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.57 -23.9 24.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.174 -0.954 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -86.25 -10.38 54.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 0.0 109.439 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.973 HD12 ' HB1' ' A' ' 101' ' ' ALA . 3.1 mm? -86.3 -63.62 1.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.898 . . . . 0.0 109.644 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 125' ' ' ILE . . . -54.18 -18.67 4.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 109.86 -179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -54.59 -41.04 69.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.983 . . . . 0.0 109.623 -179.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -87.23 -36.3 18.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 121' ' ' LEU . 1.7 mp -64.6 -10.52 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.244 -0.91 . . . . 0.0 109.427 -179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.512 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -69.53 -35.46 75.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.158 -0.964 . . . . 0.0 109.476 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.518 ' HA ' HG22 ' A' ' 130' ' ' VAL . 1.6 pp0? -81.09 5.33 16.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.703 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.835 ' O ' HD23 ' A' ' 128' ' ' LEU . 2.3 tt -86.14 -36.23 19.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.172 -0.955 . . . . 0.0 109.417 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -34.74 62.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.161 179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 49' ' ' MET . 35.5 m -72.38 -36.56 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.0 109.525 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 128' ' ' LEU . 3.6 tt -68.26 -31.37 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.202 -0.936 . . . . 0.0 109.608 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -75.29 -16.55 60.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.498 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -71.03 -42.1 69.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.647 -179.95 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.816 HG21 ' CD ' ' A' ' 87' ' ' GLN . 9.7 t -74.1 -14.13 60.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.56 -179.811 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -60.09 -35.72 75.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.11 -0.994 . . . . 0.0 109.176 179.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -95.75 -3.98 44.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.335 -0.853 . . . . 0.0 109.252 179.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -58.49 -57.09 14.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.474 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.3 ptp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.444 179.797 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.447 ' O ' ' HG3' ' A' ' 21' ' ' GLU . 7.2 mtm -152.59 141.49 21.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -162.04 177.17 9.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.208 -0.932 . . . . 0.0 109.397 -179.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.829 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 2.4 p90 -166.05 -149.09 0.1 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.557 ' HA ' HG12 ' A' ' 20' ' ' VAL . 2.7 t60 -133.05 147.54 52.21 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 108.886 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.037 HD23 HG21 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -140.23 169.96 16.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.194 178.975 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.027 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -157.75 103.59 1.91 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.896 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.599 ' O ' HG13 ' A' ' 8' ' ' VAL . 3.6 p -116.39 102.94 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.131 -0.981 . . . . 0.0 109.515 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG13 ' HA ' ' A' ' 14' ' ' GLN . 15.0 t -111.55 156.4 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.94 . . . . 0.0 109.522 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.589 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 15.4 t -122.13 78.96 1.54 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.296 -0.878 . . . . 0.0 109.655 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 10' ' ' SER . . . 69.14 -85.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.132 -0.98 . . . . 0.0 109.573 179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.77 30.88 4.82 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 0.0 109.507 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.69 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.0 109.248 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.741 ' HA ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -52.27 144.99 11.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.67 -179.853 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.593 ' SD ' HG23 ' A' ' 62' ' ' ILE . 13.9 mtt -127.96 -77.75 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.262 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.672 ' CD1' ' HG ' ' A' ' 6' ' ' LEU . 34.7 t80 -103.49 123.83 47.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.418 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 17' ' ' SER . 14.8 p -152.12 103.04 2.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -0.909 . . . . 0.0 109.458 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.0 -155.32 26.05 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.761 ' C ' HG12 ' A' ' 20' ' ' VAL . 8.5 mt -61.33 178.69 0.26 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.119 -1.224 . . . . 0.0 108.937 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.037 HG21 HD23 ' A' ' 6' ' ' LEU . 0.1 OUTLIER 175.88 113.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.784 -1.197 . . . . 0.0 109.888 -177.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 55' ' ' GLN . 6.6 tt0 -76.17 -43.04 44.55 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.235 -0.916 . . . . 0.0 109.085 179.242 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -165.94 134.51 3.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.987 -1.071 . . . . 0.0 110.586 179.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.872 HD11 HG12 ' A' ' 34' ' ' ILE . 39.0 pt -98.71 -148.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' HG23 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -176.1 132.99 0.25 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.94 -1.1 . . . . 0.0 109.259 179.791 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.476 HG23 ' HA2' ' A' ' 33' ' ' GLY . 4.1 t -140.25 131.26 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.976 -1.078 . . . . 0.0 109.324 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.7 m -132.61 113.89 13.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.519 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.76 -119.64 2.62 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.6 p -122.65 -6.63 8.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.553 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.01 -91.86 0.34 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 0.0 109.525 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.92 142.8 34.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.98 63.1 1.58 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.127 -1.219 . . . . 0.0 109.821 -179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.503 ' HA ' HD23 ' A' ' 32' ' ' LEU . 8.9 mt -141.26 162.36 35.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.152 -0.967 . . . . 0.0 109.595 179.562 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' CA ' HG13 ' A' ' 23' ' ' ILE . . . -106.05 -116.64 4.19 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.882 HG21 HG21 ' A' ' 76' ' ' VAL . 17.5 mm -153.05 141.1 13.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.531 -0.982 . . . . 0.0 108.373 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -139.37 172.99 5.6 Favored Pre-proline 0 C--N 1.298 -1.647 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.745 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 31.6 Cg_endo -73.26 85.29 1.25 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.034 1.823 . . . . 0.0 109.975 179.755 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.57 20.16 2.19 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 -179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.53 ' CD2' ' O ' ' A' ' 39' ' ' ALA . 59.1 t60 -55.0 139.61 40.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.103 -1.233 . . . . 0.0 109.381 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -43.68 162.15 0.19 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.322 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 34.2 Cg_endo -76.85 75.68 4.41 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.501 2.134 . . . . 0.0 110.233 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.15 140.35 30.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.6 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.05 107.55 4.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 109.236 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.731 HG23 ' N ' ' A' ' 44' ' ' ALA . 11.8 t -175.25 -139.18 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.185 -0.947 . . . . 0.0 109.209 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.731 ' N ' HG23 ' A' ' 43' ' ' THR . . . -99.67 179.2 4.61 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.883 -1.136 . . . . 0.0 109.403 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.628 ' O ' HG23 ' A' ' 45' ' ' ILE . 1.3 tp -111.84 118.82 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.464 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HG3' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -54.78 144.83 44.34 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.852 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HB3' ' HA ' ' A' ' 65' ' ' SER . 35.8 Cg_endo -78.5 172.7 14.83 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.661 2.241 . . . . 0.0 110.436 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.47 -153.98 19.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.864 ' HB2' HG13 ' A' ' 130' ' ' VAL . 4.7 ppp? -102.83 -178.93 3.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -1.124 . . . . 0.0 109.289 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 51' ' ' ARG . 3.9 mt -154.33 165.11 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.128 -0.982 . . . . 0.0 110.235 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.538 ' N ' ' CG2' ' A' ' 50' ' ' ILE . 0.3 OUTLIER -152.85 151.03 29.94 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.357 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.656 ' CG2' HG22 ' A' ' 23' ' ' ILE . 21.5 mt -153.39 163.63 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.745 -1.222 . . . . 0.0 110.769 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' N ' HG22 ' A' ' 52' ' ' ILE . 67.3 t -139.84 109.46 3.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.703 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' HIS . 14.8 tttm -64.86 119.8 11.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.634 -0.666 . . . . 0.0 109.537 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.58 ' HG2' ' CD2' ' A' ' 56' ' ' HIS . 52.0 tt0 42.75 -93.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 109.75 179.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.58 ' CD2' ' HG2' ' A' ' 55' ' ' GLN . 0.5 OUTLIER -154.87 56.49 0.67 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.004 -1.06 . . . . 0.0 109.606 -179.941 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -130.44 -98.25 0.81 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.74 176.92 4.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.344 -1.092 . . . . 0.0 109.372 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 1.3 pt-20 -121.95 146.02 47.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.436 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.61 147.54 34.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 134' ' ' THR . 8.9 m-85 -102.85 155.58 18.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.671 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.593 HG23 ' SD ' ' A' ' 15' ' ' MET . 65.5 mt -153.47 145.84 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.598 179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.542 ' CD2' ' HB ' ' A' ' 84' ' ' ILE . 4.0 t80 -147.47 133.08 18.79 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.819 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.802 ' C ' HD22 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -167.79 168.17 12.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.057 -1.027 . . . . 0.0 110.107 -179.58 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.605 ' N ' HD22 ' A' ' 64' ' ' LEU . 1.4 m -150.19 92.87 1.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.379 -0.826 . . . . 0.0 109.296 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.94 105.09 1.77 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.544 ' C ' HD13 ' A' ' 68' ' ' ILE . . . -177.2 -178.48 46.93 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.864 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.1 mm -118.79 135.71 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -1.176 . . . . 0.0 109.414 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.617 HD23 ' C ' ' A' ' 69' ' ' LEU . 1.5 tt -112.89 152.27 29.49 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.261 -0.899 . . . . 0.0 109.578 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.41 ' N ' ' HG ' ' A' ' 69' ' ' LEU . 3.0 tt0 -161.12 133.16 5.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 40' ' ' PRO . 13.5 p -99.89 140.64 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.176 -0.953 . . . . 0.0 109.838 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.579 ' CB ' ' CD ' ' A' ' 73' ' ' PRO . 1.3 mt-30 -120.6 -178.77 0.62 Allowed Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 72' ' ' GLN . 35.8 Cg_endo -79.63 82.58 2.46 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.4 2.067 . . . . 0.0 111.005 -179.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.47 -9.62 64.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.484 ' HB2' ' OE1' ' A' ' 72' ' ' GLN . 10.0 m-20 -131.85 160.89 34.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.131 -1.217 . . . . 0.0 109.695 -179.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.882 HG21 HG21 ' A' ' 34' ' ' ILE . 12.5 t -137.64 152.3 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.112 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -151.04 162.63 40.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.162 -0.961 . . . . 0.0 109.846 -179.951 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.0 OUTLIER -179.34 139.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.426 -0.796 . . . . 0.0 109.103 179.857 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 6.0 mp -106.23 174.05 6.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.916 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -164.21 165.49 21.96 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.265 -0.897 . . . . 0.0 109.589 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -108.27 -45.42 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.313 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 52.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.333 -0.854 . . . . 0.0 109.218 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -142.4 110.49 5.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 0.0 109.689 -179.835 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.788 HG23 ' CG ' ' A' ' 88' ' ' ASP . 3.3 mt -137.75 73.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.38 -0.825 . . . . 0.0 109.057 179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.414 ' O ' ' C ' ' A' ' 86' ' ' GLY . 8.9 ptp180 -43.93 163.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 109.532 -179.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.531 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -44.06 -58.01 4.56 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.799 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -47.91 -87.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -1.196 . . . . 0.0 109.329 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.788 ' CG ' HG23 ' A' ' 84' ' ' ILE . 18.8 t70 68.26 19.0 9.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 88' ' ' ASP . 0.2 OUTLIER 71.97 34.26 1.51 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.321 -0.862 . . . . 0.0 109.627 179.824 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.76 161.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 109.453 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -138.45 -65.46 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.237 -0.914 . . . . 0.0 109.631 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.67 -12.22 51.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 109.719 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.17 9.05 13.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 0.0 109.626 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.5 -26.28 19.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.335 179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.408 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -70.17 -18.02 63.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.378 -0.827 . . . . 0.0 109.519 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -77.93 -18.67 55.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -0.921 . . . . 0.0 109.433 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.34 62.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -0.929 . . . . 0.0 109.629 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -79.81 -22.77 42.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.12 -0.988 . . . . 0.0 109.617 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' N ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -76.22 -48.48 20.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 109.733 -179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.08 -30.32 67.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.152 -0.967 . . . . 0.0 109.713 -179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.86 -20.22 26.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 109.65 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 98' ' ' LYS . 3.0 tt0 -80.3 -38.26 31.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 109.381 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.17 -32.0 70.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.138 179.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.6 -27.87 67.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.314 -0.866 . . . . 0.0 109.296 179.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 121' ' ' LEU . 25.6 mt -88.97 21.09 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.314 -0.866 . . . . 0.0 109.647 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.43 ' O ' ' CB ' ' A' ' 107' ' ' SER . 19.3 p -57.35 -63.51 1.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.504 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 106' ' ' SER . 0.4 OUTLIER 168.01 94.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.43 -179.984 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 -153.51 0.55 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.569 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.97 166.53 13.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 109.523 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 123.85 152.59 8.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.49 -56.47 3.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -1.112 . . . . 0.0 109.37 179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.34 23.0 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.29 179.777 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.4 ' OD1' ' C ' ' A' ' 113' ' ' ASP . 37.4 t0 -75.73 -95.79 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.404 -0.81 . . . . 0.0 109.206 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -71.19 -20.58 62.26 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.45 75.98 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.225 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -70.77 -34.12 71.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.93 -22.88 67.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.0 179.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.2 t -53.59 -40.76 65.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.374 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.49 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . -73.65 -38.79 64.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 0.0 109.26 179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -57.02 -20.36 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.86 . . . . 0.0 109.422 179.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 105' ' ' ILE . 7.2 tp -78.08 -65.34 0.99 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.366 -0.834 . . . . 0.0 109.64 -179.844 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' A' ' 125' ' ' ILE . . . -49.39 -29.69 6.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 119' ' ' ALA . 2.3 mptt -65.88 -43.69 87.56 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.153 -0.967 . . . . 0.0 109.411 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.87 -20.98 64.28 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.908 . . . . 0.0 109.696 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 122' ' ' ALA . 10.5 mm -70.2 -14.02 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.638 -179.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.43 -18.73 47.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.433 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.581 ' O ' HG23 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -69.11 -29.9 68.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.537 179.976 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.462 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.9 OUTLIER -74.72 -13.05 60.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.602 -179.868 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.2 mtt-85 -84.45 -39.75 18.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.864 HG13 ' HB2' ' A' ' 49' ' ' MET . 2.7 m -70.58 -22.25 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 127' ' ' GLN . 23.4 pt -87.55 -32.61 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HG2' HG13 ' A' ' 131' ' ' ILE . 18.8 mm-40 -83.1 -17.84 41.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.698 -179.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -85.33 -46.78 10.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.962 . . . . 0.0 109.499 179.867 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 61' ' ' PHE . 11.1 t -75.16 -13.18 60.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.406 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -47.48 -27.38 1.72 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.398 179.909 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -82.76 -38.03 23.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.823 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -56.68 -71.85 0.09 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.109 -0.994 . . . . 0.0 109.668 -179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.432 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.23 0.538 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 3' ' ' THR . 13.6 mtp -84.94 93.76 8.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 0.0 109.528 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -177.77 143.38 0.33 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.977 . . . . 0.0 109.684 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.67 ' CZ ' HG22 ' A' ' 34' ' ' ILE . 1.8 p90 -137.7 -145.47 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.336 -0.852 . . . . 0.0 109.713 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.838 ' O ' HG22 ' A' ' 76' ' ' VAL . 35.6 t-80 -131.37 140.46 49.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.926 -1.109 . . . . 0.0 110.493 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.853 HD21 HG21 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -109.96 127.65 54.9 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.327 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' HB3' ' OG1' ' A' ' 77' ' ' THR . 0.2 OUTLIER -135.73 63.64 1.59 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.956 -1.09 . . . . 0.0 109.307 179.516 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.838 HG23 ' CG2' ' A' ' 78' ' ' VAL . 1.9 p -99.64 131.04 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 109.211 -179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -130.7 144.68 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 -179.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 83' ' ' ALA . 0.4 OUTLIER -153.05 -157.42 0.79 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.372 -0.83 . . . . 0.0 109.222 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 81' ' ' ASP . . . -43.51 122.85 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 108.985 179.782 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.51 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.5 mt-10 76.35 78.98 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.39 -0.818 . . . . 0.0 108.989 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 12' ' ' GLU . 23.3 tm0? -41.47 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.343 -0.848 . . . . 0.0 109.788 -179.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 172.64 47.11 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 0.0 109.772 179.84 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -93.7 -93.56 0.17 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.967 . . . . 0.0 109.346 179.774 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.621 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 1.1 t80 -134.04 111.44 10.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.045 -1.034 . . . . 0.0 109.959 179.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.413 ' N ' ' HD1' ' A' ' 16' ' ' PHE . 51.4 p -136.3 71.87 1.43 Allowed 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.258 -0.901 . . . . 0.0 109.38 178.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 19' ' ' LEU . . . -169.39 167.97 40.91 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HA ' HD23 ' A' ' 19' ' ' LEU . 18.8 mt -46.18 167.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.262 -1.14 . . . . 0.0 109.409 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.765 HG11 ' HB2' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -167.64 168.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.967 . . . . 0.0 109.549 -179.318 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.571 ' N ' ' CG2' ' A' ' 20' ' ' VAL . 3.5 tt0 -120.17 -37.35 3.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -167.92 124.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.929 -1.107 . . . . 0.0 110.721 179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.853 HG21 HD21 ' A' ' 6' ' ' LEU . 19.5 pt -99.09 -159.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 50' ' ' ILE . 1.2 tt0 -177.04 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.865 -1.147 . . . . 0.0 109.789 179.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 50' ' ' ILE . 0.8 OUTLIER -99.34 99.78 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 109.588 179.907 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 26' ' ' THR . 5.8 t -100.14 129.49 46.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.868 . . . . 0.0 109.329 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.28 -90.34 0.51 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.2 p -134.45 -43.5 0.77 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -1.177 . . . . 0.0 109.647 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -101.72 -78.0 0.54 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.555 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.81 114.43 6.32 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.64 25.25 11.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.446 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.437 HD13 ' OH ' ' A' ' 35' ' ' TYR . 11.6 mt -122.15 157.65 31.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 109.544 179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.542 ' HA3' HG13 ' A' ' 23' ' ' ILE . . . -99.83 -109.51 3.06 Favored Glycine 0 N--CA 1.483 1.808 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 178.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.67 HG22 ' CZ ' ' A' ' 4' ' ' TYR . 22.8 mm -153.82 155.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 109.319 178.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -150.66 175.19 2.97 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.334 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 35' ' ' TYR . 32.7 Cg_endo -74.05 82.28 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.12 1.88 . . . . 0.0 110.057 179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.37 26.78 2.57 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.622 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.586 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . 9.1 t-160 -55.21 -89.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -1.097 . . . . 0.0 109.553 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -172.5 168.98 2.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.413 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.829 ' HA ' HG11 ' A' ' 71' ' ' VAL . 36.2 Cg_endo -78.43 70.02 7.42 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.671 2.248 . . . . 0.0 110.703 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.499 ' HB3' ' CD1' ' A' ' 69' ' ' LEU . 2.9 mm? -84.58 142.06 30.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 109.188 179.677 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.646 HD21 ' OE1' ' A' ' 70' ' ' GLU . 1.2 mt -151.85 49.38 0.8 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.086 -1.008 . . . . 0.0 109.558 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -126.51 -152.51 0.52 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.46 179.72 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.668 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 69' ' ' LEU . 1.2 mt -128.55 168.7 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 109.416 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.34 167.67 8.92 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.533 ' CA ' ' O ' ' A' ' 65' ' ' SER . 35.6 Cg_endo -78.01 135.56 14.04 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.661 2.241 . . . . 0.0 110.381 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 26' ' ' THR . . . 177.31 -158.36 23.8 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.489 ' HB2' ' CG1' ' A' ' 130' ' ' VAL . 16.8 ptm -100.43 173.97 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -1.087 . . . . 0.0 109.102 179.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.767 HG23 ' H ' ' A' ' 62' ' ' ILE . 2.4 tt -148.41 103.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.041 -1.037 . . . . 0.0 110.283 -179.614 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' HA ' ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -99.3 147.26 25.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.866 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.773 ' CG2' HG22 ' A' ' 23' ' ' ILE . 12.6 mt -149.48 167.93 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.021 -1.05 . . . . 0.0 110.868 -178.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 59' ' ' GLU . 66.5 t -137.85 106.46 3.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -70.27 127.53 33.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 109.562 -179.387 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER 45.51 -158.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.235 -0.916 . . . . 0.0 109.37 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.68 82.79 4.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 58' ' ' HIS . . . 142.75 146.09 4.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 57' ' ' GLY . 22.1 t-80 75.2 162.09 0.25 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.644 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.8 pt-20 -170.34 132.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.277 -0.889 . . . . 0.0 109.32 179.843 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.22 138.17 51.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.151 -0.968 . . . . 0.0 109.246 -179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.93 ' C ' HD13 ' A' ' 62' ' ' ILE . 12.1 p90 -123.19 129.1 50.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.093 -179.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -112.64 -146.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.35 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.839 ' CE1' HD12 ' A' ' 84' ' ' ILE . 1.3 t80 -169.98 141.98 2.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.018 . . . . 0.0 109.133 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 pp -142.41 -175.98 4.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.512 -179.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.533 ' O ' ' CA ' ' A' ' 47' ' ' PRO . 23.1 t -117.32 -46.54 2.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 109.519 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.34 -143.93 3.79 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 79' ' ' LEU . . . 116.92 174.55 17.21 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.9 mt -105.06 129.34 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -1.116 . . . . 0.0 109.472 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.965 HD13 ' O ' ' A' ' 69' ' ' LEU . 0.3 OUTLIER -100.56 118.23 36.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.309 -0.869 . . . . 0.0 109.47 -179.898 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.902 ' N ' HD22 ' A' ' 69' ' ' LEU . 15.0 tt0 -122.93 141.48 51.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.128 179.74 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.829 HG11 ' HA ' ' A' ' 40' ' ' PRO . 12.2 p -101.53 150.69 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.733 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.548 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 4.1 mt-30 -137.23 173.83 5.06 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.0 108.87 179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 72' ' ' GLN . 35.7 Cg_endo -78.58 110.12 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.456 2.104 . . . . 0.0 110.669 -179.66 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.514 ' O ' ' CB ' ' A' ' 75' ' ' ASN . . . 69.15 37.73 82.13 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.58 ' CB ' ' HB3' ' A' ' 5' ' ' HIS . 1.5 p30 165.37 162.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.05 -1.265 . . . . 0.0 110.006 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 5' ' ' HIS . 32.8 m -142.34 163.32 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.53 -0.731 . . . . 0.0 109.099 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 7' ' ' ASP . 40.7 m -160.2 132.81 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.056 -1.028 . . . . 0.0 109.742 179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.838 ' CG2' HG23 ' A' ' 8' ' ' VAL . 3.0 m -127.52 153.79 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 109.339 179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' O ' ' CA ' ' A' ' 67' ' ' GLY . 1.2 mp -111.97 121.61 45.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.016 . . . . 0.0 109.763 -179.88 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 10' ' ' SER . . . -133.72 168.41 18.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.178 179.698 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.63 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -126.13 -17.7 5.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 110.133 -179.737 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.2 m -113.22 142.74 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.101 -0.999 . . . . 0.0 109.807 -179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB2' ' HB2' ' A' ' 10' ' ' SER . . . -150.47 132.99 15.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 0.0 109.068 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.839 HD12 ' CE1' ' A' ' 63' ' ' TYR . 57.6 mt -115.29 -40.46 2.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 -179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.426 ' O ' ' C ' ' A' ' 86' ' ' GLY . 7.8 ttp180 69.77 133.91 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.363 -0.835 . . . . 0.0 109.348 -179.815 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.701 ' HA2' HG23 ' A' ' 130' ' ' VAL . . . -41.58 -40.8 3.0 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.823 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 18.3 mt-30 -73.41 -61.94 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.133 -1.216 . . . . 0.0 109.393 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.482 ' HB2' HG22 ' A' ' 84' ' ' ILE . 27.4 t70 62.69 12.83 5.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.842 . . . . 0.0 109.785 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 tp 57.56 38.53 27.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 109.571 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 177.5 159.23 0.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.729 ' CB ' HD11 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -153.19 -50.03 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.064 -1.022 . . . . 0.0 109.855 -179.686 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.32 -32.44 72.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.166 -0.959 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -79.07 -17.49 55.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 109.847 -179.692 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.763 ' HB1' ' OE1' ' A' ' 127' ' ' GLN . . . -90.51 -12.0 38.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -0.914 . . . . 0.0 109.296 179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.695 ' HG2' HD21 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -78.02 -24.12 47.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 -179.941 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.55 -15.03 58.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.569 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.9 87.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.92 -37.19 13.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.408 -0.807 . . . . 0.0 109.724 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.02 -50.89 15.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.965 . . . . 0.0 109.691 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -17.75 14.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 121' ' ' LEU . . . -89.52 -32.25 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.141 -0.975 . . . . 0.0 109.643 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.737 ' O ' HG22 ' A' ' 105' ' ' ILE . 35.4 tp10 -73.99 -27.07 60.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 -35.08 67.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 0.0 109.564 -179.845 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.13 2.47 39.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.685 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 102' ' ' GLU . 1.7 tp -69.52 -19.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.515 -179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.1 p -89.71 -29.39 18.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.672 -179.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.3 m -60.58 92.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.19 -0.943 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 113' ' ' ASP . 10.9 m -162.59 -148.5 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.399 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 113' ' ' ASP . 1.4 t-160 -140.66 -150.16 0.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.973 . . . . 0.0 109.678 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -77.22 0.35 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 112' ' ' VAL . 2.0 m-20 -80.51 177.0 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -1.161 . . . . 0.0 109.726 -179.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 111' ' ' ASP . 10.6 m 41.37 33.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.515 -0.741 . . . . 0.0 109.64 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 51.1 t0 -83.89 -96.78 0.06 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.325 -0.86 . . . . 0.0 109.059 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -66.62 -18.25 65.27 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.36 87.68 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.357 0.599 . . . . 0.0 109.394 179.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 112' ' ' VAL . 22.0 mt-30 -88.41 -16.99 31.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.365 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.626 ' HB1' HD12 ' A' ' 105' ' ' ILE . . . -72.96 -27.14 61.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.82 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.2 t -60.22 -16.6 34.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 123' ' ' LYS . . . -81.69 -61.11 2.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -68.75 -9.02 48.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 0.0 109.642 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD22 HD13 ' A' ' 105' ' ' ILE . 11.8 tp -89.12 -60.71 1.88 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.601 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.8 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -78.26 5.65 9.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.877 . . . . 0.0 110.036 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 119' ' ' ALA . 4.1 tttt -73.28 -45.79 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.59 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.08 -6.75 41.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' A' ' 122' ' ' ALA . 2.0 mp -84.73 -14.48 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 109.341 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.646 ' HB3' ' HE2' ' A' ' 63' ' ' TYR . . . -67.15 -32.46 73.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 0.0 109.17 179.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.763 ' OE1' ' HB1' ' A' ' 94' ' ' ALA . 10.8 pt20 -82.5 -29.79 30.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.359 -0.838 . . . . 0.0 109.1 179.752 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.695 HD21 ' HG2' ' A' ' 95' ' ' MET . 0.6 OUTLIER -74.67 -13.31 60.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.4 -0.813 . . . . 0.0 109.374 179.919 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -89.65 -53.74 4.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.59 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.701 HG23 ' HA2' ' A' ' 86' ' ' GLY . 34.4 m -67.77 -27.91 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.72 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.729 HD11 ' CB ' ' A' ' 91' ' ' GLU . 3.8 tt -65.11 -38.35 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.609 -179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.453 ' N ' HG23 ' A' ' 131' ' ' ILE . 4.8 mm-40 -67.23 -8.3 30.67 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.188 -0.945 . . . . 0.0 109.557 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.463 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -86.26 -44.22 12.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.134 -0.979 . . . . 0.0 109.727 -179.843 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.8 t -82.33 -9.55 59.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -55.3 -45.68 76.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.848 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 137' ' ' ALA . 1.3 ptmt -85.75 -16.61 38.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 0.0 109.689 -179.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 136' ' ' LYS . . . -43.78 -39.49 3.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.188 -0.945 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 mtp . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.505 -179.937 . . . . . . . . 0 0 . 1 stop_ save_